<SEC-DOCUMENT>0000711404-22-000053.txt : 20221209
<SEC-HEADER>0000711404-22-000053.hdr.sgml : 20221209
<ACCEPTANCE-DATETIME>20221209161643
ACCESSION NUMBER:		0000711404-22-000053
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		116
CONFORMED PERIOD OF REPORT:	20221031
FILED AS OF DATE:		20221209
DATE AS OF CHANGE:		20221209

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			COOPER COMPANIES, INC.
		CENTRAL INDEX KEY:			0000711404
		STANDARD INDUSTRIAL CLASSIFICATION:	OPHTHALMIC GOODS [3851]
		IRS NUMBER:				942657368
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-08597
		FILM NUMBER:		221454972

	BUSINESS ADDRESS:	
		STREET 1:		6101 BOLLINGER CANYON ROAD
		STREET 2:		SUITE 500
		CITY:			SAN RAMON
		STATE:			CA
		ZIP:			94583
		BUSINESS PHONE:		9254603600

	MAIL ADDRESS:	
		STREET 1:		6101 BOLLINGER CANYON ROAD
		STREET 2:		SUITE 500
		CITY:			SAN RAMON
		STATE:			CA
		ZIP:			94583

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	COOPER COMPANIES INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	COOPERVISION INC
		DATE OF NAME CHANGE:	19870701
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>coo-20221031.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:c1100544-9949-49e4-a84a-324e954b65ab,g:6f410f64-26fc-4654-ba7e-29974b75a0fc,d:fcd99b6df4104f80be938ce77dc8288d--><html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:coo="http://www.coopercos.com/20221031" xmlns:srt="http://fasb.org/srt/2022" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>coo-20221031</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF80L2ZyYWc6YzM5NDkxZWQxZWNiNDM1NmExN2I3NjkzNGZmZTg4YzkvdGFibGU6Y2NkODMzOTYxNzA4NDBlNTk2ZDhlMTlmZTc4OGUxMTMvdGFibGVyYW5nZTpjY2Q4MzM5NjE3MDg0MGU1OTZkOGUxOWZlNzg4ZTExM18yLTEtMS0xLTU4NTM3_dea16023-0511-4f11-89de-7cf79aa954c2">false</ix:nonNumeric><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF80L2ZyYWc6YzM5NDkxZWQxZWNiNDM1NmExN2I3NjkzNGZmZTg4YzkvdGFibGU6Y2NkODMzOTYxNzA4NDBlNTk2ZDhlMTlmZTc4OGUxMTMvdGFibGVyYW5nZTpjY2Q4MzM5NjE3MDg0MGU1OTZkOGUxOWZlNzg4ZTExM18zLTEtMS0xLTU4NTM3_6cb2d39d-6041-408e-8daa-253753f84b66">2022</ix:nonNumeric><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF80L2ZyYWc6YzM5NDkxZWQxZWNiNDM1NmExN2I3NjkzNGZmZTg4YzkvdGFibGU6Y2NkODMzOTYxNzA4NDBlNTk2ZDhlMTlmZTc4OGUxMTMvdGFibGVyYW5nZTpjY2Q4MzM5NjE3MDg0MGU1OTZkOGUxOWZlNzg4ZTExM180LTEtMS0xLTU4NTM3_7083212e-fe94-438b-a76d-f4a92e6e7e0c">FY</ix:nonNumeric><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF80L2ZyYWc6YzM5NDkxZWQxZWNiNDM1NmExN2I3NjkzNGZmZTg4YzkvdGFibGU6Y2NkODMzOTYxNzA4NDBlNTk2ZDhlMTlmZTc4OGUxMTMvdGFibGVyYW5nZTpjY2Q4MzM5NjE3MDg0MGU1OTZkOGUxOWZlNzg4ZTExM181LTEtMS0xLTU4NTM3_ac1610bf-fe42-4314-809f-d36589a1ab4d">0000711404</ix:nonNumeric><ix:nonNumeric contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTktMC0xLTEtNTg1Mzc_56db2c71-ed4a-4692-8d61-7c04b7423899">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201613Member</ix:nonNumeric><ix:nonNumeric contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfMi0wLTEtMS01ODUzNw_f2af3d8b-af98-47fa-9e18-c521fd473e5f">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfMi0wLTEtMS01ODUzNw_fafffb75-d216-4f4d-8142-6f0bc8bdcc25">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNC0wLTEtMS01ODUzNw_20f60483-65f4-4940-bd27-ff3038fea748">http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNC0wLTEtMS01ODUzNw_238f6c6d-7462-42ec-bc2d-2f272994dc20">http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNS0wLTEtMS01ODUzNw_cd2a4655-0b1b-4300-89ec-ea2b04899df1">http://www.coopercos.com/20221031#LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNS0wLTEtMS01ODUzNw_efad86ee-3171-4680-acc9-262cd136b6e2">http://www.coopercos.com/20221031#LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" name="us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzQtMC0xLTEtNTg1Mzc_9604cf56-7a6c-46d2-bdf5-d8f031e83daf">http://fasb.org/us-gaap/2022#SellingGeneralAndAdministrativeExpense</ix:nonNumeric><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzQtMC0xLTEtNTg1Mzc_b92a1fd2-f912-44aa-9c7e-af89ec70cb06">http://fasb.org/us-gaap/2022#SellingGeneralAndAdministrativeExpense</ix:nonNumeric><ix:nonNumeric contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzctMC0xLTEtODU4NTc_141e84ec-4e7b-4dbb-a1d9-b69da3b28fc9">http://fasb.org/us-gaap/2022#DebtCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzctMC0xLTEtODU4NTc_47c29b41-9b44-43cc-a1c4-67a03e586316">http://fasb.org/us-gaap/2022#DebtCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzE2LTAtMS0xLTg1ODY1_1411df30-957e-4c30-8c9d-b44d0a42fc69">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations</ix:nonNumeric><ix:nonNumeric contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzE2LTAtMS0xLTg1ODY1_b721c839-4714-4bc4-a058-6a751c018797">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i945bc86fd16b49b48c0754f8f46cd4cc_D20211217-20211217" decimals="3" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xNzkwL2ZyYWc6NWQ0OWIwYjE4NmU3NDFmNmE1YzFkYTU5ZDdjODJjZWMvdGV4dHJlZ2lvbjo1ZDQ5YjBiMTg2ZTc0MWY2YTVjMWRhNTlkN2M4MmNlY180OTQ3ODAyMzI1MzU1_b04d29e5-f2a7-4238-a299-a4ac2bc32024">0.50</ix:nonFraction><ix:nonNumeric contextRef="ic67deac3adaf43fc8e4e0743d905cdbe_D20211101-20221031" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzY3ODM_6bc749ef-684e-4774-a7cb-72940d101aed">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="ib5093ad2403f457e815c9833c4647814_D20211101-20221031" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzc1MjA_66aa3933-ae43-4ccf-b4c9-c3b93a1275c1">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzQtMC0xLTEtNTg1Mzc_111e8ddc-226d-4304-959a-b934b7d622c2">http://www.coopercos.com/20221031#LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzQtMC0xLTEtNTg1Mzc_36ebe715-6c70-4c33-ab4e-77078f30596f">http://www.coopercos.com/20221031#LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzQtMC0xLTEtNTg1Mzc_8ba49eaf-48ae-4cbc-b09c-7e9a7b0ad98d">http://www.coopercos.com/20221031#LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzUtMC0xLTEtNTg1Mzc_07a95161-0974-465a-ac1c-175b72fdb90d">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</ix:nonNumeric><ix:nonNumeric contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzUtMC0xLTEtNTg1Mzc_34fc253a-7253-4b21-920e-c9ce51841c5c">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</ix:nonNumeric><ix:nonNumeric contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzUtMC0xLTEtNTg1Mzc_73a230e2-9634-4eba-833b-aa7156e9f4ce">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</ix:nonNumeric><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzgtMC0xLTEtNTg1Mzc_08e3d8ed-42a7-4cda-a134-26367a3edca1">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</ix:nonNumeric><ix:nonNumeric contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzgtMC0xLTEtNTg1Mzc_40c89b78-ce45-4552-a50e-59b206d64cbd">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</ix:nonNumeric><ix:nonNumeric contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzgtMC0xLTEtNTg1Mzc_c32484f2-1db6-4923-b0d9-5be0212a7130">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="coo-20221031.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i430ebcbddebc425c968858950136be1a_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i944d7fd0de234233b44eb4bcb8fa8987_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i5c6912625915414abeea18d6c508ec80_I20221201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i92626cab45db4a19a73bbd1ffef1f631_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:GenerateLifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9670e8e6c214908bb980ca8b9163492_D20211217-20211217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:GenerateLifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-17</xbrli:startDate><xbrli:endDate>2021-12-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d0f2b3e11b74394ad583fa260d2434b_I20211217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:GenerateLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i893b343911d346c78ad0d7715f7d33d0_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15080967286843b083f296cee9e2bdd7_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic40025e930f74fd19b2ce688c42296d1_I20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:CommonStockExcludingTreasuryStockParNetValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c34808bb01e43038bfe5000593b89e4_I20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebd4ad7541d14f359dbe82c616c0ab00_I20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:TreasuryStockParNetValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i640e2b66e7b443a4a5e3988728a72e3d_I20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4862aa9bb8ef43508c2cc981078ef274_I20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide1724bcbd604d64aec96d6a7f39d61b_I20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cb5a13a16e74334a69daeb5cb71f84c_I20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5167c03ea3ab44e7b464a93ec06fc66e_I20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i538b018151b043f48a11b745f431a4dc_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieafb6aa788314d68858bdce8b8cc9452_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib49675071eae40dfab504de223e18ee9_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:CommonStockExcludingTreasuryStockParNetValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i979761737a724a468a53d50ec7fdc9d4_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81f7068bcd6a4b5092ed7c04a932aa4c_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03991b00df3c49439458880f97362831_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:CommonStockExcludingTreasuryStockParNetValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffb2fe484e3846c9bd0a06b30ea69c83_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29dbc102232c4927bebb87096c5efbd1_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:TreasuryStockParNetValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id99ee9ce8f314279b8ed0d124990935e_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15ff03e12d5e49abb65998853b7f5c15_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9c7c5de6c0d4c81bba6613a87b7c142_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76280949e11f40589848621ccf9e17d7_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae603271d4564d759045232140ef888b_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ff34bac9bd34f02a659325f60bd6946_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92ad3fcf3fa24292a93bc23096208379_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:CommonStockExcludingTreasuryStockParNetValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91a298fab24f46b08cad8c03bf310938_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i813ba48615004049bda2cd1adc7a200f_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a9a9c9f91ca422180b746b351012dba_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10b91becc0cf4d67b8ccd40f10fc6633_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0e07227018a48699fc5b6e0852505fe_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:CommonStockExcludingTreasuryStockParNetValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84e5415a196749599d0e6e0005250229_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ba42cdb4ce44091bf3d217dca29f463_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:TreasuryStockParNetValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33dae8774a9d446da11e92d8456741ad_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1debae85ed14b3aa606b0f2a2bf613a_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fca87f8caea41ba87bb56ee5ee38701_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9c8cbde74104a3982b2d1bdc730d863_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74ee878bb50944f89b4a3dc97d5aec72_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i864fde92b4e34849bbc81ca4a0f19094_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18d6974b69cf479299decdec035def9e_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:CommonStockExcludingTreasuryStockParNetValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb7ea73d4acf4eb7aae210fcfd94fd7a_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9123c64ce444cffba4dda081d73bc13_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia71ce847bd5e4c5989f4eeafd6a550a9_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:CommonStockExcludingTreasuryStockParNetValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i685c57aff67b45abacf0deaf8e923fa0_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27bf67955d844c6798e8e8fa5d42494d_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:TreasuryStockParNetValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2fe242b18cf42e7bc71473cf1d4fa86_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13f3c04d8bda4a5ea3fcba710edd83fb_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc5e797e87ea4a7caf9a6a4e9c552fc7_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb24416eba0042eea28cba51d9346b77_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="business_unit"><xbrli:measure>coo:business_unit</xbrli:measure></xbrli:unit><xbrli:context id="i464c13efabb24917bf19bc8289bce72b_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic23b9b3f6d3c4e14bc47f1dc4aaaf851_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7961f9072dbe43cd94f80a154bca4da3_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic287f5f4035d4d3da007edafaf1a3fa0_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iead04709e17747fe86865c67855d124e_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c4f820f05374f5f815a531d9a560aa7_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c73a0636d374fd6b53feb1438cbe3ff_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if513250ff04c4191b9e9da3d94c6c176_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a3c8a9647004da681ccc361aa33e519_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id75b52051d824284a67f698730bd6d07_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e7e9ff574584a7d870bff7258dbde9e_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b2af60b11694e86bd8e533c1e3014ba_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idabbabf9caaa404aac078818ec07abc5_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib13a9242898a43f9842a944029424ab7_D20220801-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a728882a111429c8b376cccf1bd73ef_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i628a683f9df74396a991320942dabd37_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4377d2468ae64603815ed52f5106831e_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i4755ba4225344dd7b4f9fae0941a7939_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4490227610e34141bead62dd395b0373_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f75554f20cb46aca33f75fa5f6502ee_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9b719bd522e4ee9954e7e380e5d3eeb_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i942ea2bc8344447e8693e560ce6e340b_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i907460a095fa4821a0921af76f91e5e4_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf1a11a6c31f47a18aa6688a9b14bd5b_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i226050fcb98849a48ca2d0868ba5c7bc_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76bc41d306494128a518ecbb65cf02e7_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6adfb3a01e034e82af78c7dad7558f19_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f59291a9d824a74b48fc9ac4fbaead3_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f5ad20d5b9a49469f369636c87ebb17_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f19b0d477094c1d871e211e7657ece7_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieba1d7a126cf491983e2cc68fca1e7ab_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94797e6c57ca4c538683063a5cffce19_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a09f770943a476f971ff4bc25761545_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8955c25df4054801abf90c55eec9954c_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad97efcffb85427888b5504029d82982_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12e4f0e0cd4a46a0bf59c1a45e99906c_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:CookMedicalsReproductiveHealthBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic10ee393b7e044b093750ebeec1f6c8a_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="coo:BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis">coo:PayablesSecondInstallmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:CookMedicalsReproductiveHealthBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7818a8cacc84e89aa1d06e47767b0bc_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="coo:BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis">coo:PayablesThirdInstallmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:CookMedicalsReproductiveHealthBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fec09130d504bee8c893a02191e8224_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:CookMedicalsReproductiveHealthBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="coo:BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis">coo:PayablesFirstInstallmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b34bc1e1b3d46e09f4bc621ba4b91f4_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="coo:BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis">coo:PayablesFourthInstallmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:CookMedicalsReproductiveHealthBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:GenerateLifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f3295cb8a9341809bbb733c539b6249_D20211217-20211217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:GenerateLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanFacility2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-17</xbrli:startDate><xbrli:endDate>2021-12-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefe968cac09746bc97e9dc95581ecbbd_I20211217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:GenerateLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e939ba156464566a17cd5b1cde99696_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:GenerateLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic738218133bd484dabc79502af59dec3_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:GenerateLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3211f44a486b4d46a6d52e32c86746c2_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:GenerateLifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99d2bd9111f1487a8c7a382f53e39f32_I20210201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="coo:AssetAquisitionAxis">coo:PrivatelyHeldMedicalDeviceCompanyDevelopedMaraWaterVaporAblationSystemMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic28dd8b3e9104664aab70f457f386c99_I20210119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cdebe36232d41e6a395e5517f2650a0_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie874cf747ecd4b75835fe8d98669733f_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i369447ccf1304ac393c75433b2da8574_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic12ec65ec7b84054a21489d444adacc6_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e049c53ca9040a0b53609d89212a62b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">coo:SightGlassVisionIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e7cdc32ae2445039739777ea8b26dae_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">coo:EssilorInternationalSASMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a591cbb772f491288113182f88e2c51_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="reporting_unit"><xbrli:measure>coo:reporting_unit</xbrli:measure></xbrli:unit><xbrli:context id="idd2d0c2eeead43aab5ae86328389cce3_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7331fcd87a2241c0b7dfa12a4cdaa7b3_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i144fdaeefe67410baf1810389c09a562_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaeae5667d45b495b88915bbc72c256cd_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3421ee2f74cd428aa2c026d3ac5f1798_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i445d23b2879040a09a5d53dc620f8b08_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfbfa01dbda3465490aba1443bc5a27e_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebeef7c0d08c42438b2be3731f602914_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c3cf741cce74b56b90505abfc3135d4_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30ee62456f6841a38e22988758ba7ea5_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">coo:CompositeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i407ff2a6ca46463ea28d8844c283b1d7_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">coo:CompositeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d0efd8be16c45d2873b2c8fa83fee18_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">coo:CompositeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77b415e656bc4ea68b948eb7f695456d_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1433809bee9a4008bf8d115c1d460826_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2afa4e343dd4305a9d4850614554f7e_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i115d9ee442ae4c56a41f07744f19fbc4_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08f13a8230854e86893bff6282ab94ac_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i878f78528c3f40cd99f777c89d5d2e00_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia510700702624ebfb92ea3d3b9bb1934_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">coo:LicenseAndDistributionRightsAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b16c8a519f143b9a35f452e86b54283_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">coo:LicenseAndDistributionRightsAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf516f29728c49ea8d13657c5e377a8e_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">coo:LicenseAndDistributionRightsAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4917c3481374f0a93818dc20a45502a_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">coo:OverdraftAndOtherCreditFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b0fe802f23047fd86412c4b0a12e7f4_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">coo:OverdraftAndOtherCreditFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ab931d901624913a0875c155dd2c744_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">coo:TermLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57b61e00e7774e95a89c8142b3bf5838_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">coo:TermLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9659d4a6cff4b4dbd9b2f26ba14ea06_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fad6966df8143e8a4914f53e33375a2_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55a407bf120641c6a3267ea45f9bc655_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b694e0c04a748c58139e1321f99fd2a_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c45cfe81e384f56bae429ccfb71c2ec_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">coo:OtherDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18d4ac0f0b1a4888ac43f875e832794d_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">coo:OtherDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifca29665c5264825877b7058a88003d2_I20211217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanFacility2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id51c61469fa640639cd76808539e31f4_D20211217-20211217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanFacility2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-17</xbrli:startDate><xbrli:endDate>2021-12-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b809e82e20145e888d01efebc590393_D20211217-20211217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanFacility2021BaseRateLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-17</xbrli:startDate><xbrli:endDate>2021-12-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53ffe4696c6f4b47b2e4b518a1cf3c2a_D20211217-20211217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanFacility2021AdjustedLIBORateLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-17</xbrli:startDate><xbrli:endDate>2021-12-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a01079f97ba4d5783870ec5bc57cdca_D20211217-20211217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanFacility2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-17</xbrli:startDate><xbrli:endDate>2021-12-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifffdb3949fef4f5385e7019378e75442_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanFacility2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i228f4290d6fd4f95876b3825317e8cd3_D20211102-20211102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">coo:TermLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanAgreement2021364DayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-02</xbrli:startDate><xbrli:endDate>2021-11-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia94dc74dbbad4a8d9eb7e9f6962a812c_I20211102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">coo:TermLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanAgreement2021364DayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfb7453c47b34db1bb9c7e36494babea_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">coo:TermLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanAgreement2021364DayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i227390cb7d3741d68bbf2a306e8d317d_D20211102-20211102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">coo:TermLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanAgreement2021364DayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-02</xbrli:startDate><xbrli:endDate>2021-11-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia014d234e2444dd4bb45dd43ef342980_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e590effe8254728b5dd3d8a3dd2c200_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">coo:TermLoanFacility2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc00728eabe64bf9abfe0f08253a79f6_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">coo:TermLoanFacility2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91b88612cab0454c851fa2d99d1c3fd4_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99285324fc244ac586029dfa2f4f68a8_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">coo:RevolvingCreditFacilityAndTermLoanFacility2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9500e33949584e7fba3a70a9736253fa_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">coo:RevolvingCreditFacilityAndTermLoanFacility2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e8360d369424d82ba580ad6e272eaf1_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">coo:RevolvingCreditFacilityAndTermLoanFacility2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5ae1b08f4874f7aa187763d59539a86_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">coo:RevolvingCreditFacilityAndTermLoanFacility2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib107e383db7648e0a06edb90e19e4ed9_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">coo:RevolvingCreditFacilityAndTermLoanFacility2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b1692dde0d0413fa5ee769ae29445c9_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d7d408231a140f9950399b4dc433531_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d41f939e43e4627b5b87dc3739b80c0_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">coo:TermLoanFacility2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29e6d6b4446144a4b28b291aa1417e38_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20f77777d3384f55a365a87853e42b20_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:EuropeanCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43df8cc9f4d3428b869e34da6854f047_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:EuropeanCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cb922e3a6634ae5b78e0db7ecf40f80_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:AsianPacificCreditFacilitiesYenDenominatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3dec29ada164a17b0ecfcff9b29d05d_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:AsianPacificCreditFacilitiesYenDenominatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i945bc86fd16b49b48c0754f8f46cd4cc_D20211217-20211217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanFacility2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-17</xbrli:startDate><xbrli:endDate>2021-12-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia18ddf672b66483baceea8655de8da4b_I20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a8c7e344a6d4ca6aa5bbb5af896bb9a_D20210501-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fdb5f114ab64b349676d31f17804de9_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fec0e4443b8407cbcb12c6d06cf6eaa_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i735d9bf4f5c64cc190f684cf557f76ac_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9037379de7ad40cb960f5f67523ae233_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i994f6d46a07848c48bb5f57d06e47f95_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60a5f62358f3456f94c7622fcccd1de1_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b52a596f80946beb247cfd6e8e457d0_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e5449ed4ace4f148ff5db6afd1d1441_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2a66fe928654ff892f449b28dccbcea_I20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4939e43dc1c44e3c84ba8a60db483c8f_I20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i767587fb433c468584f3f7356b9737e4_I20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic33f40436aa045c7a3aa5a02afaafef0_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac86d4da8948474188bad8e7f5a66f87_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1ce184d806940dc9e3ac0e3283e5a05_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i984b27946ae74a7a86ccd23408d602d5_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2b158c1317d4810ba6145502cf9fa62_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia689d6db1dcf416ba5f2200ae5e5f4b5_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib785f9fe0b6f449a807bde4146343b94_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57f3229c828a483a94464d9bda7f0fc2_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65542b1a9cb447ac8968bcb17317427b_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd134a9b985a4f77a31f6656483a2e78_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d514c5d060040099cd2656f450fc3e6_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf2ee51bda7b413c809c36bd987d5e20_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6d7c5e2927b491cb9d48756d4126817_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i105b86b96182466c89e084e2d8117b5e_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9244242144c45aa9048eeaa500730b3_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d0f42512b5a468fa0175b728ddf3071_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27afd0c9af1c4f46a1ee89390596bd3b_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbc93be7f95b42e8959f15b98f6e9285_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26915257e03c4b6fbdd14345564b2a64_I20111231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2011-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00964b16a5864689921a5cd1f5431741_I20170331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaaeec49689584b009b3148ed2f1bb819_D20160301-20160331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-03-01</xbrli:startDate><xbrli:endDate>2016-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="director"><xbrli:measure>coo:director</xbrli:measure></xbrli:unit><xbrli:context id="ic2850480bc384efa8b688e7df1dd278a_I20160331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a96f2cd61fa40c1b78c32485036c8cf_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia678a09e2bb14a1d80e45900f2d335b2_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34c6e3ecdc714534b64a27e81133d571_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3c66c33e415421ca03a2aadddb8dbaa_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60fe14742746448cac80ed3337c5356e_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74e4fb1d833e4139a5e462dc894a6a8c_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e7be87b88184c459d07d5e3a87d0602_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5316f98d06b94776b210ad2c61336af0_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadbfb62be93b49f19b18d5333619cf75_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib43f171b08e2457494485fe6afa22232_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14f3575ceef54408bd5ad9d8562d1bb6_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53613739fd6240a4ade0fbe47617e606_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bf32de8054e4d5cb01fb90b42cafafc_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36efa04f987e49038157484c638ab7d6_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27ec16ba40e149c58fa3c4003f0419fa_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f3a691bb67a4ed98d8c94bd5d067867_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic67deac3adaf43fc8e4e0743d905cdbe_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a6b156ffce448468a38a7cb9a9f5284_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45529f605588475bb1f13e0535eaa215_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:DirectorsPlan2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5093ad2403f457e815c9833c4647814_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27a4fb29e4284efe98e1175e5c0e2891_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e988aefd55b4136aafbe1e6601e0d10_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57f5c7d0d50a48669bf760069cb4c005_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55102374da8b426cb0c7d8637de24dc2_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8553c50d62874816b3cf637114eb13b1_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i419dcfba3297431ba7f0c26398d2e903_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb72813cd59747189c7d292f82b5c7d5_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf39cdcb16094b55b8a7d809ab1a25b6_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i342792221366432e9408d5dc0256f8b3_D20190318-20190318"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-18</xbrli:startDate><xbrli:endDate>2019-03-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9037d5644ce4d68b1a7e215ab8301e5_I20190318"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4291f2db677e4d3aa394368650faea88_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a09d9736b484620af2ea6732aa8cf6f_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b2d744fbde74052be31c86e76d32cdb_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63cbbcb6c872410eb8569b17394ff5b7_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">coo:ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i624452a49f29415dbd617b4589408c5a_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">coo:ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81df2e32936447de9004b3e72091ab2b_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">coo:ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0436b7aab9ec44818925071f5beef55c_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">coo:ChangeInAssumptionsForDefinedBenefitPlansChangeInAssumedPaymentFormElectionProbabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e6b59d888914091a12f486903db9b8f_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">coo:ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a4fc69a1c8544d984b2860446a8cc59_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7fe4c21857c4580a2bb918c4d443e6c_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35a7d060cc03406aa06d6d2e52af7aa8_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f8e8579bd9f4de1bc128c354594f563_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquityFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i334d9d36817a404198eaa63d441b7876_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquityFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b597c9875e84d9dbaa5078086f54163_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquityFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a8c5a86d4af47dd80e81eee5d90e1df_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id997ec317814462ba72540f4ef32a2a3_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c1611da45144b90bea4e31bcb16786b_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26a8e3f73198439181c7db0f9541574a_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">coo:BondMutualFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03153ed49cfc47abba8d0d3108d50a1f_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">coo:BondMutualFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i986cc010c8c04831b70f7128a9b44c17_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">coo:BondMutualFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib85025a9deaf4843aee211787d365a16_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c51826bf4c24060b6544fe06a5f0acc_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c61c0e5f7d448f083a8214f4affcc5d_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c6597a1b5d9405b8074c5402317fb16_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab1f3fcc011d42c9b46e9e09fd09d128_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb7d578f2c5c4230b76ef6494dab18ee_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquityFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e74d409e85a41d5a2c110a4229eb2bc_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquityFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib60d652edf684fe681874a2a2fa83fa0_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquityFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e523df95698455d89c863a25a39cc0a_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9478c54d56244163bd2004c364491b0a_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64acac4cceb34e55a9056341c5bb4477_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50b1c25ad93b40649c4bcf9197d4e9d0_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">coo:BondMutualFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5edcbbc801c346c28e2c94d9e4d8c524_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">coo:BondMutualFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f08d2ac862b4de1a91c5b0e239533aa_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">coo:BondMutualFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a330158da9f4490afbea9f2a383c0cc_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bcdee130e56454594be5def8b90a9e9_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffb0171583b6494dbb6fea0de231f654_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>coo:segment</xbrli:measure></xbrli:unit><xbrli:context id="i25cde43e219544f999a9522e40885def_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:ToricLensMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc3c52f498cc45aea41930decf8ee38f_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:ToricLensMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia253e12523d043d49f3b05b362ac4db3_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:ToricLensMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d10aa172f4241199dca5d1ca8ce9dc3_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:MultifocalLensMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85d55c68caa34e448ff17017cfacbd34_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:MultifocalLensMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc783e59e8564dc5a184e25dc3297b9e_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:MultifocalLensMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccd45949f93e4f0d856a82cc74ad6f30_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:SingleUseSphereLensMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib621e690024248a09198dea9ac20e44d_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:SingleUseSphereLensMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8bb2845023f4ba69135007f32f07bfd_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:SingleUseSphereLensMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib70d98549d8f495a9abc9b2d97f90135_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:NonSingleUseSphereAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8072fe66c6ab44ba885a43c3d95061e4_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:NonSingleUseSphereAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae8aae422ef74e84b2422bd0e0d79312_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:NonSingleUseSphereAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i102f306f3b6e41189c2e3d4c415079d8_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9d6919196ca46a88ce3671aa7019026_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9dd5db5ac5f0464c9c4532ca81435932_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:OfficeAndSurgicalProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if06952d7a77e4c6d9f9444b9a19fa7aa_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:OfficeAndSurgicalProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6ed314c0ed34367adef4b03b91bf0e0_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:OfficeAndSurgicalProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25dfc4b265ed4288baedea76cb9d2444_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:FertilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51cce661b93d48838c95d5583bafe501_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:FertilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i309196da87d847b0b037f6d29c6d95e8_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:FertilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb221ec949be4a1a87f43dd831ca8d8c_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibca59e6c981d48c5a555d3d4902818d1_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bc30f40f79641898ba6c790c0142777_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6eec52445a764506b37023f966f522cd_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i114133db3f4f46f0be519e2bb98d778d_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if236740745ec431d90e33cfc8a948539_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e7e37cad2a94f059cebebab71490b56_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0a609362bee4d6c9058db39abefa7dc_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1636568fa5e84bdabf27c057ce6618aa_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7703e214bc54be8bcb93e4d048e2560_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if848d1e35557456494fec2c118fc8064_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5bd3183833a4311ba1940f6e13e8c58_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i706aed7d18eb42adb67c45317cebd9df_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fac46c673ae44a6a51e56072ef333f6_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifda5545cd7a64877bb275e348b90dff5_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i949cdb7296c2413c8bd74737698ae04c_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i936768573f894f27889c7dd715937761_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib167cd4900e94a9d8cbe4bf12709f074_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2fed7da6fdf4c2d84c04555713219a8_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4195fe02b707490a8d61b963c66350fa_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2772f61aefe64ddbba24fc95a9137207_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1c3c38f11c44e2da46bd9a800f94386_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i203ba6d20b6f4590bfc5a2c49c100182_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ca5a267e7864693ae8d23449d787c29_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib878f9b3ae04474a863b123b65f168ab_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbf6d52286234783b4187fc8c1b84be2_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie853cb4e9b8e4c04b1094493101d98a5_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i872ddcd0dec342a68a42c53d1feac123_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b2584e8265f4b1eb31b69d99591c665_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">coo:CorporateReconcilingItemsAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if091820da3fa469ca8e63a4e7e623ebb_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idee380fa4cc94aa2949150146bc1b833_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98cba8f6abe845659e16156082ad2d25_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">coo:CorporateReconcilingItemsAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9a9fbd6fa9745abbc18a527935e6729_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24ed2c06038c4e21a954497f6fc03687_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i632fce02d0a14ee2a54b08cb02f4a530_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5472d5f5ea1840df9d91ec3db5081155_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d31ba7c78554e01be3531b7db972065_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ac8281323054a3383ab48d0fa752407_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5e3fde5895f43fba4395a3f2a394105_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie429681883c245819521a0c57f11ffa7_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89ef065c99254e85b8c2f8427f8cc1cf_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">coo:CorporateReconcilingItemsAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11563134ef8a45bda7a59afedae161f7_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib09f048a3bb546ec9d3d473f3290ba4b_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if12e23677c7d4f59bf1b6b56f97c0a96_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">coo:CorporateReconcilingItemsAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3982025069c42019719d3ae187bfac5_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d212cf3f853423d91d402573665e3a3_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3a74826cb834e35868ee80db8fd1abf_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00b1d9c5ee034b9c8a36252aa25fa6a0_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec65f950a0dc4854914e26a734104e19_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1599f6e5dec74f248141c4cf3566bf65_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3910c6d00f04f0abdb3fbfd16d3e64e_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia32d9258c18848e5abfe9c919bc12cfe_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i750be365ff0047e49e7f299808203d52_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">coo:CorporateReconcilingItemsAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81cc03f2a4a74c3986074b3bee49852f_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92fdd7459bad4408a8a71b8370a03266_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04406ea9810f4b8190f8776aa444ef9f_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">coo:CorporateReconcilingItemsAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9149d6cbeb354638969dcb45da4ca29a_I20200406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="interest_rate_swap_contract"><xbrli:measure>coo:interest_rate_swap_contract</xbrli:measure></xbrli:unit><xbrli:context id="ib93ee62619474af5844402d5b5e2fc5e_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i306e8ebbe94442a5b09f45b81f9f9362_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib09f9a58a78443b18bed2336686e605e_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18b387b0bc824160a72bc4a7fa134526_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc574a9b39cc4fd0b3d2a6b2e338dea8_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1dda5d68145148858749f4a3d0187b10_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2357db2168d54d15b89a15c1f04fcf81_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i007a38e974f04b6fa9067c5041cfd72b_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea2aa42170064029a14838912d3185ac_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedb5b89d45e54e028ef271a4be6338b8_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a10babdc03d448fb7f6f049b019e92b_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9b7be6dd72e444c91e43d8ed9b4980b_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92f0a4209532457b97330c2599af126b_D20201101-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b0bc537a9784c479a6e47674c4a3455_I20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb1e445d83e7435f82ac0109d212736a_D20191101-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000711404</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ifcd99b6df4104f80be938ce77dc8288d_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">________________________</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:90%">FORM <ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDgw_f65d1ff4-b667-4bde-a27a-ffc458cee7dd">10-K</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">________________________</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:2.276%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.524%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGFibGU6N2VhZmU0ZDhlYmQzNDkyZDg1NmI3ZjI5Mjg2ZmY2ZTQvdGFibGVyYW5nZTo3ZWFmZTRkOGViZDM0OTJkODU2YjdmMjkyODZmZjZlNF8wLTAtMS0xLTU4NTM3_e4b5e514-c8fa-4fd9-bf6d-4b490c8cbaf8">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE FISCAL YEAR ENDED <ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18xNjk_f04c0670-9baf-4e8a-8e31-bc84a36749a5"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18xNjk_c003a6b2-66cd-49ac-b489-b1661d1b2a63">OCTOBER 31</ix:nonNumeric>, 2022</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:2.276%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.524%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGFibGU6ZjhhODJjODE4MjIyNDY1MWExYzY5MzZiZjE4ZjVhOTcvdGFibGVyYW5nZTpmOGE4MmM4MTgyMjI0NjUxYTFjNjkzNmJmMThmNWE5N18wLTAtMS0xLTU4NTM3_a30a444d-0eb2-465f-ad40-babf1a953e65">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE TRANSITION PERIOD FROM       TO</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">COMMISSION FILE NO. <ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDY3_bbb3ed75-d0b2-45f7-b6b9-adbd1ca8bc68">001-08597</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">________________________</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:90%"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDcz_f3600aa4-e629-45fc-bdb9-626b87fe2f68">THE COOPER COMPANIES, INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">________________________</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.215%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGFibGU6YWQ0NmQyYjY0MjI1NDYzMThmMGZmYzk2OGFiYmQxNjQvdGFibGVyYW5nZTphZDQ2ZDJiNjQyMjU0NjMxOGYwZmZjOTY4YWJiZDE2NF8wLTAtMS0xLTU4NTM3_86d7741b-fcf5-4093-8cd1-eb957a4b15a8">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGFibGU6YWQ0NmQyYjY0MjI1NDYzMThmMGZmYzk2OGFiYmQxNjQvdGFibGVyYW5nZTphZDQ2ZDJiNjQyMjU0NjMxOGYwZmZjOTY4YWJiZDE2NF8wLTEtMS0xLTU4NTM3_107c6ae1-c0a9-495e-826c-082c902c50b5">94-2657368</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDc0_fc4895fd-7762-4d02-910f-b2690b923a52">6101 Bollinger Canyon Road</ix:nonNumeric>,</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> <ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDc1_577bd5cc-f94e-4267-958d-956d9e55f895">Suite 500</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDgx_c33ca152-dbd3-4c01-9038-7727285c1c2e">San Ramon</ix:nonNumeric>, <ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDY4_e81ca4f9-f58a-4230-8d49-8c9e98144600">California</ix:nonNumeric>, <ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDc2_f5aa0416-dd33-41d4-bddf-1039e5a79cf6">94583</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices) (Zip Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(<ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDgy_1bbaad5c-ae85-4033-8cbc-51fc23d4089d">925</ix:nonNumeric>) <ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDgz_2cf00e3f-685f-4169-833a-a8ca048ade7e">460-3600</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">________________________</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"></td><td style="width:32.877%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.058%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGFibGU6YmIxYzA0MmQ5N2I3NDE3Y2JkZTA0ZGIzOWIxMjE3Y2QvdGFibGVyYW5nZTpiYjFjMDQyZDk3Yjc0MTdjYmRlMDRkYjM5YjEyMTdjZF8xLTAtMS0xLTU4NTM3_a02b6fd3-e970-4d37-b1dd-b7da86058683">Common Stock, $.10 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGFibGU6YmIxYzA0MmQ5N2I3NDE3Y2JkZTA0ZGIzOWIxMjE3Y2QvdGFibGVyYW5nZTpiYjFjMDQyZDk3Yjc0MTdjYmRlMDRkYjM5YjEyMTdjZF8xLTItMS0xLTU4NTM3_8447f10f-9755-4865-9633-567b0894686e">COO</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGFibGU6YmIxYzA0MmQ5N2I3NDE3Y2JkZTA0ZGIzOWIxMjE3Y2QvdGFibGVyYW5nZTpiYjFjMDQyZDk3Yjc0MTdjYmRlMDRkYjM5YjEyMTdjZF8xLTQtMS0xLTU4NTM3_3ea30890-6c23-4d0e-ac27-13d8588aef38">The New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Securities registered pursuant to Section&#160;12(g) of the Act:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> None</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">________________________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDc3_4f777701-fabf-48f7-b655-f1348f3ce5d4">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d) of the Act.&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; <ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDg0_f28f36ef-5f3b-4e78-99ea-10d9caf74ab4">No</ix:nonNumeric>&#160;&#160; </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDcx_73a56202-ff1f-4052-aaba-60e59bdd980b">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  &#160;&#160;&#160;No  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDYz_93da0be6-6fdc-4580-bb71-f91160b723cf">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  &#160;&#160;&#160;No  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company. See definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   <ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDY5_77498162-0529-43b8-9c13-232ac6cbf2b9">Large accelerated filer</ix:nonNumeric> &#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">     Accelerated filer  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;    Non-accelerated filer  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;    Smaller reporting company  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDcy_ff345cbc-9808-4277-9da2-435bdf5b04d2">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   Emerging growth company </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDY0_e31b6ee3-41ea-4d7b-a13d-f943476b7dee">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;                                                    </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDcw_0656a9ca-086b-427d-aa02-4a267da4b6b1">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   &#160;&#160;&#160;No  &#9744;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160; No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDY1_b76b0e45-5905-48fc-9e2a-3ecde529feb1">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The aggregate market value of shares held by non-affiliates was $<ix:nonFraction unitRef="usd" contextRef="i944d7fd0de234233b44eb4bcb8fa8987_I20220430" decimals="-8" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zMTU3_a1654248-6815-49f1-b8be-01af24583bb1">17.7</ix:nonFraction> billion based on the closing price of the registrant&#8217;s common stock on the New York Stock Exchange on April 30, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Number of shares outstanding of the registrant's common stock, as of December 1, 2022: <ix:nonFraction unitRef="shares" contextRef="i5c6912625915414abeea18d6c508ec80_I20221201" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDE4_d20628ca-b73f-48c2-97d7-4c01cb81b272">49,354,384</ix:nonFraction></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Documents Incorporated by Reference:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDY2_e6f7c8b7-3b3f-406f-aac0-4d39b8b7d91f" escape="true"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.343%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Document</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Part of Form 10-K</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Portions of the Proxy Statement for the Annual Meeting<br/>of Stockholders scheduled to be held in March 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Part&#160;III</span></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our independent registered public accounting firm is <ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18xMDk5NTExNjMxNTE3_077f5627-3202-4c5a-8c13-23d97ab192e8">KPMG LLP</ix:nonNumeric>, <ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18xMDk5NTExNjMxNTE2_2de8332c-83ab-4932-9fc3-6fb892e41b64">San Francisco, CA</ix:nonNumeric>, Auditor ID: <ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18xMDk5NTExNjMxNTEy_ff760178-1457-4579-a38e-fe7bbd9cd7e8">185</ix:nonNumeric>.</span></div></ix:nonNumeric><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ifcd99b6df4104f80be938ce77dc8288d_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Annual Report on Form 10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">for the Fiscal Year Ended October&#160;31, 2022 </span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Table of Contents</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">PART&#160;I</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Business</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifcd99b6df4104f80be938ce77dc8288d_16">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Risk Factors</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifcd99b6df4104f80be938ce77dc8288d_19">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Unresolved Staff Comments</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifcd99b6df4104f80be938ce77dc8288d_22">49</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Properties</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifcd99b6df4104f80be938ce77dc8288d_25">50</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Legal Proceedings</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifcd99b6df4104f80be938ce77dc8288d_28">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 4. </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mine Safety Disclosures</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifcd99b6df4104f80be938ce77dc8288d_31">51</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">PART II</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifcd99b6df4104f80be938ce77dc8288d_37">52</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Reserved</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifcd99b6df4104f80be938ce77dc8288d_46">53</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Management's Discussion and Analysis of Financial Condition and Results of Operations</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifcd99b6df4104f80be938ce77dc8288d_49">54</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Quantitative and Qualitative Disclosure about Market Risk</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifcd99b6df4104f80be938ce77dc8288d_67">65</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Financial Statements and Supplementary Data</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifcd99b6df4104f80be938ce77dc8288d_70">66</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifcd99b6df4104f80be938ce77dc8288d_139">103</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Controls and Procedures</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifcd99b6df4104f80be938ce77dc8288d_142">103</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other Information</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifcd99b6df4104f80be938ce77dc8288d_145">103</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 9C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifcd99b6df4104f80be938ce77dc8288d_148">103</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">PART III</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Directors, Executive Officers and Corporate Governance</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifcd99b6df4104f80be938ce77dc8288d_154">104</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Executive Compensation</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifcd99b6df4104f80be938ce77dc8288d_157">104</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifcd99b6df4104f80be938ce77dc8288d_160">104</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Certain Relationships and Related Transactions, and Director Independence</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifcd99b6df4104f80be938ce77dc8288d_163">104</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Principal Accounting Fees and Services</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifcd99b6df4104f80be938ce77dc8288d_166">104</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">PART IV</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Exhibits and Financial Statement Schedules</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifcd99b6df4104f80be938ce77dc8288d_172">105</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Item 16.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Form 10-K Summary</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifcd99b6df4104f80be938ce77dc8288d_181">109</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ifcd99b6df4104f80be938ce77dc8288d_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">PART I</span></div><div><span><br/></span></div><div id="ifcd99b6df4104f80be938ce77dc8288d_13"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">This Annual Report on Form 10-K contains &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. These include statements relating to plans, prospects, goals, strategies, future actions, events or performance and other statements which are other than statements of historical fact, including: statements regarding the expected impact of global macroeconomic conditions, the COVID-19 pandemic and the war in Ukraine on our business; and statements regarding acquisitions (including the acquired companies' financial position, market position, product development and business strategy, expected cost synergies, expected timing and benefits of the transaction, difficulties in integrating entities or operations, as well as estimates of our and the acquired entities' future expenses, sales and earnings per share) that are forward-looking. In addition, all statements regarding anticipated growth in our net sales, anticipated effects of any product recalls, anticipated market conditions, planned product launches and expected results of operations and integration of any acquisition are forward-looking. To identify these statements, look for words like &#8220;believes,&#8221; &#8220;outlook,&#8221; &#8220;probable,&#8221; &#8220;expects,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;seeks,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;estimates&#8221; or &#8220;anticipates&#8221; and similar words or phrases. Forward-looking statements necessarily depend on assumptions, data or methods that may be incorrect or imprecise and are subject to risks and uncertainties. Among the factors that could cause our actual results and future actions to differ materially from those described in forward-looking statements are those described in our Securities and Exchange Commission filings, including the &#8220;Business,&#8221; &#8220;Risk Factors&#8221; and &#8220;Management's Discussion and Analysis of Financial Condition and Results of Operations&#8221; sections in this Annual Report on Form 10-K for the fiscal year ended October&#160;31, 2022, as such Risk Factors may be updated in quarterly filings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We caution investors that forward-looking statements reflect our analysis only on their stated date. We disclaim any intent to update them except as required by law.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Summary Risk Factors</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our business faces significant risks. In addition to the summary below, you should carefully review the &#8220;Risk Factors&#8221; section of this Annual Report on Form 10-K. We may be subject to additional risks and uncertainties not presently known to us or that we currently deem immaterial. Our business, financial condition and results of operations could be materially adversely affected by any of these risks, and the trading prices of our common stock could decline by virtue of these risks. These risks should be read in conjunction with the other information in this report. Some of the more significant risks relating to our business include:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Adverse changes in the global or regional general business, political and economic conditions, including the impact of continuing uncertainty and instability of certain countries, that could adversely affect our global markets, and the potential adverse economic impact and related uncertainty caused by these items, including but not limited to, the COVID-19 pandemic, inflation and escalating global trade barriers.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">The effects of the COVID-19 pandemic and related economic disruptions and new governmental regulations on our business, results of operations, cash flow and financial condition, including but not limited to the potential impact on our sales, operations and supply chain.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">The impact of Russia's invasion of Ukraine and the global response to this invasion on the global economy, European economy, financial markets, energy markets, currency rates and our ability to supply product to, or through, affected countries.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Foreign currency exchange rate and interest rate fluctuations including the risk of fluctuations in the value of foreign currencies or interest rates that would decrease our net sales and earnings.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Our existing and future variable rate indebtedness and associated interest expense is impacted by rate increases, which could adversely affect our financial health or limit our ability to borrow additional funds.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%;padding-left:32.68pt">Changes in tax laws, examinations by tax authorities, and changes in our geographic composition of income. </span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Acquisition-related adverse effects including the failure to successfully achieve the anticipated net sales, margins and earnings benefits of acquisitions, integration delays or costs and the requirement to record significant adjustments to the preliminary fair value of assets acquired and liabilities assumed within the measurement period, required regulatory approvals for an acquisition not being obtained or being delayed or subject to conditions that are not anticipated, adverse impacts of changes to accounting controls and reporting procedures, contingent liabilities or indemnification obligations, increased leverage and lack of access to available financing (including financing for the acquisition or refinancing of debt owed by us on a timely basis and on reasonable terms).</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Compliance costs and potential liability in connection with U.S. and foreign laws and health care regulations pertaining to privacy and security of personal information, such as HIPAA and the California Consumer Privacy Act (CCPA) in the U.S. and the General Data Protection Regulation (GDPR) requirements in Europe, including but not limited to those resulting from data security breaches.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">A major disruption in the operations of our manufacturing, accounting and financial reporting, research and development, distribution facilities or raw material supply chain due to the COVID-19 pandemic, integration of acquisitions, man-made or natural disasters, cybersecurity incidents or other causes.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">A major disruption in the operations of our manufacturing, accounting and financial reporting, research and development or distribution facilities due to technological problems, including any related to our information systems maintenance, enhancements or new system deployments, integrations or upgrades.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Market consolidation of large customers globally through mergers or acquisitions resulting in a larger proportion or concentration of our business being derived from fewer customers.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Disruptions in supplies of raw materials, particularly components used to manufacture our silicone hydrogel lenses.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">New U.S. and foreign government laws and regulations, and changes in existing laws, regulations and enforcement guidance, which affect areas of our operations including, but not limited to, those affecting the health care industry, including the contact lens industry specifically and the medical device or pharmaceutical industries generally, including but not limited to the EU Medical Devices Regulation (MDR) and the EU In Vitro Diagnostic Medical Devices Regulation (IVDR).</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Legal costs, insurance expenses, settlement costs and the risk of an adverse decision, prohibitive injunction or settlement related to product liability, patent infringement or other litigation.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Limitations on sales following product introductions due to poor market acceptance.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">New competitors, product innovations or technologies, including but not limited to, technological advances by competitors, new products and patents attained by competitors, and competitors' expansion through acquisitions.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Reduced sales, loss of customers and costs and expenses related to product recalls and warning letters.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Failure to receive, or delays in receiving, regulatory approvals or certifications for products.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Failure of our customers and end users to obtain adequate coverage and reimbursement from third-party payors for our products and services.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">The requirement to provide for a significant liability or to write off, or accelerate depreciation on, a significant asset, including goodwill, other intangible assets and idle manufacturing facilities and equipment.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">The success of our research and development activities and other start-up projects.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Dilution to earnings per share from acquisitions or issuing stock.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Impact and costs incurred from changes in&#160;accounting&#160;standards and policies.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Risks related to environmental, social and corporate governance (ESG) issues, including those related to climate change and sustainability.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="ifcd99b6df4104f80be938ce77dc8288d_16"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">. Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Cooper Companies, Inc. (Cooper, we or the Company), a Delaware corporation organized in 1980, is a global medical device company publicly traded on the NYSE (NYSE: COO). Cooper operates through two business units, CooperVision and CooperSurgical. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">CooperVision is a global manufacturer providing products for contact lens wearers. CooperVision develops, manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. CooperVision designs its products to solve vision challenges such as astigmatism, presbyopia and myopia; with a broad collection of spherical, toric and multifocal contact lenses. CooperVision offers contact lenses in a variety of materials including silicone hydrogel Aquaform&#174; technology and phosphorylcholine technology (PC) Technology&#8482;. CooperVision also manufactures and markets myopia management and specialty eyecare products which it gained through a series of orthokeratology (ortho-k) and scleral lens acquisitions. In November 2019, CooperVision's internally developed MiSight&#174; 1 day lens became first and only approved product by the United States Food and Drug Administration (FDA) for myopia control and is indicated to slow the progression of myopia in children when treatment is initiated between the ages of 8-12. The MiSight 1 day lens became available in the U.S. in fiscal 2020 and in August 2021, CooperVision received Chinese National Medical Products Administration (NMPA) approval for its MiSight</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:112%;position:relative;top:-3.32pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"> 1 day lens for use in China. CooperVision&#8217;s major manufacturing and distribution facilities are located in Belgium, Costa Rica, Hungary, Puerto Rico, the UK and the U.S., with other smaller locations also existing in multiple locations around the world. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">CooperSurgical's business competes in the general health care market with a focus on advancing the health of women, babies and families through a diversified portfolio of products and services. Our fertility portfolio encompasses medical device coverage of the in vitro fertilization (IVF) cycle, egg and sperm donation, and cryopreservation. Our office and surgical platform encompasses more than 600 clinically-relevant medical devices used in gynecology and obstetrics, including contraception and labor &amp; delivery, as well as cord blood and cord tissue storage services. CooperSurgical has established its market presence and distribution system by developing products and acquiring companies, products and services that complement its business model. We categorize CooperSurgical product sales based on the point of health care delivery, which includes products used in medical office and surgical procedures, primarily by Obstetricians/Gynecologists (OB/GYN); and fertility products/equipment and genetic testing services used primarily in fertility clinics and laboratories. CooperSurgical's major manufacturing, cryostorage and distribution facilities are located in Costa Rica, the Netherlands, the United Kingdom and the United States, with other smaller locations also existing in multiple locations around the world. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision and CooperSurgical each operate in highly competitive environments. Both of Cooper's businesses compete predominantly on the bases of product quality and differentiation, technological benefits, price, service levels and reliability.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">COOPERVISION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision competes in the worldwide soft contact lens market and services three primary regions: the Americas, EMEA (Europe, Middle East and Africa) and Asia Pacific. The contact lens market has two major product categories:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Spherical lenses including lenses that correct near- and farsightedness uncomplicated by more complex visual defects.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Toric and multifocal lenses including lenses that, in addition to correcting near- and farsightedness, address more complex visual defects such as astigmatism, myopia and presbyopia by adding optical properties of cylinder and axis, which correct for irregularities in the shape of the cornea. Myopia management contact lenses slow the progression of myopia in children 8 to 12 years of age at initiation of the treatment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In order to achieve comfortable and healthy contact lens wear, products are sold with recommended replacement schedules, often defined as modalities, with the primary modalities being single-use lenses and frequent replacement (FRP) lenses, which are designed for two-week and monthly replacement. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision offers spherical, toric, multifocal and toric multifocal lens products in most modalities. We believe that in order to compete successfully in the numerous categories of the contact lens market, companies must offer differentiated products that are priced competitively and manufactured efficiently. CooperVision uses different manufacturing processes, primarily cast molding, to produce its lenses. We believe this allows CooperVision to compete in its markets by:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%;padding-left:14.68pt">Producing high, medium and low volumes of lenses made with a variety of materials for a broader range of market niches: single-use, two-week and monthly disposable sphere, toric and multifocal lenses, custom toric lenses for patients with a high degree of astigmatism, and myopia management contact lenses.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Offering a wide range of lens parameters, leading to a higher rate of successful fitting for practitioners and better visual acuity for patients.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The market for spherical lenses is growing with the addition of new value-added products, such as spherical lenses to alleviate dry eye symptoms, reduce eye fatigue from use of digital devices and add aspherical optical properties and/or higher oxygen permeable lenses such as silicone hydrogels, and myopia management contact lenses for 8 to 12 years (age-appropriate) children.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Sales of contact lenses utilizing silicone hydrogel materials continue to grow. Silicone hydrogel materials supply a higher level of oxygen to the cornea, as measured by the transmissibility of oxygen through a given thickness of material, or &#8220;dk/t,&#8221; than traditional hydrogel lenses. We believe our ability to compete successfully with a full range of silicone hydrogel products is an important factor to achieving success in our business. Silicone hydrogel lenses represent a significant portion of CooperVision's contact lens sales and our Biofinity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> brand is CooperVision's leading product line in terms of sales. Under the Biofinity brand, CooperVision markets monthly silicone hydrogel spherical (including Biofinity Energys</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">), toric, extended range toric, multifocal and toric multifocal lens products. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision markets single-use silicone hydrogel lenses with a complete line of spherical, toric, extended range toric and multifocal lenses under our clariti</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> 1 day brand and single-use silicone hydrogel spherical, toric and multifocal lenses under our MyDay</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">brand. We also compete in the traditional single-use hydrogel product segment with branded lenses including our Proclear</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> and Biomedics</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> 1 day lenses. We believe the global market for single-use contact lenses will continue to grow and that our competitive silicone hydrogel and traditional hydrogel product offerings represent an opportunity for our business. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In addition to its silicone hydrogel product offerings, CooperVision competes in the contact lens market with other traditional hydrogel products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">CooperVision focuses on supporting the growth of all customers including key accounts (optical chains, global retailers, certain buying groups and mass merchandisers) by investing in selling, promotional and advertising activities. Further, we are increasing investment in our distribution and packaging capabilities to support the growth of our business and to continue providing quality service with our industry leading SKU range and customized offerings. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">CooperVision believes that myopia management opens up an attractive new market for contact lenses. With MiSight, CooperVision offers the only FDA approved</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:112%;position:relative;top:-3.32pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"> and first Chinese NMPA approved product to control the progression of myopia in age-appropriate children. CooperVision is investing to create this new market by educating eye care practitioners, patients and their families which increases awareness.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">CooperVision is focused on greater worldwide market penetration of recently introduced products, and we continue to expand our presence in existing and emerging markets, both organically and through acquisitions. In fiscal 2022, CooperVision acquired a privately-held Denmark-based ortho-k contact lens distributor. In fiscal 2021, CooperVision acquired a privately-held medical device company and a privately-held UK contact lenses manufacturer. These acquisitions expanded CooperVision&#8217;s specialty eye care portfolio and its leadership in addressing the increasing severity and prevalence of myopia.</span></div><div style="margin-top:9pt"><span><br/></span></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Indications for use of MiSight&#174; 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with &#8804; 0.75 diopters of astigmatism. The lens is to be discarded after each removal.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Contact Lens Product Sales</span></div><div style="text-align:center"><img src="coo-20221031_g1.jpg" alt="coo-20221031_g1.jpg" style="height:266px;margin-bottom:5pt;vertical-align:text-bottom;width:300px"/></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Single-use spheres</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> &#8211; This includes Biomedics 1 day, clariti 1 day, MyDay, MiSight and Proclear 1 day</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Toric</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> &#8211; This includes Avaira Vitality toric, Biomedics toric, Biofinity toric, clariti 1 day toric, MyDay toric and Proclear toric</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Multifocal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> &#8211; This includes Biofinity multifocal, Biofinity toric multifocal, clariti 1 day multifocal, MyDay multifocal and Proclear 1 day multifocal</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Non single-use sphere, other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"> &#8211; This includes our Avaira Vitality spheres, frequent replacement product (FRP) lens portfolio (Biofinity spheres, Biofinity Energys, Biomedics, Proclear spheres, clariti spheres), ortho-k, scleral and custom lenses, contact lens solutions and other</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">CooperVision Competition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The contact lens market is highly competitive. CooperVision's largest competitors in the worldwide market and its primary competitors in the spherical, toric and multifocal lens categories of that market are Johnson &amp; Johnson Vision Care, Inc., Alcon Inc. and Bausch Health Companies Inc. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Certain of CooperVision's competitors may have greater financial resources, larger research and development budgets, larger sales forces, greater market penetration and/or larger manufacturing volumes. CooperVision seeks to offer a high level of customer service through its direct sales organizations around the world and through telephone sales and technical service representatives who consult with eye care professionals about the use of our lens products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision also competes with manufacturers of eyeglasses and with refractive surgical procedures that correct visual defects including laser vision correction. CooperVision believes that laser vision correction is not a significant threat to its sales of contact lenses based on the growth of the contact lens market over the past decade.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision competes in the silicone hydrogel segment of the market with its following products: clariti 1 day brand of single-use sphere, toric and multifocal lenses; MyDay</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> single-use spherical, toric and multifocal lenses; Biofinity monthly spherical, toric, multifocal and toric multifocal lenses and Avaira Vitality</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> two-week spherical and toric lenses. CooperVision believes the clariti 1 day and MyDay brands of single-use contact lenses provide the broadest product portfolio in the single-use silicone hydrogel market. CooperVision offers both branded and private label/store brand options in contact lenses. Its private label option is frequently offered as part of a larger customized solution for its customers. It also competes in the specialty contact lens space with its FDA approved MiSight 1 day contact lens for myopia management in age-appropriate children as well as ortho-k and scleral lenses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In addition to a broad offering of silicone hydrogel and specialty contact lenses, CooperVision competes with different manufacturing processes which allow it to produce a broad range of spheres, toric and multifocal lens parameters, which we believe provides wide choices for patient and practitioner and a high level of visual acuity. We also compete based on our customer and professional services. CooperVision believes that there are opportunities for contact lenses to gain market share, particularly in markets where the penetration of contact lenses in the vision correction market is low.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">COOPERSURGICAL</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperSurgical offers a broad array of products and services focused on advancing the health of women, babies and families through a diversified portfolio of products and services including medical devices, fertility, genomics, diagnostics, cryostorage, contraception and healthcare technology services (such as cord blood and cord tissue storage and genomic testing). We offer quality products, innovative technologies and superior services to health care professionals and patients worldwide. CooperSurgical collaborates with health care professionals to identify products and new technologies from disposable products to diagnostic tests to sophisticated instruments and equipment, to bring new products to market. The result is a broad portfolio of products and services that are intended to aid in the delivery of improved clinical outcomes for families and that health care professionals use routinely in the diagnosis and treatment of a wide spectrum of women's health and reproductive issues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">A focus area for CooperSurgical is key accounts, which include large group practices, integrated delivery networks and certain buying groups within the office/surgical business and fertility clinic networks within the fertility business. We believe our portfolio of offerings and focus on service, quality and clinical education will support the accelerated growth of our business in these key account groups.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Since its inception in 1990, CooperSurgical has established its market presence and distribution system by developing products and acquiring products and companies that complement its business model.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">In fiscal 2022, CooperSurgical acquired both a private cryopreservation services company and Generate Life Sciences (Generate), a privately-held leading provider of donor egg and sperm for fertility treatments, fertility cryopreservation services and newborn stem cell storage (cord blood &amp; cord tissue). In fiscal 2021, CooperSurgical acquired three privately-held medical device companies and one privately-held IVF cryostorage software solutions company. We intend to continue investing in CooperSurgical's business with the goal of expanding our integrated solutions model within the areas of family health, fertility and diagnostics.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">In April 2022, CooperSurgical entered into an asset purchase agreement to acquire Cook Medical's Reproductive Health business, a manufacturer of minimally invasive medical devices focused on the fertility, obstetrics and gynecology markets. The aggregate consideration is $875.0&#160;million in cash, with $675.0&#160;million payable at the closing and the remaining $200.0&#160;million payable in $50.0&#160;million installments following each of the first, second, third and fourth anniversaries of the closing. The transaction is subject to customary closing conditions, such as receipt of required regulatory approvals. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Market for Women's and Family Health Care</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperSurgical participates in the market for women's and family health care with its diversified product lines in three major categories based on the point of health care delivery: hospitals and surgical centers, OB/GYN medical offices and fertility clinics. In recent years, including with the acquisition of Generate in fiscal 2022, CooperSurgical&#8217;s business increasingly includes marketing and selling to end consumers of healthcare technology and reproductive planning products and services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperSurgical expects patient visits to women&#8217;s health provider offices in the U.S. to increase over the next decade. From adolescent care to geriatrics, there is increasing global awareness of women&#8217;s health issues. During the reproductive years, fertility awareness and family planning and healthcare are key areas of focus. The attention in maternity care to improving access to safe, effective, and equitable obstetrical care continues. As we expect an increase in the population of women over the age of 65, office visits focused around abnormal bleeding, incontinence and menopause will likely increase. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Another trend in the market for women's health care includes the continued migration of OB/GYN health care professionals away from private practice ownership and toward aligning with group practices or employment with hospitals and health care systems. This overall trend of consolidation of healthcare systems includes the increasing influence of supply chain controls, such as value analysis committees, on product evaluation and procurement across these care-delivery systems. CooperSurgical believes that the market factors that are driving this trend will continue. We believe our broad product portfolio can be a benefit in this changing environment as health systems look to standardize and consolidate vendors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Recent trends of patient-centered, value-based care include the development of more cost-effective health care delivery models, including moving treatment out of hospitals and surgery centers and into the office setting without compromising care. We expect to see continued changes in reimbursement and clinical best practices as payment models and policies continue to evolve. </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">The OB/GYN market encompasses the following significant points of healthcare delivery:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Routine office visits: annual well-women checkups, preventative cancer screening and contraception. </span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Evaluation and management (E/M) office visits: assessment of menstrual disorders, pelvic infections, urinary incontinence, abnormal Pap smears, fertility concerns, pregnancy and menopause. Approximately a third of gynecology office visits are related to abnormal uterine bleeding.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Trends in the OB/GYN market include: </span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Office-based and outpatient procedures are increasing given high patient satisfaction, reduction of health system cost and comparative clinical outcomes.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Hysterectomy and cesarean section remain common hospital surgical interventions in women worldwide. </span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Pregnancy and childbirth complications are on the rise.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">The obstetrician is a key contributor to stem cell storage, facilitating the collection of cord blood and cord tissue following delivery in most markets. </span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Initial evaluation and treatments for infertility, such as uterine assessment, ovulatory medications and intrauterine insemination (IUI), begin with the OB/GYN and then transition to fertility clinics. </span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">With respect to fertility clinics, CooperSurgical expects growth in fertility treatments as:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%;padding-left:13.27pt">Infertility rates are increasing globally, and there is a significant unmet need for fertility services.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Patient awareness of and access to services are increasing at a rapid pace.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%;padding-left:14.68pt">The number of fertility clinics is rising worldwide.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%;padding-left:14.68pt">The fertility market is fueled by dynamics such as increasing maternal age, single parents by choice, and LGBTQ+ identifying individuals starting families.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%;padding-left:14.68pt">Improved product offerings such as donor activity and cryopreservation services</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%;padding-left:14.68pt">Technology improvements for both male and female infertility challenges</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%;padding-left:14.68pt">Greater worldwide disposable income</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Women's and Family Health Care Product Sales</span></div><div><span><br/></span></div><div style="text-align:center"><img src="coo-20221031_g2.jpg" alt="coo-20221031_g2.jpg" style="height:266px;margin-bottom:5pt;vertical-align:text-bottom;width:300px"/></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Office/Surgical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"> &#8211; This includes Endosee endometrial imaging products, Fetal Pillow cephalic elevation devices for use in Cesarean sections, illuminated speculum products, Lone Star retractor systems, loop electrosurgical excision procedure (LEEP) products, Mara water ablation systems, newborn stem cell storage, PARAGARD contraceptive IUDs, point-of-care products and uterine positioning products.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Fertility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"> &#8211; Our significant fertility products and services include cryostorage, donor gamete services, fertility consumables and equipment and genomic services (including preimplantation genetic testing).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">CooperSurgical Competition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperSurgical focuses on selected segments of the women's and family health care market with a diversified portfolio of products and services including medical devices in outpatient and operating room settings, fertility, contraception and healthcare technology services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Competitive factors in these segments in which CooperSurgical competes include technological and scientific advances, product quality and availability, price, customer service including response time and effective communication of product information to physicians, consumers, fertility clinics and hospitals. Competition in the medical device industry is dynamic and involves the search for technological and therapeutic innovations. CooperSurgical's strategy includes developing and acquiring new solutions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperSurgical competes in categories across women&#8217;s health, including routine care, diagnostics and medical devices used in outpatient care, surgical procedures and labor and delivery. Larger companies such as Johnson &amp; Johnson, Medtronic and Hologic have offerings that compete with our products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperSurgical offers private cord blood and cord tissue cryostorage services in the U.S., Canada and Australia. In that field, we compete primarily with ViaCord, a division of Perkin Elmer, in the U.S., as well as other smaller companies globally. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperSurgical also offers PARAGARD, which is the only FDA approved, non-hormonal Intrauterine Device (IUD) contraceptive option in the U.S. and has a 10-year use indication. With PARAGARD, we compete with manufacturers of hormonal IUDs including Bayer and AbbVie, Long Acting Reversible Contraceptives (LARCs), including Organon, and other forms of birth control. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperSurgical also competes in the fertility category of the women's and family health care market. We have broad product offerings for fertility evaluations and IVF procedures by OB/GYN, reproductive endocrinologists and embryologists. These include products for use by the OB/GYN in their offices for initial evaluations with office-based hysteroscopy and first line treatments such as intrauterine insemination. In fertility clinics, our products include media, micro-tools and lab equipment. Additionally, services offered to clinics and families undergoing assisted reproductive technologies include genomics, donor gametes and cryostorage. CooperSurgical competes with a large number of competitors in the fertility market including Vitrolife Group, FujiFilm-Irvine Scientific, Cook Medical, Hamilton Thorne, Natera and Invitae. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">RESEARCH AND DEVELOPMENT</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company employs approximately 300 people in research and development. CooperVision's product development and clinical research is supported by internal and external specialists in lens design, formulation science, polymer chemistry, engineering, clinical trials, microbiology and biochemistry. CooperVision's research and development activities primarily include programs to develop new contact lens designs and manufacturing technology, along with improving formulations and existing products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperSurgical conducts research and development in-house and has consulting agreements with external specialists in software, hardware and electrical engineering, genetic science and embryology. CooperSurgical's research and development activities include the design and improvement of surgical procedure devices, and the advancement and expansion of CooperSurgical's portfolio of fertility and general OB/GYN offerings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">GOVERNMENT REGULATION</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Medical Device Regulation in the United States</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Most of our products are medical devices subject to extensive regulation by the FDA in the U.S. and other regulatory bodies abroad. The Federal Food, Drug, and Cosmetic Act (FDCA) and FDA regulations govern, among other things, medical device design and development, testing, manufacturing, labeling, storage, record keeping, premarket clearance or approval, advertising and promotion, and sales and distribution. Unless an exemption applies, each medical device we </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">wish to distribute commercially in the U.S. will require either premarket notification to the FDA requesting clearance for commercial distribution under Section 510(k) of the FDCA, or premarket approval (PMA) from the FDA. A majority of the medical devices we currently market have received FDA clearance through the 510(k) process or approval through the PMA process. Because we cannot be assured that any new products we develop, or any product enhancements, will be exempt from the premarket clearance or approval requirements or will be subject to the shorter 510(k) clearance process rather than the PMA process, significant delays in the introduction of any new products or product enhancements may occur.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Device Classification</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The FDA classifies medical devices into one of three classes&#8212;Class I, II or III&#8212;depending on the degree of risk associated with each medical device and the extent of control needed to ensure its safety and effectiveness. Both CooperVision and CooperSurgical develop and market medical devices subject to different levels of FDA regulation depending on the classification of the device. Class III devices, such as flexible and extended wear contact lenses, require extensive premarket testing and approval, while Class I and II devices require lower levels of regulation. The majority of CooperSurgical's products are Class II devices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Class I devices are devices with the lowest risk and are those for which safety and effectiveness can be assured by adherence to the FDA's general regulatory controls for medical devices, which include compliance with the applicable portions of the FDA's Quality System Regulation (QSR), facility registration and product listing, reporting of adverse medical events, and appropriate, truthful and non-misleading labeling, advertising, and promotional materials (General Controls). Some Class I devices also require premarket clearance by the FDA through the 510(k) premarket notification process described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Class II devices are moderate risk devices, which are subject to the FDA's General Controls, and any other special controls as deemed necessary by the FDA to ensure the safety and effectiveness of the device, such as performance standards, post-market surveillance, FDA guidelines or particularized labeling requirements. Premarket review and clearance by the FDA for Class&#160;II devices is accomplished through the 510(k) premarket notification procedure. Pursuant to the Medical Device User Fee and Amendments to the FDA Reauthorization Act (MDUFA IV), unless a specific exemption applies, 510(k) premarket notification submissions require payment of user fees. Certain Class II devices are exempt from this premarket review process.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Class III devices are those devices deemed by the FDA to pose the greatest risk, such as life-sustaining, life-supporting or certain implantable devices, or which have a new intended use, or use advanced technology that is not substantially equivalent to that of a legally marketed device. The safety and effectiveness of Class III devices cannot be assured solely by the General Controls and other special controls such as those listed above. These devices almost always require formal clinical studies to demonstrate safety and effectiveness and must be approved through the PMA process described below. PMA applications (and supplemental PMA applications) are subject to substantially higher user fees under MDUFA IV than are 510(k) premarket notifications.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">510(k) Clearance Pathway</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">When we are required to obtain a 510(k) clearance for a Class I or Class II device that we wish to market, we must submit a premarket notification to the FDA demonstrating that the device is substantially equivalent to a legally marketed predicate device. A predicate device is a legally marketed device that is not subject to a PMA, a device that was legally marketed in commercial distribution in the U.S. before May 28, 1976 (a pre-amendments device) and, for which the FDA has not yet called for the submission of a PMA, a device that has been reclassified from Class III to Class II or I, or a device that was found substantially equivalent through the 510(k) premarket notification process. The FDA aims to make substantial equivalence determinations following receipt of a 510(k) premarket notification within 90 days of submission of the notification, but as a practical matter, clearance can take significantly longer. Although many 510(k) pre-market notifications are cleared without clinical data, in some cases, the FDA requires additional information to support substantial equivalence. If the FDA agrees that the device is substantially equivalent to a predicate device, it will grant 510(k) clearance to commercially market the device. If the FDA determines that the device is not substantially equivalent to a legally marketed predicate, the device is automatically designated as a Class III device. The device sponsor must fulfill more rigorous PMA requirements, or can request a risk-based classification determination for the device in accordance with the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> process, which is a route to market for novel medical devices that are low to moderate risk and are not substantially equivalent to a predicate device.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">After a device receives 510(k) clearance, any modification that could significantly affect its safety or effectiveness, or that would constitute a major change or modification in its intended use, will require a new 510(k) clearance or, depending on the modification, PMA approval or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> classification. The FDA requires each manufacturer to make this determination initially, but the FDA can review any such decision and can disagree with a manufacturer's determination. If </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">the FDA disagrees with a manufacturer's determination that a new clearance or approval is not required for a particular modification, the FDA may require the manufacturer to cease marketing and/or recall the modified device until 510(k) clearance or until premarket approval is obtained or a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">de novo </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">classification request is granted. In these circumstances, a manufacturer also may be subject to significant regulatory fines or penalties. We have made and plan to continue to make additional product enhancements and modifications to our devices that we believe do not require new 510(k) clearances.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Over the last several years, the FDA has proposed reforms to its 510(k) clearance process, and such proposals could include increased requirements for clinical data and a longer review period, or could make it more difficult for manufacturers to utilize the 510(k) clearance process for their products. For example, in November 2018, FDA officials announced steps that the FDA intended to take to modernize the premarket notification pathway under Section 510(k) of the FDCA. Among other things, the FDA announced that it planned to develop proposals to drive manufacturers utilizing the 510(k) pathway toward the use of newer predicates. These proposals included plans to potentially sunset certain older devices that were used as predicates under the 510(k) clearance pathway, and to potentially publish a list of devices that have been cleared on the basis of demonstrated substantial equivalence to predicate devices that are more than 10 years old. These proposals have not yet been finalized or adopted.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In September 2019, the FDA published updated guidance describing an optional &#8220;safety and performance based&#8221; premarket review pathway for manufacturers of &#8220;certain, well-understood device types&#8221; to demonstrate substantial equivalence under the 510(k) clearance pathway by showing that such device meets objective safety and performance criteria established by the FDA, thereby obviating the need for manufacturers to compare the safety and performance of their medical devices to specific predicate devices in the clearance process. The FDA maintains a list of device types appropriate for the &#8220;safety and performance based&#8221; pathway and continues to develop product-specific guidance documents that identify the performance criteria for each such device type, as well as recommended testing methods, where feasible. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Premarket Approval Pathway</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">A PMA application must be submitted if the device cannot be cleared through the 510(k) premarket notification procedures or if the device has been previously classified as Class III (unless otherwise 510(k) exempt). The PMA process is much more demanding than the 510(k) premarket notification process. A PMA application must be supported by extensive data including, but not limited to, technical, non-clinical, clinical trials, manufacturing and labeling to demonstrate to the FDA's satisfaction the safety and effectiveness of the device for its intended use.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Following receipt of a PMA application, the FDA conducts an administrative review to determine whether the application is sufficiently complete to permit a substantive review. If it is not, the agency will refuse to file the PMA. If it is, the FDA will accept the application for filing and begin the review. The FDA, by statute and regulation, has 180 days to review an accepted PMA application, although the review generally occurs over a significantly longer period of time, and can take up to several years. During this review period, the FDA may request additional information, including clinical data, non-clinical data or clarification of information already provided, and the FDA may issue a major deficiency letter to the applicant, requesting the applicant's response to deficiencies communicated by the FDA. The FDA considers a PMA or PMA supplement to have been voluntarily withdrawn if an applicant fails to respond to an FDA request for information (e.g., major deficiency letter) within 180 days after the FDA issues such request. Also, during the review period, an advisory panel of experts from outside the FDA may be convened to review and evaluate the application and provide recommendations to the FDA as to the approvability of the device. In addition, the FDA will conduct a preapproval inspection of the manufacturing facility to ensure compliance with the QSR, which, among other things requires manufacturers to implement and follow elaborate design, testing, control, documentation and other quality assurance procedures in the device design and manufacturing process. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The FDA will approve the new device for commercial distribution if it determines that the data and information in the PMA constitute valid scientific evidence and that there is reasonable assurance that the device is safe and effective for its intended use(s). The FDA may approve a PMA application with post-approval conditions intended to ensure the safety and effectiveness of the device including, among other things, restrictions on labeling, promotion, sale and distribution and collection of long-term follow-up data from patients in the clinical study that supported approval. The FDA may also condition approval of a PMA application on some form of post-market surveillance when deemed necessary to protect the public health or to provide additional safety and efficacy data for the device in a larger population or for a longer period of use. In such cases, the manufacturer might be required to follow certain patient groups for a number of years and to make periodic reports to the FDA on the clinical status of those patients. Failure to comply with the conditions of approval can result in materially adverse enforcement action, including the loss or withdrawal of the approval. New PMA applications or PMA application supplements are required for significant modifications to the manufacturing process, labeling and design of a device that is approved through the PMA process. PMA supplements often require submission of the same type of information as a PMA application, except that the supplement is limited to information needed to support any changes </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">from the device covered by the original PMA application, and may not require as extensive clinical data or the convening of an advisory panel.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Clinical Trials for Medical Devices</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">A clinical trial is almost always required to support a PMA application and is sometimes required to obtain clearance of a 510(k) premarket notification. These trials may require submission of an application for an investigational device exemption (IDE) to the FDA depending on the device. If the device under evaluation does not present a significant risk to human health, then the device sponsor is not required to submit an IDE application to the FDA before initiating human clinical trials, but must still comply with abbreviated IDE requirements when conducting such trials. A significant risk device is one that presents a potential for serious risk to the health, safety or welfare of a patient and either is implanted, used in supporting or sustaining human life, substantially important in diagnosing, curing, mitigating or treating disease or otherwise preventing impairment of human health, or otherwise presents a potential for serious risk to a subject. If the device presents a &#8220;significant risk&#8221; to human health, the sponsor must submit an IDE application to the FDA and obtain IDE approval prior to commencing the human clinical trials. The IDE application, which includes a clinical study protocol, must be supported by appropriate data, such as animal and laboratory testing results, showing that the potential benefits of testing the device in humans and the importance of the knowledge to be gained outweighs the risks to human subjects from the proposed investigation that the testing protocol is scientifically sound and there is reason to believe that the device as proposed for use will be effective. The IDE will automatically become effective 30 days after receipt by the FDA unless the FDA notifies the company that the investigation may not begin. If the FDA determines that there are deficiencies or other concerns with an IDE for which it requires modification, the FDA may permit a clinical trial to proceed under a conditional approval. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Regardless of the degree of risk presented by the medical device, clinical studies must be approved by, and conducted under the oversight of, an Institutional Review Board (IRB) for each clinical site. The IRB is responsible for the initial and continuing review of the study, and may pose additional requirements for the conduct of the study. There can be no assurance that submission of an IDE will result in the ability to commence clinical trials. Additionally, after a trial begins, the FDA may place it on hold or terminate it if, among other reasons, it concludes that the clinical subjects are exposed to unacceptable health risks that outweigh the benefits of participation in the study. During a study, we are required to comply with the FDA's IDE requirements for investigator selection, trial monitoring, reporting, record keeping and prohibitions on the promotion of investigational devices or making safety or efficacy claims for them. We are also responsible for the appropriate labeling and distribution of investigational devices. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Continuing FDA and Other Government Agency Regulation of Medical Devices</span></div><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">After a device is placed on the market, numerous regulatory requirements apply. These include: establishment registration and device listing with the FDA; the QSR, which requires manufacturers to follow design, testing, production, control, complaint handling, documentation and other quality assurance procedures during the manufacturing process; labeling regulations, which prohibit the promotion of products for uncleared or unapproved or &#8220;off-label&#8221; uses and impose other restrictions on labeling, advertising and promotion; new FDA unique device identifier regulations, which require changes to labeling and packaging; and medical device reporting regulations, which require that manufacturers report to the FDA if their device may have caused or contributed to a death or serious injury or malfunctioned in a way that would likely cause or contribute to a death or serious injury if it were to recur. The FDA has broad post-market and regulatory enforcement powers. We are subject to unannounced inspections for cause by the FDA to determine our compliance with the QSR and other regulations.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Failure to comply with applicable regulatory requirements, which are subject to new legislation and change, can result in enforcement action by the FDA, or other federal and state government agencies which may include, but may not be limited to, any of the following sanctions or consequences: warning letters or untitled letters; fines, injunctions and civil penalties; recall, seizure or import holds of our products; operating restrictions, suspension or shutdown of production; refusing to issue certificates to foreign governments needed to export products for sale in other countries; refusing our request for 510(k) clearance or premarket approval of new or modified products; withdrawing 510(k) clearance or premarket approvals that are already granted; and criminal prosecution.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Laboratory Developed Tests</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We provide certain genetic testing laboratory services. In the U.S., under the FDCA and the FDA&#8217;s regulatory framework, in vitro diagnostic devices (IVDs) are a type of medical device that can be used in the diagnosis or detection of diseases, such as cancer, or other conditions. The FDA considers Laboratory Developed Tests (LDTs) to be a subset of IVDs, which are intended for clinical use and are designed, manufactured, and used within a single laboratory. Although the FDA has statutory authority to assure that medical devices, including IVDs, are safe and effective for their intended uses, the FDA </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">has historically exercised its enforcement discretion and not enforced certain applicable provisions of the FDCA and regulations with respect to certain LDTs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Even under its current enforcement discretion policy, the FDA has issued warning letters to IVD manufacturers for commercializing laboratory tests that were purported to be LDTs but that the FDA alleged failed to meet the definition of an LDT or otherwise were not subject to the FDA&#8217;s policy on enforcement discretion over LDTs because they presented a potential safety risk or because they were marketed directly to consumers without the involvement of a health care professional. Additionally, the FDA could change its policy of enforcement discretion for LDTs, even without legislation. For example, in recent years, the FDA has stated its intention to modify its enforcement discretion policy with respect to LDTs. Specifically, on July 31, 2014, the FDA notified Congress of its intent to modify, in a risk-based manner, its policy of enforcement discretion with respect to LDTs. On October 3, 2014, the FDA issued two draft guidance documents entitled &#8220;Framework for Regulatory Oversight of Laboratory Developed Tests (LDTs),&#8221; or the Framework Guidance, and &#8220;FDA Notification and Medical Device Reporting for LDTs,&#8221; or the Reporting Guidance. The Framework Guidance stated that FDA intended to modify its policy of enforcement discretion with respect to LDTs in a risk-based manner consistent with the classification of medical devices generally in Classes I through III. The Reporting Guidance would have further enabled the FDA to collect information regarding the LDTs currently being offered for clinical use through a notification process, as well as to enforce its regulations for reporting safety issues and collecting information on any known or suspected adverse events related to the use of an LDT. The FDA halted finalization of this guidance in November 2016 to allow for further public discussion on an appropriate oversight approach for LDTs and to give congressional authorizing committees the opportunity to develop a legislative solution. In January 2017, the FDA issued a discussion paper on possible approaches to LDT regulation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Legislative and administrative proposals proposing to amend the FDA&#8217;s oversight of LDTs have been introduced in recent years and we expect that new legislative and administrative proposals will continue to be introduced from time to time. For example, key congressional committees with jurisdiction over FDA matters have indicated an interest in continuing negotiations on potential legislation regarding LDTs. In March 2020, the VALID Act was introduced in the House and an identical version of the bill was introduced in the U.S. Senate. If passed in its current form, the VALID Act would create a new category of medical products separate from medical devices called &#8220;in vitro clinical tests,&#8221; or IVCTs. As proposed, the bill would establish a risk-based approach to imposing requirements related to premarket review, quality systems, and labeling requirements on all IVCTs, including LDTs, but would create exemptions for certain LDTs marketed before the effective date of the bill (though other regulatory requirements may apply, such as registration and adverse event reporting). In June 2021, a revised version of the VALID Act was reintroduced in both the House and the Senate. It is unclear whether the VALID Act or any other legislative proposals (including any proposals to reduce FDA oversight of LDTs) would be passed by Congress or signed into law by the President. Depending on the approach adopted under any potential legislation, certain LDTs could become subject to some form of premarket review, potentially with a transition period for compliance and a grandfathering provision.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">If Congress does not take action in connection with the VALID Act or other LDT legislation, it is possible that the FDA could change its regulatory policy governing LDTs in a way that could require that our currently marketed genetic tests, and any future products that we anticipate marketing as LDTs, comply with certain additional FDA requirements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As we operate a genetic testing laboratory, we are required to hold certain federal, state and local licenses, certifications and permits to conduct our business. Under the Clinical Laboratory Improvement Amendments of 1988, or CLIA, we are required to hold a certificate applicable to the type of laboratory tests we perform and to comply with standards applicable to our operations, including test processes, personnel, facilities administration, equipment maintenance, recordkeeping, quality systems and proficiency testing. We have current certification under CLIA to perform testing at our New Jersey facility. To renew our CLIA certificate, we are subject to survey and inspection every two years to assess compliance with program standards. The regulatory and compliance standards applicable to the testing we perform may change over time, and any such changes could have a material effect on our business. Penalties for non-compliance with CLIA requirements include suspension, limitation or revocation of the laboratory&#8217;s CLIA certificate, as well as a directed plan of correction, state on-site monitoring, civil money penalties, civil injunctive suit or criminal penalties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In addition to federal certification requirements of laboratories under CLIA, licensure is required and maintained for our laboratory under state law. Such laws establish standards for the day-to-day operation of a clinical reference laboratory, including the training and skills required of personnel and quality control. In addition, state laws mandate proficiency testing, which involves testing of specimens that have been specifically prepared for the laboratory. In addition, certain states require licensing of out-of-state laboratories in order to receive and test specimens from those tests. If a laboratory is out of compliance with such statutory or regulatory standards, the state may suspend, limit, revoke or annul the laboratory&#8217;s license, censure the holder of the license or assess civil money penalties. </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">FDA Regulation of HCT/Ps</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">We currently operate a provider of donor egg and sperm for fertility treatments, fertility cryopreservation services and newborn stem cell storage. Donated reproductive tissue (eggs or sperm) are regulated by the FDA as human cells, tissues, and cellular and tissue-based products (HCT/Ps). In addition, Section 361 of the Public Health Service Act (PHSA) authorizes the FDA to issue regulations to prevent the introduction, transmission or spread of communicable disease with respect to HCT/Ps. HCT/Ps regulated as &#8220;361 HCT/Ps&#8221; are subject to requirements relating to registering facilities and listing products with the FDA, and stringent requirements for processing, storing, labeling and distributing HCT/Ps, including required labeling information, screening and testing for tissue donor eligibility, record keeping and adverse event reporting, among other applicable requirements and laws. 361 HCT/Ps do not require 510(k) clearance, PMA approval, submission of a Biologics License Application, or other premarket authorization from the FDA before marketing. However, to be regulated as a 361 HCT/P, the product must, among other things, be &#8220;minimally manipulated,&#8221; which for structural tissue products means that the manufacturing processes do not alter the original relevant characteristics of the tissue relating to the tissue&#8217;s utility for reconstruction, repair, or replacement, and for cells or nonstructural tissue products, means that the manufacturing processes do not alter the relevant biological characteristics of cells or tissues. A 361 HCT/P must also be intended for &#8220;homologous use,&#8221; which refers to use in the repair, reconstruction, replacement, or supplementation of a recipient&#8217;s cells or tissues with an HCT/P that performs the same basic function or functions in the recipient as in the donor. HCT/Ps that do not meet the criteria of Section 361 are regulated under Section 351 of the PHSA. Unlike 361 HCT/Ps, HCT/Ps regulated as &#8220;351 HCT/Ps&#8221; are subject to premarket review and/or approval by the FDA, as required. We believe our HCT/Ps are regulated as 361 HCT/Ps. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Pharmaceutical Regulation in the United States</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">FDA has determined that the primary mode of action for PARAGARD is the drug component and is therefore regulated by FDA&#8217;s Center for Drug Evaluation and Research as a drug product.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In the U.S., the FDA regulates drugs under the FDCA and its implementing regulations. The process of obtaining regulatory approvals and the subsequent compliance with applicable federal, state, local and foreign statutes and regulations requires the expenditure of substantial time and financial resources. Failure to comply with the applicable U.S. requirements at any time during the product development process, approval process or after approval, may subject an applicant to a variety of administrative or judicial sanctions, such as the FDA&#8217;s refusal to approve pending New Drug Applications (NDA), withdrawal of an approval, imposition of a clinical hold, untitled letters, warning letters, product recalls, product seizures, total or partial suspension of production or distribution, injunctions, fines, refusals of government contracts, restitution, disgorgement or civil or criminal penalties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Any drug products manufactured or distributed by us pursuant to FDA approvals are subject to continuing regulation by the FDA, including manufacturing, periodic reporting, product sampling and distribution, advertising, promotion, drug shortage reporting, compliance with any post-approval requirements imposed as a conditional of approval such as Phase 4 clinical trials, a Risk Evaluation and Mitigation Strategy (REMS), and surveillance, recordkeeping and reporting requirements, including adverse experiences. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">After approval, most changes to the approved product, such as adding new indications or other labeling claims are subject to further testing to new clinical investigation requirements and prior FDA review and approval. There also are continuing, annual program fee requirements for any approved products and the establishments at which such products are manufactured, as well as new application fees for supplemental applications with clinical data. Drug manufacturers and their subcontractors are required to register their establishments with the FDA and certain state agencies and to list their drug products and are subject to periodic announced and unannounced inspections by the FDA and these state agencies for compliance with Good Manufacturing Practices, or cGMPs, and other requirements, which impose procedural and documentation requirements upon us and our third-party manufacturers. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Changes to the manufacturing process are strictly regulated and often require prior FDA approval before being implemented, or FDA notification. FDA regulations also require investigation and correction of any deviations from cGMPs specifications and impose reporting and documentation requirements upon the sponsor and any third-party manufacturers that the sponsor may decide to use. Accordingly, manufacturers must continue to expend time, money and effort in the area of production and quality control to maintain cGMP compliance. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in withdrawal of marketing approval, mandatory revisions to the approved labeling to add new safety information or other limitations, imposition of post-market studies or clinical trials to assess new safety risks, or imposition of distribution or other restrictions under a REMS program, among other consequences. </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The FDA closely regulates the marketing and promotion of drugs. A company can make only those claims relating to safety and efficacy, purity and potency that are approved by the FDA. Physicians, in their independent professional medical judgement, may prescribe legally available products for uses that are not described in the product&#8217;s labeling and that differ from those tested by us and approved by the FDA. We, however, are prohibited from marketing or promoting drugs for uses outside of the approved labeling. In addition, the distribution of prescription pharmaceutical products, including samples, is subject to the Prescription Drug Marketing Act (PDMA), which regulates the distribution of drugs and drug samples at the federal level, and sets minimum standards for the registration and regulation of drug distributors by the states. Both the PDMA and state laws limit the distribution of prescription pharmaceutical product samples and impose requirements to ensure accountability in distribution. The Drug Supply Chain Security Act also imposes obligations on manufacturers of pharmaceutical products related to product and tracking and serialization. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Failure to comply with any of the FDA&#8217;s requirements, which are subject to new legislation and change, could result in significant adverse enforcement actions. These include a variety of administrative or judicial sanctions, such as refusal to approve pending applications, license suspension or revocation, withdrawal of an approval, imposition of a clinical hold or termination of clinical trials, warning letters, untitled letters, cyber letters, modification of promotional materials or labeling, product recalls, product seizures or detentions, refusal to allow imports or exports, total or partial suspension of production or distribution, debarment, injunctions, fines, consent decrees, corporate integrity agreements, refusals of government contracts and new orders under existing contracts, exclusion from participation in federal and state healthcare programs, restitution, disgorgement or civil or criminal penalties, including fines and imprisonment. It is also possible that failure to comply with the FDA&#8217;s requirements relating to the promotion of prescription drugs may lead to investigations alleging violations of federal and state healthcare fraud and abuse and other laws, as well as state consumer protection laws. Any of these sanctions could result in adverse publicity, among other adverse consequences. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Foreign Regulation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Health authorities in foreign countries regulate Cooper's clinical studies and medical device sales. The regulations vary widely from country to country. Even if the FDA has cleared or approved a product in the U.S., the regulatory agencies or notified bodies in other countries must approve or certify new products before they may be marketed there. The time required to obtain approval or certification in another country may be longer or shorter than that required for FDA clearance or approval, and the requirements may differ. There is a trend towards harmonization of quality system standards among the European Union (EU), U.S., Canada and various other industrialized countries. Japan has one of the most rigorous regulatory systems in the world and requires in-country clinical trials. The Japanese quality and regulatory standards remain stringent even with the more recent harmonization efforts and updated Japanese regulations. China is also updating its regulations and is requiring rigorous in-country product testing. These regulatory procedures require a considerable investment in time and resources and usually result in a substantial delay between new product development and marketing. If the Company does not maintain compliance with regulatory standards or if problems occur after marketing, product approval may be withdrawn.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In addition to FDA regulatory requirements, CooperVision maintains ISO 13485 certification and CE marks for its products and CooperSurgical maintains ISO 13485 certification for medical devices and ISO 15189 certification for the Genomics laboratories. The ISO 13485 Quality Measurement System registration is now also required for registration of products in Asia Pacific and Latin American countries. In order to maintain these quality benchmarks, the Company is subjected to rigorous biannual reassessment audits of its quality systems and procedures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Regulation of Medical Devices and In Vitro Diagnostic Medical Devices in the European Union</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The EU has adopted specific directives and regulations regulating the design, manufacture, clinical investigations, conformity assessment, labeling and adverse event reporting for medical devices (including IVDs). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In the EU, until May 25, 2021, medical devices were regulated by the Council Directive 93/42/EEC (the EU MDD) which has been repealed and replaced by Regulation (EU) No 2017/745 (the EU MDR). Similarly, until May 25, 2022, IVDs were regulated by Directive 98/79/EC (the EU IVDD) which has been repealed and replaced by Regulation (EU) 2017/746 of the European Parliament and of the Council (the EU IVDR). However, on October 14, 2021, the European Commission proposed a &#8220;progressive&#8221; roll-out of the EU IVDR to prevent disruption in the supply of IVDs. The European Parliament and Council adopted the proposed regulation on December 15, 2021. The EU IVDR became applicable on May 26, 2022 but there is a tiered system extending the grace period for many devices (depending on their risk classification) before they have to be fully compliant with the regulation. Unlike directives, regulations are directly applicable in all EU member states without the need for member states to implement into national law. Both regulations were adopted to establish a modernized and more robust EU legislative framework, with the aim of ensuring better protection of public health and patient safety.</span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our current certificates have been granted under the EU MDD and the EU IVDD. Devices lawfully placed on the market pursuant to the EU MDD prior to May 26, 2021 may generally continue to be made available on the market or put into service until May 26, 2025, provided that the requirements of the transitional provisions are fulfilled. In particular, the certificate in question must still be valid. Similarly, with respect to IVDs, they may generally continue to be made available provided that the requirements of the transitional provisions are fulfilled. However, respectively as of May 26, 2021 and May 26, 2022 some of the EU MDR and EU IVDR requirements apply in place of the corresponding requirements of the former directives with regard to registration of economic operators and of devices, post-market surveillance and vigilance requirements. Pursuing marketing of medical devices (including IVDs) in the EU will notably require that our devices be certified under the new regimes set forth in the EU MDR and the EU IVDR when our current certificates expire.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Both the EU MDR and the EU IVDR seek to:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">strengthen the rules on placing devices on the market and reinforce surveillance once they are available;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">establish explicit provisions on manufacturers&#8217; responsibilities for the follow-up of the quality, performance and safety of devices placed on the market;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">establish explicit provisions on importers&#8217; and distributors&#8217; obligations and responsibilities; </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">impose an obligation to identify a responsible person who is ultimately responsible for all aspects of compliance with the requirements of the new regulation;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">improve the traceability of medical devices throughout the supply chain to the end-user or patient through the introduction of a unique identification number, to increase the ability of manufacturers and regulatory authorities to trace specific devices through the supply chain and to facilitate the prompt and efficient recall of medical devices that have been found to present a safety risk;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">set up a central database (Eudamed) to provide patients, healthcare professionals and the public with comprehensive information on products available in the EU; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">strengthen rules for the assessment of certain high-risk devices that may have to undergo an additional check by experts before they are placed on the market.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In the EU, there is currently no premarket government review of medical devices (including IVDs). However, all medical devices (including IVDs) placed on the EU market must meet general safety and performance requirements , including that a medical device must be designed and manufactured in such a way that, during normal conditions of use, it is suitable for its intended purpose. Medical devices must be safe and effective and must not compromise the clinical condition or safety of patients, or the safety and health of users and, where applicable, other persons, provided that any risks which may be associated with their use constitute acceptable risks when weighed against the benefits to the patient and are compatible with a high level of protection of health and safety, taking into account the generally acknowledged state of the art. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Compliance with the general safety and performance requirements is a prerequisite for European Conformity Marking (CE mark) without which medical devices cannot be marketed or sold in the EU. To demonstrate compliance with the general safety and performance requirements medical device manufacturers must undergo a conformity assessment procedure, which varies according to the type of medical device and its (risk) classification. Except for low-risk medical devices (Class I) or general IVDs (Class A), where the manufacturer can self-assess the conformity of its products with the general safety and performance requirements (except for any parts which relate to sterility, metrology or reuse aspects of a medical device), a conformity assessment procedure requires the intervention of a notified body. Notified bodies are independent organizations designated by EU member states to assess the conformity of devices before being placed on the market. A notified body would typically audit and examine a product&#8217;s technical dossiers and the manufacturers&#8217; quality system (notified body must presume that quality systems which implement the relevant harmonized standards&#8212;ISO 13485:2016 for Quality Management Systems&#8212;conform to these requirements). If satisfied that the relevant product conforms to the general safety and performance requirements, the notified body issues a certificate of conformity, which the manufacturer uses as a basis for its own declaration of conformity. The manufacturer may then apply the CE mark to the device, which allows the device to be placed on the market throughout the EU. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Throughout the term of the certificate of conformity, the manufacturer will be subject to periodic surveillance audits to verify continued compliance with the applicable requirements. In particular, there will be a new audit by the notified body before it will renew the relevant certificate(s).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">All manufacturers placing medical devices on the market in the EU must comply with the EU medical device vigilance system. Under this system, serious incidents and Field Safety Corrective Actions (FSCAs) must be reported to the relevant authorities of the EU member states. Manufacturers are required to take FSCAs to prevent or reduce a risk of a serious incident associated with the use of a medical device that is made available on the market. An FSCA may include the recall, modification, exchange, destruction or retrofitting of the device. </span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The advertising and promotion of medical devices is subject to some general principles set forth by EU directives. Only devices that are CE marked may be marketed and advertised in the EU in accordance with their intended purpose. Directive 2006/114/EC concerning misleading and comparative advertising and Directive 2005/29/EC on unfair commercial practices, while not specific to the advertising of medical devices, also apply to the advertising thereof and contain general rules, for example requiring that advertisements are evidenced, balanced and not misleading. Specific requirements are defined at the national level. EU member states laws related to the advertising and promotion of medical devices, which vary between jurisdictions, may limit or restrict the advertising and promotion of products to the general public and may impose limitations on promotional activities with healthcare professionals.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In the EU, regulatory authorities have the power to carry out announced and, if necessary, unannounced inspections of companies, as well as suppliers and/or sub-contractors and, where necessary, the facilities of professional users. Failure to comply with regulatory requirements (as applicable) could require time and resources to respond to the regulatory authorities&#8217; observations and to implement corrective and preventive actions, as appropriate. Regulatory authorities have broad compliance and enforcement powers, and if such issues cannot be resolved to their satisfaction can take a variety of actions, including untitled or warning letters, fines, consent decrees, injunctions, or civil or criminal penalties.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Regulation of Laboratory Developed Tests in the European Union</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In the EU, laboratory developed tests (LDTs) are exempt from the regulations that govern medical devices and IVDs under certain conditions. According to the former Article 1(5) of the EU IVDD, &#8220;[this Directive] shall not apply to devices manufactured and used only within the same health institution and on the premises of their manufacture or used on premises in the immediate vicinity without having been transferred to another legal entity.&#8221; Article 1(5) further provided that this exemption did not affect the right of an EU member state from imposing &#8220;appropriate protection requirements.&#8221; In order to fall within this exemption under the EU IVDD, medical devices, including laboratory developed tests, had to be designed and used within such health institution (which may include hospitals, laboratories and public health institutions that support the healthcare system and/or address patient needs but do not treat or care for patients directly) on a non-industrial scale, without being released into the market. However, the legal framework for applying the exemption under the EU IVDD to laboratory developed tests was not entirely clear, as the EU IVDD did not specify what non-industrial scale would be.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Since the EU IVDR became applicable, it may provide greater clarity on the regulation of LDTs. Under the EU IVDR, the general safety and performance requirements set out in Annex I of the EU IVDR are also applicable to devices manufactured and used only within health institutions. Manufacturers of such devices are required to demonstrate conformity with the general safety and performance requirements set out in Annex I of the EU IVDR through performance evaluations in accordance with Article 56 of the EU IVDR and the manufacturer&#8217;s quality management system framework.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The EU IVDR provides that the relevant general safety and performance requirements set out in Annex I of the EU IVDR do not generally apply to devices manufactured and used only within health institutions established in the EU, provided that the conditions set out in Article 5 of the EU IVDR are met. Under the EU IVDR, health institutions may manufacture, modify and use medical devices within such institutions, thereby addressing the specific needs of target patient groups on a non-industrial scale. Under such circumstances, where the LDTs are manufactured and used strictly within health institutions (which may include hospitals, laboratories, public health institutions that support the healthcare system and/or address patient needs but do not treat or care for patients directly), LDTs would continue to be exempt from regulation. However, compared to the previous regulatory regime, the exemptions for LDTs have, overall, been narrowed, as even in relation to LDTs, health institutions, among others, are required to provide information upon request on the use of such devices to their competent authority and each health institution will have to draw up a declaration which it will make publicly available. If these conditions are not met and/or diagnostic tests are manufactured and used only within health institutions but &#8220;on an industrial scale,&#8221; such tests will qualify as IVDs with the full applicability of the EU IVDR. LDTs regulated by the EU IVDR are subject to conformity assessments and inspections by the relevant competent authority, who will also review the declarations and statements made by the health institutions in relation to their LDTs. Our current and future tests will need to be analyzed as to whether any or all of them would qualify for an exemption under Article 5 of the EU IVDR or otherwise we will be required to comply with various certification and documentation criteria, and we may be subject to conformity assessments and inspections. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The aforementioned EU rules are generally applicable in the European Economic Area (EEA) which consists of the 27 EU member states plus Norway, Liechtenstein and Iceland.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">The Impact of Brexit</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Following a national referendum and enactment of legislation by the government of the UK, the UK formally withdrew from the EU on January 31, 2020, commonly referred to as &#8220;Brexit&#8221;, and, following the expiry of the Brexit transitional period on December 31, 2020, the UK now operates under a distinct regulatory regime and certain EU laws now only </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">apply to the UK in respect of Northern Ireland (as laid out in the Protocol on Ireland and Northern Ireland). The Medicines and Healthcare products Regulatory Agency (MHRA) is now the UK&#8217;s standalone regulator. Although the UK and EU have now reached an agreement on its future trading relationship (implemented in the EU-UK Trade and Cooperation Agreement from January 1, 2021, or the TCA), the agreement does not cover all regulatory areas regarding medical devices (including IVDs), which may be subject to future bilateral discussions going forward and could further change the relationship between the UK and the EU in this regard.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">EU laws which were directly applicable before the end of the transitional period or have been transposed into UK law through secondary legislation continue to be applicable as &#8220;retained EU law.&#8221; However, new legislation such as the EU MDR and EU IVDR will not be applicable. The UK government has introduced a new Medicines and Medical Devices Act which seeks to address regulatory gaps through implementing regulations and delegated powers covering the fields of human medicines, clinical studies of human medicines, and medical devices. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Significantly, under the TCA there is no mutual recognition of regulatory regimes and certifications between the EU and the UK. Post-Brexit, amendments have been made to the existing UK medical devices legislation which require medical devices to be registered with the MHRA before being placed on the Great Britain market. Manufacturers based outside of the UK need to appoint a UK Responsible Person to register devices with the MHRA. Following a government consultation on changes to the UK&#8217;s medical device regulations, the response to which was published on June 26, 2022, it is anticipated that amendments to the legislation will soon be published by the government and should become applicable by July 1, 2023 so that medical devices placed on the market in Great Britain (England, Scotland, and Wales) will require a UK Conformity Assessment (UKCA) mark. However, within the government&#8217;s consultation response, it has proposed that transition periods will be included in the revised legislation so that products with existing and valid conformity assessments (CE mark or UKCA mark) could continue to be placed on the Great Britain market for a maximum of 3-5 years after July 1, 2023, depending on which legislation the medical device has been certified under. IVDs with valid certification can continue to be placed on the market until the earlier of certificate expiry or for a period of five years following publication of the new regulations. However, UKCA marking alone will not be recognized in the EU. The rules for placing medical devices on the Northern Ireland market will differ from those in the Great Britain. These modifications may have an effect on the way we intend to conduct our business in these countries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Other Health Care Regulation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We may be subject to various federal, state and foreign laws pertaining to health care fraud and abuse, including anti-kickback laws and physician self-referral, false claims laws and physician payment transparency laws and regulations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In the U.S., the federal Anti-Kickback Statute prohibits, among other things, any person or entity, from knowingly and willfully offering, paying, soliciting, or receiving any remuneration, directly or indirectly, overtly or covertly, in cash or in kind, to induce or in return for purchasing, leasing, ordering, or arranging for the purchase, lease or order of any item or service reimbursable under Medicare, Medicaid or other federal healthcare programs. The term remuneration has been interpreted broadly to include anything of value. There are a number of statutory exceptions and regulatory safe harbors protecting some common activities from prosecution. The exceptions and safe harbors are drawn narrowly and practices that involve remuneration that may be alleged to be intended to induce prescribing, purchasing, or recommending may be subject to scrutiny if they do not qualify for an exception or safe harbor. Failure to meet all of the requirements of a particular applicable statutory exception or regulatory safe harbor does not make the conduct per se illegal under the Anti-Kickback Statute. Instead, the legality of the arrangement will be evaluated on a case-by-case basis based on a cumulative review of all of its facts and circumstances. In addition, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The federal physician self-referral prohibitions, commonly known as the Stark Law, generally prohibit entities from billing a patient or the Medicare or Medicaid programs for certain designated health services, including clinical laboratory services, when the physician ordering the service, or any member of such physician&#8217;s immediate family, has a financial interest, such as an ownership or investment interest in or compensation arrangement with us, unless the arrangement meets an exception to the prohibition. These prohibitions apply regardless of any intent by the parties to induce or reward referrals or the reasons for the financial relationship and the referral. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The federal False Claims Act prohibits, among other things, any person or entity from knowingly presenting, or causing to be presented, a false claim for payment to, or approval by, the federal government or knowingly making, using, or causing to be made or used a false record or statement material to a false or fraudulent claim to the federal government. A claim includes &#8220;any request or demand&#8221; for money or property presented to the U.S. government. In addition, a claim including items or services resulting from a violation of the federal Anti-Kickback Statute or Stark Law constitutes a false or fraudulent claim for purposes of the federal False Claims Act.</span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The federal Health Insurance Portability and Accountability Act of 1996 also created new federal criminal statutes that prohibit knowingly and willfully executing, or attempting to execute, a scheme to defraud or to obtain, by means of false or fraudulent pretenses, representations or promises, any money or property owned by, or under the control or custody of, any healthcare benefit program, including private third-party payors and knowingly and willfully falsifying, concealing or covering up by trick, scheme or device, a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items, or services. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. Also, many states have similar fraud and abuse statutes or regulations that apply to items and services reimbursed under Medicaid and other state programs, or, in several states, apply regardless of the payor.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In addition, the federal government, as part of the Patient Protection and Affordable Care Act (the ACA), as well as certain state governments have enacted laws aimed at increasing transparency in relationships between medical device companies and health care professionals. We are now required by the federal Physician Payments Sunshine Act and similar state and foreign laws to report annually many types of payments made and items of value provided to licensed health care professionals and teaching hospitals, as well as certain ownership and investment interests held by physicians (as defined by statute) and their immediate family members. Certain states also mandate implementation of commercial compliance programs, impose restrictions on device manufacturer marketing practices and tracking and/or require the reporting of gifts, compensation and other remuneration to physicians. In addition, certain foreign jurisdictions have adopted, or are currently acting to implement, similar laws. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In the EU, many member states have adopted specific anti-gift statutes that further limit commercial practices for medical devices (including IVDs), in particular vis-&#224;-vis healthcare professionals and organizations. Additionally, there has been a recent trend of increased regulation of payments and transfers of value provided to healthcare professionals or entities. In addition, many EU member states have adopted national &#8220;Sunshine Acts&#8221; which impose reporting and transparency requirements (often on an annual basis), similar to the requirements in the U.S., on medical device manufacturers. Certain countries also mandate implementation of commercial compliance programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Violations of these laws may be punishable by criminal and civil sanctions, including fines and civil monetary penalties, the possibility of exclusion from federal healthcare programs (including Medicare and Medicaid), disgorgement and corporate integrity agreements, which impose, among other things, rigorous operational and monitoring requirements on companies. Similar sanctions and penalties, as well as imprisonment, also can be imposed upon executive officers and employees of such companies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Coverage and Reimbursement</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Market acceptance and sales of our CooperSurgical products to our customers, who primarily consist of hospitals and surgical centers, OB/GYN medical offices and fertility clinics, will depend on the availability of payor coverage and the adequacy of reimbursement, for the procedures using our products, by government insurance programs and other third-party payors. Payor coverage and reimbursement for procedures using medical devices in the U.S. and international markets vary significantly by country.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In the U.S., our currently approved products are commonly treated as general supplies utilized in surgical procedures and if covered by third-party payors, are paid for as part of the procedure. Outside of the U.S., there are many reimbursement programs through private payors as well as government programs. In some countries, government reimbursement is the predominant program available to patients and hospitals. Our commercial success depends in part on the extent to which governmental authorities, private health insurers and other third-party payors provide coverage for and establish adequate reimbursement levels for the procedures during which our products are used. Failure by physicians, hospitals, surgery centers, fertility clinics and other users of our products to obtain sufficient coverage and reimbursement from third-party payors for procedures in which our products are used, or adverse changes in government and private third-party payors&#8217; coverage and reimbursement policies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We believe the overall escalating cost of medical products and services being paid for by the government and private health insurance has led to, and will continue to lead to, increased pressures on the healthcare and medical device industry to reduce the costs of products and services. All third-party reimbursement programs are developing increasingly sophisticated methods of controlling healthcare costs through prospective reimbursement and capitation programs, group purchasing, redesign of benefits, requiring second opinions prior to major surgery, careful review of bills, encouragement of healthier lifestyles and other preventative services and exploration of more cost-effective methods of delivering healthcare. In addition to uncertainties surrounding coverage policies, there are periodic changes to reimbursement levels. Third-party payors regularly update reimbursement amounts and also from time to time revise the methodologies used to determine reimbursement amounts. This includes routine updates to payments to physicians, hospitals and ambulatory surgery centers for procedures during which our products are used. These updates could directly impact the demand for our products.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">With respect to drug coverage and reimbursement, third-party payors are increasingly challenging the price and examining the medical necessity and cost-effectiveness of drugs, in addition to their safety and efficacy. Adoption of price controls and cost-containment measures, and adoption of more restrictive policies in jurisdictions with existing controls and measures, could further limit sales of PARAGARD or any other drug product that receives approval. Third-party payors may not consider our products to be medically necessary or cost-effective compared to other available therapies, or the rebate percentages required to secure favorable coverage may not yield an adequate margin over cost or may not enable us to maintain price levels sufficient to realize an appropriate return on our investment in drug development. Additionally, decreases in third-party reimbursement for any product or a decision by a third-party payor not to cover a product could reduce physician usage and patient demand for the product.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In international markets including the EU, reimbursement and healthcare payment systems vary significantly by country, and many countries have instituted price ceilings on specific product lines and procedures. There can be no assurance that procedures using our products will be covered for a specific indication, that our products will be considered cost-effective by third-party payors, that an adequate level of reimbursement will be available or that the third-party payors&#8217; reimbursement policies will not adversely affect our ability to sell our products profitably. For example, in the EU, member states impose controls on whether products are reimbursable by national or regional health service providers and on the prices at which devices are reimbursed under state-run healthcare schemes. More and more, local, product specific reimbursement law is applied as an overlay to medical device regulation, which has provided an additional layer of clearance requirement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Healthcare Reform</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In the U.S, there has been, and continues to be, several legislative and regulatory changes and proposed changes regarding the healthcare system that could prevent or delay marketing approval of product candidates, restrict or regulate post-approval activities, and affect the profitable sale of product candidates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Among policy makers and payors in the U.S, there is significant interest in promoting changes in healthcare systems with the stated goals of containing healthcare costs, improving quality and/or expanding access. Passed in March 2010, the ACA substantially changed the way healthcare is financed by both governmental and private insurers, and significantly affected the pharmaceutical, medical device and clinical laboratory industries. Among other things, the ACA increased the minimum level of Medicaid rebates payable by manufacturers of brand name drugs from 15.1% to 23.1%; required collection of rebates for drugs paid by Medicaid managed care organizations; required manufacturers to participate in a coverage gap discount program, in which manufacturers must agree to offer point-of-sale discounts off negotiated prices of applicable brand drugs to eligible beneficiaries during their coverage gap period, as a condition for the manufacturer&#8217;s outpatient drugs to be covered under Medicare Part D; imposed a non-deductible annual fee on pharmaceutical manufacturers or importers who sell certain &#8220;branded prescription drugs&#8221; to specified federal government programs, introduced a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted, or injected; expanded eligibility criteria for Medicaid programs; created a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct comparative clinical effectiveness research, along with funding for such research; and established a Center for Medicare &amp; Medicaid Innovation at the CMS to test innovative payment and service delivery models to lower Medicare and Medicaid spending, potentially including prescription drug spending.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Since its enactment, there have been judicial and political challenges to certain aspects of the ACA. On June 17, 2021, the U.S. Supreme Court rejected a challenge by a group of states and individuals to the constitutionality of the ACA. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Moreover, there has recently been heightened governmental scrutiny over the manner in which manufacturers set prices for their marketed products, which has resulted in several Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for pharmaceutical products. Most recently, on August 16, 2022, the Inflation Reduction Act of 2022, or IRA, was signed into law. Among other things, the IRA requires manufacturers of certain drugs to engage in price negotiations with Medicare (beginning in 2026), with prices that can be negotiated subject to a cap; imposes rebates under Medicare Part B and Medicare Part D to penalize price increases that outpace inflation (first due in 2023); and replaces the Part D coverage gap discount program with a new discounting program (beginning in 2025). Individual states in the U.S. have also become increasingly active in implementing regulations designed to control pharmaceutical product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. In addition, regional healthcare authorities and individual hospitals are increasingly using bidding procedures to determine which drugs and suppliers will be included in their healthcare programs. Furthermore, there has been increased interest by third-party payors and governmental authorities in reference pricing systems and publication of discounts and list prices.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In foreign countries where we market our products, recent healthcare reform has taken place as well. For instance in December 2021, the EU Regulation No 2021/2282 on Health Technology Assessment (HTA) amending Directive </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">2011/24/EU, was adopted. This regulation, which became effective in January 2022, intends to boost cooperation among EU member states in assessing health technologies, including some medical devices, and providing the basis for cooperation at the EU level for joint clinical assessments in these areas. The regulation foresees a three-year transitional period and will permit EU member states to use common HTA tools, methodologies, and procedures across the EU, working together in four main areas, including joint clinical assessment of the innovative health technologies with the most potential impact for patients, joint scientific consultations whereby developers can seek advice from HTA authorities, identification of emerging health technologies to identify promising technologies early, and continuing voluntary cooperation in other areas. Individual EU member states will continue to be responsible for assessing non-clinical (e.g., economic, social, ethical) aspects of health technologies, and making decisions on pricing and reimbursement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We expect that additional state, federal and foreign healthcare reform measures will be adopted in the future, any of which could limit the amounts that state, federal and foreign governments will pay for healthcare products and services, which could result in reduced demand for our products or additional pricing pressures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Data Privacy and Security Laws and Regulations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Numerous state, federal and foreign laws, including consumer protection laws and regulations, govern the collection, dissemination, use, access to, confidentiality and security of personal information, including health-related information. In the U.S., numerous federal and state laws and regulations, including data breach notification laws, health information privacy laws, and federal and state consumer protection laws and regulations, that govern the collection, use, disclosure, and protection of health-related and other personal information could apply to our operations or the operations of our partners. For example, the Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, and regulations implemented thereunder (collectively, HIPAA) imposes privacy, security and breach notification obligations on certain health care providers, health plans, and health care clearinghouses, known as covered entities, as well as their business associates that perform certain services that involve creating, receiving, maintaining or transmitting individually identifiable health information for or on behalf of such covered entities. Entities that are found to be in violation of HIPAA as the result of a breach of unsecured protected health information, a complaint about privacy practices or an audit by HHS, may be subject to significant civil, criminal and administrative fines and penalties and/or additional reporting and oversight obligations if required to enter into a resolution agreement and corrective action plan with HHS to settle allegations of HIPAA non-compliance. Further, entities that knowingly obtain, use, or disclose individually identifiable health information maintained by a HIPAA covered entity in a manner that is not authorized or permitted by HIPAA may be subject to criminal penalties. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Even when HIPAA does not apply, according to the Federal Trade Commission (FTC), violating consumers&#8217; privacy rights or failing to take appropriate steps to keep consumers&#8217; personal information secure may constitute unfair acts or practices in or affecting commerce in violation of Section 5(a) of the Federal Trade Commission Act. The FTC expects a company&#8217;s data security measures to be reasonable and appropriate in light of the sensitivity and volume of consumer information it holds, the size and complexity of its business, and the cost of available tools to improve security and reduce vulnerabilities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">In addition, certain state and non-U.S. laws, such as the EU General Data Protection Regulation (GDPR), govern the privacy and security of personal data, including health-related data in certain circumstances, some of which are more stringent than HIPAA and many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts. Failure to comply with these laws, where applicable, can result in the imposition of significant civil and/or criminal penalties and private litigation. For example, the California Consumer Privacy Act (CCPA) went into effect on January 1, 2020. The CCPA, among other things, creates data privacy obligations for covered companies and provides certain privacy rights to California residents, including the right to access and delete their personal information, opt out of certain personal information sharing, and receive detailed information about how their personal information is used. The CCPA also creates a private right of action with statutory damages for certain data breaches, thereby potentially increasing risks associated with a data breach. Further, the California Privacy Rights Act (CPRA), which will go into effect on January 1, 2023, significantly amends the CCPA and will impose additional data protection obligations on covered businesses, including additional consumer rights processes, limitations on data uses, new audit requirements for higher risk data, and opt outs for certain uses of sensitive data. It will also create a new California data protection agency authorized to issue substantive regulations and could result in increased privacy and information security enforcement. In Europe, the GDPR went into effect in May 2018 and imposes strict requirements for processing the personal data in the context of an establishment in the EEA or the processing of personal data of individuals within the EEA. The GDPR imposes comprehensive data privacy compliance obligations in relation to collection, processing, sharing, disclosure, transfer and other use of data relating to an identifiable living individual or &#8220;personal data,&#8221; including a principal of accountability and the obligation to demonstrate compliance through policies, procedures, training and audit. In addition, the GDPR increases the scrutiny of transfers of personal data from the EEA, including clinical trial sites located in the EEA to the U.S. and other jurisdictions that the European Commission does not recognize as having &#8220;adequate&#8221; data protection laws; in July 2020, the Court of Justice of the EU (CJEU) limited how organizations could lawfully transfer personal data from the EEA to the U.S. by invalidating the EU-US Privacy Shield and imposing further </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">restrictions on use of the standard contractual clauses, which could increase our costs and our ability to efficiently process personal data from the EEA. Indeed, while the CJEU upheld the adequacy of the standard contractual clauses (a standard form of contract approved by the European Commission as an adequate personal data transfer mechanism, and potential alternative to the Privacy Shield), it made clear that reliance on them alone may not necessarily be sufficient in all circumstances. Use of the standard contractual clauses must now be assessed on a case-by-case basis taking into account the legal regime applicable in the destination country, in particular applicable surveillance laws and rights of individuals and additional measures and/or contractual provisions may need to be put in place. Subsequent European court and regulator decisions have taken a restrictive approach to international data transfers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Companies that must comply with the GDPR face increased compliance obligations and risk, including more robust regulatory enforcement of data protection requirements and potential fines for noncompliance of up to &#8364;20 million or 4% of the annual global revenues of the noncompliant undertaking, whichever is greater. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Additionally, following the UK&#8217;s withdrawal from the EU, and the expiry of the transition period, companies will have to comply with the GDPR and the GDPR as incorporated into the UK national law, the latter regime having the ability to separately fine up to the greater of &#163;17.5 million or 4% of annual global turnover. The European Commission has adopted an adequacy decision in favor of the UK, enabling data transfers from EU member states to the UK without additional safeguards. However, the UK adequacy decision will automatically expire in June 2025 unless the European Commission re-assesses and renews/extends that decision, and remains under review by the Commission during this period. The relationship between the UK and the EU in relation to certain aspects of data protection law remains unclear, and it is unclear how UK data protection laws and regulations will develop in the medium to long term, and how data transfers to and from the UK will be regulated in the long term. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">RAW MATERIALS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our businesses utilize various chemicals, packaging materials, components, parts and raw materials which are generally available from more than one source. However, in certain instances we acquire components and materials from sole suppliers to make our silicone hydrogel contact lens, certain medical devices and IVF products. Supply of these materials is protected by contractual agreements and safety stocks. However, if current raw material suppliers fail to supply sufficient materials on a timely basis, or at all for any reason, we could experience inventory shortages and disruption in the supply of products if we were required to use an alternative supplier on short notice.&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">MARKETING AND DISTRIBUTION</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision markets our products through our own field sales representatives, distributors and eye care practitioners, including optometrists, ophthalmologists, opticians and optical chains. CooperVision also sells to distributors and to mass merchandisers who offer eye care services. To support the sale and use of CooperVision products, CooperVision engages in various activities and offers a variety of services. These include clinical training, digital marketing for the customer, e-commerce, telemarketing, social media, and journal advertisements. CooperVision also invested in tools that allow our customers to offer their patients monthly purchase and delivery subscriptions. In certain smaller countries, CooperVision often uses distributors and leverages our distributors' sales and marketing resources to attract major customers to CooperVision. With the addition of MiSight, CooperVision has expanded the breadth and depth of its sales support by adding myopia management specialists while it has expanded awareness campaigns to include direct to consumer elements including print, internet/social media, radio and television. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperSurgical's products are marketed by a network of dedicated field sales representatives, independent agents and distributors. CooperSurgical augments its sales and marketing activities by participating in national and regional industry trade shows, professional educational programs and internet promotions including e-commerce, social media and collaborative efforts with professional organizations, telemarketing, direct mail and advertising in professional journals. Since the addition of PARAGARD and cord blood and cord tissue storage services, CooperSurgical has also expanded its awareness campaigns to include direct to consumer elements including print, internet/social media, radio and television.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">PATENTS, TRADEMARKS AND LICENSING AGREEMENTS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Cooper owns or licenses a variety of domestic and foreign patents, which, in total, are material to our overall business. The names of certain Cooper's products are protected by trademark registrations in the U.S. Patent and Trademark Office and, in some cases, also in foreign trademark offices. Applications are pending for additional trademark and patent registrations. Cooper intends to protect our intellectual property rights aggressively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In addition to trademarks and patent licenses, we own certain trade secrets, copyrights, know-how and other intellectual property.</span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Aquaform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:112%;position:relative;top:-3.32pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">, Avaira</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:112%;position:relative;top:-3.32pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">, Avaira Vitality</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:112%;position:relative;top:-3.32pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:112%;position:relative;top:-3.32pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Biofinity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:112%;position:relative;top:-3.32pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">, Biofinity Energys</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:112%;position:relative;top:-3.32pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">, MyDay</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:112%;position:relative;top:-3.32pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">, MiSight</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:112%;position:relative;top:-3.32pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">, ActivControl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:112%;position:relative;top:-3.32pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">, Proclear</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:112%;position:relative;top:-3.32pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"> and Biomedics</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:112%;position:relative;top:-3.32pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"> are registered trademarks of The Cooper Companies, Inc., its affiliates and/or subsidiaries. PC Technology&#8482; and FIPS&#8482; are trademarks of The Cooper Companies, Inc., its affiliates and/or subsidiaries. The clariti</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:112%;position:relative;top:-3.32pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"> mark is a registered trademark of The Cooper Companies, Inc., its affiliates and/or subsidiaries worldwide except in the U.S. where the use of clariti</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:112%;position:relative;top:-3.32pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"> is licensed. PARAGARD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:112%;position:relative;top:-3.32pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">, Mara</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:112%;position:relative;top:-3.32pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">, Fetal Pillow</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:112%;position:relative;top:-3.32pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"> and Endosee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:112%;position:relative;top:-3.32pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">are registered trademarks of CooperSurgical, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">DEPENDENCE ON CUSTOMERS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">No customer accounted for 10% or more of our consolidated net revenue in fiscal 2022 and 2021. See Note 12. Business Segment Information of the Consolidated Financial Statements for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">GOVERNMENT CONTRACTS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Neither of our business units is materially subject to profit renegotiation or termination of contracts or subcontracts at the election of the U.S. government.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">SEASONALITY</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision and CooperSurgical net sales in the fiscal first quarter, which runs from November 1 through January&#160;31, are typically lower than subsequent quarters, as patient traffic to practitioners' offices, fertility clinics, and hospitals/surgical centers for surgical procedures is relatively light during the holiday season.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">COMPLIANCE WITH ENVIRONMENTAL LAWS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Federal, state and local provisions that regulate the discharge of materials into the environment, or relate to the protection of the environment, do not currently materially affect Cooper's capital expenditures, earnings or competitive position.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In addition, the Company continues to monitor and comply with environmental health and safety regulations in countries in which it operates throughout the world, in particular, EU and China Restrictions on the use of certain Hazardous Substances in electrical and electronic equipment (RoHS) and Registration, Evaluation, Authorization and Restriction of Chemical substances (REACH).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">HUMAN CAPITAL RESOURCES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of October&#160;31, 2022, we had a workforce of more than 14,000. We believe we have good relations with our workforce. Our employees are located around the world, with 52% in Americas, 43% in EMEA and 5% in Asia Pacific. Human capital management areas of focus include a people-focused culture; embedding diversity and inclusion; fostering an environment of health, safety, and well-being; investing in and developing our employees through training and engagement. In addition, we regularly conduct an employee survey to gauge employee engagement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Chart below shows percentage of employees located in Americas, EMEA and Asia Pacific as of October&#160;31, 2022.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><img src="coo-20221031_g3.jpg" alt="coo-20221031_g3.jpg" style="height:250px;margin-bottom:5pt;vertical-align:text-bottom;width:250px"/></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Additional information is included in our annual ESG Report (located on our website at www.coopercos.com/esg). Information on our website, including the ESG Report, shall not be deemed incorporated by reference into this Annual Report.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:115%">CYBERSECURITY</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In the normal course of business, we may collect and store personal information and other sensitive information, including proprietary and confidential business information, trade secrets, intellectual property, information regarding trial participants in connection with clinical trials, sensitive third-party information and employee information. To protect this information, our existing cybersecurity policies require continuous monitoring and detection programs, network security precautions, and in-depth security assessment of vendors. We maintain various protections designed to safeguard against cyberattacks, including firewalls and virus detection software. We have established and regularly test our disaster recovery plan and we protect against business interruption by backing up our major systems. In addition, we periodically scan our environment for any vulnerabilities, perform penetration testing and engage third parties to assess effectiveness of our data security practices. A third-party security consultant conducts regular network security reviews, scans and audits. In addition, we maintain insurance that includes cybersecurity coverage.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our cybersecurity program is led by a team of highly skilled cybersecurity professionals, including 10 dedicated internal cybersecurity resources. Four members of the security team currently have CISSP credentials, five members hold one or more GIAC/SANS cybersecurity certificates, and in total the team has over 40 security and network certifications. In addition to our internal security staff, we partner with various third-party security service providers, including two 24/7 SOC teams, to augment our staffing, expertise, and hours of operation. The program incorporates industry-standard frameworks, policies and practices designed to protect the privacy and security of our sensitive information. The program also includes a suite of best-in-breed security technologies and tools to implement and automate security protections for our networks, employees, and customers. Our cybersecurity team reports to the Audit Committee quarterly on information security and cybersecurity matters, or as needed. Our Audit Committee, which is comprised of several members from our Board of Directors, has oversight responsibility for our data security practices and we believe the committee has the requisite skills and visibility into the design and operation of our data security practices to fulfill this responsibility effectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Despite the implementation of our cybersecurity program, our security measures cannot guarantee that a significant cyberattack will not occur. A successful attack on our information technology systems could have significant consequences to the business. While we devote resources to our security measures to protect our systems and information, these measures cannot provide absolute security. See &#8220;Risk Factors &#8211; Risks Relating to Our Business&#8221; for additional information about the risks to our business associated with a breach or compromise to our information security systems.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">AVAILABLE INFORMATION</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Cooper Companies, Inc. Internet address is http://www.coopercos.com. The information on the Company's website is not part of this or any other report we file with, or furnish to, the Securities and Exchange Commission (SEC). Our annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, along with all other reports and amendments filed with or furnished to the SEC, are publicly available free of charge on our website as soon as reasonably practicable. The SEC maintains a website that contains such reports, proxy and information statements and other information whose Internet address is http://www.sec.gov. The Company's Corporate Governance Principles, Code of Conduct and charters of each standing committee of the Board of Directors are also posted on the Company's website.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="ifcd99b6df4104f80be938ce77dc8288d_19"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item 1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Risk Factors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Our business faces significant risks. These risks include those described below and may include additional risks and uncertainties not presently known to us or that we currently deem immaterial. Our business, financial condition and results of operations could be materially adversely affected by any of these risks, and the trading prices of our common stock could decline by virtue of these risks. These risks should be read in conjunction with the other information in this report.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Risks Relating to Our Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Current market conditions and recessionary pressures in one or more of our markets could impact our ability to grow our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Over the last few years in the U.S. and globally, market and economic conditions have been challenging, particularly in light of the COVID-19 pandemic. Foreign countries, in particular the Euro zone, have experienced recessionary pressures and face continued concerns about the systemic impacts of adverse economic conditions and geopolitical issues. Any negative impact on economic conditions and international markets, continued volatility or deterioration in the debt and equity capital markets, inflation, deflation or other adverse economic conditions may adversely affect our liquidity and financial condition. It may limit our ability to replace maturing liabilities and to access the capital markets to meet liquidity needs, which could have a material adverse effect on our financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Ongoing uncertain economic and financial market conditions may also adversely affect the financial condition of our customers, suppliers and other business partners. When our customers&#8217; financial conditions are adversely affected, customers may reduce their purchases of our products or we may not be able to collect accounts receivable, each of which could have a material adverse impact on our business operations or financial results. Our global business has been negatively affected by local economic conditions, including inflation, increasing labor costs, recession, and currency exchange rate fluctuations, which has adversely affected our cost to manufacture and provide our products and services and revenues generated through sales of such products and services. There is no guarantee that we will be able to fully absorb any such additional costs or revenue declines in the prices for our products and services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision and CooperSurgical are encountering consolidation in their customer bases and emergence of more centralized large customer groups and retail chains. Due to this trend, global and regional key account customers now represent a larger proportion or concentration of our business and any disruption to these relationships may have a material adverse impact on our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Inflation could materially adversely affect our business and operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our operating results could be materially impacted by changes in the overall macroeconomic environment and other economic factors that impact our cost structure and revenue results. Changes in economic conditions, supply chain constraints, logistics challenges, labor shortages, the war in Ukraine, and steps taken by governments and central banks, particularly in response to the COVID-19 pandemic, as well as other stimulus and spending programs, have led to higher inflation, which is likely to lead to an increase in costs and may cause changes in fiscal and monetary policy, including increased interest rates. In a higher inflationary environment, we may be unable to raise the prices of our products and services sufficiently to keep up with the rate of inflation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Our substantial and expanding international operations are subject to uncertainties which could affect our operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">A significant portion of our current operations are conducted and located outside the U.S., and our growth strategy involves expanding our existing foreign operations and entering into new foreign jurisdictions. We have significant manufacturing and distribution sites in North America, Latin America and Europe. More than half of our net sales for the fiscal years ended October 31, 2022 and 2021, were derived from the sale of products outside the United States. We believe that sales outside the United States will continue to account for a material portion of our total net sales for the foreseeable future. International operations and business expansion plans are subject to numerous additional risks, including the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">difficulty managing a large organization spread throughout various countries;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">fluctuations in currency exchange rates adversely affecting our results;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">difficulty managing the effects of the COVID-19 pandemic on our ability to operate internationally and for our employees to travel internationally;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">challenges associated with enforcing intellectual property rights in some foreign countries;</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">difficulty gaining market share in countries such as China because of regulatory restrictions and customer preferences;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">difficulty growing our sales in emerging markets such as China, India, Russia, Brazil and other developing nations due to, among other things, customer acceptance, undeveloped and/or unfamiliar distribution channels, regulatory restrictions and changes, and business knowledge of these new markets;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">foreign earnings being subject to withholding requirements or the imposition of tariffs, exchange controls or other restrictions, including the tariffs enacted by the Chinese government on certain U.S. goods, the scope and duration of which remain uncertain;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">challenges in complying with a variety of international legal, compliance and regulatory requirements such as the Foreign Corrupt Practices Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act, the UK Bribery Act, international data security and privacy laws, EU MDR and EU IVDR;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">foreign customers creating longer payment cycles than customers in the U.S.;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">failure to comply with U.S. Department of Commerce and other nations' import-export controls may result in fines and/or penalties;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">general economic and political conditions in the countries where we operate having an adverse effect on our operations in those countries or being unfavorable to our growth strategy;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">natural disasters, pandemics, war, terrorism, labor disruptions and international conflicts may cause significant economic disruption and political and social instability, resulting in decreased demand for our products, adversely affecting our manufacturing and distribution capabilities, or causing interruptions in our supply chain; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">foreign governments adopting regulations, including those similar to the EU MDR and EU IVDR or take other actions that would have a direct or indirect adverse impact on our business and market opportunities, including but not limited to increased enforcement of potentially conflicting and ambiguous anti-bribery and privacy laws;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">challenges enforcing agreements and collecting receivables through some foreign legal systems; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">unforeseen economic or political events in certain countries that may have an impact on our customers' ability or preferences to buy our products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As we continue to expand our business globally, our success will depend, in large part, on our ability to anticipate and effectively manage these and other risks associated with our international operations. However, any of these factors could adversely affect our international operations and, consequently, our operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">The war between Russia and Ukraine could adversely affect our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On February 24, 2022, Russian military forces launched a military action in Ukraine, and sustained conflict and disruption in the region is likely. The length, impact, and outcome of this ongoing military conflict is highly unpredictable and could lead to significant market and other disruptions, including significant volatility in commodity prices and supply of energy resources, instability in financial markets, supply chain interruptions, political and social instability, trade disputes or trade barriers, changes in consumer or purchaser preferences, as well as an increase in cyberattacks and espionage.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The war has led to significant sanctions programs imposed by the U.S., the European Union, the UK, Canada, Switzerland, Japan, and other countries against Russia, Belarus, the Crimea Region of Ukraine, the so-called Donetsk People&#8217;s Republic, and the so-called Luhansk People&#8217;s Republic, including, among others:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">blocking sanctions against some of the largest state-owned and private Russian financial institutions (and their subsequent removal from the Society for Worldwide Interbank Financial Telecommunication payment system) and certain Russian businesses, some of which have significant financial and trade ties to the European Union;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">blocking sanctions against Russian and Belarusian individuals, including the Russian President, other politicians, and those with government connections or involved in Russian military activities; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">blocking of Russia&#8217;s foreign currency reserves as well as expansion of sectoral sanctions and export and trade restrictions, limitations on investments and access to capital markets, and bans on various Russian imports; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">enhanced export controls and trade sanctions targeting Russia&#8217;s imports of technological goods as a whole, including tighter controls on exports and reexports of dual-use items, stricter licensing policy with respect to issuing export licenses, and/or increased use of &#8220;end-use&#8221; controls to block or impose licensing requirements on exports, as well as higher import tariffs and a prohibition on exporting luxury goods to Russia and Belarus.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In retaliation against new international sanctions and as part of measures to stabilize and support the volatile Russian financial and currency markets, the Russian authorities also imposed significant currency control measures aimed at restricting the outflow of foreign currency and capital from Russia, imposed various restrictions on transacting with non-Russian parties, banned exports of various products, and imposed other economic and financial restrictions. The situation is rapidly evolving, and additional sanctions by Russia on the one hand, and by the other countries on the other hand, could adversely affect the global economy, financial markets, energy supply and prices, certain critical materials and metals, supply chains, and global logistics and could adversely affect our business, financial condition, and results of operations.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Our business must be conducted in compliance with applicable economic and trade sanctions laws and regulations, including those administered and enforced by the U.S. Department of Treasury&#8217;s Office of Foreign Assets Control, the U.S. Department of State, the U.S. Department of Commerce, the United Nations Security Council, and other relevant governmental authorities. If we are found to be in violation of U.S. sanctions or export control laws, it could result in substantial fines and penalties for us and for individuals working for us. We are actively monitoring the situation in Ukraine and Russia and assessing its impact on our business, including our business partners, employees and customers. To date, we have not experienced any material interruptions in our infrastructure, supplies, technology systems, or networks needed to support our operations. The conflict has caused us to modify our operations in Russia and could lead to additional modifications in Russia. We cannot predict the progress or outcome of the war or its impacts in the territories where we operate. The extent and duration of the military action, sanctions, other consequences, such as Russia imposing restrictions on transactions or banning the export of energy products, including natural gas, and the resulting market disruptions could be significant and could potentially have substantial impact on the global economy and our business for an unknown period of time. Any such disruption may also magnify the impact of other risks described in this section.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Our results of operations have been adversely affected, and our results of operations, cash flow and financial condition could be materially adversely affected in the future, by the global COVID-19 pandemic and related economic disruptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The COVID-19 pandemic has negatively impacted business and healthcare activity globally and has created significant volatility, uncertainty and economic disruption within the markets in which we operate. The pandemic has adversely affected and is likely to further adversely affect nearly all aspects of our business and markets, including our sales, operations, cash flow and workforce and the operations of our customers, suppliers, vendors and business partners. Among other things, many optical practitioners and retailers, hospitals, medical offices and fertility clinics closed their facilities, restricted access, or delayed or canceled patient visits, exams and elective medical procedures in response to the pandemic, and many customers that have reopened are experiencing reduced patient visits, which has resulted in reduced demand for and sales of our products and services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">To the extent the COVID-19 pandemic persists, with surges in infection and associated government responses, our results of operations, cash flow and financial condition could be materially adversely affected in numerous ways, including, but not limited to, decreased net sales from sales of our products and services due to customer facility closures, restricted access and reduced patient visits, exams and elective medical procedures; disruption in the manufacture and distribution of our products, including increased manufacturing and distribution costs, reduced manufacturing capacity and inadequate inventory levels; increased risk of inventory that may expire; write-offs or obsolescence of inventory, equipment or other assets; disruptions to or increased costs from our raw material and product suppliers and broader supply chain and distribution systems; delays in our clinical trials which could negatively impact our new product pipeline milestones and regulatory clearances, approvals or certifications; extended delays in or defaults on payments of outstanding receivables; insolvency of customers, suppliers, vendors and business partners; an inability to access lending, capital markets and other sources of liquidity when needed on reasonable terms or at all; an inability to comply with financial covenants in our debt agreements; and future restructuring, impairment and other charges.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The extent to which the COVID-19 pandemic and related economic disruptions impact our business, results of operations, cash flow and financial condition will depend on future developments, which are highly uncertain, difficult to predict and largely outside of our control, including, but not limited to, the continued spread, duration and severity of the pandemic outbreak; the occurrence, spread, duration and severity of any subsequent wave or waves of outbreaks, including the emergence and spread of variants of the COVID-19 virus; the impact on our customers and suppliers; the actions taken by the U.S. and foreign governments to contain the pandemic, address its impact or respond to the reduction in global and local economic activity; the occurrence, duration and severity of a global, regional or national recession, depression or other sustained adverse market event; and how quickly and to what extent normal economic and operating conditions can resume. Even after the COVID-19 pandemic has subsided, we may continue to experience materially adverse effects on our results of operations and financial condition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Acquisitions that we have made and may make in the future involve numerous risks.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We have a history of acquiring businesses and products that have significantly contributed to our growth in recent years. As part of our growth strategy, we intend to continue to consider acquiring complementary technologies, products and businesses. Future acquisitions could result in potentially dilutive issuances of equity securities, the incurrence of debt and contingent liabilities and an increase in amortization and/or impairments of goodwill and other intangible assets, which could have a material adverse effect upon our business, financial condition and results of operations. In fiscal 2022, CooperVision acquired a privately-held Denmark-based ortho-k contact lens distributor. In fiscal 2021, CooperVision acquired a privately held medical device company and a privately-held UK contact lenses manufacturer. In fiscal 2022, CooperSurgical acquired a private cryopreservation services company and Generate Life Sciences (Generate), a privately-held provider of donor egg and sperm for fertility treatments, fertility cryopreservation services and newborn stem cell storage (cord blood &amp; cord tissue). In fiscal 2021, CooperSurgical acquired three privately-held medical device companies </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">and one privately-held IVF cryostorage software solutions company. Risks we could face with respect to these acquisitions include:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">failure to successfully obtain the anticipated revenues, margins and earnings benefits;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">difficulties in, and expenses related to, the integration of the operations, technologies, products and personnel of the acquired company and establishment of appropriate accounting controls and reporting procedures and other regulatory compliance procedures, including but not limited to third-party compliance and due diligence;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">increased leverage and the risk of lack of access to available financing, including financing for the acquisition or refinancing of debt owed by us on a timely basis and on reasonable terms;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">risks of entering markets in which we have no or limited prior experience;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">potential loss of employees;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">an inability to identify and consummate future acquisitions on favorable terms or at all;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">diversion of management's attention away from other business concerns;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">risks of the acquired company&#8217;s noncompliance with applicable laws or regulations;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">expenses of any undisclosed or potential liabilities, contingent liabilities or indemnification obligations of the acquired company;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">expenses, including restructuring expenses, to shut-down our own locations or terminate our employees;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">application of and compliance with new and unfamiliar regulatory frameworks such as regulation applicable to our newly acquired fertility-related businesses;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Failure to successfully obtain or maintain reimbursements under the third-party payor plans, including but not limited to governmental programs, due to complex reporting and payment obligations;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">a dilution of earnings per share; and</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">risks inherent in accounting allocations and the risk that we are required to record significant adjustments to the preliminary fair value of assets acquired and liabilities assumed within the measurement period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">We face risks associated with disruption of our manufacturing, distribution and storage operations, including possible failure to develop necessary manufacturing processes, or constrained, idle or excess capacity, which could adversely affect our profitability or competitive position. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">We manufacture a significant portion of the medical device products we sell. Any prolonged disruption in the operations of our existing manufacturing or distribution facilities or our fertility and stem cell storage facilities, whether due to the effects of the COVID-19 pandemic and related work stoppages, technical or labor difficulties, integration difficulties, destruction of or damage to any facility (as a result of natural disaster, use and storage of hazardous materials or other events), enforcement action by the FDA or other regulatory body if we are found to be in non-compliance with current Good Manufacturing Practices (cGMP) or similar foreign requirements or other reasons, could have a material adverse effect on our business, financial condition and results of operations. In addition, materials such as silicone hydrogel require improvements to our manufacturing processes to make them cost effective. While we have improved our manufacturing capabilities for our silicone hydrogel products, our failure to continue to develop improvements to our manufacturing processes and reduce our cost of goods could significantly impact our ability to compete. Conversely, constrained, excess or idle capacity, which could result from acquisitions, unexpected demand, inaccurate sales forecasting or unexpected manufacturing efficiencies, could significantly impact our profitability, capital investments, customer service levels and near-term financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision manufactures molded contact lenses, which represent the majority of our contact lens revenues, primarily at our facilities in Costa Rica, Hungary, Puerto Rico, the UK and the U.S., with other smaller facilities also existing in multiple locations around the world. CooperSurgical manufactures the majority of its products in Costa Rica, the UK and the U.S., with other smaller locations also existing in multiple locations around the world. In November 2017, CooperSurgical purchased a manufacturing facility in Costa Rica to consolidate a portion of global manufacturing. We manufacture certain products at only one manufacturing site for certain markets, and certain of our products are approved for manufacturing only at one site. If there were any prolonged disruption in the operations of the approved facility, it could take a significant amount of time to obtain required regulatory approvals, validate a second site and replace lost product, which could result in lost customers and thereby reduce sales, profitability and market share.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision distributes products out of Belgium, Hungary, the UK and the U.S. and various smaller international distribution sites. CooperSurgical primarily distributes products out of its facilities in the U.S. and the Netherlands and </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">operates fertility and stem cell storage facilities in the U.S., Canada and Australia. Any prolonged disruption in the operations of our existing distribution or storage facilities, whether due to technical or labor difficulties, challenges related to system implementation, destruction of or damage to any facility (as a result of natural disaster, use and storage of hazardous materials or other events) or other reasons, could have a material adverse effect on our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Cybersecurity threats continue to increase in frequency and sophistication; a successful cybersecurity attack could interrupt or disrupt our information technology systems, or those of our third-party service providers, or cause the loss of confidential or protected data which could disrupt our business, force us to incur excessive costs or cause reputational harm.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Security breaches, computer malware and computer hacking attacks have become more prevalent across industries and may occur on our systems or those of our third-party service providers or partners. The size and complexity of our information systems make such systems potentially vulnerable to service interruptions or to security breaches from inadvertent or intentional actions by our employees or vendors, or from attacks by malicious third parties. Such attacks are increasing in their frequency, levels of persistence, levels of sophistication and intensity, and are being conducted by sophisticated and organized groups and individuals with a wide range of motives and expertise, especially given increased vulnerability of corporate information technology systems as distributed work environments have become prevalent (including as a result of the COVID-19 pandemic). In addition to unauthorized access to or acquisition of personal data, confidential information, intellectual property or other sensitive information, such attacks could include the deployment of harmful malware and ransomware, and may use a variety of methods, including denial-of-service attacks, social engineering and other means, to attain such unauthorized access or acquisition or otherwise affect service reliability and threaten the confidentiality, integrity and availability of information. Like many other companies, we experience attempted cybersecurity actions on a frequent basis, and the frequency of such attempts could increase in the future. While we have invested in the protection of data and information technology, there can be no assurance that our efforts will prevent or quickly identify service interruptions or security breaches. The techniques used by cybercriminals change frequently, may not be recognized until launched and can originate from a wide variety of sources, including outside groups such as external service providers, organized crime affiliates, terrorist organizations or hostile foreign governments or agencies. We cannot assure that our data protection efforts and our investment in information technology will prevent significant breakdowns, data leakages or breaches in our systems or those of our third-party services providers or partners. Any such interruption or breach of our systems could adversely affect our business operations and/or result in the loss of critical or sensitive confidential information or intellectual property, and could result in financial, legal, business and reputational harm to us. We maintain cyber liability insurance; however, this insurance may not be sufficient to cover the financial, legal, business or reputational losses that may result from an interruption or breach of our systems.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">We manage our businesses utilizing complex integrated software and hardware information technology operating systems that are regularly maintained and upgraded; an interruption or disruption to these systems could disrupt our business or force us to incur excessive costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We utilize complex integrated software and hardware operating systems, including enterprise resource planning and warehouse management systems,&#160;to support our business units and we have a continuous improvement strategy in place to keep our systems and overarching technology stable and in line with business needs and growth. Regular upgrades of our computer hardware and software revisions are typical and expected. We employ controlled change management methodologies to plan, test and execute all such system upgrades and improvements, and we believe that we assign adequate staffing and other resources to projects to ensure successful implementation. However, we cannot assure that our systems will meet our future business needs or that upgrades will operate as designed. We cannot assure that there will not be associated excessive costs or disruptions in portions of our business in the course of our maintenance, support and/or upgrade of these systems.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We are in the midst of a multiyear process of implementing new enterprise resource planning (ERP) systems at CooperVision and CooperSurgical. Implementing a new ERP system is not only costly but complex and difficult. Implementing a new ERP system can negatively affect not only financial accounting and reporting processes but also external commercial activities such as order receipt and product delivery. There can be no assurance that we will successfully implement our new ERP system or that we will avoid these and other negative impacts from our implementation efforts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Pricing pressure from our competitors, customers and changes in third-party coverage and reimbursement may adversely affect demand for our products and negatively impact our operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Competition in our industry has increased as a result of new market entrants, new technologies and as more established companies have intensified competitive pricing pressure. As a result of these competitive forces, we believe there will continue to be pricing pressure in the future. Because our CooperSurgical products are generally purchased by hospitals and surgical centers, OB/GYN medical offices and fertility clinics, and billed to various third-party payors, changes in the </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">purchasing behavior of such customers or the amount such payors are willing to reimburse our customers for procedures using our products, including as a result of healthcare reform initiatives, could create additional pricing pressure on us. In addition to these competitive forces, we continue to see pricing pressure as our customers introduce new pricing structures into their contracts and agreements, including fixed price formulas, capitated pricing and structured pricing intended to contain healthcare costs. Such trends may adversely affect demand for our products and may drive down the prices we are able to charge for our products, both of which would negatively affect our operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">We rely on independent suppliers in our supply chain for raw materials, packaging materials and components, mechanical equipment and some finished goods; we could experience inventory shortages if any of these suppliers encounter a manufacturing or distribution disruption</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our businesses utilize various chemicals, packaging materials, components, parts and raw materials which are generally available from more than one source. However, in certain instances we acquire components and materials from sole or primary suppliers to make our silicone hydrogel contact lens, certain medical devices and IVF products. We also source mechanical equipment and in certain instances finished goods from OEM suppliers. Supply of these goods, items and materials is protected by contractual agreements, availability of alternative suppliers and/or safety stocks. However, if current suppliers fail to supply sufficient goods, items or materials to us on a timely basis, or at all for any reason, we could experience inventory shortages and disruption in our supply of products. For example, among other situations, some of the primary material used to make our silicone hydrogel contact lens products, including MyDay, Biofinity, Avaira and clariti, are supplied by few or sole suppliers, and the failure of a key or sole supplier to timely supply sufficient items and materials necessary for the manufacture of our silicone hydrogel contact lenses could in turn disrupt our supply of those lenses to the market, which would have a material adverse effect on our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our supply chain and our cost of goods also may be negatively impacted by unanticipated price increases due to factors such as inflation, including wage inflation, or to supply restrictions beyond our control or the control of our suppliers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">If we fail to protect our intellectual property adequately, our business could suffer.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We consider our intellectual property rights, including patents, trade secrets, trademarks and licensing agreements, to be an integral component of our business. We attempt to protect our intellectual property rights through a combination of patent, trademark, copyright and trade secret laws, as well as licensing agreements and third-party nondisclosure and assignment agreements. Our failure to obtain or maintain adequate protection of our intellectual property rights for any reason could have a material adverse effect on our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We also may seek to enforce our intellectual property rights on others through litigation. Our claims, even if meritorious, may be found invalid or inapplicable to a party we believe infringes or has misappropriated our intellectual property rights. In addition, litigation can:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">be expensive and time consuming to prosecute or defend; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">result in a finding that we do not have certain intellectual property rights or that such rights lack sufficient scope or strength; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">divert management's attention and resources; or </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">require us to license our intellectual property.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We have applied for patent protection in the U.S., the UK and other foreign jurisdictions relating to certain existing and proposed processes and products. We cannot assure that any of our patent applications will be approved. Patent applications in the U.S., the UK and other foreign jurisdictions are maintained in secrecy for a period of time, which may last until patents are issued, and since publication of discoveries in the scientific or patent literature tends to lag behind actual discoveries by several months, we cannot be certain that we will be the first creator of inventions covered by any patent application we make or the first to file patent applications on such inventions. The patents we own could be challenged, invalidated or circumvented by others and may not be of sufficient scope or strength to provide us with any meaningful protection or commercial advantage. We also cannot assure that we will have adequate resources to enforce our patents.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Both CooperVision and CooperSurgical also rely on proprietary technology which is unpatented. It is possible that others will independently develop the same or similar technology or otherwise obtain access to our unpatented technology. To protect our trade secrets and other proprietary information, we require employees, consultants, advisors and collaborators to enter into confidentiality agreements and assignment agreements, which generally provide that inventions conceived by the party in the course of rendering services to us will be our exclusive property. However, we cannot assure that these </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">confidentiality agreements will provide meaningful protection for our trade secrets, know-how or other proprietary information in the event of any unauthorized use, misappropriation or disclosure of such trade secrets, know-how or other proprietary information. Enforcing a claim that a party illegally obtained and is using our trade secrets is difficult, expensive and time consuming and the outcome is unpredictable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We rely on trademarks to establish a market identity for our products. To maintain the value of our trademarks, we might have to file lawsuits against third parties to prevent them from using trademarks confusingly similar to or dilutive of our registered or unregistered trademarks. We also might not obtain registrations for our pending or future trademark applications and might have to defend our registered trademark and pending applications from challenge by third parties. Enforcing or defending our registered and unregistered trademarks might result in significant litigation costs and damages, including the inability to continue using certain trademarks.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The laws of foreign countries in which we do business or contemplate doing business in the future may not recognize intellectual property rights or protect them to the same extent as do the laws of the U.S. Adverse determinations in a judicial or administrative proceeding could prevent us from manufacturing and selling our products or prevent us from stopping others from manufacturing and selling competing products, and thereby have a material adverse effect on our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Our products or processes could be subject to claims of infringement of the intellectual property of others.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our competitors in both the U.S. and foreign countries, some of which have substantially greater resources and have made substantial investments in competing technologies, as well as other third parties, may have applied for or obtained, or may in the future apply for and obtain, patents that will prevent, limit or otherwise interfere with our ability to make and sell our existing and planned products. In the contact lens industry, CooperVision, its competitors and other third parties hold patents covering contact lens designs, business methods, processes and materials. Claims that our products, business methods or processes infringe upon the proprietary rights of others often are not asserted until after commencement of commercial sales of products incorporating our technology.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Significant litigation regarding intellectual property rights exists in our industries. For example, CooperVision in the past faced significant patent litigation over its silicone hydrogel contact lens products. Third parties have made, and may make in the future, claims of infringement against us or our contract manufacturers in connection with the use of our technology. Any claims, even those without merit, could:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">be expensive and time consuming to defend; </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">cause us to cease making, licensing or selling products that incorporate the challenged intellectual property; </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">require us to redesign or re-engineer our products, if feasible; </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">divert management's attention and resources; or </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">require us to enter into royalty or licensing agreements in order to obtain the right to use a necessary product, component or process.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We cannot be certain of the outcome of any litigation. Any royalty or licensing agreement, if required, may not be available to us on acceptable terms or at all. Our failure to obtain the necessary licenses or other rights could prevent the sale, manufacture, or distribution of some of our products and, therefore, could have a material adverse effect on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">A successful claim of infringement against us or our contract manufacturers in connection with the use of our technology, in particular if we are unable to manufacture or sell any of our planned products in any major market, could adversely affect our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">We could experience losses from product liability claims or legal claims relating to our service offerings, including such claims and other losses resulting from sales of counterfeit and other infringing products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">We face an inherent risk of exposure to product liability claims in the event that the use of our products results in personal injury. We also face the risk that defects in the design or manufacture of our products or sales of counterfeit or other infringing products might necessitate a product recall and other actions by manufacturers, distributors or retailers in order to safeguard the health of consumers and protect the integrity of the subject brand. Additionally, we face the inherent risk of exposure to legal claims, including negligence, relating to our provision of certain service offerings, including the accuracy and quality of our genetic testing, fertility cryopreservation, fertility donor gamete supply, and stem cell storage services.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">These risks may be heightened due to our direct-to-consumer marketing efforts for some of our products and services (e.g., stem cell storage and Paragard IUDs). Consumers may halt or delay purchases of a product or service that is </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">the subject of a claim or recall or has been counterfeited. We handle some risk with third-party carrier policies that are subject to deductibles and limitations. These insurance policies may become more expensive (or not be available) for new risks we may assume when we acquire new businesses. For example, professional liability insurance for our genomics, gamete and tissue storage businesses could add significant cost. There can be no assurance that we will not experience material losses due to product liability claims or recalls, legal claims relating to our service offerings, or a decline in sales resulting from sales of counterfeit or other infringing products, in the future.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">If our products are not accepted by the market, we will not be able to sustain or expand our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Certain of our proposed products have not yet been clinically tested or commercially introduced, and some of our existing products are marketed and sold on the basis of potential future medical or therapeutic value (assuming technology advances), and we cannot be sure that any of them will achieve market acceptance or generate revenues or operating profits. The development of a market for our products may be influenced by many factors, some of which are out of our control, including:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">acceptance of our products by eye care and health care practitioners;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">the cost competitiveness of our products;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">consumer reluctance to try and use a new product;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">regulatory and legislative requirements;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">adequate coverage and reimbursement by third-party payors;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">lack of scientific advancements to validate the medical value of certain products, such as stored cord blood or cord tissue (or scientific advancements in other medical approaches that reduce or eliminate the value of such products); and</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">the earlier release of competitive products, such as new silicone hydrogel products or contraceptive technologies, into the market by our competitors; and the emergence of newer and more competitive products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">We operate in the highly competitive health care industry and there can be no assurance that we will be able to compete successfully.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Each of our businesses operates within a highly competitive environment. In our soft contact lens business, CooperVision faces intense competition from competitors' products, in particular silicone hydrogel contact lenses, and may face increasing competition as other new products enter the market. Our largest competitors in the contact lens business, Johnson &amp; Johnson Vision Care, Inc., Alcon Inc. and Bausch Health Companies Inc. may have substantially greater financial resources, larger research and development budgets, larger sales forces, greater market penetration and/or larger manufacturing volumes than CooperVision. They offer competitive products and differentiated materials, plus a variety of other eye care products including lens care products and ophthalmic pharmaceuticals, which may give them a competitive advantage in marketing their lenses. The market for contact lenses is intensely competitive and is characterized by declining sales volumes for older product lines and growing demand for silicone hydrogel-based products. Our ability to respond to these competitive pressures will depend on our ability to decrease our costs and maintain gross margins and operating results and to introduce new products successfully, on a timely basis in the Americas, EMEA and Asia Pacific, and to achieve manufacturing efficiencies and sufficient manufacturing capacity and capabilities for such products. Any significant decrease in our costs per lens will depend, in part, on our ability to increase sales volume and production capabilities and our ability to secure adequate supply of materials used in production at reasonable costs. Our failure to respond to competitive pressures in a timely manner could have a material adverse effect on our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">To a lesser extent, CooperVision also competes with manufacturers of eyeglasses and providers of other forms of vision correction including ophthalmic surgery.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">There can be no assurance that we will not encounter increased competition in the future, for example with increased product entries from Asia Pacific contact lens manufacturers, or that our competitors' newer contact lens products will not successfully erode CooperVision's contact lens business, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The contact lens industry also continues to evolve with respect to the introduction of new distribution and fulfillment models and service technologies which may conflict with CooperVision&#8217;s strategy or interfere with its customers&#8217; relationships and loyalty. For example, more contact lenses are being fulfilled directly to the consumer by manufacturers and wholesalers via online platforms, telemedicine is gaining popularity and more vision correction prescriptions are being provided through online refractive exams rather than in office by an eye care practitioner. CooperVision&#8217;s failure to adapt </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">to the threats posed by these new and emerging distribution models and Internet driven services may have a material adverse impact on our business, financial condition and results of operations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperSurgical focuses on selected segments of the family and women's health care market with a diversified portfolio of products and services including medical devices in outpatient and operating room settings, fertility, contraception and healthcare technology services. Competitive factors in these segments in which CooperSurgical competes include technological and scientific advances, product quality and availability, price, customer service including response time and effective communication of product information to physicians, consumers, fertility clinics and hospitals. Competition in the medical device industry is dynamic and involves the search for technological and therapeutic innovations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperSurgical competes with a number of manufacturers and service providers in its women&#8217;s family health care market areas. Some of these competitors have substantially greater financial and personnel resources and sell a broader range of products, which may give them an advantage in marketing competitive products. In addition, some of CooperSurgical&#8217;s markets, such as genomics, contraception and cord blood and cord tissue storage, are characterized by rapid technological advancement. We face the risk that demand for our products will not grow or will decline if our competitors are more successful than us at innovating in these and other areas. There is also risk that emerging technologies or technology advancements could reduce the medical value of certain of our products and services, such as cord blood and cord tissue storage, which could adversely affect our business. In recent years, CooperSurgical has also expanded direct-to-consumer products and services, which requires implementing new competitive strategies and increases the importance of customer service and consumer reputation as competitive factors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">New medical and technological developments may reduce the need for our products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Technological developments in the eye care, family and women's health care, and diagnostics testing industries, such as new surgical procedures or medical devices, and genetic testing technology may limit demand for our products and services. For example, corneal refractive surgical procedures such as Lasik surgery and the development of new pharmaceutical products may decrease the demand for our optical products. If these new advances provide a practical alternative to traditional vision correction, the demand for contact lenses and eyeglasses may materially decrease. We cannot assure that medical advances and technological developments will not have a material adverse effect on our businesses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Product innovations are important in the industry in which we operate, and we face the risk of product obsolescence if we are unable to develop new products or gain regulatory approvals or certifications or if our competitors introduce new products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Product innovations are important in the contact lens market in which CooperVision competes and in the areas of the health care industry in which CooperSurgical competes. CooperVision, both internally and externally with third parties, invests in new product development, including the development of silicone hydrogel-based contact lenses. While much of CooperVision&#8217;s research and development activities are performed internally, it also uses external research and development investment in collaborations and joint development with third parties. CooperSurgical has historically purchased, leveraged or licensed the technology developments of others. CooperSurgical also has invested in expanding the internal research and development function with the goal of organic growth and to complement our acquisitions strategy. Research and development time commitments, higher feasibility risk with longer term projects, greater dependence on, and reduced control over, third-party deliverables, the cost of obtaining necessary regulatory approval or certification and other costs related to product innovations can be substantial. There can be no assurance that we will successfully obtain necessary regulatory approvals, certifications or clearances for our new products or that our new products will successfully compete in the marketplace and, as a result, justify the expense involved in their development and regulatory approval or certification. In addition, our competitors may have developed or may in the future develop new products or technologies. With respect to our CooperVision products, these developments could include contact lenses with anti-microbial or anti-allergenic features, or &#8220;smart&#8221; contact lenses that incorporate electronics, which could lead to the obsolescence of one or more of our products. Competitors may also introduce new uses for contact lenses, such as for drug delivery or the control of myopia. With respect to CooperSurgical products and services, novel contraceptive devices or methods, genetic testing methods and disease treatments could reduce or eliminate demand for certain of our products and services. Failure to develop new product offerings and technological changes and to offer products that provide performance that is at least comparable to competing products could have a material adverse effect on our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">We face risks related to environmental matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our facilities are subject to a broad range of U.S federal, state, local and foreign environmental laws and requirements, including those governing discharges to the air and water, the handling or disposal of solid and hazardous substances and wastes, remediation of contamination associated with the release of hazardous substances at our facilities and offsite disposal locations and occupational safety and health. We have made, and will continue to make, expenditures to comply with such laws and requirements. Future events, such as changes in existing laws and regulations, or the enforcement thereof, or the discovery of contamination at our facilities, may give rise to additional compliance or remediation costs that could have a material adverse effect on our business, financial condition and results of operations. Such laws and requirements are constantly changing, are different in every jurisdiction and can impose substantial fines and sanctions for violations. As a manufacturer of various products, we are exposed to some risk of claims with respect to environmental matters, and there can be no assurance that material costs or liabilities will not be incurred in connection with any such claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We continue to evaluate the necessary steps for compliance with regulations as they are enacted. These regulations include, for example, regulations enacted in the European Union such as the Registration, Evaluation, Authorization and Restriction of Chemical Substances, which requires the registration of and regulates use of certain chemicals, the Restriction on the Use of Certain Hazardous Substances in Electrical and Electronic Equipment Directive, which regulates the use of certain hazardous substances in certain products our CooperSurgical division manufactures. These and similar legislation that has been or is in the process of being enacted in Japan, China and various states of the U.S. may require us to re-design certain products to ensure compliance with the applicable laws and regulations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Environmental, social and corporate governance (ESG) issues, including those related to climate change and sustainability, may have an adverse effect on our business, financial condition and results of operations and damage our reputation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">There is an increasing focus from certain investors, customers, consumers, employees and other stakeholders concerning ESG matters. Additionally, public interest and legislative pressure related to public companies&#8217; ESG practices continue to grow. If our ESG practices fail to meet regulatory requirements or investor, customer, consumer, employee or other stakeholders' evolving expectations and standards for responsible corporate citizenship in areas including environmental stewardship, support for local communities, Board of Director and employee diversity, human capital management, employee health and safety practices, product quality, supply chain management, corporate governance and transparency, our reputation, brand and employee retention may be negatively impacted, and our customers and suppliers may be unwilling to continue to do business with us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Customers, consumers, investors and other stakeholders are increasingly focusing on environmental issues, including climate change, energy and water use, plastic waste and other sustainability concerns. Concern over climate change or plastics and packaging materials, in particular, may result in new or increased legal and regulatory requirements to reduce or mitigate impacts to the environment. Changing customer and consumer preferences or increased regulatory requirements may result in increased demands or requirements regarding plastics and packaging materials, including single-use and non-recyclable plastic products and packaging, other components of our products and their environmental impact on sustainability, or increased customer and consumer concerns or perceptions (whether accurate or inaccurate) regarding the effects of substances present in certain of our products. Complying with these demands or requirements could cause us to incur additional manufacturing, operating or product development costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">If we do not adapt to or comply with new regulations, or fail to meet evolving investor, industry or stakeholder expectations and concerns regarding ESG issues, investors may reconsider their capital investment in our Company, and customers and consumers may choose to stop purchasing our products, which could have a material adverse effect on our reputation, business or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">If we do not retain our key personnel and attract and retain other highly skilled employees, our business could suffer. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">If we fail to recruit, develop and retain the necessary personnel, our business and our ability to obtain new customers, develop new products and provide acceptable levels of customer service could suffer. The success of our business is heavily dependent on the leadership of our key management personnel. Our success also depends on our ability to recruit, develop and retain and motivate highly skilled sales, marketing, manufacturing engineering and scientific personnel. Competition for these persons in our industry is intense, and we may not be able to successfully recruit, train or retain qualified personnel. We are experiencing increasing challenges in building and retaining our workforce in certain markets, where pressure from inflation and competition have exacerbated turnover and retention trends continuing from the COVID-19 pandemic. Labor shortages and competition for qualified personnel could cause disruptions in our business operations.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Provisions of our governing documents and Delaware law may have anti-takeover effects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Certain provisions of our Second Restated Certificate of Incorporation and Amended and Restated By-Laws may inhibit changes in control of the Company not approved by our Board of Directors. These provisions include&#160;advance notice requirements for stockholder proposals and nominations. We also have the protections of Section&#160;203 of the Delaware General Corporation Law, which could have anti-takeover effects. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Risks Relating to Government Regulation of Manufacture and Sale of Our Products and Services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">The costs of complying with the requirements of federal, state and foreign laws pertaining to the privacy and security of personal information, including health related information and the potential liability associated with failure to do so could materially adversely affect our business and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Numerous laws and regulations govern the collection, dissemination, use, privacy, confidentiality, security, availability and integrity of individually identifiable information, including protected health information (PHI). We collect and process individually identifiable information in multiple ways in our various business lines and are subject to risk associated with compliance with many of these laws and regulations. Some of our businesses expose us to increasingly stringent regulations for handling personal information (where, for example, we collect or process personal data deemed to be sensitive by regulatory authorities, such as PHI). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Under U.S. law, HIPAA establishes national privacy and security standards for protection of PHI by covered entities, such as our genetics testing subsidiaries, and the business associates with whom such entities contract for services, including another one of our subsidiaries, Eye Care Prime LLC, which offers value-added software solutions for eye care professionals. HIPAA requires both covered entities and business associates to develop and maintain policies and procedures for PHI that is used or disclosed, and to adopt administrative, physical and technical safeguards to protect PHI. When we are acting as a business associate, our clients that are covered entities are mandated by HIPAA to enter into written agreements with us - known as business associate agreements - that require us to safeguard PHI in accordance with HIPAA. Our genetics testing subsidiaries are likewise required to enter into business associate agreements with any of their business associates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Mandatory penalties for HIPAA violations can be significant. A single breach incident can result in violations of multiple standards. If a person knowingly or intentionally obtains or discloses PHI in violation of HIPAA requirements, criminal penalties may also be imposed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We maintain safeguards that we believe are reasonable and appropriate to protect the privacy and security of PHI and other personally identifiable information consistent with applicable law and our contractual obligations; however, our systems may be vulnerable to physical break-ins, viruses, hackers, and other potential sources of security breaches. In addition, we may not be able to prevent incidences of inappropriate use or unauthorized access to PHI by our employees or contractors, despite the safeguards. Any such breaches could result in exposure to liability under federal and state laws and/or under our contractual arrangements and could adversely impact our business. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Even when HIPAA does not apply, according to the FTC, violating consumers&#8217; privacy rights or failing to take appropriate steps to keep consumers&#8217; personal information secure may constitute unfair acts or practices in or affecting commerce in violation of Section 5(a) of the Federal Trade Commission Act. The FTC expects a company&#8217;s data security measures to be reasonable and appropriate in light of the sensitivity and volume of consumer information it holds, the size and complexity of its business, and the cost of available tools to improve security and reduce vulnerabilities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Further, California enacted the CCPA, which went into effect on January 1, 2020. The CCPA gives California residents certain rights to access and delete their personal information, opt out of certain personal information sharing, and receive detailed information about how their personal information is used. The CCPA provides for civil penalties for violations, as well as a private right of action for data breaches that is expected to increase data breach litigation. Although there are limited exemptions for health-related information, including PHI and clinical trial data, the CCPA may increase our compliance costs and potential liability. Further, the CPRA, which will go into effect on January 1, 2023, significantly amends the CCPA and will impose additional data protection obligations on covered businesses, including additional consumer rights processes, limitations on data uses, new audit requirements for higher risk processing, and opt outs for certain uses of sensitive data. It will also create a new California data protection agency authorized to issue substantive regulations and could result in increased privacy and information security enforcement. Similar laws have been proposed or enacted in other states and at the federal level, and when passed, such laws may have potentially conflicting requirements that would make compliance challenging.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">We are also subject to laws and regulations in countries other than U.S. covering data privacy and the protection of health-related and other personal information. EU and EEA member states and other jurisdictions have adopted data protection laws and regulations, which impose significant compliance obligations. For example, the GDPR went into effect on May </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">25, 2018, and imposes stringent operational requirements for processors and controllers of personal data in the context of an establishment in the EEA or the processing of personal data of individuals within the EEA, including, for example, expanded disclosures about how personal information is to be used, limitations on retention of information, increased requirements pertaining to health data and pseudonymized (e.g. key-coded) data, mandatory data breach notification requirements, handling data subject access requests and higher standards for data controllers to demonstrate that they have obtained valid consent for certain data processing activities. In addition, countries of the EEA may impose further obligations relating to the processing of genetic, biometric or health data, which could further add to our compliance costs and limit how we process this information. Some of the personal data we process in respect of clinical trial participants is special category or sensitive personal data under the GDPR, and subject to additional compliance obligations and to local law derogations. We may be subject to diverging requirements under EU member state laws and UK law, such as whether consent can be used as the legal basis for processing in clinical trials and the roles, responsibilities and liabilities as between contract research organizations and sponsors. As these laws develop, we may need to make operational changes to adapt to these diverging rules, which could increase our costs and adversely affect our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">In addition, the GDPR increases the scrutiny of transfers of personal data from the EEA, including from clinical trial sites located in the EEA, to the U.S. and other jurisdictions that the European Commission does not recognize as having &#8220;adequate&#8221; data protection laws. In July 2020, the Court of Justice of the European Union issued its judgment in the Schrems II case and limited how organizations could lawfully transfer personal data from the EEA to the U.S. by invalidating the EU-US Privacy Shield and imposing further restrictions on use of the standard contractual clauses, which could increase our costs and our ability to efficiently process personal data from the EEA. Indeed, while the CJEU upheld the adequacy of the standard contractual clauses (a standard form of contract approved by the European Commission as an adequate personal data transfer mechanism, and potential alternative to the Privacy Shield), it made clear that reliance on them alone may not necessarily be sufficient in all circumstances. Use of the standard contractual clauses must now be assessed on a case-by-case basis taking into account the legal regime applicable in the destination country, in particular applicable surveillance laws and rights of individuals and additional measures and/or contractual provisions may need to be put in place. Subsequent European court and regulator decisions have taken a restrictive approach to international data transfers. On June 4, 2021, the European Commission adopted the new standard contractual clauses for the transfer of personal data to third countries (New SCCs). The New SCCs combine general clauses applicable in all cases with four modules that are adapted to different transfer scenarios. While the New SCCs better address the Schrems II requirements and the modern digital economy, with its diverse processing realities and often complex processing chains with multiple parties and sometimes changing roles, they are generally more complicated to prepare and adopt. On June 18, 2021, the European Data Protection Board issued Recommendations 01/2020 on measures that supplement transfer tools to ensure compliance with the EU level of protection of personal data.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">The European Commission has adopted an adequacy decision in favor of the UK, enabling data transfers from EU member states to the UK without additional safeguards. However, the UK adequacy decision will automatically expire in June 2025 unless the European Commission re-assesses and renews/extends that decision, and remains under review by the Commission during this period. The relationship between the UK and the EU in relation to certain aspects of data protection law remains unclear, and it is unclear how UK data protection laws and regulations will develop in the medium to longer term, and how data transfers to and from the UK will be regulated in the long term, which exposes us to further compliance risk.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Compliance with U.S. and foreign privacy and security laws, rules and regulations could require us to take on more onerous obligations in our contracts, require us to engage in costly compliance exercises, restrict our ability to collect, use and disclose data, or in some cases, impact our or our partners&#8217; or suppliers&#8217; ability to operate in certain jurisdictions. Each of these constantly evolving laws can be subject to varying interpretations. Any failure or perceived failure by us to comply with privacy or security laws, policies, legal obligations or industry standards or any security incident that results in the unauthorized release or transfer of personally identifiable information may result in governmental enforcement actions and investigations including by European Data Protection Supervisory Authorities, fines and penalties, litigation and/or adverse publicity, including by consumer advocacy groups, and could cause our customers to lose trust in us, which could have an adverse effect on our reputation and business. For example, companies that must comply with the GDPR face increased compliance obligations and risk, including more robust regulatory enforcement of data protection requirements and potential fines for noncompliance of up to &#8364;20 million or 4% of the annual global revenues of the noncompliant undertaking, whichever is greater. Additionally, following the UK&#8217;s withdrawal from the EEA and the EU, and the expiry of the transition period, companies will have to comply with the GDPR and the GDPR as incorporated into the UK national law (the UK GDPR), the latter regime having the ability to separately fine up to the greater of &#163;17.5&#160;million or 4% of annual global turnover. In addition to fines, a breach of the GDPR and/or UK GDPR may result in regulatory investigations, reputational damage, orders to cease or change our data processing activities, enforcement notices, assessment notices for a compulsory audit and/or civil claims (including class actions). Such failures could have a material adverse effect on our financial condition and operations. If the third parties we work with violate applicable laws, contractual obligations or suffer a security breach, such violations may also put us in breach of our obligations under privacy laws and regulations and could in turn have a material adverse effect on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">When we acquire companies or business that engage personal data processing, we may become subject to additional regulation or scrutiny, particularly if such activity is different in nature from what we have done in the past. For example, </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">with the recent addition of cord blood and cord tissue storage (and other cryostorage) businesses, we interact directly with our customers and collect and maintain personal information regarding our customers and donors. Acquisitions like this could subject us to additional regulatory and consumer liability risk and the cost of analyzing and integrating new privacy compliance programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Changes in legislation and government regulation of the health care industry both in the United States and internationally, as well as third-party payors' efforts to control the costs of health care could materially adversely affect our business.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The ACA made extensive changes to the delivery of health care in the U.S. Among the provisions of the ACA, of greatest importance to the medical device industry and pharmaceutical industry are the following:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Establishment of the Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct comparative clinical effectiveness research, along with funding for such research;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Payment system reforms including a national pilot program on payment bundling to encourage hospitals, physicians and other providers to improve the coordination, quality and efficiency of certain health care services through bundled payment models;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Establishment of a Center for Medicare &amp; Medicaid Innovation at CMS to test innovative payment and service delivery models to lower Medicare and Medicaid spending; and</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">An increase in the statutory minimum rebates a manufacturer must pay under the Medicaid Drug Rebate Program to 23.1% and 13% of the average manufacturer price for most branded and generic drugs, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">These measures could result in decreased net revenues or increased expenses from our fertility, office and surgical products and decrease potential returns from our development efforts. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Other legislative changes have been proposed and adopted since the ACA was enacted. The Budget Control Act of 2011, among other things, included aggregate reductions to Medicare payments to providers. In addition, the Medicare Access and CHIP Reauthorization Act of 2015, among other things, repealed the formula by which Medicare made annual payment adjustments to physicians and replaced the former formula with fixed annual updates and a new system of incentive payments began in 2019 that are based on various performance measures and physicians&#8217; participation in alternative payment models such as accountable care organizations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Other legislative changes have been proposed and adopted in the U.S. since the ACA was enacted. For example, on March 11, 2021, President Biden signed the American Rescue Plan Act of 2021 into law, which eliminates the statutory Medicaid drug rebate cap, currently set at 100% of a drug&#8217;s average manufacturer price (AMP), beginning January 1, 2024. Most recently, on August 16, 2022, the Inflation Reduction Act of 2022, or IRA, was signed into law. Among other things, the IRA requires manufacturers of certain drugs to engage in price negotiations with Medicare (beginning in 2026), with prices that can be negotiated subject to a cap; imposes rebates under Medicare Part B and Medicare Part D to penalize price increases that outpace inflation (first due in 2023); and replaces the Part D coverage gap discount program with a new discounting program (beginning in 2025). The IRA permits the Secretary of the Department of Health and Human Services (HHS) to implement many of these provisions through guidance, as opposed to regulation, for the initial years. For that and other reasons, it is currently unclear how the IRA will be effectuated and the impact of the IRA on the pharmaceutical industry cannot yet be fully determined.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In foreign countries where we market our products, recent healthcare reform has taken place as well. For instance, in December 2021, the EU Regulation No 2021/2282 on Health Technology Assessment (HTA) amending Directive 2011/24/EU was adopted. This regulation, which became effective in January 2022, intends to boost cooperation among EU member states in assessing health technologies, including some medical devices, and providing the basis for cooperation at the EU level for joint clinical assessments in these areas. The regulation foresees a three-year transitional period and will permit EU member states to use common HTA tools, methodologies, and procedures across the EU, working together in four main areas, including joint clinical assessment of the innovative health technologies with the most potential impact for patients, joint scientific consultations whereby developers can seek advice from HTA authorities, identification of emerging health technologies to identify promising technologies early, and continuing voluntary cooperation in other areas. Individual EU member states will continue to be responsible for assessing non-clinical (e.g., economic, social, ethical) aspects of health technologies, and making decisions on pricing and reimbursement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We expect that additional state, federal and foreign health care reform measures will be adopted in the future, including those initiatives affecting coverage and reimbursement for our products, any of which could limit the amounts that federal state and foreign governments will pay for health care products and services, which could adversely affect the growth of the market for our products or demand for our products, or result in additional pricing pressures. Also, any adoption of </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">health care reform proposals on a state-by-state basis could require us to develop state-specific marketing and sales approaches. We cannot predict the effect such reforms or the prospect of their enactment may have on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In addition, third-party payors, whether governmental or commercial, whether inside the U.S. or abroad, increasingly attempt to contain or reduce the costs of health care. These cost-control methods include prospective payment systems, capitated rates, group purchasing, redesign of benefits, requiring pre-authorizations or second opinions prior to certain medical procedures, encouragement of healthier lifestyles and exploration of more cost-effective methods of delivering health care. Although cost controls or other requirements imposed by third-party payors have not historically had a significant effect on contact lens prices or distribution practices, this could change in the future and could adversely affect our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We may enroll as in-network providers and suppliers with certain payors. Although, becoming an in-network provider or enrolling as a supplier means that we have agreed with these payors to provide certain of our tests at negotiated rates, it does not obligate any physicians to order our tests or guarantee that we will receive reimbursement for our tests from these or any other payors at adequate levels. Thus, these payor relationships, or any similar relationships we may establish in the future, may not result in acceptable levels of reimbursement for our tests or meaningful increases in our physician customer base. We cannot predict whether, under what circumstances, or at what payment levels payors will cover and reimburse for our tests. If we fail to establish and maintain broad coverage and reimbursement for our tests, our ability to generate increased revenue and grow our test volume and customer base could be limited and our future prospects and our business could suffer.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Laws pertaining to health care fraud and abuse could materially adversely affect our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We may be subject to various federal, state and foreign laws pertaining to health care fraud and abuse, including anti-kickback, physician self-referral false claims and physician payment transparency laws and regulations. These laws may constrain the business or financial arrangements and relationships through which we conduct our operations, including our commercial laboratory operations and how we research, market, sell and distribute any products for which we obtain marketing approval. Such laws include:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">the federal Anti-Kickback Statute, which prohibits, among other things, persons or entities from knowingly and willfully soliciting, offering, receiving or providing any remuneration (including any kickback, bribe or certain rebates), directly or indirectly, overtly or covertly, in cash or in kind, in return for, either the referral of an individual or the purchase, lease, or order, or arranging for or recommending the purchase, lease, or order of any good, facility, item or service, for which payment may be made, in whole or in part, under a federal healthcare program such as Medicare and Medicaid. A person or entity does not need to have actual knowledge of the federal Anti-Kickback Statute or specific intent to violate it in order to have committed a violation;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">the federal physician self-referral prohibitions, commonly known as the Stark Law, which generally prohibit entities from billing a patient or the Medicare or Medicaid programs for certain designated health services, including clinical laboratory services, when the physician ordering the service, or any member of such physician&#8217;s immediate family, has a financial interest, such as an ownership or investment interest in or compensation arrangement with us, unless the arrangement meets an exception to the prohibition. These prohibitions apply regardless of any intent by the parties to induce or reward referrals or the reasons for the financial relationship and the referral;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">the federal false claims laws, including the civil False Claims Act, and civil monetary penalties laws, which prohibit, among other things, individuals or entities from knowingly presenting, or causing to be presented, to the federal government, claims for payment or approval that are false or fraudulent, or knowingly making, using or causing to be made or used, a false record or statement material to a false or fraudulent claim, or knowingly making or causing to be made a false statement to avoid, decrease or conceal an obligation to pay money to the federal government. In addition, the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute or Stark Law constitutes a false or fraudulent claim for purposes of the civil False Claims Act;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">the federal Health Insurance Portability and Accountability Act of 1996, which imposes criminal and civil liability for, among other things, knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program, or knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false statement, in connection with the delivery of, or payment for, healthcare benefits, items or services. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">the federal Physician Payments Sunshine Act, which requires certain manufacturers of drugs, devices, biologics and medical supplies for which payment is available under Medicare, Medicaid or the Children&#8217;s Health Insurance Program (with certain exceptions) to report annually to the CMS, information related to payments and other &#8220;transfers of value&#8221; made to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals, as well as ownership and investment interests held by such healthcare professionals and their immediate family members. Beginning in 2022, applicable manufacturers also will be required to report such information regarding payments and transfers of value provided during the previous year to physician assistants, nurse practitioners, clinical nurse specialists, certified nurse anesthetists and certified nurse-midwives; and</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">analogous state and foreign laws and regulations, such as state anti-kickback and false claims laws, which may apply to sales or marketing arrangements and claims involving healthcare items or services reimbursed by non-governmental third-party payors, including private insurers and self-pay patients; some state laws that require biotechnology companies to comply with the industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government and may require drug and device manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers or marketing expenditures; some state laws that require biotechnology companies to report information on the pricing of certain drug products; and some state and local laws that require the registration of sales representatives. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In addition, federal government price reporting laws, among other things, require us to calculate and report complex pricing metrics to government programs, where such reported prices may be used in the calculation of reimbursement and/or discounts on our marketed drugs. Participation in these programs and compliance with the applicable requirements may subject us to potentially significant discounts on our products, increased infrastructure costs and potentially limit our ability to offer certain marketplace discounts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Violations of these laws are punishable by criminal and civil sanctions, including, in some instances, exclusion from participation in federal and state health care programs, including Medicare, Medicaid, Veterans Administration health programs and TRICARE. Similarly, if the physicians or other providers or entities with whom we do business are found to be non-compliant with applicable laws, they may be subject to sanctions, which could indirectly have a negative impact on our business, financial condition and results of operations. Because of the complex and far-reaching nature of these laws, there can be no assurance that we would not be required to alter one or more of our practices to be in compliance with these laws. Any violations of these laws or regulations could result in a material adverse effect on our business, financial condition and results of operations. In addition, changes in these laws, regulations, or administrative or judicial interpretations, may require us to further change our business practices or subject our existing business practices to legal challenges, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Legislative or regulatory reforms in the United States or Europe may make it more difficult and costly for us to obtain regulatory clearances, approvals or certifications for our products or to manufacture, market or distribute our products after clearance or approval is obtained.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">From time to time, legislation is drafted and introduced in Congress that could significantly change the statutory provisions governing the regulation of medical devices. In addition, the FDA may change its clearance and approval policies, adopt additional regulations or revise existing regulations, or take other actions, which may prevent or delay approval or clearance of our future products under development or impact our ability to modify our currently cleared products on a timely basis. For example, over the last several years, the FDA has proposed reforms to its 510(k) clearance process, and such proposals could include increased requirements for clinical data and a longer review period, or could make it more difficult for manufacturers to utilize the 510(k) clearance process for their products. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In addition, FDA regulations and guidance are often revised or reinterpreted by the FDA in ways that may significantly affect our business and our products. Any new statutes, regulations or revisions or reinterpretations of existing regulations may impose additional costs or lengthen review times of any future products or make it more difficult to obtain clearance or approval for, manufacture, market or distribute our products. We cannot determine what effect changes in regulations, statutes, legal interpretation or policies, when and if promulgated, enacted or adopted may have on our business in the future. Such changes could, among other things, require additional testing prior to obtaining clearance or approval; changes to manufacturing methods; recall, replacement or discontinuance of our products; or additional record keeping.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">In addition to traditional regulatory controls on medical devices, our business could be affected by emerging laws or regulations limiting our ability offer certain of our products and services. For example, in the U.S., the reversal by the U.S. Supreme Court of Roe v. Wade has raised concerns in the fertility industry that more restrictive laws could limit access to various reproductive services. New and emerging laws may be interpreted to limit access to contraceptive technologies or cryostorage services, which could adversely affect certain aspects of CooperSurgical&#8217;s business.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">In addition, the EU landscape concerning medical devices (including IVDs) has recently evolved. A new set of two EU regulations have been adopted on April 5, 2017. On May 26, 2021, the EU MDR became applicable and replaced previous directives. As to the EU IVDR, it became applicable on May 26, 2022. However, on October 14, 2021, the European Commission proposed a &#8220;progressive&#8221; roll-out of the EU IVDR to prevent disruption in the supply of IVDs. The European Parliament and Council adopted the proposed regulation on December 15, 2021. The EU IVDR fully applies since May 26, 2022 but there will be a tiered system extending the grace period for many devices (depending on their risk classification) before they have to be fully compliant with the regulation. Both regulations have been adopted to establish a uniform, transparent, predictable and sustainable regulatory framework across the EU for medical devices (including IVDs) and ensure a high level of safety and health while supporting innovation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">These modifications may have an effect on the way we intend to develop our business in the EU and EEA. For example, as a result of the transition towards the new regimes, notified body review times have lengthened, and product introductions could be delayed or canceled. Additionally, only a few notified bodies have been designated for EU IVDR certification, which could adversely affect our ability to grow our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Following the end of the &#8220;Brexit&#8221; transitional period, from January 1, 2021, the Medicines and Healthcare products Regulatory Agency (MHRA) became the UK&#8217;s independent regulatory agency for medical devices. Post-Brexit, amendments have been made to the existing UK medical devices legislation which require medical devices to be registered with the MHRA before being placed on the Great Britain market. Manufacturers based outside of the UK need to appoint a UK Responsible Person to register devices with the MHRA. Following a government consultation on changes to the UK&#8217;s medical device regulations, the response to which was published on June 26, 2022, it is anticipated that amendments to the legislation will soon be published by the government and should become applicable by July 1, 2023 so that medical devices placed on the market in Great Britain (England, Scotland, and Wales) will require a UK Conformity Assessment (UKCA) mark. However, within the government&#8217;s consultation response, it has proposed that transition periods will be included in the revised legislation so that products with existing and valid conformity assessments (CE mark or UKCA mark) could continue to be placed on the Great Britain market for a maximum of 3-5 years after July 1, 2023, depending on which legislation the medical device has been certified under. IVDs with valid certification can continue to be placed on the market until the earlier of certificate expiry or for a period of five years following publication of the new regulations. However, UKCA marking alone will not be recognized in the EU. The rules for placing medical devices on the Northern Ireland market will differ from those in Great Britain. These modifications may have an effect on the way we intend to conduct our business in these countries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Our medical device products are subject to reporting requirements and recalls, even after receiving regulatory clearance, approval or certification, which could harm our reputation, business and financial results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">After a device is placed on the market, numerous regulatory requirements apply, including the FDA's QSR regulations, which require manufacturers to follow, among other things, design, testing, production, control, documentation and other quality assurance procedures during the manufacturing process; labeling regulations, which prohibit the promotion of products for unapproved or &#8220;off-label&#8221; uses and impose other restrictions on labeling; and medical device reporting regulations that require us to report to FDA or similar governmental bodies in other countries if our products may have caused or contributed to a death or serious injury or malfunction in a way that would be reasonably likely to contribute to death or serious injury if the malfunction were to recur. The FDA and similar governmental bodies in other countries have the authority to require the recall of our products in the event of material deficiencies or defects in design or manufacture or in the event that a product poses an unacceptable risk to health. Medical device manufacturers, such as CooperVision and CooperSurgical, may, under their own initiative, recall a product if a reasonable possibility of serious injury or&#160;any material deficiency in a device is found, or withdraw a product to improve device performance or for other reasons. The FDA requires that certain classifications of recalls be reported to the FDA within 10 working days after the recall is initiated. Recalls of any of our products may divert managerial and financial resources and have an adverse effect on our financial condition and results of operations. A recall could harm our reputation with customers and consumers which could reduce the sales of our products. In addition, the FDA or other foreign governmental agencies may implement enforcement actions in connection with a recall which could impair our product offerings and be harmful to our business and financial results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">If our manufacturing operations fail to comply with applicable regulations, our manufacturing could be delayed or disrupted, our products could be subject to recall, and sales and profitability could suffer.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Our manufacturing operations and processes are required to comply with numerous federal, state and foreign regulatory requirements, including the FDA's cGMP for medical devices, known as the QSR regulations, which govern the procedures related to the design, testing, production processes, controls, quality assurance, labeling, packaging, storage, importing, exporting and shipping of our products. We also are subject to state requirements and licenses applicable to manufacturers of medical devices. In addition, we must engage in extensive recordkeeping and reporting and must make available our manufacturing facilities and records for periodic unscheduled inspections by governmental agencies, including the FDA, state authorities and comparable agencies (as well as audits by notified bodies) in other countries. </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Failure to comply with QSR requirements and other applicable domestic or international regulatory requirements or to respond to any adverse inspectional observations or product safety issues could result in disruption of our operations and manufacturing delays in addition to, among other things, warning letters, significant fines, injunctions, suspension of approvals, seizures, recalls or import holds of products, operating restrictions and criminal prosecutions. As a result, any failure to comply with applicable requirements could adversely affect our product sales and profitability. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Our failure to comply with regulatory requirements or to receive regulatory clearance, approval or certification for our products or operations could adversely affect our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our products and operations are subject to rigorous regulation by the FDA, and numerous other federal, state and foreign governmental authorities. In the U.S., the FDA regulates virtually all aspects of medical device and pharmaceutical design, development, testing, manufacture, safety, labeling (including, for example, unique device identifier regulations), storage, recordkeeping, reporting, marketing, promotion, advertising and distribution, as well as product import and export. Our failure to comply with FDA regulations could lead to the imposition of administrative or judicial sanctions, including injunctions, fines, warning letters, suspensions or the loss of regulatory approvals, product recalls, termination of distribution or product seizures. In the most egregious cases, criminal sanctions or closure of our manufacturing facilities are possible.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our medical devices and pharmaceutical products require clearance or approval by the FDA before they can be commercially distributed in the U.S. and may require similar approvals by foreign regulatory agencies before distribution in foreign jurisdictions. Medical devices and drug products may only be marketed for the indications for which they are approved or cleared. The process of obtaining, renewing and maintaining regulatory clearances and approvals to market a medical device, particularly from the FDA, can be costly and time consuming. There can be no assurance that such clearances and approvals will be granted on a timely basis, if at all, and significant delays in the introduction of any new products or product enhancements may occur, which could adversely affect our competitive position and results of operations. In addition, the FDA and authorities in foreign jurisdictions may change their policies, adopt additional regulations or revise existing regulations, each of which could prevent or delay premarket approval or clearance of our products, increase the cost of compliance, impose additional regulatory requirements on us, or otherwise impact our ability to market our currently approved or cleared products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Modifications and enhancements to medical devices also require a new FDA clearance or approval if they could significantly affect its safety or effectiveness or would constitute a major change in its intended use, design or manufacture. The FDA requires every manufacturer to make this determination in the first instance, but the FDA may review any manufacturer's decision. We have made modifications and enhancements to our medical devices that we do not believe require a new clearance or application, but we cannot confirm that the FDA will agree with our decisions. If the FDA requires us to seek clearance or approval for a modification of a previously cleared product for which we have concluded that new clearances or approvals are unnecessary, we may be required to cease marketing or to recall the modified product until we obtain clearance or approval, and we may be subject to significant regulatory fines or penalties, which could have a material adverse effect on our financial results and competitive position. We also cannot assure that we will be successful in obtaining clearances or approvals for our modifications, if required.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our efforts to promote some of our products and services via direct-to-consumer marketing initiatives may subject us to additional scrutiny by the FDA, FTC or other agencies. For example, we promote Paragard and cord blood and cord tissue storage directly to end consumers. Regulatory agencies may scrutinize our practices with respect to effective communication of risk information, benefits or claims with respect to such products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Any failure to comply with ongoing regulatory requirements may significantly and adversely affect our ability to commercialize and generate revenue from our products and product candidates. If regulatory sanctions are applied or if regulatory approval is withdrawn, the value of our Company and our operating results may be adversely affected. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The FDA&#8217;s and other regulatory authorities&#8217; policies may change and additional government regulations may be enacted that could prevent, limit or delay regulatory approval of our product candidates. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may be subject to enforcement action and we may not achieve or sustain profitability, which would adversely affect our business, prospects, financial condition and results of operations. We also cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative or executive action, either in the U.S. or abroad.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Subject to transitional provisions and in order to sell our products in the EU, our products must respectively comply with general safety and performance requirements of the EU MDR and the EU IVDR. Compliance with these requirements is a prerequisite to be able to affix the European Conformity (CE) mark to our products, without which they cannot be sold or marketed in the EU. All medical devices placed on the market in the EU must meet the general safety and performance </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">requirements laid down in the Annexes to the EU MDR and EU IVDR including that a medical device must be designed and manufactured in such a way that, during normal conditions of use, it is suitable for its intended purpose. Medical devices must be safe and effective and must not compromise the clinical condition or safety of patients, or the safety and health of users and, where applicable, other persons, provided that any risks which may be associated with their use constitute acceptable risks when weighed against the benefits to the patient and are compatible with a high level of protection of health and safety, taking into account the generally acknowledged state of the art. To demonstrate compliance with the general safety and performance requirements we must undergo a conformity assessment procedure, which varies according to the type of medical device and its (risk) classification. Except for low-risk medical devices (Class I) or general IVDs (Class A), where the manufacturer can self-assess the conformity of its products with the general safety and performance requirements (except for any parts which relate to sterility, metrology or reuse aspects of a medical device), a conformity assessment procedure requires the intervention of a notified body. Notified bodies are independent organizations designated by EU member states to assess the conformity of devices before being placed on the market. A notified body would typically audit and examine a product&#8217;s technical dossiers and the manufacturers&#8217; quality system (notified body must presume that quality systems which implement the relevant harmonized standards&#8212;ISO 13485:2016 for Quality Management Systems&#8212;conform to these requirements). If satisfied that the relevant product conforms to the general safety and performance requirements, the notified body issues a certificate of conformity, which the manufacturer uses as a basis for its own declaration of conformity. The manufacturer may then apply the CE mark to the device, which allows the device to be placed on the market throughout the EU. If we fail to remain in compliance with applicable EU laws, directives or regulations, we would be unable to continue to affix the CE mark to our products, which would prevent us from selling them within the EU and EEA. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">The EU regulatory landscape concerning medical devices (including IVDs) has recently evolved and the new requirements may have a significant effect on the way we conduct our business in the EU and the EEA. Following Brexit, the UK regulatory landscape concerning medical devices (including IVDs) is evolving and may have a significant effect on the way we conduct our business in the UK. See Risk Factors &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:112%"> &#8220;Legislative or regulatory reforms in the United States or Europe may make it more difficult and costly for us to obtain regulatory clearances, approvals or certifications for our products or to manufacture, market or distribute our products after clearance or approval is obtained&#8221;.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Development and marketing of our products are subject to strict governmental regulation by foreign regulatory agencies, and failure to receive, or delay in receiving, foreign qualifications or certifications could have a material adverse effect on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In many of the foreign countries in which we market our products, we are subject to regulations affecting, among other things, product standards, packaging requirements, labeling requirements, import restrictions, tariff regulations, the reporting of certain payments to health care practitioners in certain markets (for example, the French anti-gift legislation), duties and tax requirements. Many of the regulations applicable to our devices and products in such countries are similar to those of the FDA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In many countries, the national health or social security organizations require our products to be qualified before they can be marketed with the benefit of reimbursement eligibility. To date, we have not experienced difficulty in complying with these regulations. However, our failure to receive, or delays in the receipt of, relevant foreign qualifications could have a material adverse effect on our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Increased regulatory scrutiny of genetic testing may adversely affect our business through increased costs and risks associated with gaining marketing approvals or certifications and potential decreased demand for our genetic testing services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We offer certain genetic testing services to help identify the likelihood of pregnancy as well as identify possible disorders or diseases of a child prior to birth. Regulatory and legislative proposals addressing oversight of genetic testing have been introduced in the U.S., and we expect that new proposals will be introduced from time to time both in the U.S. and in foreign countries in the future. Although the FDA has statutory authority to assure that medical devices, including IVDs, are safe and effective for their intended uses, the FDA has historically exercised its enforcement discretion and not enforced applicable provisions of the FDCA and regulations with respect to laboratory developed tests (LDTs). We believe our tests fall within the definition of an LDT. As a result, we believe our tests are not currently subject to the FDA&#8217;s enforcement of its medical device regulations and the applicable FDCA provisions. However, if there are changes in the FDA&#8217;s policy, or if the FDA disagrees that our marketed tests are LDTs or that we are marketing our tests outside the scope of the FDA&#8217;s current policy of enforcement discretion, we may become subject to extensive regulatory requirements and may be required to stop selling our existing tests or launching any other tests we may develop and to conduct additional clinical trials or take other actions prior to continuing to market our tests. This could significantly increase the costs and expenses of conducting, or otherwise harm, our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Legislative proposals addressing the FDA&#8217;s oversight of LDT have been introduced by Congress in the past and new legislative proposals may be introduced from time to time in the future. The likelihood that Congress will pass such legislation and the extent to which such legislation may affect the FDA&#8217;s ability to enforce its medical device regulations </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">with respect to certain LDT is difficult to predict at this time. If the FDA ultimately begins to enforce its medical device requirements with respect to LDT, our genetic tests may be subject to additional regulatory requirements imposed by the FDA, the nature and extent of which would depend upon applicable final guidance or regulation by the FDA or instruction by Congress. If the FDA imposes significant changes to the regulation of LDT it could reduce our revenue or increase our costs and adversely affect our business, prospects, results of operations or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Any new FDA enforcement policies affecting LDT or new legislation, regulations such as the EU IVDR regulation may result in increased regulatory burdens on our ability to continue marketing our genetic products and to develop and introduce new products in the future, which could reduce our revenue or increase our costs and adversely affect our business, prospects, results of operations or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In addition, changes in the way the EU regulates LDTs could result in additional expenses for offering our current and any future tests or possibly delay or suspend development or commercialization of such tests. In the EU, the regulatory landscape has recently evolved and the general safety and performance requirements set out in Annex I are also applicable to devices manufactured and used only within health institutions. The exemptions provided under the EU IVDR for LDTs remain to be further interpreted and clarified. If our tests do not qualify for an exemption, we may be subject to the full application of the EU IVDR with respect to some or all of our existing, as well as future, tests, and we would be required to expend additional time and resources to complying with the requirements of the EU IVDR.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">If we fail to comply with applicable federal, state, local and foreign laboratory licensing requirements, we could lose the ability to perform our genetic tests or experience disruptions to our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We are subject to the Clinical Laboratory Improvement Amendments of 1988 (CLIA), UK Human Fertilization &amp; Embryology Association (HFEA) regulating IVF, a federal law regulating clinical laboratories that perform testing on specimens derived from humans for the purpose of providing information for the diagnosis, prevention or treatment of disease. Our clinical laboratories must be certified under CLIA and ISO 15189 in order for us to perform testing on human specimens. In addition, our proprietary tests must also be recognized as part of our accredited programs under CLIA so that we can offer them in our laboratory. CLIA is intended to ensure the quality and reliability of clinical laboratories in the U.S. by mandating specific standards in the areas of personnel qualifications, administration, and participation in proficiency testing, patient test management, quality control, quality assurance and inspections. The law also requires us to maintain a state laboratory license to conduct testing in that state. Our laboratories are located in Japan, the UK and U.S., and we must maintain the requisite licenses in each jurisdiction.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Any sanction imposed under CLIA, its implementing regulations, or state or foreign laws or regulations governing licensure, or our failure to renew a CLIA certificate, a state license or accreditation, could have a material and adverse effect on our diagnostic testing business, operating results and financial condition. The CMS also has the authority to impose a wide range of sanctions, including revocation of the CLIA certification along with a bar on the ownership or operation of a CLIA-certified laboratory by any owners or operators of the deficient laboratory. If we were to lose our CLIA certification or required state licensure, we would not be able to operate our clinical laboratory and conduct our tests, in full or in particular states, which would adversely impact our diagnostic testing business, operating results, and financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Our HCT/P products are subject to extensive government regulation and our failure to comply with these requirements could cause our business to suffer.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In the U.S., we provide donor egg and sperm for fertility treatments, in addition to fertility cryopreservation services and newborn stem cell storage (cord blood and cord tissue). Donated reproductive tissues, including eggs and sperm, as well as cord blood and cord tissue, are regulated to by the FDA as human cells, tissues and cellular or tissue-based products (HCT/Ps). In the U.S., we are marketing these HCT/Ps pursuant to Section 361 of the Public Health Service Act (PHSA) and 21 C.F.R. Part 1271 of FDA&#8217;s regulations. The so-called &#8220;361 HCT/Ps&#8221; are not currently subject to the FDA requirements to obtain marketing authorizations, so long as they meet certain criteria set forth in FDA regulations. However, HCT/Ps regulated as 361 HCT/Ps are currently subject to requirements relating to registering facilities and listing products with the FDA, as well as stringent requirements relating to processing, storing, labeling and distributing HCT/Ps, including, screening and testing for tissue donor eligibility, providing required labeling information, record keeping and adverse event reporting. If we fail to comply with these requirements, we could be subject to FDA allegations of noncompliance or enforcement action, including, for example, warning letters, fines, injunctions, product recalls or seizures, and, in the most serious cases, criminal penalties. To be regulated as 361 HCT/Ps, these products must meet the FDA&#8217;s criteria to be considered &#8220;minimally manipulated&#8221; and intended for &#8220;homologous use,&#8221; among other requirements. HCT/Ps that do not meet the criteria to be considered 361 HCT/Ps are subject to the FDA&#8217;s regulatory requirements applicable to medical devices, biologics or drugs, including, importantly, the requirement for premarket review and approval or clearance prior to marketing.</span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We believe our HCT/Ps are regulated solely under Section 361 of the PHSA, and therefore, we have not sought or obtained 510(k) clearance, PMA approval, or licensure through a Biologics License Application (BLA) for such HCT/Ps. However, the FDA could disagree with our determination that these human tissue products are 361 HCT/Ps and could determine that these products are biologics requiring a BLA or medical devices requiring 510(k) clearance or PMA approval, and could require that we cease marketing such products and/or recall them pending appropriate clearance, approval or licensure from the FDA, which would adversely affect our business, results of operations and financial condition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In addition, the FDA may in the future modify the scope of its enforcement discretion with respect to 361 HCT/Ps or change its position on which current or future products qualify as 361 HCT/Ps, or determine that some or all of our HCT/P products may not be lawfully marketed without a marketing authorization. Any regulatory changes could have adverse consequences for us and make it more difficult or expensive for us to conduct our business by requiring pre-market clearance or approval and compliance with additional post-market regulatory requirements with respect to those products. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Disruptions at the FDA and other government agencies or notified bodies caused by funding shortages or global health concerns could hinder their ability to hire, retain or deploy key leadership and other personnel, or otherwise prevent new or modified products from being developed, cleared or approved or commercialized in a timely manner or at all, which could negatively impact our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">The ability of the FDA, foreign agencies and notified bodies to review and clear, approve or certify new products can be affected by a variety of factors, including government budget and funding levels, statutory, regulatory, and policy changes, the FDA&#8217;s, foreign agencies&#8217; and notified bodies&#8217; ability to hire and retain key personnel and accept the payment of user fees, and other events that may otherwise affect the FDA&#8217;s, foreign agencies&#8217; and notified bodies&#8217; ability to perform routine functions. Average review times at the FDA, foreign agencies and notified bodies have fluctuated in recent years as a result. In addition, government funding of other government agencies that fund research and development activities is subject to the political process, which is inherently fluid and unpredictable. Disruptions at the FDA, foreign agencies and notified bodies and other agencies may also slow the time necessary for new drugs and medical devices or modifications to cleared or approved drugs and medical devices to be reviewed, approved and/or certified by necessary government agencies or notified bodies, which would adversely affect our business.&#160;For example, over the last several years, the U.S. government has shut down several times and certain regulatory agencies, such as the FDA, have had to furlough critical employees and stop critical activities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Separately, in response to the COVID-19 pandemic, starting in March 2020, the FDA postponed most inspections of foreign and domestic manufacturing facilities. Subsequently, in July 2020, the FDA resumed certain on-site inspections of domestic manufacturing facilities subject to a risk-based prioritization system. The FDA utilized this risk-based system to assist in determining when and where it was safest to conduct prioritized domestic inspections. In May 2021, the FDA outlined a detailed plan to move toward a more consistent state of inspectional operations, and in July 2021, the FDA resumed standard inspectional operations of domestic facilities. Since that time, the FDA has continued to monitor and implement changes to its inspectional activities to ensure the safety of its employees and those of the firms it regulates as it adapts to the evolving COVID-19 pandemic. Regulatory authorities outside the U.S. have adopted similar restrictions or other policy measures in response to the COVID-19 pandemic. If a prolonged government shutdown occurs, or if global health concerns continue to prevent the FDA, other regulatory authorities or notified bodies from conducting their regular inspections, reviews, or other regulatory activities, it could significantly impact the ability of the FDA, other regulatory authorities or notified bodies to timely review and process our regulatory submissions, which could have a material adverse effect on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">In the EU, notified bodies must be officially designated to certify products and services in accordance with the EU MDR and EU IVDR. Several notified bodies have been designated under the EU MDR but only a few notified bodies have been designated under the EU IVDR so far. The COVID-19 pandemic has significantly slowed down their designation process and the current designated notified bodies are facing a large amount of requests with the new regulations, as a consequence of which review times may have lengthened. This situation may impact the ability of our notified body to timely review and process our regulatory submissions and perform its audits. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Ethical, legal and social concerns related to the use of genetic information, sperm and egg selection services and stem cells could reduce demand for our service offerings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">Genetic testing, sperm and egg selection services and the use of stem cells have raised ethical, legal and social issues regarding privacy and the appropriate uses of information related to these services. Government authorities could, for social or other purposes, limit or regulate the use of genetic information or genetic testing or prohibit testing for genetic predisposition to certain conditions, particularly for those that have no known cure. They also could limit, regulate or prohibit (1) sperm and egg selection services or (2) the use of stem cells. Ethical, legal or social concerns may lead patients to refuse to use, or physicians to be reluctant to order or recommend, genetic tests, sperm and egg selection services and stem cell storage services even if permissible. These and other ethical, legal and social concerns may limit market </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">acceptance and adoption of our service offerings or reduce the potential markets for our service offerings, either of which could have an adverse effect on our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Risks Relating to Interest and Foreign Exchange Rates, Debt and Equity</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Exchange rate fluctuations and foreign currency hedges could adversely affect our financial results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As a result of our international operations, currency exchange rate fluctuations may affect our results of operations and financial position. Our most significant currency exposures are the British pound sterling, euro and Japanese yen. We expect to generate an increasing portion of our revenue and incur a significant portion of our expenses in currencies other than U.S. dollars. To the extent we are unable to materially offset non-functional currency flows, exchange rate fluctuations could have a positive or negative impact on our financial condition and results of operations. Because our consolidated financial results are reported in U.S. dollars, if we generate sales or earnings in other currencies, the translation of those results into U.S. dollars can result in a significant increase or decrease in the amount of those sales or earnings and can make it more difficult for our shareholders to understand the relative strengths or weaknesses of the underlying business on a period-over-period comparative basis. Although we may enter into foreign exchange agreements with financial institutions to reduce our net exposure to fluctuations in foreign currency values relative to our non-functional currency obligations or balances, they would not eliminate that risk entirely. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">We are vulnerable to interest rate risk with respect to our debt.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">We are subject to interest rate risk in connection with the issuance of variable and fixed-rate debt. In order to maintain a desired mix of fixed-rate and variable-rate debt, from time to time we may use interest rate swap agreements to fix a portion of our variable-rate debt as further described in Note 13. Financial Derivatives and Hedging of the Consolidated Financial Statements. We may not be successful in structuring such swap agreements to manage our risks effectively, which could adversely affect our business, earnings and financial condition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The UK&#8217;s Financial Conduct Authority (FCA), which regulates the London Interbank Offered Rate&#160;(LIBOR), announced in July 2017 that it will no longer persuade or require banks to submit rates for&#160;LIBOR&#160;after 2021. In March 2021, the FCA confirmed its intention to stop requiring banks to submit rates required to calculate LIBOR after 2021. However, for U.S. dollar-denominated (USD) LIBOR, only one-week and two-month USD LIBOR will cease to be published after 2021, and all remaining USD LIBOR tenors will continue being published until June 2023. We have multiple debt facilities which bear interest at a variable rate based on the Eurodollar&#160;LIBOR&#160;rate in effect from time to time. A change or transition away from&#160;LIBOR&#160;as a common reference rate in the global financial market could have a material adverse effect on our business. Our management continues to monitor the status and discussions regarding&#160;LIBOR. We do not expect a material impact on our financial statements related to this transition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Our indebtedness could adversely affect our financial health and prevent us from fulfilling our debt obligations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We have now and expect to continue to have a significant amount of indebtedness. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our indebtedness could:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">increase our vulnerability to general adverse economic and industry conditions;</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">require us to dedicate a substantial portion of our cash flow from operations to payments on our indebtedness, thereby reducing the availability of our cash flow to fund working capital, capital expenditures, acquisitions, research and development efforts and other general corporate purposes;</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">limit our flexibility in planning for, or reacting to, changes in our business and the industry in which we operate;</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">place us at a competitive disadvantage compared to our competitors that have less debt;</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">result in greater interest rate risk and volatility;</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">limit our ability to borrow additional funds; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">make it more difficult for us to satisfy our obligations with respect to our debt, including our obligation to repay our credit facilities under certain circumstances, or refinance our indebtedness on favorable terms or at all.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our credit facilities contain financial and other restrictive covenants that could limit our ability to engage in activities that may be in our long-term best interests. Our failure to comply with those covenants could result in an event of default which, if not cured or waived, could result in the acceleration of all of our debt, which could adversely affect our business, earnings and financial condition.</span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Volatility in the securities markets, interest rates, and other factors could substantially increase our defined benefit plan costs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We sponsor a defined benefit plan for certain employees in the U.S. This defined benefit plan is funded with trust assets invested in a diversified portfolio of securities and other investments. Changes in interest rates, mortality rates, early retirement rates, investment returns, discount rates and the market value of plan assets can affect the funded status of our defined benefit plan and cause volatility in the net periodic benefit cost and future funding requirements of the plan. A significant increase in our obligations or future funding requirements could have a negative impact on our results of operations and cash flows from operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Risks Relating to Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Changes in tax laws, examinations by tax authorities, and changes in our geographic composition of income could adversely affect our cash flows, results of operations, and financial condition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Income taxes and other taxes are based on enacted tax laws and the results of operations in each jurisdiction. Taxes could significantly increase due to changes in tax laws or changes in our interpretation of those laws. Changes in tax laws could result from a framework being developed by the Organisation for Economic Co-operation and Development (OECD), a global policy forum, that, if implemented, includes a global minimum tax rate of 15%. Taxes could also significantly increase due to changes in accounting guidance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Income taxes and other taxes could significantly increase based on the resolution of tax authority examinations. Tax authorities could challenge our interpretations of tax laws and estimates we use to calculate taxes. Tax authorities could also challenge our positions related to transfer pricing and intercompany transactions, including the valuation of intangible assets. Tax examinations can result in costly litigation with significant interest and penalties and ultimate settlement can take several years. For example, we have engaged (and expect to continue to engage) with tax authorities over tax positions we have taken in connection with acquisitions, and such examinations could cause us to incur significant expense (and adverse determinations by the tax authority could result in penalties).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Our effective tax rate could fluctuate based on the geographic composition of income, which could significantly change based on our business results and acquisitions. Our effective tax rate could also fluctuate based on changes in estimates, changes in excess tax benefits from share-based compensation, changes in non-deductible expenses, and the valuation of deferred tax assets and liabilities. These fluctuations could have an adverse effect on our cash flows, results of operations, and financial condition.</span></div><div id="ifcd99b6df4104f80be938ce77dc8288d_22"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item 1B. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Unresolved Staff Comments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">None.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="ifcd99b6df4104f80be938ce77dc8288d_25"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item&#160;2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Properties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following is a summary of Cooper's principal facilities as of October&#160;31, 2022. We generally lease our office and operations facilities but own several manufacturing and research and development facilities, including 298,852 square feet in the United Kingdom, 350,600 square feet in Costa Rica, 78,767 square feet in New York and 33,630 square feet in Texas. Our lease agreements expire at various dates through the year 2045. We believe our properties are suitable and adequate for our businesses.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.252%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:65.087%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Location</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Approximate<br/>Square Feet</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Operations</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">AMERICAS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United States:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;California  </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">201,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Executive offices; CooperVision manufacturing, research &amp; development and administrative offices; CooperSurgical research &amp; development, distribution and administrative offices</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;New York</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">349,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision and CooperSurgical distribution and administrative offices</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">New Jersey</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">37,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperSurgical research and development, distribution and administrative offices</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Connecticut</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">285,538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperSurgical distribution and administrative offices</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Arizona</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision manufacturing</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Puerto Rico</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">563,284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision manufacturing, research and development and distribution</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">60,035&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision manufacturing and administrative office; CooperSurgical research &amp; development, distribution and administrative offices</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Brazil</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">38,623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision distribution and administrative office</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other Americas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">45,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision distribution and administrative offices; CooperSurgical research &amp; development, distribution and administrative offices</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">EMEA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">691,131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision manufacturing, distribution, research &amp; development and administrative offices; CooperSurgical  research &amp; development, administrative offices</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Hungary</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">330,149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision manufacturing</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Belgium</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">279,967&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision distribution</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">181,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision distribution and administrative office; CooperSurgical administrative office</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">86,027&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision administrative offices; CooperSurgical research &amp; development and distribution</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">125,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision distribution and administrative offices; CooperSurgical administrative offices</span></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">ASIA PACIFIC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">103,533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision distribution and administrative offices; CooperSurgical laboratory/research &amp; development</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32,844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision marketing and distribution; CooperSurgical research &amp; development and distribution</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other Asia Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">91,244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision distribution, marketing and administrative offices; CooperSurgical marketing and administrative office</span></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="ifcd99b6df4104f80be938ce77dc8288d_28"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Information regarding legal proceedings is included in Note 11. Contingencies of the Consolidated Financial Statements.</span></div><div id="ifcd99b6df4104f80be938ce77dc8288d_31"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item 4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Mine Safety Disclosures.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="ifcd99b6df4104f80be938ce77dc8288d_34"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PART II</span></div><div><span><br/></span></div><div id="ifcd99b6df4104f80be938ce77dc8288d_37"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item&#160;5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Cooper's common stock, par value $0.10 per share, is traded on the New York Stock Exchange under the symbol &#8220;COO.&#8221; At December 1, 2022, there were 268 common stockholders of record.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Dividend Policy</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our current policy is to pay annual cash dividends on our common stock of $0.06 per share, in two semiannual payments of $0.03 per share each. In dollar terms, we paid cash for dividends of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">$3.0&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> in each of fiscal 2022 and 2021. Dividends are paid when, as and if declared at the discretion of our Board of Directors from funds legally available for that purpose. Our Board of Directors periodically reviews our dividend policy and considers the Company's earnings, financial condition, liquidity needs, business plans and opportunities and other factors in making and setting dividend policy.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Performance Graph</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following graph compares the cumulative total return on Cooper's common stock with the cumulative total return of the Standard &amp; Poor 500 and the Standard&#160;&amp; Poor's Health Care Equipment Index for the five-year period ended October&#160;31, 2022. The graph assumes that the value of the investment in Cooper and in each index was $100 on October&#160;31, 2017 and assumes that all dividends were reinvested. </span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">COMPARISON OF 5 YEAR CUMULATIVE TOTAL RETURN*</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Among The Cooper Companies, Inc., </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">the S&amp;P 500 Index and the S&amp;P Health Care Equipment Index</span></div><div style="text-align:justify"><span><br/></span></div><div><img src="coo-20221031_g4.jpg" alt="coo-20221031_g4.jpg" style="height:360px;margin-bottom:5pt;vertical-align:text-bottom;width:600px"/></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">*$100 invested on October 31, 2017 in stock or index, including reinvestment of dividends.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Fiscal year ending October 31.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Copyright&#169; 2022 Standard &amp; Poor's, a division of S&amp;P Global. All rights reserved.</span></div><div><span><br/></span></div><div id="ifcd99b6df4104f80be938ce77dc8288d_40"></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">There was no share repurchase activity during the three-month period ended October&#160;31, 2022.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><div id="ifcd99b6df4104f80be938ce77dc8288d_43"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Equity Compensation Plan Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table sets forth certain information as of October&#160;31, 2022, concerning the shares of our Common Stock that may be issued under any form of award granted under our equity compensation plans in effect as of October&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.053%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.970%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.140%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Plan Category</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:700;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(A)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price of Outstanding Options, Warrants and Rights<br/>(B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in Column A)<br/>(C)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Equity compensation plans approved by shareholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,432,459</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$264.85</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,671,522</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Equity compensation plans not approved by shareholders</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,432,459</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$264.85</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,671,522</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> The amount of total securities to be issued under Company equity plans upon exercise of outstanding options, warrants and rights shown in Column A includes 289,238 Restricted Stock Units granted pursuant to the Company's equity plans. These awards allow for the distribution of shares to the grant recipient upon the completion of time-based vesting periods. The total also includes 79,378 shares representing the maximum number of shares that may be issued subject to Performance Share Awards outstanding as of the end of the fiscal year. Restricted Stock Units and Performance Share Awards do not have an associated exercise price. Accordingly, these awards are not reflected in the weighted-average exercise price disclosed in Column B. </span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:112%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"> Includes information with respect to the Third Amended and Restated 2007 Long Term Incentive Plan for Employees (2007 Plan) and the 2019 Employee Stock Purchase Plan (2019 ESPP), as discussed in Note 9. Stock Plans of the Consolidated Financial Statements. Also includes information from Second Amended and Restated 2006 Long Term Incentive Plan for Non-Employee Directors, which expired by its terms in March 2019, and the 2020 Long Term Incentive Plan for Non-Employee Directors (2020 Directors' Plan), which was approved by stockholders on March 18, 2020 and provides for the issuance of up to 50,000 shares of Common Stock. As of October&#160;31, 2022, up to 690,596 shares of Common Stock may be issued pursuant to the 2007 Plan, up to</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"> 948,090 s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">hares of Common Stock may be issued pursuant to the 2019 ESPP and up to</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">32,836</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">shares of Common Stock may be issued pursuant to the 2020 Directors' Plan. </span></div><div id="ifcd99b6df4104f80be938ce77dc8288d_46"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item&#160;6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Reserved</span></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="ifcd99b6df4104f80be938ce77dc8288d_49"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item&#160;7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Management's Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;text-decoration:underline">Note numbers refer to &#8220;Notes to Consolidated Financial Statements&#8221; in Item&#160;8. Financial Statements and Supplementary Data.</span></div><div id="ifcd99b6df4104f80be938ce77dc8288d_52"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Results of Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In this section, we discuss the results of our operations for fiscal 2022 compared with fiscal 2021. We discuss our cash flows and current financial condition under &#8220;Capital Resources and Liquidity.&#8221; For a discussion related to fiscal 2021 compared with fiscal 2020, please refer to Item 7 of Part II, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in our Annual Report on Form 10-K for the Year Ended October&#160;31, 2021, which was filed with the United States Securities and Exchange Commission (SEC) on December 10, 2021, and is available on the SEC's website at www.sec.gov and our Investor Relations website at investor.coopercos.com.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Within the tables presented, percentages are calculated based on the underlying whole-dollar amounts and, therefore, may not recalculate exactly from the rounded numbers used for disclosure purposes.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Outlook</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We are optimistic about the long-term prospects for the worldwide contact lens and general health care markets, and the resilience of and growth prospects for our businesses and products. However, we face significant risks and uncertainties in our global operating environment as further described in the &#8220;Risk Factors&#8221; section in Part I, Item 1A of this filing. These risks include uncertain global and regional business, political and economic conditions, including but not limited to those associated with the COVID-19 pandemic, Russia&#8217;s invasion of Ukraine, inflation, foreign exchange rate fluctuations, regulatory developments, supply chain disruptions, and escalating global trade barriers. These risks and uncertainties have adversely affected our sales, cash flow and current performance in the past and are likely to further adversely affect our future sales, cash flow and performance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Global Market and Economic Conditions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> - Over the last few years in the U.S. and globally, market and economic conditions have been challenging, particularly in light of the COVID-19 pandemic. Foreign countries, in particular the Euro zone, have experienced recessionary pressures and face continued concerns about the systemic impacts of adverse economic conditions and geopolitical issues. In addition, changes in economic conditions, supply chain constraints, logistics challenges, labor shortages, the war in Ukraine, and steps taken by governments and central banks, particularly in response to the COVID-19 pandemic, as well as other stimulus and spending programs, have led to higher inflation, which is likely to lead to an increase in costs and may cause changes in fiscal and monetary policy, including increased interest rates. In a higher inflationary environment, we may be unable to raise the prices of our products and services sufficiently to keep up with the rate of inflation. These economic conditions could have a material adverse effect on our results of operations and financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:112%">COVID-19&#160;Considerations - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">The COVID-19 pandemic and health crisis led to ongoing economic and societal disruptions and uncertainties that have negatively impacted business and healthcare activity globally. As a result of healthcare systems responding to the demands of managing the pandemic, governments around the world imposing measures designed to reduce the transmission of the COVID-19 virus, and individuals responding to the concerns of contracting the COVID-19 virus, many optical practitioners and retailers, hospitals, medical offices and fertility clinics closed their facilities, restricted access, or delayed or canceled patient visits, exams and elective medical procedures, and many customers that have reopened are experiencing reduced patient visits. These factors have had, and in the future may continue to have, an adverse effect on our sales, operating results and cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We have taken an active role in addressing the pandemic&#8217;s impact on our employees, suppliers, distribution channels, operations and customers, including taking precautionary measures and developing contingency plans with respect to our operations and to help ensure the safety of our personnel in all our facilities, and we have endeavored and continue to follow recommended actions of government and health authorities to protect our employees worldwide. As of the date of this filing, we have not experienced any significant disruption at our manufacturing facilities or in our access to necessary raw materials and other supplies or with our distribution network; however, we have experienced higher unabsorbed fixed overhead costs, labor inefficiencies, delays in receiving certain raw materials, higher cost of production and higher freight charges as a result of&#160;the COVID-19 pandemic.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">At this time, future developments with respect to the COVID-19 pandemic remain highly uncertain and largely outside of our control. We cannot predict the spread, duration and severity of the pandemic or any subsequent outbreaks, potential actions taken by governments to respond to the pandemic, or potential impacts on global and local economic activity. We </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">will continue to closely monitor the developments relating to the COVID-19 pandemic and the responses from governments and private sector participants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">For more information on the risks associated with&#160;the COVID-19 pandemic, refer to Part I, Item 1A, "Risk Factors" herein.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">CooperVision</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> - We compete in the worldwide contact lens market with our spherical, toric, multifocal, toric multifocal contact lenses offered in a variety of materials including using silicone hydrogel Aquaform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> technology and PC Technology&#8482;. We believe that there will be lower contact lens wearer dropout rates as technology improves and enhances the wearing experience through a combination of improved designs and materials and the growth of preferred modalities such as single-use and monthly wearing options. CooperVision also competes in the myopia management and specialty eye care contact lens markets with myopia management contact lenses using its ActivControl&#174; technology and with products such as orthokeratology (ortho-k) and scleral lenses. In November 2019, CooperVision received U.S. Food and Drug Administration (FDA) approval for its MiSight</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> 1 day lens, which is the first and only FDA-approved product indicated to slow the progression of myopia in children with treatment initiated between the ages of 8-12 and became available in the United States during fiscal 2020. In August 2021, CooperVision received Chinese National Medical Products Administration (NMPA) approval for its MiSight</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> 1 day lens for use in China. CooperVision is focused on greater worldwide market penetration using recently introduced products, and we continue to expand our presence in existing and emerging markets, including through acquisitions. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision acquired the following entity during fiscal 2022:</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;      A privately-held Denmark-based ortho-k contact lens distributor in May 2022</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision acquired the following entities during fiscal 2021:</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">A privately-held UK contact lens manufacturer in April 2021</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%;padding-left:14.68pt">A privately-held medical device company (SightGlass Vision Inc. (SGV), a developer of spectacle lenses for myopia management) in January 2021</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">During the second quarter of fiscal 2022, the Company initiated a plan to exit its contact lens care business, a non-core business unit of the CooperVision segment. We expect the exit activity to be substantially completed in the first half of fiscal 2023. Exit charges recognized in the three and twelve months ended October 31, 2022, were $9.2&#160;million and $33.2&#160;million, of which $26.7&#160;million is recognized in cost of sales and $6.5&#160;million is recognized in selling, general, and administrative expense in the Consolidated Statements of Income. Exit costs primarily related to inventory write-down, asset impairments and employee-related costs. Total exit costs are expected to be in a range of $30.0&#160;million to $40.0&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">In March 2022, CooperVision and Essilor International SAS (Essilor) entered into a Contribution Agreement and a Stock Purchase Agreement under which Essilor paid CooperVision $52.1&#160;million in exchange for a 50% interest in SGV and a proportionate share of certain revenue-based milestone payments related to the January 2021 acquisition of SGV by CooperVision. As part of these agreements, each party contributed their interest in SGV and $10&#160;million in cash to form a new joint venture. CooperVision then remeasured the fair value of its retained equity investment in the joint venture at $90.0&#160;million which resulted in a $56.9&#160;million gain in Other (income) expense on deconsolidation of SGV.</span></div><div><span><br/></span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">On November 1, 2022, subsequent to the fiscal year ended October 31, 2022, CooperVision closed an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) to acquire a U.S. based privately held leading expert in specialty contact lenses for both normal and irregular corneal conditions. The Company is in the process of finalizing purchase accounting information.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our ability to compete successfully with a full range of silicone hydrogel products is an important factor to achieving our desired future levels of sales growth and profitability. CooperVision manufactures and markets a wide variety of silicone hydrogel contact lenses. Our single-use silicone hydrogel product franchises, clariti</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">and MyDay</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">, remain a focus as we expect increasing demand for these products as well as future single-use products as the global contact lens market continues to shift to this modality. Outside of single-use, the Biofinity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> and Avaira Vitality</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> product families comprise our focus in the FRP, or frequent replacement product, market which encompasses the 2-week and monthly modalities. Included in this segment are unique products such as Biofinity Energys</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">, which helps individuals with digital eye fatigue.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">CooperSurgical -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> Our CooperSurgical business competes in the general health care market with a commitment to advancing the health of women, babies and families through its diversified portfolio of products and services focusing on women's health and fertility. CooperSurgical has established its market presence and distribution system by developing products and acquiring companies, products and services that complement its business model. </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperSurgical acquired the following entities during fiscal 2022:</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;      A private cryopreservation services company in April 2022</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;      Generate Life Sciences (Generate), a privately-held leading provider of donor egg and sperm for fertility treatments, fertility cryopreservation services and newborn stem cell storage (cord blood &amp; cord tissue) in December 2021</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperSurgical acquired the following entities during fiscal 2021:</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">A privately-held medical device company that develops single-use illuminating medical devices in May 2021</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">A privately-held medical device company in March 2021</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">A privately-held medical device company in February 2021</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">A privately-held in vitro fertilization (IVF) cryostorage software solutions company in December 2020</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">On April 6, 2022, CooperSurgical entered into an asset purchase agreement to acquire Cook Medical's Reproductive Health business, a manufacturer of minimally invasive medical devices focused on the fertility, obstetrics and gynecology markets. The aggregate consideration is $875.0&#160;million in cash, with $675.0&#160;million payable at the closing and the remaining $200.0&#160;million payable in $50.0&#160;million installments following each of the first, second, third and fourth anniversaries of the closing. The transaction is subject to customary closing conditions, such as receipt of required regulatory approvals.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Transition from LIBOR</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">The UK&#8217;s Financial Conduct Authority (FCA), which regulates the London Interbank Offered Rate&#160;(LIBOR), announced in July 2017 that it will no longer persuade or require banks to submit rates for&#160;LIBOR&#160;after 2021. In March 2021, the FCA confirmed its intention to stop requiring banks to submit rates required to calculate LIBOR after 2021. However, for U.S. dollar-denominated (USD) LIBOR, only one-week and two-month USD LIBOR will cease to be published after 2021, and all remaining USD LIBOR tenors will continue being published until June 2023. Further, in March 2020, the Financial Accounting Standards Board (FASB) issued ASU 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">. This guidance provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. We have material contracts that are indexed to LIBOR and are continuing to monitor this activity and evaluate the related risk. We are continuing to evaluate the scope of impacted contracts and the potential impact. We are also monitoring the developments regarding alternative rates and may amend certain contracts to accommodate those rates if the contract does not already specify a replacement rate. While the notional value of agreements potentially indexed to LIBOR is material, we do not expect a material impact on our financial statements related to this transition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We believe that current cash, cash equivalents and future cash flow from operating activities will be sufficient to meet our anticipated cash needs, including working capital needs, capital expenditures and contractual obligations for at least 12 months from the issuance date of the financial statements included in this annual report. To the extent additional funds are necessary to meet our liquidity needs such as that for acquisitions, share repurchases, cash dividends or other activities as we execute our business strategy, we anticipate that additional funds will be obtained through the incurrence of additional indebtedness, additional equity financings or a combination of these potential sources of funds; however, such financing may not be available on favorable terms, or at all.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">2022 Compared with 2021</span></div><div style="margin-top:9pt;text-align:center"><img src="coo-20221031_g5.jpg" alt="coo-20221031_g5.jpg" style="height:254px;margin-bottom:5pt;vertical-align:text-bottom;width:386px"/></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">CooperVision Net Sales</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The contact lens market has two major product categories:</span></div><div style="margin-top:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Spherical lenses including lenses that correct near- and farsightedness uncomplicated by more complex visual defects; and</span></div><div style="margin-top:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Toric and multifocal lenses including lenses that, in addition to correcting near- and farsightedness, address more complex visual defects such as astigmatism and presbyopia by adding optical properties of cylinder and axis, which correct for irregularities in the shape of the cornea.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">CooperVision Net Sales by Category</span></div><div style="margin-top:9pt;text-align:center"><img src="coo-20221031_g6.jpg" alt="coo-20221031_g6.jpg" style="height:286px;margin-bottom:5pt;vertical-align:text-bottom;width:300px"/><img src="coo-20221031_g7.jpg" alt="coo-20221031_g7.jpg" style="height:286px;margin-bottom:5pt;vertical-align:text-bottom;width:300px"/></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Single-use spheres</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> &#8211; This includes Biomedics 1 day, clariti 1 day, MyDay, MiSight and Proclear 1 day</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Toric</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> &#8211; This includes Avaira Vitality toric, Biomedics toric, Biofinity toric, clariti 1 day toric, MyDay toric and Proclear toric</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Multifocal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> &#8211; This includes Biofinity multifocal, Biofinity toric multifocal, clariti 1 day multifocal, MyDay multifocal and Proclear 1 day multifocal</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Non single-use sphere, other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"> &#8211; This includes our Avaira Vitality spheres, frequent replacement product (FRP) lens portfolio (Biofinity spheres, Biofinity Energys, Biomedics, Proclear spheres, clariti spheres), ortho-k, scleral and custom lenses, contact lens solutions and other</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.117%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.079%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.079%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022 vs. 2021 %&#160;Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Toric</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">737.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">697.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Multifocal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">264.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">238.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Single-use spheres</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">661.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">616.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non single-use sphere, other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">579.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">599.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,243.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,152.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In the fiscal year ended October&#160;31, 2022, the growth experienced across all categories (except for "Other" as mentioned below) was partially offset by unfavorable foreign exchange rate fluctuations, which approximated $149.5&#160;million. Sales growth was primarily driven by an increase in the volume of lenses sold across our core portfolio due to a recovery in demand from the impact of the COVID-19 pandemic.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Toric and multifocal lenses grew primarily through the success of MyDay and Biofinity.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Single-use sphere lenses grew primarily through MyDay, clariti and MiSight lenses.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Non single-use sphere lenses grew primarily through Biofinity and ortho-k.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">"Other" products decreased primarily due to exit of the contact lens care business. Contact lens care represented approximately 1% and 2% of net sales in fiscal 2022 and 2021.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">Total silicone hydrogel products increased by 7%, representing 78% of net sales in fiscal 2022 compared to 76% in fiscal 2021.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">CooperVision Net Sales by Geography</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision competes in the worldwide soft contact lens market and services in three primary regions: the Americas, EMEA (Europe, Middle East and Africa) and Asia Pacific.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.201%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">($ in millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022 vs. 2021 %&#160;Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">887.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">832.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">843.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">819.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">512.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">500.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,243.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,152.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision's growth in net sales across all regions was primarily attributable to market gains of silicone hydrogel contact lenses. Refer to CooperVision Net Sales by Category above for further discussion.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">CooperSurgical Net Sales by Category</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperSurgical supplies the family health care market with a diversified portfolio of products and services. Our office and surgical offerings include products that facilitate surgical and non-surgical procedures that are commonly performed primarily by obstetricians and gynecologists in hospitals, surgical centers, fertility clinics and medical offices. Fertility offerings include highly specialized products and services that target the IVF process, including diagnostics testing with a goal to make fertility treatment safer, more efficient and convenient.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The chart below shows the percentage of net sales of office and surgical products and fertility.</span></div><div style="margin-top:9pt;text-align:center"><img src="coo-20221031_g8.jpg" alt="coo-20221031_g8.jpg" style="height:286px;margin-bottom:5pt;vertical-align:text-bottom;width:300px"/><img src="coo-20221031_g9.jpg" alt="coo-20221031_g9.jpg" style="height:286px;margin-bottom:5pt;vertical-align:text-bottom;width:300px"/></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Office/Surgical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"> &#8211; This includes Endosee endometrial imaging products, Fetal Pillow cephalic elevation devices for use in Cesarean sections, illuminated speculum products, Lone Star retractor systems, loop electrosurgical excision procedure (LEEP) products, Mara water ablation systems, newborn stem cell storage, PARAGARD contraceptive IUDs, point-of-care products and uterine positioning products.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Fertility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"> &#8211; Our significant fertility products and services include cryostorage, donor gamete services, fertility consumables and equipment and genomic services (including preimplantation genetic testing).</span></div><div style="margin-top:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.355%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.441%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022 vs. 2021 %&#160;Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Office and surgical products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">633.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">451.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Fertility</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">431.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">319.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,065.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">770.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">e fiscal year ended October&#160;31, 2022, net sales increase in both categories was mainly due to the Generate acquisition. The increase was offset by unfavorable foreign exchange rate fluctuations, which approximated $33.4&#160;million.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Gross Margin</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Consolidated Gross Margin decreased in fiscal 2022 to 65% compared to 67% in fiscal 2021 primarily driven by unfavorable currency and contact lens care exit costs. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Selling, General and Administrative Expense (SGA)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.156%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.951%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.951%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.082%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.319%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%&#160;Net<br/>Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%&#160;Net<br/>Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022 vs. 2021 <br/>% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">826.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">843.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperSurgical</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">320.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">53.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">47.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,342.2&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,211.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision's SGA decreased in fiscal 2022 compared to fiscal 2021 primarily due to the $56.8&#160;million increase in fair value of the contingent consideration related to SGV acquisition in fiscal 2021, partially offset by increase in SGA to support sales growth. </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperSurgical's SGA increased in fiscal 2022 compared to fiscal 2021 primarily due to the addition of Generate's SGA and acquisition and integration expenses. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Corporate SGA increased in fiscal 2022 compared to fiscal 2021 primarily due to share-based compensation related expenses.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Research and Development Expense (R&amp;D)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.073%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.921%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.320%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%&#160;Net<br/>Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%&#160;Net<br/>Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022 vs. 2021 <br/>% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">62.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">61.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperSurgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">47.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">31.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">110.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">92.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision's R&amp;D expense increased in fiscal 2022 compared to fiscal 2021 primarily due to myopia management programs and timing of R&amp;D projects. CooperVision's R&amp;D activities are primarily focused on the development of contact lenses, manufacturing technology and process enhancements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperSurgical's R&amp;D expense increased in fiscal 2022 compared to fiscal 2021 mainly due to the addition of Generate's R&amp;D expense. CooperSurgical's R&amp;D activities are focused on developing and refining diagnostic and therapeutic products including medical interventions, surgical devices and fertility solutions.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Amortization Expense</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.073%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%&#160;Net<br/>Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%&#160;Net<br/>Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022 vs. 2021 <br/>% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperSurgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">147.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">110.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">179.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">146.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision's amortization expense decreased in absolute dollars in fiscal 2022 compared to fiscal 2021, primarily due to the deconsolidation of SGV.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperSurgical's amortization expense increased in absolute dollars in fiscal 2022 compared to fiscal 2021, primarily due to the amortization of intangible assets newly acquired through acquisitions.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Operating Income </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.111%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.111%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.160%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%&#160;Net<br/>Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%&#160;Net<br/>Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022 vs. 2021 <br/>% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">494.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">481.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperSurgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">67.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">71.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(53.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(47.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">507.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">505.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperVision's operating income increased in fiscal 2022 compared to fiscal 2021, primarily due to an increase in net sales partially offset by net changes in operating expenses. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CooperSurgical's operating income decreased in fiscal 2022 compared to fiscal 2021, primarily due to an increase in SGA and amortization expenses, partially offset by an increase in net sales.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Corporate operating loss increased in fiscal 2022 compared to fiscal 2021, primarily due to higher share-based compensation expense.</span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On a consolidated basis, operating income increased in fiscal 2022 compared to fiscal 2021, primarily due to an increase in consolidated net sales.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.073%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.441%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%&#160;Net<br/>Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%&#160;Net<br/>Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022 vs. 2021 <br/>% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">57.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Interest expense increased during fiscal 2022 compared to the prior year, primarily due to higher average debt balances and higher interest rates.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Other (Income) Expense, Net</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.959%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Investment gain</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(47.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign exchange loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other expense (income), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(25.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Investment gain primarily consists of a gain on remeasurement of the fair value of retained equity investment in SGV as a result of deconsolidation.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Foreign exchange loss is primarily associated with the strengthening of the US dollar against foreign currencies and the effect on intercompany receivables.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Other expense (income), net increased in fiscal 2022, primarily due to a loss on minority investments, partially offset by defined benefit plan related income.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Provision for Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">The effective tax rates for fiscal 2022 and 2021 were 18.8% and (499.1)%, respectively. The increase was primarily due to an intra-group transfer of intellectual property in fiscal 2021 and UK tax rate change in fiscal 2021, as discussed below. The increase was also due to changes in the geographic composition of pre-tax earnings and changes in excess tax benefits from share-based compensation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">The effective tax rate for fiscal 2022 was lower than the US federal statutory rate primarily due to foreign earnings in jurisdictions with lower tax rates and changes in unrecognized tax benefits, partially offset by foreign earnings subject to US tax. The effective tax rate for fiscal 2021 was lower than the US federal statutory tax rate primarily due to the intra-group transfer, UK tax rate change, and earnings in foreign jurisdictions with lower tax rates partially offset by foreign earnings subject to US tax. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">In November 2020, the Company completed an intra-group transfer of certain intellectual property and related assets of CooperVision to a UK subsidiary as part of a group restructuring to establish headquarters operations in the UK. Determining fair value involved significant judgment related to future revenue growth, operating margins, and discount rates. The transfer resulted in a step-up of the UK tax-deductible basis in the intellectual property and goodwill, creating a temporary difference between the book basis and the tax basis of these assets. As a result, the Company recognized a deferred tax asset of $1,987.9 million, with a corresponding income tax benefit, during the first quarter of fiscal 2021. During the third quarter of fiscal 2021, the Company recognized a $536.7 million tax benefit related primarily to the remeasurement of this deferred tax asset caused by the UK enactment of a 25% corporate tax rate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">See Note 6. Income Taxes for additional information.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><div id="ifcd99b6df4104f80be938ce77dc8288d_55"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">CAPITAL RESOURCES AND LIQUIDITY </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Working capital at October&#160;31, 2022 and October&#160;31, 2021, was $253.4&#160;million and $733.2&#160;million, respectively. The decrease in working capital is primarily due to an increase in accounts payable as a result of timing of payment to vendors, and an increase in short-term debt due to the 364-day term loan agreement entered into during fiscal 2022. See Note 5. Financing Arrangements for further information.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The $43.1 million increase in inventories was primarily due to higher sales, and the buildup of inventory for future product launches.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Cash Flow</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.841%"><tr><td style="width:1.0%"></td><td style="width:64.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.874%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">692.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">738.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">486.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">(1,831.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">(450.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">(364.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">1,193.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">(311.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">(95.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Effect of exchange rate changes on cash, cash equivalents, restricted<br/>cash and restricted cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Increase (decrease) in cash, cash equivalents, restricted cash and<br/>restricted cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">42.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">(20.2)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">27.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Operating cash flow</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Cash provided by operating activities in fiscal 2022 was lower than cash provided by operating activities in fiscal 2021, primarily due to settlement of contingent consideration of $52.3 million.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Investing Cash Flow</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Cash used in investing activities in fiscal 2022 was higher than cash used in investing activities in fiscal 2021, primarily attributable to $1.6 billion cash paid, net of cash acquired, for the Generate acquisition, partially offset by $52.1 million proceeds from the sale of a 50% interest in SGV. See Note 3. Acquisitions and Joint Venture for further information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Financing Cash Flow</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Cash was provided by financing activities in fiscal 2022 compared to used in financing activities in fiscal 2021, primarily due to a decrease in repayments of long-term debt obligations by $854.5&#160;million, and net proceeds from short-term debt of $329.3 million in fiscal 2022, compared to net repayments of short-term debt obligations of $321.3 million in fiscal 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">The following is a summary of the maximum commitments and the net amounts available to us under different credit facilities as of October&#160;31, 2022:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.730%"><tr><td style="width:1.0%"></td><td style="width:28.481%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.832%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.993%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.325%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Facility Limit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Outstanding Borrowings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Outstanding Letters of Credit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total Amount Available</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Maturity Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Revolving Credit:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2020 Revolving Credit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,290.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,288.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">April 1, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Term Loan:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2021 364-Day Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">840.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">338.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">November 1, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2020 Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">850.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">850.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">April 1, 2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2021 Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,500.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,500.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">December 17, 2026</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,480.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,688.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,288.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of October&#160;31, 2022, the Company was in compliance with all debt covenants. See Note 5. Financing Arrangements for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Considering recent market conditions and the COVID-19 pandemic crisis, we have re-evaluated our operating cash flows and cash requirements and continue to believe that current cash, cash equivalents, future cash flow from operating activities and cash available under our 2020 Credit Agreement will be sufficient to meet our anticipated cash needs, including working capital needs, capital expenditures and contractual obligations for at least 12 months from the issuance date of the </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Consolidated Financial Statements included in this quarterly report. To the extent additional funds are necessary to meet our liquidity needs such as that for acquisitions, share repurchases, cash dividends or other activities as we execute our business strategy, we anticipate that additional funds will be obtained through the incurrence of additional indebtedness, additional equity financings or a combination of these potential sources of funds; however, such financing may not be available on favorable terms, or at all.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Share Repurchases</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In December 2011, the Company's Board of Directors authorized the 2012 Share Repurchase Program and through subsequent amendments, the most recent in March 2017, the total repurchase authorization was increased from $500.0 million to $1.0 billion of the Company's common stock. The program has no expiration date and may be discontinued at any time. Purchases under the 2012 Share Repurchase Program are subject to a review of the circumstances in place at the time and may be made from time to time as permitted by securities laws and other legal requirements.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In fiscal 2022, we repurchased 191,165 shares of our common stock for $78.5 million. At October&#160;31, 2022, $256.4 million remained authorized for repurchase under the program. See Note 8. Stockholders&#8217; Equity for additional information.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In fiscal 2022 and 2021, the Company declared regular dividends of 6 cents per share (a semiannual dividend of 3 cents per share) and paid a total of $3.0&#160;million in each fiscal year.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">CONTRACTUAL OBLIGATIONS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of October&#160;31, 2022, we had the following contractual obligations: </span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.047%"><tr><td style="width:1.0%"></td><td style="width:40.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Payments Due by Fiscal Year</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2024 &amp; 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2026 &amp; 2027</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2028 &amp; Beyond</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">319.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Transition tax on unremitted foreign earnings and profits </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">100.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Purchase obligations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">270.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total contractual obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">690.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">288.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">308.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">93.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of October&#160;31, 2022, we had $100.4 million of income tax liabilities related to the one-time transition tax that resulted from the enactment of the 2017 US Tax Act, which is payable in annual installments through fiscal 2026. The installment for fiscal 2022 is classified as a current income tax payable on our consolidated balance sheet.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We are unable to reliably estimate the timing of future payments related to uncertain tax positions and have excluded $25.4 million of long-term income taxes payable from the table above. See Note 6. Income Taxes for additional information.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Purchase obligations consist of agreements to purchase goods and services that are enforceable and legally binding and includes obligations for inventory, capital expenditures and other operating expense commitments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The table above excludes future payments for operating leases, long-term debt, and our defined benefit plan. The minimum future payments for operating leases are disclosed in Note 2. Operating Leases and future maturities of long-term debt are disclosed in Note 5. Financing Arrangements. The expected future benefit payments for our Retirement Income Plan through 2032 are disclosed in Note 10. Employee Benefits.</span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><div id="ifcd99b6df4104f80be938ce77dc8288d_61"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Critical Accounting Estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Management estimates and judgments are an integral part of financial statements prepared in accordance with GAAP. We believe that the critical accounting policies described in this section address the more significant estimates required of management when preparing the Consolidated Financial Statements in accordance with GAAP. We consider an accounting estimate critical if changes in the estimate may have a material impact on our financial condition or results of operations. We believe that the accounting estimates employed are appropriate and resulting balances are reasonable; however, actual results could differ from the original estimates, requiring adjustment to these balances in future periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">We believe the followings represent our critical accounting policies and estimates used in the preparation of our consolidated financial statements:</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Revenue recognition - We recognize revenue from product sales when obligations under the terms of a contract with the customer are satisfied; generally, this occurs with the transfer of control of the goods to customers and/or when services are rendered. Our payment terms are typically between 30 to 120 days. Provisions for certain rebates, sales incentives, volume discounts, contractual pricing allowances and product returns are accounted for as variable consideration and recorded as a reduction in sales. </span></div><div style="margin-top:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Product discounts, including certain rebates, sales incentives, and volume discounts are granted based on terms of the arrangement with direct distribution customers and at times the indirect end consumer. We evaluate contractual terms, historical experience, and perform internal analysis to estimate total product discounts at the time revenue is recognized. CooperSurgical rebates are predominately related to the Medicaid rebate provision that is estimated based upon contractual terms, historical experience, and trend analysis.</span></div><div style="margin-top:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Sales returns are estimated and recorded based on historical sales return data. Promotional programs, such as cooperative advertising arrangements, are recorded in the same period as related sales. Reasonably likely changes to assumptions used to calculate the accruals for rebates, sales incentives, volume discounts, contractual pricing allowances and product returns are not anticipated to have a material effect on the financial statements. We currently disclose the impact of changes to assumptions in the quarterly or annual filing in which there is a material financial statement impact.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Business combinations - We routinely consummate business combinations. Results of operations for acquired companies are included in our consolidated results of operations from the date of acquisition. We recognize separately from goodwill, the identifiable assets acquired, including acquired in-process research and development, the liabilities assumed, and any noncontrolling interest in the acquiree at the acquisition date fair values as defined by accounting standards related to fair value measurements. Key assumptions routinely utilized the allocation of purchase price to intangible assets include discount rates, and projected financial information such as revenue projections for companies acquired. As of the acquisition date, goodwill is measured as the excess of consideration given, over the net of the acquisition date fair values of the identifiable assets acquired and the liabilities assumed. Direct acquisition costs are expensed as incurred.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">Income taxes - Income taxes are estimated based on enacted income tax laws and the results of operations in each jurisdiction. Deferred tax assets and liabilities are estimated based on temporary differences between the financial reporting basis and income tax basis of assets and liabilities. Deferred tax assets are reduced by a valuation allowance to the extent it is more likely than not they are not expected to be realized. Long-term tax payable is estimated income tax to be paid for unrecognized tax benefits. A tax benefit is recognized if it is more likely than not a tax position will be sustained based on its technical merits in a tax authority examination, based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority.</span></div><div id="ifcd99b6df4104f80be938ce77dc8288d_58"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Accounting Pronouncements </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Information regarding new accounting pronouncements is included in Note 1. Organization and Significant Accounting Policies.</span></div><div style="margin-top:9pt"><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><div id="ifcd99b6df4104f80be938ce77dc8288d_67"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item&#160;7A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Quantitative and Qualitative Disclosure About Market Risk.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We are exposed to market risks that relate principally to changes in interest rates and foreign currency fluctuations. We do not enter into derivative financial instrument transactions for speculative purposes.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Risk</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We operate multiple foreign subsidiaries that manufacture and market our products worldwide. As a result, our earnings, cash flow and financial position are exposed to foreign currency risk from foreign currency denominated receivables and payables, sales transactions, capital expenditures and net investment in certain foreign operations. Most of our operations outside the United States have their local currency as their functional currency. We are exposed to risks caused by changes in foreign exchange, principally our British pound sterling, euro and Japanese yen denominated debt and receivables denominated in currencies other than the United States dollar, and from operations in other foreign currencies. We did not have any cross-currency swaps or foreign currency forward contracts as of October&#160;31, 2022. At October&#160;31, 2022, a uniform hypothetical 5% increase or decrease in the foreign currency exchange rates in comparison to the United States dollar would have resulted in a corresponding increase or decrease of approximately $35.0&#160;million in operating income for the fiscal year ended October&#160;31, 2022. For additional information, see Item&#160;1A. Risk Factors - "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Our substantial and expanding international operations are subject to uncertainties which could affect our operating results.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">" and Note 1. Organization and Significant Accounting Policies for additional information.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Risk</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We are exposed to risks associated with changes in interest rates, as the interest rates on our revolving lines of credit and term loans may vary with the federal funds rate and LIBOR. As of October&#160;31, 2022, we had outstanding debt for an aggregate carrying amount of $2.7&#160;billion. We have entered, and in the future may enter, into interest rate swaps to manage interest rate risk. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our ultimate realized gain or loss with respect to interest rate fluctuations will depend on interest rates, the exposures that arise during the period and our hedging strategies at that time. If interest rates were to increase or decrease by 1% or 100 basis points, annual interest expense would increase or decrease by approximately $4.6&#160;million based on average debt outstanding, after consideration of our interest rate swap contracts, during the fourth quarter of fiscal 2022. For further information about our debt, see Item&#160;1A. Risk Factors - "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">We are vulnerable to interest rate risk with respect to our debt.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">", and Note 5. Financing Arrangements for additional information.</span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><div id="ifcd99b6df4104f80be938ce77dc8288d_70"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item&#160;8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Financial Statements and Supplementary Data.</span></div><div id="ifcd99b6df4104f80be938ce77dc8288d_73"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">To the Stockholders and the Board of Directors</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Cooper Companies, Inc.:</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Opinions on the Consolidated Financial Statements and Internal Control Over Financial Reporting </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of The Cooper Companies, Inc. and subsidiaries (the Company) as of October&#160;31, 2022 and 2021, the related consolidated statements of income, comprehensive income, stockholders&#8217; equity, and cash flows for each of the years in the three-year period ended October&#160;31, 2022, and the related notes and financial statement Schedule II (collectively, the consolidated financial statements). We also have audited the Company&#8217;s internal control over financial reporting as of October&#160;31, 2022, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8211; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of October&#160;31, 2022 and 2021, and the results of its operations and its cash flows for each of the years in the three-year period ended October&#160;31, 2022, in conformity with U.S. generally accepted accounting principles. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of October&#160;31, 2022 based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8211; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Cooper Companies, Inc., acquired Generate Life Sciences (Generate) on December 17, 2021, and management excluded from its assessment of the effectiveness of the Company&#8217;s internal control over financial reporting as of October&#160;31, 2022, Generate&#8217;s internal control over financial reporting associated with total assets of $2.1&#160;billion and total revenues of $<ix:nonFraction unitRef="usd" contextRef="i92626cab45db4a19a73bbd1ffef1f631_D20211101-20221031" decimals="-5" name="us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83My9mcmFnOjUyNjQ3MWVlMjI4ZTQ3YjdhMzQ0MDBhNTQ4YTI4YmI0L3RleHRyZWdpb246NTI2NDcxZWUyMjhlNDdiN2EzNDQwMGE1NDhhMjhiYjRfMTcwNDI0MzAyNTM1OTM_8fc17235-8111-4d18-b216-167609d950ab">249.5</ix:nonFraction>&#160;million included in the consolidated financial statements of the Company as of and for the year ended October&#160;31, 2022. Our audit of internal control over financial reporting of the Company also excluded an evaluation of the internal control over financial reporting of Generate.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Basis for Opinions </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management&#8217;s Annual Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s consolidated financial statements and an opinion on the Company&#8217;s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Definition and Limitations of Internal Control Over Financial Reporting </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Critical Audit Matter</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Fair value of acquired customer relationships intangible asset</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As discussed in Notes 1 and 3 to the consolidated financial statements, the Company consummated the acquisition of Generate Life Sciences (Generate) for $<ix:nonFraction unitRef="usd" contextRef="ia9670e8e6c214908bb980ca8b9163492_D20211217-20211217" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83My9mcmFnOjUyNjQ3MWVlMjI4ZTQ3YjdhMzQ0MDBhNTQ4YTI4YmI0L3RleHRyZWdpb246NTI2NDcxZWUyMjhlNDdiN2EzNDQwMGE1NDhhMjhiYjRfMjM2Mzk1MDAwMzI0Njc_401e261a-3c82-4e00-aa15-c924174d6bb1">1.663</ix:nonFraction>&#160;billion during the year ended October&#160;31, 2022. The acquisition-date fair value of Generate&#8217;s customer relationships intangible assets was $<ix:nonFraction unitRef="usd" contextRef="i7d0f2b3e11b74394ad583fa260d2434b_I20211217" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83My9mcmFnOjUyNjQ3MWVlMjI4ZTQ3YjdhMzQ0MDBhNTQ4YTI4YmI0L3RleHRyZWdpb246NTI2NDcxZWUyMjhlNDdiN2EzNDQwMGE1NDhhMjhiYjRfMjM2Mzk1MDAwMzI0ODQ_bb6f1c15-1fb3-460d-863e-40f9114e89c7">718.3</ix:nonFraction> million, which included a customer relationships intangible asset related to newborn stem cell storage contracts (stem cell customer relationships intangible asset). </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We identified the evaluation of the acquisition-date fair value of the stem cell customer relationships intangible asset in the acquisition of Generate as a critical audit matter. We performed sensitivity analyses to determine the key assumptions used to value the stem cell customer relationships intangible asset which required challenging auditor judgment. The fair value of the acquired intangible assets were sensitive to possible changes in the forecasted revenue and discount rate assumptions, requiring a high degree of auditor judgment and the assistance of valuation professionals with specialized skills and knowledge.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls related to the Company&#8217;s acquisition-date valuation process, including controls over the development of the key assumptions identified above. We evaluated forecasted revenue by comparing it to the historical performance of peer companies, the Company and the acquired business. We also assessed the Company&#8217;s ability to accurately forecast by comparing forecasted revenue of the acquired business to actual results since the acquisition date. We involved valuation professionals with specialized skills and knowledge, who assisted in (1) evaluating the discount rate by comparing it against a discount rate range that was independently developed based on publicly available market data for comparable entities, and (2) developing a fair value estimate of the stem cell customer relationships intangible asset using the Company&#8217;s cash flow projections and independently developed range of discount rates and comparing it to the Company&#8217;s estimate.</span></div><div style="margin-bottom:10pt"><span><br/></span></div><div style="margin-bottom:10pt"><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">/s/ KPMG LLP</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 1982.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">San Francisco, California</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">December&#160;9, 2022</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><div id="ifcd99b6df4104f80be938ce77dc8288d_76"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Consolidated Statements of Income</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October 31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions, except for earnings per share)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMS0xLTEtMS01ODUzNw_fc0fdf11-8691-4acc-85d5-4b32134cfaa9">3,308.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMS0zLTEtMS01ODUzNw_ffbc6875-b2d6-471c-9f7a-4c8e9d55b4ef">2,922.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMS01LTEtMS01ODUzNw_e8b5cdd6-6939-463b-a873-565ebd2eafa7">2,430.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMi0xLTEtMS01ODUzNw_22b06dd0-78cf-4da3-b676-c30fd0eb3cd2">1,168.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMi0zLTEtMS01ODUzNw_cdf69deb-65be-418b-93c7-c905d6b27add">966.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMi01LTEtMS01ODUzNw_91167c7c-5a31-47c3-87aa-917414308386">896.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMy0xLTEtMS01ODUzNw_cca8734d-da65-4f15-91eb-539be09aad8b">2,139.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMy0zLTEtMS01ODUzNw_e68f2ac9-caad-4d56-8fa6-b476a8d78b02">1,955.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMy01LTEtMS01ODUzNw_62c9a9c5-c8a1-4f04-9e68-a97d5136646e">1,534.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfNC0xLTEtMS01ODUzNw_6797ec11-65bd-4d24-adbd-f42da410aef9">1,342.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfNC0zLTEtMS01ODUzNw_5f720ff2-3388-4e0b-86e1-24a45108625a">1,211.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfNC01LTEtMS01ODUzNw_e25be993-e324-4bb5-bc6d-f61ee8c36e89">992.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfNS0xLTEtMS01ODUzNw_31a6094a-c980-4a05-9dd0-053b66ef7e53">110.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfNS0zLTEtMS01ODUzNw_32e81b14-0410-4c07-b25f-49e762265305">92.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfNS01LTEtMS01ODUzNw_b31f463f-0871-48d5-87ad-5fef0265f9f8">93.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfNi0xLTEtMS01ODUzNw_e97ada0e-2426-4b0a-b44d-8af332df28d2">179.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfNi0zLTEtMS01ODUzNw_c450dae1-f0e8-4cca-afa7-54b17726fbcd">146.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfNi01LTEtMS01ODUzNw_693a8657-53bd-4729-ae7c-dccc66361f64">137.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfOS0xLTEtMS01ODUzNw_9e588c8c-9e6a-44c6-b62b-cb268eb67d5e">507.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfOS0zLTEtMS01ODUzNw_26ca817f-38e6-49b9-bc88-3d646850f392">505.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfOS01LTEtMS01ODUzNw_3c6094e2-0f8c-4d2e-b07c-ed48731d0b0f">311.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMTAtMS0xLTEtNTg1Mzc_e68b74f9-5010-4ad1-88d7-7cc356eaaf5d">57.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMTAtMy0xLTEtNTg1Mzc_074413ed-3c81-4348-b6a3-6b1f4b95656e">23.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMTAtNS0xLTEtNTg1Mzc_275f1189-2f59-4c4c-bbae-d3b739feff55">36.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMTMtMS0xLTEtNTg1Mzc_506268d5-1bc3-43c4-936c-91f2b9838208">25.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMTMtMy0xLTEtNTg1Mzc_ab036cb6-4732-469d-82ed-f53986de2dbd">8.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMTMtNS0xLTEtNTg1Mzc_af96d44f-f4f0-42a0-98aa-075abfcf2700">8.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMTQtMS0xLTEtNTg1Mzc_54fc7ac6-9475-4021-bdff-b3d0ac0262d3">475.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMTQtMy0xLTEtNTg1Mzc_cee215bb-80dd-4232-83a8-51f52dc0b2b7">491.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMTQtNS0xLTEtNTg1Mzc_f74ad240-5b45-4f59-b234-e3298839d70b">266.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Provision for income taxes (Note 6)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMTUtMS0xLTEtNTg1Mzc_11157a28-bd21-40ab-93f1-2fa425bd5595">89.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMTUtMy0xLTEtNTg1Mzc_23d7eb6f-c830-410b-a486-cf7ad86378be">2,453.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMTUtNS0xLTEtNTg1Mzc_bf58d96a-48de-4ae0-a026-66be1466ee29">28.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMTYtMS0xLTEtNTg1Mzc_24ded758-845f-4f74-aee5-53eb1712dc0e">385.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMTYtMy0xLTEtNTg1Mzc_d9cd0e5d-f261-481b-8262-8b675624c34f">2,944.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMTYtNS0xLTEtNTg1Mzc_8380f3df-3172-40da-9ac9-e22c9e2ad5e8">238.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Earnings per share (Note 7)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMjAtMS0xLTEtNTg1Mzc_dccef1f4-0824-4e06-af65-3a4ba6913b7d">7.83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMjAtMy0xLTEtNTg1Mzc_872844dc-ae68-415a-b0b6-bb0fff7be6f5">59.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMjAtNS0xLTEtNTg1Mzc_5ae330b3-4a9d-49a5-ba76-69a9f9387774">4.85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMjEtMS0xLTEtNTg1Mzc_92c5790e-eaff-41d1-bc0f-cde1744f60e2">7.76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMjEtMy0xLTEtNTg1Mzc_38dbffec-8153-491b-98c2-cf6072bd04b2">59.16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMjEtNS0xLTEtNTg1Mzc_42fe8677-63d5-44c1-8d98-ebd85b1f4db0">4.81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Number of shares used to compute earnings per share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMjMtMS0xLTEtNTg1Mzc_0ad32d14-c854-4e80-bae0-de99af14503e">49.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMjMtMy0xLTEtNTg1Mzc_6eb9f889-e445-48ec-bac9-711d7af8f51f">49.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMjMtNS0xLTEtNTg1Mzc_75c99196-b3d5-4c27-bf53-9176461fd51e">49.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMjQtMS0xLTEtNTg1Mzc_bc367a3b-ebe0-4719-8bd3-ead7392edda8">49.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMjQtMy0xLTEtNTg1Mzc_20f716d7-fdae-494c-a506-49bc548b77a4">49.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMjQtNS0xLTEtNTg1Mzc_8011c3a7-38a3-449f-85c5-9745775a67c4">49.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these Consolidated Financial Statements.</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><div id="ifcd99b6df4104f80be938ce77dc8288d_79"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Consolidated Statements of Comprehensive Income</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.319%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October 31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfMS0xLTEtMS01ODUzNw_32e00dd1-b001-4c65-a95c-32c0cca0a560">385.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfMS0zLTEtMS01ODUzNw_bfe52e2e-5411-434f-b1c1-03c027d2ef70">2,944.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfMS01LTEtMS01ODUzNw_addb743c-89e6-41c5-9e21-0d85da7efb2b">238.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive (loss) income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash flow hedges, net of tax of $<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfMy0wLTEtMS01ODUzNy90ZXh0cmVnaW9uOjc0ODVjYmQzZTAwMjRjMTJhNTlmZGFiZjVkYjhiNDE1XzQ3_c5e05bd1-ad48-4fd5-8b88-37ec6559976c">26.1</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfMy0wLTEtMS01ODUzNy90ZXh0cmVnaW9uOjc0ODVjYmQzZTAwMjRjMTJhNTlmZGFiZjVkYjhiNDE1XzU1_0f8dd16b-c57b-42b3-ade3-441c0a2c7b11">8.2</ix:nonFraction> and $(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfMy0wLTEtMS01ODUzNy90ZXh0cmVnaW9uOjc0ODVjYmQzZTAwMjRjMTJhNTlmZGFiZjVkYjhiNDE1XzE3MDQyNDMwMjMwNjUw_4d5d9781-0062-42ff-987d-b02fa145be74">4.1</ix:nonFraction>), respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfMy0xLTEtMS01ODUzNw_fae8f4db-120d-4432-9209-54f55946d099">81.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfMy0zLTEtMS01ODUzNw_41b7d92c-7b8f-4360-ab6e-660213b1f3ca">26.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfMy01LTEtMS01ODUzNw_04b38089-6258-4176-a6de-755b11f148f6">13.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Change in minimum pension liability, net of tax of $<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfNC0wLTEtMS01ODUzNy90ZXh0cmVnaW9uOmI4ZWQ2MDQyMDI2NzRhZWNiNDdjNTY5M2ExMTY2ODA5XzY2_a52c69ba-39b7-4276-a34b-bb7615b2db5b">8.7</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfNC0wLTEtMS01ODUzNy90ZXh0cmVnaW9uOmI4ZWQ2MDQyMDI2NzRhZWNiNDdjNTY5M2ExMTY2ODA5Xzcx_61f0c3e4-6b2b-4abf-8b38-2f5d42fe923d">7.2</ix:nonFraction> and $(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfNC0wLTEtMS01ODUzNy90ZXh0cmVnaW9uOmI4ZWQ2MDQyMDI2NzRhZWNiNDdjNTY5M2ExMTY2ODA5Xzc5_5550cd77-d9b2-4dbf-be1e-5c1c60e28cae">4.0</ix:nonFraction>), respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfNC0xLTEtMS01ODUzNw_ee253d3e-b82f-4b61-b047-a60fdf275ed4">27.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfNC0zLTEtMS01ODUzNw_490a869b-950e-4225-aae4-22662576262b">22.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfNC01LTEtMS01ODUzNw_daefd5b9-b6db-4836-af95-15d07c4c360e">12.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfNS0xLTEtMS01ODUzNw_b5423280-4ccd-4ee6-8e1f-bfd21c6f3ad7">234.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfNS0zLTEtMS01ODUzNw_75df0a94-6714-46f6-9c3a-e8b17a727309">82.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfNS01LTEtMS01ODUzNw_0ebb7c4f-7547-48f3-8a66-00613fc7456e">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive (loss) income </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfOC0xLTEtMS01ODUzNw_b83319f4-b6d7-4564-ae14-0a7d4b83f1d1">125.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfOC0zLTEtMS01ODUzNw_c12243ab-4cec-4470-9d04-2557d200b340">130.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfOC01LTEtMS01ODUzNw_00930435-bc16-4023-ba74-ad2c1206cf27">24.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfOS0xLTEtMS01ODUzNw_3fdb60a7-275b-49df-9841-de1b05688ce1">260.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfOS0zLTEtMS01ODUzNw_48480add-4911-4276-9fd5-b52ba37e94e4">3,075.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfOS01LTEtMS01ODUzNw_97d1bf78-068c-4d20-8dc8-9efc0f73fcce">213.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these Consolidated Financial Statements.</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><div id="ifcd99b6df4104f80be938ce77dc8288d_82"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Consolidated Balance Sheets</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.125%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October 31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMy0xLTEtMS01ODUzNw_d52d95ae-5f0c-42ef-b5a3-ef3a03ad2cd8">138.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMy0zLTEtMS01ODUzNw_fcd23e79-d73a-43a1-bb32-7ce83bed26df">95.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Trade accounts receivable, net of allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNC0wLTEtMS01ODUzNy90ZXh0cmVnaW9uOmVkMTJiYzQyZTdhMDQ2ZDlhOTQ0NjI2ODMxZjQyYmFiXzc0_1a7c57e4-3ac0-4d39-b39d-5da397e032e8">20.7</ix:nonFraction> at October&#160;31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNC0wLTEtMS01ODUzNy90ZXh0cmVnaW9uOmVkMTJiYzQyZTdhMDQ2ZDlhOTQ0NjI2ODMxZjQyYmFiXzEwMg_350db8f1-467a-43bc-b742-0abb4cdc42ff">9.2</ix:nonFraction> at October&#160;31, 2021 </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNC0xLTEtMS01ODUzNw_2dad2362-2013-4889-a56a-ff2d057b1932">557.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNC0zLTEtMS01ODUzNw_281fd75e-972a-47b8-9905-e4b3d9175f2e">515.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Inventories (Note 1)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNS0xLTEtMS01ODUzNw_f2b9a577-6162-4c39-8032-bed4dbf4e469">628.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNS0zLTEtMS01ODUzNw_e2d5df0a-c9ab-4da8-9598-ab6015d635a2">585.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Prepaid expense and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNy0xLTEtMS01ODUzNw_b2b1860e-e9b8-40d5-b565-03c420bcca50">208.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNy0zLTEtMS01ODUzNw_a917f58e-71ce-4db2-8222-25d24abcf4f7">179.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Assets held-for-sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfOC0xLTEtMS01ODUzNw_56f3fa5d-035e-40b3-a89e-1caabfc2c1c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfOC0zLTEtMS01ODUzNw_3cc28913-e45e-4e92-869a-a998e4e57cdd">89.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfOS0xLTEtMS01ODUzNw_b69c083a-7231-4709-8b44-fee9dfa97a71">1,533.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfOS0zLTEtMS01ODUzNw_ff178016-bee3-4166-ad16-6355fe248123">1,465.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMTItMS0xLTEtNTg1Mzc_979763cb-a7f6-4b28-b29e-29185d6c05f8">1,432.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMTItMy0xLTEtNTg1Mzc_7bd99e2d-a2d7-4b00-a24c-68dd461fe4fd">1,347.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Goodwill (Note 4)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMTQtMS0xLTEtNTg1Mzc_372b7be6-fc82-4674-b32b-85e98a5b1dc0">3,609.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMTQtMy0xLTEtNTg1Mzc_46bb10bc-bdb1-4cf2-8041-5560a12f908b">2,574.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other intangibles, net (Note 4)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMTUtMS0xLTEtNTg1Mzc_0daa77df-0c05-440a-ac46-bffc552c0d4b">1,885.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMTUtMy0xLTEtNTg1Mzc_55da9b79-dcad-44ed-8cab-af31b468bcef">1,271.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMTYtMS0xLTEtNTg1Mzc_60d864c9-a42b-43db-857f-668f12ff2866">2,443.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMTYtMy0xLTEtNTg1Mzc_84117ba0-312c-41c6-b48d-c3752e336791">2,546.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMTctMS0xLTEtNTg1Mzc_3f421fb9-f930-4caa-a254-86399ea7bc15">587.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMTctMy0xLTEtNTg1Mzc_83ed9c40-ba3d-49e2-8bd5-9fee8746e3ae">401.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMTgtMS0xLTEtNTg1Mzc_cc2841c4-a74d-4dbd-8048-3117615369a2">11,492.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMTgtMy0xLTEtNTg1Mzc_f4cbbd0a-72c5-409e-b121-50d7659462ac">9,606.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Short-term debt (Note 5)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMjEtMS0xLTEtNTg1Mzc_8934dcc3-066e-4ceb-8fb0-fac420d20041">412.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMjEtMy0xLTEtNTg1Mzc_1e6be9b6-c753-446f-843c-24eef14bb39f">83.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMjItMS0xLTEtNTg1Mzc_588f2119-e6b4-4174-a675-3f1ba6ec530a">248.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMjItMy0xLTEtNTg1Mzc_c39f990c-004a-4b5a-8785-3ce23968251d">161.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Employee compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMjMtMS0xLTEtNTg1Mzc_b523d95b-2aa0-46b6-ad16-f6794bb5de35">152.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMjMtMy0xLTEtNTg1Mzc_29cb0e33-ebe3-4408-a34b-bf9ca54dfe4c">148.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMjQtMS0xLTEtNTg1Mzc_b963092f-5049-43bf-890b-c24b4142e675">93.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMjQtMy0xLTEtNTg1Mzc_a16aa106-b137-402d-baf1-40f8211d983b">19.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMjYtMS0xLTEtNTg1Mzc_b82b68c8-8126-4cf3-b0bd-912ca46255f6">373.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMjYtMy0xLTEtNTg1Mzc_97300513-4147-47ba-b9d9-94e132e99e96">317.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Liabilities held-for-sale </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMjctMS0xLTEtNTg1Mzc_0e996668-62c7-4ebe-ae6d-7639af56a546">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMjctMy0xLTEtNTg1Mzc_7638bc4a-70c7-4e65-9404-d42221ed29b7">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMjgtMS0xLTEtNTg1Mzc_82fdc105-be58-4b3f-b5a7-85191ef34358">1,280.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMjgtMy0xLTEtNTg1Mzc_f32f9dac-67b6-425c-8e23-c4d93581ee15">732.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-term debt (Note 5)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMjktMS0xLTEtNTg1Mzc_5cccfc27-fe6e-4cab-bac1-62f24ccac11b">2,350.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMjktMy0xLTEtNTg1Mzc_fef1ab43-2423-4a5c-b346-cb82d0e057fe">1,397.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzAtMS0xLTEtNTg1Mzc_b76778ff-6bbd-47d1-852a-74bd85f6dec7">149.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzAtMy0xLTEtNTg1Mzc_14fbdc32-c4fb-4d6d-aa9b-3866f8234dcf">24.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-term tax payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzEtMS0xLTEtNTg1Mzc_1df4d1ed-e179-41ab-8521-08d89f5e4246">113.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzEtMy0xLTEtNTg1Mzc_07202b8e-64e8-43c4-b388-3ea5ee6767c5">139.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzAtMS0xLTEtMTAzNzM4_72637dbb-816c-434c-aef2-f424e5874c1f">198.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzAtMy0xLTEtMTAzNzQ2_dff26a7b-d2b5-4887-bda3-fc0787a7fa13">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accrued pension liability and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="coo:LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzMtMS0xLTEtNTg1Mzc_4f0ee0d4-7827-4788-aa27-657b6ce39f31">225.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="coo:LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzMtMy0xLTEtNTg1Mzc_0a0f51db-0262-4098-a213-64e1289fddc6">370.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzQtMS0xLTEtNTg1Mzc_c22696b3-392d-448b-86b9-82abfa2ea3aa">4,317.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzQtMy0xLTEtNTg1Mzc_9f13f5fb-e8da-4360-9544-eb5e73fc46e8">2,664.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Contingencies (Note 12)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzUtMS0xLTEtNTg1Mzc_7c7bfba7-2281-4735-af59-1fed6c853361"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzUtMy0xLTEtNTg1Mzc_280d28ca-9289-4ec6-85dc-cbff68ea48b9"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="2" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzctMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjo3MzFiYzM2ZTYxNzk0ZGFlYTNmZTExYTg4ZThiNjVkOF8yMQ_26c1f9f4-1a9f-4b44-9ec7-09c90e94f4a8"><ix:nonFraction unitRef="usdPerShare" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="2" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzctMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjo3MzFiYzM2ZTYxNzk0ZGFlYTNmZTExYTg4ZThiNjVkOF8yMQ_9922a2e1-e6bc-42f2-9b60-67ae4531c877">10</ix:nonFraction></ix:nonFraction> cents par value, <ix:nonFraction unitRef="shares" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzctMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjo3MzFiYzM2ZTYxNzk0ZGFlYTNmZTExYTg4ZThiNjVkOF80MQ_99c058ce-fad3-4bb5-a722-2053f98f13a6"><ix:nonFraction unitRef="shares" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzctMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjo3MzFiYzM2ZTYxNzk0ZGFlYTNmZTExYTg4ZThiNjVkOF80MQ_efae0d1b-46ac-44e4-8262-98b9363df7cd">1.0</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="0" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzctMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjo3MzFiYzM2ZTYxNzk0ZGFlYTNmZTExYTg4ZThiNjVkOF82Mw_0b35a8fc-00da-408f-8d4e-5d86b9fb6f2a"><ix:nonFraction unitRef="shares" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzctMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjo3MzFiYzM2ZTYxNzk0ZGFlYTNmZTExYTg4ZThiNjVkOF82Mw_4b3f2208-82db-4316-a03a-af00f759aa87"><ix:nonFraction unitRef="shares" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzctMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjo3MzFiYzM2ZTYxNzk0ZGFlYTNmZTExYTg4ZThiNjVkOF82Mw_54ab4a74-093f-4aee-9172-e3984c2e298d"><ix:nonFraction unitRef="shares" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="0" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzctMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjo3MzFiYzM2ZTYxNzk0ZGFlYTNmZTExYTg4ZThiNjVkOF82Mw_c06e3e88-d9d1-4cf8-afe3-af7ba9b719c7">zero</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued or outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzctMS0xLTEtNTg1Mzc_87fff49f-c10a-484e-9ec5-5211acec432a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzctMy0xLTEtNTg1Mzc_f450ce60-a1f6-4b09-b152-541379573de8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzgtMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjoxOWZiYjI0OGQzMDU0MDBmOTFkODA5ZWQxMGNiODhmMl8xOA_0fd460d6-752a-4d9a-9a94-af2b759a1128"><ix:nonFraction unitRef="usdPerShare" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzgtMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjoxOWZiYjI0OGQzMDU0MDBmOTFkODA5ZWQxMGNiODhmMl8xOA_e26f950a-ed93-416a-a241-db9fad9a2256">10</ix:nonFraction></ix:nonFraction> cents par value, <ix:nonFraction unitRef="shares" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzgtMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjoxOWZiYjI0OGQzMDU0MDBmOTFkODA5ZWQxMGNiODhmMl8zOA_8aa91e1c-4832-4834-ac31-3a1961367c79"><ix:nonFraction unitRef="shares" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzgtMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjoxOWZiYjI0OGQzMDU0MDBmOTFkODA5ZWQxMGNiODhmMl8zOA_a785ffd4-2a7c-499d-91c1-53cb1d006050">120.0</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzgtMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjoxOWZiYjI0OGQzMDU0MDBmOTFkODA5ZWQxMGNiODhmMl82MA_c5504aaf-b339-4785-9c9a-4a0e11603df2">53.8</ix:nonFraction> issued and <ix:nonFraction unitRef="shares" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzgtMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjoxOWZiYjI0OGQzMDU0MDBmOTFkODA5ZWQxMGNiODhmMl83NA_543d6fc9-ad33-4d91-9e1c-63e0ab6b9089">49.3</ix:nonFraction> outstanding at October&#160;31, 2022 and <ix:nonFraction unitRef="shares" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzgtMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjoxOWZiYjI0OGQzMDU0MDBmOTFkODA5ZWQxMGNiODhmMl8xMTM_5ad81376-1ff4-45fa-9989-62176b8301b4">53.7</ix:nonFraction> issued and <ix:nonFraction unitRef="shares" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzgtMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjoxOWZiYjI0OGQzMDU0MDBmOTFkODA5ZWQxMGNiODhmMl8xMjc_050b70eb-ffd6-41da-b876-167e3669a49c">49.3</ix:nonFraction> outstanding at October&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzgtMS0xLTEtNTg1Mzc_1c0a21b1-9a73-4115-93ff-9483d82e3f59">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzgtMy0xLTEtNTg1Mzc_642b08f5-6778-4e84-aa39-3af338d83317">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzktMS0xLTEtNTg1Mzc_9417919a-5894-443b-a6ba-a6a050bba605">1,765.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzktMy0xLTEtNTg1Mzc_add689f0-80d2-4c21-bb7e-d0ece5142848">1,715.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNDAtMS0xLTEtNTg1Mzc_1f8f117c-2609-462f-83b2-07599eb1ead7">466.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNDAtMy0xLTEtNTg1Mzc_c54a0d8f-70f2-4f60-899b-f31238512ed5">341.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNDItMS0xLTEtNTg1Mzc_af023b28-637f-4f1a-a7e0-d380f02a7800">6,584.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNDItMy0xLTEtNTg1Mzc_17cad631-4640-4007-b3e2-50a45b01ec34">6,202.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Treasury stock at cost: <ix:nonFraction unitRef="shares" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNDMtMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjozZmM0NGMxYmU3ZmY0MzRjOTVhMWNhN2Y2NzMzZjA5MV8yOA_cf027db6-491d-47c9-9736-e30dde98cc72">4.5</ix:nonFraction> shares at October&#160;31, 2022 and <ix:nonFraction unitRef="shares" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNDMtMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjozZmM0NGMxYmU3ZmY0MzRjOTVhMWNhN2Y2NzMzZjA5MV82Mg_9c7ead27-68fc-442c-806c-da1c6ff0cbf1">4.4</ix:nonFraction> shares at October&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:TreasuryStockCommonValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNDMtMS0xLTEtNTg1Mzc_13694475-59ef-4c23-82da-60c95965f51c">714.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:TreasuryStockCommonValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNDMtMy0xLTEtNTg1Mzc_3fc4f946-c3f2-4506-a673-5a487aa3017a">639.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total Cooper stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNDQtMS0xLTEtNTg1Mzc_fc8a996a-9321-4f64-93c9-48cc9592b222">7,174.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNDQtMy0xLTEtNTg1Mzc_d72541c9-e882-4c58-91f4-603333c1be60">6,941.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNDUtMS0xLTEtNTg1Mzc_41111eba-7ae1-403d-ae64-67841674ea82">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNDUtMy0xLTEtNTg1Mzc_08813743-6bdb-47a1-8155-9046e805de81">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Stockholders&#8217; equity (Note 8)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNDYtMS0xLTEtNTg1Mzc_dd3f1ad4-69da-4cb1-9be2-241927d64a82">7,174.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNDYtMy0xLTEtNTg1Mzc_fec0f22b-a44a-44a1-8393-fbcf62ff5d10">6,942.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNDctMS0xLTEtNTg1Mzc_a6ebc348-2181-43cc-8afe-e8bd99627e87">11,492.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNDctMy0xLTEtNTg1Mzc_b2d9a3ea-bc8d-41e9-b02e-32d5776e6270">9,606.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these Consolidated Financial Statements.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><div id="ifcd99b6df4104f80be938ce77dc8288d_85"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Consolidated Statements of Stockholders' Equity </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.893%"><tr><td style="width:1.0%"></td><td style="width:29.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.568%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.926%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.461%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.317%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.317%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.242%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.681%"></td><td style="width:0.1%"></td></tr><tr style="height:48pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total<br/>Stockholders'<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic40025e930f74fd19b2ce688c42296d1_I20191031" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMi0xLTEtMS01ODUzNw_07c1191a-c93f-4694-bac9-236fd5484cc3">49.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40025e930f74fd19b2ce688c42296d1_I20191031" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMi0zLTEtMS01ODUzNw_6300bb48-8070-4e15-8122-7961b2eed8bb">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4c34808bb01e43038bfe5000593b89e4_I20191031" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMi01LTEtMS01ODUzNw_3f8d89ff-f34b-408c-b335-88cc61b3b0de">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd4ad7541d14f359dbe82c616c0ab00_I20191031" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMi03LTEtMS01ODUzNw_d52bddc4-4666-4fdb-afe3-97fa22ad747c">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i640e2b66e7b443a4a5e3988728a72e3d_I20191031" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMi05LTEtMS01ODUzNw_4949d275-1230-430b-994e-a3a6656be913">1,615.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4862aa9bb8ef43508c2cc981078ef274_I20191031" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMi0xMS0xLTEtNTg1Mzc_3ebd32db-28b9-4e48-b529-f360cdecba77">447.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide1724bcbd604d64aec96d6a7f39d61b_I20191031" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMi0xMy0xLTEtNTg1Mzc_cda954f6-0462-4fa2-adc3-eecbd9144b2c">3,026.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c34808bb01e43038bfe5000593b89e4_I20191031" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMi0xNS0xLTEtNTg1Mzc_35e54a1f-7be9-41f1-9f3e-a7b9663fe268">571.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cb5a13a16e74334a69daeb5cb71f84c_I20191031" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMi0xNy0xLTEtNTg1Mzc_ac8856d6-e897-4630-b29d-570110ea402b">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5167c03ea3ab44e7b464a93ec06fc66e_I20191031" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMi0xOS0xLTEtNTg1Mzc_53540b1b-fff7-432f-b3a3-03b3a4e67cb3">3,628.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i538b018151b043f48a11b745f431a4dc_D20191101-20201031" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMy0xMy0xLTEtNTg1Mzc_a765d34b-a0ef-490d-abbd-141235e05f83">238.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMy0xOS0xLTEtNTg1Mzc_f04ad4cc-d51b-44e2-adb6-18001a13fd95">238.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieafb6aa788314d68858bdce8b8cc9452_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfNC0xMS0xLTEtNTg1Mzc_130965be-c01a-49ac-ace3-b92c18b6693c">24.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfNC0xOS0xLTEtNTg1Mzc_9f985a59-0762-449f-9044-20308c05cbdd">24.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Issuance of common stock for stock plans, net and employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib49675071eae40dfab504de223e18ee9_D20191101-20201031" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfNS0xLTEtMS01ODUzNw_bf17f98c-d18c-4c68-a289-899611486a18">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i979761737a724a468a53d50ec7fdc9d4_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfNS05LTEtMS01ODUzNw_bb5b334e-9969-4554-985c-35f9da842319">5.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i81f7068bcd6a4b5092ed7c04a932aa4c_D20191101-20201031" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfNS0xNS0xLTEtNTg1Mzc_b55b85fb-ffd9-4f15-bc43-e5f7bd8f711a">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfNS0xOS0xLTEtNTg1Mzc_8e246801-a790-404a-aea0-681a96b7f9f5">3.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Treasury stock repurchase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib49675071eae40dfab504de223e18ee9_D20191101-20201031" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfNy0xLTEtMS01ODUzNw_97e8cd84-55a1-4b1e-b093-ce837e4ac2c8">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i81f7068bcd6a4b5092ed7c04a932aa4c_D20191101-20201031" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfNy01LTEtMS01ODUzNw_2dc3e145-a277-4bbd-abee-74b811294605">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81f7068bcd6a4b5092ed7c04a932aa4c_D20191101-20201031" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfNy0xNS0xLTEtNTg1Mzc_433293d8-7719-410c-9ae0-5d901541813d">47.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfNy0xOS0xLTEtNTg1Mzc_886bf1da-a787-4dcd-9a1c-3b6f5d58515a">47.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Dividends on common stock ($<ix:nonFraction unitRef="usdPerShare" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfOC0wLTEtMS01ODUzNy90ZXh0cmVnaW9uOjg4ZWI4M2RmMzZlOTQ0ZTliMmYwNGZhYzdjZDI3YzNiXzE3MDQyNDMwMjMwNTk3_c2be021d-fe9b-4e61-9ad2-bb481cd8ba3f">0.03</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i538b018151b043f48a11b745f431a4dc_D20191101-20201031" decimals="-5" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfOC0xMy0xLTEtNTg1Mzc_c386c3bd-522c-45cb-aef2-b8d46fce6801">3.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfOC0xOS0xLTEtNTg1Mzc_175bde55-814c-4c12-814a-4d74a2a45241">3.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i979761737a724a468a53d50ec7fdc9d4_D20191101-20201031" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfOS05LTEtMS01ODUzNw_190b9a16-cd26-49f7-846c-9dce03dd635c">36.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfOS0xOS0xLTEtNTg1Mzc_527bae26-3a08-44e9-869c-0c7e64124e8b">36.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i03991b00df3c49439458880f97362831_I20201031" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTAtMS0xLTEtNTg1Mzc_e0a25605-77ad-4534-9053-7be6869eb835">49.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03991b00df3c49439458880f97362831_I20201031" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTAtMy0xLTEtNTg1Mzc_d3d22ddc-46be-464d-9051-1a40074f80c0">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iffb2fe484e3846c9bd0a06b30ea69c83_I20201031" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTAtNS0xLTEtNTg1Mzc_0662fdbc-e3cd-493d-a4cc-cd3e8e788b41">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29dbc102232c4927bebb87096c5efbd1_I20201031" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTAtNy0xLTEtNTg1Mzc_6cee2203-9672-4077-9cf0-7d2994977be5">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id99ee9ce8f314279b8ed0d124990935e_I20201031" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTAtOS0xLTEtNTg1Mzc_1eb37c8b-ad06-49bc-9913-af3ddf0be905">1,646.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15ff03e12d5e49abb65998853b7f5c15_I20201031" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTAtMTEtMS0xLTU4NTM3_b0f71a21-2743-46dc-bb6a-56848e1f49fe">472.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9c7c5de6c0d4c81bba6613a87b7c142_I20201031" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTAtMTMtMS0xLTU4NTM3_de99d98d-30bb-403a-94a5-5af609c0e728">3,261.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffb2fe484e3846c9bd0a06b30ea69c83_I20201031" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTAtMTUtMS0xLTU4NTM3_aa48ca81-f3c1-4ff3-9c46-26bf02d4e5c4">617.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76280949e11f40589848621ccf9e17d7_I20201031" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTAtMTctMS0xLTU4NTM3_b01ea97a-8f33-444b-b461-f1113e70d22e">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTAtMTktMS0xLTU4NTM3_e022a63a-c102-439e-89e5-e70371910560">3,824.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae603271d4564d759045232140ef888b_D20201101-20211031" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTEtMTMtMS0xLTU4NTM3_d2cde958-c08b-4527-b19c-770eaa3f7928">2,944.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTEtMTktMS0xLTU4NTM3_a9f0e0a2-71cf-42f6-9913-01fca98950d8">2,944.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ff34bac9bd34f02a659325f60bd6946_D20201101-20211031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTItMTEtMS0xLTU4NTM3_a8064364-1a8f-4110-886c-3b6fc386df59">130.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTItMTktMS0xLTU4NTM3_b609b9ff-a8db-4edd-805b-4751490f4761">130.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Issuance of common stock for stock plans, net and employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i92ad3fcf3fa24292a93bc23096208379_D20201101-20211031" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTMtMS0xLTEtNTg1Mzc_31b0a616-05ae-4632-8b38-4a60eb512625">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92ad3fcf3fa24292a93bc23096208379_D20201101-20211031" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTMtMy0xLTEtNTg1Mzc_dd9b3bf5-af38-4d67-9aa8-902c89c9ab72">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91a298fab24f46b08cad8c03bf310938_D20201101-20211031" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTMtOS0xLTEtNTg1Mzc_f9b7a8bb-4558-42e2-a982-a82e892846c8">24.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i813ba48615004049bda2cd1adc7a200f_D20201101-20211031" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTMtMTUtMS0xLTU4NTM3_35d72727-bb8e-4204-a0de-bdecec19397b">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTMtMTktMS0xLTU4NTM3_e956b357-c078-48e6-8171-b79746891307">27.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Treasury stock repurchase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i92ad3fcf3fa24292a93bc23096208379_D20201101-20211031" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTUtMS0xLTEtNTg1Mzc_ddc827ff-5536-4862-ae82-5f7725f63c73">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i813ba48615004049bda2cd1adc7a200f_D20201101-20211031" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTUtNS0xLTEtNTg1Mzc_667d7baf-b935-43b2-8496-c063be985b6e">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i813ba48615004049bda2cd1adc7a200f_D20201101-20211031" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTUtMTUtMS0xLTU4NTM3_bb9eb55d-8162-4b77-b006-17dca3019311">24.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTUtMTktMS0xLTU4NTM3_e992f706-a6aa-4a8b-8dc0-7ff49536f5b5">24.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Dividends on common stock ($<ix:nonFraction unitRef="usdPerShare" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTctMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjo3ODFmYmZhOTVmZDM0MjVkOThiYzNjOGQ2MzA3ZjVlZV8xNzA0MjQzMDIzMDU5Nw_e843de22-c61b-40b1-b315-0fbac08b1490">0.03</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae603271d4564d759045232140ef888b_D20201101-20211031" decimals="-5" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTctMTMtMS0xLTU4NTM3_281c7447-d7b5-4cc7-8878-cb82a699d11f">3.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTctMTktMS0xLTU4NTM3_78b86891-c0ee-4a2d-9c8b-eaca0acf3b01">3.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91a298fab24f46b08cad8c03bf310938_D20201101-20211031" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTgtOS0xLTEtNTg1Mzc_90fbdf14-dd85-4703-a8d4-dc0234204683">43.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTgtMTktMS0xLTU4NTM3_3593dda1-2f83-46e7-b0cc-822b972f816d">43.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTktMC0xLTEtNTg1Mzc_56db2c71-ed4a-4692-8d61-7c04b7423899">ASU 2016-13 adoption</span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a9a9c9f91ca422180b746b351012dba_I20201031" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTktMTMtMS0xLTU4NTM3_d6655796-86d1-4b4d-9814-b306743db51a">1.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10b91becc0cf4d67b8ccd40f10fc6633_I20201031" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTktMTktMS0xLTU4NTM3_e3404d61-213f-40d9-a0a3-685c1ce3b36e">1.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if0e07227018a48699fc5b6e0852505fe_I20211031" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjQtMS0xLTEtNTg1Mzc_0a4b4e17-fc13-49d4-b977-0ba156baa3df">49.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0e07227018a48699fc5b6e0852505fe_I20211031" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjQtMy0xLTEtNTg1Mzc_c1123790-229e-49f3-8822-e19ccbbfc12b">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i84e5415a196749599d0e6e0005250229_I20211031" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjQtNS0xLTEtNTg1Mzc_36aa7eb5-66be-4a71-a3b5-91acf795e156">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ba42cdb4ce44091bf3d217dca29f463_I20211031" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjQtNy0xLTEtNTg1Mzc_c1c1dfa8-bd9d-4e7d-b5c0-fc9678ce88bf">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33dae8774a9d446da11e92d8456741ad_I20211031" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjQtOS0xLTEtNTg1Mzc_0f81f829-d745-4d25-9f0d-c7fc1947d2a6">1,715.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1debae85ed14b3aa606b0f2a2bf613a_I20211031" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjQtMTEtMS0xLTU4NTM3_a9113050-ad51-41f1-9cf7-c6f7ff439644">341.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fca87f8caea41ba87bb56ee5ee38701_I20211031" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjQtMTMtMS0xLTU4NTM3_64d3a5f5-25ca-4527-87fa-dc38186ffa12">6,202.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84e5415a196749599d0e6e0005250229_I20211031" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjQtMTUtMS0xLTU4NTM3_8a01c2b9-503a-4ddb-9fba-419f33f2d0a2">639.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9c8cbde74104a3982b2d1bdc730d863_I20211031" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjQtMTctMS0xLTU4NTM3_c2896335-418c-4c4d-99ed-205a55720443">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjQtMTktMS0xLTU4NTM3_e9dadd1e-e7a1-461e-b3f5-914a2836969b">6,942.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74ee878bb50944f89b4a3dc97d5aec72_D20211101-20221031" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjUtMTMtMS0xLTU4NTM3_b8e825b5-195f-4888-b5b6-246b85b20049">385.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjUtMTktMS0xLTU4NTM3_b923ae0d-901f-45ca-8bfa-a52fc18317d7">385.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i864fde92b4e34849bbc81ca4a0f19094_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjYtMTEtMS0xLTU4NTM3_8aa8653e-1406-42ea-912d-804e07e01c92">125.5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjYtMTktMS0xLTU4NTM3_4a033747-410f-4a1a-8e03-3008c7b8f28c">125.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Issuance of common stock for stock plans, net and employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i18d6974b69cf479299decdec035def9e_D20211101-20221031" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjctMS0xLTEtNTg1Mzc_bfbe9a60-25ee-4538-9d17-dc1d75764009">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb7ea73d4acf4eb7aae210fcfd94fd7a_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjctOS0xLTEtNTg1Mzc_b38cb606-e4af-46b8-a5d0-0c91848c27fb">2.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia9123c64ce444cffba4dda081d73bc13_D20211101-20221031" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjctMTUtMS0xLTU4NTM3_732b05ac-c4b7-4415-ba4d-015c7cfcd6a5">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjctMTktMS0xLTU4NTM3_40def1c2-0ab8-49fd-8b50-f0a7ba7cbb5c">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Treasury stock repurchase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i18d6974b69cf479299decdec035def9e_D20211101-20221031" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjktMS0xLTEtNTg1Mzc_75e6cf8e-2394-4e58-a626-8c3ca8ce8228">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia9123c64ce444cffba4dda081d73bc13_D20211101-20221031" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjktNS0xLTEtNTg1Mzc_d41d0553-87c1-4f9c-83e7-bddd687bd579">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9123c64ce444cffba4dda081d73bc13_D20211101-20221031" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjktMTUtMS0xLTU4NTM3_14e3fe1d-b5e6-4ef8-abeb-77c94f7bd43e">78.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjktMTktMS0xLTU4NTM3_d5a3530b-c8e2-4e75-b63e-006184e06e73">78.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Dividends on common stock ($<ix:nonFraction unitRef="usdPerShare" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMzEtMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjoxZWFkZWY2M2ZmNjQ0MTEwOTUzZjBiYTVhMjc3YmYxY18zMQ_ee05da4e-f1f1-4e6d-a7a2-f39803384237">0.03</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74ee878bb50944f89b4a3dc97d5aec72_D20211101-20221031" decimals="-5" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMzEtMTMtMS0xLTU4NTM3_9f693bc4-253b-43d6-b5ab-ff2f8cbd2ff0">3.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMzEtMTktMS0xLTU4NTM3_a42159ae-0c6d-41cb-8c50-2073ab0c8f9a">3.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb7ea73d4acf4eb7aae210fcfd94fd7a_D20211101-20221031" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMzItOS0xLTEtNTg1Mzc_7de4748b-aece-4fe0-8acd-b6f4e18dddd6">52.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMzItMTktMS0xLTU4NTM3_67f36d24-90eb-4ef7-b6b3-e2efe319c923">52.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia71ce847bd5e4c5989f4eeafd6a550a9_I20221031" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMzUtMS0xLTEtNTg1Mzc_f87ae15a-9120-4534-9d38-491100fa538c">49.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia71ce847bd5e4c5989f4eeafd6a550a9_I20221031" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMzUtMy0xLTEtNTg1Mzc_5e8665cf-5fdd-4922-81a0-cdfe57f739ce">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i685c57aff67b45abacf0deaf8e923fa0_I20221031" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMzUtNS0xLTEtNTg1Mzc_d6fc56e3-0b7f-4cac-8d26-bb7b638f9cce">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27bf67955d844c6798e8e8fa5d42494d_I20221031" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMzUtNy0xLTEtNTg1Mzc_696e4e10-1b2c-44ee-8779-90ee3c6024ef">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2fe242b18cf42e7bc71473cf1d4fa86_I20221031" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMzUtOS0xLTEtNTg1Mzc_7fcd1dec-d064-475a-9b12-5ef9cde83615">1,765.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13f3c04d8bda4a5ea3fcba710edd83fb_I20221031" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMzUtMTEtMS0xLTU4NTM3_5ee4eb47-5d8f-4766-86a5-8bd222cb86a1">466.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5e797e87ea4a7caf9a6a4e9c552fc7_I20221031" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMzUtMTMtMS0xLTU4NTM3_5f2baf63-827d-4789-a0c7-11b069027eee">6,584.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i685c57aff67b45abacf0deaf8e923fa0_I20221031" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMzUtMTUtMS0xLTU4NTM3_fc5348f9-1c77-4694-ba1c-9be637614879">714.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb24416eba0042eea28cba51d9346b77_I20221031" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMzUtMTctMS0xLTU4NTM3_a7032821-c728-4bdf-8ab9-962c6f89802b">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMzUtMTktMS0xLTU4NTM3_74128683-38e6-4c4e-a82a-409b7b68d705">7,174.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these Consolidated Financial Statements.</span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><div id="ifcd99b6df4104f80be938ce77dc8288d_88"></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October 31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMi0xLTEtMS01ODUzNw_baf7246f-741b-4666-9cb0-3a099486aa28">385.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMi0zLTEtMS01ODUzNw_dfbb5c56-10ad-4151-9830-e4e1c9940d62">2,944.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMi01LTEtMS01ODUzNw_4cebf031-3270-4df8-8d04-9003921400d7">238.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:OtherDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNC0xLTEtMS01ODUzNw_07cc17bb-d29e-443a-87cf-d477b76936e1">346.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:OtherDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNC0zLTEtMS01ODUzNw_cea4197b-dec8-43e8-9d52-de5658cd376b">309.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:OtherDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNC01LTEtMS01ODUzNw_e221d32e-84c9-4651-86a0-e716d2c34d9d">287.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impairment of intangibles</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNS0xLTEtMS01ODUzNw_b1bb6f76-4a94-435e-bffc-c3198f8a77c9">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNS0zLTEtMS01ODUzNw_afddd81d-19cf-4caf-9c11-fad73fc1fc05">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNS01LTEtMS01ODUzNw_1b6c29b8-e923-455a-aa83-cbf532bcddee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNy0xLTEtMS01ODUzNw_06864616-0919-4fa7-9e2c-6f084f1d31a5">54.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNy0zLTEtMS01ODUzNw_7ca6a2ec-b498-4b8f-bcac-a8d88df4dc04">43.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNy01LTEtMS01ODUzNw_6f6fcb18-7879-4f6b-9f13-594faf2ebdbe">37.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-cash operating lease expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfOS0xLTEtMS01ODUzNw_bfa882de-00b0-4ba9-ab6b-2b07e1bd6c96">32.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfOS0zLTEtMS01ODUzNw_1d19596c-21d2-43bf-a109-a9b316139a23">31.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfOS01LTEtMS01ODUzNw_0fa9a572-caad-4f37-9c47-030d8ad7c33e">32.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impairment and loss on disposal of property, plant and equipment, and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" sign="-" name="coo:GainLossOnSaleOfAssetsAndAssetImpairmentChargesAndOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMTAtMS0xLTEtNTg1Mzc_4e8ca067-d4e9-442e-984d-ad7d0d561c72">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="coo:GainLossOnSaleOfAssetsAndAssetImpairmentChargesAndOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMTAtMy0xLTEtNTg1Mzc_3dcfcc58-8533-43b5-a353-8ce1b01e1346">5.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" sign="-" name="coo:GainLossOnSaleOfAssetsAndAssetImpairmentChargesAndOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMTAtNS0xLTEtNTg1Mzc_be652762-915f-4270-8f82-abd05787a679">17.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMTEtMS0xLTEtNTg1Mzc_c818081c-2873-42b4-b8ed-1b28baf1d92d">10.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMTEtMy0xLTEtNTg1Mzc_5dc30a45-1f03-4155-82c1-3866619f6d9a">66.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMTEtNS0xLTEtNTg1Mzc_5694a7c5-4511-46a9-b3a3-4aeb7302e703">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMTItMS0xLTEtNTg1Mzc_89009cf3-9791-415e-b7f8-91b8f77de7fe">53.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMTItMy0xLTEtNTg1Mzc_4eb0a4ba-956e-4c69-b0a8-71fdbba97baf">2,502.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMTItNS0xLTEtNTg1Mzc_b147a443-0fa0-43b4-81af-5af06ff168d6">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Change in assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMTgtMS0xLTEtNTg1Mzc_dc473573-5bb0-48b2-b7d4-b75a9c28c58b">33.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMTgtMy0xLTEtNTg1Mzc_3176ae52-288e-42f5-8f26-17b4fc8275f9">75.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMTgtNS0xLTEtNTg1Mzc_b6efd30e-e4b7-493d-a59c-4335e9f2229f">8.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMTktMS0xLTEtNTg1Mzc_30bc1d84-60b5-4d96-9e57-dc04d8ed6c26">40.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMTktMy0xLTEtNTg1Mzc_1802da15-7859-4d7a-a429-a4c1e562ecb9">9.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMTktNS0xLTEtNTg1Mzc_d51b9177-cde5-4986-a7ae-04edf6d179d1">62.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjAtMS0xLTEtNTg1Mzc_89eaf58c-ea03-4fc9-8fd1-943d84f98fec">16.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjAtMy0xLTEtNTg1Mzc_39b07c53-2eca-43ea-ad0d-e870496cc60a">69.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjAtNS0xLTEtNTg1Mzc_2ffc5a28-63ff-44d1-ad23-4d153a2dce68">41.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating lease right-of-use assets and liabilities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" sign="-" name="coo:IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjEtMS0xLTEtNTg1Mzc_041d898d-3436-4e13-9c04-34e00a4f9d62">51.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" sign="-" name="coo:IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjEtMy0xLTEtNTg1Mzc_48cc5a9b-7140-45d0-9f8d-344a4f997311">27.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" sign="-" name="coo:IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjEtNS0xLTEtNTg1Mzc_c55347b5-04da-4b87-90b1-1c3ca6206707">20.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjItMS0xLTEtNTg1Mzc_ffeeaa6a-8d71-4746-980e-0fa27ffb2c19">49.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjItMy0xLTEtNTg1Mzc_0f8a5860-c5c6-4072-bdaf-608f499805d8">16.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjItNS0xLTEtNTg1Mzc_bc3c81e0-f758-40ba-8b81-3b42f4b77345">23.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjMtMS0xLTEtNTg1Mzc_5625e11a-d85d-4939-bcd2-6fd35660b4cf">32.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjMtMy0xLTEtNTg1Mzc_08c280ee-14c4-484b-a78d-fc4ca34f3c9c">59.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjMtNS0xLTEtNTg1Mzc_9887fc9c-570f-4fa4-848d-702085fc68df">9.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjQtMS0xLTEtNTg1Mzc_98540ca3-a5b1-41cc-8a53-0efce7f35214">27.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjQtMy0xLTEtNTg1Mzc_d831035f-4229-4019-a2e9-db6930035d7d">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjQtNS0xLTEtNTg1Mzc_5eead83d-3a4a-4329-b83e-3d04e08967f7">12.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjUtMS0xLTEtNTg1Mzc_351407b5-fcfc-464c-bbd0-389d1333506b">34.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjUtMy0xLTEtNTg1Mzc_cc2727bc-7123-4695-ac27-cdf5c67d84ba">21.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjUtNS0xLTEtNTg1Mzc_f676d702-6fcd-456c-80ec-6028b1a86895">12.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Settlement of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" sign="-" name="coo:IncreaseDecreaseInContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjEtMS0xLTEtMTAwNDQx_044c4d93-9f11-4005-a5df-7836b7962c44">52.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="coo:IncreaseDecreaseInContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjEtMy0xLTEtMTAwNDUx_b2536ebc-fa85-4956-b3d8-04874f8d4fe5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="coo:IncreaseDecreaseInContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjEtNS0xLTEtMTAwNDU5_fddc76b3-8798-4d46-91ef-4daed0f2c0b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjYtMS0xLTEtNTg1Mzc_69f7ee41-65d5-413f-8fa2-b0d160e07d91">692.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjYtMy0xLTEtNTg1Mzc_773dff8c-2375-496c-bd56-1b2a90c7adfb">738.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjYtNS0xLTEtNTg1Mzc_e700688c-50ff-42ad-ae3d-de6ebbbbf69a">486.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjgtMS0xLTEtNTg1Mzc_8109e19f-b396-4d55-bf0f-7178fa25f742">242.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjgtMy0xLTEtNTg1Mzc_9a559fca-e3c8-4f34-8723-d1215eb77d38">214.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjgtNS0xLTEtNTg1Mzc_3832b737-cc77-47b2-9433-f270ee7b1f29">310.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Acquisitions of businesses and assets, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="coo:PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjktMS0xLTEtNTg1Mzc_defe2f32-8d36-44b3-b860-9f593562999f">1,641.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="coo:PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjktMy0xLTEtNTg1Mzc_1ef0ce10-eb60-462e-937e-6ee9bc39455e">235.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="coo:PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjktNS0xLTEtNTg1Mzc_5b9a3b03-9a06-4530-866c-16400d1ed386">54.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Proceeds from sale of interest in a subsidiary</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjUtMS0xLTEtOTk4MDE_32758148-4c53-42fa-9a77-4a9acf27f408">52.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjUtMy0xLTEtOTk4MTE_b6734f55-395c-44f6-8aa4-6d3c68e747d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjUtNS0xLTEtOTk4MTc_0cfa050d-dc56-4457-97ee-2e59ce80297b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzEtMS0xLTEtNTg1Mzc_30706d5d-c4bf-4f4b-9803-500423761e4f">1,831.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzEtMy0xLTEtNTg1Mzc_ac2d40cf-44fd-4e30-a4b3-0106a6b7c4cd">450.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzEtNS0xLTEtNTg1Mzc_f73a7a4c-0b0e-4901-985d-ef337184a4cb">364.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Proceeds from long-term debt, net of issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzMtMS0xLTEtNTg1Mzc_f488dee7-1487-443b-bbc2-a2cbe390a1da">1,511.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzMtMy0xLTEtNTg1Mzc_1f65663d-23fd-4a4c-b4a6-5daf6c311daa">1,427.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzMtNS0xLTEtNTg1Mzc_cf3afd40-bff2-465d-ba62-ee3372e0e374">3,199.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzQtMS0xLTEtNTg1Mzc_6025f7d4-4218-4a11-a0c7-a1e25197add4">561.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzQtMy0xLTEtNTg1Mzc_fd95c058-213a-4ca3-bd58-8d6df9ff5b45">1,416.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzQtNS0xLTEtNTg1Mzc_e06cb524-cf06-4855-ada8-0c04f410a3f8">3,235.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net proceeds from (repayments of) short-term debt, other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzYtMS0xLTEtNTg1Mzc_90118d1e-30b4-4d15-94a6-09a30107181c">329.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzYtMy0xLTEtNTg1Mzc_fff6beae-0a53-42bd-b2bc-13c6fc8d76fc">321.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzYtNS0xLTEtNTg1Mzc_ac95c81f-ef3f-4c04-aaa3-5276c36b04d2">4.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzgtMS0xLTEtNTg1Mzc_3ecb1833-84d9-4d96-af3b-71f044a412a7">78.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzgtMy0xLTEtNTg1Mzc_f7528fc1-9711-42ec-a5c0-88d0c95f564f">24.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzgtNS0xLTEtNTg1Mzc_3586823a-be00-42a2-b094-4618197ec4ad">47.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Proceeds related to share-based compensation awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzktMS0xLTEtNTg1Mzc_fd4ffb87-9c12-4c13-bc7a-516ba6868d5d">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzktMy0xLTEtNTg1Mzc_da7109bc-10ee-4769-a4ce-9468c4e09774">33.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzktNS0xLTEtNTg1Mzc_3161c570-49a5-4dc9-9703-3304aede830d">13.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Payments related to share-based compensation awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNDAtMS0xLTEtNTg1Mzc_5d6cd64d-2cfa-4786-ad2d-e39344d3a829">16.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNDAtMy0xLTEtNTg1Mzc_41f8a673-9079-4546-a3d7-60f35021891d">13.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNDAtNS0xLTEtNTg1Mzc_4d451059-73c9-4ac4-a634-dd879fe9a35b">20.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Dividends on common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNDMtMS0xLTEtNTg1Mzc_f5f163cc-1ddd-4169-8544-44f2b115660d">3.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNDMtMy0xLTEtNTg1Mzc_2e42df64-f63d-495c-83c2-7b19aeb55e77">3.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNDMtNS0xLTEtNTg1Mzc_98df6278-2057-4638-91eb-cf03885aeb73">3.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Issuance of common stock for employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:ProceedsFromStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNDQtMS0xLTEtNTg1Mzc_f309b4be-5d87-42f9-90ec-c8eea9cac0f0">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:ProceedsFromStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNDQtMy0xLTEtNTg1Mzc_7546991e-7496-4bae-957e-fd5c3786c97e">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:ProceedsFromStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNDQtNS0xLTEtNTg1Mzc_5ebfd15b-a73e-4821-acea-fceb9c3d5b75">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Settlement of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNDctMS0xLTEtNTg1Mzc_0f8d2450-bc15-4c86-b71c-94efd07abf7d">2.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNDctMy0xLTEtNTg1Mzc_f57c1881-3991-4e0a-bb4b-0bd2b07d42da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNDctNS0xLTEtNTg1Mzc_97d70f09-a9d9-45c6-a944-04b89b552914">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTAtMS0xLTEtNTg1Mzc_2bab77d0-3bf1-462a-9d73-ff329471d469">1,193.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTAtMy0xLTEtNTg1Mzc_314f1ad8-4f7a-4af9-ad71-bbb546b6799a">311.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTAtNS0xLTEtNTg1Mzc_daf267e2-a975-4523-a7cc-8d1ed06ba726">95.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTEtMS0xLTEtNTg1Mzc_98de1902-fbcb-4d42-ad19-9e6da10594e5">12.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTEtMy0xLTEtNTg1Mzc_eb7837f0-c19e-4cdf-b4a3-813f8f4e07f7">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTEtNS0xLTEtNTg1Mzc_bd4b4695-a708-4c47-a7a5-0569597c0609">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents and restricted cash </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTItMS0xLTEtNTg1Mzc_7b9558bf-ef7b-478e-9726-914e6c7947d7">42.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTItMy0xLTEtNTg1Mzc_e20b1d48-315f-4a4a-bd93-9813b933e2b0">20.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTItNS0xLTEtNTg1Mzc_66d1bfa9-61bf-42d9-a46b-ca5347063f54">27.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash, cash equivalents, restricted cash and cash held for sale at beginning of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTMtMS0xLTEtNTg1Mzc_40661b36-ff88-4ddd-a043-3fcfcd382d4d">96.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTMtMy0xLTEtNTg1Mzc_84d4ccec-dae2-4383-b755-fdd05731c0f3">116.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5167c03ea3ab44e7b464a93ec06fc66e_I20191031" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTMtNS0xLTEtNTg1Mzc_3c634be2-ddc0-4d56-a4e4-597029c3683b">89.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTQtMS0xLTEtNTg1Mzc_85a7c19d-27ff-404d-bcbb-1e648c3369ce">138.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTQtMy0xLTEtNTg1Mzc_917e4fd2-c45f-4ad7-b1d7-63d7a612640c">96.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTQtNS0xLTEtNTg1Mzc_3a53a5eb-594e-4d0b-a466-7a2571d7f191">116.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Supplemental disclosures of cash flow information:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Cash paid for:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTctMS0xLTEtNTg1Mzc_7d6b61fc-3f6e-4565-8575-6b96930658fb">49.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTctMy0xLTEtNTg1Mzc_4f11cf96-b155-435f-afcf-afc98a08e6b2">28.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTctNS0xLTEtNTg1Mzc_386fb12f-44b8-4cd1-874b-ab373d15f00a">46.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October 31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTgtMS0xLTEtNTg1Mzc_7fbb3789-2b51-4db1-af90-326514aebddd">66.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTgtMy0xLTEtNTg1Mzc_135e6b6c-856d-49d7-ab7b-4191014634fb">63.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTgtNS0xLTEtNTg1Mzc_ecff98b2-e586-4f09-bd42-3e2276d1d48a">51.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTktMS0xLTEtNTg1Mzc_5c6e4d92-b399-4509-8a03-7cf80dfa24b8">45.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTktMy0xLTEtNTg1Mzc_21a3cfba-0117-4772-965f-89e642385b19">37.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTktNS0xLTEtNTg1Mzc_0e5d48fd-c6f3-45a2-ae37-d70232639c18">40.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating lease ROU assets obtained in exchange for lease obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNjItMS0xLTEtNzU2NDk_30291e04-bd27-4aa9-9fc4-15a046496299">29.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNjItMy0xLTEtNzU2NTg_747853a4-6446-4c04-b9b3-48eb4ed9b6fb">26.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNjItNS0xLTEtNzU2Njc_cf4d57e8-22fd-4f5e-915f-492bada354b0">17.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Reconciliation of cash flow information:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNjEtMS0xLTEtNTg1Mzc_8fc8aeb4-61a9-4462-b70f-b03173c1bbe7">138.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNjEtMy0xLTEtNTg1Mzc_5f5ee187-7d4e-4b46-8b1d-beb4c7c418a5">95.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNjEtNS0xLTEtNTg1Mzc_0266038d-fca9-4c4c-bb50-16ca42bf3302">115.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Restricted cash included in other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNjItMS0xLTEtNTg1Mzc_8ee1ada1-7be9-412a-a78e-b23bc8c644f0">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNjItMy0xLTEtNTg1Mzc_91588827-24c2-425d-8b12-2a7bbc0bafef">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031" decimals="-5" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNjItNS0xLTEtNTg1Mzc_9004f026-84a0-41a4-b91a-ab3c12437d1c">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNjMtMS0xLTEtNTg1Mzc_79c9988e-e356-4ef2-a431-4fef4a24a02c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNjMtMy0xLTEtNTg1Mzc_f87d5fbb-e4cf-4ac5-a0bf-207aa1f3681e">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNjMtNS0xLTEtNTg1Mzc_8c2e5285-6a58-449e-b113-fa5cac3837b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total cash, cash equivalents, restricted cash and cash held for sale</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNjQtMS0xLTEtNTg1Mzc_e27aa3dd-661f-4281-a519-9e9b947f2d98">138.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNjQtMy0xLTEtNTg1Mzc_908b9207-a357-4fe4-ad61-c517b03d30bc">96.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNjQtNS0xLTEtNTg1Mzc_42aeb229-7566-43bf-a5c0-e5c325417598">116.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these Consolidated Financial Statements.</span></div><div id="ifcd99b6df4104f80be938ce77dc8288d_91"></div><div style="text-align:center"><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><div id="ifcd99b6df4104f80be938ce77dc8288d_94"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMzM5Mzk_8adbe11f-29b4-47ac-b654-7f49efd9a3ca" continuedAt="i9650927cccad4d20989b9969a8809e32" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 1. Organization and Significant Accounting Policies</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Organization</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Cooper Companies, Inc. (Cooper, we or the Company) is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through <ix:nonFraction unitRef="business_unit" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="INF" name="coo:NumberOfBusinessUnits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMTk1_9670d14f-fc92-4ced-ad56-3eae3a83da7c">two</ix:nonFraction> business units, CooperVision and CooperSurgical.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">CooperVision primarily develops, manufactures and markets a broad range of soft contact lenses for the worldwide vision correction market.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">CooperSurgical primarily develops, manufactures, markets medical devices and procedures solutions, and provides services to improve health care delivery to women, babies and families. </span></div><div style="padding-left:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNDk0NzgwMjM5NTY1Mg_f8169c5a-31bd-4887-a5c0-93fbcc4300eb" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Principles of Consolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The financial statements in this report include the results of all of Cooper's consolidated entities. All significant intercompany transactions and balances are eliminated on consolidation.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMzM5NDA_15cd8d02-6bbe-4774-988e-ada30fde2793" continuedAt="i88f8423e431d4908909bf92848f49f9a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The preparation of Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of net sales and expenses during the reporting period. Actual results could differ from those estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In particular, the COVID-19 pandemic negatively impacted business and healthcare activity globally. As a result of healthcare systems responding to the demands of managing the pandemic, governments around the world imposing measures designed to reduce the transmission of the COVID-19 virus, and individuals responding to the concerns of contracting the COVID-19 virus, many optical practitioners and retailers, hospitals, medical offices and fertility clinics closed their facilities, restricted access, or delayed or canceled patient visits, exams and elective medical procedures, and many customers that have reopened are experiencing reduced patient visits. These factors have had, and in the future may have, an adverse effect on our sales, operating results and cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The full extent to which the pandemic will directly or indirectly impact the Company's business, results of operations, and financial condition, including sales, expenses, manufacturing, clinical trials, research and development costs, reserves and allowances, fair value measurements, asset impairment charges, contingent consideration obligations, and the effectiveness of the Company's hedging instruments, will depend on future developments that are highly uncertain and difficult to predict. These developments include, but are not limited to, the duration and spread of the outbreak (including new and more contagious variants of COVID-19), its severity, the actions to contain the virus or address its impact, the timing, distribution, public acceptance and efficacy of vaccines and other treatments, United States and foreign government actions to respond to the reduction in global economic activity, and how quickly and to what extent normal economic and operating conditions can resume. There was not a material impact to the estimates in the Company&#8217;s Consolidated Financial Statements for fiscal 2022. </span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><ix:continuation id="i88f8423e431d4908909bf92848f49f9a">The Company continually monitors and evaluates the estimates used as additional information becomes available. Adjustments will be made to these provisions periodically to reflect new facts and circumstances that may indicate that historical experience may not be indicative of current and/or future results. The Company&#8217;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material changes to the estimates and material impacts to the Company&#8217;s Consolidated Financial Statements in future reporting periods.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMzM5MjI_06cfe132-ab71-439e-8fee-cbbb11bfe087" continuedAt="i13ef6ccad29f44e0a3bfd8e57e6766a9" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Net Sales </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company sells its products principally to a limited number of distributors, group purchasing organizations, eye care or health care professionals including independent practices, corporate retailers, hospitals and clinics or authorized resellers (collectively, its Customers). These Customers may subsequently resell the Company&#8217;s products to eye care or health care providers and patients. In addition to product supply and distribution agreements with Customers, the Company enters into arrangements with health care providers and payors that provide for government-mandated and/or privately negotiated rebates, chargebacks and discounts with respect to the purchase of the Company&#8217;s products. The Company considers purchase orders, which in some cases are governed by master sales agreements, to be contracts with a customer. As part of its consideration of the contract, the Company evaluates certain factors including the customer&#8217;s ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations.</span></div></ix:nonNumeric></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="i9650927cccad4d20989b9969a8809e32" continuedAt="ibe60e5f3b9054637bfe2ffaf1d525df4"><ix:continuation id="i13ef6ccad29f44e0a3bfd8e57e6766a9"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Revenues from product sales are recognized when the Customer obtains control of the Company&#8217;s product, which occurs at a point in time, typically upon shipment or delivery to the Customer. Taxes collected from Customers relating to product sales and remitted to governmental authorities are excluded from revenues. The Company expenses incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that the Company would have recognized is <ix:nonNumeric contextRef="i464c13efabb24917bf19bc8289bce72b_I20221031" name="us-gaap:CapitalizedContractCostAmortizationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNzEwOA_a5f0b866-92f4-465a-bdfa-4d1056e4e2c8">one year</ix:nonNumeric> or less. See Note 12. Business Segment Information for disaggregation of revenue.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Reserves for Variable Consideration</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Revenues from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration for which reserves are established and which result from discounts, returns, chargebacks, rebates and other allowances that are offered within contracts between the Company and its Customers, health care providers, payors and other indirect customers relating to the Company&#8217;s sales of its products. These reserves are based on the amounts earned or to be claimed on the related sales and are classified primarily in current liabilities. Variable consideration is estimated based on the most likely amount or expected value approach, depending on which method the Company expects to better predict the amount of consideration to which it will be entitled. Once the Company elects one of the methods to estimate variable consideration for a particular type of performance obligation, the Company applies that method consistently.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Where appropriate, these estimates take into consideration a range of possible outcomes which are probability-weighted for relevant factors such as the Company&#8217;s historical experience, current contractual and statutory requirements, specific known market events and trends, industry data and forecasted customer buying and payment patterns. Overall, these reserves reflect the Company&#8217;s best estimates of the amount of consideration to which it is entitled based on the terms of the contract.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Trade Discounts and Allowances</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company generally provides Customers with discounts, which include incentive fees that are stated in the Company&#8217;s contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized. </span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Product Returns</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Consistent with industry practice, the Company generally offers Customers a limited right of return for a product that has been purchased from the Company. The Company estimates the amount of its product sales that may be returned by its Customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized. Historically, returns have been infrequent and insignificant relative to our total sales. Our refund liability for product returns was $<ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:ContractWithCustomerRefundLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMTAyNjY_4b2af2e5-3ab2-447d-bee6-3bb914dc573f">14.5</ix:nonFraction> million </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">and&#160;$<ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:ContractWithCustomerRefundLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMTAyNzM_ddb079b7-a072-474a-a5d4-34dd05d91c3a">13.7</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;at&#160;October&#160;31, 2022 and 2021, respectively, which is included in Accrued Liabilities on our Consolidated Balance Sheets and represents the expected value of the aggregate refunds that will be due to our customers.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Rebates and Chargebacks</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Rebates are estimated based on contractual terms, historical experience, customer mix, trend analysis and projected market conditions in the various markets served.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Chargebacks for fees and discounts to providers represent the estimated obligations resulting from contractual commitments to sell products to qualified healthcare providers at prices lower than the list wholesale prices charged to the Company&#8217;s direct customers. For certain office and surgical products in CooperSurgical, customers charge the Company for the difference between what they pay for the product and the ultimate selling price to the qualified healthcare providers. These reserves are established in the same period that the related revenue is recognized, resulting in a reduction of product revenue. Chargeback amounts are generally determined at the time of resale to the qualified healthcare provider by customers. CooperSurgical rebates are predominately related to the Medicaid rebate provision that is estimated based upon contractual terms, historical experience, and trend analysis.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Contract Liabilities</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Deferred revenue primarily represents prepaid stem cell storage as part of the CooperSurgical business unit. Revenue related to stem cell storage is recognized over the service period, which can range from one year to the lifetime of a customer.</span></div></ix:continuation><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNDk0NzgwMjUwNTUyOA_a52c3b3f-b155-444c-aa36-058759721c3e" continuedAt="i2a858b7af2294a79a3f1e703497efaaf" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We grant various share-based compensation awards, including stock options, performance unit shares, restricted stock and restricted stock units. The Company accounts for share-based compensation expense based on estimated grant-date fair value, and expenses the amount over the vesting period of the award. Determining the fair value of share-based awards at the grant date requires judgment, including estimating Cooper's stock price volatility, employee exercise behaviors and related employee forfeiture rates. </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="ibe60e5f3b9054637bfe2ffaf1d525df4" continuedAt="ib04022ad77734ced9d2030df09939f49"><ix:continuation id="i2a858b7af2294a79a3f1e703497efaaf"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The expected life of the share-based awards is based on the observed and expected time to post-vesting forfeiture and/or exercise. Groups of employees that have similar historical exercise behavior are considered separately for valuation purposes. In determining the expected volatility, management considers implied volatility from publicly-traded options on Cooper's common stock at the date of grant, historical volatility and other factors. The risk-free interest rate is based on the continuous rates provided by the United States Treasury with a term equal to the expected life of the award. The dividend yield is based on the projected annual dividend payment per share, divided by the stock price at the date of grant.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Forfeitures are estimated at the time of grant, based on historical experience, and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.</span></div></ix:continuation><div style="margin-top:9pt"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNDk0NzgwMjUwNTUyOQ_724af340-f9ae-4c31-9c40-b52d9ff1a029" continuedAt="id712afd336ba4b4487a87ddbba5bf8d2" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Foreign Currency Translation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></ix:nonNumeric></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><ix:continuation id="id712afd336ba4b4487a87ddbba5bf8d2">Most of our operations outside the United States use their local currency as their functional currency. We translate these assets and liabilities into United States dollars at year-end exchange rates. We translate income and expense accounts at average rates for each month. We record gains and losses from the translation of financial statements in foreign currencies into United States dollars in other comprehensive income. We record gains and losses from changes in exchange rates on transactions denominated in currencies other than each reporting location's functional currency in net income for each period.</ix:continuation> We recorded in other expense and income a net foreign exchange loss of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMTY0OTI2NzU3MDY2Ng_6141fb35-5f89-4fb6-881d-cc7fddca87dc">22.0</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> for fiscal</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> 2022, $<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMTY0OTI2NzU3MDY4Nw_db8b5f8a-78a3-49ad-a154-cb37ac8258d8">5.5</ix:nonFraction> million for fiscal 2021 and $<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMTY0OTI2NzU3MDcxMQ_9a302159-a0a5-4987-a2e0-d8b5bc4be5ff">1.2</ix:nonFraction> million for fiscal 2020.</span></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNDk0NzgwMjUwNTUzMA_e1c55a8e-4378-454f-9d90-e0f3fb5a8cd1" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Financial Derivatives and Hedging</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Derivatives are recorded on the Consolidation Balance Sheets at fair value. Accounting for gains or losses resulting from changes in the values of those derivatives depends on the use of the derivative instrument and whether it qualifies for hedge accounting.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">The gain or loss on derivative instruments designated and qualifying for cash flow hedge accounting is deferred in other comprehensive income. The changes in fair value for all trades that are not designated for hedge accounting are recognized in current period earnings. Deferred gains or losses from designated cash flow hedges are reclassified into earnings in the period that the hedged interest expense affects earnings. The effectiveness of cash flow hedges is assessed at inception and quarterly thereafter. The Company does not offset fair value amounts recognized for derivative instruments in its Consolidated Balance Sheets for presentation purposes.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNDk0NzgwMjUwNTUzMQ_2ffd3811-abbe-4c2a-a1b6-882ba8111100" continuedAt="i6f7096d906584a31853ddcf12e899a2e" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:107%">Fair Value Measurements</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Accounting standards define fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value. An asset&#8217;s or liability&#8217;s level is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are valued and disclosed in one of the following three levels of the valuation hierarchy:</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Level 1: Quoted market prices in active markets for identical assets or liabilities.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Level 3: Unobservable inputs reflecting the reporting entity&#8217;s own assumptions.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The carrying value of cash and cash equivalents, accounts receivable, prepaid expense and other current assets, lines of credit, accounts payable and other current liabilities approximate fair value due to the short-term nature of such instruments and the ability to obtain financing on similar terms. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The carrying value of the Company's revolving credit facility and term loans approximates fair value based on current market rates (Level 2).</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The fair value of the Company's&#160;interest&#160;rate&#160;swap&#160;contracts is measured on a recurring basis by netting the discounted future fixed cash payments and the discounted expected variable cash receipts. The variable cash receipts are based on the expectation of future interest rates (forward curves) derived from observable market interest rate&#160;curves. The&#160;interest&#160;rate&#160;swap&#160;contracts were categorized as Level 2 in the fair value hierarchy, as the inputs to the derivative pricing model are generally observable and do not contain a high level of subjectivity. The gain or loss on the derivatives is recorded as a component of accumulated other comprehensive income and subsequently reclassified into interest expense in the same period during which the hedged transaction affects earnings. Refer to Note 13. Financial Derivatives and Hedging for further information.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company uses fair value measures when determining assets and liabilities acquired in an acquisition, which are considered a Level 3 measurement. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The fair value of the Company's contingent consideration for which a liability is recorded and the initial measurement of the joint venture interest are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> a Level 3 measurement</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">and the change in fair value is recognized in selling, </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="ib04022ad77734ced9d2030df09939f49" continuedAt="i3e4a37765cb940c3bc4c0722786ac9e9"><div style="margin-top:9pt"><ix:continuation id="i6f7096d906584a31853ddcf12e899a2e"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">general and administrative expense in the Consolidated Statements of Income.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Note 3. Acquisitions and Joint Venture for further information.</span></ix:continuation></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNDk0NzgwMjUwNTUzMg_4fbc5f90-782d-44fb-b104-27fd0f9ca38c" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Income taxes</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Income taxes are estimated based on enacted income tax laws and the results of operations in each jurisdiction. Deferred tax assets and liabilities are estimated based on temporary differences between the financial reporting basis and income tax basis of assets and liabilities. Deferred tax assets are also estimated based on net operating loss and tax credit carryforwards. Deferred tax assets are reduced by a valuation allowance to the extent it is more likely than not they are not expected to be realized. Adjustments to deferred tax assets and liabilities due to changes in tax laws, changes in jurisdiction from intra-group transfers of assets, and changes in judgment regarding a valuation allowance are recognized in provision for income taxes in the quarter in which such changes occur. Long-term tax payable is estimated income tax to be paid for unrecognized tax benefits. A tax benefit is recognized if it is more likely than not a tax position will be sustained based on its technical merits in a tax authority examination, based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority. Adjustments to unrecognized tax benefits due to changes in judgment are recognized in provision for income taxes in the quarter in which such changes occur. Interest and penalties related to unrecognized tax benefits are recognized in provision for income taxes.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNDk0NzgwMjUwNTUzMw_b5959d41-d63c-4b87-859a-c7e34ee207a5" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Earnings Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We determine basic earnings per share (EPS) by using the weighted average number of shares outstanding. We determine diluted EPS by increasing the weighted average number of shares outstanding in the denominator by the number of outstanding dilutive equity awards using the treasury stock method.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNDk0NzgwMjUwNTUzNA_338277a8-23e2-4705-a854-843cc90a5872" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company considers all short-term, highly liquid investments purchased with maturities of three months or less to be&#160;cash equivalents.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNDk0NzgwMjUwNTUzNQ_7d44622a-e982-4012-bb2b-7dd5379f1535" continuedAt="id6d6761aaab34980b53293b628bb9b04" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost or net realizable value. Cost is computed using standard cost that approximates actual cost, on a first-in, first-out basis.</span></div></ix:nonNumeric><div><span><br/></span></div><div style="margin-top:5pt"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNDk0NzgwMjUwNTUzNg_60460e6c-7871-4bdc-b774-46325ffdbfe3" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.802%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOjMyNDNkYmE2Yzc5NTQ1MzFiYTZjNzQ0ZGE0OTQ1ZmY0L3RhYmxlcmFuZ2U6MzI0M2RiYTZjNzk1NDUzMWJhNmM3NDRkYTQ5NDVmZjRfMS0xLTEtMS02Nzk4Nw_5f9793f5-10e0-4f3f-bded-2fe9208b051c">173.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOjMyNDNkYmE2Yzc5NTQ1MzFiYTZjNzQ0ZGE0OTQ1ZmY0L3RhYmxlcmFuZ2U6MzI0M2RiYTZjNzk1NDUzMWJhNmM3NDRkYTQ5NDVmZjRfMS0zLTEtMS02Nzk4Nw_817df8a6-8954-4d90-8d48-1762efdba889">137.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOjMyNDNkYmE2Yzc5NTQ1MzFiYTZjNzQ0ZGE0OTQ1ZmY0L3RhYmxlcmFuZ2U6MzI0M2RiYTZjNzk1NDUzMWJhNmM3NDRkYTQ5NDVmZjRfMi0xLTEtMS02Nzk4Nw_46e8350c-f4b8-4940-b76c-55e6b2628568">15.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOjMyNDNkYmE2Yzc5NTQ1MzFiYTZjNzQ0ZGE0OTQ1ZmY0L3RhYmxlcmFuZ2U6MzI0M2RiYTZjNzk1NDUzMWJhNmM3NDRkYTQ5NDVmZjRfMi0zLTEtMS02Nzk4Nw_f91fbfbd-ea74-439d-abe1-6cfce39c5189">14.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOjMyNDNkYmE2Yzc5NTQ1MzFiYTZjNzQ0ZGE0OTQ1ZmY0L3RhYmxlcmFuZ2U6MzI0M2RiYTZjNzk1NDUzMWJhNmM3NDRkYTQ5NDVmZjRfMy0xLTEtMS02Nzk4Nw_a974f8ae-7cbf-48d6-9abc-97e759d6fe8b">439.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOjMyNDNkYmE2Yzc5NTQ1MzFiYTZjNzQ0ZGE0OTQ1ZmY0L3RhYmxlcmFuZ2U6MzI0M2RiYTZjNzk1NDUzMWJhNmM3NDRkYTQ5NDVmZjRfMy0zLTEtMS02Nzk4Nw_66882bd9-4be0-4221-8fff-9ae195b9c637">433.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOjMyNDNkYmE2Yzc5NTQ1MzFiYTZjNzQ0ZGE0OTQ1ZmY0L3RhYmxlcmFuZ2U6MzI0M2RiYTZjNzk1NDUzMWJhNmM3NDRkYTQ5NDVmZjRfNC0xLTEtMS02Nzk4Nw_d06a9f40-6c39-4781-9672-f100e04a05e3">628.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOjMyNDNkYmE2Yzc5NTQ1MzFiYTZjNzQ0ZGE0OTQ1ZmY0L3RhYmxlcmFuZ2U6MzI0M2RiYTZjNzk1NDUzMWJhNmM3NDRkYTQ5NDVmZjRfNC0zLTEtMS02Nzk4Nw_6b5f416d-440d-460d-b724-7b585b43714a">585.6</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></ix:nonNumeric></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><ix:continuation id="id6d6761aaab34980b53293b628bb9b04">In assessing the value of inventories, we make estimates and judgments regarding aging of inventories and other relevant issues potentially affecting the salable condition of products and estimated prices at which those products will sell. On an ongoing basis, we review the carrying value of our inventory, measuring number of months on hand and other indications of salability. We reduce the value of inventory if there are indications that the carrying value is greater than net realizable value, resulting in a new, lower-cost basis for that inventory. Subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis. While estimates are involved, historically, obsolescence has not been a significant factor due to long product dating and lengthy product life cycles.</ix:continuation> </span></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNDk0NzgwMjUwNTUzOA_5a52ee72-b066-48c1-bd35-745bf084ac78" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We record property, plant, and equipment at cost. We compute depreciation expense using the straight-line method over the estimated useful lives of the assets. Useful lives are generally <ix:nonNumeric contextRef="ic23b9b3f6d3c4e14bc47f1dc4aaaf851_D20211101-20221031" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMTQ5OTI5_c85ece8a-19a0-44a1-9a74-681216cdfa3a">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i7961f9072dbe43cd94f80a154bca4da3_D20211101-20221031" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMTQ5OTM0_4fe40283-551d-4b89-b425-b0657145ba44">15</ix:nonNumeric> years except for buildings which are depreciated over <ix:nonNumeric contextRef="ic287f5f4035d4d3da007edafaf1a3fa0_D20211101-20221031" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMTQ1MjY5_78ff7f52-4d36-43f1-aa10-0c6ef4d78d0c">30</ix:nonNumeric> to <ix:nonNumeric contextRef="iead04709e17747fe86865c67855d124e_D20211101-20221031" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMTQ5OTM4_a6aa27d1-d849-40d3-a329-c53ad1f4b28b">40</ix:nonNumeric> years and leasehold improvements, which we amortize over the shorter of the useful life or the lease term. We charge maintenance and repairs to expense as we incur them.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="i3e4a37765cb940c3bc4c0722786ac9e9" continuedAt="i396581767690402eb8d22faba80f2843"><div style="margin-top:5pt"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNDk0NzgwMjUwNTUzOQ_bd4933b5-bb08-40e6-a744-107dc4572994" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.802%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Land and improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c4f820f05374f5f815a531d9a560aa7_I20221031" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfMS0xLTEtMS02ODAwMA_6c90407a-72dc-4a49-a8c6-18d94ce3ee65">18.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c73a0636d374fd6b53feb1438cbe3ff_I20211031" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfMS0zLTEtMS02ODAwMA_938617af-7bfb-4c32-a2eb-543bfe5333cf">20.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if513250ff04c4191b9e9da3d94c6c176_I20221031" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfMi0xLTEtMS02ODAwMA_d205193b-bde7-4b25-a728-e24bb890615b">415.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a3c8a9647004da681ccc361aa33e519_I20211031" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfMi0zLTEtMS02ODAwMA_9ad91e42-39f1-4d6d-bc20-c5ab391f0036">388.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id75b52051d824284a67f698730bd6d07_I20221031" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfMy0xLTEtMS02ODAwMA_2a8d392d-7273-409a-8b81-40921501ec66">1,973.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e7e9ff574584a7d870bff7258dbde9e_I20211031" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfMy0zLTEtMS02ODAwMA_29ac16d5-5f1a-418c-b44b-cfc37684acf6">1,863.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b2af60b11694e86bd8e533c1e3014ba_I20221031" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfNC0xLTEtMS02ODAwMA_045543a0-6647-4be8-aa7d-e4726f719f30">393.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idabbabf9caaa404aac078818ec07abc5_I20211031" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfNC0zLTEtMS02ODAwMA_8545381d-1290-4740-8a90-b15b30478fff">383.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Property, plant and equipment, at cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfNS0xLTEtMS04NTY4OA_bdb84bcc-65c9-4d1c-bff9-c8e0271b16e2">2,800.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfNS0zLTEtMS04NTY4OA_b27e058c-d818-4a02-93a4-a43766768926">2,655.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfNi0xLTEtMS02ODAwMA_86cfa77e-fc76-44e6-aec7-1b8d0b283a10">1,387.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfNi0zLTEtMS02ODAwMA_a8651c8b-449b-459c-8339-05cd09f7b4bd">1,308.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfNy0xLTEtMS02ODAwMA_1d601ec9-d07b-4b7f-bea1-41ebe4eba4cd">1,413.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfNy0zLTEtMS02ODAwMA_7d3b891b-e2f4-4ae9-9475-629a19e9e704">1,347.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease ROU assets, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfOS0xLTEtMS05NTMwMA_677811be-aae1-4323-a580-ca834d0121b9">19.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfOS0zLTEtMS05NTMwNA_91fed10c-0cfe-4bf8-a736-94f21aa77cd4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfOS0xLTEtMS05OTk4NQ_1179959c-5e23-4b1f-afba-36bafd97b9d3">1,432.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfOS0zLTEtMS05OTk4NQ_048cf6cd-8e49-47b0-b6c0-8d65d9563c1b">1,347.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></ix:nonNumeric></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMzQwMTY_2f6d8c18-9bd2-4e95-8748-fe29b668f8d2" continuedAt="i0448cb42f01f49e8bf0647039aa80cf9" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Leases </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We consider an arrangement a lease if the arrangement transfers the right to control the use of an identified asset in exchange for consideration. We have operating leases, but do not have material financing leases. The Company primarily has operating leases for office, manufacturing and warehouse space, vehicles, and office equipment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Lease right-of-use assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make payments arising from the lease agreement. These assets and liabilities are recognized at the commencement of the lease based upon the present value of the future minimum lease payments over the lease term. The lease term reflects the noncancellable period of the lease together with periods covered by an option to extend or terminate the lease when management is reasonably certain that it will exercise such option. Changes in the lease term assumption could impact the right-of-use assets and lease liabilities recognized on the Consolidated Balance Sheets. As our leases typically do not contain a readily determinable implicit rate, we determine the present value of the lease liability using our incremental borrowing rate at the lease commencement date based on the lease term on a collateralized basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company&#8217;s operating leases typically include non-lease components such as common-area maintenance costs. The Company has elected to include non-lease components with lease payments for the purpose of calculating lease right-of-use assets and liabilities, to the extent that they are fixed. Non-lease components that are not fixed are expensed as incurred as variable lease payments.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Leases with a term of one year or less are not recognized on the Consolidated Balance Sheets, while the associated lease payments are expensed in the Consolidated Statements of Income and Comprehensive Income on a straight-line basis over the lease term.</span></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><ix:continuation id="i0448cb42f01f49e8bf0647039aa80cf9">Operating leases are classified in &#8220;Other current liabilities&#8221;, &#8220;Accrued pension liability and other&#8221;, and &#8220;Other assets&#8221; on our consolidated balance sheets. Operating lease expense is recognized on a straight-line basis over the expected lease term and included in selling, general and administrative expenses in the Consolidated Statements of Income. Financing leases are classified in "Property, plant and equipment", "Short-term debt", and "Long-term debt" on our consolidated balance sheets.</ix:continuation> See Note 2. Operating Leases and Note 5. Financing Arrangements for further information.</span></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:InternalUseSoftwarePolicy" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNDk0NzgwMjUwNTU0MQ_ecd2c0ee-0ec9-4058-a92b-4a24e2242246" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Cloud Computing Arrangements </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">The Company capitalizes certain costs related to the acquisition and development of internal use software, including implementation costs incurred in a cloud computing arrangement, during the application development stages of projects. Capitalized implementation costs are amortized on a straight-line basis over the expected term of the hosting arrangement, which includes consideration of the non-cancellable contractual term and reasonably certain renewals. Costs incurred during the preliminary project or the post-implementation/operation stages of the project are expensed as incurred. Implementation costs are included in &#8220;Other assets&#8221; in the Consolidated Balance Sheets. Amortization of capitalized implementation costs is included in the same line item in the Consolidated Statements of Income as the expense for fees for the associated hosting arrangement.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMzM4ODU_eff1de0e-ed97-466d-bc89-3d94bafa25d6" continuedAt="id71d462c7d14475da90568f17d7878b3" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Valuation of goodwill</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We evaluate goodwill for impairment annually during the fiscal third quarter and when an event occurs or circumstances change such that it is reasonably possible that impairment may exist. Goodwill is tested for impairment at the reporting unit level by performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. We perform a qualitative assessment to test each reporting unit's goodwill for impairment, which </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="i396581767690402eb8d22faba80f2843" continuedAt="idae594f7d1634ac69b557b8539f3a6f7"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><ix:continuation id="id71d462c7d14475da90568f17d7878b3">includes industry and market considerations, overall financial performance and other relevant events and factors affecting each reporting unit. Based on our qualitative assessment, if we determine that the fair value of a reporting unit is more likely than not to be less than its carrying amount, the fair value of a reporting unit will be compared with its carrying amount and an impairment charge will be recognized for the amount that the carrying value exceeds the fair value of the reporting unit.</ix:continuation></span></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNDk0NzgwMjUwNTU0Mw_a744a5c8-0eb5-4587-bf5d-41e041bdff30" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Long-lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We review long-lived assets held and used, intangible assets with definite useful lives and assets held for sale for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If an evaluation of recoverability is required, the estimated undiscounted future cash flows associated with the asset group are compared to the asset group's carrying amount to determine if a write-down is required. If the undiscounted cash flows are less than the carrying amount, an impairment loss is recorded to the extent that the carrying amount exceeds the fair value. If management has committed to a plan to dispose of long-lived assets, the assets to be disposed of are reported at the lower of carrying amount or fair value less estimated costs to sell.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNDk0NzgwMjUwNTU0NA_05f4928d-4cf9-4c19-8462-c050a89779d7" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Indefinite-lived Intangible Assets</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We assess indefinite-lived intangible assets annually in the third quarter of the fiscal year, or whenever events or changes in circumstances indicate that the carrying amount of an indefinite-lived intangible asset (asset group) may not be recoverable. We evaluate whether the indefinite-lived intangible asset is impaired by comparing its carrying value to its fair value. If the carrying value of an indefinite-lived intangible asset is not recoverable, an impairment loss is recognized based on the amount by which the carrying value exceeds the fair value.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:BusinessCombinationsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMzM4Njg_1c78bc9a-ebfe-46d9-98b6-28a5671dbdc3" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Business combinations</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We routinely consummate business combinations. Results of operations for acquired companies are included in our consolidated results of operations from the date of acquisition. We recognize separately from goodwill, the identifiable assets acquired, including acquired in-process research and development, the liabilities assumed, and any noncontrolling interest in the acquiree at the acquisition date fair values as defined by accounting standards related to fair value measurements. Key assumptions routinely utilized in allocation of purchase price to intangible assets include discount rates and projected financial information such as revenue projections for companies acquired. As of the acquisition date, goodwill is measured as the excess of consideration given, over the net of the acquisition date fair values of the identifiable assets acquired and the liabilities assumed. Direct acquisition costs are expensed as incurred.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMzM4OTI_290b7937-789c-4949-89ed-268c9d69a99d" continuedAt="i4589ce85c23846ef92f8ba9df83eae63" escape="true">Litigation</ix:nonNumeric></span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><ix:continuation id="i4589ce85c23846ef92f8ba9df83eae63">We are subject to various legal proceedings, claims, litigation, investigations and contingencies arising out of the ordinary course of business. If we believe the likelihood of an adverse legal outcome is probable and the amount is estimable, we accrue a liability in accordance with accounting guidance for contingencies. We consult with legal counsel on matters related to litigation and seek input both within and outside the Company.</ix:continuation>&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:StockholdersEquityPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMzM5Mzc_4f6d496f-96d0-4088-a168-3de6e24daaa7" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Treasury Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We record treasury stock purchases under the cost method whereby the entire cost of the acquired stock is recorded as treasury stock.</span></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Exit costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">During the second quarter of fiscal 2022, the Company initiated a plan to exit its contact lens care business, a non-core business unit of the CooperVision segment. We expect the exit activity to be substantially completed in the first half of fiscal 2023. Exit charges recognized in the three and twelve months ended October 31, 2022, were $<ix:nonFraction unitRef="usd" contextRef="ib13a9242898a43f9842a944029424ab7_D20220801-20221031" decimals="-5" name="us-gaap:BusinessExitCosts1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMjc0ODc3OTI1MzQxOA_e32ff1e2-d4d5-4b09-a32e-b207aea299a3">9.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:BusinessExitCosts1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMjc0ODc3OTI1MzQzMg_9ee49e97-6f88-4154-863c-0b500809c9e8">33.2</ix:nonFraction>&#160;million, of which $<ix:nonFraction unitRef="usd" contextRef="i3a728882a111429c8b376cccf1bd73ef_D20211101-20221031" decimals="-5" name="us-gaap:BusinessExitCosts1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMjc0ODc3OTI1MzQ0Nw_7bd6adc6-7191-4fe3-8dee-da1f5b0f4ec0">26.7</ix:nonFraction>&#160;million is recognized in cost of sales and $<ix:nonFraction unitRef="usd" contextRef="i628a683f9df74396a991320942dabd37_D20211101-20221031" decimals="-5" name="us-gaap:BusinessExitCosts1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMjc0ODc3OTI1MzQ2Mg_f1b6c28e-5474-4333-b65f-e789f971059b">6.5</ix:nonFraction>&#160;million is recognized in selling, general, and administrative expense in the Consolidated Statements of Income. Exit costs primarily related to inventory write-down, asset impairments and employee-related costs. Total exit costs are expected to be in a range of $<ix:nonFraction unitRef="usd" contextRef="i464c13efabb24917bf19bc8289bce72b_I20221031" decimals="-5" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMjc0ODc3OTI1MzQ3Ng_d56bb594-21c3-4b3e-bf0f-17bd4590edc8">30.0</ix:nonFraction>&#160;million to $<ix:nonFraction unitRef="usd" contextRef="i4377d2468ae64603815ed52f5106831e_I20221031" decimals="-5" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMjc0ODc3OTI1MzQ5MQ_822e7b14-09a2-4661-b970-bcb84ee3340e">40.0</ix:nonFraction>&#160;million.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNDk0NzgwMjM5NTc0Mw_25bd7e8f-2c22-4814-8a68-c5e80363a3e5" continuedAt="ia8fb6b94bc6f443bb88397293567a90e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Accounting Pronouncements Recently Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">On November 1, 2021, we prospectively adopted ASU 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"> to the business combinations entered into during fiscal 2022. This update requires that an acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts with Customers.</span></div></ix:nonNumeric></ix:continuation><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="idae594f7d1634ac69b557b8539f3a6f7" continuedAt="i4cc47e4ac3944aafac4e1323859dbae0"><ix:continuation id="ia8fb6b94bc6f443bb88397293567a90e" continuedAt="i2fae9a970b40493daec279b479fa961a"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Accounting Pronouncements Issued Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">and subsequent amendment to the initial guidance:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"> ASU 2021-01, Reference Rate Reform (Topic 848)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">: Scope (collectively, &#8220;Topic 848&#8221;). Topic 848 provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The guidance generally can be applied from March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of ASU 2020-04 on the Consolidated Condensed Financial Statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In November 2021, the FASB issued ASU 2021-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">This update requires annual disclosures about transactions with a government that are accounted for by applying a grant or contribution accounting model by analogy. This standard is effective for fiscal years beginning after December 15, 2021, and should be applied either prospectively or retrospectively. Early adoption is permitted. The Company is currently evaluating the impact of ASU 2021-10 on the Consolidated Condensed Financial Statements.</span></div></ix:continuation></ix:continuation><div style="margin-bottom:8pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"><ix:continuation id="i4cc47e4ac3944aafac4e1323859dbae0"><ix:continuation id="i2fae9a970b40493daec279b479fa961a">No other recently issued accounting pronouncements had or are expected to have a material impact on our Consolidated Financial Statements.</ix:continuation></ix:continuation>&#160;</span></div><div id="ifcd99b6df4104f80be938ce77dc8288d_97"></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RleHRyZWdpb246OGJiMDg3MzE2NTdhNDc0OGI0ZjEyZGY4NzljMjk3MzVfMjc3NA_d671feb5-543a-4567-96a9-4472eefafefa" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 2. Operating Leases</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="coo:AssetsAndLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RleHRyZWdpb246OGJiMDg3MzE2NTdhNDc0OGI0ZjEyZGY4NzljMjk3MzVfMjc2OQ_a70ccd10-34cf-4344-89c6-19cf9b2403a6" escape="true"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table presents information about leases on the Consolidated Balance Sheets: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.013%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.578%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.581%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">October&#160;31,<br/>(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfMi0wLTEtMS01ODUzNw_f2af3d8b-af98-47fa-9e18-c521fd473e5f"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfMi0wLTEtMS01ODUzNw_fafffb75-d216-4f4d-8142-6f0bc8bdcc25">Operating lease right-of-use assets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfMi0yLTEtMS01ODUzNw_8789a14e-7022-4f9a-b213-8a35243ab8c3">230.1</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfMi00LTEtMS01ODUzNw_84eb453b-906b-420e-b874-5c764fe8d385">257.0</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNC0wLTEtMS01ODUzNw_20f60483-65f4-4940-bd27-ff3038fea748"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNC0wLTEtMS01ODUzNw_238f6c6d-7462-42ec-bc2d-2f272994dc20">Operating lease liabilities, current</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNC0yLTEtMS01ODUzNw_7f804bbd-9f85-418b-b193-12979cc830c2">35.5</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNC00LTEtMS01ODUzNw_672229bd-a07c-4534-a4f9-c903621bfdac">35.7</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNS0wLTEtMS01ODUzNw_cd2a4655-0b1b-4300-89ec-ea2b04899df1"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNS0wLTEtMS01ODUzNw_efad86ee-3171-4680-acc9-262cd136b6e2">Operating lease liabilities, non-current</span></span> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNS0yLTEtMS01ODUzNw_a865ed3f-eed8-410e-bb75-9b795be981ec">205.5</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNS00LTEtMS01ODUzNw_72aef861-c4da-4a21-86df-dffd177a2220">231.7</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNi0yLTEtMS01ODUzNw_68d576a4-818b-4327-9807-c4bad13b53c1">241.0</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNi00LTEtMS01ODUzNw_94e2a440-44a3-47ff-996d-88830bb8133f">267.4</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfOC0yLTEtMS01ODUzNw_f6b4ef3b-f140-48d2-a81a-ee429b2c09e4">9.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfOC00LTEtMS01ODUzNw_7119c9a7-5a9d-4675-b39b-0e1ceeee2146">10.6</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="2" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfOS0yLTEtMS01ODUzNw_13f650e9-e4f6-442d-af15-52186748df70">3</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="2" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfOS00LTEtMS01ODUzNw_c3e425f2-48ea-46fd-8aa6-bad9c6387e60">3</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Operating lease expense for the fiscal years ended October&#160;31, 2022, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RleHRyZWdpb246OGJiMDg3MzE2NTdhNDc0OGI0ZjEyZGY4NzljMjk3MzVfNTQ5NzU1ODIyOTg2_c8e3cb6e-3e01-4e37-91d8-c0c2b51567e9">45.0</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RleHRyZWdpb246OGJiMDg3MzE2NTdhNDc0OGI0ZjEyZGY4NzljMjk3MzVfNTQ5NzU1ODIzMDA1_70ef7149-22ce-4f48-a6bf-53bde2ba8fb5">44.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RleHRyZWdpb246OGJiMDg3MzE2NTdhNDc0OGI0ZjEyZGY4NzljMjk3MzVfNTQ5NzU1ODIzMDIx_0adf5bf7-56ab-474b-9343-01cdb851adf3">41.2</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Maturity of Lease Liabilities </span></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RleHRyZWdpb246OGJiMDg3MzE2NTdhNDc0OGI0ZjEyZGY4NzljMjk3MzVfMjc3MQ_e7f2c0ed-e5ab-48b5-867d-a6a30532890f" escape="true"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The minimum rental payments required under operating leases that have initial or remaining noncancellable lease terms in excess of one year as of October&#160;31, 2022 are: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.126%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjRkZDNmZTBlZWQ1YzRiMmZiMGM0Nzg2MDY2MmNiNjNlL3RhYmxlcmFuZ2U6NGRkM2ZlMGVlZDVjNGIyZmIwYzQ3ODYwNjYyY2I2M2VfMS0yLTEtMS01ODUzNw_a058f708-3f47-4d45-b720-b4f496e60a0d">42.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjRkZDNmZTBlZWQ1YzRiMmZiMGM0Nzg2MDY2MmNiNjNlL3RhYmxlcmFuZ2U6NGRkM2ZlMGVlZDVjNGIyZmIwYzQ3ODYwNjYyY2I2M2VfMi0yLTEtMS01ODUzNw_3cd7c452-eb87-487d-90f0-8ac80a4fc6bf">36.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjRkZDNmZTBlZWQ1YzRiMmZiMGM0Nzg2MDY2MmNiNjNlL3RhYmxlcmFuZ2U6NGRkM2ZlMGVlZDVjNGIyZmIwYzQ3ODYwNjYyY2I2M2VfMy0yLTEtMS01ODUzNw_b21bd95e-eb7b-4ad3-a785-d5d3dbb9a08e">32.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjRkZDNmZTBlZWQ1YzRiMmZiMGM0Nzg2MDY2MmNiNjNlL3RhYmxlcmFuZ2U6NGRkM2ZlMGVlZDVjNGIyZmIwYzQ3ODYwNjYyY2I2M2VfNC0yLTEtMS01ODUzNw_0ceb8e13-c39d-4e53-914f-7959e95413c7">30.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjRkZDNmZTBlZWQ1YzRiMmZiMGM0Nzg2MDY2MmNiNjNlL3RhYmxlcmFuZ2U6NGRkM2ZlMGVlZDVjNGIyZmIwYzQ3ODYwNjYyY2I2M2VfNS0yLTEtMS01ODUzNw_a4f6fe56-ca33-47b9-b29c-b53e60d73555">26.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjRkZDNmZTBlZWQ1YzRiMmZiMGM0Nzg2MDY2MmNiNjNlL3RhYmxlcmFuZ2U6NGRkM2ZlMGVlZDVjNGIyZmIwYzQ3ODYwNjYyY2I2M2VfNi0yLTEtMS01ODUzNw_73012021-aa7f-46d5-834d-3ea90f311290">115.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjRkZDNmZTBlZWQ1YzRiMmZiMGM0Nzg2MDY2MmNiNjNlL3RhYmxlcmFuZ2U6NGRkM2ZlMGVlZDVjNGIyZmIwYzQ3ODYwNjYyY2I2M2VfNy0yLTEtMS01ODUzNw_8709d745-f0d5-47dd-afb5-ad6be56503ae">284.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjRkZDNmZTBlZWQ1YzRiMmZiMGM0Nzg2MDY2MmNiNjNlL3RhYmxlcmFuZ2U6NGRkM2ZlMGVlZDVjNGIyZmIwYzQ3ODYwNjYyY2I2M2VfOC0yLTEtMS01ODUzNw_c5777bbd-34c3-4f7f-9266-eaa38fc9bdf6">43.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjRkZDNmZTBlZWQ1YzRiMmZiMGM0Nzg2MDY2MmNiNjNlL3RhYmxlcmFuZ2U6NGRkM2ZlMGVlZDVjNGIyZmIwYzQ3ODYwNjYyY2I2M2VfOS0yLTEtMS01ODUzNw_de9579d6-3fbb-486c-af72-3370b60b5f31">241.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><div><span><br/></span></div><div id="ifcd99b6df4104f80be938ce77dc8288d_100"></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="coo:BusinessCombinationAndAssetAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzkzOTA_cfc21157-eac1-4604-8abf-f17cf08ccc09" continuedAt="i354add5f62984c56bf94285beee6c888" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 3. Acquisitions and Joint Venture</span></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="coo:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedAndAssetAcquisitionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzkzOTE_02733cda-f0d6-43fe-93e3-6fbb0520c3ca" escape="true"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following is a summary of the allocation of the total purchase consideration for business and asset acquisitions that the Company completed during fiscal 2022, 2021, and 2020:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.193%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Technology</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4755ba4225344dd7b4f9fae0941a7939_I20221031" decimals="-5" name="coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzEtMS0xLTEtNTg1Mzc_7900e262-2467-4baa-ac1c-c0ecd75c4de0">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4490227610e34141bead62dd395b0373_I20211031" decimals="-5" name="coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzEtMy0xLTEtNTg1Mzc_6bdd99e8-3af4-480d-a993-21775215d4b3">178.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f75554f20cb46aca33f75fa5f6502ee_I20201031" decimals="-5" name="coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzEtNS0xLTEtNTg1Mzc_d30c2a64-5441-4b27-a81d-de1feb4f19e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">In-Process Research &amp; Development (IPR&amp;D)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9b719bd522e4ee9954e7e380e5d3eeb_I20221031" decimals="-5" name="coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzItMS0xLTEtNTg1Mzc_730c1105-ad18-45ac-8e20-24d30e0bf7e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942ea2bc8344447e8693e560ce6e340b_I20211031" decimals="-5" name="coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzItMy0xLTEtNTg1Mzc_d897b762-cbf0-4a12-a546-d625273a1f31">20.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i907460a095fa4821a0921af76f91e5e4_I20201031" decimals="-5" name="coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzItNS0xLTEtNTg1Mzc_53097561-ea7b-4e32-97e4-10677b80289f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf1a11a6c31f47a18aa6688a9b14bd5b_I20221031" decimals="-5" name="coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzMtMS0xLTEtNTg1Mzc_d56f0345-c344-4228-a3e5-6451ead5a6b9">729.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i226050fcb98849a48ca2d0868ba5c7bc_I20211031" decimals="-5" name="coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzMtMy0xLTEtNTg1Mzc_82d018f1-f805-4c7e-9591-1cbe814b489a">7.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76bc41d306494128a518ecbb65cf02e7_I20201031" decimals="-5" name="coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzMtNS0xLTEtNTg1Mzc_40107cd0-ab84-49b4-bbfc-871643e4cfc4">11.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6adfb3a01e034e82af78c7dad7558f19_I20221031" decimals="-5" name="coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzQtMS0xLTEtNTg1Mzc_44f6c9e6-7911-4091-927a-16f801087bb5">55.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f59291a9d824a74b48fc9ac4fbaead3_I20211031" decimals="-5" name="coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzQtMy0xLTEtNTg1Mzc_6cbc55f0-8ecb-4d4c-a507-594c8d000d75">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f5ad20d5b9a49469f369636c87ebb17_I20201031" decimals="-5" name="coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzQtNS0xLTEtNTg1Mzc_ae61cefd-506f-4f4b-9373-ec352b9e01dd">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f19b0d477094c1d871e211e7657ece7_I20221031" decimals="-5" name="coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzUtMS0xLTEtNTg1Mzc_291ef362-4bc7-4011-be7d-82e460203078">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieba1d7a126cf491983e2cc68fca1e7ab_I20211031" decimals="-5" name="coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzUtMy0xLTEtNTg1Mzc_e30dd4a1-48d0-42c5-8650-be7dd916d61b">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94797e6c57ca4c538683063a5cffce19_I20201031" decimals="-5" name="coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzUtNS0xLTEtNTg1Mzc_1a95ed9d-433e-4bef-9784-3627040264d9">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total identifiable intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a09f770943a476f971ff4bc25761545_I20221031" decimals="-5" name="coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzYtMS0xLTEtNTg1Mzc_982ac9bc-7ae7-4000-8ac0-69b4ce8f57ec">786.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8955c25df4054801abf90c55eec9954c_I20211031" decimals="-5" name="coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzYtMy0xLTEtNTg1Mzc_0ea9a3c2-1f85-42fa-9956-5c3023378ce3">208.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad97efcffb85427888b5504029d82982_I20201031" decimals="-5" name="coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzYtNS0xLTEtNTg1Mzc_361b6537-aa34-4c9e-90cd-a94748f38ac3">20.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a09f770943a476f971ff4bc25761545_I20221031" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzgtMS0xLTEtNTg1Mzc_89f85d01-f1e4-4c8e-b942-fc470a5e1351">1,184.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8955c25df4054801abf90c55eec9954c_I20211031" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzgtMy0xLTEtNTg1Mzc_addc39be-c244-4d9e-b386-10b9a64c51aa">91.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad97efcffb85427888b5504029d82982_I20201031" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzgtNS0xLTEtNTg1Mzc_4fe1b3c3-88d1-4dec-979a-6ba9a4bf5400">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net tangible liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a09f770943a476f971ff4bc25761545_I20221031" decimals="-5" sign="-" name="coo:BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzktMS0xLTEtNTg1Mzc_816af264-de64-4737-877b-9ca724250ad9">286.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8955c25df4054801abf90c55eec9954c_I20211031" decimals="-5" sign="-" name="coo:BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzktMy0xLTEtNTg1Mzc_0d39e9a3-7eb3-4c54-8914-dca4a7a40805">10.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad97efcffb85427888b5504029d82982_I20201031" decimals="-5" sign="-" name="coo:BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzktNS0xLTEtNTg1Mzc_a8669371-599e-4469-9c46-92a332f594a3">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Fair value of contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a09f770943a476f971ff4bc25761545_I20221031" decimals="-5" name="coo:BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzEwLTEtMS0xLTU4NTM3_0d264b86-66a0-45aa-9590-f84e6cc19f5a">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8955c25df4054801abf90c55eec9954c_I20211031" decimals="-5" name="coo:BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzEwLTMtMS0xLTU4NTM3_6951684a-af2b-4864-b3b5-97395c7bdd09">39.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad97efcffb85427888b5504029d82982_I20201031" decimals="-5" name="coo:BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzEwLTUtMS0xLTU4NTM3_007fb6ab-3ee7-4b7c-80e8-261abab7e300">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total closing purchase price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a09f770943a476f971ff4bc25761545_I20221031" decimals="-5" name="coo:BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzExLTEtMS0xLTU4NTM3_a2046389-a033-4288-8851-fe278e97b28c">1,683.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8955c25df4054801abf90c55eec9954c_I20211031" decimals="-5" name="coo:BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzExLTMtMS0xLTU4NTM3_b2fd4a90-a049-4d7a-aedc-9a9ee35979b8">249.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad97efcffb85427888b5504029d82982_I20201031" decimals="-5" name="coo:BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzExLTUtMS0xLTU4NTM3_017f799d-fcef-4490-8e66-437c1377f8ba">35.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">All acquisitions were funded by cash generated from operations or facility borrowings. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">For business acquisitions, the Company recorded tangible and intangible assets acquired and liabilities assumed at their fair values as of the applicable date of acquisition. For asset acquisitions, the Company recorded tangible and intangible assets acquired and liabilities assumed at their estimated and relative fair values as of the applicable date of acquisition.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company believes these acquisitions strengthen CooperSurgical's and CooperVision's businesses through the addition of new distributors or complementary products and services.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Fiscal Year 2022</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On May 31, 2022, CooperVision completed the acquisition of a privately-held Denmark-based contact lens distributor focusing on orthokeratology and scleral contact lenses. This acquisition expands CooperVision's ortho-k eye care portfolio in the Nordic market.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">On April 6, 2022, CooperSurgical completed the acquisition of a private cryopreservation services company that specializes in cryogenic services. The purchase price allocation is preliminary, and the Company is in the process of finalizing information primarily related to the effect on taxes and the corresponding impact on goodwill.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:110%">Refer to "Fiscal Year 2021" below for details on formation of a joint venture with Essilor International and related activities that occurred in fiscal year 2022 following the acquisition of SightGlass Vision, Inc. (SGV) in fiscal year 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">On April 6, 2022, CooperSurgical entered into an asset purchase agreement to acquire Cook Medical's Reproductive Health business, a manufacturer of minimally invasive medical devices focused on the fertility, obstetrics and gynecology markets. The aggregate consideration is $<ix:nonFraction unitRef="usd" contextRef="i12e4f0e0cd4a46a0bf59c1a45e99906c_D20221101-20230131" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMjI1Njg_070f88fc-fb7f-4bd9-b12b-b237cbf8f5ab">875.0</ix:nonFraction>&#160;million in cash, with $<ix:nonFraction unitRef="usd" contextRef="i12e4f0e0cd4a46a0bf59c1a45e99906c_D20221101-20230131" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMjI1ODQ_6026eb66-bda6-4961-bb87-9d09d521a0ef">675.0</ix:nonFraction>&#160;million payable at the closing and the remaining $<ix:nonFraction unitRef="usd" contextRef="i12e4f0e0cd4a46a0bf59c1a45e99906c_D20221101-20230131" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMjI2MDA_0b790353-75e1-4966-aac9-4d6ef644e639">200.0</ix:nonFraction>&#160;million payable in $<ix:nonFraction unitRef="usd" contextRef="ic10ee393b7e044b093750ebeec1f6c8a_D20221101-20230131" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMjUxMjc_160b8d12-b4e5-46f9-ac7c-79aaaccfdf29"><ix:nonFraction unitRef="usd" contextRef="if7818a8cacc84e89aa1d06e47767b0bc_D20221101-20230131" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMjUxMjc_68f26dc5-ee29-4965-8f68-1f9608a41797"><ix:nonFraction unitRef="usd" contextRef="i7fec09130d504bee8c893a02191e8224_D20221101-20230131" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMjUxMjc_9b29ed67-108b-4170-9aca-e227e6f34c97"><ix:nonFraction unitRef="usd" contextRef="i6b34bc1e1b3d46e09f4bc621ba4b91f4_D20221101-20230131" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMjUxMjc_e3b559d1-ba36-465f-b174-c6382fd440e6">50.0</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;million installments following each of the first, second, third and fourth anniversaries of the closing. The transaction is subject to customary closing conditions, such as receipt of required regulatory approvals.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Generate Life Sciences&#174;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">On December 17, 2021, CooperSurgical completed the acquisition of <ix:nonFraction unitRef="number" contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMjUxMjE_c0ee469a-e12f-4fb4-8734-60e5cb968abf">100</ix:nonFraction>% of the equity interests in Generate Life Sciences (Generate), a privately held leading provider of donor egg and sperm for fertility treatments, fertility cryopreservation services and newborn stem cell storage (cord blood &amp; cord tissue), and paid an aggregate purchase consideration of approximately $<ix:nonFraction unitRef="usd" contextRef="ia9670e8e6c214908bb980ca8b9163492_D20211217-20211217" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMjI2MTc_401e261a-3c82-4e00-aa15-c924174d6bb1">1.663</ix:nonFraction>&#160;billion, reflecting working capital, and other adjustments. The cash consideration was funded through a combination of $<ix:nonFraction unitRef="usd" contextRef="i3f3295cb8a9341809bbb733c539b6249_D20211217-20211217" decimals="-8" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMjI2MzM_0c4db9c5-e376-4459-bad1-cc849233c24b">1.5</ix:nonFraction>&#160;billion in proceeds from the issuance of a senior unsecured term loan and available cash on hand.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">The Company has accounted for the acquisition of Generate as a business combination, in accordance with ASC Topic 805, Business Combinations. <ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzQ5NDc4MDIzOTMzNzU_c2c7c746-e3d0-44fe-a65d-865593e23f4e" continuedAt="iabd2d1a8cda2473ebcb4650836bdd1a3" escape="true">The following table summarizes the preliminary fair values of assets acquired and liabilities assumed as of the acquisition date:</ix:nonNumeric></span></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="i354add5f62984c56bf94285beee6c888" continuedAt="ie67a2785649947a7bcd5c3dcbce7826c"><div style="margin-top:9pt"><ix:continuation id="iabd2d1a8cda2473ebcb4650836bdd1a3"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.335%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.465%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:107%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Cash and cash equivalents</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzItMS0xLTEtNzcxNzQ_b2fcdf25-bd4c-489b-8311-93530b435012">58.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Trade accounts receivable, net</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzMtMS0xLTEtNzcxNzQ_c2065bbd-bbc3-448f-b6c0-63157a37dc2c">18.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Inventories</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzQtMS0xLTEtNzcxNzQ_038b540c-6be7-47e5-9f92-57ce4873363d">3.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Prepaid expense and other current assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzUtMS0xLTEtNzcxNzQ_c6aefc04-625a-46c7-a689-df55fb9d806e">33.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Total current assets</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzYtMS0xLTEtNzcxNzQ_648751ac-8d1a-4b78-93d6-6664a00c2794">113.5</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Property, plant and equipment</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzctMS0xLTEtNzcxNzQ_d7bddd7d-11c1-4a18-a487-ec4872495048">42.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzktMS0xLTEtNzcxNzQ_e4ebb135-358d-462b-b387-858fc297d3af">1,177.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d0f2b3e11b74394ad583fa260d2434b_I20211217" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzEwLTEtMS0xLTc3MTc0_bb6f1c15-1fb3-460d-863e-40f9114e89c7">718.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Trademarks</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefe968cac09746bc97e9dc95581ecbbd_I20211217" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzExLTEtMS0xLTc3MTc0_cfd40a85-b11f-4a34-97e5-457045ff6f2a">54.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Other assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzEzLTEtMS0xLTc3MTc0_deb9d979-42ad-41b9-ab65-9a8d92198be7">21.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Total assets acquired</span></div></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"><ix:nonFraction unitRef="usd" contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzE0LTEtMS0xLTc3MTc0_0c3f9cc8-befb-4762-a30f-c7dda52442fd">2,128.1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Current liabilities:</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Accounts payable</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzE3LTEtMS0xLTc3MTk4_b56dce8f-2caa-4c06-856e-7ef252363f7b">12.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Employee compensation and benefits</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217" decimals="-5" name="coo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesEmployeeRelatedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzE4LTEtMS0xLTc3MTk4_2c2c011f-6600-4098-bd97-650c9b26c579">12.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzIwLTEtMS0xLTc3MTk4_0a552122-a961-48db-a614-ebec66b06c1c">68.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Other current liabilities</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzIxLTEtMS0xLTc3MTk4_e955b0eb-f9f7-459e-8267-6b0f6e9488f4">12.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzIyLTEtMS0xLTc3MTk4_0fb4a7b8-967b-40d3-87b2-3659a1a0c998">105.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Deferred tax liabilities</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzIzLTEtMS0xLTc3MTk4_0e73c8e7-bfe9-4b6b-bcd4-d51000131428">147.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Lease liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217" decimals="-5" name="coo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzI0LTEtMS0xLTc3MTk4_910fd79a-bc34-4904-b1dc-92ef309fffa9">16.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Deferred revenue</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217" decimals="-5" name="coo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzI1LTEtMS0xLTc3MTk4_0eb39bf5-16fa-4d3e-9122-c83e5756253a">192.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Other long-term liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzI4LTEtMS0xLTEwMzM2NQ_e58dddac-e9db-4f78-b3c0-a69b30f0fcb9">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Total liabilities assumed</span></div></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzI3LTEtMS0xLTc3MTk4_1efe0dd0-1d49-4814-b39f-d61cd08d5009">465.0</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Total purchase price</span></div></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"><ix:nonFraction unitRef="usd" contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzI5LTEtMS0xLTc3MjA3_8c42dd77-2074-4cf9-8017-4c1619eae15e">1,663.1</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">The Company is in the process of finalizing purchase accounting information primarily related to deferred tax adjustments and the corresponding impact on goodwill. The Company recorded measurement period adjustments of $<ix:nonFraction unitRef="usd" contextRef="i92626cab45db4a19a73bbd1ffef1f631_D20211101-20221031" decimals="-5" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMzc5NTM_85455ff7-43ea-4a68-b4c1-876773590415">115.3</ix:nonFraction>&#160;million to goodwill in fiscal 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Deferred revenue was recognized in accordance with ASC Topic 606, Revenue from Contracts with Customers, as a result of the adoption of ASU 2021-08. See Note 1. Organization and Significant Accounting Policies for additional information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company currently estimates that customer relationships will be amortized over <ix:nonNumeric contextRef="i7e939ba156464566a17cd5b1cde99696_D20211101-20221031" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzQ5NDc4MDIzOTM2NjE_0e58836c-311d-4957-905f-b2ed40c42cdd">20</ix:nonNumeric> years and trademarks will be amortized over <ix:nonNumeric contextRef="ic738218133bd484dabc79502af59dec3_D20211101-20221031" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzQ5NDc4MDIzOTM2NjI_d48634dd-7eea-4e37-abf3-840c71dc5c78">15</ix:nonNumeric> years. Goodwill is primarily attributable to assembled workforce and expected synergies to be achieved. The goodwill recognized is not deductible for tax purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The transaction costs associated with the acquisition consisted primarily of legal, regulatory and financial advisory fees, which were expensed as incurred as selling, general and administrative expense.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Generate's revenue and net income for the period from the acquisition date to October 31, 2022, were </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i92626cab45db4a19a73bbd1ffef1f631_D20211101-20221031" decimals="-5" name="us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMzgwMzQ_8fc17235-8111-4d18-b216-167609d950ab">249.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i92626cab45db4a19a73bbd1ffef1f631_D20211101-20221031" decimals="-5" name="us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMzgwNTA_95dfa9da-a732-498e-a0ca-f53703c160ee">27.8</ix:nonFraction>&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">, respectively. <ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzQ5NDc4MDIzOTMzNzY_59be055b-166f-4e3f-b05b-406da0a92245" continuedAt="i0bf64b56d3324c7f9d50eb8193169054" escape="true">The following unaudited pro forma information summarizes the combined results of operations of the Company and Generate as if the acquisition had been completed at the beginning of the Company&#8217;s fiscal 2021:</ix:nonNumeric></span></div><div><span><br/></span></div><div><ix:continuation id="i0bf64b56d3324c7f9d50eb8193169054"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.318%"><tr><td style="width:1.0%"></td><td style="width:57.220%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.050%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.422%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.406%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.425%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:107%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:107%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"><ix:nonFraction unitRef="usd" contextRef="i92626cab45db4a19a73bbd1ffef1f631_D20211101-20221031" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo1NmI5Y2JmYWRiZjM0MDM4ODgyZTFjMjg1MTQ2ODg0ZS90YWJsZXJhbmdlOjU2YjljYmZhZGJmMzQwMzg4ODJlMWMyODUxNDY4ODRlXzEtMi0xLTEtNzc0MzQ_1cb1c4cd-bd5f-4bab-9064-3bf953f0004e">3,344.3</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"><ix:nonFraction unitRef="usd" contextRef="i3211f44a486b4d46a6d52e32c86746c2_D20201101-20211031" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo1NmI5Y2JmYWRiZjM0MDM4ODgyZTFjMjg1MTQ2ODg0ZS90YWJsZXJhbmdlOjU2YjljYmZhZGJmMzQwMzg4ODJlMWMyODUxNDY4ODRlXzEtNC0xLTEtODU3OTU_dadb37df-6fed-4c30-93d6-a8d92ce9d21c">3,183.2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"><ix:nonFraction unitRef="usd" contextRef="i92626cab45db4a19a73bbd1ffef1f631_D20211101-20221031" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo1NmI5Y2JmYWRiZjM0MDM4ODgyZTFjMjg1MTQ2ODg0ZS90YWJsZXJhbmdlOjU2YjljYmZhZGJmMzQwMzg4ODJlMWMyODUxNDY4ODRlXzItMi0xLTEtODU3OTg_fa59ec59-3f08-470d-b65b-d4438336385e">370.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"><ix:nonFraction unitRef="usd" contextRef="i3211f44a486b4d46a6d52e32c86746c2_D20201101-20211031" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo1NmI5Y2JmYWRiZjM0MDM4ODgyZTFjMjg1MTQ2ODg0ZS90YWJsZXJhbmdlOjU2YjljYmZhZGJmMzQwMzg4ODJlMWMyODUxNDY4ODRlXzItNC0xLTEtODU3OTg_b6bc4238-928a-4c17-88f1-952452da08e1">2,959.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The unaudited pro forma information for fiscal 2022 and 2021 was calculated after applying the Company's accounting policies and the impact of acquisition date fair value adjustments. The adjustments primarily include increased amortization for the fair value of acquired intangible assets, increased depreciation for the fair value of acquired property, plant, and equipment, </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="ie67a2785649947a7bcd5c3dcbce7826c" continuedAt="i49cb5e874c5c463bbc2a795c535f1761"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">increased revenue as a result of the ASU 2021-08 deferred revenue adjustments, decreased interest expense as a result of the reversal of Generate's historical interest expense partially offset by additional interest expense on the debt obtained to finance the transaction.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The pro forma information does not reflect the effect of costs or synergies that would have been expected to result from the integration of the acquisition. The pro forma information does not purport to be indicative of the results of operations that actually would have resulted had the acquisition occurred at the beginning of fiscal 2021, or of future results of the consolidated entities.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Subsequent Event</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">On November 1, 2022, subsequent to the fiscal year ended October 31, 2022, CooperVision closed an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) to acquire a U.S. based privately held leading expert in specialty contact lenses for both normal and irregular corneal conditions. The Company is in the process of finalizing purchase accounting information.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Fiscal Year 2021</span></div><div style="margin-top:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On May 3, 2021, CooperSurgical completed the acquisition of a privately-held medical device company that develops single-use illumin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">ating medical devices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On April 26, 2021, CooperVision completed the acquisition of a privately-held UK contact lens manufacturer focusing on specialty contact lenses. This acquisition expands CooperVision&#8217;s specialty eye care portfolio and accelerates its development of myopia management solutions in the UK.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On March 1, 2021, CooperSurgical completed the acquisition of a privately-held medical device company that designed and developed an innovative obstetric product for use in urgent obstetrics to reduce risks associated with childbirth.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On February 1, 2021, CooperSurgical acquired all of the remaining equity interests of a privately-held medical device company that developed the Mara</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> Water Vapor Ablation System, which is used for endometrial ablation. The Company accounted for this acquisition as an asset acquisition, whereby the Company allocated the total cost of the acquisition to the net assets acquired on the basis of their estimated relative fair values on the acquisition date with <ix:nonFraction unitRef="usd" contextRef="i99d2bd9111f1487a8c7a382f53e39f32_I20210201" decimals="0" name="us-gaap:Goodwill" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzQ5NDc4MDI0MTg0MTU_9b92b5df-ef57-42f8-9037-64f85e972f37">no</ix:nonFraction> goodwill recognized. The primary asset acquired in this asset acquisition is Technology.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On January 19, 2021, CooperVision acquired all of the remaining equity interests of SGV, a privately-held medical device company that developed spectacle lenses for myopia management. The transaction included potential payments of future consideration that were contingent upon the achievement of the regulatory approval milestone (the regulatory approval payment) and the acquired business reaching certain revenue thresholds over a specified period (the revenue payments). The undiscounted range of the contingent consideration was <ix:nonFraction unitRef="usd" contextRef="ic28dd8b3e9104664aab70f457f386c99_I20210119" decimals="0" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzQ5NDc4MDIzOTMzNzg_8acd52dd-295e-4ee2-a395-aa1fbe4cb028">zero</ix:nonFraction> to $<ix:nonFraction unitRef="usd" contextRef="ic28dd8b3e9104664aab70f457f386c99_I20210119" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMjUxODI_e4e27847-9fca-4ace-8148-0495b22c6301">139.1</ix:nonFraction>&#160;million payable to the other former equity interest owners.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The fair value of the regulatory approval payment was determined using an option pricing framework based on the expected payment under the contractual terms and the estimates of the probability of achieving the regulatory approval. The fair value of the revenue payments was determined using a Monte Carlo simulation based on the revenue projections and the expected payment for each simulation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In March 2022, the entities amended the terms of the contingent consideration, which resulted in CooperVision paying $<ix:nonFraction unitRef="usd" contextRef="i1cdebe36232d41e6a395e5517f2650a0_D20220301-20220331" decimals="-5" name="coo:BusinessCombinationPaymentToSettleContingentConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMjUyMTg_6a18b24c-d0be-45ba-8086-5a88e5a55872">42.9</ix:nonFraction>&#160;million to the former equity interest owners in exchange for the elimination of the revenue payments. CooperVision recognized a net gain of $<ix:nonFraction unitRef="usd" contextRef="ie874cf747ecd4b75835fe8d98669733f_D20211101-20221031" decimals="-5" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMjUyODU_68971140-6eb7-4edf-ac5b-8435a7f1eadc">12.2</ix:nonFraction>&#160;million during fiscal 2022. As of October 31, 2022, the remaining contingent liability related to regulatory approval payment was $<ix:nonFraction unitRef="usd" contextRef="i369447ccf1304ac393c75433b2da8574_I20221031" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMjUzMTQ_b4bc60c2-e5e8-4728-bdcf-cfba3d69e1e8">31.8</ix:nonFraction>&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">In March 2022, CooperVision and Essilor International SAS (Essilor) entered into a Contribution Agreement and a Stock Purchase Agreement under which Essilor paid CooperVision $<ix:nonFraction unitRef="usd" contextRef="ic12ec65ec7b84054a21489d444adacc6_D20220301-20220331" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzE2NDkyNjc1MDk5ODc_204e0a85-4c38-4ea0-afb5-94a6dff0736a">52.1</ix:nonFraction>&#160;million in exchange for a <ix:nonFraction unitRef="number" contextRef="i0e049c53ca9040a0b53609d89212a62b_I20220331" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzQ5NDc4MDIzOTMzODk_85edc28a-fd1b-4d5b-8788-0fa990ad0716">50</ix:nonFraction>% interest in SGV and a proportionate share of certain revenue-based milestone payments related to the January 2021 acquisition of SGV by CooperVision. As part of these agreements, each party contributed their interest in SGV and $<ix:nonFraction unitRef="usd" contextRef="ic12ec65ec7b84054a21489d444adacc6_D20220301-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzE2NDkyNjc1MDk5NzU_7ba80524-1c62-4542-88e4-20943f9a818c"><ix:nonFraction unitRef="usd" contextRef="i0e7cdc32ae2445039739777ea8b26dae_D20220301-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzE2NDkyNjc1MDk5NzU_fc2eeed7-c964-4d2a-bf78-e3f462aa45f7">10</ix:nonFraction></ix:nonFraction>&#160;million in cash to form a new joint venture. CooperVision then remeasured the fair value of its retained equity investment in the joint venture at $<ix:nonFraction unitRef="usd" contextRef="i6a591cbb772f491288113182f88e2c51_I20220331" decimals="-5" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzQ5NDc4MDIzOTMzOTU_79c34028-fbaf-4a4f-aacb-102440a316cf">90.0</ix:nonFraction>&#160;million which resulted in a $<ix:nonFraction unitRef="usd" contextRef="ic12ec65ec7b84054a21489d444adacc6_D20220301-20220331" decimals="-5" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMjUzODY_f7972be1-96d2-460a-aee3-97ae8df90a88">56.9</ix:nonFraction>&#160;million gain in Other (income) expense on deconsolidation of SGV. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The fair value of the joint venture was determined using the income valuation approach. Under the income approach, we used a discounted cash flow model (&#8220;DCF&#8221;) in which cash flows anticipated over several periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate expected rate of return. The discount rate used for cash flows reflects capital market conditions and the specific risks associated with the business. This valuation approaches is considered a Level 3 fair value measurement. Fair value determination requires complex assumptions and judgment by management in projecting future operating results, selecting guideline companies for comparisons, determining appropriate </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="i49cb5e874c5c463bbc2a795c535f1761"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">market value multiples, selecting the discount rate to measure the risks inherent in the future cash flows. Any material changes in key assumptions, including failure to meet business plans, deterioration in the financial market, an increase in interest rate or an increase in the cost of equity financing by market participants within the industry or other unanticipated events and circumstances, may affect such estimates.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On December 31, 2020, CooperSurgical completed the acquisition of a privately-held in vitro fertilization (IVF) cryostorage software solutions company.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The pro forma results of operations of these acquisitions have not been presented because the effect of the business combinations described above was not material to the consolidated results of operations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Fiscal Year 2020</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On August 7, 2020, CooperVision completed the acquisition of a privately-held U.S contact lens manufacturer focusing on ortho-k lenses. This acquisition expands CooperVision&#8217;s specialty eye care portfolio and its leadership in addressing the increasing severity and prevalence of myopia.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On December 13, 2019, CooperSurgical completed the acquisition of a privately-held distributor of IVF medical devices and systems.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The pro forma results of operations of these acquisitions have not been presented because the effect of the business combinations described above was not material to the consolidated results of operations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Contingent Consideration</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s business combinations involve potential payments of future consideration that are contingent upon the achievement of regulatory milestones and/or the acquired business reaching certain revenue thresholds. A liability is recorded for the estimated fair value of the contingent consideration on the acquisition date. The fair value of the contingent consideration is remeasured at each reporting period, and the change in fair value is recognized in selling, general and administrative expense in the Consolidated Statements of Income.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzkzOTM_55e91409-6b9c-4e62-84b6-0738bc755e59" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the beginning and ending balances of contingent consideration:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.294%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.898%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzEtMS0xLTEtNTg1Mzc_fe3bd0ff-63a3-4996-979e-50706a2b4b50">97.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzEtMy0xLTEtNTg1Mzc_0fb7efa4-6ffa-4218-b250-be123141dd70">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Purchase price contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzItMS0xLTEtNTg1Mzc_188cd24a-4ba4-404a-ad48-880ad89086ea">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzItMy0xLTEtNTg1Mzc_d5e4c08e-0a92-47ab-bc06-7b6dccf5f990">31.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzMtMS0xLTEtNTg1Mzc_db4e48b7-af3d-4441-9a8b-bfbd2f0b1a72">55.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzMtMy0xLTEtNTg1Mzc_17f6f00e-3077-474f-962a-4a71d403d3a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzQtMC0xLTEtNTg1Mzc_9604cf56-7a6c-46d2-bdf5-d8f031e83daf"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzQtMC0xLTEtNTg1Mzc_b92a1fd2-f912-44aa-9c7e-af89ec70cb06">Change in fair value</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzQtMS0xLTEtNTg1Mzc_9d3cdde6-8dd7-4b93-abff-d8d7fa8bafbd">10.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzQtMy0xLTEtNTg1Mzc_216ffafb-d6bb-4151-8d06-a234c1c82dd0">66.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzUtMS0xLTEtNTg1Mzc_54e17b90-5e6d-4f05-96be-dd599f1fbbf3">33.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzUtMy0xLTEtNTg1Mzc_45fd5416-d5aa-4db3-b9ab-8b75b1e4409f">97.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="ifcd99b6df4104f80be938ce77dc8288d_103"></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90ZXh0cmVnaW9uOjFlZTViYzliZDZiMzRmMDliOWU0MDEyNjUyMDhjZjg4XzU0Mzg_569faf36-c3cf-449b-8465-055170ea7ad5" continuedAt="i6214e2a40aa842be80ead344d8b7e39d" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 4. Intangible Assets</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="reporting_unit" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="0" name="us-gaap:NumberOfReportingUnits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90ZXh0cmVnaW9uOjFlZTViYzliZDZiMzRmMDliOWU0MDEyNjUyMDhjZjg4XzkzNDU4NDg4NzAwMDU_4e0ea5f3-3875-4043-b9a7-9ec08b224f9c">three</ix:nonFraction> reporting units: CooperVision and within the CooperSurgical segment, Office/Surgical and Fertility, reflecting the current way the Company manages its business. There was <ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90ZXh0cmVnaW9uOjFlZTViYzliZDZiMzRmMDliOWU0MDEyNjUyMDhjZjg4XzkzNDU4NDg4NzAxODA_6188646a-efe4-4234-9ca7-00be7d732f2f"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90ZXh0cmVnaW9uOjFlZTViYzliZDZiMzRmMDliOWU0MDEyNjUyMDhjZjg4XzkzNDU4NDg4NzAxODA_682ee9fa-4b6e-4e4c-a1e5-3a6e3926722b"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90ZXh0cmVnaW9uOjFlZTViYzliZDZiMzRmMDliOWU0MDEyNjUyMDhjZjg4XzkzNDU4NDg4NzAxODA_b260c016-ae03-407e-81c6-6bf66f5d0ff0">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> impairment of goodwill in its reporting units in fiscal 2022, 2021, and 2020.</span></div><div style="margin-top:5pt"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90ZXh0cmVnaW9uOjFlZTViYzliZDZiMzRmMDliOWU0MDEyNjUyMDhjZjg4XzU0MTk_08cf14c8-ac38-4373-8ac8-e7c6b06bd882" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.334%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.578%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.578%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.582%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">CooperVision</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">CooperSurgical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd2d0c2eeead43aab5ae86328389cce3_I20211031" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTpiNzNlOTdkNDZmNGM0Y2EyYTM3N2MzMzc0YjMyNmI0Zi90YWJsZXJhbmdlOmI3M2U5N2Q0NmY0YzRjYTJhMzc3YzMzNzRiMzI2YjRmXzQtMS0xLTEtNTg1Mzc_0ddf0110-9a3f-4c3b-9606-f313ce739b84">1,841.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7331fcd87a2241c0b7dfa12a4cdaa7b3_I20211031" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTpiNzNlOTdkNDZmNGM0Y2EyYTM3N2MzMzc0YjMyNmI0Zi90YWJsZXJhbmdlOmI3M2U5N2Q0NmY0YzRjYTJhMzc3YzMzNzRiMzI2YjRmXzQtMy0xLTEtNTg1Mzc_81f18017-2b4c-49f9-9e48-52dfb35de24f">733.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTpiNzNlOTdkNDZmNGM0Y2EyYTM3N2MzMzc0YjMyNmI0Zi90YWJsZXJhbmdlOmI3M2U5N2Q0NmY0YzRjYTJhMzc3YzMzNzRiMzI2YjRmXzQtNS0xLTEtNTg1Mzc_03d5344b-887c-4e89-9a6c-a4dfcc4d99ef">2,574.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i144fdaeefe67410baf1810389c09a562_D20211101-20221031" decimals="-5" name="us-gaap:GoodwillPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTpiNzNlOTdkNDZmNGM0Y2EyYTM3N2MzMzc0YjMyNmI0Zi90YWJsZXJhbmdlOmI3M2U5N2Q0NmY0YzRjYTJhMzc3YzMzNzRiMzI2YjRmXzUtMS0xLTEtNTg1Mzc_2c6c36c6-a59d-4dcd-a03c-7c65a75a2044">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaeae5667d45b495b88915bbc72c256cd_D20211101-20221031" decimals="-5" name="us-gaap:GoodwillPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTpiNzNlOTdkNDZmNGM0Y2EyYTM3N2MzMzc0YjMyNmI0Zi90YWJsZXJhbmdlOmI3M2U5N2Q0NmY0YzRjYTJhMzc3YzMzNzRiMzI2YjRmXzUtMy0xLTEtNTg1Mzc_023401d2-0b4b-4691-9e51-1ec1f2bb6093">1,183.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:GoodwillPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTpiNzNlOTdkNDZmNGM0Y2EyYTM3N2MzMzc0YjMyNmI0Zi90YWJsZXJhbmdlOmI3M2U5N2Q0NmY0YzRjYTJhMzc3YzMzNzRiMzI2YjRmXzUtNS0xLTEtNTg1Mzc_2cbe4c61-ba53-433d-91eb-93b935b6dd7d">1,184.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i144fdaeefe67410baf1810389c09a562_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTpiNzNlOTdkNDZmNGM0Y2EyYTM3N2MzMzc0YjMyNmI0Zi90YWJsZXJhbmdlOmI3M2U5N2Q0NmY0YzRjYTJhMzc3YzMzNzRiMzI2YjRmXzctMS0xLTEtNTg1Mzc_e6914ec4-f738-4df4-972b-afa444ae7c90">131.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaeae5667d45b495b88915bbc72c256cd_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTpiNzNlOTdkNDZmNGM0Y2EyYTM3N2MzMzc0YjMyNmI0Zi90YWJsZXJhbmdlOmI3M2U5N2Q0NmY0YzRjYTJhMzc3YzMzNzRiMzI2YjRmXzctMy0xLTEtNTg1Mzc_aca283fb-8adb-4620-97da-9f3208fa7247">17.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTpiNzNlOTdkNDZmNGM0Y2EyYTM3N2MzMzc0YjMyNmI0Zi90YWJsZXJhbmdlOmI3M2U5N2Q0NmY0YzRjYTJhMzc3YzMzNzRiMzI2YjRmXzctNS0xLTEtNTg1Mzc_8c0d3445-8de4-47b3-9a98-589046884611">149.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3421ee2f74cd428aa2c026d3ac5f1798_I20221031" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTpiNzNlOTdkNDZmNGM0Y2EyYTM3N2MzMzc0YjMyNmI0Zi90YWJsZXJhbmdlOmI3M2U5N2Q0NmY0YzRjYTJhMzc3YzMzNzRiMzI2YjRmXzgtMS0xLTEtNTg1Mzc_9970a4af-a64e-47e5-bc04-82b47ddca015">1,710.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i445d23b2879040a09a5d53dc620f8b08_I20221031" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTpiNzNlOTdkNDZmNGM0Y2EyYTM3N2MzMzc0YjMyNmI0Zi90YWJsZXJhbmdlOmI3M2U5N2Q0NmY0YzRjYTJhMzc3YzMzNzRiMzI2YjRmXzgtMy0xLTEtNTg1Mzc_1e619ab6-e190-41fc-999c-565ca491d400">1,899.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTpiNzNlOTdkNDZmNGM0Y2EyYTM3N2MzMzc0YjMyNmI0Zi90YWJsZXJhbmdlOmI3M2U5N2Q0NmY0YzRjYTJhMzc3YzMzNzRiMzI2YjRmXzgtNS0xLTEtNTg1Mzc_3444a1bc-fe80-43c1-80bd-9c9b6909622b">3,609.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Of the October&#160;31, 2022 goodwill balance, $<ix:nonFraction unitRef="usd" contextRef="i445d23b2879040a09a5d53dc620f8b08_I20221031" decimals="-5" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90ZXh0cmVnaW9uOjFlZTViYzliZDZiMzRmMDliOWU0MDEyNjUyMDhjZjg4Xzcy_fe7bff45-2da4-41b6-a157-65eeebeb8d3a">214.1</ix:nonFraction> million for CooperSurgical and $<ix:nonFraction unitRef="usd" contextRef="i3421ee2f74cd428aa2c026d3ac5f1798_I20221031" decimals="-5" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90ZXh0cmVnaW9uOjFlZTViYzliZDZiMzRmMDliOWU0MDEyNjUyMDhjZjg4XzEwNw_bd965af1-4cb2-4228-89e0-861fa9cad3c0">22.4</ix:nonFraction> million for CooperVision is expected to be deductible for tax purposes. Of the October&#160;31, 2021 goodwill balance, $<ix:nonFraction unitRef="usd" contextRef="i7331fcd87a2241c0b7dfa12a4cdaa7b3_I20211031" decimals="-5" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90ZXh0cmVnaW9uOjFlZTViYzliZDZiMzRmMDliOWU0MDEyNjUyMDhjZjg4XzIyNA_6983e079-f809-41f7-b064-e00048ddad5d">137.2</ix:nonFraction>&#160;million for CooperSurgical and $<ix:nonFraction unitRef="usd" contextRef="idd2d0c2eeead43aab5ae86328389cce3_I20211031" decimals="-5" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90ZXh0cmVnaW9uOjFlZTViYzliZDZiMzRmMDliOWU0MDEyNjUyMDhjZjg4XzI1MA_9358d99d-fd52-4e0e-94a5-e1ec8fed6314">24.6</ix:nonFraction>&#160;million for CooperVision was expected to be deductible for tax purposes.</span></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="i6214e2a40aa842be80ead344d8b7e39d"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90ZXh0cmVnaW9uOjFlZTViYzliZDZiMzRmMDliOWU0MDEyNjUyMDhjZjg4XzU0MTE_1a25e083-c9ec-4b9d-8229-1a835d829e5f" escape="true"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90ZXh0cmVnaW9uOjFlZTViYzliZDZiMzRmMDliOWU0MDEyNjUyMDhjZjg4XzU0Mjg_d6ee0b5b-a151-4e12-b728-ba9b016a128a" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Other Intangible Assets</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.012%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.359%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;October 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Weighted Average Amortization Period (in years)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets with definite lives:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Trademarks</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbfa01dbda3465490aba1443bc5a27e_I20221031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzMtMS0xLTEtNTg1Mzc_905ef449-1017-4f57-9e52-72657a0c06f3">209.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbfa01dbda3465490aba1443bc5a27e_I20221031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzMtMy0xLTEtNTg1Mzc_6cf1733f-2eaa-4c50-b531-405bfc0a6290">62.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebeef7c0d08c42438b2be3731f602914_I20211031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzMtNS0xLTEtNTg1Mzc_bca31500-5470-4c81-b9e0-4c42e3c6a234">156.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebeef7c0d08c42438b2be3731f602914_I20211031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzMtNy0xLTEtNTg1Mzc_529daefc-d71a-4641-ba63-70a837a31d1c">49.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0c3cf741cce74b56b90505abfc3135d4_D20211101-20221031" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzMtOS0xLTEtNTg1Mzc_1bff90c2-e9c6-4fd6-9336-6e00c17b866f">15</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Composite intangible asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30ee62456f6841a38e22988758ba7ea5_I20221031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzQtMS0xLTEtNTg1Mzc_590004c2-11b1-4afe-ace9-d346fcd43565">1,061.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30ee62456f6841a38e22988758ba7ea5_I20221031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzQtMy0xLTEtNTg1Mzc_c9ed9151-103c-490a-96b4-172a994486b4">354.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i407ff2a6ca46463ea28d8844c283b1d7_I20211031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzQtNS0xLTEtNTg1Mzc_44af8063-6cc2-4e55-a29e-8ccc1a7c4ed6">1,061.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i407ff2a6ca46463ea28d8844c283b1d7_I20211031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzQtNy0xLTEtNTg1Mzc_327e312e-5951-4e9d-8eda-9d1fe538c100">283.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1d0efd8be16c45d2873b2c8fa83fee18_D20211101-20221031" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzQtOS0xLTEtNTg1Mzc_2f8d4d34-b5bf-4290-a49a-47630da0dda2">15</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77b415e656bc4ea68b948eb7f695456d_I20221031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzUtMS0xLTEtNTg1Mzc_dbfa9022-bf06-4f5c-8e23-c6c664c8e569">504.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77b415e656bc4ea68b948eb7f695456d_I20221031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzUtMy0xLTEtNTg1Mzc_517cc929-6995-40f6-a5c5-b3bb5287da42">317.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1433809bee9a4008bf8d115c1d460826_I20211031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzUtNS0xLTEtNTg1Mzc_d49808d9-bbd2-46f1-9b15-08e39ca33cfb">513.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1433809bee9a4008bf8d115c1d460826_I20211031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzUtNy0xLTEtNTg1Mzc_43de74d5-2dd5-43d7-ac47-0cb29b23deb2">287.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id2afa4e343dd4305a9d4850614554f7e_D20211101-20221031" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzUtOS0xLTEtNTg1Mzc_5263a8cd-2941-4d8f-a044-df9af29fbdbb">12</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i115d9ee442ae4c56a41f07744f19fbc4_I20221031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzYtMS0xLTEtNTg1Mzc_b9cd33a3-2c40-4b8d-8aa0-4e090dd771f4">1,092.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i115d9ee442ae4c56a41f07744f19fbc4_I20221031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzYtMy0xLTEtNTg1Mzc_4987a1e0-c035-4517-8df4-aa0052ae8741">287.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f13a8230854e86893bff6282ab94ac_I20211031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzYtNS0xLTEtNTg1Mzc_f6999412-ccbc-4dc1-872d-3c9d4fec91e2">378.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f13a8230854e86893bff6282ab94ac_I20211031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzYtNy0xLTEtNTg1Mzc_acece41d-81d1-4313-bd8f-aa9a38f8d912">240.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i878f78528c3f40cd99f777c89d5d2e00_D20211101-20221031" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzYtOS0xLTEtNTg1Mzc_dc0c9520-49ef-464f-9e3b-86688caabc62">19</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">License and distribution rights and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia510700702624ebfb92ea3d3b9bb1934_I20221031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzctMS0xLTEtNTg1Mzc_f61f748c-c99c-47c1-a31c-3b4fc354b8bd">50.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia510700702624ebfb92ea3d3b9bb1934_I20221031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzctMy0xLTEtNTg1Mzc_636176fe-5d67-461c-b313-66c9a850d145">23.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b16c8a519f143b9a35f452e86b54283_I20211031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzctNS0xLTEtNTg1Mzc_d1dd6849-a2b0-43ec-b6ec-95fa37c75e9b">33.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b16c8a519f143b9a35f452e86b54283_I20211031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzctNy0xLTEtNTg1Mzc_e8ce8d43-44cc-4930-b756-9516c58b47c8">21.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iaf516f29728c49ea8d13657c5e377a8e_D20211101-20221031" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzctOS0xLTEtNTg1Mzc_02d7e4d9-7101-4344-85d9-3234a9437c7e">11</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzgtMS0xLTEtNTg1Mzc_1280e26f-91ea-48ec-b918-55a6b2f2a304">2,919.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzgtMy0xLTEtNTg1Mzc_22822022-3327-43cc-9a92-fa627a2c7bbc">1,044.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzgtNS0xLTEtNTg1Mzc_06303774-a5ce-4a9f-8432-ea43312ee802">2,143.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzgtNy0xLTEtNTg1Mzc_5e8e1535-6bc7-4ca0-be6f-9f2bee557b0b">881.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzgtOS0xLTEtNTg1Mzc_74560454-59ca-4cbb-a5fd-bce81c87d6e0">16</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: accumulated amortization and translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzktMS0xLTEtNTg1Mzc_22822022-3327-43cc-9a92-fa627a2c7bbc">1,044.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzktNS0xLTEtNTg1Mzc_5e8e1535-6bc7-4ca0-be6f-9f2bee557b0b">881.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets with definite lives, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzEwLTEtMS0xLTU4NTM3_50448438-f315-45a0-bd65-1200e5a68bde">1,874.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzEwLTUtMS0xLTU4NTM3_b3656d28-2b14-4f90-9684-8d18dd9dc816">1,261.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets with indefinite lives, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzExLTEtMS0xLTU4NTM3_4993c5ec-9ca0-41c7-859a-35968b539d4f">10.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzExLTUtMS0xLTU4NTM3_3ee7f101-1c1b-49f9-93dd-59b01b77a6c3">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total other intangibles, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzEyLTEtMS0xLTU4NTM3_af55fce9-d220-43a8-903e-fd4c79a38ec4">1,885.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzEyLTUtMS0xLTU4NTM3_66403fdc-1f56-4e8f-88be-6f827898f2d1">1,271.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Intangible assets with indefinite lives include technology and trademarks.</span></div></ix:nonNumeric></ix:nonNumeric><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Balances include foreign currency translation adjustments. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Intangible assets with definite lives are amortized over the estimated useful life of the assets. <ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90ZXh0cmVnaW9uOjFlZTViYzliZDZiMzRmMDliOWU0MDEyNjUyMDhjZjg4XzU0MjA_1b4b2117-c1bf-40f4-a7ab-e628a93c72b0" continuedAt="i43476d3fe12c439da44fc615ac485e50" escape="true">As of October&#160;31, 2022, the estimate of future amortization expenses for intangible assets with definite lives is as follows:</ix:nonNumeric></span></div><div style="margin-top:14pt;text-align:center"><ix:continuation id="i43476d3fe12c439da44fc615ac485e50"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.786%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.014%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Fiscal years:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTplNTYxMmRhNjVmNjg0YzkxYWI0N2RhZjE2NTA3OTBmYS90YWJsZXJhbmdlOmU1NjEyZGE2NWY2ODRjOTFhYjQ3ZGFmMTY1MDc5MGZhXzEtMS0xLTEtNTg1Mzc_96a5dcf1-bcc0-49dc-aa2a-8892ef6a7ccb">183.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTplNTYxMmRhNjVmNjg0YzkxYWI0N2RhZjE2NTA3OTBmYS90YWJsZXJhbmdlOmU1NjEyZGE2NWY2ODRjOTFhYjQ3ZGFmMTY1MDc5MGZhXzItMS0xLTEtNTg1Mzc_24c14a7b-fd3c-46fd-80de-727f7b1e214c">179.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTplNTYxMmRhNjVmNjg0YzkxYWI0N2RhZjE2NTA3OTBmYS90YWJsZXJhbmdlOmU1NjEyZGE2NWY2ODRjOTFhYjQ3ZGFmMTY1MDc5MGZhXzMtMS0xLTEtNTg1Mzc_b9552af2-b744-4a5a-b723-c00ebf23574b">169.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTplNTYxMmRhNjVmNjg0YzkxYWI0N2RhZjE2NTA3OTBmYS90YWJsZXJhbmdlOmU1NjEyZGE2NWY2ODRjOTFhYjQ3ZGFmMTY1MDc5MGZhXzQtMS0xLTEtNTg1Mzc_1e579209-6da2-4fdb-afc0-e6e0fe0be663">162.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="coo:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTplNTYxMmRhNjVmNjg0YzkxYWI0N2RhZjE2NTA3OTBmYS90YWJsZXJhbmdlOmU1NjEyZGE2NWY2ODRjOTFhYjQ3ZGFmMTY1MDc5MGZhXzUtMS0xLTEtNTg1Mzc_227f0c4b-92d7-4769-83a5-a3e66d689948">1,180.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total remaining amortization for intangible assets with definite lives</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTplNTYxMmRhNjVmNjg0YzkxYWI0N2RhZjE2NTA3OTBmYS90YWJsZXJhbmdlOmU1NjEyZGE2NWY2ODRjOTFhYjQ3ZGFmMTY1MDc5MGZhXzYtMS0xLTEtNTg1Mzc_98b295c2-fa42-476d-acba-241623f89499">1,874.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></ix:continuation></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company considered the impact on its near and long-term forecasts from the general deterioration of economic and market conditions as a result of higher inflation, regional and global conflict, supply chain disruption, and the ongoing disruptions of the COVID-19 pandemic and determined that it was not more likely than not that the fair value of reporting units or relevant asset groups was below carrying amounts. Therefore, the Company determined that there was <ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="0" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90ZXh0cmVnaW9uOjFlZTViYzliZDZiMzRmMDliOWU0MDEyNjUyMDhjZjg4XzUzMDA_2fbb094e-4baf-4e59-8bc9-9f5bbf3b0c56"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="0" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90ZXh0cmVnaW9uOjFlZTViYzliZDZiMzRmMDliOWU0MDEyNjUyMDhjZjg4XzUzMDA_a63d7f50-6096-4282-bf07-902c366f487a">no</ix:nonFraction></ix:nonFraction> impairment to either its definite-lived or indefinite-lived intangible assets during fiscal 2022, 2021 and 2020. There was an immaterial impairment charge related to our exit from the contact lens care business.</span></div></ix:continuation><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><div id="ifcd99b6df4104f80be938ce77dc8288d_106"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzc0ODk_6783866d-e6a2-4c19-b214-206f5e8584d1" continuedAt="ibc9b3c1fa42841cca52b6785dd1f9d5c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 5. Financing Arrangements</span></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzc0ODU_5dd48819-230b-47a0-8291-2402bafe63b6" escape="true"><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company had outstanding debt as follows:</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.107%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.413%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.416%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Overdraft and other credit facilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4917c3481374f0a93818dc20a45502a_I20221031" decimals="-5" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzMtMS0xLTEtNTg1Mzc_2a39eccb-4d9e-4b3d-9f37-fd84eb6f38bb">57.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b0fe802f23047fd86412c4b0a12e7f4_I20211031" decimals="-5" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzMtMy0xLTEtNTg1Mzc_5bb4f16b-caf0-4555-aa48-160e8fc47159">83.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Term loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ab931d901624913a0875c155dd2c744_I20221031" decimals="-5" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzQtMS0xLTEtNTg1Mzc_00df01ee-7d0a-4840-8321-6c4ed10a3b0b">338.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57b61e00e7774e95a89c8142b3bf5838_I20211031" decimals="-5" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzQtMy0xLTEtNTg1Mzc_04bbf450-54f2-48eb-99c4-7069b1a42452">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: unamortized debt issuance cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DeferredFinanceCostsCurrentNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzUtMS0xLTEtNTg1Mzc_adf107d8-ee31-4805-8a28-2a7896bb2a7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:DeferredFinanceCostsCurrentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzUtMy0xLTEtNTg1Mzc_01a14898-1a1d-4fa2-a9f1-c466328b1fce">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Short-term debt, excluding financing leases</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="coo:ShortTermDebtNetOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzYtMS0xLTEtNTg1Mzc_c1154961-92b0-468b-8f4a-78354c545ab6">395.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="coo:ShortTermDebtNetOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzYtMy0xLTEtNTg1Mzc_106a685b-8362-40eb-9c64-b7f7715d43c3">82.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzctMC0xLTEtODU4NTc_141e84ec-4e7b-4dbb-a1d9-b69da3b28fc9"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzctMC0xLTEtODU4NTc_47c29b41-9b44-43cc-a1c4-67a03e586316">Financing lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzctMS0xLTEtNzc3MTM_27bca237-7658-435a-8a78-83c18c740960">16.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzctMy0xLTEtNzc3Mjc_e4234995-53da-4743-a3fa-9df987fb78ed">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Short-term debt</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzgtMS0xLTEtNzc3MzU_3bdcdcaa-08b1-46b6-a551-b1e10cd089cf">412.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzgtMy0xLTEtNzc3NTc_52cd860b-23a7-49d3-8a48-319297b4f8a0">83.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Revolving credit</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9659d4a6cff4b4dbd9b2f26ba14ea06_I20221031" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzgtMS0xLTEtNTg1Mzc_1080c160-0c84-4679-8941-44a0eb4909b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fad6966df8143e8a4914f53e33375a2_I20211031" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzgtMy0xLTEtNTg1Mzc_ec76343a-176e-4b9f-997e-9ca756c40e85">546.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Term loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55a407bf120641c6a3267ea45f9bc655_I20221031" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzktMS0xLTEtNTg1Mzc_f652b0be-0511-4cf0-be3f-89a06f8c88e4">2,350.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b694e0c04a748c58139e1321f99fd2a_I20211031" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzktMy0xLTEtNTg1Mzc_0c50c724-b44b-43b9-8781-6cdc910ea50c">850.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45cfe81e384f56bae429ccfb71c2ec_I20221031" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzEwLTEtMS0xLTU4NTM3_134b1c02-6c34-4b6f-b146-973f1f51269c">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d4ac0f0b1a4888ac43f875e832794d_I20211031" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzEwLTMtMS0xLTU4NTM3_c1db2229-c0f6-49aa-b0a5-1c7dbd54e614">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: unamortized debt issuance cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DeferredFinanceCostsNoncurrentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzExLTEtMS0xLTU4NTM3_45f660fe-54bd-418e-9286-8e2a324a0876">3.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:DeferredFinanceCostsNoncurrentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzExLTMtMS0xLTU4NTM3_e8172579-e821-415c-80d1-eb7c6b1f1001">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-term debt, excluding financing leases</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzEyLTEtMS0xLTU4NTM3_3a34019d-0c73-4371-8eac-fe94d5ec2bf8">2,347.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzEyLTMtMS0xLTU4NTM3_15280b6a-9d10-4720-9db8-8f61cb94b384">1,396.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzE2LTAtMS0xLTg1ODY1_1411df30-957e-4c30-8c9d-b44d0a42fc69"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzE2LTAtMS0xLTg1ODY1_b721c839-4714-4bc4-a058-6a751c018797">Financing lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzE2LTEtMS0xLTc3ODc3_5f0f7fea-c9b6-4e7a-8510-e376084b9576">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzE2LTMtMS0xLTc3ODg1_0f18d536-1f72-401c-b8aa-11ae782eddca">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzE3LTEtMS0xLTc3ODk2_ac06660c-bc79-43f9-9150-24802fd801e9">2,350.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzE3LTMtMS0xLTc3OTIy_c238faf0-2462-45d9-8cd7-c0777733f882">1,397.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzE0LTEtMS0xLTU4NTM3_48ebab3d-7f70-414e-a1db-c4ea3699b4be">2,763.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzE0LTMtMS0xLTU4NTM3_71b80aa2-df6b-4263-9611-8b4ae0ad185b">1,481.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of October&#160;31, 2022, the Company was in compliance with all debt covenants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Term Loan Agreement on December 17, 2021</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On December 17, 2021, the Company entered into a Term Loan Agreement (the 2021 Credit Agreement) by and among the Company, the lenders from time to time party thereto, and PNC Bank, National Association, as administrative agent. The 2021 Credit Agreement provides for a term loan facility (the 2021 Term Loan Facility) in an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="ifca29665c5264825877b7058a88003d2_I20211217" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzE3MDQyNDMwMjYwNTM1_d2cd1701-5320-41d2-a735-093aa37b73e5">1.5</ix:nonFraction>&#160;billion, which, unless terminated earlier, matures on December 17, 2026. In addition, the Company has the ability from time to time to request an increase to the commitments under the 2021 Term Loan Facility or to establish a new term loan facility under the 2021 Credit Agreement in an aggregate principal amount not to exceed $<ix:nonFraction unitRef="usd" contextRef="ifca29665c5264825877b7058a88003d2_I20211217" decimals="-6" name="coo:LineOfCreditFacilityAccordionFeatureIncreaseLimit" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzE3MDQyNDMwMjYwNTY0_a1124d05-4de8-4913-863d-6330774fd79a">1.125</ix:nonFraction>&#160;billion, upon prior written notice to the administrative agent and subject to the discretionary participation of the lenders funding such term loans and certain limitations set forth in the 2021 Credit Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Amounts outstanding under the 2021 Term Loan Facility will bear interest, at the Company&#8217;s option, at either (i) the alternate base rate, which is a rate per annum equal to the greatest of (a) the administrative agent&#8217;s prime rate, (b) one-half of one percent in excess of the federal funds effective rate and (c) <ix:nonFraction unitRef="number" contextRef="id51c61469fa640639cd76808539e31f4_D20211217-20211217" decimals="2" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" format="ixt-sec:numwordsen" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzE3MDQyNDMwMjYwNTgz_0bea46b1-5020-465c-ae17-ae89503b9d7b">one</ix:nonFraction> percent in excess of the adjusted London interbank offered rate (&#8220;LIBOR&#8221;) for a one-month interest period on such day, or (ii) the adjusted LIBOR, plus, in each case, an applicable rate of, initially, <ix:nonFraction unitRef="number" contextRef="i6b809e82e20145e888d01efebc590393_D20211217-20211217" decimals="0" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" format="ixt:fixed-zero" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzE3MDQyNDMwMjYwNjAx_7e6956e8-34cd-49a0-a251-2ded10971d21">zero</ix:nonFraction> basis points, in respect of base rate loans, and <ix:nonFraction unitRef="number" contextRef="i53ffe4696c6f4b47b2e4b518a1cf3c2a_D20211217-20211217" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzE3MDQyNDMwMjYwNjIz_d4729df4-b68b-4599-9857-4421a7acf061">75</ix:nonFraction> basis points, in respect of adjusted LIBOR loans. Following a specified period after the closing date, the applicable rates will be determined quarterly by reference to a grid based upon the Company&#8217;s ratio of consolidated net indebtedness to consolidated EBITDA, each as defined in the 2021 Credit Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company may prepay loan balances from time to time, in whole or in part, without premium or penalty (other than any related breakage costs).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On December 17, 2021, the Company borrowed $<ix:nonFraction unitRef="usd" contextRef="i2a01079f97ba4d5783870ec5bc57cdca_D20211217-20211217" decimals="-8" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzE3MDQyNDMwMjYwNjQz_f75659ac-0d2b-4d8b-a9ab-07eae2cec49b">1.5</ix:nonFraction>&#160;billion under the 2021 Term Loan Facility and used the proceeds to fund the acquisition of Generate. Refer to Note 3. Acquisitions and Joint Venture for more details.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The interest rate on the 2021 Term Loan Facility was <ix:nonFraction unitRef="number" contextRef="ifffdb3949fef4f5385e7019378e75442_I20221031" decimals="4" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzE3MDQyNDMwMjYwNjc4_22f1e366-4560-46d0-b221-3fba19cd4c8a">4.44</ix:nonFraction>% at October&#160;31, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The 2021 Credit Agreement contains customary restrictive covenants, as well as financial covenants that require the Company to maintain a certain Total Leverage Ratio and Interest Coverage Ratio, each as defined in the 2021 Credit Agreement, consistent with the 2020 Credit Agreement discussed below.</span></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="ibc9b3c1fa42841cca52b6785dd1f9d5c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Term Loan Agreement on November 2, 2021</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On November 2, 2021, the Company entered into a <ix:nonNumeric contextRef="i228f4290d6fd4f95876b3825317e8cd3_D20211102-20211102" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzIzNA_5f8508ab-16a0-452b-bcac-411c0716d0bc">364</ix:nonNumeric>-day, $<ix:nonFraction unitRef="usd" contextRef="ia94dc74dbbad4a8d9eb7e9f6962a812c_I20211102" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzI0Mg_761f35ae-adf0-4c65-b433-505f3c8aec29">840.0</ix:nonFraction>&#160;million, term loan agreement by and among the Company, the lenders party thereto and The Bank of Nova Scotia, as administrative agent, which matured subsequent to year end on November 1, 2022. The Company used part of the funds to partially repay outstanding borrowings under the 2020 Revolving Credit Facility and for general corporate purposes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We repaid $<ix:nonFraction unitRef="usd" contextRef="idfb7453c47b34db1bb9c7e36494babea_D20211101-20221031" decimals="-5" name="us-gaap:RepaymentsOfShortTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzQ5NDc4MDIzNjM2OTc_bb371118-3ef9-480c-88c1-f42afb5b810d">502.0</ix:nonFraction>&#160;million during fiscal 2022. Amounts outstanding under the 2021 <ix:nonNumeric contextRef="i228f4290d6fd4f95876b3825317e8cd3_D20211102-20211102" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzE3MDQyNDMwMjYxNTEx_4b5a590d-1f6e-4068-8d72-c93ff4e6b6b0">364</ix:nonNumeric>-Day Term Loan Agreement will bear interest, at the Company&#8217;s option, at either the alternate base rate, or the adjusted LIBOR (each as defined in the 2021 <ix:nonNumeric contextRef="i228f4290d6fd4f95876b3825317e8cd3_D20211102-20211102" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzE3MDQyNDMwMjYxNTE2_b013be8b-a061-4f37-aa87-f0e2e7901f0b">364</ix:nonNumeric>-Day Term Loan Agreement), plus, in the case of adjusted LIBOR loans, an applicable rate of <ix:nonFraction unitRef="number" contextRef="i227390cb7d3741d68bbf2a306e8d317d_D20211102-20211102" decimals="3" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzE3MDQyNDMwMjYxNTMx_ac054bff-b84a-4b75-87bf-3141a7a3a75a">60</ix:nonFraction> basis points.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The 2021 <ix:nonNumeric contextRef="i228f4290d6fd4f95876b3825317e8cd3_D20211102-20211102" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzE3MDQyNDMwMjYxNTIx_be48f161-c084-44dd-9d8c-8cca9383432d">364</ix:nonNumeric>-Day Term Loan Agreement contains customary restrictive covenants, as well as financial covenants that require the Company to maintain a certain total leverage ratio and interest coverage ratio, each as defined in the 2021 <ix:nonNumeric contextRef="i228f4290d6fd4f95876b3825317e8cd3_D20211102-20211102" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzE3MDQyNDMwMjYxNTI2_31225f0f-7ebc-4df1-98f3-9a94b032efa3">364</ix:nonNumeric>-Day Term Loan Agreement, consistent with the 2020 Credit Agreement discussed below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Revolving Credit and Term Loan Agreement on April 1, 2020</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">On April 1, 2020, the Company entered into a Revolving Credit and Term Loan Agreement (the 2020 Credit Agreement), among the Company, CooperVision International Holding Company, LP, CooperSurgical Netherlands B.V., CooperVision Holding Kft. the lenders from time to time party thereto, and KeyBank National Association, as administrative agent. The 2020 Credit Agreement provides for (a)&#160;a multicurrency revolving credit facility (the 2020 Revolving Credit Facility) in an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="ia014d234e2444dd4bb45dd43ef342980_I20200401" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzE1NzU_d43367fd-adb7-4b92-b88a-365f2f12c1b2">1.29</ix:nonFraction> billion and (b)&#160;a term loan facility (the 2020 Term Loan Facility) in an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i1e590effe8254728b5dd3d8a3dd2c200_I20200401" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzE2NzM_6c5367bd-ee19-4237-b7ce-984058e42626">850.0</ix:nonFraction> million, each of which, unless terminated earlier, mature on April 1, 2025. The Company used $<ix:nonFraction unitRef="usd" contextRef="ifc00728eabe64bf9abfe0f08253a79f6_D20200401-20200401" decimals="-5" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzQ5NDc4MDIzMzkwOTQ_7aea535d-f8cb-482a-ac6c-61e0f9dbaac8">850.0</ix:nonFraction>&#160;million under the 2020 Term Loan Facility and $<ix:nonFraction unitRef="usd" contextRef="i91b88612cab0454c851fa2d99d1c3fd4_D20200401-20200401" decimals="-5" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzQ5NDc4MDIzMzkxMTA_89e6e50b-7093-4b67-84bb-1d69c9015bf4">445.0</ix:nonFraction>&#160;million under the 2020 Revolving Credit Facility to fully repay all borrowings outstanding under a previously existing term loan agreement and transfer all letters of credit and borrowings outstanding under a previously existing credit agreement to the 2020 Credit Agreement. The Company has an uncommitted option to increase the revolving credit facility or establish a new term loan in an aggregate amount up to $<ix:nonFraction unitRef="usd" contextRef="i99285324fc244ac586029dfa2f4f68a8_I20200401" decimals="-6" name="coo:LineOfCreditFacilityAccordionFeatureIncreaseLimit" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzQ5NDc4MDIzNDM4MDA_8e7aad8b-059c-43ef-8a32-841b46392f5f">1.605</ix:nonFraction>&#160;billion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On October 30, 2020, the Company entered into Amendment No. 1 to the 2020 Credit Agreement, adding CooperVision International Limited as a revolving borrower and releasing certain borrowers in the 2020 Credit Agreement. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">On December 17, 2021, the Company entered into Amendment No.2 to the 2020 Credit Agreement, modifying the 2020 Credit Agreement by, among other things, adding CooperSurgical Holdings Limited as a revolving borrower, releasing CooperVision Holding Kft as a borrower, and updating the benchmark replacement language in the 2020 Credit Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">The 2020 Credit Agreement will bear interest, at the Company&#8217;s option, at either the base rate, or the adjusted LIBOR or adjusted foreign currency rate, plus, in each case, an applicable rate of between <ix:nonFraction unitRef="number" contextRef="i9500e33949584e7fba3a70a9736253fa_D20200401-20200401" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzIyNjY_fe45d59c-8fb2-4b03-b108-b06b075301ee">0.00</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i9e8360d369424d82ba580ad6e272eaf1_D20200401-20200401" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzIyNzM_9d26e947-dc75-4748-9fc7-39c127cbccb4">0.50</ix:nonFraction>% in respect of base rate loans, and between <ix:nonFraction unitRef="number" contextRef="id5ae1b08f4874f7aa187763d59539a86_D20200401-20200401" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzIzMTk_e76ec421-210c-415f-bf1e-c1e6bc63bc9d">0.75</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ib107e383db7648e0a06edb90e19e4ed9_D20200401-20200401" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzIzMjY_83167c72-4766-44b7-9fdd-25a7647b722e">1.50</ix:nonFraction>% in respect of adjusted LIBOR or adjusted foreign currency rate loans, in each case in accordance with a pricing grid tied to the Total Leverage Ratio, as defined in the 2020 Credit Agreement. The Company may borrow, repay and re-borrow amounts available under the Revolving Credit Facility, subject to voluntary reduction of the revolving commitment.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company pays an annual commitment fee that ranges from <ix:nonFraction unitRef="number" contextRef="i2b1692dde0d0413fa5ee769ae29445c9_D20200401-20200401" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzI4MDA_2dc8b5f6-f82b-4680-b87d-f6ccaf9727f9">0.10</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i6d7d408231a140f9950399b4dc433531_D20200401-20200401" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzI4MDY_07979654-24ad-4017-ae93-b61c6659865f">0.20</ix:nonFraction>% of the unused portion of the 2020 Revolving Credit Facility based upon the Company&#8217;s Total Leverage Ratio, as defined in the 2020 Credit Agreement. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">At October&#160;31, 2022, the Company had $<ix:nonFraction unitRef="usd" contextRef="i1d41f939e43e4627b5b87dc3739b80c0_I20221031" decimals="-5" name="us-gaap:LongTermLineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzM5ODY_f4946c7c-7a6d-4023-ab65-f74cb30381cc">850.0</ix:nonFraction> million outstanding under the 2020 Term Loan Facility and <ix:nonFraction unitRef="usd" contextRef="i29e6d6b4446144a4b28b291aa1417e38_I20221031" decimals="-5" name="us-gaap:LongTermLineOfCredit" format="ixt-sec:numwordsen" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzQwMzk_506c60f4-f155-4cf0-ada9-38fe00b2da4f">none</ix:nonFraction> outstanding under the 2020 Revolving Credit Facility. The interest rate on the 2020 Term Loan Facility was <ix:nonFraction unitRef="number" contextRef="i1d41f939e43e4627b5b87dc3739b80c0_I20221031" decimals="4" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzQxNDk_1fde5f09-149a-4583-b76e-157fd1dcdf6b">4.13</ix:nonFraction>% at October&#160;31, 2022. The interest rate on the 2020 Revolving Credit Facility was <ix:nonFraction unitRef="number" contextRef="i29e6d6b4446144a4b28b291aa1417e38_I20221031" decimals="4" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzQyMzM_d978fd0e-6a3e-478e-90ee-6159066a5964">4.13</ix:nonFraction>% at October&#160;31, 2022.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Payments on the outstanding long-term debt balance of $<ix:nonFraction unitRef="usd" contextRef="i1d41f939e43e4627b5b87dc3739b80c0_I20221031" decimals="-5" name="us-gaap:LongTermLineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzEwOTk1MTE2MzEyNzcz_3256a1c9-fd89-4b48-ba4f-2d2d2f5d0764">850.0</ix:nonFraction>&#160;million are due in the fiscal year ending October 31, 2025.</span></div><div style="margin-top:6pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">European and Asian Pacific Credit Facilities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company maintains European credit facilities. The aggregate facility limit was $<ix:nonFraction unitRef="usd" contextRef="i20f77777d3384f55a365a87853e42b20_I20221031" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzU1MzI_c8baecb8-2fdd-4ac1-80ed-b0f6b04a2172">30.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i43df8cc9f4d3428b869e34da6854f047_I20211031" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzE3MDQyNDMwMjY5OTI2_d03477df-6a82-4ed2-8021-85ce6439351c">35.8</ix:nonFraction>&#160;million at October&#160;31, 2022 and 2021, respectively. At October&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="i20f77777d3384f55a365a87853e42b20_I20221031" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzU4ODg_bdc4a9ad-19f9-4420-81e0-6d87286fb9b3">12.3</ix:nonFraction> million of the facilities was utilized and the weighted average interest rate on the outstanding balances was <ix:nonFraction unitRef="number" contextRef="i20f77777d3384f55a365a87853e42b20_I20221031" decimals="4" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzU5OTA_ac61bb58-3fed-443e-b36c-cd0097241abe">2.46</ix:nonFraction>%. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company maintains Yen-denominated credit facilities in Japan. The aggregate facility limit was $<ix:nonFraction unitRef="usd" contextRef="i6cb922e3a6634ae5b78e0db7ecf40f80_I20221031" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzYxODE_9d0901d8-500d-4ccf-9d78-2c1c2cbec8b5">73.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if3dec29ada164a17b0ecfcff9b29d05d_I20211031" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzE3MDQyNDMwMjY5OTQx_1b1925d5-ebc1-4b4e-964e-47cc3272fd41">95.0</ix:nonFraction>&#160;million at October&#160;31, 2022 and 2021, respectively. At October&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="i6cb922e3a6634ae5b78e0db7ecf40f80_I20221031" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzY0MDQ_3a1ed716-42b3-43b9-bfcc-5db6c677c3d6">45.4</ix:nonFraction> million of the combined facilities was utilized and the weighted average interest rate on the outstanding balances was <ix:nonFraction unitRef="number" contextRef="i6cb922e3a6634ae5b78e0db7ecf40f80_I20221031" decimals="4" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzY1MTU_e539f17f-e8b5-4e3e-b89f-f082f8fce430">0.40</ix:nonFraction>%. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Each facility is supported by a continuing and unconditional guaranty.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><div id="ifcd99b6df4104f80be938ce77dc8288d_109"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQzNzM_4b9bf354-48da-4b9a-827e-9d8037d5e748" continuedAt="if0337f3656ee449888967f9ceb4eb4e2" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 6. Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Effective Tax Rate</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">The effective tax rates for fiscal 2022 and 2021 were <ix:nonFraction unitRef="number" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQ5NDc4MDIzNDk3ODc_a2d09ac5-d369-44fb-ac8c-04af88ae7d8e">18.8</ix:nonFraction>% and (<ix:nonFraction unitRef="number" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQ5NDc4MDIzNDk3OTQ_a0ca359c-8097-462b-a17e-3199ed8d18de">499.1</ix:nonFraction>)%, respectively. The increase was primarily due to an intra-group transfer of intellectual property in fiscal 2021 and UK tax rate change in fiscal 2021, as discussed below. The increase was also due to changes in the geographic composition of pre-tax earnings and changes in excess tax benefits from share-based compensation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">The effective tax rate for fiscal 2022 was lower than the US federal statutory rate primarily due to foreign earnings in jurisdictions with lower tax rates and changes in unrecognized tax benefits, partially offset by foreign earnings subject to US tax. The effective tax rate for fiscal 2021 was lower than the US federal statutory tax rate primarily due to the intra-group transfer, UK tax rate change, and earnings in foreign jurisdictions with lower tax rates partially offset by foreign earnings subject to US tax. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">In November 2020, the Company completed an intra-group transfer of certain intellectual property and related assets of CooperVision to a UK subsidiary as part of a group restructuring to establish headquarters operations in the UK. Determining fair value involved significant judgment related to future revenue growth, operating margins, and discount rates. The transfer resulted in a step-up of the UK tax-deductible basis in the intellectual property and goodwill, creating a temporary difference between the book basis and the tax basis of these assets. As a result, the Company recognized a deferred tax asset of $<ix:nonFraction unitRef="usd" contextRef="ia18ddf672b66483baceea8655de8da4b_I20210131" decimals="-5" name="us-gaap:DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQ5NDc4MDIzNDk4MDQ_3323cf81-39bd-40e7-8b04-9ee9fe3726ce">1,987.9</ix:nonFraction>&#160;million, with a corresponding income tax benefit, during the first quarter of fiscal 2021. During the third quarter of fiscal 2021, the Company recognized a $<ix:nonFraction unitRef="usd" contextRef="i9a8c7e344a6d4ca6aa5bbb5af896bb9a_D20210501-20210731" decimals="-5" sign="-" name="coo:EffectiveIncomeTaxRateReconciliationChangeInEnactedForeignTaxRateAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQ5NDc4MDIzNDk4MjI_fa4b1409-4713-4fe2-97de-45d957e52f9d">536.7</ix:nonFraction>&#160;million tax benefit related primarily to the remeasurement of this deferred tax asset caused by the UK enactment of a 25% corporate tax rate.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQzOTE_c07dae0a-4063-4bf8-9c6c-0f4343a43a54" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Components of income before income taxes:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.884%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/>(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo0ZmJhOTU2NTAwY2U0OTBkYTU1OTVmYTEzMDcwOGViYy90YWJsZXJhbmdlOjRmYmE5NTY1MDBjZTQ5MGRhNTU5NWZhMTMwNzA4ZWJjXzItMS0xLTEtNTg1Mzc_d0018468-43ca-4bbd-b6bb-f19e667e8245">31.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo0ZmJhOTU2NTAwY2U0OTBkYTU1OTVmYTEzMDcwOGViYy90YWJsZXJhbmdlOjRmYmE5NTY1MDBjZTQ5MGRhNTU5NWZhMTMwNzA4ZWJjXzItMy0xLTEtNTg1Mzc_7096ddf9-6981-4855-866f-b553b1898e37">31.0</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo0ZmJhOTU2NTAwY2U0OTBkYTU1OTVmYTEzMDcwOGViYy90YWJsZXJhbmdlOjRmYmE5NTY1MDBjZTQ5MGRhNTU5NWZhMTMwNzA4ZWJjXzItNS0xLTEtNTg1Mzc_0fb04727-1bb8-4734-91e1-2ec2b5a10943">88.0</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo0ZmJhOTU2NTAwY2U0OTBkYTU1OTVmYTEzMDcwOGViYy90YWJsZXJhbmdlOjRmYmE5NTY1MDBjZTQ5MGRhNTU5NWZhMTMwNzA4ZWJjXzMtMS0xLTEtNTg1Mzc_a79a2ad4-9f80-4d0b-aae5-4fbb435e576f">443.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo0ZmJhOTU2NTAwY2U0OTBkYTU1OTVmYTEzMDcwOGViYy90YWJsZXJhbmdlOjRmYmE5NTY1MDBjZTQ5MGRhNTU5NWZhMTMwNzA4ZWJjXzMtMy0xLTEtNTg1Mzc_08e099b3-31c5-48c3-9491-9fdbd15c204b">522.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo0ZmJhOTU2NTAwY2U0OTBkYTU1OTVmYTEzMDcwOGViYy90YWJsZXJhbmdlOjRmYmE5NTY1MDBjZTQ5MGRhNTU5NWZhMTMwNzA4ZWJjXzMtNS0xLTEtNTg1Mzc_ed7c7093-722c-4119-805f-4df55d3abdc6">354.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo0ZmJhOTU2NTAwY2U0OTBkYTU1OTVmYTEzMDcwOGViYy90YWJsZXJhbmdlOjRmYmE5NTY1MDBjZTQ5MGRhNTU5NWZhMTMwNzA4ZWJjXzQtMS0xLTEtNTg1Mzc_c6190f34-4203-42e5-a2f3-c7927ea36c4f">475.3</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo0ZmJhOTU2NTAwY2U0OTBkYTU1OTVmYTEzMDcwOGViYy90YWJsZXJhbmdlOjRmYmE5NTY1MDBjZTQ5MGRhNTU5NWZhMTMwNzA4ZWJjXzQtMy0xLTEtNTg1Mzc_740a61ea-6a7d-4768-9623-121ef21a909f">491.5</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo0ZmJhOTU2NTAwY2U0OTBkYTU1OTVmYTEzMDcwOGViYy90YWJsZXJhbmdlOjRmYmE5NTY1MDBjZTQ5MGRhNTU5NWZhMTMwNzA4ZWJjXzQtNS0xLTEtNTg1Mzc_e7d1a91f-6553-431c-80ce-2d17cd9ab1a5">266.5</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="if0337f3656ee449888967f9ceb4eb4e2" continuedAt="ib5464e483efa4dcab75cabf5ee8f2dd3"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQzNjA_0e0e2e72-9a85-49ce-8da6-81a82a86e577" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Components of provision for income taxes: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.884%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzItMS0xLTEtNTg1Mzc_492544c4-7e23-45fc-8691-6bff00b45466">10.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzItMy0xLTEtNTg1Mzc_b7a0fa21-33a0-408c-b50f-a0ef766c7876">21.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzItNS0xLTEtNTg1Mzc_87122fba-4dcf-46fb-9a15-6e4e46d92d58">1.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzMtMS0xLTEtNTg1Mzc_ed7469a3-006a-45a2-8657-97ccc2d18f57">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzMtMy0xLTEtNTg1Mzc_ee447f09-3a7c-4a11-a111-24671f0bdc44">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzMtNS0xLTEtNTg1Mzc_f7352ef9-a381-4b39-b3c2-be6ab288dc8c">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzQtMS0xLTEtNTg1Mzc_e9ace9fd-93cc-444b-8980-594253ffc23c">21.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzQtMy0xLTEtNTg1Mzc_bcda9159-442b-4da2-8ca0-f0de2d2bfc3a">26.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzQtNS0xLTEtNTg1Mzc_9a24ccf0-bb87-4306-9f63-62aa9357a6e6">26.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzUtMS0xLTEtNTg1Mzc_7b4d8be0-ee6f-4add-83da-370b46021016">35.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzUtMy0xLTEtNTg1Mzc_67b0a79c-0d85-4310-8cf1-052911c6f155">49.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzUtNS0xLTEtNTg1Mzc_de7732db-89d6-4e3e-b21a-e6fb003272c4">29.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzgtMS0xLTEtNTg1Mzc_00eb8fe4-7184-41fa-869b-944fdd8bb932">10.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzgtMy0xLTEtNTg1Mzc_a81800b1-a15d-4f4e-9d4e-13b4c0e8b7f6">8.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzgtNS0xLTEtNTg1Mzc_9407dc3b-c911-47c6-bb36-e580f521e84b">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzktMS0xLTEtNTg1Mzc_9a7f2945-32dd-4f15-9d5b-0df250fc322f">2.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzktMy0xLTEtNTg1Mzc_f6664963-22f8-428e-a501-f3b07e4be497">0.5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzktNS0xLTEtNTg1Mzc_1ed9b7d1-31c1-4ed8-b3b7-654c069323e1">0.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzEwLTEtMS0xLTU4NTM3_03aa61df-1613-4be6-8d1a-3e2efaca3fbd">45.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzEwLTMtMS0xLTU4NTM3_9c49d757-ef60-4ca1-8a40-69518382c6b8">2,492.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzEwLTUtMS0xLTU4NTM3_1ec126c3-a6c4-4661-9362-63660efce78b">4.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzExLTEtMS0xLTU4NTM3_936fa109-267b-4572-aa3a-780f26931cc8">53.9</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzExLTMtMS0xLTU4NTM3_e5de104d-0ee7-4faa-a7ae-449da3ed81e0">2,502.2</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzExLTUtMS0xLTU4NTM3_e00d7a51-e626-44e8-97a6-b54f46f9db15">0.9</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzEyLTEtMS0xLTU4NTM3_72eb6e95-65ba-47ab-b349-4a60d831ed9b">89.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzEyLTMtMS0xLTU4NTM3_2f3aaaf7-7b9a-4ea9-b826-1e8c16538400">2,453.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzEyLTUtMS0xLTU4NTM3_6a261427-2d98-449f-8725-e26c252ee887">28.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQzODc_9450d5a0-6ce7-4e48-b584-a047507fa819" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Reconciliation between the expected provision for income taxes at the US federal statutory rate and the provision for income taxes:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.884%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Provision for income taxes at United States statutory tax rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzEtMS0xLTEtNTg1Mzc_1c5dd94f-4779-48e2-9f44-7c010cf3f6b3">99.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzEtMy0xLTEtNTg1Mzc_26e25180-5ae2-4d58-b1e6-9a8208dd4318">103.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzEtNS0xLTEtNTg1Mzc_6c2e5b9d-14da-4ef9-a502-1aaac6382092">56.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(Decrease) increase in taxes resulting from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign earnings in jurisdictions with lower tax rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzMtMS0xLTEtNTg1Mzc_0c72af81-b091-4bcc-aec6-62b4a11bf0ca">22.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzMtMy0xLTEtNTg1Mzc_1f18ee0e-bcfc-4be0-bcb1-7a25e5da8fa8">43.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzMtNS0xLTEtNTg1Mzc_e71d50cc-729d-4033-af4d-5ab383712e53">54.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign earnings subject to United States tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:IncomeTaxReconciliationRepatriationOfForeignEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzQtMS0xLTEtNTg1Mzc_34034c35-3e9e-4c7a-b246-295d337e1219">20.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:IncomeTaxReconciliationRepatriationOfForeignEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzQtMy0xLTEtNTg1Mzc_221929ce-4cc7-46f7-9b58-09b0e5804b01">25.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:IncomeTaxReconciliationRepatriationOfForeignEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzQtNS0xLTEtNTg1Mzc_1a4ede86-82d9-4393-8fad-a6c7bf156dd3">32.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Excess tax benefits from share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzYtMS0xLTEtNTg1Mzc_36aa5304-ef97-4b08-8ecc-16b252defdab">2.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzYtMy0xLTEtNTg1Mzc_0224e829-9a28-4200-ac87-d5b2196d993a">13.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzYtNS0xLTEtNTg1Mzc_f15e8614-5758-422f-a69d-a6443f2f49c5">6.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred tax asset step-up</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzctMS0xLTEtNTg1Mzc_31dd7fe0-b2e3-42e4-b0f3-6f0c72e4e48c">3.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzctMy0xLTEtNTg1Mzc_3f0a6147-7833-4d36-81f6-2276a4e36457">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzctNS0xLTEtNTg1Mzc_6b8915ed-3aa6-4a59-a0f5-b8203feac9fd">9.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United States provision-to-return</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="coo:EffectiveIncomeTaxRateReconciliationChangeInDomesticFederalTaxReturnAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzgtMS0xLTEtNTg1Mzc_b4053f9a-a324-4fd6-b3c7-19ebd11db5da">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" sign="-" name="coo:EffectiveIncomeTaxRateReconciliationChangeInDomesticFederalTaxReturnAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzgtMy0xLTEtNTg1Mzc_f06ba356-2b16-46df-86a7-a8d1880ae5f7">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="coo:EffectiveIncomeTaxRateReconciliationChangeInDomesticFederalTaxReturnAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzgtNS0xLTEtNTg1Mzc_403dcaec-503e-4f6f-bdbf-7e57ac1fbd63">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intra-group transfer to UK subsidiary</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:IncomeTaxReconciliationDispositionOfAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzktMS0xLTEtNTg1Mzc_ed1f40ae-ddc9-426d-9945-fc4e5b883cf0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationDispositionOfAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzktMy0xLTEtNTg1Mzc_87f0208d-0c53-47b7-bf4b-9e1565087187">1,987.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:IncomeTaxReconciliationDispositionOfAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzktNS0xLTEtNTg1Mzc_f254eb0f-5017-4f0e-aa4b-5a7bef4f9bd8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Remeasurement of deferred tax assets from UK rate change</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzEwLTEtMS0xLTU4NTM3_ff399e0f-c09d-4c31-acc2-47c70b3caa32">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzEwLTMtMS0xLTU4NTM3_5e5dfc92-a890-4641-8902-90005cf52120">536.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzEwLTUtMS0xLTU4NTM3_bcb6cfa0-3ab5-430f-8946-4e7d5e5822b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Change in unrecognized tax benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" sign="-" name="coo:EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzExLTEtMS0xLTU4NTM3_b2404dea-8b0c-4fef-a93e-2d2a10b408bd">12.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" sign="-" name="coo:EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzExLTMtMS0xLTU4NTM3_1beffee3-4cbb-42a5-b999-6fb3336a21c6">7.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" sign="-" name="coo:EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzExLTUtMS0xLTU4NTM3_5581e904-5fbc-4b64-b2bf-7abf32a74aad">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">State tax provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzEyLTEtMS0xLTkyMjUx_ea795503-c260-4285-a193-8f0f5c004c29">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzEyLTMtMS0xLTkyMjUx_3c0ac939-57a7-4f00-a69d-902b46397376">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzEyLTUtMS0xLTkyMjUx_9fac0192-6666-416d-b1c2-05c8f8192531">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzEyLTEtMS0xLTU4NTM3_4122b329-eb06-4938-872a-5c256e966441">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzEyLTMtMS0xLTU4NTM3_9731ab42-b0b0-4008-a5c4-42efe02bfa2e">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzEyLTUtMS0xLTU4NTM3_1f94d450-cd37-4bc1-85d8-f7fdb5e500a8">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzEzLTEtMS0xLTU4NTM3_10ad87f1-1abe-49e9-b322-87d80f253795">89.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzEzLTMtMS0xLTU4NTM3_84967a83-5574-42c3-96ae-2272a931f0f8">2,453.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzEzLTUtMS0xLTU4NTM3_eb0a67ff-f1c2-4318-ba84-8ef411c7e7fc">28.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="ib5464e483efa4dcab75cabf5ee8f2dd3" continuedAt="i2cdb931d050345438ec5a9983c7f9047"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQzNjM_8f7af7ae-9a02-4e6d-9f47-8b3516ea28e5" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Components of deferred tax assets and liabilities:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.063%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzItMS0xLTEtNTg1Mzc_38a2b334-7a59-4b09-b7c4-f809d851beb7">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzItMy0xLTEtNTg1Mzc_698cb5ea-dbfe-4a0a-b98e-a56d08cda6fc">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DeferredTaxAssetsInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzMtMS0xLTEtNTg1Mzc_62d58958-794e-4c11-91fa-86e6534c3d9b">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:DeferredTaxAssetsInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzMtMy0xLTEtNTg1Mzc_aa02e103-f68d-441f-9ff6-bb83cfde05fd">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accrued liabilities, reserves and compensation accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzQtMS0xLTEtNTg1Mzc_a2ac3af3-0429-4cc1-af56-5f822439b0c8">79.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzQtMy0xLTEtNTg1Mzc_d9b26a62-990a-43ee-a4d1-b2dd3c8a7565">78.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign deferred tax assets </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzUtMS0xLTEtNTg1Mzc_6104bc25-fa24-4b9b-af65-d13fb0789c0e">2,500.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzUtMy0xLTEtNTg1Mzc_eaa0bf5f-6e81-4228-90be-5723e87ea311">2,531.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzYtMS0xLTEtNTg1Mzc_e1891336-254f-4df8-aa3c-eac17b1f69f0">14.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzYtMy0xLTEtNTg1Mzc_79c4d464-63b0-4cb8-b8f1-877c1c171df7">28.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net operating loss and tax credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="coo:DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzctMS0xLTEtNTg1Mzc_b38c0e2b-b950-4610-8601-9d90b332b520">19.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="coo:DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzctMy0xLTEtNTg1Mzc_914a3cd3-71ec-4247-9560-68edc9b3c9fa">19.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzgtMS0xLTEtNTg1Mzc_bc7050d3-2dcf-4756-b787-fbd831113438">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzgtMy0xLTEtNTg1Mzc_e7ce44ce-ebc4-4993-86c6-d946486548a8">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Capitalized research and experimental expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzktMS0xLTEtNTg1Mzc_26fc84bb-5fb3-45bf-90b4-159fa5d9d37e">15.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzktMy0xLTEtNTg1Mzc_7e621026-858c-4c8d-82a6-f7b833a514c7">13.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total gross deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzExLTEtMS0xLTU4NTM3_bdb1efc4-fc50-4e0d-9299-4f380ef2218b">2,641.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzExLTMtMS0xLTU4NTM3_4a839ec3-0c46-41da-b55d-0c364d89068e">2,687.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzEyLTEtMS0xLTU4NTM3_6ccb583d-a050-4b1d-a1ad-c23875bc9665">60.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzEyLTMtMS0xLTU4NTM3_4ae0b98a-be98-4d07-aef2-d6933730b162">51.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzEzLTEtMS0xLTU4NTM3_31afb6ef-4419-44fe-8f72-001001ee9442">2,581.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzEzLTMtMS0xLTU4NTM3_2f260b13-2d33-4fe2-b40b-7dd7dd45415b">2,635.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Tax deductible goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzE1LTEtMS0xLTU4NTM3_359a4d48-6021-4638-91de-e126d0b945c5">39.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzE1LTMtMS0xLTU4NTM3_a42bd767-bd32-41cf-9262-323ac5fd5e61">34.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzE1LTEtMS0xLTk5OTk5_8316b6fe-f32e-4155-8d06-ebddc1f7c421">153.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzE1LTMtMS0xLTk5OTk5_c878e2ba-1b53-4f3d-ac75-4fd809badbf2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzE2LTEtMS0xLTU4NTM3_2d8b098f-b18d-4369-93b9-c7f9eba12a70">48.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzE2LTMtMS0xLTU4NTM3_2155cc02-7d88-4241-b638-93b504fadd78">46.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="coo:DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzE5LTEtMS0xLTU4NTM3_6459ea36-091e-4695-8f5f-f36f67a07417">45.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="coo:DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzE5LTMtMS0xLTU4NTM3_3429f9a2-bc42-49cb-b579-5205a251ec69">32.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total gross deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzIyLTEtMS0xLTU4NTM3_55ec422d-fdee-414b-8586-74a02016e96c">287.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzIyLTMtMS0xLTU4NTM3_c1cabf08-b4b7-40e6-a10b-855b4b52dcbf">113.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzIzLTEtMS0xLTU4NTM3_dcbf8eb7-7a69-47f8-bb1d-b992a88e774d">2,293.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzIzLTMtMS0xLTU4NTM3_13e9ce4b-e78e-4521-8a52-707c3d5085f5">2,522.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In assessing the realizability of deferred tax assets, the Company analyzes whether some or all deferred tax assets will not be realized. This analysis considers historical taxable income, the projected reversal of deferred tax liabilities, projected taxable income and tax planning strategies. Based upon this analysis, it is more likely than not the deferred tax assets, net of valuation allowance, will be realized. The increase in valuation allowance is primarily related to foreign tax attributes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">At October 31, 2022, the Company had federal net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i1fdb5f114ab64b349676d31f17804de9_I20221031" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQ5NDc4MDIzNDk4Mzg_8b23b2b1-3f69-4036-990b-97cbfd331086">65.4</ix:nonFraction>&#160;million and state net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i4fec0e4443b8407cbcb12c6d06cf6eaa_I20221031" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQ5NDc4MDIzNDk4NTM_19daf0b8-6682-4635-87ea-0c7ae9f59feb">97.3</ix:nonFraction>&#160;million. Federal net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i1fdb5f114ab64b349676d31f17804de9_I20221031" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQ5NDc4MDIzNDk4ODI_baf7ac2e-a37d-4f7b-8122-6e70811f5370">17.1</ix:nonFraction>&#160;million expire on various dates between 2025 and 2037 and $<ix:nonFraction unitRef="usd" contextRef="i1fdb5f114ab64b349676d31f17804de9_I20221031" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQ5NDc4MDIzNDk4OTc_31bb23e8-e961-4c1c-b6e6-e545214affbb">48.3</ix:nonFraction>&#160;million do not expire. The state net operating loss carryforwards expire on various dates between 2026 through 2042.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">A tax benefit is recognized if it is more likely than not that a tax position will be sustained on its technical merits, based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority. </span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="i2cdb931d050345438ec5a9983c7f9047"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQzODI_c4882452-01e2-4b3a-858b-9e6fdd96c0ca" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Changes in unrecognized tax benefits:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.737%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.063%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo2MmFmMDM1YWI4NzE0ZjZkYTE1ZjBiZmZjN2NhZjAyZC90YWJsZXJhbmdlOjYyYWYwMzVhYjg3MTRmNmRhMTVmMGJmZmM3Y2FmMDJkXzEtMS0xLTEtNTg1Mzc_d6a2e6d8-f818-45aa-8eda-836f50ad5cb2">58.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Decrease based on tax positions in prior fiscal years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo2MmFmMDM1YWI4NzE0ZjZkYTE1ZjBiZmZjN2NhZjAyZC90YWJsZXJhbmdlOjYyYWYwMzVhYjg3MTRmNmRhMTVmMGJmZmM3Y2FmMDJkXzItMS0xLTEtNTg1Mzc_312b4031-8152-4670-9158-9b936eda7993">8.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Increase based on tax positions in current fiscal year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo2MmFmMDM1YWI4NzE0ZjZkYTE1ZjBiZmZjN2NhZjAyZC90YWJsZXJhbmdlOjYyYWYwMzVhYjg3MTRmNmRhMTVmMGJmZmM3Y2FmMDJkXzMtMS0xLTEtNTg1Mzc_7fcfc40b-ec4f-47ff-800c-9ac3d3609415">307.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo2MmFmMDM1YWI4NzE0ZjZkYTE1ZjBiZmZjN2NhZjAyZC90YWJsZXJhbmdlOjYyYWYwMzVhYjg3MTRmNmRhMTVmMGJmZmM3Y2FmMDJkXzQtMS0xLTEtNTg1Mzc_f2d47dcf-76a2-4a72-aef3-9be4bea8c44f">1.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lapses of statutes of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo2MmFmMDM1YWI4NzE0ZjZkYTE1ZjBiZmZjN2NhZjAyZC90YWJsZXJhbmdlOjYyYWYwMzVhYjg3MTRmNmRhMTVmMGJmZmM3Y2FmMDJkXzUtMS0xLTEtNTg1Mzc_21e847b1-5be0-44ed-bd65-183cdf8fe9ac">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo2MmFmMDM1YWI4NzE0ZjZkYTE1ZjBiZmZjN2NhZjAyZC90YWJsZXJhbmdlOjYyYWYwMzVhYjg3MTRmNmRhMTVmMGJmZmM3Y2FmMDJkXzYtMS0xLTEtNTg1Mzc_f76066fc-70b9-41ff-be4b-5d5f95451c38">353.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Decrease based on tax positions in prior fiscal years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo2MmFmMDM1YWI4NzE0ZjZkYTE1ZjBiZmZjN2NhZjAyZC90YWJsZXJhbmdlOjYyYWYwMzVhYjg3MTRmNmRhMTVmMGJmZmM3Y2FmMDJkXzctMS0xLTEtNTg1Mzc_10a9943e-6c3f-486c-85a9-bb92a3ea001e">12.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo2MmFmMDM1YWI4NzE0ZjZkYTE1ZjBiZmZjN2NhZjAyZC90YWJsZXJhbmdlOjYyYWYwMzVhYjg3MTRmNmRhMTVmMGJmZmM3Y2FmMDJkXzgtMS0xLTEtNTg1Mzc_edd6ccba-1dd8-4749-855e-dd156914ce5c">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lapses of statutes of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo2MmFmMDM1YWI4NzE0ZjZkYTE1ZjBiZmZjN2NhZjAyZC90YWJsZXJhbmdlOjYyYWYwMzVhYjg3MTRmNmRhMTVmMGJmZmM3Y2FmMDJkXzEwLTEtMS0xLTU4NTM3_b7af7b27-af62-4f6d-9e6d-4ea3ce335dfa">4.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo2MmFmMDM1YWI4NzE0ZjZkYTE1ZjBiZmZjN2NhZjAyZC90YWJsZXJhbmdlOjYyYWYwMzVhYjg3MTRmNmRhMTVmMGJmZmM3Y2FmMDJkXzEyLTEtMS0xLTU4NTM3_9089eacc-51a8-44b2-840e-7ed72daa132f">336.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">These tax benefits, if recognized, would reduce provision for income taxes for 2022, 2021 and 2020, by $<ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQ5NDc4MDIzNDk5NTk_622a30be-eebc-4f68-bd7c-d86b50c3a6aa">324.3</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQ5NDc4MDIzNDk5NzU_e8cb9807-b5d5-4a59-a316-fece3ffee0ad">336.5</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQ5NDc4MDIzNDk5OTE_5f795435-06d5-49b2-85e3-3e65997579bf">46.0</ix:nonFraction>&#160;million, respectively. Interest and penalties related to unrecognized tax benefits are recognized in provision for income taxes. As of October 31, 2022, 2021 and 2020, accrued gross interest and penalties related to unrecognized tax benefits was $<ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQ5NDc4MDIzNTAwMDY_31748eda-54cb-4b46-b694-aa406b460c11">5.4</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQ5NDc4MDIzNTAwMjA_908f5420-9667-41e7-b24c-711fa1bbc82e">6.4</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQ5NDc4MDIzNTAwMzQ_5c5658f2-4a4c-4f5a-8199-24652ec4f17f">7.3</ix:nonFraction>&#160;million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Included in the balance of unrecognized tax benefits at October 31, 2022 is $<ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQ5NDc4MDIzNTAwNDg_397b30e2-4d0b-4f8b-99fe-2b8a50e4c6d1">9.1</ix:nonFraction>&#160;million related to tax positions for which it is reasonably possible that the total amounts could change during the next twelve months.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Filed tax returns are subject to examination by tax authorities in major tax jurisdictions after fiscal 2016, including the UK and the US.</span></div></ix:continuation><div><span><br/></span></div><div id="ifcd99b6df4104f80be938ce77dc8288d_112"></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90ZXh0cmVnaW9uOmMwNWEwMGE4ZjYwNzRiNTM5YjQ3YTVjZWNlNzg1MDJmXzI5OQ_ba31b2e6-012e-4d3b-92d6-00bd303f5dd6" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 7. Earnings Per Share</span></div><div style="margin-top:14pt"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90ZXh0cmVnaW9uOmMwNWEwMGE4ZjYwNzRiNTM5YjQ3YTVjZWNlNzg1MDJmXzMwMQ_9349781c-6825-45bf-a891-77f1340484a9" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.135%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October 31,</span></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions, except for earnings per share)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzItMS0xLTEtNTg1Mzc_0c9a75d1-30e4-4bba-89c1-d51d275529a1"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzItMS0xLTEtNTg1Mzc_31097b26-6c77-4775-b400-fc94b482772a">385.8</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzItMy0xLTEtNTg1Mzc_c09de6c6-b135-4353-949d-f8960410c37c"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzItMy0xLTEtNTg1Mzc_fc3b2e52-5539-4283-a1c7-15b00b9c3745">2,944.7</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzItNS0xLTEtNTg1Mzc_5011ae34-c0b8-4389-b81f-ed9747614793"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzItNS0xLTEtNTg1Mzc_c4ea812f-7526-4321-a4c4-6449a4ffae45">238.4</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">Basic:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Weighted average common shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzQtMS0xLTEtNTg1Mzc_609a7ae3-b1c2-4577-a35e-473c350493f8">49.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzQtMy0xLTEtNTg1Mzc_4533d291-6db6-406b-875d-e42c4f59cea6">49.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzQtNS0xLTEtNTg1Mzc_b748fde4-3d85-41bb-8c1e-2b1ebbcecec3">49.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzUtMS0xLTEtNTg1Mzc_90fdf320-f538-4745-95fb-7aff14225c42">7.83</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzUtMy0xLTEtNTg1Mzc_711a5646-9afa-45fc-b33a-1fe80f701960">59.80</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzUtNS0xLTEtNTg1Mzc_d9825f69-5257-4854-aa28-eca7720b2b62">4.85</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">Diluted:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Weighted average common shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzctMS0xLTEtNTg1Mzc_7f335c54-df3e-440c-a164-f976254f0ccc">49.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzctMy0xLTEtNTg1Mzc_7e910d86-67ee-4ba7-bfce-0830f1bf535b">49.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzctNS0xLTEtNTg1Mzc_9ad5e843-5bf4-47fd-8357-d4cdf9eee2fd">49.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Effect of dilutive stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzgtMS0xLTEtNTg1Mzc_5aadeb44-4d40-4258-9b61-a58ea5102a23">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzgtMy0xLTEtNTg1Mzc_4aa633a0-e3f2-424b-a2b1-61cd625831f0">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzgtNS0xLTEtNTg1Mzc_d4b47fd6-e061-4574-a0f8-46f15559d2d5">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Diluted weighted average common shares</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzktMS0xLTEtNTg1Mzc_088558a0-3a81-4e1c-8fc5-3d7b4df31c55">49.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzktMy0xLTEtNTg1Mzc_26ee0cb1-a1de-4258-8447-4cb492d8f095">49.8</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzktNS0xLTEtNTg1Mzc_bcb76925-be59-4f44-a783-fd6502d55277">49.6</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzEwLTEtMS0xLTU4NTM3_726833be-22cd-4ee4-a748-6db7db78a70d">7.76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzEwLTMtMS0xLTU4NTM3_352e0339-3726-481d-88cb-2dd6d0b23d98">59.16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzEwLTUtMS0xLTU4NTM3_2ced4559-6380-4a45-a16f-f409306be22b">4.81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></ix:nonNumeric></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90ZXh0cmVnaW9uOmMwNWEwMGE4ZjYwNzRiNTM5YjQ3YTVjZWNlNzg1MDJmXzMwOA_8cc567c6-80c1-4c55-9923-adae281be38c" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table sets forth stock options to purchase our common stock and restricted stock units that were not included in the diluted earnings per share calculation because their effect would have been antidilutive for the periods presented:</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.248%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.248%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.251%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October 31,</span></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In thousands, except exercise prices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Stock option shares excluded</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i735d9bf4f5c64cc190f684cf557f76ac_D20211101-20221031" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZToyNWViMjY1MWY3NGQ0YTEzODc2MzFhYjU2ZTZjYmIwOS90YWJsZXJhbmdlOjI1ZWIyNjUxZjc0ZDRhMTM4NzYzMWFiNTZlNmNiYjA5XzItMS0xLTEtNTg1Mzc_00c04627-f074-4d3c-b3fc-329944cc0b74">227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9037379de7ad40cb960f5f67523ae233_D20201101-20211031" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZToyNWViMjY1MWY3NGQ0YTEzODc2MzFhYjU2ZTZjYmIwOS90YWJsZXJhbmdlOjI1ZWIyNjUxZjc0ZDRhMTM4NzYzMWFiNTZlNmNiYjA5XzItMy0xLTEtNTg1Mzc_1a288c49-11e9-48dc-bb91-f174602efd20">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i994f6d46a07848c48bb5f57d06e47f95_D20191101-20201031" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZToyNWViMjY1MWY3NGQ0YTEzODc2MzFhYjU2ZTZjYmIwOS90YWJsZXJhbmdlOjI1ZWIyNjUxZjc0ZDRhMTM4NzYzMWFiNTZlNmNiYjA5XzItNS0xLTEtNTg1Mzc_48d50320-0ca0-4dc3-ac2f-95614868d6a9">207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Exercise prices</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZToyNWViMjY1MWY3NGQ0YTEzODc2MzFhYjU2ZTZjYmIwOS90YWJsZXJhbmdlOjI1ZWIyNjUxZjc0ZDRhMTM4NzYzMWFiNTZlNmNiYjA5XzMtMS0xLTEtNTg1MzcvdGV4dHJlZ2lvbjozMzVmMWUzMjY1NTI0N2FjYmRlZDA5M2U3ZjQ2ZDhjMF81NDk3NTU4MTM5MTY_4fd9a41b-5d29-41a9-8324-897b8b92c836">300.12</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZToyNWViMjY1MWY3NGQ0YTEzODc2MzFhYjU2ZTZjYmIwOS90YWJsZXJhbmdlOjI1ZWIyNjUxZjc0ZDRhMTM4NzYzMWFiNTZlNmNiYjA5XzMtMS0xLTEtNTg1MzcvdGV4dHJlZ2lvbjozMzVmMWUzMjY1NTI0N2FjYmRlZDA5M2U3ZjQ2ZDhjMF81NDk3NTU4MTM5MjY_455d2c4c-67b9-4e0e-8b0e-57e2a4611294">406.17</ix:nonFraction></span></div></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZToyNWViMjY1MWY3NGQ0YTEzODc2MzFhYjU2ZTZjYmIwOS90YWJsZXJhbmdlOjI1ZWIyNjUxZjc0ZDRhMTM4NzYzMWFiNTZlNmNiYjA5XzMtMy0xLTEtNTg1Mzc_080d1a1e-6fd4-4557-96d5-6cfbae0ed05c"><ix:nonFraction unitRef="usdPerShare" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZToyNWViMjY1MWY3NGQ0YTEzODc2MzFhYjU2ZTZjYmIwOS90YWJsZXJhbmdlOjI1ZWIyNjUxZjc0ZDRhMTM4NzYzMWFiNTZlNmNiYjA5XzMtMy0xLTEtNTg1Mzc_2d062b09-c799-47a9-ae09-8f2fce20169c">345.74</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZToyNWViMjY1MWY3NGQ0YTEzODc2MzFhYjU2ZTZjYmIwOS90YWJsZXJhbmdlOjI1ZWIyNjUxZjc0ZDRhMTM4NzYzMWFiNTZlNmNiYjA5XzMtNS0xLTEtNTg1Mzc_443906b0-be16-4ee2-9776-1681c74172f2"><ix:nonFraction unitRef="usdPerShare" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZToyNWViMjY1MWY3NGQ0YTEzODc2MzFhYjU2ZTZjYmIwOS90YWJsZXJhbmdlOjI1ZWIyNjUxZjc0ZDRhMTM4NzYzMWFiNTZlNmNiYjA5XzMtNS0xLTEtNTg1Mzc_f5f6daea-ff28-44cf-8a18-87d8818ecf84">304.54</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Restricted stock units excluded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i60a5f62358f3456f94c7622fcccd1de1_D20211101-20221031" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZToyNWViMjY1MWY3NGQ0YTEzODc2MzFhYjU2ZTZjYmIwOS90YWJsZXJhbmdlOjI1ZWIyNjUxZjc0ZDRhMTM4NzYzMWFiNTZlNmNiYjA5XzQtMS0xLTEtNTg1Mzc_6ed7071d-6f8c-4608-8a2b-6382f04e2344">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5b52a596f80946beb247cfd6e8e457d0_D20201101-20211031" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZToyNWViMjY1MWY3NGQ0YTEzODc2MzFhYjU2ZTZjYmIwOS90YWJsZXJhbmdlOjI1ZWIyNjUxZjc0ZDRhMTM4NzYzMWFiNTZlNmNiYjA5XzQtMy0xLTEtNTg1Mzc_d891cea3-b590-4146-9e9a-a5e2dfa71704">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5e5449ed4ace4f148ff5db6afd1d1441_D20191101-20201031" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZToyNWViMjY1MWY3NGQ0YTEzODc2MzFhYjU2ZTZjYmIwOS90YWJsZXJhbmdlOjI1ZWIyNjUxZjc0ZDRhMTM4NzYzMWFiNTZlNmNiYjA5XzQtNS0xLTEtNTg1Mzc_b81ef11f-946c-4a3a-809b-c9e485b4791c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><div id="ifcd99b6df4104f80be938ce77dc8288d_115"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90ZXh0cmVnaW9uOmUxMDM3MGE4MDUyODQxNTdhZmNhZjJkMTBlYjU1NDhhXzEyNjE_80beb470-76e0-4491-9838-7a64b1c621b7" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 8. Stockholders&#8217; Equity</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90ZXh0cmVnaW9uOmUxMDM3MGE4MDUyODQxNTdhZmNhZjJkMTBlYjU1NDhhXzEyNTY_62211c89-9728-4277-b546-70f00a72d0b0" continuedAt="i66d74e885f36496bbe2981872d726b14" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Analysis of Changes in Accumulated Other Comprehensive Income (Loss):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Minimum Pension Liability</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic2a66fe928654ff892f449b28dccbcea_I20191031" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzEtMS0xLTEtNTg1Mzc_69bed3f6-a9f7-4af4-9f27-6f7592d6a8fd">403.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4939e43dc1c44e3c84ba8a60db483c8f_I20191031" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzEtNS0xLTEtNTg1Mzc_b20218a0-dce9-4e00-9c9d-38dd4a6e74fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767587fb433c468584f3f7356b9737e4_I20191031" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzEtNy0xLTEtNTg1Mzc_51f4b72b-0b39-4cc2-9b48-485451598dd0">43.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4862aa9bb8ef43508c2cc981078ef274_I20191031" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzEtOS0xLTEtNTg1Mzc_9b586250-d3a7-4cb7-983d-f0858a13c5a6">447.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gross change in value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic33f40436aa045c7a3aa5a02afaafef0_D20191101-20201031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzItMS0xLTEtNTg1Mzc_a49a1388-975f-4d33-8443-1c851ad51180">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac86d4da8948474188bad8e7f5a66f87_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzItNS0xLTEtNTg1Mzc_6bfedd7a-86d9-43f2-9d81-a5c0d770ed3d">17.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1ce184d806940dc9e3ac0e3283e5a05_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzItNy0xLTEtNTg1Mzc_86defe1b-267b-4fe0-91a5-ee05228537d8">16.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzItOS0xLTEtNTg1Mzc_338aa336-e4e8-405b-a49d-611ac9463164">33.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic33f40436aa045c7a3aa5a02afaafef0_D20191101-20201031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzMtMS0xLTEtNTg1Mzc_8624dd55-58d1-4f09-a6b3-a3d94c8209ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac86d4da8948474188bad8e7f5a66f87_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzMtNS0xLTEtNTg1Mzc_fef9700c-c7ef-4185-b577-e01a8a746dbf">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1ce184d806940dc9e3ac0e3283e5a05_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzMtNy0xLTEtNTg1Mzc_306ec3e4-d4e8-4f3c-bdab-2de8c073429b">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzMtOS0xLTEtNTg1Mzc_fc1cafc2-bbcf-4c7c-a69a-3f50c929a5d9">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i984b27946ae74a7a86ccd23408d602d5_I20201031" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzUtMS0xLTEtNTg1Mzc_b5986adf-6730-4128-a993-62bd2b7e2fef">402.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2b158c1317d4810ba6145502cf9fa62_I20201031" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzUtNS0xLTEtNTg1Mzc_39e054bc-c03a-4202-8c5d-6f7b336fcc9d">13.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia689d6db1dcf416ba5f2200ae5e5f4b5_I20201031" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzUtNy0xLTEtNTg1Mzc_42b7f2e8-ea5f-48fe-bc24-a58a1338d298">56.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15ff03e12d5e49abb65998853b7f5c15_I20201031" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzUtOS0xLTEtNTg1Mzc_b9492ee3-239f-45d0-aac0-ab3f0f0e918d">472.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gross change in value</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib785f9fe0b6f449a807bde4146343b94_D20201101-20211031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzYtMS0xLTEtNTg1Mzc_4e620fef-1483-44bc-b065-74584a092b0f">82.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57f3229c828a483a94464d9bda7f0fc2_D20201101-20211031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzYtNS0xLTEtNTg1Mzc_9e55a213-ae34-4c0c-9be3-122626aab4fc">34.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65542b1a9cb447ac8968bcb17317427b_D20201101-20211031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzYtNy0xLTEtNTg1Mzc_89e9e648-9b4c-483b-b2e4-4a43ace5525d">29.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzYtOS0xLTEtNTg1Mzc_30e4d607-19b7-43a3-87df-3f1d8f974f92">146.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib785f9fe0b6f449a807bde4146343b94_D20201101-20211031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzctMS0xLTEtNTg1Mzc_060599a5-aef3-4591-a691-2145f8bcecf1">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i57f3229c828a483a94464d9bda7f0fc2_D20201101-20211031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzctNS0xLTEtNTg1Mzc_d70862ec-e3d2-4d74-bf06-f19778c4355e">8.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65542b1a9cb447ac8968bcb17317427b_D20201101-20211031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzctNy0xLTEtNTg1Mzc_a5df8a06-1ab3-4b73-b971-a8e17ac8f8d0">7.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzctOS0xLTEtNTg1Mzc_8f481aa5-99bf-425d-b99b-8802f3f7b2bd">15.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd134a9b985a4f77a31f6656483a2e78_I20211031" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzktMS0xLTEtNTg1Mzc_f1048b8a-00b0-436e-a5e4-11bf524472e1">320.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d514c5d060040099cd2656f450fc3e6_I20211031" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzktNS0xLTEtNTg1Mzc_0a00bc7c-a733-4d36-9b59-7dc2f01f61f2">13.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf2ee51bda7b413c809c36bd987d5e20_I20211031" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzktNy0xLTEtNTg1Mzc_50dbbc47-bc89-4369-812e-1fe7afaee875">34.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1debae85ed14b3aa606b0f2a2bf613a_I20211031" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzktOS0xLTEtNTg1Mzc_410a0b92-67f8-45fc-a630-3d8c4c9c6e0f">341.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gross change in value</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6d7c5e2927b491cb9d48756d4126817_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzEwLTEtMS0xLTU4NTM3_807e631f-f5b3-45d9-9d47-0f6687dd2439">234.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i105b86b96182466c89e084e2d8117b5e_D20211101-20221031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzEwLTUtMS0xLTU4NTM3_de76d857-2941-4227-a170-9fa6297f82a1">107.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9244242144c45aa9048eeaa500730b3_D20211101-20221031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzEwLTctMS0xLTU4NTM3_5c7f4ce6-02cd-483c-9b5b-5fea66fdfd6b">36.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzEwLTktMS0xLTU4NTM3_15310139-5fa4-45de-a52b-ec5d0b21b03a">90.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6d7c5e2927b491cb9d48756d4126817_D20211101-20221031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzEyLTEtMS0xLTU4NTM3_a91af651-0eff-402f-b230-663328a87af0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i105b86b96182466c89e084e2d8117b5e_D20211101-20221031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzEyLTUtMS0xLTU4NTM3_4e6f1935-a56b-42ad-9ea5-251b39380047">26.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib9244242144c45aa9048eeaa500730b3_D20211101-20221031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzEyLTctMS0xLTU4NTM3_47a90a6b-39e5-465a-b39f-e24bc21b91e6">8.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzEyLTktMS0xLTU4NTM3_2d42f7ba-6c93-447e-a4a7-005accd88789">34.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d0f42512b5a468fa0175b728ddf3071_I20221031" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzEzLTEtMS0xLTU4NTM3_f83808e7-91d8-4460-9a67-bef2b26fd1c0">555.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27afd0c9af1c4f46a1ee89390596bd3b_I20221031" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzEzLTUtMS0xLTU4NTM3_be3e8b7f-a6a8-4840-ad2e-a9c3382ceab6">94.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbc93be7f95b42e8959f15b98f6e9285_I20221031" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzEzLTctMS0xLTU4NTM3_779442aa-057e-454b-a165-4d86b43cd379">6.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13f3c04d8bda4a5ea3fcba710edd83fb_I20221031" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzEzLTktMS0xLTU4NTM3_4e3d5bd2-0de5-439c-822b-7668d2894b26">466.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Share Repurchases </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In December 2011, the Company's Board of Directors authorized the 2012 Share Repurchase Program and through subsequent amendments, the most recent in March 2017, the total repurchase authorization was increased from $<ix:nonFraction unitRef="usd" contextRef="i26915257e03c4b6fbdd14345564b2a64_I20111231" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90ZXh0cmVnaW9uOmUxMDM3MGE4MDUyODQxNTdhZmNhZjJkMTBlYjU1NDhhXzM0Mw_0c662bf4-f8b1-4b6b-a138-73434b3d4f46">500.0</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i00964b16a5864689921a5cd1f5431741_I20170331" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90ZXh0cmVnaW9uOmUxMDM3MGE4MDUyODQxNTdhZmNhZjJkMTBlYjU1NDhhXzM0OQ_ad531a41-0557-4a1c-8d73-981b5f34ee11">1.0</ix:nonFraction> billion of the Company's common stock. This program has no expiration date and may be discontinued at any time. Purchases under the 2012 Share Repurchase Program are subject to a review of the circumstances in place at the time and may be made from time to time as permitted by securities laws and other legal requirements.</span></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ScheduleOfTreasuryStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90ZXh0cmVnaW9uOmUxMDM3MGE4MDUyODQxNTdhZmNhZjJkMTBlYjU1NDhhXzEyNTk_030977df-cc12-4b3b-b4fb-a73f5cc56913" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">For the years ended October&#160;31, 2022 and 2021, the Company's share repurchases were as follow:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.224%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.355%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.357%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Number of shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTplOTNlZGZiYjM3ZTU0Zjc0YWNjNGY4MmEzYzgwY2Y4NC90YWJsZXJhbmdlOmU5M2VkZmJiMzdlNTRmNzRhY2M0ZjgyYTNjODBjZjg0XzEtMS0xLTEtNTg1Mzc_545a7c07-a730-4bc9-96be-61f3aec0d50a">191,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTplOTNlZGZiYjM3ZTU0Zjc0YWNjNGY4MmEzYzgwY2Y4NC90YWJsZXJhbmdlOmU5M2VkZmJiMzdlNTRmNzRhY2M0ZjgyYTNjODBjZjg0XzEtMy0xLTEtNTg1Mzc_5457fb4d-cec3-4264-bd96-108dd1cd1aef">69,622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Average repurchase price per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="1" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTplOTNlZGZiYjM3ZTU0Zjc0YWNjNGY4MmEzYzgwY2Y4NC90YWJsZXJhbmdlOmU5M2VkZmJiMzdlNTRmNzRhY2M0ZjgyYTNjODBjZjg0XzItMS0xLTEtNTg1Mzc_b03cfb78-df8e-48f6-82da-c02cf29393c0">410.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="1" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTplOTNlZGZiYjM3ZTU0Zjc0YWNjNGY4MmEzYzgwY2Y4NC90YWJsZXJhbmdlOmU5M2VkZmJiMzdlNTRmNzRhY2M0ZjgyYTNjODBjZjg0XzItMy0xLTEtNTg1Mzc_3ccd15ec-eefa-4f79-b417-01aab9141070">356.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total costs of shares repurchased (in millions)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTplOTNlZGZiYjM3ZTU0Zjc0YWNjNGY4MmEzYzgwY2Y4NC90YWJsZXJhbmdlOmU5M2VkZmJiMzdlNTRmNzRhY2M0ZjgyYTNjODBjZjg0XzMtMS0xLTEtNTg1Mzc_962db3d0-b971-455c-a03a-c927b98dfc83">78.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTplOTNlZGZiYjM3ZTU0Zjc0YWNjNGY4MmEzYzgwY2Y4NC90YWJsZXJhbmdlOmU5M2VkZmJiMzdlNTRmNzRhY2M0ZjgyYTNjODBjZjg0XzMtMy0xLTEtNTg1Mzc_755561ef-025e-4775-9609-f56bb177e969">24.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">At October&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90ZXh0cmVnaW9uOmUxMDM3MGE4MDUyODQxNTdhZmNhZjJkMTBlYjU1NDhhXzc3MA_48dcd173-271a-4f1c-801e-5d047395f633">256.4</ix:nonFraction> million remained authorized for repurchase under the program.</span></div></ix:nonNumeric><div><span><br/></span></div><div id="ifcd99b6df4104f80be938ce77dc8288d_118"></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzEwNDYz_8529556f-ca48-4fff-b9a0-50b1256acb19" continuedAt="i812dcada57ab47f5a00d77207e2930b4" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 9. Stock Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2007 Long-Term Incentive Plan (2007 Plan)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In March 2007, we received stockholder approval of the 2007 Plan. The 2007 Plan was subsequently amended and restated, and granted stockholder approval in March 2009, March 2011, and March 2016.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Third Amended and Restated 2007 Plan is designed to increase our stockholder value by attracting, retaining and motivating key employees and consultants who directly influence our profitability. The Third Amended and Restated 2007 Plan authorizes either our Board of Directors, or a designated committee thereof composed of <ix:nonFraction unitRef="director" contextRef="iaaeec49689584b009b3148ed2f1bb819_D20160301-20160331" decimals="INF" name="coo:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzI4NDc_309da2b7-914c-4241-9ce5-8080872fb75d">two</ix:nonFraction> or more Non-Employee Directors, to grant to eligible individuals during the period ending December&#160;31, 2026, up to <ix:nonFraction unitRef="shares" contextRef="ic2850480bc384efa8b688e7df1dd278a_I20160331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzI5NjU_b381f079-990d-4844-ac87-f83a44eadad6">6,930,000</ix:nonFraction> shares in the form of specified equity awards including stock options, restricted stock units and performance share awards, subject to adjustment for future stock splits, stock dividends, expirations, forfeitures and similar events. RSUs have no dividend or voting rights prior to vesting. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of October&#160;31, 2022, <ix:nonFraction unitRef="shares" contextRef="i5a96f2cd61fa40c1b78c32485036c8cf_I20221031" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzQ0ODI_002d3b8a-1d5e-4981-bc11-b57016b0d7ce">690,596</ix:nonFraction> shares remained available under the Third Amended and Restated 2007 Plan for future grants. The amount of available shares includes shares which may be distributed under performance share awards.</span></div></ix:nonNumeric><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="i812dcada57ab47f5a00d77207e2930b4" continuedAt="i79a900e5d23e42ad8a2bee0785af587e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzEwNDcx_2b50d2a1-b57a-4847-abe7-d9a4ad1e713d" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Compensation expense and the related tax benefit recognized in our Consolidated Statements of Income for share-based awards, including the Employee Stock Purchase Plan, were as follows:</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.593%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October 31,</span></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i628a683f9df74396a991320942dabd37_D20211101-20221031" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo1ZWI1NWFiYzEwOTI0MGQ0ODUyMjY4YjJjOWY5YWVkYi90YWJsZXJhbmdlOjVlYjU1YWJjMTA5MjQwZDQ4NTIyNjhiMmM5ZjlhZWRiXzItMS0xLTEtNTg1Mzc_b8ee1141-5483-4058-9d72-1be4877d473b">46.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia678a09e2bb14a1d80e45900f2d335b2_D20201101-20211031" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo1ZWI1NWFiYzEwOTI0MGQ0ODUyMjY4YjJjOWY5YWVkYi90YWJsZXJhbmdlOjVlYjU1YWJjMTA5MjQwZDQ4NTIyNjhiMmM5ZjlhZWRiXzItMy0xLTEtNTg1Mzc_acdb358d-07ac-48be-b873-ec8af77d0273">38.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34c6e3ecdc714534b64a27e81133d571_D20191101-20201031" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo1ZWI1NWFiYzEwOTI0MGQ0ODUyMjY4YjJjOWY5YWVkYi90YWJsZXJhbmdlOjVlYjU1YWJjMTA5MjQwZDQ4NTIyNjhiMmM5ZjlhZWRiXzItNS0xLTEtNTg1Mzc_51baf0eb-852b-4b8d-a908-c1c8f31b876f">32.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a728882a111429c8b376cccf1bd73ef_D20211101-20221031" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo1ZWI1NWFiYzEwOTI0MGQ0ODUyMjY4YjJjOWY5YWVkYi90YWJsZXJhbmdlOjVlYjU1YWJjMTA5MjQwZDQ4NTIyNjhiMmM5ZjlhZWRiXzMtMS0xLTEtNTg1Mzc_f656f854-f12f-49e1-a7fc-d9c019272f3b">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c66c33e415421ca03a2aadddb8dbaa_D20201101-20211031" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo1ZWI1NWFiYzEwOTI0MGQ0ODUyMjY4YjJjOWY5YWVkYi90YWJsZXJhbmdlOjVlYjU1YWJjMTA5MjQwZDQ4NTIyNjhiMmM5ZjlhZWRiXzMtMy0xLTEtNTg1Mzc_5a68a865-f572-41b0-991e-bca6e6d4fdcd">3.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60fe14742746448cac80ed3337c5356e_D20191101-20201031" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo1ZWI1NWFiYzEwOTI0MGQ0ODUyMjY4YjJjOWY5YWVkYi90YWJsZXJhbmdlOjVlYjU1YWJjMTA5MjQwZDQ4NTIyNjhiMmM5ZjlhZWRiXzMtNS0xLTEtNTg1Mzc_65fe3493-ddec-4aa8-a798-e76da5845879">4.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74e4fb1d833e4139a5e462dc894a6a8c_D20211101-20221031" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo1ZWI1NWFiYzEwOTI0MGQ0ODUyMjY4YjJjOWY5YWVkYi90YWJsZXJhbmdlOjVlYjU1YWJjMTA5MjQwZDQ4NTIyNjhiMmM5ZjlhZWRiXzQtMS0xLTEtNTg1Mzc_84a2a1dc-b29f-44d5-9010-96f94a485422">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e7be87b88184c459d07d5e3a87d0602_D20201101-20211031" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo1ZWI1NWFiYzEwOTI0MGQ0ODUyMjY4YjJjOWY5YWVkYi90YWJsZXJhbmdlOjVlYjU1YWJjMTA5MjQwZDQ4NTIyNjhiMmM5ZjlhZWRiXzQtMy0xLTEtNTg1Mzc_d2c0a08f-39b9-4537-8d40-041496d037d8">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5316f98d06b94776b210ad2c61336af0_D20191101-20201031" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo1ZWI1NWFiYzEwOTI0MGQ0ODUyMjY4YjJjOWY5YWVkYi90YWJsZXJhbmdlOjVlYjU1YWJjMTA5MjQwZDQ4NTIyNjhiMmM5ZjlhZWRiXzQtNS0xLTEtNTg1Mzc_e2b7136a-36f2-4aa4-a334-14d9018faea9">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total compensation expense</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo1ZWI1NWFiYzEwOTI0MGQ0ODUyMjY4YjJjOWY5YWVkYi90YWJsZXJhbmdlOjVlYjU1YWJjMTA5MjQwZDQ4NTIyNjhiMmM5ZjlhZWRiXzUtMS0xLTEtNTg1Mzc_37539f08-8c90-421f-9505-be7b7fef6b50">54.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo1ZWI1NWFiYzEwOTI0MGQ0ODUyMjY4YjJjOWY5YWVkYi90YWJsZXJhbmdlOjVlYjU1YWJjMTA5MjQwZDQ4NTIyNjhiMmM5ZjlhZWRiXzUtMy0xLTEtNTg1Mzc_ed1aa1a5-30a7-4f33-a62c-dff277ec6e15">44.7</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo1ZWI1NWFiYzEwOTI0MGQ0ODUyMjY4YjJjOWY5YWVkYi90YWJsZXJhbmdlOjVlYjU1YWJjMTA5MjQwZDQ4NTIyNjhiMmM5ZjlhZWRiXzUtNS0xLTEtNTg1Mzc_3acc71f2-467c-46ac-b868-d080f346e0c5">38.6</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Related income tax benefit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo1ZWI1NWFiYzEwOTI0MGQ0ODUyMjY4YjJjOWY5YWVkYi90YWJsZXJhbmdlOjVlYjU1YWJjMTA5MjQwZDQ4NTIyNjhiMmM5ZjlhZWRiXzYtMS0xLTEtNTg1Mzc_9be3bb2b-dcc4-4a0a-9e10-d584b776951a">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo1ZWI1NWFiYzEwOTI0MGQ0ODUyMjY4YjJjOWY5YWVkYi90YWJsZXJhbmdlOjVlYjU1YWJjMTA5MjQwZDQ4NTIyNjhiMmM5ZjlhZWRiXzYtMy0xLTEtNTg1Mzc_7d3b80b5-6880-44b9-9353-1d3fc6d32eca">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo1ZWI1NWFiYzEwOTI0MGQ0ODUyMjY4YjJjOWY5YWVkYi90YWJsZXJhbmdlOjVlYjU1YWJjMTA5MjQwZDQ4NTIyNjhiMmM5ZjlhZWRiXzYtNS0xLTEtNTg1Mzc_e7dd9176-5a0f-4528-84ed-9c2b5467a24b">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Stock Options </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The fair value of each stock option award granted is estimated on the date of grant using the Black-Scholes option valuation model and assumptions noted in the following table. </span></div><div style="margin-top:5pt;text-align:center"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzEwNDQ2_eaa8905e-b704-4202-8efb-5d67720cc53a" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.037%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Years Ended October&#160;31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iadbfb62be93b49f19b18d5333619cf75_D20211101-20221031" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo2ODg1NzJiNmRjNzk0MDVlYjYwMDAyOTA1NDM5MWY2Mi90YWJsZXJhbmdlOjY4ODU3MmI2ZGM3OTQwNWViNjAwMDI5MDU0MzkxZjYyXzEtMS0xLTEtNTg1Mzc_6dfd0e2e-22d8-47c4-b9e0-84fdcb58c683">4.1</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib43f171b08e2457494485fe6afa22232_D20201101-20211031" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo2ODg1NzJiNmRjNzk0MDVlYjYwMDAyOTA1NDM5MWY2Mi90YWJsZXJhbmdlOjY4ODU3MmI2ZGM3OTQwNWViNjAwMDI5MDU0MzkxZjYyXzEtMy0xLTEtNTg1Mzc_a4cd4b12-4793-49fd-b72a-c747bd76343a">4.0</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo2ODg1NzJiNmRjNzk0MDVlYjYwMDAyOTA1NDM5MWY2Mi90YWJsZXJhbmdlOjY4ODU3MmI2ZGM3OTQwNWViNjAwMDI5MDU0MzkxZjYyXzEtNS0xLTEtNTg1Mzc_5252a810-bdc5-464e-9e83-d14b3f869e18">4.4</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iadbfb62be93b49f19b18d5333619cf75_D20211101-20221031" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo2ODg1NzJiNmRjNzk0MDVlYjYwMDAyOTA1NDM5MWY2Mi90YWJsZXJhbmdlOjY4ODU3MmI2ZGM3OTQwNWViNjAwMDI5MDU0MzkxZjYyXzItMS0xLTEtNTg1Mzc_404f40a8-3cfd-48b3-9c63-bfcea2ceae4c">25.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib43f171b08e2457494485fe6afa22232_D20201101-20211031" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo2ODg1NzJiNmRjNzk0MDVlYjYwMDAyOTA1NDM5MWY2Mi90YWJsZXJhbmdlOjY4ODU3MmI2ZGM3OTQwNWViNjAwMDI5MDU0MzkxZjYyXzItMy0xLTEtNTg1Mzc_7b370501-2103-4f12-8710-35ed33f1261f">30.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i14f3575ceef54408bd5ad9d8562d1bb6_D20191101-20201031" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo2ODg1NzJiNmRjNzk0MDVlYjYwMDAyOTA1NDM5MWY2Mi90YWJsZXJhbmdlOjY4ODU3MmI2ZGM3OTQwNWViNjAwMDI5MDU0MzkxZjYyXzItNS0xLTEtNTg1Mzc_4f24274d-6bdb-4a7f-b11d-e0c0d3277583">24.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iadbfb62be93b49f19b18d5333619cf75_D20211101-20221031" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo2ODg1NzJiNmRjNzk0MDVlYjYwMDAyOTA1NDM5MWY2Mi90YWJsZXJhbmdlOjY4ODU3MmI2ZGM3OTQwNWViNjAwMDI5MDU0MzkxZjYyXzMtMS0xLTEtNTg1Mzc_cc147c2e-ffa3-4cb3-ba02-dc920a277db5">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib43f171b08e2457494485fe6afa22232_D20201101-20211031" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo2ODg1NzJiNmRjNzk0MDVlYjYwMDAyOTA1NDM5MWY2Mi90YWJsZXJhbmdlOjY4ODU3MmI2ZGM3OTQwNWViNjAwMDI5MDU0MzkxZjYyXzMtMy0xLTEtNTg1Mzc_72bbe32f-6d8c-47f9-88da-c1ef5ad090d8">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i14f3575ceef54408bd5ad9d8562d1bb6_D20191101-20201031" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo2ODg1NzJiNmRjNzk0MDVlYjYwMDAyOTA1NDM5MWY2Mi90YWJsZXJhbmdlOjY4ODU3MmI2ZGM3OTQwNWViNjAwMDI5MDU0MzkxZjYyXzMtNS0xLTEtNTg1Mzc_d7bfa7d9-9ba2-430d-b05b-25d036d21afc">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iadbfb62be93b49f19b18d5333619cf75_D20211101-20221031" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo2ODg1NzJiNmRjNzk0MDVlYjYwMDAyOTA1NDM5MWY2Mi90YWJsZXJhbmdlOjY4ODU3MmI2ZGM3OTQwNWViNjAwMDI5MDU0MzkxZjYyXzQtMS0xLTEtNTg1Mzc_766cd154-3a44-4ed3-a24a-c66857012303">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib43f171b08e2457494485fe6afa22232_D20201101-20211031" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo2ODg1NzJiNmRjNzk0MDVlYjYwMDAyOTA1NDM5MWY2Mi90YWJsZXJhbmdlOjY4ODU3MmI2ZGM3OTQwNWViNjAwMDI5MDU0MzkxZjYyXzQtMy0xLTEtNTg1Mzc_0f5c52ce-3119-4b91-b302-59833eaf48f7">0.02</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i14f3575ceef54408bd5ad9d8562d1bb6_D20191101-20201031" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo2ODg1NzJiNmRjNzk0MDVlYjYwMDAyOTA1NDM5MWY2Mi90YWJsZXJhbmdlOjY4ODU3MmI2ZGM3OTQwNWViNjAwMDI5MDU0MzkxZjYyXzQtNS0xLTEtNTg1Mzc_1b4e11b8-d9d5-4abb-bec8-824dc80e141b">0.02</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzEwNDg1_33a4820c-58fb-40ee-94e8-fac42ca2f69f" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The activity and status of our stock option plans are summarized below: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.971%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise&#160;Price<br/>Per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Outstanding at October&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i53613739fd6240a4ade0fbe47617e606_I20211031" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzEtMS0xLTEtNTg1Mzc_84663534-1d07-466b-9dff-e9ca78dccc86">972,692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i53613739fd6240a4ade0fbe47617e606_I20211031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzEtMy0xLTEtNTg1Mzc_bb8ed2ff-1153-4638-9110-8c63088a2303">245.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iadbfb62be93b49f19b18d5333619cf75_D20211101-20221031" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzItMS0xLTEtNTg1Mzc_766770ff-d9dd-4066-8cd7-d78710c43bfa">122,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iadbfb62be93b49f19b18d5333619cf75_D20211101-20221031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzItMy0xLTEtNTg1Mzc_c54cfe28-24c0-4ae1-aed6-752e73e9c92f">403.44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iadbfb62be93b49f19b18d5333619cf75_D20211101-20221031" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzMtMS0xLTEtNTg1Mzc_a96a0e62-43cf-45f3-aedb-1dc1f3a9654c">26,866</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iadbfb62be93b49f19b18d5333619cf75_D20211101-20221031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzMtMy0xLTEtNTg1Mzc_47ac4b09-fafa-4be7-b641-c337d22c8ef8">171.87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iadbfb62be93b49f19b18d5333619cf75_D20211101-20221031" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzQtMS0xLTEtNTg1Mzc_3641f33b-9422-4947-a7ad-40467ed3807f">4,743</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iadbfb62be93b49f19b18d5333619cf75_D20211101-20221031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzQtMy0xLTEtNTg1Mzc_61f46486-d2e8-483c-aaa7-e7fa424c11d8">325.21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Outstanding at October&#160;31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7bf32de8054e4d5cb01fb90b42cafafc_I20221031" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzUtMS0xLTEtNTg1Mzc_3e232295-a0e0-49b5-8f20-a77fec293838">1,063,843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7bf32de8054e4d5cb01fb90b42cafafc_I20221031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzUtMy0xLTEtNTg1Mzc_4ca19fd6-1356-4b18-ae36-7a74e6e7e922">264.85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iadbfb62be93b49f19b18d5333619cf75_D20211101-20221031" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzUtNS0xLTEtNTg1Mzc_621769ec-9ec7-4129-a89f-2c885ee8f15a">5.75</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Vested and expected to vest at October 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzYtMS0xLTEtNTg1Mzc_713acebd-e9ed-48e0-b9b8-60bf51a211ea">1,038,594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzYtMy0xLTEtNTg1Mzc_80e9dbfc-433a-4540-bd11-fb225f0be88e">262.91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzYtNS0xLTEtNTg1Mzc_0db6b12f-ab3e-49bc-a382-5d73beaadf76">5.70</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzYtNy0xLTEtNTg1Mzc_ae19cd0d-3934-494d-8414-b84692573a7b">38,806,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Vested and exercisable at October&#160;31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzctMS0xLTEtNTg1Mzc_749ecba6-0fb0-47bd-b68e-9ffc57ac10d3">624,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzctMy0xLTEtNTg1Mzc_36d4e9c8-397d-44a8-becb-08dc57146eee">223.45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzctNS0xLTEtNTg1Mzc_7c313e03-5947-4fe8-bacd-fd68b1e83a2c">4.57</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="0" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzctNy0xLTEtNTg1Mzc_6301802d-731e-45bc-9a34-5163f477f3f7">35,586,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The weighted-average fair value of options granted during fiscal 2022, 2021 and 2020, estimated as of the grant date using the Black-Scholes option pricing model, for the 2007 Plan was $<ix:nonFraction unitRef="usdPerShare" contextRef="i36efa04f987e49038157484c638ab7d6_D20211101-20221031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzQ5NDc4MDIzNTQyMDA_ff61c6f1-ff75-4691-bed8-5149aaf3728c">90.41</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="i27ec16ba40e149c58fa3c4003f0419fa_D20201101-20211031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzU0OTc1NTg0MjIxOA_4a31852f-fb22-450e-841e-840eee13407e">84.10</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i8f3a691bb67a4ed98d8c94bd5d067867_D20191101-20201031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzU0OTc1NTg0MjIyNg_bddca365-9d14-4060-acbf-145ea8a3ea74">70.45</ix:nonFraction>, respectively. The total intrinsic value of options exercised during the fiscal years ended October&#160;31, 2022, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="i36efa04f987e49038157484c638ab7d6_D20211101-20221031" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzI3NDg3NzkwOTg0OTM_41120ab7-ed08-4c5a-8f5f-53f959726dff">6.6</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i27ec16ba40e149c58fa3c4003f0419fa_D20201101-20211031" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzY1MTc_e7f1beea-243b-47eb-a9bd-1c7e083da46a">64.7</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i8f3a691bb67a4ed98d8c94bd5d067867_D20191101-20201031" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzY1MjQ_54546418-67f3-4472-b935-2e722ed02a7a">22.6</ix:nonFraction>&#160;million, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Stock options outstanding under our current plans have been granted at prices which are either equal to or above the market value of the common stock on the date of grant. Options granted under the 2007 Plan generally vest over a range of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzY3ODM_6bc749ef-684e-4774-a7cb-72940d101aed">three</span> to <ix:nonNumeric contextRef="i2a6b156ffce448468a38a7cb9a9f5284_D20211101-20221031" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzY3ODk_413fef31-df53-42c0-8fcf-459508f41fd3">five years</ix:nonNumeric> based on service conditions and expire no later than <ix:nonNumeric contextRef="i36efa04f987e49038157484c638ab7d6_D20211101-20221031" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzY4NDU_1e7b3389-de97-4fad-a95f-8e21c1e0a09a">ten years</ix:nonNumeric> after the grant date. Options granted under the 2020 Directors' Plan generally vest in <ix:nonNumeric contextRef="i45529f605588475bb1f13e0535eaa215_D20211101-20221031" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzY5MzU_ff411f84-45c3-41ea-b662-f3bad2490f07">one year</ix:nonNumeric> and expire no later than <ix:nonNumeric contextRef="i45529f605588475bb1f13e0535eaa215_D20211101-20221031" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzY5NjM_1b26c1c2-94ad-460f-84f6-27e7d1410930">ten years</ix:nonNumeric> after the grant date. We generally recognize compensation expense ratably over the vesting period. As of October&#160;31, 2022, there was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzI3NDg3NzkwOTg1MjE_c17db738-1421-428b-b270-a7f8644effe7">21.0</ix:nonFraction>&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> of total unrecognized compensation cost related to nonvested options, which is expected to be recognized over a remaining weighted-average vesting period of <ix:nonNumeric contextRef="iadbfb62be93b49f19b18d5333619cf75_D20211101-20221031" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzI3NDg3NzkwOTg1NDI_747a2d8d-8684-4cff-a91d-d3b034c183c5">2.3</ix:nonNumeric> years.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="i79a900e5d23e42ad8a2bee0785af587e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Restricted Stock Units</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">RSUs granted under the 2007 Plan generally vest over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzc1MjA_66aa3933-ae43-4ccf-b4c9-c3b93a1275c1">three</span> to <ix:nonNumeric contextRef="i27a4fb29e4284efe98e1175e5c0e2891_D20211101-20221031" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzc1MjY_107651d6-1423-40ea-b229-ae2f86eefdae">five years</ix:nonNumeric>. The grant-date fair value of RSUs is estimated based on the market price of our common stock. We recognize compensation expense ratably over the vesting period. As of October&#160;31, 2022, there was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i2e988aefd55b4136aafbe1e6601e0d10_I20221031" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzI3NDg3NzkwOTg1NjU_4783dc7f-225c-4cc2-83c1-c40efe4c37ae">64.4</ix:nonFraction>&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> of total unrecognized compensation cost related to nonvested RSUs, which is expected to be recognized over a remaining weighted-average vesting period of <ix:nonNumeric contextRef="i57f5c7d0d50a48669bf760069cb4c005_D20211101-20221031" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzc5NDg_58dd37de-538b-4936-a4bf-c47c0802cfbb">2.5</ix:nonNumeric> years.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzEwNDg5_6d9482d3-e77b-408f-bc8b-74d699444ec1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The status of our non-vested RSUs is summarized below:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.248%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.192%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant&#160;Date&#160;Fair<br/>Value&#160;Per&#160;Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-vested RSUs at October&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i55102374da8b426cb0c7d8637de24dc2_I20211031" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZToxNDA5NjVmYjAzZDY0NWU2YjNlY2M1MTdiNmQzYjg3My90YWJsZXJhbmdlOjE0MDk2NWZiMDNkNjQ1ZTZiM2VjYzUxN2I2ZDNiODczXzEtMS0xLTEtNTg1Mzc_f760b392-2071-400f-8174-f8d3a8a1229b">317,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i55102374da8b426cb0c7d8637de24dc2_I20211031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZToxNDA5NjVmYjAzZDY0NWU2YjNlY2M1MTdiNmQzYjg3My90YWJsZXJhbmdlOjE0MDk2NWZiMDNkNjQ1ZTZiM2VjYzUxN2I2ZDNiODczXzEtMy0xLTEtNTg1Mzc_951cc14a-b081-4ef7-a467-bf43d3d06c37">293.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i57f5c7d0d50a48669bf760069cb4c005_D20211101-20221031" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZToxNDA5NjVmYjAzZDY0NWU2YjNlY2M1MTdiNmQzYjg3My90YWJsZXJhbmdlOjE0MDk2NWZiMDNkNjQ1ZTZiM2VjYzUxN2I2ZDNiODczXzItMS0xLTEtNTg1Mzc_514a1854-4ad5-4092-8943-9087402bb120">113,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i57f5c7d0d50a48669bf760069cb4c005_D20211101-20221031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZToxNDA5NjVmYjAzZDY0NWU2YjNlY2M1MTdiNmQzYjg3My90YWJsZXJhbmdlOjE0MDk2NWZiMDNkNjQ1ZTZiM2VjYzUxN2I2ZDNiODczXzItMy0xLTEtNTg1Mzc_58d44bcd-5280-42ff-a76b-77afc24e0773">399.21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Vested and issued</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i57f5c7d0d50a48669bf760069cb4c005_D20211101-20221031" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZToxNDA5NjVmYjAzZDY0NWU2YjNlY2M1MTdiNmQzYjg3My90YWJsZXJhbmdlOjE0MDk2NWZiMDNkNjQ1ZTZiM2VjYzUxN2I2ZDNiODczXzMtMS0xLTEtNTg1Mzc_a98f6f63-fc95-4c67-a323-2190803b68e3">113,301</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i57f5c7d0d50a48669bf760069cb4c005_D20211101-20221031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZToxNDA5NjVmYjAzZDY0NWU2YjNlY2M1MTdiNmQzYjg3My90YWJsZXJhbmdlOjE0MDk2NWZiMDNkNjQ1ZTZiM2VjYzUxN2I2ZDNiODczXzMtMy0xLTEtNTg1Mzc_65d32e93-fcb6-48ec-a5ff-23c19b56f202">271.74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i57f5c7d0d50a48669bf760069cb4c005_D20211101-20221031" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZToxNDA5NjVmYjAzZDY0NWU2YjNlY2M1MTdiNmQzYjg3My90YWJsZXJhbmdlOjE0MDk2NWZiMDNkNjQ1ZTZiM2VjYzUxN2I2ZDNiODczXzQtMS0xLTEtNTg1Mzc_80fd9249-6081-4c0f-9959-b5e3f1c59c22">27,875</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i57f5c7d0d50a48669bf760069cb4c005_D20211101-20221031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZToxNDA5NjVmYjAzZDY0NWU2YjNlY2M1MTdiNmQzYjg3My90YWJsZXJhbmdlOjE0MDk2NWZiMDNkNjQ1ZTZiM2VjYzUxN2I2ZDNiODczXzQtMy0xLTEtNTg1Mzc_e3b5f7c8-267c-4b5c-822c-48fed9ef886a">324.67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-vested RSUs at October&#160;31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2e988aefd55b4136aafbe1e6601e0d10_I20221031" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZToxNDA5NjVmYjAzZDY0NWU2YjNlY2M1MTdiNmQzYjg3My90YWJsZXJhbmdlOjE0MDk2NWZiMDNkNjQ1ZTZiM2VjYzUxN2I2ZDNiODczXzUtMS0xLTEtNTg1Mzc_a1e342bf-a851-479a-aca4-398c6b390eb1">289,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2e988aefd55b4136aafbe1e6601e0d10_I20221031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZToxNDA5NjVmYjAzZDY0NWU2YjNlY2M1MTdiNmQzYjg3My90YWJsZXJhbmdlOjE0MDk2NWZiMDNkNjQ1ZTZiM2VjYzUxN2I2ZDNiODczXzUtMy0xLTEtNTg1Mzc_0bf580f5-fba9-40ad-8fde-ab8c8507836c">340.68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Performance Units</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Performance units may be granted to selected key employees with vesting contingent upon meeting future reported earnings per share goals over a defined performance cycle, usually <ix:nonNumeric contextRef="i8553c50d62874816b3cf637114eb13b1_D20211101-20221031" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzgyMTA_8641b635-a493-4e67-8ec1-8ad49feb5464">three years</ix:nonNumeric>. Performance units, if earned, may be paid in cash or shares of common stock. We granted performance unit awards on December 8, 2020 under the 2007 Plan. The performance shares actually earned will range from <ix:nonFraction unitRef="number" contextRef="i419dcfba3297431ba7f0c26398d2e903_D20211101-20221031" decimals="INF" name="coo:ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzg0MjI_4e0d3d99-8c7a-42f3-8238-dc3a721ad1cb">zero</ix:nonFraction> to <ix:nonFraction unitRef="number" contextRef="ieb72813cd59747189c7d292f82b5c7d5_D20211101-20221031" decimals="INF" name="coo:ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzg0Mjg_f738a903-da5e-4675-9cb1-734ae7c64607">200</ix:nonFraction>% of the target number of performance shares for performance periods ending in fiscal 2021 through fiscal 2024. Subject to limited exceptions set forth in the performance share plan, any shares earned will be distributed in the subsequent fiscal year after the performance period. The fair value of performance unit awards is estimated on the date of grant based on the current market price of our common stock and the estimate of probability of award achievement. This estimate is reviewed each fiscal quarter and adjustments are recorded if it is determined that the estimate of probability of award achievement has changed.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We recognize compensation expense ratably over the vesting period. As of October&#160;31, 2022, there was $<ix:nonFraction unitRef="usd" contextRef="iaf39cdcb16094b55b8a7d809ab1a25b6_I20221031" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzkxNDU_82432018-1b86-422b-99c5-8edf1c1f7845">11.2</ix:nonFraction>&#160;million of total unrecognized compensation cost related to non-vested performance units, which is expected to be recognized over a remaining weighted-average vesting period of <ix:nonNumeric contextRef="i8553c50d62874816b3cf637114eb13b1_D20211101-20221031" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzkzMTY_c179345f-6b4c-49e0-8216-f0b1624c6580">1.8</ix:nonNumeric> years.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On March 18, 2019, the Company received stockholder approval for the Employee Stock Purchase Plan (ESPP). The first offering period began on November 4, 2019 and offerings are generally made on a quarterly basis. The purpose of the ESPP is to provide eligible employees of the Company with the opportunity to acquire shares of common stock at <ix:nonFraction unitRef="number" contextRef="i342792221366432e9408d5dc0256f8b3_D20190318-20190318" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzk2OTM_cc9e33c7-2d85-40cd-8e33-64102655c7aa">85</ix:nonFraction>% of the market price on the last business day of each offering period by means of accumulated payroll deductions. The ESPP initially authorized the issuance of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="id9037d5644ce4d68b1a7e215ab8301e5_I20190318" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzk5OTE_9302cb18-8ebc-4340-b6b7-1629df2cf1ee">1,000,000</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> shares of common stock. These shares will be made available from shares of common stock reacquired by the Company as Treasury Stock. During fiscal 2022 and 2021, we issued <ix:nonFraction unitRef="shares" contextRef="i4291f2db677e4d3aa394368650faea88_D20211101-20221031" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzEwMTY2_69eedb2d-f6eb-462e-879d-a8f91a75f53d">22,695</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i1a09d9736b484620af2ea6732aa8cf6f_D20201101-20211031" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzEwMTcz_9337ccac-6647-4c8a-b68b-659911865760">17,575</ix:nonFraction> shares to our employees under the ESPP, respectively. At October&#160;31, 2022, the number of shares remaining available for future issuance under the ESPP was <ix:nonFraction unitRef="shares" contextRef="i6b2d744fbde74052be31c86e76d32cdb_I20221031" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzEwMzMx_384632c6-94a2-451f-bc2f-f4b9f5d255b4">948,090</ix:nonFraction> shares. Total ESPP share-based compensation recognized during fiscal 2022 and 2021 was $<ix:nonFraction unitRef="usd" contextRef="i4291f2db677e4d3aa394368650faea88_D20211101-20221031" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzEwNDIx_d37851ad-e388-43d0-940b-5ba26b3dbb00">1.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i1a09d9736b484620af2ea6732aa8cf6f_D20201101-20211031" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzEwNDI4_6fca45af-fdec-45d6-8457-77dbdf818315">1.0</ix:nonFraction> million, respectively.</span></div></ix:continuation><div><span><br/></span></div><div id="ifcd99b6df4104f80be938ce77dc8288d_121"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 10. Employee Benefits</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzY4MTY_921b1a1d-b5ee-4307-b793-72a8ddb97a57" continuedAt="i868f0fe378734077b0a0621923860394" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Cooper's Retirement Income Plan</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company's Retirement Income Plan (Plan), a defined benefit plan, is only available to full-time United States employees, subject to the soft freeze mentioned below. The Company's contributions are designed to fund normal cost on a current basis and to fund the estimated prior service cost of benefit improvements. The unit credit actuarial cost method is used to determine the annual cost. The Company pays the entire cost of the Plan and funds such costs as they accrue. Virtually all of the assets of the Plan are comprised of equities and participation in equity and fixed income funds.</span></div></ix:nonNumeric><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="i868f0fe378734077b0a0621923860394" continuedAt="i3a4851436852436b9f2b172d4bba696c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company uses individual spot rates along the yield curve that correspond with the timing of each benefit payment to determine the service and interest costs of components of its net periodic benefit cost utilizing the correlation of projected cash outflows and corresponding spot rates on the yield curve. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzY4MzI_a328962b-d602-4519-8ba7-745e788318b2" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table sets forth the Plan's benefit obligations and fair value of the Plan assets at October&#160;31, 2022, 2021 and 2020 and the funded status of the Plan and net periodic pension costs for each of the years in the three-year periods ended October&#160;31, 2022. The net amounts recognized in the Consolidated Balance Sheets consist of noncurrent liabilities. The accumulated benefit obligation was $<ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzE3NTkyMTg2MDU5NzU2_b7c63d33-ee8f-4868-8342-8242f99beca6">134.9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzE3NTkyMTg2MDU5NzYy_7908d1cc-e0f7-41cf-8374-3f72f43db3be">207.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031" decimals="-5" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzE3NTkyMTg2MDU5ODA4_b9743713-214d-4174-83fe-aa4865829775">195.8</ix:nonFraction> million for the years ended October&#160;31, 2022, 2021 and 2020.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Retirement Income Plan</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.049%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.677%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Change in benefit obligation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Benefit obligation, beginning of year</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzItMS0xLTEtNTg1Mzc_e5dfc34c-0b34-4550-9c9f-a4af690b616d">230.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzItMy0xLTEtNTg1Mzc_c489e2f7-5c2d-4351-be8b-030616fbd6cb">218.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5167c03ea3ab44e7b464a93ec06fc66e_I20191031" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzItNS0xLTEtNTg1Mzc_33ff8018-06b5-4752-ab41-9386559c6783">189.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzMtMS0xLTEtNTg1Mzc_a059f12c-ba3b-493e-8711-d40b73049188">18.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzMtMy0xLTEtNTg1Mzc_fab976ab-18d4-4b7f-85ed-4b9721e5b79c">17.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzMtNS0xLTEtNTg1Mzc_69d7d563-d882-419b-bc4d-636e10cc360b">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzQtMC0xLTEtNTg1Mzc_111e8ddc-226d-4304-959a-b934b7d622c2"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzQtMC0xLTEtNTg1Mzc_36ebe715-6c70-4c33-ab4e-77078f30596f"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzQtMC0xLTEtNTg1Mzc_8ba49eaf-48ae-4cbc-b09c-7e9a7b0ad98d">Interest cost</span></span></span></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzQtMS0xLTEtNTg1Mzc_40f6581d-af22-4bdd-b210-9c2e596cb61d">5.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzQtMy0xLTEtNTg1Mzc_85cf87be-3887-487b-ae65-e40f1c08deb8">4.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzQtNS0xLTEtNTg1Mzc_3922735f-0f1f-4967-bf8d-152e84b046ea">5.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzUtMS0xLTEtNTg1Mzc_c9ce3a18-7d5c-44fa-a24c-3cbc7fddead5">13.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzUtMy0xLTEtNTg1Mzc_41ee9c5a-074f-4fa0-86f8-ef80d5654572">11.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzUtNS0xLTEtNTg1Mzc_748b18d5-8ebd-4390-ac1f-807c1d08f63b">10.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Actuarial (gain)/loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzctMS0xLTEtNTg1Mzc_b3389574-83de-4848-ad93-700d461a0e06">93.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzctMy0xLTEtNTg1Mzc_71fd6b8c-69d5-468f-a015-f01b898c9cc5">2.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzctNS0xLTEtNTg1Mzc_70964152-b1d0-4135-87f7-9637cfa6301d">20.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Benefit obligation, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzgtMS0xLTEtNTg1Mzc_f48384a4-c685-4ca6-82c2-966b8724f3f0">148.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzgtMy0xLTEtNTg1Mzc_e745ded4-b4b4-4e7f-a194-d5df019f5a5b">230.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzgtNS0xLTEtNTg1Mzc_1f348857-028b-4681-b2ff-631da1ae3810">218.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Change in plan assets</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzEwLTEtMS0xLTU4NTM3_f2e747ba-2055-423f-8af6-a1e49da10532">199.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzEwLTMtMS0xLTU4NTM3_b45c771c-7a9a-44f0-be89-35bbd0bc09e8">159.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5167c03ea3ab44e7b464a93ec06fc66e_I20191031" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzEwLTUtMS0xLTU4NTM3_98748e92-2ed4-4823-88ea-0de4f35a532c">136.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzExLTEtMS0xLTU4NTM3_5481cb25-3799-40dc-8909-319fda0b12c1">43.5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzExLTMtMS0xLTU4NTM3_6808ab58-2af1-43a3-aa85-45fd7a526524">38.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzExLTUtMS0xLTU4NTM3_0883cc3a-b370-40bd-98e7-59508e91fdc8">10.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzEyLTEtMS0xLTU4NTM3_2ee30d79-3622-4cd9-9cd9-600783cc361c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzEyLTMtMS0xLTU4NTM3_0db83d8e-ffbe-4b71-8bdf-70f18f600f54">12.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzEyLTUtMS0xLTU4NTM3_40c937d7-a650-4ff6-ac24-4369de0d4151">23.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzEzLTEtMS0xLTU4NTM3_9d5cabfb-aa09-44a9-b1cd-9d3764870c0a">13.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzEzLTMtMS0xLTU4NTM3_0941d511-583d-4c9d-8126-1b80e08b5726">11.5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzEzLTUtMS0xLTU4NTM3_6f6cbc62-463e-4331-af6c-a8c94cbfe5cb">10.0</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Fair value of plan assets, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzE0LTEtMS0xLTU4NTM3_abf7b95c-e087-4989-a525-ccfd0d690a8a">142.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzE0LTMtMS0xLTU4NTM3_306a9676-d354-4853-8284-c343812f01a7">199.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzE0LTUtMS0xLTU4NTM3_d592bada-3269-4fc0-8a31-50cf3d4b814e">159.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Funded status at end of year</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzE1LTEtMS0xLTU4NTM3_7bceb846-98d3-4d09-842b-a8e7932f28c2">5.1</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzE1LTMtMS0xLTU4NTM3_e202be1d-daac-420c-a8f9-4155641b3486">31.4</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzE1LTUtMS0xLTU4NTM3_e3b7b120-674a-4bfc-a7df-8eb76715d901">59.3</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzY3NzQ_ca621a10-bf6c-4255-a9bd-236521f05a99" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.049%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.677%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amounts recognized in accumulated other comprehensive income consist of:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net loss</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZToyMGEzNTA0Y2IzYWU0OThiYjhlNjNmODRmZjcyMzllOS90YWJsZXJhbmdlOjIwYTM1MDRjYjNhZTQ5OGJiOGU2M2Y4NGZmNzIzOWU5XzQtMS0xLTEtNTg1Mzc_604083cf-fa8d-4f4a-9015-33fcac5c2c02">8.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZToyMGEzNTA0Y2IzYWU0OThiYjhlNjNmODRmZjcyMzllOS90YWJsZXJhbmdlOjIwYTM1MDRjYjNhZTQ5OGJiOGU2M2Y4NGZmNzIzOWU5XzQtMy0xLTEtNTg1Mzc_ae7472c7-d47c-42c0-a9df-d25ef2318698">44.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZToyMGEzNTA0Y2IzYWU0OThiYjhlNjNmODRmZjcyMzllOS90YWJsZXJhbmdlOjIwYTM1MDRjYjNhZTQ5OGJiOGU2M2Y4NGZmNzIzOWU5XzQtNS0xLTEtNTg1Mzc_0a0406da-f29a-4d44-9ef8-d7a46337ca4e">74.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZToyMGEzNTA0Y2IzYWU0OThiYjhlNjNmODRmZjcyMzllOS90YWJsZXJhbmdlOjIwYTM1MDRjYjNhZTQ5OGJiOGU2M2Y4NGZmNzIzOWU5XzUtMS0xLTEtNTg1Mzc_067c51bb-6084-4e16-8cd7-376ab4258ecc">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZToyMGEzNTA0Y2IzYWU0OThiYjhlNjNmODRmZjcyMzllOS90YWJsZXJhbmdlOjIwYTM1MDRjYjNhZTQ5OGJiOGU2M2Y4NGZmNzIzOWU5XzUtMy0xLTEtNTg1Mzc_b8fe8e2e-0fee-4dc1-bfc8-3dabbf97f22f">44.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZToyMGEzNTA0Y2IzYWU0OThiYjhlNjNmODRmZjcyMzllOS90YWJsZXJhbmdlOjIwYTM1MDRjYjNhZTQ5OGJiOGU2M2Y4NGZmNzIzOWU5XzUtNS0xLTEtNTg1Mzc_a5c1a4c3-7c66-4406-ac65-3d266860c584">74.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></ix:nonNumeric></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="coo:ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzY4NTE_5d43830a-6952-4ff7-807e-fd453cf820c7" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.049%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.677%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Reconciliation of (prepaid) accrued pension cost:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(Prepaid)/Accrued pension cost at prior fiscal year end</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" sign="-" name="coo:AccruedPrepaidPensionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowODk0NTQ2MDAwZDI0YTg5ODk3ZmExMmM3NDcwZGY4Ni90YWJsZXJhbmdlOjA4OTQ1NDYwMDBkMjRhODk4OTdmYTEyYzc0NzBkZjg2XzItMS0xLTEtNTg1Mzc_b9714f1f-7d07-4d63-ac10-6a095adbfaa4">13.0</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031" decimals="-5" sign="-" name="coo:AccruedPrepaidPensionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowODk0NTQ2MDAwZDI0YTg5ODk3ZmExMmM3NDcwZGY4Ni90YWJsZXJhbmdlOjA4OTQ1NDYwMDBkMjRhODk4OTdmYTEyYzc0NzBkZjg2XzItMy0xLTEtNTg1Mzc_b375453a-772b-4cea-abba-277570e4b02d">14.8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5167c03ea3ab44e7b464a93ec06fc66e_I20191031" decimals="-5" sign="-" name="coo:AccruedPrepaidPensionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowODk0NTQ2MDAwZDI0YTg5ODk3ZmExMmM3NDcwZGY4Ni90YWJsZXJhbmdlOjA4OTQ1NDYwMDBkMjRhODk4OTdmYTEyYzc0NzBkZjg2XzItNS0xLTEtNTg1Mzc_ff74edc8-6fbe-4716-bc15-58b71af6644f">3.7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowODk0NTQ2MDAwZDI0YTg5ODk3ZmExMmM3NDcwZGY4Ni90YWJsZXJhbmdlOjA4OTQ1NDYwMDBkMjRhODk4OTdmYTEyYzc0NzBkZjg2XzMtMS0xLTEtNTg1Mzc_cb22d3f8-fdd9-4ccc-9ac9-e957a2bf5439">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowODk0NTQ2MDAwZDI0YTg5ODk3ZmExMmM3NDcwZGY4Ni90YWJsZXJhbmdlOjA4OTQ1NDYwMDBkMjRhODk4OTdmYTEyYzc0NzBkZjg2XzMtMy0xLTEtNTg1Mzc_bbde0642-e59e-4ecf-aa42-820af28bd696">14.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowODk0NTQ2MDAwZDI0YTg5ODk3ZmExMmM3NDcwZGY4Ni90YWJsZXJhbmdlOjA4OTQ1NDYwMDBkMjRhODk4OTdmYTEyYzc0NzBkZjg2XzMtNS0xLTEtNTg1Mzc_93f4de72-7865-4748-95d6-a4923387293e">12.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Contributions made during the year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowODk0NTQ2MDAwZDI0YTg5ODk3ZmExMmM3NDcwZGY4Ni90YWJsZXJhbmdlOjA4OTQ1NDYwMDBkMjRhODk4OTdmYTEyYzc0NzBkZjg2XzQtMS0xLTEtNTg1Mzc_5ffa3eae-1039-4134-a391-250d0987b177">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowODk0NTQ2MDAwZDI0YTg5ODk3ZmExMmM3NDcwZGY4Ni90YWJsZXJhbmdlOjA4OTQ1NDYwMDBkMjRhODk4OTdmYTEyYzc0NzBkZjg2XzQtMy0xLTEtNTg1Mzc_3bdb3c3d-b9d3-4dc4-8d89-610f6083bfd9">12.7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowODk0NTQ2MDAwZDI0YTg5ODk3ZmExMmM3NDcwZGY4Ni90YWJsZXJhbmdlOjA4OTQ1NDYwMDBkMjRhODk4OTdmYTEyYzc0NzBkZjg2XzQtNS0xLTEtNTg1Mzc_9b611026-b658-474d-bc4a-68f93d014aa2">23.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(Prepaid)/Accrued pension cost at fiscal year end</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" sign="-" name="coo:AccruedPrepaidPensionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowODk0NTQ2MDAwZDI0YTg5ODk3ZmExMmM3NDcwZGY4Ni90YWJsZXJhbmdlOjA4OTQ1NDYwMDBkMjRhODk4OTdmYTEyYzc0NzBkZjg2XzYtMS0xLTEtNTg1Mzc_2b4433da-4d4d-4620-80f0-2322866edb6d">2.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" sign="-" name="coo:AccruedPrepaidPensionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowODk0NTQ2MDAwZDI0YTg5ODk3ZmExMmM3NDcwZGY4Ni90YWJsZXJhbmdlOjA4OTQ1NDYwMDBkMjRhODk4OTdmYTEyYzc0NzBkZjg2XzYtMy0xLTEtNTg1Mzc_56b3712a-b35c-49a3-81f5-bfce5d91746b">13.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031" decimals="-5" sign="-" name="coo:AccruedPrepaidPensionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowODk0NTQ2MDAwZDI0YTg5ODk3ZmExMmM3NDcwZGY4Ni90YWJsZXJhbmdlOjA4OTQ1NDYwMDBkMjRhODk4OTdmYTEyYzc0NzBkZjg2XzYtNS0xLTEtNTg1Mzc_b01161fc-5da4-4067-852f-6cbaa837036f">14.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="i3a4851436852436b9f2b172d4bba696c" continuedAt="i05f4eb4edc0a493081389f6e66cc0b0c"><div style="margin-top:5pt;text-align:center"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzY4NTg_1654d2a6-e4a8-4fdd-b824-16be988468be" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.049%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.677%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Components of net periodic benefit cost and other amounts recognized in the Consolidated Statements of Income:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net periodic benefit cost:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzMtMS0xLTEtNTg1Mzc_fd2ae3a4-f5e7-4e80-9a9d-ebc834b76fcd">18.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzMtMy0xLTEtNTg1Mzc_a34731d6-99a0-4845-9e39-3639c74d154a">17.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzMtNS0xLTEtNTg1Mzc_07bab2b3-1805-46fc-b162-ee66300f302e">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzQtMS0xLTEtNTg1Mzc_4bf827d7-6969-4637-919e-c62bb94f9d33">5.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzQtMy0xLTEtNTg1Mzc_ede3ff50-68a1-4d42-a4ad-8fa64f9b620f">4.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzQtNS0xLTEtNTg1Mzc_ed731229-c2e4-4bb7-ba76-f3ecd0195738">5.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzUtMC0xLTEtNTg1Mzc_07a95161-0974-465a-ac1c-175b72fdb90d"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzUtMC0xLTEtNTg1Mzc_34fc253a-7253-4b21-920e-c9ce51841c5c"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzUtMC0xLTEtNTg1Mzc_73a230e2-9634-4eba-833b-aa7156e9f4ce">Expected return on plan assets</span></span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzUtMS0xLTEtNTg1Mzc_4d709e3a-de1f-4459-9995-f1f1228cd529">15.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzUtMy0xLTEtNTg1Mzc_7d0ef009-32b7-4287-af60-3a190ff799c0">12.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzUtNS0xLTEtNTg1Mzc_0b264eb1-4664-4a7d-8205-127a58e65273">10.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzgtMC0xLTEtNTg1Mzc_08e3d8ed-42a7-4cda-a134-26367a3edca1"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzgtMC0xLTEtNTg1Mzc_40c89b78-ce45-4552-a50e-59b206d64cbd"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzgtMC0xLTEtNTg1Mzc_c32484f2-1db6-4923-b0d9-5be0212a7130">Recognized actuarial loss</span></span></span></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzgtMS0xLTEtNTg1Mzc_86208c96-e140-4983-80ae-5a9b1c524595">2.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzgtMy0xLTEtNTg1Mzc_7de0eece-8972-4c83-8d0b-3b59b45f376d">5.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzgtNS0xLTEtNTg1Mzc_6d277249-e45f-4b66-a487-781c4819a3c9">4.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net periodic pension cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzktMS0xLTEtNTg1Mzc_830619b4-0deb-42a4-968b-3b651c2e2543">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzktMy0xLTEtNTg1Mzc_65b55523-1e63-4ceb-bb77-fdaac6d238ff">14.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzktNS0xLTEtNTg1Mzc_a623b436-b0c0-4b5e-bc27-7ce07afefe9e">12.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></ix:nonNumeric></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzY3NzU_16af6f9c-d756-4e95-bfab-ef1fc59b6dd0" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.049%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.677%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Other changes in plan assets and benefit obligations recognized in other comprehensive income:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net (gain) loss</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo0ZTliNjkxOTc5MGU0ZTdlODAyYWUxNWQ3NGI3OTkzOC90YWJsZXJhbmdlOjRlOWI2OTE5NzkwZTRlN2U4MDJhZTE1ZDc0Yjc5OTM4XzQtMS0xLTEtNTg1Mzc_2b50d695-547c-4e48-83bb-3b496cd77bef">34.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo0ZTliNjkxOTc5MGU0ZTdlODAyYWUxNWQ3NGI3OTkzOC90YWJsZXJhbmdlOjRlOWI2OTE5NzkwZTRlN2U4MDJhZTE1ZDc0Yjc5OTM4XzQtMy0xLTEtNTg1Mzc_086f1171-595a-404c-b19d-bec1198e13f6">24.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo0ZTliNjkxOTc5MGU0ZTdlODAyYWUxNWQ3NGI3OTkzOC90YWJsZXJhbmdlOjRlOWI2OTE5NzkwZTRlN2U4MDJhZTE1ZDc0Yjc5OTM4XzQtNS0xLTEtNTg1Mzc_10cf517f-e277-43ab-9918-91d0d905e82c">20.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amortizations of net gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo0ZTliNjkxOTc5MGU0ZTdlODAyYWUxNWQ3NGI3OTkzOC90YWJsZXJhbmdlOjRlOWI2OTE5NzkwZTRlN2U4MDJhZTE1ZDc0Yjc5OTM4XzctMS0xLTEtNTg1Mzc_55df281c-02b6-47dc-806c-b619b43d9670">2.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo0ZTliNjkxOTc5MGU0ZTdlODAyYWUxNWQ3NGI3OTkzOC90YWJsZXJhbmdlOjRlOWI2OTE5NzkwZTRlN2U4MDJhZTE1ZDc0Yjc5OTM4XzctMy0xLTEtNTg1Mzc_d461f6f9-c1bd-4348-b574-6da06dc7f666">5.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo0ZTliNjkxOTc5MGU0ZTdlODAyYWUxNWQ3NGI3OTkzOC90YWJsZXJhbmdlOjRlOWI2OTE5NzkwZTRlN2U4MDJhZTE1ZDc0Yjc5OTM4XzctNS0xLTEtNTg1Mzc_b1db127b-14f2-43df-aedd-94850e75a81b">4.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total recognized in other comprehensive (income) loss</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo0ZTliNjkxOTc5MGU0ZTdlODAyYWUxNWQ3NGI3OTkzOC90YWJsZXJhbmdlOjRlOWI2OTE5NzkwZTRlN2U4MDJhZTE1ZDc0Yjc5OTM4XzExLTEtMS0xLTU4NTM3_2f50dd83-c232-405a-9914-e6afbb71ca34">36.6</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo0ZTliNjkxOTc5MGU0ZTdlODAyYWUxNWQ3NGI3OTkzOC90YWJsZXJhbmdlOjRlOWI2OTE5NzkwZTRlN2U4MDJhZTE1ZDc0Yjc5OTM4XzExLTMtMS0xLTU4NTM3_2eaafbd4-7519-47ed-8e54-8952624aec02">29.8</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo0ZTliNjkxOTc5MGU0ZTdlODAyYWUxNWQ3NGI3OTkzOC90YWJsZXJhbmdlOjRlOWI2OTE5NzkwZTRlN2U4MDJhZTE1ZDc0Yjc5OTM4XzExLTUtMS0xLTU4NTM3_049e6bf8-138a-40a1-8985-9076b92decb6">16.8</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total recognized in net periodic benefit cost and other comprehensive (income) loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo0ZTliNjkxOTc5MGU0ZTdlODAyYWUxNWQ3NGI3OTkzOC90YWJsZXJhbmdlOjRlOWI2OTE5NzkwZTRlN2U4MDJhZTE1ZDc0Yjc5OTM4XzEyLTEtMS0xLTU4NTM3_b5f3273a-53dd-4658-a141-730970c81aac">26.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo0ZTliNjkxOTc5MGU0ZTdlODAyYWUxNWQ3NGI3OTkzOC90YWJsZXJhbmdlOjRlOWI2OTE5NzkwZTRlN2U4MDJhZTE1ZDc0Yjc5OTM4XzEyLTMtMS0xLTU4NTM3_606bf593-ad46-4b83-aed9-6bcb88bad9b8">15.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo0ZTliNjkxOTc5MGU0ZTdlODAyYWUxNWQ3NGI3OTkzOC90YWJsZXJhbmdlOjRlOWI2OTE5NzkwZTRlN2U4MDJhZTE1ZDc0Yjc5OTM4XzEyLTUtMS0xLTU4NTM3_611b579e-44dc-4603-9cc1-6b0504ce88c5">29.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzY3NzE_dc6a747d-b0f9-425d-b513-bab38b445796" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.049%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.677%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Years Ended October&#160;31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Weighted-average assumptions used in computing the net periodic pension cost and projected benefit obligation at year end:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Discount rate for determining net periodic pension cost:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Projected Benefit Obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="4" name="coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzMtMS0xLTEtNTg1Mzc_b57c3e5b-1e93-4cb2-85e8-a7582b588f85">2.76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="4" name="coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzMtMy0xLTEtNTg1Mzc_43dbfda8-92ac-4b33-ba56-7218af4e8981">2.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="4" name="coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzMtNS0xLTEtNTg1Mzc_80b0f202-e917-4d86-8e40-3c460113ec3f">3.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Service Cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="4" name="coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzQtMS0xLTEtNTg1Mzc_63112f7a-8696-4eb1-b97e-ff71cee7cce4">2.79</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="4" name="coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzQtMy0xLTEtNTg1Mzc_0143dbfe-1758-4ed5-a036-518207579ecc">2.86</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="4" name="coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzQtNS0xLTEtNTg1Mzc_62f3356c-4f07-425e-be37-eb7cc68d1ae9">3.18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest Cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="4" name="coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzUtMS0xLTEtNTg1Mzc_c371b325-bfa0-4ee1-ba2d-10b60e51d7f7">2.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="4" name="coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzUtMy0xLTEtNTg1Mzc_98a05296-916f-446b-9a33-e060ad33fb7e">2.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="4" name="coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzUtNS0xLTEtNTg1Mzc_c4e3247b-192a-471a-9534-42dcd20ed7bc">2.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Discount rate for determining benefit obligations at year end</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzYtMS0xLTEtNTg1Mzc_6b8ebde4-1a23-4d0c-b5e0-0ab3da5e90f9">5.74</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzYtMy0xLTEtNTg1Mzc_c070e61a-b08a-4b2f-9f41-166068061425">2.76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzYtNS0xLTEtNTg1Mzc_07e9e085-aecf-45f7-90f2-dea24fd1e28b">2.78</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Rate of compensation increase for determining expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzctMS0xLTEtNTg1Mzc_261bdf66-97b8-430d-87c4-2ce03f96d646">3.60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzctMy0xLTEtNTg1Mzc_ea5f3146-0c5c-4cde-99eb-3de0c00895ee">3.60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzctNS0xLTEtNTg1Mzc_cfb1b2e1-f506-4d3f-826b-222c6ec6f9cf">3.60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Rate of compensation increase for determining benefit obligations at year end</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzgtMS0xLTEtNTg1Mzc_401c2374-9d3b-4bcf-9085-d3672f3b4ad6">3.60</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzgtMy0xLTEtNTg1Mzc_31aa376c-a4cc-44c7-b2cd-2fbd4152c6e3">3.60</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzgtNS0xLTEtNTg1Mzc_d874beea-e8e4-46cc-b8ae-2f7fb95bf50d">3.60</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Expected rate of return on plan assets for determining net periodic pension cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzktMS0xLTEtNTg1Mzc_2762618b-9821-421a-a683-3ba3053071ed">8.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzktMy0xLTEtNTg1Mzc_8750bda1-58e0-48c4-aac5-fc6e4800c562">8.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzktNS0xLTEtNTg1Mzc_ed1c7389-88a6-44b8-b46a-f2098d3bd401">8.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Expected rate of return on plan assets at year end</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="4" name="coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzEwLTEtMS0xLTU4NTM3_871a3cd7-749b-40c2-b298-bcfed055e859">8.00</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="4" name="coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzEwLTMtMS0xLTU4NTM3_63df3679-b4bb-48d1-b4a6-7773b125fb22">8.00</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031" decimals="4" name="coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzEwLTUtMS0xLTU4NTM3_9af59132-708b-4b9b-86a7-af80daa3ece7">8.00</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Measurement date for determining assets and benefit obligations at year end</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10/31/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10/31/2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10/31/2020</span></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The discount rate enables us to state expected future cash flows at a present value on the measurement date. The discount rate used for the Plan is based primarily on the yields of a universe of high-quality corporate bonds rated AA or above, with durations corresponding to the expected durations of the benefit obligations. A change in the discount rate will cause the present value of benefit obligations to change in the opposite direction. If a discount rate of <ix:nonFraction unitRef="number" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="4" name="coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzE2ODA_3ea4d0e4-8aab-4d12-96df-d226e1b1e8b0">2.76</ix:nonFraction>%, which is <ix:nonFraction unitRef="number" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="4" sign="-" name="coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligationIncreaseDecrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzE2OTM_d141bcf4-1992-478d-aa71-122ca982039c">0.02</ix:nonFraction>% lower than prior fiscal year, had been used, the projected benefit obligation would have been $<ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="coo:DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationEffectOfChangeInDiscountRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzE3OTA_10092c73-5a37-4a78-8d63-df9ed894ccde">217.2</ix:nonFraction> million, and the accumulated benefit obligation would have been $<ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="coo:DefinedBenefitPlanAssumptionsUsedCalculatingAccumulatedBenefitObligationEffectOfChangeInDiscountRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzE4NDk_0072cccb-49ec-4d16-b56c-5764a9d04ded">194.2</ix:nonFraction> million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The expected rate of return on plan assets was determined based on a review of historical returns, both for this plan and for medium- to large-sized defined benefit pension funds with similar asset allocations. This review generated separate expected returns for each asset class listed below. These expected future returns were then blended based on this Plan's target asset allocation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Reasons for Significant Liability Gains and Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The projected benefit obligation experienced a net gain of approximately $<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzIzNjk_7bb4abc4-0aaf-4604-9837-11a704e53ca3">93.2</ix:nonFraction>&#160;million during the year. This net gain is primarily due to gains from assumption changes of approximately $<ix:nonFraction unitRef="usd" contextRef="i63cbbcb6c872410eb8569b17394ff5b7_D20211101-20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzI0Njc_6c54aec3-3c29-4519-91f3-947d5799362a">97.1</ix:nonFraction>&#160;million, offset by losses of approximately $<ix:nonFraction unitRef="usd" contextRef="i624452a49f29415dbd617b4589408c5a_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzI0OTk_53f26d91-f371-4dea-a9f3-35946dadbf03">3.9</ix:nonFraction>&#160;million </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="i05f4eb4edc0a493081389f6e66cc0b0c" continuedAt="if5e2364fbd404fb1b9230092f8ce1f9a"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">due to demographic experience. The key assumption changes were the increase in the discount rate (gain of $<ix:nonFraction unitRef="usd" contextRef="i81df2e32936447de9004b3e72091ab2b_D20211101-20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzI2MDg_4347cbe4-4614-4084-9596-ecb82a5503ee">72.7</ix:nonFraction>&#160;million), a change in the assumed payment form election probabilities (gain of $<ix:nonFraction unitRef="usd" contextRef="i0436b7aab9ec44818925071f5beef55c_D20211101-20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzI2NzI_695ee8fe-fa53-4c22-8bd1-14287fca0691">0.3</ix:nonFraction>&#160;million), and changes in assumptions for lump sum determination (gain of $<ix:nonFraction unitRef="usd" contextRef="i5e6b59d888914091a12f486903db9b8f_D20211101-20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzI3NDA_49c0845b-dbca-422e-adb1-64b2312c1f3f">24.1</ix:nonFraction>&#160;million). The primary reasons for demographic losses were the net effect of retirement rates, termination rates, salary increases and other experience that was different from assumed. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzY3ODE_d184fb02-e6c8-4c9a-866f-072b53ae1f86" continuedAt="i4a8b22929d30439a83db0b897f101988" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Plan Assets</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Weighted-average asset allocations at year end, by asset category are as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.450%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.450%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.453%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Years Ended October&#160;31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Asset category</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7a4fc69a1c8544d984b2860446a8cc59_I20221031" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTozZjFmYmI4YmFhMDM0NGY3YjI4NTdmM2E4OGJiZWNhNS90YWJsZXJhbmdlOjNmMWZiYjhiYWEwMzQ0ZjdiMjg1N2YzYTg4YmJlY2E1XzItMS0xLTEtNTg1Mzc_b63d8a62-cdc2-4fa3-b8fb-8e57b5c2be74">2.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id7fe4c21857c4580a2bb918c4d443e6c_I20211031" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTozZjFmYmI4YmFhMDM0NGY3YjI4NTdmM2E4OGJiZWNhNS90YWJsZXJhbmdlOjNmMWZiYjhiYWEwMzQ0ZjdiMjg1N2YzYTg4YmJlY2E1XzItMy0xLTEtNTg1Mzc_7c6fb297-71d0-4ea2-9eee-5032b03261f9">5.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i35a7d060cc03406aa06d6d2e52af7aa8_I20201031" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTozZjFmYmI4YmFhMDM0NGY3YjI4NTdmM2E4OGJiZWNhNS90YWJsZXJhbmdlOjNmMWZiYjhiYWEwMzQ0ZjdiMjg1N2YzYTg4YmJlY2E1XzItNS0xLTEtNTg1Mzc_3bd2b0aa-e150-45e1-9276-91e2ac411baa">11.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Equity mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6f8e8579bd9f4de1bc128c354594f563_I20221031" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTozZjFmYmI4YmFhMDM0NGY3YjI4NTdmM2E4OGJiZWNhNS90YWJsZXJhbmdlOjNmMWZiYjhiYWEwMzQ0ZjdiMjg1N2YzYTg4YmJlY2E1XzQtMS0xLTEtNTg1Mzc_ada7ac63-62d1-4263-88c3-fab35e4e77eb">65.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i334d9d36817a404198eaa63d441b7876_I20211031" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTozZjFmYmI4YmFhMDM0NGY3YjI4NTdmM2E4OGJiZWNhNS90YWJsZXJhbmdlOjNmMWZiYjhiYWEwMzQ0ZjdiMjg1N2YzYTg4YmJlY2E1XzQtMy0xLTEtNTg1Mzc_276da1ca-e28a-493f-a2fe-c946955268ce">62.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6b597c9875e84d9dbaa5078086f54163_I20201031" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTozZjFmYmI4YmFhMDM0NGY3YjI4NTdmM2E4OGJiZWNhNS90YWJsZXJhbmdlOjNmMWZiYjhiYWEwMzQ0ZjdiMjg1N2YzYTg4YmJlY2E1XzQtNS0xLTEtNTg1Mzc_1a6652b3-f705-446c-84b3-4077ab845bcf">57.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Hedging Strategy Funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3a8c5a86d4af47dd80e81eee5d90e1df_I20221031" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTozZjFmYmI4YmFhMDM0NGY3YjI4NTdmM2E4OGJiZWNhNS90YWJsZXJhbmdlOjNmMWZiYjhiYWEwMzQ0ZjdiMjg1N2YzYTg4YmJlY2E1XzUtMS0xLTEtNTg1Mzc_38263b08-1795-4f46-99a6-b26b5f53fce3">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id997ec317814462ba72540f4ef32a2a3_I20211031" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTozZjFmYmI4YmFhMDM0NGY3YjI4NTdmM2E4OGJiZWNhNS90YWJsZXJhbmdlOjNmMWZiYjhiYWEwMzQ0ZjdiMjg1N2YzYTg4YmJlY2E1XzUtMy0xLTEtNTg1Mzc_83332306-b010-46d9-bf9b-c88a0856768e">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9c1611da45144b90bea4e31bcb16786b_I20201031" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTozZjFmYmI4YmFhMDM0NGY3YjI4NTdmM2E4OGJiZWNhNS90YWJsZXJhbmdlOjNmMWZiYjhiYWEwMzQ0ZjdiMjg1N2YzYTg4YmJlY2E1XzUtNS0xLTEtNTg1Mzc_5a125bbb-1a69-4bfa-931c-54669910be04">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Bond mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i26a8e3f73198439181c7db0f9541574a_I20221031" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTozZjFmYmI4YmFhMDM0NGY3YjI4NTdmM2E4OGJiZWNhNS90YWJsZXJhbmdlOjNmMWZiYjhiYWEwMzQ0ZjdiMjg1N2YzYTg4YmJlY2E1XzctMS0xLTEtNTg1Mzc_d9a3ea37-86e7-41f1-a791-6c645d766b48">27.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i03153ed49cfc47abba8d0d3108d50a1f_I20211031" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTozZjFmYmI4YmFhMDM0NGY3YjI4NTdmM2E4OGJiZWNhNS90YWJsZXJhbmdlOjNmMWZiYjhiYWEwMzQ0ZjdiMjg1N2YzYTg4YmJlY2E1XzctMy0xLTEtNTg1Mzc_f203846f-90f2-4100-8348-1c7e8ad7ad7c">27.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i986cc010c8c04831b70f7128a9b44c17_I20201031" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTozZjFmYmI4YmFhMDM0NGY3YjI4NTdmM2E4OGJiZWNhNS90YWJsZXJhbmdlOjNmMWZiYjhiYWEwMzQ0ZjdiMjg1N2YzYTg4YmJlY2E1XzctNS0xLTEtNTg1Mzc_b0d8b127-6faf-4bc9-901f-bda1276aff87">26.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTozZjFmYmI4YmFhMDM0NGY3YjI4NTdmM2E4OGJiZWNhNS90YWJsZXJhbmdlOjNmMWZiYjhiYWEwMzQ0ZjdiMjg1N2YzYTg4YmJlY2E1XzgtMS0xLTEtNTg1Mzc_cf6e7fdd-5264-4227-854b-3f1dfd38ec10">100.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTozZjFmYmI4YmFhMDM0NGY3YjI4NTdmM2E4OGJiZWNhNS90YWJsZXJhbmdlOjNmMWZiYjhiYWEwMzQ0ZjdiMjg1N2YzYTg4YmJlY2E1XzgtMy0xLTEtNTg1Mzc_bf8d1554-76fd-472f-86fb-c33157258cb1">100.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTozZjFmYmI4YmFhMDM0NGY3YjI4NTdmM2E4OGJiZWNhNS90YWJsZXJhbmdlOjNmMWZiYjhiYWEwMzQ0ZjdiMjg1N2YzYTg4YmJlY2E1XzgtNS0xLTEtNTg1Mzc_8150243d-7fb1-45d0-9f2a-47eb387ab80c">100.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Plan invests in a diversified portfolio of assets intended to minimize risk of poor returns while maximizing expected portfolio returns. To achieve the long-term rate of return, plan assets will be invested in a mixture of instruments, including but not limited to, corporate common stock (may include the Company's stock), investment grade bond funds, cash, balanced funds, real estate funds, small or large cap equity funds and international equity funds. The allocation of assets will be determined by the investment manager and will typically include <ix:nonFraction unitRef="number" contextRef="ib85025a9deaf4843aee211787d365a16_I20221031" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzM1Nzc_0e954f34-8165-4757-b2f7-c55045edbbc5">50</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i8c51826bf4c24060b6544fe06a5f0acc_I20221031" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzM1ODM_fcc8312a-df7e-4918-a4fe-ff5e55130fdd">70</ix:nonFraction>% equities with the remainder invested in fixed income, hedging strategy funds and cash. Presently, this diversified portfolio is expected to return roughly <ix:nonFraction unitRef="number" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="2" name="coo:DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzM3NDQ_7a09c4a3-14a7-4245-8338-c34dad2360a9">8</ix:nonFraction>% in the long run.</span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i4a8b22929d30439a83db0b897f101988"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of the measurement date of October&#160;31, 2022, the fair value measurement of plan assets is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.541%"><tr><td style="width:1.0%"></td><td style="width:47.287%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.499%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in Active<br/>Markets for<br/>Identical&#160;Assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Significant<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Asset category</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a4fc69a1c8544d984b2860446a8cc59_I20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzItMS0xLTEtNTg1Mzc_c4bb6a30-04c4-450f-82f1-9ba33fd010c1">2.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c61c0e5f7d448f083a8214f4affcc5d_I20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzItMy0xLTEtNTg1Mzc_5ba64cb7-9bf6-4f99-902e-364c8992b2e1">2.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c6597a1b5d9405b8074c5402317fb16_I20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzItNS0xLTEtNTg1Mzc_3e937c13-46d4-4b6c-a0aa-246e9c5bea40">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab1f3fcc011d42c9b46e9e09fd09d128_I20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzItNy0xLTEtNTg1Mzc_4b1566b2-025d-470e-953a-cb05e0232eaa">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Equity mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f8e8579bd9f4de1bc128c354594f563_I20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzQtMS0xLTEtNTg1Mzc_bb5269a4-4a78-4d5b-8560-0dfdcf9016d3">93.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb7d578f2c5c4230b76ef6494dab18ee_I20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzQtMy0xLTEtNTg1Mzc_46266706-f4d3-428d-aeea-46bc33d937ec">93.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e74d409e85a41d5a2c110a4229eb2bc_I20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzQtNS0xLTEtNTg1Mzc_b70d28ad-c804-445f-82b6-428a31a1df43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib60d652edf684fe681874a2a2fa83fa0_I20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzQtNy0xLTEtNTg1Mzc_124b768d-d486-4524-ae1e-6ea62537f6ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Hedging Strategy Funds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a8c5a86d4af47dd80e81eee5d90e1df_I20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzUtMS0xLTEtNTg1Mzc_c654f8bc-c368-485c-9a15-cff4398d5c5b">7.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e523df95698455d89c863a25a39cc0a_I20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzUtMy0xLTEtNTg1Mzc_40c5088c-a508-4104-afd7-7329f0c608d8">7.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9478c54d56244163bd2004c364491b0a_I20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzUtNS0xLTEtNTg1Mzc_969269b0-5394-4361-8b9e-8b42aeed4e6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64acac4cceb34e55a9056341c5bb4477_I20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzUtNy0xLTEtNTg1Mzc_5dabd018-af1c-4ca5-a06a-4a84b4ae6ba1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Bond mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26a8e3f73198439181c7db0f9541574a_I20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzYtMS0xLTEtNTg1Mzc_d3857191-2d8e-4972-962d-cf0f0584ab62">38.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50b1c25ad93b40649c4bcf9197d4e9d0_I20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzYtMy0xLTEtNTg1Mzc_36074d13-8d12-4ecc-92ee-7a259b513974">14.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5edcbbc801c346c28e2c94d9e4d8c524_I20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzYtNS0xLTEtNTg1Mzc_fab7a57e-fec3-4b47-9e8e-2d6b86eeec37">24.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f08d2ac862b4de1a91c5b0e239533aa_I20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzYtNy0xLTEtNTg1Mzc_a63eadc5-d212-4e1f-b7f5-78e61c0e136a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzctMS0xLTEtNTg1Mzc_1cb30f54-8857-474c-97fb-e8d392a54af3">142.9</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a330158da9f4490afbea9f2a383c0cc_I20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzctMy0xLTEtNTg1Mzc_9dc51cfa-465f-4e93-a3e5-fa817b4a1b00">118.8</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bcdee130e56454594be5def8b90a9e9_I20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzctNS0xLTEtNTg1Mzc_ca95669a-e465-45a4-8192-79e17d41d37e">24.1</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffb0171583b6494dbb6fea0de231f654_I20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzctNy0xLTEtNTg1Mzc_b9b00b42-a9ed-4527-92e0-aa3377eab060">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Plan has an established process for determining the fair value of plan assets. For investments in equity and bond mutual funds, and real estate funds, fair value is based on observable, Level 1 inputs.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">While the Company believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Plan Cash Flows</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Contributions</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company made <ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzQ5NDc4MDIzNDAwNzk_611aacf7-64f6-46ac-bc84-37223bebbb87">no</ix:nonFraction> contributions to the Plan in fiscal 2022. The Company contributions to the Plan were $<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzQ5NzA_d9a8b7da-25b0-477f-b23f-64a99d66ba19">12.7</ix:nonFraction>&#160;million for fiscal 2021 and, $<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzQ5OTQ_29477878-1b0b-4992-98b2-882b4b8e9ead">23.4</ix:nonFraction>&#160;million for fiscal 2020. The Company closely monitors the funded status of the Plan with respect to legislative and accounting rules. The Company does not expect to make a contribution to the Plan during fiscal 2023.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="if5e2364fbd404fb1b9230092f8ce1f9a"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzY3NTM_552417a5-f4f3-478c-b385-d08de3f9c748" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Estimated Future Benefit Payments</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:88.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.451%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTpkNjBkNDFjOWQzMjA0MjVmOTNiNmQzMDFjZjU5YzM1Ny90YWJsZXJhbmdlOmQ2MGQ0MWM5ZDMyMDQyNWY5M2I2ZDMwMWNmNTljMzU3XzEtMS0xLTEtNTg1Mzc_9ef9c9fe-07b2-4fac-8ade-3aedbcb3dd20">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2024</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTpkNjBkNDFjOWQzMjA0MjVmOTNiNmQzMDFjZjU5YzM1Ny90YWJsZXJhbmdlOmQ2MGQ0MWM5ZDMyMDQyNWY5M2I2ZDMwMWNmNTljMzU3XzItMS0xLTEtNTg1Mzc_59438799-b6a9-4adb-a1b9-2ec440933887">11.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTpkNjBkNDFjOWQzMjA0MjVmOTNiNmQzMDFjZjU5YzM1Ny90YWJsZXJhbmdlOmQ2MGQ0MWM5ZDMyMDQyNWY5M2I2ZDMwMWNmNTljMzU3XzMtMS0xLTEtNTg1Mzc_c977adbf-fc38-4f30-aaa8-4e03ec0e53b3">11.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2026</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTpkNjBkNDFjOWQzMjA0MjVmOTNiNmQzMDFjZjU5YzM1Ny90YWJsZXJhbmdlOmQ2MGQ0MWM5ZDMyMDQyNWY5M2I2ZDMwMWNmNTljMzU3XzQtMS0xLTEtNTg1Mzc_03fb1d18-c259-4922-be65-27f3bb24ad06">11.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2027</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTpkNjBkNDFjOWQzMjA0MjVmOTNiNmQzMDFjZjU5YzM1Ny90YWJsZXJhbmdlOmQ2MGQ0MWM5ZDMyMDQyNWY5M2I2ZDMwMWNmNTljMzU3XzUtMS0xLTEtNTg1Mzc_09f68529-2bb5-46d2-91f2-eeaa631f0208">11.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2028-2032</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTpkNjBkNDFjOWQzMjA0MjVmOTNiNmQzMDFjZjU5YzM1Ny90YWJsZXJhbmdlOmQ2MGQ0MWM5ZDMyMDQyNWY5M2I2ZDMwMWNmNTljMzU3XzYtMS0xLTEtNTg1Mzc_11313761-9381-451f-985b-27c70ae41562">66.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Plan Soft Freeze</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On June 18, 2019 the Board of Directors of the Company approved a soft freeze of the Plan effective August 1, 2019. The Plan was closed to employees hired on or after August 1, 2019, including former participants or employees rehired on or after August 1, 2019 and employees hired in connection with a stock or asset acquisition, merger or other similar transaction on or after August 1, 2019. Existing employees already covered by the Plan, continue to accrue their benefits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Cooper's 401(k) Savings Plan</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Cooper's 401(k) savings plan provides for the deferral of compensation as described in the Internal Revenue Code and is available to substantially all United States employees. Employees who participate in the 401(k) plan may elect to have up to <ix:nonFraction unitRef="number" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="INF" name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzYwMTY_ea8ff2ea-c531-48a0-b273-e2d7a546d624">75</ix:nonFraction>% of their pre-tax salary or wages deferred and contributed to the trust established under the Plan. Cooper's contributions on account of participating employees, were $<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzYxODU_6ab4bd47-4233-47df-ac7e-7a4c11e240df">9.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzYxODk_bfac7f97-fc9a-4b14-934e-54f81836c248">7.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzYxOTY_a350478e-7650-4839-a070-687a633a52f4">6.8</ix:nonFraction> million for the years ended October&#160;31, 2022, 2021 and 2020, respectively.</span></div></ix:continuation><div><span><br/></span></div><div id="ifcd99b6df4104f80be938ce77dc8288d_127"></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjcvZnJhZzo0NTIzNDdkMTQ5ZTg0ZTg2ODU0NjhmZWJiOTM1NWQ2My90ZXh0cmVnaW9uOjQ1MjM0N2QxNDllODRlODY4NTQ2OGZlYmI5MzU1ZDYzXzc3OQ_82d01316-3275-4e12-b778-e8ab945e8f38" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 11. Contingencies </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company is involved in various lawsuits, claims and other legal matters from time to time that arise in the ordinary course of conducting business, including matters involving our products, intellectual property, supplier relationships, distributors, competitor relationships, employees and other matters. The Company does not believe that the ultimate resolution of these proceedings or claims pending against it could have a material adverse effect on its financial condition or results of operations. At each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">. Legal fees are expensed as incurred.</span></div></ix:nonNumeric><div id="ifcd99b6df4104f80be938ce77dc8288d_130"></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90ZXh0cmVnaW9uOjZkMTQ1NDM0ZTYyMzQ0OWM5M2I0NzU1NmNmMTdiZDE3XzI1Mjk_eac9c0fa-e311-4d74-812d-fafbd7f69888" continuedAt="ia6d75a8691b14048a85d1f8ef9c84d6d" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 12. Business Segment Information</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company discloses information about its operating segments, which were established based on the way that management organizes segments within the Company for making operating decisions and assessing financial performance. The Company's <ix:nonFraction unitRef="segment" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90ZXh0cmVnaW9uOjZkMTQ1NDM0ZTYyMzQ0OWM5M2I0NzU1NmNmMTdiZDE3XzI4Mw_802ab368-288f-40aa-a9ea-689ce2d80af3">two</ix:nonFraction> operating segments are described below. </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.68pt">CooperVision. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Competes in the worldwide contact lens market by developing, manufacturing and marketing a broad range of products for contact lens wearers, featuring advanced materials and optics.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.68pt">CooperSurgical. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Competes in the general health care market with a focus on advancing the health of women, babies and families through a diversified portfolio of products and services focusing on women's health and fertility.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company uses operating income, as presented in our financial reports, as the primary measure of segment profitability. The Company does not allocate costs from corporate functions to segment operating income. The Company uses the same accounting policies to generate segment results as it does for consolidated results.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">No customers accounted for 10% or more of our consolidated net revenue in fiscal 2022, 2021 and 2020. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Total identifiable assets are those used in continuing operations except cash and cash equivalents, which the Company includes as corporate assets. </span></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="ia6d75a8691b14048a85d1f8ef9c84d6d" continuedAt="i1f21afedcb744c3c9baa6735ce5c53d2"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90ZXh0cmVnaW9uOjZkMTQ1NDM0ZTYyMzQ0OWM5M2I0NzU1NmNmMTdiZDE3XzI1MjY_44f1a512-a999-4ad6-a471-fbfa329f9f1a" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table presents a summary of our business segment net sales:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.593%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision net sales by category:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Toric lens</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25cde43e219544f999a9522e40885def_D20211101-20221031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzItMS0xLTEtNTg1Mzc_b83ae601-ca9e-4716-a2ac-ef337d0ae915">737.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc3c52f498cc45aea41930decf8ee38f_D20201101-20211031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzItMy0xLTEtNTg1Mzc_c10c0ccf-2fca-46a5-b809-8285d1937a08">697.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia253e12523d043d49f3b05b362ac4db3_D20191101-20201031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzItNS0xLTEtNTg1Mzc_293bb21a-b197-4c6f-ac51-d09656226c76">598.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Multifocal lens</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d10aa172f4241199dca5d1ca8ce9dc3_D20211101-20221031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzMtMS0xLTEtNTg1Mzc_2543d7a9-836f-4d80-8ac9-9b4e9a7e8a77">264.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85d55c68caa34e448ff17017cfacbd34_D20201101-20211031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzMtMy0xLTEtNTg1Mzc_0c3f2323-8d3d-4c33-aa1e-6ffebfc1a85b">238.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc783e59e8564dc5a184e25dc3297b9e_D20191101-20201031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzMtNS0xLTEtNTg1Mzc_04d57c35-5f2e-4bca-821f-7deffaaea021">197.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Single-use sphere lens</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccd45949f93e4f0d856a82cc74ad6f30_D20211101-20221031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzQtMS0xLTEtNTg1Mzc_6309276a-544d-4e85-9943-1308fb462dbe">661.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib621e690024248a09198dea9ac20e44d_D20201101-20211031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzQtMy0xLTEtNTg1Mzc_cd9b5232-b19b-4d9a-b3f9-4a6ddcd8f732">616.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8bb2845023f4ba69135007f32f07bfd_D20191101-20201031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzQtNS0xLTEtNTg1Mzc_2b20bc8e-efa1-4ba9-a368-e9b859da5a66">529.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non single-use sphere, other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib70d98549d8f495a9abc9b2d97f90135_D20211101-20221031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzUtMS0xLTEtNTg1Mzc_ccfe34ba-d408-4591-ab93-d2c252a9bfc9">579.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8072fe66c6ab44ba885a43c3d95061e4_D20201101-20211031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzUtMy0xLTEtNTg1Mzc_5598492b-c93d-49c8-b298-a1eda4334fb7">599.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae8aae422ef74e84b2422bd0e0d79312_D20191101-20201031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzUtNS0xLTEtNTg1Mzc_f690d70c-cc25-45d3-a768-bb4d256c30f9">518.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total CooperVision net sales</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i144fdaeefe67410baf1810389c09a562_D20211101-20221031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzYtMS0xLTEtNTg1Mzc_555758cc-ad1b-4b43-a2df-37cdc723f116">2,243.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i102f306f3b6e41189c2e3d4c415079d8_D20201101-20211031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzYtMy0xLTEtNTg1Mzc_d404c7c3-e801-4e08-b250-af12bf46818c">2,152.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9d6919196ca46a88ce3671aa7019026_D20191101-20201031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzYtNS0xLTEtNTg1Mzc_fb2082f0-6d48-4b3e-86c6-b44402627bb6">1,843.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperSurgical net sales by category:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Office and surgical products</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dd5db5ac5f0464c9c4532ca81435932_D20211101-20221031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzgtMS0xLTEtNTg1Mzc_05e27896-4b9b-495a-a4cc-458f2f24ac6d">633.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if06952d7a77e4c6d9f9444b9a19fa7aa_D20201101-20211031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzgtMy0xLTEtNTg1Mzc_ac8c3ccb-db99-4eff-8b8f-46dd5a1358e2">451.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6ed314c0ed34367adef4b03b91bf0e0_D20191101-20201031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzgtNS0xLTEtNTg1Mzc_e7c5b18c-322b-41f6-81e0-0eef1343d1b0">358.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fertility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25dfc4b265ed4288baedea76cb9d2444_D20211101-20221031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzktMS0xLTEtNTg1Mzc_df543a00-1a7d-445f-b792-24cf97750cf3">431.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51cce661b93d48838c95d5583bafe501_D20201101-20211031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzktMy0xLTEtNTg1Mzc_2a3cc6ef-3de1-4c24-b4ef-f43e0d34e39b">319.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i309196da87d847b0b037f6d29c6d95e8_D20191101-20201031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzktNS0xLTEtNTg1Mzc_4a38178f-f08f-4fdd-8826-b926dc78063f">229.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total CooperSurgical net sales</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaeae5667d45b495b88915bbc72c256cd_D20211101-20221031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzEwLTEtMS0xLTU4NTM3_8d005f62-c69c-4876-b3e9-d04531894429">1,065.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb221ec949be4a1a87f43dd831ca8d8c_D20201101-20211031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzEwLTMtMS0xLTU4NTM3_d0a972d8-fe60-4b7f-b5de-af232f40d7c0">770.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibca59e6c981d48c5a555d3d4902818d1_D20191101-20201031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzEwLTUtMS0xLTU4NTM3_7add32a6-f21d-4a04-b1ce-893692ec38bf">587.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzExLTEtMS0xLTU4NTM3_bc6fd2d7-0aeb-48b2-9412-383518fe987c">3,308.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzExLTMtMS0xLTU4NTM3_66059faa-f1d3-468a-a90c-c0c552777416">2,922.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzExLTUtMS0xLTU4NTM3_34d88d56-5f4c-469d-b8ab-a6b3da22dbc2">2,430.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="i1f21afedcb744c3c9baa6735ce5c53d2" continuedAt="i3c70c59465c944d1941402e2ddb76cca"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90ZXh0cmVnaW9uOjZkMTQ1NDM0ZTYyMzQ0OWM5M2I0NzU1NmNmMTdiZDE3XzI1MDM_eb4b6086-d56e-4508-ac2f-0d8eae39c26f" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Information by business segment for each of the years in the three-year period ended October&#160;31, 2022, follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.312%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.120%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.594%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">CooperVision</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">CooperSurgical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bc30f40f79641898ba6c790c0142777_D20211101-20221031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzItMS0xLTEtNTg1Mzc_c46ce756-54d7-426e-882c-a2cc2d3f7aef">2,243.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6eec52445a764506b37023f966f522cd_D20211101-20221031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzItMy0xLTEtNTg1Mzc_a5be65b3-aefa-4c13-b622-0a52a6abc798">1,065.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i114133db3f4f46f0be519e2bb98d778d_D20211101-20221031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzItNS0xLTEtNTg1Mzc_f4d57399-115f-4aaf-af55-3b5abdc6781e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzItNy0xLTEtNTg1Mzc_dcbabc2c-86f2-4569-8db3-f959d1ce4636">3,308.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bc30f40f79641898ba6c790c0142777_D20211101-20221031" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzMtMS0xLTEtNTg1Mzc_e9e0662a-4dda-451c-8c28-2873e29d5580">494.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6eec52445a764506b37023f966f522cd_D20211101-20221031" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzMtMy0xLTEtNTg1Mzc_2a3865b2-57b2-491e-abf3-6774ee083767">67.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i114133db3f4f46f0be519e2bb98d778d_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzMtNS0xLTEtNTg1Mzc_18c82d57-9996-4a6c-b5c3-8e3a708497ac">53.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzMtNy0xLTEtNTg1Mzc_5199d062-4e6f-4da7-a6d4-3a1d4f6cfdd1">507.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzQtNy0xLTEtNTg1Mzc_6c708d46-2616-42f7-820d-7afea2e378d7">57.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other (income), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzUtNy0xLTEtNTg1Mzc_dab2110a-0d26-4644-a8d5-2702d5a254ad">25.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzYtNy0xLTEtNTg1Mzc_a198a35f-074d-4146-ba2f-85e07fb29864">475.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Identifiable assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if236740745ec431d90e33cfc8a948539_I20221031" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzctMS0xLTEtNTg1Mzc_d43779fe-b94d-4dbe-8ea6-d4fc31a1aa4a">6,778.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e7e37cad2a94f059cebebab71490b56_I20221031" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzctMy0xLTEtNTg1Mzc_db88b8c9-d8ba-49ca-b14e-c5c9962d2c06">4,407.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a609362bee4d6c9058db39abefa7dc_I20221031" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzctNS0xLTEtNTg1Mzc_fc57baa5-9f2d-4afe-87c4-20029cd2bf1d">305.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzctNy0xLTEtNTg1Mzc_7554e1d7-c6f7-403e-bcd8-7ba670549682">11,492.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bc30f40f79641898ba6c790c0142777_D20211101-20221031" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzgtMS0xLTEtNTg1Mzc_222f6d91-1d71-44bf-90b2-6752e9f8c4e0">144.5</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6eec52445a764506b37023f966f522cd_D20211101-20221031" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzgtMy0xLTEtNTg1Mzc_c7c6b6f5-986a-4067-9352-2ee98de40cd4">22.1</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i114133db3f4f46f0be519e2bb98d778d_D20211101-20221031" decimals="-5" name="us-gaap:Depreciation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzgtNS0xLTEtNTg1Mzc_d0f181b7-af4c-43b6-ba28-9389acb1f585">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzgtNy0xLTEtNTg1Mzc_05e1bca5-7133-420c-acbe-7758220f2dfd">166.6</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bc30f40f79641898ba6c790c0142777_D20211101-20221031" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzktMS0xLTEtNTg1Mzc_4aa0d4f0-eeff-45cc-a8d4-b631842831ac">32.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6eec52445a764506b37023f966f522cd_D20211101-20221031" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzktMy0xLTEtNTg1Mzc_1119244c-a6c7-4e8d-a8fd-dcf176708eb0">147.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i114133db3f4f46f0be519e2bb98d778d_D20211101-20221031" decimals="-5" name="us-gaap:AdjustmentForAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzktNS0xLTEtNTg1Mzc_7c828a1d-17c9-4117-bce7-ef5abf429aaa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzktNy0xLTEtNTg1Mzc_fc0bbb5e-e2e3-4adb-9202-d21d9862cf0b">179.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bc30f40f79641898ba6c790c0142777_D20211101-20221031" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzEwLTEtMS0xLTU4NTM3_3d98b866-0535-4e78-b87c-04b832a2b825">223.0</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6eec52445a764506b37023f966f522cd_D20211101-20221031" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzEwLTMtMS0xLTU4NTM3_0ba89a3d-8099-457b-8537-8a0eeb5dea82">19.0</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i114133db3f4f46f0be519e2bb98d778d_D20211101-20221031" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzEwLTUtMS0xLTU4NTM3_a1458681-6462-4aa0-a949-cf806fa9620a">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzEwLTctMS0xLTU4NTM3_32965a8b-4abb-46b1-bdff-3d41bce9fa2e">242.0</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1636568fa5e84bdabf27c057ce6618aa_D20201101-20211031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzEyLTEtMS0xLTU4NTM3_af69f8fd-c55e-4cf3-bced-05be0710a45e">2,152.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7703e214bc54be8bcb93e4d048e2560_D20201101-20211031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzEyLTMtMS0xLTU4NTM3_790c2985-f852-449b-abb0-6c98b541a176">770.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if848d1e35557456494fec2c118fc8064_D20201101-20211031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzEyLTUtMS0xLTU4NTM3_0ca6e8ef-418e-47a8-8353-e9e9eb5cb521">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzEyLTctMS0xLTU4NTM3_de9a869b-5f69-4872-82ab-78f588c0c1e8">2,922.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1636568fa5e84bdabf27c057ce6618aa_D20201101-20211031" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzEzLTEtMS0xLTU4NTM3_19fdd26d-45a0-4e1d-b53d-d5d721ff763f">481.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7703e214bc54be8bcb93e4d048e2560_D20201101-20211031" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzEzLTMtMS0xLTU4NTM3_67c3f6ad-864a-4b81-8ee5-add957818702">71.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if848d1e35557456494fec2c118fc8064_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzEzLTUtMS0xLTU4NTM3_af019527-e842-4e67-9ea2-d98d101376bb">47.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzEzLTctMS0xLTU4NTM3_f20f7902-77b2-4096-b5de-612097eb399a">505.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzE0LTctMS0xLTU4NTM3_66291326-9ca6-4c21-b85c-470290d06fe3">23.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other (income), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzE1LTctMS0xLTU4NTM3_2c6c4626-2a07-4644-a6c0-a18f09e24084">8.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzE2LTctMS0xLTU4NTM3_dc84ecce-14e1-4cc5-9885-fd23df7a0a0f">491.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Identifiable assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5bd3183833a4311ba1940f6e13e8c58_I20211031" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzE3LTEtMS0xLTU4NTM3_92839ddd-90ad-48a7-ae71-4fa83ec478a8">6,965.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i706aed7d18eb42adb67c45317cebd9df_I20211031" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzE3LTMtMS0xLTU4NTM3_762cd039-77d3-4d1d-ac68-faad60c6877d">2,395.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fac46c673ae44a6a51e56072ef333f6_I20211031" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzE3LTUtMS0xLTU4NTM3_49ae13fc-1a41-4ace-b65e-5881dfb2d7e2">244.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzE3LTctMS0xLTU4NTM3_82bef8aa-5019-472d-af68-cc66ac562b0b">9,606.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1636568fa5e84bdabf27c057ce6618aa_D20201101-20211031" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzE4LTEtMS0xLTU4NTM3_910e6c7c-b58d-4afe-baba-bb41f845f8f2">148.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7703e214bc54be8bcb93e4d048e2560_D20201101-20211031" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzE4LTMtMS0xLTU4NTM3_432deca5-d109-4e61-a33d-4630c5dffeb3">14.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if848d1e35557456494fec2c118fc8064_D20201101-20211031" decimals="-5" name="us-gaap:Depreciation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzE4LTUtMS0xLTU4NTM3_013030b1-085e-41d5-a89f-3c997d99f81e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzE4LTctMS0xLTU4NTM3_7f031c85-a7be-4867-a064-7ab98c857662">163.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1636568fa5e84bdabf27c057ce6618aa_D20201101-20211031" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzE5LTEtMS0xLTU4NTM3_44e72cf9-0adf-490c-b8b7-d2917a6f55d7">35.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7703e214bc54be8bcb93e4d048e2560_D20201101-20211031" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzE5LTMtMS0xLTU4NTM3_53355865-ace5-40fc-8dc0-6dec0df7f729">110.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if848d1e35557456494fec2c118fc8064_D20201101-20211031" decimals="-5" name="us-gaap:AdjustmentForAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzE5LTUtMS0xLTU4NTM3_b6dfa306-bd6c-41d7-a070-35004ec1fe4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzE5LTctMS0xLTU4NTM3_e7d2016b-e081-45e5-8e12-31682d153c31">146.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1636568fa5e84bdabf27c057ce6618aa_D20201101-20211031" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzIwLTEtMS0xLTU4NTM3_9322faf2-2111-4277-909d-3efc98790fc5">190.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7703e214bc54be8bcb93e4d048e2560_D20201101-20211031" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzIwLTMtMS0xLTU4NTM3_577720a3-119e-4ca2-a8b3-581f2c38b19e">24.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if848d1e35557456494fec2c118fc8064_D20201101-20211031" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzIwLTUtMS0xLTU4NTM3_baaf3651-0a42-4286-abd3-b60bb89e235c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzIwLTctMS0xLTU4NTM3_49dd5f72-b833-4ed5-8335-88c191566abb">214.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifda5545cd7a64877bb275e348b90dff5_D20191101-20201031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzIyLTEtMS0xLTU4NTM3_fc2fa297-aed4-4920-b595-f6aa17c90ac3">1,843.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cdb7296c2413c8bd74737698ae04c_D20191101-20201031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzIyLTMtMS0xLTU4NTM3_56aebea8-1997-4a87-a7a9-368d4373a759">587.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i936768573f894f27889c7dd715937761_D20191101-20201031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzIyLTUtMS0xLTU4NTM3_7a1efc39-9573-4d17-bd60-e6f13a262fcd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzIyLTctMS0xLTU4NTM3_1e6e3610-7e10-4246-b37b-9b2ba4d547df">2,430.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifda5545cd7a64877bb275e348b90dff5_D20191101-20201031" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzIzLTEtMS0xLTU4NTM3_c8510eed-91b2-4cfd-a11d-06170c0fd8cb">375.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i949cdb7296c2413c8bd74737698ae04c_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzIzLTMtMS0xLTU4NTM3_6bc2aad7-d38f-4d64-aa84-191ed87231cd">14.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i936768573f894f27889c7dd715937761_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzIzLTUtMS0xLTU4NTM3_a84a1ef7-026d-40e5-aca2-9fea015f4b22">49.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzIzLTctMS0xLTU4NTM3_5984f60b-89b3-4a7f-91d8-6ad82282db11">311.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzI0LTctMS0xLTU4NTM3_3317a563-6ab1-426c-979a-d058660b46a0">36.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzI1LTctMS0xLTU4NTM3_f2f5f55d-d635-4778-98d1-cf76d454e86f">8.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzI2LTctMS0xLTU4NTM3_fdd77cb4-1448-47c2-9eca-c206387b9fb2">266.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Identifiable assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib167cd4900e94a9d8cbe4bf12709f074_I20201031" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzI3LTEtMS0xLTU4NTM3_08921989-ca34-4a6e-a848-1ed36eca6683">4,236.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2fed7da6fdf4c2d84c04555713219a8_I20201031" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzI3LTMtMS0xLTU4NTM3_3089f72b-c963-43e4-9b4c-5301fb14fa18">2,293.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4195fe02b707490a8d61b963c66350fa_I20201031" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzI3LTUtMS0xLTU4NTM3_c2d2ca7a-07c3-43b6-9068-fcbf63ba132e">207.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzI3LTctMS0xLTU4NTM3_8fbfedb2-1da2-418b-9f0c-7955a1a43a8a">6,737.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifda5545cd7a64877bb275e348b90dff5_D20191101-20201031" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzI4LTEtMS0xLTU4NTM3_4f813065-0368-4902-8703-6ae909d62e6d">138.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cdb7296c2413c8bd74737698ae04c_D20191101-20201031" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzI4LTMtMS0xLTU4NTM3_c673f5e6-ddca-4eeb-82e6-2c3955da9508">11.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i936768573f894f27889c7dd715937761_D20191101-20201031" decimals="-5" name="us-gaap:Depreciation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzI4LTUtMS0xLTU4NTM3_a5b6f3c3-26c4-47f5-9fa9-0b2af629d88c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzI4LTctMS0xLTU4NTM3_802e228b-1bd0-44a3-834b-d19c087af7ce">149.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifda5545cd7a64877bb275e348b90dff5_D20191101-20201031" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzI5LTEtMS0xLTU4NTM3_9eacbc57-51fb-4314-b311-2582cf5220a3">32.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cdb7296c2413c8bd74737698ae04c_D20191101-20201031" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzI5LTMtMS0xLTU4NTM3_e4b5fbd5-c067-43b8-8bea-783f439e8bd5">104.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i936768573f894f27889c7dd715937761_D20191101-20201031" decimals="-5" name="us-gaap:AdjustmentForAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzI5LTUtMS0xLTU4NTM3_e5943c8a-1821-4fc4-be27-ba0d5f681810">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzI5LTctMS0xLTU4NTM3_c68bf30d-59a0-43dc-a697-5981597a6215">137.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifda5545cd7a64877bb275e348b90dff5_D20191101-20201031" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzMwLTEtMS0xLTU4NTM3_8c3bbeed-e22e-4ef8-a12a-af83591042c9">260.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cdb7296c2413c8bd74737698ae04c_D20191101-20201031" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzMwLTMtMS0xLTU4NTM3_a00065ab-9d5f-409d-bb19-50b98e46e0e6">50.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i936768573f894f27889c7dd715937761_D20191101-20201031" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzMwLTUtMS0xLTU4NTM3_f7b1b3c2-2121-486b-87de-505101d9be30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzMwLTctMS0xLTU4NTM3_d51b0e87-d797-48e2-bfd4-c301b12a45c9">310.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:continuation id="i3c70c59465c944d1941402e2ddb76cca"><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90ZXh0cmVnaW9uOjZkMTQ1NDM0ZTYyMzQ0OWM5M2I0NzU1NmNmMTdiZDE3XzI1Mjc_9248fc77-f349-4b5f-8a97-7c97d609968e" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Information by geographical area by country of domicile for each of the years in the three-year period ended October&#160;31, 2022, follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.594%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">United<br/>States</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Rest of<br/>World,&#160;Other<br/>Eliminations<br/>&amp; Corporate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales to unaffiliated customers</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2772f61aefe64ddbba24fc95a9137207_D20211101-20221031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzItMS0xLTEtNTg1Mzc_5f34697a-4972-4ed2-9063-cc51ae9a3d6e">1,638.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1c3c38f11c44e2da46bd9a800f94386_D20211101-20221031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzItMy0xLTEtNTg1Mzc_67a88d5a-f7e9-4802-b8ed-3d1ea25ab151">987.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i203ba6d20b6f4590bfc5a2c49c100182_D20211101-20221031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzItNS0xLTEtNTg1Mzc_a82cb585-e0a4-4f3a-b76a-5ec26987059b">682.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzItNy0xLTEtNTg1Mzc_a986481d-b0f3-41ba-ae92-fbb1e526951f">3,308.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Sales between geographic areas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ca5a267e7864693ae8d23449d787c29_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzMtMS0xLTEtNTg1Mzc_02f5b9d9-c44a-4c3f-8c54-74c8d6594342">514.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib878f9b3ae04474a863b123b65f168ab_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzMtMy0xLTEtNTg1Mzc_2f5cd192-bbd6-4d4f-a811-802bac0d362d">897.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbf6d52286234783b4187fc8c1b84be2_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzMtNS0xLTEtNTg1Mzc_de5c2eaa-b820-4378-82d6-3315b45493d5">1,411.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie853cb4e9b8e4c04b1094493101d98a5_D20211101-20221031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzQtMS0xLTEtNTg1Mzc_3c92d269-8593-4078-9d1b-cb676478aa11">2,152.9</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i872ddcd0dec342a68a42c53d1feac123_D20211101-20221031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzQtMy0xLTEtNTg1Mzc_4dd175eb-df32-428e-9407-5a9e5c467972">1,884.5</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b2584e8265f4b1eb31b69d99591c665_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzQtNS0xLTEtNTg1Mzc_3b664b35-be3a-404b-825a-57da881c254d">729.0</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzQtNy0xLTEtNTg1Mzc_a13857dc-b026-45c7-903b-9a18acbc9834">3,308.4</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie853cb4e9b8e4c04b1094493101d98a5_D20211101-20221031" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzUtMS0xLTEtNTg1Mzc_6a011098-189d-4166-88f6-0e2f2126c2c9">71.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i872ddcd0dec342a68a42c53d1feac123_D20211101-20221031" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzUtMy0xLTEtNTg1Mzc_20230ea0-8373-45c8-be6f-c6265135d602">403.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b2584e8265f4b1eb31b69d99591c665_D20211101-20221031" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzUtNS0xLTEtNTg1Mzc_e16558db-0716-48ec-9bd6-a3a3cd0e33ff">32.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzUtNy0xLTEtNTg1Mzc_c64e58a6-5fe0-4039-ad17-b82ebcc84db0">507.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-lived assets</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if091820da3fa469ca8e63a4e7e623ebb_I20221031" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzYtMS0xLTEtNTg1Mzc_87ad2509-cecf-4ec4-8692-7fc3569ef2e5">856.1</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee380fa4cc94aa2949150146bc1b833_I20221031" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzYtMy0xLTEtNTg1Mzc_e85640ea-708b-4f42-9b8e-1be509c2dbd6">310.8</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98cba8f6abe845659e16156082ad2d25_I20221031" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzYtNS0xLTEtNTg1Mzc_2dc12d46-ff6d-440f-8482-0bba087e5918">266.0</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzYtNy0xLTEtNTg1Mzc_d256c815-cf02-4119-b17b-08e55eb117f4">1,432.9</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales to unaffiliated customers</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9a9fbd6fa9745abbc18a527935e6729_D20201101-20211031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzgtMS0xLTEtNTg1Mzc_71eef9c5-bec0-4aec-a761-277c963dbc97">1,339.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ed2c06038c4e21a954497f6fc03687_D20201101-20211031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzgtMy0xLTEtNTg1Mzc_47a70459-aa79-46e0-9981-7d322a6c3043">957.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632fce02d0a14ee2a54b08cb02f4a530_D20201101-20211031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzgtNS0xLTEtNTg1Mzc_7aa501ed-143c-4316-b633-2ca57088abb5">625.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzgtNy0xLTEtNTg1Mzc_de8c0db8-82f8-41be-b72f-728f1f465ffc">2,922.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Sales between geographic areas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5472d5f5ea1840df9d91ec3db5081155_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzktMS0xLTEtNTg1Mzc_bac843e7-7dbd-440a-92c7-743e61e5561d">494.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d31ba7c78554e01be3531b7db972065_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzktMy0xLTEtNTg1Mzc_e9567066-b660-4158-b32b-32a91e43c5e3">815.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ac8281323054a3383ab48d0fa752407_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzktNS0xLTEtNTg1Mzc_e89c3fea-5d2b-4308-9034-bd9054a50f84">1,310.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5e3fde5895f43fba4395a3f2a394105_D20201101-20211031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzEwLTEtMS0xLTU4NTM3_16c6a59f-e401-4995-9dea-8722328a55b2">1,834.1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie429681883c245819521a0c57f11ffa7_D20201101-20211031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzEwLTMtMS0xLTU4NTM3_53144d17-80be-497f-acf6-45319ff04267">1,773.0</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89ef065c99254e85b8c2f8427f8cc1cf_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzEwLTUtMS0xLTU4NTM3_4bd6b926-ff42-49ef-854b-7806420645ec">684.6</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzEwLTctMS0xLTU4NTM3_85af0ec4-5d9a-4c15-b51d-6f99c65ea67c">2,922.5</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating (loss) income</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5e3fde5895f43fba4395a3f2a394105_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzExLTEtMS0xLTU4NTM3_bdf67e45-7cf2-43d6-846c-b13684ba4e6e">26.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie429681883c245819521a0c57f11ffa7_D20201101-20211031" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzExLTMtMS0xLTU4NTM3_2242cd16-4829-4195-820f-7380025b1aa3">416.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89ef065c99254e85b8c2f8427f8cc1cf_D20201101-20211031" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzExLTUtMS0xLTU4NTM3_bd349919-8e2b-4863-ae3c-64e482e2b1cd">116.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzExLTctMS0xLTU4NTM3_beee020b-68aa-4298-9569-b2f030275df5">505.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-lived assets</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11563134ef8a45bda7a59afedae161f7_I20211031" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzEyLTEtMS0xLTU4NTM3_a638efff-27c9-46c0-816c-9a41dbb4cb01">737.5</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib09f048a3bb546ec9d3d473f3290ba4b_I20211031" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzEyLTMtMS0xLTU4NTM3_f475f59f-dc50-429a-bd1d-a0fd2e31ffc8">377.2</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if12e23677c7d4f59bf1b6b56f97c0a96_I20211031" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzEyLTUtMS0xLTU4NTM3_0735731b-213c-4333-8ce6-e2160684595e">232.9</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzEyLTctMS0xLTU4NTM3_8c182961-8906-46dd-ae11-86722b17f067">1,347.6</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales to unaffiliated customers</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3982025069c42019719d3ae187bfac5_D20191101-20201031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE0LTEtMS0xLTU4NTM3_c9099757-4bd4-4eab-b0aa-f31498833dbd">1,103.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d212cf3f853423d91d402573665e3a3_D20191101-20201031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE0LTMtMS0xLTU4NTM3_586456aa-87d6-4921-b28f-f40450d5f822">789.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3a74826cb834e35868ee80db8fd1abf_D20191101-20201031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE0LTUtMS0xLTU4NTM3_cf244139-0a18-4c00-8924-7ce6101c32e6">537.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE0LTctMS0xLTU4NTM3_d30cbe0d-8024-44db-8591-f454e3183fee">2,430.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Sales between geographic areas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00b1d9c5ee034b9c8a36252aa25fa6a0_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE1LTEtMS0xLTU4NTM3_58c08773-1be2-4219-b473-9952c9732aba">391.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec65f950a0dc4854914e26a734104e19_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE1LTMtMS0xLTU4NTM3_628641f7-55ad-4bdd-bd2e-ed859aa4a21f">327.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1599f6e5dec74f248141c4cf3566bf65_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE1LTUtMS0xLTU4NTM3_3d544a5e-005f-45ea-b61c-edd1a917e24c">718.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3910c6d00f04f0abdb3fbfd16d3e64e_D20191101-20201031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE2LTEtMS0xLTU4NTM3_4419f218-48fc-4c43-bd73-80fe785968a9">1,495.3</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia32d9258c18848e5abfe9c919bc12cfe_D20191101-20201031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE2LTMtMS0xLTU4NTM3_7489dca5-0749-426f-ab7c-d8426392a490">1,116.9</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i750be365ff0047e49e7f299808203d52_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE2LTUtMS0xLTU4NTM3_ecde6d6a-bb61-4dfb-beba-3c8e98e0d9dd">181.3</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE2LTctMS0xLTU4NTM3_cedf7ce2-d90f-4ec7-a99c-5615a94c7431">2,430.9</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating (loss) income</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib3910c6d00f04f0abdb3fbfd16d3e64e_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE3LTEtMS0xLTU4NTM3_330d60ce-1b1c-4ea0-ac9b-a6b66dee01be">14.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia32d9258c18848e5abfe9c919bc12cfe_D20191101-20201031" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE3LTMtMS0xLTU4NTM3_67514481-be7e-46fb-be4a-4e4f04632032">21.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i750be365ff0047e49e7f299808203d52_D20191101-20201031" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE3LTUtMS0xLTU4NTM3_42fcf37d-6800-486d-80cb-7b56cef746e6">304.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE3LTctMS0xLTU4NTM3_32ea34ad-b07b-47db-ac64-8445fae657d5">311.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-lived assets</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81cc03f2a4a74c3986074b3bee49852f_I20201031" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE4LTEtMS0xLTU4NTM3_ef5a9338-cca2-44d3-b1e9-925fa340d7f9">721.3</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92fdd7459bad4408a8a71b8370a03266_I20201031" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE4LTMtMS0xLTU4NTM3_334a2274-bc1d-4827-8d67-d4e5f91262d0">363.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04406ea9810f4b8190f8776aa444ef9f_I20201031" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE4LTUtMS0xLTU4NTM3_6a0d6a81-3704-4aaa-b34a-dc35d16637d0">197.6</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE4LTctMS0xLTU4NTM3_1ff49b10-1530-4eb0-b73f-9e3df9146d3c">1,281.9</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><div id="ifcd99b6df4104f80be938ce77dc8288d_133"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90ZXh0cmVnaW9uOmYzNzc3OGI5MDUxMTQ3YTk4OTA2OWYxNjA4ZmI4NjczXzMyNDA_01ef3762-997f-4ae1-aff3-37c83c944dfa" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 13. Financial Derivatives and Hedging</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As part of the Company&#8217;s overall risk management practices the Company enters into financial derivatives, interest rate swaps designated as cash flow hedges, to hedge the Company's exposure to changes in cash flows associated with its variable rate debt.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Credit risk related to derivative transactions reflects the risk that a party to the transaction could fail to meet its obligation under the derivative contracts. Therefore, the Company&#8217;s exposure to the counterparty&#8217;s credit risk is generally limited to the amounts, if any, by which the counterparty&#8217;s obligations to the Company exceed the Company&#8217;s obligations to the counterparty. The Company&#8217;s policy is to enter into contracts only with financial institutions which meet certain minimum credit ratings to help mitigate counterparty credit risk.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On April 6, 2020 the Company entered into <ix:nonFraction unitRef="interest_rate_swap_contract" contextRef="i9149d6cbeb354638969dcb45da4ca29a_I20200406" decimals="INF" name="us-gaap:NumberOfInterestRateDerivativesHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90ZXh0cmVnaW9uOmYzNzc3OGI5MDUxMTQ3YTk4OTA2OWYxNjA4ZmI4NjczXzk3NzU_23924947-d381-471c-8fcf-cb7fa09149bf">six</ix:nonFraction> interest rate swap contracts which were used to hedge its exposure to changes in cash flows associated with its variable rate debt and were designated as derivatives in a cash flow hedge. The payment streams were based on a total notional amount of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i9149d6cbeb354638969dcb45da4ca29a_I20200406" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90ZXh0cmVnaW9uOmYzNzc3OGI5MDUxMTQ3YTk4OTA2OWYxNjA4ZmI4NjczXzk3Nzk_f41a0483-8cb8-46e7-b70e-53902d80eef3">1.5</ix:nonFraction>&#160;billion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> at the inception of the contracts. As of October&#160;31, 2022, <ix:nonFraction unitRef="interest_rate_swap_contract" contextRef="ib93ee62619474af5844402d5b5e2fc5e_I20221031" decimals="INF" name="coo:NumberOfInterestRateDerivativesMatured" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90ZXh0cmVnaW9uOmYzNzc3OGI5MDUxMTQ3YTk4OTA2OWYxNjA4ZmI4NjczXzk3ODM_fe9d2d59-54ac-4251-9d9f-f46ba6c3ebd1">three</ix:nonFraction> of the <ix:nonFraction unitRef="interest_rate_swap_contract" contextRef="i9149d6cbeb354638969dcb45da4ca29a_I20200406" decimals="INF" name="us-gaap:NumberOfInterestRateDerivativesHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90ZXh0cmVnaW9uOmYzNzc3OGI5MDUxMTQ3YTk4OTA2OWYxNjA4ZmI4NjczXzk3ODc_3e1e7019-6d7c-490a-beb5-563163abfb2e">six</ix:nonFraction> interest rate swap contracts have matured and the outstanding contracts have a total notional amount of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="ib93ee62619474af5844402d5b5e2fc5e_I20221031" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90ZXh0cmVnaW9uOmYzNzc3OGI5MDUxMTQ3YTk4OTA2OWYxNjA4ZmI4NjczXzk3OTU_6643189e-8261-43d1-a220-432728048440">1.0</ix:nonFraction>&#160;billion and remaining maturities of <ix:nonNumeric contextRef="i306e8ebbe94442a5b09f45b81f9f9362_D20211101-20221031" name="us-gaap:DerivativeTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90ZXh0cmVnaW9uOmYzNzc3OGI5MDUxMTQ3YTk4OTA2OWYxNjA4ZmI4NjczXzk3OTE_66a3d227-8b68-4512-8766-e7e9db3cd7d1">five years</ix:nonNumeric> or less.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company did not have any cross-currency swaps or foreign currency forward contracts as of October&#160;31, 2022.</span></div><div style="margin-bottom:7pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The pre-tax impact of gain on derivatives designated for hedge accounting recognized in other comprehensive income (loss) was&#160;$<ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="coo:AOCICashFlowHedgeCumulativeGainLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90ZXh0cmVnaW9uOmYzNzc3OGI5MDUxMTQ3YTk4OTA2OWYxNjA4ZmI4NjczXzIzMTk_ae2ed5ce-29d7-4aa6-bca4-95ee4ff33862">124.5</ix:nonFraction> million&#160;($<ix:nonFraction unitRef="usd" contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031" decimals="-5" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90ZXh0cmVnaW9uOmYzNzc3OGI5MDUxMTQ3YTk4OTA2OWYxNjA4ZmI4NjczXzIzMjM_fcbee02f-6c13-4dbf-abc9-6e95f529d0be">30.1</ix:nonFraction> million, net of tax) as of October&#160;31, 2022. The pre-tax impact of gain on derivatives designated for hedge accounting recognized in other comprehensive income (loss) was&#160;$<ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="coo:AOCICashFlowHedgeCumulativeGainLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90ZXh0cmVnaW9uOmYzNzc3OGI5MDUxMTQ3YTk4OTA2OWYxNjA4ZmI4NjczXzI0ODk_e3414c10-0a2e-4289-858a-1041824413f9">17.2</ix:nonFraction>&#160;million&#160;($<ix:nonFraction unitRef="usd" contextRef="i15080967286843b083f296cee9e2bdd7_I20211031" decimals="-5" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90ZXh0cmVnaW9uOmYzNzc3OGI5MDUxMTQ3YTk4OTA2OWYxNjA4ZmI4NjczXzI0OTM_06e7d1cf-56b9-4b8e-af29-e3d25523331c">13.1</ix:nonFraction>&#160;million, net of tax) as of October&#160;31, 2021. The fair value of derivative instruments are classified in "Other non-current assets" on our consolidated balance sheets.</span></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90ZXh0cmVnaW9uOmYzNzc3OGI5MDUxMTQ3YTk4OTA2OWYxNjA4ZmI4NjczXzMyMzc_b6ac8b95-eb29-468b-b714-031d1b878a3d" escape="true"><div style="margin-bottom:7pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table summarizes the amounts recognized with respect to our derivative instruments within the accompanying Consolidated Statements of Income:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.080%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.301%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Periods Ended October 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Derivatives designated as cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Location of Loss (Income) Recognized on Derivatives</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest expense (income)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib09f9a58a78443b18bed2336686e605e_D20211101-20221031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90YWJsZToyOGZmYmJlZDExZDY0MTI2YmEyNmE0ZjkwMzU1YmIyZi90YWJsZXJhbmdlOjI4ZmZiYmVkMTFkNjQxMjZiYTI2YTRmOTAzNTViYjJmXzMtMy0xLTEtNTg1Mzc_d4367511-cc31-47cf-9c2d-3702e196ca85">2.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18b387b0bc824160a72bc4a7fa134526_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90YWJsZToyOGZmYmJlZDExZDY0MTI2YmEyNmE0ZjkwMzU1YmIyZi90YWJsZXJhbmdlOjI4ZmZiYmVkMTFkNjQxMjZiYTI2YTRmOTAzNTViYjJmXzMtNS0xLTEtNTg1Mzc_320da99f-c2d5-49a4-ad9f-4accb1d82ad7">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc574a9b39cc4fd0b3d2a6b2e338dea8_D20191101-20201031" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90YWJsZToyOGZmYmJlZDExZDY0MTI2YmEyNmE0ZjkwMzU1YmIyZi90YWJsZXJhbmdlOjI4ZmZiYmVkMTFkNjQxMjZiYTI2YTRmOTAzNTViYjJmXzMtNy0xLTEtNTg1Mzc_28d8addf-8273-4723-b114-b64209213047">3.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company expects that ($<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90ZXh0cmVnaW9uOmYzNzc3OGI5MDUxMTQ3YTk4OTA2OWYxNjA4ZmI4NjczXzI5MjQ_09248a02-1604-4cc3-971a-1e65eb65bce7">38.3</ix:nonFraction> million) recorded as a component of accumulated other comprehensive income (loss) will be realized in the Consolidated Statements of Income over the next twelve months and the amount will vary depending on prevailing interest rates.</span></div><div><span><br/></span></div><ix:continuation id="i66d74e885f36496bbe2981872d726b14"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table details the changes in accumulated other comprehensive income:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.658%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.378%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance as of October 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1dda5d68145148858749f4a3d0187b10_I20201031" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90YWJsZTplNWRmY2M2ZGE4MmU0NjMyOTlhMjAxODMwNTgwMjZmMi90YWJsZXJhbmdlOmU1ZGZjYzZkYTgyZTQ2MzI5OWEyMDE4MzA1ODAyNmYyXzEtMi0xLTEtNTg1Mzc_6363d860-9852-4aac-9824-afc73bc50317">17.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amount recognized in other comprehensive income on interest rate swap contracts, gross ($<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90YWJsZTplNWRmY2M2ZGE4MmU0NjMyOTlhMjAxODMwNTgwMjZmMi90YWJsZXJhbmdlOmU1ZGZjYzZkYTgyZTQ2MzI5OWEyMDE4MzA1ODAyNmYyXzItMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjo2OTQwNjgxMTY1ZjQ0M2VkOTRjZWE2MmRlOTE5ZWNmOF85Mg_c2981de8-e032-4878-bf96-687255d864ce">20.0</ix:nonFraction>, net of tax)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57f3229c828a483a94464d9bda7f0fc2_D20201101-20211031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90YWJsZTplNWRmY2M2ZGE4MmU0NjMyOTlhMjAxODMwNTgwMjZmMi90YWJsZXJhbmdlOmU1ZGZjYzZkYTgyZTQ2MzI5OWEyMDE4MzA1ODAyNmYyXzItMi0xLTEtNTg1Mzc_2c2f53d2-e0dd-40dd-b2e0-01e76bf514fe">26.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amount reclassified from other comprehensive income into earnings, gross ($<ix:nonFraction unitRef="usd" contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90YWJsZTplNWRmY2M2ZGE4MmU0NjMyOTlhMjAxODMwNTgwMjZmMi90YWJsZXJhbmdlOmU1ZGZjYzZkYTgyZTQ2MzI5OWEyMDE4MzA1ODAyNmYyXzMtMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjoxYjdmMTcxNzJkZjI0N2EyOTE3MTcyZjdhNGU4NTlkZV83OA_d88249c0-8f7f-45d7-81cb-6f736fb96c08">6.1</ix:nonFraction>, net of tax)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57f3229c828a483a94464d9bda7f0fc2_D20201101-20211031" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90YWJsZTplNWRmY2M2ZGE4MmU0NjMyOTlhMjAxODMwNTgwMjZmMi90YWJsZXJhbmdlOmU1ZGZjYzZkYTgyZTQ2MzI5OWEyMDE4MzA1ODAyNmYyXzMtMi0xLTEtNTg1Mzc_7ad0c142-4d5b-4424-9ec4-a9476001e674">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance gain as of October 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2357db2168d54d15b89a15c1f04fcf81_I20211031" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90YWJsZTplNWRmY2M2ZGE4MmU0NjMyOTlhMjAxODMwNTgwMjZmMi90YWJsZXJhbmdlOmU1ZGZjYzZkYTgyZTQ2MzI5OWEyMDE4MzA1ODAyNmYyXzQtMi0xLTEtNTg1Mzc_096b6d7e-dcdb-42fc-8687-306f8953d793">17.2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amount recognized in other comprehensive income on interest rate swap contracts, gross ($<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90YWJsZTplNWRmY2M2ZGE4MmU0NjMyOTlhMjAxODMwNTgwMjZmMi90YWJsZXJhbmdlOmU1ZGZjYzZkYTgyZTQ2MzI5OWEyMDE4MzA1ODAyNmYyXzUtMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjpjYzczZDRlZTllZjg0ZmQ0ODIwYWU3M2Q5NGY2NTIzMl8yNzQ4Nzc5MDY5NTY5_5ddd6880-5a5d-4020-b351-8f2d89e2ac3d">79.7</ix:nonFraction>, net of tax)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i105b86b96182466c89e084e2d8117b5e_D20211101-20221031" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90YWJsZTplNWRmY2M2ZGE4MmU0NjMyOTlhMjAxODMwNTgwMjZmMi90YWJsZXJhbmdlOmU1ZGZjYzZkYTgyZTQ2MzI5OWEyMDE4MzA1ODAyNmYyXzUtMi0xLTEtNTg1Mzc_17fc38a0-6c4d-4385-a40c-9fc1bcba8a04">105.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amount reclassified from other comprehensive income into earnings, gross ($<ix:nonFraction unitRef="usd" contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90YWJsZTplNWRmY2M2ZGE4MmU0NjMyOTlhMjAxODMwNTgwMjZmMi90YWJsZXJhbmdlOmU1ZGZjYzZkYTgyZTQ2MzI5OWEyMDE4MzA1ODAyNmYyXzYtMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjo3ZTlkM2ZiM2EzNzY0NjBlOTFiMjM5YjkwNzE5YTk5Ml8yNzQ4Nzc5MDY5NTUx_af08ab80-29d8-4a15-b782-bce3ff5fbe08">1.7</ix:nonFraction>, net of tax)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i105b86b96182466c89e084e2d8117b5e_D20211101-20221031" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90YWJsZTplNWRmY2M2ZGE4MmU0NjMyOTlhMjAxODMwNTgwMjZmMi90YWJsZXJhbmdlOmU1ZGZjYzZkYTgyZTQ2MzI5OWEyMDE4MzA1ODAyNmYyXzYtMi0xLTEtNTg1Mzc_c6658d7c-4523-46ca-9741-2ffe6bd7487c">2.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance gain as of October 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i007a38e974f04b6fa9067c5041cfd72b_I20221031" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90YWJsZTplNWRmY2M2ZGE4MmU0NjMyOTlhMjAxODMwNTgwMjZmMi90YWJsZXJhbmdlOmU1ZGZjYzZkYTgyZTQ2MzI5OWEyMDE4MzA1ODAyNmYyXzctMi0xLTEtNTg1Mzc_80a3c198-1435-4c25-84a0-ffbfbe5f021c">124.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:continuation></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><div id="ifcd99b6df4104f80be938ce77dc8288d_139"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item 9. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="ifcd99b6df4104f80be938ce77dc8288d_142"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item 9A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Controls and Procedures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company has established and currently maintains disclosure controls and procedures designed to ensure that information required to be disclosed in its reports filed under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission's rules and forms and that such information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosures. In designing and evaluating the disclosure controls and procedures, management recognizes that controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving desired control objectives. In reaching a reasonable level of assurance, management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In conjunction with the close of each fiscal quarter, the Company conducts a review and evaluation, under the supervision and with the participation of the Company's management, including the Chief Executive Officer (our Principal Executive Officer) and Chief Financial Officer (our Principal Financial Officer), of the effectiveness of the design and operation of the Company's disclosure controls and procedures. The Company's Chief Executive Officer and Chief Financial Officer based upon their evaluation as of October&#160;31, 2022, the end of the fiscal period covered in this report, concluded that the Company's disclosure controls and procedures were effective at the reasonable assurance level.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Management's Annual Report on Internal Control Over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Because of its inherent limitations, internal control over financial reporting may not prevent or detect all misstatements, errors or fraud. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Management assessed the effectiveness of the Company's internal control over financial reporting as of October&#160;31, 2022, based on the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Internal Control - Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">. Based on this assessment, management, under the supervision and with the participation of the Company's Chief Executive Officer and Chief Financial Officer, concluded that the Company's internal control over financial reporting was effective as of October&#160;31, 2022. The Company acquired Generate Life Sciences on December 17, 2021, and management excluded it from its assessment of the effectiveness of internal control over financial reporting as of October 31, 2022. Generate&#8217;s and its subsidiaries&#8217; internal control over financial reporting associated with total assets of $2.1&#160;billion and total revenues of $249.5&#160;million included in the consolidated financial statements of The Cooper Companies, Inc. as of and for the year ended October 31, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company's independent registered public accounting firm, KPMG LLP, has audited the effectiveness of the Company's internal control over financial reporting as of October&#160;31, 2022, as stated in their report in Part II, Item 8 of this Annual Report on Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">There have been no changes in the Company's internal control over financial reporting during the Company's fiscal quarter ended October&#160;31, 2022, that materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.</span></div><div><span><br/></span></div><div id="ifcd99b6df4104f80be938ce77dc8288d_145"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item 9B. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Other Information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="ifcd99b6df4104f80be938ce77dc8288d_148"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item 9C. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><div id="ifcd99b6df4104f80be938ce77dc8288d_151"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">PART III</span></div><div style="text-align:center"><span><br/></span></div><div id="ifcd99b6df4104f80be938ce77dc8288d_154"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item 10. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Directors, Executive Officers and Corporate Governance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The information required by this item is incorporated by reference to the Company&#8217;s Proxy Statement for the Annual Meeting of Stockholders scheduled to be held in March 2023 (the 2023 Proxy Statement).</span></div><div><span><br/></span></div><div id="ifcd99b6df4104f80be938ce77dc8288d_157"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item 11. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Executive Compensation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The information required by this item is incorporated by reference to the 2023 Proxy Statement.</span></div><div><span><br/></span></div><div id="ifcd99b6df4104f80be938ce77dc8288d_160"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item 12. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">See Item 5. Market for Registrant's Common Equity and Related Stockholder Matters - Equity Compensation Plan Information. Additional information required by this item is incorporated by reference to the 2023 Proxy Statement.</span></div><div style="text-align:justify"><span><br/></span></div><div id="ifcd99b6df4104f80be938ce77dc8288d_163"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item 13. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Certain Relationships and Related Transactions, and Director Independence.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The information required by this item is incorporated by reference to the 2023 Proxy Statement.</span></div><div><span><br/></span></div><div id="ifcd99b6df4104f80be938ce77dc8288d_166"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item 14. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Principal Accounting Fees and Services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The information required by this item is incorporated by reference to &#8220;Report of the Audit Committee&#8221; section of the 2023 Proxy Statement.</span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><div id="ifcd99b6df4104f80be938ce77dc8288d_169"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">PART IV</span></div><div><span><br/></span></div><div id="ifcd99b6df4104f80be938ce77dc8288d_172"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item 15. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Exhibits and Financial Statement Schedules.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;1. Financial Statements</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following financial statements are filed as a part of this report:</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Report of KPMG LLP, Independent Registered Public Accounting Firm</span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Consolidated Financial Statements:</span></div><div style="padding-left:85.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Statements of Income for the years ended October&#160;31, 2022, 2021 and 2020</span></div><div style="padding-left:85.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Statements of Comprehensive Income for the years ended October&#160;31, 2022, 2021 and 2020</span></div><div style="padding-left:85.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Balance Sheets as of October&#160;31, 2022 and 2021</span></div><div style="padding-left:85.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Statements of Stockholders' Equity for the years ended October&#160;31, 2022, 2021 and 2020</span></div><div style="padding-left:85.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Statements of Cash Flows for the years ended October&#160;31, 2022, 2021 and 2020</span></div><div style="padding-left:85.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;2. Financial Statement Schedules of the Company.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%;text-decoration:underline">Schedule Number</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%;text-decoration:underline">Description</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Schedule II&#160;&#160;&#160;&#160;Valuation and Qualifying Accounts</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">(b) &#160;&#160;&#160;&#160;Exhibits.</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The exhibits listed on the accompanying Exhibit Index are filed as part of this report.</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">All other schedules which are included in the applicable accounting regulations of the Securities and Exchange Commission are not required here because they are not applicable.</span></div><div style="margin-top:9pt;text-align:justify"><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><div id="ifcd99b6df4104f80be938ce77dc8288d_175"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div></div><ix:nonNumeric contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xNzUvZnJhZzo5NDZlYzM0MjZhNTc0MGZkYTU1ZTcyOWE3YjUwYTk3Ni90ZXh0cmVnaW9uOjk0NmVjMzQyNmE1NzQwZmRhNTVlNzI5YTdiNTBhOTc2XzI3Mw_6aed0499-908d-45ef-806b-6705e4f4acda" escape="true"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Schedule II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">VALUATION AND QUALIFYING ACCOUNTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Three Years Ended October&#160;31, 2022 </span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.201%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.201%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.201%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.203%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Balance<br/>Beginning<br/>of Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Reductions/ Charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Balance<br/>at End<br/>of Year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred income tax valuation allowance:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Year Ended October&#160;31, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea2aa42170064029a14838912d3185ac_I20211031" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xNzUvZnJhZzo5NDZlYzM0MjZhNTc0MGZkYTU1ZTcyOWE3YjUwYTk3Ni90YWJsZToyMWVlYjMzNDdhMzc0MzkxYjc4N2RkZTE0N2YyZTFmNS90YWJsZXJhbmdlOjIxZWViMzM0N2EzNzQzOTFiNzg3ZGRlMTQ3ZjJlMWY1XzItMS0xLTEtNTg1Mzc_241c030c-bd57-4472-8f22-2c7111b7c76b">51.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedb5b89d45e54e028ef271a4be6338b8_D20211101-20221031" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xNzUvZnJhZzo5NDZlYzM0MjZhNTc0MGZkYTU1ZTcyOWE3YjUwYTk3Ni90YWJsZToyMWVlYjMzNDdhMzc0MzkxYjc4N2RkZTE0N2YyZTFmNS90YWJsZXJhbmdlOjIxZWViMzM0N2EzNzQzOTFiNzg3ZGRlMTQ3ZjJlMWY1XzItMy0xLTEtNTg1Mzc_1c529819-0657-4df3-ad66-f972fd58324d">13.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iedb5b89d45e54e028ef271a4be6338b8_D20211101-20221031" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xNzUvZnJhZzo5NDZlYzM0MjZhNTc0MGZkYTU1ZTcyOWE3YjUwYTk3Ni90YWJsZToyMWVlYjMzNDdhMzc0MzkxYjc4N2RkZTE0N2YyZTFmNS90YWJsZXJhbmdlOjIxZWViMzM0N2EzNzQzOTFiNzg3ZGRlMTQ3ZjJlMWY1XzItNS0xLTEtNTg1Mzc_98fffc59-4235-420e-afcb-09e1fa77acb3">5.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a10babdc03d448fb7f6f049b019e92b_I20221031" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xNzUvZnJhZzo5NDZlYzM0MjZhNTc0MGZkYTU1ZTcyOWE3YjUwYTk3Ni90YWJsZToyMWVlYjMzNDdhMzc0MzkxYjc4N2RkZTE0N2YyZTFmNS90YWJsZXJhbmdlOjIxZWViMzM0N2EzNzQzOTFiNzg3ZGRlMTQ3ZjJlMWY1XzItNy0xLTEtNTg1Mzc_f36d0ff2-486c-4604-8802-134327fffc21">60.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Year Ended October&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9b7be6dd72e444c91e43d8ed9b4980b_I20201031" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xNzUvZnJhZzo5NDZlYzM0MjZhNTc0MGZkYTU1ZTcyOWE3YjUwYTk3Ni90YWJsZToyMWVlYjMzNDdhMzc0MzkxYjc4N2RkZTE0N2YyZTFmNS90YWJsZXJhbmdlOjIxZWViMzM0N2EzNzQzOTFiNzg3ZGRlMTQ3ZjJlMWY1XzMtMS0xLTEtNTg1Mzc_21be9857-db78-4f25-896f-347337142dd1">45.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92f0a4209532457b97330c2599af126b_D20201101-20211031" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xNzUvZnJhZzo5NDZlYzM0MjZhNTc0MGZkYTU1ZTcyOWE3YjUwYTk3Ni90YWJsZToyMWVlYjMzNDdhMzc0MzkxYjc4N2RkZTE0N2YyZTFmNS90YWJsZXJhbmdlOjIxZWViMzM0N2EzNzQzOTFiNzg3ZGRlMTQ3ZjJlMWY1XzMtMy0xLTEtNTg1Mzc_bd24090d-79aa-4209-af71-685dc704153b">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92f0a4209532457b97330c2599af126b_D20201101-20211031" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xNzUvZnJhZzo5NDZlYzM0MjZhNTc0MGZkYTU1ZTcyOWE3YjUwYTk3Ni90YWJsZToyMWVlYjMzNDdhMzc0MzkxYjc4N2RkZTE0N2YyZTFmNS90YWJsZXJhbmdlOjIxZWViMzM0N2EzNzQzOTFiNzg3ZGRlMTQ3ZjJlMWY1XzMtNS0xLTEtNTg1Mzc_7f8d0181-ecab-400a-b8e4-ac80d2a056ec">2.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea2aa42170064029a14838912d3185ac_I20211031" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xNzUvZnJhZzo5NDZlYzM0MjZhNTc0MGZkYTU1ZTcyOWE3YjUwYTk3Ni90YWJsZToyMWVlYjMzNDdhMzc0MzkxYjc4N2RkZTE0N2YyZTFmNS90YWJsZXJhbmdlOjIxZWViMzM0N2EzNzQzOTFiNzg3ZGRlMTQ3ZjJlMWY1XzMtNy0xLTEtNTg1Mzc_004e8e46-09c1-4c43-b5c6-2029964dc69f">51.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Year Ended October&#160;31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0bc537a9784c479a6e47674c4a3455_I20191031" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xNzUvZnJhZzo5NDZlYzM0MjZhNTc0MGZkYTU1ZTcyOWE3YjUwYTk3Ni90YWJsZToyMWVlYjMzNDdhMzc0MzkxYjc4N2RkZTE0N2YyZTFmNS90YWJsZXJhbmdlOjIxZWViMzM0N2EzNzQzOTFiNzg3ZGRlMTQ3ZjJlMWY1XzQtMS0xLTEtNTg1Mzc_91126e41-7c3f-4481-9cec-85e1ef420b33">41.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb1e445d83e7435f82ac0109d212736a_D20191101-20201031" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xNzUvZnJhZzo5NDZlYzM0MjZhNTc0MGZkYTU1ZTcyOWE3YjUwYTk3Ni90YWJsZToyMWVlYjMzNDdhMzc0MzkxYjc4N2RkZTE0N2YyZTFmNS90YWJsZXJhbmdlOjIxZWViMzM0N2EzNzQzOTFiNzg3ZGRlMTQ3ZjJlMWY1XzQtMy0xLTEtNTg1Mzc_0db2d83e-49c1-4150-8674-104676af59ec">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb1e445d83e7435f82ac0109d212736a_D20191101-20201031" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xNzUvZnJhZzo5NDZlYzM0MjZhNTc0MGZkYTU1ZTcyOWE3YjUwYTk3Ni90YWJsZToyMWVlYjMzNDdhMzc0MzkxYjc4N2RkZTE0N2YyZTFmNS90YWJsZXJhbmdlOjIxZWViMzM0N2EzNzQzOTFiNzg3ZGRlMTQ3ZjJlMWY1XzQtNS0xLTEtNTg1Mzc_03495ec8-92fc-486c-875d-aeb07e1e6061">2.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9b7be6dd72e444c91e43d8ed9b4980b_I20201031" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xNzUvZnJhZzo5NDZlYzM0MjZhNTc0MGZkYTU1ZTcyOWE3YjUwYTk3Ni90YWJsZToyMWVlYjMzNDdhMzc0MzkxYjc4N2RkZTE0N2YyZTFmNS90YWJsZXJhbmdlOjIxZWViMzM0N2EzNzQzOTFiNzg3ZGRlMTQ3ZjJlMWY1XzQtNy0xLTEtNTg1Mzc_e3951e67-cf76-406d-a0c2-e224b7d58e8a">45.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><div id="ifcd99b6df4104f80be938ce77dc8288d_178"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">EXHIBIT INDEX</span></div><div style="margin-top:5pt;padding-left:27pt;padding-right:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.565%"><tr><td style="width:1.0%"></td><td style="width:9.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.383%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Description of Document</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312506006352/dex31.htm">Second Restated Certificate of Incorporation filed with the Delaware Secretary of State, incorporated by reference to Exhibit 3.1 of the Company's Current Report on Form 8-K dated January 13, 2006</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312518351217/d657351dex31.htm">Amended and Restated By-Laws, The Cooper Companies, Inc., dated December 12, 2018, incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K dated December 18, 2018</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000071140419000051/coo-ex41.htm">Description of Securities of The Cooper Companies, Inc. Registered under Section 12 of the Exchange Act, incorporated by reference to Exhibit 4.1 to the Company&#8217;s Annual Report on Form 10-K for the year ended October 31, 2019</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.1#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312507197691/dex101.htm">The Cooper Companies, Inc. Change in Control Severance Plan, dated May 21, 2007, incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10&#8209;Q for the fiscal quarter ended July 31, 2007</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.2#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000071140419000026/coo-ex101_2019x04x30x10q.htm">Executive Employment Agreement by and between The Cooper Companies, Inc. and Albert G. White III, effective as of November 1, 2018, incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q filed on May 31, 2019</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.3#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000071140419000026/coo-ex103_2019x04x30x10q.htm">Executive Employment Agreement by and between The Cooper Companies, Inc. and Daniel G. McBride, effective as of November 1, 2018, incorporated by reference to Exhibit 10.3 to the Company's Quarterly Report on Form 10-Q filed on May 31, 2019</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.4#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000071140419000026/coo-ex102_2019x04x30x10q.htm">Executive Employment Agreement by and between The Cooper Companies, Inc. and Brian G. Andrews, effective as of November 1, 2018, incorporated by reference to Exhibit 10.2 to the Company's Quarterly Report on Form 10-Q filed on May 31, 2019</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.5#<br/></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000071140419000026/coo-ex104_2019x04x30x10q.htm">Executive Employment Agreement by and between The Cooper Companies, Inc. and Holly R. Sheffield, effective as of November 1, 2018, incorporated by reference to Exhibit 10.4 to the Company's Quarterly Report on Form 10-Q filed on May 31, 2019</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.6#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312516443302/d117679ddef14a.htm">The Third Amended and Restated 2007 Long-Term Incentive Plan of The Cooper Companies, Inc., incorporated by reference to the Company's Proxy Statement filed January 29, 2016</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.7#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312507270797/dex1032.htm">Form of Non-Qualified Stock Option Agreement Pursuant to the 2007 Long-Term Incentive Plan of The Cooper Companies, Inc., incorporated by reference to Exhibit 10.32 of the Company's Annual Report on Form 10-K for the fiscal year ended October&#160;31, 2007</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.8#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312507270797/dex1034.htm">Form of Deferred Stock Agreement Pursuant to the 2007 Long-Term Incentive Plan of The Cooper Companies, Inc., incorporated by reference to Exhibit 10.34 of the Company's Annual Report on Form 10-K for the fiscal year ended October 31, 2007</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.9#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312509029284/dex101.htm">Form of Long Term Performance Share Award Agreement Pursuant to the 2007 Long-Term Incentive Plan of The Cooper Companies, Inc., incorporated by reference to Exhibit&#160;10.1 of the Company's Current Report on Form 8-K dated February 13, 2009</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.10#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312519025849/d686735ddef14a.htm">The Cooper Companies, Inc.&#8217;s 2019 Employee Stock Purchase Plan incorporated by reference to Company&#8217;s Proxy Statement filed February 01, 2019</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.11#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312520024203/d873721ddef14a.htm#toc873721_23">The 2020 Long Term Incentive Plan for Non-Employee Directors of The Cooper Companies, Inc., incorporated by reference to the Company's Proxy Statement filed February 4, 2020</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.12#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312519315153/d844723dex101.htm">Form of Restricted Stock Unit Agreement pursuant to the 2020 Long Term Incentive Plan for Non-Employee Directors of The Cooper Companies, Inc</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312519315153/d844723dex101.htm">.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312519315153/d844723dex101.htm">, incorporated by reference to Exhibit 10.13</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312519315153/d844723dex101.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312519315153/d844723dex101.htm">to the C</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312519315153/d844723dex101.htm">ompan</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312519315153/d844723dex101.htm">y's An</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312519315153/d844723dex101.htm">nual Report on Form 10-K for the fiscal </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312519315153/d844723dex101.htm">year ended October 31, 2020</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312519315153/d844723dex101.htm">, incorporated by reference to Exhibit 10.1</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312508257120/dex1041.htm">License Agreement dated as of November 19, 2007, by and among CIBA Vision AG, CIBA Vision Corporate and CooperVision, Inc., incorporated by reference to Exhibit 10.41 to the Company's Annual Report on Form 10-K for the fiscal year ended October 31, 2008</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.14</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312512513185/d458352dex991.htm">Amendment No. 1 to the License Agreement dated as of November 19, 2007, by and among CIBA Vision AG, CIBA Vision Corporate and CooperVision, Inc., incorporated by reference to Exhibit 99.1 of the Company&#8217;s Current Report on Form 8-K filed on December 21, 2012</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.15</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312505004815/dex101.htm">Lease Contract dated as of November 6, 2003, by and between The Puerto Rico Industrial Development Company and Ocular Sciences Puerto Rico, Inc., incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K dated January 12, 2005</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.16</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312505004815/dex102.htm">First Supplement and Amendment to Lease Contract dated as of December 30, 2003, by and between The Puerto Rico Industrial Development Company and Ocular Sciences Puerto Rico, Inc., incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K dated January 12, 2005</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.17</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312505004815/dex103.htm">Assignment of Lease Agreement dated as of June 29, 2004, by and among Ocular Sciences Puerto Rico, Inc., Ocular Sciences Cayman Islands Corporation and The Puerto Rico Industrial Development Company, incorporated by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K dated January 12, 2005</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:5pt;padding-left:27pt;padding-right:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.565%"><tr><td style="width:1.0%"></td><td style="width:9.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.383%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Description of Document</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.18</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000156459020014844/coo-ex101_8.htm">Revolving Credit and Term Loan Agreement, dated as of April 1, 2020, among the Company, CooperVision International Holding Company, LP, CooperSurgical Netherlands B.V., CooperVision Holding Kft., the lenders from time to time party thereto and KeyBank National Association, as administrative agent, incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K dated April 2, 2020</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.19</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/711404/000071140420000042/c00-ex102020201031x10k.htm">Amendment No. 1 and Joinder, dated as of October 30, 2020, to Revolving Credit and Term Loan Agreement, dated as of April 1, 2020, among the Company, CooperVision International Holding Company, LP, CooperSurgical Netherlands B.V., CooperVision Holding Kft., the lenders from time to time party thereto and KeyBank National Association, as administrative agent, incorporated by reference to Exhibit 10.20 to the Company's Annual Report on Form 10-K for the fiscal year ended October 31, 2020</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.20</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/711404/000119312521321676/d235792dex101.htm">Loan Agreement, dated as of November 2, 2021, among the Company, the lenders party thereto and The Bank of Nova Scotia, as administrative agent, incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K dated November 5, 2021</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.21</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000119312521361145/d272863dex101.htm">Term Loan Agreement, dated as of December 17, 2021, by and among The Cooper Companies, Inc., the lenders from time to time party thereto, and PNC Bank, National Association, as administrative agent, incorporated by reference to the Company's Current Report on Form 8-K filed on December 17, 2021.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.22</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000071140422000015/coo-ex103_2022x01x31x10q.htm">Amendment No.2 and Joinder, dated as of December 17, 2021, to Revolving Credit and Term Loan Agreement, dated as of April 1, 2020, among the Company, CooperVision International Limited, CooperVision Holding Kft., CooperSurgical Holdings Limited, the lenders party thereto, and KeyBank, National Association, as administrative agent</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000071140422000015/coo-ex103_2022x01x31x10q.htm">, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000071140422000015/coo-ex103_2022x01x31x10q.htm"> Exhibit 10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000071140422000015/coo-ex103_2022x01x31x10q.htm">3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/711404/000071140422000015/coo-ex103_2022x01x31x10q.htm"> of the Company's Current Report on Form 8-K filed December 10, 2021</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.23#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/711404/000119312521353917/d220660dex101.htm">The Cooper Companies, Inc. 2022 Incentive Payment Plan, incorporated by reference to Exhibit 10.1 of the Company's Current Report on Form 8-K filed December 10, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/711404/000119312521353917/d220660dex101.htm">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.24</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/711404/000119312521326207/d204711dex21.htm">Agreement and Plan of Merger, dated as of November 6, 2021, by and among The Cooper Companies, Inc., CooperSurgical, Inc., Bruin Merger Sub, LLC, GI Generate Parent LLC, and GI Partners Acquisitions LLC., incorporated by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K dated November 10, 2021</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="coo-ex21_20221031x10k.htm">Subsidiaries</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:45pt;padding-right:27pt;text-align:justify;text-indent:-45pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="coo-ex23_20221031x10k.htm">Consent of Independent Registered Public Accounting Firm</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Power of Attorney (included on signature page hereto)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="coo-ex311_20221031x10k.htm">Certification of the Chief Executive Officer, pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="coo-ex312_20221031x10k.htm">Certification of the Chief Financial Officer, pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="coo-ex321_20221031x10k.htm">Certification of the Chief Executive Officer, pursuant to 18 U.S.C. Section 1350</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="coo-ex322_20221031x10k.htm">Certification of the Chief Financial Officer, pursuant to 18 U.S.C. Section 1350</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">The following materials from the Company's Annual Report on Form 10-K for the year ended October 31, 2022, formatted in Inline XBRL (Extensible Business Reporting Language):(i) Consolidated Statements of Income for the years ended October 31, 2022, 2021 and 2020 (ii) Consolidated Statements of Comprehensive Income for the years ended October 31, 2022, 2021 and 2020 (iii) Consolidated Balance Sheets at October 31, 2022 and 2021, (iv) Consolidated Statements of Stockholders' Equity for the years ended October 31, 2022, 2021 and 2020 (v) Consolidated Statements of Cash Flows for the years ended October 31, 2022, 2021 and 2020, (vi) related notes to consolidated financial statements and (vii) Schedule II Valuation and Qualifying Accounts</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="margin-top:5pt;padding-right:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The agreement received confidential treatment from the Securities and Exchange Commission with respect to certain portions of this exhibit. Omitted portions have been filed separately with the Commission. </span></div><div style="padding-left:22.5pt;padding-right:27pt;text-indent:-22.5pt"><span><br/></span></div><div style="padding-left:22.5pt;padding-right:27pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">#&#160;&#160;&#160;&#160;Indicates management contract or compensatory plan.</span></div><div style="padding-left:22.5pt;padding-right:27pt;text-indent:-20.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">*      The certifications attached as Exhibits 32.1 and 32.2 that accompany this Annual Report on Form 10-K are not deemed filed with the SEC and are not to be incorporated by reference into any filing of The Cooper Companies, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Form 10-K, irrespective of any general incorporation language contained in such filing.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><div id="ifcd99b6df4104f80be938ce77dc8288d_181"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Item 16. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Form 10-K Summary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><div id="ifcd99b6df4104f80be938ce77dc8288d_184"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on December&#160;9, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:288pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC.</span></div><div style="padding-left:288pt;text-align:justify"><span><br/></span></div><div style="padding-left:288pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;text-decoration:underline">By:       /s/ Albert G. White, III     </span></div><div style="padding-left:288pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">              </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> Albert G. White, III </span></div><div style="padding-left:288pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> President &amp; Chief Executive Officer</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on the dates set forth opposite their respective names.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.156%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.242%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.774%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Signature</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Capacity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Date</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">/s/    ALBERT G. WHITE, III </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">President, Chief Executive Officer and Director (Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">December 9, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(Albert G. White, III)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">/s/    ROBERT S. WEISS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Chairman of the Board</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">December 9, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(Robert S. Weiss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">/s/    WILLIAM A. KOZY</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Vice Chairman of the Board and Lead Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">December 9, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(William A. Kozy)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">/s/    BRIAN G. ANDREWS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Executive Vice President, Chief Financial Officer and Treasurer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">December 9, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(Brian G. Andrews)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">/s/    AGOSTINO RICUPATI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Senior Vice President and Chief Accounting Officer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">December 9, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(Agostino Ricupati)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">/s/    COLLEEN E. JAY</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">December 9, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(Colleen E. Jay)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">/s/    JODY S. LINDELL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">December 9, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(Jody S. Lindell)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">/s/    GARY S. PETERSMEYER</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">December 9, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(Gary S. Petersmeyer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">/s/    MARIA RIVAS M.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">December 9, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(Maria Rivas M.D.)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">/s/    TERESA S. MADDEN</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">December 9, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(Teresa S. Madden)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">/s/    CYNTHIA L. LUCCHESE</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">December 9, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(Cynthia L. Lucchese)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><div id="ifcd99b6df4104f80be938ce77dc8288d_187"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">CORPORATE INFORMATION</span></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:31.805%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.644%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.647%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">BOARD OF DIRECTORS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Robert S. Weiss</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Chairman of the Board</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">William A. Kozy</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Vice Chairman and Lead Director</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Colleen E. Jay</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Director</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Jody S. Lindell</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">President and Chief Executive Officer,</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">S.G. Management, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Cynthia L. Lucchese</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Chief Strategy Officer, Penske Entertainment Corp.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Teresa S. Madden</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Director</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Gary S. Petersmeyer</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Director</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Maria Rivas M.D.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Global Chief Medical Affairs Officer and Head of Evidence Generation, Pfizer, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Albert G. White, III</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">President &amp; Chief Executive Officer</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">COMMITTEES OF THE BOARD</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Audit Committee</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Teresa S. Madden (Chairman)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Jody S. Lindell </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cynthia L. Lucchese </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gary S. Petersmeyer</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Maria Rivas M.D.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Corporate Governance and Nominating Committee</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">William A. Kozy (Chairman)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Colleen E. Jay</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Jody S. Lindell</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cynthia L. Lucchese</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Maria Rivas M.D.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Organization and Compensation Committee</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Colleen E. Jay (Chairman)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">William A. Kozy</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Teresa S. Madden</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gary S. Petersmeyer</span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">EXECUTIVE OFFICERS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Albert G. White, III</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Daniel G. McBride</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Executive Vice President and Chief Operating Officer </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Brian G. Andrews</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Executive Vice President, Chief Financial Officer and Treasurer</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Agostino Ricupati</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Senior Vice President and Chief Accounting Officer</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Nicholas S. Khadder</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Vice President, General Counsel and Corporate Secretary</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Holly R. Sheffield</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">President of CooperSurgical, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">Gerard H. Warner III</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">President of CooperVision, Inc.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">PRINCIPAL SUBSIDIARIES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">CooperVision, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6101 Bollinger Canyon Road</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Suite 500</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">San Ramon, CA 94583</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">925-460-3600</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">www.coopervision.com</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">CooperSurgical, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">75 Corporate Drive</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Trumbull, CT 06611</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">203-601-5200</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">www.coopersurgical.com</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">CORPORATE OFFICES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%">The Cooper Companies, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6101 Bollinger Canyon Road</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Suite 500</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">San Ramon, CA 94583</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">925-460-3600</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">www.coopercos.com</span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">INVESTOR INFORMATION</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Recent news releases, the annual report on Securities and Exchange Commission Form 10-K, information about the Company's corporate governance program, recent investor presentations, replays of quarterly conference calls and historical stock quotes are available on our Web site at www.coopercos.com.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">INVESTOR RELATIONS CONTACT</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">Kim Duncan</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Vice President, Investor Relations and Risk Management</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6101 Bollinger Canyon Road</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Suite 500</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">San Ramon, CA 94583</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Voice: 925-460-3663</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">E-mail: ir@cooperco.com</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">ANNUAL MEETING</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">The Cooper Companies will hold its Annual Stockholders' Meeting in March 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">TRANSFER AGENT</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">American Stock Transfer &amp; Trust Company</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6201 15th Avenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Brooklyn, NY 11219</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">800-937-5449</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">TRADEMARKS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">The Cooper Companies, Inc., its subsidiaries or affiliates own, license or distribute the registered trademarks, common law trademarks and trade names referenced in this report.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">INDEPENDENT AUDITORS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">KPMG LLP</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">STOCK EXCHANGE LISTING</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">The New York Stock Exchange</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Ticker Symbol &#8220;COO&#8221;</span></div></td></tr></table></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>2
<FILENAME>coo-ex21_20221031x10k.htm
<DESCRIPTION>EX-21
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i846183e61d224d8bb217db01b6011125_1"></div><div style="min-height:13.5pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SUBSIDIARIES OF THE COOPER COMPANIES, INC. A DELAWARE CORPORATION</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.166%"><tr><td style="width:0.1%"></td><td style="width:2.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.382%"></td><td style="width:0.1%"></td></tr><tr><td colspan="72" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NAME</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">JURISDICTION OF INCORPORATION</font></td></tr><tr><td colspan="72" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Cooper Companies, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="66" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">New York</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="60" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Paragon Vision Sciences, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Arizona</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="60" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cooper Global Holdings, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">The Cooper Companies Global Holdings LP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">England-Wales</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Global Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">CooperVision International Holding Company, LP</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">England-Wales</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision do Brasil Ltda</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Singapore Pte Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Singapore</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Optical Trade (Shanghai) Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CVI Contact Lens Pvt. Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">India</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperSurgical Canada, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Ontario</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Vision Manufacturing Puerto Rico LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Puerto Rico</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Manufacturing Costa Rica SRL</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Costa Rica</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision (UK) Holdings Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Manufacturing Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Australia Pty Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Distribution SRL</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Canada Corp.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision S.A.S.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Italia srl</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Italy</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Nederland BV</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Nederland, Belgian Branch</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Japan, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Japan</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Iberia SL</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Spain</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision S.A. (Pty) Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">South Africa</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Nordic AB</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Sweden</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Sarl</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision RUS LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Russia</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Israel Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Israel</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision Lens Care Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Sauflon CL Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision CL Kft</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Hungary</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="66" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cooper Medical, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="60" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperSurgical, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperGenomics, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Invitro Genetics LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Reprogenetics LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">LifeGlobal Group LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Connecticut</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Generate Parent LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="54" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Generate Intermediate LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Generate Life Sciences, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Generate GCP Coinvest LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Generate L Blocker LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Generate NQ Blocker LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Generate LNQ Holdings LLC </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cryobank Holdings LLC </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">California Cryobank LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CCB-Kitazato LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CCB-DEB LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CCB-Fertility Tech LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Donor Application LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">DEB Donor Egg Bank Canada Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Canada</font></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:13.5pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.166%"><tr><td style="width:0.1%"></td><td style="width:2.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.382%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">California Cryobank Stem Cell Services LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CCB-NWC LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CCB-MCB LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Generate IP Holdings LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Generate Sperm Bank Canada Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CBR Acquisition Holding Corp.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CBR Systems, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Generate International LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Insception Biosciences, Inc. </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Generate Life Sciences Australia Pty Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Generate CC Australia Pty Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">SC Storage Holdings Pty Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">SC Storage Finance Pty Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">SC Storage Operations Pty Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cell Care Australia Pty Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cell Care Australia Pty Ltd, New Zealand Branch</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="60" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperSurgical Distribution B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="60" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Cooper Surgical Holdings Ltd.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">CooperMedical S.r.l.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Costa Rica</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Invitro Genetics Ltd.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Research Instruments Ltd.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Origio A&#47;S</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Denmark</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Each subsidiary is wholly-owned either by The Cooper Companies, Inc. or by the wholly-owned subsidiary under which it is indented in the list above.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>3
<FILENAME>coo-ex23_20221031x10k.htm
<DESCRIPTION>EX-23
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i4ce565e10998430b874d37c331096389_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Exhibit 23</font></div><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;text-decoration:underline">Consent of Independent Registered Public Accounting Firm</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:18pt"><font><br></font></div><div style="margin-bottom:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">We consent to the incorporation by reference in the registration statements (Nos. 333-22417, 333-25051, 333-27639, 333-40431, 333-80795, 333-34206, 333-48152, and 333-108066) on Form S-3 and registration statements (Nos. 333-10977, 333-58839, 333-67954, 333-101366, 333-104346, 333-115520, 333-133719, 333-133720, 333-143338, 333-158892, 333-174682, 333-233577, and 333-237505) on Form S-8 of our report dated December&#160;9, 2022, with respect to the consolidated financial statements and financial statement Schedule II of The Cooper Companies, Inc. and the effectiveness of internal control over financial reporting.</font></div><div style="margin-bottom:10pt;text-align:justify"><font><br></font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#47;s&#47; KPMG LLP</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">San Francisco, California</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">December&#160;9, 2022</font></div><div style="margin-bottom:13pt;text-align:justify"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>coo-ex311_20221031x10k.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ibb07a83df95649bf83f3b9ca8be6f323_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION PURSUANT TO EXCHANGE ACT RULE 13a-14(a)&#47;15d-14(a) </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">AS ADOPTED PURSUANT TO SECTION 302 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Albert G. White III, certify that&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this annual report on Form 10-K of The Cooper Companies, Inc. (the &#8220;registrant&#8221;)&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)  Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)  Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="padding-left:18pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.416%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 9, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Albert G. White III</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Albert G. White III</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer </font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>coo-ex312_20221031x10k.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i063fbf7659904f27bede6739f8e64b4a_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2 </font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION PURSUANT TO EXCHANGE ACT RULE 13a-14(a)&#47;15d-14(a) </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">AS ADOPTED PURSUANT TO SECTION 302 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Brian G. Andrews, certify that&#58; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this annual report on Form 10-K of The Cooper Companies, Inc. (the &#8220;registrant&#8221;)&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)  Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)  Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="padding-left:18pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.704%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.705%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 9, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Brian G. Andrews</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian G. Andrews</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Executive Vice President, Chief Financial Officer and Treasurer<br></font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>coo-ex321_20221031x10k.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i447f9fd0cebd4a98909b38dd48067575_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002 </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Albert G. White III, do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Annual Report on Form 10-K of The Cooper Companies, Inc. (the &#34;Company&#34;) for the fiscal year ended October&#160;31, 2022, as filed with the Securities and Exchange Commission (the &#8220;Report&#8221;), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and  </font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. </font></div><div style="margin-top:9pt;padding-left:45pt"><font><br></font></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.310%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 9, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Albert G. White III</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Albert G. White III</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div style="margin-top:9pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>coo-ex322_20221031x10k.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="idf3b3ef791be4b12bdf730aafa946009_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002 </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Brian G. Andrews, do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Annual Report on Form 10-K of The Cooper Companies, Inc. (the &#34;Company&#34;) for the fiscal year ended October&#160;31, 2022, as filed with the Securities and Exchange Commission (the &#8220;Report&#8221;), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and  </font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. </font></div><div style="margin-top:9pt;padding-left:45pt"><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 9, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Brian G. Andrews</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian G. Andrews</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Financial Officer and Treasurer</font></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>coo-20221031.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:c1100544-9949-49e4-a84a-324e954b65ab,g:6f410f64-26fc-4654-ba7e-29974b75a0fc-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:coo="http://www.coopercos.com/20221031" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.coopercos.com/20221031">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="coo-20221031_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="coo-20221031_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="coo-20221031_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="coo-20221031_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.coopercos.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.coopercos.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofIncome" roleURI="http://www.coopercos.com/role/ConsolidatedStatementsofIncome">
        <link:definition>0000003 - Statement - Consolidated Statements of Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome">
        <link:definition>0000004 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncomeParenthetical" roleURI="http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical">
        <link:definition>0000005 - Statement - Consolidated Statements of Comprehensive Income (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.coopercos.com/role/ConsolidatedBalanceSheets">
        <link:definition>0000006 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.coopercos.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000007 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquity" roleURI="http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity">
        <link:definition>0000008 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquityParenthetical" roleURI="http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical">
        <link:definition>0000009 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>0000010 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPolicies" roleURI="http://www.coopercos.com/role/OrganizationandSignificantAccountingPolicies">
        <link:definition>0000011 - Disclosure - Organization and Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeases" roleURI="http://www.coopercos.com/role/OperatingLeases">
        <link:definition>0000012 - Disclosure - Operating Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandJointVenture" roleURI="http://www.coopercos.com/role/AcquisitionsandJointVenture">
        <link:definition>0000013 - Disclosure - Acquisitions and Joint Venture</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssets" roleURI="http://www.coopercos.com/role/IntangibleAssets">
        <link:definition>0000014 - Disclosure - Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancingArrangements" roleURI="http://www.coopercos.com/role/FinancingArrangements">
        <link:definition>0000015 - Disclosure - Financing Arrangements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.coopercos.com/role/IncomeTaxes">
        <link:definition>0000016 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.coopercos.com/role/EarningsPerShare">
        <link:definition>0000017 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.coopercos.com/role/StockholdersEquity">
        <link:definition>0000018 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockPlans" roleURI="http://www.coopercos.com/role/StockPlans">
        <link:definition>0000019 - Disclosure - Stock Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefits" roleURI="http://www.coopercos.com/role/EmployeeBenefits">
        <link:definition>0000020 - Disclosure - Employee Benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Contingencies" roleURI="http://www.coopercos.com/role/Contingencies">
        <link:definition>0000021 - Disclosure - Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentInformation" roleURI="http://www.coopercos.com/role/BusinessSegmentInformation">
        <link:definition>0000022 - Disclosure - Business Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialDerivativesandHedging" roleURI="http://www.coopercos.com/role/FinancialDerivativesandHedging">
        <link:definition>0000023 - Disclosure - Financial Derivatives and Hedging</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleII" roleURI="http://www.coopercos.com/role/ScheduleII">
        <link:definition>0000024 - Disclosure - Schedule II</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPoliciesPolicies" roleURI="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies">
        <link:definition>0000025 - Disclosure - Organization and Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPoliciesTables" roleURI="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesTables">
        <link:definition>0000026 - Disclosure - Organization and Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesTables" roleURI="http://www.coopercos.com/role/OperatingLeasesTables">
        <link:definition>0000027 - Disclosure - Operating Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandJointVentureTables" roleURI="http://www.coopercos.com/role/AcquisitionsandJointVentureTables">
        <link:definition>0000028 - Disclosure - Acquisitions and Joint Venture (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsTables" roleURI="http://www.coopercos.com/role/IntangibleAssetsTables">
        <link:definition>0000029 - Disclosure - Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://www.coopercos.com/role/DebtTables">
        <link:definition>0000030 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.coopercos.com/role/IncomeTaxesTables">
        <link:definition>0000031 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.coopercos.com/role/EarningsPerShareTables">
        <link:definition>0000032 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://www.coopercos.com/role/StockholdersEquityTables">
        <link:definition>0000033 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockPlansTables" roleURI="http://www.coopercos.com/role/StockPlansTables">
        <link:definition>0000034 - Disclosure - Stock Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsTables" roleURI="http://www.coopercos.com/role/EmployeeBenefitsTables">
        <link:definition>0000035 - Disclosure - Employee Benefits (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentInformationTables" roleURI="http://www.coopercos.com/role/BusinessSegmentInformationTables">
        <link:definition>0000036 - Disclosure - Business Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialDerivativesandHedgingTables" roleURI="http://www.coopercos.com/role/FinancialDerivativesandHedgingTables">
        <link:definition>0000037 - Disclosure - Financial Derivatives and Hedging (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>0000038 - Disclosure - Organization and Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPoliciesInventoryDetails" roleURI="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesInventoryDetails">
        <link:definition>0000039 - Disclosure - Organization and Significant Accounting Policies - Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails" roleURI="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails">
        <link:definition>0000040 - Disclosure - Organization and Significant Accounting Policies - Property Plant and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails" roleURI="http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails">
        <link:definition>0000041 - Disclosure - Operating Leases - Leases on the Consolidated Condensed Balance Sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesNarrativeDetails" roleURI="http://www.coopercos.com/role/OperatingLeasesNarrativeDetails">
        <link:definition>0000042 - Disclosure - Operating Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails" roleURI="http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails">
        <link:definition>0000043 - Disclosure - Operating Leases - Minimum Rental Payments Required Under Operating Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails_1" roleURI="http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails_1">
        <link:definition>0000043 - Disclosure - Operating Leases - Minimum Rental Payments Required Under Operating Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails" roleURI="http://www.coopercos.com/role/AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails">
        <link:definition>0000044 - Disclosure - Acquisitions and Joint Venture - Total Purchase Consideration for Business and Asset Acquisitions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandJointVentureNarrativeDetails" roleURI="http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails">
        <link:definition>0000045 - Disclosure - Acquisitions and Joint Venture - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" roleURI="http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails">
        <link:definition>0000046 - Disclosure - Acquisitions and Joint Venture - Recognized Identified Assets Acquired and Liabilities Assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandJointVentureProformaInformationDetails" roleURI="http://www.coopercos.com/role/AcquisitionsandJointVentureProformaInformationDetails">
        <link:definition>0000047 - Disclosure - Acquisitions and Joint Venture - Proforma Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandJointVentureContingentConsiderationReconciliationDetails" roleURI="http://www.coopercos.com/role/AcquisitionsandJointVentureContingentConsiderationReconciliationDetails">
        <link:definition>0000048 - Disclosure - Acquisitions and Joint Venture - Contingent Consideration Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsGoodwillDetails" roleURI="http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails">
        <link:definition>0000049 - Disclosure - Intangible Assets - Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNarrativeDetails" roleURI="http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails">
        <link:definition>0000050 - Disclosure - Intangible Assets - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsOtherIntangibleAssetsDetails" roleURI="http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails">
        <link:definition>0000051 - Disclosure - Intangible Assets - Other Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails" roleURI="http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails">
        <link:definition>0000052 - Disclosure - Intangible Assets - Estimated Amortization Expenses for Intangible Assets with Definite Lives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancingArrangementsTotalDebtDetails" roleURI="http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails">
        <link:definition>0000053 - Disclosure - Financing Arrangements - Total Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancingArrangementsNarrativeDetails" roleURI="http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails">
        <link:definition>0000054 - Disclosure - Financing Arrangements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.coopercos.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>0000055 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeBeforeIncomeTaxesDetails" roleURI="http://www.coopercos.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails">
        <link:definition>0000056 - Disclosure - Income Taxes - Income Before Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeTaxProvisionBenefitDetails" roleURI="http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails">
        <link:definition>0000057 - Disclosure - Income Taxes - Income Tax Provision (Benefit) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails" roleURI="http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails">
        <link:definition>0000058 - Disclosure - Income Taxes - Reconciliation between the Expected Provision for Income taxes at the US Federal Statutory Rate and the Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>0000059 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesChangesinUnrecognizedTaxBenefitsDetails" roleURI="http://www.coopercos.com/role/IncomeTaxesChangesinUnrecognizedTaxBenefitsDetails">
        <link:definition>0000060 - Disclosure - Income Taxes - Changes in Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareBasicandDilutedDetails" roleURI="http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails">
        <link:definition>0000061 - Disclosure - Earnings Per Share - Basic and Diluted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails" roleURI="http://www.coopercos.com/role/EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails">
        <link:definition>0000062 - Disclosure - Earnings Per Share - Stock Options to Purchase Common Stock and Restricted Stock Units Not Included in Diluted Earnings Per Share Due to Antidilutive Effect (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails" roleURI="http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails">
        <link:definition>0000063 - Disclosure - Stockholders' Equity - Changes in Accumulated Other Comprehensive Income (Loss) Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityNarrativeDetails" roleURI="http://www.coopercos.com/role/StockholdersEquityNarrativeDetails">
        <link:definition>0000064 - Disclosure - Stockholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityShareRepurchasesDetails" roleURI="http://www.coopercos.com/role/StockholdersEquityShareRepurchasesDetails">
        <link:definition>0000065 - Disclosure - Stockholders' Equity - Share Repurchases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockPlansNarrativeDetails" roleURI="http://www.coopercos.com/role/StockPlansNarrativeDetails">
        <link:definition>0000066 - Disclosure - Stock Plans - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails" roleURI="http://www.coopercos.com/role/StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails">
        <link:definition>0000067 - Disclosure - Stock Plans - Compensation Expense and Related Income Tax Benefit for Share-Based Awards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails" roleURI="http://www.coopercos.com/role/StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails">
        <link:definition>0000068 - Disclosure - Stock Plans - Assumptions Used in Estimating Fair Value of Stock Options Award Granted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockPlansStockOptionPlansDetails" roleURI="http://www.coopercos.com/role/StockPlansStockOptionPlansDetails">
        <link:definition>0000069 - Disclosure - Stock Plans - Stock Option Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockPlansNonVestedRSUsDetails" roleURI="http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails">
        <link:definition>0000070 - Disclosure - Stock Plans - Non-Vested RSUs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsNarrativeDetails" roleURI="http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails">
        <link:definition>0000071 - Disclosure - Employee Benefits - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails" roleURI="http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails">
        <link:definition>0000072 - Disclosure - Employee Benefits - Changes in Benefit Obligation, Changes in Plan Assets and Funded Status (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails" roleURI="http://www.coopercos.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails">
        <link:definition>0000073 - Disclosure - Employee Benefits - Amounts Recognized in Accumulated Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsReconciliationofPrepaidAccruedPensionCostDetails" roleURI="http://www.coopercos.com/role/EmployeeBenefitsReconciliationofPrepaidAccruedPensionCostDetails">
        <link:definition>0000074 - Disclosure - Employee Benefits - Reconciliation of Prepaid (Accrued) Pension Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails" roleURI="http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails">
        <link:definition>0000075 - Disclosure - Employee Benefits - Components of Net Periodic Pension Costs and Other Amounts Recognized in Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails" roleURI="http://www.coopercos.com/role/EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails">
        <link:definition>0000076 - Disclosure - Employee Benefits - Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails" roleURI="http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails">
        <link:definition>0000077 - Disclosure - Employee Benefits - Weighted-Average Assumptions Used in Computing Net Periodic Pension Cost and Projected Benefit Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails" roleURI="http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails">
        <link:definition>0000078 - Disclosure - Employee Benefits - Weighted-Average Asset Allocations by Asset Category (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails" roleURI="http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails">
        <link:definition>0000079 - Disclosure - Employee Benefits - Fair Value Measurement of Plan Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsEstimatedFutureBenefitPaymentsDetails" roleURI="http://www.coopercos.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetails">
        <link:definition>0000080 - Disclosure - Employee Benefits - Estimated Future Benefit Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentInformationNarrativeDetails" roleURI="http://www.coopercos.com/role/BusinessSegmentInformationNarrativeDetails">
        <link:definition>0000081 - Disclosure - Business Segment Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentInformationBusinessSegmentNetSalesDetails" roleURI="http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails">
        <link:definition>0000082 - Disclosure - Business Segment Information - Business Segment Net Sales (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentInformationBusinessSegmentInformationDetails" roleURI="http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails">
        <link:definition>0000083 - Disclosure - Business Segment Information - Business Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails" roleURI="http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails">
        <link:definition>0000084 - Disclosure - Business Segment Information - Information by Geographical Area by Country of Domicile (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialDerivativesandHedgingNarrativeDetails" roleURI="http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails">
        <link:definition>0000085 - Disclosure - Financial Derivatives and Hedging - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails" roleURI="http://www.coopercos.com/role/FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails">
        <link:definition>0000086 - Disclosure - Financial Derivatives and Hedging - Derivative Instruments Recognized in Condensed Consolidated Statements of Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails" roleURI="http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails">
        <link:definition>0000087 - Disclosure - Financial Derivatives and Hedging - Changes in Accumulated Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIDetails" roleURI="http://www.coopercos.com/role/ScheduleIIDetails">
        <link:definition>0000088 - Disclosure - Schedule II (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="coo_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationEffectOfChangeInDiscountRate" abstract="false" name="DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationEffectOfChangeInDiscountRate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_GainLossOnSaleOfAssetsAndAssetImpairmentChargesAndOther" abstract="false" name="GainLossOnSaleOfAssetsAndAssetImpairmentChargesAndOther" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember" abstract="true" name="SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract" abstract="true" name="DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis" abstract="true" name="BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="coo_BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" abstract="false" name="BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember" abstract="true" name="ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet" abstract="false" name="IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember" abstract="true" name="ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_SightGlassVisionIncMember" abstract="true" name="SightGlassVisionIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_AccruedPrepaidPensionCosts" abstract="false" name="AccruedPrepaidPensionCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_TermLoanAgreement2021364DayMember" abstract="true" name="TermLoanAgreement2021364DayMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="coo_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_AsianPacificCreditFacilitiesYenDenominatedMember" abstract="true" name="AsianPacificCreditFacilitiesYenDenominatedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" abstract="true" name="OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="coo_CommonStockExcludingTreasuryStockParNetValueMember" abstract="true" name="CommonStockExcludingTreasuryStockParNetValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_IncreaseDecreaseInContingentConsiderationLiability" abstract="false" name="IncreaseDecreaseInContingentConsiderationLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems" abstract="true" name="ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="coo_RestOfTheWorldMember" abstract="true" name="RestOfTheWorldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_AssetAquisitionDomain" abstract="true" name="AssetAquisitionDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_CreditAgreement2020Member" abstract="true" name="CreditAgreement2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_EuropeanCreditFacilityMember" abstract="false" name="EuropeanCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_FertilityMember" abstract="true" name="FertilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember" abstract="true" name="AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_EffectiveIncomeTaxRateReconciliationChangeInDomesticFederalTaxReturnAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationChangeInDomesticFederalTaxReturnAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_BondMutualFundsMember" abstract="false" name="BondMutualFundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_EmployeeStockPurchasePlanMember" abstract="true" name="EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_RevolvingCreditFacilityAndTermLoanFacility2020Member" abstract="true" name="RevolvingCreditFacilityAndTermLoanFacility2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_TermLoansMember" abstract="true" name="TermLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_CookMedicalsReproductiveHealthBusinessMember" abstract="true" name="CookMedicalsReproductiveHealthBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_TreasuryStockParNetValueMember" abstract="false" name="TreasuryStockParNetValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" abstract="false" name="DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember" abstract="true" name="ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_CorporateReconcilingItemsAndEliminationsMember" abstract="true" name="CorporateReconcilingItemsAndEliminationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" abstract="false" name="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_EssilorInternationalSASMember" abstract="true" name="EssilorInternationalSASMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_PayablesSecondInstallmentMember" abstract="true" name="PayablesSecondInstallmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_CoopervisionSegmentMember" abstract="true" name="CoopervisionSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_TermLoanFacility2021AdjustedLIBORateLoansMember" abstract="true" name="TermLoanFacility2021AdjustedLIBORateLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain" abstract="true" name="BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_BusinessAcquisitionAndAssetAcquisitionDomain" abstract="true" name="BusinessAcquisitionAndAssetAcquisitionDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_MultifocalLensMember" abstract="true" name="MultifocalLensMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent" abstract="false" name="LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredRevenue" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredRevenue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract" abstract="true" name="DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligationIncreaseDecrease" abstract="false" name="DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligationIncreaseDecrease" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="coo_PayablesFirstInstallmentMember" abstract="true" name="PayablesFirstInstallmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_OfficeAndSurgicalProductsMember" abstract="true" name="OfficeAndSurgicalProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_AssetAquisitionAxis" abstract="true" name="AssetAquisitionAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="coo_PayablesThirdInstallmentMember" abstract="true" name="PayablesThirdInstallmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward" abstract="true" name="AOCIAttributableToParentBeforeReclassificationAndTaxRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="coo_LicenseAndDistributionRightsAndOtherMember" abstract="true" name="LicenseAndDistributionRightsAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_CoopersurgicalSegmentMember" abstract="true" name="CoopersurgicalSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable" abstract="true" name="ScheduleofLongTermAndShortTermDebtInstrumentsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="coo_AOCICashFlowHedgeCumulativeGainLossBeforeTax" abstract="false" name="AOCICashFlowHedgeCumulativeGainLossBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation" abstract="false" name="DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="coo_OtherDebtMember" abstract="true" name="OtherDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_TermLoanFacility2021BaseRateLoansMember" abstract="true" name="TermLoanFacility2021BaseRateLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_EffectiveIncomeTaxRateReconciliationChangeInEnactedForeignTaxRateAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationChangeInEnactedForeignTaxRateAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_SingleUseSphereLensMember" abstract="true" name="SingleUseSphereLensMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember" abstract="true" name="ThirdAmendedAndRestated2007LongTermIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_DefinedBenefitPlanAssumptionsUsedCalculatingAccumulatedBenefitObligationEffectOfChangeInDiscountRate" abstract="false" name="DefinedBenefitPlanAssumptionsUsedCalculatingAccumulatedBenefitObligationEffectOfChangeInDiscountRate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit" abstract="false" name="LineOfCreditFacilityAccordionFeatureIncreaseLimit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionTable" abstract="true" name="ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" abstract="false" name="DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="coo_NumberOfBusinessUnits" abstract="false" name="NumberOfBusinessUnits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="coo_NonSingleUseSphereAndOtherMember" abstract="true" name="NonSingleUseSphereAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_PayablesFourthInstallmentMember" abstract="true" name="PayablesFourthInstallmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember" abstract="true" name="ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_ShortTermDebtNetOfDebtIssuanceCosts" abstract="false" name="ShortTermDebtNetOfDebtIssuanceCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd" abstract="false" name="DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="coo_NumberOfInterestRateDerivativesMatured" abstract="false" name="NumberOfInterestRateDerivativesMatured" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="coo_BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability" abstract="false" name="BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign" abstract="false" name="DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_TermLoanFacility2020Member" abstract="true" name="TermLoanFacility2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_PrivatelyHeldMedicalDeviceCompanyDevelopedMaraWaterVaporAblationSystemMember" abstract="true" name="PrivatelyHeldMedicalDeviceCompanyDevelopedMaraWaterVaporAblationSystemMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_GenerateLifeSciencesMember" abstract="true" name="GenerateLifeSciencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock" abstract="false" name="ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems" abstract="true" name="ScheduleofLongTermAndShortTermDebtInstrumentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="coo_OverdraftAndOtherCreditFacilitiesMember" abstract="true" name="OverdraftAndOtherCreditFacilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_TermLoanFacility2021Member" abstract="true" name="TermLoanFacility2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember" abstract="true" name="PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired" abstract="false" name="PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards" abstract="false" name="DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" abstract="false" name="BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_BusinessAcquisitionAndAssetAcquisitionAxis" abstract="true" name="BusinessAcquisitionAndAssetAcquisitionAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="coo_BusinessCombinationPaymentToSettleContingentConsideration" abstract="false" name="BusinessCombinationPaymentToSettleContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_BusinessCombinationAndAssetAcquisitionTextBlock" abstract="false" name="BusinessCombinationAndAssetAcquisitionTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="coo_ToricLensMember" abstract="true" name="ToricLensMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesEmployeeRelatedLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesEmployeeRelatedLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage" abstract="false" name="DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="coo_AccruedPensionCostRollForward" abstract="true" name="AccruedPensionCostRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="coo_CompositeMember" abstract="true" name="CompositeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet" abstract="false" name="BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="coo_DirectorsPlan2020Member" abstract="true" name="DirectorsPlan2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInAssumedPaymentFormElectionProbabilitiesMember" abstract="true" name="ChangeInAssumptionsForDefinedBenefitPlansChangeInAssumedPaymentFormElectionProbabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="coo_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedAndAssetAcquisitionsTableTextBlock" abstract="false" name="ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedAndAssetAcquisitionsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>coo-20221031_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:c1100544-9949-49e4-a84a-324e954b65ab,g:6f410f64-26fc-4654-ba7e-29974b75a0fc-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.coopercos.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="coo-20221031.xsd#ConsolidatedStatementsofIncome"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/ConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0108432e-6641-4645-89a6-96795ffc091c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_708f02a2-1cb8-4576-8c7d-a967375d52f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0108432e-6641-4645-89a6-96795ffc091c" xlink:to="loc_us-gaap_OperatingIncomeLoss_708f02a2-1cb8-4576-8c7d-a967375d52f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_931d2513-0c03-4992-9999-d153508748da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0108432e-6641-4645-89a6-96795ffc091c" xlink:to="loc_us-gaap_InterestExpense_931d2513-0c03-4992-9999-d153508748da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_0b2d7c7d-8257-47d8-a50b-88d8dc77de41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0108432e-6641-4645-89a6-96795ffc091c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_0b2d7c7d-8257-47d8-a50b-88d8dc77de41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6d2c2542-3a00-464e-80bf-6631cbed8343" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_23b599d5-fd49-4d9e-ab4c-a29342b92c88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_6d2c2542-3a00-464e-80bf-6631cbed8343" xlink:to="loc_us-gaap_GrossProfit_23b599d5-fd49-4d9e-ab4c-a29342b92c88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_652b33eb-a3c2-47fe-a238-9482f243730e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_6d2c2542-3a00-464e-80bf-6631cbed8343" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_652b33eb-a3c2-47fe-a238-9482f243730e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_b72855ed-bbd8-4bff-b7f5-95bcb11ef1a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_6d2c2542-3a00-464e-80bf-6631cbed8343" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_b72855ed-bbd8-4bff-b7f5-95bcb11ef1a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_6b714d67-68f2-4da5-aa68-d2d554573340" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_6d2c2542-3a00-464e-80bf-6631cbed8343" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_6b714d67-68f2-4da5-aa68-d2d554573340" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_49069164-4198-455b-bf08-c9984607c0a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_61983bc2-cf22-48da-bcc3-416b3fe0eada" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_49069164-4198-455b-bf08-c9984607c0a6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_61983bc2-cf22-48da-bcc3-416b3fe0eada" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6cc5e846-8913-4a0b-80f7-bc9e4b46b1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_49069164-4198-455b-bf08-c9984607c0a6" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6cc5e846-8913-4a0b-80f7-bc9e4b46b1cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_0687b59e-9496-4521-a4d3-71dea40919bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_4b683c5d-ddd2-4cc8-b3a2-4de1c522725a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_0687b59e-9496-4521-a4d3-71dea40919bb" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_4b683c5d-ddd2-4cc8-b3a2-4de1c522725a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2f05705d-bce2-42a6-a279-b7ae9955b67d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_0687b59e-9496-4521-a4d3-71dea40919bb" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2f05705d-bce2-42a6-a279-b7ae9955b67d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="coo-20221031.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_8d54df15-22ca-4b6c-8eb2-7ce3622d875c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4c888385-4c78-40f2-bc24-ce3c9bdce0bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_8d54df15-22ca-4b6c-8eb2-7ce3622d875c" xlink:to="loc_us-gaap_NetIncomeLoss_4c888385-4c78-40f2-bc24-ce3c9bdce0bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_399aff77-ec35-4158-9912-8299e50211a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_8d54df15-22ca-4b6c-8eb2-7ce3622d875c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_399aff77-ec35-4158-9912-8299e50211a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2b0f2831-4449-483e-9b93-8eb2eaf80e54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_d6ab8f73-5021-41bf-b7be-518578573d44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2b0f2831-4449-483e-9b93-8eb2eaf80e54" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_d6ab8f73-5021-41bf-b7be-518578573d44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_18bba070-4d20-47a3-93bf-6e94b3403732" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2b0f2831-4449-483e-9b93-8eb2eaf80e54" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_18bba070-4d20-47a3-93bf-6e94b3403732" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_adf305c6-25f8-4cdc-86ad-341bf27e234d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2b0f2831-4449-483e-9b93-8eb2eaf80e54" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_adf305c6-25f8-4cdc-86ad-341bf27e234d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="coo-20221031.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_01c123e7-4aa6-413e-acbf-36fe3fca3d44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent_dfc6fd79-619e-4edd-8add-c839b2223bdc" xlink:href="coo-20221031.xsd#coo_LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_01c123e7-4aa6-413e-acbf-36fe3fca3d44" xlink:to="loc_coo_LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent_dfc6fd79-619e-4edd-8add-c839b2223bdc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_7de57b32-95f8-4608-bda3-75dc47798691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_01c123e7-4aa6-413e-acbf-36fe3fca3d44" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_7de57b32-95f8-4608-bda3-75dc47798691" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_8779ee1c-dab1-4e26-a37d-908c26630b71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_01c123e7-4aa6-413e-acbf-36fe3fca3d44" xlink:to="loc_us-gaap_LiabilitiesCurrent_8779ee1c-dab1-4e26-a37d-908c26630b71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_efc2774b-c686-490f-8ed3-99a602db8867" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_01c123e7-4aa6-413e-acbf-36fe3fca3d44" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_efc2774b-c686-490f-8ed3-99a602db8867" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2e2fa1dc-2b21-4c37-a46b-8380c417282b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_01c123e7-4aa6-413e-acbf-36fe3fca3d44" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2e2fa1dc-2b21-4c37-a46b-8380c417282b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_fb63d9d5-7157-4f45-a062-66854b8d2a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_01c123e7-4aa6-413e-acbf-36fe3fca3d44" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_fb63d9d5-7157-4f45-a062-66854b8d2a0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_fb1599d4-a5ca-4469-bd87-4a3779ef5d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_445ed943-4053-48c6-a41b-e0f80003ccac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fb1599d4-a5ca-4469-bd87-4a3779ef5d0e" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_445ed943-4053-48c6-a41b-e0f80003ccac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_526d35e1-8d5c-48d8-8d58-978d84f58883" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fb1599d4-a5ca-4469-bd87-4a3779ef5d0e" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_526d35e1-8d5c-48d8-8d58-978d84f58883" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_a8ea845f-0352-4b4a-8601-6ce1168d6280" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fb1599d4-a5ca-4469-bd87-4a3779ef5d0e" xlink:to="loc_us-gaap_AccountsPayableCurrent_a8ea845f-0352-4b4a-8601-6ce1168d6280" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_58ea0c03-7eb2-4546-84c7-87ab37ce78bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fb1599d4-a5ca-4469-bd87-4a3779ef5d0e" xlink:to="loc_us-gaap_DebtCurrent_58ea0c03-7eb2-4546-84c7-87ab37ce78bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_8e95c6e3-981f-4f2a-89e2-0fdeafd13e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fb1599d4-a5ca-4469-bd87-4a3779ef5d0e" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_8e95c6e3-981f-4f2a-89e2-0fdeafd13e7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_c2530f14-0929-48de-b13f-2c67e214777f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fb1599d4-a5ca-4469-bd87-4a3779ef5d0e" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_c2530f14-0929-48de-b13f-2c67e214777f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_1769df0f-1a45-4195-80fa-421b3dcd7d80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ef6e940e-3325-48f9-ad52-f055c28ecc75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_1769df0f-1a45-4195-80fa-421b3dcd7d80" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ef6e940e-3325-48f9-ad52-f055c28ecc75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_6b53f324-9f7e-42be-a0d9-93b12e51a49c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_1769df0f-1a45-4195-80fa-421b3dcd7d80" xlink:to="loc_us-gaap_Liabilities_6b53f324-9f7e-42be-a0d9-93b12e51a49c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_63d2af62-ae0c-44b3-bb7e-b5a91fa5fe8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_1769df0f-1a45-4195-80fa-421b3dcd7d80" xlink:to="loc_us-gaap_CommitmentsAndContingencies_63d2af62-ae0c-44b3-bb7e-b5a91fa5fe8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_12b302cd-1de8-4db2-9f40-26e5aba09c75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_85c7430a-0706-409c-9907-4a2c1e72e1b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_12b302cd-1de8-4db2-9f40-26e5aba09c75" xlink:to="loc_us-gaap_AssetsCurrent_85c7430a-0706-409c-9907-4a2c1e72e1b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_bfeb6045-218a-483c-885c-231ec3c963cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_12b302cd-1de8-4db2-9f40-26e5aba09c75" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_bfeb6045-218a-483c-885c-231ec3c963cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_efcdad72-c0ce-4de3-959e-6f6b4b6e2656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_12b302cd-1de8-4db2-9f40-26e5aba09c75" xlink:to="loc_us-gaap_Goodwill_efcdad72-c0ce-4de3-959e-6f6b4b6e2656" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_626faccb-549b-4260-b6e2-b18877203f54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_12b302cd-1de8-4db2-9f40-26e5aba09c75" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_626faccb-549b-4260-b6e2-b18877203f54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_9c3beb02-f59d-472f-b523-20801e37d3f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_12b302cd-1de8-4db2-9f40-26e5aba09c75" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_9c3beb02-f59d-472f-b523-20801e37d3f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_221c2c6e-c94e-405c-91bc-f50b3bb6cc56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_12b302cd-1de8-4db2-9f40-26e5aba09c75" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_221c2c6e-c94e-405c-91bc-f50b3bb6cc56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_958ee92d-041e-4cb7-ad36-e8c0b7bb1657" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4f7bd53e-6833-46ca-8818-44bd374ed175" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_958ee92d-041e-4cb7-ad36-e8c0b7bb1657" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4f7bd53e-6833-46ca-8818-44bd374ed175" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_8a005904-7acc-47f5-8745-e4b3233ac78a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_958ee92d-041e-4cb7-ad36-e8c0b7bb1657" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_8a005904-7acc-47f5-8745-e4b3233ac78a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_e7de5bfc-9fc7-41ca-95c1-6245bab3e80e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_958ee92d-041e-4cb7-ad36-e8c0b7bb1657" xlink:to="loc_us-gaap_InventoryNet_e7de5bfc-9fc7-41ca-95c1-6245bab3e80e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9172362f-6d61-4f2d-88f2-2f3b5e56437f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_958ee92d-041e-4cb7-ad36-e8c0b7bb1657" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9172362f-6d61-4f2d-88f2-2f3b5e56437f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_c1fd2817-8900-4be6-95e9-28abdc466a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_958ee92d-041e-4cb7-ad36-e8c0b7bb1657" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_c1fd2817-8900-4be6-95e9-28abdc466a4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_848aeb79-8c75-41e6-8e1e-64030b945366" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_c979b7bd-cf50-47a9-83aa-b11dfc7e3c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_848aeb79-8c75-41e6-8e1e-64030b945366" xlink:to="loc_us-gaap_CommonStockValue_c979b7bd-cf50-47a9-83aa-b11dfc7e3c3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0c3abd57-ba95-4430-9c8b-9a460bec36b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_848aeb79-8c75-41e6-8e1e-64030b945366" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0c3abd57-ba95-4430-9c8b-9a460bec36b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f3b4e7b1-daa1-481f-ac5e-e2c09bee5d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_848aeb79-8c75-41e6-8e1e-64030b945366" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f3b4e7b1-daa1-481f-ac5e-e2c09bee5d8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_c3c938dd-d6f3-49fd-97ba-5347f38f3473" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_848aeb79-8c75-41e6-8e1e-64030b945366" xlink:to="loc_us-gaap_TreasuryStockCommonValue_c3c938dd-d6f3-49fd-97ba-5347f38f3473" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_77b54ebb-d5aa-4035-8bb4-2db06aa4074f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_848aeb79-8c75-41e6-8e1e-64030b945366" xlink:to="loc_us-gaap_AdditionalPaidInCapital_77b54ebb-d5aa-4035-8bb4-2db06aa4074f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_8f71786e-638a-40d7-abfd-4da14ae2f721" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_848aeb79-8c75-41e6-8e1e-64030b945366" xlink:to="loc_us-gaap_PreferredStockValue_8f71786e-638a-40d7-abfd-4da14ae2f721" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_70a67f21-72b1-4d18-bca5-f0d980065d26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8fb27eac-643e-4344-8855-ec1021fe8532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_70a67f21-72b1-4d18-bca5-f0d980065d26" xlink:to="loc_us-gaap_StockholdersEquity_8fb27eac-643e-4344-8855-ec1021fe8532" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_e7996715-21e3-41d0-859d-4120221cbb1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_70a67f21-72b1-4d18-bca5-f0d980065d26" xlink:to="loc_us-gaap_MinorityInterest_e7996715-21e3-41d0-859d-4120221cbb1e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="coo-20221031.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79df7524-1461-45e0-b8c6-8e939c9c0ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_4f0927bf-ba0a-4949-8ace-d74b5046c2d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79df7524-1461-45e0-b8c6-8e939c9c0ad8" xlink:to="loc_us-gaap_ShareBasedCompensation_4f0927bf-ba0a-4949-8ace-d74b5046c2d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_bb1f60ca-9c32-4c00-ad0d-ab75a24ff44e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79df7524-1461-45e0-b8c6-8e939c9c0ad8" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_bb1f60ca-9c32-4c00-ad0d-ab75a24ff44e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_17c7fe37-dd9d-41fe-baf4-e1d9585d7af9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79df7524-1461-45e0-b8c6-8e939c9c0ad8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_17c7fe37-dd9d-41fe-baf4-e1d9585d7af9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_d9b282c1-a4fe-4c04-b217-1302ee6263d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79df7524-1461-45e0-b8c6-8e939c9c0ad8" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_d9b282c1-a4fe-4c04-b217-1302ee6263d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_1f129e79-49de-45f6-8f23-e945542bc510" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79df7524-1461-45e0-b8c6-8e939c9c0ad8" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_1f129e79-49de-45f6-8f23-e945542bc510" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_43978368-a8ce-423e-a262-22883a5e9498" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79df7524-1461-45e0-b8c6-8e939c9c0ad8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_43978368-a8ce-423e-a262-22883a5e9498" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_2c5ebce5-3f18-4001-b6ee-776cf02af090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79df7524-1461-45e0-b8c6-8e939c9c0ad8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_2c5ebce5-3f18-4001-b6ee-776cf02af090" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_5d4f2400-3c71-42ca-94b9-b78e1f289e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79df7524-1461-45e0-b8c6-8e939c9c0ad8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_5d4f2400-3c71-42ca-94b9-b78e1f289e3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2debe9ba-636d-4043-906c-b87220e925d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79df7524-1461-45e0-b8c6-8e939c9c0ad8" xlink:to="loc_us-gaap_NetIncomeLoss_2debe9ba-636d-4043-906c-b87220e925d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_GainLossOnSaleOfAssetsAndAssetImpairmentChargesAndOther_d22e8f48-154d-4598-9d24-12388beba91b" xlink:href="coo-20221031.xsd#coo_GainLossOnSaleOfAssetsAndAssetImpairmentChargesAndOther"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79df7524-1461-45e0-b8c6-8e939c9c0ad8" xlink:to="loc_coo_GainLossOnSaleOfAssetsAndAssetImpairmentChargesAndOther_d22e8f48-154d-4598-9d24-12388beba91b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_7e902746-7b48-44ef-aaa2-94566bb6b914" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79df7524-1461-45e0-b8c6-8e939c9c0ad8" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_7e902746-7b48-44ef-aaa2-94566bb6b914" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet_5f6b6f05-6e3a-4988-842b-93e0ea11a70b" xlink:href="coo-20221031.xsd#coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79df7524-1461-45e0-b8c6-8e939c9c0ad8" xlink:to="loc_coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet_5f6b6f05-6e3a-4988-842b-93e0ea11a70b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_fefb85c9-6f4f-4f49-a5ec-81e5d52b6171" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79df7524-1461-45e0-b8c6-8e939c9c0ad8" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_fefb85c9-6f4f-4f49-a5ec-81e5d52b6171" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_4d8074c4-8286-4fbd-b9eb-3a709d6c326b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79df7524-1461-45e0-b8c6-8e939c9c0ad8" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_4d8074c4-8286-4fbd-b9eb-3a709d6c326b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_682f615c-d15e-42e2-9934-913bf14ed335" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79df7524-1461-45e0-b8c6-8e939c9c0ad8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_682f615c-d15e-42e2-9934-913bf14ed335" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_40fd07dc-c46a-4ddc-b8e7-4b6c0b5caf26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79df7524-1461-45e0-b8c6-8e939c9c0ad8" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_40fd07dc-c46a-4ddc-b8e7-4b6c0b5caf26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_IncreaseDecreaseInContingentConsiderationLiability_25e45d29-b9d6-4b84-b9f6-c68722636f4a" xlink:href="coo-20221031.xsd#coo_IncreaseDecreaseInContingentConsiderationLiability"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_79df7524-1461-45e0-b8c6-8e939c9c0ad8" xlink:to="loc_coo_IncreaseDecreaseInContingentConsiderationLiability_25e45d29-b9d6-4b84-b9f6-c68722636f4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_03fb5619-260a-474e-9221-017b0447a68d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3fb3b504-28b2-4949-b68c-c2eb02110980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_03fb5619-260a-474e-9221-017b0447a68d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3fb3b504-28b2-4949-b68c-c2eb02110980" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_559b36c9-0ade-44e2-8a0e-044610eee5ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_03fb5619-260a-474e-9221-017b0447a68d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_559b36c9-0ade-44e2-8a0e-044610eee5ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8d71f233-196c-4c06-94b9-9c8d7764ea39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_03fb5619-260a-474e-9221-017b0447a68d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8d71f233-196c-4c06-94b9-9c8d7764ea39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9d390f3a-41f7-42f4-8cf4-ac18980ac90c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_03fb5619-260a-474e-9221-017b0447a68d" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9d390f3a-41f7-42f4-8cf4-ac18980ac90c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59a59cf0-0b45-49d3-bee7-14d8ad7a28b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_43d9eb9b-5349-4e0e-8ade-238ff020788b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59a59cf0-0b45-49d3-bee7-14d8ad7a28b3" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_43d9eb9b-5349-4e0e-8ade-238ff020788b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_b0781de0-4d82-472d-8819-1d97b26cc1d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59a59cf0-0b45-49d3-bee7-14d8ad7a28b3" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_b0781de0-4d82-472d-8819-1d97b26cc1d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_dcba6791-3e67-4097-a723-85f01c5ed1b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59a59cf0-0b45-49d3-bee7-14d8ad7a28b3" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_dcba6791-3e67-4097-a723-85f01c5ed1b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_0b19397e-75e5-45fc-ab27-80e590dff1ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59a59cf0-0b45-49d3-bee7-14d8ad7a28b3" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_0b19397e-75e5-45fc-ab27-80e590dff1ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_7bed3596-527b-4aa7-86b5-35aee72b64a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59a59cf0-0b45-49d3-bee7-14d8ad7a28b3" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_7bed3596-527b-4aa7-86b5-35aee72b64a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_9609aea2-f8be-44d8-ba68-0db429688300" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59a59cf0-0b45-49d3-bee7-14d8ad7a28b3" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_9609aea2-f8be-44d8-ba68-0db429688300" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_42249b98-6ac6-4cb3-b32d-1ec3beadd0d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59a59cf0-0b45-49d3-bee7-14d8ad7a28b3" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_42249b98-6ac6-4cb3-b32d-1ec3beadd0d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_05408691-7c95-4696-be1a-6b99d0209cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59a59cf0-0b45-49d3-bee7-14d8ad7a28b3" xlink:to="loc_us-gaap_ProceedsFromStockPlans_05408691-7c95-4696-be1a-6b99d0209cc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_0ad358d2-6a59-4b85-8e97-ef42bdd4e547" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59a59cf0-0b45-49d3-bee7-14d8ad7a28b3" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_0ad358d2-6a59-4b85-8e97-ef42bdd4e547" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_de02b578-1819-45d0-ab82-22d3930567d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_6ca76615-9205-4c7e-a546-e565c99940ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_de02b578-1819-45d0-ab82-22d3930567d6" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_6ca76615-9205-4c7e-a546-e565c99940ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e5f42e29-18ae-480a-88b9-37c60d4c2e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_de02b578-1819-45d0-ab82-22d3930567d6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e5f42e29-18ae-480a-88b9-37c60d4c2e5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_c9040a6d-7bca-406f-a770-69fd59f943fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_de02b578-1819-45d0-ab82-22d3930567d6" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_c9040a6d-7bca-406f-a770-69fd59f943fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_cd08637d-1446-4c2b-8ea1-714d5d4f52e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_54959b03-79f1-4825-8534-381d33829d52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_cd08637d-1446-4c2b-8ea1-714d5d4f52e6" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_54959b03-79f1-4825-8534-381d33829d52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired_c3c8a93d-ffa6-44b6-b680-1193ac0f2a3a" xlink:href="coo-20221031.xsd#coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_cd08637d-1446-4c2b-8ea1-714d5d4f52e6" xlink:to="loc_coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired_c3c8a93d-ffa6-44b6-b680-1193ac0f2a3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_3ba7b94c-2801-4862-b00e-db94379bfba0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_cd08637d-1446-4c2b-8ea1-714d5d4f52e6" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_3ba7b94c-2801-4862-b00e-db94379bfba0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesInventoryDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#OrganizationandSignificantAccountingPoliciesInventoryDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_fb2ae061-75a5-486d-abc4-19295d1a4b24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_15928384-57eb-460b-b6fc-b33548fd7960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_fb2ae061-75a5-486d-abc4-19295d1a4b24" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_15928384-57eb-460b-b6fc-b33548fd7960" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_0e8b45c0-bdf4-4b04-ae85-a5901c973ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_fb2ae061-75a5-486d-abc4-19295d1a4b24" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_0e8b45c0-bdf4-4b04-ae85-a5901c973ab0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_efb80f84-4651-433a-adf9-f16937fe5853" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_fb2ae061-75a5-486d-abc4-19295d1a4b24" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_efb80f84-4651-433a-adf9-f16937fe5853" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_52493747-f6bf-48c2-8952-0f20f2fead47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_0d4dae5a-00f7-4e65-8354-dc9876eb58a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_52493747-f6bf-48c2-8952-0f20f2fead47" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_0d4dae5a-00f7-4e65-8354-dc9876eb58a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a120f226-0b1a-46f5-8377-cc811203f12e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_52493747-f6bf-48c2-8952-0f20f2fead47" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a120f226-0b1a-46f5-8377-cc811203f12e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_f7ed2033-d559-4e68-b40a-7dff3bc6daf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_13170ddc-5d71-44cf-91e4-56348096037e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_f7ed2033-d559-4e68-b40a-7dff3bc6daf2" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_13170ddc-5d71-44cf-91e4-56348096037e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3f992bcd-bd0f-4ea5-b639-311e424e3766" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_f7ed2033-d559-4e68-b40a-7dff3bc6daf2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_3f992bcd-bd0f-4ea5-b639-311e424e3766" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_c4713885-a0ac-40f5-98ec-9b17fac7a8e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_299db193-9c88-45eb-8b2d-12b3ef91d5ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_c4713885-a0ac-40f5-98ec-9b17fac7a8e4" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_299db193-9c88-45eb-8b2d-12b3ef91d5ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_cd9835fd-5190-4701-a25d-960267c58008" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_c4713885-a0ac-40f5-98ec-9b17fac7a8e4" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_cd9835fd-5190-4701-a25d-960267c58008" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_560faf6d-5048-4dcb-bcc2-439e8ec15594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_59c0ff8d-94a4-471d-aab5-0c997db7735e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_560faf6d-5048-4dcb-bcc2-439e8ec15594" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_59c0ff8d-94a4-471d-aab5-0c997db7735e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_702dfc1c-d8d2-4b76-97c9-5e5b7fe7e82c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_560faf6d-5048-4dcb-bcc2-439e8ec15594" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_702dfc1c-d8d2-4b76-97c9-5e5b7fe7e82c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_a75afcb6-9d54-488b-b6a9-30912374e6a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_560faf6d-5048-4dcb-bcc2-439e8ec15594" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_a75afcb6-9d54-488b-b6a9-30912374e6a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_42f53b66-82c5-49bf-9c01-8db4b2e34472" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_560faf6d-5048-4dcb-bcc2-439e8ec15594" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_42f53b66-82c5-49bf-9c01-8db4b2e34472" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_20f120dc-6061-4d95-b09b-abc236c6e2aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_560faf6d-5048-4dcb-bcc2-439e8ec15594" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_20f120dc-6061-4d95-b09b-abc236c6e2aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_cd854d7c-6326-47c1-984a-2e33cb39bb19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_560faf6d-5048-4dcb-bcc2-439e8ec15594" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_cd854d7c-6326-47c1-984a-2e33cb39bb19" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails_1" xlink:type="simple" xlink:href="coo-20221031.xsd#OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails_1"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e724a0b8-adce-46e6-908b-3c96fb64283c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_605107ac-a44e-4670-9b92-498b12ad29b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e724a0b8-adce-46e6-908b-3c96fb64283c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_605107ac-a44e-4670-9b92-498b12ad29b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_5c12b8fb-01ac-4763-a73d-2879c83607a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e724a0b8-adce-46e6-908b-3c96fb64283c" xlink:to="loc_us-gaap_OperatingLeaseLiability_5c12b8fb-01ac-4763-a73d-2879c83607a0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_8ddea022-3567-44b6-97b0-d0cf2df29d27" xlink:href="coo-20221031.xsd#coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_d8e97207-a885-451d-9c04-0e62d10b73dd" xlink:href="coo-20221031.xsd#coo_BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_8ddea022-3567-44b6-97b0-d0cf2df29d27" xlink:to="loc_coo_BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_d8e97207-a885-451d-9c04-0e62d10b73dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_bf6df9cc-b2b0-4d3d-86dc-dac054ce77e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_8ddea022-3567-44b6-97b0-d0cf2df29d27" xlink:to="loc_us-gaap_Goodwill_bf6df9cc-b2b0-4d3d-86dc-dac054ce77e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet_45cd1dd7-f168-47b0-adf6-e28e77f524d9" xlink:href="coo-20221031.xsd#coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_8ddea022-3567-44b6-97b0-d0cf2df29d27" xlink:to="loc_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet_45cd1dd7-f168-47b0-adf6-e28e77f524d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability_3b8edc69-b939-4ed8-828f-53dc7ae6008c" xlink:href="coo-20221031.xsd#coo_BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_8ddea022-3567-44b6-97b0-d0cf2df29d27" xlink:to="loc_coo_BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability_3b8edc69-b939-4ed8-828f-53dc7ae6008c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_1a0bd888-e54a-4384-bf1f-b830c6dd423f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2abd85ac-e13f-4c15-b546-be07eb736b66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_1a0bd888-e54a-4384-bf1f-b830c6dd423f" xlink:to="loc_us-gaap_Goodwill_2abd85ac-e13f-4c15-b546-be07eb736b66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_599ef784-5612-4fe5-832f-36fb648fa7fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_1a0bd888-e54a-4384-bf1f-b830c6dd423f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_599ef784-5612-4fe5-832f-36fb648fa7fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_fbd60298-7506-423d-bfc9-37b830f4bab7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_1a0bd888-e54a-4384-bf1f-b830c6dd423f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_fbd60298-7506-423d-bfc9-37b830f4bab7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_8cef7d95-95d4-4f22-acac-de26eb465ee4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_1a0bd888-e54a-4384-bf1f-b830c6dd423f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_8cef7d95-95d4-4f22-acac-de26eb465ee4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_e2cd2773-65c3-43ac-8f9e-1ab793963bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_1a0bd888-e54a-4384-bf1f-b830c6dd423f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_e2cd2773-65c3-43ac-8f9e-1ab793963bd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e06d37d2-87e9-4314-9f6c-c25d0a16ad06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_9d75fbc9-3262-4747-992c-a5393d13f7f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e06d37d2-87e9-4314-9f6c-c25d0a16ad06" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_9d75fbc9-3262-4747-992c-a5393d13f7f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredRevenue_5c094441-ac8d-4a69-b5b9-30accd9c50a8" xlink:href="coo-20221031.xsd#coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredRevenue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e06d37d2-87e9-4314-9f6c-c25d0a16ad06" xlink:to="loc_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredRevenue_5c094441-ac8d-4a69-b5b9-30accd9c50a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability_1aa9444f-80c3-41ce-aecd-270c0b9cb161" xlink:href="coo-20221031.xsd#coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e06d37d2-87e9-4314-9f6c-c25d0a16ad06" xlink:to="loc_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability_1aa9444f-80c3-41ce-aecd-270c0b9cb161" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_443e446d-ebca-4a54-a2e5-fe78a21359a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e06d37d2-87e9-4314-9f6c-c25d0a16ad06" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_443e446d-ebca-4a54-a2e5-fe78a21359a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_a9ecf01f-21b2-4d52-ae38-001a96773691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e06d37d2-87e9-4314-9f6c-c25d0a16ad06" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_a9ecf01f-21b2-4d52-ae38-001a96773691" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_d02311bd-6dd8-44c9-9dbf-386188ae5d73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesEmployeeRelatedLiabilities_a61a7b11-cbc5-486b-91ca-4641e6795c2e" xlink:href="coo-20221031.xsd#coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesEmployeeRelatedLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_d02311bd-6dd8-44c9-9dbf-386188ae5d73" xlink:to="loc_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesEmployeeRelatedLiabilities_a61a7b11-cbc5-486b-91ca-4641e6795c2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_e7a8d486-d624-4f16-b734-1d4b0d52421f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_d02311bd-6dd8-44c9-9dbf-386188ae5d73" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_e7a8d486-d624-4f16-b734-1d4b0d52421f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_ed097970-1061-4ddc-9217-cbeae6df3a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_d02311bd-6dd8-44c9-9dbf-386188ae5d73" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_ed097970-1061-4ddc-9217-cbeae6df3a0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_313dd137-2759-4a2b-8605-0e12c6f9c1ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_d02311bd-6dd8-44c9-9dbf-386188ae5d73" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_313dd137-2759-4a2b-8605-0e12c6f9c1ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_3c7298cf-b390-4215-9338-abc5ec05c1a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_e45c5493-d9fc-4d72-a273-d3396bd75ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_3c7298cf-b390-4215-9338-abc5ec05c1a3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_e45c5493-d9fc-4d72-a273-d3396bd75ef4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_5802a007-b95c-483e-97b0-60d81e205cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_3c7298cf-b390-4215-9338-abc5ec05c1a3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_5802a007-b95c-483e-97b0-60d81e205cb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_d48413a8-3d23-42b0-80f9-ed844c90a690" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_3c7298cf-b390-4215-9338-abc5ec05c1a3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_d48413a8-3d23-42b0-80f9-ed844c90a690" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_b2f0ab54-470d-40a0-afed-4ed519f56839" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_3c7298cf-b390-4215-9338-abc5ec05c1a3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_b2f0ab54-470d-40a0-afed-4ed519f56839" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_5e9a0988-8a3f-468b-9d5c-c2251e91ff57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_4b2e15f7-f571-4f02-9515-529a6ca88516" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_5e9a0988-8a3f-468b-9d5c-c2251e91ff57" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_4b2e15f7-f571-4f02-9515-529a6ca88516" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_66e59139-1935-484e-9130-5d42ce175328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_5e9a0988-8a3f-468b-9d5c-c2251e91ff57" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_66e59139-1935-484e-9130-5d42ce175328" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#IntangibleAssetsOtherIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_30609cad-870d-4915-b9f7-abd5df67e339" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c89ef9b0-674d-45df-b39b-34d50919f0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_30609cad-870d-4915-b9f7-abd5df67e339" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c89ef9b0-674d-45df-b39b-34d50919f0ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_270bbe8f-31b7-4b42-88ed-62c2e997c032" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_30609cad-870d-4915-b9f7-abd5df67e339" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_270bbe8f-31b7-4b42-88ed-62c2e997c032" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6d13e86c-9b05-412c-95f1-ee4c97fa2ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_a7a10d13-e6c3-4a36-8fb5-f098847ef4a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6d13e86c-9b05-412c-95f1-ee4c97fa2ef0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_a7a10d13-e6c3-4a36-8fb5-f098847ef4a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_427c2170-db87-4f8e-8e6e-22c913922a42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6d13e86c-9b05-412c-95f1-ee4c97fa2ef0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_427c2170-db87-4f8e-8e6e-22c913922a42" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1d2ac208-8a55-4dbb-95bd-9db807c42418" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_82654fb6-0613-460e-9e29-02546755e688" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1d2ac208-8a55-4dbb-95bd-9db807c42418" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_82654fb6-0613-460e-9e29-02546755e688" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_9680328a-5ad4-43e5-b845-ed4423ab87dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1d2ac208-8a55-4dbb-95bd-9db807c42418" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_9680328a-5ad4-43e5-b845-ed4423ab87dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_67988508-4cf8-45ed-8784-af9f9b9fab00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1d2ac208-8a55-4dbb-95bd-9db807c42418" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_67988508-4cf8-45ed-8784-af9f9b9fab00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_9b6b63c7-279b-4ce3-aa98-ba7845bd2471" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1d2ac208-8a55-4dbb-95bd-9db807c42418" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_9b6b63c7-279b-4ce3-aa98-ba7845bd2471" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_f97a5a37-7a2e-47df-81c2-7b79faa32d07" xlink:href="coo-20221031.xsd#coo_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1d2ac208-8a55-4dbb-95bd-9db807c42418" xlink:to="loc_coo_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_f97a5a37-7a2e-47df-81c2-7b79faa32d07" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#FinancingArrangementsTotalDebtDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_fcf78948-629a-4de8-b1ec-3a66ab1085d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ShortTermDebtNetOfDebtIssuanceCosts_019e114f-ad6a-4239-a359-281b213559fc" xlink:href="coo-20221031.xsd#coo_ShortTermDebtNetOfDebtIssuanceCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtCurrent_fcf78948-629a-4de8-b1ec-3a66ab1085d6" xlink:to="loc_coo_ShortTermDebtNetOfDebtIssuanceCosts_019e114f-ad6a-4239-a359-281b213559fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_95f519fa-6f74-45f5-8739-4d9d0325a2f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtCurrent_fcf78948-629a-4de8-b1ec-3a66ab1085d6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_95f519fa-6f74-45f5-8739-4d9d0325a2f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_d2f40451-50ba-40ce-a82a-da88a726ecd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_bfe8d081-dbfa-4809-816c-8f97e4089697" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_d2f40451-50ba-40ce-a82a-da88a726ecd7" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_bfe8d081-dbfa-4809-816c-8f97e4089697" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_39b8b899-f0a4-4329-99eb-db39f9004bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_d2f40451-50ba-40ce-a82a-da88a726ecd7" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_39b8b899-f0a4-4329-99eb-db39f9004bf4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_851985f9-50db-4968-8a97-ce0ad591caa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_2946ba8f-482e-4b9d-adcf-f81e82be7aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_851985f9-50db-4968-8a97-ce0ad591caa1" xlink:to="loc_us-gaap_DebtCurrent_2946ba8f-482e-4b9d-adcf-f81e82be7aa4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_c15aebcf-2814-42fd-b44b-5f372eb51cb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_851985f9-50db-4968-8a97-ce0ad591caa1" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_c15aebcf-2814-42fd-b44b-5f372eb51cb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ShortTermDebtNetOfDebtIssuanceCosts_ed353930-682c-4c5a-8a29-4ab581d2a1f3" xlink:href="coo-20221031.xsd#coo_ShortTermDebtNetOfDebtIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_2fbf143d-bc32-4d68-9961-49c131432d91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_coo_ShortTermDebtNetOfDebtIssuanceCosts_ed353930-682c-4c5a-8a29-4ab581d2a1f3" xlink:to="loc_us-gaap_ShortTermBorrowings_2fbf143d-bc32-4d68-9961-49c131432d91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsCurrentNet_5cc4f43b-3c22-44ed-9d24-5beb9580a0a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsCurrentNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_coo_ShortTermDebtNetOfDebtIssuanceCosts_ed353930-682c-4c5a-8a29-4ab581d2a1f3" xlink:to="loc_us-gaap_DeferredFinanceCostsCurrentNet_5cc4f43b-3c22-44ed-9d24-5beb9580a0a0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#IncomeTaxesIncomeBeforeIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d4c36959-64f9-4154-b580-f0937b048b41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_4a7364a9-388f-4be0-888e-377dbffd1708" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d4c36959-64f9-4154-b580-f0937b048b41" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_4a7364a9-388f-4be0-888e-377dbffd1708" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_d33db27f-a131-45e3-94ed-72d39db9fb5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d4c36959-64f9-4154-b580-f0937b048b41" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_d33db27f-a131-45e3-94ed-72d39db9fb5e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#IncomeTaxesIncomeTaxProvisionBenefitDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_8550846a-7687-4464-af1c-b4c7c6d19d10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_71d4f045-2ad0-4226-893f-cf72a31b1a66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_8550846a-7687-4464-af1c-b4c7c6d19d10" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_71d4f045-2ad0-4226-893f-cf72a31b1a66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_171c2fae-6600-4b9a-8b0e-5523ab2c6999" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_8550846a-7687-4464-af1c-b4c7c6d19d10" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_171c2fae-6600-4b9a-8b0e-5523ab2c6999" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_b73ed656-f8d6-432b-89a8-207f81e559e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_8550846a-7687-4464-af1c-b4c7c6d19d10" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_b73ed656-f8d6-432b-89a8-207f81e559e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_06e20ca4-1b62-417b-8d8e-8106466b97de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_3ca8c625-19bf-4ca9-a6a7-bb4954d6922a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_06e20ca4-1b62-417b-8d8e-8106466b97de" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_3ca8c625-19bf-4ca9-a6a7-bb4954d6922a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_63a3f809-fb5c-42a7-b248-673b5a0c8757" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_06e20ca4-1b62-417b-8d8e-8106466b97de" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_63a3f809-fb5c-42a7-b248-673b5a0c8757" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_7dfebf4d-1e23-4a87-8a38-b088aedff4ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_06e20ca4-1b62-417b-8d8e-8106466b97de" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_7dfebf4d-1e23-4a87-8a38-b088aedff4ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_fac2608b-e92e-43f0-b3ed-c9e04ef7de42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_d720839f-828b-42f0-b920-4f7c20888694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_fac2608b-e92e-43f0-b3ed-c9e04ef7de42" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_d720839f-828b-42f0-b920-4f7c20888694" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1d9ef18a-733f-4e6c-80f1-da9012c2bc07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_fac2608b-e92e-43f0-b3ed-c9e04ef7de42" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1d9ef18a-733f-4e6c-80f1-da9012c2bc07" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_91249659-8afb-4f16-89c3-de827a9ecd75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_18974498-c032-4155-ae4b-f575816c7ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_91249659-8afb-4f16-89c3-de827a9ecd75" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_18974498-c032-4155-ae4b-f575816c7ebd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_6deb0afa-1217-4d56-a647-b23fed74c2ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_91249659-8afb-4f16-89c3-de827a9ecd75" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_6deb0afa-1217-4d56-a647-b23fed74c2ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_9704afab-ff29-4f43-ad0a-db0c07f5ca24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_91249659-8afb-4f16-89c3-de827a9ecd75" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_9704afab-ff29-4f43-ad0a-db0c07f5ca24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount_30dc5ea2-bffa-42fe-b0f1-678d8a7c95ea" xlink:href="coo-20221031.xsd#coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_91249659-8afb-4f16-89c3-de827a9ecd75" xlink:to="loc_coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount_30dc5ea2-bffa-42fe-b0f1-678d8a7c95ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_3db28dda-4ae4-4507-a917-df3471ccb808" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_91249659-8afb-4f16-89c3-de827a9ecd75" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_3db28dda-4ae4-4507-a917-df3471ccb808" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings_98b757cd-a7b8-4c83-9960-8bf491bdcb89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_91249659-8afb-4f16-89c3-de827a9ecd75" xlink:to="loc_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings_98b757cd-a7b8-4c83-9960-8bf491bdcb89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_a85289ba-7e9b-463b-b36b-ef8a72e291e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_91249659-8afb-4f16-89c3-de827a9ecd75" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_a85289ba-7e9b-463b-b36b-ef8a72e291e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_EffectiveIncomeTaxRateReconciliationChangeInDomesticFederalTaxReturnAmount_b9e46c4d-1d3b-405f-bf21-0095039c2630" xlink:href="coo-20221031.xsd#coo_EffectiveIncomeTaxRateReconciliationChangeInDomesticFederalTaxReturnAmount"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_91249659-8afb-4f16-89c3-de827a9ecd75" xlink:to="loc_coo_EffectiveIncomeTaxRateReconciliationChangeInDomesticFederalTaxReturnAmount_b9e46c4d-1d3b-405f-bf21-0095039c2630" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_a5f53d70-f80f-4dd2-be73-bbc977180d85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_91249659-8afb-4f16-89c3-de827a9ecd75" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_a5f53d70-f80f-4dd2-be73-bbc977180d85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationDispositionOfAssets_28c18326-4497-49fb-bb21-dc2d82b4aba9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationDispositionOfAssets"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_91249659-8afb-4f16-89c3-de827a9ecd75" xlink:to="loc_us-gaap_IncomeTaxReconciliationDispositionOfAssets_28c18326-4497-49fb-bb21-dc2d82b4aba9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_830da532-6526-4ef9-af02-b7dae52af400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_91249659-8afb-4f16-89c3-de827a9ecd75" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_830da532-6526-4ef9-af02-b7dae52af400" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_5e1c01bc-0a29-4c92-a065-79ec4d0881fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_da735c13-7b95-4d27-8a77-96a9ac7e086b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_5e1c01bc-0a29-4c92-a065-79ec4d0881fc" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_da735c13-7b95-4d27-8a77-96a9ac7e086b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_7a0d8df4-fcce-4846-bd25-2d1bece264c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_5e1c01bc-0a29-4c92-a065-79ec4d0881fc" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_7a0d8df4-fcce-4846-bd25-2d1bece264c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_d990ae10-bc92-42e5-ad52-ec5f244e2fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_5e1c01bc-0a29-4c92-a065-79ec4d0881fc" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_d990ae10-bc92-42e5-ad52-ec5f244e2fdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_598479f6-ae7e-4550-8477-eb01d54b2a13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_5e1c01bc-0a29-4c92-a065-79ec4d0881fc" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_598479f6-ae7e-4550-8477-eb01d54b2a13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards_aaf10de0-1160-4894-93ff-1fa088292512" xlink:href="coo-20221031.xsd#coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_5e1c01bc-0a29-4c92-a065-79ec4d0881fc" xlink:to="loc_coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards_aaf10de0-1160-4894-93ff-1fa088292512" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_7ac3b855-802d-4547-baf7-22851abd6413" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_5e1c01bc-0a29-4c92-a065-79ec4d0881fc" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_7ac3b855-802d-4547-baf7-22851abd6413" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_87bd5bc8-5fee-4381-b3af-008a23475d24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_5e1c01bc-0a29-4c92-a065-79ec4d0881fc" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_87bd5bc8-5fee-4381-b3af-008a23475d24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_2f36fae1-9221-46bd-ad13-ea788784bf95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_5e1c01bc-0a29-4c92-a065-79ec4d0881fc" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_2f36fae1-9221-46bd-ad13-ea788784bf95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_341d4866-5f5a-447f-a90c-b43f38a3a471" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_2ab7d49c-8152-45dc-a122-7605b58a259e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_341d4866-5f5a-447f-a90c-b43f38a3a471" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_2ab7d49c-8152-45dc-a122-7605b58a259e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_64b5cbe6-5944-4f7c-89a6-d2b386f2b222" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_341d4866-5f5a-447f-a90c-b43f38a3a471" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_64b5cbe6-5944-4f7c-89a6-d2b386f2b222" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_24bcb975-e103-4cd7-ac99-6b9b9be9d8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_af13e930-dfff-4c2a-be9b-ca4ebe371cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_24bcb975-e103-4cd7-ac99-6b9b9be9d8b6" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_af13e930-dfff-4c2a-be9b-ca4ebe371cc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_709ee93e-f26c-496f-a8f2-74c26b943b86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_24bcb975-e103-4cd7-ac99-6b9b9be9d8b6" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_709ee93e-f26c-496f-a8f2-74c26b943b86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_6f6d53de-5907-41c5-b218-004e4e5d5e85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_3c5af3ff-4ff1-4dc5-9b5d-fd62e70f0a89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_6f6d53de-5907-41c5-b218-004e4e5d5e85" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_3c5af3ff-4ff1-4dc5-9b5d-fd62e70f0a89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign_4ef3ab75-7b82-44b4-887e-bc5c011d8efa" xlink:href="coo-20221031.xsd#coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_6f6d53de-5907-41c5-b218-004e4e5d5e85" xlink:to="loc_coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign_4ef3ab75-7b82-44b4-887e-bc5c011d8efa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_d721b421-83b3-4740-ac30-441ef6b9aea1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_6f6d53de-5907-41c5-b218-004e4e5d5e85" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_d721b421-83b3-4740-ac30-441ef6b9aea1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_e80bae11-fc8f-466f-9390-4e6f5087265c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_6f6d53de-5907-41c5-b218-004e4e5d5e85" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_e80bae11-fc8f-466f-9390-4e6f5087265c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#EarningsPerShareBasicandDilutedDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_21723afe-85b4-4f68-81af-155a3806a2b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f118a10a-419b-419e-8b80-195b23da971a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_21723afe-85b4-4f68-81af-155a3806a2b4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f118a10a-419b-419e-8b80-195b23da971a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_57382b70-c180-4c0c-99fa-91f9ee8cd379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_21723afe-85b4-4f68-81af-155a3806a2b4" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_57382b70-c180-4c0c-99fa-91f9ee8cd379" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_269cca2c-f34d-477c-9908-4d74d58f0e45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_23a978f9-abc5-4f3f-ae54-b77310b815c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_269cca2c-f34d-477c-9908-4d74d58f0e45" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_23a978f9-abc5-4f3f-ae54-b77310b815c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_3f0488b9-7eb8-4efd-adef-d13ddc2d5dfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_269cca2c-f34d-477c-9908-4d74d58f0e45" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_3f0488b9-7eb8-4efd-adef-d13ddc2d5dfe" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_566ac946-e4e4-40aa-bdf8-83ce34a066fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_6a36b098-9389-491e-a4aa-37df28b6beec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_566ac946-e4e4-40aa-bdf8-83ce34a066fa" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_6a36b098-9389-491e-a4aa-37df28b6beec" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_01f57377-942c-4a7a-aa12-b5321325eefe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_ca8f61d2-23d8-47ee-a5a7-0d9abf610a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_01f57377-942c-4a7a-aa12-b5321325eefe" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_ca8f61d2-23d8-47ee-a5a7-0d9abf610a6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_a30e895d-5042-4530-a5dc-d8bc433021fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_01f57377-942c-4a7a-aa12-b5321325eefe" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_a30e895d-5042-4530-a5dc-d8bc433021fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_b8022f98-8b26-4273-86fd-63b0d0c4adc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_01f57377-942c-4a7a-aa12-b5321325eefe" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_b8022f98-8b26-4273-86fd-63b0d0c4adc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_16ad49d4-8621-4bed-98f8-b9afd40d85e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_01f57377-942c-4a7a-aa12-b5321325eefe" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_16ad49d4-8621-4bed-98f8-b9afd40d85e5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_12a62bf2-32c2-4de7-a040-d673450affd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax_e0e8f58f-6429-4497-92ae-2eb5c4bcb6fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_12a62bf2-32c2-4de7-a040-d673450affd5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax_e0e8f58f-6429-4497-92ae-2eb5c4bcb6fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax_2d5cdc84-e3ca-45f8-9410-bfdc1988b98d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_12a62bf2-32c2-4de7-a040-d673450affd5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax_2d5cdc84-e3ca-45f8-9410-bfdc1988b98d" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>coo-20221031_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:c1100544-9949-49e4-a84a-324e954b65ab,g:6f410f64-26fc-4654-ba7e-29974b75a0fc-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="coo-20221031.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended" id="i9c97c0032e4c4e7ea35b01a8ac981049_ConsolidatedStatementsofStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5dc850ff-c3c7-4f81-b65a-4ab89cf41b4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d435f524-7775-427e-9a02-57e2cbcc95eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5dc850ff-c3c7-4f81-b65a-4ab89cf41b4f" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d435f524-7775-427e-9a02-57e2cbcc95eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_fa326ec7-617d-4ac9-8251-fb9a4834bb53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d435f524-7775-427e-9a02-57e2cbcc95eb" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_fa326ec7-617d-4ac9-8251-fb9a4834bb53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_90f4a76f-dd9e-4e94-8a1c-9b210d1eee5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d435f524-7775-427e-9a02-57e2cbcc95eb" xlink:to="loc_us-gaap_TreasuryStockCommonShares_90f4a76f-dd9e-4e94-8a1c-9b210d1eee5c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4e5f5f82-360c-49f0-87e5-b1801e6a3e76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d435f524-7775-427e-9a02-57e2cbcc95eb" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4e5f5f82-360c-49f0-87e5-b1801e6a3e76" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5a81638f-a06a-4a65-823c-2ea6561cb754" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d435f524-7775-427e-9a02-57e2cbcc95eb" xlink:to="loc_us-gaap_NetIncomeLoss_5a81638f-a06a-4a65-823c-2ea6561cb754" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_aa0083dd-b427-46bd-85da-c8ef3e38ba11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d435f524-7775-427e-9a02-57e2cbcc95eb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_aa0083dd-b427-46bd-85da-c8ef3e38ba11" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_11db9d4e-b9fa-4f19-90dc-839c2a729936" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d435f524-7775-427e-9a02-57e2cbcc95eb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_11db9d4e-b9fa-4f19-90dc-839c2a729936" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_2db0782b-6245-4291-b173-6e521bf29fef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d435f524-7775-427e-9a02-57e2cbcc95eb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_2db0782b-6245-4291-b173-6e521bf29fef" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_6b69202e-6bb4-4492-9373-0e04a4e0f1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d435f524-7775-427e-9a02-57e2cbcc95eb" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_6b69202e-6bb4-4492-9373-0e04a4e0f1d7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_e5a82e0c-5ced-4a83-9b41-8c8851e2a0eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d435f524-7775-427e-9a02-57e2cbcc95eb" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_e5a82e0c-5ced-4a83-9b41-8c8851e2a0eb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_4f3aacc6-6d69-4154-aac2-b07ee8720d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d435f524-7775-427e-9a02-57e2cbcc95eb" xlink:to="loc_us-gaap_DividendsCommonStock_4f3aacc6-6d69-4154-aac2-b07ee8720d4b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b155a78c-30f1-4eb3-bba7-5b44a1ff28eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d435f524-7775-427e-9a02-57e2cbcc95eb" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b155a78c-30f1-4eb3-bba7-5b44a1ff28eb" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d76c5b76-1d55-4f17-b05c-26233578d03f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_16f7cfb9-929b-4fed-b43b-96ebb44b9a36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_241322c1-7838-4075-a5c4-d03ebbaf04d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_aafc8036-bd02-4f4d-a79c-dbf01d6f960a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5dc850ff-c3c7-4f81-b65a-4ab89cf41b4f" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_aafc8036-bd02-4f4d-a79c-dbf01d6f960a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_32677b96-f124-4a36-a281-03f272ce8773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_5dc850ff-c3c7-4f81-b65a-4ab89cf41b4f" xlink:to="loc_us-gaap_StatementTable_32677b96-f124-4a36-a281-03f272ce8773" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d1bf1ba9-9267-441b-94ca-ea9fbcfd95f6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_32677b96-f124-4a36-a281-03f272ce8773" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d1bf1ba9-9267-441b-94ca-ea9fbcfd95f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d1bf1ba9-9267-441b-94ca-ea9fbcfd95f6_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d1bf1ba9-9267-441b-94ca-ea9fbcfd95f6" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d1bf1ba9-9267-441b-94ca-ea9fbcfd95f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e0d50753-f549-4ad9-a4a1-c31c6578b396" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d1bf1ba9-9267-441b-94ca-ea9fbcfd95f6" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e0d50753-f549-4ad9-a4a1-c31c6578b396" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_a2921c28-a23a-4bf6-b0ee-b4bec77f96aa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e0d50753-f549-4ad9-a4a1-c31c6578b396" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_a2921c28-a23a-4bf6-b0ee-b4bec77f96aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_95ae6653-8fae-42d7-9014-9465852c6a89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_32677b96-f124-4a36-a281-03f272ce8773" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_95ae6653-8fae-42d7-9014-9465852c6a89" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_95ae6653-8fae-42d7-9014-9465852c6a89_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_95ae6653-8fae-42d7-9014-9465852c6a89" xlink:to="loc_us-gaap_EquityComponentDomain_95ae6653-8fae-42d7-9014-9465852c6a89_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0146e6ca-82de-4232-9c3c-1a64f92edc68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_95ae6653-8fae-42d7-9014-9465852c6a89" xlink:to="loc_us-gaap_EquityComponentDomain_0146e6ca-82de-4232-9c3c-1a64f92edc68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CommonStockExcludingTreasuryStockParNetValueMember_c6bc9962-f2c7-49c7-8c75-fa82563681d8" xlink:href="coo-20221031.xsd#coo_CommonStockExcludingTreasuryStockParNetValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0146e6ca-82de-4232-9c3c-1a64f92edc68" xlink:to="loc_coo_CommonStockExcludingTreasuryStockParNetValueMember_c6bc9962-f2c7-49c7-8c75-fa82563681d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_d61bb630-eadb-442a-a61f-25fa3ca5d287" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0146e6ca-82de-4232-9c3c-1a64f92edc68" xlink:to="loc_us-gaap_TreasuryStockCommonMember_d61bb630-eadb-442a-a61f-25fa3ca5d287" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TreasuryStockParNetValueMember_c6e6559c-699d-403c-a877-3068d713e19c" xlink:href="coo-20221031.xsd#coo_TreasuryStockParNetValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0146e6ca-82de-4232-9c3c-1a64f92edc68" xlink:to="loc_coo_TreasuryStockParNetValueMember_c6e6559c-699d-403c-a877-3068d713e19c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_5ac8a2a8-f5ff-482b-a85e-96406f771870" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0146e6ca-82de-4232-9c3c-1a64f92edc68" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_5ac8a2a8-f5ff-482b-a85e-96406f771870" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_84a9346c-ff86-4567-86ac-5361ebc12e7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0146e6ca-82de-4232-9c3c-1a64f92edc68" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_84a9346c-ff86-4567-86ac-5361ebc12e7b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_158693cf-499c-4056-9751-d2ce6c04fc3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0146e6ca-82de-4232-9c3c-1a64f92edc68" xlink:to="loc_us-gaap_RetainedEarningsMember_158693cf-499c-4056-9751-d2ce6c04fc3c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_79bb480c-e5af-436c-8611-ad39527599cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0146e6ca-82de-4232-9c3c-1a64f92edc68" xlink:to="loc_us-gaap_NoncontrollingInterestMember_79bb480c-e5af-436c-8611-ad39527599cd" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#OrganizationandSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i0631757ae2104258a95995581e0f890b_OrganizationandSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8f3f6b08-a6a6-4ee1-9448-7403ed30e967" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_NumberOfBusinessUnits_2c88b0cc-22a5-4c47-92a3-98182ca3867c" xlink:href="coo-20221031.xsd#coo_NumberOfBusinessUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8f3f6b08-a6a6-4ee1-9448-7403ed30e967" xlink:to="loc_coo_NumberOfBusinessUnits_2c88b0cc-22a5-4c47-92a3-98182ca3867c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_41ee87f1-66ca-486b-a7a8-845778d72ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8f3f6b08-a6a6-4ee1-9448-7403ed30e967" xlink:to="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_41ee87f1-66ca-486b-a7a8-845778d72ce5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerRefundLiability_4f4e50af-657a-45ab-84a3-56a54ae5f94c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerRefundLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8f3f6b08-a6a6-4ee1-9448-7403ed30e967" xlink:to="loc_us-gaap_ContractWithCustomerRefundLiability_4f4e50af-657a-45ab-84a3-56a54ae5f94c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_41917d61-017e-45c3-bffe-cc6068786a88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8f3f6b08-a6a6-4ee1-9448-7403ed30e967" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_41917d61-017e-45c3-bffe-cc6068786a88" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_610c9fdc-ec94-4fed-acd1-5f5fc414157d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8f3f6b08-a6a6-4ee1-9448-7403ed30e967" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_610c9fdc-ec94-4fed-acd1-5f5fc414157d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_26d69a8e-26c0-456f-83a4-b537c2c6c056" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessExitCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8f3f6b08-a6a6-4ee1-9448-7403ed30e967" xlink:to="loc_us-gaap_BusinessExitCosts1_26d69a8e-26c0-456f-83a4-b537c2c6c056" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_076dbaf4-22fb-4ba5-aa5b-4d882a14cfed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8f3f6b08-a6a6-4ee1-9448-7403ed30e967" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_076dbaf4-22fb-4ba5-aa5b-4d882a14cfed" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c2254f60-5df1-4504-a7ea-ae6175e1c92c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8f3f6b08-a6a6-4ee1-9448-7403ed30e967" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c2254f60-5df1-4504-a7ea-ae6175e1c92c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4ca3dcc0-16f9-4719-915c-ba7e5c90dc27" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c2254f60-5df1-4504-a7ea-ae6175e1c92c" xlink:to="loc_srt_RangeAxis_4ca3dcc0-16f9-4719-915c-ba7e5c90dc27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4ca3dcc0-16f9-4719-915c-ba7e5c90dc27_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_4ca3dcc0-16f9-4719-915c-ba7e5c90dc27" xlink:to="loc_srt_RangeMember_4ca3dcc0-16f9-4719-915c-ba7e5c90dc27_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a8577588-a783-42f9-959e-9e6e42aa235e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_4ca3dcc0-16f9-4719-915c-ba7e5c90dc27" xlink:to="loc_srt_RangeMember_a8577588-a783-42f9-959e-9e6e42aa235e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a934b05a-9266-44df-b2e8-95b6927ceabb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a8577588-a783-42f9-959e-9e6e42aa235e" xlink:to="loc_srt_MinimumMember_a934b05a-9266-44df-b2e8-95b6927ceabb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_30d0c0b0-6d1e-4796-83de-2d228b12e153" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a8577588-a783-42f9-959e-9e6e42aa235e" xlink:to="loc_srt_MaximumMember_30d0c0b0-6d1e-4796-83de-2d228b12e153" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c71fe903-a8c9-49e0-acfa-0da6d701c4b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c2254f60-5df1-4504-a7ea-ae6175e1c92c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c71fe903-a8c9-49e0-acfa-0da6d701c4b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c71fe903-a8c9-49e0-acfa-0da6d701c4b2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c71fe903-a8c9-49e0-acfa-0da6d701c4b2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c71fe903-a8c9-49e0-acfa-0da6d701c4b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8efcecaa-5ef0-4f63-93df-a94c613b5ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c71fe903-a8c9-49e0-acfa-0da6d701c4b2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8efcecaa-5ef0-4f63-93df-a94c613b5ebd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_58a615dd-2dd4-4863-8903-d9186286f412" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8efcecaa-5ef0-4f63-93df-a94c613b5ebd" xlink:to="loc_us-gaap_BuildingMember_58a615dd-2dd4-4863-8903-d9186286f412" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_57fe6b36-7afb-49e3-b182-8d85fc51b156" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c2254f60-5df1-4504-a7ea-ae6175e1c92c" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_57fe6b36-7afb-49e3-b182-8d85fc51b156" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_57fe6b36-7afb-49e3-b182-8d85fc51b156_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_57fe6b36-7afb-49e3-b182-8d85fc51b156" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_57fe6b36-7afb-49e3-b182-8d85fc51b156_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d1ad4503-f06e-49b4-91ae-630ecdecf4c4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_57fe6b36-7afb-49e3-b182-8d85fc51b156" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d1ad4503-f06e-49b4-91ae-630ecdecf4c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_7595a828-7d7f-4ba8-b237-1a23683fd809" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d1ad4503-f06e-49b4-91ae-630ecdecf4c4" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_7595a828-7d7f-4ba8-b237-1a23683fd809" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_041666ea-2964-4b84-a248-4a41e1c07727" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c2254f60-5df1-4504-a7ea-ae6175e1c92c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_041666ea-2964-4b84-a248-4a41e1c07727" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_041666ea-2964-4b84-a248-4a41e1c07727_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_041666ea-2964-4b84-a248-4a41e1c07727" xlink:to="loc_us-gaap_EquityComponentDomain_041666ea-2964-4b84-a248-4a41e1c07727_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8405ef33-b8ae-4780-b870-618f144b8a40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_041666ea-2964-4b84-a248-4a41e1c07727" xlink:to="loc_us-gaap_EquityComponentDomain_8405ef33-b8ae-4780-b870-618f144b8a40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_6d7255df-5b13-447c-939f-2ffc75e8946d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8405ef33-b8ae-4780-b870-618f144b8a40" xlink:to="loc_us-gaap_RetainedEarningsMember_6d7255df-5b13-447c-939f-2ffc75e8946d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_dc97ff98-f926-486c-9ea3-93f492e2a0da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c2254f60-5df1-4504-a7ea-ae6175e1c92c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_dc97ff98-f926-486c-9ea3-93f492e2a0da" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_dc97ff98-f926-486c-9ea3-93f492e2a0da_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_dc97ff98-f926-486c-9ea3-93f492e2a0da" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_dc97ff98-f926-486c-9ea3-93f492e2a0da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_cb7b3543-6878-47d9-8f7f-87a49c69c5f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_dc97ff98-f926-486c-9ea3-93f492e2a0da" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_cb7b3543-6878-47d9-8f7f-87a49c69c5f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_0837aa0f-db4b-4d41-a9b7-6d33d1d1744e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cb7b3543-6878-47d9-8f7f-87a49c69c5f5" xlink:to="loc_us-gaap_CostOfSalesMember_0837aa0f-db4b-4d41-a9b7-6d33d1d1744e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_82e3a39f-472b-48f2-a097-16233cd8d430" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cb7b3543-6878-47d9-8f7f-87a49c69c5f5" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_82e3a39f-472b-48f2-a097-16233cd8d430" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails" xlink:type="extended" id="i825b4574d6964480b4cacbb8d6b9cdb4_OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b083b84b-8b90-41a7-90c1-dffd61917661" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_d87e8256-a122-4c08-b3be-442bfe9ea476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b083b84b-8b90-41a7-90c1-dffd61917661" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_d87e8256-a122-4c08-b3be-442bfe9ea476" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7236837b-c8ff-4973-9535-71877ccf09b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b083b84b-8b90-41a7-90c1-dffd61917661" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7236837b-c8ff-4973-9535-71877ccf09b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_20941e93-5178-411f-9022-890ef55ad1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b083b84b-8b90-41a7-90c1-dffd61917661" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_20941e93-5178-411f-9022-890ef55ad1fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_27f0cf01-e0fa-46e1-b5f3-7ab264a8ab26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b083b84b-8b90-41a7-90c1-dffd61917661" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_27f0cf01-e0fa-46e1-b5f3-7ab264a8ab26" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_bbfc00f7-af83-459c-9a91-9c6c37f2f87e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b083b84b-8b90-41a7-90c1-dffd61917661" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_bbfc00f7-af83-459c-9a91-9c6c37f2f87e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5ca95522-a55b-4816-9f44-594b9e8adc65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b083b84b-8b90-41a7-90c1-dffd61917661" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5ca95522-a55b-4816-9f44-594b9e8adc65" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f732a011-d7c9-43fc-af64-652c603b1848" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5ca95522-a55b-4816-9f44-594b9e8adc65" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f732a011-d7c9-43fc-af64-652c603b1848" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f732a011-d7c9-43fc-af64-652c603b1848_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f732a011-d7c9-43fc-af64-652c603b1848" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f732a011-d7c9-43fc-af64-652c603b1848_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_87f5f249-8260-4469-87b5-91cc5f1fdd7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f732a011-d7c9-43fc-af64-652c603b1848" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_87f5f249-8260-4469-87b5-91cc5f1fdd7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovementsMember_2c03fdd4-285a-476c-9087-45eb28f42e59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandAndLandImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_87f5f249-8260-4469-87b5-91cc5f1fdd7d" xlink:to="loc_us-gaap_LandAndLandImprovementsMember_2c03fdd4-285a-476c-9087-45eb28f42e59" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_087582a8-f2ad-494d-af06-483b57d4af77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_87f5f249-8260-4469-87b5-91cc5f1fdd7d" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_087582a8-f2ad-494d-af06-483b57d4af77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_dbfc97ce-3f8b-4880-b269-165f19ac3243" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_87f5f249-8260-4469-87b5-91cc5f1fdd7d" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_dbfc97ce-3f8b-4880-b269-165f19ac3243" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_c243aec9-d126-4ee3-999d-a8d2b3ed1b01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_87f5f249-8260-4469-87b5-91cc5f1fdd7d" xlink:to="loc_us-gaap_ConstructionInProgressMember_c243aec9-d126-4ee3-999d-a8d2b3ed1b01" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails" xlink:type="extended" id="i549219f37109418dbc708d0450dde31e_AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems_2e0eb618-f6f1-42f0-be1e-d0877ae7a395" xlink:href="coo-20221031.xsd#coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_8e833d2a-0544-41d0-97fc-ddbb3ae7e467" xlink:href="coo-20221031.xsd#coo_BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems_2e0eb618-f6f1-42f0-be1e-d0877ae7a395" xlink:to="loc_coo_BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_8e833d2a-0544-41d0-97fc-ddbb3ae7e467" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0af39db3-a9e9-4378-9c5f-20b4bf6e7cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems_2e0eb618-f6f1-42f0-be1e-d0877ae7a395" xlink:to="loc_us-gaap_Goodwill_0af39db3-a9e9-4378-9c5f-20b4bf6e7cc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet_97e318a5-e051-4b95-8249-4ba6777001b7" xlink:href="coo-20221031.xsd#coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems_2e0eb618-f6f1-42f0-be1e-d0877ae7a395" xlink:to="loc_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet_97e318a5-e051-4b95-8249-4ba6777001b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability_655c2400-77a7-44f9-9455-22636757adc1" xlink:href="coo-20221031.xsd#coo_BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems_2e0eb618-f6f1-42f0-be1e-d0877ae7a395" xlink:to="loc_coo_BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability_655c2400-77a7-44f9-9455-22636757adc1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_cfb86b5c-ef0b-4010-b659-d7502e2f8f15" xlink:href="coo-20221031.xsd#coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems_2e0eb618-f6f1-42f0-be1e-d0877ae7a395" xlink:to="loc_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_cfb86b5c-ef0b-4010-b659-d7502e2f8f15" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionTable_9b2f818d-5737-416b-8df5-d515a5585d28" xlink:href="coo-20221031.xsd#coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems_2e0eb618-f6f1-42f0-be1e-d0877ae7a395" xlink:to="loc_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionTable_9b2f818d-5737-416b-8df5-d515a5585d28" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessAcquisitionAndAssetAcquisitionAxis_e6b53702-367a-4c62-8292-fd1c23161613" xlink:href="coo-20221031.xsd#coo_BusinessAcquisitionAndAssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionTable_9b2f818d-5737-416b-8df5-d515a5585d28" xlink:to="loc_coo_BusinessAcquisitionAndAssetAcquisitionAxis_e6b53702-367a-4c62-8292-fd1c23161613" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessAcquisitionAndAssetAcquisitionDomain_e6b53702-367a-4c62-8292-fd1c23161613_default" xlink:href="coo-20221031.xsd#coo_BusinessAcquisitionAndAssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_coo_BusinessAcquisitionAndAssetAcquisitionAxis_e6b53702-367a-4c62-8292-fd1c23161613" xlink:to="loc_coo_BusinessAcquisitionAndAssetAcquisitionDomain_e6b53702-367a-4c62-8292-fd1c23161613_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessAcquisitionAndAssetAcquisitionDomain_3163f592-9cd5-42cf-aaaa-e72a1f39644f" xlink:href="coo-20221031.xsd#coo_BusinessAcquisitionAndAssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_coo_BusinessAcquisitionAndAssetAcquisitionAxis_e6b53702-367a-4c62-8292-fd1c23161613" xlink:to="loc_coo_BusinessAcquisitionAndAssetAcquisitionDomain_3163f592-9cd5-42cf-aaaa-e72a1f39644f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember_17c5a815-e5a6-4e5f-af51-b109ed0cc65f" xlink:href="coo-20221031.xsd#coo_SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_BusinessAcquisitionAndAssetAcquisitionDomain_3163f592-9cd5-42cf-aaaa-e72a1f39644f" xlink:to="loc_coo_SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember_17c5a815-e5a6-4e5f-af51-b109ed0cc65f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_06b1559b-26b7-4874-8ee9-20ce1dd2737e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionTable_9b2f818d-5737-416b-8df5-d515a5585d28" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_06b1559b-26b7-4874-8ee9-20ce1dd2737e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_06b1559b-26b7-4874-8ee9-20ce1dd2737e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_06b1559b-26b7-4874-8ee9-20ce1dd2737e" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_06b1559b-26b7-4874-8ee9-20ce1dd2737e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10f090c2-4d6f-4602-9b06-d76b3a52c9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_06b1559b-26b7-4874-8ee9-20ce1dd2737e" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10f090c2-4d6f-4602-9b06-d76b3a52c9a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_939d73e6-5940-454d-add1-6fe1e5f7ffa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10f090c2-4d6f-4602-9b06-d76b3a52c9a1" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_939d73e6-5940-454d-add1-6fe1e5f7ffa8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_1981a6c0-319b-466c-9b2f-772013c89782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10f090c2-4d6f-4602-9b06-d76b3a52c9a1" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_1981a6c0-319b-466c-9b2f-772013c89782" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_bc962057-1724-41d4-97b8-b0c17ff4fcd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10f090c2-4d6f-4602-9b06-d76b3a52c9a1" xlink:to="loc_us-gaap_CustomerRelationshipsMember_bc962057-1724-41d4-97b8-b0c17ff4fcd2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_5d1ea5d7-2e56-45a0-ad93-a6a3a44a9854" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10f090c2-4d6f-4602-9b06-d76b3a52c9a1" xlink:to="loc_us-gaap_TrademarksMember_5d1ea5d7-2e56-45a0-ad93-a6a3a44a9854" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_f6e00634-1d15-4d02-b87a-be10e5cdcbbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10f090c2-4d6f-4602-9b06-d76b3a52c9a1" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_f6e00634-1d15-4d02-b87a-be10e5cdcbbf" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#AcquisitionsandJointVentureNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails" xlink:type="extended" id="i70aa9e3be18e4c23889ace2235e2ead9_AcquisitionsandJointVentureNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_e1a504e3-2e92-4991-b3a6-fafef0e03b42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_e1a504e3-2e92-4991-b3a6-fafef0e03b42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_ff6631c4-bceb-4cdb-9078-06c6c6f9e864" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_ff6631c4-bceb-4cdb-9078-06c6c6f9e864" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_2395a22c-c9e1-4faf-b3ae-a3a56ee5ef7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_2395a22c-c9e1-4faf-b3ae-a3a56ee5ef7e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_9cdad62d-cca0-4106-9f79-1b937c4c4bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_9cdad62d-cca0-4106-9f79-1b937c4c4bfe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_5eb94c8a-15a7-4372-82d0-74e602a6fe9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_5eb94c8a-15a7-4372-82d0-74e602a6fe9a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_c8dad6aa-96e0-4e53-aca1-b2bef4de80c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_c8dad6aa-96e0-4e53-aca1-b2bef4de80c2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_902b5d24-f49f-49ce-ae95-63d665fa3756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_902b5d24-f49f-49ce-ae95-63d665fa3756" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_8d647874-4c8c-4618-be68-10612dab0cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_8d647874-4c8c-4618-be68-10612dab0cdc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_9a4877fb-8ba9-45b6-b5ff-939a5b3663cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_9a4877fb-8ba9-45b6-b5ff-939a5b3663cc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5960b7ac-49de-48f3-960d-4e6f823f2032" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_Goodwill_5960b7ac-49de-48f3-960d-4e6f823f2032" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_bedfd302-9619-411e-933f-c7a02975f483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_bedfd302-9619-411e-933f-c7a02975f483" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_b80f7b5c-9625-47f7-990a-a73d68052c42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_b80f7b5c-9625-47f7-990a-a73d68052c42" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationPaymentToSettleContingentConsideration_31ef0d75-a7ba-474a-91fd-6c5271bd5203" xlink:href="coo-20221031.xsd#coo_BusinessCombinationPaymentToSettleContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_coo_BusinessCombinationPaymentToSettleContingentConsideration_31ef0d75-a7ba-474a-91fd-6c5271bd5203" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss_9dcbadd9-a301-4f05-a710-6cee797692ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss_9dcbadd9-a301-4f05-a710-6cee797692ae" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_d8c94ca3-917a-4e85-91a7-3d557cf842d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_d8c94ca3-917a-4e85-91a7-3d557cf842d1" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_40376353-f997-46c7-9c32-1ba5bed17273" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_40376353-f997-46c7-9c32-1ba5bed17273" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_b7e4fca6-414b-4319-83ba-f71ae54b072c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_b7e4fca6-414b-4319-83ba-f71ae54b072c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_9abbb17e-8633-4b1d-8a5b-bd501c910622" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_9abbb17e-8633-4b1d-8a5b-bd501c910622" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_125033cd-1736-4646-814b-3fa0e6b26278" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_EquityMethodInvestments_125033cd-1736-4646-814b-3fa0e6b26278" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_92e02d8a-e101-438b-8861-2f8235e7175f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_92e02d8a-e101-438b-8861-2f8235e7175f" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_23b9aece-94f0-40af-a86c-2e1458428b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_23b9aece-94f0-40af-a86c-2e1458428b1f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3dc06ac4-99a7-42bd-8519-28faed95fe14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_23b9aece-94f0-40af-a86c-2e1458428b1f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3dc06ac4-99a7-42bd-8519-28faed95fe14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3dc06ac4-99a7-42bd-8519-28faed95fe14_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3dc06ac4-99a7-42bd-8519-28faed95fe14" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3dc06ac4-99a7-42bd-8519-28faed95fe14_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e18d6c9e-0787-427d-9e45-e424c4f6b95a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3dc06ac4-99a7-42bd-8519-28faed95fe14" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e18d6c9e-0787-427d-9e45-e424c4f6b95a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CookMedicalsReproductiveHealthBusinessMember_c218d03a-a57d-4d3c-b556-3df6d4528d48" xlink:href="coo-20221031.xsd#coo_CookMedicalsReproductiveHealthBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e18d6c9e-0787-427d-9e45-e424c4f6b95a" xlink:to="loc_coo_CookMedicalsReproductiveHealthBusinessMember_c218d03a-a57d-4d3c-b556-3df6d4528d48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_GenerateLifeSciencesMember_b1e8179d-9227-45bc-8285-91efd1f63bff" xlink:href="coo-20221031.xsd#coo_GenerateLifeSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e18d6c9e-0787-427d-9e45-e424c4f6b95a" xlink:to="loc_coo_GenerateLifeSciencesMember_b1e8179d-9227-45bc-8285-91efd1f63bff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember_cc5f6075-aff8-4e2f-9b41-351f3cbb7450" xlink:href="coo-20221031.xsd#coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e18d6c9e-0787-427d-9e45-e424c4f6b95a" xlink:to="loc_coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember_cc5f6075-aff8-4e2f-9b41-351f3cbb7450" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_0f14a1cf-bfc2-4e84-a32a-c381a78c8041" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_23b9aece-94f0-40af-a86c-2e1458428b1f" xlink:to="loc_srt_StatementScenarioAxis_0f14a1cf-bfc2-4e84-a32a-c381a78c8041" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_0f14a1cf-bfc2-4e84-a32a-c381a78c8041_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_0f14a1cf-bfc2-4e84-a32a-c381a78c8041" xlink:to="loc_srt_ScenarioUnspecifiedDomain_0f14a1cf-bfc2-4e84-a32a-c381a78c8041_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_fe9099f7-7dc3-4487-be61-61e49cfac5f8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_0f14a1cf-bfc2-4e84-a32a-c381a78c8041" xlink:to="loc_srt_ScenarioUnspecifiedDomain_fe9099f7-7dc3-4487-be61-61e49cfac5f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_06f733b1-05a0-4068-95e6-203679f31bad" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_fe9099f7-7dc3-4487-be61-61e49cfac5f8" xlink:to="loc_srt_ScenarioForecastMember_06f733b1-05a0-4068-95e6-203679f31bad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_b727b664-428e-4ca7-af51-fbc0affaff18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_23b9aece-94f0-40af-a86c-2e1458428b1f" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_b727b664-428e-4ca7-af51-fbc0affaff18" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b727b664-428e-4ca7-af51-fbc0affaff18_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b727b664-428e-4ca7-af51-fbc0affaff18" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b727b664-428e-4ca7-af51-fbc0affaff18_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_7bd765ad-935a-4ced-8f8e-e63b13e31528" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b727b664-428e-4ca7-af51-fbc0affaff18" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_7bd765ad-935a-4ced-8f8e-e63b13e31528" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_9fc7819a-fb54-469d-ae03-b0f6061354b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_7bd765ad-935a-4ced-8f8e-e63b13e31528" xlink:to="loc_us-gaap_SubsequentEventMember_9fc7819a-fb54-469d-ae03-b0f6061354b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis_70f9ad3a-813e-444d-89f8-c6a5be004019" xlink:href="coo-20221031.xsd#coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_23b9aece-94f0-40af-a86c-2e1458428b1f" xlink:to="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis_70f9ad3a-813e-444d-89f8-c6a5be004019" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_70f9ad3a-813e-444d-89f8-c6a5be004019_default" xlink:href="coo-20221031.xsd#coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis_70f9ad3a-813e-444d-89f8-c6a5be004019" xlink:to="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_70f9ad3a-813e-444d-89f8-c6a5be004019_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_2702715c-134b-4abd-b857-aa49eecec0fa" xlink:href="coo-20221031.xsd#coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis_70f9ad3a-813e-444d-89f8-c6a5be004019" xlink:to="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_2702715c-134b-4abd-b857-aa49eecec0fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PayablesFirstInstallmentMember_adca6634-2019-48de-af1f-7150fd5ff68e" xlink:href="coo-20221031.xsd#coo_PayablesFirstInstallmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_2702715c-134b-4abd-b857-aa49eecec0fa" xlink:to="loc_coo_PayablesFirstInstallmentMember_adca6634-2019-48de-af1f-7150fd5ff68e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PayablesSecondInstallmentMember_175644e3-ee45-4f59-8b96-304912f755d1" xlink:href="coo-20221031.xsd#coo_PayablesSecondInstallmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_2702715c-134b-4abd-b857-aa49eecec0fa" xlink:to="loc_coo_PayablesSecondInstallmentMember_175644e3-ee45-4f59-8b96-304912f755d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PayablesThirdInstallmentMember_d9f49bb2-1be1-42ac-8feb-87626554d5df" xlink:href="coo-20221031.xsd#coo_PayablesThirdInstallmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_2702715c-134b-4abd-b857-aa49eecec0fa" xlink:to="loc_coo_PayablesThirdInstallmentMember_d9f49bb2-1be1-42ac-8feb-87626554d5df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PayablesFourthInstallmentMember_dc552ddd-e09e-47c2-8a54-f5a76aae6967" xlink:href="coo-20221031.xsd#coo_PayablesFourthInstallmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_2702715c-134b-4abd-b857-aa49eecec0fa" xlink:to="loc_coo_PayablesFourthInstallmentMember_dc552ddd-e09e-47c2-8a54-f5a76aae6967" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_6215a943-9531-4030-acef-f1b4b18cf88a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_23b9aece-94f0-40af-a86c-2e1458428b1f" xlink:to="loc_us-gaap_CreditFacilityAxis_6215a943-9531-4030-acef-f1b4b18cf88a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_6215a943-9531-4030-acef-f1b4b18cf88a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_6215a943-9531-4030-acef-f1b4b18cf88a" xlink:to="loc_us-gaap_CreditFacilityDomain_6215a943-9531-4030-acef-f1b4b18cf88a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_65f24729-5c88-41e8-b50d-89fcc93ebd15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_6215a943-9531-4030-acef-f1b4b18cf88a" xlink:to="loc_us-gaap_CreditFacilityDomain_65f24729-5c88-41e8-b50d-89fcc93ebd15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_9c48f64f-d6aa-4510-8cc5-82fc118da73a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_65f24729-5c88-41e8-b50d-89fcc93ebd15" xlink:to="loc_us-gaap_LineOfCreditMember_9c48f64f-d6aa-4510-8cc5-82fc118da73a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6063349c-d862-4714-8cd9-4b4189b45ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_23b9aece-94f0-40af-a86c-2e1458428b1f" xlink:to="loc_us-gaap_DebtInstrumentAxis_6063349c-d862-4714-8cd9-4b4189b45ca3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6063349c-d862-4714-8cd9-4b4189b45ca3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_6063349c-d862-4714-8cd9-4b4189b45ca3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6063349c-d862-4714-8cd9-4b4189b45ca3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_eadde719-c921-492c-b398-89e9f64c75bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_6063349c-d862-4714-8cd9-4b4189b45ca3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_eadde719-c921-492c-b398-89e9f64c75bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanFacility2021Member_4c53bcef-ed5a-4ca4-b789-c5537d19939a" xlink:href="coo-20221031.xsd#coo_TermLoanFacility2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eadde719-c921-492c-b398-89e9f64c75bc" xlink:to="loc_coo_TermLoanFacility2021Member_4c53bcef-ed5a-4ca4-b789-c5537d19939a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e7d31583-6621-4b6b-ad5c-816d2ec45d20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_23b9aece-94f0-40af-a86c-2e1458428b1f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e7d31583-6621-4b6b-ad5c-816d2ec45d20" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e7d31583-6621-4b6b-ad5c-816d2ec45d20_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e7d31583-6621-4b6b-ad5c-816d2ec45d20" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e7d31583-6621-4b6b-ad5c-816d2ec45d20_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c2450bf7-f6b9-4ed6-8998-f107166342e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e7d31583-6621-4b6b-ad5c-816d2ec45d20" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c2450bf7-f6b9-4ed6-8998-f107166342e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_56e85647-1d7d-40f4-8373-b01bc5e1776a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c2450bf7-f6b9-4ed6-8998-f107166342e0" xlink:to="loc_us-gaap_CustomerRelationshipsMember_56e85647-1d7d-40f4-8373-b01bc5e1776a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_99c22c9f-dc9e-44de-9436-6f7853a4bc35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c2450bf7-f6b9-4ed6-8998-f107166342e0" xlink:to="loc_us-gaap_TrademarksMember_99c22c9f-dc9e-44de-9436-6f7853a4bc35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_16c7b107-a2d0-4e95-8457-e61c04e64a95" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_23b9aece-94f0-40af-a86c-2e1458428b1f" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_16c7b107-a2d0-4e95-8457-e61c04e64a95" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_16c7b107-a2d0-4e95-8457-e61c04e64a95_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_16c7b107-a2d0-4e95-8457-e61c04e64a95" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_16c7b107-a2d0-4e95-8457-e61c04e64a95_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_d99e5427-5c1b-446f-b10a-cae99de5d23e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_16c7b107-a2d0-4e95-8457-e61c04e64a95" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_d99e5427-5c1b-446f-b10a-cae99de5d23e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_SightGlassVisionIncMember_4c70042c-efb2-4028-a970-eea656bddce6" xlink:href="coo-20221031.xsd#coo_SightGlassVisionIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d99e5427-5c1b-446f-b10a-cae99de5d23e" xlink:to="loc_coo_SightGlassVisionIncMember_4c70042c-efb2-4028-a970-eea656bddce6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_f01274f7-33c8-4afb-8192-25689a3ce2ba" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_23b9aece-94f0-40af-a86c-2e1458428b1f" xlink:to="loc_dei_LegalEntityAxis_f01274f7-33c8-4afb-8192-25689a3ce2ba" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f01274f7-33c8-4afb-8192-25689a3ce2ba_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_f01274f7-33c8-4afb-8192-25689a3ce2ba" xlink:to="loc_dei_EntityDomain_f01274f7-33c8-4afb-8192-25689a3ce2ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_4fbf2674-11a0-4530-8016-ed3c45df0c5f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_f01274f7-33c8-4afb-8192-25689a3ce2ba" xlink:to="loc_dei_EntityDomain_4fbf2674-11a0-4530-8016-ed3c45df0c5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_EssilorInternationalSASMember_c32b934b-94f3-45db-89e2-e80d2ebd1283" xlink:href="coo-20221031.xsd#coo_EssilorInternationalSASMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_4fbf2674-11a0-4530-8016-ed3c45df0c5f" xlink:to="loc_coo_EssilorInternationalSASMember_c32b934b-94f3-45db-89e2-e80d2ebd1283" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AssetAquisitionAxis_2a3cbf17-c5af-474e-97af-e8d9a0ac0475" xlink:href="coo-20221031.xsd#coo_AssetAquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_23b9aece-94f0-40af-a86c-2e1458428b1f" xlink:to="loc_coo_AssetAquisitionAxis_2a3cbf17-c5af-474e-97af-e8d9a0ac0475" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AssetAquisitionDomain_2a3cbf17-c5af-474e-97af-e8d9a0ac0475_default" xlink:href="coo-20221031.xsd#coo_AssetAquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_coo_AssetAquisitionAxis_2a3cbf17-c5af-474e-97af-e8d9a0ac0475" xlink:to="loc_coo_AssetAquisitionDomain_2a3cbf17-c5af-474e-97af-e8d9a0ac0475_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AssetAquisitionDomain_753be4bd-e16a-4307-b295-0d098db7fd55" xlink:href="coo-20221031.xsd#coo_AssetAquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_coo_AssetAquisitionAxis_2a3cbf17-c5af-474e-97af-e8d9a0ac0475" xlink:to="loc_coo_AssetAquisitionDomain_753be4bd-e16a-4307-b295-0d098db7fd55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PrivatelyHeldMedicalDeviceCompanyDevelopedMaraWaterVaporAblationSystemMember_764a9f92-dfc8-4f37-8ae7-0f5796158930" xlink:href="coo-20221031.xsd#coo_PrivatelyHeldMedicalDeviceCompanyDevelopedMaraWaterVaporAblationSystemMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_AssetAquisitionDomain_753be4bd-e16a-4307-b295-0d098db7fd55" xlink:to="loc_coo_PrivatelyHeldMedicalDeviceCompanyDevelopedMaraWaterVaporAblationSystemMember_764a9f92-dfc8-4f37-8ae7-0f5796158930" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended" id="i06b6e24db6924187bde0d4cda1590340_AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ef4f74ce-3120-4e30-9135-c758dc191f55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_86afaea9-255b-44f2-9343-0daf07580158" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ef4f74ce-3120-4e30-9135-c758dc191f55" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_86afaea9-255b-44f2-9343-0daf07580158" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_8a0a3066-16a3-4994-9f2a-7db46ac11ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_86afaea9-255b-44f2-9343-0daf07580158" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_8a0a3066-16a3-4994-9f2a-7db46ac11ed7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_cf247206-e515-479a-b99f-6fc2aa6952ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_8a0a3066-16a3-4994-9f2a-7db46ac11ed7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_cf247206-e515-479a-b99f-6fc2aa6952ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_54d0ca83-9e48-4e84-9871-dcef5a7a5977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_8a0a3066-16a3-4994-9f2a-7db46ac11ed7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_54d0ca83-9e48-4e84-9871-dcef5a7a5977" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_bedf1301-8333-4ea4-a202-d5414ee9dfbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_8a0a3066-16a3-4994-9f2a-7db46ac11ed7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_bedf1301-8333-4ea4-a202-d5414ee9dfbc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_75b26c95-cc7b-4634-9772-54367cb25525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_8a0a3066-16a3-4994-9f2a-7db46ac11ed7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_75b26c95-cc7b-4634-9772-54367cb25525" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_9b6d054e-da56-40d7-af18-887bbf6a4633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_8a0a3066-16a3-4994-9f2a-7db46ac11ed7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_9b6d054e-da56-40d7-af18-887bbf6a4633" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c4603325-4e60-49e2-93a6-3eff5ae7f7f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_86afaea9-255b-44f2-9343-0daf07580158" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c4603325-4e60-49e2-93a6-3eff5ae7f7f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ec215856-6071-4ef1-ad5b-3851c0fcd8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_86afaea9-255b-44f2-9343-0daf07580158" xlink:to="loc_us-gaap_Goodwill_ec215856-6071-4ef1-ad5b-3851c0fcd8b7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0372aad9-de13-4cb0-8ef0-37ee0e7bdc10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_86afaea9-255b-44f2-9343-0daf07580158" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0372aad9-de13-4cb0-8ef0-37ee0e7bdc10" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_3cfffb41-06fd-4965-9f84-3fefa8b52c03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_86afaea9-255b-44f2-9343-0daf07580158" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_3cfffb41-06fd-4965-9f84-3fefa8b52c03" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_038d17c7-6b60-4f90-a5b7-b43e114fa6d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_86afaea9-255b-44f2-9343-0daf07580158" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_038d17c7-6b60-4f90-a5b7-b43e114fa6d8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_247628d1-069f-418b-896a-2b6da4e3d333" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ef4f74ce-3120-4e30-9135-c758dc191f55" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_247628d1-069f-418b-896a-2b6da4e3d333" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_6f42c673-1600-4a69-8538-728f8c807987" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_247628d1-069f-418b-896a-2b6da4e3d333" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_6f42c673-1600-4a69-8538-728f8c807987" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_683b93a0-bcf3-43be-8903-52440c6f678c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_6f42c673-1600-4a69-8538-728f8c807987" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_683b93a0-bcf3-43be-8903-52440c6f678c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesEmployeeRelatedLiabilities_2dfde892-7577-4edb-a12d-ce0fdf852097" xlink:href="coo-20221031.xsd#coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesEmployeeRelatedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_6f42c673-1600-4a69-8538-728f8c807987" xlink:to="loc_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesEmployeeRelatedLiabilities_2dfde892-7577-4edb-a12d-ce0fdf852097" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_6341a3db-ee6b-42c8-b6b2-4e2c0f910410" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_6f42c673-1600-4a69-8538-728f8c807987" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_6341a3db-ee6b-42c8-b6b2-4e2c0f910410" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_83d363ce-cb2e-442b-b93a-c85cbe8e7541" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_6f42c673-1600-4a69-8538-728f8c807987" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_83d363ce-cb2e-442b-b93a-c85cbe8e7541" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_44c05a76-ac7f-4935-93c8-57d92038a993" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_6f42c673-1600-4a69-8538-728f8c807987" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_44c05a76-ac7f-4935-93c8-57d92038a993" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_e80eb74d-6917-4806-8776-bcbe15e0cce2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_247628d1-069f-418b-896a-2b6da4e3d333" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_e80eb74d-6917-4806-8776-bcbe15e0cce2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability_650ab85f-9b10-446e-a735-9541a0624ef8" xlink:href="coo-20221031.xsd#coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_247628d1-069f-418b-896a-2b6da4e3d333" xlink:to="loc_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability_650ab85f-9b10-446e-a735-9541a0624ef8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredRevenue_37f73e56-13f8-4b15-889e-d1251962cfb4" xlink:href="coo-20221031.xsd#coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_247628d1-069f-418b-896a-2b6da4e3d333" xlink:to="loc_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredRevenue_37f73e56-13f8-4b15-889e-d1251962cfb4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_d3ccc8dc-c467-4d8d-ba6b-4eec0834922d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_247628d1-069f-418b-896a-2b6da4e3d333" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_d3ccc8dc-c467-4d8d-ba6b-4eec0834922d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_57b4cd90-c431-4da9-b005-d80ab27d30a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_247628d1-069f-418b-896a-2b6da4e3d333" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_57b4cd90-c431-4da9-b005-d80ab27d30a8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_8a1745ea-1104-4b24-9db2-556c601f9678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ef4f74ce-3120-4e30-9135-c758dc191f55" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_8a1745ea-1104-4b24-9db2-556c601f9678" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cc7d0eb0-a45e-497c-8b15-28652d4d2393" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ef4f74ce-3120-4e30-9135-c758dc191f55" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cc7d0eb0-a45e-497c-8b15-28652d4d2393" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_47d56c8f-4659-4078-9673-969c6d9f539a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cc7d0eb0-a45e-497c-8b15-28652d4d2393" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_47d56c8f-4659-4078-9673-969c6d9f539a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_47d56c8f-4659-4078-9673-969c6d9f539a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_47d56c8f-4659-4078-9673-969c6d9f539a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_47d56c8f-4659-4078-9673-969c6d9f539a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1cbcc945-3b9b-4cf4-8b61-872cae1df498" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_47d56c8f-4659-4078-9673-969c6d9f539a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1cbcc945-3b9b-4cf4-8b61-872cae1df498" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_GenerateLifeSciencesMember_99ee89cf-75c6-4f83-9385-85aae99b3ce2" xlink:href="coo-20221031.xsd#coo_GenerateLifeSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1cbcc945-3b9b-4cf4-8b61-872cae1df498" xlink:to="loc_coo_GenerateLifeSciencesMember_99ee89cf-75c6-4f83-9385-85aae99b3ce2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fcb8220d-88c8-4140-b4c4-902d14518e60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cc7d0eb0-a45e-497c-8b15-28652d4d2393" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fcb8220d-88c8-4140-b4c4-902d14518e60" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fcb8220d-88c8-4140-b4c4-902d14518e60_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fcb8220d-88c8-4140-b4c4-902d14518e60" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fcb8220d-88c8-4140-b4c4-902d14518e60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ea51196-7c27-416e-8e53-979f07c42e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fcb8220d-88c8-4140-b4c4-902d14518e60" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ea51196-7c27-416e-8e53-979f07c42e0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_5a377db8-c630-4e35-b168-46abd516e7b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ea51196-7c27-416e-8e53-979f07c42e0c" xlink:to="loc_us-gaap_CustomerRelationshipsMember_5a377db8-c630-4e35-b168-46abd516e7b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_fae82438-838a-407b-b912-881f5ec0a6c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ea51196-7c27-416e-8e53-979f07c42e0c" xlink:to="loc_us-gaap_TrademarksMember_fae82438-838a-407b-b912-881f5ec0a6c1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/AcquisitionsandJointVentureProformaInformationDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#AcquisitionsandJointVentureProformaInformationDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/AcquisitionsandJointVentureProformaInformationDetails" xlink:type="extended" id="i9306bf1187404c56b75ce34c609e68e9_AcquisitionsandJointVentureProformaInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_2fc86855-11d0-442b-8f06-1637d0bb5be6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_ff14d0e6-34b1-425e-8671-808a42be5af2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fc86855-11d0-442b-8f06-1637d0bb5be6" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_ff14d0e6-34b1-425e-8671-808a42be5af2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_4cac1828-58da-4ee7-ac21-2e658f511922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fc86855-11d0-442b-8f06-1637d0bb5be6" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_4cac1828-58da-4ee7-ac21-2e658f511922" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_01fbe42e-a5d2-4919-ac51-309abfd615dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fc86855-11d0-442b-8f06-1637d0bb5be6" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_01fbe42e-a5d2-4919-ac51-309abfd615dc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_07bedfb9-790c-4e5a-897b-7032fc8cae13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_01fbe42e-a5d2-4919-ac51-309abfd615dc" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_07bedfb9-790c-4e5a-897b-7032fc8cae13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_07bedfb9-790c-4e5a-897b-7032fc8cae13_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_07bedfb9-790c-4e5a-897b-7032fc8cae13" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_07bedfb9-790c-4e5a-897b-7032fc8cae13_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e9d95c0b-b562-4ebd-8630-8c17674c9d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_07bedfb9-790c-4e5a-897b-7032fc8cae13" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e9d95c0b-b562-4ebd-8630-8c17674c9d2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_GenerateLifeSciencesMember_c5f149a0-4575-4ceb-b0cd-1322d116bb1e" xlink:href="coo-20221031.xsd#coo_GenerateLifeSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e9d95c0b-b562-4ebd-8630-8c17674c9d2e" xlink:to="loc_coo_GenerateLifeSciencesMember_c5f149a0-4575-4ceb-b0cd-1322d116bb1e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#IntangibleAssetsGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails" xlink:type="extended" id="ia4a9446555c44185bae14bf67112e2a0_IntangibleAssetsGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_e81808c4-2ae3-45fd-8d37-c892e0d53660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_33842427-a8f6-40e9-9894-0237c2e842f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_e81808c4-2ae3-45fd-8d37-c892e0d53660" xlink:to="loc_us-gaap_GoodwillRollForward_33842427-a8f6-40e9-9894-0237c2e842f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1c7265ce-0f2d-4a45-ab7a-a662f4dcf307" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_33842427-a8f6-40e9-9894-0237c2e842f9" xlink:to="loc_us-gaap_Goodwill_1c7265ce-0f2d-4a45-ab7a-a662f4dcf307" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease_9101416f-598f-4f7c-95ce-31ec43993df2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_33842427-a8f6-40e9-9894-0237c2e842f9" xlink:to="loc_us-gaap_GoodwillPeriodIncreaseDecrease_9101416f-598f-4f7c-95ce-31ec43993df2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_91e69432-3c23-49cb-a33e-892d5b52565e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_33842427-a8f6-40e9-9894-0237c2e842f9" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_91e69432-3c23-49cb-a33e-892d5b52565e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_65528418-a09d-4a41-a829-306f3f614fc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_60d33582-e1f7-484d-b882-394d5eecd740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_e81808c4-2ae3-45fd-8d37-c892e0d53660" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_60d33582-e1f7-484d-b882-394d5eecd740" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_eecc1f60-c26e-40ae-ab94-4cbf6f2ee62c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_60d33582-e1f7-484d-b882-394d5eecd740" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_eecc1f60-c26e-40ae-ab94-4cbf6f2ee62c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_eecc1f60-c26e-40ae-ab94-4cbf6f2ee62c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_eecc1f60-c26e-40ae-ab94-4cbf6f2ee62c" xlink:to="loc_us-gaap_SegmentDomain_eecc1f60-c26e-40ae-ab94-4cbf6f2ee62c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_55dc52e7-2038-426e-bdd2-9a796eec26bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_eecc1f60-c26e-40ae-ab94-4cbf6f2ee62c" xlink:to="loc_us-gaap_SegmentDomain_55dc52e7-2038-426e-bdd2-9a796eec26bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CoopervisionSegmentMember_f51fb146-04d4-433a-bf87-5cc282e09646" xlink:href="coo-20221031.xsd#coo_CoopervisionSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_55dc52e7-2038-426e-bdd2-9a796eec26bc" xlink:to="loc_coo_CoopervisionSegmentMember_f51fb146-04d4-433a-bf87-5cc282e09646" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CoopersurgicalSegmentMember_eb9017e8-9dcb-42ba-bd16-884fe7859b55" xlink:href="coo-20221031.xsd#coo_CoopersurgicalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_55dc52e7-2038-426e-bdd2-9a796eec26bc" xlink:to="loc_coo_CoopersurgicalSegmentMember_eb9017e8-9dcb-42ba-bd16-884fe7859b55" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#IntangibleAssetsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails" xlink:type="extended" id="i0c4a4616791243318eac310bcd448f5a_IntangibleAssetsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_0efbfbeb-956b-45a4-bcf8-0e708f009226" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_a1759dd1-488f-478d-9547-cb4412afb97c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_0efbfbeb-956b-45a4-bcf8-0e708f009226" xlink:to="loc_us-gaap_NumberOfReportingUnits_a1759dd1-488f-478d-9547-cb4412afb97c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_6525ab1f-d144-498b-9746-655fb276d44d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_0efbfbeb-956b-45a4-bcf8-0e708f009226" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_6525ab1f-d144-498b-9746-655fb276d44d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_5d884ebd-5e40-431e-8cfe-1e5996994455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_0efbfbeb-956b-45a4-bcf8-0e708f009226" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_5d884ebd-5e40-431e-8cfe-1e5996994455" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_d3d4f3cb-34a9-4d61-974e-2538908bb679" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_0efbfbeb-956b-45a4-bcf8-0e708f009226" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_d3d4f3cb-34a9-4d61-974e-2538908bb679" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_777e45dc-9a23-463e-a9e0-e64aef74dfec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_0efbfbeb-956b-45a4-bcf8-0e708f009226" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_777e45dc-9a23-463e-a9e0-e64aef74dfec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_4051d2c8-e7b6-4617-bb10-010993735809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_0efbfbeb-956b-45a4-bcf8-0e708f009226" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_4051d2c8-e7b6-4617-bb10-010993735809" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7964e59c-1b54-456a-87f2-e9298a492934" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_4051d2c8-e7b6-4617-bb10-010993735809" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7964e59c-1b54-456a-87f2-e9298a492934" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7964e59c-1b54-456a-87f2-e9298a492934_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7964e59c-1b54-456a-87f2-e9298a492934" xlink:to="loc_us-gaap_SegmentDomain_7964e59c-1b54-456a-87f2-e9298a492934_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_aa9cf632-a454-4eac-a87a-61ed17718e4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7964e59c-1b54-456a-87f2-e9298a492934" xlink:to="loc_us-gaap_SegmentDomain_aa9cf632-a454-4eac-a87a-61ed17718e4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CoopersurgicalSegmentMember_39e273f4-9ec8-46d8-9b9f-cabee2802a7d" xlink:href="coo-20221031.xsd#coo_CoopersurgicalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_aa9cf632-a454-4eac-a87a-61ed17718e4d" xlink:to="loc_coo_CoopersurgicalSegmentMember_39e273f4-9ec8-46d8-9b9f-cabee2802a7d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CoopervisionSegmentMember_587c7e9d-4244-4041-8c83-c1c60d7ae9fb" xlink:href="coo-20221031.xsd#coo_CoopervisionSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_aa9cf632-a454-4eac-a87a-61ed17718e4d" xlink:to="loc_coo_CoopervisionSegmentMember_587c7e9d-4244-4041-8c83-c1c60d7ae9fb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#IntangibleAssetsOtherIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails" xlink:type="extended" id="i30fdc84cc7a54751b145b92b2c712c64_IntangibleAssetsOtherIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3a5d3430-16a2-4fc7-a9b4-b751673697a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_95fee933-3507-4aeb-8df7-b0904301b92d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3a5d3430-16a2-4fc7-a9b4-b751673697a6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_95fee933-3507-4aeb-8df7-b0904301b92d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_68983929-4951-4c28-b218-0bd452101730" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3a5d3430-16a2-4fc7-a9b4-b751673697a6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_68983929-4951-4c28-b218-0bd452101730" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b05021c0-5c6e-42f7-9522-8d34a6813520" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3a5d3430-16a2-4fc7-a9b4-b751673697a6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b05021c0-5c6e-42f7-9522-8d34a6813520" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_32d4d129-70a6-4557-bac0-6a16012345a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3a5d3430-16a2-4fc7-a9b4-b751673697a6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_32d4d129-70a6-4557-bac0-6a16012345a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_06c6f680-578c-47fc-89af-4565cec4da73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3a5d3430-16a2-4fc7-a9b4-b751673697a6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_06c6f680-578c-47fc-89af-4565cec4da73" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6bfb28eb-24f0-4955-a40d-09aa370e324a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3a5d3430-16a2-4fc7-a9b4-b751673697a6" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6bfb28eb-24f0-4955-a40d-09aa370e324a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8ab8a0a6-e89d-43be-8a3f-9247ad1af9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3a5d3430-16a2-4fc7-a9b4-b751673697a6" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8ab8a0a6-e89d-43be-8a3f-9247ad1af9a1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b0d20252-cf6a-4a1a-879a-905a930c0bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8ab8a0a6-e89d-43be-8a3f-9247ad1af9a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b0d20252-cf6a-4a1a-879a-905a930c0bc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b0d20252-cf6a-4a1a-879a-905a930c0bc4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b0d20252-cf6a-4a1a-879a-905a930c0bc4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b0d20252-cf6a-4a1a-879a-905a930c0bc4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_18be200b-666e-431e-9b3c-5ff62134f7f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b0d20252-cf6a-4a1a-879a-905a930c0bc4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_18be200b-666e-431e-9b3c-5ff62134f7f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_6abc9b22-d84c-40fd-895f-d74ec9c3032c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_18be200b-666e-431e-9b3c-5ff62134f7f1" xlink:to="loc_us-gaap_TrademarksMember_6abc9b22-d84c-40fd-895f-d74ec9c3032c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CompositeMember_c16dfed2-7549-4bd2-a4e2-828c78092d3e" xlink:href="coo-20221031.xsd#coo_CompositeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_18be200b-666e-431e-9b3c-5ff62134f7f1" xlink:to="loc_coo_CompositeMember_c16dfed2-7549-4bd2-a4e2-828c78092d3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_814af4a8-e397-46ad-a12f-158866b44b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_18be200b-666e-431e-9b3c-5ff62134f7f1" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_814af4a8-e397-46ad-a12f-158866b44b5e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_d5e5dfbc-2494-4340-acf1-cfe9808a57b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_18be200b-666e-431e-9b3c-5ff62134f7f1" xlink:to="loc_us-gaap_CustomerRelationshipsMember_d5e5dfbc-2494-4340-acf1-cfe9808a57b6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_LicenseAndDistributionRightsAndOtherMember_da9dd96f-a983-4480-a06c-b98ccf87dab0" xlink:href="coo-20221031.xsd#coo_LicenseAndDistributionRightsAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_18be200b-666e-431e-9b3c-5ff62134f7f1" xlink:to="loc_coo_LicenseAndDistributionRightsAndOtherMember_da9dd96f-a983-4480-a06c-b98ccf87dab0" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#FinancingArrangementsTotalDebtDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails" xlink:type="extended" id="i6a8a72bc3e154c3e87f869eed3ed3575_FinancingArrangementsTotalDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_49b5b0ee-0030-4f61-8aeb-ef10f7085d4b" xlink:href="coo-20221031.xsd#coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowingsAbstract_33749987-870d-44e7-b9b9-a32a97a6f6b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowingsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_49b5b0ee-0030-4f61-8aeb-ef10f7085d4b" xlink:to="loc_us-gaap_ShortTermBorrowingsAbstract_33749987-870d-44e7-b9b9-a32a97a6f6b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_6e3896b7-321d-4040-8f84-b7d95b51ab66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract_33749987-870d-44e7-b9b9-a32a97a6f6b7" xlink:to="loc_us-gaap_ShortTermBorrowings_6e3896b7-321d-4040-8f84-b7d95b51ab66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsCurrentNet_1a959440-c485-4026-b8e8-216ef6721158" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsCurrentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract_33749987-870d-44e7-b9b9-a32a97a6f6b7" xlink:to="loc_us-gaap_DeferredFinanceCostsCurrentNet_1a959440-c485-4026-b8e8-216ef6721158" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ShortTermDebtNetOfDebtIssuanceCosts_337602f2-3d82-4423-aef1-a6ce164cfc81" xlink:href="coo-20221031.xsd#coo_ShortTermDebtNetOfDebtIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract_33749987-870d-44e7-b9b9-a32a97a6f6b7" xlink:to="loc_coo_ShortTermDebtNetOfDebtIssuanceCosts_337602f2-3d82-4423-aef1-a6ce164cfc81" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_1b13cd67-f2c6-40de-8477-a0be8f0f7af2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract_33749987-870d-44e7-b9b9-a32a97a6f6b7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_1b13cd67-f2c6-40de-8477-a0be8f0f7af2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_8cfbf105-15e4-4f36-9e29-3a215e15f670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract_33749987-870d-44e7-b9b9-a32a97a6f6b7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_8cfbf105-15e4-4f36-9e29-3a215e15f670" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_49844e9b-ad37-478e-9827-9f4f5bf96a83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract_33749987-870d-44e7-b9b9-a32a97a6f6b7" xlink:to="loc_us-gaap_DebtCurrent_49844e9b-ad37-478e-9827-9f4f5bf96a83" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAbstract_6589c158-d66d-4aa3-b62f-2f8eceacd4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_49b5b0ee-0030-4f61-8aeb-ef10f7085d4b" xlink:to="loc_us-gaap_LongTermDebtAbstract_6589c158-d66d-4aa3-b62f-2f8eceacd4eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_69d0c695-593e-4da5-9586-653495527df0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtAbstract_6589c158-d66d-4aa3-b62f-2f8eceacd4eb" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_69d0c695-593e-4da5-9586-653495527df0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_6c81bb58-69d9-4843-ab6d-821a6d60db3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtAbstract_6589c158-d66d-4aa3-b62f-2f8eceacd4eb" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_6c81bb58-69d9-4843-ab6d-821a6d60db3d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_2d6cddf4-e60f-4324-81ab-5c1176a7dff3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtAbstract_6589c158-d66d-4aa3-b62f-2f8eceacd4eb" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_2d6cddf4-e60f-4324-81ab-5c1176a7dff3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_8744f063-2599-4e8c-ad68-52f6873109ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtAbstract_6589c158-d66d-4aa3-b62f-2f8eceacd4eb" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_8744f063-2599-4e8c-ad68-52f6873109ae" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_618a4ad0-4514-45de-80f5-20542c8e4fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtAbstract_6589c158-d66d-4aa3-b62f-2f8eceacd4eb" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_618a4ad0-4514-45de-80f5-20542c8e4fb0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_34d16202-e550-42e4-bbe1-39731e7d91f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtAbstract_6589c158-d66d-4aa3-b62f-2f8eceacd4eb" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_34d16202-e550-42e4-bbe1-39731e7d91f8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_920db39b-6cfd-402b-af55-f33e512ce453" xlink:href="coo-20221031.xsd#coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_49b5b0ee-0030-4f61-8aeb-ef10f7085d4b" xlink:to="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_920db39b-6cfd-402b-af55-f33e512ce453" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_2bfb9ac1-f870-4bd0-8980-911505fe5c74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_920db39b-6cfd-402b-af55-f33e512ce453" xlink:to="loc_us-gaap_CreditFacilityAxis_2bfb9ac1-f870-4bd0-8980-911505fe5c74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2bfb9ac1-f870-4bd0-8980-911505fe5c74_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_2bfb9ac1-f870-4bd0-8980-911505fe5c74" xlink:to="loc_us-gaap_CreditFacilityDomain_2bfb9ac1-f870-4bd0-8980-911505fe5c74_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5810b021-9899-4f38-bb00-e0a5d88b5f38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_2bfb9ac1-f870-4bd0-8980-911505fe5c74" xlink:to="loc_us-gaap_CreditFacilityDomain_5810b021-9899-4f38-bb00-e0a5d88b5f38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_75434f37-6318-4de3-8818-eb72cb2269e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_5810b021-9899-4f38-bb00-e0a5d88b5f38" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_75434f37-6318-4de3-8818-eb72cb2269e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e9e5d0fe-6991-41e0-a7a3-b10377fd3057" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_920db39b-6cfd-402b-af55-f33e512ce453" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e9e5d0fe-6991-41e0-a7a3-b10377fd3057" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e9e5d0fe-6991-41e0-a7a3-b10377fd3057_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e9e5d0fe-6991-41e0-a7a3-b10377fd3057" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e9e5d0fe-6991-41e0-a7a3-b10377fd3057_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_bef56611-b8c5-45bf-a836-615bbad71cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e9e5d0fe-6991-41e0-a7a3-b10377fd3057" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_bef56611-b8c5-45bf-a836-615bbad71cd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_e018e644-78e3-454e-baae-54df962e4900" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bef56611-b8c5-45bf-a836-615bbad71cd3" xlink:to="loc_us-gaap_LineOfCreditMember_e018e644-78e3-454e-baae-54df962e4900" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_c339883e-c161-4efd-aa96-4f5e55c88020" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MediumTermNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bef56611-b8c5-45bf-a836-615bbad71cd3" xlink:to="loc_us-gaap_MediumTermNotesMember_c339883e-c161-4efd-aa96-4f5e55c88020" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_OtherDebtMember_895cc8a6-c6f2-45b6-816c-ef23885ccc16" xlink:href="coo-20221031.xsd#coo_OtherDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bef56611-b8c5-45bf-a836-615bbad71cd3" xlink:to="loc_coo_OtherDebtMember_895cc8a6-c6f2-45b6-816c-ef23885ccc16" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_13022d1d-667f-4698-b456-39b5e6f32112" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_920db39b-6cfd-402b-af55-f33e512ce453" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_13022d1d-667f-4698-b456-39b5e6f32112" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_13022d1d-667f-4698-b456-39b5e6f32112_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_13022d1d-667f-4698-b456-39b5e6f32112" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_13022d1d-667f-4698-b456-39b5e6f32112_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_511368b7-6f6e-4b48-b27f-2cdf5195bedb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_13022d1d-667f-4698-b456-39b5e6f32112" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_511368b7-6f6e-4b48-b27f-2cdf5195bedb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_OverdraftAndOtherCreditFacilitiesMember_cac4da6d-7f7f-4d79-9a60-cb64b342d4ed" xlink:href="coo-20221031.xsd#coo_OverdraftAndOtherCreditFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_511368b7-6f6e-4b48-b27f-2cdf5195bedb" xlink:to="loc_coo_OverdraftAndOtherCreditFacilitiesMember_cac4da6d-7f7f-4d79-9a60-cb64b342d4ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoansMember_03f289af-9a2f-41b8-8831-4189a352acab" xlink:href="coo-20221031.xsd#coo_TermLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_511368b7-6f6e-4b48-b27f-2cdf5195bedb" xlink:to="loc_coo_TermLoansMember_03f289af-9a2f-41b8-8831-4189a352acab" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#FinancingArrangementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails" xlink:type="extended" id="ia071dd49e4334437a79bb35b71cd2f79_FinancingArrangementsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_f7ca0d53-f81c-4872-bda0-3e4e9ddf52f5" xlink:href="coo-20221031.xsd#coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_fc8cf5a7-0179-44fe-b641-97f8133c8b02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_f7ca0d53-f81c-4872-bda0-3e4e9ddf52f5" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_fc8cf5a7-0179-44fe-b641-97f8133c8b02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit_500d7f41-cba6-485f-8921-d3c1c61e41c4" xlink:href="coo-20221031.xsd#coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_f7ca0d53-f81c-4872-bda0-3e4e9ddf52f5" xlink:to="loc_coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit_500d7f41-cba6-485f-8921-d3c1c61e41c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_430fe791-416b-45a1-bd82-86be5f25c362" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_f7ca0d53-f81c-4872-bda0-3e4e9ddf52f5" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_430fe791-416b-45a1-bd82-86be5f25c362" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_8ba5f203-85d4-4c52-84b4-ccc154fc38a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_f7ca0d53-f81c-4872-bda0-3e4e9ddf52f5" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_8ba5f203-85d4-4c52-84b4-ccc154fc38a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_22177537-a351-4f51-ab80-76854c2c176f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_f7ca0d53-f81c-4872-bda0-3e4e9ddf52f5" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_22177537-a351-4f51-ab80-76854c2c176f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_c4b87b41-341f-49d7-8bf4-ee4ed796d869" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_f7ca0d53-f81c-4872-bda0-3e4e9ddf52f5" xlink:to="loc_us-gaap_DebtInstrumentTerm_c4b87b41-341f-49d7-8bf4-ee4ed796d869" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_a1a4303d-f090-4a5a-a74f-6828a652b6bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_f7ca0d53-f81c-4872-bda0-3e4e9ddf52f5" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_a1a4303d-f090-4a5a-a74f-6828a652b6bf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_dd3d090b-e381-4b74-9fb7-61c181e39808" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_f7ca0d53-f81c-4872-bda0-3e4e9ddf52f5" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_dd3d090b-e381-4b74-9fb7-61c181e39808" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_69ccf6f2-740c-4b2e-802f-e1e86409fbc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_f7ca0d53-f81c-4872-bda0-3e4e9ddf52f5" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_69ccf6f2-740c-4b2e-802f-e1e86409fbc8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit_67b19839-c34a-4443-9fc3-4f9a1b278e18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_f7ca0d53-f81c-4872-bda0-3e4e9ddf52f5" xlink:to="loc_us-gaap_LongTermLineOfCredit_67b19839-c34a-4443-9fc3-4f9a1b278e18" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_fa001d89-740b-40d1-8030-1cd751fdc869" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_f7ca0d53-f81c-4872-bda0-3e4e9ddf52f5" xlink:to="loc_us-gaap_LineOfCredit_fa001d89-740b-40d1-8030-1cd751fdc869" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_15e94d83-e225-4ece-9bc2-a852d1ad6eee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_f7ca0d53-f81c-4872-bda0-3e4e9ddf52f5" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_15e94d83-e225-4ece-9bc2-a852d1ad6eee" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_88966646-6fe7-48ae-9972-627beeb54cad" xlink:href="coo-20221031.xsd#coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_f7ca0d53-f81c-4872-bda0-3e4e9ddf52f5" xlink:to="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_88966646-6fe7-48ae-9972-627beeb54cad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_781765c8-a962-401d-b896-7c9bd6517b85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_88966646-6fe7-48ae-9972-627beeb54cad" xlink:to="loc_us-gaap_DebtInstrumentAxis_781765c8-a962-401d-b896-7c9bd6517b85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_781765c8-a962-401d-b896-7c9bd6517b85_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_781765c8-a962-401d-b896-7c9bd6517b85" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_781765c8-a962-401d-b896-7c9bd6517b85_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b6620795-1158-47c9-8c90-4f0aaafb4d59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_781765c8-a962-401d-b896-7c9bd6517b85" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b6620795-1158-47c9-8c90-4f0aaafb4d59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanFacility2021Member_f722f6c8-0aff-4e67-872f-00334fd4a29e" xlink:href="coo-20221031.xsd#coo_TermLoanFacility2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b6620795-1158-47c9-8c90-4f0aaafb4d59" xlink:to="loc_coo_TermLoanFacility2021Member_f722f6c8-0aff-4e67-872f-00334fd4a29e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanFacility2021BaseRateLoansMember_9dfc0e28-f95a-4426-af1b-4c8e123c54a8" xlink:href="coo-20221031.xsd#coo_TermLoanFacility2021BaseRateLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b6620795-1158-47c9-8c90-4f0aaafb4d59" xlink:to="loc_coo_TermLoanFacility2021BaseRateLoansMember_9dfc0e28-f95a-4426-af1b-4c8e123c54a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanFacility2021AdjustedLIBORateLoansMember_36a0948e-48ca-4d6c-8fea-4fbffe8507ed" xlink:href="coo-20221031.xsd#coo_TermLoanFacility2021AdjustedLIBORateLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b6620795-1158-47c9-8c90-4f0aaafb4d59" xlink:to="loc_coo_TermLoanFacility2021AdjustedLIBORateLoansMember_36a0948e-48ca-4d6c-8fea-4fbffe8507ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanAgreement2021364DayMember_5758b0e4-5e56-4dce-8601-9d4384c8e81d" xlink:href="coo-20221031.xsd#coo_TermLoanAgreement2021364DayMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b6620795-1158-47c9-8c90-4f0aaafb4d59" xlink:to="loc_coo_TermLoanAgreement2021364DayMember_5758b0e4-5e56-4dce-8601-9d4384c8e81d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CreditAgreement2020Member_02d33c41-9683-451c-89ca-3cf0411f1498" xlink:href="coo-20221031.xsd#coo_CreditAgreement2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b6620795-1158-47c9-8c90-4f0aaafb4d59" xlink:to="loc_coo_CreditAgreement2020Member_02d33c41-9683-451c-89ca-3cf0411f1498" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_EuropeanCreditFacilityMember_9849c09a-c7a2-430a-876a-9110ba768145" xlink:href="coo-20221031.xsd#coo_EuropeanCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b6620795-1158-47c9-8c90-4f0aaafb4d59" xlink:to="loc_coo_EuropeanCreditFacilityMember_9849c09a-c7a2-430a-876a-9110ba768145" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AsianPacificCreditFacilitiesYenDenominatedMember_31b2bcb4-2400-4dfb-bc2b-b034165e8b6e" xlink:href="coo-20221031.xsd#coo_AsianPacificCreditFacilitiesYenDenominatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b6620795-1158-47c9-8c90-4f0aaafb4d59" xlink:to="loc_coo_AsianPacificCreditFacilitiesYenDenominatedMember_31b2bcb4-2400-4dfb-bc2b-b034165e8b6e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a5a1a384-1cdb-49d1-bcfe-aeb0e8c08180" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_88966646-6fe7-48ae-9972-627beeb54cad" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a5a1a384-1cdb-49d1-bcfe-aeb0e8c08180" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a5a1a384-1cdb-49d1-bcfe-aeb0e8c08180_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a5a1a384-1cdb-49d1-bcfe-aeb0e8c08180" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a5a1a384-1cdb-49d1-bcfe-aeb0e8c08180_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8d7a6435-c6ea-4968-916d-cd9021857e71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a5a1a384-1cdb-49d1-bcfe-aeb0e8c08180" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8d7a6435-c6ea-4968-916d-cd9021857e71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_976caf75-dd91-4e79-a8ae-113e8f683747" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8d7a6435-c6ea-4968-916d-cd9021857e71" xlink:to="loc_us-gaap_LineOfCreditMember_976caf75-dd91-4e79-a8ae-113e8f683747" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_671055d9-449a-4246-9be1-f5378dbbede1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_88966646-6fe7-48ae-9972-627beeb54cad" xlink:to="loc_us-gaap_CreditFacilityAxis_671055d9-449a-4246-9be1-f5378dbbede1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_671055d9-449a-4246-9be1-f5378dbbede1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_671055d9-449a-4246-9be1-f5378dbbede1" xlink:to="loc_us-gaap_CreditFacilityDomain_671055d9-449a-4246-9be1-f5378dbbede1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_9c1006be-922a-46ac-b9b1-09481faa8d34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_671055d9-449a-4246-9be1-f5378dbbede1" xlink:to="loc_us-gaap_CreditFacilityDomain_9c1006be-922a-46ac-b9b1-09481faa8d34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_ed9cca15-c8de-4c92-8f93-27a68c57a1fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_9c1006be-922a-46ac-b9b1-09481faa8d34" xlink:to="loc_us-gaap_LineOfCreditMember_ed9cca15-c8de-4c92-8f93-27a68c57a1fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_9f09032d-8287-4fdd-9278-698deedaa82f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_9c1006be-922a-46ac-b9b1-09481faa8d34" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_9f09032d-8287-4fdd-9278-698deedaa82f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanFacility2020Member_aba13040-8c55-4d23-904b-4c8381556ea9" xlink:href="coo-20221031.xsd#coo_TermLoanFacility2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_9c1006be-922a-46ac-b9b1-09481faa8d34" xlink:to="loc_coo_TermLoanFacility2020Member_aba13040-8c55-4d23-904b-4c8381556ea9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_RevolvingCreditFacilityAndTermLoanFacility2020Member_da0bc8a1-638f-40f2-beb5-fa58b1f876b5" xlink:href="coo-20221031.xsd#coo_RevolvingCreditFacilityAndTermLoanFacility2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_9c1006be-922a-46ac-b9b1-09481faa8d34" xlink:to="loc_coo_RevolvingCreditFacilityAndTermLoanFacility2020Member_da0bc8a1-638f-40f2-beb5-fa58b1f876b5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_4199f594-f090-400f-af9e-db1b73b50c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_88966646-6fe7-48ae-9972-627beeb54cad" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_4199f594-f090-400f-af9e-db1b73b50c3c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_4199f594-f090-400f-af9e-db1b73b50c3c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_4199f594-f090-400f-af9e-db1b73b50c3c" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_4199f594-f090-400f-af9e-db1b73b50c3c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_71a2d1dc-7668-4803-b507-3006a36d1f07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_4199f594-f090-400f-af9e-db1b73b50c3c" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_71a2d1dc-7668-4803-b507-3006a36d1f07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoansMember_30e4030c-a10d-47a6-b2ae-cfffd2159a2c" xlink:href="coo-20221031.xsd#coo_TermLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_71a2d1dc-7668-4803-b507-3006a36d1f07" xlink:to="loc_coo_TermLoansMember_30e4030c-a10d-47a6-b2ae-cfffd2159a2c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_c074cdaf-561d-469d-9afe-068eb4593479" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_88966646-6fe7-48ae-9972-627beeb54cad" xlink:to="loc_us-gaap_VariableRateAxis_c074cdaf-561d-469d-9afe-068eb4593479" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_c074cdaf-561d-469d-9afe-068eb4593479_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_c074cdaf-561d-469d-9afe-068eb4593479" xlink:to="loc_us-gaap_VariableRateDomain_c074cdaf-561d-469d-9afe-068eb4593479_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_91427cd0-674a-4bfd-83b7-920b13b4c205" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_c074cdaf-561d-469d-9afe-068eb4593479" xlink:to="loc_us-gaap_VariableRateDomain_91427cd0-674a-4bfd-83b7-920b13b4c205" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_a9b25880-f638-4a54-8fbd-1e9b6d219b08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_91427cd0-674a-4bfd-83b7-920b13b4c205" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_a9b25880-f638-4a54-8fbd-1e9b6d219b08" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_2da0ba80-785e-4266-a347-b912a89cd011" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_91427cd0-674a-4bfd-83b7-920b13b4c205" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_2da0ba80-785e-4266-a347-b912a89cd011" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_4ffafa7a-3850-4fcd-954d-257a769fdf05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_91427cd0-674a-4bfd-83b7-920b13b4c205" xlink:to="loc_us-gaap_BaseRateMember_4ffafa7a-3850-4fcd-954d-257a769fdf05" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f1d59b96-7e3d-40a1-92dd-72dc7994c6cf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_88966646-6fe7-48ae-9972-627beeb54cad" xlink:to="loc_srt_RangeAxis_f1d59b96-7e3d-40a1-92dd-72dc7994c6cf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f1d59b96-7e3d-40a1-92dd-72dc7994c6cf_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f1d59b96-7e3d-40a1-92dd-72dc7994c6cf" xlink:to="loc_srt_RangeMember_f1d59b96-7e3d-40a1-92dd-72dc7994c6cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a02a42a0-00c4-4797-a6a2-b618ea4eb014" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f1d59b96-7e3d-40a1-92dd-72dc7994c6cf" xlink:to="loc_srt_RangeMember_a02a42a0-00c4-4797-a6a2-b618ea4eb014" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b1879fe7-141c-4eb3-a5b6-cd0ef1457f28" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a02a42a0-00c4-4797-a6a2-b618ea4eb014" xlink:to="loc_srt_MinimumMember_b1879fe7-141c-4eb3-a5b6-cd0ef1457f28" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e0fb2000-727b-455f-b75a-3a4ed89e5951" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a02a42a0-00c4-4797-a6a2-b618ea4eb014" xlink:to="loc_srt_MaximumMember_e0fb2000-727b-455f-b75a-3a4ed89e5951" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="if17bb0715e2f48898e7967f564de2af8_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_16081c8b-5846-4330-a348-f1fb5496b571" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b0a09544-9845-4747-b0e6-ef5be708dfb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_16081c8b-5846-4330-a348-f1fb5496b571" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b0a09544-9845-4747-b0e6-ef5be708dfb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_7546cfe1-e21e-42c9-b8a5-619cb8ba2c84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_16081c8b-5846-4330-a348-f1fb5496b571" xlink:to="loc_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_7546cfe1-e21e-42c9-b8a5-619cb8ba2c84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_EffectiveIncomeTaxRateReconciliationChangeInEnactedForeignTaxRateAmount_5358bfe9-2af6-462f-94b7-6588e84c426a" xlink:href="coo-20221031.xsd#coo_EffectiveIncomeTaxRateReconciliationChangeInEnactedForeignTaxRateAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_16081c8b-5846-4330-a348-f1fb5496b571" xlink:to="loc_coo_EffectiveIncomeTaxRateReconciliationChangeInEnactedForeignTaxRateAmount_5358bfe9-2af6-462f-94b7-6588e84c426a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_74c5056e-7346-490f-bb2c-a3b7c7496264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_16081c8b-5846-4330-a348-f1fb5496b571" xlink:to="loc_us-gaap_OperatingLossCarryforwards_74c5056e-7346-490f-bb2c-a3b7c7496264" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_0ae3b0dc-b448-4725-80ac-13ec9a495be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_16081c8b-5846-4330-a348-f1fb5496b571" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_0ae3b0dc-b448-4725-80ac-13ec9a495be1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_0b32887b-375a-488a-8576-c01810ed9047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_16081c8b-5846-4330-a348-f1fb5496b571" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_0b32887b-375a-488a-8576-c01810ed9047" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_7860118e-905b-4e47-80a3-ec543a03ef26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_16081c8b-5846-4330-a348-f1fb5496b571" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_7860118e-905b-4e47-80a3-ec543a03ef26" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_df8d1715-01f9-4375-9779-291a0fbb4a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_16081c8b-5846-4330-a348-f1fb5496b571" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_df8d1715-01f9-4375-9779-291a0fbb4a5a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_a026122a-b301-4ec2-82a6-019c54f4b22b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_16081c8b-5846-4330-a348-f1fb5496b571" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_a026122a-b301-4ec2-82a6-019c54f4b22b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_b3053ee4-d927-4a79-99d9-00b37553586e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_16081c8b-5846-4330-a348-f1fb5496b571" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_b3053ee4-d927-4a79-99d9-00b37553586e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_0864182b-e6f0-4f43-a04a-3751c7534e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_16081c8b-5846-4330-a348-f1fb5496b571" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_0864182b-e6f0-4f43-a04a-3751c7534e5a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_f746eb96-e1f6-43cc-9efc-652de30bac82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_0864182b-e6f0-4f43-a04a-3751c7534e5a" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_f746eb96-e1f6-43cc-9efc-652de30bac82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_f746eb96-e1f6-43cc-9efc-652de30bac82_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_f746eb96-e1f6-43cc-9efc-652de30bac82" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_f746eb96-e1f6-43cc-9efc-652de30bac82_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_70db1693-1ae5-4a5b-afef-e043a02b486b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_f746eb96-e1f6-43cc-9efc-652de30bac82" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_70db1693-1ae5-4a5b-afef-e043a02b486b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_4fba448c-fbc7-4928-9000-3562796e5854" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_70db1693-1ae5-4a5b-afef-e043a02b486b" xlink:to="loc_us-gaap_DomesticCountryMember_4fba448c-fbc7-4928-9000-3562796e5854" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_03cc9cf3-d264-45c9-979b-5e794c24a6a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_70db1693-1ae5-4a5b-afef-e043a02b486b" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_03cc9cf3-d264-45c9-979b-5e794c24a6a0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails" xlink:type="extended" id="ie17545241c70470eb46189c6eefc802e_EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4ec90d33-ecaf-4141-b505-0cb193538802" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_55c81aae-adc9-47b0-8d51-e305a24f1386" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4ec90d33-ecaf-4141-b505-0cb193538802" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_55c81aae-adc9-47b0-8d51-e305a24f1386" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_02f0444e-3292-4597-ad89-2cbcf08235b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4ec90d33-ecaf-4141-b505-0cb193538802" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_02f0444e-3292-4597-ad89-2cbcf08235b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_8c5b0ee0-23d8-4762-b2c4-3b84e191b032" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4ec90d33-ecaf-4141-b505-0cb193538802" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_8c5b0ee0-23d8-4762-b2c4-3b84e191b032" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ca35cd0c-0a50-40aa-8f4f-10626afebf47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4ec90d33-ecaf-4141-b505-0cb193538802" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ca35cd0c-0a50-40aa-8f4f-10626afebf47" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3adcc9ba-68c6-4edb-8700-32b72bb74c51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ca35cd0c-0a50-40aa-8f4f-10626afebf47" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3adcc9ba-68c6-4edb-8700-32b72bb74c51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3adcc9ba-68c6-4edb-8700-32b72bb74c51_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3adcc9ba-68c6-4edb-8700-32b72bb74c51" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3adcc9ba-68c6-4edb-8700-32b72bb74c51_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_65826981-4363-4973-89c7-870dc9e1615e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3adcc9ba-68c6-4edb-8700-32b72bb74c51" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_65826981-4363-4973-89c7-870dc9e1615e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_c8811a47-8c4b-44dd-b949-255d4db09e53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_65826981-4363-4973-89c7-870dc9e1615e" xlink:to="loc_us-gaap_EmployeeStockOptionMember_c8811a47-8c4b-44dd-b949-255d4db09e53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_de6fe601-d152-49c9-a3a7-bcd389cf2d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_65826981-4363-4973-89c7-870dc9e1615e" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_de6fe601-d152-49c9-a3a7-bcd389cf2d9b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails" xlink:type="extended" id="ia6853c6fee2949e984925de192ddbd45_StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_82f002b4-0070-45dc-b76a-ac5969e8a3b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c74d9ba6-5988-4f09-afe6-2c5ae0780222" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_82f002b4-0070-45dc-b76a-ac5969e8a3b0" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c74d9ba6-5988-4f09-afe6-2c5ae0780222" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_35c9587f-e55c-4815-a7f8-b954826ba69c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c74d9ba6-5988-4f09-afe6-2c5ae0780222" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_35c9587f-e55c-4815-a7f8-b954826ba69c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_e6284327-a49d-4b80-88eb-b80626cf3450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c74d9ba6-5988-4f09-afe6-2c5ae0780222" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_e6284327-a49d-4b80-88eb-b80626cf3450" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_66baac95-dda7-4ec0-b4cd-abba99a8afe4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c74d9ba6-5988-4f09-afe6-2c5ae0780222" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_66baac95-dda7-4ec0-b4cd-abba99a8afe4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cdb15331-0824-46eb-8871-c2d95162c307" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_cb2b184e-34c3-42de-a632-668de84296a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_82f002b4-0070-45dc-b76a-ac5969e8a3b0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_cb2b184e-34c3-42de-a632-668de84296a2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a4527c8a-9cc5-41ab-9909-b5d0002e0fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_cb2b184e-34c3-42de-a632-668de84296a2" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a4527c8a-9cc5-41ab-9909-b5d0002e0fdf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a4527c8a-9cc5-41ab-9909-b5d0002e0fdf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a4527c8a-9cc5-41ab-9909-b5d0002e0fdf" xlink:to="loc_us-gaap_EquityComponentDomain_a4527c8a-9cc5-41ab-9909-b5d0002e0fdf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7ef3060a-bd1b-4f3d-bef5-1c3fde5e1c01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a4527c8a-9cc5-41ab-9909-b5d0002e0fdf" xlink:to="loc_us-gaap_EquityComponentDomain_7ef3060a-bd1b-4f3d-bef5-1c3fde5e1c01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1515f8ad-e774-442d-b1c4-ba28a2912d83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7ef3060a-bd1b-4f3d-bef5-1c3fde5e1c01" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1515f8ad-e774-442d-b1c4-ba28a2912d83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_af5dfe6d-4667-4ee9-89a7-a32f6d8634c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1515f8ad-e774-442d-b1c4-ba28a2912d83" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_af5dfe6d-4667-4ee9-89a7-a32f6d8634c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_5dd215f5-3a02-4ab3-8d53-192c75b639ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1515f8ad-e774-442d-b1c4-ba28a2912d83" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_5dd215f5-3a02-4ab3-8d53-192c75b639ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_c2567918-3662-40ff-a2c3-82134e322bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1515f8ad-e774-442d-b1c4-ba28a2912d83" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_c2567918-3662-40ff-a2c3-82134e322bb6" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockPlansNarrativeDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#StockPlansNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/StockPlansNarrativeDetails" xlink:type="extended" id="i8363f250b316424cb9bfb79a1ec74426_StockPlansNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee_cb0c7d8c-70fe-440d-91c0-4fdfcdb26a27" xlink:href="coo-20221031.xsd#coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee_cb0c7d8c-70fe-440d-91c0-4fdfcdb26a27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_9a4c571a-51f2-476b-ac56-792e6f4507da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_9a4c571a-51f2-476b-ac56-792e6f4507da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_222d3804-81e6-4093-b899-ed13a89d3ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_222d3804-81e6-4093-b899-ed13a89d3ec0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_42ba82a6-3b39-447e-b1c7-412b19b79fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_42ba82a6-3b39-447e-b1c7-412b19b79fa0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_36826451-29d3-4947-9dbe-3610e931c4ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_36826451-29d3-4947-9dbe-3610e931c4ab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_26ba0da5-aa23-4379-8755-dbbf51d29915" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_26ba0da5-aa23-4379-8755-dbbf51d29915" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_7467d224-1c64-4f17-95ef-f6a3519c8328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_7467d224-1c64-4f17-95ef-f6a3519c8328" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_e3a37557-2257-4b83-b65e-8529536757df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_e3a37557-2257-4b83-b65e-8529536757df" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_75233d16-eac9-4d5a-b7cc-f40fbc5bdfb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_75233d16-eac9-4d5a-b7cc-f40fbc5bdfb1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_5a6f9480-2c26-40b5-8f95-75fc26755ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_5a6f9480-2c26-40b5-8f95-75fc26755ad9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_d52143e3-0cb6-43f6-9cbb-4379a0531e29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_d52143e3-0cb6-43f6-9cbb-4379a0531e29" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned_45e10be2-a5be-418d-8173-9f1829298622" xlink:href="coo-20221031.xsd#coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned_45e10be2-a5be-418d-8173-9f1829298622" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_8dddc91f-9d25-4a9e-b1f7-f0dca4058c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_8dddc91f-9d25-4a9e-b1f7-f0dca4058c4c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_265784ff-3f98-4936-9f0d-ca269e9a7f94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_265784ff-3f98-4936-9f0d-ca269e9a7f94" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_9642516b-0146-4ae9-99f5-934d5f89f830" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_9642516b-0146-4ae9-99f5-934d5f89f830" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_a7299e29-ab35-4e5b-a731-5d1ce93c678d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_a7299e29-ab35-4e5b-a731-5d1ce93c678d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_01fb74f1-8bc4-4d6a-bf9c-837d58bab4dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_01fb74f1-8bc4-4d6a-bf9c-837d58bab4dc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_37e58600-539c-48c5-8643-8fd43d52292c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_01fb74f1-8bc4-4d6a-bf9c-837d58bab4dc" xlink:to="loc_us-gaap_PlanNameAxis_37e58600-539c-48c5-8643-8fd43d52292c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_37e58600-539c-48c5-8643-8fd43d52292c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_37e58600-539c-48c5-8643-8fd43d52292c" xlink:to="loc_us-gaap_PlanNameDomain_37e58600-539c-48c5-8643-8fd43d52292c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_0f9a46db-745a-491c-a161-c2537aa87e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_37e58600-539c-48c5-8643-8fd43d52292c" xlink:to="loc_us-gaap_PlanNameDomain_0f9a46db-745a-491c-a161-c2537aa87e1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember_a99662a1-f85d-4566-a488-87d9ce93a333" xlink:href="coo-20221031.xsd#coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_0f9a46db-745a-491c-a161-c2537aa87e1f" xlink:to="loc_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember_a99662a1-f85d-4566-a488-87d9ce93a333" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DirectorsPlan2020Member_c9c7691f-d0bf-4553-9198-6a704e8af246" xlink:href="coo-20221031.xsd#coo_DirectorsPlan2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_0f9a46db-745a-491c-a161-c2537aa87e1f" xlink:to="loc_coo_DirectorsPlan2020Member_c9c7691f-d0bf-4553-9198-6a704e8af246" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_EmployeeStockPurchasePlanMember_7b94816e-bb1d-4e38-ab66-c114e58c8681" xlink:href="coo-20221031.xsd#coo_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_0f9a46db-745a-491c-a161-c2537aa87e1f" xlink:to="loc_coo_EmployeeStockPurchasePlanMember_7b94816e-bb1d-4e38-ab66-c114e58c8681" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6ccf90be-6dce-4323-826d-49ec06f44bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_01fb74f1-8bc4-4d6a-bf9c-837d58bab4dc" xlink:to="loc_us-gaap_AwardTypeAxis_6ccf90be-6dce-4323-826d-49ec06f44bc8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6ccf90be-6dce-4323-826d-49ec06f44bc8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6ccf90be-6dce-4323-826d-49ec06f44bc8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6ccf90be-6dce-4323-826d-49ec06f44bc8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7d46fcb0-bd21-4fae-809b-a0fbcf5b00b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6ccf90be-6dce-4323-826d-49ec06f44bc8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7d46fcb0-bd21-4fae-809b-a0fbcf5b00b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_59a08961-4773-4196-bda1-5161d2d74ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7d46fcb0-bd21-4fae-809b-a0fbcf5b00b8" xlink:to="loc_us-gaap_EmployeeStockOptionMember_59a08961-4773-4196-bda1-5161d2d74ebf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_7f839b57-ee7d-47f4-a8a5-1002ad90a3f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7d46fcb0-bd21-4fae-809b-a0fbcf5b00b8" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_7f839b57-ee7d-47f4-a8a5-1002ad90a3f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_516ff457-e328-4eef-a8f8-7ff13b6e5555" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7d46fcb0-bd21-4fae-809b-a0fbcf5b00b8" xlink:to="loc_us-gaap_PerformanceSharesMember_516ff457-e328-4eef-a8f8-7ff13b6e5555" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_05c85a0d-581c-4bc7-b40d-cb53efc278ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7d46fcb0-bd21-4fae-809b-a0fbcf5b00b8" xlink:to="loc_us-gaap_EmployeeStockMember_05c85a0d-581c-4bc7-b40d-cb53efc278ec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7067b237-9d68-45d5-b726-aca8a481f1cb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_01fb74f1-8bc4-4d6a-bf9c-837d58bab4dc" xlink:to="loc_srt_RangeAxis_7067b237-9d68-45d5-b726-aca8a481f1cb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7067b237-9d68-45d5-b726-aca8a481f1cb_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7067b237-9d68-45d5-b726-aca8a481f1cb" xlink:to="loc_srt_RangeMember_7067b237-9d68-45d5-b726-aca8a481f1cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fd031bb9-232f-4892-9c2d-43a4860d14f3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7067b237-9d68-45d5-b726-aca8a481f1cb" xlink:to="loc_srt_RangeMember_fd031bb9-232f-4892-9c2d-43a4860d14f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b2adec19-0240-44ff-b755-4592224586d0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fd031bb9-232f-4892-9c2d-43a4860d14f3" xlink:to="loc_srt_MinimumMember_b2adec19-0240-44ff-b755-4592224586d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a2050b51-894d-4c11-a331-a4e9c6f3a4c2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fd031bb9-232f-4892-9c2d-43a4860d14f3" xlink:to="loc_srt_MaximumMember_a2050b51-894d-4c11-a331-a4e9c6f3a4c2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails" xlink:type="extended" id="i3c129d57de0d4df6ae54c1ff1430199f_StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_68842ec8-45b4-4a22-bc1f-a82f491b8179" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_91c4703c-494b-4572-b125-fd855cbb663e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_68842ec8-45b4-4a22-bc1f-a82f491b8179" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_91c4703c-494b-4572-b125-fd855cbb663e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_48522a94-0a10-4d7b-a726-96a104d815a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_68842ec8-45b4-4a22-bc1f-a82f491b8179" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_48522a94-0a10-4d7b-a726-96a104d815a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_fcd02593-8dc6-4090-9f82-0c6f034c6361" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_68842ec8-45b4-4a22-bc1f-a82f491b8179" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_fcd02593-8dc6-4090-9f82-0c6f034c6361" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b840e92b-c30a-4ff6-8b13-0c1101d4ef27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_fcd02593-8dc6-4090-9f82-0c6f034c6361" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b840e92b-c30a-4ff6-8b13-0c1101d4ef27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b840e92b-c30a-4ff6-8b13-0c1101d4ef27_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b840e92b-c30a-4ff6-8b13-0c1101d4ef27" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b840e92b-c30a-4ff6-8b13-0c1101d4ef27_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_92cf4a6e-0c22-418a-b07e-0e2b78b6e4dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b840e92b-c30a-4ff6-8b13-0c1101d4ef27" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_92cf4a6e-0c22-418a-b07e-0e2b78b6e4dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_9bd2dfce-15fd-44a9-adef-128008002565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_92cf4a6e-0c22-418a-b07e-0e2b78b6e4dc" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_9bd2dfce-15fd-44a9-adef-128008002565" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_c7354327-c0dd-444e-a376-969f43d9de14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_92cf4a6e-0c22-418a-b07e-0e2b78b6e4dc" xlink:to="loc_us-gaap_CostOfSalesMember_c7354327-c0dd-444e-a376-969f43d9de14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_c6d0c9c1-a934-40e3-ba1a-2781c44319fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_92cf4a6e-0c22-418a-b07e-0e2b78b6e4dc" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_c6d0c9c1-a934-40e3-ba1a-2781c44319fc" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails" xlink:type="extended" id="ia7015d1d87254c259d3ec1e6e177af81_StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_319cee84-a3d4-4eab-a7ad-0e90227b891c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_87751fe1-ca6a-4b3a-a57c-b79c374f0f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_319cee84-a3d4-4eab-a7ad-0e90227b891c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_87751fe1-ca6a-4b3a-a57c-b79c374f0f2c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_7a85e382-7004-4854-97da-c25296c1c06e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_319cee84-a3d4-4eab-a7ad-0e90227b891c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_7a85e382-7004-4854-97da-c25296c1c06e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_467764c5-a5e3-44b8-a99f-6b6111b29ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_319cee84-a3d4-4eab-a7ad-0e90227b891c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_467764c5-a5e3-44b8-a99f-6b6111b29ec5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_0e852796-da7c-4fa5-bf2d-902aae587579" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_319cee84-a3d4-4eab-a7ad-0e90227b891c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_0e852796-da7c-4fa5-bf2d-902aae587579" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_245abcb8-fe5e-4b4e-a5d6-ba1803a6a7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_319cee84-a3d4-4eab-a7ad-0e90227b891c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_245abcb8-fe5e-4b4e-a5d6-ba1803a6a7c3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4c4f1225-66a5-4424-a207-e94d41f239c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_245abcb8-fe5e-4b4e-a5d6-ba1803a6a7c3" xlink:to="loc_us-gaap_AwardTypeAxis_4c4f1225-66a5-4424-a207-e94d41f239c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4c4f1225-66a5-4424-a207-e94d41f239c6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_4c4f1225-66a5-4424-a207-e94d41f239c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4c4f1225-66a5-4424-a207-e94d41f239c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8228a903-dea3-4c81-a229-85318783317d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_4c4f1225-66a5-4424-a207-e94d41f239c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8228a903-dea3-4c81-a229-85318783317d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_edc7f785-3723-4f53-808d-eb2ea206b904" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8228a903-dea3-4c81-a229-85318783317d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_edc7f785-3723-4f53-808d-eb2ea206b904" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockPlansStockOptionPlansDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#StockPlansStockOptionPlansDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/StockPlansStockOptionPlansDetails" xlink:type="extended" id="i6c7a268ba3b44c9a98d194d99f9f7635_StockPlansStockOptionPlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_64bd5dc7-bae9-49c6-a729-b5fef2f0b2bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_56a899fe-0dcd-45ff-a3d1-1a47cb79901c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_64bd5dc7-bae9-49c6-a729-b5fef2f0b2bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_56a899fe-0dcd-45ff-a3d1-1a47cb79901c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b286db7f-3d80-4570-aaff-cf7e1c1018e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_56a899fe-0dcd-45ff-a3d1-1a47cb79901c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b286db7f-3d80-4570-aaff-cf7e1c1018e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_6c18cccf-8414-4d7e-8619-11dfab28fc95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_56a899fe-0dcd-45ff-a3d1-1a47cb79901c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_6c18cccf-8414-4d7e-8619-11dfab28fc95" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6fb458ef-b3d8-4166-a6d4-df48e62825af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_56a899fe-0dcd-45ff-a3d1-1a47cb79901c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6fb458ef-b3d8-4166-a6d4-df48e62825af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1ad703ce-ed3a-4576-ad10-81e49973270a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_56a899fe-0dcd-45ff-a3d1-1a47cb79901c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1ad703ce-ed3a-4576-ad10-81e49973270a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_36576946-5316-48ed-b6d4-ddad491a0b45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_9702cca2-f133-44b0-981f-ecbc90440a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_56a899fe-0dcd-45ff-a3d1-1a47cb79901c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_9702cca2-f133-44b0-981f-ecbc90440a9b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_01630564-8d36-456f-9773-c5adeee00a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_56a899fe-0dcd-45ff-a3d1-1a47cb79901c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_01630564-8d36-456f-9773-c5adeee00a3a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_08f0e79b-ecc2-4b56-bb15-0818eecbfa2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_64bd5dc7-bae9-49c6-a729-b5fef2f0b2bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_08f0e79b-ecc2-4b56-bb15-0818eecbfa2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_add265f4-a612-4d29-a0b1-445708175708" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_08f0e79b-ecc2-4b56-bb15-0818eecbfa2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_add265f4-a612-4d29-a0b1-445708175708" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_67f61b98-2b09-446e-9b1a-4b32a7f88195" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_08f0e79b-ecc2-4b56-bb15-0818eecbfa2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_67f61b98-2b09-446e-9b1a-4b32a7f88195" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_8629f230-9867-4712-a958-054adaab15f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_08f0e79b-ecc2-4b56-bb15-0818eecbfa2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_8629f230-9867-4712-a958-054adaab15f3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_681f41b7-492d-4497-9ca7-fa1c2b7f7721" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_08f0e79b-ecc2-4b56-bb15-0818eecbfa2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_681f41b7-492d-4497-9ca7-fa1c2b7f7721" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_131f239c-b005-4219-90a3-ec5b14a1b43a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_b4bf6e96-c4aa-42d4-8a28-f57b62e4c5d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_08f0e79b-ecc2-4b56-bb15-0818eecbfa2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_b4bf6e96-c4aa-42d4-8a28-f57b62e4c5d7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_becd9d9d-df86-4a6d-be37-eb8d601c574e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_08f0e79b-ecc2-4b56-bb15-0818eecbfa2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_becd9d9d-df86-4a6d-be37-eb8d601c574e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_f035b1fb-6ffe-479a-a01d-9e0f6b1f8fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_64bd5dc7-bae9-49c6-a729-b5fef2f0b2bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_f035b1fb-6ffe-479a-a01d-9e0f6b1f8fc3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_7b8c4389-0e4b-4f3f-959c-22116eafe482" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_f035b1fb-6ffe-479a-a01d-9e0f6b1f8fc3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_7b8c4389-0e4b-4f3f-959c-22116eafe482" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_a3f04910-ce2b-43eb-8a10-3a0d29c1611c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_f035b1fb-6ffe-479a-a01d-9e0f6b1f8fc3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_a3f04910-ce2b-43eb-8a10-3a0d29c1611c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_f579518e-7aa8-4ce0-b94a-8ec168081cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_f035b1fb-6ffe-479a-a01d-9e0f6b1f8fc3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_f579518e-7aa8-4ce0-b94a-8ec168081cfe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_375c3cfa-e56e-46ff-a886-d48c1d4c8263" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_f035b1fb-6ffe-479a-a01d-9e0f6b1f8fc3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_375c3cfa-e56e-46ff-a886-d48c1d4c8263" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_bf9ce66c-b964-48ce-b485-f03a5a616691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_f035b1fb-6ffe-479a-a01d-9e0f6b1f8fc3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_bf9ce66c-b964-48ce-b485-f03a5a616691" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bdcdaa87-88ae-4ed1-8857-50117269f641" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_64bd5dc7-bae9-49c6-a729-b5fef2f0b2bd" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bdcdaa87-88ae-4ed1-8857-50117269f641" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_eafe5658-d1c2-4a46-b2f9-e42fee748de8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bdcdaa87-88ae-4ed1-8857-50117269f641" xlink:to="loc_us-gaap_AwardTypeAxis_eafe5658-d1c2-4a46-b2f9-e42fee748de8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_eafe5658-d1c2-4a46-b2f9-e42fee748de8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_eafe5658-d1c2-4a46-b2f9-e42fee748de8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_eafe5658-d1c2-4a46-b2f9-e42fee748de8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a05fbd1e-e87d-4012-9e04-79fe9582fd1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_eafe5658-d1c2-4a46-b2f9-e42fee748de8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a05fbd1e-e87d-4012-9e04-79fe9582fd1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4794ba1e-3be3-4c37-899f-ea18ac04ece8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a05fbd1e-e87d-4012-9e04-79fe9582fd1d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4794ba1e-3be3-4c37-899f-ea18ac04ece8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#StockPlansNonVestedRSUsDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails" xlink:type="extended" id="ia4a8e74974de4398b09244c3e33f3227_StockPlansNonVestedRSUsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c924bdb-efa2-454e-a439-74b463bdd8e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_03a8e473-9969-4411-a965-46b403ff9594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c924bdb-efa2-454e-a439-74b463bdd8e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_03a8e473-9969-4411-a965-46b403ff9594" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_51523a4d-005c-476e-bd53-d376f6e9a2f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_03a8e473-9969-4411-a965-46b403ff9594" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_51523a4d-005c-476e-bd53-d376f6e9a2f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6c52bf20-533d-4499-a2cd-aac08c6ab96d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_03a8e473-9969-4411-a965-46b403ff9594" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6c52bf20-533d-4499-a2cd-aac08c6ab96d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_cf73f642-d863-4345-95bb-e366aad274e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_03a8e473-9969-4411-a965-46b403ff9594" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_cf73f642-d863-4345-95bb-e366aad274e9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_99182f52-1678-4b8e-bec1-b1db0ee9df55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_03a8e473-9969-4411-a965-46b403ff9594" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_99182f52-1678-4b8e-bec1-b1db0ee9df55" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_51b5f9ca-f54b-47f5-b2fc-da0504d81df0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_42057218-9f42-4dd2-a97f-2c37d72c0c28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c924bdb-efa2-454e-a439-74b463bdd8e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_42057218-9f42-4dd2-a97f-2c37d72c0c28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6bc8c14e-c5e4-41b3-bb8c-a0f26492f1bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_42057218-9f42-4dd2-a97f-2c37d72c0c28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6bc8c14e-c5e4-41b3-bb8c-a0f26492f1bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2146faf7-ec79-428d-86b6-f0bfe350d130" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_42057218-9f42-4dd2-a97f-2c37d72c0c28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2146faf7-ec79-428d-86b6-f0bfe350d130" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_91c30464-5089-4ab8-aefe-771fb4761de9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_42057218-9f42-4dd2-a97f-2c37d72c0c28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_91c30464-5089-4ab8-aefe-771fb4761de9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_96ef3c47-b9f5-4972-a3d1-1dc4a249a6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_42057218-9f42-4dd2-a97f-2c37d72c0c28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_96ef3c47-b9f5-4972-a3d1-1dc4a249a6b8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_26b14e7d-08e8-41de-98f6-de4c0bb5e229" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4d3fa5e2-8b5c-4902-8604-97d1a01c144f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c924bdb-efa2-454e-a439-74b463bdd8e6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4d3fa5e2-8b5c-4902-8604-97d1a01c144f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_586d1b2b-beaa-4b06-9118-77f4285337cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4d3fa5e2-8b5c-4902-8604-97d1a01c144f" xlink:to="loc_us-gaap_AwardTypeAxis_586d1b2b-beaa-4b06-9118-77f4285337cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_586d1b2b-beaa-4b06-9118-77f4285337cd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_586d1b2b-beaa-4b06-9118-77f4285337cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_586d1b2b-beaa-4b06-9118-77f4285337cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c5815456-4857-4f26-8006-8308f61d5edd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_586d1b2b-beaa-4b06-9118-77f4285337cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c5815456-4857-4f26-8006-8308f61d5edd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e772d026-5b32-40ee-abfe-f9dfbeaa77df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c5815456-4857-4f26-8006-8308f61d5edd" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e772d026-5b32-40ee-abfe-f9dfbeaa77df" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#EmployeeBenefitsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails" xlink:type="extended" id="i57c3637d88b94d4ab69bbf0d051f3209_EmployeeBenefitsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_21c877d9-da72-4c28-9d7a-1eca593b6188" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_0c3809db-ad72-406e-a3b4-1b6ebcab0f58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_21c877d9-da72-4c28-9d7a-1eca593b6188" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_0c3809db-ad72-406e-a3b4-1b6ebcab0f58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation_7781609a-31e1-4eeb-8e59-525c0fd2f525" xlink:href="coo-20221031.xsd#coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_21c877d9-da72-4c28-9d7a-1eca593b6188" xlink:to="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation_7781609a-31e1-4eeb-8e59-525c0fd2f525" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligationIncreaseDecrease_2cbb599c-4520-4abd-ba76-bb3b08dd1f3d" xlink:href="coo-20221031.xsd#coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligationIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_21c877d9-da72-4c28-9d7a-1eca593b6188" xlink:to="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligationIncreaseDecrease_2cbb599c-4520-4abd-ba76-bb3b08dd1f3d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationEffectOfChangeInDiscountRate_65266953-be2b-4b08-b354-844b1087702a" xlink:href="coo-20221031.xsd#coo_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationEffectOfChangeInDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_21c877d9-da72-4c28-9d7a-1eca593b6188" xlink:to="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationEffectOfChangeInDiscountRate_65266953-be2b-4b08-b354-844b1087702a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingAccumulatedBenefitObligationEffectOfChangeInDiscountRate_79fa49da-01ee-4c79-8fc1-ad15d53ee138" xlink:href="coo-20221031.xsd#coo_DefinedBenefitPlanAssumptionsUsedCalculatingAccumulatedBenefitObligationEffectOfChangeInDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_21c877d9-da72-4c28-9d7a-1eca593b6188" xlink:to="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingAccumulatedBenefitObligationEffectOfChangeInDiscountRate_79fa49da-01ee-4c79-8fc1-ad15d53ee138" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_c8bf1022-7a0c-4bb8-924b-cde9b6fa722c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_21c877d9-da72-4c28-9d7a-1eca593b6188" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_c8bf1022-7a0c-4bb8-924b-cde9b6fa722c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_bfee3972-bd36-49d9-addc-7fb0cf1eaba0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_21c877d9-da72-4c28-9d7a-1eca593b6188" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_bfee3972-bd36-49d9-addc-7fb0cf1eaba0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage_bbb02151-9a5d-4982-b63e-2c475af6446e" xlink:href="coo-20221031.xsd#coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_21c877d9-da72-4c28-9d7a-1eca593b6188" xlink:to="loc_coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage_bbb02151-9a5d-4982-b63e-2c475af6446e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_188c0193-abf3-49fe-99fe-823987e03adb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_21c877d9-da72-4c28-9d7a-1eca593b6188" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_188c0193-abf3-49fe-99fe-823987e03adb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_6cf90af6-bf07-4c82-a509-e4a22e3155d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_21c877d9-da72-4c28-9d7a-1eca593b6188" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_6cf90af6-bf07-4c82-a509-e4a22e3155d3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_2e5cdcc1-b6d3-4a1a-ae95-65fb2d3d02b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_21c877d9-da72-4c28-9d7a-1eca593b6188" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_2e5cdcc1-b6d3-4a1a-ae95-65fb2d3d02b9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8e28ac41-6186-458e-9c8a-b4258d1d9359" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_21c877d9-da72-4c28-9d7a-1eca593b6188" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8e28ac41-6186-458e-9c8a-b4258d1d9359" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_01fc19fb-1bd5-46ea-bd51-a2299911db9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8e28ac41-6186-458e-9c8a-b4258d1d9359" xlink:to="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_01fc19fb-1bd5-46ea-bd51-a2299911db9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_01fc19fb-1bd5-46ea-bd51-a2299911db9b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_01fc19fb-1bd5-46ea-bd51-a2299911db9b" xlink:to="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_01fc19fb-1bd5-46ea-bd51-a2299911db9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_985b6b7f-3108-4a74-b8ff-02751809bf08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_01fc19fb-1bd5-46ea-bd51-a2299911db9b" xlink:to="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_985b6b7f-3108-4a74-b8ff-02751809bf08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember_67729c1f-a52d-4795-9f41-138e7a15b1a6" xlink:href="coo-20221031.xsd#coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_985b6b7f-3108-4a74-b8ff-02751809bf08" xlink:to="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember_67729c1f-a52d-4795-9f41-138e7a15b1a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember_60c7e016-28f6-4e1e-91b3-e4d2e1a35249" xlink:href="coo-20221031.xsd#coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_985b6b7f-3108-4a74-b8ff-02751809bf08" xlink:to="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember_60c7e016-28f6-4e1e-91b3-e4d2e1a35249" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember_8fbc320e-698c-4414-8750-7ff01a37f212" xlink:href="coo-20221031.xsd#coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_985b6b7f-3108-4a74-b8ff-02751809bf08" xlink:to="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember_8fbc320e-698c-4414-8750-7ff01a37f212" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInAssumedPaymentFormElectionProbabilitiesMember_6422b66d-4ca0-4f6f-b639-61a9a86f18ef" xlink:href="coo-20221031.xsd#coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInAssumedPaymentFormElectionProbabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_985b6b7f-3108-4a74-b8ff-02751809bf08" xlink:to="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInAssumedPaymentFormElectionProbabilitiesMember_6422b66d-4ca0-4f6f-b639-61a9a86f18ef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember_1c9428bf-991c-4e72-81ef-6aee2bc33147" xlink:href="coo-20221031.xsd#coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_985b6b7f-3108-4a74-b8ff-02751809bf08" xlink:to="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember_1c9428bf-991c-4e72-81ef-6aee2bc33147" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dd340217-285b-4232-9037-4b9bdec1c940" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8e28ac41-6186-458e-9c8a-b4258d1d9359" xlink:to="loc_srt_RangeAxis_dd340217-285b-4232-9037-4b9bdec1c940" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dd340217-285b-4232-9037-4b9bdec1c940_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_dd340217-285b-4232-9037-4b9bdec1c940" xlink:to="loc_srt_RangeMember_dd340217-285b-4232-9037-4b9bdec1c940_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_edb3c45e-8d97-4c32-8705-8f4dc5fbcc5d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_dd340217-285b-4232-9037-4b9bdec1c940" xlink:to="loc_srt_RangeMember_edb3c45e-8d97-4c32-8705-8f4dc5fbcc5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1c5247f8-7f4d-4d15-9030-74eb2860b180" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_edb3c45e-8d97-4c32-8705-8f4dc5fbcc5d" xlink:to="loc_srt_MinimumMember_1c5247f8-7f4d-4d15-9030-74eb2860b180" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4946a784-89b3-4aef-a8d3-7d5212045bef" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_edb3c45e-8d97-4c32-8705-8f4dc5fbcc5d" xlink:to="loc_srt_MaximumMember_4946a784-89b3-4aef-a8d3-7d5212045bef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2a207a31-270c-48d8-aa44-28c7fb5b2afe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8e28ac41-6186-458e-9c8a-b4258d1d9359" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2a207a31-270c-48d8-aa44-28c7fb5b2afe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_2a207a31-270c-48d8-aa44-28c7fb5b2afe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2a207a31-270c-48d8-aa44-28c7fb5b2afe" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_2a207a31-270c-48d8-aa44-28c7fb5b2afe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_0737621b-c8d0-44a4-9df8-563f2d4b24a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2a207a31-270c-48d8-aa44-28c7fb5b2afe" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_0737621b-c8d0-44a4-9df8-563f2d4b24a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_9945cf86-af4e-4ca4-aab5-e5d0876ec6b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_0737621b-c8d0-44a4-9df8-563f2d4b24a1" xlink:to="loc_us-gaap_EquitySecuritiesMember_9945cf86-af4e-4ca4-aab5-e5d0876ec6b6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails" xlink:type="extended" id="ib1b3b0aba12e4f6cad1456c639e1198c_EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems_7169b88a-af57-405a-bc3b-eec132473d41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_70462e19-c7cc-4d9a-aaf8-a795164416ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems_7169b88a-af57-405a-bc3b-eec132473d41" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_70462e19-c7cc-4d9a-aaf8-a795164416ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable_cb8781d2-ac3f-49b1-b3a7-e54d50c2de2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems_7169b88a-af57-405a-bc3b-eec132473d41" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable_cb8781d2-ac3f-49b1-b3a7-e54d50c2de2f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_769ca821-2837-4823-8e61-77eee974cdf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable_cb8781d2-ac3f-49b1-b3a7-e54d50c2de2f" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_769ca821-2837-4823-8e61-77eee974cdf3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_769ca821-2837-4823-8e61-77eee974cdf3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_769ca821-2837-4823-8e61-77eee974cdf3" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_769ca821-2837-4823-8e61-77eee974cdf3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_141fd7b9-c466-4744-8f1f-4ecb1f2406db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_769ca821-2837-4823-8e61-77eee974cdf3" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_141fd7b9-c466-4744-8f1f-4ecb1f2406db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_f1133085-47af-4008-bcda-a275e98c48fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_141fd7b9-c466-4744-8f1f-4ecb1f2406db" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_f1133085-47af-4008-bcda-a275e98c48fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityFundsMember_186e5178-0824-4ed0-a8a6-70908b3921a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_141fd7b9-c466-4744-8f1f-4ecb1f2406db" xlink:to="loc_us-gaap_EquityFundsMember_186e5178-0824-4ed0-a8a6-70908b3921a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember_bfb65a6c-6c41-4c07-ab1c-3981744f436e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgeFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_141fd7b9-c466-4744-8f1f-4ecb1f2406db" xlink:to="loc_us-gaap_HedgeFundsMember_bfb65a6c-6c41-4c07-ab1c-3981744f436e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BondMutualFundsMember_4db1399b-408c-4ab7-b852-c29aa8a65189" xlink:href="coo-20221031.xsd#coo_BondMutualFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_141fd7b9-c466-4744-8f1f-4ecb1f2406db" xlink:to="loc_coo_BondMutualFundsMember_4db1399b-408c-4ab7-b852-c29aa8a65189" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails" xlink:type="extended" id="i54ed8dfa67344ebdbebfafa973b21661_EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems_12cbcf4e-c5af-42fe-a00c-a975658f1e78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_74953b3c-6f36-484d-8b80-9ee164077606" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems_12cbcf4e-c5af-42fe-a00c-a975658f1e78" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_74953b3c-6f36-484d-8b80-9ee164077606" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable_7f4053e0-7c0b-496f-a49d-f4c2f4a11723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems_12cbcf4e-c5af-42fe-a00c-a975658f1e78" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable_7f4053e0-7c0b-496f-a49d-f4c2f4a11723" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_fbfbcd3f-2837-498c-b006-0d6bf44948b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable_7f4053e0-7c0b-496f-a49d-f4c2f4a11723" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_fbfbcd3f-2837-498c-b006-0d6bf44948b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_fbfbcd3f-2837-498c-b006-0d6bf44948b9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_fbfbcd3f-2837-498c-b006-0d6bf44948b9" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_fbfbcd3f-2837-498c-b006-0d6bf44948b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_9cb4bb61-7239-4691-9799-a438ad5bddd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_fbfbcd3f-2837-498c-b006-0d6bf44948b9" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_9cb4bb61-7239-4691-9799-a438ad5bddd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_e1deac8b-0c4c-4b7a-bcdf-0593757f56a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_9cb4bb61-7239-4691-9799-a438ad5bddd3" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_e1deac8b-0c4c-4b7a-bcdf-0593757f56a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityFundsMember_83aa7069-74d7-4459-9477-b6b0e1d30035" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_9cb4bb61-7239-4691-9799-a438ad5bddd3" xlink:to="loc_us-gaap_EquityFundsMember_83aa7069-74d7-4459-9477-b6b0e1d30035" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember_b49af7f8-eaa4-4897-b982-1e2ac4a59821" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgeFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_9cb4bb61-7239-4691-9799-a438ad5bddd3" xlink:to="loc_us-gaap_HedgeFundsMember_b49af7f8-eaa4-4897-b982-1e2ac4a59821" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BondMutualFundsMember_ec0ca03d-2c41-494b-9772-332a734c9fa4" xlink:href="coo-20221031.xsd#coo_BondMutualFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_9cb4bb61-7239-4691-9799-a438ad5bddd3" xlink:to="loc_coo_BondMutualFundsMember_ec0ca03d-2c41-494b-9772-332a734c9fa4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_92ca3eb0-e559-48f4-bd40-698625fad109" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable_7f4053e0-7c0b-496f-a49d-f4c2f4a11723" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_92ca3eb0-e559-48f4-bd40-698625fad109" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_92ca3eb0-e559-48f4-bd40-698625fad109_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_92ca3eb0-e559-48f4-bd40-698625fad109" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_92ca3eb0-e559-48f4-bd40-698625fad109_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0cd289ee-9500-4f39-8283-935ef7b2e3fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_92ca3eb0-e559-48f4-bd40-698625fad109" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0cd289ee-9500-4f39-8283-935ef7b2e3fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_90f22c01-ce0c-4d21-892c-f2bcc5d02a87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0cd289ee-9500-4f39-8283-935ef7b2e3fd" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_90f22c01-ce0c-4d21-892c-f2bcc5d02a87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_c9f88ca9-c9fa-4d0c-85fe-575e1785b8c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0cd289ee-9500-4f39-8283-935ef7b2e3fd" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_c9f88ca9-c9fa-4d0c-85fe-575e1785b8c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_f4c5d818-afbc-47e5-b13c-8a179c65a337" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0cd289ee-9500-4f39-8283-935ef7b2e3fd" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_f4c5d818-afbc-47e5-b13c-8a179c65a337" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#BusinessSegmentInformationBusinessSegmentNetSalesDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails" xlink:type="extended" id="i33a0d24ff9c04538baa80c556dcf9a40_BusinessSegmentInformationBusinessSegmentNetSalesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_65cbf2f6-27ef-4fde-9406-9ae8151307ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3189d45e-b677-4108-bc2f-0f93d6ccd706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_65cbf2f6-27ef-4fde-9406-9ae8151307ed" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3189d45e-b677-4108-bc2f-0f93d6ccd706" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_69d6c717-5524-4058-b274-d5061fcd9138" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_65cbf2f6-27ef-4fde-9406-9ae8151307ed" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_69d6c717-5524-4058-b274-d5061fcd9138" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_03d9348a-bd6c-443a-b16d-5153a04fa086" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_69d6c717-5524-4058-b274-d5061fcd9138" xlink:to="loc_srt_ProductOrServiceAxis_03d9348a-bd6c-443a-b16d-5153a04fa086" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_03d9348a-bd6c-443a-b16d-5153a04fa086_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_03d9348a-bd6c-443a-b16d-5153a04fa086" xlink:to="loc_srt_ProductsAndServicesDomain_03d9348a-bd6c-443a-b16d-5153a04fa086_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8f6a79cc-6e0e-4ccc-9100-af8896c6bf09" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_03d9348a-bd6c-443a-b16d-5153a04fa086" xlink:to="loc_srt_ProductsAndServicesDomain_8f6a79cc-6e0e-4ccc-9100-af8896c6bf09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ToricLensMember_7342279b-0101-4d2a-8437-2c85098cb469" xlink:href="coo-20221031.xsd#coo_ToricLensMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8f6a79cc-6e0e-4ccc-9100-af8896c6bf09" xlink:to="loc_coo_ToricLensMember_7342279b-0101-4d2a-8437-2c85098cb469" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_MultifocalLensMember_7236843f-95f6-44a2-8f08-54b56cd7354a" xlink:href="coo-20221031.xsd#coo_MultifocalLensMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8f6a79cc-6e0e-4ccc-9100-af8896c6bf09" xlink:to="loc_coo_MultifocalLensMember_7236843f-95f6-44a2-8f08-54b56cd7354a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_SingleUseSphereLensMember_0915ce71-c68e-44fb-a7ac-580dae10aae5" xlink:href="coo-20221031.xsd#coo_SingleUseSphereLensMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8f6a79cc-6e0e-4ccc-9100-af8896c6bf09" xlink:to="loc_coo_SingleUseSphereLensMember_0915ce71-c68e-44fb-a7ac-580dae10aae5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_NonSingleUseSphereAndOtherMember_633f02d8-52f0-4e40-ac34-ed37be60b1a9" xlink:href="coo-20221031.xsd#coo_NonSingleUseSphereAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8f6a79cc-6e0e-4ccc-9100-af8896c6bf09" xlink:to="loc_coo_NonSingleUseSphereAndOtherMember_633f02d8-52f0-4e40-ac34-ed37be60b1a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_OfficeAndSurgicalProductsMember_4b01e0c7-f587-4621-8a25-82428d0fd7a3" xlink:href="coo-20221031.xsd#coo_OfficeAndSurgicalProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8f6a79cc-6e0e-4ccc-9100-af8896c6bf09" xlink:to="loc_coo_OfficeAndSurgicalProductsMember_4b01e0c7-f587-4621-8a25-82428d0fd7a3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_FertilityMember_abd45b59-e961-4cb0-b20f-900e3679cc23" xlink:href="coo-20221031.xsd#coo_FertilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8f6a79cc-6e0e-4ccc-9100-af8896c6bf09" xlink:to="loc_coo_FertilityMember_abd45b59-e961-4cb0-b20f-900e3679cc23" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_984fb874-3cb5-4fec-9256-259b5660b0b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_69d6c717-5524-4058-b274-d5061fcd9138" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_984fb874-3cb5-4fec-9256-259b5660b0b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_984fb874-3cb5-4fec-9256-259b5660b0b2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_984fb874-3cb5-4fec-9256-259b5660b0b2" xlink:to="loc_us-gaap_SegmentDomain_984fb874-3cb5-4fec-9256-259b5660b0b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ce36b8c6-0e84-46f6-bc3f-610ac818986c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_984fb874-3cb5-4fec-9256-259b5660b0b2" xlink:to="loc_us-gaap_SegmentDomain_ce36b8c6-0e84-46f6-bc3f-610ac818986c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CoopervisionSegmentMember_e0a561b4-c7ce-4f97-bf01-95a6ce1aeebe" xlink:href="coo-20221031.xsd#coo_CoopervisionSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ce36b8c6-0e84-46f6-bc3f-610ac818986c" xlink:to="loc_coo_CoopervisionSegmentMember_e0a561b4-c7ce-4f97-bf01-95a6ce1aeebe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CoopersurgicalSegmentMember_3f1df060-8974-4fe9-9c93-edf4005ddc75" xlink:href="coo-20221031.xsd#coo_CoopersurgicalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ce36b8c6-0e84-46f6-bc3f-610ac818986c" xlink:to="loc_coo_CoopersurgicalSegmentMember_3f1df060-8974-4fe9-9c93-edf4005ddc75" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#BusinessSegmentInformationBusinessSegmentInformationDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails" xlink:type="extended" id="idc122d5a200c4a9c839c1a966222815d_BusinessSegmentInformationBusinessSegmentInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_487c384b-ff0a-4ae4-bd26-0045c356cce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b57f1d44-1b90-4f1f-aa87-e6bf30ba035a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_487c384b-ff0a-4ae4-bd26-0045c356cce1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b57f1d44-1b90-4f1f-aa87-e6bf30ba035a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ea36c214-18da-4a87-a838-e8f12a52832a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_487c384b-ff0a-4ae4-bd26-0045c356cce1" xlink:to="loc_us-gaap_OperatingIncomeLoss_ea36c214-18da-4a87-a838-e8f12a52832a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_63706395-39a7-43d9-9ed8-58b754484d72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_487c384b-ff0a-4ae4-bd26-0045c356cce1" xlink:to="loc_us-gaap_InterestExpense_63706395-39a7-43d9-9ed8-58b754484d72" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_eec487f4-b80a-4bb0-bfd1-023a5252a18b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_487c384b-ff0a-4ae4-bd26-0045c356cce1" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_eec487f4-b80a-4bb0-bfd1-023a5252a18b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ee97875d-e8e9-4103-ba09-5f4bae64a4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_487c384b-ff0a-4ae4-bd26-0045c356cce1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ee97875d-e8e9-4103-ba09-5f4bae64a4eb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_25b0f5e1-124d-454d-a4c1-06d749504314" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_487c384b-ff0a-4ae4-bd26-0045c356cce1" xlink:to="loc_us-gaap_Assets_25b0f5e1-124d-454d-a4c1-06d749504314" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_ebf4841f-3908-43ea-83b0-0630db7286e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_487c384b-ff0a-4ae4-bd26-0045c356cce1" xlink:to="loc_us-gaap_Depreciation_ebf4841f-3908-43ea-83b0-0630db7286e3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_5ce83038-ab1b-4774-af8f-d671c0041c19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_487c384b-ff0a-4ae4-bd26-0045c356cce1" xlink:to="loc_us-gaap_AdjustmentForAmortization_5ce83038-ab1b-4774-af8f-d671c0041c19" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_645d3f96-8ecb-4a5f-8de3-572e9eec4695" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_487c384b-ff0a-4ae4-bd26-0045c356cce1" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_645d3f96-8ecb-4a5f-8de3-572e9eec4695" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7da2f702-c1b5-4158-a27e-3110316d8288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_487c384b-ff0a-4ae4-bd26-0045c356cce1" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7da2f702-c1b5-4158-a27e-3110316d8288" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_2b390424-a243-40d1-a662-06d8349d5ab2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7da2f702-c1b5-4158-a27e-3110316d8288" xlink:to="loc_srt_ConsolidationItemsAxis_2b390424-a243-40d1-a662-06d8349d5ab2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_2b390424-a243-40d1-a662-06d8349d5ab2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_2b390424-a243-40d1-a662-06d8349d5ab2" xlink:to="loc_srt_ConsolidationItemsDomain_2b390424-a243-40d1-a662-06d8349d5ab2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_f40b5c62-7538-4c20-b38d-161a3f5a3576" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_2b390424-a243-40d1-a662-06d8349d5ab2" xlink:to="loc_srt_ConsolidationItemsDomain_f40b5c62-7538-4c20-b38d-161a3f5a3576" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_b94b8f73-9630-4d71-b7db-3d251c5aef74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_f40b5c62-7538-4c20-b38d-161a3f5a3576" xlink:to="loc_us-gaap_CorporateNonSegmentMember_b94b8f73-9630-4d71-b7db-3d251c5aef74" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_f9c75212-4c16-4658-83ea-d8f9451caec6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_f40b5c62-7538-4c20-b38d-161a3f5a3576" xlink:to="loc_us-gaap_OperatingSegmentsMember_f9c75212-4c16-4658-83ea-d8f9451caec6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_570a5eeb-a1b6-44ee-911d-3ada3a4e788b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7da2f702-c1b5-4158-a27e-3110316d8288" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_570a5eeb-a1b6-44ee-911d-3ada3a4e788b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_570a5eeb-a1b6-44ee-911d-3ada3a4e788b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_570a5eeb-a1b6-44ee-911d-3ada3a4e788b" xlink:to="loc_us-gaap_SegmentDomain_570a5eeb-a1b6-44ee-911d-3ada3a4e788b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d7159494-3060-431c-8367-3de1893ab388" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_570a5eeb-a1b6-44ee-911d-3ada3a4e788b" xlink:to="loc_us-gaap_SegmentDomain_d7159494-3060-431c-8367-3de1893ab388" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CoopervisionSegmentMember_a9f6fcd2-88a3-45b5-80a9-cbd3fab325a8" xlink:href="coo-20221031.xsd#coo_CoopervisionSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d7159494-3060-431c-8367-3de1893ab388" xlink:to="loc_coo_CoopervisionSegmentMember_a9f6fcd2-88a3-45b5-80a9-cbd3fab325a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CoopersurgicalSegmentMember_e462d957-d15e-4ffc-a386-a9753b31cdfb" xlink:href="coo-20221031.xsd#coo_CoopersurgicalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d7159494-3060-431c-8367-3de1893ab388" xlink:to="loc_coo_CoopersurgicalSegmentMember_e462d957-d15e-4ffc-a386-a9753b31cdfb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails" xlink:type="extended" id="iaec9844a2c7f4264a5fd7466fb1f9547_BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_4ed672eb-515b-4cca-a8d1-ab1cbec221ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1c860af1-d399-4375-8271-92940fed46d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4ed672eb-515b-4cca-a8d1-ab1cbec221ff" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1c860af1-d399-4375-8271-92940fed46d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_bef66cb0-7d32-4860-afa2-67bd60ff2350" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4ed672eb-515b-4cca-a8d1-ab1cbec221ff" xlink:to="loc_us-gaap_OperatingIncomeLoss_bef66cb0-7d32-4860-afa2-67bd60ff2350" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_19186f3d-6302-4596-b270-9046213f2e49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4ed672eb-515b-4cca-a8d1-ab1cbec221ff" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_19186f3d-6302-4596-b270-9046213f2e49" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_75b29e40-88b8-4467-a88f-4497c3b57669" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4ed672eb-515b-4cca-a8d1-ab1cbec221ff" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_75b29e40-88b8-4467-a88f-4497c3b57669" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_077d84b0-7353-4fab-bd91-a1ff0f1698e5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_75b29e40-88b8-4467-a88f-4497c3b57669" xlink:to="loc_srt_ConsolidationItemsAxis_077d84b0-7353-4fab-bd91-a1ff0f1698e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_077d84b0-7353-4fab-bd91-a1ff0f1698e5_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_077d84b0-7353-4fab-bd91-a1ff0f1698e5" xlink:to="loc_srt_ConsolidationItemsDomain_077d84b0-7353-4fab-bd91-a1ff0f1698e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a14f65f5-48d9-4008-a8b2-af0ad187fd4e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_077d84b0-7353-4fab-bd91-a1ff0f1698e5" xlink:to="loc_srt_ConsolidationItemsDomain_a14f65f5-48d9-4008-a8b2-af0ad187fd4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_GeographyEliminationsMember_5a7b287d-6639-4428-b7b8-21c459364bae" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_GeographyEliminationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a14f65f5-48d9-4008-a8b2-af0ad187fd4e" xlink:to="loc_srt_GeographyEliminationsMember_5a7b287d-6639-4428-b7b8-21c459364bae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReportableGeographicalComponentsMember_6afa515c-02a1-4453-9f47-42808a1eb5a5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReportableGeographicalComponentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a14f65f5-48d9-4008-a8b2-af0ad187fd4e" xlink:to="loc_srt_ReportableGeographicalComponentsMember_6afa515c-02a1-4453-9f47-42808a1eb5a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CorporateReconcilingItemsAndEliminationsMember_97b466b0-bb27-4332-9a1f-b15cc44cbf4c" xlink:href="coo-20221031.xsd#coo_CorporateReconcilingItemsAndEliminationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a14f65f5-48d9-4008-a8b2-af0ad187fd4e" xlink:to="loc_coo_CorporateReconcilingItemsAndEliminationsMember_97b466b0-bb27-4332-9a1f-b15cc44cbf4c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_37ad85ac-02d7-4f9e-a5e8-378219b30105" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_75b29e40-88b8-4467-a88f-4497c3b57669" xlink:to="loc_srt_StatementGeographicalAxis_37ad85ac-02d7-4f9e-a5e8-378219b30105" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_37ad85ac-02d7-4f9e-a5e8-378219b30105_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_37ad85ac-02d7-4f9e-a5e8-378219b30105" xlink:to="loc_srt_SegmentGeographicalDomain_37ad85ac-02d7-4f9e-a5e8-378219b30105_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_4d12c3fb-00ab-40ba-8be3-487fb9a83ef5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_37ad85ac-02d7-4f9e-a5e8-378219b30105" xlink:to="loc_srt_SegmentGeographicalDomain_4d12c3fb-00ab-40ba-8be3-487fb9a83ef5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_6417d1dc-300c-4a26-8f4c-83aa55a948c0" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4d12c3fb-00ab-40ba-8be3-487fb9a83ef5" xlink:to="loc_country_US_6417d1dc-300c-4a26-8f4c-83aa55a948c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_2aeeeefb-21f7-4f66-b5d9-9bf59f5c20b4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4d12c3fb-00ab-40ba-8be3-487fb9a83ef5" xlink:to="loc_srt_EuropeMember_2aeeeefb-21f7-4f66-b5d9-9bf59f5c20b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_RestOfTheWorldMember_fa338bc1-2640-4f5b-b558-edc55e78a00e" xlink:href="coo-20221031.xsd#coo_RestOfTheWorldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4d12c3fb-00ab-40ba-8be3-487fb9a83ef5" xlink:to="loc_coo_RestOfTheWorldMember_fa338bc1-2640-4f5b-b558-edc55e78a00e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#FinancialDerivativesandHedgingNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails" xlink:type="extended" id="icff29268a09c45489ba4e7b61c99bb41_FinancialDerivativesandHedgingNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c57c779c-72db-41dd-88e5-a2db249f99eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_c5c7750c-188b-453c-9040-3ba156acaa4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c57c779c-72db-41dd-88e5-a2db249f99eb" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_c5c7750c-188b-453c-9040-3ba156acaa4e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_8a350621-cb71-4ebd-9632-e2a2ab5abd24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c57c779c-72db-41dd-88e5-a2db249f99eb" xlink:to="loc_us-gaap_DerivativeNotionalAmount_8a350621-cb71-4ebd-9632-e2a2ab5abd24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_NumberOfInterestRateDerivativesMatured_f72864ca-4163-4a59-ac24-99d4d439492f" xlink:href="coo-20221031.xsd#coo_NumberOfInterestRateDerivativesMatured"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c57c779c-72db-41dd-88e5-a2db249f99eb" xlink:to="loc_coo_NumberOfInterestRateDerivativesMatured_f72864ca-4163-4a59-ac24-99d4d439492f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract_dd1b36cc-42d5-4094-abab-9c5c34be2af9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c57c779c-72db-41dd-88e5-a2db249f99eb" xlink:to="loc_us-gaap_DerivativeTermOfContract_dd1b36cc-42d5-4094-abab-9c5c34be2af9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AOCICashFlowHedgeCumulativeGainLossBeforeTax_7252ef7f-6ead-4482-90b7-b7a79223542a" xlink:href="coo-20221031.xsd#coo_AOCICashFlowHedgeCumulativeGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c57c779c-72db-41dd-88e5-a2db249f99eb" xlink:to="loc_coo_AOCICashFlowHedgeCumulativeGainLossBeforeTax_7252ef7f-6ead-4482-90b7-b7a79223542a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_651741be-e7c5-4122-843e-b1d4f4f14e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c57c779c-72db-41dd-88e5-a2db249f99eb" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_651741be-e7c5-4122-843e-b1d4f4f14e4b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_fdaf480b-5c45-4b05-b1a1-417d1e545230" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c57c779c-72db-41dd-88e5-a2db249f99eb" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_fdaf480b-5c45-4b05-b1a1-417d1e545230" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a243614e-c012-483c-8abb-b7547968f6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c57c779c-72db-41dd-88e5-a2db249f99eb" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a243614e-c012-483c-8abb-b7547968f6bd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3dc4eaf2-eff8-4b3a-bc63-ab5c860eab61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a243614e-c012-483c-8abb-b7547968f6bd" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3dc4eaf2-eff8-4b3a-bc63-ab5c860eab61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3dc4eaf2-eff8-4b3a-bc63-ab5c860eab61_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3dc4eaf2-eff8-4b3a-bc63-ab5c860eab61" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3dc4eaf2-eff8-4b3a-bc63-ab5c860eab61_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8208dd12-df1f-46f6-97ea-f13d95ceb405" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3dc4eaf2-eff8-4b3a-bc63-ab5c860eab61" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8208dd12-df1f-46f6-97ea-f13d95ceb405" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_3ff369e8-fc84-4eeb-8063-70eee58874ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8208dd12-df1f-46f6-97ea-f13d95ceb405" xlink:to="loc_us-gaap_InterestRateSwapMember_3ff369e8-fc84-4eeb-8063-70eee58874ce" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails" xlink:type="extended" id="ib66479da5c86486fa11a13e0ae14114d_FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_1b4dcc2d-ebc2-4e89-ac97-d87816e4977d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_958dfea8-67c2-4848-a4ba-b5e6ba04902a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_1b4dcc2d-ebc2-4e89-ac97-d87816e4977d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_958dfea8-67c2-4848-a4ba-b5e6ba04902a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_d9f703ab-a414-4c62-b1a0-42c6ae9119c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_1b4dcc2d-ebc2-4e89-ac97-d87816e4977d" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_d9f703ab-a414-4c62-b1a0-42c6ae9119c4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e80bb7c7-8065-4542-b661-a9fb1fe3466d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_d9f703ab-a414-4c62-b1a0-42c6ae9119c4" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e80bb7c7-8065-4542-b661-a9fb1fe3466d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e80bb7c7-8065-4542-b661-a9fb1fe3466d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e80bb7c7-8065-4542-b661-a9fb1fe3466d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e80bb7c7-8065-4542-b661-a9fb1fe3466d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_18b09a50-23e7-4257-a544-ec810d604b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e80bb7c7-8065-4542-b661-a9fb1fe3466d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_18b09a50-23e7-4257-a544-ec810d604b8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_d1bd7a73-c3dd-4172-8b40-6bbc01260feb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_18b09a50-23e7-4257-a544-ec810d604b8c" xlink:to="loc_us-gaap_InterestExpenseMember_d1bd7a73-c3dd-4172-8b40-6bbc01260feb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0ec84c8d-693d-4ed5-9b04-52cabe6fec66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_d9f703ab-a414-4c62-b1a0-42c6ae9119c4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0ec84c8d-693d-4ed5-9b04-52cabe6fec66" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0ec84c8d-693d-4ed5-9b04-52cabe6fec66_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0ec84c8d-693d-4ed5-9b04-52cabe6fec66" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0ec84c8d-693d-4ed5-9b04-52cabe6fec66_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2b82f7fa-351c-4aeb-be41-6b69df1eb0b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0ec84c8d-693d-4ed5-9b04-52cabe6fec66" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2b82f7fa-351c-4aeb-be41-6b69df1eb0b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_046e7cac-cf24-44ef-a7ab-61303d702294" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2b82f7fa-351c-4aeb-be41-6b69df1eb0b4" xlink:to="loc_us-gaap_InterestRateSwapMember_046e7cac-cf24-44ef-a7ab-61303d702294" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended" id="i766498b8c56e43e795d3cbe923d4a702_FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_28367408-7a01-4d6c-a764-8d67d249728c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_03b20f1a-e1c7-4be8-b5c3-d925f0c99fd0" xlink:href="coo-20221031.xsd#coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_28367408-7a01-4d6c-a764-8d67d249728c" xlink:to="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_03b20f1a-e1c7-4be8-b5c3-d925f0c99fd0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a82c05fa-bd10-4c26-8f9c-65aea12cf0b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_03b20f1a-e1c7-4be8-b5c3-d925f0c99fd0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a82c05fa-bd10-4c26-8f9c-65aea12cf0b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_038aefab-a4a8-4eb0-b682-446ce90d3ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_03b20f1a-e1c7-4be8-b5c3-d925f0c99fd0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_038aefab-a4a8-4eb0-b682-446ce90d3ffc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_cd99a298-a879-46b4-b645-7db7dcf39393" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_03b20f1a-e1c7-4be8-b5c3-d925f0c99fd0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_cd99a298-a879-46b4-b645-7db7dcf39393" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_a066edfb-2849-404e-ba55-a58a648f9511" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_03b20f1a-e1c7-4be8-b5c3-d925f0c99fd0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_a066edfb-2849-404e-ba55-a58a648f9511" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_fae733b9-3b80-4662-afa8-3a796b25583f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_03b20f1a-e1c7-4be8-b5c3-d925f0c99fd0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_fae733b9-3b80-4662-afa8-3a796b25583f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0929703a-213f-49d8-aab2-aeb38b9a84ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_65c564ad-59f5-4a03-9af0-1f891c107f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_28367408-7a01-4d6c-a764-8d67d249728c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_65c564ad-59f5-4a03-9af0-1f891c107f7b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7296cfe5-d7d9-4521-b563-31c77023f69c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_65c564ad-59f5-4a03-9af0-1f891c107f7b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7296cfe5-d7d9-4521-b563-31c77023f69c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7296cfe5-d7d9-4521-b563-31c77023f69c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7296cfe5-d7d9-4521-b563-31c77023f69c" xlink:to="loc_us-gaap_EquityComponentDomain_7296cfe5-d7d9-4521-b563-31c77023f69c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_04958b82-4b63-41da-8a51-721f190c8f50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7296cfe5-d7d9-4521-b563-31c77023f69c" xlink:to="loc_us-gaap_EquityComponentDomain_04958b82-4b63-41da-8a51-721f190c8f50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember_35830e0c-5cc6-4ca4-891a-979fe73655f0" xlink:href="coo-20221031.xsd#coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_04958b82-4b63-41da-8a51-721f190c8f50" xlink:to="loc_coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember_35830e0c-5cc6-4ca4-891a-979fe73655f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_125c5bc3-42a1-4121-97b4-01932b7468d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_04958b82-4b63-41da-8a51-721f190c8f50" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_125c5bc3-42a1-4121-97b4-01932b7468d0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/ScheduleIIDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#ScheduleIIDetails"/>
  <link:definitionLink xlink:role="http://www.coopercos.com/role/ScheduleIIDetails" xlink:type="extended" id="id2dba100ca484056a459c53f6a911698_ScheduleIIDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_3aad8607-f393-4cea-83fd-f416716b974a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_c80dc3db-42dc-4918-8e6a-113c191430fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_3aad8607-f393-4cea-83fd-f416716b974a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_c80dc3db-42dc-4918-8e6a-113c191430fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_e374cdf8-a4c3-4572-ab7b-7543b0cdb615" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_3aad8607-f393-4cea-83fd-f416716b974a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_e374cdf8-a4c3-4572-ab7b-7543b0cdb615" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_3368e081-942c-4d4f-b740-80937720a544" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_3aad8607-f393-4cea-83fd-f416716b974a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_3368e081-942c-4d4f-b740-80937720a544" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_6d57211a-16a6-46e6-8e21-d369ef08e8c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_1c45a5b0-f9f7-430f-a46d-5e109bef8979" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_3aad8607-f393-4cea-83fd-f416716b974a" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_1c45a5b0-f9f7-430f-a46d-5e109bef8979" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_69a0d7f5-ab06-4a7b-991c-751041f9d844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_1c45a5b0-f9f7-430f-a46d-5e109bef8979" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_69a0d7f5-ab06-4a7b-991c-751041f9d844" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_69a0d7f5-ab06-4a7b-991c-751041f9d844_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_69a0d7f5-ab06-4a7b-991c-751041f9d844" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_69a0d7f5-ab06-4a7b-991c-751041f9d844_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_b2b3f003-95ef-432f-8d77-c9fdd944f618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_69a0d7f5-ab06-4a7b-991c-751041f9d844" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_b2b3f003-95ef-432f-8d77-c9fdd944f618" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_dcac830c-5a33-44f0-a17f-9ca36d8c9e21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_b2b3f003-95ef-432f-8d77-c9fdd944f618" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_dcac830c-5a33-44f0-a17f-9ca36d8c9e21" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent_55109b6f-3107-4148-a369-175e0cf5f0df" xlink:href="coo-20221031.xsd#coo_LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="loc_coo_LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent_55109b6f-3107-4148-a369-175e0cf5f0df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="loc_coo_LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent_55109b6f-3107-4148-a369-175e0cf5f0df" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>coo-20221031_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:c1100544-9949-49e4-a84a-324e954b65ab,g:6f410f64-26fc-4654-ba7e-29974b75a0fc-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_92366062-f765-4f90-8fec-d0fb7b76d63d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_a4ab55d7-81a9-4b67-b0c6-2f63db90083e_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_be382d93-e473-42f7-b49c-747427eeabf8_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_8292711f-db83-4aee-819a-7e4e81545c7f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_bb225ec0-3add-421a-b04f-4736a3a48cae_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_64774581-dda9-49fb-81c4-457f772a7297_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, gross</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_EffectiveIncomeTaxRateReconciliationChangeInDomesticFederalTaxReturnAmount_15643b01-fe2e-4e73-9720-1cf10bd8e57b_terseLabel_en-US" xlink:label="lab_coo_EffectiveIncomeTaxRateReconciliationChangeInDomesticFederalTaxReturnAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States provision-to-return</link:label>
    <link:label id="lab_coo_EffectiveIncomeTaxRateReconciliationChangeInDomesticFederalTaxReturnAmount_label_en-US" xlink:label="lab_coo_EffectiveIncomeTaxRateReconciliationChangeInDomesticFederalTaxReturnAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change In Domestic Federal Tax Return, Amount</link:label>
    <link:label id="lab_coo_EffectiveIncomeTaxRateReconciliationChangeInDomesticFederalTaxReturnAmount_documentation_en-US" xlink:label="lab_coo_EffectiveIncomeTaxRateReconciliationChangeInDomesticFederalTaxReturnAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change In Domestic Federal Tax Return, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_EffectiveIncomeTaxRateReconciliationChangeInDomesticFederalTaxReturnAmount" xlink:href="coo-20221031.xsd#coo_EffectiveIncomeTaxRateReconciliationChangeInDomesticFederalTaxReturnAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_EffectiveIncomeTaxRateReconciliationChangeInDomesticFederalTaxReturnAmount" xlink:to="lab_coo_EffectiveIncomeTaxRateReconciliationChangeInDomesticFederalTaxReturnAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract_758050b9-8919-4050-9d04-1e335439698b_terseLabel_en-US" xlink:label="lab_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average assumptions used in computing the net periodic pension cost and projected benefit obligation at year end:</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract_label_en-US" xlink:label="lab_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost And Benefit Obligation [Abstract]</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract_documentation_en-US" xlink:label="lab_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost And Benefit Obligation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract" xlink:href="coo-20221031.xsd#coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract" xlink:to="lab_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount_5c5c01c6-38b0-478a-828c-211e230079a2_terseLabel_en-US" xlink:label="lab_coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrecognized tax benefits</link:label>
    <link:label id="lab_coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount_label_en-US" xlink:label="lab_coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change In Unrecognized Tax Benefits, Amount</link:label>
    <link:label id="lab_coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount_documentation_en-US" xlink:label="lab_coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change In Unrecognized Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" xlink:href="coo-20221031.xsd#coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" xlink:to="lab_coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_67c5e474-589e-4551-b4f6-0b0162b98066_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessExitCosts1_0b024af3-4360-4aac-8a6a-4d8c371cd983_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exit charges</link:label>
    <link:label id="lab_us-gaap_BusinessExitCosts1_label_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Exit Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessExitCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessExitCosts1" xlink:to="lab_us-gaap_BusinessExitCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_afeb5999-dac4-4af3-aceb-07baec019d1d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_a1e95c1f-45fa-4455-8393-2c7ac0784ee5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_eb6f70f4-0038-481f-9813-8750c097d14a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_a238830e-4c56-4f38-a5ab-7e855e1911a7_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, at cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_ea46f54d-7026-4b64-9aed-7a9693f2a14b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends on common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_9f6b1ee8-3bf3-4dc5-af6d-b34f1a857491_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_8a85f47a-c2a0-4831-9b1a-98dc2cee7d05_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a0d035c7-bdf1-4216-8220-da4331a1aff0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_869a1e4d-8797-4191-8727-1488f5451f74_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_31334eb1-3d95-41c2-8e61-adb6e8a91cf3_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_cb7ea764-5fe1-4072-801a-8ba57016d86d_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_56ff988e-d228-4ac9-bd11-09c6c23de3f5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_c08e5a8f-e80b-41d8-9b74-20a86fbc1390_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of information by geographical area by country of domicile</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_78b898d1-ef78-4bc9-9c82-7b16dce64491_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_942a298c-6160-443c-aa54-ca10d75995f9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f6cacd29-0d93-48ff-8ac4-1722063943f3_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_GenerateLifeSciencesMember_1bdbd3d9-429b-40db-b4a6-7479bef81373_terseLabel_en-US" xlink:label="lab_coo_GenerateLifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Generate Life Sciences</link:label>
    <link:label id="lab_coo_GenerateLifeSciencesMember_label_en-US" xlink:label="lab_coo_GenerateLifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Generate Life Sciences [Member]</link:label>
    <link:label id="lab_coo_GenerateLifeSciencesMember_documentation_en-US" xlink:label="lab_coo_GenerateLifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Generate Life Sciences</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_GenerateLifeSciencesMember" xlink:href="coo-20221031.xsd#coo_GenerateLifeSciencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_GenerateLifeSciencesMember" xlink:to="lab_coo_GenerateLifeSciencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_eac5d48e-ff3c-43e3-8f8f-59af60c3abe7_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash held for sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_40b5da19-e098-4c0f-9ce9-df37285842f6_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option shares and restricted stock units excluded (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_aad37b38-7c5c-4b1f-8b98-e079e348e9e1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_b95a201c-35f2-40a3-98ed-12096fa3ca41_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember_5e328964-0663-4760-8987-91fef4fd709f_terseLabel_en-US" xlink:label="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Assumptions For Defined Benefit Plans, Change In Lump Sum Determination</link:label>
    <link:label id="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember_label_en-US" xlink:label="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Assumptions For Defined Benefit Plans, Change In Lump Sum Determination [Member]</link:label>
    <link:label id="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember_documentation_en-US" xlink:label="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Assumptions For Defined Benefit Plans, Change In Lump Sum Determination [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember" xlink:href="coo-20221031.xsd#coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember" xlink:to="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_2d3b440b-45d5-469a-9bd7-0e5d9267f73f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_e766bd92-6763-4558-ac4b-295e8f5f70f3_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingAccumulatedBenefitObligationEffectOfChangeInDiscountRate_fb6eb369-8fe7-46b1-b12e-5d57d00c10f5_terseLabel_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingAccumulatedBenefitObligationEffectOfChangeInDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected defined accumulated benefit obligation</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingAccumulatedBenefitObligationEffectOfChangeInDiscountRate_label_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingAccumulatedBenefitObligationEffectOfChangeInDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Accumulated Benefit Obligation, Effect Of Change In Discount Rate</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingAccumulatedBenefitObligationEffectOfChangeInDiscountRate_documentation_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingAccumulatedBenefitObligationEffectOfChangeInDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Accumulated Benefit Obligation, Effect Of Change In Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingAccumulatedBenefitObligationEffectOfChangeInDiscountRate" xlink:href="coo-20221031.xsd#coo_DefinedBenefitPlanAssumptionsUsedCalculatingAccumulatedBenefitObligationEffectOfChangeInDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingAccumulatedBenefitObligationEffectOfChangeInDiscountRate" xlink:to="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingAccumulatedBenefitObligationEffectOfChangeInDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_500523ae-d135-42af-b128-cc0761441d12_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase based on tax positions in current fiscal year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_4dc5d041-0ed7-4067-b159-ff46ecfcab93_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_94662b3c-4cc6-4df3-94e6-648178829eab_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember_1cccec21-eee6-467c-af41-eee126fa1f26_terseLabel_en-US" xlink:label="lab_coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Privately-Held Medical Device Company, Spectacle Lenses, Portion Attributable To Former Equity Interest Owners</link:label>
    <link:label id="lab_coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember_label_en-US" xlink:label="lab_coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Privately-Held Medical Device Company, Portion Attributable To Former Equity Interest Owners [Member]</link:label>
    <link:label id="lab_coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember_documentation_en-US" xlink:label="lab_coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Privately-Held Medical Device Company, Portion Attributable To Former Equity Interest Owners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember" xlink:href="coo-20221031.xsd#coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember" xlink:to="lab_coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_6e6014b1-d770-490f-9f87-d963efe30ec9_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets, beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_8fe35632-1212-4be6-a5af-d15f230b310b_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets, end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_94b29117-69c5-4635-9e26-ff9b35a131f6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_ba2d9328-5974-48a9-8ab4-fc625bcf1dde_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_6d283120-bad1-485e-9e90-a1810cc00237_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosures of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_45ce80b9-d2f2-416b-b86a-72ef42abd836_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total unrecognized compensation cost related to nonvested units</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_c4edf933-04e5-4d3c-88d4-619600acf79a_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_417cf897-3a34-46cc-bcd8-7c42ee03eeb1_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_fdf45d9f-2627-4a22-9f50-f252ceeebf97_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_cee03fd6-fefa-4df4-b5bb-fecc20afba30_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9b4ea3a9-7cf5-4a69-8ba6-26be50914b84_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_eb4923aa-93d5-4c9f-a050-5dbe95303020_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, ending balance, Weighted Average Remaining Contractual Term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_PayablesFirstInstallmentMember_a4e06e97-546f-4aee-a9d6-4b080a264edf_terseLabel_en-US" xlink:label="lab_coo_PayablesFirstInstallmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables First Installment</link:label>
    <link:label id="lab_coo_PayablesFirstInstallmentMember_label_en-US" xlink:label="lab_coo_PayablesFirstInstallmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables First Installment [Member]</link:label>
    <link:label id="lab_coo_PayablesFirstInstallmentMember_documentation_en-US" xlink:label="lab_coo_PayablesFirstInstallmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables First Installment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PayablesFirstInstallmentMember" xlink:href="coo-20221031.xsd#coo_PayablesFirstInstallmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_PayablesFirstInstallmentMember" xlink:to="lab_coo_PayablesFirstInstallmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_e841246c-0999-4c80-97a7-b5dd50c6b42b_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_369421c7-3616-45d7-9fcf-56cceac4ff67_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit obligation, actuarial gain (loss)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_c0f2638c-03f9-43ee-97ac-baedbfcf8b42_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial (gain)/loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_60c8e8ed-758d-482d-9258-62543424348e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_65442f51-afe3-4223-adc1-75b7f5a97244_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_7f659ce2-c541-47a7-a4b6-c125f989a0b8_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total recognized in other comprehensive (income) loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_b3177729-1e06-41ea-8a6e-03526148f947_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_22a5a3fd-c477-4063-98fe-51f31e72a8fd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_5c291f4d-6b41-45d2-9044-2b3c31e794b4_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c005d7ba-88cc-4298-bb93-c5f301ebab38_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_ba40e7d1-6a45-45cc-913b-eb78a3be2ceb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_05948e43-356c-48a2-abf8-9b8a674f41a1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_f3c0e770-d375-49c0-8d35-ebae24ad4e03_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, excluding financing leases</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_f691ca6e-f6db-4bcd-a8f4-87f0cdeafe3e_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_25b01447-651f-4cce-88b5-13d15e2d1391_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a33afeeb-1fb8-4377-9076-6e06e5808346_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_815f380c-a959-45a2-8ffc-cc6f54ba6847_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement period adjustment to goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f3897c33-9dfb-416f-a3f5-82875fdf4195_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_d1699789-01cd-4f91-b808-469281f8055e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated future benefit payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_8a1ce124-7ff6-47c3-9fd6-f7a669db0de1_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e82235fe-a376-43bf-b555-fdf45dd0b1c1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_78bb9457-b1ce-4d69-a755-58b5fd94213b_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_ebe819ca-170b-484b-ae26-21494d001aa6_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_de433429-05c8-4d5c-afa8-1f38e8c1658c_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_74732fee-d4ad-4533-a3ff-cfb0fc94ce7a_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_8ec8642c-d2b6-4137-9e57-83aea03ba4fd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Exercise&#160;Price Per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_37b5f5c0-740c-45bd-b105-b42ac37f5924_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9f5c4a3b-645a-4817-94f8-8f774cc4fc29_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of net periodic benefit cost and other amounts recognized in the Consolidated Statements of Income:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_ac4bf068-6d6f-4e2e-93da-4b8c4089b4c4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationDispositionOfAssets_81e51204-321d-4819-853f-cc03e43d0854_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationDispositionOfAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intra-group transfer to UK subsidiary</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationDispositionOfAssets_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationDispositionOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Disposition of Asset, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationDispositionOfAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationDispositionOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationDispositionOfAssets" xlink:to="lab_us-gaap_IncomeTaxReconciliationDispositionOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_36f8c468-d435-4117-b3af-9d14fb2df2ab_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_f84e03d9-0c6f-4f03-8e90-6ebc75288328_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undiscounted range of the contingent consideration, minimum</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_62eab354-12d5-4dc7-adef-69879cb0893d_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested RSUs, beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d34bcc4f-1931-4756-b4a9-c5f862ba9721_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested RSUs, ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_a30376bf-5934-4e69-80d0-853aa8509527_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_37beb7b1-8b55-4141-892a-f618b375ab4d_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_AssetAquisitionDomain_997dd41f-e665-4ba2-941a-da5a87d95f97_terseLabel_en-US" xlink:label="lab_coo_AssetAquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Aquisition [Domain]</link:label>
    <link:label id="lab_coo_AssetAquisitionDomain_label_en-US" xlink:label="lab_coo_AssetAquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Aquisition [Domain]</link:label>
    <link:label id="lab_coo_AssetAquisitionDomain_documentation_en-US" xlink:label="lab_coo_AssetAquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Aquisition [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AssetAquisitionDomain" xlink:href="coo-20221031.xsd#coo_AssetAquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_AssetAquisitionDomain" xlink:to="lab_coo_AssetAquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_67b3f661-97b8-4350-8cb8-be6538094ade_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount recognized in other comprehensive income on interest rate swap contracts, gross</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_b4b71c21-75d4-4412-adf5-4b17454f082f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_OfficeAndSurgicalProductsMember_81f8c9d0-d797-4882-8086-a13ac3352857_terseLabel_en-US" xlink:label="lab_coo_OfficeAndSurgicalProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office and surgical products</link:label>
    <link:label id="lab_coo_OfficeAndSurgicalProductsMember_label_en-US" xlink:label="lab_coo_OfficeAndSurgicalProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office And Surgical Products [Member]</link:label>
    <link:label id="lab_coo_OfficeAndSurgicalProductsMember_documentation_en-US" xlink:label="lab_coo_OfficeAndSurgicalProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office And Surgical Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_OfficeAndSurgicalProductsMember" xlink:href="coo-20221031.xsd#coo_OfficeAndSurgicalProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_OfficeAndSurgicalProductsMember" xlink:to="lab_coo_OfficeAndSurgicalProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_eb07d53d-9a9c-4e85-96f1-921837604c58_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember_ec5195ad-b125-4e56-8f98-3e9ab2b40b9d_terseLabel_en-US" xlink:label="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Assumptions For Defined Benefit Plans, Change In Discount Rate</link:label>
    <link:label id="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember_label_en-US" xlink:label="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Assumptions For Defined Benefit Plans, Change In Discount Rate [Member]</link:label>
    <link:label id="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember_documentation_en-US" xlink:label="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Assumptions For Defined Benefit Plans, Change In Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember" xlink:href="coo-20221031.xsd#coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember" xlink:to="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_TermLoanAgreement2021364DayMember_dff12346-1ee9-4be2-93d7-cf38e5f3e4b3_terseLabel_en-US" xlink:label="lab_coo_TermLoanAgreement2021364DayMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Agreement 2021, 364 Day</link:label>
    <link:label id="lab_coo_TermLoanAgreement2021364DayMember_label_en-US" xlink:label="lab_coo_TermLoanAgreement2021364DayMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Agreement 2021, 364 Day [Member]</link:label>
    <link:label id="lab_coo_TermLoanAgreement2021364DayMember_documentation_en-US" xlink:label="lab_coo_TermLoanAgreement2021364DayMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Agreement 2021, 364 Day</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanAgreement2021364DayMember" xlink:href="coo-20221031.xsd#coo_TermLoanAgreement2021364DayMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_TermLoanAgreement2021364DayMember" xlink:to="lab_coo_TermLoanAgreement2021364DayMember" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent_9862efe6-772f-4d02-a989-fc08a58e1962_terseLabel_en-US" xlink:label="lab_coo_LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued pension liability and other</link:label>
    <link:label id="lab_coo_LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent_label_en-US" xlink:label="lab_coo_LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Pension Plan And Other, Noncurrent</link:label>
    <link:label id="lab_coo_LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent_documentation_en-US" xlink:label="lab_coo_LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Pension Plan And Other, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent" xlink:href="coo-20221031.xsd#coo_LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent" xlink:to="lab_coo_LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_3f568be1-9416-4495-b420-4d9714e7d42b_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company's contribution to the pension plan</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_58bc0aea-b63d-4394-94ea-5e9de0e3d77b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_a91c404d-81f5-4469-af43-b2e8af02ce48_negatedNetLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions made during the year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_AsianPacificCreditFacilitiesYenDenominatedMember_48df69dc-ca11-4a80-8af5-68d5d5c15902_terseLabel_en-US" xlink:label="lab_coo_AsianPacificCreditFacilitiesYenDenominatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asian Pacific Credit Facilities - Yen-Denominated</link:label>
    <link:label id="lab_coo_AsianPacificCreditFacilitiesYenDenominatedMember_label_en-US" xlink:label="lab_coo_AsianPacificCreditFacilitiesYenDenominatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asian Pacific Credit Facilities - Yen-Denominated [Member]</link:label>
    <link:label id="lab_coo_AsianPacificCreditFacilitiesYenDenominatedMember_documentation_en-US" xlink:label="lab_coo_AsianPacificCreditFacilitiesYenDenominatedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asian Pacific Credit Facilities - Yen-Denominated [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AsianPacificCreditFacilitiesYenDenominatedMember" xlink:href="coo-20221031.xsd#coo_AsianPacificCreditFacilitiesYenDenominatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_AsianPacificCreditFacilitiesYenDenominatedMember" xlink:to="lab_coo_AsianPacificCreditFacilitiesYenDenominatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredRevenue_6dc1ccc7-0644-449c-9243-6eec80dea30a_terseLabel_en-US" xlink:label="lab_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredRevenue_label_en-US" xlink:label="lab_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Deferred Revenue</link:label>
    <link:label id="lab_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredRevenue_documentation_en-US" xlink:label="lab_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredRevenue" xlink:href="coo-20221031.xsd#coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredRevenue" xlink:to="lab_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_3dc10413-65ce-487e-a553-8861de74a35e_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_52b6bd80-115a-47b0-8080-b37dea23b926_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f7cc3e03-09cb-4895-8003-375bb3ddb140_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expense and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_745f03a1-4b44-4440-88f7-24e1e0071d98_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_b40ed3ee-44e3-41f9-95ec-f30a0a5fb33b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of interest in a subsidiary</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Interest in Consolidated Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_02cae2c0-c93e-4ebc-8a34-913ee1292977_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_79020e61-de50-40de-a883-247675cf0efd_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_c279c1b9-0411-4f12-9e1c-88110ed51e78_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumptions used in estimating fair value of stock options award granted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_ad803643-c3b5-4df2-9b01-c0f374e1d689_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_da6d7202-9c03-49fa-8473-81862889193d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_6f63c04e-b4a1-488b-b67d-6f684dc86ecd_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total unrecognized compensation cost expected to be recognized over a remaining weighted-average vesting period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_0e2371b7-c6cf-4920-b973-666c424ffc9c_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and exercisable at end of period, Weighted-Average Remaining Contractual Term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_6ebf6197-5b13-4542-a494-59ce410d8677_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of finite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_c7ee8d7f-bb0c-49be-94ee-22c9645f297c_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire business</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_4d8e01ca-61b4-4457-9197-641d5cd34bb8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_a1bc0ddb-0184-4148-81fe-e07f13a39b35_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_9d7f45ef-70ce-4659-a881-e9ab872d09fe_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_ce61146a-c0eb-482a-995b-323a9b27df39_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermLineOfCredit_228f43f2-703d-4405-8b6b-9b3aedb4cced_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermLineOfCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt outstanding</link:label>
    <link:label id="lab_us-gaap_LongTermLineOfCredit_label_en-US" xlink:label="lab_us-gaap_LongTermLineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermLineOfCredit" xlink:to="lab_us-gaap_LongTermLineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_5c6d0354-5735-40f0-a09b-72928864f5bc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationEffectOfChangeInDiscountRate_3912267e-5165-4d49-bfdb-b4afa46d62c4_terseLabel_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationEffectOfChangeInDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected defined benefit plan benefit obligation</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationEffectOfChangeInDiscountRate_label_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationEffectOfChangeInDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Projected Benefit Obligation, Effect Of Change In Discount Rate</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationEffectOfChangeInDiscountRate_documentation_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationEffectOfChangeInDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Projected Benefit Obligation, Effect Of Change In Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationEffectOfChangeInDiscountRate" xlink:href="coo-20221031.xsd#coo_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationEffectOfChangeInDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationEffectOfChangeInDiscountRate" xlink:to="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationEffectOfChangeInDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_d2e42bc8-913b-4ffb-8f30-e3af62b11ed3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range of exercise prices, higher limit (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_fc4bbad4-2956-464e-af4b-58d3f58ffb44_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_fec724ed-06c4-4abb-af55-66908fecc856_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_21342af9-104f-46fa-abca-2e2ec0eca4a6_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ff244e6b-2e3e-4c07-be99-258248533312_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity (Note 8)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7001d766-ae38-43e1-a37d-053eef193566_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e3ceca42-2b7b-428f-bd78-7ed67b50da45_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_74794c2b-e3f2-4b5d-ac00-54b8c4af5694_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_19e9e794-24be-4fd9-a104-4b9cf3564fe1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_6ea86629-8f8a-4df6-a440-2b6e486ee17c_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_36cbc626-314d-49a9-a940-28b84e6c8bdc_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_ad563253-e1b5-4a7f-8903-e8272727c708_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_56481c89-302f-49d5-a039-2208f9e74e4d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount recognized in other comprehensive income on interest rate swaps contracts, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_PrivatelyHeldMedicalDeviceCompanyDevelopedMaraWaterVaporAblationSystemMember_440b0f64-a76d-4fcd-a69c-0b3e3c321ee0_terseLabel_en-US" xlink:label="lab_coo_PrivatelyHeldMedicalDeviceCompanyDevelopedMaraWaterVaporAblationSystemMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Privately-Held Medical Device Company, Developed Mara Water Vapor Ablation System</link:label>
    <link:label id="lab_coo_PrivatelyHeldMedicalDeviceCompanyDevelopedMaraWaterVaporAblationSystemMember_label_en-US" xlink:label="lab_coo_PrivatelyHeldMedicalDeviceCompanyDevelopedMaraWaterVaporAblationSystemMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Privately-Held Medical Device Company, Developed Mara Water Vapor Ablation System [Member]</link:label>
    <link:label id="lab_coo_PrivatelyHeldMedicalDeviceCompanyDevelopedMaraWaterVaporAblationSystemMember_documentation_en-US" xlink:label="lab_coo_PrivatelyHeldMedicalDeviceCompanyDevelopedMaraWaterVaporAblationSystemMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Privately-Held Medical Device Company, Developed Mara Water Vapor Ablation System</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PrivatelyHeldMedicalDeviceCompanyDevelopedMaraWaterVaporAblationSystemMember" xlink:href="coo-20221031.xsd#coo_PrivatelyHeldMedicalDeviceCompanyDevelopedMaraWaterVaporAblationSystemMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_PrivatelyHeldMedicalDeviceCompanyDevelopedMaraWaterVaporAblationSystemMember" xlink:to="lab_coo_PrivatelyHeldMedicalDeviceCompanyDevelopedMaraWaterVaporAblationSystemMember" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost_2915978d-8751-48e2-90da-516b6bf24b02_terseLabel_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Cost</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost_label_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Service Cost</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost_documentation_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" xlink:href="coo-20221031.xsd#coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" xlink:to="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_09ef1f1d-63f8-4071-b498-1bb7707e954e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess tax benefits from share-based compensation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_1b78bc6a-b91a-4789-9ce7-4ac3f8ceef9f_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7be8631f-2fef-4dfd-b6af-89f7c1d67a41_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ce23a528-e986-4afd-a7dc-711eb795e24a_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_4fa83103-4138-478c-a459-dd28126ed92f_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_72945cba-f352-4b75-bfb2-7513f0b28598_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_ba561f32-aa7e-45bf-97a0-a6b251861f27_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average repurchase price per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0beb7fb2-f2a7-4f45-9c13-1e8679dee357_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_8c989943-6046-4605-b455-b92e5d586ce9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_82fa3f45-4f90-43be-b172-dad884f03bd9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_GeographyEliminationsMember_65b51796-744b-4182-b6af-69f466d7d617_terseLabel_en-US" xlink:label="lab_srt_GeographyEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geography Eliminations</link:label>
    <link:label id="lab_srt_GeographyEliminationsMember_label_en-US" xlink:label="lab_srt_GeographyEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geography Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_GeographyEliminationsMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_GeographyEliminationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_GeographyEliminationsMember" xlink:to="lab_srt_GeographyEliminationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_d322bb59-0a84-4065-bfe5-68235b3fc095_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Derivatives and Hedging</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d21666b7-f519-43de-89c8-2e7aa0d29742_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5033dfe0-4675-4ded-b895-4b252e4fa8be_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_5b18eb32-f546-4ef2-bd9e-942d0297fbb8_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_6d0214a5-fafc-4014-88f0-0b0dfbb67185_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0129e5ee-bd1c-40bb-81c1-1c7a8e353d5d_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_24366561-ed75-4b34-803d-2bd9c3776c4e_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_32fa740b-46d8-4a38-99a5-67707ff09b2a_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortizationPeriod_6b2ab44c-08d5-41d4-b845-33569352868f_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized contract cost, amortization period (or less)</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortizationPeriod_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:to="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_935d98ed-2ac5-49a6-b1c2-6aabde89935c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables incurred in acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_1c5fb25c-b4a9-4e8d-ac0b-906cab36c6c3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_BusinessAcquisitionAndAssetAcquisitionDomain_2341ce59-2cfe-4e93-8f55-02546bf4b3d3_terseLabel_en-US" xlink:label="lab_coo_BusinessAcquisitionAndAssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition And Asset Acquisition [Domain]</link:label>
    <link:label id="lab_coo_BusinessAcquisitionAndAssetAcquisitionDomain_label_en-US" xlink:label="lab_coo_BusinessAcquisitionAndAssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition And Asset Acquisition [Domain]</link:label>
    <link:label id="lab_coo_BusinessAcquisitionAndAssetAcquisitionDomain_documentation_en-US" xlink:label="lab_coo_BusinessAcquisitionAndAssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Business Acquisition And Asset Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessAcquisitionAndAssetAcquisitionDomain" xlink:href="coo-20221031.xsd#coo_BusinessAcquisitionAndAssetAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_BusinessAcquisitionAndAssetAcquisitionDomain" xlink:to="lab_coo_BusinessAcquisitionAndAssetAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_615423e6-a2ba-465c-8090-444b424d32db_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_TermLoanFacility2021AdjustedLIBORateLoansMember_4922f0d8-f557-4c3e-81c2-d54eed50d795_terseLabel_en-US" xlink:label="lab_coo_TermLoanFacility2021AdjustedLIBORateLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility 2021, Adjusted LIBO Rate Loans</link:label>
    <link:label id="lab_coo_TermLoanFacility2021AdjustedLIBORateLoansMember_label_en-US" xlink:label="lab_coo_TermLoanFacility2021AdjustedLIBORateLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility 2021, Adjusted LIBO Rate Loans [Member]</link:label>
    <link:label id="lab_coo_TermLoanFacility2021AdjustedLIBORateLoansMember_documentation_en-US" xlink:label="lab_coo_TermLoanFacility2021AdjustedLIBORateLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility 2021, Adjusted LIBO Rate Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanFacility2021AdjustedLIBORateLoansMember" xlink:href="coo-20221031.xsd#coo_TermLoanFacility2021AdjustedLIBORateLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_TermLoanFacility2021AdjustedLIBORateLoansMember" xlink:to="lab_coo_TermLoanFacility2021AdjustedLIBORateLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_2421204a-0b9d-460d-8426-c793e121b348_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_56b26c2f-75b4-47ba-84f5-470b8e939712_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_63c44d27-5d4e-4237-89c9-e1b2ab983e66_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_91ecf294-9db4-4a48-a46f-ca70a330eba4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_c6915775-fd87-4358-8a2d-03af0c205248_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_RestOfTheWorldMember_46690fc0-a4f4-404a-acc7-476cb57d54d9_terseLabel_en-US" xlink:label="lab_coo_RestOfTheWorldMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World</link:label>
    <link:label id="lab_coo_RestOfTheWorldMember_label_en-US" xlink:label="lab_coo_RestOfTheWorldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest Of The World [Member]</link:label>
    <link:label id="lab_coo_RestOfTheWorldMember_documentation_en-US" xlink:label="lab_coo_RestOfTheWorldMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest Of The World [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_RestOfTheWorldMember" xlink:href="coo-20221031.xsd#coo_RestOfTheWorldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_RestOfTheWorldMember" xlink:to="lab_coo_RestOfTheWorldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_79b341b1-cfa8-40e9-a261-33990c7e2649_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_b57359be-d883-4283-b291-a229b9edcc12_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_PayablesThirdInstallmentMember_b1f5ff11-8b1d-45a9-a823-c32d76995907_terseLabel_en-US" xlink:label="lab_coo_PayablesThirdInstallmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables Third Installment</link:label>
    <link:label id="lab_coo_PayablesThirdInstallmentMember_label_en-US" xlink:label="lab_coo_PayablesThirdInstallmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables Third Installment [Member]</link:label>
    <link:label id="lab_coo_PayablesThirdInstallmentMember_documentation_en-US" xlink:label="lab_coo_PayablesThirdInstallmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables Third Installment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PayablesThirdInstallmentMember" xlink:href="coo-20221031.xsd#coo_PayablesThirdInstallmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_PayablesThirdInstallmentMember" xlink:to="lab_coo_PayablesThirdInstallmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_07fe6c37-c5ed-4e84-82fe-76601d254cd0_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a7aa11c9-a2bf-444a-bc8e-4bd7994dded3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f000b2fc-abc6-44e1-95b2-c5f5f7ef9dc9_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_a9fb9a9b-3c65-424e-946f-13d7e73b5f14_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation expense and related income tax benefit for share-based awards</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_IncreaseDecreaseInContingentConsiderationLiability_dc2cfc45-9555-4d8b-9113-191ae5262207_terseLabel_en-US" xlink:label="lab_coo_IncreaseDecreaseInContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement of contingent consideration</link:label>
    <link:label id="lab_coo_IncreaseDecreaseInContingentConsiderationLiability_label_en-US" xlink:label="lab_coo_IncreaseDecreaseInContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Contingent Consideration Liability</link:label>
    <link:label id="lab_coo_IncreaseDecreaseInContingentConsiderationLiability_documentation_en-US" xlink:label="lab_coo_IncreaseDecreaseInContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Contingent Consideration Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_IncreaseDecreaseInContingentConsiderationLiability" xlink:href="coo-20221031.xsd#coo_IncreaseDecreaseInContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_IncreaseDecreaseInContingentConsiderationLiability" xlink:to="lab_coo_IncreaseDecreaseInContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_31a6fa86-db59-4ad5-a840-005c4526e062_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_521e999f-2fa9-4b93-b12e-c5943c25c623_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_c77d662c-27ba-4b57-9926-500850a2a060_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_CreditAgreement2020Member_e0307ea6-e9c7-41b9-9a13-ebb3e0bba5e8_terseLabel_en-US" xlink:label="lab_coo_CreditAgreement2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement 2020</link:label>
    <link:label id="lab_coo_CreditAgreement2020Member_label_en-US" xlink:label="lab_coo_CreditAgreement2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement 2020 [Member]</link:label>
    <link:label id="lab_coo_CreditAgreement2020Member_documentation_en-US" xlink:label="lab_coo_CreditAgreement2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CreditAgreement2020Member" xlink:href="coo-20221031.xsd#coo_CreditAgreement2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_CreditAgreement2020Member" xlink:to="lab_coo_CreditAgreement2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_82951879-4d2e-4632-9b12-c04bfff59358_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_f463477a-7bb9-4330-a00e-a8497ed909e0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_4d7907fa-7d65-4062-9fca-e5374631e27b_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_28a33899-342d-4755-a3dd-029cccb60098_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e8dd1bf7-52e6-4463-8a2a-0dba4ab2fe42_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_fc23920b-01cd-443b-ac06-3bb8cd0a8325_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_49846340-2c15-4487-b38c-edefc57be965_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_14e2e0e0-41db-431b-a6d5-fc99dae4c037_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_d0b6bec8-e029-4791-826b-417de4904154_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and exercisable at end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_e3c031ba-6a70-4fad-bd15-e4170c562440_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes:</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_76294db0-592c-4e4d-98d8-f181769520bc_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of business acquisition, pro forma information</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_d672f736-93a4-40c1-8415-77f5c09aa23c_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_11f0f426-397b-4990-afb4-692e2b3555d2_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining amortization expenses for intangible assets with definite lives</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_5891b676-a056-4a20-b282-d0a159f58e45_terseLabel_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_label_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_us-gaap_PlanAssetCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c6803187-2401-4300-9478-156a0db850da_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_243c3672-eab8-4163-aae7-6c5a197fafd7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedAndAssetAcquisitionsTableTextBlock_5da6f33d-a44c-4e74-8e47-da035c7a004b_terseLabel_en-US" xlink:label="lab_coo_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedAndAssetAcquisitionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total purchase consideration for business and asset acquisitions</link:label>
    <link:label id="lab_coo_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedAndAssetAcquisitionsTableTextBlock_label_en-US" xlink:label="lab_coo_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedAndAssetAcquisitionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Recognized Identified Assets Acquired And Liabilities Assumed And Asset Acquisitions [Table Text Block]</link:label>
    <link:label id="lab_coo_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedAndAssetAcquisitionsTableTextBlock_documentation_en-US" xlink:label="lab_coo_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedAndAssetAcquisitionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Recognized Identified Assets Acquired And Liabilities Assumed And Asset Acquisitions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedAndAssetAcquisitionsTableTextBlock" xlink:href="coo-20221031.xsd#coo_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedAndAssetAcquisitionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedAndAssetAcquisitionsTableTextBlock" xlink:to="lab_coo_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedAndAssetAcquisitionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_b24fb942-63de-48ca-8e32-992a90a0b625_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_6b03c022-f02d-4338-9c1a-458263681b59_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_18cb1845-8368-4220-89bc-5cbcfa7129ce_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest at end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit_81936c83-b3d0-46ad-a371-dc1168076fb7_terseLabel_en-US" xlink:label="lab_coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential additional borrowing capacity</link:label>
    <link:label id="lab_coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit_label_en-US" xlink:label="lab_coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Accordion Feature, Increase Limit</link:label>
    <link:label id="lab_coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit_documentation_en-US" xlink:label="lab_coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Accordion Feature, Increase Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:href="coo-20221031.xsd#coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:to="lab_coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_ab273ece-de5a-4cc1-9e90-a39f76ab5c13_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_4070ecc1-fc9e-4dbb-b86f-ec032e260603_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_BusinessCombinationAndAssetAcquisitionTextBlock_a94bdbb7-05e0-4dce-9f5f-bcd452f9679e_terseLabel_en-US" xlink:label="lab_coo_BusinessCombinationAndAssetAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and Joint Venture</link:label>
    <link:label id="lab_coo_BusinessCombinationAndAssetAcquisitionTextBlock_label_en-US" xlink:label="lab_coo_BusinessCombinationAndAssetAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination And Asset Acquisition [Text Block]</link:label>
    <link:label id="lab_coo_BusinessCombinationAndAssetAcquisitionTextBlock_documentation_en-US" xlink:label="lab_coo_BusinessCombinationAndAssetAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination And Asset Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationAndAssetAcquisitionTextBlock" xlink:href="coo-20221031.xsd#coo_BusinessCombinationAndAssetAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_BusinessCombinationAndAssetAcquisitionTextBlock" xlink:to="lab_coo_BusinessCombinationAndAssetAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_72947cd1-c4bd-4fa7-b2a7-b909710d5b03_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_adef21d5-bfcd-45df-b1dc-3c5280792e21_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_de37603a-ddeb-4b02-b511-c400bf9ddcca_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember_d923b6eb-fd86-45d5-9d7a-bbca9bb4e3a1_terseLabel_en-US" xlink:label="lab_coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Before Tax, Parent</link:label>
    <link:label id="lab_coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember_label_en-US" xlink:label="lab_coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Before Tax, Parent [Member]</link:label>
    <link:label id="lab_coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember_documentation_en-US" xlink:label="lab_coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Before Tax, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember" xlink:href="coo-20221031.xsd#coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember" xlink:to="lab_coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_7a4b0e1d-dfd0-43b2-b3df-76809d343d16_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill (Note 4)</link:label>
    <link:label id="lab_us-gaap_Goodwill_d0103386-3148-4898-a8e8-97ec8811f51e_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_325bca46-0c32-40f0-bd6a-2df4521edeea_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning</link:label>
    <link:label id="lab_us-gaap_Goodwill_0fca1526-c534-4519-8765-070c60ab71ce_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, ending</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6052a6e6-5e55-40e2-8a81-e99db251b14c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_8e3869ba-341a-44ce-8889-a016fdb17e54_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsCurrentNet_5899e5f4-0188-4b1f-ae65-09369cfb2edf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsCurrentNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: unamortized debt issuance cost</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsCurrentNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsCurrentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Current, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsCurrentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsCurrentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsCurrentNet" xlink:to="lab_us-gaap_DeferredFinanceCostsCurrentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityFundsMember_7864b686-b9a6-4006-8843-64bf47116462_terseLabel_en-US" xlink:label="lab_us-gaap_EquityFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity mutual funds</link:label>
    <link:label id="lab_us-gaap_EquityFundsMember_label_en-US" xlink:label="lab_us-gaap_EquityFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityFundsMember" xlink:to="lab_us-gaap_EquityFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_ea076cd8-8110-49e9-aa04-a050f4e35cbf_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes (Note 6)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_10d64a31-6ac3-44d7-ae6b-9f1eac514f93_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_82c7a7c6-8b54-45f0-866c-085c848f2c2d_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_9f96a045-91dc-4bd8-8779-558f810ccebc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_cd3b4632-9433-4109-ae0a-6f8143b95e69_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_ff950df4-a313-47c3-8a61-5b43479e1386_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_AssetAquisitionAxis_2fa4884b-362c-47cd-81d3-d79216ca85d4_terseLabel_en-US" xlink:label="lab_coo_AssetAquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Aquisition [Axis]</link:label>
    <link:label id="lab_coo_AssetAquisitionAxis_label_en-US" xlink:label="lab_coo_AssetAquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Aquisition [Axis]</link:label>
    <link:label id="lab_coo_AssetAquisitionAxis_documentation_en-US" xlink:label="lab_coo_AssetAquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Aquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AssetAquisitionAxis" xlink:href="coo-20221031.xsd#coo_AssetAquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_AssetAquisitionAxis" xlink:to="lab_coo_AssetAquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_9f764dd9-56d8-4741-b588-dc91138a5ae3_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember_e50db00b-0b42-4abc-b380-6b93e112f067_terseLabel_en-US" xlink:label="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Assumptions For Defined Benefit Plans, Change In Key Assumptions</link:label>
    <link:label id="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember_label_en-US" xlink:label="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Assumptions For Defined Benefit Plans, Change In Key Assumptions [Member]</link:label>
    <link:label id="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember_documentation_en-US" xlink:label="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Assumptions For Defined Benefit Plans, Change In Key Assumptions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember" xlink:href="coo-20221031.xsd#coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember" xlink:to="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_db25a7d0-c359-44e3-865e-8102f5035d5a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalUseSoftwarePolicy_4b843c52-c200-455b-8f84-fd4576e3644c_terseLabel_en-US" xlink:label="lab_us-gaap_InternalUseSoftwarePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cloud Computing Arrangements</link:label>
    <link:label id="lab_us-gaap_InternalUseSoftwarePolicy_label_en-US" xlink:label="lab_us-gaap_InternalUseSoftwarePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Use Software, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalUseSoftwarePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalUseSoftwarePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalUseSoftwarePolicy" xlink:to="lab_us-gaap_InternalUseSoftwarePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_cf5d8f99-9f05-4ee3-9f06-eda2fe450209_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_18f77283-b04c-42b0-9e46-74a84232a56e_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $10 cents par value, 120.0 shares authorized, 53.8 issued and 49.3 outstanding at October&#160;31, 2022 and 53.7 issued and 49.3 outstanding at October&#160;31, 2021</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_1c09b44e-7174-4cb3-959a-d8f20b7e0f34_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_4df39025-c7ef-47bf-a864-a61b9981d6d4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_8e0a6e03-05d7-46ff-92e5-7e4659f59f2a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options to purchase common stock and restricted stock units not included in diluted earnings per share calculation due to antidilutive effect</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_49d908d3-ff39-4ab2-8e25-2b5a6df553ae_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_933c684d-6be5-4bd9-b33b-18ef5f22aa8f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8d60126d-2320-419b-b261-7493f5cbc278_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, restricted cash and cash held for sale at beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ee508ee8-49c7-4a6d-b2ac-3b585fe49353_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_811d164c-67e5-4d7a-ab6c-85eb18224b40_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents, restricted cash and cash held for sale</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_461e5588-d3d5-47a3-9af7-1e9e537002b1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_537b0669-3202-4c06-8518-b49377be59df_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_fc1fcd84-1a26-4ffb-aba0-aaf6dc6bfe0a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_50889149-647a-4106-ae93-bfdd2c365b33_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price contingent consideration</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_cebd9cdc-d445-481a-a29f-f881e0289a7f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest at end of period, Weighted-Average Remaining Contractual Term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_ab12abf4-e494-4690-9938-81389e6a4fc6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_048f9af9-2937-4ca7-b853-8a6b4d9bd6be_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_ca929d31-8c3c-4660-a1e5-f16fa17436cc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable_bb7f3d8a-30d7-4e03-a95a-c2320a369ff5_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Allocation [Table]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Allocation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation_d25ee550-9b1c-4f96-9017-639e8fc803cb_terseLabel_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation_d2edf6f9-8737-4281-adb2-bc503fc5eaff_verboseLabel_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected Benefit Obligation</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation_label_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Projected Benefit Obligation</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation_documentation_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Projected Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation" xlink:href="coo-20221031.xsd#coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation" xlink:to="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_24343d87-25dc-410c-aad4-5a6f1a95e71e_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_e52f4ed9-313f-4085-8969-c6625e08145c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9d5bcb1e-875c-43b3-89a8-f11c9ec036c9_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Amortization Period (in years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_523afd1a-6c7b-46f9-857c-8b7c58a514f6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_7cf07df1-8d62-4a36-8364-4bd5b76f6ec0_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5f6d8098-a433-440a-8a4e-9b4a8d5ce92e_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_00f05b5a-b8e7-479b-b985-07bd6b2e35e0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_1461b05d-2eb2-4370-953b-2f71c2c3be8b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_73009af1-6f15-44bf-956c-c42c4dbd1637_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_c49dce09-808d-4faa-bca7-24f4043b0e7f_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_8ecbcb2d-f6a0-4713-97ca-69fab8d07851_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other changes in plan assets and benefit obligations recognized in other comprehensive income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4b16ab38-69b1-409a-b363-cba539d1a8c9_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_a11a32cd-7cbe-46b0-a002-117d0c33151c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_c5e48afd-d2c6-41f5-a52d-17a1eaa8a99d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ef30dd78-ef4d-4655-bafe-b3b2caf794b7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0566954f-a934-4898-88dc-89110f8e7200_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and exercisable at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_6e0bf4d1-2c67-4335-84b6-9d6b16dabe3a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price percentage of fair market value on date of grant of awards</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a2b54032-e2ab-4c5b-9cdc-77d0a53c7a9b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_9db4a449-a991-4b52-be3d-0a8394f4c3ce_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments recognized in condensed consolidated statements of income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_78ca58e7-a98e-4963-b908-80a8c87befa1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangibles</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_139fc611-6644-4cf9-a959-99f807682427_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_59aa9741-5ab9-419f-8828-ff918eadc58b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number&#160;of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_078dc0b4-46c3-4ba8-8fac-b36511c75f63_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_76447749-7bc6-4633-ac2a-9fe859603758_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_29cc28a3-e5c0-4906-b44c-b8e43a324978_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_e63f533e-d875-4543-b215-04836175f4dd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in minimum pension liability, net of tax of $8.7, $7.2 and $(4.0), respectively</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_a80b312a-63cd-4675-8750-f47024190f3e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_RevolvingCreditFacilityAndTermLoanFacility2020Member_cf2d2b87-8962-4a72-a23a-2ad98e892cd5_terseLabel_en-US" xlink:label="lab_coo_RevolvingCreditFacilityAndTermLoanFacility2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility And Term Loan Facility 2020</link:label>
    <link:label id="lab_coo_RevolvingCreditFacilityAndTermLoanFacility2020Member_label_en-US" xlink:label="lab_coo_RevolvingCreditFacilityAndTermLoanFacility2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility And Term Loan Facility 2020 [Member]</link:label>
    <link:label id="lab_coo_RevolvingCreditFacilityAndTermLoanFacility2020Member_documentation_en-US" xlink:label="lab_coo_RevolvingCreditFacilityAndTermLoanFacility2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility And Term Loan Facility 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_RevolvingCreditFacilityAndTermLoanFacility2020Member" xlink:href="coo-20221031.xsd#coo_RevolvingCreditFacilityAndTermLoanFacility2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_RevolvingCreditFacilityAndTermLoanFacility2020Member" xlink:to="lab_coo_RevolvingCreditFacilityAndTermLoanFacility2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_f1050695-8a0b-4748-a6a9-1673bb94642c_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember_09a524b0-b43c-4600-8d52-2ad842cff578_terseLabel_en-US" xlink:label="lab_coo_SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series Of Individually Immaterial Business Acquisitions And Asset Acquisitions</link:label>
    <link:label id="lab_coo_SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember_label_en-US" xlink:label="lab_coo_SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series Of Individually Immaterial Business Acquisitions And Asset Acquisitions [Member]</link:label>
    <link:label id="lab_coo_SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember_documentation_en-US" xlink:label="lab_coo_SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series Of Individually Immaterial Business Acquisitions And Asset Acquisitions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember" xlink:href="coo-20221031.xsd#coo_SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember" xlink:to="lab_coo_SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_856bf906-2967-4379-b96e-fd8ea4ff8e84_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_074f06f3-b6aa-459e-b7fb-39f7324cbb2a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax deductible goodwill</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet_dc31dcf5-d338-4659-93aa-f8b1b9f36d67_terseLabel_en-US" xlink:label="lab_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net tangible liabilities</link:label>
    <link:label id="lab_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet_label_en-US" xlink:label="lab_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination And Asset Acquisition, Recognized Identifiable Assets Acquired And Liabilities Assumed, Tangible Assets (Liabilities), Net</link:label>
    <link:label id="lab_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet_documentation_en-US" xlink:label="lab_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination And Asset Acquisition, Recognized Identifiable Assets Acquired And Liabilities Assumed, Tangible Assets (Liabilities), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet" xlink:href="coo-20221031.xsd#coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet" xlink:to="lab_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d0d3dc57-e179-4ba7-80e2-919332945128_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_91305975-0818-46d3-a53c-6baf0a2b5a3f_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_OverdraftAndOtherCreditFacilitiesMember_0c5e3159-5ab4-4ce4-b440-bf96e9e3818c_terseLabel_en-US" xlink:label="lab_coo_OverdraftAndOtherCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Overdraft and other credit facilities</link:label>
    <link:label id="lab_coo_OverdraftAndOtherCreditFacilitiesMember_label_en-US" xlink:label="lab_coo_OverdraftAndOtherCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Overdraft And Other Credit Facilities [Member]</link:label>
    <link:label id="lab_coo_OverdraftAndOtherCreditFacilitiesMember_documentation_en-US" xlink:label="lab_coo_OverdraftAndOtherCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Overdraft And Other Credit Facilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_OverdraftAndOtherCreditFacilitiesMember" xlink:href="coo-20221031.xsd#coo_OverdraftAndOtherCreditFacilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_OverdraftAndOtherCreditFacilitiesMember" xlink:to="lab_coo_OverdraftAndOtherCreditFacilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c50fc806-79dd-4552-8cab-9a3c325fd66d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_CoopersurgicalSegmentMember_c4c7d151-c1fc-4152-96e1-47bc72871ca0_terseLabel_en-US" xlink:label="lab_coo_CoopersurgicalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CooperSurgical</link:label>
    <link:label id="lab_coo_CoopersurgicalSegmentMember_label_en-US" xlink:label="lab_coo_CoopersurgicalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coopersurgical Segment [Member]</link:label>
    <link:label id="lab_coo_CoopersurgicalSegmentMember_documentation_en-US" xlink:label="lab_coo_CoopersurgicalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coopersurgical Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CoopersurgicalSegmentMember" xlink:href="coo-20221031.xsd#coo_CoopersurgicalSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_CoopersurgicalSegmentMember" xlink:to="lab_coo_CoopersurgicalSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_230b8027-3e6d-4c14-b7fc-7313ac042f62_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_30e277dc-c9b4-4e19-af22-32b964fe74ac_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ReportableGeographicalComponentsMember_a2f762e7-923b-4e80-bdb1-7c184c9d7773_terseLabel_en-US" xlink:label="lab_srt_ReportableGeographicalComponentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reportable Geographical Components</link:label>
    <link:label id="lab_srt_ReportableGeographicalComponentsMember_label_en-US" xlink:label="lab_srt_ReportableGeographicalComponentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reportable Geographical Components [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReportableGeographicalComponentsMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReportableGeographicalComponentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ReportableGeographicalComponentsMember" xlink:to="lab_srt_ReportableGeographicalComponentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_7d1627b3-0e80-4b19-b523-f0913a807bb0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_21c1513b-8693-41ac-b17e-d5f398092a6a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired_6a7c099d-2124-4840-a4e3-a692f8c82140_negatedLabel_en-US" xlink:label="lab_coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions of businesses and assets, net of cash acquired</link:label>
    <link:label id="lab_coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired_label_en-US" xlink:label="lab_coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire Businesses And Assets, Net Of Cash Acquired</link:label>
    <link:label id="lab_coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired_documentation_en-US" xlink:label="lab_coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire Businesses And Assets, Net Of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired" xlink:href="coo-20221031.xsd#coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired" xlink:to="lab_coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_2a6db3a8-8862-4716-8b5e-29b51b3e983c_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_e1e2f753-1d7d-4de2-b575-25d4d6c243a3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of net periodic pension costs and other amounts recognized in other comprehensive income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability_fcb1556b-02c6-411d-9802-65310c70ebcc_terseLabel_en-US" xlink:label="lab_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability_label_en-US" xlink:label="lab_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Operating Lease, Liability</link:label>
    <link:label id="lab_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability_documentation_en-US" xlink:label="lab_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability" xlink:href="coo-20221031.xsd#coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability" xlink:to="lab_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_c8fab2ee-fe59-4c7f-90ae-ac0cd1323134_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionTable_70b59a6b-e23d-4ed7-8e4f-dbd4cc7dd107_terseLabel_en-US" xlink:label="lab_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Business Acquisitions And Asset Acquisition, By Acquisition [Table]</link:label>
    <link:label id="lab_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionTable_label_en-US" xlink:label="lab_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Business Acquisitions And Asset Acquisition, By Acquisition [Table]</link:label>
    <link:label id="lab_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionTable_documentation_en-US" xlink:label="lab_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Business Acquisitions And Asset Acquisition, By Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionTable" xlink:href="coo-20221031.xsd#coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionTable" xlink:to="lab_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_CookMedicalsReproductiveHealthBusinessMember_2cd1dd79-91fd-456f-8edb-70427bf9865b_terseLabel_en-US" xlink:label="lab_coo_CookMedicalsReproductiveHealthBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cook Medicals Reproductive Health Business</link:label>
    <link:label id="lab_coo_CookMedicalsReproductiveHealthBusinessMember_label_en-US" xlink:label="lab_coo_CookMedicalsReproductiveHealthBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cook Medicals Reproductive Health Business [Member]</link:label>
    <link:label id="lab_coo_CookMedicalsReproductiveHealthBusinessMember_documentation_en-US" xlink:label="lab_coo_CookMedicalsReproductiveHealthBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cook Medicals Reproductive Health Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CookMedicalsReproductiveHealthBusinessMember" xlink:href="coo-20221031.xsd#coo_CookMedicalsReproductiveHealthBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_CookMedicalsReproductiveHealthBusinessMember" xlink:to="lab_coo_CookMedicalsReproductiveHealthBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_176d65db-8d64-4098-aa48-9a3099f3e50c_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset allocation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_7cfeb0a3-2cc1-4715-bde1-a9ae97e737df_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related income tax benefit</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_ebe45279-381b-444f-9ec3-11cc69cbc053_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_56cea34d-6ad0-47b5-9bec-fd8a3662eb53_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_5658b17a-3503-421b-aace-c849d2c743e7_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4a95d5ec-d955-4f58-8ba8-82437ec55272_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_6ff230d7-13c6-4ac0-8972-9e80a8f5e29e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_42e2fe00-79b4-4e99-9387-f40da695476b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average assumptions used in computing net periodic pension cost and projected benefit obligation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_5684bc31-2857-4797-a6bc-5599df43f896_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_4fd999d9-7a2d-4c32-bb1f-ce77ca7eea7b_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expense</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_65a54cf3-aa49-4647-a67d-8e2964fd2004_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_af716706-0818-4295-9b47-02be444f9d31_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or expired (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_724515d5-1a05-42b2-9ade-3ea290d724c5_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares used to compute earnings per share:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_a6e81c75-53b6-4a28-80a9-fb4969c64709_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories (Note 1)</link:label>
    <link:label id="lab_us-gaap_InventoryNet_bb462a48-fb5a-44cc-8def-690af65283ac_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_4420812b-eab9-4cd3-acb8-5950c1b187ad_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_e4ab60b3-7001-4efd-a8e3-cd4fe8a5c05e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_87b0c99c-ddcc-4f52-9819-bbc04f6ba564_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest at end of period, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_CommonStockExcludingTreasuryStockParNetValueMember_14eba8f6-41b3-45c0-a622-4650929ea3fe_terseLabel_en-US" xlink:label="lab_coo_CommonStockExcludingTreasuryStockParNetValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Shares</link:label>
    <link:label id="lab_coo_CommonStockExcludingTreasuryStockParNetValueMember_label_en-US" xlink:label="lab_coo_CommonStockExcludingTreasuryStockParNetValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Excluding Treasury Stock Par Net Value [Member]</link:label>
    <link:label id="lab_coo_CommonStockExcludingTreasuryStockParNetValueMember_documentation_en-US" xlink:label="lab_coo_CommonStockExcludingTreasuryStockParNetValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Excluding Treasury Stock Par Net Value [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CommonStockExcludingTreasuryStockParNetValueMember" xlink:href="coo-20221031.xsd#coo_CommonStockExcludingTreasuryStockParNetValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_CommonStockExcludingTreasuryStockParNetValueMember" xlink:to="lab_coo_CommonStockExcludingTreasuryStockParNetValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_TermLoanFacility2021Member_77a3b615-92dc-4999-bda5-197c7ceb0429_terseLabel_en-US" xlink:label="lab_coo_TermLoanFacility2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility 2021</link:label>
    <link:label id="lab_coo_TermLoanFacility2021Member_label_en-US" xlink:label="lab_coo_TermLoanFacility2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility 2021 [Member]</link:label>
    <link:label id="lab_coo_TermLoanFacility2021Member_documentation_en-US" xlink:label="lab_coo_TermLoanFacility2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanFacility2021Member" xlink:href="coo-20221031.xsd#coo_TermLoanFacility2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_TermLoanFacility2021Member" xlink:to="lab_coo_TermLoanFacility2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_69e64a72-d39c-439b-a6b4-c74fbfd2c78e_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_96dbd067-1956-4b6f-bdd0-10ebb16abef9_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInAssumedPaymentFormElectionProbabilitiesMember_d879db5b-9f4b-4e50-a8ce-22b37b663797_terseLabel_en-US" xlink:label="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInAssumedPaymentFormElectionProbabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Assumptions For Defined Benefit Plans, Change In Assumed Payment Form Election Probabilities</link:label>
    <link:label id="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInAssumedPaymentFormElectionProbabilitiesMember_label_en-US" xlink:label="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInAssumedPaymentFormElectionProbabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Assumptions For Defined Benefit Plans, Change In Assumed Payment Form Election Probabilities [Member]</link:label>
    <link:label id="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInAssumedPaymentFormElectionProbabilitiesMember_documentation_en-US" xlink:label="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInAssumedPaymentFormElectionProbabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Assumptions For Defined Benefit Plans, Change In Assumed Payment Form Election Probabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInAssumedPaymentFormElectionProbabilitiesMember" xlink:href="coo-20221031.xsd#coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInAssumedPaymentFormElectionProbabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInAssumedPaymentFormElectionProbabilitiesMember" xlink:to="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInAssumedPaymentFormElectionProbabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_8e2cda29-fbae-433b-87d3-0bc8e92db551_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, ownership percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_54401001-7228-43ee-a2ae-b97f93a95f44_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_9268e2c2-31cb-42a7-9d75-3735fa70b22b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diversified portfolio, allocation of assets in equities</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_fa9b01b9-b5ad-4958-9616-5409db371cc9_terseLabel_en-US" xlink:label="lab_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long Term and Short Term Debt Instruments [Table]</link:label>
    <link:label id="lab_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_label_en-US" xlink:label="lab_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long Term And Short Term Debt Instruments [Table]</link:label>
    <link:label id="lab_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_documentation_en-US" xlink:label="lab_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long Term And Short Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable" xlink:href="coo-20221031.xsd#coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable" xlink:to="lab_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_318ac2fa-d19e-405d-a741-b6468e24c430_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_1a8cd282-154a-45f9-b1a2-4adf607aaf8a_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $10 cents par value, 1.0 shares authorized, zero shares issued or outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_3cae57c5-bfa8-4f3f-b31c-e78c632a0bb9_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_f7d90d39-bf59-4312-a63b-8dd476a0dd0e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_cb874f48-0a9f-46d1-89d5-8e9994d8ae98_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_e9628a05-21ab-465a-a62c-d2200b8d989e_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-Known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_2f1267b4-06ef-4cd1-89ae-f7dc73ca4e30_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_25296742-9eaf-4b66-98e2-fd204f562a5d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt (Note 5)</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_837fc47d-607f-4bf0-a57b-00f84faf75e5_totalLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_6515980f-b20d-4887-a74f-23eeb732415e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_f67dd58b-8c8c-4b4d-bc39-733c0ff73626_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Unobservable Inputs (Level 3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_a2e3a981-9cf8-4979-8fff-ca3c3b793258_verboseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Plans</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_4a275b1b-2125-4271-9635-ceb8dd88910b_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_447fa4c0-147a-476f-b693-70b69870e825_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_97a7f57e-d2bd-4192-b1cc-b9a2315e1097_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_c2b2e06f-5325-4f6e-843d-d6dd0cc28340_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets and liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock_4716d6bf-e3ea-4181-8023-e95fa889bb86_terseLabel_en-US" xlink:label="lab_coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of prepaid (accrued) pension cost</link:label>
    <link:label id="lab_coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock_label_en-US" xlink:label="lab_coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Reconciliation Of Prepaid (Accrued) Pension Cost [Table Text Block]</link:label>
    <link:label id="lab_coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock_documentation_en-US" xlink:label="lab_coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Reconciliation Of Prepaid (Accrued) Pension Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock" xlink:href="coo-20221031.xsd#coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock" xlink:to="lab_coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_ed3ec3c3-91dd-4399-a955-ede96cab0362_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_72e1994d-cf8c-4398-8567-98a44ad649d6_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_ad3e2cf9-e9dc-41f1-ad82-1c2a8d9eb9e4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_2a5c5a70-a8fb-4b7b-86e9-09fccd138981_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_35283121-3dd9-48af-9970-6c92bd00f2e7_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a29cac37-e7c3-4653-b908-8ad0d1de8f3e_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_97c4e071-8ec8-44e3-837c-d72326428497_terseLabel_en-US" xlink:label="lab_coo_BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total identifiable intangible assets</link:label>
    <link:label id="lab_coo_BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_coo_BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination And Asset Acquisitions, Recognized Identifiable Assets Acquired And Liabilities Assumed, Intangible Assets, Other Than Goodwill</link:label>
    <link:label id="lab_coo_BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_documentation_en-US" xlink:label="lab_coo_BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination And Asset Acquisitions, Recognized Identifiable Assets Acquired And Liabilities Assumed, Intangible Assets, Other Than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="coo-20221031.xsd#coo_BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_coo_BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_5908808b-0d9f-43ce-aa70-08561bb07b82_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Observable Inputs (Level 2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_af057f59-1b55-4360-bc1f-ce93d2f45aaf_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill deductible for tax purposes</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_534c938d-e0f8-43c5-a3ed-0ea854f99a7f_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_SingleUseSphereLensMember_86fd9c31-402c-4b3a-a210-1538e531d14a_terseLabel_en-US" xlink:label="lab_coo_SingleUseSphereLensMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Single-use sphere lens</link:label>
    <link:label id="lab_coo_SingleUseSphereLensMember_label_en-US" xlink:label="lab_coo_SingleUseSphereLensMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Single Use Sphere Lens [Member]</link:label>
    <link:label id="lab_coo_SingleUseSphereLensMember_documentation_en-US" xlink:label="lab_coo_SingleUseSphereLensMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Single Use Sphere Lens [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_SingleUseSphereLensMember" xlink:href="coo-20221031.xsd#coo_SingleUseSphereLensMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_SingleUseSphereLensMember" xlink:to="lab_coo_SingleUseSphereLensMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_82f53b95-f697-413b-812f-db2286aa5ccc_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_607c9ebe-2894-47b5-9fe3-7ce48a4a919a_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangibles, net (Note 4)</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_49901d90-5ece-4367-8358-11c3426623d2_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other intangibles, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_98be9912-07b1-466e-ad42-6700f49072b5_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_bc27f471-2615-41a7-a62f-d4c7ea78bea4_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_1a20e21a-e95e-484c-83b6-0940725900a5_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease ROU assets, net</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, before Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock_dab51fa0-b7ba-411f-8b5d-ad2b44b5c14d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts recognized in accumulated other comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Periodic Benefit Cost Not yet Recognized [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_2a0bc293-35be-4a70-9390-b51619a7db2a_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term tax payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_964b7726-6c5b-43b4-813e-fa9c9016d69c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal net operating losses expiring</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_af68a89e-4349-422a-81a9-a5d88135c68a_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would impact the effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_ef8ee852-501c-42bb-b011-e80515930402_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award expiration date (no more than)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_edc80f1e-f7c2-49fc-b992-cb2d34321b0e_terseLabel_en-US" xlink:label="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Consideration Transferred Liabilities Incurred By Type [Domain]</link:label>
    <link:label id="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_label_en-US" xlink:label="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Consideration Transferred Liabilities Incurred By Type [Domain]</link:label>
    <link:label id="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_documentation_en-US" xlink:label="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Consideration Transferred Liabilities Incurred By Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain" xlink:href="coo-20221031.xsd#coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain" xlink:to="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_41e5f954-a1c7-43c7-bb6f-632c578198a5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range of exercise prices, lower limit (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_3e6ef001-e36c-4b26-9ddd-fe604c9d7c76_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remeasurement of deferred tax assets from UK rate change</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_d6712383-0183-4ca3-b131-ad7668d99f5c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_3ed34ab1-e416-46f3-9614-7d33a2c564e9_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_fbbe8a60-2996-4c05-9cda-5f4a22348e11_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_72a80bde-9992-4c87-8afd-dc8a55f158e8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_4001d6a2-5780-47c5-9101-62b69bf571c2_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_f92129da-79ab-41a2-be52-0f197d31a34c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_5bb929e7-825d-4054-8120-a1b0ab7498a8_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of cash flow information:</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_GainLossOnSaleOfAssetsAndAssetImpairmentChargesAndOther_e822afb5-e2ab-42be-90b7-c1b6f2ac2d2f_negatedTerseLabel_en-US" xlink:label="lab_coo_GainLossOnSaleOfAssetsAndAssetImpairmentChargesAndOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment and loss on disposal of property, plant and equipment, and other</link:label>
    <link:label id="lab_coo_GainLossOnSaleOfAssetsAndAssetImpairmentChargesAndOther_label_en-US" xlink:label="lab_coo_GainLossOnSaleOfAssetsAndAssetImpairmentChargesAndOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Sale Of Assets And Asset Impairment Charges And Other</link:label>
    <link:label id="lab_coo_GainLossOnSaleOfAssetsAndAssetImpairmentChargesAndOther_documentation_en-US" xlink:label="lab_coo_GainLossOnSaleOfAssetsAndAssetImpairmentChargesAndOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Sale Of Assets And Asset Impairment Charges And Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_GainLossOnSaleOfAssetsAndAssetImpairmentChargesAndOther" xlink:href="coo-20221031.xsd#coo_GainLossOnSaleOfAssetsAndAssetImpairmentChargesAndOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_GainLossOnSaleOfAssetsAndAssetImpairmentChargesAndOther" xlink:to="lab_coo_GainLossOnSaleOfAssetsAndAssetImpairmentChargesAndOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_892fe69a-36f2-4a49-8141-6ec90ff4b0e6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and issued (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_ac36f890-e780-4952-991c-07a12a131dbd_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_6d9e5d92-0060-4589-b851-a7528a60157f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized to be granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_TermLoanFacility2020Member_e0d59a05-91b1-4a99-bfe2-0c720f3aa3e3_terseLabel_en-US" xlink:label="lab_coo_TermLoanFacility2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility 2020</link:label>
    <link:label id="lab_coo_TermLoanFacility2020Member_label_en-US" xlink:label="lab_coo_TermLoanFacility2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility 2020 [Member]</link:label>
    <link:label id="lab_coo_TermLoanFacility2020Member_documentation_en-US" xlink:label="lab_coo_TermLoanFacility2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanFacility2020Member" xlink:href="coo-20221031.xsd#coo_TermLoanFacility2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_TermLoanFacility2020Member" xlink:to="lab_coo_TermLoanFacility2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_f47e8b3c-3d87-4949-955b-07e37e6d4893_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_label_en-US" xlink:label="lab_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:to="lab_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_107e9a85-e5a0-45c7-9768-8e8e8c54869b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_9c2275a1-337b-43c3-8c68-b37b93dbdb12_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation between the expected provision for income taxes at the US federal statutory rate and the provision for income taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5634b4c1-e8d7-4d9a-9168-7545810decc3_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_85552e75-b537-4273-a8d9-ffede90f3a3c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_9d6b449d-fe63-440a-9420-7000f8f5b9b0_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_33cc1f09-1d35-4d55-8a0c-d1b1179c7b44_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9af3815d-ac70-41d6-973f-60c807af9ab3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9760784d-6e0a-475b-9f78-b47fcb2d6c34_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_3f336071-9637-48fa-b2d8-5d0fd74625ce_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price to acquire business</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_LicenseAndDistributionRightsAndOtherMember_627eff88-5742-4e1b-86d3-3ed20964cc17_terseLabel_en-US" xlink:label="lab_coo_LicenseAndDistributionRightsAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License and distribution rights and other</link:label>
    <link:label id="lab_coo_LicenseAndDistributionRightsAndOtherMember_label_en-US" xlink:label="lab_coo_LicenseAndDistributionRightsAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License And Distribution Rights And Other [Member]</link:label>
    <link:label id="lab_coo_LicenseAndDistributionRightsAndOtherMember_documentation_en-US" xlink:label="lab_coo_LicenseAndDistributionRightsAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License and Distribution Rights and Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_LicenseAndDistributionRightsAndOtherMember" xlink:href="coo-20221031.xsd#coo_LicenseAndDistributionRightsAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_LicenseAndDistributionRightsAndOtherMember" xlink:to="lab_coo_LicenseAndDistributionRightsAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_7f609e2f-757a-43b3-890d-bb4c7a98f401_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_dd5654ad-7981-4509-bf49-f470803f1cb9_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_44167a3c-9463-4ae9-ac13-6b619f75bdcb_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowingsAbstract_2007cf20-b7aa-49db-b47a-e2dfd786eb2b_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowingsAbstract_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowingsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract" xlink:to="lab_us-gaap_ShortTermBorrowingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_647e77f5-dabc-474a-8a91-ce15f7a20c84_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate</link:label>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_f84cf0d2-e58b-4b46-b207-119bbad2edbc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_NumberOfBusinessUnits_6a44c965-d655-4322-8bee-f51229f54828_terseLabel_en-US" xlink:label="lab_coo_NumberOfBusinessUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of business units</link:label>
    <link:label id="lab_coo_NumberOfBusinessUnits_label_en-US" xlink:label="lab_coo_NumberOfBusinessUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Business Units</link:label>
    <link:label id="lab_coo_NumberOfBusinessUnits_documentation_en-US" xlink:label="lab_coo_NumberOfBusinessUnits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Business Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_NumberOfBusinessUnits" xlink:href="coo-20221031.xsd#coo_NumberOfBusinessUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_NumberOfBusinessUnits" xlink:to="lab_coo_NumberOfBusinessUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_8d89a0a8-d519-47e8-bb60-154fa7b0ce13_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_ee23e0fc-aebc-48fa-9a9a-c7757b23a2b9_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of short-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_bdeb4edb-d274-4886-805b-48c7624d545e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_21f673f0-79f2-4841-93e7-a775045665bb_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to form joint venture</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d74efd32-a4e4-40a3-a3ed-7edbe9b6b101_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average fair value of each option granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_c997ad4e-d8ab-4ede-aad5-49c9049c48da_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_041b3942-1b2d-4bc6-ad41-c48d101525c0_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d6d60b1f-aa35-4d84-86f0-0accc491216f_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTermOfContract_7de21f32-a8c9-443c-859e-c34ae019b5bb_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTermOfContract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap contracts, contract term (or less)</link:label>
    <link:label id="lab_us-gaap_DerivativeTermOfContract_label_en-US" xlink:label="lab_us-gaap_DerivativeTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTermOfContract" xlink:to="lab_us-gaap_DerivativeTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_72c7d927-1206-4c85-924f-27b440730a0e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_a44e8b9f-598a-4558-b5c4-15a6177fc044_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation, beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_7f4339f8-d7db-4810-bb92-76a050a01927_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation, end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_6c7d4ebb-201d-4637-bd0a-d1bc35a97713_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of earnings per share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_27c0fa51-1ee6-4de7-a1ef-b0f8e743c606_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate at Period End</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_62587f05-0baf-4d94-bc72-31f7c3cdbd52_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease ROU assets obtained in exchange for lease obligations</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis_13cbb643-323e-4ec9-abf2-a40d95be0cef_terseLabel_en-US" xlink:label="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Consideration Transferred Liabilities Incurred By Type [Axis]</link:label>
    <link:label id="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis_label_en-US" xlink:label="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Consideration Transferred Liabilities Incurred By Type [Axis]</link:label>
    <link:label id="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis_documentation_en-US" xlink:label="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Consideration Transferred Liabilities Incurred By Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis" xlink:href="coo-20221031.xsd#coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis" xlink:to="lab_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_446976f1-f685-4d4a-b7e4-8abf29837425_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_f4e76dcd-e7bd-483d-a225-47424062af59_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of compensation increase for determining expense</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bf0ad61a-5e69-4adb-a1e8-5ddb26133a76_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_484fc29f-3d93-432c-b0e9-dd58a75838ea_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_d51739a2-b80c-4f2b-9fa6-c11c7f1565b2_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_f86ca6a2-2bb1-4acc-8584-58e84bf0ef64_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_7dbcc956-a024-4c56-ba0d-464939728b9c_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal amount</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_4244254d-f2c0-48e3-b900-6842329c971a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_37d06e72-d9f0-4258-a1fb-3eb3a2e114e2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expense and other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_7e9d7de1-4e6e-4059-9923-47cc16d6b073_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plant and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_cd4df601-02e5-48ce-9b77-b23f37eff7ee_negatedLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions/ Charges</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax_bd97fcf7-9d84-4625-8ac9-fcbd1a14b6a6_terseLabel_en-US" xlink:label="lab_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total recognized in net periodic benefit cost and other comprehensive (income) loss</link:label>
    <link:label id="lab_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amount Recognized in Net Periodic Benefit Cost (Credit) and Other Comprehensive (Income) Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" xlink:to="lab_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDepreciationAndAmortization_ba7db35e-d90f-46f6-970f-5709fe2a737d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_OtherDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_OtherDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDepreciationAndAmortization" xlink:to="lab_us-gaap_OtherDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_3a87fdc5-56c4-48fd-9fb3-31e66b764a56_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_b387925f-896c-47fe-bc29-41725e22052e_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3472b4b8-4cd8-4739-be82-c4e11ef8b66e_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_31eb97bc-234f-40e9-9a23-76f522f69529_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lapses of statutes of limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_5d8c8069-5e55-46c9-a878-210674ad242e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2d6debea-a8fc-4c0c-881d-ab1d35c3fccf_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic pension cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_0efc80eb-4811-4cac-984c-e4e29a84a6b7_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_bb4ade85-ef10-4712-9bbd-3b275e1ba690_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_a0c6a836-5d4c-42a0-bb12-9a33c865970b_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_f594f471-8cd4-4e8e-98cb-5634fbeeb4ef_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived assets</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_083da740-4367-43fa-ae04-8728caace706_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock repurchase</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_b38ad2a6-cd0a-4955-b730-826db229f775_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total costs of shares repurchased (in millions)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_2bba14ba-c406-4a3e-a3da-b6b0079bcf03_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_81647a08-94fa-4c8c-8431-76624097ffa3_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_9c9872cd-3984-41bb-a166-49f0e24ed39e_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_0bcfaf8a-e577-4abb-928b-4b0fdfbfac20_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_8fc94818-cd6e-479c-b261-cf23efb2e265_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_3e49fd66-059e-4cce-9cb2-27ba7a552c63_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalFundsEffectiveSwapRateMember_8afa6207-74f8-4218-847c-8683a13f68df_terseLabel_en-US" xlink:label="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fed Funds Effective Rate Overnight Index Swap Rate</link:label>
    <link:label id="lab_us-gaap_FederalFundsEffectiveSwapRateMember_label_en-US" xlink:label="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fed Funds Effective Rate Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:to="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss_03d1b6fd-27ec-4dff-8d4c-ced30c404f69_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investment gain realized before acquisition of remaining equity interest</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_fe2a4e18-1b02-496a-8083-625967c63ef0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of compensation increase for determining benefit obligations at year end</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_73adc138-d2b0-442d-8cd3-564537941759_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_2e81b6cc-cba6-48a6-9c6f-6f7c56b2161b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax asset step-up</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_937394f7-348e-4119-82ca-417c06811ea1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_a44e232b-6f1e-4e9b-9caa-49822ea5b03d_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of interest rate swap contracts held</link:label>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_label_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Interest Rate Derivatives Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:to="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_6ac116f5-7206-41f3-8496-9f1fe452ab47_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock at cost: 4.5 shares at October&#160;31, 2022 and 4.4 shares at October&#160;31, 2021</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_83c1870f-e9e2-44da-bcfd-1447bd41f1ff_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_EmployeeStockPurchasePlanMember_89e8dd51-2169-45a4-bf7a-9b994f43becd_terseLabel_en-US" xlink:label="lab_coo_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_coo_EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_coo_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_coo_EmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_coo_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_EmployeeStockPurchasePlanMember" xlink:href="coo-20221031.xsd#coo_EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_EmployeeStockPurchasePlanMember" xlink:to="lab_coo_EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_a6addd91-a797-48d5-a5b3-7bef5df4c156_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_1336db7c-feeb-48bf-bf9d-df90d48265b2_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_724c58c4-d5bc-473a-a902-1e4f993790fa_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_a7a5fd06-97a9-4845-b6e5-43b4a30f4255_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_8eea98ea-ed33-429a-aa51-72bf6b8eeb1c_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted&#160;Prices in Active Markets for Identical&#160;Assets (Level 1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_cb145432-b7c8-4bd9-b4d6-222323b7e216_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment [Abstract]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_4bd5879b-7b75-40b4-b283-031da1f5527e_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings_b5b830c4-d5b5-42b8-a76c-4b9106e2eff1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign earnings subject to United States tax</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings" xlink:to="lab_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_c1f9c435-f816-4059-9e31-901cb96c8dd6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual revenue generated</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:to="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_a49d6184-9f9e-4349-bcd1-7fb3315a00e8_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_d2364c6f-4908-4219-877e-a75ef84db438_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-Process Research &amp; Development (IPR&amp;D)</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_2dac14b4-f7e4-4a8e-b038-b299a8a05cab_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum annual contributions per employee in 401k savings plan</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:to="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_d5694e0b-8a45-4185-98e8-b5bd211198be_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total exit costs expected</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis_a878b41d-4e74-4b15-a698-2ab8d388c8ca_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:to="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_7e076ea2-3abc-4ed0-b152-9fdeca18ed06_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_a0ef3719-d19a-4cad-a010-cbf5c2044ad7_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateTypeDomain_9d3e1a97-0f4d-40e0-bba3-4056792f04b8_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateTypeDomain_label_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:to="lab_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_a8af50ca-0942-416d-ac9b-1384bb665949_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss recognized on derivatives within interest expense</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_7d513023-b9a7-40fb-a5e7-cd4d315cba2f_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount reclassified from other comprehensive income into earnings, gross</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_27b339d9-3721-4505-8160-55d80e2468c6_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_2a12dd5c-a319-444f-b1ad-db941c024560_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_8409ad96-eb7c-465f-b1a9-28ebdc8cbf10_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_584c3811-5ad2-4637-b9df-7278b7fc5f8d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for stock plans, net and employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_532603c9-70b8-4bb5-98a9-00327e2f3516_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_0d82d13d-a671-4721-af29-cf19e46bf5ac_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_AuditInformationAbstract_label_en-US" xlink:label="lab_coo_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_coo_AuditInformationAbstract_documentation_en-US" xlink:label="lab_coo_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AuditInformationAbstract" xlink:href="coo-20221031.xsd#coo_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_AuditInformationAbstract" xlink:to="lab_coo_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_44631737-fabe-449b-805b-41d1676e81d5_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_EssilorInternationalSASMember_4ce480da-b626-4b6e-b15a-7083d0aae89e_terseLabel_en-US" xlink:label="lab_coo_EssilorInternationalSASMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Essilor International SAS</link:label>
    <link:label id="lab_coo_EssilorInternationalSASMember_label_en-US" xlink:label="lab_coo_EssilorInternationalSASMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Essilor International SAS [Member]</link:label>
    <link:label id="lab_coo_EssilorInternationalSASMember_documentation_en-US" xlink:label="lab_coo_EssilorInternationalSASMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Essilor International SAS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_EssilorInternationalSASMember" xlink:href="coo-20221031.xsd#coo_EssilorInternationalSASMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_EssilorInternationalSASMember" xlink:to="lab_coo_EssilorInternationalSASMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_251768a3-2eff-4bc7-b916-e6181fef66f7_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_a174fa5c-174f-428f-b173-1fdb351d3983_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_760b28f9-d3c1-49af-adf9-84662eede082_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_08d6ec50-abff-48e7-ac8d-ffb8fa418e83_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Arrangements</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_7c61d074-868d-4646-9b89-47f3d10f11ed_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_71533290-4bff-4ee0-92d1-8c844bdbfab7_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_AccruedPrepaidPensionCosts_8f63804e-d6f7-4fe6-ad7d-96fc03436301_periodStartLabel_en-US" xlink:label="lab_coo_AccruedPrepaidPensionCosts" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Prepaid)/Accrued pension cost at prior fiscal year end</link:label>
    <link:label id="lab_coo_AccruedPrepaidPensionCosts_6a4c12b1-d4c0-49c3-b659-5ff9d75c0fb7_periodEndLabel_en-US" xlink:label="lab_coo_AccruedPrepaidPensionCosts" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Prepaid)/Accrued pension cost at fiscal year end</link:label>
    <link:label id="lab_coo_AccruedPrepaidPensionCosts_label_en-US" xlink:label="lab_coo_AccruedPrepaidPensionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued (Prepaid) Pension Costs</link:label>
    <link:label id="lab_coo_AccruedPrepaidPensionCosts_documentation_en-US" xlink:label="lab_coo_AccruedPrepaidPensionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued (Prepaid) Pension Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AccruedPrepaidPensionCosts" xlink:href="coo-20221031.xsd#coo_AccruedPrepaidPensionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_AccruedPrepaidPensionCosts" xlink:to="lab_coo_AccruedPrepaidPensionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_26c265bf-a33e-4096-ac4a-1dc803b0b8fe_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_a0f08f54-b8eb-482f-abe4-8095cf385e3b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease based on tax positions in prior fiscal years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_04b40e4b-e443-46a0-ad9c-17d70304931d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average asset allocations and fair value measurement of plan assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_AccruedPensionCostRollForward_b2d810fc-da68-4f3c-a5cf-33dc8e7e2085_terseLabel_en-US" xlink:label="lab_coo_AccruedPensionCostRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of (prepaid) accrued pension cost:</link:label>
    <link:label id="lab_coo_AccruedPensionCostRollForward_label_en-US" xlink:label="lab_coo_AccruedPensionCostRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Pension Cost [Roll Forward]</link:label>
    <link:label id="lab_coo_AccruedPensionCostRollForward_documentation_en-US" xlink:label="lab_coo_AccruedPensionCostRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Pension Cost [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AccruedPensionCostRollForward" xlink:href="coo-20221031.xsd#coo_AccruedPensionCostRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_AccruedPensionCostRollForward" xlink:to="lab_coo_AccruedPensionCostRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a31b4bdb-00f7-49c7-9a7b-361ce89c1c50_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MediumTermNotesMember_97481760-08e2-4d19-a5e8-5fb766daf770_terseLabel_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loans</link:label>
    <link:label id="lab_us-gaap_MediumTermNotesMember_label_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medium-term Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MediumTermNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MediumTermNotesMember" xlink:to="lab_us-gaap_MediumTermNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage_54cbd307-a78d-4565-af88-96807ed55473_terseLabel_en-US" xlink:label="lab_coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected long-term return on diversified portfolio</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage_label_en-US" xlink:label="lab_coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Target Allocation, Expected Long Term Return, Percentage</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage_documentation_en-US" xlink:label="lab_coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Target Allocation, Expected Long Term Return, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage" xlink:href="coo-20221031.xsd#coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage" xlink:to="lab_coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_bce46491-61e1-4eb7-89d3-a5bde77b5b13_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_75c2c4f0-83db-4474-a57d-04dac415d8e9_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_5fbd219f-bf9f-4df0-be40-13719482ec85_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_cda13600-0067-41d8-8c1a-cac8d7bb061e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_f144dbe1-4e5d-4f35-844f-df20324b2aee_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_848dc1e4-f53a-4a34-918b-d7bd9ab1fc45_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in accumulated other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_4603f104-b89a-4427-9d1d-92eef5e5e325_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_f6def710-0f00-4fdd-b56d-a5b1cc52d390_verboseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identifiable assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_c7bcd25e-9276-468f-a600-e4db3b3507e6_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share (Note 7)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_4bd8f5b0-7291-44eb-92af-06ec2876bc32_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Units</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_36918c57-85dc-47b0-adf9-00f805bb92e4_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_09aa6791-b1cb-4713-9627-27a629b1705f_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_c515c543-cee5-415b-8cd9-4cf299b65ba2_terseLabel_en-US" xlink:label="lab_coo_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_coo_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_label_en-US" xlink:label="lab_coo_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, After Year Four</link:label>
    <link:label id="lab_coo_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_documentation_en-US" xlink:label="lab_coo_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:href="coo-20221031.xsd#coo_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:to="lab_coo_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_769b91dc-e073-4a09-9278-dd6b8bdfef8c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_07b6bab3-f17b-426b-821a-bd26a5b8829c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards_32333d2f-4801-435d-8245-7704b23a8ba5_terseLabel_en-US" xlink:label="lab_coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss and tax credit carryforwards</link:label>
    <link:label id="lab_coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards_label_en-US" xlink:label="lab_coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards And Tax Credit Carryforwards</link:label>
    <link:label id="lab_coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards_documentation_en-US" xlink:label="lab_coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards And Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards" xlink:href="coo-20221031.xsd#coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards" xlink:to="lab_coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_6b83881c-8e85-4bb2-bcce-3eeb8b59f97d_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase program, maximum amount authorized</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_ff74ed7f-7f40-4531-8a8d-576aac38baaa_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAbstract_ac430d1e-0689-4f66-8ee6-5cbfc89c84b2_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAbstract_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Unclassified [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAbstract" xlink:to="lab_us-gaap_LongTermDebtAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_a626cb2f-4e07-4584-b4ff-0f0730248e8c_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f6b14afe-898a-424a-baed-4635545b6cf6_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_f95942d7-5dd9-432e-bd99-62f5cc119f78_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_6680fdc2-2329-4ca5-94a9-75073878dae3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_303c5d8f-2e05-4c48-a743-9966daf9a1fb_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_db7ae112-84db-4256-96c7-e8dab831457a_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_39484ff4-b048-435a-bead-fd1e5a6ebc4e_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4037431-9b51-4adb-a179-011d7d1c1540_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_3953f286-0380-4128-97a8-58425b6c5b8d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockPlans" xlink:to="lab_us-gaap_ProceedsFromStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_cdcbf1ff-e517-4403-9310-9733020f0738_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for stock plans, net and employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_a875b42f-11fc-4d40-aa70-3833f377d41e_terseLabel_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on derivatives recognized in other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_label_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:to="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_eb340f21-e2b8-4291-a05b-af2d341294b7_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation of goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_PayablesSecondInstallmentMember_b05a438c-3976-448c-9043-857892380aea_terseLabel_en-US" xlink:label="lab_coo_PayablesSecondInstallmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables Second Installment</link:label>
    <link:label id="lab_coo_PayablesSecondInstallmentMember_label_en-US" xlink:label="lab_coo_PayablesSecondInstallmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables Second Installment [Member]</link:label>
    <link:label id="lab_coo_PayablesSecondInstallmentMember_documentation_en-US" xlink:label="lab_coo_PayablesSecondInstallmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables Second Installment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PayablesSecondInstallmentMember" xlink:href="coo-20221031.xsd#coo_PayablesSecondInstallmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_PayablesSecondInstallmentMember" xlink:to="lab_coo_PayablesSecondInstallmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_98675c40-8b21-4ef5-83ac-fe81d1c49aa4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_450c7e52-2b19-4e80-bae2-12f7de2a83e5_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_49bf65d6-1fed-4009-9f0a-0e146562443d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustment</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_2feb2885-f6e3-4755-afca-1c0dc1e495f2_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_0274e41a-36c7-4bb1-a639-f1e106ac2947_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_2dd14a8c-575c-4a00-a6cb-c9cfc79af85d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0b006473-db19-422a-88c2-9ec8d54197a4_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_OtherDebtMember_69870acd-6c28-42f6-a86f-e80edf45fcc3_terseLabel_en-US" xlink:label="lab_coo_OtherDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_coo_OtherDebtMember_label_en-US" xlink:label="lab_coo_OtherDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Debt [Member]</link:label>
    <link:label id="lab_coo_OtherDebtMember_documentation_en-US" xlink:label="lab_coo_OtherDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_OtherDebtMember" xlink:href="coo-20221031.xsd#coo_OtherDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_OtherDebtMember" xlink:to="lab_coo_OtherDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_85c62e15-9804-42ab-93e1-9d36323c76c9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028-2032</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_CompositeMember_3215c317-21c9-4503-826a-a78343f45214_verboseLabel_en-US" xlink:label="lab_coo_CompositeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Composite intangible asset</link:label>
    <link:label id="lab_coo_CompositeMember_label_en-US" xlink:label="lab_coo_CompositeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Composite [Member]</link:label>
    <link:label id="lab_coo_CompositeMember_documentation_en-US" xlink:label="lab_coo_CompositeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Composite [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CompositeMember" xlink:href="coo-20221031.xsd#coo_CompositeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_CompositeMember" xlink:to="lab_coo_CompositeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_908da64f-d80a-4ad1-ba94-ccd93b2b90af_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash included in other current assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_197f8d21-de5b-4cdd-abf8-4b7544da40ce_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_7c3c5317-ba45-49e3-b009-45cb033b71c7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_959d2363-3c1c-4cd3-9550-d8f6946e6f07_terseLabel_en-US" xlink:label="lab_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable To Parent, Before Reclassification And Tax [Roll Forward]</link:label>
    <link:label id="lab_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_label_en-US" xlink:label="lab_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable To Parent, Before Reclassification And Tax [Roll Forward]</link:label>
    <link:label id="lab_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_documentation_en-US" xlink:label="lab_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable To Parent, Before Reclassification And Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward" xlink:href="coo-20221031.xsd#coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward" xlink:to="lab_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_635944c4-dc74-486c-8c18-cbb1920102ea_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_CorporateReconcilingItemsAndEliminationsMember_4071e6e9-af33-42c9-a5c7-8b0736fa3820_terseLabel_en-US" xlink:label="lab_coo_CorporateReconcilingItemsAndEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eliminations, Corporate and Reconciling Items</link:label>
    <link:label id="lab_coo_CorporateReconcilingItemsAndEliminationsMember_label_en-US" xlink:label="lab_coo_CorporateReconcilingItemsAndEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Reconciling Items And Eliminations [Member]</link:label>
    <link:label id="lab_coo_CorporateReconcilingItemsAndEliminationsMember_documentation_en-US" xlink:label="lab_coo_CorporateReconcilingItemsAndEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Reconciling Items And Eliminations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CorporateReconcilingItemsAndEliminationsMember" xlink:href="coo-20221031.xsd#coo_CorporateReconcilingItemsAndEliminationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_CorporateReconcilingItemsAndEliminationsMember" xlink:to="lab_coo_CorporateReconcilingItemsAndEliminationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0b0c3200-b321-4ab0-ab9f-36525bb18a17_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_d3e92b69-850d-4419-a12b-5c36880e0b17_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_f96da208-a2af-45b5-8f73-bd8c3ec4a3ae_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_69ac91a4-9104-4f1a-8332-732068bbfe7f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_a1a47051-e7f5-453e-a586-dda589f0b49d_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_22598b80-2bdf-4ad8-b997-938be623c366_periodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_5f141b68-5ddd-4ca5-8520-4abf78eed9ca_periodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_54d8383e-f9ba-4a1a-9feb-f3dee323e4f8_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_da8718b2-ed34-4a10-a242-506cac769211_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems_396af49a-ef84-40bc-b09d-0ec5f5674376_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_555d2696-7385-4c3c-bfad-67be7b56f5d7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_9f4ffeab-f334-4d69-893c-63cd6747902e_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_14d0349d-a2a2-4154-b0de-4a6ddf16bd4e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_b941075c-366a-4bb2-ac9b-0e5a2a4cd6c4_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR)</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_3bded5be-6b5a-4df4-b77e-264377cbf212_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedges, net of tax of $26.1, $8.2 and $(4.1), respectively</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerRefundLiability_0a400753-1331-42d1-9044-7423cb42079c_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerRefundLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refund liability for product returns</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerRefundLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerRefundLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Refund Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerRefundLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerRefundLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerRefundLiability" xlink:to="lab_us-gaap_ContractWithCustomerRefundLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_dc5db6bc-93c3-49b2-887e-60d31287582a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_0ea495e8-9a26-4804-a4a5-54aa88637a96_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangibles</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_052d56a9-23cc-4a7d-94cf-211bf5fef4ab_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_1af4e06a-741f-400a-839c-d699b2c12c71_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1cbae1d8-f1f2-4eb4-a009-463da4018178_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_2c8b92ea-9a3b-47b5-9bae-f702d173903d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_b9fbf5d8-1d0d-4dd4-848a-34305b13f789_totalLabel_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_label_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Long-Term and Short-Term, Combined Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:to="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligationIncreaseDecrease_6ac89aee-fef4-457d-ac12-9e415ba35a57_negatedTerseLabel_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligationIncreaseDecrease" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate, decrease</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligationIncreaseDecrease_label_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligationIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Projected Benefit Obligation, Increase (Decrease)</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligationIncreaseDecrease_documentation_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligationIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Projected Benefit Obligation, Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligationIncreaseDecrease" xlink:href="coo-20221031.xsd#coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligationIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligationIncreaseDecrease" xlink:to="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligationIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_23e6e5f2-6432-471f-a408-ecd14a4ca45d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Pension Liability</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandAndLandImprovementsMember_2a70f579-df62-43a6-9b73-d55af6ba8c1d_terseLabel_en-US" xlink:label="lab_us-gaap_LandAndLandImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land and improvements</link:label>
    <link:label id="lab_us-gaap_LandAndLandImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LandAndLandImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land and Land Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandAndLandImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandAndLandImprovementsMember" xlink:to="lab_us-gaap_LandAndLandImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_b3e55a09-923c-4065-aebc-459e16a9afae_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_0a98957f-e891-49b5-8914-44638a163daa_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Cooper stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_2f30f295-e995-471b-9f4d-f2e456932ab6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Derivatives and Hedging</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_b212e62f-a626-4c32-a49a-cdb8a8120230_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_EuropeanCreditFacilityMember_0c10c2d4-ce79-4870-88d8-c2d4adcc5dcb_terseLabel_en-US" xlink:label="lab_coo_EuropeanCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Credit Facilities</link:label>
    <link:label id="lab_coo_EuropeanCreditFacilityMember_label_en-US" xlink:label="lab_coo_EuropeanCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Credit Facility [Member]</link:label>
    <link:label id="lab_coo_EuropeanCreditFacilityMember_documentation_en-US" xlink:label="lab_coo_EuropeanCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_EuropeanCreditFacilityMember" xlink:href="coo-20221031.xsd#coo_EuropeanCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_EuropeanCreditFacilityMember" xlink:to="lab_coo_EuropeanCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStock_1f7bb468-01f8-40b5-892c-6216ff6e021d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends on common stock ($0.03 per share)</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStock" xlink:to="lab_us-gaap_DividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_d7b6c6ab-2851-49c6-b4ce-c01b3fefe6bf_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a262dc15-0f30-45f1-b38a-49aa4ad0f81a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_e768cccf-5c39-4894-b9ac-baa6a314af92_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_BusinessCombinationPaymentToSettleContingentConsideration_50c3d75c-65bf-49d0-b270-ae3ddb1daa17_terseLabel_en-US" xlink:label="lab_coo_BusinessCombinationPaymentToSettleContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment to settle former equity interest owners</link:label>
    <link:label id="lab_coo_BusinessCombinationPaymentToSettleContingentConsideration_label_en-US" xlink:label="lab_coo_BusinessCombinationPaymentToSettleContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Payment to Settle Contingent Consideration</link:label>
    <link:label id="lab_coo_BusinessCombinationPaymentToSettleContingentConsideration_documentation_en-US" xlink:label="lab_coo_BusinessCombinationPaymentToSettleContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Payment to Settle Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationPaymentToSettleContingentConsideration" xlink:href="coo-20221031.xsd#coo_BusinessCombinationPaymentToSettleContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_BusinessCombinationPaymentToSettleContingentConsideration" xlink:to="lab_coo_BusinessCombinationPaymentToSettleContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_71a8cc84-06c6-40ec-9c05-a7510738105a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration reconciliation</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_d51cb964-89b7-4acf-ac08-05d650cb74cd_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_4fc87438-de2b-4e44-a19e-ee7387a38248_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_a4f5cd96-1438-462e-92c3-e1529c85329c_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total unrecognized compensation cost related to nonvested options</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_MultifocalLensMember_5e0688dc-f9f5-4bea-9906-ce1dc812beb6_terseLabel_en-US" xlink:label="lab_coo_MultifocalLensMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multifocal lens</link:label>
    <link:label id="lab_coo_MultifocalLensMember_label_en-US" xlink:label="lab_coo_MultifocalLensMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multifocal Lens [Member]</link:label>
    <link:label id="lab_coo_MultifocalLensMember_documentation_en-US" xlink:label="lab_coo_MultifocalLensMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multifocal Lens [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_MultifocalLensMember" xlink:href="coo-20221031.xsd#coo_MultifocalLensMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_MultifocalLensMember" xlink:to="lab_coo_MultifocalLensMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_a8df808a-20c6-476f-b385-b24e9767a4a6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares remaining for future grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_355528c0-2e54-4c9b-9f17-3bf49111e8bb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_ab9c23a7-242b-480c-9980-68c04add2cbc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of non-vested RSUs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_9ace34fd-73cd-442b-b9e0-de4524029491_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_afa58c33-476d-4e43-b6f5-4a2d97f06df1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and issued (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_823c2482-06a9-4034-84b0-5aea875e74f6_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment realized gain</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Realized Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_f29aaf82-a938-4cb5-8e55-892ea4fd3155_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, non-current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_61672853-c26c-44fa-a690-619f70e1c165_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized research and experimental expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_fa942120-ae6a-4df9-9734-7d28fdae3285_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of share repurchases</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_d047964e-c016-4b0c-9cc2-ebe15c45ba54_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_473084c9-8a49-4336-9db7-ec44d8b7d5eb_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock repurchase (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_adeb9f31-9c04-4f45-84e8-9d190ae07f8a_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_60b85125-67b2-43b5-a749-29765b19a843_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross change in value</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_e319ab0b-542a-4d1b-b36f-4c3fe419a3bd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement of contingent consideration</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_e4563174-e20e-41a2-9c6a-8c72663f20b9_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets with indefinite lives, net</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList_b9f15e24-8848-4be3-9cdb-b0a9c1ec3813_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_BusinessAcquisitionAndAssetAcquisitionAxis_bc60220a-cc42-400b-bb34-baf6b2d955f4_terseLabel_en-US" xlink:label="lab_coo_BusinessAcquisitionAndAssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition And Asset Acquisition [Axis]</link:label>
    <link:label id="lab_coo_BusinessAcquisitionAndAssetAcquisitionAxis_label_en-US" xlink:label="lab_coo_BusinessAcquisitionAndAssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition And Asset Acquisition [Axis]</link:label>
    <link:label id="lab_coo_BusinessAcquisitionAndAssetAcquisitionAxis_documentation_en-US" xlink:label="lab_coo_BusinessAcquisitionAndAssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition And Asset Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessAcquisitionAndAssetAcquisitionAxis" xlink:href="coo-20221031.xsd#coo_BusinessAcquisitionAndAssetAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_BusinessAcquisitionAndAssetAcquisitionAxis" xlink:to="lab_coo_BusinessAcquisitionAndAssetAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_25a9927d-23cc-4709-a7ce-0c45fa0c6738_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net of allowance for credit losses of $20.7 at October&#160;31, 2022 and $9.2 at October&#160;31, 2021</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_d07a338d-d0ae-46b1-9487-f8fc25f6c29a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd_0c038aba-666e-46e4-a248-9c2515c5fac6_terseLabel_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected rate of return on plan assets at year end</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd_label_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate Of Return On Plan Assets At Year End</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd_documentation_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate Of Return On Plan Assets At Year End</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd" xlink:href="coo-20221031.xsd#coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd" xlink:to="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_03b971e6-e8d9-4cd4-bd1a-415e32f28340_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1466622d-f50f-44ef-8c31-6cb369977d58_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested RSUs, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_65392fc1-0e77-45e8-98b2-3af39ce034b5_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested RSUs, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_7e8a2717-1da1-483d-bd97-29f0097b72f4_negatedLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense (income), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_64311e60-8c61-448c-acbe-a5059323c15f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net additions</link:label>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:to="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_7283bb10-2c44-4888-8436-d787e083055b_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_ab178314-3571-49a6-8495-74aac6d19eb5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_1c7ba498-2980-44a2-af5a-5f07497ad913_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expense</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract_93ce8de6-987f-4068-ad3f-0425135ae47e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts recognized in accumulated other comprehensive income consist of:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_034b899a-874d-403c-a229-d4588bbdb307_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_9aa30eb2-af60-46d1-86b0-231fe4c50963_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c4c7931e-1c55-4aa8-b09f-a1d4339b8a2c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_76a6a14f-d8f8-446c-92c4-339176a84b58_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_NumberOfInterestRateDerivativesMatured_db93d761-dd32-488e-8a86-a25830adcd38_terseLabel_en-US" xlink:label="lab_coo_NumberOfInterestRateDerivativesMatured" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of interest rate swap contracts matured</link:label>
    <link:label id="lab_coo_NumberOfInterestRateDerivativesMatured_label_en-US" xlink:label="lab_coo_NumberOfInterestRateDerivativesMatured" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Interest Rate Derivatives Matured</link:label>
    <link:label id="lab_coo_NumberOfInterestRateDerivativesMatured_documentation_en-US" xlink:label="lab_coo_NumberOfInterestRateDerivativesMatured" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Interest Rate Derivatives Matured</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_NumberOfInterestRateDerivativesMatured" xlink:href="coo-20221031.xsd#coo_NumberOfInterestRateDerivativesMatured"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_NumberOfInterestRateDerivativesMatured" xlink:to="lab_coo_NumberOfInterestRateDerivativesMatured" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_4042f615-4fde-4d5f-968c-8893623ca642_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_b5f5a43c-c67c-4bac-89c1-bf572a639e8f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_f5d4d9ca-1142-4efe-82af-6a98416544ba_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_637f9443-f0ce-4e19-9c9d-749695fc771b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_280dfa75-9794-45b0-a7e5-1c92a991b2b5_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_ada79f64-eae6-464e-9c36-5146a544dc2d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of stock option plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_TreasuryStockParNetValueMember_d1c66882-46ed-4065-88f2-eefcbfc79471_terseLabel_en-US" xlink:label="lab_coo_TreasuryStockParNetValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Par Net Value</link:label>
    <link:label id="lab_coo_TreasuryStockParNetValueMember_label_en-US" xlink:label="lab_coo_TreasuryStockParNetValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Par Net Value [Member]</link:label>
    <link:label id="lab_coo_TreasuryStockParNetValueMember_documentation_en-US" xlink:label="lab_coo_TreasuryStockParNetValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Par Net Value [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TreasuryStockParNetValueMember" xlink:href="coo-20221031.xsd#coo_TreasuryStockParNetValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_TreasuryStockParNetValueMember" xlink:to="lab_coo_TreasuryStockParNetValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_35e6dd7b-dbc7-4b3b-b78f-df436894c674_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_79256717-427f-4716-ad01-422223e1f010_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_015067e5-8805-4340-9d33-c2b5575991df_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_5a9761b4-43a9-43c6-a70a-6bd567e2eb83_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInventory" xlink:to="lab_us-gaap_DeferredTaxAssetsInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_99fc04e5-a6e6-4bf9-a12c-503d92736401_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Pronouncements Recently Adopted and Accounting Pronouncements Issued Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_c8047734-b922-4f4c-98d6-7e63600c6d06_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities, reserves and compensation accruals</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_9dd4e67d-ef32-4ed0-aca7-e705125ac61c_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember_4edd2855-6c72-4511-adbc-2c48f123233f_terseLabel_en-US" xlink:label="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Assumptions For Defined Benefit Plans, Change In Demographic Experience</link:label>
    <link:label id="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember_label_en-US" xlink:label="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Assumptions For Defined Benefit Plans, Change In Demographic Experience [Member]</link:label>
    <link:label id="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember_documentation_en-US" xlink:label="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Assumptions For Defined Benefit Plans, Change In Demographic Experience [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember" xlink:href="coo-20221031.xsd#coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember" xlink:to="lab_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_3fb8dc87-2b59-4f11-a41a-b77f2e450942_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign earnings in jurisdictions with lower tax rates</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e91ec126-f431-40d9-afe1-7d16b78e1751_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_e350d534-f361-4c61-939a-aa6d61bbcc21_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_f7e1c29a-bb59-4d18-bf16-e7942c31fdea_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember_70b22abf-68f5-47bd-95e4-bd8114a6f0c1_terseLabel_en-US" xlink:label="lab_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Amended and Restated 2007 Long-Term Incentive Plan</link:label>
    <link:label id="lab_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember_label_en-US" xlink:label="lab_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Amended And Restated 2007 Long-Term Incentive Plan [Member]</link:label>
    <link:label id="lab_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember_documentation_en-US" xlink:label="lab_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Amended And Restated 2007 Long-Term Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember" xlink:href="coo-20221031.xsd#coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember" xlink:to="lab_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_e68be06c-8d4c-4811-abb3-f44659ef4d23_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7ee516fa-6e78-4613-a181-44fe856b3a5d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_62dbf6b6-bbba-4cc1-a221-85d80e3652d0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3ae89e97-ee75-4c1d-adb6-05f9354f7630_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted in period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_f0d5dd78-0dc3-48e3-856e-47a3ab5a1169_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_df96742f-fdd4-4075-a361-96b11c1828c9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_6f5fd26d-330e-49e4-abe3-b939b99ae1eb_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_11faf1ca-8772-40c5-8092-37acd4386408_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_5e572190-cd6a-4d7e-880f-acf4d301b9e2_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_TermLoansMember_bf5a20e5-f299-49dc-a501-f5890c2c1c7d_terseLabel_en-US" xlink:label="lab_coo_TermLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loans</link:label>
    <link:label id="lab_coo_TermLoansMember_label_en-US" xlink:label="lab_coo_TermLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loans [Member]</link:label>
    <link:label id="lab_coo_TermLoansMember_documentation_en-US" xlink:label="lab_coo_TermLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoansMember" xlink:href="coo-20221031.xsd#coo_TermLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_TermLoansMember" xlink:to="lab_coo_TermLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_8c85245a-a02b-45ba-8f5e-33ea06e39ef2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intrinsic value of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_34ea5ef8-7baa-4023-8358-8ec580b94600_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2801f69c-fd9b-40b6-bef8-3a0e2f3c1d0f_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted average common shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_fe05e549-c4b0-467c-a632-96c8982cb73a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_d5d1c6ad-d369-42ab-bdc5-b1131df72326_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_b2994184-4c54-4c29-89ea-68b71392a7d9_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:label id="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_bcc7ebd0-ecbb-4fe8-9766-ecbe39f8dc91_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_afbb4c6d-7c71-49a3-a2e7-1eff98038de9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends on common stock (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_b5d8e50e-6220-4b4b-b21d-bac0ee1ae1d7_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_d7083f33-daab-428e-9a22-c12a8412e9a1_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_48b209bb-bead-4a63-a20a-f8ed1e71c4c8_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized actuarial loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Actuarial Gain (Loss), Immediate Recognition as Component in Net Periodic Benefit (Cost) Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_936bf60d-8ca1-4fcb-b917-261f57227448_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax_bc953cfe-3114-4a58-8df5-7a235b627e0d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (gain) loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6154e4fc-caf2-48cf-9024-2f4333fa6123_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_53c21cf8-d168-4bd4-af42-008961480d81_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions by employer in 401k savings plan</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ecbed920-2812-487c-9234-a5532c54ad7a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_c1d43fb0-9217-4c7f-bc59-bf2315bd7668_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_00f6d3b3-4eb7-4c54-b698-dc1450841c99_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative loss expected to be realized in earnings over the next twelve months</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c0225076-c36c-4ffd-8371-5f9514cf52ff_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and exercisable at end of period, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_5ab7ca22-dce9-4bd4-b4f9-8d61a22a84f3_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_ShortTermDebtNetOfDebtIssuanceCosts_342e0007-d170-4118-928e-2fa6d0768a97_totalLabel_en-US" xlink:label="lab_coo_ShortTermDebtNetOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt, excluding financing leases</link:label>
    <link:label id="lab_coo_ShortTermDebtNetOfDebtIssuanceCosts_label_en-US" xlink:label="lab_coo_ShortTermDebtNetOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Net Of Debt Issuance Costs</link:label>
    <link:label id="lab_coo_ShortTermDebtNetOfDebtIssuanceCosts_documentation_en-US" xlink:label="lab_coo_ShortTermDebtNetOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Net Of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ShortTermDebtNetOfDebtIssuanceCosts" xlink:href="coo-20221031.xsd#coo_ShortTermDebtNetOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_ShortTermDebtNetOfDebtIssuanceCosts" xlink:to="lab_coo_ShortTermDebtNetOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_90a0911d-a374-45a7-9c7a-23e7fac9ab98_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of definite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Finite-Lived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_b0b1d32e-607b-46e7-83d8-8d445b558863_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_55b42c04-c84d-4c31-a72e-e855ddc4d7c5_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income, basic</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_a26044d7-5d1d-4248-82c1-35c929681b58_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from long-term debt, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_454bd6be-e105-424a-ad0c-637d07e7fa1b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_a3c9322b-ae67-444f-97c3-82a1bd12a2b4_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held-for-sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_f79a8bd3-e1d3-439e-b80f-ebeba6b27080_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_f84eef61-8af7-4320-b429-02abccd7022b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedges, tax provision (benefit)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_232eea90-99c4-4e8e-9495-71d52d5e2725_negatedLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net foreign exchange loss</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_98f765a4-3d78-4c2f-a24c-755ba80d2e12_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_4b5280f7-873a-4421-9ac2-da1bc0a1da9d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_f88ecee8-02e1-4cdd-8105-2b6af7c1d832_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Original debt amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_6938eda1-3d93-47ce-aa80-0cc3597a5f76_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from line of credit</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Long-Term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_TermLoanFacility2021BaseRateLoansMember_e78e06bc-f78c-4d3b-8983-2cefc5718ba2_terseLabel_en-US" xlink:label="lab_coo_TermLoanFacility2021BaseRateLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility, 2021 Base Rate Loans</link:label>
    <link:label id="lab_coo_TermLoanFacility2021BaseRateLoansMember_label_en-US" xlink:label="lab_coo_TermLoanFacility2021BaseRateLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility, 2021 Base Rate Loans [Member]</link:label>
    <link:label id="lab_coo_TermLoanFacility2021BaseRateLoansMember_documentation_en-US" xlink:label="lab_coo_TermLoanFacility2021BaseRateLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility, 2021 Base Rate Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanFacility2021BaseRateLoansMember" xlink:href="coo-20221031.xsd#coo_TermLoanFacility2021BaseRateLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_TermLoanFacility2021BaseRateLoansMember" xlink:to="lab_coo_TermLoanFacility2021BaseRateLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems_681309bc-cc99-41dd-8fe8-68b2fabc5492_terseLabel_en-US" xlink:label="lab_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Business Acquisitions And Asset Acquisition, By Acquisition [Line Items]</link:label>
    <link:label id="lab_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems_label_en-US" xlink:label="lab_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Business Acquisitions And Asset Acquisition, By Acquisition [Line Items]</link:label>
    <link:label id="lab_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems_documentation_en-US" xlink:label="lab_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule Of Business Acquisitions And Asset Acquisition, By Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems" xlink:href="coo-20221031.xsd#coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems" xlink:to="lab_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_ea985036-fb2d-4ef2-8daf-397dde21746b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds related to share-based compensation awards</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_AOCICashFlowHedgeCumulativeGainLossBeforeTax_f4808c1c-2c48-49ba-b1bc-025b061ac891_terseLabel_en-US" xlink:label="lab_coo_AOCICashFlowHedgeCumulativeGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax impact of gain (loss) on derivatives recognized in other comprehensive income (loss)</link:label>
    <link:label id="lab_coo_AOCICashFlowHedgeCumulativeGainLossBeforeTax_label_en-US" xlink:label="lab_coo_AOCICashFlowHedgeCumulativeGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), Before Tax</link:label>
    <link:label id="lab_coo_AOCICashFlowHedgeCumulativeGainLossBeforeTax_documentation_en-US" xlink:label="lab_coo_AOCICashFlowHedgeCumulativeGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AOCICashFlowHedgeCumulativeGainLossBeforeTax" xlink:href="coo-20221031.xsd#coo_AOCICashFlowHedgeCumulativeGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_AOCICashFlowHedgeCumulativeGainLossBeforeTax" xlink:to="lab_coo_AOCICashFlowHedgeCumulativeGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_91563457-4f4a-472e-a13d-060c0d037ba3_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of business segment information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_7b1f84be-bbd7-46c6-916c-2b6e81055760_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in minimum pension liability, tax provision (benefit)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_15187c43-8e05-45b4-9eba-246011989d90_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_03d63862-9f8f-4d5d-9baa-fad47e6654d8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_10d9c173-99bb-46df-abd7-bf599bef5d88_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal net operating losses not subject to expiration</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign_a5d4bf49-2fb9-4262-a180-2d2701948b1d_negatedTerseLabel_en-US" xlink:label="lab_coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign deferred tax liabilities</link:label>
    <link:label id="lab_coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign_label_en-US" xlink:label="lab_coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Purchase Accounting Adjustments, Foreign</link:label>
    <link:label id="lab_coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign_documentation_en-US" xlink:label="lab_coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Purchase Accounting Adjustments, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign" xlink:href="coo-20221031.xsd#coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign" xlink:to="lab_coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee_f4cb7c87-e443-40c6-9e49-cdf4ffad6cac_terseLabel_en-US" xlink:label="lab_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of non-employee directors in committee</link:label>
    <link:label id="lab_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee_label_en-US" xlink:label="lab_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Terms Of Award, Grants In Period, Number Of Non Employee Directors In Committee</link:label>
    <link:label id="lab_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee_documentation_en-US" xlink:label="lab_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Terms Of Award, Grants In Period, Number Of Non Employee Directors In Committee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee" xlink:href="coo-20221031.xsd#coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee" xlink:to="lab_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_6ab30a0b-64f7-42ed-866a-bb816d58f3b6_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_SightGlassVisionIncMember_db7115ed-6e90-4e13-b0a7-ef904d61fffa_terseLabel_en-US" xlink:label="lab_coo_SightGlassVisionIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SightGlass Vision, Inc.</link:label>
    <link:label id="lab_coo_SightGlassVisionIncMember_label_en-US" xlink:label="lab_coo_SightGlassVisionIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SightGlass Vision, Inc. [Member]</link:label>
    <link:label id="lab_coo_SightGlassVisionIncMember_documentation_en-US" xlink:label="lab_coo_SightGlassVisionIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SightGlass Vision, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_SightGlassVisionIncMember" xlink:href="coo-20221031.xsd#coo_SightGlassVisionIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_SightGlassVisionIncMember" xlink:to="lab_coo_SightGlassVisionIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_b4df2c16-dab5-40ed-a9db-6285f204aaf2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of recognized identified assets acquired and liabilities assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f7f45b89-bd53-487a-beec-a17ca869a401_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_7fb55b04-7a32-46f2-8c76-19212383181a_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_b922940f-e4ba-463a-b308-d01d7c9a4695_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Expected Return (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Expected Return (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2c65933d-c033-4adc-95b0-2081f38b4634_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Assets and Liabilities [Abstract]</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Assets and Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_e0957631-261d-4312-b94f-fe9a9e1bcc32_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d39f82fb-7992-4a09-9120-3f3448969389_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_FertilityMember_92992720-67d2-4095-9561-7b46b684372b_terseLabel_en-US" xlink:label="lab_coo_FertilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fertility</link:label>
    <link:label id="lab_coo_FertilityMember_label_en-US" xlink:label="lab_coo_FertilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fertility [Member]</link:label>
    <link:label id="lab_coo_FertilityMember_documentation_en-US" xlink:label="lab_coo_FertilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fertility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_FertilityMember" xlink:href="coo-20221031.xsd#coo_FertilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_FertilityMember" xlink:to="lab_coo_FertilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_bed95491-7109-4288-baf7-360f44d6f8de_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_d7ecc730-f3cb-451e-8e8c-39cfef146e27_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undiscounted range of the contingent consideration, maximum</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_PayablesFourthInstallmentMember_8356276d-2157-496f-865d-c3cb6878a510_terseLabel_en-US" xlink:label="lab_coo_PayablesFourthInstallmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables Fourth Installment</link:label>
    <link:label id="lab_coo_PayablesFourthInstallmentMember_label_en-US" xlink:label="lab_coo_PayablesFourthInstallmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables Fourth Installment [Member]</link:label>
    <link:label id="lab_coo_PayablesFourthInstallmentMember_documentation_en-US" xlink:label="lab_coo_PayablesFourthInstallmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables Fourth Installment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PayablesFourthInstallmentMember" xlink:href="coo-20221031.xsd#coo_PayablesFourthInstallmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_PayablesFourthInstallmentMember" xlink:to="lab_coo_PayablesFourthInstallmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_8ad15e6b-6ee4-4b97-a21f-76b2263eb8b9_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_41a9aae5-fb9b-4753-95ae-b5de822464e7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_c79eca03-4d60-4b1b-90f7-cca466ad13ee_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_EffectiveIncomeTaxRateReconciliationChangeInEnactedForeignTaxRateAmount_99270e31-162c-4076-b44d-de912272208a_negatedTerseLabel_en-US" xlink:label="lab_coo_EffectiveIncomeTaxRateReconciliationChangeInEnactedForeignTaxRateAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit related to remeasurement of deferred tax assets due to UK change in tax rate</link:label>
    <link:label id="lab_coo_EffectiveIncomeTaxRateReconciliationChangeInEnactedForeignTaxRateAmount_label_en-US" xlink:label="lab_coo_EffectiveIncomeTaxRateReconciliationChangeInEnactedForeignTaxRateAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change In Enacted Foreign Tax Rate, Amount</link:label>
    <link:label id="lab_coo_EffectiveIncomeTaxRateReconciliationChangeInEnactedForeignTaxRateAmount_documentation_en-US" xlink:label="lab_coo_EffectiveIncomeTaxRateReconciliationChangeInEnactedForeignTaxRateAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change In Enacted Foreign Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_EffectiveIncomeTaxRateReconciliationChangeInEnactedForeignTaxRateAmount" xlink:href="coo-20221031.xsd#coo_EffectiveIncomeTaxRateReconciliationChangeInEnactedForeignTaxRateAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_EffectiveIncomeTaxRateReconciliationChangeInEnactedForeignTaxRateAmount" xlink:to="lab_coo_EffectiveIncomeTaxRateReconciliationChangeInEnactedForeignTaxRateAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems_f6607cec-cebf-4751-9328-b2a61c8b611d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Allocation [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Allocation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet_48af8d72-08bc-45f9-b362-079de38d5c24_terseLabel_en-US" xlink:label="lab_coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets and liabilities, net</link:label>
    <link:label id="lab_coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet_label_en-US" xlink:label="lab_coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Lease, Right-Of-Use Asset And Liability, Net</link:label>
    <link:label id="lab_coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet_documentation_en-US" xlink:label="lab_coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Lease, Right-Of-Use Asset And Liability, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet" xlink:href="coo-20221031.xsd#coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet" xlink:to="lab_coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f2afca0b-8e6f-4fd7-a227-386c37870027_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_910d12fc-1399-4b4d-845e-7238ec23a611_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_4cd097e3-ce13-4143-9346-09db61c7580a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected rate of return on plan assets for determining net periodic pension cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesEmployeeRelatedLiabilities_0ef790e4-bb5a-4205-8eb8-d593c3cc4011_terseLabel_en-US" xlink:label="lab_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee compensation and benefits</link:label>
    <link:label id="lab_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Employee-related Liabilities</link:label>
    <link:label id="lab_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesEmployeeRelatedLiabilities_documentation_en-US" xlink:label="lab_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Employee-related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesEmployeeRelatedLiabilities" xlink:href="coo-20221031.xsd#coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesEmployeeRelatedLiabilities" xlink:to="lab_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_CoopervisionSegmentMember_0184ab7e-31fb-4888-827a-88220a6ecf51_terseLabel_en-US" xlink:label="lab_coo_CoopervisionSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CooperVision</link:label>
    <link:label id="lab_coo_CoopervisionSegmentMember_label_en-US" xlink:label="lab_coo_CoopervisionSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coopervision Segment [Member]</link:label>
    <link:label id="lab_coo_CoopervisionSegmentMember_documentation_en-US" xlink:label="lab_coo_CoopervisionSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coopervision Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CoopervisionSegmentMember" xlink:href="coo-20221031.xsd#coo_CoopervisionSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_CoopervisionSegmentMember" xlink:to="lab_coo_CoopervisionSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_8381c9f9-f79f-45c9-aca6-b540693c41dc_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_7f7a9190-ac30-48dd-a645-d2c18e373bb3_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_1d7efb7a-dda4-40eb-ac41-4e31f35c8fb0_totalLabel_en-US" xlink:label="lab_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total closing purchase price</link:label>
    <link:label id="lab_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination And Asset Acquisition, Recognized Identifiable Assets Acquired, Goodwill, And Liabilities Assumed, Net</link:label>
    <link:label id="lab_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_documentation_en-US" xlink:label="lab_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination And Asset Acquisition, Recognized Identifiable Assets Acquired, Goodwill, And Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="coo-20221031.xsd#coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_d952bb69-0fe0-45ef-a24f-f9b9cf36dddc_terseLabel_en-US" xlink:label="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in benefit obligation, changes in plan assets and funded status</link:label>
    <link:label id="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:to="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_4d003084-c61f-4286-9660-3a2dc9ab6120_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reporting units</link:label>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_label_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reporting Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportingUnits" xlink:to="lab_us-gaap_NumberOfReportingUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_26674c45-43f2-46ce-a6b9-f26574daecc4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_71b0a345-e72d-4e73-85ce-cdca551889d9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issued to employees</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_cd446fc4-4ed5-4ab7-ab13-0dce6308bd30_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets with definite lives, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityPolicyTextBlock_5118714f-b55b-4cee-be6b-b2eb598226cc_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityPolicyTextBlock" xlink:to="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_a4c70f6a-bee4-4f7b-9f18-321cf1058564_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_cde162db-a0c1-4bae-a671-212e196cfc21_terseLabel_en-US" xlink:label="lab_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long Term and Short Term Debt Instruments [Line Items]</link:label>
    <link:label id="lab_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_label_en-US" xlink:label="lab_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long Term And Short Term Debt Instruments [Line Items]</link:label>
    <link:label id="lab_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_documentation_en-US" xlink:label="lab_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Long Term And Short Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems" xlink:href="coo-20221031.xsd#coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems" xlink:to="lab_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d3f4d5d6-6781-4f81-9d03-e63b781c1eef_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_382ad007-7441-415b-aa07-ac3dfc381d88_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_1cc80ca1-4bb7-4e48-b524-ce08a5d66cc1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination And Asset Acquisition [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_b1688a61-f4e3-41f7-83c1-b82e791e34b6_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_2d79d0a3-7aaa-4a39-a2c7-bb880d65856d_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_8ad433ca-4558-4700-8051-d88ba9335bea_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Beginning of Year</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_47e41947-09b1-4e3b-9e33-7caa236d3151_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at End of Year</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_e063ab15-9152-47f3-b8c1-39199afad9a4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_39cc0add-ed71-4d4f-ad7e-3f221fb1387f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_AssetsAndLiabilitiesLesseeTableTextBlock_48c3cb2b-a46b-47f6-8032-d78b61529cfa_terseLabel_en-US" xlink:label="lab_coo_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases on the Consolidated Condensed Balance Sheet</link:label>
    <link:label id="lab_coo_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_coo_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_coo_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_coo_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="coo-20221031.xsd#coo_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_coo_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3dbf3f11-01ad-473d-ac65-636df8e432c9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_bb0947ad-a1a2-42fe-8188-5a8fb030c8f8_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_04c269ec-ee13-4982-9f49-931370ae0008_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_d9584712-4eda-4595-8cb8-40614d8442e8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_076655e6-61db-4baf-a95c-31f18855e263_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_6b91ae78-f0a8-4f1f-a899-eb3d0a16c95c_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_2d5142b1-da1b-496a-a859-65d13686dff1_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_33d594ef-1943-4026-b4e9-f0d0cfe64f80_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_56dccaea-f902-40b1-9aad-c3b34b4d79ef_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_1da01c3f-a2b8-485f-a2b0-14b0933197ab_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual net income generated</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:to="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_437f4a16-9ef8-4103-ba31-b45cfe6d997a_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_acf0dd66-c702-4d82-90a9-407689a6909c_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_e14a50b5-c936-432d-8b88-9c0257d00950_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies (Note 12)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_29c35596-5f11-4901-8af9-4752f40bc150_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f828e475-4b25-40a2-b97f-600008688556_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a20bd0bc-412b-4b79-a02d-2b03676d5179_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_ea38d36b-df2e-45cd-b65e-4046ceb43dbc_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of business segment net sales</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_ab31ac23-a35b-42ee-b83e-59016242f059_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount reclassified from other comprehensive income into earnings, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_d5225bb9-928a-41fa-b62f-cacf20c8b2b2_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held-for-sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_BondMutualFundsMember_30d19a46-408c-457c-a47c-f501a4221f26_terseLabel_en-US" xlink:label="lab_coo_BondMutualFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bond mutual funds</link:label>
    <link:label id="lab_coo_BondMutualFundsMember_label_en-US" xlink:label="lab_coo_BondMutualFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bond Mutual Funds [Member]</link:label>
    <link:label id="lab_coo_BondMutualFundsMember_documentation_en-US" xlink:label="lab_coo_BondMutualFundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bond Mutual Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BondMutualFundsMember" xlink:href="coo-20221031.xsd#coo_BondMutualFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_BondMutualFundsMember" xlink:to="lab_coo_BondMutualFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_acc8600e-5c7e-47c0-9b74-e7fa1a5a3fc7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c23361a7-b221-498a-8ef8-fa19a162a49a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3ed3d4a8-eeeb-4ce3-8ebf-92525c1023e5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_DirectorsPlan2020Member_4a12322b-ad2c-44dc-908a-adbff7c12317_terseLabel_en-US" xlink:label="lab_coo_DirectorsPlan2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Directors Plan</link:label>
    <link:label id="lab_coo_DirectorsPlan2020Member_label_en-US" xlink:label="lab_coo_DirectorsPlan2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Directors Plan 2020 [Member]</link:label>
    <link:label id="lab_coo_DirectorsPlan2020Member_documentation_en-US" xlink:label="lab_coo_DirectorsPlan2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Directors Plan 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DirectorsPlan2020Member" xlink:href="coo-20221031.xsd#coo_DirectorsPlan2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_DirectorsPlan2020Member" xlink:to="lab_coo_DirectorsPlan2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_70a468ae-5156-4972-b605-5cfd7c077571_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_28a24d66-01de-471c-888c-8847625751ab_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:to="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_3b22280b-8c6e-4444-950f-7934da194306_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Indefinite-Lived, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_03e45130-268e-4ba3-b0bb-586409f0ff41_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares remaining available for future issuance</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_03a6adc4-913e-48c2-9c61-16db72059b5e_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_a15e413e-5b1d-46e5-b34d-e6a4ae89b2c7_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_54a7011a-2501-42bf-82aa-37385107f6f8_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_8bfab34b-d298-4aed-8c39-3affb041f301_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_19395ed6-28d2-4d1e-93f4-62151f3ea2d8_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_c575981d-295e-40a5-b697-b25b61a98bba_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_0c46f5a9-d868-4e8c-8c22-867df01c9668_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_5b1093ae-1fcf-4b67-9229-957454997818_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_e78d3d38-591d-4fb8-b8f7-ce91acd7c854_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_c7d0ce1f-9ce0-488b-9e7c-fbe1f6134277_terseLabel_en-US" xlink:label="lab_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_label_en-US" xlink:label="lab_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Assets And Liabilities, Lessee [Abstract]</link:label>
    <link:label id="lab_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_documentation_en-US" xlink:label="lab_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Assets And Liabilities, Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:href="coo-20221031.xsd#coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:to="lab_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_2ed95065-a770-4ddc-afd1-9bb2d9b793ec_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_3f5ad92a-bcdf-4613-9de1-78a91a2ab1df_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate for determining benefit obligations at year end</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_a913d2ce-7c52-4cbf-8e96-a46618f51076_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments related to share-based compensation awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_fed668d1-73b2-4aee-8cad-e8861112dbbf_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract_a163a0d3-55da-45b4-a9f0-4ea14888f95c_terseLabel_en-US" xlink:label="lab_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other changes in plan assets and benefit obligations recognized in other comprehensive income:</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract_label_en-US" xlink:label="lab_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amount Recognized In Net Periodic Benefit Cost (Credit) And Other Comprehensive (Income) Loss, Before Tax1 [Abstract]</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract_documentation_en-US" xlink:label="lab_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US"></link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract" xlink:href="coo-20221031.xsd#coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract" xlink:to="lab_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_cafb39f2-f7c3-4a79-80b5-6b7b6374bb5b_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_c68ebbcd-d992-435c-bfc7-1d11d6a68550_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase program, remaining authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_7eafbda6-b6b5-4c8a-b2ff-100a12c18e28_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_d8f09eaf-2a64-480c-9c54-0d744aa95286_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total gross deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_b0d259ee-4754-4801-87ca-fa9d10f7818e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_35e72099-b016-411b-aa79-6bf339bf5ee0_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax_54834e82-8d6d-40e7-9ac9-64d145b72068_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortizations of net gain</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_10870781-a118-4b92-a3e3-f019ba71cda8_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued gross interest and penalties related to uncertain tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_43ad1c21-35a7-45b6-b6eb-97cc801a75a9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_7d3d879f-a03a-4f39-8ed4-60a47cf353a6_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income, diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_6a98a6f1-eb92-4065-a443-cd3d50132866_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_dd2c5c96-96e7-4818-a4ae-7febe7edaa7f_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_fd14eb49-aeda-4ebc-b075-bf2ead318578_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_f5bb80c0-fd3a-4e5b-9cc3-501c6fa50c44_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_a633b9c6-e2d1-4c2e-8511-64e99d4f54ea_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_822810f2-d635-4c60-b125-272405b7ab71_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_2cff5438-6dd0-4428-827f-19810b70c069_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_d2e18297-809b-441b-8ee8-7aa8c517c513_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning of the period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_00f13c70-c375-42fd-951b-85e7a2db2f6f_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End of the period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_792113d3-833b-4947-b7a7-f1bc40b6e79a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_e74a7028-b283-485b-bc5f-f5ee91c1c2a1_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability_99c75837-f6f7-44ef-8112-bb447073713e_negatedLabel_en-US" xlink:label="lab_coo_BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of contingent consideration</link:label>
    <link:label id="lab_coo_BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability_label_en-US" xlink:label="lab_coo_BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination And Asset Acquisitions, Contingent Consideration, Liability</link:label>
    <link:label id="lab_coo_BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability_documentation_en-US" xlink:label="lab_coo_BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination And Asset Acquisitions, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability" xlink:href="coo-20221031.xsd#coo_BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability" xlink:to="lab_coo_BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_dc47cc44-4544-4271-bb7e-2ddb0d85667f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_4d92321a-5748-47ab-8b76-881ef467a4f1_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_7186abbb-c020-40a8-9caa-f8eda47eb2f0_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_c260906f-f7ac-43c3-a888-4d9cb005e0f4_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_ebc4a512-1686-4bb2-8d50-919f311a81de_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum rental payments required under operating leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_4e39e3ce-6ba8-437f-bec2-67ce60934fe3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_2bc002b1-bc32-41ef-8d43-97b146227f7d_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant change in unrecognized tax benefits that is reasonably possible during the next twelve months</link:label>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_label_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:to="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_0dd51a3c-a581-4a7d-8f9d-f23d1bc98437_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_0f8f1c7f-53bd-4be1-bfb2-b9d1e1780374_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effect</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_da5eda51-bdfc-4c47-9da8-4056531b0ca8_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgeFundsMember_e71d88d0-7584-43a8-9f19-4b29acf4f1a4_terseLabel_en-US" xlink:label="lab_us-gaap_HedgeFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Strategy Funds</link:label>
    <link:label id="lab_us-gaap_HedgeFundsMember_label_en-US" xlink:label="lab_us-gaap_HedgeFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgeFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgeFundsMember" xlink:to="lab_us-gaap_HedgeFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned_08fb1764-8888-47ff-9da3-4459844d6195_terseLabel_en-US" xlink:label="lab_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Target percentage of shares earned</link:label>
    <link:label id="lab_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned_label_en-US" xlink:label="lab_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Target Percentage Of Shares Earned</link:label>
    <link:label id="lab_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned_documentation_en-US" xlink:label="lab_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Target Percentage Of Shares Earned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned" xlink:href="coo-20221031.xsd#coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned" xlink:to="lab_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_ca0067c5-dbf7-4e0c-90b5-fa3da538e06c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from (repayments of) short-term debt, other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable_adaad791-7db4-48d4-9b5f-de863ca4e6e0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Table]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_11eb673b-f6fb-4f10-9afd-88ae88f3ce1c_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_deb09951-006a-4c1a-a3c4-c96ce1d5a76e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_dfe4562e-9018-4e84-aa3a-1c707a1167c9_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_a57a20d9-768a-4412-b555-406c2ac92437_verboseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_3cdccf3b-d234-4f49-b034-43bdd51f5e15_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_8f09941b-ff4b-455d-98f3-032597cccc6a_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funded status at end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_231735cc-d19c-4712-aa0b-cb61bc40b7bf_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total gross deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost_14293b78-ea73-4616-896b-e25f2da57826_terseLabel_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Cost</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost_label_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Interest Cost</link:label>
    <link:label id="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost_documentation_en-US" xlink:label="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" xlink:href="coo-20221031.xsd#coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" xlink:to="lab_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_515b5062-faf4-42a6-82dc-fc60e8201fcc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_1d3cdbd3-4b2d-46b7-affe-c95a563f52e7_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule II</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_bd15ab8c-9fe9-4bd0-aa0e-dcb149de7881_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate for determining net periodic pension cost:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_ced0e55e-664e-40b3-af27-940c48a2c0aa_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_NonSingleUseSphereAndOtherMember_f164ef7c-a4ff-4774-beef-8a813cf5330f_terseLabel_en-US" xlink:label="lab_coo_NonSingleUseSphereAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non single-use sphere, other</link:label>
    <link:label id="lab_coo_NonSingleUseSphereAndOtherMember_label_en-US" xlink:label="lab_coo_NonSingleUseSphereAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Single-Use Sphere And Other [Member]</link:label>
    <link:label id="lab_coo_NonSingleUseSphereAndOtherMember_documentation_en-US" xlink:label="lab_coo_NonSingleUseSphereAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Single-Use Sphere And Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_NonSingleUseSphereAndOtherMember" xlink:href="coo-20221031.xsd#coo_NonSingleUseSphereAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_NonSingleUseSphereAndOtherMember" xlink:to="lab_coo_NonSingleUseSphereAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_53d3ad14-d84a-4415-a2f6-0ef566dc80f5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Grant&#160;Date&#160;Fair Value&#160;Per&#160;Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_coo_ToricLensMember_ee885078-6771-484e-b089-59911a5428a7_terseLabel_en-US" xlink:label="lab_coo_ToricLensMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Toric lens</link:label>
    <link:label id="lab_coo_ToricLensMember_label_en-US" xlink:label="lab_coo_ToricLensMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Toric Lens [Member]</link:label>
    <link:label id="lab_coo_ToricLensMember_documentation_en-US" xlink:label="lab_coo_ToricLensMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Toric Lens [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ToricLensMember" xlink:href="coo-20221031.xsd#coo_ToricLensMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_coo_ToricLensMember" xlink:to="lab_coo_ToricLensMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_3136c506-09c5-4eeb-9e12-a14158014d7b_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_30a4ec68-3943-4aa3-b464-ed16ca753e0b_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: unamortized debt issuance cost</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Noncurrent, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_ef2358ed-cfff-41fa-9a80-91d24f414257_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangibles</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_2e0a32ca-8b8a-4f23-926d-366aa5a86410_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_3033cd59-e07e-4ca6-bd0f-d31166adc3c9_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_a3ba343d-7724-4b06-8aad-4306018d17f5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c7690279-78e4-4204-9b57-bc7d4d7d3792_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes at United States statutory tax rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_62500083-5e70-4df6-9bfb-9068f80b9315_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_343cfcf4-7d29-44c5-8a97-9e8175a51b09_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax asset, intra-entity sale of certain intellectual property rights</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Intra-entity Transfer, Asset Other than Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" xlink:to="lab_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_fda6a516-ccce-4545-a660-1d2c85cf5aa4_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Immediate Recognition of Actuarial Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Immediate Recognition of Actuarial Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_c762ea55-7a34-45c2-bb1f-bb4a68cd2f55_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization and Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Description and Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_73e6485c-da2b-462e-9deb-f7ea4cc83095_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_e32428e0-5e5f-49f9-b7ba-5002eb70e3e1_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_98a7bdc9-351f-4d9d-aa8d-4418c7fdf87f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>coo-20221031_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:c1100544-9949-49e4-a84a-324e954b65ab,g:6f410f64-26fc-4654-ba7e-29974b75a0fc-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.coopercos.com/role/CoverPage" xlink:type="simple" xlink:href="coo-20221031.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_4a106c3a-6e21-4e7a-96a7-00aa4a376eb9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_DocumentType_4a106c3a-6e21-4e7a-96a7-00aa4a376eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_f43b88b1-2ab5-4c4b-9413-3931eca8f809" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_DocumentAnnualReport_f43b88b1-2ab5-4c4b-9413-3931eca8f809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_024b4b70-aeeb-476f-8512-f8297ecea464" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_DocumentPeriodEndDate_024b4b70-aeeb-476f-8512-f8297ecea464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_f61ab205-9844-4c7c-a359-3d3aa6bab3fc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_CurrentFiscalYearEndDate_f61ab205-9844-4c7c-a359-3d3aa6bab3fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_e3670d07-3a40-4b84-9b70-f53d7ae5b76c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_DocumentTransitionReport_e3670d07-3a40-4b84-9b70-f53d7ae5b76c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_9451342d-9629-484f-a91a-4b5b70802c87" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_EntityFileNumber_9451342d-9629-484f-a91a-4b5b70802c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_8e86ac4e-317c-42c9-b5f3-2a63f0e7aef1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_EntityRegistrantName_8e86ac4e-317c-42c9-b5f3-2a63f0e7aef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_504c7c93-6608-4f54-a7d0-28110c6c9259" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_EntityIncorporationStateCountryCode_504c7c93-6608-4f54-a7d0-28110c6c9259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_958f2db8-0687-421e-bed1-10be2ba5d3c8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_EntityTaxIdentificationNumber_958f2db8-0687-421e-bed1-10be2ba5d3c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_1a4c31d8-3a32-4e7e-b761-993937cae53e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_EntityAddressAddressLine1_1a4c31d8-3a32-4e7e-b761-993937cae53e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_bac310ad-32d4-4fd1-a471-4d6f1dce2c30" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_EntityAddressAddressLine2_bac310ad-32d4-4fd1-a471-4d6f1dce2c30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_fd5daa2a-83b4-48c7-8df3-302c9e3a5335" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_EntityAddressCityOrTown_fd5daa2a-83b4-48c7-8df3-302c9e3a5335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_064c31df-f036-4ba1-85af-74a25a4a1070" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_EntityAddressStateOrProvince_064c31df-f036-4ba1-85af-74a25a4a1070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_52634eff-3c17-49a0-b20f-62bf97bc1cb4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_EntityAddressPostalZipCode_52634eff-3c17-49a0-b20f-62bf97bc1cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_cf92039f-90c7-4f5d-b552-477a050bd72c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_CityAreaCode_cf92039f-90c7-4f5d-b552-477a050bd72c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_c0683a9f-98d7-4e30-b046-7f56837d52e5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_LocalPhoneNumber_c0683a9f-98d7-4e30-b046-7f56837d52e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_81bcebb0-7818-4d1e-b854-82dd358c65a6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_Security12bTitle_81bcebb0-7818-4d1e-b854-82dd358c65a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_2b097d08-4434-4a41-8e74-e009614be902" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_TradingSymbol_2b097d08-4434-4a41-8e74-e009614be902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_033bbd5e-b79a-4b9d-96c3-1d8e05d0ac9f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_SecurityExchangeName_033bbd5e-b79a-4b9d-96c3-1d8e05d0ac9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_b307ed4a-35eb-4180-a0e3-da00b19ccdf7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_b307ed4a-35eb-4180-a0e3-da00b19ccdf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_0e22625d-bbf5-43b4-8bc1-4e2f04db2f41" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_EntityVoluntaryFilers_0e22625d-bbf5-43b4-8bc1-4e2f04db2f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_08a5cc9b-2910-4be4-87b3-48c53f84155b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_EntityCurrentReportingStatus_08a5cc9b-2910-4be4-87b3-48c53f84155b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_988c325b-6cbd-45a0-a3c6-835e37ff94af" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_EntityInteractiveDataCurrent_988c325b-6cbd-45a0-a3c6-835e37ff94af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_12051b26-6ce4-41ba-842e-f405294ed00f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_EntityFilerCategory_12051b26-6ce4-41ba-842e-f405294ed00f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_77405c4e-76de-4fad-b3a9-d8fb64a6aac7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_EntitySmallBusiness_77405c4e-76de-4fad-b3a9-d8fb64a6aac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_1b22ddfb-4bf1-426b-a178-92dc48670d00" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_EntityEmergingGrowthCompany_1b22ddfb-4bf1-426b-a178-92dc48670d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_953b1b3c-c3e3-4418-b199-343c1555c96c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_IcfrAuditorAttestationFlag_953b1b3c-c3e3-4418-b199-343c1555c96c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_825fdf06-b79f-42ed-b8a6-c64396a3dc4a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_EntityShellCompany_825fdf06-b79f-42ed-b8a6-c64396a3dc4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_6295d4d9-92db-40e7-a56d-5e6661424d7e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_EntityPublicFloat_6295d4d9-92db-40e7-a56d-5e6661424d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_cdaaced2-f37a-4cea-a905-fb9753bcc421" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_cdaaced2-f37a-4cea-a905-fb9753bcc421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_549464a7-36cd-4a30-9d75-2fe8ac2153b7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_AmendmentFlag_549464a7-36cd-4a30-9d75-2fe8ac2153b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_8b0351d4-eba1-4521-8936-81309216c553" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_DocumentFiscalYearFocus_8b0351d4-eba1-4521-8936-81309216c553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_aa03cf8d-8a3f-4f8d-b89c-3a4834bc98be" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_DocumentFiscalPeriodFocus_aa03cf8d-8a3f-4f8d-b89c-3a4834bc98be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_2f62f96b-6218-4176-abb1-a840bb7c0a68" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_EntityCentralIndexKey_2f62f96b-6218-4176-abb1-a840bb7c0a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_2696046f-b34c-4f5b-9213-3c6bcef22396" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37c0b73e-dfe3-481f-a977-f27d5c40a45c" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_2696046f-b34c-4f5b-9213-3c6bcef22396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/AuditInformation" xlink:type="simple" xlink:href="coo-20221031.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_coo_AuditInformationAbstract_8d295d36-40cd-4538-88bd-75e5e71b040c" xlink:href="coo-20221031.xsd#coo_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_ecc13239-0d33-4ba8-ad15-947ded38a970" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_AuditInformationAbstract_8d295d36-40cd-4538-88bd-75e5e71b040c" xlink:to="loc_dei_AuditorName_ecc13239-0d33-4ba8-ad15-947ded38a970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_82df9cd4-6392-4623-8cc6-1510a6174961" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_AuditInformationAbstract_8d295d36-40cd-4538-88bd-75e5e71b040c" xlink:to="loc_dei_AuditorLocation_82df9cd4-6392-4623-8cc6-1510a6174961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_40fe8b2d-c3eb-4c16-a597-77bca1a0520c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_AuditInformationAbstract_8d295d36-40cd-4538-88bd-75e5e71b040c" xlink:to="loc_dei_AuditorFirmId_40fe8b2d-c3eb-4c16-a597-77bca1a0520c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="coo-20221031.xsd#ConsolidatedStatementsofIncome"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/ConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_4f2c7d61-f76a-4045-a2ac-1782c9e45447" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d28c212c-b9a9-4a31-92e7-de6c3c8f7708" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4f2c7d61-f76a-4045-a2ac-1782c9e45447" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d28c212c-b9a9-4a31-92e7-de6c3c8f7708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_6d43bedb-fbb1-43f1-b49f-b4b244235daa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4f2c7d61-f76a-4045-a2ac-1782c9e45447" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_6d43bedb-fbb1-43f1-b49f-b4b244235daa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_e74698f2-3cac-4ee0-b866-5f72992b2fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4f2c7d61-f76a-4045-a2ac-1782c9e45447" xlink:to="loc_us-gaap_GrossProfit_e74698f2-3cac-4ee0-b866-5f72992b2fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_51624984-f4ef-40fa-b2e1-72d47bdd4511" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4f2c7d61-f76a-4045-a2ac-1782c9e45447" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_51624984-f4ef-40fa-b2e1-72d47bdd4511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_57f26951-1f1b-4b6a-ad0c-d029a7a7c252" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4f2c7d61-f76a-4045-a2ac-1782c9e45447" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_57f26951-1f1b-4b6a-ad0c-d029a7a7c252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_39f3f229-8e52-405b-a6dc-d7ab1837f7bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4f2c7d61-f76a-4045-a2ac-1782c9e45447" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_39f3f229-8e52-405b-a6dc-d7ab1837f7bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d0ee04c8-07b2-41b4-b9e3-7a26af1ebe5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4f2c7d61-f76a-4045-a2ac-1782c9e45447" xlink:to="loc_us-gaap_OperatingIncomeLoss_d0ee04c8-07b2-41b4-b9e3-7a26af1ebe5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_f6ae6ae5-627d-4589-b489-6787dc77746e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4f2c7d61-f76a-4045-a2ac-1782c9e45447" xlink:to="loc_us-gaap_InterestExpense_f6ae6ae5-627d-4589-b489-6787dc77746e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_f26404b2-76d3-47b6-8b83-4cb47d806122" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4f2c7d61-f76a-4045-a2ac-1782c9e45447" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_f26404b2-76d3-47b6-8b83-4cb47d806122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9cc8ef5d-d1f1-40be-b3ea-6629f115ee23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4f2c7d61-f76a-4045-a2ac-1782c9e45447" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9cc8ef5d-d1f1-40be-b3ea-6629f115ee23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_02bd77d2-0ec0-4a69-a2e3-e53f33849bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4f2c7d61-f76a-4045-a2ac-1782c9e45447" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_02bd77d2-0ec0-4a69-a2e3-e53f33849bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3d06f629-e831-48a8-8bcb-85ea39a69099" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4f2c7d61-f76a-4045-a2ac-1782c9e45447" xlink:to="loc_us-gaap_NetIncomeLoss_3d06f629-e831-48a8-8bcb-85ea39a69099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_837fe477-2a54-4a1e-9580-4b0d0f97d5aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4f2c7d61-f76a-4045-a2ac-1782c9e45447" xlink:to="loc_us-gaap_EarningsPerShareAbstract_837fe477-2a54-4a1e-9580-4b0d0f97d5aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_08dd7c78-2acc-482d-87b7-5f4fa4952874" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_837fe477-2a54-4a1e-9580-4b0d0f97d5aa" xlink:to="loc_us-gaap_EarningsPerShareBasic_08dd7c78-2acc-482d-87b7-5f4fa4952874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_989f26e3-3a66-441d-a0fa-f125a7aab507" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_837fe477-2a54-4a1e-9580-4b0d0f97d5aa" xlink:to="loc_us-gaap_EarningsPerShareDiluted_989f26e3-3a66-441d-a0fa-f125a7aab507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1ccc1562-748b-4256-9e98-c57c6f924274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4f2c7d61-f76a-4045-a2ac-1782c9e45447" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1ccc1562-748b-4256-9e98-c57c6f924274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3ae75686-35da-4083-9d64-9451c67bd40e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1ccc1562-748b-4256-9e98-c57c6f924274" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3ae75686-35da-4083-9d64-9451c67bd40e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b3781113-1312-4b3b-b84f-fe29b10c6343" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1ccc1562-748b-4256-9e98-c57c6f924274" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b3781113-1312-4b3b-b84f-fe29b10c6343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="coo-20221031.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3678fbc1-1104-49c2-8f71-c2dae6d3b0f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_632468d3-3a6c-4212-af11-5c8cda2e54d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3678fbc1-1104-49c2-8f71-c2dae6d3b0f1" xlink:to="loc_us-gaap_NetIncomeLoss_632468d3-3a6c-4212-af11-5c8cda2e54d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0846899a-dc98-411f-8692-05f8430f7774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3678fbc1-1104-49c2-8f71-c2dae6d3b0f1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0846899a-dc98-411f-8692-05f8430f7774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_f01b01fd-3051-4a77-ab2f-8060b23455b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0846899a-dc98-411f-8692-05f8430f7774" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_f01b01fd-3051-4a77-ab2f-8060b23455b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_8f77f526-bc7b-4896-85ac-cc4b760cd984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0846899a-dc98-411f-8692-05f8430f7774" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_8f77f526-bc7b-4896-85ac-cc4b760cd984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1465a9b7-2fb7-4a45-b4c6-550873a5e4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0846899a-dc98-411f-8692-05f8430f7774" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1465a9b7-2fb7-4a45-b4c6-550873a5e4e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2b80cf12-0c73-4e9e-a498-eddce081ec04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0846899a-dc98-411f-8692-05f8430f7774" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2b80cf12-0c73-4e9e-a498-eddce081ec04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_56400996-27b0-4f37-b804-227078ad3b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3678fbc1-1104-49c2-8f71-c2dae6d3b0f1" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_56400996-27b0-4f37-b804-227078ad3b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical" xlink:type="simple" xlink:href="coo-20221031.xsd#ConsolidatedStatementsofComprehensiveIncomeParenthetical"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_931cc38c-e09b-4b4d-a3a3-fcafbdb22279" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_a254a5aa-2251-463c-ab06-f4245d76c95a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_931cc38c-e09b-4b4d-a3a3-fcafbdb22279" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_a254a5aa-2251-463c-ab06-f4245d76c95a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_0ac12f1e-f2d0-4825-bcdf-687d306cdf73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_931cc38c-e09b-4b4d-a3a3-fcafbdb22279" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_0ac12f1e-f2d0-4825-bcdf-687d306cdf73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="coo-20221031.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_141a5c84-04d3-4d2a-afe1-5a59280a300c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_2c6abbe7-f11c-45fb-a825-defc1800ef71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_141a5c84-04d3-4d2a-afe1-5a59280a300c" xlink:to="loc_us-gaap_AssetsAbstract_2c6abbe7-f11c-45fb-a825-defc1800ef71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_a044738a-99a3-4300-8d08-faef5c09d120" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2c6abbe7-f11c-45fb-a825-defc1800ef71" xlink:to="loc_us-gaap_AssetsCurrentAbstract_a044738a-99a3-4300-8d08-faef5c09d120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_935a6450-9e07-4a28-af06-062ace515ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a044738a-99a3-4300-8d08-faef5c09d120" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_935a6450-9e07-4a28-af06-062ace515ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_2730f98e-6559-42fe-9af8-852e6cf9d8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a044738a-99a3-4300-8d08-faef5c09d120" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_2730f98e-6559-42fe-9af8-852e6cf9d8a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_41cab961-0094-464b-a1de-9bb2934d663b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a044738a-99a3-4300-8d08-faef5c09d120" xlink:to="loc_us-gaap_InventoryNet_41cab961-0094-464b-a1de-9bb2934d663b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_aaaa2fd2-8863-411a-a94c-7d5eb3d7fb3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a044738a-99a3-4300-8d08-faef5c09d120" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_aaaa2fd2-8863-411a-a94c-7d5eb3d7fb3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_218acd09-aef9-4313-b43b-f4ed1c2f75c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a044738a-99a3-4300-8d08-faef5c09d120" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_218acd09-aef9-4313-b43b-f4ed1c2f75c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a53229d8-513a-4632-8e38-31bbf7e4fa98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a044738a-99a3-4300-8d08-faef5c09d120" xlink:to="loc_us-gaap_AssetsCurrent_a53229d8-513a-4632-8e38-31bbf7e4fa98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_b3d92896-2be6-4629-b26e-04fac90d6a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2c6abbe7-f11c-45fb-a825-defc1800ef71" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_b3d92896-2be6-4629-b26e-04fac90d6a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9c31de6f-c525-4734-9b1c-721b58e11762" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2c6abbe7-f11c-45fb-a825-defc1800ef71" xlink:to="loc_us-gaap_Goodwill_9c31de6f-c525-4734-9b1c-721b58e11762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6eb8aef7-1179-405d-8b61-12b38cb0ad10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2c6abbe7-f11c-45fb-a825-defc1800ef71" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6eb8aef7-1179-405d-8b61-12b38cb0ad10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_cea256bb-14b5-4ca3-aa04-667eb19b78c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2c6abbe7-f11c-45fb-a825-defc1800ef71" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_cea256bb-14b5-4ca3-aa04-667eb19b78c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_2273f6b1-136a-479e-9f4f-c942dca4bba4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2c6abbe7-f11c-45fb-a825-defc1800ef71" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_2273f6b1-136a-479e-9f4f-c942dca4bba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_29ecc594-41c5-45ab-aa66-3e65f9bb2568" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2c6abbe7-f11c-45fb-a825-defc1800ef71" xlink:to="loc_us-gaap_Assets_29ecc594-41c5-45ab-aa66-3e65f9bb2568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2dd810d5-6848-4f90-a957-043bb860e2a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_141a5c84-04d3-4d2a-afe1-5a59280a300c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2dd810d5-6848-4f90-a957-043bb860e2a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_ed941dc8-2b94-4d9a-988e-793084892acf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2dd810d5-6848-4f90-a957-043bb860e2a8" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_ed941dc8-2b94-4d9a-988e-793084892acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_4a975bf4-5bca-4264-9703-1d2f8959e904" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ed941dc8-2b94-4d9a-988e-793084892acf" xlink:to="loc_us-gaap_DebtCurrent_4a975bf4-5bca-4264-9703-1d2f8959e904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_d0cab0d0-ffcb-4d11-8d69-4e99d0baaf34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ed941dc8-2b94-4d9a-988e-793084892acf" xlink:to="loc_us-gaap_AccountsPayableCurrent_d0cab0d0-ffcb-4d11-8d69-4e99d0baaf34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_6ba85aad-411b-439b-8155-641328dfbc91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ed941dc8-2b94-4d9a-988e-793084892acf" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_6ba85aad-411b-439b-8155-641328dfbc91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_b5c4ef0b-e525-42b3-bad2-65011f7f795b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ed941dc8-2b94-4d9a-988e-793084892acf" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_b5c4ef0b-e525-42b3-bad2-65011f7f795b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_214384bb-2eef-4d65-8627-9e1efb026cba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ed941dc8-2b94-4d9a-988e-793084892acf" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_214384bb-2eef-4d65-8627-9e1efb026cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_9d2d874b-4a27-4417-b423-9269e4edcb1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ed941dc8-2b94-4d9a-988e-793084892acf" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_9d2d874b-4a27-4417-b423-9269e4edcb1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ff47fcc4-08aa-4c45-9ca7-d22847f894a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ed941dc8-2b94-4d9a-988e-793084892acf" xlink:to="loc_us-gaap_LiabilitiesCurrent_ff47fcc4-08aa-4c45-9ca7-d22847f894a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_87863038-35c8-4053-b362-d9a723ae3a03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2dd810d5-6848-4f90-a957-043bb860e2a8" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_87863038-35c8-4053-b362-d9a723ae3a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_6ea41095-ea5f-492b-be00-0c72ca06239c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2dd810d5-6848-4f90-a957-043bb860e2a8" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_6ea41095-ea5f-492b-be00-0c72ca06239c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_3e2c2932-eb7e-4a9d-93f4-62ca90acb89e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2dd810d5-6848-4f90-a957-043bb860e2a8" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_3e2c2932-eb7e-4a9d-93f4-62ca90acb89e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_55cc30ed-f3b1-4332-a9aa-e3f7bfdedd50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2dd810d5-6848-4f90-a957-043bb860e2a8" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_55cc30ed-f3b1-4332-a9aa-e3f7bfdedd50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent_c7800b1a-3c11-4cdd-a5fb-85e387d20410" xlink:href="coo-20221031.xsd#coo_LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2dd810d5-6848-4f90-a957-043bb860e2a8" xlink:to="loc_coo_LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent_c7800b1a-3c11-4cdd-a5fb-85e387d20410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_50717e62-1499-46df-a6c6-26aabad50bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2dd810d5-6848-4f90-a957-043bb860e2a8" xlink:to="loc_us-gaap_Liabilities_50717e62-1499-46df-a6c6-26aabad50bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_287d9bed-bc44-4dd8-9c21-a335686cef63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2dd810d5-6848-4f90-a957-043bb860e2a8" xlink:to="loc_us-gaap_CommitmentsAndContingencies_287d9bed-bc44-4dd8-9c21-a335686cef63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_92ebaac6-7c5b-468a-ba11-2cc518f48549" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2dd810d5-6848-4f90-a957-043bb860e2a8" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_92ebaac6-7c5b-468a-ba11-2cc518f48549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_b2493f04-c498-48ad-8bba-893cce29a2b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_92ebaac6-7c5b-468a-ba11-2cc518f48549" xlink:to="loc_us-gaap_PreferredStockValue_b2493f04-c498-48ad-8bba-893cce29a2b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_de21810f-d796-471e-8162-acf4dafb1533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_92ebaac6-7c5b-468a-ba11-2cc518f48549" xlink:to="loc_us-gaap_CommonStockValue_de21810f-d796-471e-8162-acf4dafb1533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_a8b84d7d-7532-4ccc-a4aa-b93ab9275cce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_92ebaac6-7c5b-468a-ba11-2cc518f48549" xlink:to="loc_us-gaap_AdditionalPaidInCapital_a8b84d7d-7532-4ccc-a4aa-b93ab9275cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6483a362-436c-4715-95af-e8fb20534e62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_92ebaac6-7c5b-468a-ba11-2cc518f48549" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6483a362-436c-4715-95af-e8fb20534e62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_bab49d49-5dd5-4f68-9e12-e81a848434c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_92ebaac6-7c5b-468a-ba11-2cc518f48549" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_bab49d49-5dd5-4f68-9e12-e81a848434c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_770ff6ce-ada1-488e-a682-1abbc247946d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_92ebaac6-7c5b-468a-ba11-2cc518f48549" xlink:to="loc_us-gaap_TreasuryStockCommonValue_770ff6ce-ada1-488e-a682-1abbc247946d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5310bf8c-e702-4c9e-96ba-332ebcf16951" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_92ebaac6-7c5b-468a-ba11-2cc518f48549" xlink:to="loc_us-gaap_StockholdersEquity_5310bf8c-e702-4c9e-96ba-332ebcf16951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_e3e79862-e1f3-4ef1-889d-25a5b65242e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_92ebaac6-7c5b-468a-ba11-2cc518f48549" xlink:to="loc_us-gaap_MinorityInterest_e3e79862-e1f3-4ef1-889d-25a5b65242e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c4d9ce88-b7f1-41c3-b02a-1cf1ab2c1b13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_92ebaac6-7c5b-468a-ba11-2cc518f48549" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c4d9ce88-b7f1-41c3-b02a-1cf1ab2c1b13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_705ed02d-56c7-4d33-9186-4be99e54680e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2dd810d5-6848-4f90-a957-043bb860e2a8" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_705ed02d-56c7-4d33-9186-4be99e54680e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="coo-20221031.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_76171ce2-7a9b-43f1-9b82-ca224b37f245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_bfc8505d-eebd-4892-a9f2-fdd5c910e8ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_76171ce2-7a9b-43f1-9b82-ca224b37f245" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_bfc8505d-eebd-4892-a9f2-fdd5c910e8ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1ff3ea6e-1c01-4c0c-a437-a1cce24f64c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_76171ce2-7a9b-43f1-9b82-ca224b37f245" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1ff3ea6e-1c01-4c0c-a437-a1cce24f64c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_9925b0d7-a2b0-48de-92a4-16a022e9ed41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_76171ce2-7a9b-43f1-9b82-ca224b37f245" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_9925b0d7-a2b0-48de-92a4-16a022e9ed41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_733988ab-fb09-42ee-975d-e706ce27414e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_76171ce2-7a9b-43f1-9b82-ca224b37f245" xlink:to="loc_us-gaap_PreferredStockSharesIssued_733988ab-fb09-42ee-975d-e706ce27414e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_58138557-522f-439d-a50d-e255e8e116e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_76171ce2-7a9b-43f1-9b82-ca224b37f245" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_58138557-522f-439d-a50d-e255e8e116e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_89419564-c551-445e-bc76-92bc34b6cf30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_76171ce2-7a9b-43f1-9b82-ca224b37f245" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_89419564-c551-445e-bc76-92bc34b6cf30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_0b5bcae9-d135-4ec5-ba17-d2bcaa36a1a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_76171ce2-7a9b-43f1-9b82-ca224b37f245" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_0b5bcae9-d135-4ec5-ba17-d2bcaa36a1a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_f17c8c1b-ec15-4218-8e42-ddf967f9ce5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_76171ce2-7a9b-43f1-9b82-ca224b37f245" xlink:to="loc_us-gaap_CommonStockSharesIssued_f17c8c1b-ec15-4218-8e42-ddf967f9ce5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_660d00be-b2c1-4a38-9b0e-c91278139ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_76171ce2-7a9b-43f1-9b82-ca224b37f245" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_660d00be-b2c1-4a38-9b0e-c91278139ea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_731d4bc8-e74e-473a-ab7a-293ada97ad04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_76171ce2-7a9b-43f1-9b82-ca224b37f245" xlink:to="loc_us-gaap_TreasuryStockCommonShares_731d4bc8-e74e-473a-ab7a-293ada97ad04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="coo-20221031.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_d008ec1a-9dd5-43b5-bec1-5681d8df011f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_32677b96-f124-4a36-a281-03f272ce8773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_d008ec1a-9dd5-43b5-bec1-5681d8df011f" xlink:to="loc_us-gaap_StatementTable_32677b96-f124-4a36-a281-03f272ce8773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d1bf1ba9-9267-441b-94ca-ea9fbcfd95f6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_32677b96-f124-4a36-a281-03f272ce8773" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d1bf1ba9-9267-441b-94ca-ea9fbcfd95f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e0d50753-f549-4ad9-a4a1-c31c6578b396" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d1bf1ba9-9267-441b-94ca-ea9fbcfd95f6" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e0d50753-f549-4ad9-a4a1-c31c6578b396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_a2921c28-a23a-4bf6-b0ee-b4bec77f96aa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e0d50753-f549-4ad9-a4a1-c31c6578b396" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_a2921c28-a23a-4bf6-b0ee-b4bec77f96aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_95ae6653-8fae-42d7-9014-9465852c6a89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_32677b96-f124-4a36-a281-03f272ce8773" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_95ae6653-8fae-42d7-9014-9465852c6a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0146e6ca-82de-4232-9c3c-1a64f92edc68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_95ae6653-8fae-42d7-9014-9465852c6a89" xlink:to="loc_us-gaap_EquityComponentDomain_0146e6ca-82de-4232-9c3c-1a64f92edc68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CommonStockExcludingTreasuryStockParNetValueMember_c6bc9962-f2c7-49c7-8c75-fa82563681d8" xlink:href="coo-20221031.xsd#coo_CommonStockExcludingTreasuryStockParNetValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0146e6ca-82de-4232-9c3c-1a64f92edc68" xlink:to="loc_coo_CommonStockExcludingTreasuryStockParNetValueMember_c6bc9962-f2c7-49c7-8c75-fa82563681d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_d61bb630-eadb-442a-a61f-25fa3ca5d287" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0146e6ca-82de-4232-9c3c-1a64f92edc68" xlink:to="loc_us-gaap_TreasuryStockCommonMember_d61bb630-eadb-442a-a61f-25fa3ca5d287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TreasuryStockParNetValueMember_c6e6559c-699d-403c-a877-3068d713e19c" xlink:href="coo-20221031.xsd#coo_TreasuryStockParNetValueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0146e6ca-82de-4232-9c3c-1a64f92edc68" xlink:to="loc_coo_TreasuryStockParNetValueMember_c6e6559c-699d-403c-a877-3068d713e19c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_5ac8a2a8-f5ff-482b-a85e-96406f771870" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0146e6ca-82de-4232-9c3c-1a64f92edc68" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_5ac8a2a8-f5ff-482b-a85e-96406f771870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_84a9346c-ff86-4567-86ac-5361ebc12e7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0146e6ca-82de-4232-9c3c-1a64f92edc68" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_84a9346c-ff86-4567-86ac-5361ebc12e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_158693cf-499c-4056-9751-d2ce6c04fc3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0146e6ca-82de-4232-9c3c-1a64f92edc68" xlink:to="loc_us-gaap_RetainedEarningsMember_158693cf-499c-4056-9751-d2ce6c04fc3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_79bb480c-e5af-436c-8611-ad39527599cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0146e6ca-82de-4232-9c3c-1a64f92edc68" xlink:to="loc_us-gaap_NoncontrollingInterestMember_79bb480c-e5af-436c-8611-ad39527599cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5dc850ff-c3c7-4f81-b65a-4ab89cf41b4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_32677b96-f124-4a36-a281-03f272ce8773" xlink:to="loc_us-gaap_StatementLineItems_5dc850ff-c3c7-4f81-b65a-4ab89cf41b4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d435f524-7775-427e-9a02-57e2cbcc95eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5dc850ff-c3c7-4f81-b65a-4ab89cf41b4f" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d435f524-7775-427e-9a02-57e2cbcc95eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_fa326ec7-617d-4ac9-8251-fb9a4834bb53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d435f524-7775-427e-9a02-57e2cbcc95eb" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_fa326ec7-617d-4ac9-8251-fb9a4834bb53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_90f4a76f-dd9e-4e94-8a1c-9b210d1eee5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d435f524-7775-427e-9a02-57e2cbcc95eb" xlink:to="loc_us-gaap_TreasuryStockCommonShares_90f4a76f-dd9e-4e94-8a1c-9b210d1eee5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4e5f5f82-360c-49f0-87e5-b1801e6a3e76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d435f524-7775-427e-9a02-57e2cbcc95eb" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4e5f5f82-360c-49f0-87e5-b1801e6a3e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5a81638f-a06a-4a65-823c-2ea6561cb754" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d435f524-7775-427e-9a02-57e2cbcc95eb" xlink:to="loc_us-gaap_NetIncomeLoss_5a81638f-a06a-4a65-823c-2ea6561cb754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_aa0083dd-b427-46bd-85da-c8ef3e38ba11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d435f524-7775-427e-9a02-57e2cbcc95eb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_aa0083dd-b427-46bd-85da-c8ef3e38ba11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_11db9d4e-b9fa-4f19-90dc-839c2a729936" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d435f524-7775-427e-9a02-57e2cbcc95eb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_11db9d4e-b9fa-4f19-90dc-839c2a729936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_2db0782b-6245-4291-b173-6e521bf29fef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d435f524-7775-427e-9a02-57e2cbcc95eb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_2db0782b-6245-4291-b173-6e521bf29fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_6b69202e-6bb4-4492-9373-0e04a4e0f1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d435f524-7775-427e-9a02-57e2cbcc95eb" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_6b69202e-6bb4-4492-9373-0e04a4e0f1d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_e5a82e0c-5ced-4a83-9b41-8c8851e2a0eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d435f524-7775-427e-9a02-57e2cbcc95eb" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_e5a82e0c-5ced-4a83-9b41-8c8851e2a0eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_4f3aacc6-6d69-4154-aac2-b07ee8720d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d435f524-7775-427e-9a02-57e2cbcc95eb" xlink:to="loc_us-gaap_DividendsCommonStock_4f3aacc6-6d69-4154-aac2-b07ee8720d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b155a78c-30f1-4eb3-bba7-5b44a1ff28eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d435f524-7775-427e-9a02-57e2cbcc95eb" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b155a78c-30f1-4eb3-bba7-5b44a1ff28eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d76c5b76-1d55-4f17-b05c-26233578d03f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d435f524-7775-427e-9a02-57e2cbcc95eb" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d76c5b76-1d55-4f17-b05c-26233578d03f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_16f7cfb9-929b-4fed-b43b-96ebb44b9a36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d435f524-7775-427e-9a02-57e2cbcc95eb" xlink:to="loc_us-gaap_TreasuryStockCommonShares_16f7cfb9-929b-4fed-b43b-96ebb44b9a36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_241322c1-7838-4075-a5c4-d03ebbaf04d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d435f524-7775-427e-9a02-57e2cbcc95eb" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_241322c1-7838-4075-a5c4-d03ebbaf04d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_aafc8036-bd02-4f4d-a79c-dbf01d6f960a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5dc850ff-c3c7-4f81-b65a-4ab89cf41b4f" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_aafc8036-bd02-4f4d-a79c-dbf01d6f960a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="simple" xlink:href="coo-20221031.xsd#ConsolidatedStatementsofStockholdersEquityParenthetical"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_000fd83e-60fb-44d8-bfb8-bb5469c0cc4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_601b91c5-e3b1-434c-ae06-f0321d976181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_000fd83e-60fb-44d8-bfb8-bb5469c0cc4c" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_601b91c5-e3b1-434c-ae06-f0321d976181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="coo-20221031.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_8029b684-cb92-4d6f-971e-a0d43ad6ae07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5d339d4e-a534-487e-b1ba-5ca5862be2aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8029b684-cb92-4d6f-971e-a0d43ad6ae07" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5d339d4e-a534-487e-b1ba-5ca5862be2aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_152453eb-ce0c-46b0-ab5b-72cc8960249c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5d339d4e-a534-487e-b1ba-5ca5862be2aa" xlink:to="loc_us-gaap_NetIncomeLoss_152453eb-ce0c-46b0-ab5b-72cc8960249c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_96b518c4-16ae-47cc-981d-d8a2d5b18575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5d339d4e-a534-487e-b1ba-5ca5862be2aa" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_96b518c4-16ae-47cc-981d-d8a2d5b18575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_4e45b86d-2425-42b5-a29f-4965230e81ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_96b518c4-16ae-47cc-981d-d8a2d5b18575" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_4e45b86d-2425-42b5-a29f-4965230e81ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_64a6d26d-4a95-4ed3-a351-b0e436c70501" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_96b518c4-16ae-47cc-981d-d8a2d5b18575" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_64a6d26d-4a95-4ed3-a351-b0e436c70501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_8eb7f8f0-d5d1-4fb5-9728-f84980ef38c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_96b518c4-16ae-47cc-981d-d8a2d5b18575" xlink:to="loc_us-gaap_ShareBasedCompensation_8eb7f8f0-d5d1-4fb5-9728-f84980ef38c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_8666ee39-cbce-4e23-a485-78dcdf9a5f54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_96b518c4-16ae-47cc-981d-d8a2d5b18575" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_8666ee39-cbce-4e23-a485-78dcdf9a5f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_GainLossOnSaleOfAssetsAndAssetImpairmentChargesAndOther_924d4815-405e-42c6-8364-2c763072b602" xlink:href="coo-20221031.xsd#coo_GainLossOnSaleOfAssetsAndAssetImpairmentChargesAndOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_96b518c4-16ae-47cc-981d-d8a2d5b18575" xlink:to="loc_coo_GainLossOnSaleOfAssetsAndAssetImpairmentChargesAndOther_924d4815-405e-42c6-8364-2c763072b602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b1caca40-f665-4c41-ba00-bde4de63a1b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_96b518c4-16ae-47cc-981d-d8a2d5b18575" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b1caca40-f665-4c41-ba00-bde4de63a1b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_93d936a1-4f4c-482c-8579-59dab65cad77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_96b518c4-16ae-47cc-981d-d8a2d5b18575" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_93d936a1-4f4c-482c-8579-59dab65cad77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_660a7bee-0b26-44d8-9b22-0130ec4ab3c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5d339d4e-a534-487e-b1ba-5ca5862be2aa" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_660a7bee-0b26-44d8-9b22-0130ec4ab3c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_44386431-d38a-4598-b874-459965003bad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_660a7bee-0b26-44d8-9b22-0130ec4ab3c5" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_44386431-d38a-4598-b874-459965003bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_663b2467-e9d2-4506-9cdb-8772abddce9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_660a7bee-0b26-44d8-9b22-0130ec4ab3c5" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_663b2467-e9d2-4506-9cdb-8772abddce9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_249f82f1-f86c-4f77-9c73-0cc8898d0ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_660a7bee-0b26-44d8-9b22-0130ec4ab3c5" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_249f82f1-f86c-4f77-9c73-0cc8898d0ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet_88c249b4-5d30-428f-8ca5-33b246581cbb" xlink:href="coo-20221031.xsd#coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_660a7bee-0b26-44d8-9b22-0130ec4ab3c5" xlink:to="loc_coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet_88c249b4-5d30-428f-8ca5-33b246581cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_05cf5a57-bbd0-4935-868c-295cf2e98147" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_660a7bee-0b26-44d8-9b22-0130ec4ab3c5" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_05cf5a57-bbd0-4935-868c-295cf2e98147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_1cd2087f-5f3e-46e0-9d8c-6256f710bf21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_660a7bee-0b26-44d8-9b22-0130ec4ab3c5" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_1cd2087f-5f3e-46e0-9d8c-6256f710bf21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_69c87771-d879-4533-9bfa-f368456af164" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_660a7bee-0b26-44d8-9b22-0130ec4ab3c5" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_69c87771-d879-4533-9bfa-f368456af164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_2739dcee-6301-458d-8612-c4965c680f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_660a7bee-0b26-44d8-9b22-0130ec4ab3c5" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_2739dcee-6301-458d-8612-c4965c680f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_IncreaseDecreaseInContingentConsiderationLiability_57920fc9-23e1-478a-8736-e1614bbf385d" xlink:href="coo-20221031.xsd#coo_IncreaseDecreaseInContingentConsiderationLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_660a7bee-0b26-44d8-9b22-0130ec4ab3c5" xlink:to="loc_coo_IncreaseDecreaseInContingentConsiderationLiability_57920fc9-23e1-478a-8736-e1614bbf385d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d454bbc-029a-4cd1-90c2-e17213ae3518" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5d339d4e-a534-487e-b1ba-5ca5862be2aa" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d454bbc-029a-4cd1-90c2-e17213ae3518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ea0e5f0f-9bf4-4f5b-9028-79467e8b3f43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8029b684-cb92-4d6f-971e-a0d43ad6ae07" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ea0e5f0f-9bf4-4f5b-9028-79467e8b3f43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b8cb774f-214f-4189-97df-84a6680e0829" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ea0e5f0f-9bf4-4f5b-9028-79467e8b3f43" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b8cb774f-214f-4189-97df-84a6680e0829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired_87c30f9d-da33-49f2-9600-d1053aece37f" xlink:href="coo-20221031.xsd#coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ea0e5f0f-9bf4-4f5b-9028-79467e8b3f43" xlink:to="loc_coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired_87c30f9d-da33-49f2-9600-d1053aece37f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_933abadf-aba3-4dbc-bd2f-e1263a3be5f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ea0e5f0f-9bf4-4f5b-9028-79467e8b3f43" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_933abadf-aba3-4dbc-bd2f-e1263a3be5f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_dfbb792c-5953-4dde-b87b-fe98d8d4eba0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ea0e5f0f-9bf4-4f5b-9028-79467e8b3f43" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_dfbb792c-5953-4dde-b87b-fe98d8d4eba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_57afab8a-1a02-4236-b8d1-8bba7bbf8e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8029b684-cb92-4d6f-971e-a0d43ad6ae07" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_57afab8a-1a02-4236-b8d1-8bba7bbf8e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_7bdae55d-335b-422e-92d2-8ed81ad210bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_57afab8a-1a02-4236-b8d1-8bba7bbf8e8d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_7bdae55d-335b-422e-92d2-8ed81ad210bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_15eab258-5d03-4afc-805b-90085969b922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_57afab8a-1a02-4236-b8d1-8bba7bbf8e8d" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_15eab258-5d03-4afc-805b-90085969b922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_3a1e83d9-f723-43d7-be7d-0231fdc5f70c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_57afab8a-1a02-4236-b8d1-8bba7bbf8e8d" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_3a1e83d9-f723-43d7-be7d-0231fdc5f70c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_18ca5525-a2e6-4544-a5e6-d4994e12d290" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_57afab8a-1a02-4236-b8d1-8bba7bbf8e8d" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_18ca5525-a2e6-4544-a5e6-d4994e12d290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_98a3998a-f599-485d-b4cc-ced703c26d73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_57afab8a-1a02-4236-b8d1-8bba7bbf8e8d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_98a3998a-f599-485d-b4cc-ced703c26d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_16ed4845-31f6-475a-bc7f-65902ba8069f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_57afab8a-1a02-4236-b8d1-8bba7bbf8e8d" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_16ed4845-31f6-475a-bc7f-65902ba8069f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_8fbe7950-6aa2-42a0-95b1-dd417c8ee1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_57afab8a-1a02-4236-b8d1-8bba7bbf8e8d" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_8fbe7950-6aa2-42a0-95b1-dd417c8ee1bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_12528ca9-8119-4666-81d6-5ca6ed747f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_57afab8a-1a02-4236-b8d1-8bba7bbf8e8d" xlink:to="loc_us-gaap_ProceedsFromStockPlans_12528ca9-8119-4666-81d6-5ca6ed747f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_9eb0a0c0-8a7a-42d4-b913-ba082db21761" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_57afab8a-1a02-4236-b8d1-8bba7bbf8e8d" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_9eb0a0c0-8a7a-42d4-b913-ba082db21761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c909b289-f447-4d95-8334-0da89bfe7405" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_57afab8a-1a02-4236-b8d1-8bba7bbf8e8d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c909b289-f447-4d95-8334-0da89bfe7405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8a7a5f18-66d6-4659-b88f-370e019e43f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8029b684-cb92-4d6f-971e-a0d43ad6ae07" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8a7a5f18-66d6-4659-b88f-370e019e43f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_282ca1a1-9563-4d27-b829-637e48472d83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8029b684-cb92-4d6f-971e-a0d43ad6ae07" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_282ca1a1-9563-4d27-b829-637e48472d83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4d30ac7b-3ef4-4856-93e0-884d874f4ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8029b684-cb92-4d6f-971e-a0d43ad6ae07" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4d30ac7b-3ef4-4856-93e0-884d874f4ce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a5c6cbd3-7275-4d7f-8998-6c2bdfa1df1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8029b684-cb92-4d6f-971e-a0d43ad6ae07" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a5c6cbd3-7275-4d7f-8998-6c2bdfa1df1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_7260787d-a24f-45d8-8de0-8ca2918b6654" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8029b684-cb92-4d6f-971e-a0d43ad6ae07" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_7260787d-a24f-45d8-8de0-8ca2918b6654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_66da6bb4-d604-432c-9007-43a1c880cb6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_7260787d-a24f-45d8-8de0-8ca2918b6654" xlink:to="loc_us-gaap_InterestPaidNet_66da6bb4-d604-432c-9007-43a1c880cb6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_efb42d24-d6ee-48b4-84ea-136833e036ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_7260787d-a24f-45d8-8de0-8ca2918b6654" xlink:to="loc_us-gaap_IncomeTaxesPaid_efb42d24-d6ee-48b4-84ea-136833e036ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_6a2384b8-a26d-489c-a532-a47d30812eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_7260787d-a24f-45d8-8de0-8ca2918b6654" xlink:to="loc_us-gaap_OperatingLeasePayments_6a2384b8-a26d-489c-a532-a47d30812eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_c526ff7d-e061-4f4a-8ac2-0cc2d79609d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_7260787d-a24f-45d8-8de0-8ca2918b6654" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_c526ff7d-e061-4f4a-8ac2-0cc2d79609d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_dca9bb48-1c77-44d2-8e53-a74e7a11445c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8029b684-cb92-4d6f-971e-a0d43ad6ae07" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_dca9bb48-1c77-44d2-8e53-a74e7a11445c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_639748a7-47ce-48bb-95f7-2325a1556083" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_dca9bb48-1c77-44d2-8e53-a74e7a11445c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_639748a7-47ce-48bb-95f7-2325a1556083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_ff265b74-adef-45eb-afa1-8181178e4d52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_dca9bb48-1c77-44d2-8e53-a74e7a11445c" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_ff265b74-adef-45eb-afa1-8181178e4d52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_50c5d6e2-7c1e-43b7-97b1-7ccb4fbb1e23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_dca9bb48-1c77-44d2-8e53-a74e7a11445c" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_50c5d6e2-7c1e-43b7-97b1-7ccb4fbb1e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7dad04e0-ed3a-451e-b140-484d772125b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_dca9bb48-1c77-44d2-8e53-a74e7a11445c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7dad04e0-ed3a-451e-b140-484d772125b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OrganizationandSignificantAccountingPolicies" xlink:type="simple" xlink:href="coo-20221031.xsd#OrganizationandSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/OrganizationandSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8325af4c-8d0b-4fde-8f5f-fa5d9868b14f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_fd5c89c8-9276-49ff-8a1f-f8e38857fb29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8325af4c-8d0b-4fde-8f5f-fa5d9868b14f" xlink:to="loc_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_fd5c89c8-9276-49ff-8a1f-f8e38857fb29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OperatingLeases" xlink:type="simple" xlink:href="coo-20221031.xsd#OperatingLeases"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/OperatingLeases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_04f208a1-317f-42c6-a796-657017f5e67e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_770c2155-281f-410f-b014-a08472b2545a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_04f208a1-317f-42c6-a796-657017f5e67e" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_770c2155-281f-410f-b014-a08472b2545a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/AcquisitionsandJointVenture" xlink:type="simple" xlink:href="coo-20221031.xsd#AcquisitionsandJointVenture"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/AcquisitionsandJointVenture" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_fd4bcfe2-bede-40d8-b8f5-fc4c53739537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationAndAssetAcquisitionTextBlock_c62a82e1-9b6a-40b4-a196-e19472e696cc" xlink:href="coo-20221031.xsd#coo_BusinessCombinationAndAssetAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_fd4bcfe2-bede-40d8-b8f5-fc4c53739537" xlink:to="loc_coo_BusinessCombinationAndAssetAcquisitionTextBlock_c62a82e1-9b6a-40b4-a196-e19472e696cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IntangibleAssets" xlink:type="simple" xlink:href="coo-20221031.xsd#IntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/IntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ed3b920c-ad06-444f-9334-a93503825a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_3daeef50-4d79-4ec5-b0a0-f1d58ab653cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ed3b920c-ad06-444f-9334-a93503825a5e" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_3daeef50-4d79-4ec5-b0a0-f1d58ab653cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/FinancingArrangements" xlink:type="simple" xlink:href="coo-20221031.xsd#FinancingArrangements"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/FinancingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2fddcb64-ad80-42a8-9945-43c3dbc68e13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_47d27a12-0e56-4ba5-9165-559ac051185e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2fddcb64-ad80-42a8-9945-43c3dbc68e13" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_47d27a12-0e56-4ba5-9165-559ac051185e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IncomeTaxes" xlink:type="simple" xlink:href="coo-20221031.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9f260d30-019b-440f-b18b-df84b1d93172" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_3ed0914c-d3b4-4b05-9a1c-ae4e572920b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9f260d30-019b-440f-b18b-df84b1d93172" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_3ed0914c-d3b4-4b05-9a1c-ae4e572920b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EarningsPerShare" xlink:type="simple" xlink:href="coo-20221031.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_41415753-66dc-482c-9157-db43ad175c37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_d0021d53-a76e-4797-b68d-570e1cbdb149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_41415753-66dc-482c-9157-db43ad175c37" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_d0021d53-a76e-4797-b68d-570e1cbdb149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockholdersEquity" xlink:type="simple" xlink:href="coo-20221031.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_58d2d07d-3ca6-44ed-932c-284c46106945" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_aa26f853-7ec8-4479-b136-05a346465be7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_58d2d07d-3ca6-44ed-932c-284c46106945" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_aa26f853-7ec8-4479-b136-05a346465be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockPlans" xlink:type="simple" xlink:href="coo-20221031.xsd#StockPlans"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/StockPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a8dd84c5-84fa-42f7-a165-57d5b472c3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_753e05f3-e814-4e30-88d9-ff5b3d59128a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a8dd84c5-84fa-42f7-a165-57d5b472c3ee" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_753e05f3-e814-4e30-88d9-ff5b3d59128a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefits" xlink:type="simple" xlink:href="coo-20221031.xsd#EmployeeBenefits"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/EmployeeBenefits" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7d0b228d-8adf-469d-bda9-373a8ba914be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_ddeb5e6d-a2df-41d1-af7e-f24d03f04c26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7d0b228d-8adf-469d-bda9-373a8ba914be" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_ddeb5e6d-a2df-41d1-af7e-f24d03f04c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/Contingencies" xlink:type="simple" xlink:href="coo-20221031.xsd#Contingencies"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/Contingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2e3b7c11-f897-4df2-a6f7-e32e988c3ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_d9f3a073-7d65-432e-b0fb-e71272a4b340" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2e3b7c11-f897-4df2-a6f7-e32e988c3ca9" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_d9f3a073-7d65-432e-b0fb-e71272a4b340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/BusinessSegmentInformation" xlink:type="simple" xlink:href="coo-20221031.xsd#BusinessSegmentInformation"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/BusinessSegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_912e3ce8-89a0-474a-8621-672338605692" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_252dbb97-e028-43c2-8399-b2d1fcd3691c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_912e3ce8-89a0-474a-8621-672338605692" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_252dbb97-e028-43c2-8399-b2d1fcd3691c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/FinancialDerivativesandHedging" xlink:type="simple" xlink:href="coo-20221031.xsd#FinancialDerivativesandHedging"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/FinancialDerivativesandHedging" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0cdc454b-d2d5-4824-a597-2fd0730b70f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_1112bc61-1908-4482-bb59-8160f23c0a96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0cdc454b-d2d5-4824-a597-2fd0730b70f3" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_1112bc61-1908-4482-bb59-8160f23c0a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/ScheduleII" xlink:type="simple" xlink:href="coo-20221031.xsd#ScheduleII"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/ScheduleII" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_c6c67952-6fa4-4497-b6dc-5a17010c6e5e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_1b721cf3-f3e2-4473-9318-cb4823b86a8b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_c6c67952-6fa4-4497-b6dc-5a17010c6e5e" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_1b721cf3-f3e2-4473-9318-cb4823b86a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="coo-20221031.xsd#OrganizationandSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_67ad7f6d-39e1-4330-824f-b96b5a11911b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_527c370b-0a2d-4109-998d-58c9d975abf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_67ad7f6d-39e1-4330-824f-b96b5a11911b" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_527c370b-0a2d-4109-998d-58c9d975abf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_7ca6fac7-e6ac-4d99-90b1-0c655bddff14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_67ad7f6d-39e1-4330-824f-b96b5a11911b" xlink:to="loc_us-gaap_UseOfEstimates_7ca6fac7-e6ac-4d99-90b1-0c655bddff14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_9e7f6616-4a63-4b2a-9478-aafe9e73cb71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_67ad7f6d-39e1-4330-824f-b96b5a11911b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_9e7f6616-4a63-4b2a-9478-aafe9e73cb71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_a651e7fd-00fb-42f4-a1e3-c6940335a1f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_67ad7f6d-39e1-4330-824f-b96b5a11911b" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_a651e7fd-00fb-42f4-a1e3-c6940335a1f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_10c9b0f1-9004-409a-a2d1-d038c4a54679" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_67ad7f6d-39e1-4330-824f-b96b5a11911b" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_10c9b0f1-9004-409a-a2d1-d038c4a54679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_18e927ba-7bc4-422f-8720-b2ad41516cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_67ad7f6d-39e1-4330-824f-b96b5a11911b" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_18e927ba-7bc4-422f-8720-b2ad41516cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_61c205d4-ab82-437b-8638-fea40832df6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_67ad7f6d-39e1-4330-824f-b96b5a11911b" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_61c205d4-ab82-437b-8638-fea40832df6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_7fa8bacb-990d-4107-81fe-5c5cf634595e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_67ad7f6d-39e1-4330-824f-b96b5a11911b" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_7fa8bacb-990d-4107-81fe-5c5cf634595e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_29ac9d77-1c21-46e3-bcb0-c57eadf0af2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_67ad7f6d-39e1-4330-824f-b96b5a11911b" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_29ac9d77-1c21-46e3-bcb0-c57eadf0af2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_3f2a1c95-e754-4375-85e7-b53b232f0176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_67ad7f6d-39e1-4330-824f-b96b5a11911b" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_3f2a1c95-e754-4375-85e7-b53b232f0176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_5a62a91b-4c2e-49f0-b3dc-5d41f574723b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_67ad7f6d-39e1-4330-824f-b96b5a11911b" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_5a62a91b-4c2e-49f0-b3dc-5d41f574723b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_51062635-2c07-43d4-b440-ecadcfec6c03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_67ad7f6d-39e1-4330-824f-b96b5a11911b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_51062635-2c07-43d4-b440-ecadcfec6c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_b5f63cae-120f-40fe-a382-ba2b4c078050" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_67ad7f6d-39e1-4330-824f-b96b5a11911b" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_b5f63cae-120f-40fe-a382-ba2b4c078050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalUseSoftwarePolicy_6f32b099-9edc-4cdd-b096-5d62f23acb9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalUseSoftwarePolicy"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_67ad7f6d-39e1-4330-824f-b96b5a11911b" xlink:to="loc_us-gaap_InternalUseSoftwarePolicy_6f32b099-9edc-4cdd-b096-5d62f23acb9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_4dacbbf4-aab4-4958-af36-7f7c4e082874" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_67ad7f6d-39e1-4330-824f-b96b5a11911b" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_4dacbbf4-aab4-4958-af36-7f7c4e082874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_aa6020e6-6d2d-4440-b4d2-4a7574f7c909" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_67ad7f6d-39e1-4330-824f-b96b5a11911b" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_aa6020e6-6d2d-4440-b4d2-4a7574f7c909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_8ba509fd-ba47-4bcd-85fe-08e1f5f6ed9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_67ad7f6d-39e1-4330-824f-b96b5a11911b" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_8ba509fd-ba47-4bcd-85fe-08e1f5f6ed9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_6c509e74-76b7-480f-bff7-ba02d6d383bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_67ad7f6d-39e1-4330-824f-b96b5a11911b" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_6c509e74-76b7-480f-bff7-ba02d6d383bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_3695a146-cf9c-4502-877b-ce3e25b27ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_67ad7f6d-39e1-4330-824f-b96b5a11911b" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_3695a146-cf9c-4502-877b-ce3e25b27ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPolicyTextBlock_20fa83ee-a830-4bbc-9bcb-891a29108c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_67ad7f6d-39e1-4330-824f-b96b5a11911b" xlink:to="loc_us-gaap_StockholdersEquityPolicyTextBlock_20fa83ee-a830-4bbc-9bcb-891a29108c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_33615ff3-9f47-4106-a388-bc0dd81e844d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_67ad7f6d-39e1-4330-824f-b96b5a11911b" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_33615ff3-9f47-4106-a388-bc0dd81e844d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="coo-20221031.xsd#OrganizationandSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7700780f-09d6-4280-ae8a-c2584dac7531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_e419bff7-8115-4597-87d2-4a63c7c46ec9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7700780f-09d6-4280-ae8a-c2584dac7531" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_e419bff7-8115-4597-87d2-4a63c7c46ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_7bde8ed8-6998-461a-b8bc-8c26156abb2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7700780f-09d6-4280-ae8a-c2584dac7531" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_7bde8ed8-6998-461a-b8bc-8c26156abb2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OperatingLeasesTables" xlink:type="simple" xlink:href="coo-20221031.xsd#OperatingLeasesTables"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/OperatingLeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f0f2cf89-a8e4-46aa-b830-3c1f704f7640" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AssetsAndLiabilitiesLesseeTableTextBlock_bd924af6-59e4-49b6-968d-c31eae392f69" xlink:href="coo-20221031.xsd#coo_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f0f2cf89-a8e4-46aa-b830-3c1f704f7640" xlink:to="loc_coo_AssetsAndLiabilitiesLesseeTableTextBlock_bd924af6-59e4-49b6-968d-c31eae392f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_d3805605-8eba-42be-ba96-504d55f46520" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f0f2cf89-a8e4-46aa-b830-3c1f704f7640" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_d3805605-8eba-42be-ba96-504d55f46520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/AcquisitionsandJointVentureTables" xlink:type="simple" xlink:href="coo-20221031.xsd#AcquisitionsandJointVentureTables"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/AcquisitionsandJointVentureTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_95bf9787-314c-4ee5-a517-0901c5d0d594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedAndAssetAcquisitionsTableTextBlock_eae314d9-a801-4953-ae58-8c556bdb1d8a" xlink:href="coo-20221031.xsd#coo_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedAndAssetAcquisitionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_95bf9787-314c-4ee5-a517-0901c5d0d594" xlink:to="loc_coo_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedAndAssetAcquisitionsTableTextBlock_eae314d9-a801-4953-ae58-8c556bdb1d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_8853a074-9036-4762-9136-52abfb1c62e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_95bf9787-314c-4ee5-a517-0901c5d0d594" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_8853a074-9036-4762-9136-52abfb1c62e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_e3e51f91-4114-4063-8a2b-3963421a75e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_95bf9787-314c-4ee5-a517-0901c5d0d594" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_e3e51f91-4114-4063-8a2b-3963421a75e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_b05533eb-078f-4290-974e-3a438205def8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_95bf9787-314c-4ee5-a517-0901c5d0d594" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_b05533eb-078f-4290-974e-3a438205def8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IntangibleAssetsTables" xlink:type="simple" xlink:href="coo-20221031.xsd#IntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/IntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6db4ce72-5848-410d-9a6a-6d5a150857cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_46ecab33-dc42-4a1e-af4b-05c2f748c6aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6db4ce72-5848-410d-9a6a-6d5a150857cd" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_46ecab33-dc42-4a1e-af4b-05c2f748c6aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_a4864e4c-789d-4a95-868a-e8f30f1a06b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6db4ce72-5848-410d-9a6a-6d5a150857cd" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_a4864e4c-789d-4a95-868a-e8f30f1a06b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_3d0c6333-0704-49b5-aa57-799784a39608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6db4ce72-5848-410d-9a6a-6d5a150857cd" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_3d0c6333-0704-49b5-aa57-799784a39608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_0c032cc9-1577-4bb3-b3a4-5a6550e89f33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6db4ce72-5848-410d-9a6a-6d5a150857cd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_0c032cc9-1577-4bb3-b3a4-5a6550e89f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/DebtTables" xlink:type="simple" xlink:href="coo-20221031.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_4349f7e0-70ad-4776-bd55-57965386f4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_66fbdabe-e0be-4abb-88e9-eb0629623062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4349f7e0-70ad-4776-bd55-57965386f4cd" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_66fbdabe-e0be-4abb-88e9-eb0629623062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="coo-20221031.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_3bcda236-6e27-45f8-a027-ff34e23dae8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_19bb46dc-d64d-464a-8a2b-55a47b2d158b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3bcda236-6e27-45f8-a027-ff34e23dae8c" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_19bb46dc-d64d-464a-8a2b-55a47b2d158b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_ca8afd0c-6e74-4197-8d7a-3dbf3c311b23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3bcda236-6e27-45f8-a027-ff34e23dae8c" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_ca8afd0c-6e74-4197-8d7a-3dbf3c311b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_ddb6d647-b3ef-4812-bc20-d6c9ca6e13f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3bcda236-6e27-45f8-a027-ff34e23dae8c" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_ddb6d647-b3ef-4812-bc20-d6c9ca6e13f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_18ddee5b-b664-45ef-b900-b28cc8cd07e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3bcda236-6e27-45f8-a027-ff34e23dae8c" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_18ddee5b-b664-45ef-b900-b28cc8cd07e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_94dd27df-b338-43d5-be05-c6f908b79b04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3bcda236-6e27-45f8-a027-ff34e23dae8c" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_94dd27df-b338-43d5-be05-c6f908b79b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="coo-20221031.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ac0197d0-9b9b-44cf-9ede-a6a2526a8539" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_40bfa82b-9009-4cec-b49e-5b9eaf289438" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ac0197d0-9b9b-44cf-9ede-a6a2526a8539" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_40bfa82b-9009-4cec-b49e-5b9eaf289438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_81ecde30-805a-4375-a064-c499c251d379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ac0197d0-9b9b-44cf-9ede-a6a2526a8539" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_81ecde30-805a-4375-a064-c499c251d379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="coo-20221031.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_3f2e95ab-b105-446f-9b04-0e87004ac1c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_a207415e-1d8a-44a9-8ca1-29a2a3994b46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_3f2e95ab-b105-446f-9b04-0e87004ac1c5" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_a207415e-1d8a-44a9-8ca1-29a2a3994b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_b3c7eb1e-78b2-4764-a26d-176ee5d1ddc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_3f2e95ab-b105-446f-9b04-0e87004ac1c5" xlink:to="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_b3c7eb1e-78b2-4764-a26d-176ee5d1ddc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockPlansTables" xlink:type="simple" xlink:href="coo-20221031.xsd#StockPlansTables"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/StockPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_84b1bdff-04ec-4c24-a6b5-63f28d4256c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_89516f45-5ad0-48b1-9408-1ed860b43ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_84b1bdff-04ec-4c24-a6b5-63f28d4256c9" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_89516f45-5ad0-48b1-9408-1ed860b43ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_d2946930-6d95-434c-822d-2b27cf99501d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_84b1bdff-04ec-4c24-a6b5-63f28d4256c9" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_d2946930-6d95-434c-822d-2b27cf99501d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_2d7682d3-0296-46c8-8056-5028310fac7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_84b1bdff-04ec-4c24-a6b5-63f28d4256c9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_2d7682d3-0296-46c8-8056-5028310fac7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_54448735-ab96-438d-8cd8-68d9da96501e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_84b1bdff-04ec-4c24-a6b5-63f28d4256c9" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_54448735-ab96-438d-8cd8-68d9da96501e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsTables" xlink:type="simple" xlink:href="coo-20221031.xsd#EmployeeBenefitsTables"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_42e1fe28-eec8-49c7-8dbd-2f571a29922c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_7ae41d41-5826-465c-9677-1bd26596f874" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_42e1fe28-eec8-49c7-8dbd-2f571a29922c" xlink:to="loc_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_7ae41d41-5826-465c-9677-1bd26596f874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock_a9ee2ab9-dcbd-4590-9e9d-4892cf332e10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_42e1fe28-eec8-49c7-8dbd-2f571a29922c" xlink:to="loc_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock_a9ee2ab9-dcbd-4590-9e9d-4892cf332e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock_5770b49d-3a93-444a-94aa-19ae76a9d667" xlink:href="coo-20221031.xsd#coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_42e1fe28-eec8-49c7-8dbd-2f571a29922c" xlink:to="loc_coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock_5770b49d-3a93-444a-94aa-19ae76a9d667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_047ad893-22a3-4114-a3a3-aff873a62789" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_42e1fe28-eec8-49c7-8dbd-2f571a29922c" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_047ad893-22a3-4114-a3a3-aff873a62789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_1d0121f3-6985-4715-a2b8-fe88d59e5669" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_42e1fe28-eec8-49c7-8dbd-2f571a29922c" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_1d0121f3-6985-4715-a2b8-fe88d59e5669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_30106456-1422-4ee0-ac29-7a0c4ea34cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_42e1fe28-eec8-49c7-8dbd-2f571a29922c" xlink:to="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_30106456-1422-4ee0-ac29-7a0c4ea34cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_b08712dc-72fe-4f80-8b1d-ed1b951c944e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_42e1fe28-eec8-49c7-8dbd-2f571a29922c" xlink:to="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_b08712dc-72fe-4f80-8b1d-ed1b951c944e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_0fcf1023-3d12-48a9-85f6-58987009acac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_42e1fe28-eec8-49c7-8dbd-2f571a29922c" xlink:to="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_0fcf1023-3d12-48a9-85f6-58987009acac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/BusinessSegmentInformationTables" xlink:type="simple" xlink:href="coo-20221031.xsd#BusinessSegmentInformationTables"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/BusinessSegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_b6fbfa20-ab23-473b-90f9-04ee25e0c9f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_d6394fae-a12d-484e-9d8b-67babc1d6790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b6fbfa20-ab23-473b-90f9-04ee25e0c9f4" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_d6394fae-a12d-484e-9d8b-67babc1d6790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_9d163e06-3094-474b-8ecb-ca69268a1e61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b6fbfa20-ab23-473b-90f9-04ee25e0c9f4" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_9d163e06-3094-474b-8ecb-ca69268a1e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_927c32db-485a-4f34-9db8-85677950ff46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b6fbfa20-ab23-473b-90f9-04ee25e0c9f4" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_927c32db-485a-4f34-9db8-85677950ff46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/FinancialDerivativesandHedgingTables" xlink:type="simple" xlink:href="coo-20221031.xsd#FinancialDerivativesandHedgingTables"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/FinancialDerivativesandHedgingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_327d4c00-242a-44d7-bbf1-da17aa5770a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_ff26cda1-3887-4cdc-850c-f71c2e7e4f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_327d4c00-242a-44d7-bbf1-da17aa5770a3" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_ff26cda1-3887-4cdc-850c-f71c2e7e4f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_42fa02fa-f8e5-4153-937d-1f110b7df7c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_327d4c00-242a-44d7-bbf1-da17aa5770a3" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_42fa02fa-f8e5-4153-937d-1f110b7df7c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#OrganizationandSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b4666361-c17b-4eba-a218-efc5cf80f634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c2254f60-5df1-4504-a7ea-ae6175e1c92c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b4666361-c17b-4eba-a218-efc5cf80f634" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c2254f60-5df1-4504-a7ea-ae6175e1c92c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4ca3dcc0-16f9-4719-915c-ba7e5c90dc27" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c2254f60-5df1-4504-a7ea-ae6175e1c92c" xlink:to="loc_srt_RangeAxis_4ca3dcc0-16f9-4719-915c-ba7e5c90dc27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a8577588-a783-42f9-959e-9e6e42aa235e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_4ca3dcc0-16f9-4719-915c-ba7e5c90dc27" xlink:to="loc_srt_RangeMember_a8577588-a783-42f9-959e-9e6e42aa235e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a934b05a-9266-44df-b2e8-95b6927ceabb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a8577588-a783-42f9-959e-9e6e42aa235e" xlink:to="loc_srt_MinimumMember_a934b05a-9266-44df-b2e8-95b6927ceabb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_30d0c0b0-6d1e-4796-83de-2d228b12e153" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a8577588-a783-42f9-959e-9e6e42aa235e" xlink:to="loc_srt_MaximumMember_30d0c0b0-6d1e-4796-83de-2d228b12e153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c71fe903-a8c9-49e0-acfa-0da6d701c4b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c2254f60-5df1-4504-a7ea-ae6175e1c92c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c71fe903-a8c9-49e0-acfa-0da6d701c4b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8efcecaa-5ef0-4f63-93df-a94c613b5ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c71fe903-a8c9-49e0-acfa-0da6d701c4b2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8efcecaa-5ef0-4f63-93df-a94c613b5ebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_58a615dd-2dd4-4863-8903-d9186286f412" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8efcecaa-5ef0-4f63-93df-a94c613b5ebd" xlink:to="loc_us-gaap_BuildingMember_58a615dd-2dd4-4863-8903-d9186286f412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_57fe6b36-7afb-49e3-b182-8d85fc51b156" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c2254f60-5df1-4504-a7ea-ae6175e1c92c" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_57fe6b36-7afb-49e3-b182-8d85fc51b156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d1ad4503-f06e-49b4-91ae-630ecdecf4c4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_57fe6b36-7afb-49e3-b182-8d85fc51b156" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d1ad4503-f06e-49b4-91ae-630ecdecf4c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_7595a828-7d7f-4ba8-b237-1a23683fd809" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d1ad4503-f06e-49b4-91ae-630ecdecf4c4" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_7595a828-7d7f-4ba8-b237-1a23683fd809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_041666ea-2964-4b84-a248-4a41e1c07727" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c2254f60-5df1-4504-a7ea-ae6175e1c92c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_041666ea-2964-4b84-a248-4a41e1c07727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8405ef33-b8ae-4780-b870-618f144b8a40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_041666ea-2964-4b84-a248-4a41e1c07727" xlink:to="loc_us-gaap_EquityComponentDomain_8405ef33-b8ae-4780-b870-618f144b8a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_6d7255df-5b13-447c-939f-2ffc75e8946d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8405ef33-b8ae-4780-b870-618f144b8a40" xlink:to="loc_us-gaap_RetainedEarningsMember_6d7255df-5b13-447c-939f-2ffc75e8946d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_dc97ff98-f926-486c-9ea3-93f492e2a0da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c2254f60-5df1-4504-a7ea-ae6175e1c92c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_dc97ff98-f926-486c-9ea3-93f492e2a0da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_cb7b3543-6878-47d9-8f7f-87a49c69c5f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_dc97ff98-f926-486c-9ea3-93f492e2a0da" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_cb7b3543-6878-47d9-8f7f-87a49c69c5f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_0837aa0f-db4b-4d41-a9b7-6d33d1d1744e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cb7b3543-6878-47d9-8f7f-87a49c69c5f5" xlink:to="loc_us-gaap_CostOfSalesMember_0837aa0f-db4b-4d41-a9b7-6d33d1d1744e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_82e3a39f-472b-48f2-a097-16233cd8d430" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cb7b3543-6878-47d9-8f7f-87a49c69c5f5" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_82e3a39f-472b-48f2-a097-16233cd8d430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8f3f6b08-a6a6-4ee1-9448-7403ed30e967" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c2254f60-5df1-4504-a7ea-ae6175e1c92c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8f3f6b08-a6a6-4ee1-9448-7403ed30e967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_NumberOfBusinessUnits_2c88b0cc-22a5-4c47-92a3-98182ca3867c" xlink:href="coo-20221031.xsd#coo_NumberOfBusinessUnits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8f3f6b08-a6a6-4ee1-9448-7403ed30e967" xlink:to="loc_coo_NumberOfBusinessUnits_2c88b0cc-22a5-4c47-92a3-98182ca3867c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_41ee87f1-66ca-486b-a7a8-845778d72ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8f3f6b08-a6a6-4ee1-9448-7403ed30e967" xlink:to="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_41ee87f1-66ca-486b-a7a8-845778d72ce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerRefundLiability_4f4e50af-657a-45ab-84a3-56a54ae5f94c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerRefundLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8f3f6b08-a6a6-4ee1-9448-7403ed30e967" xlink:to="loc_us-gaap_ContractWithCustomerRefundLiability_4f4e50af-657a-45ab-84a3-56a54ae5f94c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_41917d61-017e-45c3-bffe-cc6068786a88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8f3f6b08-a6a6-4ee1-9448-7403ed30e967" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_41917d61-017e-45c3-bffe-cc6068786a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_610c9fdc-ec94-4fed-acd1-5f5fc414157d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8f3f6b08-a6a6-4ee1-9448-7403ed30e967" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_610c9fdc-ec94-4fed-acd1-5f5fc414157d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_26d69a8e-26c0-456f-83a4-b537c2c6c056" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessExitCosts1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8f3f6b08-a6a6-4ee1-9448-7403ed30e967" xlink:to="loc_us-gaap_BusinessExitCosts1_26d69a8e-26c0-456f-83a4-b537c2c6c056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_076dbaf4-22fb-4ba5-aa5b-4d882a14cfed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8f3f6b08-a6a6-4ee1-9448-7403ed30e967" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_076dbaf4-22fb-4ba5-aa5b-4d882a14cfed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesInventoryDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#OrganizationandSignificantAccountingPoliciesInventoryDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_25e2d198-fb79-47a9-84df-fa5179c2c2bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_7aaa6715-c21f-44e4-ad36-56e395b492db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_25e2d198-fb79-47a9-84df-fa5179c2c2bd" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_7aaa6715-c21f-44e4-ad36-56e395b492db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_9b38de5b-10f4-4bae-ac31-7ab5daf6f9d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_25e2d198-fb79-47a9-84df-fa5179c2c2bd" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_9b38de5b-10f4-4bae-ac31-7ab5daf6f9d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_fa40a6d5-b6a5-4625-9508-dd0a71d49f00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_25e2d198-fb79-47a9-84df-fa5179c2c2bd" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_fa40a6d5-b6a5-4625-9508-dd0a71d49f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_79ffcad5-0fd9-4088-8733-9fb477220f56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_25e2d198-fb79-47a9-84df-fa5179c2c2bd" xlink:to="loc_us-gaap_InventoryNet_79ffcad5-0fd9-4088-8733-9fb477220f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7ca0f125-2082-4b14-b422-6c330705c06f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5ca95522-a55b-4816-9f44-594b9e8adc65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7ca0f125-2082-4b14-b422-6c330705c06f" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5ca95522-a55b-4816-9f44-594b9e8adc65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f732a011-d7c9-43fc-af64-652c603b1848" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5ca95522-a55b-4816-9f44-594b9e8adc65" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f732a011-d7c9-43fc-af64-652c603b1848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_87f5f249-8260-4469-87b5-91cc5f1fdd7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f732a011-d7c9-43fc-af64-652c603b1848" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_87f5f249-8260-4469-87b5-91cc5f1fdd7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovementsMember_2c03fdd4-285a-476c-9087-45eb28f42e59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandAndLandImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_87f5f249-8260-4469-87b5-91cc5f1fdd7d" xlink:to="loc_us-gaap_LandAndLandImprovementsMember_2c03fdd4-285a-476c-9087-45eb28f42e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_087582a8-f2ad-494d-af06-483b57d4af77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_87f5f249-8260-4469-87b5-91cc5f1fdd7d" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_087582a8-f2ad-494d-af06-483b57d4af77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_dbfc97ce-3f8b-4880-b269-165f19ac3243" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_87f5f249-8260-4469-87b5-91cc5f1fdd7d" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_dbfc97ce-3f8b-4880-b269-165f19ac3243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_c243aec9-d126-4ee3-999d-a8d2b3ed1b01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_87f5f249-8260-4469-87b5-91cc5f1fdd7d" xlink:to="loc_us-gaap_ConstructionInProgressMember_c243aec9-d126-4ee3-999d-a8d2b3ed1b01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b083b84b-8b90-41a7-90c1-dffd61917661" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5ca95522-a55b-4816-9f44-594b9e8adc65" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b083b84b-8b90-41a7-90c1-dffd61917661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_d87e8256-a122-4c08-b3be-442bfe9ea476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b083b84b-8b90-41a7-90c1-dffd61917661" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_d87e8256-a122-4c08-b3be-442bfe9ea476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7236837b-c8ff-4973-9535-71877ccf09b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b083b84b-8b90-41a7-90c1-dffd61917661" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7236837b-c8ff-4973-9535-71877ccf09b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_20941e93-5178-411f-9022-890ef55ad1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b083b84b-8b90-41a7-90c1-dffd61917661" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_20941e93-5178-411f-9022-890ef55ad1fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_27f0cf01-e0fa-46e1-b5f3-7ab264a8ab26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b083b84b-8b90-41a7-90c1-dffd61917661" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_27f0cf01-e0fa-46e1-b5f3-7ab264a8ab26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_bbfc00f7-af83-459c-9a91-9c6c37f2f87e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b083b84b-8b90-41a7-90c1-dffd61917661" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_bbfc00f7-af83-459c-9a91-9c6c37f2f87e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_8ec300dc-4925-4a13-9af1-f488b484b8b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_93dedd79-9858-4f44-987d-657aa6d2832c" xlink:href="coo-20221031.xsd#coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8ec300dc-4925-4a13-9af1-f488b484b8b2" xlink:to="loc_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_93dedd79-9858-4f44-987d-657aa6d2832c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_4f383e50-34f0-45cb-9252-67f6b7b8cbab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_93dedd79-9858-4f44-987d-657aa6d2832c" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_4f383e50-34f0-45cb-9252-67f6b7b8cbab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_ebb860a5-290c-4e89-9329-8238a70fa118" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_93dedd79-9858-4f44-987d-657aa6d2832c" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_ebb860a5-290c-4e89-9329-8238a70fa118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_c9a1e331-6a6b-4896-847e-2bafb732cd41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_93dedd79-9858-4f44-987d-657aa6d2832c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_c9a1e331-6a6b-4896-847e-2bafb732cd41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_292258d7-709d-4fdc-a16d-8066f40e9f60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_93dedd79-9858-4f44-987d-657aa6d2832c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_292258d7-709d-4fdc-a16d-8066f40e9f60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_5fa8ed42-ab46-464a-849b-9d59b0731e19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_93dedd79-9858-4f44-987d-657aa6d2832c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_5fa8ed42-ab46-464a-849b-9d59b0731e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_36629e25-716d-4334-bc3a-4f9b57e420d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_93dedd79-9858-4f44-987d-657aa6d2832c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_36629e25-716d-4334-bc3a-4f9b57e420d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_4c863b7f-75cb-425b-a077-c5dd423fa1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_93dedd79-9858-4f44-987d-657aa6d2832c" xlink:to="loc_us-gaap_OperatingLeaseLiability_4c863b7f-75cb-425b-a077-c5dd423fa1fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_71084e77-f74c-4229-833f-14b1f0765fac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_93dedd79-9858-4f44-987d-657aa6d2832c" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_71084e77-f74c-4229-833f-14b1f0765fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_94c1ead4-5880-46f1-ba73-a616202cd85c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_93dedd79-9858-4f44-987d-657aa6d2832c" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_94c1ead4-5880-46f1-ba73-a616202cd85c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OperatingLeasesNarrativeDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#OperatingLeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/OperatingLeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_b0dd158f-af3b-49e6-b874-20801f983764" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_a65eb102-b2ea-4366-9846-9993ee4d88d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b0dd158f-af3b-49e6-b874-20801f983764" xlink:to="loc_us-gaap_OperatingLeaseCost_a65eb102-b2ea-4366-9846-9993ee4d88d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_17c74020-b14b-4879-9098-47ded7836ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1a5cfd97-1a1c-4a20-a720-e77e20a71691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_17c74020-b14b-4879-9098-47ded7836ddc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1a5cfd97-1a1c-4a20-a720-e77e20a71691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_dd29961f-d8eb-42da-815d-3a84570f043d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_17c74020-b14b-4879-9098-47ded7836ddc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_dd29961f-d8eb-42da-815d-3a84570f043d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_9b09f158-11a3-475b-87a9-fda90476d675" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_17c74020-b14b-4879-9098-47ded7836ddc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_9b09f158-11a3-475b-87a9-fda90476d675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7601c495-19c7-4d1f-ac13-af740863ccc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_17c74020-b14b-4879-9098-47ded7836ddc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7601c495-19c7-4d1f-ac13-af740863ccc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_319cc71c-4912-4083-8ddc-dff9e91eb407" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_17c74020-b14b-4879-9098-47ded7836ddc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_319cc71c-4912-4083-8ddc-dff9e91eb407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_81d3e7b3-191e-48cd-ac5d-22d321b3f73b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_17c74020-b14b-4879-9098-47ded7836ddc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_81d3e7b3-191e-48cd-ac5d-22d321b3f73b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_007ada24-23dc-4497-a397-7b7b89085e97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_17c74020-b14b-4879-9098-47ded7836ddc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_007ada24-23dc-4497-a397-7b7b89085e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_7ebaaf0c-fb59-4436-9a25-8e629f8059c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_17c74020-b14b-4879-9098-47ded7836ddc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_7ebaaf0c-fb59-4436-9a25-8e629f8059c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_ff592472-5a5d-4d35-bd5b-5dd10eb857e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_17c74020-b14b-4879-9098-47ded7836ddc" xlink:to="loc_us-gaap_OperatingLeaseLiability_ff592472-5a5d-4d35-bd5b-5dd10eb857e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails_1" xlink:type="simple" xlink:href="coo-20221031.xsd#OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails_1"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.coopercos.com/role/AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_917936bd-3f30-4025-84a9-e95cc0e867ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionTable_9b2f818d-5737-416b-8df5-d515a5585d28" xlink:href="coo-20221031.xsd#coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_917936bd-3f30-4025-84a9-e95cc0e867ef" xlink:to="loc_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionTable_9b2f818d-5737-416b-8df5-d515a5585d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessAcquisitionAndAssetAcquisitionAxis_e6b53702-367a-4c62-8292-fd1c23161613" xlink:href="coo-20221031.xsd#coo_BusinessAcquisitionAndAssetAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionTable_9b2f818d-5737-416b-8df5-d515a5585d28" xlink:to="loc_coo_BusinessAcquisitionAndAssetAcquisitionAxis_e6b53702-367a-4c62-8292-fd1c23161613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessAcquisitionAndAssetAcquisitionDomain_3163f592-9cd5-42cf-aaaa-e72a1f39644f" xlink:href="coo-20221031.xsd#coo_BusinessAcquisitionAndAssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_BusinessAcquisitionAndAssetAcquisitionAxis_e6b53702-367a-4c62-8292-fd1c23161613" xlink:to="loc_coo_BusinessAcquisitionAndAssetAcquisitionDomain_3163f592-9cd5-42cf-aaaa-e72a1f39644f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember_17c5a815-e5a6-4e5f-af51-b109ed0cc65f" xlink:href="coo-20221031.xsd#coo_SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_BusinessAcquisitionAndAssetAcquisitionDomain_3163f592-9cd5-42cf-aaaa-e72a1f39644f" xlink:to="loc_coo_SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember_17c5a815-e5a6-4e5f-af51-b109ed0cc65f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_06b1559b-26b7-4874-8ee9-20ce1dd2737e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionTable_9b2f818d-5737-416b-8df5-d515a5585d28" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_06b1559b-26b7-4874-8ee9-20ce1dd2737e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10f090c2-4d6f-4602-9b06-d76b3a52c9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_06b1559b-26b7-4874-8ee9-20ce1dd2737e" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10f090c2-4d6f-4602-9b06-d76b3a52c9a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_939d73e6-5940-454d-add1-6fe1e5f7ffa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10f090c2-4d6f-4602-9b06-d76b3a52c9a1" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_939d73e6-5940-454d-add1-6fe1e5f7ffa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_1981a6c0-319b-466c-9b2f-772013c89782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10f090c2-4d6f-4602-9b06-d76b3a52c9a1" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_1981a6c0-319b-466c-9b2f-772013c89782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_bc962057-1724-41d4-97b8-b0c17ff4fcd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10f090c2-4d6f-4602-9b06-d76b3a52c9a1" xlink:to="loc_us-gaap_CustomerRelationshipsMember_bc962057-1724-41d4-97b8-b0c17ff4fcd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_5d1ea5d7-2e56-45a0-ad93-a6a3a44a9854" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10f090c2-4d6f-4602-9b06-d76b3a52c9a1" xlink:to="loc_us-gaap_TrademarksMember_5d1ea5d7-2e56-45a0-ad93-a6a3a44a9854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_f6e00634-1d15-4d02-b87a-be10e5cdcbbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10f090c2-4d6f-4602-9b06-d76b3a52c9a1" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_f6e00634-1d15-4d02-b87a-be10e5cdcbbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems_2e0eb618-f6f1-42f0-be1e-d0877ae7a395" xlink:href="coo-20221031.xsd#coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionTable_9b2f818d-5737-416b-8df5-d515a5585d28" xlink:to="loc_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems_2e0eb618-f6f1-42f0-be1e-d0877ae7a395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_8e833d2a-0544-41d0-97fc-ddbb3ae7e467" xlink:href="coo-20221031.xsd#coo_BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems_2e0eb618-f6f1-42f0-be1e-d0877ae7a395" xlink:to="loc_coo_BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_8e833d2a-0544-41d0-97fc-ddbb3ae7e467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0af39db3-a9e9-4378-9c5f-20b4bf6e7cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems_2e0eb618-f6f1-42f0-be1e-d0877ae7a395" xlink:to="loc_us-gaap_Goodwill_0af39db3-a9e9-4378-9c5f-20b4bf6e7cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet_97e318a5-e051-4b95-8249-4ba6777001b7" xlink:href="coo-20221031.xsd#coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems_2e0eb618-f6f1-42f0-be1e-d0877ae7a395" xlink:to="loc_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet_97e318a5-e051-4b95-8249-4ba6777001b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability_655c2400-77a7-44f9-9455-22636757adc1" xlink:href="coo-20221031.xsd#coo_BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems_2e0eb618-f6f1-42f0-be1e-d0877ae7a395" xlink:to="loc_coo_BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability_655c2400-77a7-44f9-9455-22636757adc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_cfb86b5c-ef0b-4010-b659-d7502e2f8f15" xlink:href="coo-20221031.xsd#coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems_2e0eb618-f6f1-42f0-be1e-d0877ae7a395" xlink:to="loc_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_cfb86b5c-ef0b-4010-b659-d7502e2f8f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#AcquisitionsandJointVentureNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_656ea8e7-b8b7-4692-8d7a-1d424bc0ba13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_23b9aece-94f0-40af-a86c-2e1458428b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_656ea8e7-b8b7-4692-8d7a-1d424bc0ba13" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_23b9aece-94f0-40af-a86c-2e1458428b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3dc06ac4-99a7-42bd-8519-28faed95fe14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_23b9aece-94f0-40af-a86c-2e1458428b1f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3dc06ac4-99a7-42bd-8519-28faed95fe14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e18d6c9e-0787-427d-9e45-e424c4f6b95a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3dc06ac4-99a7-42bd-8519-28faed95fe14" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e18d6c9e-0787-427d-9e45-e424c4f6b95a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CookMedicalsReproductiveHealthBusinessMember_c218d03a-a57d-4d3c-b556-3df6d4528d48" xlink:href="coo-20221031.xsd#coo_CookMedicalsReproductiveHealthBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e18d6c9e-0787-427d-9e45-e424c4f6b95a" xlink:to="loc_coo_CookMedicalsReproductiveHealthBusinessMember_c218d03a-a57d-4d3c-b556-3df6d4528d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_GenerateLifeSciencesMember_b1e8179d-9227-45bc-8285-91efd1f63bff" xlink:href="coo-20221031.xsd#coo_GenerateLifeSciencesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e18d6c9e-0787-427d-9e45-e424c4f6b95a" xlink:to="loc_coo_GenerateLifeSciencesMember_b1e8179d-9227-45bc-8285-91efd1f63bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember_cc5f6075-aff8-4e2f-9b41-351f3cbb7450" xlink:href="coo-20221031.xsd#coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e18d6c9e-0787-427d-9e45-e424c4f6b95a" xlink:to="loc_coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember_cc5f6075-aff8-4e2f-9b41-351f3cbb7450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_0f14a1cf-bfc2-4e84-a32a-c381a78c8041" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_23b9aece-94f0-40af-a86c-2e1458428b1f" xlink:to="loc_srt_StatementScenarioAxis_0f14a1cf-bfc2-4e84-a32a-c381a78c8041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_fe9099f7-7dc3-4487-be61-61e49cfac5f8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_0f14a1cf-bfc2-4e84-a32a-c381a78c8041" xlink:to="loc_srt_ScenarioUnspecifiedDomain_fe9099f7-7dc3-4487-be61-61e49cfac5f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_06f733b1-05a0-4068-95e6-203679f31bad" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_fe9099f7-7dc3-4487-be61-61e49cfac5f8" xlink:to="loc_srt_ScenarioForecastMember_06f733b1-05a0-4068-95e6-203679f31bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_b727b664-428e-4ca7-af51-fbc0affaff18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_23b9aece-94f0-40af-a86c-2e1458428b1f" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_b727b664-428e-4ca7-af51-fbc0affaff18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_7bd765ad-935a-4ced-8f8e-e63b13e31528" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b727b664-428e-4ca7-af51-fbc0affaff18" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_7bd765ad-935a-4ced-8f8e-e63b13e31528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_9fc7819a-fb54-469d-ae03-b0f6061354b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_7bd765ad-935a-4ced-8f8e-e63b13e31528" xlink:to="loc_us-gaap_SubsequentEventMember_9fc7819a-fb54-469d-ae03-b0f6061354b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis_70f9ad3a-813e-444d-89f8-c6a5be004019" xlink:href="coo-20221031.xsd#coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_23b9aece-94f0-40af-a86c-2e1458428b1f" xlink:to="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis_70f9ad3a-813e-444d-89f8-c6a5be004019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_2702715c-134b-4abd-b857-aa49eecec0fa" xlink:href="coo-20221031.xsd#coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis_70f9ad3a-813e-444d-89f8-c6a5be004019" xlink:to="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_2702715c-134b-4abd-b857-aa49eecec0fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PayablesFirstInstallmentMember_adca6634-2019-48de-af1f-7150fd5ff68e" xlink:href="coo-20221031.xsd#coo_PayablesFirstInstallmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_2702715c-134b-4abd-b857-aa49eecec0fa" xlink:to="loc_coo_PayablesFirstInstallmentMember_adca6634-2019-48de-af1f-7150fd5ff68e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PayablesSecondInstallmentMember_175644e3-ee45-4f59-8b96-304912f755d1" xlink:href="coo-20221031.xsd#coo_PayablesSecondInstallmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_2702715c-134b-4abd-b857-aa49eecec0fa" xlink:to="loc_coo_PayablesSecondInstallmentMember_175644e3-ee45-4f59-8b96-304912f755d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PayablesThirdInstallmentMember_d9f49bb2-1be1-42ac-8feb-87626554d5df" xlink:href="coo-20221031.xsd#coo_PayablesThirdInstallmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_2702715c-134b-4abd-b857-aa49eecec0fa" xlink:to="loc_coo_PayablesThirdInstallmentMember_d9f49bb2-1be1-42ac-8feb-87626554d5df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PayablesFourthInstallmentMember_dc552ddd-e09e-47c2-8a54-f5a76aae6967" xlink:href="coo-20221031.xsd#coo_PayablesFourthInstallmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain_2702715c-134b-4abd-b857-aa49eecec0fa" xlink:to="loc_coo_PayablesFourthInstallmentMember_dc552ddd-e09e-47c2-8a54-f5a76aae6967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_6215a943-9531-4030-acef-f1b4b18cf88a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_23b9aece-94f0-40af-a86c-2e1458428b1f" xlink:to="loc_us-gaap_CreditFacilityAxis_6215a943-9531-4030-acef-f1b4b18cf88a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_65f24729-5c88-41e8-b50d-89fcc93ebd15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_6215a943-9531-4030-acef-f1b4b18cf88a" xlink:to="loc_us-gaap_CreditFacilityDomain_65f24729-5c88-41e8-b50d-89fcc93ebd15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_9c48f64f-d6aa-4510-8cc5-82fc118da73a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_65f24729-5c88-41e8-b50d-89fcc93ebd15" xlink:to="loc_us-gaap_LineOfCreditMember_9c48f64f-d6aa-4510-8cc5-82fc118da73a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6063349c-d862-4714-8cd9-4b4189b45ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_23b9aece-94f0-40af-a86c-2e1458428b1f" xlink:to="loc_us-gaap_DebtInstrumentAxis_6063349c-d862-4714-8cd9-4b4189b45ca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_eadde719-c921-492c-b398-89e9f64c75bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_6063349c-d862-4714-8cd9-4b4189b45ca3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_eadde719-c921-492c-b398-89e9f64c75bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanFacility2021Member_4c53bcef-ed5a-4ca4-b789-c5537d19939a" xlink:href="coo-20221031.xsd#coo_TermLoanFacility2021Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eadde719-c921-492c-b398-89e9f64c75bc" xlink:to="loc_coo_TermLoanFacility2021Member_4c53bcef-ed5a-4ca4-b789-c5537d19939a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e7d31583-6621-4b6b-ad5c-816d2ec45d20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_23b9aece-94f0-40af-a86c-2e1458428b1f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e7d31583-6621-4b6b-ad5c-816d2ec45d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c2450bf7-f6b9-4ed6-8998-f107166342e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e7d31583-6621-4b6b-ad5c-816d2ec45d20" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c2450bf7-f6b9-4ed6-8998-f107166342e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_56e85647-1d7d-40f4-8373-b01bc5e1776a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c2450bf7-f6b9-4ed6-8998-f107166342e0" xlink:to="loc_us-gaap_CustomerRelationshipsMember_56e85647-1d7d-40f4-8373-b01bc5e1776a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_99c22c9f-dc9e-44de-9436-6f7853a4bc35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c2450bf7-f6b9-4ed6-8998-f107166342e0" xlink:to="loc_us-gaap_TrademarksMember_99c22c9f-dc9e-44de-9436-6f7853a4bc35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_16c7b107-a2d0-4e95-8457-e61c04e64a95" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_23b9aece-94f0-40af-a86c-2e1458428b1f" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_16c7b107-a2d0-4e95-8457-e61c04e64a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_d99e5427-5c1b-446f-b10a-cae99de5d23e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_16c7b107-a2d0-4e95-8457-e61c04e64a95" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_d99e5427-5c1b-446f-b10a-cae99de5d23e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_SightGlassVisionIncMember_4c70042c-efb2-4028-a970-eea656bddce6" xlink:href="coo-20221031.xsd#coo_SightGlassVisionIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d99e5427-5c1b-446f-b10a-cae99de5d23e" xlink:to="loc_coo_SightGlassVisionIncMember_4c70042c-efb2-4028-a970-eea656bddce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_f01274f7-33c8-4afb-8192-25689a3ce2ba" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_23b9aece-94f0-40af-a86c-2e1458428b1f" xlink:to="loc_dei_LegalEntityAxis_f01274f7-33c8-4afb-8192-25689a3ce2ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_4fbf2674-11a0-4530-8016-ed3c45df0c5f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_f01274f7-33c8-4afb-8192-25689a3ce2ba" xlink:to="loc_dei_EntityDomain_4fbf2674-11a0-4530-8016-ed3c45df0c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_EssilorInternationalSASMember_c32b934b-94f3-45db-89e2-e80d2ebd1283" xlink:href="coo-20221031.xsd#coo_EssilorInternationalSASMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_4fbf2674-11a0-4530-8016-ed3c45df0c5f" xlink:to="loc_coo_EssilorInternationalSASMember_c32b934b-94f3-45db-89e2-e80d2ebd1283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AssetAquisitionAxis_2a3cbf17-c5af-474e-97af-e8d9a0ac0475" xlink:href="coo-20221031.xsd#coo_AssetAquisitionAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_23b9aece-94f0-40af-a86c-2e1458428b1f" xlink:to="loc_coo_AssetAquisitionAxis_2a3cbf17-c5af-474e-97af-e8d9a0ac0475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AssetAquisitionDomain_753be4bd-e16a-4307-b295-0d098db7fd55" xlink:href="coo-20221031.xsd#coo_AssetAquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_AssetAquisitionAxis_2a3cbf17-c5af-474e-97af-e8d9a0ac0475" xlink:to="loc_coo_AssetAquisitionDomain_753be4bd-e16a-4307-b295-0d098db7fd55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_PrivatelyHeldMedicalDeviceCompanyDevelopedMaraWaterVaporAblationSystemMember_764a9f92-dfc8-4f37-8ae7-0f5796158930" xlink:href="coo-20221031.xsd#coo_PrivatelyHeldMedicalDeviceCompanyDevelopedMaraWaterVaporAblationSystemMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_AssetAquisitionDomain_753be4bd-e16a-4307-b295-0d098db7fd55" xlink:to="loc_coo_PrivatelyHeldMedicalDeviceCompanyDevelopedMaraWaterVaporAblationSystemMember_764a9f92-dfc8-4f37-8ae7-0f5796158930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_23b9aece-94f0-40af-a86c-2e1458428b1f" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_e1a504e3-2e92-4991-b3a6-fafef0e03b42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_e1a504e3-2e92-4991-b3a6-fafef0e03b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_ff6631c4-bceb-4cdb-9078-06c6c6f9e864" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_ff6631c4-bceb-4cdb-9078-06c6c6f9e864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_2395a22c-c9e1-4faf-b3ae-a3a56ee5ef7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_2395a22c-c9e1-4faf-b3ae-a3a56ee5ef7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_9cdad62d-cca0-4106-9f79-1b937c4c4bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_9cdad62d-cca0-4106-9f79-1b937c4c4bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_5eb94c8a-15a7-4372-82d0-74e602a6fe9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_5eb94c8a-15a7-4372-82d0-74e602a6fe9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_c8dad6aa-96e0-4e53-aca1-b2bef4de80c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_c8dad6aa-96e0-4e53-aca1-b2bef4de80c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_902b5d24-f49f-49ce-ae95-63d665fa3756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_902b5d24-f49f-49ce-ae95-63d665fa3756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_8d647874-4c8c-4618-be68-10612dab0cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_8d647874-4c8c-4618-be68-10612dab0cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_9a4877fb-8ba9-45b6-b5ff-939a5b3663cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_9a4877fb-8ba9-45b6-b5ff-939a5b3663cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5960b7ac-49de-48f3-960d-4e6f823f2032" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_Goodwill_5960b7ac-49de-48f3-960d-4e6f823f2032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_bedfd302-9619-411e-933f-c7a02975f483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_bedfd302-9619-411e-933f-c7a02975f483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_b80f7b5c-9625-47f7-990a-a73d68052c42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_b80f7b5c-9625-47f7-990a-a73d68052c42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationPaymentToSettleContingentConsideration_31ef0d75-a7ba-474a-91fd-6c5271bd5203" xlink:href="coo-20221031.xsd#coo_BusinessCombinationPaymentToSettleContingentConsideration"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_coo_BusinessCombinationPaymentToSettleContingentConsideration_31ef0d75-a7ba-474a-91fd-6c5271bd5203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss_9dcbadd9-a301-4f05-a710-6cee797692ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss_9dcbadd9-a301-4f05-a710-6cee797692ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_d8c94ca3-917a-4e85-91a7-3d557cf842d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_d8c94ca3-917a-4e85-91a7-3d557cf842d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_40376353-f997-46c7-9c32-1ba5bed17273" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_40376353-f997-46c7-9c32-1ba5bed17273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_b7e4fca6-414b-4319-83ba-f71ae54b072c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_b7e4fca6-414b-4319-83ba-f71ae54b072c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_9abbb17e-8633-4b1d-8a5b-bd501c910622" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_9abbb17e-8633-4b1d-8a5b-bd501c910622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_125033cd-1736-4646-814b-3fa0e6b26278" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_EquityMethodInvestments_125033cd-1736-4646-814b-3fa0e6b26278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_92e02d8a-e101-438b-8861-2f8235e7175f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eb7e2748-e789-4d96-b7b2-91bb8b21afe8" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_92e02d8a-e101-438b-8861-2f8235e7175f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_9dca77ef-0a43-478e-a4ee-88699e2a5374" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cc7d0eb0-a45e-497c-8b15-28652d4d2393" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_9dca77ef-0a43-478e-a4ee-88699e2a5374" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cc7d0eb0-a45e-497c-8b15-28652d4d2393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_47d56c8f-4659-4078-9673-969c6d9f539a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cc7d0eb0-a45e-497c-8b15-28652d4d2393" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_47d56c8f-4659-4078-9673-969c6d9f539a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1cbcc945-3b9b-4cf4-8b61-872cae1df498" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_47d56c8f-4659-4078-9673-969c6d9f539a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1cbcc945-3b9b-4cf4-8b61-872cae1df498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_GenerateLifeSciencesMember_99ee89cf-75c6-4f83-9385-85aae99b3ce2" xlink:href="coo-20221031.xsd#coo_GenerateLifeSciencesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1cbcc945-3b9b-4cf4-8b61-872cae1df498" xlink:to="loc_coo_GenerateLifeSciencesMember_99ee89cf-75c6-4f83-9385-85aae99b3ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fcb8220d-88c8-4140-b4c4-902d14518e60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cc7d0eb0-a45e-497c-8b15-28652d4d2393" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fcb8220d-88c8-4140-b4c4-902d14518e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ea51196-7c27-416e-8e53-979f07c42e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fcb8220d-88c8-4140-b4c4-902d14518e60" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ea51196-7c27-416e-8e53-979f07c42e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_5a377db8-c630-4e35-b168-46abd516e7b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ea51196-7c27-416e-8e53-979f07c42e0c" xlink:to="loc_us-gaap_CustomerRelationshipsMember_5a377db8-c630-4e35-b168-46abd516e7b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_fae82438-838a-407b-b912-881f5ec0a6c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ea51196-7c27-416e-8e53-979f07c42e0c" xlink:to="loc_us-gaap_TrademarksMember_fae82438-838a-407b-b912-881f5ec0a6c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ef4f74ce-3120-4e30-9135-c758dc191f55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cc7d0eb0-a45e-497c-8b15-28652d4d2393" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_ef4f74ce-3120-4e30-9135-c758dc191f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_86afaea9-255b-44f2-9343-0daf07580158" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ef4f74ce-3120-4e30-9135-c758dc191f55" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_86afaea9-255b-44f2-9343-0daf07580158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_8a0a3066-16a3-4994-9f2a-7db46ac11ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_86afaea9-255b-44f2-9343-0daf07580158" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_8a0a3066-16a3-4994-9f2a-7db46ac11ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_cf247206-e515-479a-b99f-6fc2aa6952ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_8a0a3066-16a3-4994-9f2a-7db46ac11ed7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_cf247206-e515-479a-b99f-6fc2aa6952ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_54d0ca83-9e48-4e84-9871-dcef5a7a5977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_8a0a3066-16a3-4994-9f2a-7db46ac11ed7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_54d0ca83-9e48-4e84-9871-dcef5a7a5977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_bedf1301-8333-4ea4-a202-d5414ee9dfbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_8a0a3066-16a3-4994-9f2a-7db46ac11ed7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_bedf1301-8333-4ea4-a202-d5414ee9dfbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_75b26c95-cc7b-4634-9772-54367cb25525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_8a0a3066-16a3-4994-9f2a-7db46ac11ed7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_75b26c95-cc7b-4634-9772-54367cb25525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_9b6d054e-da56-40d7-af18-887bbf6a4633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_8a0a3066-16a3-4994-9f2a-7db46ac11ed7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_9b6d054e-da56-40d7-af18-887bbf6a4633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c4603325-4e60-49e2-93a6-3eff5ae7f7f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_86afaea9-255b-44f2-9343-0daf07580158" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c4603325-4e60-49e2-93a6-3eff5ae7f7f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ec215856-6071-4ef1-ad5b-3851c0fcd8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_86afaea9-255b-44f2-9343-0daf07580158" xlink:to="loc_us-gaap_Goodwill_ec215856-6071-4ef1-ad5b-3851c0fcd8b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0372aad9-de13-4cb0-8ef0-37ee0e7bdc10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_86afaea9-255b-44f2-9343-0daf07580158" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0372aad9-de13-4cb0-8ef0-37ee0e7bdc10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_3cfffb41-06fd-4965-9f84-3fefa8b52c03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_86afaea9-255b-44f2-9343-0daf07580158" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_3cfffb41-06fd-4965-9f84-3fefa8b52c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_038d17c7-6b60-4f90-a5b7-b43e114fa6d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_86afaea9-255b-44f2-9343-0daf07580158" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_038d17c7-6b60-4f90-a5b7-b43e114fa6d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_247628d1-069f-418b-896a-2b6da4e3d333" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ef4f74ce-3120-4e30-9135-c758dc191f55" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_247628d1-069f-418b-896a-2b6da4e3d333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_6f42c673-1600-4a69-8538-728f8c807987" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_247628d1-069f-418b-896a-2b6da4e3d333" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_6f42c673-1600-4a69-8538-728f8c807987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_683b93a0-bcf3-43be-8903-52440c6f678c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_6f42c673-1600-4a69-8538-728f8c807987" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_683b93a0-bcf3-43be-8903-52440c6f678c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesEmployeeRelatedLiabilities_2dfde892-7577-4edb-a12d-ce0fdf852097" xlink:href="coo-20221031.xsd#coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesEmployeeRelatedLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_6f42c673-1600-4a69-8538-728f8c807987" xlink:to="loc_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesEmployeeRelatedLiabilities_2dfde892-7577-4edb-a12d-ce0fdf852097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_6341a3db-ee6b-42c8-b6b2-4e2c0f910410" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_6f42c673-1600-4a69-8538-728f8c807987" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_6341a3db-ee6b-42c8-b6b2-4e2c0f910410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_83d363ce-cb2e-442b-b93a-c85cbe8e7541" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_6f42c673-1600-4a69-8538-728f8c807987" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_83d363ce-cb2e-442b-b93a-c85cbe8e7541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_44c05a76-ac7f-4935-93c8-57d92038a993" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_6f42c673-1600-4a69-8538-728f8c807987" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_44c05a76-ac7f-4935-93c8-57d92038a993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_e80eb74d-6917-4806-8776-bcbe15e0cce2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_247628d1-069f-418b-896a-2b6da4e3d333" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_e80eb74d-6917-4806-8776-bcbe15e0cce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability_650ab85f-9b10-446e-a735-9541a0624ef8" xlink:href="coo-20221031.xsd#coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_247628d1-069f-418b-896a-2b6da4e3d333" xlink:to="loc_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability_650ab85f-9b10-446e-a735-9541a0624ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredRevenue_37f73e56-13f8-4b15-889e-d1251962cfb4" xlink:href="coo-20221031.xsd#coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredRevenue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_247628d1-069f-418b-896a-2b6da4e3d333" xlink:to="loc_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredRevenue_37f73e56-13f8-4b15-889e-d1251962cfb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_d3ccc8dc-c467-4d8d-ba6b-4eec0834922d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_247628d1-069f-418b-896a-2b6da4e3d333" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_d3ccc8dc-c467-4d8d-ba6b-4eec0834922d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_57b4cd90-c431-4da9-b005-d80ab27d30a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_247628d1-069f-418b-896a-2b6da4e3d333" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_57b4cd90-c431-4da9-b005-d80ab27d30a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_8a1745ea-1104-4b24-9db2-556c601f9678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ef4f74ce-3120-4e30-9135-c758dc191f55" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_8a1745ea-1104-4b24-9db2-556c601f9678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/AcquisitionsandJointVentureProformaInformationDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#AcquisitionsandJointVentureProformaInformationDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/AcquisitionsandJointVentureProformaInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ab092fa1-f372-4e52-9965-581c4ca01b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_01fbe42e-a5d2-4919-ac51-309abfd615dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ab092fa1-f372-4e52-9965-581c4ca01b7e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_01fbe42e-a5d2-4919-ac51-309abfd615dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_07bedfb9-790c-4e5a-897b-7032fc8cae13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_01fbe42e-a5d2-4919-ac51-309abfd615dc" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_07bedfb9-790c-4e5a-897b-7032fc8cae13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e9d95c0b-b562-4ebd-8630-8c17674c9d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_07bedfb9-790c-4e5a-897b-7032fc8cae13" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e9d95c0b-b562-4ebd-8630-8c17674c9d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_GenerateLifeSciencesMember_c5f149a0-4575-4ceb-b0cd-1322d116bb1e" xlink:href="coo-20221031.xsd#coo_GenerateLifeSciencesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e9d95c0b-b562-4ebd-8630-8c17674c9d2e" xlink:to="loc_coo_GenerateLifeSciencesMember_c5f149a0-4575-4ceb-b0cd-1322d116bb1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_2fc86855-11d0-442b-8f06-1637d0bb5be6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_01fbe42e-a5d2-4919-ac51-309abfd615dc" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_2fc86855-11d0-442b-8f06-1637d0bb5be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_ff14d0e6-34b1-425e-8671-808a42be5af2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fc86855-11d0-442b-8f06-1637d0bb5be6" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_ff14d0e6-34b1-425e-8671-808a42be5af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_4cac1828-58da-4ee7-ac21-2e658f511922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2fc86855-11d0-442b-8f06-1637d0bb5be6" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_4cac1828-58da-4ee7-ac21-2e658f511922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/AcquisitionsandJointVentureContingentConsiderationReconciliationDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#AcquisitionsandJointVentureContingentConsiderationReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/AcquisitionsandJointVentureContingentConsiderationReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_e7878713-8f23-43b8-96e1-122fc4b99998" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_da9f68e0-bbda-4c47-89f1-3741ffbaa5a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_e7878713-8f23-43b8-96e1-122fc4b99998" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_da9f68e0-bbda-4c47-89f1-3741ffbaa5a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6055ff4e-c253-40b2-9518-af22c3f2bbb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_da9f68e0-bbda-4c47-89f1-3741ffbaa5a4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6055ff4e-c253-40b2-9518-af22c3f2bbb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_5fecaef1-cd9c-4b68-b376-85780652a1cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_da9f68e0-bbda-4c47-89f1-3741ffbaa5a4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_5fecaef1-cd9c-4b68-b376-85780652a1cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_22de23b8-8d46-4b16-a466-017b5e5be8f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_da9f68e0-bbda-4c47-89f1-3741ffbaa5a4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_22de23b8-8d46-4b16-a466-017b5e5be8f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_8739013d-c223-43de-907c-4b8de098d59d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_da9f68e0-bbda-4c47-89f1-3741ffbaa5a4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_8739013d-c223-43de-907c-4b8de098d59d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_acb7217a-5cb5-4d7b-b726-03e72d103e04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_da9f68e0-bbda-4c47-89f1-3741ffbaa5a4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_acb7217a-5cb5-4d7b-b726-03e72d103e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_75f3b14c-be71-47cb-8af4-eefbb760a276" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_e7878713-8f23-43b8-96e1-122fc4b99998" xlink:to="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_75f3b14c-be71-47cb-8af4-eefbb760a276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#IntangibleAssetsGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2c3d069a-296c-462a-8904-19d31d0afce7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_60d33582-e1f7-484d-b882-394d5eecd740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2c3d069a-296c-462a-8904-19d31d0afce7" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_60d33582-e1f7-484d-b882-394d5eecd740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_eecc1f60-c26e-40ae-ab94-4cbf6f2ee62c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_60d33582-e1f7-484d-b882-394d5eecd740" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_eecc1f60-c26e-40ae-ab94-4cbf6f2ee62c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_55dc52e7-2038-426e-bdd2-9a796eec26bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_eecc1f60-c26e-40ae-ab94-4cbf6f2ee62c" xlink:to="loc_us-gaap_SegmentDomain_55dc52e7-2038-426e-bdd2-9a796eec26bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CoopervisionSegmentMember_f51fb146-04d4-433a-bf87-5cc282e09646" xlink:href="coo-20221031.xsd#coo_CoopervisionSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_55dc52e7-2038-426e-bdd2-9a796eec26bc" xlink:to="loc_coo_CoopervisionSegmentMember_f51fb146-04d4-433a-bf87-5cc282e09646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CoopersurgicalSegmentMember_eb9017e8-9dcb-42ba-bd16-884fe7859b55" xlink:href="coo-20221031.xsd#coo_CoopersurgicalSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_55dc52e7-2038-426e-bdd2-9a796eec26bc" xlink:to="loc_coo_CoopersurgicalSegmentMember_eb9017e8-9dcb-42ba-bd16-884fe7859b55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_e81808c4-2ae3-45fd-8d37-c892e0d53660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_60d33582-e1f7-484d-b882-394d5eecd740" xlink:to="loc_us-gaap_GoodwillLineItems_e81808c4-2ae3-45fd-8d37-c892e0d53660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_33842427-a8f6-40e9-9894-0237c2e842f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_e81808c4-2ae3-45fd-8d37-c892e0d53660" xlink:to="loc_us-gaap_GoodwillRollForward_33842427-a8f6-40e9-9894-0237c2e842f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1c7265ce-0f2d-4a45-ab7a-a662f4dcf307" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_33842427-a8f6-40e9-9894-0237c2e842f9" xlink:to="loc_us-gaap_Goodwill_1c7265ce-0f2d-4a45-ab7a-a662f4dcf307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease_9101416f-598f-4f7c-95ce-31ec43993df2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_33842427-a8f6-40e9-9894-0237c2e842f9" xlink:to="loc_us-gaap_GoodwillPeriodIncreaseDecrease_9101416f-598f-4f7c-95ce-31ec43993df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_91e69432-3c23-49cb-a33e-892d5b52565e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_33842427-a8f6-40e9-9894-0237c2e842f9" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_91e69432-3c23-49cb-a33e-892d5b52565e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_65528418-a09d-4a41-a829-306f3f614fc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_33842427-a8f6-40e9-9894-0237c2e842f9" xlink:to="loc_us-gaap_Goodwill_65528418-a09d-4a41-a829-306f3f614fc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#IntangibleAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_22388630-9a39-4ab7-a4bf-a760a662e9d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_4051d2c8-e7b6-4617-bb10-010993735809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_22388630-9a39-4ab7-a4bf-a760a662e9d8" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_4051d2c8-e7b6-4617-bb10-010993735809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7964e59c-1b54-456a-87f2-e9298a492934" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_4051d2c8-e7b6-4617-bb10-010993735809" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7964e59c-1b54-456a-87f2-e9298a492934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_aa9cf632-a454-4eac-a87a-61ed17718e4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7964e59c-1b54-456a-87f2-e9298a492934" xlink:to="loc_us-gaap_SegmentDomain_aa9cf632-a454-4eac-a87a-61ed17718e4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CoopersurgicalSegmentMember_39e273f4-9ec8-46d8-9b9f-cabee2802a7d" xlink:href="coo-20221031.xsd#coo_CoopersurgicalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_aa9cf632-a454-4eac-a87a-61ed17718e4d" xlink:to="loc_coo_CoopersurgicalSegmentMember_39e273f4-9ec8-46d8-9b9f-cabee2802a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CoopervisionSegmentMember_587c7e9d-4244-4041-8c83-c1c60d7ae9fb" xlink:href="coo-20221031.xsd#coo_CoopervisionSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_aa9cf632-a454-4eac-a87a-61ed17718e4d" xlink:to="loc_coo_CoopervisionSegmentMember_587c7e9d-4244-4041-8c83-c1c60d7ae9fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_0efbfbeb-956b-45a4-bcf8-0e708f009226" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_4051d2c8-e7b6-4617-bb10-010993735809" xlink:to="loc_us-gaap_GoodwillLineItems_0efbfbeb-956b-45a4-bcf8-0e708f009226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_a1759dd1-488f-478d-9547-cb4412afb97c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_0efbfbeb-956b-45a4-bcf8-0e708f009226" xlink:to="loc_us-gaap_NumberOfReportingUnits_a1759dd1-488f-478d-9547-cb4412afb97c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_6525ab1f-d144-498b-9746-655fb276d44d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_0efbfbeb-956b-45a4-bcf8-0e708f009226" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_6525ab1f-d144-498b-9746-655fb276d44d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_5d884ebd-5e40-431e-8cfe-1e5996994455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_0efbfbeb-956b-45a4-bcf8-0e708f009226" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_5d884ebd-5e40-431e-8cfe-1e5996994455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_d3d4f3cb-34a9-4d61-974e-2538908bb679" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_0efbfbeb-956b-45a4-bcf8-0e708f009226" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_d3d4f3cb-34a9-4d61-974e-2538908bb679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_777e45dc-9a23-463e-a9e0-e64aef74dfec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_0efbfbeb-956b-45a4-bcf8-0e708f009226" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_777e45dc-9a23-463e-a9e0-e64aef74dfec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#IntangibleAssetsOtherIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b7e754aa-89b3-48ec-a8dd-5cf2531033a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8ab8a0a6-e89d-43be-8a3f-9247ad1af9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b7e754aa-89b3-48ec-a8dd-5cf2531033a9" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8ab8a0a6-e89d-43be-8a3f-9247ad1af9a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b0d20252-cf6a-4a1a-879a-905a930c0bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8ab8a0a6-e89d-43be-8a3f-9247ad1af9a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b0d20252-cf6a-4a1a-879a-905a930c0bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_18be200b-666e-431e-9b3c-5ff62134f7f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b0d20252-cf6a-4a1a-879a-905a930c0bc4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_18be200b-666e-431e-9b3c-5ff62134f7f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_6abc9b22-d84c-40fd-895f-d74ec9c3032c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_18be200b-666e-431e-9b3c-5ff62134f7f1" xlink:to="loc_us-gaap_TrademarksMember_6abc9b22-d84c-40fd-895f-d74ec9c3032c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CompositeMember_c16dfed2-7549-4bd2-a4e2-828c78092d3e" xlink:href="coo-20221031.xsd#coo_CompositeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_18be200b-666e-431e-9b3c-5ff62134f7f1" xlink:to="loc_coo_CompositeMember_c16dfed2-7549-4bd2-a4e2-828c78092d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_814af4a8-e397-46ad-a12f-158866b44b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_18be200b-666e-431e-9b3c-5ff62134f7f1" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_814af4a8-e397-46ad-a12f-158866b44b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_d5e5dfbc-2494-4340-acf1-cfe9808a57b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_18be200b-666e-431e-9b3c-5ff62134f7f1" xlink:to="loc_us-gaap_CustomerRelationshipsMember_d5e5dfbc-2494-4340-acf1-cfe9808a57b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_LicenseAndDistributionRightsAndOtherMember_da9dd96f-a983-4480-a06c-b98ccf87dab0" xlink:href="coo-20221031.xsd#coo_LicenseAndDistributionRightsAndOtherMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_18be200b-666e-431e-9b3c-5ff62134f7f1" xlink:to="loc_coo_LicenseAndDistributionRightsAndOtherMember_da9dd96f-a983-4480-a06c-b98ccf87dab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3a5d3430-16a2-4fc7-a9b4-b751673697a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8ab8a0a6-e89d-43be-8a3f-9247ad1af9a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3a5d3430-16a2-4fc7-a9b4-b751673697a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_95fee933-3507-4aeb-8df7-b0904301b92d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3a5d3430-16a2-4fc7-a9b4-b751673697a6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_95fee933-3507-4aeb-8df7-b0904301b92d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_68983929-4951-4c28-b218-0bd452101730" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3a5d3430-16a2-4fc7-a9b4-b751673697a6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_68983929-4951-4c28-b218-0bd452101730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b05021c0-5c6e-42f7-9522-8d34a6813520" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3a5d3430-16a2-4fc7-a9b4-b751673697a6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b05021c0-5c6e-42f7-9522-8d34a6813520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_32d4d129-70a6-4557-bac0-6a16012345a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3a5d3430-16a2-4fc7-a9b4-b751673697a6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_32d4d129-70a6-4557-bac0-6a16012345a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_06c6f680-578c-47fc-89af-4565cec4da73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3a5d3430-16a2-4fc7-a9b4-b751673697a6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_06c6f680-578c-47fc-89af-4565cec4da73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6bfb28eb-24f0-4955-a40d-09aa370e324a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3a5d3430-16a2-4fc7-a9b4-b751673697a6" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6bfb28eb-24f0-4955-a40d-09aa370e324a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b4736f9a-e00a-406b-bafa-0aabbea9057b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_ae1cc256-e051-4078-a3b2-b18a28ac9dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b4736f9a-e00a-406b-bafa-0aabbea9057b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_ae1cc256-e051-4078-a3b2-b18a28ac9dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_abbe9ff7-2bb8-4ce5-b656-ce26f528c865" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b4736f9a-e00a-406b-bafa-0aabbea9057b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_abbe9ff7-2bb8-4ce5-b656-ce26f528c865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6eea0fe6-57b3-4e32-bf6d-706bf8d277a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b4736f9a-e00a-406b-bafa-0aabbea9057b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6eea0fe6-57b3-4e32-bf6d-706bf8d277a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_54d93d7c-8863-4008-b150-9b88ea58d34f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b4736f9a-e00a-406b-bafa-0aabbea9057b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_54d93d7c-8863-4008-b150-9b88ea58d34f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_d5ba9805-2d85-411d-8820-84729830fa27" xlink:href="coo-20221031.xsd#coo_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b4736f9a-e00a-406b-bafa-0aabbea9057b" xlink:to="loc_coo_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_d5ba9805-2d85-411d-8820-84729830fa27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7683a567-914f-4457-bd2d-c1594ffac1a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b4736f9a-e00a-406b-bafa-0aabbea9057b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7683a567-914f-4457-bd2d-c1594ffac1a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#FinancingArrangementsTotalDebtDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ec06246f-a508-40e2-b6ed-b42e2e194151" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_920db39b-6cfd-402b-af55-f33e512ce453" xlink:href="coo-20221031.xsd#coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ec06246f-a508-40e2-b6ed-b42e2e194151" xlink:to="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_920db39b-6cfd-402b-af55-f33e512ce453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_2bfb9ac1-f870-4bd0-8980-911505fe5c74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_920db39b-6cfd-402b-af55-f33e512ce453" xlink:to="loc_us-gaap_CreditFacilityAxis_2bfb9ac1-f870-4bd0-8980-911505fe5c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5810b021-9899-4f38-bb00-e0a5d88b5f38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_2bfb9ac1-f870-4bd0-8980-911505fe5c74" xlink:to="loc_us-gaap_CreditFacilityDomain_5810b021-9899-4f38-bb00-e0a5d88b5f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_75434f37-6318-4de3-8818-eb72cb2269e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_5810b021-9899-4f38-bb00-e0a5d88b5f38" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_75434f37-6318-4de3-8818-eb72cb2269e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e9e5d0fe-6991-41e0-a7a3-b10377fd3057" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_920db39b-6cfd-402b-af55-f33e512ce453" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e9e5d0fe-6991-41e0-a7a3-b10377fd3057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_bef56611-b8c5-45bf-a836-615bbad71cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e9e5d0fe-6991-41e0-a7a3-b10377fd3057" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_bef56611-b8c5-45bf-a836-615bbad71cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_e018e644-78e3-454e-baae-54df962e4900" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bef56611-b8c5-45bf-a836-615bbad71cd3" xlink:to="loc_us-gaap_LineOfCreditMember_e018e644-78e3-454e-baae-54df962e4900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_c339883e-c161-4efd-aa96-4f5e55c88020" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MediumTermNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bef56611-b8c5-45bf-a836-615bbad71cd3" xlink:to="loc_us-gaap_MediumTermNotesMember_c339883e-c161-4efd-aa96-4f5e55c88020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_OtherDebtMember_895cc8a6-c6f2-45b6-816c-ef23885ccc16" xlink:href="coo-20221031.xsd#coo_OtherDebtMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bef56611-b8c5-45bf-a836-615bbad71cd3" xlink:to="loc_coo_OtherDebtMember_895cc8a6-c6f2-45b6-816c-ef23885ccc16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_13022d1d-667f-4698-b456-39b5e6f32112" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_920db39b-6cfd-402b-af55-f33e512ce453" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_13022d1d-667f-4698-b456-39b5e6f32112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_511368b7-6f6e-4b48-b27f-2cdf5195bedb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_13022d1d-667f-4698-b456-39b5e6f32112" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_511368b7-6f6e-4b48-b27f-2cdf5195bedb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_OverdraftAndOtherCreditFacilitiesMember_cac4da6d-7f7f-4d79-9a60-cb64b342d4ed" xlink:href="coo-20221031.xsd#coo_OverdraftAndOtherCreditFacilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_511368b7-6f6e-4b48-b27f-2cdf5195bedb" xlink:to="loc_coo_OverdraftAndOtherCreditFacilitiesMember_cac4da6d-7f7f-4d79-9a60-cb64b342d4ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoansMember_03f289af-9a2f-41b8-8831-4189a352acab" xlink:href="coo-20221031.xsd#coo_TermLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_511368b7-6f6e-4b48-b27f-2cdf5195bedb" xlink:to="loc_coo_TermLoansMember_03f289af-9a2f-41b8-8831-4189a352acab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_49b5b0ee-0030-4f61-8aeb-ef10f7085d4b" xlink:href="coo-20221031.xsd#coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_920db39b-6cfd-402b-af55-f33e512ce453" xlink:to="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_49b5b0ee-0030-4f61-8aeb-ef10f7085d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowingsAbstract_33749987-870d-44e7-b9b9-a32a97a6f6b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowingsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_49b5b0ee-0030-4f61-8aeb-ef10f7085d4b" xlink:to="loc_us-gaap_ShortTermBorrowingsAbstract_33749987-870d-44e7-b9b9-a32a97a6f6b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_6e3896b7-321d-4040-8f84-b7d95b51ab66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract_33749987-870d-44e7-b9b9-a32a97a6f6b7" xlink:to="loc_us-gaap_ShortTermBorrowings_6e3896b7-321d-4040-8f84-b7d95b51ab66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsCurrentNet_1a959440-c485-4026-b8e8-216ef6721158" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsCurrentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract_33749987-870d-44e7-b9b9-a32a97a6f6b7" xlink:to="loc_us-gaap_DeferredFinanceCostsCurrentNet_1a959440-c485-4026-b8e8-216ef6721158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ShortTermDebtNetOfDebtIssuanceCosts_337602f2-3d82-4423-aef1-a6ce164cfc81" xlink:href="coo-20221031.xsd#coo_ShortTermDebtNetOfDebtIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract_33749987-870d-44e7-b9b9-a32a97a6f6b7" xlink:to="loc_coo_ShortTermDebtNetOfDebtIssuanceCosts_337602f2-3d82-4423-aef1-a6ce164cfc81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_1b13cd67-f2c6-40de-8477-a0be8f0f7af2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract_33749987-870d-44e7-b9b9-a32a97a6f6b7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_1b13cd67-f2c6-40de-8477-a0be8f0f7af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_8cfbf105-15e4-4f36-9e29-3a215e15f670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract_33749987-870d-44e7-b9b9-a32a97a6f6b7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_8cfbf105-15e4-4f36-9e29-3a215e15f670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_49844e9b-ad37-478e-9827-9f4f5bf96a83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract_33749987-870d-44e7-b9b9-a32a97a6f6b7" xlink:to="loc_us-gaap_DebtCurrent_49844e9b-ad37-478e-9827-9f4f5bf96a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAbstract_6589c158-d66d-4aa3-b62f-2f8eceacd4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_49b5b0ee-0030-4f61-8aeb-ef10f7085d4b" xlink:to="loc_us-gaap_LongTermDebtAbstract_6589c158-d66d-4aa3-b62f-2f8eceacd4eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_69d0c695-593e-4da5-9586-653495527df0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_6589c158-d66d-4aa3-b62f-2f8eceacd4eb" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_69d0c695-593e-4da5-9586-653495527df0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_6c81bb58-69d9-4843-ab6d-821a6d60db3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_6589c158-d66d-4aa3-b62f-2f8eceacd4eb" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_6c81bb58-69d9-4843-ab6d-821a6d60db3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_2d6cddf4-e60f-4324-81ab-5c1176a7dff3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_6589c158-d66d-4aa3-b62f-2f8eceacd4eb" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_2d6cddf4-e60f-4324-81ab-5c1176a7dff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_8744f063-2599-4e8c-ad68-52f6873109ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_6589c158-d66d-4aa3-b62f-2f8eceacd4eb" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_8744f063-2599-4e8c-ad68-52f6873109ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_618a4ad0-4514-45de-80f5-20542c8e4fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_6589c158-d66d-4aa3-b62f-2f8eceacd4eb" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_618a4ad0-4514-45de-80f5-20542c8e4fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_34d16202-e550-42e4-bbe1-39731e7d91f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_6589c158-d66d-4aa3-b62f-2f8eceacd4eb" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_34d16202-e550-42e4-bbe1-39731e7d91f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_ab5b8d5d-3e59-4f21-880b-976d5c2ddc62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ec06246f-a508-40e2-b6ed-b42e2e194151" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_ab5b8d5d-3e59-4f21-880b-976d5c2ddc62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#FinancingArrangementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_99618a13-4b46-499f-8d8b-b2a1d877392a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_88966646-6fe7-48ae-9972-627beeb54cad" xlink:href="coo-20221031.xsd#coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_99618a13-4b46-499f-8d8b-b2a1d877392a" xlink:to="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_88966646-6fe7-48ae-9972-627beeb54cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_781765c8-a962-401d-b896-7c9bd6517b85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_88966646-6fe7-48ae-9972-627beeb54cad" xlink:to="loc_us-gaap_DebtInstrumentAxis_781765c8-a962-401d-b896-7c9bd6517b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b6620795-1158-47c9-8c90-4f0aaafb4d59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_781765c8-a962-401d-b896-7c9bd6517b85" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b6620795-1158-47c9-8c90-4f0aaafb4d59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanFacility2021Member_f722f6c8-0aff-4e67-872f-00334fd4a29e" xlink:href="coo-20221031.xsd#coo_TermLoanFacility2021Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b6620795-1158-47c9-8c90-4f0aaafb4d59" xlink:to="loc_coo_TermLoanFacility2021Member_f722f6c8-0aff-4e67-872f-00334fd4a29e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanFacility2021BaseRateLoansMember_9dfc0e28-f95a-4426-af1b-4c8e123c54a8" xlink:href="coo-20221031.xsd#coo_TermLoanFacility2021BaseRateLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b6620795-1158-47c9-8c90-4f0aaafb4d59" xlink:to="loc_coo_TermLoanFacility2021BaseRateLoansMember_9dfc0e28-f95a-4426-af1b-4c8e123c54a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanFacility2021AdjustedLIBORateLoansMember_36a0948e-48ca-4d6c-8fea-4fbffe8507ed" xlink:href="coo-20221031.xsd#coo_TermLoanFacility2021AdjustedLIBORateLoansMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b6620795-1158-47c9-8c90-4f0aaafb4d59" xlink:to="loc_coo_TermLoanFacility2021AdjustedLIBORateLoansMember_36a0948e-48ca-4d6c-8fea-4fbffe8507ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanAgreement2021364DayMember_5758b0e4-5e56-4dce-8601-9d4384c8e81d" xlink:href="coo-20221031.xsd#coo_TermLoanAgreement2021364DayMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b6620795-1158-47c9-8c90-4f0aaafb4d59" xlink:to="loc_coo_TermLoanAgreement2021364DayMember_5758b0e4-5e56-4dce-8601-9d4384c8e81d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CreditAgreement2020Member_02d33c41-9683-451c-89ca-3cf0411f1498" xlink:href="coo-20221031.xsd#coo_CreditAgreement2020Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b6620795-1158-47c9-8c90-4f0aaafb4d59" xlink:to="loc_coo_CreditAgreement2020Member_02d33c41-9683-451c-89ca-3cf0411f1498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_EuropeanCreditFacilityMember_9849c09a-c7a2-430a-876a-9110ba768145" xlink:href="coo-20221031.xsd#coo_EuropeanCreditFacilityMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b6620795-1158-47c9-8c90-4f0aaafb4d59" xlink:to="loc_coo_EuropeanCreditFacilityMember_9849c09a-c7a2-430a-876a-9110ba768145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AsianPacificCreditFacilitiesYenDenominatedMember_31b2bcb4-2400-4dfb-bc2b-b034165e8b6e" xlink:href="coo-20221031.xsd#coo_AsianPacificCreditFacilitiesYenDenominatedMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b6620795-1158-47c9-8c90-4f0aaafb4d59" xlink:to="loc_coo_AsianPacificCreditFacilitiesYenDenominatedMember_31b2bcb4-2400-4dfb-bc2b-b034165e8b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a5a1a384-1cdb-49d1-bcfe-aeb0e8c08180" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_88966646-6fe7-48ae-9972-627beeb54cad" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a5a1a384-1cdb-49d1-bcfe-aeb0e8c08180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8d7a6435-c6ea-4968-916d-cd9021857e71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a5a1a384-1cdb-49d1-bcfe-aeb0e8c08180" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8d7a6435-c6ea-4968-916d-cd9021857e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_976caf75-dd91-4e79-a8ae-113e8f683747" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8d7a6435-c6ea-4968-916d-cd9021857e71" xlink:to="loc_us-gaap_LineOfCreditMember_976caf75-dd91-4e79-a8ae-113e8f683747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_671055d9-449a-4246-9be1-f5378dbbede1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_88966646-6fe7-48ae-9972-627beeb54cad" xlink:to="loc_us-gaap_CreditFacilityAxis_671055d9-449a-4246-9be1-f5378dbbede1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_9c1006be-922a-46ac-b9b1-09481faa8d34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_671055d9-449a-4246-9be1-f5378dbbede1" xlink:to="loc_us-gaap_CreditFacilityDomain_9c1006be-922a-46ac-b9b1-09481faa8d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_ed9cca15-c8de-4c92-8f93-27a68c57a1fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_9c1006be-922a-46ac-b9b1-09481faa8d34" xlink:to="loc_us-gaap_LineOfCreditMember_ed9cca15-c8de-4c92-8f93-27a68c57a1fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_9f09032d-8287-4fdd-9278-698deedaa82f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_9c1006be-922a-46ac-b9b1-09481faa8d34" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_9f09032d-8287-4fdd-9278-698deedaa82f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoanFacility2020Member_aba13040-8c55-4d23-904b-4c8381556ea9" xlink:href="coo-20221031.xsd#coo_TermLoanFacility2020Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_9c1006be-922a-46ac-b9b1-09481faa8d34" xlink:to="loc_coo_TermLoanFacility2020Member_aba13040-8c55-4d23-904b-4c8381556ea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_RevolvingCreditFacilityAndTermLoanFacility2020Member_da0bc8a1-638f-40f2-beb5-fa58b1f876b5" xlink:href="coo-20221031.xsd#coo_RevolvingCreditFacilityAndTermLoanFacility2020Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_9c1006be-922a-46ac-b9b1-09481faa8d34" xlink:to="loc_coo_RevolvingCreditFacilityAndTermLoanFacility2020Member_da0bc8a1-638f-40f2-beb5-fa58b1f876b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_4199f594-f090-400f-af9e-db1b73b50c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_88966646-6fe7-48ae-9972-627beeb54cad" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_4199f594-f090-400f-af9e-db1b73b50c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_71a2d1dc-7668-4803-b507-3006a36d1f07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_4199f594-f090-400f-af9e-db1b73b50c3c" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_71a2d1dc-7668-4803-b507-3006a36d1f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_TermLoansMember_30e4030c-a10d-47a6-b2ae-cfffd2159a2c" xlink:href="coo-20221031.xsd#coo_TermLoansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_71a2d1dc-7668-4803-b507-3006a36d1f07" xlink:to="loc_coo_TermLoansMember_30e4030c-a10d-47a6-b2ae-cfffd2159a2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_c074cdaf-561d-469d-9afe-068eb4593479" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_88966646-6fe7-48ae-9972-627beeb54cad" xlink:to="loc_us-gaap_VariableRateAxis_c074cdaf-561d-469d-9afe-068eb4593479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_91427cd0-674a-4bfd-83b7-920b13b4c205" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_c074cdaf-561d-469d-9afe-068eb4593479" xlink:to="loc_us-gaap_VariableRateDomain_91427cd0-674a-4bfd-83b7-920b13b4c205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_a9b25880-f638-4a54-8fbd-1e9b6d219b08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_91427cd0-674a-4bfd-83b7-920b13b4c205" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_a9b25880-f638-4a54-8fbd-1e9b6d219b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_2da0ba80-785e-4266-a347-b912a89cd011" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_91427cd0-674a-4bfd-83b7-920b13b4c205" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_2da0ba80-785e-4266-a347-b912a89cd011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_4ffafa7a-3850-4fcd-954d-257a769fdf05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_91427cd0-674a-4bfd-83b7-920b13b4c205" xlink:to="loc_us-gaap_BaseRateMember_4ffafa7a-3850-4fcd-954d-257a769fdf05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f1d59b96-7e3d-40a1-92dd-72dc7994c6cf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_88966646-6fe7-48ae-9972-627beeb54cad" xlink:to="loc_srt_RangeAxis_f1d59b96-7e3d-40a1-92dd-72dc7994c6cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a02a42a0-00c4-4797-a6a2-b618ea4eb014" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f1d59b96-7e3d-40a1-92dd-72dc7994c6cf" xlink:to="loc_srt_RangeMember_a02a42a0-00c4-4797-a6a2-b618ea4eb014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b1879fe7-141c-4eb3-a5b6-cd0ef1457f28" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a02a42a0-00c4-4797-a6a2-b618ea4eb014" xlink:to="loc_srt_MinimumMember_b1879fe7-141c-4eb3-a5b6-cd0ef1457f28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e0fb2000-727b-455f-b75a-3a4ed89e5951" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a02a42a0-00c4-4797-a6a2-b618ea4eb014" xlink:to="loc_srt_MaximumMember_e0fb2000-727b-455f-b75a-3a4ed89e5951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_f7ca0d53-f81c-4872-bda0-3e4e9ddf52f5" xlink:href="coo-20221031.xsd#coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable_88966646-6fe7-48ae-9972-627beeb54cad" xlink:to="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_f7ca0d53-f81c-4872-bda0-3e4e9ddf52f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_fc8cf5a7-0179-44fe-b641-97f8133c8b02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_f7ca0d53-f81c-4872-bda0-3e4e9ddf52f5" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_fc8cf5a7-0179-44fe-b641-97f8133c8b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit_500d7f41-cba6-485f-8921-d3c1c61e41c4" xlink:href="coo-20221031.xsd#coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_f7ca0d53-f81c-4872-bda0-3e4e9ddf52f5" xlink:to="loc_coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit_500d7f41-cba6-485f-8921-d3c1c61e41c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_430fe791-416b-45a1-bd82-86be5f25c362" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_f7ca0d53-f81c-4872-bda0-3e4e9ddf52f5" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_430fe791-416b-45a1-bd82-86be5f25c362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_8ba5f203-85d4-4c52-84b4-ccc154fc38a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_f7ca0d53-f81c-4872-bda0-3e4e9ddf52f5" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_8ba5f203-85d4-4c52-84b4-ccc154fc38a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_22177537-a351-4f51-ab80-76854c2c176f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_f7ca0d53-f81c-4872-bda0-3e4e9ddf52f5" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_22177537-a351-4f51-ab80-76854c2c176f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_c4b87b41-341f-49d7-8bf4-ee4ed796d869" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_f7ca0d53-f81c-4872-bda0-3e4e9ddf52f5" xlink:to="loc_us-gaap_DebtInstrumentTerm_c4b87b41-341f-49d7-8bf4-ee4ed796d869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_a1a4303d-f090-4a5a-a74f-6828a652b6bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_f7ca0d53-f81c-4872-bda0-3e4e9ddf52f5" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_a1a4303d-f090-4a5a-a74f-6828a652b6bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_dd3d090b-e381-4b74-9fb7-61c181e39808" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_f7ca0d53-f81c-4872-bda0-3e4e9ddf52f5" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_dd3d090b-e381-4b74-9fb7-61c181e39808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_69ccf6f2-740c-4b2e-802f-e1e86409fbc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_f7ca0d53-f81c-4872-bda0-3e4e9ddf52f5" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_69ccf6f2-740c-4b2e-802f-e1e86409fbc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit_67b19839-c34a-4443-9fc3-4f9a1b278e18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_f7ca0d53-f81c-4872-bda0-3e4e9ddf52f5" xlink:to="loc_us-gaap_LongTermLineOfCredit_67b19839-c34a-4443-9fc3-4f9a1b278e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_fa001d89-740b-40d1-8030-1cd751fdc869" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_f7ca0d53-f81c-4872-bda0-3e4e9ddf52f5" xlink:to="loc_us-gaap_LineOfCredit_fa001d89-740b-40d1-8030-1cd751fdc869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_15e94d83-e225-4ece-9bc2-a852d1ad6eee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems_f7ca0d53-f81c-4872-bda0-3e4e9ddf52f5" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_15e94d83-e225-4ece-9bc2-a852d1ad6eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_41ba5ba5-02d3-495f-a236-2fcc8ea457dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_0864182b-e6f0-4f43-a04a-3751c7534e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_41ba5ba5-02d3-495f-a236-2fcc8ea457dd" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_0864182b-e6f0-4f43-a04a-3751c7534e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_f746eb96-e1f6-43cc-9efc-652de30bac82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_0864182b-e6f0-4f43-a04a-3751c7534e5a" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_f746eb96-e1f6-43cc-9efc-652de30bac82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_70db1693-1ae5-4a5b-afef-e043a02b486b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_f746eb96-e1f6-43cc-9efc-652de30bac82" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_70db1693-1ae5-4a5b-afef-e043a02b486b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_4fba448c-fbc7-4928-9000-3562796e5854" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_70db1693-1ae5-4a5b-afef-e043a02b486b" xlink:to="loc_us-gaap_DomesticCountryMember_4fba448c-fbc7-4928-9000-3562796e5854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_03cc9cf3-d264-45c9-979b-5e794c24a6a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_70db1693-1ae5-4a5b-afef-e043a02b486b" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_03cc9cf3-d264-45c9-979b-5e794c24a6a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_16081c8b-5846-4330-a348-f1fb5496b571" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_0864182b-e6f0-4f43-a04a-3751c7534e5a" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_16081c8b-5846-4330-a348-f1fb5496b571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b0a09544-9845-4747-b0e6-ef5be708dfb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_16081c8b-5846-4330-a348-f1fb5496b571" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b0a09544-9845-4747-b0e6-ef5be708dfb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_7546cfe1-e21e-42c9-b8a5-619cb8ba2c84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_16081c8b-5846-4330-a348-f1fb5496b571" xlink:to="loc_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_7546cfe1-e21e-42c9-b8a5-619cb8ba2c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_EffectiveIncomeTaxRateReconciliationChangeInEnactedForeignTaxRateAmount_5358bfe9-2af6-462f-94b7-6588e84c426a" xlink:href="coo-20221031.xsd#coo_EffectiveIncomeTaxRateReconciliationChangeInEnactedForeignTaxRateAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_16081c8b-5846-4330-a348-f1fb5496b571" xlink:to="loc_coo_EffectiveIncomeTaxRateReconciliationChangeInEnactedForeignTaxRateAmount_5358bfe9-2af6-462f-94b7-6588e84c426a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_74c5056e-7346-490f-bb2c-a3b7c7496264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_16081c8b-5846-4330-a348-f1fb5496b571" xlink:to="loc_us-gaap_OperatingLossCarryforwards_74c5056e-7346-490f-bb2c-a3b7c7496264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_0ae3b0dc-b448-4725-80ac-13ec9a495be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_16081c8b-5846-4330-a348-f1fb5496b571" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_0ae3b0dc-b448-4725-80ac-13ec9a495be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_0b32887b-375a-488a-8576-c01810ed9047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_16081c8b-5846-4330-a348-f1fb5496b571" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_0b32887b-375a-488a-8576-c01810ed9047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_7860118e-905b-4e47-80a3-ec543a03ef26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_16081c8b-5846-4330-a348-f1fb5496b571" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_7860118e-905b-4e47-80a3-ec543a03ef26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_df8d1715-01f9-4375-9779-291a0fbb4a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_16081c8b-5846-4330-a348-f1fb5496b571" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_df8d1715-01f9-4375-9779-291a0fbb4a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_a026122a-b301-4ec2-82a6-019c54f4b22b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_16081c8b-5846-4330-a348-f1fb5496b571" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_a026122a-b301-4ec2-82a6-019c54f4b22b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_b3053ee4-d927-4a79-99d9-00b37553586e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_16081c8b-5846-4330-a348-f1fb5496b571" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_b3053ee4-d927-4a79-99d9-00b37553586e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#IncomeTaxesIncomeBeforeIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_3f4435cb-a679-4a95-a8c9-ab6d4a439034" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_914f9392-6343-4d73-b8fb-8f5e326e0eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3f4435cb-a679-4a95-a8c9-ab6d4a439034" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_914f9392-6343-4d73-b8fb-8f5e326e0eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_f2adea1f-76d7-49df-8d61-fafdf88cef57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_914f9392-6343-4d73-b8fb-8f5e326e0eaa" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_f2adea1f-76d7-49df-8d61-fafdf88cef57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_8bc459f9-5394-44b8-a3b0-ab94ad957573" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_914f9392-6343-4d73-b8fb-8f5e326e0eaa" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_8bc459f9-5394-44b8-a3b0-ab94ad957573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8b27730a-7724-4721-8f15-e9825fb1483a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_914f9392-6343-4d73-b8fb-8f5e326e0eaa" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8b27730a-7724-4721-8f15-e9825fb1483a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#IncomeTaxesIncomeTaxProvisionBenefitDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d749ed16-3179-4cd9-9340-66071044ff94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_c2dfda69-db0e-41c6-a332-09b1871e7d85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d749ed16-3179-4cd9-9340-66071044ff94" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_c2dfda69-db0e-41c6-a332-09b1871e7d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_e7778f80-4b5d-4122-a692-c96d4528e341" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_c2dfda69-db0e-41c6-a332-09b1871e7d85" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_e7778f80-4b5d-4122-a692-c96d4528e341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_16db8ece-ff91-478f-b57c-9ea50dd00286" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_c2dfda69-db0e-41c6-a332-09b1871e7d85" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_16db8ece-ff91-478f-b57c-9ea50dd00286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_03955207-2750-40c4-a004-c4ceef346916" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_c2dfda69-db0e-41c6-a332-09b1871e7d85" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_03955207-2750-40c4-a004-c4ceef346916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_24f84182-27d9-4a0b-afb2-9f1f1e737d09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_c2dfda69-db0e-41c6-a332-09b1871e7d85" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_24f84182-27d9-4a0b-afb2-9f1f1e737d09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_5b9dde28-689b-4164-b5a7-a83832996463" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d749ed16-3179-4cd9-9340-66071044ff94" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_5b9dde28-689b-4164-b5a7-a83832996463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_d6335866-484a-41a0-accb-ae9b98dcc339" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_5b9dde28-689b-4164-b5a7-a83832996463" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_d6335866-484a-41a0-accb-ae9b98dcc339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_0cc3bcc7-c272-471d-b0af-f2fe4ea6bd39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_5b9dde28-689b-4164-b5a7-a83832996463" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_0cc3bcc7-c272-471d-b0af-f2fe4ea6bd39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_752b2562-0fdf-4045-8f3c-3c4ac9586f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_5b9dde28-689b-4164-b5a7-a83832996463" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_752b2562-0fdf-4045-8f3c-3c4ac9586f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_fd0114e7-cf3a-4e6b-ada0-131a7aceab25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_5b9dde28-689b-4164-b5a7-a83832996463" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_fd0114e7-cf3a-4e6b-ada0-131a7aceab25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a6c5f188-7c74-4067-8b0e-1d3ea79033c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d749ed16-3179-4cd9-9340-66071044ff94" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a6c5f188-7c74-4067-8b0e-1d3ea79033c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_c1f4830d-5077-49c8-bdc1-c0e1e9f55182" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_39c8ee2d-7218-4cb9-b118-109e199518a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c1f4830d-5077-49c8-bdc1-c0e1e9f55182" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_39c8ee2d-7218-4cb9-b118-109e199518a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_fa1cea54-3ade-4f31-a266-3b565bb24e82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c1f4830d-5077-49c8-bdc1-c0e1e9f55182" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_fa1cea54-3ade-4f31-a266-3b565bb24e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings_5cb4e748-8e18-49ea-ba63-c8ef64065faf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c1f4830d-5077-49c8-bdc1-c0e1e9f55182" xlink:to="loc_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings_5cb4e748-8e18-49ea-ba63-c8ef64065faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_ed301b85-68e2-4bcf-99aa-e911bff3698d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c1f4830d-5077-49c8-bdc1-c0e1e9f55182" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_ed301b85-68e2-4bcf-99aa-e911bff3698d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_107058a0-b57d-4ae5-9dd4-22e5a00f946d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c1f4830d-5077-49c8-bdc1-c0e1e9f55182" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_107058a0-b57d-4ae5-9dd4-22e5a00f946d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_EffectiveIncomeTaxRateReconciliationChangeInDomesticFederalTaxReturnAmount_13e0a3aa-fb80-4124-bfc6-123e88d6c22f" xlink:href="coo-20221031.xsd#coo_EffectiveIncomeTaxRateReconciliationChangeInDomesticFederalTaxReturnAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c1f4830d-5077-49c8-bdc1-c0e1e9f55182" xlink:to="loc_coo_EffectiveIncomeTaxRateReconciliationChangeInDomesticFederalTaxReturnAmount_13e0a3aa-fb80-4124-bfc6-123e88d6c22f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationDispositionOfAssets_743dd628-78ae-4861-af3c-04bd5174e9ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationDispositionOfAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c1f4830d-5077-49c8-bdc1-c0e1e9f55182" xlink:to="loc_us-gaap_IncomeTaxReconciliationDispositionOfAssets_743dd628-78ae-4861-af3c-04bd5174e9ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_4df219c1-a1d1-4c27-903a-a9418f6121a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c1f4830d-5077-49c8-bdc1-c0e1e9f55182" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_4df219c1-a1d1-4c27-903a-a9418f6121a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount_6af929d3-8e92-40e9-996b-caea8a7a0cad" xlink:href="coo-20221031.xsd#coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c1f4830d-5077-49c8-bdc1-c0e1e9f55182" xlink:to="loc_coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount_6af929d3-8e92-40e9-996b-caea8a7a0cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_725d96de-c7a8-4b38-a337-ba45e711f9f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c1f4830d-5077-49c8-bdc1-c0e1e9f55182" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_725d96de-c7a8-4b38-a337-ba45e711f9f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_53816c23-a630-42c5-8eff-6aba8f29ee13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c1f4830d-5077-49c8-bdc1-c0e1e9f55182" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_53816c23-a630-42c5-8eff-6aba8f29ee13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_bd946f32-3836-41c8-83a0-bac850d9d206" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c1f4830d-5077-49c8-bdc1-c0e1e9f55182" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_bd946f32-3836-41c8-83a0-bac850d9d206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_44fd4a60-578f-42e2-bbe3-7be25d65054f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_8ed191a4-1e5e-4ccf-8099-49e0de740144" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_44fd4a60-578f-42e2-bbe3-7be25d65054f" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_8ed191a4-1e5e-4ccf-8099-49e0de740144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract_cd2682fa-2e96-4964-bfcf-98d000b0c7e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_8ed191a4-1e5e-4ccf-8099-49e0de740144" xlink:to="loc_us-gaap_DeferredTaxAssetsNetAbstract_cd2682fa-2e96-4964-bfcf-98d000b0c7e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_3279a41d-aa67-4188-9a91-acdfd76ed2e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_cd2682fa-2e96-4964-bfcf-98d000b0c7e8" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_3279a41d-aa67-4188-9a91-acdfd76ed2e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_adcfe6c8-143a-4218-a845-47ea16bbd813" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_cd2682fa-2e96-4964-bfcf-98d000b0c7e8" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_adcfe6c8-143a-4218-a845-47ea16bbd813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_7896fbe5-eefd-4394-964a-2da4947280cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_cd2682fa-2e96-4964-bfcf-98d000b0c7e8" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_7896fbe5-eefd-4394-964a-2da4947280cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_3f28eef9-7bc1-40d7-a13d-0bfc4c5245d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_cd2682fa-2e96-4964-bfcf-98d000b0c7e8" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_3f28eef9-7bc1-40d7-a13d-0bfc4c5245d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_14b9a9c7-ed7b-4e55-87dc-27970189af3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_cd2682fa-2e96-4964-bfcf-98d000b0c7e8" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_14b9a9c7-ed7b-4e55-87dc-27970189af3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards_c4cc9b78-94b3-4f58-ac8a-2ee05ddc8421" xlink:href="coo-20221031.xsd#coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_cd2682fa-2e96-4964-bfcf-98d000b0c7e8" xlink:to="loc_coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards_c4cc9b78-94b3-4f58-ac8a-2ee05ddc8421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_c8a642f6-6265-4bc5-bda7-2d7807b1c188" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_cd2682fa-2e96-4964-bfcf-98d000b0c7e8" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_c8a642f6-6265-4bc5-bda7-2d7807b1c188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_1405c9aa-b1c9-4765-bbf7-871f8c56b460" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_cd2682fa-2e96-4964-bfcf-98d000b0c7e8" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_1405c9aa-b1c9-4765-bbf7-871f8c56b460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_23afe6e3-3fde-4c4a-aad3-668936e876ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_cd2682fa-2e96-4964-bfcf-98d000b0c7e8" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_23afe6e3-3fde-4c4a-aad3-668936e876ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_769fd52b-4fac-41b2-98af-d583a175a8b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_cd2682fa-2e96-4964-bfcf-98d000b0c7e8" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_769fd52b-4fac-41b2-98af-d583a175a8b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_aab6205d-23a2-48a0-be62-3e7b5f41bca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_cd2682fa-2e96-4964-bfcf-98d000b0c7e8" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_aab6205d-23a2-48a0-be62-3e7b5f41bca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_054aaa34-16cc-4580-8905-6749b8953f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_8ed191a4-1e5e-4ccf-8099-49e0de740144" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_054aaa34-16cc-4580-8905-6749b8953f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_7fe28218-d445-430b-93ff-43272087fb7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_054aaa34-16cc-4580-8905-6749b8953f7f" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_7fe28218-d445-430b-93ff-43272087fb7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_21d945c7-8ed4-46ce-9689-008f171aaa4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_054aaa34-16cc-4580-8905-6749b8953f7f" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_21d945c7-8ed4-46ce-9689-008f171aaa4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_2581cd6f-97f9-416f-bfee-c838dc229682" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_054aaa34-16cc-4580-8905-6749b8953f7f" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_2581cd6f-97f9-416f-bfee-c838dc229682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign_1f5d1766-89fe-4c50-85c5-5f96c15bdb1a" xlink:href="coo-20221031.xsd#coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_054aaa34-16cc-4580-8905-6749b8953f7f" xlink:to="loc_coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign_1f5d1766-89fe-4c50-85c5-5f96c15bdb1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_70265425-4a87-4104-b261-4ab662d2de08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_054aaa34-16cc-4580-8905-6749b8953f7f" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_70265425-4a87-4104-b261-4ab662d2de08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_7304fdb5-bf85-4828-865a-a8fa9313f5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_8ed191a4-1e5e-4ccf-8099-49e0de740144" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_7304fdb5-bf85-4828-865a-a8fa9313f5d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/IncomeTaxesChangesinUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#IncomeTaxesChangesinUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/IncomeTaxesChangesinUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_df98d3f5-77d3-4777-8cb8-65856bf38e63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a4b66091-a661-46ec-a0be-68525504b05a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_df98d3f5-77d3-4777-8cb8-65856bf38e63" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a4b66091-a661-46ec-a0be-68525504b05a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_8a9d1676-9a33-4159-92a5-e9ed5d4fb82c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a4b66091-a661-46ec-a0be-68525504b05a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_8a9d1676-9a33-4159-92a5-e9ed5d4fb82c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_16233bb7-3e4a-4da7-b6f0-b7e877e0a5a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a4b66091-a661-46ec-a0be-68525504b05a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_16233bb7-3e4a-4da7-b6f0-b7e877e0a5a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_9b1d360e-82da-4e07-99af-91e0f8b7325e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a4b66091-a661-46ec-a0be-68525504b05a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_9b1d360e-82da-4e07-99af-91e0f8b7325e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_554ef151-c32d-4d6c-a03f-54a46aaed542" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a4b66091-a661-46ec-a0be-68525504b05a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_554ef151-c32d-4d6c-a03f-54a46aaed542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_b1befdf1-42a4-4110-b416-b02e80fe3ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a4b66091-a661-46ec-a0be-68525504b05a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_b1befdf1-42a4-4110-b416-b02e80fe3ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_9d933af8-4e1c-40cf-8ff0-04eb5b1ca581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a4b66091-a661-46ec-a0be-68525504b05a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_9d933af8-4e1c-40cf-8ff0-04eb5b1ca581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#EarningsPerShareBasicandDilutedDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_308adb14-dd3e-41f3-a0cf-40455f298735" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_22481b81-46df-4e0a-899f-c8aa2658994e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_308adb14-dd3e-41f3-a0cf-40455f298735" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_22481b81-46df-4e0a-899f-c8aa2658994e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_a8dab9b3-d510-406b-a100-6049446ad6f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_308adb14-dd3e-41f3-a0cf-40455f298735" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_a8dab9b3-d510-406b-a100-6049446ad6f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_4289e7b1-605d-46c4-8d69-09f78b52a60f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_308adb14-dd3e-41f3-a0cf-40455f298735" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_4289e7b1-605d-46c4-8d69-09f78b52a60f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ca039148-2d7a-42f9-91b2-651efe402590" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_4289e7b1-605d-46c4-8d69-09f78b52a60f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ca039148-2d7a-42f9-91b2-651efe402590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_ebfbcf60-6021-4b45-98b1-b663397b8bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_4289e7b1-605d-46c4-8d69-09f78b52a60f" xlink:to="loc_us-gaap_EarningsPerShareBasic_ebfbcf60-6021-4b45-98b1-b663397b8bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_1016c0cc-5ac9-41dd-ac01-ea7b5c09e2ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_308adb14-dd3e-41f3-a0cf-40455f298735" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_1016c0cc-5ac9-41dd-ac01-ea7b5c09e2ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_de8d57af-cc75-4699-9f82-5d59f3189cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_1016c0cc-5ac9-41dd-ac01-ea7b5c09e2ff" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_de8d57af-cc75-4699-9f82-5d59f3189cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a6694dc5-466d-4a49-a386-6e428f6ba1a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_1016c0cc-5ac9-41dd-ac01-ea7b5c09e2ff" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a6694dc5-466d-4a49-a386-6e428f6ba1a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_ec1a6e3a-2ee9-487d-91b7-8c6c72b59505" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_1016c0cc-5ac9-41dd-ac01-ea7b5c09e2ff" xlink:to="loc_us-gaap_EarningsPerShareDiluted_ec1a6e3a-2ee9-487d-91b7-8c6c72b59505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2c10f181-b2ce-4c6c-a385-b59110ef96eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ca35cd0c-0a50-40aa-8f4f-10626afebf47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2c10f181-b2ce-4c6c-a385-b59110ef96eb" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ca35cd0c-0a50-40aa-8f4f-10626afebf47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3adcc9ba-68c6-4edb-8700-32b72bb74c51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ca35cd0c-0a50-40aa-8f4f-10626afebf47" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3adcc9ba-68c6-4edb-8700-32b72bb74c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_65826981-4363-4973-89c7-870dc9e1615e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3adcc9ba-68c6-4edb-8700-32b72bb74c51" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_65826981-4363-4973-89c7-870dc9e1615e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_c8811a47-8c4b-44dd-b949-255d4db09e53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_65826981-4363-4973-89c7-870dc9e1615e" xlink:to="loc_us-gaap_EmployeeStockOptionMember_c8811a47-8c4b-44dd-b949-255d4db09e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_de6fe601-d152-49c9-a3a7-bcd389cf2d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_65826981-4363-4973-89c7-870dc9e1615e" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_de6fe601-d152-49c9-a3a7-bcd389cf2d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4ec90d33-ecaf-4141-b505-0cb193538802" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ca35cd0c-0a50-40aa-8f4f-10626afebf47" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4ec90d33-ecaf-4141-b505-0cb193538802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_55c81aae-adc9-47b0-8d51-e305a24f1386" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4ec90d33-ecaf-4141-b505-0cb193538802" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_55c81aae-adc9-47b0-8d51-e305a24f1386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_02f0444e-3292-4597-ad89-2cbcf08235b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4ec90d33-ecaf-4141-b505-0cb193538802" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_02f0444e-3292-4597-ad89-2cbcf08235b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_8c5b0ee0-23d8-4762-b2c4-3b84e191b032" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4ec90d33-ecaf-4141-b505-0cb193538802" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_8c5b0ee0-23d8-4762-b2c4-3b84e191b032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_86ff343c-0965-4348-8bc8-f8847912e13c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_cb2b184e-34c3-42de-a632-668de84296a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_86ff343c-0965-4348-8bc8-f8847912e13c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_cb2b184e-34c3-42de-a632-668de84296a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a4527c8a-9cc5-41ab-9909-b5d0002e0fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_cb2b184e-34c3-42de-a632-668de84296a2" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a4527c8a-9cc5-41ab-9909-b5d0002e0fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7ef3060a-bd1b-4f3d-bef5-1c3fde5e1c01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a4527c8a-9cc5-41ab-9909-b5d0002e0fdf" xlink:to="loc_us-gaap_EquityComponentDomain_7ef3060a-bd1b-4f3d-bef5-1c3fde5e1c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1515f8ad-e774-442d-b1c4-ba28a2912d83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7ef3060a-bd1b-4f3d-bef5-1c3fde5e1c01" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1515f8ad-e774-442d-b1c4-ba28a2912d83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_af5dfe6d-4667-4ee9-89a7-a32f6d8634c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1515f8ad-e774-442d-b1c4-ba28a2912d83" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_af5dfe6d-4667-4ee9-89a7-a32f6d8634c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_5dd215f5-3a02-4ab3-8d53-192c75b639ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1515f8ad-e774-442d-b1c4-ba28a2912d83" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_5dd215f5-3a02-4ab3-8d53-192c75b639ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_c2567918-3662-40ff-a2c3-82134e322bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1515f8ad-e774-442d-b1c4-ba28a2912d83" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_c2567918-3662-40ff-a2c3-82134e322bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_82f002b4-0070-45dc-b76a-ac5969e8a3b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_cb2b184e-34c3-42de-a632-668de84296a2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_82f002b4-0070-45dc-b76a-ac5969e8a3b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c74d9ba6-5988-4f09-afe6-2c5ae0780222" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_82f002b4-0070-45dc-b76a-ac5969e8a3b0" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c74d9ba6-5988-4f09-afe6-2c5ae0780222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_35c9587f-e55c-4815-a7f8-b954826ba69c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c74d9ba6-5988-4f09-afe6-2c5ae0780222" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_35c9587f-e55c-4815-a7f8-b954826ba69c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_e6284327-a49d-4b80-88eb-b80626cf3450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c74d9ba6-5988-4f09-afe6-2c5ae0780222" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_e6284327-a49d-4b80-88eb-b80626cf3450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_66baac95-dda7-4ec0-b4cd-abba99a8afe4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c74d9ba6-5988-4f09-afe6-2c5ae0780222" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_66baac95-dda7-4ec0-b4cd-abba99a8afe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cdb15331-0824-46eb-8871-c2d95162c307" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c74d9ba6-5988-4f09-afe6-2c5ae0780222" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cdb15331-0824-46eb-8871-c2d95162c307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#StockholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_abb9b970-3320-49eb-9ca1-063d8b11f1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_f83c0a8d-10f2-4057-a7ae-664daf9dfe79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_abb9b970-3320-49eb-9ca1-063d8b11f1c6" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_f83c0a8d-10f2-4057-a7ae-664daf9dfe79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_1f7e30d3-55fd-4d67-8857-011d5789e189" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_abb9b970-3320-49eb-9ca1-063d8b11f1c6" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_1f7e30d3-55fd-4d67-8857-011d5789e189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockholdersEquityShareRepurchasesDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#StockholdersEquityShareRepurchasesDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/StockholdersEquityShareRepurchasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_07d872c4-89de-440f-9f71-c421faba9367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_6a1b2e4f-f9b4-41d6-8d4d-786220aa2fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_07d872c4-89de-440f-9f71-c421faba9367" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_6a1b2e4f-f9b4-41d6-8d4d-786220aa2fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_f28264bc-ed37-4c04-9132-c7a41c71ce0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_07d872c4-89de-440f-9f71-c421faba9367" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_f28264bc-ed37-4c04-9132-c7a41c71ce0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_41d54a36-a5cc-45dc-9513-730fab926758" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_07d872c4-89de-440f-9f71-c421faba9367" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_41d54a36-a5cc-45dc-9513-730fab926758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockPlansNarrativeDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#StockPlansNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/StockPlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e6c0fa63-6d37-428b-a185-07bc29ce471e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_01fb74f1-8bc4-4d6a-bf9c-837d58bab4dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e6c0fa63-6d37-428b-a185-07bc29ce471e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_01fb74f1-8bc4-4d6a-bf9c-837d58bab4dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_37e58600-539c-48c5-8643-8fd43d52292c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_01fb74f1-8bc4-4d6a-bf9c-837d58bab4dc" xlink:to="loc_us-gaap_PlanNameAxis_37e58600-539c-48c5-8643-8fd43d52292c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_0f9a46db-745a-491c-a161-c2537aa87e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_37e58600-539c-48c5-8643-8fd43d52292c" xlink:to="loc_us-gaap_PlanNameDomain_0f9a46db-745a-491c-a161-c2537aa87e1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember_a99662a1-f85d-4566-a488-87d9ce93a333" xlink:href="coo-20221031.xsd#coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_0f9a46db-745a-491c-a161-c2537aa87e1f" xlink:to="loc_coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember_a99662a1-f85d-4566-a488-87d9ce93a333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DirectorsPlan2020Member_c9c7691f-d0bf-4553-9198-6a704e8af246" xlink:href="coo-20221031.xsd#coo_DirectorsPlan2020Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_0f9a46db-745a-491c-a161-c2537aa87e1f" xlink:to="loc_coo_DirectorsPlan2020Member_c9c7691f-d0bf-4553-9198-6a704e8af246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_EmployeeStockPurchasePlanMember_7b94816e-bb1d-4e38-ab66-c114e58c8681" xlink:href="coo-20221031.xsd#coo_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_0f9a46db-745a-491c-a161-c2537aa87e1f" xlink:to="loc_coo_EmployeeStockPurchasePlanMember_7b94816e-bb1d-4e38-ab66-c114e58c8681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6ccf90be-6dce-4323-826d-49ec06f44bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_01fb74f1-8bc4-4d6a-bf9c-837d58bab4dc" xlink:to="loc_us-gaap_AwardTypeAxis_6ccf90be-6dce-4323-826d-49ec06f44bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7d46fcb0-bd21-4fae-809b-a0fbcf5b00b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6ccf90be-6dce-4323-826d-49ec06f44bc8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7d46fcb0-bd21-4fae-809b-a0fbcf5b00b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_59a08961-4773-4196-bda1-5161d2d74ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7d46fcb0-bd21-4fae-809b-a0fbcf5b00b8" xlink:to="loc_us-gaap_EmployeeStockOptionMember_59a08961-4773-4196-bda1-5161d2d74ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_7f839b57-ee7d-47f4-a8a5-1002ad90a3f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7d46fcb0-bd21-4fae-809b-a0fbcf5b00b8" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_7f839b57-ee7d-47f4-a8a5-1002ad90a3f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_516ff457-e328-4eef-a8f8-7ff13b6e5555" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7d46fcb0-bd21-4fae-809b-a0fbcf5b00b8" xlink:to="loc_us-gaap_PerformanceSharesMember_516ff457-e328-4eef-a8f8-7ff13b6e5555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_05c85a0d-581c-4bc7-b40d-cb53efc278ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7d46fcb0-bd21-4fae-809b-a0fbcf5b00b8" xlink:to="loc_us-gaap_EmployeeStockMember_05c85a0d-581c-4bc7-b40d-cb53efc278ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7067b237-9d68-45d5-b726-aca8a481f1cb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_01fb74f1-8bc4-4d6a-bf9c-837d58bab4dc" xlink:to="loc_srt_RangeAxis_7067b237-9d68-45d5-b726-aca8a481f1cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fd031bb9-232f-4892-9c2d-43a4860d14f3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7067b237-9d68-45d5-b726-aca8a481f1cb" xlink:to="loc_srt_RangeMember_fd031bb9-232f-4892-9c2d-43a4860d14f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b2adec19-0240-44ff-b755-4592224586d0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fd031bb9-232f-4892-9c2d-43a4860d14f3" xlink:to="loc_srt_MinimumMember_b2adec19-0240-44ff-b755-4592224586d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a2050b51-894d-4c11-a331-a4e9c6f3a4c2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fd031bb9-232f-4892-9c2d-43a4860d14f3" xlink:to="loc_srt_MaximumMember_a2050b51-894d-4c11-a331-a4e9c6f3a4c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_01fb74f1-8bc4-4d6a-bf9c-837d58bab4dc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee_cb0c7d8c-70fe-440d-91c0-4fdfcdb26a27" xlink:href="coo-20221031.xsd#coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee_cb0c7d8c-70fe-440d-91c0-4fdfcdb26a27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_9a4c571a-51f2-476b-ac56-792e6f4507da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_9a4c571a-51f2-476b-ac56-792e6f4507da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_222d3804-81e6-4093-b899-ed13a89d3ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_222d3804-81e6-4093-b899-ed13a89d3ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_42ba82a6-3b39-447e-b1c7-412b19b79fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_42ba82a6-3b39-447e-b1c7-412b19b79fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_36826451-29d3-4947-9dbe-3610e931c4ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_36826451-29d3-4947-9dbe-3610e931c4ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_26ba0da5-aa23-4379-8755-dbbf51d29915" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_26ba0da5-aa23-4379-8755-dbbf51d29915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_7467d224-1c64-4f17-95ef-f6a3519c8328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_7467d224-1c64-4f17-95ef-f6a3519c8328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_e3a37557-2257-4b83-b65e-8529536757df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_e3a37557-2257-4b83-b65e-8529536757df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_75233d16-eac9-4d5a-b7cc-f40fbc5bdfb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_75233d16-eac9-4d5a-b7cc-f40fbc5bdfb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_5a6f9480-2c26-40b5-8f95-75fc26755ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_5a6f9480-2c26-40b5-8f95-75fc26755ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_d52143e3-0cb6-43f6-9cbb-4379a0531e29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_d52143e3-0cb6-43f6-9cbb-4379a0531e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned_45e10be2-a5be-418d-8173-9f1829298622" xlink:href="coo-20221031.xsd#coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned_45e10be2-a5be-418d-8173-9f1829298622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_8dddc91f-9d25-4a9e-b1f7-f0dca4058c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_8dddc91f-9d25-4a9e-b1f7-f0dca4058c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_265784ff-3f98-4936-9f0d-ca269e9a7f94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_265784ff-3f98-4936-9f0d-ca269e9a7f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_9642516b-0146-4ae9-99f5-934d5f89f830" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_9642516b-0146-4ae9-99f5-934d5f89f830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_a7299e29-ab35-4e5b-a731-5d1ce93c678d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fc2baac-0a02-48cd-a11c-24132e7878fd" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_a7299e29-ab35-4e5b-a731-5d1ce93c678d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_84deb0dc-ed25-4b92-8aba-185e5d6e74b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_fcd02593-8dc6-4090-9f82-0c6f034c6361" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_84deb0dc-ed25-4b92-8aba-185e5d6e74b1" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_fcd02593-8dc6-4090-9f82-0c6f034c6361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b840e92b-c30a-4ff6-8b13-0c1101d4ef27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_fcd02593-8dc6-4090-9f82-0c6f034c6361" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b840e92b-c30a-4ff6-8b13-0c1101d4ef27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_92cf4a6e-0c22-418a-b07e-0e2b78b6e4dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b840e92b-c30a-4ff6-8b13-0c1101d4ef27" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_92cf4a6e-0c22-418a-b07e-0e2b78b6e4dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_9bd2dfce-15fd-44a9-adef-128008002565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_92cf4a6e-0c22-418a-b07e-0e2b78b6e4dc" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_9bd2dfce-15fd-44a9-adef-128008002565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_c7354327-c0dd-444e-a376-969f43d9de14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_92cf4a6e-0c22-418a-b07e-0e2b78b6e4dc" xlink:to="loc_us-gaap_CostOfSalesMember_c7354327-c0dd-444e-a376-969f43d9de14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_c6d0c9c1-a934-40e3-ba1a-2781c44319fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_92cf4a6e-0c22-418a-b07e-0e2b78b6e4dc" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_c6d0c9c1-a934-40e3-ba1a-2781c44319fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_68842ec8-45b4-4a22-bc1f-a82f491b8179" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_fcd02593-8dc6-4090-9f82-0c6f034c6361" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_68842ec8-45b4-4a22-bc1f-a82f491b8179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_91c4703c-494b-4572-b125-fd855cbb663e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_68842ec8-45b4-4a22-bc1f-a82f491b8179" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_91c4703c-494b-4572-b125-fd855cbb663e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_48522a94-0a10-4d7b-a726-96a104d815a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_68842ec8-45b4-4a22-bc1f-a82f491b8179" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_48522a94-0a10-4d7b-a726-96a104d815a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_77373fa2-966d-422d-ab4c-45ce7ff78ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_245abcb8-fe5e-4b4e-a5d6-ba1803a6a7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_77373fa2-966d-422d-ab4c-45ce7ff78ee7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_245abcb8-fe5e-4b4e-a5d6-ba1803a6a7c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4c4f1225-66a5-4424-a207-e94d41f239c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_245abcb8-fe5e-4b4e-a5d6-ba1803a6a7c3" xlink:to="loc_us-gaap_AwardTypeAxis_4c4f1225-66a5-4424-a207-e94d41f239c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8228a903-dea3-4c81-a229-85318783317d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_4c4f1225-66a5-4424-a207-e94d41f239c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8228a903-dea3-4c81-a229-85318783317d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_edc7f785-3723-4f53-808d-eb2ea206b904" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8228a903-dea3-4c81-a229-85318783317d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_edc7f785-3723-4f53-808d-eb2ea206b904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_319cee84-a3d4-4eab-a7ad-0e90227b891c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_245abcb8-fe5e-4b4e-a5d6-ba1803a6a7c3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_319cee84-a3d4-4eab-a7ad-0e90227b891c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_87751fe1-ca6a-4b3a-a57c-b79c374f0f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_319cee84-a3d4-4eab-a7ad-0e90227b891c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_87751fe1-ca6a-4b3a-a57c-b79c374f0f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_7a85e382-7004-4854-97da-c25296c1c06e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_319cee84-a3d4-4eab-a7ad-0e90227b891c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_7a85e382-7004-4854-97da-c25296c1c06e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_467764c5-a5e3-44b8-a99f-6b6111b29ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_319cee84-a3d4-4eab-a7ad-0e90227b891c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_467764c5-a5e3-44b8-a99f-6b6111b29ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_0e852796-da7c-4fa5-bf2d-902aae587579" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_319cee84-a3d4-4eab-a7ad-0e90227b891c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_0e852796-da7c-4fa5-bf2d-902aae587579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockPlansStockOptionPlansDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#StockPlansStockOptionPlansDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/StockPlansStockOptionPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d92fabab-519b-49f8-8b94-1dddde745416" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bdcdaa87-88ae-4ed1-8857-50117269f641" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d92fabab-519b-49f8-8b94-1dddde745416" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bdcdaa87-88ae-4ed1-8857-50117269f641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_eafe5658-d1c2-4a46-b2f9-e42fee748de8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bdcdaa87-88ae-4ed1-8857-50117269f641" xlink:to="loc_us-gaap_AwardTypeAxis_eafe5658-d1c2-4a46-b2f9-e42fee748de8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a05fbd1e-e87d-4012-9e04-79fe9582fd1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_eafe5658-d1c2-4a46-b2f9-e42fee748de8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a05fbd1e-e87d-4012-9e04-79fe9582fd1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4794ba1e-3be3-4c37-899f-ea18ac04ece8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a05fbd1e-e87d-4012-9e04-79fe9582fd1d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4794ba1e-3be3-4c37-899f-ea18ac04ece8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_64bd5dc7-bae9-49c6-a729-b5fef2f0b2bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bdcdaa87-88ae-4ed1-8857-50117269f641" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_64bd5dc7-bae9-49c6-a729-b5fef2f0b2bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_56a899fe-0dcd-45ff-a3d1-1a47cb79901c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_64bd5dc7-bae9-49c6-a729-b5fef2f0b2bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_56a899fe-0dcd-45ff-a3d1-1a47cb79901c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b286db7f-3d80-4570-aaff-cf7e1c1018e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_56a899fe-0dcd-45ff-a3d1-1a47cb79901c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b286db7f-3d80-4570-aaff-cf7e1c1018e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_6c18cccf-8414-4d7e-8619-11dfab28fc95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_56a899fe-0dcd-45ff-a3d1-1a47cb79901c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_6c18cccf-8414-4d7e-8619-11dfab28fc95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6fb458ef-b3d8-4166-a6d4-df48e62825af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_56a899fe-0dcd-45ff-a3d1-1a47cb79901c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6fb458ef-b3d8-4166-a6d4-df48e62825af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1ad703ce-ed3a-4576-ad10-81e49973270a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_56a899fe-0dcd-45ff-a3d1-1a47cb79901c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1ad703ce-ed3a-4576-ad10-81e49973270a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_36576946-5316-48ed-b6d4-ddad491a0b45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_56a899fe-0dcd-45ff-a3d1-1a47cb79901c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_36576946-5316-48ed-b6d4-ddad491a0b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_9702cca2-f133-44b0-981f-ecbc90440a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_56a899fe-0dcd-45ff-a3d1-1a47cb79901c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_9702cca2-f133-44b0-981f-ecbc90440a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_01630564-8d36-456f-9773-c5adeee00a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_56a899fe-0dcd-45ff-a3d1-1a47cb79901c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_01630564-8d36-456f-9773-c5adeee00a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_08f0e79b-ecc2-4b56-bb15-0818eecbfa2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_64bd5dc7-bae9-49c6-a729-b5fef2f0b2bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_08f0e79b-ecc2-4b56-bb15-0818eecbfa2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_add265f4-a612-4d29-a0b1-445708175708" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_08f0e79b-ecc2-4b56-bb15-0818eecbfa2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_add265f4-a612-4d29-a0b1-445708175708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_67f61b98-2b09-446e-9b1a-4b32a7f88195" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_08f0e79b-ecc2-4b56-bb15-0818eecbfa2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_67f61b98-2b09-446e-9b1a-4b32a7f88195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_8629f230-9867-4712-a958-054adaab15f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_08f0e79b-ecc2-4b56-bb15-0818eecbfa2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_8629f230-9867-4712-a958-054adaab15f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_681f41b7-492d-4497-9ca7-fa1c2b7f7721" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_08f0e79b-ecc2-4b56-bb15-0818eecbfa2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_681f41b7-492d-4497-9ca7-fa1c2b7f7721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_131f239c-b005-4219-90a3-ec5b14a1b43a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_08f0e79b-ecc2-4b56-bb15-0818eecbfa2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_131f239c-b005-4219-90a3-ec5b14a1b43a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_b4bf6e96-c4aa-42d4-8a28-f57b62e4c5d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_08f0e79b-ecc2-4b56-bb15-0818eecbfa2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_b4bf6e96-c4aa-42d4-8a28-f57b62e4c5d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_becd9d9d-df86-4a6d-be37-eb8d601c574e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_08f0e79b-ecc2-4b56-bb15-0818eecbfa2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_becd9d9d-df86-4a6d-be37-eb8d601c574e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_f035b1fb-6ffe-479a-a01d-9e0f6b1f8fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_64bd5dc7-bae9-49c6-a729-b5fef2f0b2bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_f035b1fb-6ffe-479a-a01d-9e0f6b1f8fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_7b8c4389-0e4b-4f3f-959c-22116eafe482" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_f035b1fb-6ffe-479a-a01d-9e0f6b1f8fc3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_7b8c4389-0e4b-4f3f-959c-22116eafe482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_a3f04910-ce2b-43eb-8a10-3a0d29c1611c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_f035b1fb-6ffe-479a-a01d-9e0f6b1f8fc3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_a3f04910-ce2b-43eb-8a10-3a0d29c1611c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_f579518e-7aa8-4ce0-b94a-8ec168081cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_f035b1fb-6ffe-479a-a01d-9e0f6b1f8fc3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_f579518e-7aa8-4ce0-b94a-8ec168081cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_375c3cfa-e56e-46ff-a886-d48c1d4c8263" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_f035b1fb-6ffe-479a-a01d-9e0f6b1f8fc3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_375c3cfa-e56e-46ff-a886-d48c1d4c8263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_bf9ce66c-b964-48ce-b485-f03a5a616691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_f035b1fb-6ffe-479a-a01d-9e0f6b1f8fc3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_bf9ce66c-b964-48ce-b485-f03a5a616691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#StockPlansNonVestedRSUsDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d174a252-5069-4d0c-9514-c4a999d34cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4d3fa5e2-8b5c-4902-8604-97d1a01c144f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d174a252-5069-4d0c-9514-c4a999d34cf4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4d3fa5e2-8b5c-4902-8604-97d1a01c144f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_586d1b2b-beaa-4b06-9118-77f4285337cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4d3fa5e2-8b5c-4902-8604-97d1a01c144f" xlink:to="loc_us-gaap_AwardTypeAxis_586d1b2b-beaa-4b06-9118-77f4285337cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c5815456-4857-4f26-8006-8308f61d5edd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_586d1b2b-beaa-4b06-9118-77f4285337cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c5815456-4857-4f26-8006-8308f61d5edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e772d026-5b32-40ee-abfe-f9dfbeaa77df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c5815456-4857-4f26-8006-8308f61d5edd" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e772d026-5b32-40ee-abfe-f9dfbeaa77df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c924bdb-efa2-454e-a439-74b463bdd8e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4d3fa5e2-8b5c-4902-8604-97d1a01c144f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c924bdb-efa2-454e-a439-74b463bdd8e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_03a8e473-9969-4411-a965-46b403ff9594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c924bdb-efa2-454e-a439-74b463bdd8e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_03a8e473-9969-4411-a965-46b403ff9594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_51523a4d-005c-476e-bd53-d376f6e9a2f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_03a8e473-9969-4411-a965-46b403ff9594" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_51523a4d-005c-476e-bd53-d376f6e9a2f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6c52bf20-533d-4499-a2cd-aac08c6ab96d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_03a8e473-9969-4411-a965-46b403ff9594" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6c52bf20-533d-4499-a2cd-aac08c6ab96d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_cf73f642-d863-4345-95bb-e366aad274e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_03a8e473-9969-4411-a965-46b403ff9594" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_cf73f642-d863-4345-95bb-e366aad274e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_99182f52-1678-4b8e-bec1-b1db0ee9df55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_03a8e473-9969-4411-a965-46b403ff9594" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_99182f52-1678-4b8e-bec1-b1db0ee9df55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_51b5f9ca-f54b-47f5-b2fc-da0504d81df0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_03a8e473-9969-4411-a965-46b403ff9594" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_51b5f9ca-f54b-47f5-b2fc-da0504d81df0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_42057218-9f42-4dd2-a97f-2c37d72c0c28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c924bdb-efa2-454e-a439-74b463bdd8e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_42057218-9f42-4dd2-a97f-2c37d72c0c28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6bc8c14e-c5e4-41b3-bb8c-a0f26492f1bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_42057218-9f42-4dd2-a97f-2c37d72c0c28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6bc8c14e-c5e4-41b3-bb8c-a0f26492f1bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2146faf7-ec79-428d-86b6-f0bfe350d130" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_42057218-9f42-4dd2-a97f-2c37d72c0c28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2146faf7-ec79-428d-86b6-f0bfe350d130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_91c30464-5089-4ab8-aefe-771fb4761de9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_42057218-9f42-4dd2-a97f-2c37d72c0c28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_91c30464-5089-4ab8-aefe-771fb4761de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_96ef3c47-b9f5-4972-a3d1-1dc4a249a6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_42057218-9f42-4dd2-a97f-2c37d72c0c28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_96ef3c47-b9f5-4972-a3d1-1dc4a249a6b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_26b14e7d-08e8-41de-98f6-de4c0bb5e229" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_42057218-9f42-4dd2-a97f-2c37d72c0c28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_26b14e7d-08e8-41de-98f6-de4c0bb5e229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#EmployeeBenefitsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e874b3ba-d1e5-4ba1-baa3-d570e2eef399" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8e28ac41-6186-458e-9c8a-b4258d1d9359" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e874b3ba-d1e5-4ba1-baa3-d570e2eef399" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8e28ac41-6186-458e-9c8a-b4258d1d9359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_01fc19fb-1bd5-46ea-bd51-a2299911db9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8e28ac41-6186-458e-9c8a-b4258d1d9359" xlink:to="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_01fc19fb-1bd5-46ea-bd51-a2299911db9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_985b6b7f-3108-4a74-b8ff-02751809bf08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_01fc19fb-1bd5-46ea-bd51-a2299911db9b" xlink:to="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_985b6b7f-3108-4a74-b8ff-02751809bf08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember_67729c1f-a52d-4795-9f41-138e7a15b1a6" xlink:href="coo-20221031.xsd#coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_985b6b7f-3108-4a74-b8ff-02751809bf08" xlink:to="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember_67729c1f-a52d-4795-9f41-138e7a15b1a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember_60c7e016-28f6-4e1e-91b3-e4d2e1a35249" xlink:href="coo-20221031.xsd#coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_985b6b7f-3108-4a74-b8ff-02751809bf08" xlink:to="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember_60c7e016-28f6-4e1e-91b3-e4d2e1a35249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember_8fbc320e-698c-4414-8750-7ff01a37f212" xlink:href="coo-20221031.xsd#coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_985b6b7f-3108-4a74-b8ff-02751809bf08" xlink:to="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember_8fbc320e-698c-4414-8750-7ff01a37f212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInAssumedPaymentFormElectionProbabilitiesMember_6422b66d-4ca0-4f6f-b639-61a9a86f18ef" xlink:href="coo-20221031.xsd#coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInAssumedPaymentFormElectionProbabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_985b6b7f-3108-4a74-b8ff-02751809bf08" xlink:to="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInAssumedPaymentFormElectionProbabilitiesMember_6422b66d-4ca0-4f6f-b639-61a9a86f18ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember_1c9428bf-991c-4e72-81ef-6aee2bc33147" xlink:href="coo-20221031.xsd#coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_985b6b7f-3108-4a74-b8ff-02751809bf08" xlink:to="loc_coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember_1c9428bf-991c-4e72-81ef-6aee2bc33147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dd340217-285b-4232-9037-4b9bdec1c940" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8e28ac41-6186-458e-9c8a-b4258d1d9359" xlink:to="loc_srt_RangeAxis_dd340217-285b-4232-9037-4b9bdec1c940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_edb3c45e-8d97-4c32-8705-8f4dc5fbcc5d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_dd340217-285b-4232-9037-4b9bdec1c940" xlink:to="loc_srt_RangeMember_edb3c45e-8d97-4c32-8705-8f4dc5fbcc5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1c5247f8-7f4d-4d15-9030-74eb2860b180" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_edb3c45e-8d97-4c32-8705-8f4dc5fbcc5d" xlink:to="loc_srt_MinimumMember_1c5247f8-7f4d-4d15-9030-74eb2860b180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4946a784-89b3-4aef-a8d3-7d5212045bef" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_edb3c45e-8d97-4c32-8705-8f4dc5fbcc5d" xlink:to="loc_srt_MaximumMember_4946a784-89b3-4aef-a8d3-7d5212045bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2a207a31-270c-48d8-aa44-28c7fb5b2afe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8e28ac41-6186-458e-9c8a-b4258d1d9359" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2a207a31-270c-48d8-aa44-28c7fb5b2afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_0737621b-c8d0-44a4-9df8-563f2d4b24a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2a207a31-270c-48d8-aa44-28c7fb5b2afe" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_0737621b-c8d0-44a4-9df8-563f2d4b24a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_9945cf86-af4e-4ca4-aab5-e5d0876ec6b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_0737621b-c8d0-44a4-9df8-563f2d4b24a1" xlink:to="loc_us-gaap_EquitySecuritiesMember_9945cf86-af4e-4ca4-aab5-e5d0876ec6b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_21c877d9-da72-4c28-9d7a-1eca593b6188" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8e28ac41-6186-458e-9c8a-b4258d1d9359" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_21c877d9-da72-4c28-9d7a-1eca593b6188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_0c3809db-ad72-406e-a3b4-1b6ebcab0f58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_21c877d9-da72-4c28-9d7a-1eca593b6188" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_0c3809db-ad72-406e-a3b4-1b6ebcab0f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation_7781609a-31e1-4eeb-8e59-525c0fd2f525" xlink:href="coo-20221031.xsd#coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_21c877d9-da72-4c28-9d7a-1eca593b6188" xlink:to="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation_7781609a-31e1-4eeb-8e59-525c0fd2f525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligationIncreaseDecrease_2cbb599c-4520-4abd-ba76-bb3b08dd1f3d" xlink:href="coo-20221031.xsd#coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligationIncreaseDecrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_21c877d9-da72-4c28-9d7a-1eca593b6188" xlink:to="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligationIncreaseDecrease_2cbb599c-4520-4abd-ba76-bb3b08dd1f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationEffectOfChangeInDiscountRate_65266953-be2b-4b08-b354-844b1087702a" xlink:href="coo-20221031.xsd#coo_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationEffectOfChangeInDiscountRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_21c877d9-da72-4c28-9d7a-1eca593b6188" xlink:to="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationEffectOfChangeInDiscountRate_65266953-be2b-4b08-b354-844b1087702a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingAccumulatedBenefitObligationEffectOfChangeInDiscountRate_79fa49da-01ee-4c79-8fc1-ad15d53ee138" xlink:href="coo-20221031.xsd#coo_DefinedBenefitPlanAssumptionsUsedCalculatingAccumulatedBenefitObligationEffectOfChangeInDiscountRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_21c877d9-da72-4c28-9d7a-1eca593b6188" xlink:to="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingAccumulatedBenefitObligationEffectOfChangeInDiscountRate_79fa49da-01ee-4c79-8fc1-ad15d53ee138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_c8bf1022-7a0c-4bb8-924b-cde9b6fa722c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_21c877d9-da72-4c28-9d7a-1eca593b6188" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_c8bf1022-7a0c-4bb8-924b-cde9b6fa722c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_bfee3972-bd36-49d9-addc-7fb0cf1eaba0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_21c877d9-da72-4c28-9d7a-1eca593b6188" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_bfee3972-bd36-49d9-addc-7fb0cf1eaba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage_bbb02151-9a5d-4982-b63e-2c475af6446e" xlink:href="coo-20221031.xsd#coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_21c877d9-da72-4c28-9d7a-1eca593b6188" xlink:to="loc_coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage_bbb02151-9a5d-4982-b63e-2c475af6446e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_188c0193-abf3-49fe-99fe-823987e03adb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_21c877d9-da72-4c28-9d7a-1eca593b6188" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_188c0193-abf3-49fe-99fe-823987e03adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_6cf90af6-bf07-4c82-a509-e4a22e3155d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_21c877d9-da72-4c28-9d7a-1eca593b6188" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_6cf90af6-bf07-4c82-a509-e4a22e3155d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_2e5cdcc1-b6d3-4a1a-ae95-65fb2d3d02b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_21c877d9-da72-4c28-9d7a-1eca593b6188" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_2e5cdcc1-b6d3-4a1a-ae95-65fb2d3d02b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0ed4eb78-45b2-47ec-bfb4-2451d8e62dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_4ed92b1e-31c6-4db7-b4ce-c782863a45c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0ed4eb78-45b2-47ec-bfb4-2451d8e62dc7" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_4ed92b1e-31c6-4db7-b4ce-c782863a45c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_03866bdf-76a2-48a7-b681-110bc13d191f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_4ed92b1e-31c6-4db7-b4ce-c782863a45c3" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_03866bdf-76a2-48a7-b681-110bc13d191f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_c794f70f-d23d-4767-9654-c3d607b58fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_4ed92b1e-31c6-4db7-b4ce-c782863a45c3" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_c794f70f-d23d-4767-9654-c3d607b58fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_b862e986-20df-4652-9998-eccd91aadd30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_4ed92b1e-31c6-4db7-b4ce-c782863a45c3" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_b862e986-20df-4652-9998-eccd91aadd30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_e54e80eb-7a83-4032-8029-579b3627ca5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_4ed92b1e-31c6-4db7-b4ce-c782863a45c3" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_e54e80eb-7a83-4032-8029-579b3627ca5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_cef0c25a-dc55-4284-bf0a-4e592f94feaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_4ed92b1e-31c6-4db7-b4ce-c782863a45c3" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_cef0c25a-dc55-4284-bf0a-4e592f94feaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_049bccc4-895e-4125-8667-d9977834d293" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_4ed92b1e-31c6-4db7-b4ce-c782863a45c3" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_049bccc4-895e-4125-8667-d9977834d293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList_e69acfa2-8b8a-4245-a7f8-68b2983d2680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0ed4eb78-45b2-47ec-bfb4-2451d8e62dc7" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList_e69acfa2-8b8a-4245-a7f8-68b2983d2680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a164ef70-f926-431a-9d04-2a68c87bff12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0ed4eb78-45b2-47ec-bfb4-2451d8e62dc7" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a164ef70-f926-431a-9d04-2a68c87bff12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_02a00084-1e93-46a2-9275-166f60304731" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a164ef70-f926-431a-9d04-2a68c87bff12" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_02a00084-1e93-46a2-9275-166f60304731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_e71e686c-7d68-41e8-a4a7-cc71045397d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a164ef70-f926-431a-9d04-2a68c87bff12" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_e71e686c-7d68-41e8-a4a7-cc71045397d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_089a428e-f68a-41bf-9e79-0c3a7498b0e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a164ef70-f926-431a-9d04-2a68c87bff12" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_089a428e-f68a-41bf-9e79-0c3a7498b0e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_cdb944ea-e4fb-4073-ad36-5e40794697c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a164ef70-f926-431a-9d04-2a68c87bff12" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_cdb944ea-e4fb-4073-ad36-5e40794697c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_042d1ddb-5f36-4a2a-83e3-b91c7634b67e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a164ef70-f926-431a-9d04-2a68c87bff12" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_042d1ddb-5f36-4a2a-83e3-b91c7634b67e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_6a938510-3552-4416-a687-7701dc5c92c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0ed4eb78-45b2-47ec-bfb4-2451d8e62dc7" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_6a938510-3552-4416-a687-7701dc5c92c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_358f224a-74a9-4f8d-91cb-5eb8aa69b8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract_874a7d5e-5cc2-4cf0-82ce-7b4e1a40f978" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_358f224a-74a9-4f8d-91cb-5eb8aa69b8ce" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract_874a7d5e-5cc2-4cf0-82ce-7b4e1a40f978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_949d0aca-aba1-47c5-af48-c2dedc22913d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract_874a7d5e-5cc2-4cf0-82ce-7b4e1a40f978" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_949d0aca-aba1-47c5-af48-c2dedc22913d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_214fff1c-5406-4901-8cf6-23bba8297f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract_874a7d5e-5cc2-4cf0-82ce-7b4e1a40f978" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_214fff1c-5406-4901-8cf6-23bba8297f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsReconciliationofPrepaidAccruedPensionCostDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#EmployeeBenefitsReconciliationofPrepaidAccruedPensionCostDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsReconciliationofPrepaidAccruedPensionCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e0802c6d-4ee7-49f3-8e8b-ccd2fffd133a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AccruedPensionCostRollForward_e880b80c-17c3-49fc-b766-487c8ce8f1d2" xlink:href="coo-20221031.xsd#coo_AccruedPensionCostRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e0802c6d-4ee7-49f3-8e8b-ccd2fffd133a" xlink:to="loc_coo_AccruedPensionCostRollForward_e880b80c-17c3-49fc-b766-487c8ce8f1d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AccruedPrepaidPensionCosts_3935b7a9-dc42-49bd-8aca-30f10bdf176c" xlink:href="coo-20221031.xsd#coo_AccruedPrepaidPensionCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_AccruedPensionCostRollForward_e880b80c-17c3-49fc-b766-487c8ce8f1d2" xlink:to="loc_coo_AccruedPrepaidPensionCosts_3935b7a9-dc42-49bd-8aca-30f10bdf176c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_d3b93e8c-0a6d-4e4e-8118-e7ad05d7d51e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_AccruedPensionCostRollForward_e880b80c-17c3-49fc-b766-487c8ce8f1d2" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_d3b93e8c-0a6d-4e4e-8118-e7ad05d7d51e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_eacdbb85-db7e-4c38-aebe-3469416b37f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_AccruedPensionCostRollForward_e880b80c-17c3-49fc-b766-487c8ce8f1d2" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_eacdbb85-db7e-4c38-aebe-3469416b37f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AccruedPrepaidPensionCosts_00630a51-a96e-4dfd-92a8-1f025cba9dbd" xlink:href="coo-20221031.xsd#coo_AccruedPrepaidPensionCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_AccruedPensionCostRollForward_e880b80c-17c3-49fc-b766-487c8ce8f1d2" xlink:to="loc_coo_AccruedPrepaidPensionCosts_00630a51-a96e-4dfd-92a8-1f025cba9dbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_cbda8771-a7e9-432b-82d5-7ec2e58b7bee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_4f7f8b1f-88bb-40a4-91e5-268b85bd64cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_cbda8771-a7e9-432b-82d5-7ec2e58b7bee" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_4f7f8b1f-88bb-40a4-91e5-268b85bd64cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_aedd7a38-024c-43b2-b441-4ea7973ad5ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_4f7f8b1f-88bb-40a4-91e5-268b85bd64cf" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_aedd7a38-024c-43b2-b441-4ea7973ad5ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_d590400a-4c78-4f6a-943c-db4307d749cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_4f7f8b1f-88bb-40a4-91e5-268b85bd64cf" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_d590400a-4c78-4f6a-943c-db4307d749cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_ff5e5c1b-b781-46d4-8368-b2efedc370ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_4f7f8b1f-88bb-40a4-91e5-268b85bd64cf" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_ff5e5c1b-b781-46d4-8368-b2efedc370ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_ded50d0d-ee6c-4e0f-bf45-8f6c05635d03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_4f7f8b1f-88bb-40a4-91e5-268b85bd64cf" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_ded50d0d-ee6c-4e0f-bf45-8f6c05635d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_0fd62a88-60fa-41e5-8994-57ad7db51119" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_4f7f8b1f-88bb-40a4-91e5-268b85bd64cf" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_0fd62a88-60fa-41e5-8994-57ad7db51119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_98bdd619-d246-4c43-b290-a040d9aff9fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_4f7f8b1f-88bb-40a4-91e5-268b85bd64cf" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_98bdd619-d246-4c43-b290-a040d9aff9fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_4211df43-8511-4ec4-ace1-5c7833e9d9a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_4f7f8b1f-88bb-40a4-91e5-268b85bd64cf" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_4211df43-8511-4ec4-ace1-5c7833e9d9a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a579ae5e-d569-47ea-8277-4e407cb8b94b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract_f59cc885-e41b-4f72-bb45-f0de5a3d12f7" xlink:href="coo-20221031.xsd#coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a579ae5e-d569-47ea-8277-4e407cb8b94b" xlink:to="loc_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract_f59cc885-e41b-4f72-bb45-f0de5a3d12f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax_28aefabe-ad26-4976-9ddd-758e898b8a35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract_f59cc885-e41b-4f72-bb45-f0de5a3d12f7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax_28aefabe-ad26-4976-9ddd-758e898b8a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax_ee6e55c2-55cc-4fd7-a2e3-ef8d050cc91f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract_f59cc885-e41b-4f72-bb45-f0de5a3d12f7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax_ee6e55c2-55cc-4fd7-a2e3-ef8d050cc91f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_54b2619f-34ae-4dcd-87a6-dcb568034738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract_f59cc885-e41b-4f72-bb45-f0de5a3d12f7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_54b2619f-34ae-4dcd-87a6-dcb568034738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax_80a9101e-4e63-4472-8362-b14201ebb878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract_f59cc885-e41b-4f72-bb45-f0de5a3d12f7" xlink:to="loc_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax_80a9101e-4e63-4472-8362-b14201ebb878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_bf24c8c5-a2d4-4984-a00f-48697cd246f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract_02231da3-2b7d-48ee-8355-9b4b3c622d57" xlink:href="coo-20221031.xsd#coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_bf24c8c5-a2d4-4984-a00f-48697cd246f2" xlink:to="loc_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract_02231da3-2b7d-48ee-8355-9b4b3c622d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_d19d39d1-58fc-48b1-a43e-de7f8e14353a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract_02231da3-2b7d-48ee-8355-9b4b3c622d57" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_d19d39d1-58fc-48b1-a43e-de7f8e14353a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation_d4f70549-8e87-412c-a8d4-e6338e232109" xlink:href="coo-20221031.xsd#coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_d19d39d1-58fc-48b1-a43e-de7f8e14353a" xlink:to="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation_d4f70549-8e87-412c-a8d4-e6338e232109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost_e1817d6d-d2db-4806-898a-5b616a44dbcb" xlink:href="coo-20221031.xsd#coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_d19d39d1-58fc-48b1-a43e-de7f8e14353a" xlink:to="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost_e1817d6d-d2db-4806-898a-5b616a44dbcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost_f29b02f9-e0db-4590-b7d3-c6e6d08daa80" xlink:href="coo-20221031.xsd#coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_d19d39d1-58fc-48b1-a43e-de7f8e14353a" xlink:to="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost_f29b02f9-e0db-4590-b7d3-c6e6d08daa80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_2208ce91-3781-435b-9b24-2db1df523fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract_02231da3-2b7d-48ee-8355-9b4b3c622d57" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_2208ce91-3781-435b-9b24-2db1df523fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_355d8845-9e08-4406-a724-414ebd549b06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract_02231da3-2b7d-48ee-8355-9b4b3c622d57" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_355d8845-9e08-4406-a724-414ebd549b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_4d7e9136-efcb-4a72-99e5-278e6a1c8393" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract_02231da3-2b7d-48ee-8355-9b4b3c622d57" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_4d7e9136-efcb-4a72-99e5-278e6a1c8393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_6a626f96-0cec-403e-8929-6f147accaf9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract_02231da3-2b7d-48ee-8355-9b4b3c622d57" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_6a626f96-0cec-403e-8929-6f147accaf9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd_b57ea446-4a69-49f7-bf0d-bcbf869221f1" xlink:href="coo-20221031.xsd#coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract_02231da3-2b7d-48ee-8355-9b4b3c622d57" xlink:to="loc_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd_b57ea446-4a69-49f7-bf0d-bcbf869221f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_da794ee0-11c0-4553-a60a-432da46522a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable_cb8781d2-ac3f-49b1-b3a7-e54d50c2de2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_da794ee0-11c0-4553-a60a-432da46522a5" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable_cb8781d2-ac3f-49b1-b3a7-e54d50c2de2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_769ca821-2837-4823-8e61-77eee974cdf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable_cb8781d2-ac3f-49b1-b3a7-e54d50c2de2f" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_769ca821-2837-4823-8e61-77eee974cdf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_141fd7b9-c466-4744-8f1f-4ecb1f2406db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_769ca821-2837-4823-8e61-77eee974cdf3" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_141fd7b9-c466-4744-8f1f-4ecb1f2406db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_f1133085-47af-4008-bcda-a275e98c48fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_141fd7b9-c466-4744-8f1f-4ecb1f2406db" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_f1133085-47af-4008-bcda-a275e98c48fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityFundsMember_186e5178-0824-4ed0-a8a6-70908b3921a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityFundsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_141fd7b9-c466-4744-8f1f-4ecb1f2406db" xlink:to="loc_us-gaap_EquityFundsMember_186e5178-0824-4ed0-a8a6-70908b3921a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember_bfb65a6c-6c41-4c07-ab1c-3981744f436e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgeFundsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_141fd7b9-c466-4744-8f1f-4ecb1f2406db" xlink:to="loc_us-gaap_HedgeFundsMember_bfb65a6c-6c41-4c07-ab1c-3981744f436e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BondMutualFundsMember_4db1399b-408c-4ab7-b852-c29aa8a65189" xlink:href="coo-20221031.xsd#coo_BondMutualFundsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_141fd7b9-c466-4744-8f1f-4ecb1f2406db" xlink:to="loc_coo_BondMutualFundsMember_4db1399b-408c-4ab7-b852-c29aa8a65189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems_7169b88a-af57-405a-bc3b-eec132473d41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable_cb8781d2-ac3f-49b1-b3a7-e54d50c2de2f" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems_7169b88a-af57-405a-bc3b-eec132473d41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_70462e19-c7cc-4d9a-aaf8-a795164416ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems_7169b88a-af57-405a-bc3b-eec132473d41" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_70462e19-c7cc-4d9a-aaf8-a795164416ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c5509ba9-f5c9-4728-b407-56f05e7de3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable_7f4053e0-7c0b-496f-a49d-f4c2f4a11723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c5509ba9-f5c9-4728-b407-56f05e7de3ee" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable_7f4053e0-7c0b-496f-a49d-f4c2f4a11723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_fbfbcd3f-2837-498c-b006-0d6bf44948b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable_7f4053e0-7c0b-496f-a49d-f4c2f4a11723" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_fbfbcd3f-2837-498c-b006-0d6bf44948b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_9cb4bb61-7239-4691-9799-a438ad5bddd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_fbfbcd3f-2837-498c-b006-0d6bf44948b9" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_9cb4bb61-7239-4691-9799-a438ad5bddd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_e1deac8b-0c4c-4b7a-bcdf-0593757f56a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_9cb4bb61-7239-4691-9799-a438ad5bddd3" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_e1deac8b-0c4c-4b7a-bcdf-0593757f56a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityFundsMember_83aa7069-74d7-4459-9477-b6b0e1d30035" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityFundsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_9cb4bb61-7239-4691-9799-a438ad5bddd3" xlink:to="loc_us-gaap_EquityFundsMember_83aa7069-74d7-4459-9477-b6b0e1d30035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember_b49af7f8-eaa4-4897-b982-1e2ac4a59821" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgeFundsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_9cb4bb61-7239-4691-9799-a438ad5bddd3" xlink:to="loc_us-gaap_HedgeFundsMember_b49af7f8-eaa4-4897-b982-1e2ac4a59821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_BondMutualFundsMember_ec0ca03d-2c41-494b-9772-332a734c9fa4" xlink:href="coo-20221031.xsd#coo_BondMutualFundsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_9cb4bb61-7239-4691-9799-a438ad5bddd3" xlink:to="loc_coo_BondMutualFundsMember_ec0ca03d-2c41-494b-9772-332a734c9fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_92ca3eb0-e559-48f4-bd40-698625fad109" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable_7f4053e0-7c0b-496f-a49d-f4c2f4a11723" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_92ca3eb0-e559-48f4-bd40-698625fad109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0cd289ee-9500-4f39-8283-935ef7b2e3fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_92ca3eb0-e559-48f4-bd40-698625fad109" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0cd289ee-9500-4f39-8283-935ef7b2e3fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_90f22c01-ce0c-4d21-892c-f2bcc5d02a87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0cd289ee-9500-4f39-8283-935ef7b2e3fd" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_90f22c01-ce0c-4d21-892c-f2bcc5d02a87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_c9f88ca9-c9fa-4d0c-85fe-575e1785b8c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0cd289ee-9500-4f39-8283-935ef7b2e3fd" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_c9f88ca9-c9fa-4d0c-85fe-575e1785b8c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_f4c5d818-afbc-47e5-b13c-8a179c65a337" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0cd289ee-9500-4f39-8283-935ef7b2e3fd" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_f4c5d818-afbc-47e5-b13c-8a179c65a337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems_12cbcf4e-c5af-42fe-a00c-a975658f1e78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable_7f4053e0-7c0b-496f-a49d-f4c2f4a11723" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems_12cbcf4e-c5af-42fe-a00c-a975658f1e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_74953b3c-6f36-484d-8b80-9ee164077606" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems_12cbcf4e-c5af-42fe-a00c-a975658f1e78" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_74953b3c-6f36-484d-8b80-9ee164077606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#EmployeeBenefitsEstimatedFutureBenefitPaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c44779ee-e5ba-408c-96d2-3a0de5169a2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_f41f9e6a-b92f-4394-b0b1-97d33a7959bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c44779ee-e5ba-408c-96d2-3a0de5169a2c" xlink:to="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_f41f9e6a-b92f-4394-b0b1-97d33a7959bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_a7897f8e-35b0-412c-8116-b4460db3b5b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_f41f9e6a-b92f-4394-b0b1-97d33a7959bd" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_a7897f8e-35b0-412c-8116-b4460db3b5b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_ac49aa8d-4d46-4fd1-9a52-70d97298f664" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_f41f9e6a-b92f-4394-b0b1-97d33a7959bd" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_ac49aa8d-4d46-4fd1-9a52-70d97298f664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_68549c8e-7d87-47c3-a798-0832840018f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_f41f9e6a-b92f-4394-b0b1-97d33a7959bd" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_68549c8e-7d87-47c3-a798-0832840018f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_0f52efc7-66b8-4fb9-9039-1a7f577a63c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_f41f9e6a-b92f-4394-b0b1-97d33a7959bd" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_0f52efc7-66b8-4fb9-9039-1a7f577a63c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_ab103bf5-b28d-489f-b1fd-f4eba2b744d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_f41f9e6a-b92f-4394-b0b1-97d33a7959bd" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_ab103bf5-b28d-489f-b1fd-f4eba2b744d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_23cd54de-7323-4835-a135-beff07d88423" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_f41f9e6a-b92f-4394-b0b1-97d33a7959bd" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_23cd54de-7323-4835-a135-beff07d88423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/BusinessSegmentInformationNarrativeDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#BusinessSegmentInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/BusinessSegmentInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_7cd9da4c-c1e1-4b55-b550-dc13e5ee2534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_8ddf17ed-33f1-44e7-9094-9b604a467900" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7cd9da4c-c1e1-4b55-b550-dc13e5ee2534" xlink:to="loc_us-gaap_NumberOfOperatingSegments_8ddf17ed-33f1-44e7-9094-9b604a467900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#BusinessSegmentInformationBusinessSegmentNetSalesDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_561078bc-a480-47bc-99d7-cd8d0daf4e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_69d6c717-5524-4058-b274-d5061fcd9138" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_561078bc-a480-47bc-99d7-cd8d0daf4e5f" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_69d6c717-5524-4058-b274-d5061fcd9138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_03d9348a-bd6c-443a-b16d-5153a04fa086" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_69d6c717-5524-4058-b274-d5061fcd9138" xlink:to="loc_srt_ProductOrServiceAxis_03d9348a-bd6c-443a-b16d-5153a04fa086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8f6a79cc-6e0e-4ccc-9100-af8896c6bf09" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_03d9348a-bd6c-443a-b16d-5153a04fa086" xlink:to="loc_srt_ProductsAndServicesDomain_8f6a79cc-6e0e-4ccc-9100-af8896c6bf09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_ToricLensMember_7342279b-0101-4d2a-8437-2c85098cb469" xlink:href="coo-20221031.xsd#coo_ToricLensMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8f6a79cc-6e0e-4ccc-9100-af8896c6bf09" xlink:to="loc_coo_ToricLensMember_7342279b-0101-4d2a-8437-2c85098cb469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_MultifocalLensMember_7236843f-95f6-44a2-8f08-54b56cd7354a" xlink:href="coo-20221031.xsd#coo_MultifocalLensMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8f6a79cc-6e0e-4ccc-9100-af8896c6bf09" xlink:to="loc_coo_MultifocalLensMember_7236843f-95f6-44a2-8f08-54b56cd7354a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_SingleUseSphereLensMember_0915ce71-c68e-44fb-a7ac-580dae10aae5" xlink:href="coo-20221031.xsd#coo_SingleUseSphereLensMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8f6a79cc-6e0e-4ccc-9100-af8896c6bf09" xlink:to="loc_coo_SingleUseSphereLensMember_0915ce71-c68e-44fb-a7ac-580dae10aae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_NonSingleUseSphereAndOtherMember_633f02d8-52f0-4e40-ac34-ed37be60b1a9" xlink:href="coo-20221031.xsd#coo_NonSingleUseSphereAndOtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8f6a79cc-6e0e-4ccc-9100-af8896c6bf09" xlink:to="loc_coo_NonSingleUseSphereAndOtherMember_633f02d8-52f0-4e40-ac34-ed37be60b1a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_OfficeAndSurgicalProductsMember_4b01e0c7-f587-4621-8a25-82428d0fd7a3" xlink:href="coo-20221031.xsd#coo_OfficeAndSurgicalProductsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8f6a79cc-6e0e-4ccc-9100-af8896c6bf09" xlink:to="loc_coo_OfficeAndSurgicalProductsMember_4b01e0c7-f587-4621-8a25-82428d0fd7a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_FertilityMember_abd45b59-e961-4cb0-b20f-900e3679cc23" xlink:href="coo-20221031.xsd#coo_FertilityMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8f6a79cc-6e0e-4ccc-9100-af8896c6bf09" xlink:to="loc_coo_FertilityMember_abd45b59-e961-4cb0-b20f-900e3679cc23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_984fb874-3cb5-4fec-9256-259b5660b0b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_69d6c717-5524-4058-b274-d5061fcd9138" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_984fb874-3cb5-4fec-9256-259b5660b0b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ce36b8c6-0e84-46f6-bc3f-610ac818986c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_984fb874-3cb5-4fec-9256-259b5660b0b2" xlink:to="loc_us-gaap_SegmentDomain_ce36b8c6-0e84-46f6-bc3f-610ac818986c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CoopervisionSegmentMember_e0a561b4-c7ce-4f97-bf01-95a6ce1aeebe" xlink:href="coo-20221031.xsd#coo_CoopervisionSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ce36b8c6-0e84-46f6-bc3f-610ac818986c" xlink:to="loc_coo_CoopervisionSegmentMember_e0a561b4-c7ce-4f97-bf01-95a6ce1aeebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CoopersurgicalSegmentMember_3f1df060-8974-4fe9-9c93-edf4005ddc75" xlink:href="coo-20221031.xsd#coo_CoopersurgicalSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ce36b8c6-0e84-46f6-bc3f-610ac818986c" xlink:to="loc_coo_CoopersurgicalSegmentMember_3f1df060-8974-4fe9-9c93-edf4005ddc75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_65cbf2f6-27ef-4fde-9406-9ae8151307ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_69d6c717-5524-4058-b274-d5061fcd9138" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_65cbf2f6-27ef-4fde-9406-9ae8151307ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3189d45e-b677-4108-bc2f-0f93d6ccd706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_65cbf2f6-27ef-4fde-9406-9ae8151307ed" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3189d45e-b677-4108-bc2f-0f93d6ccd706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#BusinessSegmentInformationBusinessSegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_2a16abb6-f1e7-4828-b0b3-2639e60e42c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7da2f702-c1b5-4158-a27e-3110316d8288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_2a16abb6-f1e7-4828-b0b3-2639e60e42c6" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7da2f702-c1b5-4158-a27e-3110316d8288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_2b390424-a243-40d1-a662-06d8349d5ab2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7da2f702-c1b5-4158-a27e-3110316d8288" xlink:to="loc_srt_ConsolidationItemsAxis_2b390424-a243-40d1-a662-06d8349d5ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_f40b5c62-7538-4c20-b38d-161a3f5a3576" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_2b390424-a243-40d1-a662-06d8349d5ab2" xlink:to="loc_srt_ConsolidationItemsDomain_f40b5c62-7538-4c20-b38d-161a3f5a3576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_b94b8f73-9630-4d71-b7db-3d251c5aef74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_f40b5c62-7538-4c20-b38d-161a3f5a3576" xlink:to="loc_us-gaap_CorporateNonSegmentMember_b94b8f73-9630-4d71-b7db-3d251c5aef74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_f9c75212-4c16-4658-83ea-d8f9451caec6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_f40b5c62-7538-4c20-b38d-161a3f5a3576" xlink:to="loc_us-gaap_OperatingSegmentsMember_f9c75212-4c16-4658-83ea-d8f9451caec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_570a5eeb-a1b6-44ee-911d-3ada3a4e788b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7da2f702-c1b5-4158-a27e-3110316d8288" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_570a5eeb-a1b6-44ee-911d-3ada3a4e788b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d7159494-3060-431c-8367-3de1893ab388" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_570a5eeb-a1b6-44ee-911d-3ada3a4e788b" xlink:to="loc_us-gaap_SegmentDomain_d7159494-3060-431c-8367-3de1893ab388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CoopervisionSegmentMember_a9f6fcd2-88a3-45b5-80a9-cbd3fab325a8" xlink:href="coo-20221031.xsd#coo_CoopervisionSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d7159494-3060-431c-8367-3de1893ab388" xlink:to="loc_coo_CoopervisionSegmentMember_a9f6fcd2-88a3-45b5-80a9-cbd3fab325a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CoopersurgicalSegmentMember_e462d957-d15e-4ffc-a386-a9753b31cdfb" xlink:href="coo-20221031.xsd#coo_CoopersurgicalSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d7159494-3060-431c-8367-3de1893ab388" xlink:to="loc_coo_CoopersurgicalSegmentMember_e462d957-d15e-4ffc-a386-a9753b31cdfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_487c384b-ff0a-4ae4-bd26-0045c356cce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7da2f702-c1b5-4158-a27e-3110316d8288" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_487c384b-ff0a-4ae4-bd26-0045c356cce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b57f1d44-1b90-4f1f-aa87-e6bf30ba035a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_487c384b-ff0a-4ae4-bd26-0045c356cce1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b57f1d44-1b90-4f1f-aa87-e6bf30ba035a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ea36c214-18da-4a87-a838-e8f12a52832a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_487c384b-ff0a-4ae4-bd26-0045c356cce1" xlink:to="loc_us-gaap_OperatingIncomeLoss_ea36c214-18da-4a87-a838-e8f12a52832a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_63706395-39a7-43d9-9ed8-58b754484d72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_487c384b-ff0a-4ae4-bd26-0045c356cce1" xlink:to="loc_us-gaap_InterestExpense_63706395-39a7-43d9-9ed8-58b754484d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_eec487f4-b80a-4bb0-bfd1-023a5252a18b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_487c384b-ff0a-4ae4-bd26-0045c356cce1" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_eec487f4-b80a-4bb0-bfd1-023a5252a18b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ee97875d-e8e9-4103-ba09-5f4bae64a4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_487c384b-ff0a-4ae4-bd26-0045c356cce1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ee97875d-e8e9-4103-ba09-5f4bae64a4eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_25b0f5e1-124d-454d-a4c1-06d749504314" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_487c384b-ff0a-4ae4-bd26-0045c356cce1" xlink:to="loc_us-gaap_Assets_25b0f5e1-124d-454d-a4c1-06d749504314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_ebf4841f-3908-43ea-83b0-0630db7286e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_487c384b-ff0a-4ae4-bd26-0045c356cce1" xlink:to="loc_us-gaap_Depreciation_ebf4841f-3908-43ea-83b0-0630db7286e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_5ce83038-ab1b-4774-af8f-d671c0041c19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_487c384b-ff0a-4ae4-bd26-0045c356cce1" xlink:to="loc_us-gaap_AdjustmentForAmortization_5ce83038-ab1b-4774-af8f-d671c0041c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_645d3f96-8ecb-4a5f-8de3-572e9eec4695" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_487c384b-ff0a-4ae4-bd26-0045c356cce1" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_645d3f96-8ecb-4a5f-8de3-572e9eec4695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_0fe7aafb-23e4-42cf-b5c5-fc2a8305fa62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_75b29e40-88b8-4467-a88f-4497c3b57669" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0fe7aafb-23e4-42cf-b5c5-fc2a8305fa62" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_75b29e40-88b8-4467-a88f-4497c3b57669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_077d84b0-7353-4fab-bd91-a1ff0f1698e5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_75b29e40-88b8-4467-a88f-4497c3b57669" xlink:to="loc_srt_ConsolidationItemsAxis_077d84b0-7353-4fab-bd91-a1ff0f1698e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a14f65f5-48d9-4008-a8b2-af0ad187fd4e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_077d84b0-7353-4fab-bd91-a1ff0f1698e5" xlink:to="loc_srt_ConsolidationItemsDomain_a14f65f5-48d9-4008-a8b2-af0ad187fd4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_GeographyEliminationsMember_5a7b287d-6639-4428-b7b8-21c459364bae" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_GeographyEliminationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a14f65f5-48d9-4008-a8b2-af0ad187fd4e" xlink:to="loc_srt_GeographyEliminationsMember_5a7b287d-6639-4428-b7b8-21c459364bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ReportableGeographicalComponentsMember_6afa515c-02a1-4453-9f47-42808a1eb5a5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReportableGeographicalComponentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a14f65f5-48d9-4008-a8b2-af0ad187fd4e" xlink:to="loc_srt_ReportableGeographicalComponentsMember_6afa515c-02a1-4453-9f47-42808a1eb5a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_CorporateReconcilingItemsAndEliminationsMember_97b466b0-bb27-4332-9a1f-b15cc44cbf4c" xlink:href="coo-20221031.xsd#coo_CorporateReconcilingItemsAndEliminationsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a14f65f5-48d9-4008-a8b2-af0ad187fd4e" xlink:to="loc_coo_CorporateReconcilingItemsAndEliminationsMember_97b466b0-bb27-4332-9a1f-b15cc44cbf4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_37ad85ac-02d7-4f9e-a5e8-378219b30105" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_75b29e40-88b8-4467-a88f-4497c3b57669" xlink:to="loc_srt_StatementGeographicalAxis_37ad85ac-02d7-4f9e-a5e8-378219b30105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_4d12c3fb-00ab-40ba-8be3-487fb9a83ef5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_37ad85ac-02d7-4f9e-a5e8-378219b30105" xlink:to="loc_srt_SegmentGeographicalDomain_4d12c3fb-00ab-40ba-8be3-487fb9a83ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_6417d1dc-300c-4a26-8f4c-83aa55a948c0" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4d12c3fb-00ab-40ba-8be3-487fb9a83ef5" xlink:to="loc_country_US_6417d1dc-300c-4a26-8f4c-83aa55a948c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_2aeeeefb-21f7-4f66-b5d9-9bf59f5c20b4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4d12c3fb-00ab-40ba-8be3-487fb9a83ef5" xlink:to="loc_srt_EuropeMember_2aeeeefb-21f7-4f66-b5d9-9bf59f5c20b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_RestOfTheWorldMember_fa338bc1-2640-4f5b-b558-edc55e78a00e" xlink:href="coo-20221031.xsd#coo_RestOfTheWorldMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4d12c3fb-00ab-40ba-8be3-487fb9a83ef5" xlink:to="loc_coo_RestOfTheWorldMember_fa338bc1-2640-4f5b-b558-edc55e78a00e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_4ed672eb-515b-4cca-a8d1-ab1cbec221ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_75b29e40-88b8-4467-a88f-4497c3b57669" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_4ed672eb-515b-4cca-a8d1-ab1cbec221ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1c860af1-d399-4375-8271-92940fed46d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4ed672eb-515b-4cca-a8d1-ab1cbec221ff" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1c860af1-d399-4375-8271-92940fed46d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_bef66cb0-7d32-4860-afa2-67bd60ff2350" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4ed672eb-515b-4cca-a8d1-ab1cbec221ff" xlink:to="loc_us-gaap_OperatingIncomeLoss_bef66cb0-7d32-4860-afa2-67bd60ff2350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_19186f3d-6302-4596-b270-9046213f2e49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4ed672eb-515b-4cca-a8d1-ab1cbec221ff" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_19186f3d-6302-4596-b270-9046213f2e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#FinancialDerivativesandHedgingNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_077ddf69-c80d-4f84-992d-acff9bc4c046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a243614e-c012-483c-8abb-b7547968f6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_077ddf69-c80d-4f84-992d-acff9bc4c046" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a243614e-c012-483c-8abb-b7547968f6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3dc4eaf2-eff8-4b3a-bc63-ab5c860eab61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a243614e-c012-483c-8abb-b7547968f6bd" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3dc4eaf2-eff8-4b3a-bc63-ab5c860eab61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8208dd12-df1f-46f6-97ea-f13d95ceb405" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3dc4eaf2-eff8-4b3a-bc63-ab5c860eab61" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8208dd12-df1f-46f6-97ea-f13d95ceb405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_3ff369e8-fc84-4eeb-8063-70eee58874ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8208dd12-df1f-46f6-97ea-f13d95ceb405" xlink:to="loc_us-gaap_InterestRateSwapMember_3ff369e8-fc84-4eeb-8063-70eee58874ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c57c779c-72db-41dd-88e5-a2db249f99eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a243614e-c012-483c-8abb-b7547968f6bd" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c57c779c-72db-41dd-88e5-a2db249f99eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_c5c7750c-188b-453c-9040-3ba156acaa4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c57c779c-72db-41dd-88e5-a2db249f99eb" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_c5c7750c-188b-453c-9040-3ba156acaa4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_8a350621-cb71-4ebd-9632-e2a2ab5abd24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c57c779c-72db-41dd-88e5-a2db249f99eb" xlink:to="loc_us-gaap_DerivativeNotionalAmount_8a350621-cb71-4ebd-9632-e2a2ab5abd24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_NumberOfInterestRateDerivativesMatured_f72864ca-4163-4a59-ac24-99d4d439492f" xlink:href="coo-20221031.xsd#coo_NumberOfInterestRateDerivativesMatured"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c57c779c-72db-41dd-88e5-a2db249f99eb" xlink:to="loc_coo_NumberOfInterestRateDerivativesMatured_f72864ca-4163-4a59-ac24-99d4d439492f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract_dd1b36cc-42d5-4094-abab-9c5c34be2af9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c57c779c-72db-41dd-88e5-a2db249f99eb" xlink:to="loc_us-gaap_DerivativeTermOfContract_dd1b36cc-42d5-4094-abab-9c5c34be2af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AOCICashFlowHedgeCumulativeGainLossBeforeTax_7252ef7f-6ead-4482-90b7-b7a79223542a" xlink:href="coo-20221031.xsd#coo_AOCICashFlowHedgeCumulativeGainLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c57c779c-72db-41dd-88e5-a2db249f99eb" xlink:to="loc_coo_AOCICashFlowHedgeCumulativeGainLossBeforeTax_7252ef7f-6ead-4482-90b7-b7a79223542a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_651741be-e7c5-4122-843e-b1d4f4f14e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c57c779c-72db-41dd-88e5-a2db249f99eb" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_651741be-e7c5-4122-843e-b1d4f4f14e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_fdaf480b-5c45-4b05-b1a1-417d1e545230" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c57c779c-72db-41dd-88e5-a2db249f99eb" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_fdaf480b-5c45-4b05-b1a1-417d1e545230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3ba1f235-dfe3-48b6-ac4d-d184b9454f69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_d9f703ab-a414-4c62-b1a0-42c6ae9119c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3ba1f235-dfe3-48b6-ac4d-d184b9454f69" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_d9f703ab-a414-4c62-b1a0-42c6ae9119c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e80bb7c7-8065-4542-b661-a9fb1fe3466d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_d9f703ab-a414-4c62-b1a0-42c6ae9119c4" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e80bb7c7-8065-4542-b661-a9fb1fe3466d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_18b09a50-23e7-4257-a544-ec810d604b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e80bb7c7-8065-4542-b661-a9fb1fe3466d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_18b09a50-23e7-4257-a544-ec810d604b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_d1bd7a73-c3dd-4172-8b40-6bbc01260feb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_18b09a50-23e7-4257-a544-ec810d604b8c" xlink:to="loc_us-gaap_InterestExpenseMember_d1bd7a73-c3dd-4172-8b40-6bbc01260feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0ec84c8d-693d-4ed5-9b04-52cabe6fec66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_d9f703ab-a414-4c62-b1a0-42c6ae9119c4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0ec84c8d-693d-4ed5-9b04-52cabe6fec66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2b82f7fa-351c-4aeb-be41-6b69df1eb0b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0ec84c8d-693d-4ed5-9b04-52cabe6fec66" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2b82f7fa-351c-4aeb-be41-6b69df1eb0b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_046e7cac-cf24-44ef-a7ab-61303d702294" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2b82f7fa-351c-4aeb-be41-6b69df1eb0b4" xlink:to="loc_us-gaap_InterestRateSwapMember_046e7cac-cf24-44ef-a7ab-61303d702294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_1b4dcc2d-ebc2-4e89-ac97-d87816e4977d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_d9f703ab-a414-4c62-b1a0-42c6ae9119c4" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_1b4dcc2d-ebc2-4e89-ac97-d87816e4977d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_958dfea8-67c2-4848-a4ba-b5e6ba04902a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_1b4dcc2d-ebc2-4e89-ac97-d87816e4977d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_958dfea8-67c2-4848-a4ba-b5e6ba04902a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0d88e878-00c5-4079-a775-f830422f10f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_65c564ad-59f5-4a03-9af0-1f891c107f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0d88e878-00c5-4079-a775-f830422f10f0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_65c564ad-59f5-4a03-9af0-1f891c107f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7296cfe5-d7d9-4521-b563-31c77023f69c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_65c564ad-59f5-4a03-9af0-1f891c107f7b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7296cfe5-d7d9-4521-b563-31c77023f69c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_04958b82-4b63-41da-8a51-721f190c8f50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7296cfe5-d7d9-4521-b563-31c77023f69c" xlink:to="loc_us-gaap_EquityComponentDomain_04958b82-4b63-41da-8a51-721f190c8f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember_35830e0c-5cc6-4ca4-891a-979fe73655f0" xlink:href="coo-20221031.xsd#coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_04958b82-4b63-41da-8a51-721f190c8f50" xlink:to="loc_coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember_35830e0c-5cc6-4ca4-891a-979fe73655f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_125c5bc3-42a1-4121-97b4-01932b7468d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_04958b82-4b63-41da-8a51-721f190c8f50" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_125c5bc3-42a1-4121-97b4-01932b7468d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_28367408-7a01-4d6c-a764-8d67d249728c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_65c564ad-59f5-4a03-9af0-1f891c107f7b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_28367408-7a01-4d6c-a764-8d67d249728c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_03b20f1a-e1c7-4be8-b5c3-d925f0c99fd0" xlink:href="coo-20221031.xsd#coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_28367408-7a01-4d6c-a764-8d67d249728c" xlink:to="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_03b20f1a-e1c7-4be8-b5c3-d925f0c99fd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a82c05fa-bd10-4c26-8f9c-65aea12cf0b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_03b20f1a-e1c7-4be8-b5c3-d925f0c99fd0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a82c05fa-bd10-4c26-8f9c-65aea12cf0b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_038aefab-a4a8-4eb0-b682-446ce90d3ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_03b20f1a-e1c7-4be8-b5c3-d925f0c99fd0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_038aefab-a4a8-4eb0-b682-446ce90d3ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_cd99a298-a879-46b4-b645-7db7dcf39393" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_03b20f1a-e1c7-4be8-b5c3-d925f0c99fd0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_cd99a298-a879-46b4-b645-7db7dcf39393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_a066edfb-2849-404e-ba55-a58a648f9511" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_03b20f1a-e1c7-4be8-b5c3-d925f0c99fd0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_a066edfb-2849-404e-ba55-a58a648f9511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_fae733b9-3b80-4662-afa8-3a796b25583f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_03b20f1a-e1c7-4be8-b5c3-d925f0c99fd0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_fae733b9-3b80-4662-afa8-3a796b25583f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0929703a-213f-49d8-aab2-aeb38b9a84ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward_03b20f1a-e1c7-4be8-b5c3-d925f0c99fd0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0929703a-213f-49d8-aab2-aeb38b9a84ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.coopercos.com/role/ScheduleIIDetails" xlink:type="simple" xlink:href="coo-20221031.xsd#ScheduleIIDetails"/>
  <link:presentationLink xlink:role="http://www.coopercos.com/role/ScheduleIIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_94d7fbfa-56c6-4f3c-8c8d-e4c4b3260f8c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_1c45a5b0-f9f7-430f-a46d-5e109bef8979" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_94d7fbfa-56c6-4f3c-8c8d-e4c4b3260f8c" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_1c45a5b0-f9f7-430f-a46d-5e109bef8979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_69a0d7f5-ab06-4a7b-991c-751041f9d844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_1c45a5b0-f9f7-430f-a46d-5e109bef8979" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_69a0d7f5-ab06-4a7b-991c-751041f9d844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_b2b3f003-95ef-432f-8d77-c9fdd944f618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_69a0d7f5-ab06-4a7b-991c-751041f9d844" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_b2b3f003-95ef-432f-8d77-c9fdd944f618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_dcac830c-5a33-44f0-a17f-9ca36d8c9e21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_b2b3f003-95ef-432f-8d77-c9fdd944f618" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_dcac830c-5a33-44f0-a17f-9ca36d8c9e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_3aad8607-f393-4cea-83fd-f416716b974a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_1c45a5b0-f9f7-430f-a46d-5e109bef8979" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_3aad8607-f393-4cea-83fd-f416716b974a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_c80dc3db-42dc-4918-8e6a-113c191430fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_3aad8607-f393-4cea-83fd-f416716b974a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_c80dc3db-42dc-4918-8e6a-113c191430fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_e374cdf8-a4c3-4572-ab7b-7543b0cdb615" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_3aad8607-f393-4cea-83fd-f416716b974a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_e374cdf8-a4c3-4572-ab7b-7543b0cdb615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_3368e081-942c-4d4f-b740-80937720a544" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_3aad8607-f393-4cea-83fd-f416716b974a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_3368e081-942c-4d4f-b740-80937720a544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_6d57211a-16a6-46e6-8e21-d369ef08e8c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_3aad8607-f393-4cea-83fd-f416716b974a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_6d57211a-16a6-46e6-8e21-d369ef08e8c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>coo-20221031_g1.jpg
<TEXT>
begin 644 coo-20221031_g1.jpg
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M@6H7L_\ P2,^.VG373M!;_$75FAB9B50MH-CNP.V=H_*N:_X,=O^22_M#_\
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M_!3C]E*^ET#XPZ]+H][X^\6B>1[KQL-3TA]3N8=9D+;]2C:2/:!.7,:L0A3
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M]-Z* *?B*#Q!<Z#>V_A/4[.RU22UD73KS4;![JW@G*G8\D*2Q-*@;!*+)&6
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M[3=+TJ]\%"P^S2W*JC3B;[;.3B+S4V;1GS<Y&,']3** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M** "BBB@ HHHH **** "BBB@ HHHH **1F55+,P  R23TKYM_:1_:N:^^T>
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M_P"OA/\ T$UY6=?\BZ7R_-'K9'_R,8_/\COJ***^(/N@HHHH **** "BBB@
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M4=2+BK:7Y&XVLF_1/8ZOXQ?M?_MT?L;?\%</A?\ L]?$K]I&'QWX8^)2Z/\
MVEHP\+6VGVED-0OY[#9;JF^5?*DB\Q7:1F9<*Y?DG]/Z_(W_ (*EVNN>,O\
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MY'\/2OF,XRJZ>(HKU7ZK]3ZC)<V::P]=Z='^C_0]'HHHKY8^L"BBB@ HHHH
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M?MT_M"W%O*LD<B2LCHV0P.IRD$$=17E?Q7^#W[6__!'SQO/^UA^R/XMB\:?
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MC)7E+5I]?=LNFN^GFU<GP&$RZG5Q#:E452V[M*+M&.B:_P 5WUTVU^O*],^
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M?5[8HY:W-LT9A^S>7Y9@)BVA>%Z8(!KW'X;_  2^#'P;MY;/X0_"+PQX5BG
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M=,N]<@D@U72YM2BEL9X6<R+&(C"#&J/@IL92-N,E2RG,O?\ @E%\$[_X7S?
M2X^,_P 3V^'=_J*WNL> F\1V[:?J$OV@7+!G:U-Q!&TP\QHK>:%"V3M!.:^H
M:*P659=&DJ:II15]%M[VZ]';5;/J=#S;,I574=5N3MJ]7[OPOU5]'NNAX_\
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M& EC)KWJCLO\*_S=_N1^.^(.9O$8^&"@_=IJ[_Q/_)6^]A1117WY^>A1110
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M_P#!3/X6_M]:3XT\-^#_  E>^&/B+\.M3ETSQI\/_$-VGFV%VCR1 K/$&6:
MRQ2)YJKN4H=R#*[NV.*H2J<BEKJOFMU?:Z..6%Q$:?.XZ:/Y/9VWLSZ5K@?V
ME?VH/@+^Q]\*+SXX?M(_$:U\+^%[&>*"?4KFWFF+2R-M2..*!'EE<G/RHK'
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M_P#P2+_8Q^-WCWQGX]UWPUKFCM\2X;6+XFZ5X9U^6QLO%:V\Z3Q?;(TY#"1
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MP.>!74_$_P"!/P0^-MC9Z9\9_@WX4\76VG.SZ?;^)_#MM?I;,P 9HUG1@A(
M!(QD 5>'X>Q%+*JF#DX7<7",U&TFF_M/R[+?34SQ'$>'K9M3QD5.RDIR@Y7B
MFE]E>?=[:Z'CW_!)"VL[7_@FU\'XK&-%0^$HW8)TWM+(SGZEBQ/N35'X[_\
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M=!TR#3]*LHHFV6]O#&L<<8SR<*H&3SQ7C5U^SOXN\6_MEM^TE\??$.B/X?\
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M_9:X,TJ^QP%27E;[]#T,JI>VS"G'L[_=J>CT445^?'Z(%%%% !1110 4444
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M>YRP\N>(,P&=K8969248 Y5@/SP_X(G6OBBS_P""LO[1\'Q'\T>(UBU?[?\
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M>&I<2X3@O$.=.<J>(4'>5^2%.GK>[TO-VC%+[*OUB?.O_!##79K_ .*OQO\
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MA2TTJ?4X'\Q?#]A! D=]J;$?PQ#,<.2-\A3&2I%?0'Q?^*W@WX'?#36?BO\
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M]O<DD];117XKB,37Q=>5:M+FE+5MG[=AL-0PE"-&C%1C%6204445B;A1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
3"BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>coo-20221031_g2.jpg
<TEXT>
begin 644 coo-20221031_g2.jpg
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M@6H7L_\ P2,^.VG373M!;_$75FAB9B50MH-CNP.V=H_*N:_X,=O^22_M#_\
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M_!3C]E*^ET#XPZ]+H][X^\6B>1[KQL-3TA]3N8=9D+;]2C:2/:!.7,:L0A3
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M]-Z* *?B*#Q!<Z#>V_A/4[.RU22UD73KS4;![JW@G*G8\D*2Q-*@;!*+)&6
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M[3=+TJ]\%"P^S2W*JC3B;[;.3B+S4V;1GS<Y&,']3** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M16QIOQ#\::5@6OB&=E'\,Y\P?3YLUQ5>'*B_AU$_56_S.ZEQ+3?\2FUZ._\
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MZ9_8)_Y%SQ$/^GV#_P! :OF:OIG]@C_D7?$8_P"GV#_T!Z^5XU_Y)VKZQ_\
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M_P G\3\69KQ5C/:XJ5H+X8+X8K]7WD]7Y*R11117TI\P%%%% !1110 4444
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MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *1F55+,0 !DD]J6OBO\
MX*%?MJ,[WGP ^$NL84;H?$^K6TG4]&M(V';M(1_N?WA7O<.</8_B7,HX3#+S
ME+I&/5O]%U>AX'$O$> X8RR6,Q3\HQZRET2_5]%J8O[=_P"W5-XSGO/@M\&M
M7*Z*A,.MZU;/S?GHT,3#_ECV+#[_ $'R_?\ DFBBOZUR'(<OX=R^.$PD;);O
MK)]6WW?X+1:'\@Y_G^8\29C+&8R5V]ETBND4NR^]O5ZA1117LGB!1110 444
M4 %%%% !1110 4444 %%%% !1110 5]+_L#_ /("\2?]?=O_ .@O7S17TO\
ML#_\@/Q)_P!?=M_Z#)7RO&G_ "3M7UC_ .E(^LX(_P"2DH^DO_26?0-%%%?A
MI^\!1110 4444 %%%% !1110 4444 %%%% !1110 4444 =Y\+_B<=-:/PYX
MBN/]&/RVURY_U7^RQ_N^_;Z=/4 01D&OG.O1?A/\1R#'X4UZ?(.%LIW/3TC)
M_E^7I7S.<94FGB**]5^J_4^HR7-FFL/7>G1_H_T/1Z***^5/K HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$^KX)_Y*6C_V]_Z1(^A:***_##]Y"BBB@ HHHH **** "BBB@ HHHH ****
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M(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?2/[
MG_'CXH'_ $UL_P"4U?-U?2/[ G_'GXI'_36S_E-7R_&?_).5O^W?_2XGU?!/
M_)2T?^WO_2)'T/1117X6?O(4444 %%%% !1110 4444 %%%% !1110 4444
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MPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_*?\
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MW'T1121R)+&LJ'*LH(/M2U^9GZAN%%%% !1110 4444 %%%% !1110 4444
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M?_MW_P!+B?5<%?\ )34/^WO_ $B1]%T445^%'[T%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 >^^%[G[9X:T^ZSS)9
M1,?KL&:OUB_#F;S_  1IKYZ6P7\B1_2MJOS7$1Y,1./9O\S].PTN?#PEW2_(
M****Q-@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#QS]O^
MX-M^R'XQD'>&S3_OJ]@7^M?E]7Z>_P#!0D9_8_\ & Q_#8_^E]O7YA5_2?@X
ME_JU6?\ T^E_Z13/YE\:&_\ 6>BO^G,?_2Z@4445^LGY"%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5]&_L!?=\6#WL?\
MVXKYRK[$_9/^$-W\,? LFK:VKIJ>N>7-<V[<>1&H;RT(_O8=B?=L?PU\AQOB
MJ-'(9TIOWIN*2[VDF_N2_+N?8\"X6O6X@A5@O=IJ3D^UXN*^]O\ /L>J4445
M^)'[F%%%% !1110 445\Q?\ !0?_ (*A_"O]A#6?"'PEM?!>H>/?BI\1-0BL
MO OPYT2Z2">^>680I+/.X*VL#2D1B0JQ9@VU6".4SJU:=&'/-V1I2I5*TU""
MNSZ=HKY)_:M_;O\ VIOV#O@[:?M(_M)?LP^&=9\#VEU:P^-Y/AUXTN+K4/#J
MSR+&LZPW=E E[$)'6,D21,"ZG;MR5]$^*?\ P4&_9X^'7[".I?\ !0W1=??Q
M)X M?#2ZQI\^D#]Y?^9(L,5NH?'ER-.ZPLKX,;[@P!4BH^L4;M-V:5W?33OZ
M%_5JUDTKINRMKKV]3W*BOSZ\*?\ !9/X\>'_ (+2_M=_'O\ 8ODT_P"#EU\(
MHO&FG^,/#GB 7'D7DUR+>WT203(GFSR.\2^:H0*7!*%<L.?UG_@K[_P4BD^"
M>F?'[X6_\$JK[QYX:\5> =.\2>'M0\):_-=?8I+FY$;64\20&:YDCC^=FAC4
MC()0(&D&+S##);O:^SV[[;&RR_$M[+>VZW[;[GZ2T5@_"WQ3XB\<?#+PYXU\
M7^"KGPUJVL:#9WVJ>'+V423:5<2PI)):2,  SQ.S1D@ $J3BMZNQ--71QM6=
M@HHKR3XN_M':UX*_:D^%/[,O@WPW:ZC>>.H]9U/Q#=3RL#I&C:?;)NN J]6D
MN[BS@7=@?O'/)7%*<XP5WY+[]!PA*;LO-_=J>MT4451(4444 %%%% !1110
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ME=]4%%%%?FQ^FA1110 4444 %%%% !117Y1?\%'OV_\ P!\"?^"Q_A[X-?\
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M9I[V12R)#"NQE#2.ID<%(P[ K7,^%O\ @JE^PSXN_9%A_;?T_P"-=O#X FU
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M)OVEP,%@",UO0P3I5%.3O:"C]W4PK8U5:;A%-7FY??T^1^*W[-O[.FC?&_\
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M* "BBB@ HHHH **** "BBNJ^#?PMU3XN>.;;PM9;H[<?O=1NE'^H@!&YOJ>
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M:/ /%<N,K5:-#FIIM^2O^&AUX*C2K5U&HTEYNWROJ?5G[)'_  5E_8Y_;/\
MACXX^-7PK\3ZMI_A+X=0I+XJ\1>*=);3[6V4Q22MAW8[MD<99L?=#)_>%0>!
MO^"MG[)GC'QA\//#.K'Q/X8L?B\DK?"CQ-XIT06NF^*_+D6/;;R"1G@=BZ;$
MND@9Q)'M!\Q-WPMIG[3OQ#_X*Y?\$=?VB/V9?A5^S)9_#SXV^"I-.7QAX#\,
M:2;*/4FCOHIW\F!@)4FDCL+J V[EW#QJFYA( /DW_@H9^T'X?^*?_!)?]DOX
M'^&]#\2:3\6? .O_ -B7>@WWAN]L[JSGMH/LX$<LD2HSNRVCA4<L-XR 5('F
M5,SJTZ2DFFN6][6N^:S7DTOQ/3IY92J57!IKWK6O>RY;I^:;^5C]ROVE/V_/
M@;^S)\3O#_P.\0V>N>(O'/B71K_6-,\(>%;.*:\_LVR@EGN+R0SRQ11QA8)0
MNYPTC(5C5V! [/\ 9I_:4^#?[7?P4T/]H+X">+4UKPQX@@:2RNQ$T;HZ.4DB
MDC8!HY$=65E(X(XR""?D?]KK_@GY^T5KO_!0SP+_ ,%#/A18V/BF?3_A)J?@
MWQ5X5?4HK2=;B:RODMKNW>8K$T1GNP)5+*R(A9%D+%1P7[,?[+'Q<_8P_9&\
M"_\ !'?X??$U)?BA\03?>(/BCXM\/R-Y/@SPY-,$O+FW=U#":4!+*U8J"TS2
MS *(2!VK$8F->2G'W=;?A;[[OTL<7U?"RH1<)>]I?\>;[K+UN?>/[/W[1W@/
M]I?2->\4_#"QU.70M%\37>B6NOW5NB6FLRVK>7//9,KL9K=9A)#YI50SPOMW
M* Q[^OEC]GO_ (*)?\$ZM#_X0K]FSX&^,X],\-S:O/X(^'FHPZ1/%HNI:AI\
M<*R:?:W;+LD=1+$%=B$G8D1O*V17U/771J*I#XDWUL<=:G*G/6+2Z7"BBBM3
M(**** "BBB@ HHHH **** "O:OA7I']D>";0.N'N09W]]W3_ ,=VUY!H6ERZ
MWK-KI,.<W$ZID=@3R?P&37O\,,5O"EO"@5$4*BCL!P!7S?$5>U.%%==?N_K\
M#Z;ANA>K.L^BM]_]?B.HHHKY,^N"BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH ^!?^"J?PF/ASXI:7\6M.ML6WB*S^SWS*.E
MU  H)]-T10#_ *YM7RK7ZG_MH?!O_A=O[/NM>'+*U\W4["/^T=' &6-Q""=@
M]W0O&/=Z_+"OZE\+\Z6:\,QH3?OT'R/_  [P?I;W?^W3^4O%3(WE/%$J\%:%
M=<Z_Q;37K?WO^W@HHHK]'/S0**** "BBB@ HHHH **** "BBB@ HHHH ****
M )+6UN;ZYCLK.W>6::0)%%&I+.Q. H ZDGC%?:_[//P<MO@_X&2RNHT;5K[;
M-JLRX.'Q\L0/=4!(]R6/>O*/V,O@G]LN!\7O$MIF*%F31(I!]YQPT_T7E5]]
MQXV@U]*5^3\<9]]8K?V?0?NQ?OOO+MZ+KY^A^N\"</\ U>C_ &C77O27N+M'
MOZRZ>7J%%%%?G9^CA1110 4444 %%%% !1110 4444 %?+/Q@^('_!6;X=_M
MC2S_  J^ /P]^(WP-U"RMDM;6+Q*-(UW2IA$HFDEEN"8Y1YOF,$1&!C*#*,&
M)^IJ*SJ4W422DUZ?TS2G45-MN*=^_P#2/GS]GW]F74_@%\1?C#^USJ_@""]\
M?_&#5M-N]8\,^%+V)HK2VL+-;2UMHY[HVZ2R',T\TK",,\[*%;8K/Y]%_P $
M]_B5^U+^VIX9_;=_;MO]$6V^&ZM_PJ7X4>';N2\L]'G9U<ZE?74D<?VF[+)$
MVR.-8HS!%AY-F6^Q**AX:DTHO9.]O.][OYZ]C18FJI.2W:M?K:UK+Y:=_,S/
M&FN:KX9\'ZIXBT+PI=Z]?6&GS7%GHFGRQ)/J$J(62WC:5EC5W8!0795!;)(&
M37B'[)O[+7C+PW\+O%_CS]H:^C/Q7^,2O>_$+4-.F#KI0>%HK72;1_\ GWL8
M&\I#D[Y/-EZRFOH*BM)4XRFI/H9QJ2C!Q74_&KX-_P#!%;]M33_ GP*_9"\;
M^$[/3=!^$7Q]U+QCK/Q+M]<M&M-2TL-:26ZVD"3&[6XE*2IMEA18R@)=AC/[
M*T45CAL+2PJ:A?6V_DK(VQ.+JXMISMI?;S=V%%%%=)RA1110 4444 %%%% !
M1110!W/P.T'[9K<^O3)\EI'LB)_OMQ^BY_,5ZG6'\.?#W_"-^$[:TDCVS2KY
MUQQSN;L?H,#\*W*_/\TQ/UK&RDMEHO1?U<_0\JPWU7!1B]WJ_5_U8****\\]
M$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MK\OOVZ/@A_PI+X^ZE:Z;9^7H^N$ZEI&U<*BR,?,B'ILDW #LI3UK]0:\,_X*
M ? 3_A=7P/N-5T:R\S7/#.^_T[8N7EB"_OX1Z[D&X <EHU'>OO?#KB%9#Q%!
M57:E5]R797?NR^3Z]$V?G_B3PX^(.')NDKU:/OQ[NWQ1^:V75I'YG4445_5Y
M_(X4444 %%%% !1110 4444 %%%% !1110 5V7P-^$VH?&#QU!X?C#QV,.)M
M4NE'^JA!Y /]YONCZYQ@&N3T^PO=5OX=+TVU>>XN95B@AC7+2.QP% [DDXK[
M=^ WPBLO@_X%AT0JCZC<XFU6Y3G?+C[H/]U1\H_$X!8U\QQ3GJR; 6IO][/2
M/EWE\NGG;S/J>$\A>=YA>HOW4-9>?:/SZ^5_(Z[2],L-%TV#2-*M$@MK6%8K
M>&,85$48"CZ 5/117X6VY.[W/WI)15EL%%%%(84444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %=#\,O#7_  DG
MBJ&.:/=;VW[ZXR." >%_$X_#-<]7LWPJ\+?\(YX92:YBVW-[B6;(Y4?PK^ Y
M^I->9FV+^J81V^*6B_S^1ZF48/ZWC%=>['5_Y?,Z:BBBO@C] "BBB@ HHHH
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MGS,&CT.&0=!RKSX_-5_X$>ZFOHFHK*RM--LXM/T^V2&"")8X88EPJ(HP% [
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBBO//1"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ J]X>\.ZIXGU)-,TJ#>[<NQ^ZB]V8]A5GPCX-U?QA?_9=
M/CVQ(1Y]RX^6,?U/H/\ ]=>Q^%_"ND^$M.&GZ7#R<&69OO2-ZD_T[5Y&99K3
MP4>2.L^W;U_R/8RS*:F.ESSTAW[^2_S(O!W@[3/!VFBSLQOE?!N+AA\TA_H!
MV%:]%%?$U*DZTW.;NV?<TJ5.C34(*R04445!84444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!C^// '@[XG>%[GP9X\\/V^I:;=KB:VN%R,]F4CE6'4,"".Q
MK\^OVLOV!/&OP-EN/&GP_2YUSPH"7>14W7.G+Z3*H^9!_P ]%&./F"\$_H[2
M,JLI5@"",$'O7U?"_&&:\*XCFH/FIOXH/X7YKM+S7S36A\CQ5P9E'%F&Y<0N
M6JOAJ+XEY/\ FCY/Y-/4_&SPIX7UGQIXCL_"OAZU,UY?3B*%.V3U8GLH&23V
M )K[H^%_PZT;X6>"[3P=HH#+ NZYN-N&N)CC?(?J> .<  =J]-U#]CGX5Z-X
MSO\ XF?#CP_!I>KWT.R:!.+;KEC&@XB9N,XX^48 RQ/-:II.I:+>-8:K9O!,
MG5''ZCU'N*_1\[XVP_%,84\->,(J[B]^;]4ME\WZ?FV1<#8CA24ZF*M*<G92
M6W+^C>[^2]:]%%%?.GT84444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4458TO2=2UJ\6PTJRDGE;HD:YQ[GT'N:4I1B
MKMV0XQE)V2NRO76^!/A7J7B9DU'50]K8]02,/*/]D'H/<_AFNH\$_![3](V:
MEXDV75R.5@',<9]_[Q_3Z]:[<  8 KYG,,]2O3PW_@7^7^9]/EV0MM5,3_X#
M_G_D5]+TK3]%LDT[3+5(88QA40?J?4^]6***^7<G)W;U/JXQC%62L@HHHI#"
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *I:[X=T;Q):?8]
M9L4F7^%B,,A]0>HJ[150G*G)2B[-$SA"I%QDKIGE'BSX,ZSI)>\\/N;VW'/E
M8_>J/I_%^'/M7%R1R12&*5"K*<,K#!!]*^BZR/$G@?PWXJ0_VI8#S<86XB^6
M0?CW^AR*^AP>?U(>[B%==UO]W4^<QO#U.?O8=V?9[?)]#PJBNT\2?!77],W7
M&ARK?0CG9]V0#Z'@_@<^U<?<VMS93-;7EN\4BG#1R(58?4&OI</BL/BHWI23
M_/[CYC$83$X65JL6OR^_8CHHHKH.<**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHJ2VM;J]G6VL[:261CA8XD+,?H!2;25V-)MV1'2QQR2R"*)
M"S,<*JC))]*[/PU\%M?U/;<:Y*+&$\[#\TA'TZ#\3^%>@^&O _AOPJ@_LNP'
MFX^:YE^:0_CV^@P*\C%YWA,/I#WI>6WW_P"5SV<)D>,Q-G-<D?/?[O\ .QY_
MX3^#.L:MMO/$+M96YY\K'[UA]/X?QY]J])T+PYHWAJT%EHUBD*_QL.6<^K'J
M:O45\KC,QQ.-?OO3LMO^"?5X/+<+@5[BU[O?_@!1117"=X4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
8* "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>coo-20221031_g3.jpg
<TEXT>
begin 644 coo-20221031_g3.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOQ \$:;XR;P$;,:A;"7[,-4\SR^2,;O*7/3T%?EW7W%^SE_R0_PW_P!@\?\
MH35\WQCP/PQE. IU,+0Y9.5F^>;TL^\F?3\%\=\4YOF%2GB\1S14;I<D%K=+
MI%'T!'\?;0_ZWPS(O^[= _\ LHJS#\>/#K'_ $C1[U/]S8W\V%>645^;O(\N
M>T6OFS]*6>YDMY)_)'L%M\9_!$_^MN+F'_KK;D_^@YK3L_B'X)O\>1XDMAG_
M )[/Y?\ Z'BO#**PGP]@Y?#)K[O\CIAQ'C8_%&+^_P#S/HBVO+2]3S;.ZCE7
M^]$X8?I4E?.T,\]O();>9XV'1D8@C\JV--^(OC72\"W\03NH_AG(D'T^;-<-
M7ARJOX=1/U5O\SNI<2TG_$IM>CO_ )'N-%>8:5\=]6APFL:-!..[P.8V^N#D
M']*Z?1_B_P"#-4PD]Y)9R'^&Z3 _[Z&1^>*\RME./H:N%UY:_P#!/4H9ME]?
M13L_/3_@'445':W=K>PBXLKF.:-ONR1.&4_B*DKSVFG9GHIIJZ"BBBD,****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7]V7?H_\OR/0:*1)$E021.&5AE64Y!'K2U\^?0A1110 4444 %%%% !1110
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M3_A'X:^&VA6LOBCXS7=DN@IK.Y[;2[680M)<SK&RM+L$Z 1JR;SN^8;>??\
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M5]&5O3J*K34UU[Z'/5INE4<'NNVH44459 4444 %%%% !1110 4444 %%%%
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M%JSYU:[3B]4OA:LU=]SS,@XDQ/#TY3H4H2DW!WDI77(^9)-2CHW\2=T[+L?
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M]BCX >'?&5GX?MH'\0W.L:@B/:7%POGPVZAKN G%L\#L<-S*!D=_T7K\T/\
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MG\=OV)O"7Q@^*H^-V@^,+SPUXGF\*7GAO4KVUM4GCO-/N(WC8-&V,3)YC%)
M>"!N5P H_1+_ ()M_ GX??LU?L5>!O@O\,+&6'2-&L[E8FN) \T\CW4TDDTC
M  ,[NS,<  9P   !\LU]L?LM?\D$\/?]<9O_ $HDK\^X[RO 8?!QQ5.FE4E4
MU?K%W\E>RO;=I-W/T3@'-<PQ.-EA:M1NG&GHO22MYNW,[7V3:5CT"BBBORX_
M50HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5_0Q_.04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% 'F?QYT7RKZR\0Q(,31&";:G\2G*DGU(8@>T=>?U[=\3=&_MSP3>P*H,
MENGVF++8 ,>2Q]_DW@#U->(U]OD=?VV!47O%V_5?Y?(^%S[#^QQ[DMI*_P ]
MG_G\PK[7_98Y^ ?A[_KE/_Z42U\45]K_ +*__) _#W_7*?\ ]*):^<\0O^1/
M3_Z^+_TF1]+X=?\ (YJ?]>W_ .E1/0:***_'S]E"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .T^".M&Q\32:2[X2]
MA( S_&O(_3=7K%?/VA:F^BZS:ZK'G-O.KD#N >1^(R*^@$=)$$D; JPRI'<5
M\=Q#0Y,5&HOM+\5_P+'V?#M?GPLJ3^R_P?\ P;BT445X!]"%%%% !1110 5\
M>_MD^)CKWQIN--27='I-E#:J >-Q'F-^.9,'_=K["K\__B#X@;Q7XZUCQ(S[
MA?:E-,A]%9R5'X# _"OO_#["^TS*K7?V(V^<G_DF?GOB+BO9992H+[<K_**_
MS:,>BBBOUT_'0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH ****  8S\RAAW5AD'ZUX%XIT5O#OB*\T5@VVWG98R_5DZHWXJ0?QKW
MVO+_ ([Z*+?6+37HD %U"8I2!R73&"3[JR@?[AKW<@K^SQ;IO:2_%:_E<\#B
M'#^TP:J+>+_!Z?G8X.OM;]E7_D@7A[_KG<?^E,M?%-?:W[*G_) O#W_7.X_]
M*9:Y_$+_ )$]/_KXO_29'3X=?\CJI_U[?_I43T*BBBOQX_9@HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KW'X=:F=
M6\%V%RSY9(?*?ZH=O] ?QKPZO4O@1J!FT*\TUFR8+D./8.O^*FO#S^ESX+G_
M )6OQT_R/=X>J\F.Y/YD_P -?\SNJ***^+/MPHHHH **** ,+XGZVWAOX<Z[
MKR-A[72+B2(_[8C;;^N*^!*^TOVL-6.D_ C6MC8>Y\B!/^!3)N_\=#5\6U^N
M>'E#ERVK5_FG;[DO\V?C_B-7YLRHT?Y87^]O_)!1117Z ?G84444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7._%313K7@B[6
M-2TEIBZC ./N9W$_\ +_ (XKHJ1TCE0QS1*Z,,.C#(8=P?:M:%65"M&HNC3,
MJ]*->C*F^J:/G2OM7]E/_D@/A_\ W+C_ -*9:^-O$.D2:#KEWHTA)-M.R*S+
MC>H/RMCW&#^-?9'[*/\ R0#P_P#[MS_Z52UW<?R4\DI26SFO_29'!X>QE#/*
ML9;JF_\ TJ)Z)1117Y ?L@4444 %%%% !1110 45'%=VD\\MM#<QO)"0)HU<
M%HR1D;AVR.>:DH **** "BBB@ HJ'4M2T[1]/GU?5[^&UM+6%IKFZN90D<,:
M@EG9F("J "23P *CT76]%\2Z1;>(/#FKVNH6%Y"LUG>V5PLL,\;#*NCJ2K*1
MR"#@T75PL[7+5%%% !1110 4444 %%%% !1110 5W'P)O?)\1W5@6P)K3<!Z
ME6']&-</71_">Z-KX\LLG DWHWOE&Q^N*XLQA[3 U%Y/\-3NRVI[/'TY>:7W
MZ'M-%%%?GA^C!1110 4444 >,_MQZA]E^$=I9*W-SKD2D?[*QRL?U KY-KZ<
M_;UN=GA3P_9Y_P!9J$KX_P!V,#_V:OF.OVW@>"AP_!]Y2?XV_0_#..ZCGQ%-
M=HQ7X7_4****^O/C@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@#ROXZ:*+3Q!;:W&H"WL&V0YR3)'@9]AM*#\#7TY^
MRAS\ /#_ /NW/_I5+7B/Q;T4ZQX*N)(D+26;+<(%')"Y#?@%+'_@(KVW]D__
M )-_\/\ TNO_ $JFJ>)Z_MN&*2>\:B7_ )+*WX%<+8?V'%59K:5-O_R:-_Q/
M1:***_-3]."BBB@ HHHH *S_ !;XJ\.^!/"NI^-_%^KPZ?I.C:?-?:I?W#8C
MMK>%#))*Q[*J*S$^@K0KY4_X*%?&7X=>,_&'@K]@>]^+8\,7/Q$U;SO%NM0I
M"PTO2+2-KH02//&]NCWD\=O;+%.")899P QVALZU14J;E]WKT-*--U:BC]_I
MU/B']@']O?\ :%^&W_!=?XC?!S]L#3KG0+/]H+3=/U/PGH]_*=NEE;)9](@R
M?E63[&9+28+]ZZCVY)6OT-_X*-_MY^'O^"<G[/I_:0\:_#'5?$^AP:O;V&H0
M:+>0QW%NTQ*QN%E(#J6&TX.1D'!&<?FQ_P '&?['7Q*^',7PR_;<\$_M(>(?
M&/Q1\)>(;6RTZTO-+TN+48[-))+J"Z@BTZT@>18+E.2P<+]HZKSGT+_@LA^U
M+H/[<'_!"C2OB)X-TR=?$OBC6M#_ +1\'Q6LAO[#48G#WEL8"/- C(8ABN&C
M*/T=2?&A7K8:G7I-^]&\HWMUU]-_S/;GAZ.*J4*J7NRM&25]UIZ[?D>T^*_^
M"]?PX^&OC3X/P_%K]DOXD>&_!GQMTF*Z\$^,+J.VN)+N1T@)1=/MW>Y*![F!
M Q57D$BND;HP8^@?L_?\%8O#_P 6?V\M;_X)[?%']F_Q9\-_&]CH?]L:,GB#
M4;&[34+7RDF 8V<LJ0RF&0/L#R ;)%+*R[3^<W_!1S5['Q)X7_X)DWOAXRW\
M?@_1=+N?%9LX'E_L:)#X>C=KH*"8-KV=VA#X(:WE!Y0X]?FUG3K_ /X.JM/\
M?V-QYN@-X'&E+KT:%K%KYM'=5MQ.!Y9D+L$"[LER$^]Q1'&8E54G*ZYH+9;2
MC=_<]OQN$L%AG1YE&SY9O=[QE9?>M_PL?6GQ3_X*]_#CPCJ/Q>U/X8?!_6O&
M_A;X!3V\'Q7\2Z9J-O +2=Y"DUO8Q2G-[+;A)&F!:%5V$*[L0*J?MF_\%H_@
M'^QOHWP?^(.K^"]3\2^"?C3:I<>&?%VD7\$4-O$WV=S)<1S%61!%<Q29Y/#@
MA2O/YW_L;Z=\$OV,/VQOVB?V'/\ @J+X+^(L.D?$7Q7-?^$;G1Y_$;:;XKAD
MFN,QO::0^+[[1%+"R%HY,,DL;%6^6NU_X+N?#?P-X5T#]C'X2_#/X07OAW0?
M#/B"XO+GP65DO)O#^DO/I^P7>&D,8PDH.YF7='*JLPC)HECL4\-.HFDUTZI\
MUMK=O\T$<#A%BH4VFT];]&N6^]][_P"1]-?M,_\ !13P'^TK^RY^TI\/OC'^
MP_\ &+1_ 7@?PY;+K=[JT T2\UK3+O>/M-E]H7"2*$258Y,EHV^=0<Q'2_9'
M_;B_8I_8A_X(U?"[XY>"/#GC&R\"W;3:1X$\*:M=0WVOZOJ,NI7:_9@RE(6E
MDF2>7(*1HF<!0H6O3O\ @LQKVC:E_P $J/B\^EZG#=_V]X+:WT,6<@E.HRS%
M#$D 3/FEQR N<@$] 37Y6?&OX"?'KXA_\&_O[,_Q0^!WAG4-6UCX(>,M3O\
MQ=X9M+21[S3P^HW4B7$MN!Y@$>(6(QD17/F?<RPK$5:^'Q$FO>:@W>W][]%T
M\B,-1H8G#Q3]V+FE:_\ =_5_F?JO\%/^"HO@KQK^U;\1?V+?C=\+-1^'OCGX
M;^%$\3:H;C4H]0TVYTDPV\SSQW,2K\T:W,6Y2F,[MK-M./)_&/\ P<!? SP?
M\&?!_P"UQ/\ !77KGX+>,?'$_A:W\:6^K6S7]C=Q&;,EQI@R\<;)!)*H\PR&
M, F-694;T?\ 9O\ ^"EWP _;(^$.L_'C]G7X">*?$?B+3_A_=7?B*QF\&36I
MAN(86E30VOIXE2[EDEW(D=N9U'+N$R-WXP?M>^-/BA^UO_P2SM?'<OP!\9:+
MK.C?' M=>$?"/P]FT;P7X3TQ[2]6.&TMX$6&:XEGE!EN)!+.K'8[QAT$JQ6-
MJT:5Z<^:Z;6GFK>6VCM^ \+@:-:K:I!QLTGKW3OYZO57_&Y^Y/[1?_!1;P9\
M&/VI/ O[&/@KP:GBGXA>/=!GUS3-/N?$-OI=JEC'Y@0^?,#YD\SPRK%"BG=Y
M3EF0#)QOCO\ \%1/#G[/O_!/W4/V]/'7[/?C&WBT[6[G2;OP/,(!J%I<PZM-
MIC"XD1GBB420EBZLZ_,H4ON!/R5_P5M^ G[&/[=5MX-B\?\ Q/O/@]\0M!^%
M-AK_ ,.OBIXEM+G3M.NT>>Y']E7_ )\<;6KK) LL.YEF)N':-'V,C]S^S/\
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M-)W,HY-#$9-'%T)-S4DI1=M%)N,9)]FU;4^Y9OVR_P!DJ#X@3_"B3]I3P/\
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M27ZGM\/44\Q=7M!K[W%_H;=%%%?&GVH4444 %%%% !117A/_  4(_;J\+_\
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M\SS&695XU''ELK+KU;U?75_=9!1117H'G!1110 4444 %?06B6?]G:+::?\
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !6U\.K;[5XWTV+&<7(?\
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M=[7PV<3Y\PGY67X(^\R:')ET/.[_ !84445YAZ@4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Z)\!+#,NHZFR]%CB
M0_7)/\EKSNO8?@UIOV'P5'<,N&NIWE.?3.T?^@_K7CYY5]GE[7\S2_7]#V<A
MI>TS%/\ E3?Z?J=71117PY]V%%%% !1110 5\P_MW^%OL?BS1O&$46%OK)[:
M5@/XXFW GW(DQ_P&OIZO+_VO?"'_  E/P8O+V&+=/I$Z7L>!SM'RO^&QV/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC,;0P5/FJ/T75G9@\#7QU7DIKU?1&7\-_A9+K!37/$<+):?>AMVX:;W/HO\
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MHUL/5=.K%QDMTU9H****U,@HHHH **** "BBB@ HHHH ]D^#EF+7P';R@?\
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M?(QJTI_#)/YGV$J-:'Q1:^17HISQ2Q\21LO^\,4T DX R:T,[,**D2SNY?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
>4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>coo-20221031_g4.jpg
<TEXT>
begin 644 coo-20221031_g4.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *\+\ _\ *03Q_P#]B)I7_HQJ]TKPOP#_
M ,I!/'__ &(FE?\ HQJ /=**** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KPO
MP#_RD$\?_P#8B:5_Z,:O=*\+\ _\I!/'_P#V(FE?^C&H ]THHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "O"_ /_ "D$\?\ _8B:5_Z,:O=*\+\ _P#*03Q_
M_P!B)I7_ *,:@#W2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\+\ _\I!/
M'_\ V(FE?^C&KW2O"_ /_*03Q_\ ]B)I7_HQJ /=**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/O"OQ2^+7P8\->)?$/@:6XE\'ZMKFD174VCR3^7YLEN9%/EN?*C^8<C8,$4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !114-_?V&E64NI:I>PVUM!&7GN+B0(D:CDLS'@
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M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7A?@'_E()X_\
M^Q$TK_T8U>Z5X7X!_P"4@GC_ /[$32O_ $8U 'NE%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+MYC,_)-?8%% 'R!X_\ VG/^"M?PB_:HF\(WG_!.[PM\1?@_K'BFWLM!\;>
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$0JO@,QSM82JSH@!Z3\1?^"KG['W@G]KSPU^PEX8\5ZIXW^*'B#5!9ZAX>\
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M%CQ_X \6^"+V>^\"^.OASXJGTV_T>ZE14=]JGRIU8(JE9$+;=RHR;V)^9/\
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MI=<_9;^.6EZY?629UGPQ<EK36=*8':RW-C,%FBPV5W[3&2#M9NM>ZT %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5X7X!_Y2">/_\ L1-*_P#1
MC5[I7A?@'_E()X__ .Q$TK_T8U 'NE%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8GASPWX=\':!9^%/".@66E:7IULEOI^FZ;:I!;VL*#:D<<: *B*  %   '%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-5\1^'KHZC;> _'+):M>-&I*L-A9)@C8D*([']WEAMR:^\?VIOVG?V9_@/\
M"73OBI\=IX-2\*:AK$-C:WEII/\ :D(FE20K(0@8!-B/EOP&2P!^7OBC^S#^
MRC\;/VG_ ((?M!?L%7_AJ/7+7QU::GXN?P-+$MI_8<2M/-<744/RV\C-&MN
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M\I!/'_\ V(FE?^C&KW2O"_ /_*03Q_\ ]B)I7_HQJ /=**** "BBB@ HHHH
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M^).IZ%J]MJ5MI%Q\0DTO0I)X)5E0OI]M#M9=RC*[\$<'(K[KHH XGX\?LW?
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJJ@ #H *MT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZ,:@#W2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HKD_B_\
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M<<P8/*"R *6!(YH ^OZ*^0-%_P""H_QC\8_M1Q_L\>#_ /@E-^T3'HT'C9M
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M0U;Q9X,^)%S-?K8P7*O<0*LG!$D88''/ P17[U44  &!BBBB@ HHHH ****
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M.T,"$EG_ .$?U24E[-^21#,3&269C*VU!]"?L'?\%:?V7?V[=4OOA7I,FK>
M/BUH *>+?@U\0K,Z=X@TJ5!F3$$F/M,0Z^;%N 5E+B,MMH ^H**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O"_ /_*03Q_\ ]B)I
M7_HQJ]TKPOP#_P I!/'_ /V(FE?^C&H ]THHHH **** "BBB@ HHHH ****
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MOAYIMO)GU+I"&)]R<UZW9V5GIUK'8Z?:1001+MBAAC"H@] !P!4M% !1110
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MCZS^UI\:/AII6@/>-J&G_"#QP=$&OB?R<1WKB-S*D?E':HVD>:_/->,?#_\
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M\5KW1=$MM'TR7QS\2F9;+3K<$0V4'V2&!H+:,$A(5;:@) Q7MGPM_P"#??\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&.,VT<#1(6).U6'7N>:_2:B@#Y!^%G_! K_@C=\'?+_X1+_@GM\/KORL;/\
MA*;*77,_7^TI)]WXYKZ.^&?[/?P"^"T*VWP<^!_@_P )1HNU(_#/AFUL%5>F
M ((UP*["B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OF3_@K
M-\ OCG^T%^RLFC?L]R^=X@\/>*++7AH^Y1_:L5LLO^C@/\KL'>.4(W#&$#DD
M5]-UY[^T5XM^,W@31/#WBSX.?#J[\5_8_$\)\4:#IUQ;1W-QI+03I*T)N'16
MDCD:"0(&!?R]N<$T ?%'[ '[9/P4_:J\:7/P4_:D\-MX2^+5O\3QXJT>QN;)
MK>,:C#' CPP-+EXI2(95>&3#%)2%9F&5Q_\ @X.\!^"-*M_A5XYTOPAIEMK6
MH>*[B+4-6M[&-+FZ0)"5620 -(!@8#$X[8K3U#]DW5OVO?VP-#^,O@GX1:MX
M8G\)_&J?6?%?C'6K>.SE-C!'830Z>(]YEFG,D;X;;LB#D[SNVUU?_!:7X"_M
M"?M/VWP_\+? 7X(:WXA?PQKMQ?:I=Q26T$ 1DA"*C32J7)PW08&WDT :'_!P
M-X_UWP?^PO:>'=&N9(HO$_C>QT[4BA(#VZ0W%UL/UDMXCCO@UY;^V#XPU7X5
M_MZ?L::]X7=H9I=&TK2IA#P7M;F>&UDCXZ@QSR#'O7U)_P %%?V7];_;T_8T
MO_ /A;2Y]+\1V]Y#K'AVRUQ5A87D&]3#(0S*F^*25 V=H+J2<9KRFW_97^*O
M[4'[6_P+^+OCKX8ZKX6\/_!_P=:-KG]OK$DEWK41W);6ZH[&1(Y4CD,W^K(&
M%))X /,?V1_&6J?%3]MW]M/Q)XH=IY8=%U32H1-R4M;:6XM8H^>@$<"#'M7J
M/_!OSX]U[Q?^PM=^'M9N))8?#'CB^T[3"Y)"6[0VUUL'TDN)3C_:%1W?[*WQ
M4_9C_:L^/'Q0\#?#'5O%7AWXR^#KM]%_L!8GEM=;EW%[:X5W7RTDEDDD$Q_=
MA6PQ!'/LW_!,?]D;6?V+OV3=)^%'B^:W?Q#>WT^K>(_LC[XH[N;:OEJP^]LB
MCBC+#@E"1P10!]!4444 ?F!_P=QE;W_@DU%X5,@C.N_%CP]8+._W82S3OO/L
M-GZU^(7[3/[*OPW\5?$7Q-^UC^QS^P]X@\5?L_>"]<.FZ=:Z'+,8M0\*Z5!)
M:ZCKM[=*DDL3WEPLLT5X?E@,+AHW"JH_H,_X.+OV*?VFO^"@'_!.J3]G+]E#
MX?V7B+Q/>^.=+O9K>^UJWL5M[2 3N\PDG959MWEIMSDB0GL:_*[X!?LL?\'2
M'P-T76?V,/@WX(\"6B:?\/X-$NK.[G\,SM!H<GF*D.Z3]S*6WN&=T:1B27))
M)(!Y3_P0-^+_ /P7(\"_"3XI_#?_ ()-_LQ?#_Q/:/XATV?QAKGB/4+%)M-F
M:T:.V$'GZA;12AXXF=G$<NXD'C=S^D/[,T'_  >&>'M1U3Q+\4HOV?\ 6Y-<
M:&*VTCXE7<*V^A)'O)>%?#XC+>87 8O+,?D7 4 D]9_P:_?\$TOVS?\ @F?\
M*/BWX _:^^%FG^')?$OB33=1\/367B2TU%KF-()HY4?[,[!-F(R-V-WF' X-
M?J50!^&'[8W_  ;X?\%A?^"@WQNO?VBOVGOB+^RT/$NH3P[[71]3\73Z;:1P
MP)#'Y-I<AH!\J ,#'\QRQ9F)KTG]G[_@W4_X*"_"30(8/#O_  4.^!_P[U&,
M,'OO O['GAF[O&^8%?\ 3YT@N"1SSD$8[Y)K]AJ* /S6NO\ @B'_ ,%$?%NC
MV>E_$C_@X5^/4S6\[M+)X2T>+0MZ'&%'V>Z+# S]YF'HHJYJ_P#P;C>#?'^@
MPZ/\;/\ @K3^VMXOV$^=%J?QO#6SYR"%AEM)-H(X/S$GU[5^CM% 'YOZ1_P:
MM?\ !*)M.LM,^)>F_%#QVEE.\JGQ;\4+]_,+G+ K;-"JYXR4"DXY)KM=(_X-
MH?\ @A]HD,4%G^P=I;K%(74W?C#7+AB2,?,9;YBP]CD#TK[KHH ^9O!/_!&+
M_@DO\/\ 34TK0?\ @G%\&IXDSM?6OA_8ZE+VZRW<<KGIW;^=>B^&OV%?V(O!
M=I!8>#OV.?A7I,%J[/;0Z9\/=-@2%FQN*A( %)P,D=<5ZI10!!IFE:9HEA'I
M>C:=!:6L(Q#;6L*QQH,YP%4 #DGI4]%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %>%^ ?\ E()X_P#^Q$TK_P!&
M-7NE>%^ ?^4@GC__ +$32O\ T8U 'NE%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 5X7X!_Y2">/_P#L1-*_]&-7NE>%^ ?^4@GC_P#[$32O_1C4 >Z4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !7A?@'_ )2">/\ _L1-*_\ 1C5[I7A?
M@'_E()X__P"Q$TK_ -&-0![I1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>
M%^ ?^4@GC_\ [$32O_1C5[I7A?@'_E()X_\ ^Q$TK_T8U 'NE%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !7YY?\ !2C]@?X;_&K5+#]J_P#9/\3R^'?B=/X]AT-[S3[Q[:WNM32[:T:2
M0@;X)XYHL>:F V-Q#9#U^AM>$>/?V OAKXE\0W7B/P3X\\7>%'U;QE!XDU^S
MTCQ#<-:WMZD@>29(GD(MIGP!YL.TC .#@8 / OV2M>T[_@IU^PY<_#W_ (*
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M)X__ .Q$TK_T8U 'NE%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5X7X!_Y2
M">/_ /L1-*_]&-7NE>%^ ?\ E()X_P#^Q$TK_P!&-0![I1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %>%^ ?^4@GC__ +$32O\ T8U>Z5X7X!_Y2">/_P#L
M1-*_]&-0![I1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>%^ ?^4@GC_P#[
M$32O_1C5[I7A?@'_ )2">/\ _L1-*_\ 1C4 >Z4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !7A?@'_E()X__P"Q$TK_ -&-7NE>%^ ?^4@GC_\ [$32O_1C
M4 >Z4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !7A?@'_E()X_\ ^Q$TK_T8
MU>Z5X7X!_P"4@GC_ /[$32O_ $8U 'NE%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*Y_QKW2B@#PO_AWO\$_^AM\=_P#A97/^-'_#O?X)_P#0V^.__"RN?\:]THH
M\+_X=[_!/_H;?'?_ (65S_C1_P .]_@G_P!#;X[_ /"RN?\ &O=** /"_P#A
MWO\ !/\ Z&WQW_X65S_C1_P[W^"?_0V^._\ PLKG_&O=** /"_\ AWO\$_\
MH;?'?_A97/\ C1_P[W^"?_0V^.__  LKG_&O=** /"_^'>_P3_Z&WQW_ .%E
M<_XT?\.]_@G_ -#;X[_\+*Y_QKW2B@#PO_AWO\$_^AM\=_\ A97/^-'_  [W
M^"?_ $-OCO\ \+*Y_P :]THH \+_ .'>_P $_P#H;?'?_A97/^-'_#O?X)_]
M#;X[_P#"RN?\:]THH \+_P"'>_P3_P"AM\=_^%E<_P"-'_#O?X)_]#;X[_\
M"RN?\:]THH \+_X=[_!/_H;?'?\ X65S_C1_P[W^"?\ T-OCO_PLKG_&O=**
M /"_^'>_P3_Z&WQW_P"%E<_XT?\ #O?X)_\ 0V^._P#PLKG_ !KW2B@#PO\
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M_P"AM\=_^%E<_P"-'_#O?X)_]#;X[_\ "RN?\:]THH \+_X=[_!/_H;?'?\
MX65S_C1_P[W^"?\ T-OCO_PLKG_&O=** /"_^'>_P3_Z&WQW_P"%E<_XT?\
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M?\:]THH YOX4_"WP[\'O"*>"_"]]J5Q:).\HDU;4'N9MSG)!=^<>@[5TE%%
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MA3Q!#<^']6TN/4K#5'5H8Y+5T$BRD2!2B[#N^8 @=<5\??\ !;_X4_#33_\
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M^,KZI;?#[Q,;F\T.Z6VUO2KVPGLK[3I67<BSVMRD<T.Y?F4N@##)&<5\0_\
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MR6DPDM=S7UXD,D3*2N)(%ZC[RQIU % 'Z04444 %%%% !1110 4444 %%%%
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M.I?:]2\.>%+&POYQ)N4S1PJKJI[HK JO^RHH [^BBB@ HHHH **** "BBB@
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M#_&?CG_@JG\2O#7A#XEWOA)9_A%HHO=7T>S@EOEC^TRX2W-PDD43$]7:.0@
MA0&(=0#['HKXH^&?[:7QH\"_L=>.=0\::]_PE7C+PA\:[OX;Z)K=S9P1O?R?
M;X+:&ZFC#11%T2<M@LBN8E#,-S/7=:*?VV_#'[27@R^\*>%?'FJ_#_4TN+7X
MBP?$#5/#A-BVU3;WUH;&X,@;>7\R)5*;0-J D%0#Z<DDCAC:661515)9F.
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M\2?M.>!_BY\0M3\?Z;\&-(TS7O#FI:Q#;Q7]S%>:?+<FTE:WBCC.)8U57"#
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M^,0\4^"[O3;'0?B#-J5P^GBSEG54EMV@F6T(0G#!GSY4<8 !_0Y17R!\+?\
M@MA^R?\ %S]HZQ_9?\,_#;XP6_B'4/$$NCP7VJ?"V_MM-6>-G4LUTZ[%BRAP
MYX((]:]__9O_ &D/ G[4?@2\^(?P\T?Q!8V-CX@OM'FA\2:)+83M/:RF*1EC
ME&6B+#*N.&'(H B^,O[0NG_"_P 7^'/A7X<\(7OB;QEXL%Q)HOA^QN(H0+>W
M56GNKB:4A8(4W(,_,S,ZJB,<XS_ /[2FM^(/CC%^SUX^^"&O^%M>D\,7>NQ7
MMS=6]SIMU;P7%K PM[B%R9&W72[E=(V3 )7#J3PO[<W[)OQ7^,GBCPM\>_V7
M/BO!X4^*?@&*X&D&^ >SU.SGQYEK<+AMJL4.UBK+RP(Z.G.?LE_MQZ]\2_C]
M;_LY_M@_ :;X??&?2]$NAI3*QDL-9LW:.2X:S?<PPWV5'V[I%Q V),AE ![;
M\>/VBM#^">J^%/!4'AV[UWQ3XYU9].\*Z!9S)$;EXXC+-+)+(0L4,48W.WS-
MR JL3BK?P3^-L/Q;E\2>']4\*7.@^(?!VMC2O$>CSW*3K#,UO%<Q213)Q+%)
M#/&ZMA6Y(95(Q7Q[_P %&?B'XZ^.%D/VA?V0="FOKK]FGQ7/<ZGXJ\]?*NI@
MD:ZA86D)1OM BCV/-*Q1%5&1!*2=GH'PHUZX^(0^&8_8C^-=U!IGCI;OQ9\4
M==U*PM+_ %"XA*I$9IW>,K#>-<)]E2,*(D6WE"1[;?;0!ZK^U'^V%'^R_P")
M_!OAK5/A!K?B%O'?B&'0_#\NC7UHFZ_E($<4@N)(_+#$\-DKP<D4>#/VUO!N
MI_'FV_9C^*/P\\1^ O&VI:<U]H6G^(A:R6^L0J&+FUN;2>6-V4(Y*,58;3P<
M5Y#_ ,%4WU+3_&G[,\FGV[:A=P_'S1S#%+*L1N) > 6 VJ6/?&!GI71^+/V9
M/C5^T=^W!\/_ -H_XG^'=-\)>%/A;:73:+I::JMWJ6K7LZX+R&)?+AA7"$#>
M['8>!O.T ^HJ^>[[]O'6KKXK/\._A_\ L@_%'Q/I0U[^RHO&^E:/$-'ED6;R
M)I1.\@_<QRB16DQC]VQ&1@U[SKVF2ZWH=[HT&KW>GO=VDD*7]@RB>V+J5$L9
M=64.N=REE89 R".*^*;[X;?M%_\ !+S6_"?B7P9\>O$'Q%^#%YX@L-!\1>%_
M&3)/?^'X[J9+>"ZM;A0N461T4Q!57Y@-IW;XP#Z?^*'[0.F>!OB+H?P6\+>&
M[CQ'XS\0V<]]9:):W*0I;6,)59;RYE?B&$.RQJ0K,[L%53ABK_A3^T9X$^)W
MACQ%K=R9-!O/!FHW-AXSTK6)8UET>X@7>YD96*-$8R)4E4E71@>"& \'^$<U
M[JG_  65^+<^LLQ;2_A1HUIH^_\ AM9)(II OMYQ8GWKY]_:_P#$'BCP]\5O
MVZ;+P;)*EO<_#_PFVI+"3M#R6\$+DXZ%K>6;/J,YH ^R=$_;?\,7V@^&/B=K
M_P /-7T;P!XUU:'3_#/C"_FB"R/.2MK-<6X.^VM[@@"*1LG]Y'YBQ;^/<*^+
M?^"@6GZ/I?\ P13N[.T*I;V/@;PN+!T.-A2YT\1%2.AX&,5]=?#R]U;4_ &A
MZEKX87UQH]K)>AQSYS1*7S[[B: -BBBB@ HHHH **^4/VO/^"QG[+O[%7QDG
M^!OQ7^'GQ8U+5[?3X+Q[KPA\-+[5+(QS E0)X5*EACE>HKX9_P""O7_!PK\$
M_B-_P3^\=?"7]F3PY\9?"OBWQG'::#!XBU[X7ZAIT-A9W5U%%>NLS@8E-J9T
M0*0Q=QMY H _1;1/^"J__!-?Q'\9F_9[T/\ ;F^&%SXR%[]C70XO&%KODNMV
MW[.C[]DDV[Y?*5B^[C&>*]_KX%_93_8#_P""0/[=/_!.*Q^$?PU_8M@T[P"M
MG-H=G=^*_ *Z1XDANH5$;ZB)Y8Q<K<LW[S[1NRYSG*DK7S;_ ,$M?^#@'X:?
M G]E:V_95_;.\.?&;Q/\2/A-KFH>%-9US1_AO>:H;RVM;F1;.2>6$L1,+;RD
M8/\ .QCW$MNW$ _8RN1^.7QK\$_L]_#2^^*7CZ2Y-E9O%##:6$'FW-[<S2+%
M#;0ID;Y))'5%!(&3DD $CQ[]B'_@J)^SW^WWXJUSPA\&/!'Q(TJZ\/Z?'>7L
MGCCP#=Z/%)&[[ (GG $C9ZJ.0.:[[]L7]FWP_P#M9? ;5/@KK7BJXT*XOIX+
MC1=:M#^]L;^!Q+#*JY&_#+RH()4M@J<, #%\2_M7?$'X;7/AT?%S]EWQ%I-G
MXH\2Z9HECJ6FZQ9:A#8W%[=16T8O?+D5H,-*/F194)&W?EEW>A?&WXQ^!OV?
M/A/KOQG^)5_);:)X>L6NKZ2&+?(PR%5$7(W.[LJ*,@%F&2.M?&^C?MA_M*_L
MG^(]#^ O_!4;X96VL>&;W6K.'P_\9?#V6LIKF&=)K9[U %V.LD2N3B-AY9/E
MR#<]>P_MZ:KHG[0/A?6O^"?/@K21K/C3QIX7>^EC>[\BUT"SCF0Q:A=R[7(7
M[0L82)%9Y&&/D7,@ .[^'/[2FL>(_B1H_P +OB5\([_PCJ?B;PY/K?AH7&IP
M7:W-O T"SPRF+_4W$?VF$E/F0ACMD8J16S^TG\<4_9O^#VL_&G4/!5]KFF^'
M[-KO5;;3;B))T@7&YT$K*KX!R1N!P.,]*^*OV7OC+XT\;?LUZYXI@\9WT?[3
MGA6XM_A[#I^O0V\K6$XN%6*WAMS'M$$RPM-<3$&0FUF=GV0(%^B?VY="\6>'
M/^";?Q-TGQSXWE\1:M'X!O/M^K2V4-L)I?*^;9%"JJB9SM4[F QEF/- %>[_
M ."D?A#P9X(\(?%GXV? [QEX-\%>-DM&T?QC>O87=C +J(2P&Z%K<R2VP=""
M&:/ Y!((-?1JS)+ )[9ED5DW1E6X8$9&#Z'UKX8\3? G]H?]M+_@G=\)OV8_
M#?@S2?#GAW4_"/AF77_&.K:RL[)96]K;RK]EMHE+M*Y53ARBC!4D[MP^W?#>
MA6/A;P[8>&=,+_9M.LHK6W\QLMLC0(N3W. .: /(OA9^V*?BC^TMXP_9?@^#
MFLZ=K'@2*TE\1ZC>:A:M:)'<QK+ 8BCEY"Z,& VC&"&P>*/B;^V*WPU_:<\)
M?LLS?!S6=0UGQO;75QX?U.UU"U6S>*WC>29I2[AXRJ(3C:<Y 7).*\-^#VI_
M%C3?^"LG[2[?"OP5X=UF1]*\)?;4\0>*)],6)?[+BVE##977F$G.00F,#DYX
M/BIJ7Q7U+_@K9^SJWQ4\%^'M&E3P]XH%FGA_Q//J:RK_ &?+N+M-96IC(.,
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M .%0:B$M];U.6T@*?:9]Q,D4,S @=!LY]10!]%>&?CEXVO?B7IGPZ\<_L_\
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MVM],;#2-/A9I!";EH1),TDSF5W\E/NH@4;2[>T44 ?(NC?L)_'32?^"9,G[
MY\0>$WU-K*:P7Q']NN1!Y$EZ]T9#%]GW;QN\O;NP?O;A]RNM^/G[,WQX^,'A
M[X,V&FS>$K*Y^&7C/2O$>I^?JMTR7TMDCQ?9XB+;*+(KEM[ E3QM;&3]&T4
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M?%7[+'QZTF>[\,>+;%8+PV<PBN+:1)%EAN8'((26*6..1"01N0;@RDJ?3**
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M>TFQ9@(UDB#"4Y"AN4&#\WR_6=% &?X6M_$MMX>M8?&6I6EWJGE9OI["V:&
MR$DD1HS,P09VC<22 "3G-:%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
@% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>coo-20221031_g5.jpg
<TEXT>
begin 644 coo-20221031_g5.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"-[ +E2,\&NJOOC;\(M-^$Y^.U]\1]'C\'#35O\ _A)#>K]D-NV-L@DS@Y)
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBE?#MQXLT[Q3X;AO['5)GMHU$KPO@"1"$VL.@4#' QVG[-7[!7Q6^!7[;WQ
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MEK"1VA=E &Y=Z@@'&=ISC.,G&2 :=%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MXI?$!O%7C/PYI_Q#M;,:A)H_BQX;J74(;A9Q=P-'GR(XQ&B(KEB?,F&Q%"9
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MA_V.^F_^@3U];P)_R66 _P"OL?S/EN-O^22QO_7N7Y'X@T445_;Y_&@4444
M%%%% '["_P#!N!_R;?X__P"QW3_TCBK]%Z_.C_@W _Y-O\?_ /8[I_Z1Q5^B
M]?Q7XD_\EQC?\2_])B?V#X>_\D9@_P#"_P#TJ04445\.?9A1110 4444 %%%
M% !1110 4444 %%%% !116?XB\6^%/"%JM]XM\3:?I<#MM2;4;V.!&;T!<@$
MT :%%5='UO1?$6GQZMX?U>UOK249BNK.X66-_HRD@U:H **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MVW1=Q8*$ =]A:4 X?:GTM0 4444 %%%% !1110 4444 %%%% !1110 4444
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M^W$?B;?^ ?V!_@7X4O[NPMK9O&'C'Q/=Q1A9Y$+PVL49EC9V6+8Y=MR@2A0
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MQH\4?$Z*"TNVUJ5XX]+5))K@B#.R"UM42($* "C$2>8SYKZZ_:X^)VM?!?\
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M@+XS?#WPI_PCFA0M%I>I:,]\8M6E@5;NZP\;QJX)DBC9<E(V?#?O7ST?CO\
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M-?\ HY;_ ,LW1?\ Y#KY8HH_U1X3_P"A?0_\%4__ )$/]:N*/^@ZM_X-G_\
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M[<?PY^+GQ6\43D/=6\WB'18K/=UVO*VKFXG /3YHUQP4Q0!]#?\ !.;X=?\
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M^UK:VKC$P'VH!?,DA,AC;8&!4L ?1-%>#_M6?MX>%?V6[/P5/?\ PQU_6O\
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M?L3?M2_\% OVHK.^_:U\">,O!?PD\%HS6WA[Q/XN74;K4;PKAO+E7@AF"EI
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M_MT_C8**** "BBB@#]A?^#<#_DV_Q_\ ]CNG_I'%7Z+U^='_  ;@?\FW^/\
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MY;_RS=:_^0Z/^'UG_!,K_HY;_P LW6O_ )#K\"J*/^('\)_\_P"O_P"!4_\
MY6'_ !&;BC_GS1_\!G_\L/WU_P"'UG_!,K_HY;_RS=:_^0Z/^'UG_!,K_HY;
M_P LW6O_ )#K\"J*/^('\)_\_P"O_P"!4_\ Y6'_ !&;BC_GS1_\!G_\L/Z.
MOV</V^_V2OVN/$M_X/\ V>OBQ_PD&HZ78B\OK?\ L*_M/*@WJF_=<P1JWS,!
M@$GGI7L5?CQ_P;@_\G*^/O\ L1E_]+(:_8>OPCCOA[!<+\1U,OPLI2A%1=Y-
M-ZJ[V45^!^V<$Y]C.).'X8[$QC&<G)6BFEH[+=M_B%%%%?''UH4444 %%%%
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M4?V;C?Y/Q7^8?VOEW\_X/_([*BN-_P"%M_\ 4O\ _DW_ /84?\+;_P"I?_\
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M_B5_R,[?]<$KU,I_WI^C_0\;//\ <OFOU.?HHHKZ0^0"BBB@ HHHH ]=TO\
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MN)_U]+_)JZ.N<^*'_(N)_P!?2_R:NK!?[W#U.+,?]QJ>AY]1117UQ\(%%%%
M!1110!WGPJ_Y US_ -?7_LHKJ*Y?X5?\@:Y_Z^O_ &45U%?)X_\ WR?J?<Y9
M_N%/T/Y9'^^?K24K_?/UI*_T 6Q_#04444 %%%% 'U-_P15_Y2:?#/ZZQ_Z9
MKZOWVK\"?^"*O_*33X9_76/_ $S7U?OM7\L>.'_)5T/^O$?_ $Y4/Z8\&?\
MDEZW_7Z7_I%,****_&C]<"BBB@ HHHH **** "BBB@ KC/BU_K+#_=D_]EKL
MZXSXM?ZRP_W9/_9:[\M_WV/S_)GF9Q_R+Y_+\T<=1117U)\4%%%% !1110!Z
M;X"_Y%*S_P!U_P#T-J\H_P""DW_)A'Q;_P"Q&OO_ $6:]7\!?\BE9_[K_P#H
M;5Y1_P %)O\ DPCXM_\ 8C7W_HLUXF4_\E+0_P"OT?\ TM'U>8?\DU5_Z\R_
M](9_.C1117]WG\4!1110 4444 ?HK_P;@_\ )ROC[_L1E_\ 2R&OV'K\>/\
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M\_W+YK]3GZ***^D/D HHHH **** /7=+_P"0;;_]<$_]!%?%'_!P'_R8,/\
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M* /"_P#AWO\ !/\ Z&WQW_X65S_C1_P[W^"?_0V^._\ PLKG_&O=** /"_\
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M_"RN?\:]THH \+_X=[_!/_H;?'?_ (65S_C1_P .]_@G_P!#;X[_ /"RN?\
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MT;["6!MM4W*\8=E.'W;67;\I4$94LP!^C-%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7S%\8_P!@#75_:RL_
MVY/V6_'^G^&?'/V<VWB32-<L'GTKQ! 8Q&1+Y3+)"Y14RZ[@3&C;0P8M].T4
M >?>$]#_ &B]>\0V.L?%/Q/X=T;3[!S(^A^$1-<'4)-A4>?=7*H5B!.[RXXE
M8LJYDVAD;YT\0_\ !,/QMHGA7XR?!GX/^/\ 1+'P9\9]:@U*[FU.WF:\\.L9
MM]S'!&@V72..$W/$8Q@'?C)^S** /E[Q9_P3CT7PQXX^"WQ:^ &K6MGKGP8T
MK^Q[.SUUG$&MZ:89(VCFFC5FAES+,XD6-QNE;*$8QY?\=/V-%_9E_8=_:<^*
MOBOQ);ZKXP^*0O-:\0S6,+):V:M</)%:0;SN94,\GSM@MN'RC:*^\:R?&_@'
MP)\3/#LWA#XD>"M)\0:3<,K3Z7K>FQ7=O(5.5+1RJRG!Y&1Q0!\!_L^_L3_%
M#]LO]CS]G;0/B-X^\/6_PX\*+;Z]-9V.GS#4]09-RI:/N<Q*H#2*90<D/]P$
M9/LGC?\ 85^._@O]M_4OVSOV3OBYX;TB;Q;ID=CXT\.>+](GN;2<(L:>=&()
M$8M^ZC8+N0AU;YRLA4?2_@?X?^ _AEX>C\)?#;P3I'A[2H69H=,T/38K2W1C
MU(CB55!/? K7H ^7_P!K#]AGXI_M$_$3X*>/;7XK:9]H^$OB$:Y>3:G8.'UJ
MZ^TVL[1A8OEMH_\ 1L+]\@2 <[,M]/H7* R* V/F"G(!^O&:6B@#P?X1?L(?
M#OX2?MG_ !"_; TDQ->^-M/MH;:R6+'V"8G-[(#W,[QP/GJ#YHZ-63_P45_8
MJ\<?MK^'?!OAKPGXYTK0$\+>)TUN2XU&UDG-Q(B%%B"H5VK\Q);)/3CO7T=1
M0!\J_ME?L)?$G]L;2/$'@?QQJ'@N72M5U2QNO#.KWMM</J?@\);VJ7:VKJ M
MRDKPRD1,8ES*68MPJ6M5_8.\;/\ M[^ ?VO-&\=Z8-'\">#8_#4&A7D<KW5W
M;"&ZB,[3#Y1(/M1;;M(/E@$C=E?J"B@#XFU'_@E3XOT?X+?$C]DCX;?$71['
MX<?$GQM;Z_+>W5O*VI:)$LUO++9PQ >7< FUB5)&>,JH(*N3FNP^,/\ P3PU
MKQ7\<?@7X_\ AEXMTK2/#OP/M+>UTW1K^&66:^@C,2[#(N!&1'"H#8;)))':
MOJFB@#YO_8__ &+/'O[-_P"T?\8/CEXD\;:1J=M\5M9&I?V?96\L<FFLMQ<2
M)'N;B4;;E@6PO* XYP/I"BB@ HHHH **** "BBB@ HHHH *;-#%<1-;W$2O&
MZE71UR&!X((/44ZB@#Y0^!_[!7Q7_8E^)_BC7?V/O&WAVZ\$>,+M;J^\ ^,D
MN(AIDZ[L/:7=N'.W#%=CQ'Y50%F*AJ]>UOX&>+_C-\//%O@;]HSQA:WMEXNT
M*72GT/PY:F"TTV%U8-(DDI:2>XRP/FMM4;$"Q+\Y?U&B@#XQT/\ X)@>-=>\
M(?!WX)?&#X@Z+?>"_@UKD^I6D^F6\RWGB(^=OMHIXW&RU5 =K[7E,@X&S.1T
M/C/_ ()^^.?#_P 5OC)X^^ ?BW0[:S^./A=]-\1V6O+,K:1>/')&]];F)6\_
M<)96,+^7\[9\S;\M?5M% 'YA_P#!33]FWPW^R=^R1^SO^SYX!UJ26/1/B9"O
M]K7< WW%U*))9;AD!Q@RR,P3/"X7)QFOJ7P;^Q'\0?$O[<+?MK?M$>+_  ]?
M7ND>%/[ \+:'X;LID@CB995EN)FG8D,PGN (QN $OWVV_-[=\1O@;\%/C#):
M3?%SX/>%O%+V&[[ WB/P_;7QMLXSY9F1MF<#.,=*Z6SL[/3K.+3]/M8X+>"-
M8X((8PJ1HHP%51P    !TH ^2/V1OV"/VD_V-M=\0?"[X7_M Z _PFUK77U*
MVM;_ $.:76]-#A5>*WD\P0JS(B(97$@R@<1*2P/5>$OV+OB!X;_X*.>)/VY)
MO&>CRZ=X@\-+H?\ PCRPRB>"%4ME$WF_=9B;8$IM  <C<=N3](T4 >2>*?A7
M\?\ 3/VDKWX[?#'Q[H4NC7WA'3]'O_!.N6\R)=S6]S>S"Y6[CW&V<"Z"#]S*
M'&[< 50CF? /[$ML_P 7OB?^T+\4+C38/$OQ.\.KH-S8^'%8VVF:>(5C8"61
M4:YG<JC-*R1CY%4(,$GZ!HH _.Z[_P"".?[1FL?LJ^'OV4]3_:*\(Q:-X/\
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M(EP<_<%% 'S1J/[$_P 06_X*)67[;VE^+-#73=/\+_V%!X8:*5)&A\IT$GG
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#RCQ'_P C#?\
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MF?"G0YM.\,7T,L/AZUGM1 19P3/;QL(A_JT81;D7J$*Y /  .\HHHH ****
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M[6!&:R=1^$_PLUC2QH>K_#7P_=62[]MG<Z- \0W%2WR,I')1">.=B^@KH**
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
HB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>coo-20221031_g6.jpg
<TEXT>
begin 644 coo-20221031_g6.jpg
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M2OC59?#BXTRQ\'W45F?"M[8"PFF%RLT5P\GDO#OD$#(/](59&","*^@_"?\
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M> (9M:\$:+;:JD'AS1=-AG"V^GV]J(Q)'.\)7?<B4,]RY?:$(0<M_P $<?\
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M"PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HJCK_B7P]X5T]M5\2Z
MW:V%LO6:[G5%SZ#)Y/L.:\C\;_MN_#K0]]KX.TN[UJ9<A92/(@S_ +S L?\
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M +>=ONO8M7^MZUJK%]4U>ZN6/4W%PSD_F:JT45Z,8QBK)6/-E*4G>3N%>H_
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MD5*+NF%%%%24%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[+\^I^&\0<2XW/:MI>[36T5^;[O\N@4445]$?-A1110 4444 %%%% !1110
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M]U?'YOI'Y;OS] HHHK]'/S0**** "BBB@ HHHH **** "BBB@ HHHH ****
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MP:D9KJ&.]AN+N226(LT4.^-6\L@R$("5*^9?#'Q)^T+\9/\ @I?^TI^S+/\
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MQI_[)_P[\$?V]=67AY];^(>NC4O)@\+6LF4L(W41/Y]S=2+)L@W1E8H9)2V
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MS;^S-XO\-^!/CE\1'T#4O%\_D^&XYM$O9H[Z7S$C,:30PO&&#21Y5F!4.I(
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MXCW'Q>^'?[.O@S1/$]R7,FN:9X>MX;@%\[RK*HV%LG<5P6R<YS7E_CS_ (+
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M2_\ (RA\_P F>B4445\,?>!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!U?P:O?LGCB*'=@7,$D9_+=_[+7L-
M>$>![O[%XPTVXS@?;(U)]F.T_P Z]WKX[B&GRXN,NZ_)GV?#E3FP<H=G^:04
M445X!]"%%%% !1110 4444 %%%% !1110 4444 %!( R315+Q->?V?X<U#4,
MX\BQEDS_ +J$_P!*J$7.:BNI,Y*$7)]#\_M;U!]6UJ\U5SEKFZDE)]V8G^M5
M:**_IF,5&*2V1_+TI.4G)]0HHHIB"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "O1_@#_J]5^L'_M2O.*]'^ /W-6^
ML'_M2O,SC_D6S^7YH]3)?^1E#Y_DST6BBBOAC[P**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** );*<VMY%= _Z
MN56_(YKZ'!!&0:^<Z^A=*E\_2[:?.=]NC?FHKYCB2.E*7K^A]5PS+6K'T_4G
MHHHKY8^J"BBB@ HHHH **** "BBB@ HHHH **** "L/XG2>5\-O$,O\ =T.[
M/Y0O6Y7/?%PL/A3XG*=?^$>O<?\ ?AZZ<&KXNFO[R_,YL:[8.H_[K_)GP111
M17])G\R!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !14D-
MI=W S!;2/_N(3_*B:SN[==\]K(@]70@?K2YE>UQ\LK7L1T54GU_0+67R;O7K
M&!CT$]Y&G_H1%(WB/PPJ[CXLTC\-6@/_ +/6GLJK^R_N,_:TOYE]Y<HK&O?B
M#X)L!F?Q-:M_UQD\W_T#-1CXH_#@C)\7PCV-G<?_ !NM5A,7)75.3_[=?^1D
M\7A(NSJ17K)+]3=HKF[KXN> (!F+7#/[16LH_P#0E%4T^.7@?)$UKJHP>J6L
M9!_.45I'+L=)75.7W&4LQP$79U8_>F=A7H_P!^[JWU@_]J5X--\=/!:C_1[+
M5'/H]M&O\I#7>_LX_'SPQ<:QJ>EZA8SVJRQPO'*3OX4N&)4#@#<O3/7I7!G&
M5Y@\LJ-4WI;\T>CDV;9<LTIIU5K?\F?0-%16-_9:E;+>:?=QS1./EDB<,#^(
MJ6OS=IIV9^EIIJZ"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *]^\+OYGAG3I/[UA"?_ !P5X#7O?A#_ )%+
M2_\ L'0?^BUKYOB/^#3]6?2\-?QJGHOS-&BBBODSZ\**** "BBB@ HHHH **
M** "BBB@ HHHH *Q/B9%YWPW\00X^_H=VOYPO6W67XYM9K[P3K%E;R,LDVE7
M"1LC8(8QL 01T-;X9\N)@_-?F88I<V&FO)_D?GW3HXY)6V11LQ]%&37AC_$O
MXC2+MD\?ZVP]#JLQ_P#9JHWOB/Q#J61J.NWMQGKYUT[_ ,S7];QX<Q#^*:7W
MO_(_CZ7$N'7PTV_N7^9]$C1-9(R-(NL>OV=O\*K7:M8*6OE,('4RC;_.OG*B
MM5PU*^M;_P E_P#MC)\3QMI1_P#)O_M3Z$&M^'<E6\5:.A'59-8MU(_ O4<_
MB7PO;+ND\6:0?^N>JPO_ .@N:^?Z*T7#E.^M1_=_P3-\2U+:4U]__ /<G^)'
MP^A?9<^+[9#[12R#\XT84DGQ-^&R+N7QK;N?1;*YS^L5>'45K_JYA.LY?A_\
MB9?ZRXSI"/\ Y-_\D>QW/QE\!6S?+>W5P/6VM3G_ ,?*TP_''X=XXCUK/_8/
MA_\ C]>/T5HN'\#;>7W_ / ,GQ#CV]H_<_\ ,]6O/CMX60'[!I>H2GL)HT3^
M3M5=?V@]+'#>"+AN>HU=1_[1->8T5JLBRU*SBW\W^C1D\^S-NZDE\E^J9Z3<
M?M V[#_1/!SH?634PW\HA5(_'WQ$CDQ>'M,9>PF$K'\UD7^5<'16D<GRV.U/
M\6_S9G+.<SD]:GX)?DCNI?C_ .)Y%PGAW2$/JL<_]935&Y^-/CN5]]M=VUO[
M1VBL/_(@:N3HK6.69?#:FOGK^9E+-,QGO5?RT_(ZH_&OXD$8.N0?^"NV_P#C
M=5+SXG^/+X8G\12K_P!<8TC_ /0%%8%%:1P."@[QI17_ &ZO\C.6/QTU:563
M_P"WG_F;"_$/Q^@PGCG6 /;4Y?\ XJH;GQGXPO%VWGBO4I0>HDOI&_F:S:*T
M6'P\7=07W(R>)Q#5G-_>Q9)))7,DKEF/5F.2:2BBMC$**** "BBB@ HHHH *
MV_AUKH\/^,+.]EE"PR2>3<%FPH1^,GV!PW_ :Q**SJTXUJ4J<MFK&E&K*C5C
M4CNG?[CZ;T+Q+KGAJY^TZ-J#PDGYT'*O]5/!KT;PI\:=)U/;9^)(A93GCSER
M8F/\U_'(]Z\5\$ZZ?$?A:RU9WW2O"%G)(),B_*Q..F2-WT(K5K\IQ^5X>O.4
M*L;26EUOI^?S/UO+\UQ%"$9TI7B];/;7\OD?144L4\2SP2JZ.,HZ-D,/4$=:
M=7A/AGQMXB\)RYTJ]/E$Y>VE^:-OP[?48->E>%/B[X=U_;:ZDPL+D\;9G_=L
M?9_Z''XU\GC,GQ.&]Z/O1[K?YH^NP><X7%6C+W9=GM\F=91117DGKA1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>^^%TV>
M&=.3TL(1_P"."O J^A=*B,&F6T!'W($7\E%?-<1O]W37F_T/I^&E^\J/R7ZD
M]%%%?*'UH4444 %%%% !1110 4444 %%%% !1110 4C*KJ48 @C!![TM% 'X
MT^)]);0/$FH:$X(:ROI8"#V*.5_I5&N__:I\/GPQ^TCXWTCR]BCQ+=S1KCHD
MLAE7_P =<5P%?W#@,0L7@:5=?;C&7WI,_A+,,.\)CZM!_8E*/W-H****ZSD"
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@#T?X#:V<7WAN1CVN81@8[(_X_P"KX]C7HM>$>"-<7PYXJLM7D?;'
M'-MG)7.(V&UCCN0I)'N!7O#*58JPY!P:^*S[#^RQG.MI*_S6C_3[S[C(,1[;
M!>S>\7;Y/5?JOD)1117B'N'0>%/B3XD\*E;>&X^T6HZVLY) '^R>J_AQ[&O2
M_"GQ+\-^*MMO'/\ 9KIO^76<X)/^R>C?S]J\4HKS,9E6%Q?O6Y9=U^JZGJ8/
M-L5A+1OS1[/]'T_+R/HRBO'O"GQ<\1>']MKJ+&_MAQLF?]XH]GZ_@<].,5Z5
MX9\<>'/%D?\ Q*KT"4#+6TWRR+^'<>XR*^6Q>68K!ZR5X]U^O8^KP>:87&:1
M=I=G^G<UZ***\\]$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH ELK<W5Y%:@9,DJH!]3BOH<  8 KPCP-:&]\8:;;XR/MB,1[*=Q_05[O7
MR?$<[U:<>R;^_P#X8^NX:A:E4GW:7W?\.%%%%?-GTP4444 %%%% !1110 44
M44 %%%% !1110 4444 ?FW_P4P\+-X>_:GO]4\K:NM:39WJX'!PGD$_G :^?
MZ^S_ /@KCX-87'@WX@P1<,ESIUR^.F"LD0_67\J^,*_KW@+&K'<(X2=_ACR_
M^ -Q_)'\<>(&"> XQQE.VDI<_P#X&E+\V%%%%?7GQP4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>X_#G7!K
M_@VRNV<-+%'Y$_).'3CDGJ2NUC_O5X=7H'P(UT17UYX<FDP)D$\ 9OXUX8 >
MI4@_2.O&SS#^VP3FMXZ_+K_G\CVLAQ'L<<H/:6GSZ?Y?,],HHHKX@^Z"BBB@
M IT4LL$BS0R,CHP*NIP01W![4VBC<-CMO"GQIU?2]MIXCC:]@''G @3*/KT?
M\<'WKT?0?$VA^)K;[5HNH), /G0<.G^\IY'\CVKP*I;*^O-.N5O+"ZDAE0_)
M)$Y5A^(KQL9DN&Q%Y4_=E^'W?Y'M8/.\3A[1J>]'\?O_ ,SZ'HKS7PI\;YXM
MMGXMMO,7I]L@4!A_O+T/U&/H:]!TO5],UNT%]I-]'<1'^.-LX/H1U!]CS7R^
M*P.)P;_>1T[]#ZK"X_#8R-Z<M>W4LT445R'8%%%% !1110 4444 %%%% !11
M10 4444 %%%% '5_!JR-WXXBGVY%M!)(?RV_^S5[#7G'P$TX[]1U9EX 2%#^
M9;_V6O1Z^'SVI[3,&NR2_7]3[O(:7L\N3_F;?Z?H%%%%>.>R%%%% !1110 4
M444 %%%% !1110 4444 %%%% 'A'_!1WP(?&G[+FJWT,.^?0;RWU*$ <X5O*
MD/X1RN?^ U^:5?LCXU\+:?XY\':KX+U49MM6TV>SGXSA)(RA/Y&OQYU[1=0\
M-ZY>^'=6A\NZL+N2VN8S_#(C%6'X$&OZ(\&\R5;*L1@I/6G)27I-6_!Q?WG\
MX>-.6.CFV'QT5I4@XOU@[_BI+[BI1117[(?BP4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %:'A77'\-^(K/6
MUW8MYP953JT9X=1]5)'XUGT5,X1J0<9;/0J$Y4YJ<=UJ?1F5/*.K#LRG((]1
M17/?"S6SKG@FT>1B9+3-K+QC[@&W'_ "G/KFNAK\VK4I4*TJ<MT['Z;0JQKT
M8U([-)A11161J%%%% !1110 5:TC6]6T&[%]H]_);RC^)#PP]".A'L>*JT4I
M1C.-I*Z'&4H2O%V9Z;X4^-UG<[;/Q9;B!^GVN!24/^\O)7ZC/7H*[NUNK6^M
MUN[*YCFB<922)PRM]"*^=ZT?#WBO7O"UQ]HT74'B!/[R(\H_U4\'Z]1V(KP<
M9D5*I[U!\K[=/^ ?08//ZM.T:ZYEWZ_\$][HKC/"GQFT/6-MIKZ"PN#QYF<P
ML?J>4_'C_:KLD=)$62-PRL 593D$>HKYG$8:OA9\M6-CZC#XJABH<U*5_P"N
MHM%%%8&X4444 %%%% !1110 4444 %%%26MM+>74=G;KF260(@]23@4-I*[&
MDV[(]A^$&EG3?!,$C+AKJ1YF_$X'Z*/SKIZ@TVQBTS3H--A^Y;PK&OT4 ?TJ
M>OS;$U?;XB=3NVS],PU+V&'A3[)(****P-PHHHH **** "BBB@ HHHH ****
M "BBB@ HHHH *_-#_@HK\,S\/?VF=4U*VMMEGXC@CU2W('&]\K,,^OFH['_?
M%?I?7R__ ,%3/A2WBOX-Z?\ $W3[;=<^&+_;<LJ\_99RJ,??$@B^@+&OT'PR
MS=97Q53A-VC63IOU>L?_ "9)?,_._%')WFO"=6<%>=%JHO1:2_\ )6W\D?GW
M1117]5G\EA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 =U\"M;%KKMSH$K?+>P;XAC),D>3CV&PN3_NB
MO4J^?M!U:;0=:M=9@7<UM.LFS=@. >5/L1D'V-?0$<L%Q$EQ:R^9%(@>*0#&
M]",AOQ!!KX[B##^SQ2JK:2_%?\"Q]IP]B/:81TGO%_@_^#<6BBBO /H HHHH
M **** "BBB@ HHHH *V?"_CSQ)X2<+IEYO@SEK6?YHS^'53[@@UC45%2E3K0
MY9JZ\S2E5J49\\'9^1[)X4^*_AKQ)MM;J3[#='CRKAQL8_[+\ _0X/.!FNH(
M(."*^<ZZ/PG\4/$OA8):^=]KM%P/LUPQ.T>BMU7Z<CVKYW&9#O+#OY/]'_G]
MY]'@^('I'$KYK]5_E]Q[316%X4^(GAOQ:%AL[GR;H];.<@.3_LGH_P"'/&2!
M6[7SE6E5HSY:BLSZ6E6I5X<]-W04445F:!1110 4444 %=/\(]%_M;QG!,Z9
MCLU,[_4<+_X\0?PKF*]6^"&A?8?#TNM2IA[V7"$_\\UR!^N[\A7FYMB/J^!D
M^KT7S_X%ST\HP_UC'P71:OY?\&QVU%%%? GZ"%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5D^._!VD?$+P7JO@77H]UGJ^GRVEQ@9(5U*[A[C.
M0>Q K6HJZ=2=&HJD'9IW3[-;$5*=.M3E3FKQ:::[I[H_'#QQX0UCX?\ C'5/
M _B"'9>Z3?RVER,<%D8J2/4'&0>X(-95?6'_  5/^"I\-_$#3?C5H]IBT\01
M"UU1E7A;R)?D8_[\0 '_ %Q8]Z^3Z_L[AO.*>?9)0QT=YK5=I+22^33MY69_
M$_$V2U.'\\KX&6T)>Z^\7K%_<U?SN@HHHKVSP@HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *]E^$6N_VSX+A
MMY9,S6#FW?+98J.4/L-IVC_<->-5VGP/UPV'B>7197(CU" @#( \Q 64G_@.
M\ >K"O)SK#^WP,FMXZ_=O^!Z^28CV&/BGM+3[]OQ/6****^%/O0HHHH ****
M "BBB@ HHHH **** "BBB@ !(.0:Z_PI\8?$.A[;75\ZA;#C]Z^)4'L_?Z-G
MI@$5R%%8U\/0Q,.6K&Z-Z&)KX6?-2E9_UOW/>/#?C'P]XLA\S1K\-(%R]M(-
MLJ?5>_U&1[UJ5\[03SVLRW%M,\<B,&21&(92.X(Z5V_A/XV:G8;;/Q3 ;R$<
M"YC $RCWZ!_QP>>2:^9QF15*=Y4'S+L]_P#@_P!;GT^#S^E4M'$+E?=;?\#^
MMCU*BJ>B>(-%\1VOVS1=1CN$'WPIPR>S*>5_$<]JN5X,HRA)QDK-'T$91G%2
MB[IA1114E$^FZ?<:KJ$&FVJYDGE6-/J3BO?M+T^WTG3H-,M5Q';Q+&GT QFO
M-?@?X<^V:K-XCN(\QVB[("1UD8<G\%_]"%>HU\?Q!BO:8A45M'?U?_ /L^'L
M+[/#NM+>6WHO^"%%%%?/GT(4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!P_P"T;\'K'X[?!S6OAQ=*@N+JV,FFSO\ \L;I/FB;/8;A@_[+
M,.]?DUJFEZAHFIW.C:M9O;W=I.\-S;RKAHY%8JRD=B""/PK]G:^ O^"G?[/[
M>"OB%!\:_#UEMTSQ(_EZF(U^6&^5>I]/,0;O=D<GK7[+X1\1K"XV>4UG[M3W
MH?XTM5_V\E]\?,_%/&'AMXO PS>C'WJ7NS\X-Z/_ +=D_NE?H?+%%%%?T.?S
MD%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MVKF\7FU_LD>-(SJGVW'D_9M^I^9YF>-FS=G/&,U];_\ !-B3_@G])\$]4/\
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M[5EV=3_X+$?L^ZO+8/;277A2VDD@E'SQDRZ@=C>XR15+POX#\%^._P#@N_\
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M4*Q1GKAD(X(P/#/^"N&N?%SQ3^S5\'/$?QX^'UEX8\52>-[I=3T>POTNHK8
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>coo-20221031_g7.jpg
<TEXT>
begin 644 coo-20221031_g7.jpg
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M2OC59?#BXTRQ\'W45F?"M[8"PFF%RLT5P\GDO#OD$#(/](59&","*^@_"?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 9.L> _ WB*\_M'Q!X,T
MF^N"H4SWFG12OM'0;F4G%6]%\/Z#X;M#8>'=$L["!I"[0V5LD2%B "V% &<
M<^PJW10!CO\ #WP"^J_VZ_@?1S?>?YWVPZ9$9?-SNW[]N=V><YSFHK;X7_#.
MS\40>-[3X=Z%%K5M;FWMM7CTB%;J*$@@QK*%WJN"1M!QS6[10!C^,OAW\/\
MXBVD%A\0? NCZ[!:SB:VAUG3(KI(9!P'42*P5O<<U<UCP[X?\0Z>-)U_0K.^
MM%='6UO+5)8PR$%3M8$9! (/8BKE% %.;P[X?N-:3Q)/H5F^HQVQMX[][5#.
ML).3&'(W!">2N<9JII/P_P# >@7RZGH7@G2+*Y0$)<6FFQ1NH(P0&501D5KT
M4 4=<\,^&_$\*6_B3P_8ZA'$VZ-+ZT24(>F0'!P:JZ5\/? .A7Z:IHG@?1[.
MYCSY=S::9%'(F00<,J@C()'T-;%% &1XK^'W@+QXUDWCCP1I&LG3KD7&GG5M
M-BN/LLPZ21^8IV-P/F7!JSKGAGPWXGA2W\2>'['4(XFW1I?6B2A#TR X.#5Z
MB@#'TKX>^ ="OTU31/ ^CV=S'GR[FTTR*.1,@@X95!&02/H:34_AU\/M:OI-
M3UCP)HUW<RD&6XN=+BD=R!@99E)/  _"MFB@"OI6CZ3H-BFEZ'I=M96T9/EV
M]I L<:Y.3A5  R23^-6*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH ***9<7-M9PM<7=PD4:C+22.% ^
MI-"3;LA-I*['T5R.O_'KX-^&25U;XBZ9N7[T=M/Y[#ZK%N(KDM6_;5^"NG9%
ME)JE_CI]EL-H/_?UDKTZ&2YOB5>E0FUWY7;[]CS,1G>3X5VJXB"?;F5_NW/6
MZ*^?]1_;W\/Q,1I/PYO)QV-Q?I%G_OE7K'O?V]_$,A/]G?#FSB]//OWD_DJU
MZE/@[B*I_P N;>LH_P"=SRJG&G#=/_E_?TC+_*Q],45\L2_MW_$<Y\CPAHB\
M\;UF/'_?P5UGPV_:G\?^,]/N;W4=%T>(PSA$6&"4<;0><R&JK\'9WAJ3J5(I
M+_$B</QGD6)K*G3E)M_W6>]T5Y6GQW\2@_O-)L2/97'_ +-4\/Q[U)?^/CP[
M W^Y.R_S!KS7D>8K[*^]'IK/<M?VG]S/3:*\_MOCY8-_Q^>&YD_ZYW ;^8%:
M-G\;/!ES@3_:[?U,L&1_XZ36$\JS"&]-_+7\C>&;9=4VJ+YZ?F=?16/8^/\
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M^28:EK&WY-,M9!E#V,K<B,>W+>V.:^6OBA\<_B'\6;D_\))JQCL@V8=,M<I
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MEV\EV7XOKT2_"^(^)L5GM;E7NTEM'OYR[O\ !=.K91117TI\P%%%% !1110
M4444 %%%% !1110 4444 %%%% !7IWP%_P"03J _Z>$_]!KS&O3O@)_R"]0_
MZ^$_]!->5G7_ "+I?+\T>MD?_(QC\_R.^HHHKX@^Z"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ J[H'B#5?#6HKJ>DW)CD7AAU5Q_=8=Q5*BIG",XN,E
M=,J$Y4Y*479H]P\$^.=,\9V/F0$1748_TBV)Y7W'JOO6Y7SWI6JW^BW\>IZ9
M<M%-$V4=?Y'U'M7LO@/QW8^,[#.%BO(E'VBWS_X\OJO\ORS\9FN4RPC]K2UA
M^7_ /M<IS>.,7LJND_S_ .#Y&_1117B'NA1110 4444 %%%% !1110 4444
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M3\1U<]Q7+#2C'X5W_O/S?3LOF%%%%?3GRP4444 %%%% !1110 4444 %%%%
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M<HO:6GSZ?Y?,]5HHHKX<^["BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MIM'U6WU6W/SV\RR >N#G'X]*K44I14HM/9CC)PDI+='T3:W,-Y;1W=N^Z.5
MZ-Z@C(-/KF?A)J_]J^"K>-VR]HS0/SV'*_\ CI _"NFK\VQ%)T*\J;Z-H_3<
M/66(H1J+JDPHHHK$V"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MKQ9)H]WIS:IIL%VVGW\1CGMC)&K^5(K %77=M8$ @@BO@_\ 8C_8,_X*'_\
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M HHKA/B?^T[^SU\%M;C\-?%7XQ^']"U&6Q:^^P7^HHLT=HIPURZ9S'"#P96
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MFV\73P9O@US"496DSF0)$WDQA]WEQJ%3:*]N\2_L._LM^+O@%'^R]KGPM5O
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MY9&(/(W*1FO0?'7['/P \?\ Q5D^.=]X7U'2O&4^EG3;WQ-X6\27^CWEY:8
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MR=]WS*45;9<OI?K:***]P\(**** "O1_@#]S51[P?^U*\XKT?X _<U;ZP?\
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MUN,*Y/MV;\.?85NU\]5I5:,^6HK/S/HZ5:E7ASTW=>04445F:!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !7KGP139X,9L?>O7/Z*/Z5Y
M'7LOP?@\KP':N1_K))6_\?(_I7A\02M@4N[7ZGN\/*^/;[1?Z'3T445\6?;A
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<;^T'IS:K\%/$MJJ9
M*Z7)-C_KGB3_ -EKLJI^(=*37= OM$DQMO+.6!L],.A7^M=.#K?5\73J_P L
MD_N=SFQE'ZQ@ZE+^:+7WIH_/.BEDC>*1HI%*LI(8'L:?':7<T37$-M(\:??=
M4)"_4]J_I*ZM<_F6S;(Z*H7WBSPCI<8FO_%FFHN<-Y=XLK+]4C+./RK'OOC)
M\/+&5HDU"\O!CY9+*R^4GT/FM&1^1KIIX3%5?@@W\G;[]CFJ8O"T?CJ17S5_
MNW.GHKSR^_: @\DII7A$B4'Y9;J]W(WU144CZ!_QK(O_ (Z>.;F7S-/%A8@C
M#);V8D!_[_;R/P(KNIY'F-3>*CZM?I<\^IGN6T]I.7HG^MCUM59F"JI))P !
MUIE_/:Z3((M9OK>Q9AE1?7*0;OIO(S7A>H^.O&FJPO:ZAXJU"2"0G?;F[81?
M]\ [0/8"LFN^GPY4?\2HEZ*_XW7Y'!4XEIK^'3;]7;\+/\SV^^^)O@#3TD$G
MB>&26,X,-O#)(6^C!=A_[ZK&O_CSX5MRK:9H>H78(^=9VCM\?0@R9_(5Y317
M?3X?P,/B;EZNWY6_,X*G$./G\*4?17_.Z_ [R^^/FNR&2/3?#]C#&WW&F,DD
MB?B&53_WS6+?_%GXAZBJ+)XFEA*'*O91);M_WU$JD_B:YVBN^GEN I?#37S5
M_P [GGU<SS"K\51_)V_*Q/J&IZEJUR;S5=0GN9B.9;B5G8_B3FH***[$E%61
MQ.3D[MZA1113$%%%% !1110 4444 %%%% !1110 4444 :G@OQ"WA?Q-:ZP2
M?+23;<*!G=&W#<=S@Y'N!7O *L-R.&!Z,IR"/4&OG.O9/A%XC_MWPE':329G
MT\B"3)YV8_=GV&T;1_N&OFN(<+S0CB(]-'Z=/Q_,^GX<Q7+.6'EUU7KU_#\C
MJ****^4/K0Z=*ZKPO\6_$WA_;;WLGV^V''EW#?.H]GZ_GD?2N5HK&MAZ.(AR
MU(W1M0Q%;#3YJ4K,]P\,?$/PQXJVPV5YY5P?^76XPKD^W9OP/UQ6Y7SGTZ5U
M?A?XN^)M VV]^_V^V'&R=_G4>S]?SS[8KYW%Y!)>]AW?R?Z/_/[SZ3!\01=H
MXA6\U^J_R^X]AHK$\,?$'PSXKVQ6%[Y=P?\ EUN,*_X=F_ GWQ6W7S]6E4HS
MY9JS\SZ*E5IUH<U-W7D%%%%9F@4444 %%%% !1110 4444 %%%% !1110 44
M44 %>Y_#RV^R>"=-BQUM5?\ [Z^;^M>&@%B%49)/ %?0FF6@T_3;>P'2"!(Q
M^  _I7SG$<[4:<.[;^[_ (<^EX:A>M4GV27WO_@$]%%%?)'UX4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!^6?[3'BOXB>"_CGXK\%Q^(9
M;6+3]>N!9FSACMY!"SEXLO&JL?D9>IYKR_4]7U76KG[9K&IW%W,1@RW,S2-^
M;$FOH;_@J#X(_P"$:_:07Q/##B+Q#HMO<LX'!ECS P^H6.,_\"KYQK^R^%JV
M'QF087%4XI.4(WLDM;6E^*9_%7%='$X+B'%86I)M1J2M=MZ7O'\&@HHHKZ$^
M<"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO^"K_P /VUGX5:!\1;:#=)H>K-;7# =(;A1R?8/%&/\ @=?!%?KA^T5\-_\
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M?[9Y;]2:T:_.L=7^L8N=3N_P6B_ _2<!0^K8.%-[I:^N[_$****Y#K"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "ORS_;:^%9^$G[2'B'
M1;:V\NQU&X_M/30!A?)G)<A?99/,0?[E?J97RA_P54^$#>(?ASI/QATNTW7'
MA^Y^RZBRCDVLQ 5C[++M _Z[&OT?PNSE97Q/&C-VA77(_P#%O%_?[J_Q'YIX
MJY*\UX7E7@KSH/G7^':2^[WG_A/@JBBBOZE/Y2"BBB@ HHHH **** "BBB@
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M!_F?>\.8>,<)]8WY]O3_ (/^04445\\?1!1110 4444 %%%% !1110 4444
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MQ\[POUC!N:WAK\NO^?R/:R+%?5\:H/:>GSZ?Y?,]5HHHKX<^Z"BBB@ HHHH
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MV:%*,9)IJZ9^5?[6O[.^I_LX_%BY\+A))-&O=USH%X_/F6Y/W">[H?E;UX;
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M;1+/1M,E\#(K:=I=LMO!C[!9O@1H H&Y0W3J,]:Y7P)\'OBEX+^&O[4_P/\
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M_P"W?=W/U3@CAEPY<RQ4?\"?_I3_ /;?O[!1117YF?J 4444 %%%% !1110
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M22L_FEZGYD45]/?%3_@EI\:O"C27OPTUO3_%%J,E8"PM+K'^[(WEG\'R?2O
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
7 "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>coo-20221031_g8.jpg
<TEXT>
begin 644 coo-20221031_g8.jpg
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M2OC59?#BXTRQ\'W45F?"M[8"PFF%RLT5P\GDO#OD$#(/](59&","*^@_"?\
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M> (9M:\$:+;:JD'AS1=-AG"V^GV]J(Q)'.\)7?<B4,]RY?:$(0<M_P $<?\
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M?%F(M-\E!/W8)Z>LOYI?@NBWN4445]F?$A1110 4444 %%%% !1110 4444
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MHHH **** "BBN2^-_P 9/"GP'^&]_P#$;Q=-^YM4VVMJK /=SL#LA3W8CKV
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MZMO_ $&2OEN-/^2<K>L?_2D?6<$?\E)1])?^DL^@J***_##]X"BBB@ HHHH
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MF18[ZOB?92?NR_/I_D>JT445\4?<!1110 4444 %%%% !1110 4444 %%%%
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MAU66\=_1_P#!_,^BX=Q/)B)47M+;U7_ _([6BBBOCS[(**** "BBB@ HHHH
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M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^D/V!/^/3Q2/\
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M?FM_P3F\60VW[.O[34GCS5/$]SHEA//#>2Z)>![W3['[/=K++;F:10&CC!<
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M]!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MU%2;\ERM?FTCW*BBBOPX_=PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_)17S7$;_=TUYO\ 0^GX:7[RH_)?J6****^4/K0HHHH **** "BBB@ HHHH
M**** "BBB@ I&4,I5AD$8(-+10!^-/B;29- \1ZAH4JX:ROI8&![%'*_TJC7
M?_M4^'V\,?M(^-]),>Q?^$ENYHUQT260RK_XZXK@*_N' 8A8O TJZ^W&,OO2
M9_"688=X/'U:#^Q*4?N;04445UG(%%%% !1110 4444 %%%% !1110 4444
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MV?5&M.M4I)J+T>ZZ,^.? '_!+/4?'G[=L7_!1O\ ;;^).F>,O&^AV45E\/\
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MNM)O8II]355?[+#:M"+B>5HW215CC8E#GHK8^%/VN_"/AGQY_P '6WP(\/\
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M;=!^UJ_S/OOU*?A_P_H/A/0;+PMX6T6TTW3--M([73M.L+=88+6"-0D<4<:
M*B*H"A0    *N445>QGN%%%% !1110 4444 %%%% !73_"+1?[7\90S.N8[-
M3._U'"_^/$'\*YBO5_@AH7V#P]+K4J8>]EPF1_ F0/UW?I7FYMB/J^!D^KT7
MS_X%ST\HP_UC'P71:OY?\&QVM%%%? GZ"%%%% !1110 4444 %%%% !1110
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M):RV]%_FPHHHKY\^A"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MD4Z<:4%".RT"BBBH+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\QWUBM[&#]V/XO\ X'^9]KD6 ^KT?;37O2_!?\'?[@HHHKPCWPHHHH ****
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MB1H(XU"JHPJ@8 %+117A'OA1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
(% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>coo-20221031_g9.jpg
<TEXT>
begin 644 coo-20221031_g9.jpg
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M2OC59?#BXTRQ\'W45F?"M[8"PFF%RLT5P\GDO#OD$#(/](59&","*^@_"?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 9.L> _ WB*\_M'Q!X,T
MF^N"H4SWFG12OM'0;F4G%6]%\/Z#X;M#8>'=$L["!I"[0V5LD2%B "V% &<
M<^PJW10!CO\ #WP"^J_VZ_@?1S?>?YWVPZ9$9?-SNW[]N=V><YSFHK;X7_#.
MS\40>-[3X=Z%%K5M;FWMM7CTB%;J*$@@QK*%WJN"1M!QS6[10!C^,OAW\/\
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M/PWX0>X\&_ *&WUG45RDVOSC=9P-T/E+_P MV'][A.A&\<5\\?M0?MN?$O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M% !1110 4444 %?3/[!'_(O>(_\ K]M__0'KYFKZ8_8(_P"0#XC_ .ORW_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M#+JZMK*VDO+RX2*&%"\LLC!510,EB3P !SFOS(_;;_:@NOVB_B6T&AW+KX8T
M1WAT6'D"<YP]RP]7QQGHH P"6S]#?\%,OVFSX2\.#X >#=0VZCJ\ D\031-S
M!:'[L.1T:3N/[@QT>O@^OZ!\*>$EAZ']LXJ/O2TII]([.7K+9?W;O[1_/'BU
MQ@\17_L3"2]R.M1KK+=0]([O^]9?9"BBBOVL_#@HHHH **** "BBB@ HHHH
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MQQ]2/G?[]3]#RJK[;+Z<O*WW:!1117GGHA1110 4444 %%%% !1110 4444
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MOL.BO$_^"A'[2?B?]E']EC7OB]X)TN"ZUB&6WL],^U1EX8)9I0GFN 1D*"Q
MZ%MH/!-><_LS_M3_ !BN/VS+K]E;XE>)V\3V%W\.-.\1V&LSZ?;P7%K</;V[
M3Q,+:.-&B9I79<KN7Y5W-FNK%<0X#!YI# 5+\\N572T3GS<M];Z\CV3MI>US
MEPG#N88S*IYA3MR1YG9O5J')S-:6TYX[M7UM>Q]945Y/X2^)GC?XP_M#:E8^
M ]:^R> O GFZ=KEREM$_]O:VP&ZV1W4E(;12-[(5+3.$R1&X/K%>GAL53Q<9
M2@G9-J_1VT;7E>ZOI>S:TLWY6*PM3"2C&HUS-)M=5?5)^=K.RO:Z3L[I%%%%
M=)S!7T?^P'_Q[^*A_MV7\IZ^<*^COV S^Y\5C_:L?Y3U\OQE_P DW7_[=_\
M2XGU7!7_ "4M#_M[_P!(D?15%%%?A9^]!1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!U?P:OOLGCB*'=@7,$D
M9_+=_P"RU[#7A'@:Z^Q>,--G)P/MD:D^S':?YU[O7QW$-/EQ<9=U^3/L^'*G
M-@Y0[/\ -(****\ ^A"BBB@ HHHH **** "BBB@ HHHH **** "D9@JEF. !
MDDTM9'C_ %)M'\!ZWJZ'!M=(N9A_P&)F_I5TH.K4C!;MI?>15FJ5.4WLDW]Q
M^0'B75Y-?\1ZAKLIRU[?2W#$]R[EC_.J-%%?W/",8045LC^#)SE.;E+=ZA11
M15$A1110 5\&_P#!P!_R;-X-_P"Q[3_TBN:^\J\M_:._8[^"?[5]K9:;\;[#
M5=3L=/G\^ST^#6I[>".7:5\S;$RY;:2,G.,G&,FOG^*<LQ6<Y!7P6'MSU%97
M=ENGK9/MV/HN%,TPN2\0X?'8F_)3=WRJ[>C6EVEU[G ?LN?L\>+O"?Q)\$_'
M.X^*?B+Q!I-]\&AIC:=KEQ$\6DSL^FS(MN(T0!)%CDSD%OW*Y9N /$/"_B_Q
MQX__ ."OOQ9^'VL7&BO>#P,='\.V7B82&&.P,=I))' J_P 4BN\Q'=3(>E?<
MOP\\!:/\,O"%EX'\/7E_-8:=;I!9#4;U[B2*)$5$CWOEB JCJ2?>O-OCW^P;
M^SG^T7X_T[XK>./#^HV7B?3$6.WU_P /:Q-873(N=JL\1&<9(#?> . V.*\O
M,.'L6\!AXX.W-3J1J2BY.TO=<9)2LWUNKIJ_1:6]7+N(\(L?B)8R_+4I2IQE
M&*O'WE*+<;Q72SLT[/=ZW^/?VY/@1XF_9J_X).VOP/\ &'Q,L_%=QX=\?6T=
MM>VL97[+$XED6W(9F*E1(< GA'4  8KZ4_9^_8Q_9U\/_";PY\:F^'-M>>+[
MSX9V]OJ>N7L\LS7OFVD;R-)&[&-F)X#;<JH"*0J@#O?BC^Q=\ /C!\)M-^!O
MC+PU>MX7TJ[^U0:;:ZQ<1&6?YCYLT@?S)G+.[%G8EF=F8DG-=]X&\%:-\/?!
MFG> ]"DN9-/TJS2TLQ?7+3R+"@VHC.V2V% 4$Y. ,YJ<OX5AA\WE7JTX.FJ5
M.$$VYN+A?^9=$[*5[Z;*Y68<63Q&3QH4JLU5=6I.;24%)3Y=U%]6KN-K:[NQ
M\%_\$3?#7AR\_8H^('B"[T"REU"+Q1J<,=]):HTR1'2[3*!R-P4[FXSCD^M>
M8_LD?\H0_C=_V-MU_P"B-*K[X^&G["7[./P<3Q#!\,?#6IZ/!XD,QNK2U\07
M?D6S2KLD>VB:0I [)\GF( X3Y0P7BL[PQ_P3N_9F\&_!C7/V?/#6BZW:^$?$
M=ZMWK&D)XCNBL\H"#.XON7(CCW!2 WEKGI7B4>#\WI8'#4/<O2HUZ3:D]742
M47\.VFO5=+GNU^,\FK8_$XCW[5:]"JDXK2--MR7Q;ZZ='UL?"G[6"(?^"(7P
M2D* L/%\ #8Y&8=6KT7_ (*+:!H5Q^U9^R4UQHEH_P#:.MZ?%J!>V4_:D%YI
MJA9,CYQM)&#D8)%?4OB7_@G9^S+XP^#&A_L]^(]%UNZ\(>'+Y[S1]'?Q'=!8
M)6#C.X/N8#S)=H)(7S&QUK=^+/[%_P !?C=X<\+>'OB/H>HWK^"Y5D\-:M%K
M5Q!?V179]VXB=7.?+CY)SE%;(8 TJG!N;5<+5IODO*GA8K5VYJ#3E?W=$U=)
MZ^:04N-,HI8NE47/:-3%2>BORUTU&WO:N+LY+3R;/G'_ (+"? 67PI\/_!O[
M7_P9T*TL-=^%.MVTKBSM%1!9&X5XR54#*Q7.P[>FV>4FOH#]E/QCHG[1,=U^
MUW8:*]M!XGTBRTS0!<Q8ECL;<-)*#D9!-[/=(<<.MO$PR,5RWQP^)4NG^*=0
M_89L?V:]=O\ 0O$GP_GAT;Q+Y5Q<V-S>3EH3;3N(V*!0QFEN))0XP6()96;W
M#X9?#WP]\*/ASH?PP\*V_EZ;H&DP:?9*0,F.*,("WJQQDGN237T.78"G+B2O
MBJ$DJ=H\\;/2M%.-TVEIR/6RUM%GSN8YA4CPS0PM>+=2\N25T[T9-2::3>O.
MM+O1.2/)/V&/@A^R#\&-'\66_P"R3XSM]:MK[7O^)_)!KZ7_ -EGC#!+<%?N
M*@9MN<L0Q)9N,)^WMXQ^+V@>!M#\.?#3X':]XYTS6M5:+Q?IWAV?RKA]/1"Q
MM]^UO+29MJ.V,F/S%&"X9>N_9O\ V1O@5^R=8ZUIWP1\*RZ9%K^H"[U 37LD
MY)4$)&I<G:B!FVC_ &CDFO2Z]+#976>0K!-1H2LU:EK&/O7]WF6J:WNNK/,Q
M6:T%Q \<G*O&Z=ZNDI>[;WN5W33VL^B/RY^"/QM^)&M_\%C_ /A,M0_9EUO0
M=0U;1K32K[PI-.OG:+:-;VL)O'(C ,2(HDV@#Y6 S7HW_!<__D)?!#_L;+O_
M -"LZ^O++]ECX,:?^T5>?M56OAZX7QK?:<+&YU$ZA*8VA$:1A?*W; =L:C.,
M\>]8W[0/[$/P'_:AUG3M;^--GK>J/I$COI,,7B"XMXK-GV;FC2)E )\M.3D_
M*.:^5J<)9S_JYC<![6,YUJKG%O16YXRN^6.C?+JDFD]M#ZRGQ?DO^LF!S#V4
MH4Z%%0DEJ[\DHV7-+6*YM&VFUOJ=_P#$[X8^!/C+X#U+X9?$SPW!JVAZO!Y-
M_87!(61<A@05(965@K*RD%64$$$ UX+X]^%7@[]G_78/!'[.=M<2_%GXDV$.
MB6?B75KIKNXT;1;2*..2\8M@)#;1+&%4 &:<PARY)(^C="TE="TF'25U&[NQ
M"I N+Z<RROR3\SGENN,GL!6!X;^$'A?PY\3]?^,'VF]OM=\06]O:R7-_*KBR
MLX0=EK;@*/*BWL\K#DL[DL3A0/LLPRZ.,<)J"531.>G-&-G?E>_-JXQ?V>9R
M75/XO+LRG@E.#FW3U:AKRSE=6YEMRZ*4E]KE47T:^4_'/Q^\7_ CXP:E^Q-^
MSG]F\/Z/\-/@_?\ B674[VS6ZN-3OHH?.1)#)QL=W#S.!YCL[X9#S7T%^Q3^
MT/>_M5?LR>%_CGJNA1Z;>ZQ;S)?V<!8Q+/!/)!(T>XD[&:,LH)) 8 DD$U%\
M:_V-?A)\;_&K?$?5[K5]&UZX\-W7A_4=4T"ZCBDO]+N%99+6421R*1AFPZA9
M%SPXP,=Y\,OAKX)^#O@'2OAC\.="CTS1-%M!;Z?91,2(T!)))8DLQ)+,Q)+,
MQ)))->;E679U@\VJ2JU%]7M)1BGHE>/(DOL\D5*+[MIZ]/2S;,LDQF44HTJ;
M^L7BY2:U;M+VC;^USR<9+LDUIUW:***^I/E KZ._8"_U7BO_ 'K'_P!N*^<:
M^COV O\ 5^*_]ZQ_]N*^8XR_Y)NO_P!N_P#I<3ZK@K_DIJ'_ &]_Z1(^BJ**
M*_"C]Z"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@"6RG-K>17(/\ JY5;\CFOH<$$9!KYSKZ$TJ4SZ7;3DY+V
MZ-GZJ*^8XDCI2EZ_H?5<,RUJQ]/U+%%%%?+'U04444 %%%% !1110 4444 %
M%%% !1110 5R?QZN?L7P,\:7F<>3X3U%\_2UD-=97&?M'?\ )O7CS_L3-4_]
M)):[LL2EF5%/^>/YHX<S;CEM=K^27_I+/R.HHHK^WC^%0HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^C?V
MON^+![V/_MQ7SE7U'^POX-U?1?".K^+[^/9;ZS/"EDI'++#Y@9_H6<@?[A]J
M^5XTJ0AP[5C)V<G%+S?,G^2;^1]9P13J3XDI2BKJ*DWY+E:_-I?,]UHHHK\-
M/W@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "O??"SF3PSISGJUA"3_WP*\"KWOP?G_A$M+S_P! Z#_T6M?-
M\1_P:?JSZ7AK^-4]%^9HT445\F?7A1110 4444 %%%% !1110 4444 %%%%
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M%S<7_P /H;*V<>)[J==3A-_!"\_E7*(L,1B:<JT;0RE5!.6S/^"C_P )I_\
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MXSD'L0*U:*NG4G1J*<'9IW3[-;$5*<*U-TYJZ:LUW3W/QP\<>#]9^'WC'5/
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M_P#;LG]TK]#Y8HHHK^AS^<0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO)]S^-.+N&Z_"^=U,'/6&\'_ #1>WS6S\T^@4445]*?,!1110 4444 %%%%
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M:<>9WRQ674GJ[.?YJ/ZOY=S]/X R/FD\RK+174/R<OT7S"BBBORX_50HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ KH_AMX*D\7:T'N8S]BMB&N6_O>B#Z_P OPK(T'0[_ ,1Z
MK%I&FQ[I)6ZGHH[L?85[CX9\.V/A?1XM'L%^5!EW(YD8]6/U_P !7C9OF*PE
M'D@_?E^"[_Y'M9-ESQE;VDU[D?Q?;_,O(B1H(XT"JHPJ@8 'I2T45\0?=!11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!XO^V?^RGIG[27@3[1H\44'BG28V?1KQL*)AU-M(?[C'H3]UN>A8'\
MS=;T75O#>KW.@:]ITUG>V4[0W5K<(5>*13AE8'H017[-5\U?MX?L6Q_&K2Y/
MBE\-=.1/%EC#_I5K& /[5A4<+_UV4#"G^(?*?X<?KOAOQTLHJ++,?+]Q)^[)
M_8;Z/^ZW_P" O79NWX[XE\!/.*;S3+X_OXKWXK[:75?WDO\ P):;I7_/"BGW
M-M<6=Q):7<#Q2Q.4EBD4JR,#@@@\@@]J97]'IIJZ/YI::=F%%%% !1110 44
M44 %3:?I][JU_!I>FVSSW%S,L5O#&,M([$!5 ]22!4-?0/[%'P@^WZA+\6]=
MM<PVK-!HZ.O#RXP\ON%!V@\\ENA6O,S?,Z.49?/$U.FR[M[+_/RNSU,FRNMG
M&8PPM/KN^R6[_P N[LCVOX*_#"R^$G@"T\+0['NB/.U*X3_EK<,!N(/H,!1[
M*.Y-=9117\^8C$5<57E6JN\I-MOS9_16&P]'"8>-&DK1BDDO)!1116)L%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4^VMKB\N$M+6%I)9&"QH@R6)Z 4U$>1PB*69C@ #))KUGX8?#
MA?#D"ZYK,0-_(OR(?^6"GM_O'OZ=/6N+'XZE@:/-+=[+O_P.YW8# U<?6Y(Z
M);OM_P 'L:'P[\"P>#M,WW 5[ZX -Q(.=O\ L#V'ZG\*Z*BBO@:U:IB*KJ3=
MVS]!H4:>'I*G35D@HHHK(U"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI/\ =T]/675_+9?-]3]OX*R/^S,N^L55^\JZ^D>B^>[^2Z!1117QI]J%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4J(\CB.-2S,<*H&233K:VN+RX2UM(&DED8*D:+DL?0"O5_AS\,
M(/#:IK&MHLM^1E$ZK!]/5O?MV]3PX['T<#3YI:OHN_\ P#NP& K8^KRPT75]
MO^#Y$7PQ^&2Z(J:_K\ -X1F"!AD0#U/^U_+ZUV]%%?"XG$U<75=2H]?R\D??
M87"T<'15.FM/S\V%%%%<YT!1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%L5[N  , 45A/B.J_AII>KO_ )&\.&J2^.HWZ*W^9X]8_!GQO=X,]M;VP/\
MSWN ?_0=U;6G? 1CAM6\0@>J6\/_ +,Q_I7H]%<=3/<PJ;-1]%_G<[:60Y=3
MW3EZO_*QS&E_"#P3IN&EL9+IQ_%<RD_H,#]*Z"QTW3M,B\C3;"&W3^[#$%'Z
M5/17G5<3B*_\2;?JSTJ6&P]#^'!+T04445@;A1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
-44 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002060418800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Dec. 01, 2022</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--10-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-08597<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">THE COOPER COMPANIES, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-2657368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6101 Bollinger Canyon Road<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Ramon<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">460-3600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.10 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">COO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-Known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,354,384<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000711404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.124%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.343%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Document</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Part of Form 10-K</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Portions of the Proxy Statement for the Annual Meeting<br/>of Stockholders scheduled to be held in March 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Part&#160;III</span></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our independent registered public accounting firm is KPMG LLP, San Francisco, CA, Auditor ID: 185.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002060405616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">KPMG LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">San Francisco, CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">185<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002060499152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Income - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 3,308.4<span></span>
</td>
<td class="nump">$ 2,922.5<span></span>
</td>
<td class="nump">$ 2,430.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">1,168.8<span></span>
</td>
<td class="nump">966.7<span></span>
</td>
<td class="nump">896.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">2,139.6<span></span>
</td>
<td class="nump">1,955.8<span></span>
</td>
<td class="nump">1,534.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expense</a></td>
<td class="nump">1,342.2<span></span>
</td>
<td class="nump">1,211.2<span></span>
</td>
<td class="nump">992.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="nump">110.3<span></span>
</td>
<td class="nump">92.7<span></span>
</td>
<td class="nump">93.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangibles</a></td>
<td class="nump">179.5<span></span>
</td>
<td class="nump">146.1<span></span>
</td>
<td class="nump">137.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">507.6<span></span>
</td>
<td class="nump">505.8<span></span>
</td>
<td class="nump">311.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">57.3<span></span>
</td>
<td class="nump">23.1<span></span>
</td>
<td class="nump">36.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="num">(25.0)<span></span>
</td>
<td class="num">(8.8)<span></span>
</td>
<td class="nump">8.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">475.3<span></span>
</td>
<td class="nump">491.5<span></span>
</td>
<td class="nump">266.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes (Note 6)</a></td>
<td class="nump">89.5<span></span>
</td>
<td class="num">(2,453.2)<span></span>
</td>
<td class="nump">28.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 385.8<span></span>
</td>
<td class="nump">$ 2,944.7<span></span>
</td>
<td class="nump">$ 238.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per share (Note 7)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 7.83<span></span>
</td>
<td class="nump">$ 59.80<span></span>
</td>
<td class="nump">$ 4.85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 7.76<span></span>
</td>
<td class="nump">$ 59.16<span></span>
</td>
<td class="nump">$ 4.81<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Number of shares used to compute earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">49.3<span></span>
</td>
<td class="nump">49.2<span></span>
</td>
<td class="nump">49.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">49.7<span></span>
</td>
<td class="nump">49.8<span></span>
</td>
<td class="nump">49.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002059725568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 385.8<span></span>
</td>
<td class="nump">$ 2,944.7<span></span>
</td>
<td class="nump">$ 238.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive (loss) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Cash flow hedges, net of tax of $26.1, $8.2 and $(4.1), respectively</a></td>
<td class="nump">81.3<span></span>
</td>
<td class="nump">26.1<span></span>
</td>
<td class="num">(13.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Change in minimum pension liability, net of tax of $8.7, $7.2 and $(4.0), respectively</a></td>
<td class="nump">27.9<span></span>
</td>
<td class="nump">22.6<span></span>
</td>
<td class="num">(12.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(234.7)<span></span>
</td>
<td class="nump">82.0<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="num">(125.5)<span></span>
</td>
<td class="nump">130.7<span></span>
</td>
<td class="num">(24.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">$ 260.3<span></span>
</td>
<td class="nump">$ 3,075.4<span></span>
</td>
<td class="nump">$ 213.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002059507376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax', window );">Cash flow hedges, tax provision (benefit)</a></td>
<td class="nump">$ 26.1<span></span>
</td>
<td class="nump">$ 8.2<span></span>
</td>
<td class="num">$ (4.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax', window );">Change in minimum pension liability, tax provision (benefit)</a></td>
<td class="nump">$ 8.7<span></span>
</td>
<td class="nump">$ 7.2<span></span>
</td>
<td class="num">$ (4.0)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002068077280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 138,200<span></span>
</td>
<td class="nump">$ 95,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Trade accounts receivable, net of allowance for credit losses of $20.7 at October&#160;31, 2022 and $9.2 at October&#160;31, 2021</a></td>
<td class="nump">557,800<span></span>
</td>
<td class="nump">515,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories (Note 1)</a></td>
<td class="nump">628,700<span></span>
</td>
<td class="nump">585,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expense and other current assets</a></td>
<td class="nump">208,900<span></span>
</td>
<td class="nump">179,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">89,200<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">1,533,600<span></span>
</td>
<td class="nump">1,465,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property, plant and equipment, net</a></td>
<td class="nump">1,432,900<span></span>
</td>
<td class="nump">1,347,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill (Note 4)</a></td>
<td class="nump">3,609,700<span></span>
</td>
<td class="nump">2,574,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangibles, net (Note 4)</a></td>
<td class="nump">1,885,100<span></span>
</td>
<td class="nump">1,271,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">2,443,100<span></span>
</td>
<td class="nump">2,546,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">587,900<span></span>
</td>
<td class="nump">401,200<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">11,492,300<span></span>
</td>
<td class="nump">9,606,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Short-term debt (Note 5)</a></td>
<td class="nump">412,600<span></span>
</td>
<td class="nump">83,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">248,800<span></span>
</td>
<td class="nump">161,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee compensation and benefits</a></td>
<td class="nump">152,100<span></span>
</td>
<td class="nump">148,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">93,600<span></span>
</td>
<td class="nump">19,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">373,100<span></span>
</td>
<td class="nump">317,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,700<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,280,200<span></span>
</td>
<td class="nump">732,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">2,350,800<span></span>
</td>
<td class="nump">1,397,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities</a></td>
<td class="nump">149,900<span></span>
</td>
<td class="nump">24,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Long-term tax payable</a></td>
<td class="nump">113,200<span></span>
</td>
<td class="nump">139,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue</a></td>
<td class="nump">198,300<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent', window );">Accrued pension liability and other</a></td>
<td class="nump">225,200<span></span>
</td>
<td class="nump">370,700<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">4,317,600<span></span>
</td>
<td class="nump">2,664,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Contingencies (Note 12)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $10 cents par value, 1.0 shares authorized, zero shares issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $10 cents par value, 120.0 shares authorized, 53.8 issued and 49.3 outstanding at October&#160;31, 2022 and 53.7 issued and 49.3 outstanding at October&#160;31, 2021</a></td>
<td class="nump">5,400<span></span>
</td>
<td class="nump">5,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">1,765,500<span></span>
</td>
<td class="nump">1,715,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(466,800)<span></span>
</td>
<td class="num">(341,300)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">6,584,900<span></span>
</td>
<td class="nump">6,202,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock at cost: 4.5 shares at October&#160;31, 2022 and 4.4 shares at October&#160;31, 2021</a></td>
<td class="num">(714,500)<span></span>
</td>
<td class="num">(639,600)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Cooper stockholders' equity</a></td>
<td class="nump">7,174,500<span></span>
</td>
<td class="nump">6,941,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders&#8217; equity (Note 8)</a></td>
<td class="nump">7,174,700<span></span>
</td>
<td class="nump">6,942,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 11,492,300<span></span>
</td>
<td class="nump">$ 9,606,200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability, Defined Benefit Pension Plan And Other, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002059611744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Trade accounts receivable, allowance for credit losses</a></td>
<td class="nump">$ 20.7<span></span>
</td>
<td class="nump">$ 9.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized (in shares)</a></td>
<td class="nump">1,000,000.0<span></span>
</td>
<td class="nump">1,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">120,000,000.0<span></span>
</td>
<td class="nump">120,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">53,800,000<span></span>
</td>
<td class="nump">53,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding (in shares)</a></td>
<td class="nump">49,300,000<span></span>
</td>
<td class="nump">49,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">4,500,000<span></span>
</td>
<td class="nump">4,400,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002058707616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Shares</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Treasury Stock Par Net Value</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Noncontrolling Interests</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th">
<div>Cumulative Effect, Period of Adoption, Adjustment </div>
<div>Retained Earnings</div>
</th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, beginning balance (in shares) at Oct. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, beginning balance (in shares) at Oct. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Oct. 31, 2019</a></td>
<td class="nump">$ 3,628.6<span></span>
</td>
<td class="nump">$ 4.9<span></span>
</td>
<td class="num">$ (571.2)<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 1,615.0<span></span>
</td>
<td class="num">$ (447.1)<span></span>
</td>
<td class="nump">$ 3,026.4<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">238.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">238.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(24.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock for stock plans, net and employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock for stock plans, net and employee stock purchase plan</a></td>
<td class="num">(3.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury stock repurchase (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury stock repurchase</a></td>
<td class="num">(47.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (47.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends on common stock ($0.03 per share)</a></td>
<td class="num">(3.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">36.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, ending balance (in shares) at Oct. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Oct. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Oct. 31, 2020</a></td>
<td class="nump">$ 3,824.8<span></span>
</td>
<td class="nump">$ 4.9<span></span>
</td>
<td class="num">$ (617.3)<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">1,646.8<span></span>
</td>
<td class="num">(472.0)<span></span>
</td>
<td class="nump">3,261.8<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="num">$ (1.4)<span></span>
</td>
<td class="num">$ (1.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible Enumeration]</a></td>
<td class="text">Accounting Standards Update 2016-13 [Member]<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 2,944.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,944.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">130.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock for stock plans, net and employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock for stock plans, net and employee stock purchase plan</a></td>
<td class="nump">$ 27.2<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury stock repurchase (in shares)</a></td>
<td class="nump">69,622<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury stock repurchase</a></td>
<td class="num">$ (24.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (24.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends on common stock ($0.03 per share)</a></td>
<td class="num">(3.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">$ 43.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, ending balance (in shares) at Oct. 31, 2021</a></td>
<td class="nump">49,300,000<span></span>
</td>
<td class="nump">49,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Oct. 31, 2021</a></td>
<td class="nump">4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Oct. 31, 2021</a></td>
<td class="nump">$ 6,942.0<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="num">$ (639.6)<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">1,715.2<span></span>
</td>
<td class="num">(341.3)<span></span>
</td>
<td class="nump">6,202.1<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">385.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">385.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(125.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(125.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock for stock plans, net and employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock for stock plans, net and employee stock purchase plan</a></td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury stock repurchase (in shares)</a></td>
<td class="nump">191,165<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury stock repurchase</a></td>
<td class="num">$ (78.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (78.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends on common stock ($0.03 per share)</a></td>
<td class="num">(3.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">$ 52.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, ending balance (in shares) at Oct. 31, 2022</a></td>
<td class="nump">49,300,000<span></span>
</td>
<td class="nump">49,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Oct. 31, 2022</a></td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Oct. 31, 2022</a></td>
<td class="nump">$ 7,174.7<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="num">$ (714.5)<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 1,765.5<span></span>
</td>
<td class="num">$ (466.8)<span></span>
</td>
<td class="nump">$ 6,584.9<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 32: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 66: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 67: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 68: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002069598336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Dividends on common stock (in dollars per share)</a></td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002063651328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 385.8<span></span>
</td>
<td class="nump">$ 2,944.7<span></span>
</td>
<td class="nump">$ 238.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">346.1<span></span>
</td>
<td class="nump">309.3<span></span>
</td>
<td class="nump">287.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of intangibles</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">54.2<span></span>
</td>
<td class="nump">43.8<span></span>
</td>
<td class="nump">37.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Non-cash operating lease expense</a></td>
<td class="nump">32.2<span></span>
</td>
<td class="nump">31.8<span></span>
</td>
<td class="nump">32.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_GainLossOnSaleOfAssetsAndAssetImpairmentChargesAndOther', window );">Impairment and loss on disposal of property, plant and equipment, and other</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="num">(5.0)<span></span>
</td>
<td class="nump">17.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent consideration</a></td>
<td class="num">(10.3)<span></span>
</td>
<td class="nump">66.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="nump">53.9<span></span>
</td>
<td class="num">(2,502.2)<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(33.8)<span></span>
</td>
<td class="num">(75.5)<span></span>
</td>
<td class="nump">8.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(40.4)<span></span>
</td>
<td class="num">(9.2)<span></span>
</td>
<td class="num">(62.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(16.9)<span></span>
</td>
<td class="num">(69.1)<span></span>
</td>
<td class="num">(41.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet', window );">Operating lease right-of-use assets and liabilities, net</a></td>
<td class="num">(51.3)<span></span>
</td>
<td class="num">(27.5)<span></span>
</td>
<td class="num">(20.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">49.9<span></span>
</td>
<td class="num">(16.0)<span></span>
</td>
<td class="nump">23.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="nump">32.4<span></span>
</td>
<td class="nump">59.1<span></span>
</td>
<td class="num">(9.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Accrued income taxes</a></td>
<td class="num">(27.4)<span></span>
</td>
<td class="nump">10.0<span></span>
</td>
<td class="num">(12.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other long-term liabilities</a></td>
<td class="num">(34.2)<span></span>
</td>
<td class="num">(21.7)<span></span>
</td>
<td class="num">(12.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_IncreaseDecreaseInContingentConsiderationLiability', window );">Settlement of contingent consideration</a></td>
<td class="num">(52.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">692.4<span></span>
</td>
<td class="nump">738.6<span></span>
</td>
<td class="nump">486.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, plant and equipment</a></td>
<td class="num">(242.0)<span></span>
</td>
<td class="num">(214.4)<span></span>
</td>
<td class="num">(310.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired', window );">Acquisitions of businesses and assets, net of cash acquired</a></td>
<td class="num">(1,641.3)<span></span>
</td>
<td class="num">(235.9)<span></span>
</td>
<td class="num">(54.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries', window );">Proceeds from sale of interest in a subsidiary</a></td>
<td class="nump">52.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(1,831.2)<span></span>
</td>
<td class="num">(450.3)<span></span>
</td>
<td class="num">(364.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from long-term debt, net of issuance costs</a></td>
<td class="nump">1,511.0<span></span>
</td>
<td class="nump">1,427.4<span></span>
</td>
<td class="nump">3,199.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="num">(561.5)<span></span>
</td>
<td class="num">(1,416.0)<span></span>
</td>
<td class="num">(3,235.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt', window );">Net proceeds from (repayments of) short-term debt, other</a></td>
<td class="nump">329.3<span></span>
</td>
<td class="num">(321.3)<span></span>
</td>
<td class="num">(4.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="num">(78.5)<span></span>
</td>
<td class="num">(24.8)<span></span>
</td>
<td class="num">(47.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds related to share-based compensation awards</a></td>
<td class="nump">8.9<span></span>
</td>
<td class="nump">33.7<span></span>
</td>
<td class="nump">13.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments related to share-based compensation awards</a></td>
<td class="num">(16.8)<span></span>
</td>
<td class="num">(13.2)<span></span>
</td>
<td class="num">(20.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends on common stock</a></td>
<td class="num">(3.0)<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Issuance of common stock for employee stock purchase plan</a></td>
<td class="nump">7.2<span></span>
</td>
<td class="nump">5.8<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Settlement of contingent consideration</a></td>
<td class="num">(2.9)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">1,193.7<span></span>
</td>
<td class="num">(311.4)<span></span>
</td>
<td class="num">(95.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents and restricted cash</a></td>
<td class="num">(12.9)<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="nump">42.0<span></span>
</td>
<td class="num">(20.2)<span></span>
</td>
<td class="nump">27.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, restricted cash and cash held for sale at beginning of year</a></td>
<td class="nump">96.6<span></span>
</td>
<td class="nump">116.8<span></span>
</td>
<td class="nump">89.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of year</a></td>
<td class="nump">138.6<span></span>
</td>
<td class="nump">96.6<span></span>
</td>
<td class="nump">116.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest</a></td>
<td class="nump">49.1<span></span>
</td>
<td class="nump">28.4<span></span>
</td>
<td class="nump">46.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes</a></td>
<td class="nump">66.6<span></span>
</td>
<td class="nump">63.2<span></span>
</td>
<td class="nump">51.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating lease liabilities</a></td>
<td class="nump">45.3<span></span>
</td>
<td class="nump">37.4<span></span>
</td>
<td class="nump">40.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating lease ROU assets obtained in exchange for lease obligations</a></td>
<td class="nump">29.8<span></span>
</td>
<td class="nump">26.5<span></span>
</td>
<td class="nump">17.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Reconciliation of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">138.2<span></span>
</td>
<td class="nump">95.9<span></span>
</td>
<td class="nump">115.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash included in other current assets</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Cash held for sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents, restricted cash and cash held for sale</a></td>
<td class="nump">$ 138.6<span></span>
</td>
<td class="nump">$ 96.6<span></span>
</td>
<td class="nump">$ 116.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_GainLossOnSaleOfAssetsAndAssetImpairmentChargesAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Sale Of Assets And Asset Impairment Charges And Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_GainLossOnSaleOfAssetsAndAssetImpairmentChargesAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_IncreaseDecreaseInContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Contingent Consideration Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_IncreaseDecreaseInContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Operating Lease, Right-Of-Use Asset And Liability, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments To Acquire Businesses And Assets, Net Of Cash Acquired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the deconsolidation of a previously consolidated subsidiary or the sale of investment in consolidated subsidiaries (generally greater than 50 percent).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002069262704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock', window );">Organization and Significant Accounting Policies</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 1. Organization and Significant Accounting Policies</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Organization</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Cooper Companies, Inc. (Cooper, we or the Company) is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">CooperVision primarily develops, manufactures and markets a broad range of soft contact lenses for the worldwide vision correction market.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt">CooperSurgical primarily develops, manufactures, markets medical devices and procedures solutions, and provides services to improve health care delivery to women, babies and families. </span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Principles of Consolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The financial statements in this report include the results of all of Cooper's consolidated entities. All significant intercompany transactions and balances are eliminated on consolidation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The preparation of Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of net sales and expenses during the reporting period. Actual results could differ from those estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In particular, the COVID-19 pandemic negatively impacted business and healthcare activity globally. As a result of healthcare systems responding to the demands of managing the pandemic, governments around the world imposing measures designed to reduce the transmission of the COVID-19 virus, and individuals responding to the concerns of contracting the COVID-19 virus, many optical practitioners and retailers, hospitals, medical offices and fertility clinics closed their facilities, restricted access, or delayed or canceled patient visits, exams and elective medical procedures, and many customers that have reopened are experiencing reduced patient visits. These factors have had, and in the future may have, an adverse effect on our sales, operating results and cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The full extent to which the pandemic will directly or indirectly impact the Company's business, results of operations, and financial condition, including sales, expenses, manufacturing, clinical trials, research and development costs, reserves and allowances, fair value measurements, asset impairment charges, contingent consideration obligations, and the effectiveness of the Company's hedging instruments, will depend on future developments that are highly uncertain and difficult to predict. These developments include, but are not limited to, the duration and spread of the outbreak (including new and more contagious variants of COVID-19), its severity, the actions to contain the virus or address its impact, the timing, distribution, public acceptance and efficacy of vaccines and other treatments, United States and foreign government actions to respond to the reduction in global economic activity, and how quickly and to what extent normal economic and operating conditions can resume. There was not a material impact to the estimates in the Company&#8217;s Consolidated Financial Statements for fiscal 2022. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company continually monitors and evaluates the estimates used as additional information becomes available. Adjustments will be made to these provisions periodically to reflect new facts and circumstances that may indicate that historical experience may not be indicative of current and/or future results. The Company&#8217;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material changes to the estimates and material impacts to the Company&#8217;s Consolidated Financial Statements in future reporting periods. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Net Sales </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company sells its products principally to a limited number of distributors, group purchasing organizations, eye care or health care professionals including independent practices, corporate retailers, hospitals and clinics or authorized resellers (collectively, its Customers). These Customers may subsequently resell the Company&#8217;s products to eye care or health care providers and patients. In addition to product supply and distribution agreements with Customers, the Company enters into arrangements with health care providers and payors that provide for government-mandated and/or privately negotiated rebates, chargebacks and discounts with respect to the purchase of the Company&#8217;s products. The Company considers purchase orders, which in some cases are governed by master sales agreements, to be contracts with a customer. As part of its consideration of the contract, the Company evaluates certain factors including the customer&#8217;s ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Revenues from product sales are recognized when the Customer obtains control of the Company&#8217;s product, which occurs at a point in time, typically upon shipment or delivery to the Customer. Taxes collected from Customers relating to product sales and remitted to governmental authorities are excluded from revenues. The Company expenses incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that the Company would have recognized is one year or less. See Note 12. Business Segment Information for disaggregation of revenue.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Reserves for Variable Consideration</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Revenues from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration for which reserves are established and which result from discounts, returns, chargebacks, rebates and other allowances that are offered within contracts between the Company and its Customers, health care providers, payors and other indirect customers relating to the Company&#8217;s sales of its products. These reserves are based on the amounts earned or to be claimed on the related sales and are classified primarily in current liabilities. Variable consideration is estimated based on the most likely amount or expected value approach, depending on which method the Company expects to better predict the amount of consideration to which it will be entitled. Once the Company elects one of the methods to estimate variable consideration for a particular type of performance obligation, the Company applies that method consistently.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Where appropriate, these estimates take into consideration a range of possible outcomes which are probability-weighted for relevant factors such as the Company&#8217;s historical experience, current contractual and statutory requirements, specific known market events and trends, industry data and forecasted customer buying and payment patterns. Overall, these reserves reflect the Company&#8217;s best estimates of the amount of consideration to which it is entitled based on the terms of the contract.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Trade Discounts and Allowances</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company generally provides Customers with discounts, which include incentive fees that are stated in the Company&#8217;s contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized. </span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Product Returns</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Consistent with industry practice, the Company generally offers Customers a limited right of return for a product that has been purchased from the Company. The Company estimates the amount of its product sales that may be returned by its Customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized. Historically, returns have been infrequent and insignificant relative to our total sales. Our refund liability for product returns was $14.5 million </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">and&#160;$13.7 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;at&#160;October&#160;31, 2022 and 2021, respectively, which is included in Accrued Liabilities on our Consolidated Balance Sheets and represents the expected value of the aggregate refunds that will be due to our customers.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Rebates and Chargebacks</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Rebates are estimated based on contractual terms, historical experience, customer mix, trend analysis and projected market conditions in the various markets served.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Chargebacks for fees and discounts to providers represent the estimated obligations resulting from contractual commitments to sell products to qualified healthcare providers at prices lower than the list wholesale prices charged to the Company&#8217;s direct customers. For certain office and surgical products in CooperSurgical, customers charge the Company for the difference between what they pay for the product and the ultimate selling price to the qualified healthcare providers. These reserves are established in the same period that the related revenue is recognized, resulting in a reduction of product revenue. Chargeback amounts are generally determined at the time of resale to the qualified healthcare provider by customers. CooperSurgical rebates are predominately related to the Medicaid rebate provision that is estimated based upon contractual terms, historical experience, and trend analysis.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Contract Liabilities</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Deferred revenue primarily represents prepaid stem cell storage as part of the CooperSurgical business unit. Revenue related to stem cell storage is recognized over the service period, which can range from one year to the lifetime of a customer.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We grant various share-based compensation awards, including stock options, performance unit shares, restricted stock and restricted stock units. The Company accounts for share-based compensation expense based on estimated grant-date fair value, and expenses the amount over the vesting period of the award. Determining the fair value of share-based awards at the grant date requires judgment, including estimating Cooper's stock price volatility, employee exercise behaviors and related employee forfeiture rates. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The expected life of the share-based awards is based on the observed and expected time to post-vesting forfeiture and/or exercise. Groups of employees that have similar historical exercise behavior are considered separately for valuation purposes. In determining the expected volatility, management considers implied volatility from publicly-traded options on Cooper's common stock at the date of grant, historical volatility and other factors. The risk-free interest rate is based on the continuous rates provided by the United States Treasury with a term equal to the expected life of the award. The dividend yield is based on the projected annual dividend payment per share, divided by the stock price at the date of grant.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Forfeitures are estimated at the time of grant, based on historical experience, and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Foreign Currency Translation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Most of our operations outside the United States use their local currency as their functional currency. We translate these assets and liabilities into United States dollars at year-end exchange rates. We translate income and expense accounts at average rates for each month. We record gains and losses from the translation of financial statements in foreign currencies into United States dollars in other comprehensive income. We record gains and losses from changes in exchange rates on transactions denominated in currencies other than each reporting location's functional currency in net income for each period. We recorded in other expense and income a net foreign exchange loss of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">$22.0 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> for fiscal</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> 2022, $5.5 million for fiscal 2021 and $1.2 million for fiscal 2020.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Financial Derivatives and Hedging</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Derivatives are recorded on the Consolidation Balance Sheets at fair value. Accounting for gains or losses resulting from changes in the values of those derivatives depends on the use of the derivative instrument and whether it qualifies for hedge accounting.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">The gain or loss on derivative instruments designated and qualifying for cash flow hedge accounting is deferred in other comprehensive income. The changes in fair value for all trades that are not designated for hedge accounting are recognized in current period earnings. Deferred gains or losses from designated cash flow hedges are reclassified into earnings in the period that the hedged interest expense affects earnings. The effectiveness of cash flow hedges is assessed at inception and quarterly thereafter. The Company does not offset fair value amounts recognized for derivative instruments in its Consolidated Balance Sheets for presentation purposes.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:107%">Fair Value Measurements</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Accounting standards define fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value. An asset&#8217;s or liability&#8217;s level is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are valued and disclosed in one of the following three levels of the valuation hierarchy:</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Level 1: Quoted market prices in active markets for identical assets or liabilities.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Level 3: Unobservable inputs reflecting the reporting entity&#8217;s own assumptions.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The carrying value of cash and cash equivalents, accounts receivable, prepaid expense and other current assets, lines of credit, accounts payable and other current liabilities approximate fair value due to the short-term nature of such instruments and the ability to obtain financing on similar terms. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The carrying value of the Company's revolving credit facility and term loans approximates fair value based on current market rates (Level 2).</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The fair value of the Company's&#160;interest&#160;rate&#160;swap&#160;contracts is measured on a recurring basis by netting the discounted future fixed cash payments and the discounted expected variable cash receipts. The variable cash receipts are based on the expectation of future interest rates (forward curves) derived from observable market interest rate&#160;curves. The&#160;interest&#160;rate&#160;swap&#160;contracts were categorized as Level 2 in the fair value hierarchy, as the inputs to the derivative pricing model are generally observable and do not contain a high level of subjectivity. The gain or loss on the derivatives is recorded as a component of accumulated other comprehensive income and subsequently reclassified into interest expense in the same period during which the hedged transaction affects earnings. Refer to Note 13. Financial Derivatives and Hedging for further information.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company uses fair value measures when determining assets and liabilities acquired in an acquisition, which are considered a Level 3 measurement. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The fair value of the Company's contingent consideration for which a liability is recorded and the initial measurement of the joint venture interest are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> a Level 3 measurement</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">and the change in fair value is recognized in selling, </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">general and administrative expense in the Consolidated Statements of Income.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Note 3. Acquisitions and Joint Venture for further information.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Income taxes</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Income taxes are estimated based on enacted income tax laws and the results of operations in each jurisdiction. Deferred tax assets and liabilities are estimated based on temporary differences between the financial reporting basis and income tax basis of assets and liabilities. Deferred tax assets are also estimated based on net operating loss and tax credit carryforwards. Deferred tax assets are reduced by a valuation allowance to the extent it is more likely than not they are not expected to be realized. Adjustments to deferred tax assets and liabilities due to changes in tax laws, changes in jurisdiction from intra-group transfers of assets, and changes in judgment regarding a valuation allowance are recognized in provision for income taxes in the quarter in which such changes occur. Long-term tax payable is estimated income tax to be paid for unrecognized tax benefits. A tax benefit is recognized if it is more likely than not a tax position will be sustained based on its technical merits in a tax authority examination, based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority. Adjustments to unrecognized tax benefits due to changes in judgment are recognized in provision for income taxes in the quarter in which such changes occur. Interest and penalties related to unrecognized tax benefits are recognized in provision for income taxes.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Earnings Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We determine basic earnings per share (EPS) by using the weighted average number of shares outstanding. We determine diluted EPS by increasing the weighted average number of shares outstanding in the denominator by the number of outstanding dilutive equity awards using the treasury stock method.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company considers all short-term, highly liquid investments purchased with maturities of three months or less to be&#160;cash equivalents.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost or net realizable value. Cost is computed using standard cost that approximates actual cost, on a first-in, first-out basis.</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.802%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">173.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">137.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">439.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">433.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">628.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">585.6&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In assessing the value of inventories, we make estimates and judgments regarding aging of inventories and other relevant issues potentially affecting the salable condition of products and estimated prices at which those products will sell. On an ongoing basis, we review the carrying value of our inventory, measuring number of months on hand and other indications of salability. We reduce the value of inventory if there are indications that the carrying value is greater than net realizable value, resulting in a new, lower-cost basis for that inventory. Subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis. While estimates are involved, historically, obsolescence has not been a significant factor due to long product dating and lengthy product life cycles. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We record property, plant, and equipment at cost. We compute depreciation expense using the straight-line method over the estimated useful lives of the assets. Useful lives are generally 3 to 15 years except for buildings which are depreciated over 30 to 40 years and leasehold improvements, which we amortize over the shorter of the useful life or the lease term. We charge maintenance and repairs to expense as we incur them.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.802%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Land and improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">20.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">415.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">388.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,973.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,863.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">393.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">383.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Property, plant and equipment, at cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,800.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,655.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,387.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,308.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,413.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,347.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease ROU assets, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,432.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,347.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Leases </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We consider an arrangement a lease if the arrangement transfers the right to control the use of an identified asset in exchange for consideration. We have operating leases, but do not have material financing leases. The Company primarily has operating leases for office, manufacturing and warehouse space, vehicles, and office equipment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Lease right-of-use assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make payments arising from the lease agreement. These assets and liabilities are recognized at the commencement of the lease based upon the present value of the future minimum lease payments over the lease term. The lease term reflects the noncancellable period of the lease together with periods covered by an option to extend or terminate the lease when management is reasonably certain that it will exercise such option. Changes in the lease term assumption could impact the right-of-use assets and lease liabilities recognized on the Consolidated Balance Sheets. As our leases typically do not contain a readily determinable implicit rate, we determine the present value of the lease liability using our incremental borrowing rate at the lease commencement date based on the lease term on a collateralized basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company&#8217;s operating leases typically include non-lease components such as common-area maintenance costs. The Company has elected to include non-lease components with lease payments for the purpose of calculating lease right-of-use assets and liabilities, to the extent that they are fixed. Non-lease components that are not fixed are expensed as incurred as variable lease payments.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Leases with a term of one year or less are not recognized on the Consolidated Balance Sheets, while the associated lease payments are expensed in the Consolidated Statements of Income and Comprehensive Income on a straight-line basis over the lease term.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Operating leases are classified in &#8220;Other current liabilities&#8221;, &#8220;Accrued pension liability and other&#8221;, and &#8220;Other assets&#8221; on our consolidated balance sheets. Operating lease expense is recognized on a straight-line basis over the expected lease term and included in selling, general and administrative expenses in the Consolidated Statements of Income. Financing leases are classified in "Property, plant and equipment", "Short-term debt", and "Long-term debt" on our consolidated balance sheets. See Note 2. Operating Leases and Note 5. Financing Arrangements for further information.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Cloud Computing Arrangements </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">The Company capitalizes certain costs related to the acquisition and development of internal use software, including implementation costs incurred in a cloud computing arrangement, during the application development stages of projects. Capitalized implementation costs are amortized on a straight-line basis over the expected term of the hosting arrangement, which includes consideration of the non-cancellable contractual term and reasonably certain renewals. Costs incurred during the preliminary project or the post-implementation/operation stages of the project are expensed as incurred. Implementation costs are included in &#8220;Other assets&#8221; in the Consolidated Balance Sheets. Amortization of capitalized implementation costs is included in the same line item in the Consolidated Statements of Income as the expense for fees for the associated hosting arrangement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Valuation of goodwill</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We evaluate goodwill for impairment annually during the fiscal third quarter and when an event occurs or circumstances change such that it is reasonably possible that impairment may exist. Goodwill is tested for impairment at the reporting unit level by performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. We perform a qualitative assessment to test each reporting unit's goodwill for impairment, which </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">includes industry and market considerations, overall financial performance and other relevant events and factors affecting each reporting unit. Based on our qualitative assessment, if we determine that the fair value of a reporting unit is more likely than not to be less than its carrying amount, the fair value of a reporting unit will be compared with its carrying amount and an impairment charge will be recognized for the amount that the carrying value exceeds the fair value of the reporting unit.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Long-lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We review long-lived assets held and used, intangible assets with definite useful lives and assets held for sale for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If an evaluation of recoverability is required, the estimated undiscounted future cash flows associated with the asset group are compared to the asset group's carrying amount to determine if a write-down is required. If the undiscounted cash flows are less than the carrying amount, an impairment loss is recorded to the extent that the carrying amount exceeds the fair value. If management has committed to a plan to dispose of long-lived assets, the assets to be disposed of are reported at the lower of carrying amount or fair value less estimated costs to sell.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Indefinite-lived Intangible Assets</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We assess indefinite-lived intangible assets annually in the third quarter of the fiscal year, or whenever events or changes in circumstances indicate that the carrying amount of an indefinite-lived intangible asset (asset group) may not be recoverable. We evaluate whether the indefinite-lived intangible asset is impaired by comparing its carrying value to its fair value. If the carrying value of an indefinite-lived intangible asset is not recoverable, an impairment loss is recognized based on the amount by which the carrying value exceeds the fair value.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Business combinations</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We routinely consummate business combinations. Results of operations for acquired companies are included in our consolidated results of operations from the date of acquisition. We recognize separately from goodwill, the identifiable assets acquired, including acquired in-process research and development, the liabilities assumed, and any noncontrolling interest in the acquiree at the acquisition date fair values as defined by accounting standards related to fair value measurements. Key assumptions routinely utilized in allocation of purchase price to intangible assets include discount rates and projected financial information such as revenue projections for companies acquired. As of the acquisition date, goodwill is measured as the excess of consideration given, over the net of the acquisition date fair values of the identifiable assets acquired and the liabilities assumed. Direct acquisition costs are expensed as incurred.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Litigation</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We are subject to various legal proceedings, claims, litigation, investigations and contingencies arising out of the ordinary course of business. If we believe the likelihood of an adverse legal outcome is probable and the amount is estimable, we accrue a liability in accordance with accounting guidance for contingencies. We consult with legal counsel on matters related to litigation and seek input both within and outside the Company.&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Treasury Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We record treasury stock purchases under the cost method whereby the entire cost of the acquired stock is recorded as treasury stock.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Exit costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">During the second quarter of fiscal 2022, the Company initiated a plan to exit its contact lens care business, a non-core business unit of the CooperVision segment. We expect the exit activity to be substantially completed in the first half of fiscal 2023. Exit charges recognized in the three and twelve months ended October 31, 2022, were $9.2&#160;million and $33.2&#160;million, of which $26.7&#160;million is recognized in cost of sales and $6.5&#160;million is recognized in selling, general, and administrative expense in the Consolidated Statements of Income. Exit costs primarily related to inventory write-down, asset impairments and employee-related costs. Total exit costs are expected to be in a range of $30.0&#160;million to $40.0&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Accounting Pronouncements Recently Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">On November 1, 2021, we prospectively adopted ASU 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"> to the business combinations entered into during fiscal 2022. This update requires that an acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts with Customers.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Accounting Pronouncements Issued Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">and subsequent amendment to the initial guidance:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"> ASU 2021-01, Reference Rate Reform (Topic 848)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">: Scope (collectively, &#8220;Topic 848&#8221;). Topic 848 provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The guidance generally can be applied from March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of ASU 2020-04 on the Consolidated Condensed Financial Statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In November 2021, the FASB issued ASU 2021-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">This update requires annual disclosures about transactions with a government that are accounted for by applying a grant or contribution accounting model by analogy. This standard is effective for fiscal years beginning after December 15, 2021, and should be applied either prospectively or retrospectively. Early adoption is permitted. The Company is currently evaluating the impact of ASU 2021-10 on the Consolidated Condensed Financial Statements.</span></div>No other recently issued accounting pronouncements had or are expected to have a material impact on our Consolidated Financial Statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and accounting policies concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002061428496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Operating Leases</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 2. Operating Leases</span></div><div><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table presents information about leases on the Consolidated Balance Sheets: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.013%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.578%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.581%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">October&#160;31,<br/>(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfMi0wLTEtMS01ODUzNw_f2af3d8b-af98-47fa-9e18-c521fd473e5f"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfMi0wLTEtMS01ODUzNw_fafffb75-d216-4f4d-8142-6f0bc8bdcc25">Operating lease right-of-use assets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">230.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">257.0</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNC0wLTEtMS01ODUzNw_20f60483-65f4-4940-bd27-ff3038fea748"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNC0wLTEtMS01ODUzNw_238f6c6d-7462-42ec-bc2d-2f272994dc20">Operating lease liabilities, current</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35.7</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNS0wLTEtMS01ODUzNw_cd2a4655-0b1b-4300-89ec-ea2b04899df1"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNS0wLTEtMS01ODUzNw_efad86ee-3171-4680-acc9-262cd136b6e2">Operating lease liabilities, non-current</span></span> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">205.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">231.7</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">241.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">267.4</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Operating lease expense for the fiscal years ended October&#160;31, 2022, 2021 and 2020 was $45.0&#160;million, $44.1&#160;million and $41.2&#160;million.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Maturity of Lease Liabilities </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The minimum rental payments required under operating leases that have initial or remaining noncancellable lease terms in excess of one year as of October&#160;31, 2022 are: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.126%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">42.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">36.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">30.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">115.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">284.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">43.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">241.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002069364976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Joint Venture<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_BusinessCombinationAndAssetAcquisitionTextBlock', window );">Acquisitions and Joint Venture</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 3. Acquisitions and Joint Venture</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following is a summary of the allocation of the total purchase consideration for business and asset acquisitions that the Company completed during fiscal 2022, 2021, and 2020:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.190%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.190%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.193%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Technology</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">178.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">In-Process Research &amp; Development (IPR&amp;D)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">729.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">55.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total identifiable intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">786.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">208.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,184.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">91.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net tangible liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(286.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Fair value of contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(39.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total closing purchase price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,683.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">249.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">All acquisitions were funded by cash generated from operations or facility borrowings. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">For business acquisitions, the Company recorded tangible and intangible assets acquired and liabilities assumed at their fair values as of the applicable date of acquisition. For asset acquisitions, the Company recorded tangible and intangible assets acquired and liabilities assumed at their estimated and relative fair values as of the applicable date of acquisition.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company believes these acquisitions strengthen CooperSurgical's and CooperVision's businesses through the addition of new distributors or complementary products and services.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Fiscal Year 2022</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On May 31, 2022, CooperVision completed the acquisition of a privately-held Denmark-based contact lens distributor focusing on orthokeratology and scleral contact lenses. This acquisition expands CooperVision's ortho-k eye care portfolio in the Nordic market.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">On April 6, 2022, CooperSurgical completed the acquisition of a private cryopreservation services company that specializes in cryogenic services. The purchase price allocation is preliminary, and the Company is in the process of finalizing information primarily related to the effect on taxes and the corresponding impact on goodwill.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:110%">Refer to "Fiscal Year 2021" below for details on formation of a joint venture with Essilor International and related activities that occurred in fiscal year 2022 following the acquisition of SightGlass Vision, Inc. (SGV) in fiscal year 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">On April 6, 2022, CooperSurgical entered into an asset purchase agreement to acquire Cook Medical's Reproductive Health business, a manufacturer of minimally invasive medical devices focused on the fertility, obstetrics and gynecology markets. The aggregate consideration is $875.0&#160;million in cash, with $675.0&#160;million payable at the closing and the remaining $200.0&#160;million payable in $50.0&#160;million installments following each of the first, second, third and fourth anniversaries of the closing. The transaction is subject to customary closing conditions, such as receipt of required regulatory approvals.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Generate Life Sciences&#174;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">On December 17, 2021, CooperSurgical completed the acquisition of 100% of the equity interests in Generate Life Sciences (Generate), a privately held leading provider of donor egg and sperm for fertility treatments, fertility cryopreservation services and newborn stem cell storage (cord blood &amp; cord tissue), and paid an aggregate purchase consideration of approximately $1.663&#160;billion, reflecting working capital, and other adjustments. The cash consideration was funded through a combination of $1.5&#160;billion in proceeds from the issuance of a senior unsecured term loan and available cash on hand.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">The Company has accounted for the acquisition of Generate as a business combination, in accordance with ASC Topic 805, Business Combinations. The following table summarizes the preliminary fair values of assets acquired and liabilities assumed as of the acquisition date:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.335%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.465%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:107%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Cash and cash equivalents</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">58.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Trade accounts receivable, net</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Inventories</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Prepaid expense and other current assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Total current assets</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">113.5&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Property, plant and equipment</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">42.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,177.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">718.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Trademarks</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">54.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Other assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Total assets acquired</span></div></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">2,128.1&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Current liabilities:</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Accounts payable</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Employee compensation and benefits</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">68.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Other current liabilities</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">105.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Deferred tax liabilities</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">147.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Lease liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Deferred revenue</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">192.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Other long-term liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Total liabilities assumed</span></div></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">465.0&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Total purchase price</span></div></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">1,663.1&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">The Company is in the process of finalizing purchase accounting information primarily related to deferred tax adjustments and the corresponding impact on goodwill. The Company recorded measurement period adjustments of $115.3&#160;million to goodwill in fiscal 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Deferred revenue was recognized in accordance with ASC Topic 606, Revenue from Contracts with Customers, as a result of the adoption of ASU 2021-08. See Note 1. Organization and Significant Accounting Policies for additional information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company currently estimates that customer relationships will be amortized over 20 years and trademarks will be amortized over 15 years. Goodwill is primarily attributable to assembled workforce and expected synergies to be achieved. The goodwill recognized is not deductible for tax purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The transaction costs associated with the acquisition consisted primarily of legal, regulatory and financial advisory fees, which were expensed as incurred as selling, general and administrative expense.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Generate's revenue and net income for the period from the acquisition date to October 31, 2022, were </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">$249.5&#160;million and $27.8&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">, respectively. The following unaudited pro forma information summarizes the combined results of operations of the Company and Generate as if the acquisition had been completed at the beginning of the Company&#8217;s fiscal 2021:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.318%"><tr><td style="width:1.0%"/><td style="width:57.220%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.050%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.422%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.406%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.425%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:107%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:107%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">3,344.3&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">3,183.2&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">370.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">2,959.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The unaudited pro forma information for fiscal 2022 and 2021 was calculated after applying the Company's accounting policies and the impact of acquisition date fair value adjustments. The adjustments primarily include increased amortization for the fair value of acquired intangible assets, increased depreciation for the fair value of acquired property, plant, and equipment, </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">increased revenue as a result of the ASU 2021-08 deferred revenue adjustments, decreased interest expense as a result of the reversal of Generate's historical interest expense partially offset by additional interest expense on the debt obtained to finance the transaction.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The pro forma information does not reflect the effect of costs or synergies that would have been expected to result from the integration of the acquisition. The pro forma information does not purport to be indicative of the results of operations that actually would have resulted had the acquisition occurred at the beginning of fiscal 2021, or of future results of the consolidated entities.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Subsequent Event</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">On November 1, 2022, subsequent to the fiscal year ended October 31, 2022, CooperVision closed an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) to acquire a U.S. based privately held leading expert in specialty contact lenses for both normal and irregular corneal conditions. The Company is in the process of finalizing purchase accounting information.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Fiscal Year 2021</span></div><div style="margin-top:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On May 3, 2021, CooperSurgical completed the acquisition of a privately-held medical device company that develops single-use illumin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">ating medical devices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On April 26, 2021, CooperVision completed the acquisition of a privately-held UK contact lens manufacturer focusing on specialty contact lenses. This acquisition expands CooperVision&#8217;s specialty eye care portfolio and accelerates its development of myopia management solutions in the UK.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On March 1, 2021, CooperSurgical completed the acquisition of a privately-held medical device company that designed and developed an innovative obstetric product for use in urgent obstetrics to reduce risks associated with childbirth.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On February 1, 2021, CooperSurgical acquired all of the remaining equity interests of a privately-held medical device company that developed the Mara</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> Water Vapor Ablation System, which is used for endometrial ablation. The Company accounted for this acquisition as an asset acquisition, whereby the Company allocated the total cost of the acquisition to the net assets acquired on the basis of their estimated relative fair values on the acquisition date with no goodwill recognized. The primary asset acquired in this asset acquisition is Technology.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On January 19, 2021, CooperVision acquired all of the remaining equity interests of SGV, a privately-held medical device company that developed spectacle lenses for myopia management. The transaction included potential payments of future consideration that were contingent upon the achievement of the regulatory approval milestone (the regulatory approval payment) and the acquired business reaching certain revenue thresholds over a specified period (the revenue payments). The undiscounted range of the contingent consideration was zero to $139.1&#160;million payable to the other former equity interest owners.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The fair value of the regulatory approval payment was determined using an option pricing framework based on the expected payment under the contractual terms and the estimates of the probability of achieving the regulatory approval. The fair value of the revenue payments was determined using a Monte Carlo simulation based on the revenue projections and the expected payment for each simulation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In March 2022, the entities amended the terms of the contingent consideration, which resulted in CooperVision paying $42.9&#160;million to the former equity interest owners in exchange for the elimination of the revenue payments. CooperVision recognized a net gain of $12.2&#160;million during fiscal 2022. As of October 31, 2022, the remaining contingent liability related to regulatory approval payment was $31.8&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">In March 2022, CooperVision and Essilor International SAS (Essilor) entered into a Contribution Agreement and a Stock Purchase Agreement under which Essilor paid CooperVision $52.1&#160;million in exchange for a 50% interest in SGV and a proportionate share of certain revenue-based milestone payments related to the January 2021 acquisition of SGV by CooperVision. As part of these agreements, each party contributed their interest in SGV and $10&#160;million in cash to form a new joint venture. CooperVision then remeasured the fair value of its retained equity investment in the joint venture at $90.0&#160;million which resulted in a $56.9&#160;million gain in Other (income) expense on deconsolidation of SGV. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The fair value of the joint venture was determined using the income valuation approach. Under the income approach, we used a discounted cash flow model (&#8220;DCF&#8221;) in which cash flows anticipated over several periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate expected rate of return. The discount rate used for cash flows reflects capital market conditions and the specific risks associated with the business. This valuation approaches is considered a Level 3 fair value measurement. Fair value determination requires complex assumptions and judgment by management in projecting future operating results, selecting guideline companies for comparisons, determining appropriate </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">market value multiples, selecting the discount rate to measure the risks inherent in the future cash flows. Any material changes in key assumptions, including failure to meet business plans, deterioration in the financial market, an increase in interest rate or an increase in the cost of equity financing by market participants within the industry or other unanticipated events and circumstances, may affect such estimates.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On December 31, 2020, CooperSurgical completed the acquisition of a privately-held in vitro fertilization (IVF) cryostorage software solutions company.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The pro forma results of operations of these acquisitions have not been presented because the effect of the business combinations described above was not material to the consolidated results of operations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Fiscal Year 2020</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On August 7, 2020, CooperVision completed the acquisition of a privately-held U.S contact lens manufacturer focusing on ortho-k lenses. This acquisition expands CooperVision&#8217;s specialty eye care portfolio and its leadership in addressing the increasing severity and prevalence of myopia.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On December 13, 2019, CooperSurgical completed the acquisition of a privately-held distributor of IVF medical devices and systems.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The pro forma results of operations of these acquisitions have not been presented because the effect of the business combinations described above was not material to the consolidated results of operations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Contingent Consideration</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s business combinations involve potential payments of future consideration that are contingent upon the achievement of regulatory milestones and/or the acquired business reaching certain revenue thresholds. A liability is recorded for the estimated fair value of the contingent consideration on the acquisition date. The fair value of the contingent consideration is remeasured at each reporting period, and the change in fair value is recognized in selling, general and administrative expense in the Consolidated Statements of Income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the beginning and ending balances of contingent consideration:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.294%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.744%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.898%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">97.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Purchase price contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">31.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(55.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzQtMC0xLTEtNTg1Mzc_9604cf56-7a6c-46d2-bdf5-d8f031e83daf"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzQtMC0xLTEtNTg1Mzc_b92a1fd2-f912-44aa-9c7e-af89ec70cb06">Change in fair value</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(10.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">66.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">33.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">97.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_BusinessCombinationAndAssetAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination And Asset Acquisition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_BusinessCombinationAndAssetAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002186800352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Intangible Assets</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 4. Intangible Assets</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company has three reporting units: CooperVision and within the CooperSurgical segment, Office/Surgical and Fertility, reflecting the current way the Company manages its business. There was no impairment of goodwill in its reporting units in fiscal 2022, 2021, and 2020.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.334%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.578%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.578%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.582%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">CooperVision</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">CooperSurgical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,841.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">733.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,574.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,183.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,184.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(131.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(17.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(149.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,710.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,899.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,609.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Of the October&#160;31, 2022 goodwill balance, $214.1 million for CooperSurgical and $22.4 million for CooperVision is expected to be deductible for tax purposes. Of the October&#160;31, 2021 goodwill balance, $137.2&#160;million for CooperSurgical and $24.6&#160;million for CooperVision was expected to be deductible for tax purposes.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Other Intangible Assets</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.012%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.359%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;October 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Weighted Average Amortization Period (in years)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets with definite lives:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Trademarks</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">209.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">62.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">156.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Composite intangible asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,061.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">354.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,061.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">283.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">504.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">317.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">513.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">287.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,092.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">287.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">378.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">240.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">License and distribution rights and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">50.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">33.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,919.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,044.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,143.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">881.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: accumulated amortization and translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,044.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">881.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets with definite lives, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,874.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,261.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets with indefinite lives, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total other intangibles, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,885.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,271.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Intangible assets with indefinite lives include technology and trademarks.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Balances include foreign currency translation adjustments. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Intangible assets with definite lives are amortized over the estimated useful life of the assets. As of October&#160;31, 2022, the estimate of future amortization expenses for intangible assets with definite lives is as follows:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.786%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Fiscal years:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">183.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">179.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">169.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">162.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,180.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total remaining amortization for intangible assets with definite lives</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,874.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company considered the impact on its near and long-term forecasts from the general deterioration of economic and market conditions as a result of higher inflation, regional and global conflict, supply chain disruption, and the ongoing disruptions of the COVID-19 pandemic and determined that it was not more likely than not that the fair value of reporting units or relevant asset groups was below carrying amounts. Therefore, the Company determined that there was no impairment to either its definite-lived or indefinite-lived intangible assets during fiscal 2022, 2021 and 2020. There was an immaterial impairment charge related to our exit from the contact lens care business.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002070725504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financing Arrangements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Financing Arrangements</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 5. Financing Arrangements</span></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company had outstanding debt as follows:</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.107%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.413%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.416%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Overdraft and other credit facilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">57.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">83.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Term loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">338.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: unamortized debt issuance cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Short-term debt, excluding financing leases</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">395.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">82.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzctMC0xLTEtODU4NTc_141e84ec-4e7b-4dbb-a1d9-b69da3b28fc9"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzctMC0xLTEtODU4NTc_47c29b41-9b44-43cc-a1c4-67a03e586316">Financing lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Short-term debt</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">412.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Revolving credit</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">546.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Term loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,350.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">850.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: unamortized debt issuance cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-term debt, excluding financing leases</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,347.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,396.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzE2LTAtMS0xLTg1ODY1_1411df30-957e-4c30-8c9d-b44d0a42fc69"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzE2LTAtMS0xLTg1ODY1_b721c839-4714-4bc4-a058-6a751c018797">Financing lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,350.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,397.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,763.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,481.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of October&#160;31, 2022, the Company was in compliance with all debt covenants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Term Loan Agreement on December 17, 2021</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On December 17, 2021, the Company entered into a Term Loan Agreement (the 2021 Credit Agreement) by and among the Company, the lenders from time to time party thereto, and PNC Bank, National Association, as administrative agent. The 2021 Credit Agreement provides for a term loan facility (the 2021 Term Loan Facility) in an aggregate principal amount of $1.5&#160;billion, which, unless terminated earlier, matures on December 17, 2026. In addition, the Company has the ability from time to time to request an increase to the commitments under the 2021 Term Loan Facility or to establish a new term loan facility under the 2021 Credit Agreement in an aggregate principal amount not to exceed $1.125&#160;billion, upon prior written notice to the administrative agent and subject to the discretionary participation of the lenders funding such term loans and certain limitations set forth in the 2021 Credit Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Amounts outstanding under the 2021 Term Loan Facility will bear interest, at the Company&#8217;s option, at either (i) the alternate base rate, which is a rate per annum equal to the greatest of (a) the administrative agent&#8217;s prime rate, (b) one-half of one percent in excess of the federal funds effective rate and (c) one percent in excess of the adjusted London interbank offered rate (&#8220;LIBOR&#8221;) for a one-month interest period on such day, or (ii) the adjusted LIBOR, plus, in each case, an applicable rate of, initially, zero basis points, in respect of base rate loans, and 75 basis points, in respect of adjusted LIBOR loans. Following a specified period after the closing date, the applicable rates will be determined quarterly by reference to a grid based upon the Company&#8217;s ratio of consolidated net indebtedness to consolidated EBITDA, each as defined in the 2021 Credit Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company may prepay loan balances from time to time, in whole or in part, without premium or penalty (other than any related breakage costs).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On December 17, 2021, the Company borrowed $1.5&#160;billion under the 2021 Term Loan Facility and used the proceeds to fund the acquisition of Generate. Refer to Note 3. Acquisitions and Joint Venture for more details.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The interest rate on the 2021 Term Loan Facility was 4.44% at October&#160;31, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The 2021 Credit Agreement contains customary restrictive covenants, as well as financial covenants that require the Company to maintain a certain Total Leverage Ratio and Interest Coverage Ratio, each as defined in the 2021 Credit Agreement, consistent with the 2020 Credit Agreement discussed below.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Term Loan Agreement on November 2, 2021</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On November 2, 2021, the Company entered into a 364-day, $840.0&#160;million, term loan agreement by and among the Company, the lenders party thereto and The Bank of Nova Scotia, as administrative agent, which matured subsequent to year end on November 1, 2022. The Company used part of the funds to partially repay outstanding borrowings under the 2020 Revolving Credit Facility and for general corporate purposes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We repaid $502.0&#160;million during fiscal 2022. Amounts outstanding under the 2021 364-Day Term Loan Agreement will bear interest, at the Company&#8217;s option, at either the alternate base rate, or the adjusted LIBOR (each as defined in the 2021 364-Day Term Loan Agreement), plus, in the case of adjusted LIBOR loans, an applicable rate of 60 basis points.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The 2021 364-Day Term Loan Agreement contains customary restrictive covenants, as well as financial covenants that require the Company to maintain a certain total leverage ratio and interest coverage ratio, each as defined in the 2021 364-Day Term Loan Agreement, consistent with the 2020 Credit Agreement discussed below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Revolving Credit and Term Loan Agreement on April 1, 2020</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">On April 1, 2020, the Company entered into a Revolving Credit and Term Loan Agreement (the 2020 Credit Agreement), among the Company, CooperVision International Holding Company, LP, CooperSurgical Netherlands B.V., CooperVision Holding Kft. the lenders from time to time party thereto, and KeyBank National Association, as administrative agent. The 2020 Credit Agreement provides for (a)&#160;a multicurrency revolving credit facility (the 2020 Revolving Credit Facility) in an aggregate principal amount of $1.29 billion and (b)&#160;a term loan facility (the 2020 Term Loan Facility) in an aggregate principal amount of $850.0 million, each of which, unless terminated earlier, mature on April 1, 2025. The Company used $850.0&#160;million under the 2020 Term Loan Facility and $445.0&#160;million under the 2020 Revolving Credit Facility to fully repay all borrowings outstanding under a previously existing term loan agreement and transfer all letters of credit and borrowings outstanding under a previously existing credit agreement to the 2020 Credit Agreement. The Company has an uncommitted option to increase the revolving credit facility or establish a new term loan in an aggregate amount up to $1.605&#160;billion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On October 30, 2020, the Company entered into Amendment No. 1 to the 2020 Credit Agreement, adding CooperVision International Limited as a revolving borrower and releasing certain borrowers in the 2020 Credit Agreement. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">On December 17, 2021, the Company entered into Amendment No.2 to the 2020 Credit Agreement, modifying the 2020 Credit Agreement by, among other things, adding CooperSurgical Holdings Limited as a revolving borrower, releasing CooperVision Holding Kft as a borrower, and updating the benchmark replacement language in the 2020 Credit Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">The 2020 Credit Agreement will bear interest, at the Company&#8217;s option, at either the base rate, or the adjusted LIBOR or adjusted foreign currency rate, plus, in each case, an applicable rate of between 0.00% and 0.50% in respect of base rate loans, and between 0.75% and 1.50% in respect of adjusted LIBOR or adjusted foreign currency rate loans, in each case in accordance with a pricing grid tied to the Total Leverage Ratio, as defined in the 2020 Credit Agreement. The Company may borrow, repay and re-borrow amounts available under the Revolving Credit Facility, subject to voluntary reduction of the revolving commitment.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company pays an annual commitment fee that ranges from 0.10% to 0.20% of the unused portion of the 2020 Revolving Credit Facility based upon the Company&#8217;s Total Leverage Ratio, as defined in the 2020 Credit Agreement. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">At October&#160;31, 2022, the Company had $850.0 million outstanding under the 2020 Term Loan Facility and none outstanding under the 2020 Revolving Credit Facility. The interest rate on the 2020 Term Loan Facility was 4.13% at October&#160;31, 2022. The interest rate on the 2020 Revolving Credit Facility was 4.13% at October&#160;31, 2022.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Payments on the outstanding long-term debt balance of $850.0&#160;million are due in the fiscal year ending October 31, 2025.</span></div><div style="margin-top:6pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">European and Asian Pacific Credit Facilities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company maintains European credit facilities. The aggregate facility limit was $30.7 million and $35.8&#160;million at October&#160;31, 2022 and 2021, respectively. At October&#160;31, 2022, $12.3 million of the facilities was utilized and the weighted average interest rate on the outstanding balances was 2.46%. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company maintains Yen-denominated credit facilities in Japan. The aggregate facility limit was $73.0 million and $95.0&#160;million at October&#160;31, 2022 and 2021, respectively. At October&#160;31, 2022, $45.4 million of the combined facilities was utilized and the weighted average interest rate on the outstanding balances was 0.40%. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Each facility is supported by a continuing and unconditional guaranty.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002070799168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 6. Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Effective Tax Rate</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">The effective tax rates for fiscal 2022 and 2021 were 18.8% and (499.1)%, respectively. The increase was primarily due to an intra-group transfer of intellectual property in fiscal 2021 and UK tax rate change in fiscal 2021, as discussed below. The increase was also due to changes in the geographic composition of pre-tax earnings and changes in excess tax benefits from share-based compensation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">The effective tax rate for fiscal 2022 was lower than the US federal statutory rate primarily due to foreign earnings in jurisdictions with lower tax rates and changes in unrecognized tax benefits, partially offset by foreign earnings subject to US tax. The effective tax rate for fiscal 2021 was lower than the US federal statutory tax rate primarily due to the intra-group transfer, UK tax rate change, and earnings in foreign jurisdictions with lower tax rates partially offset by foreign earnings subject to US tax. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">In November 2020, the Company completed an intra-group transfer of certain intellectual property and related assets of CooperVision to a UK subsidiary as part of a group restructuring to establish headquarters operations in the UK. Determining fair value involved significant judgment related to future revenue growth, operating margins, and discount rates. The transfer resulted in a step-up of the UK tax-deductible basis in the intellectual property and goodwill, creating a temporary difference between the book basis and the tax basis of these assets. As a result, the Company recognized a deferred tax asset of $1,987.9&#160;million, with a corresponding income tax benefit, during the first quarter of fiscal 2021. During the third quarter of fiscal 2021, the Company recognized a $536.7&#160;million tax benefit related primarily to the remeasurement of this deferred tax asset caused by the UK enactment of a 25% corporate tax rate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Components of income before income taxes:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.884%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.064%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/>(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">31.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(31.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(88.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">443.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">522.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">354.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">475.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">491.5&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">266.5&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Components of provision for income taxes: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.884%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.064%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">29.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">45.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,492.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">53.9&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,502.2)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">89.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,453.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">28.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Reconciliation between the expected provision for income taxes at the US federal statutory rate and the provision for income taxes:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.884%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.064%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Provision for income taxes at United States statutory tax rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">99.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">103.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">56.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(Decrease) increase in taxes resulting from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign earnings in jurisdictions with lower tax rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(22.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(43.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(54.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign earnings subject to United States tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">25.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Excess tax benefits from share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred tax asset step-up</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(9.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United States provision-to-return</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intra-group transfer to UK subsidiary</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,987.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Remeasurement of deferred tax assets from UK rate change</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(536.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Change in unrecognized tax benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">State tax provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">89.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,453.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">28.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Components of deferred tax assets and liabilities:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.811%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.063%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accrued liabilities, reserves and compensation accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">79.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">78.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign deferred tax assets </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,500.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,531.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net operating loss and tax credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Capitalized research and experimental expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total gross deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,641.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,687.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(60.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(51.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,581.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,635.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Tax deductible goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(39.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(34.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(153.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(48.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(46.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(45.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(32.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total gross deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(287.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(113.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,293.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,522.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In assessing the realizability of deferred tax assets, the Company analyzes whether some or all deferred tax assets will not be realized. This analysis considers historical taxable income, the projected reversal of deferred tax liabilities, projected taxable income and tax planning strategies. Based upon this analysis, it is more likely than not the deferred tax assets, net of valuation allowance, will be realized. The increase in valuation allowance is primarily related to foreign tax attributes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">At October 31, 2022, the Company had federal net operating loss carryforwards of $65.4&#160;million and state net operating loss carryforwards of $97.3&#160;million. Federal net operating loss carryforwards of $17.1&#160;million expire on various dates between 2025 and 2037 and $48.3&#160;million do not expire. The state net operating loss carryforwards expire on various dates between 2026 through 2042.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">A tax benefit is recognized if it is more likely than not that a tax position will be sustained on its technical merits, based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Changes in unrecognized tax benefits:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.737%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.063%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">58.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Decrease based on tax positions in prior fiscal years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Increase based on tax positions in current fiscal year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">307.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lapses of statutes of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">353.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Decrease based on tax positions in prior fiscal years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lapses of statutes of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">336.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">These tax benefits, if recognized, would reduce provision for income taxes for 2022, 2021 and 2020, by $324.3&#160;million, $336.5&#160;million, and $46.0&#160;million, respectively. Interest and penalties related to unrecognized tax benefits are recognized in provision for income taxes. As of October 31, 2022, 2021 and 2020, accrued gross interest and penalties related to unrecognized tax benefits was $5.4&#160;million, $6.4&#160;million, and $7.3&#160;million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Included in the balance of unrecognized tax benefits at October 31, 2022 is $9.1&#160;million related to tax positions for which it is reasonably possible that the total amounts could change during the next twelve months.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Filed tax returns are subject to examination by tax authorities in major tax jurisdictions after fiscal 2016, including the UK and the US.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002069195632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 7. Earnings Per Share</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.285%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.135%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October 31,</span></td><td colspan="9" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions, except for earnings per share)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">385.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,944.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">238.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">Basic:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Weighted average common shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.83&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">59.80&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.85&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">Diluted:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Weighted average common shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Effect of dilutive stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Diluted weighted average common shares</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.6&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.76&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">59.16&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.81&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table sets forth stock options to purchase our common stock and restricted stock units that were not included in the diluted earnings per share calculation because their effect would have been antidilutive for the periods presented:</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.325%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.248%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.248%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.251%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October 31,</span></td><td colspan="9" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In thousands, except exercise prices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Stock option shares excluded</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Exercise prices</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$300.12 - $406.17</span></div></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">345.74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">304.54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Restricted stock units excluded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002068643376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 8. Stockholders&#8217; Equity</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Analysis of Changes in Accumulated Other Comprehensive Income (Loss):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.594%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.979%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.979%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Minimum Pension Liability</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(403.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(43.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(447.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gross change in value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(17.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(16.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(33.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(402.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(56.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(472.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gross change in value</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">82.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">146.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(15.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(320.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(34.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(341.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gross change in value</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(234.7)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">107.4&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">36.6&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(90.7)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(34.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(555.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">94.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(466.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Share Repurchases </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In December 2011, the Company's Board of Directors authorized the 2012 Share Repurchase Program and through subsequent amendments, the most recent in March 2017, the total repurchase authorization was increased from $500.0 million to $1.0 billion of the Company's common stock. This program has no expiration date and may be discontinued at any time. Purchases under the 2012 Share Repurchase Program are subject to a review of the circumstances in place at the time and may be made from time to time as permitted by securities laws and other legal requirements.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">For the years ended October&#160;31, 2022 and 2021, the Company's share repurchases were as follow:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.355%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.357%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Number of shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">191,165&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">69,622&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Average repurchase price per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">410.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">356.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total costs of shares repurchased (in millions)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">78.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">At October&#160;31, 2022, $256.4 million remained authorized for repurchase under the program.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002069142560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock Plans</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 9. Stock Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2007 Long-Term Incentive Plan (2007 Plan)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In March 2007, we received stockholder approval of the 2007 Plan. The 2007 Plan was subsequently amended and restated, and granted stockholder approval in March 2009, March 2011, and March 2016.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Third Amended and Restated 2007 Plan is designed to increase our stockholder value by attracting, retaining and motivating key employees and consultants who directly influence our profitability. The Third Amended and Restated 2007 Plan authorizes either our Board of Directors, or a designated committee thereof composed of two or more Non-Employee Directors, to grant to eligible individuals during the period ending December&#160;31, 2026, up to 6,930,000 shares in the form of specified equity awards including stock options, restricted stock units and performance share awards, subject to adjustment for future stock splits, stock dividends, expirations, forfeitures and similar events. RSUs have no dividend or voting rights prior to vesting. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of October&#160;31, 2022, 690,596 shares remained available under the Third Amended and Restated 2007 Plan for future grants. The amount of available shares includes shares which may be distributed under performance share awards.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Compensation expense and the related tax benefit recognized in our Consolidated Statements of Income for share-based awards, including the Employee Stock Purchase Plan, were as follows:</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.591%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.591%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.593%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October 31,</span></td><td colspan="9" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">46.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">38.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total compensation expense</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">54.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">44.7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">38.6&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Related income tax benefit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Stock Options </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The fair value of each stock option award granted is estimated on the date of grant using the Black-Scholes option valuation model and assumptions noted in the following table. </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.178%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.037%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Years Ended October&#160;31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.1 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.0 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.4 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">25.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">30.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The activity and status of our stock option plans are summarized below: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.508%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.971%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise&#160;Price<br/>Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Outstanding at October&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">972,692&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">245.09&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">122,760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">403.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(26,866)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">171.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(4,743)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">325.21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Outstanding at October&#160;31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,063,843&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">264.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.75</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Vested and expected to vest at October 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,038,594&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">262.91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.70</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">38,806,329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Vested and exercisable at October&#160;31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">624,512&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">223.45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.57</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35,586,767&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The weighted-average fair value of options granted during fiscal 2022, 2021 and 2020, estimated as of the grant date using the Black-Scholes option pricing model, for the 2007 Plan was $90.41, $84.10 and $70.45, respectively. The total intrinsic value of options exercised during the fiscal years ended October&#160;31, 2022, 2021 and 2020 was $6.6&#160;million, $64.7&#160;million and $22.6&#160;million, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Stock options outstanding under our current plans have been granted at prices which are either equal to or above the market value of the common stock on the date of grant. Options granted under the 2007 Plan generally vest over a range of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzY3ODM_6bc749ef-684e-4774-a7cb-72940d101aed">three</span> to five years based on service conditions and expire no later than ten years after the grant date. Options granted under the 2020 Directors' Plan generally vest in one year and expire no later than ten years after the grant date. We generally recognize compensation expense ratably over the vesting period. As of October&#160;31, 2022, there was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">$21.0&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> of total unrecognized compensation cost related to nonvested options, which is expected to be recognized over a remaining weighted-average vesting period of 2.3 years.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Restricted Stock Units</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">RSUs granted under the 2007 Plan generally vest over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzc1MjA_66aa3933-ae43-4ccf-b4c9-c3b93a1275c1">three</span> to five years. The grant-date fair value of RSUs is estimated based on the market price of our common stock. We recognize compensation expense ratably over the vesting period. As of October&#160;31, 2022, there was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">$64.4&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> of total unrecognized compensation cost related to nonvested RSUs, which is expected to be recognized over a remaining weighted-average vesting period of 2.5 years.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The status of our non-vested RSUs is summarized below:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.248%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.190%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.192%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant&#160;Date&#160;Fair<br/>Value&#160;Per&#160;Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-vested RSUs at October&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">317,335&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">293.80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">113,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">399.21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Vested and issued</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(113,301)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">271.74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(27,875)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">324.67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-vested RSUs at October&#160;31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">289,238&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">340.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Performance Units</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Performance units may be granted to selected key employees with vesting contingent upon meeting future reported earnings per share goals over a defined performance cycle, usually three years. Performance units, if earned, may be paid in cash or shares of common stock. We granted performance unit awards on December 8, 2020 under the 2007 Plan. The performance shares actually earned will range from zero to 200% of the target number of performance shares for performance periods ending in fiscal 2021 through fiscal 2024. Subject to limited exceptions set forth in the performance share plan, any shares earned will be distributed in the subsequent fiscal year after the performance period. The fair value of performance unit awards is estimated on the date of grant based on the current market price of our common stock and the estimate of probability of award achievement. This estimate is reviewed each fiscal quarter and adjustments are recorded if it is determined that the estimate of probability of award achievement has changed.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We recognize compensation expense ratably over the vesting period. As of October&#160;31, 2022, there was $11.2&#160;million of total unrecognized compensation cost related to non-vested performance units, which is expected to be recognized over a remaining weighted-average vesting period of 1.8 years.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On March 18, 2019, the Company received stockholder approval for the Employee Stock Purchase Plan (ESPP). The first offering period began on November 4, 2019 and offerings are generally made on a quarterly basis. The purpose of the ESPP is to provide eligible employees of the Company with the opportunity to acquire shares of common stock at 85% of the market price on the last business day of each offering period by means of accumulated payroll deductions. The ESPP initially authorized the issuance of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">1,000,000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> shares of common stock. These shares will be made available from shares of common stock reacquired by the Company as Treasury Stock. During fiscal 2022 and 2021, we issued 22,695 and 17,575 shares to our employees under the ESPP, respectively. At October&#160;31, 2022, the number of shares remaining available for future issuance under the ESPP was 948,090 shares. Total ESPP share-based compensation recognized during fiscal 2022 and 2021 was $1.1&#160;million and $1.0 million, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002069181136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Employee Benefits</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Cooper's Retirement Income Plan</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company's Retirement Income Plan (Plan), a defined benefit plan, is only available to full-time United States employees, subject to the soft freeze mentioned below. The Company's contributions are designed to fund normal cost on a current basis and to fund the estimated prior service cost of benefit improvements. The unit credit actuarial cost method is used to determine the annual cost. The Company pays the entire cost of the Plan and funds such costs as they accrue. Virtually all of the assets of the Plan are comprised of equities and participation in equity and fixed income funds.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company uses individual spot rates along the yield curve that correspond with the timing of each benefit payment to determine the service and interest costs of components of its net periodic benefit cost utilizing the correlation of projected cash outflows and corresponding spot rates on the yield curve. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table sets forth the Plan's benefit obligations and fair value of the Plan assets at October&#160;31, 2022, 2021 and 2020 and the funded status of the Plan and net periodic pension costs for each of the years in the three-year periods ended October&#160;31, 2022. The net amounts recognized in the Consolidated Balance Sheets consist of noncurrent liabilities. The accumulated benefit obligation was $134.9 million, $207.6 million and $195.8 million for the years ended October&#160;31, 2022, 2021 and 2020.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Retirement Income Plan</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.049%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.677%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Change in benefit obligation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Benefit obligation, beginning of year</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">230.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">218.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">189.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzQtMC0xLTEtNTg1Mzc_111e8ddc-226d-4304-959a-b934b7d622c2"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzQtMC0xLTEtNTg1Mzc_36ebe715-6c70-4c33-ab4e-77078f30596f"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzQtMC0xLTEtNTg1Mzc_8ba49eaf-48ae-4cbc-b09c-7e9a7b0ad98d">Interest cost</span></span></span></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(11.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Actuarial (gain)/loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(93.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Benefit obligation, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">148.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">230.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">218.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Change in plan assets</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">199.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">159.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">136.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(43.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">38.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(11.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Fair value of plan assets, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">142.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">199.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">159.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Funded status at end of year</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(31.4)</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(59.3)</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.049%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.677%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amounts recognized in accumulated other comprehensive income consist of:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net loss</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">44.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">74.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">44.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">74.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.049%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.677%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Reconciliation of (prepaid) accrued pension cost:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(Prepaid)/Accrued pension cost at prior fiscal year end</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(14.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Contributions made during the year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(23.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(Prepaid)/Accrued pension cost at fiscal year end</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(14.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.049%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.677%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Components of net periodic benefit cost and other amounts recognized in the Consolidated Statements of Income:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net periodic benefit cost:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzUtMC0xLTEtNTg1Mzc_07a95161-0974-465a-ac1c-175b72fdb90d"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzUtMC0xLTEtNTg1Mzc_34fc253a-7253-4b21-920e-c9ce51841c5c"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzUtMC0xLTEtNTg1Mzc_73a230e2-9634-4eba-833b-aa7156e9f4ce">Expected return on plan assets</span></span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(15.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzgtMC0xLTEtNTg1Mzc_08e3d8ed-42a7-4cda-a134-26367a3edca1"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzgtMC0xLTEtNTg1Mzc_40c89b78-ce45-4552-a50e-59b206d64cbd"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzgtMC0xLTEtNTg1Mzc_c32484f2-1db6-4923-b0d9-5be0212a7130">Recognized actuarial loss</span></span></span></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net periodic pension cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.049%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.677%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Other changes in plan assets and benefit obligations recognized in other comprehensive income:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net (gain) loss</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(34.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(24.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amortizations of net gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total recognized in other comprehensive (income) loss</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(36.6)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(29.8)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total recognized in net periodic benefit cost and other comprehensive (income) loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(26.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(15.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">29.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.049%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.677%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Years Ended October&#160;31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Weighted-average assumptions used in computing the net periodic pension cost and projected benefit obligation at year end:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Discount rate for determining net periodic pension cost:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Projected Benefit Obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Service Cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.86&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest Cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Discount rate for determining benefit obligations at year end</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Rate of compensation increase for determining expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Rate of compensation increase for determining benefit obligations at year end</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Expected rate of return on plan assets for determining net periodic pension cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Expected rate of return on plan assets at year end</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Measurement date for determining assets and benefit obligations at year end</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10/31/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10/31/2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10/31/2020</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The discount rate enables us to state expected future cash flows at a present value on the measurement date. The discount rate used for the Plan is based primarily on the yields of a universe of high-quality corporate bonds rated AA or above, with durations corresponding to the expected durations of the benefit obligations. A change in the discount rate will cause the present value of benefit obligations to change in the opposite direction. If a discount rate of 2.76%, which is 0.02% lower than prior fiscal year, had been used, the projected benefit obligation would have been $217.2 million, and the accumulated benefit obligation would have been $194.2 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The expected rate of return on plan assets was determined based on a review of historical returns, both for this plan and for medium- to large-sized defined benefit pension funds with similar asset allocations. This review generated separate expected returns for each asset class listed below. These expected future returns were then blended based on this Plan's target asset allocation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Reasons for Significant Liability Gains and Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The projected benefit obligation experienced a net gain of approximately $93.2&#160;million during the year. This net gain is primarily due to gains from assumption changes of approximately $97.1&#160;million, offset by losses of approximately $3.9&#160;million </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">due to demographic experience. The key assumption changes were the increase in the discount rate (gain of $72.7&#160;million), a change in the assumed payment form election probabilities (gain of $0.3&#160;million), and changes in assumptions for lump sum determination (gain of $24.1&#160;million). The primary reasons for demographic losses were the net effect of retirement rates, termination rates, salary increases and other experience that was different from assumed. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Plan Assets</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Weighted-average asset allocations at year end, by asset category are as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.719%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.450%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.450%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.453%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Years Ended October&#160;31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Asset category</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Equity mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">65.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">62.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">57.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Hedging Strategy Funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Bond mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">27.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Plan invests in a diversified portfolio of assets intended to minimize risk of poor returns while maximizing expected portfolio returns. To achieve the long-term rate of return, plan assets will be invested in a mixture of instruments, including but not limited to, corporate common stock (may include the Company's stock), investment grade bond funds, cash, balanced funds, real estate funds, small or large cap equity funds and international equity funds. The allocation of assets will be determined by the investment manager and will typically include 50% to 70% equities with the remainder invested in fixed income, hedging strategy funds and cash. Presently, this diversified portfolio is expected to return roughly 8% in the long run.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of the measurement date of October&#160;31, 2022, the fair value measurement of plan assets is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.541%"><tr><td style="width:1.0%"/><td style="width:47.287%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.499%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in Active<br/>Markets for<br/>Identical&#160;Assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Significant<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Asset category</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Equity mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">93.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">93.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Hedging Strategy Funds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Bond mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">38.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">142.9&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">118.8&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Plan has an established process for determining the fair value of plan assets. For investments in equity and bond mutual funds, and real estate funds, fair value is based on observable, Level 1 inputs.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">While the Company believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Plan Cash Flows</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Contributions</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company made no contributions to the Plan in fiscal 2022. The Company contributions to the Plan were $12.7&#160;million for fiscal 2021 and, $23.4&#160;million for fiscal 2020. The Company closely monitors the funded status of the Plan with respect to legislative and accounting rules. The Company does not expect to make a contribution to the Plan during fiscal 2023.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Estimated Future Benefit Payments</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.349%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.451%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2024</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2026</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2027</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2028-2032</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">66.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Plan Soft Freeze</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On June 18, 2019 the Board of Directors of the Company approved a soft freeze of the Plan effective August 1, 2019. The Plan was closed to employees hired on or after August 1, 2019, including former participants or employees rehired on or after August 1, 2019 and employees hired in connection with a stock or asset acquisition, merger or other similar transaction on or after August 1, 2019. Existing employees already covered by the Plan, continue to accrue their benefits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Cooper's 401(k) Savings Plan</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Cooper's 401(k) savings plan provides for the deferral of compensation as described in the Internal Revenue Code and is available to substantially all United States employees. Employees who participate in the 401(k) plan may elect to have up to 75% of their pre-tax salary or wages deferred and contributed to the trust established under the Plan. Cooper's contributions on account of participating employees, were $9.0 million, $7.2 million and $6.8 million for the years ended October&#160;31, 2022, 2021 and 2020, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002069237392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Contingencies</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 11. Contingencies </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company is involved in various lawsuits, claims and other legal matters from time to time that arise in the ordinary course of conducting business, including matters involving our products, intellectual property, supplier relationships, distributors, competitor relationships, employees and other matters. The Company does not believe that the ultimate resolution of these proceedings or claims pending against it could have a material adverse effect on its financial condition or results of operations. At each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">. Legal fees are expensed as incurred.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002069084096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Business Segment Information</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 12. Business Segment Information</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company discloses information about its operating segments, which were established based on the way that management organizes segments within the Company for making operating decisions and assessing financial performance. The Company's two operating segments are described below. </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.68pt">CooperVision. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Competes in the worldwide contact lens market by developing, manufacturing and marketing a broad range of products for contact lens wearers, featuring advanced materials and optics.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.68pt">CooperSurgical. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Competes in the general health care market with a focus on advancing the health of women, babies and families through a diversified portfolio of products and services focusing on women's health and fertility.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company uses operating income, as presented in our financial reports, as the primary measure of segment profitability. The Company does not allocate costs from corporate functions to segment operating income. The Company uses the same accounting policies to generate segment results as it does for consolidated results.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">No customers accounted for 10% or more of our consolidated net revenue in fiscal 2022, 2021 and 2020. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Total identifiable assets are those used in continuing operations except cash and cash equivalents, which the Company includes as corporate assets. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table presents a summary of our business segment net sales:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.591%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.591%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.593%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision net sales by category:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Toric lens</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">737.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">697.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">598.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Multifocal lens</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">264.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">238.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">197.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Single-use sphere lens</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">661.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">616.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">529.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non single-use sphere, other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">579.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">599.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">518.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total CooperVision net sales</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,243.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,152.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,843.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperSurgical net sales by category:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Office and surgical products</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">633.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">451.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">358.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fertility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">431.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">319.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">229.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total CooperSurgical net sales</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,065.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">770.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">587.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,308.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,922.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,430.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Information by business segment for each of the years in the three-year period ended October&#160;31, 2022, follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.312%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.591%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.120%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.591%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.594%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">CooperVision</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">CooperSurgical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,243.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,065.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,308.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">494.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">67.1&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(53.8)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">507.6&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">57.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other (income), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(25.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">475.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Identifiable assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,778.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,407.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">305.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11,492.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">144.5&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">166.6&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">147.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">179.5&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">223.0&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">242.0&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,152.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">770.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,922.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">481.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">71.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(47.3)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">505.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other (income), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">491.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Identifiable assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,965.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,395.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">244.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,606.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">148.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">163.2&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">110.4&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">146.1&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">190.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24.4&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">214.4&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,843.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">587.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,430.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">375.7&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(14.7)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(49.2)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">311.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">36.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">266.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Identifiable assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,236.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,293.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">207.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,737.5&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">138.2&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">149.9&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32.4&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">104.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">137.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">260.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">50.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">310.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Information by geographical area by country of domicile for each of the years in the three-year period ended October&#160;31, 2022, follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.591%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.591%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.591%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.594%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">United<br/>States</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Rest of<br/>World,&#160;Other<br/>Eliminations<br/>&amp; Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales to unaffiliated customers</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,638.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">987.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">682.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,308.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Sales between geographic areas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">514.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">897.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,411.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,152.9&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,884.5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(729.0)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,308.4&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">71.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">403.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">507.6&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-lived assets</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">856.1&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">310.8&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">266.0&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,432.9&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales to unaffiliated customers</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,339.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">957.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">625.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,922.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Sales between geographic areas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">494.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">815.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,310.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,834.1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,773.0&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(684.6)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,922.5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating (loss) income</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(26.8)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">416.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">116.4&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">505.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-lived assets</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">737.5&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">377.2&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">232.9&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,347.6&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales to unaffiliated customers</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,103.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">789.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">537.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,430.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Sales between geographic areas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">391.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">327.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(718.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,495.3&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,116.9&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(181.3)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,430.9&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating (loss) income</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(14.5)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">304.4&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">311.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-lived assets</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">721.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">363.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">197.6&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,281.9&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002069402272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Derivatives and Hedging<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Financial Derivatives and Hedging</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Note 13. Financial Derivatives and Hedging</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As part of the Company&#8217;s overall risk management practices the Company enters into financial derivatives, interest rate swaps designated as cash flow hedges, to hedge the Company's exposure to changes in cash flows associated with its variable rate debt.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Credit risk related to derivative transactions reflects the risk that a party to the transaction could fail to meet its obligation under the derivative contracts. Therefore, the Company&#8217;s exposure to the counterparty&#8217;s credit risk is generally limited to the amounts, if any, by which the counterparty&#8217;s obligations to the Company exceed the Company&#8217;s obligations to the counterparty. The Company&#8217;s policy is to enter into contracts only with financial institutions which meet certain minimum credit ratings to help mitigate counterparty credit risk.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">On April 6, 2020 the Company entered into six interest rate swap contracts which were used to hedge its exposure to changes in cash flows associated with its variable rate debt and were designated as derivatives in a cash flow hedge. The payment streams were based on a total notional amount of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">$1.5&#160;billion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> at the inception of the contracts. As of October&#160;31, 2022, three of the six interest rate swap contracts have matured and the outstanding contracts have a total notional amount of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">$1.0&#160;billion and remaining maturities of five years or less.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company did not have any cross-currency swaps or foreign currency forward contracts as of October&#160;31, 2022.</span></div><div style="margin-bottom:7pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The pre-tax impact of gain on derivatives designated for hedge accounting recognized in other comprehensive income (loss) was&#160;$124.5 million&#160;($30.1 million, net of tax) as of October&#160;31, 2022. The pre-tax impact of gain on derivatives designated for hedge accounting recognized in other comprehensive income (loss) was&#160;$17.2&#160;million&#160;($13.1&#160;million, net of tax) as of October&#160;31, 2021. The fair value of derivative instruments are classified in "Other non-current assets" on our consolidated balance sheets.</span></div><div style="margin-bottom:7pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table summarizes the amounts recognized with respect to our derivative instruments within the accompanying Consolidated Statements of Income:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.080%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.301%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Periods Ended October 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Derivatives designated as cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Location of Loss (Income) Recognized on Derivatives</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest expense (income)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company expects that ($38.3 million) recorded as a component of accumulated other comprehensive income (loss) will be realized in the Consolidated Statements of Income over the next twelve months and the amount will vary depending on prevailing interest rates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table details the changes in accumulated other comprehensive income:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.658%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.378%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance as of October 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(17.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amount recognized in other comprehensive income on interest rate swap contracts, gross ($20.0, net of tax)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amount reclassified from other comprehensive income into earnings, gross ($6.1, net of tax)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance gain as of October 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amount recognized in other comprehensive income on interest rate swap contracts, gross ($79.7, net of tax)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">105.1&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amount reclassified from other comprehensive income into earnings, gross ($1.7, net of tax)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance gain as of October 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">124.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002069310672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">Schedule II</a></td>
<td class="text"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Schedule II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">THE COOPER COMPANIES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">VALUATION AND QUALIFYING ACCOUNTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Three Years Ended October&#160;31, 2022 </span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.201%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.201%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.201%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.203%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Balance<br/>Beginning<br/>of Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Reductions/ Charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Balance<br/>at End<br/>of Year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred income tax valuation allowance:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Year Ended October&#160;31, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">51.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">60.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Year Ended October&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">45.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">51.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Year Ended October&#160;31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">41.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">45.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002060836320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Principles of Consolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The financial statements in this report include the results of all of Cooper's consolidated entities. All significant intercompany transactions and balances are eliminated on consolidation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The preparation of Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of net sales and expenses during the reporting period. Actual results could differ from those estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In particular, the COVID-19 pandemic negatively impacted business and healthcare activity globally. As a result of healthcare systems responding to the demands of managing the pandemic, governments around the world imposing measures designed to reduce the transmission of the COVID-19 virus, and individuals responding to the concerns of contracting the COVID-19 virus, many optical practitioners and retailers, hospitals, medical offices and fertility clinics closed their facilities, restricted access, or delayed or canceled patient visits, exams and elective medical procedures, and many customers that have reopened are experiencing reduced patient visits. These factors have had, and in the future may have, an adverse effect on our sales, operating results and cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The full extent to which the pandemic will directly or indirectly impact the Company's business, results of operations, and financial condition, including sales, expenses, manufacturing, clinical trials, research and development costs, reserves and allowances, fair value measurements, asset impairment charges, contingent consideration obligations, and the effectiveness of the Company's hedging instruments, will depend on future developments that are highly uncertain and difficult to predict. These developments include, but are not limited to, the duration and spread of the outbreak (including new and more contagious variants of COVID-19), its severity, the actions to contain the virus or address its impact, the timing, distribution, public acceptance and efficacy of vaccines and other treatments, United States and foreign government actions to respond to the reduction in global economic activity, and how quickly and to what extent normal economic and operating conditions can resume. There was not a material impact to the estimates in the Company&#8217;s Consolidated Financial Statements for fiscal 2022. </span></div>The Company continually monitors and evaluates the estimates used as additional information becomes available. Adjustments will be made to these provisions periodically to reflect new facts and circumstances that may indicate that historical experience may not be indicative of current and/or future results. The Company&#8217;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material changes to the estimates and material impacts to the Company&#8217;s Consolidated Financial Statements in future reporting periods.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue recognition</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Net Sales </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company sells its products principally to a limited number of distributors, group purchasing organizations, eye care or health care professionals including independent practices, corporate retailers, hospitals and clinics or authorized resellers (collectively, its Customers). These Customers may subsequently resell the Company&#8217;s products to eye care or health care providers and patients. In addition to product supply and distribution agreements with Customers, the Company enters into arrangements with health care providers and payors that provide for government-mandated and/or privately negotiated rebates, chargebacks and discounts with respect to the purchase of the Company&#8217;s products. The Company considers purchase orders, which in some cases are governed by master sales agreements, to be contracts with a customer. As part of its consideration of the contract, the Company evaluates certain factors including the customer&#8217;s ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Revenues from product sales are recognized when the Customer obtains control of the Company&#8217;s product, which occurs at a point in time, typically upon shipment or delivery to the Customer. Taxes collected from Customers relating to product sales and remitted to governmental authorities are excluded from revenues. The Company expenses incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that the Company would have recognized is one year or less. See Note 12. Business Segment Information for disaggregation of revenue.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Reserves for Variable Consideration</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Revenues from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration for which reserves are established and which result from discounts, returns, chargebacks, rebates and other allowances that are offered within contracts between the Company and its Customers, health care providers, payors and other indirect customers relating to the Company&#8217;s sales of its products. These reserves are based on the amounts earned or to be claimed on the related sales and are classified primarily in current liabilities. Variable consideration is estimated based on the most likely amount or expected value approach, depending on which method the Company expects to better predict the amount of consideration to which it will be entitled. Once the Company elects one of the methods to estimate variable consideration for a particular type of performance obligation, the Company applies that method consistently.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Where appropriate, these estimates take into consideration a range of possible outcomes which are probability-weighted for relevant factors such as the Company&#8217;s historical experience, current contractual and statutory requirements, specific known market events and trends, industry data and forecasted customer buying and payment patterns. Overall, these reserves reflect the Company&#8217;s best estimates of the amount of consideration to which it is entitled based on the terms of the contract.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Trade Discounts and Allowances</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company generally provides Customers with discounts, which include incentive fees that are stated in the Company&#8217;s contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized. </span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Product Returns</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Consistent with industry practice, the Company generally offers Customers a limited right of return for a product that has been purchased from the Company. The Company estimates the amount of its product sales that may be returned by its Customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized. Historically, returns have been infrequent and insignificant relative to our total sales. Our refund liability for product returns was $14.5 million </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">and&#160;$13.7 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;at&#160;October&#160;31, 2022 and 2021, respectively, which is included in Accrued Liabilities on our Consolidated Balance Sheets and represents the expected value of the aggregate refunds that will be due to our customers.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Rebates and Chargebacks</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Rebates are estimated based on contractual terms, historical experience, customer mix, trend analysis and projected market conditions in the various markets served.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Chargebacks for fees and discounts to providers represent the estimated obligations resulting from contractual commitments to sell products to qualified healthcare providers at prices lower than the list wholesale prices charged to the Company&#8217;s direct customers. For certain office and surgical products in CooperSurgical, customers charge the Company for the difference between what they pay for the product and the ultimate selling price to the qualified healthcare providers. These reserves are established in the same period that the related revenue is recognized, resulting in a reduction of product revenue. Chargeback amounts are generally determined at the time of resale to the qualified healthcare provider by customers. CooperSurgical rebates are predominately related to the Medicaid rebate provision that is estimated based upon contractual terms, historical experience, and trend analysis.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Contract Liabilities</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Deferred revenue primarily represents prepaid stem cell storage as part of the CooperSurgical business unit. Revenue related to stem cell storage is recognized over the service period, which can range from one year to the lifetime of a customer.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-based Compensation</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We grant various share-based compensation awards, including stock options, performance unit shares, restricted stock and restricted stock units. The Company accounts for share-based compensation expense based on estimated grant-date fair value, and expenses the amount over the vesting period of the award. Determining the fair value of share-based awards at the grant date requires judgment, including estimating Cooper's stock price volatility, employee exercise behaviors and related employee forfeiture rates. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The expected life of the share-based awards is based on the observed and expected time to post-vesting forfeiture and/or exercise. Groups of employees that have similar historical exercise behavior are considered separately for valuation purposes. In determining the expected volatility, management considers implied volatility from publicly-traded options on Cooper's common stock at the date of grant, historical volatility and other factors. The risk-free interest rate is based on the continuous rates provided by the United States Treasury with a term equal to the expected life of the award. The dividend yield is based on the projected annual dividend payment per share, divided by the stock price at the date of grant.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Forfeitures are estimated at the time of grant, based on historical experience, and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Foreign Currency Translation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span>Most of our operations outside the United States use their local currency as their functional currency. We translate these assets and liabilities into United States dollars at year-end exchange rates. We translate income and expense accounts at average rates for each month. We record gains and losses from the translation of financial statements in foreign currencies into United States dollars in other comprehensive income. We record gains and losses from changes in exchange rates on transactions denominated in currencies other than each reporting location's functional currency in net income for each period.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Financial Derivatives and Hedging</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Financial Derivatives and Hedging</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Derivatives are recorded on the Consolidation Balance Sheets at fair value. Accounting for gains or losses resulting from changes in the values of those derivatives depends on the use of the derivative instrument and whether it qualifies for hedge accounting.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">The gain or loss on derivative instruments designated and qualifying for cash flow hedge accounting is deferred in other comprehensive income. The changes in fair value for all trades that are not designated for hedge accounting are recognized in current period earnings. Deferred gains or losses from designated cash flow hedges are reclassified into earnings in the period that the hedged interest expense affects earnings. The effectiveness of cash flow hedges is assessed at inception and quarterly thereafter. The Company does not offset fair value amounts recognized for derivative instruments in its Consolidated Balance Sheets for presentation purposes.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:107%">Fair Value Measurements</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Accounting standards define fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value. An asset&#8217;s or liability&#8217;s level is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are valued and disclosed in one of the following three levels of the valuation hierarchy:</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Level 1: Quoted market prices in active markets for identical assets or liabilities.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Level 3: Unobservable inputs reflecting the reporting entity&#8217;s own assumptions.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The carrying value of cash and cash equivalents, accounts receivable, prepaid expense and other current assets, lines of credit, accounts payable and other current liabilities approximate fair value due to the short-term nature of such instruments and the ability to obtain financing on similar terms. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The carrying value of the Company's revolving credit facility and term loans approximates fair value based on current market rates (Level 2).</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The fair value of the Company's&#160;interest&#160;rate&#160;swap&#160;contracts is measured on a recurring basis by netting the discounted future fixed cash payments and the discounted expected variable cash receipts. The variable cash receipts are based on the expectation of future interest rates (forward curves) derived from observable market interest rate&#160;curves. The&#160;interest&#160;rate&#160;swap&#160;contracts were categorized as Level 2 in the fair value hierarchy, as the inputs to the derivative pricing model are generally observable and do not contain a high level of subjectivity. The gain or loss on the derivatives is recorded as a component of accumulated other comprehensive income and subsequently reclassified into interest expense in the same period during which the hedged transaction affects earnings. Refer to Note 13. Financial Derivatives and Hedging for further information.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company uses fair value measures when determining assets and liabilities acquired in an acquisition, which are considered a Level 3 measurement. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The fair value of the Company's contingent consideration for which a liability is recorded and the initial measurement of the joint venture interest are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> a Level 3 measurement</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">and the change in fair value is recognized in selling, </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">general and administrative expense in the Consolidated Statements of Income.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Note 3. Acquisitions and Joint Venture for further information.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income taxes</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Income taxes</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Income taxes are estimated based on enacted income tax laws and the results of operations in each jurisdiction. Deferred tax assets and liabilities are estimated based on temporary differences between the financial reporting basis and income tax basis of assets and liabilities. Deferred tax assets are also estimated based on net operating loss and tax credit carryforwards. Deferred tax assets are reduced by a valuation allowance to the extent it is more likely than not they are not expected to be realized. Adjustments to deferred tax assets and liabilities due to changes in tax laws, changes in jurisdiction from intra-group transfers of assets, and changes in judgment regarding a valuation allowance are recognized in provision for income taxes in the quarter in which such changes occur. Long-term tax payable is estimated income tax to be paid for unrecognized tax benefits. A tax benefit is recognized if it is more likely than not a tax position will be sustained based on its technical merits in a tax authority examination, based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority. Adjustments to unrecognized tax benefits due to changes in judgment are recognized in provision for income taxes in the quarter in which such changes occur. Interest and penalties related to unrecognized tax benefits are recognized in provision for income taxes.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Earnings Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We determine basic earnings per share (EPS) by using the weighted average number of shares outstanding. We determine diluted EPS by increasing the weighted average number of shares outstanding in the denominator by the number of outstanding dilutive equity awards using the treasury stock method.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company considers all short-term, highly liquid investments purchased with maturities of three months or less to be&#160;cash equivalents.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost or net realizable value. Cost is computed using standard cost that approximates actual cost, on a first-in, first-out basis.</span></div>In assessing the value of inventories, we make estimates and judgments regarding aging of inventories and other relevant issues potentially affecting the salable condition of products and estimated prices at which those products will sell. On an ongoing basis, we review the carrying value of our inventory, measuring number of months on hand and other indications of salability. We reduce the value of inventory if there are indications that the carrying value is greater than net realizable value, resulting in a new, lower-cost basis for that inventory. Subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis. While estimates are involved, historically, obsolescence has not been a significant factor due to long product dating and lengthy product life cycles.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We record property, plant, and equipment at cost. We compute depreciation expense using the straight-line method over the estimated useful lives of the assets. Useful lives are generally 3 to 15 years except for buildings which are depreciated over 30 to 40 years and leasehold improvements, which we amortize over the shorter of the useful life or the lease term. We charge maintenance and repairs to expense as we incur them.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Leases </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We consider an arrangement a lease if the arrangement transfers the right to control the use of an identified asset in exchange for consideration. We have operating leases, but do not have material financing leases. The Company primarily has operating leases for office, manufacturing and warehouse space, vehicles, and office equipment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Lease right-of-use assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make payments arising from the lease agreement. These assets and liabilities are recognized at the commencement of the lease based upon the present value of the future minimum lease payments over the lease term. The lease term reflects the noncancellable period of the lease together with periods covered by an option to extend or terminate the lease when management is reasonably certain that it will exercise such option. Changes in the lease term assumption could impact the right-of-use assets and lease liabilities recognized on the Consolidated Balance Sheets. As our leases typically do not contain a readily determinable implicit rate, we determine the present value of the lease liability using our incremental borrowing rate at the lease commencement date based on the lease term on a collateralized basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company&#8217;s operating leases typically include non-lease components such as common-area maintenance costs. The Company has elected to include non-lease components with lease payments for the purpose of calculating lease right-of-use assets and liabilities, to the extent that they are fixed. Non-lease components that are not fixed are expensed as incurred as variable lease payments.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Leases with a term of one year or less are not recognized on the Consolidated Balance Sheets, while the associated lease payments are expensed in the Consolidated Statements of Income and Comprehensive Income on a straight-line basis over the lease term.</span></div>Operating leases are classified in &#8220;Other current liabilities&#8221;, &#8220;Accrued pension liability and other&#8221;, and &#8220;Other assets&#8221; on our consolidated balance sheets. Operating lease expense is recognized on a straight-line basis over the expected lease term and included in selling, general and administrative expenses in the Consolidated Statements of Income. Financing leases are classified in "Property, plant and equipment", "Short-term debt", and "Long-term debt" on our consolidated balance sheets.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InternalUseSoftwarePolicy', window );">Cloud Computing Arrangements</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Cloud Computing Arrangements </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">The Company capitalizes certain costs related to the acquisition and development of internal use software, including implementation costs incurred in a cloud computing arrangement, during the application development stages of projects. Capitalized implementation costs are amortized on a straight-line basis over the expected term of the hosting arrangement, which includes consideration of the non-cancellable contractual term and reasonably certain renewals. Costs incurred during the preliminary project or the post-implementation/operation stages of the project are expensed as incurred. Implementation costs are included in &#8220;Other assets&#8221; in the Consolidated Balance Sheets. Amortization of capitalized implementation costs is included in the same line item in the Consolidated Statements of Income as the expense for fees for the associated hosting arrangement.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Valuation of goodwill</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Valuation of goodwill</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We evaluate goodwill for impairment annually during the fiscal third quarter and when an event occurs or circumstances change such that it is reasonably possible that impairment may exist. Goodwill is tested for impairment at the reporting unit level by performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. We perform a qualitative assessment to test each reporting unit's goodwill for impairment, which </span></div>includes industry and market considerations, overall financial performance and other relevant events and factors affecting each reporting unit. Based on our qualitative assessment, if we determine that the fair value of a reporting unit is more likely than not to be less than its carrying amount, the fair value of a reporting unit will be compared with its carrying amount and an impairment charge will be recognized for the amount that the carrying value exceeds the fair value of the reporting unit.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock', window );">Long-lived Assets</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%">Long-lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We review long-lived assets held and used, intangible assets with definite useful lives and assets held for sale for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If an evaluation of recoverability is required, the estimated undiscounted future cash flows associated with the asset group are compared to the asset group's carrying amount to determine if a write-down is required. If the undiscounted cash flows are less than the carrying amount, an impairment loss is recorded to the extent that the carrying amount exceeds the fair value. If management has committed to a plan to dispose of long-lived assets, the assets to be disposed of are reported at the lower of carrying amount or fair value less estimated costs to sell.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy', window );">Indefinite-lived Intangible Assets</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Indefinite-lived Intangible Assets</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We assess indefinite-lived intangible assets annually in the third quarter of the fiscal year, or whenever events or changes in circumstances indicate that the carrying amount of an indefinite-lived intangible asset (asset group) may not be recoverable. We evaluate whether the indefinite-lived intangible asset is impaired by comparing its carrying value to its fair value. If the carrying value of an indefinite-lived intangible asset is not recoverable, an impairment loss is recognized based on the amount by which the carrying value exceeds the fair value.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business combinations</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Business combinations</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We routinely consummate business combinations. Results of operations for acquired companies are included in our consolidated results of operations from the date of acquisition. We recognize separately from goodwill, the identifiable assets acquired, including acquired in-process research and development, the liabilities assumed, and any noncontrolling interest in the acquiree at the acquisition date fair values as defined by accounting standards related to fair value measurements. Key assumptions routinely utilized in allocation of purchase price to intangible assets include discount rates and projected financial information such as revenue projections for companies acquired. As of the acquisition date, goodwill is measured as the excess of consideration given, over the net of the acquisition date fair values of the identifiable assets acquired and the liabilities assumed. Direct acquisition costs are expensed as incurred.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Litigation</a></td>
<td class="text">LitigationWe are subject to various legal proceedings, claims, litigation, investigations and contingencies arising out of the ordinary course of business. If we believe the likelihood of an adverse legal outcome is probable and the amount is estimable, we accrue a liability in accordance with accounting guidance for contingencies. We consult with legal counsel on matters related to litigation and seek input both within and outside the Company.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityPolicyTextBlock', window );">Treasury Stock</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Treasury Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We record treasury stock purchases under the cost method whereby the entire cost of the acquired stock is recorded as treasury stock.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Accounting Pronouncements Recently Adopted and Accounting Pronouncements Issued Not Yet Adopted</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Accounting Pronouncements Recently Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">On November 1, 2021, we prospectively adopted ASU 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"> to the business combinations entered into during fiscal 2022. This update requires that an acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts with Customers.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Accounting Pronouncements Issued Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">and subsequent amendment to the initial guidance:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"> ASU 2021-01, Reference Rate Reform (Topic 848)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">: Scope (collectively, &#8220;Topic 848&#8221;). Topic 848 provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The guidance generally can be applied from March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of ASU 2020-04 on the Consolidated Condensed Financial Statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In November 2021, the FASB issued ASU 2021-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">This update requires annual disclosures about transactions with a government that are accounted for by applying a grant or contribution accounting model by analogy. This standard is effective for fiscal years beginning after December 15, 2021, and should be applied either prospectively or retrospectively. Early adoption is permitted. The Company is currently evaluating the impact of ASU 2021-10 on the Consolidated Condensed Financial Statements.</span></div>No other recently issued accounting pronouncements had or are expected to have a material impact on our Consolidated Financial Statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144439<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for indefinite-lived intangible assets (that is, those intangible assets not subject to amortization). This accounting policy also may address how the entity assesses whether events and circumstances continue to support an indefinite useful life and how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalUseSoftwarePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 40<br> -Section 30<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=118172244&amp;loc=d3e17916-109280<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 50<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=16397303&amp;loc=d3e19379-109286<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalUseSoftwarePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e543-108305<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21459-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002069134768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of inventory</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.802%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">173.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">137.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">439.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">433.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">628.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">585.6&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of property, plant and equipment</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.802%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Land and improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">20.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">415.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">388.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,973.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,863.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">393.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">383.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Property, plant and equipment, at cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,800.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,655.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,387.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,308.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,413.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,347.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease ROU assets, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,432.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,347.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002059517120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Leases on the Consolidated Condensed Balance Sheet</a></td>
<td class="text"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table presents information about leases on the Consolidated Balance Sheets: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.013%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.578%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.581%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">October&#160;31,<br/>(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfMi0wLTEtMS01ODUzNw_f2af3d8b-af98-47fa-9e18-c521fd473e5f"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfMi0wLTEtMS01ODUzNw_fafffb75-d216-4f4d-8142-6f0bc8bdcc25">Operating lease right-of-use assets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">230.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">257.0</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNC0wLTEtMS01ODUzNw_20f60483-65f4-4940-bd27-ff3038fea748"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNC0wLTEtMS01ODUzNw_238f6c6d-7462-42ec-bc2d-2f272994dc20">Operating lease liabilities, current</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35.7</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNS0wLTEtMS01ODUzNw_cd2a4655-0b1b-4300-89ec-ea2b04899df1"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNS0wLTEtMS01ODUzNw_efad86ee-3171-4680-acc9-262cd136b6e2">Operating lease liabilities, non-current</span></span> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">205.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">231.7</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">241.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">267.4</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Minimum rental payments required under operating leases</a></td>
<td class="text"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The minimum rental payments required under operating leases that have initial or remaining noncancellable lease terms in excess of one year as of October&#160;31, 2022 are: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.126%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">42.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">36.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">30.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">115.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">284.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">43.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">241.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002066865056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Joint Venture (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedAndAssetAcquisitionsTableTextBlock', window );">Total purchase consideration for business and asset acquisitions</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following is a summary of the allocation of the total purchase consideration for business and asset acquisitions that the Company completed during fiscal 2022, 2021, and 2020:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.190%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.190%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.193%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Technology</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">178.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">In-Process Research &amp; Development (IPR&amp;D)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">729.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">55.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total identifiable intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">786.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">208.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,184.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">91.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net tangible liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(286.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Fair value of contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(39.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total closing purchase price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,683.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">249.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of recognized identified assets acquired and liabilities assumed</a></td>
<td class="text">The following table summarizes the preliminary fair values of assets acquired and liabilities assumed as of the acquisition date:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.335%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.465%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:107%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Cash and cash equivalents</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">58.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Trade accounts receivable, net</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Inventories</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Prepaid expense and other current assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Total current assets</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">113.5&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Property, plant and equipment</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">42.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,177.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">718.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Trademarks</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">54.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Other assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Total assets acquired</span></div></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">2,128.1&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Current liabilities:</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Accounts payable</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Employee compensation and benefits</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">68.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Other current liabilities</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">105.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Deferred tax liabilities</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">147.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Lease liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Deferred revenue</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">192.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Other long-term liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Total liabilities assumed</span></div></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">465.0&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Total purchase price</span></div></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">1,663.1&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Contingent consideration reconciliation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the beginning and ending balances of contingent consideration:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.294%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.744%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.898%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">97.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Purchase price contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">31.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(55.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzQtMC0xLTEtNTg1Mzc_9604cf56-7a6c-46d2-bdf5-d8f031e83daf"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzQtMC0xLTEtNTg1Mzc_b92a1fd2-f912-44aa-9c7e-af89ec70cb06">Change in fair value</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(10.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">66.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">33.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">97.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Schedule of business acquisition, pro forma information</a></td>
<td class="text">The following unaudited pro forma information summarizes the combined results of operations of the Company and Generate as if the acquisition had been completed at the beginning of the Company&#8217;s fiscal 2021:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.318%"><tr><td style="width:1.0%"/><td style="width:57.220%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.050%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.422%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.406%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.425%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:107%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:107%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">3,344.3&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">3,183.2&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">370.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">2,959.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedAndAssetAcquisitionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Recognized Identified Assets Acquired And Liabilities Assumed And Asset Acquisitions [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedAndAssetAcquisitionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002060449248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of goodwill</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.334%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.578%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.578%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.582%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">CooperVision</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">CooperSurgical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,841.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">733.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,574.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,183.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,184.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(131.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(17.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(149.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,710.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,899.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,609.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of finite-lived intangible assets</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Other Intangible Assets</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.012%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.359%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;October 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Weighted Average Amortization Period (in years)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets with definite lives:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Trademarks</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">209.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">62.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">156.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Composite intangible asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,061.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">354.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,061.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">283.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">504.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">317.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">513.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">287.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,092.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">287.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">378.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">240.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">License and distribution rights and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">50.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">33.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,919.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,044.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,143.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">881.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: accumulated amortization and translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,044.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">881.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets with definite lives, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,874.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,261.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets with indefinite lives, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total other intangibles, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,885.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,271.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Intangible assets with indefinite lives include technology and trademarks.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of indefinite-lived intangible assets</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Other Intangible Assets</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.012%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.359%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;October 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Weighted Average Amortization Period (in years)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets with definite lives:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Trademarks</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">209.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">62.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">156.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Composite intangible asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,061.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">354.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,061.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">283.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">504.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">317.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">513.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">287.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,092.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">287.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">378.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">240.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">License and distribution rights and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">50.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">33.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,919.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,044.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,143.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">881.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: accumulated amortization and translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,044.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">881.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets with definite lives, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,874.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,261.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets with indefinite lives, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total other intangibles, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,885.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,271.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Intangible assets with indefinite lives include technology and trademarks.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock', window );">Remaining amortization expenses for intangible assets with definite lives</a></td>
<td class="text">As of October&#160;31, 2022, the estimate of future amortization expenses for intangible assets with definite lives is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.786%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Fiscal years:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">183.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">179.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">169.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">162.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,180.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total remaining amortization for intangible assets with definite lives</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,874.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002069245520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of debt</a></td>
<td class="text"><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company had outstanding debt as follows:</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.107%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.413%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.416%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Overdraft and other credit facilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">57.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">83.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Term loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">338.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: unamortized debt issuance cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Short-term debt, excluding financing leases</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">395.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">82.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzctMC0xLTEtODU4NTc_141e84ec-4e7b-4dbb-a1d9-b69da3b28fc9"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzctMC0xLTEtODU4NTc_47c29b41-9b44-43cc-a1c4-67a03e586316">Financing lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Short-term debt</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">412.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Revolving credit</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">546.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Term loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,350.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">850.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: unamortized debt issuance cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-term debt, excluding financing leases</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,347.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,396.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzE2LTAtMS0xLTg1ODY1_1411df30-957e-4c30-8c9d-b44d0a42fc69"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzE2LTAtMS0xLTg1ODY1_b721c839-4714-4bc4-a058-6a751c018797">Financing lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,350.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,397.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,763.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,481.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002066858304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Income before income taxes</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Components of income before income taxes:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.884%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.064%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/>(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">31.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(31.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(88.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">443.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">522.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">354.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">475.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">491.5&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">266.5&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Provision for income taxes</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Components of provision for income taxes: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.884%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.064%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">29.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">45.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,492.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">53.9&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,502.2)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">89.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,453.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">28.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Reconciliation between the expected provision for income taxes at the US federal statutory rate and the provision for income taxes</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Reconciliation between the expected provision for income taxes at the US federal statutory rate and the provision for income taxes:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.884%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.064%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Provision for income taxes at United States statutory tax rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">99.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">103.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">56.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(Decrease) increase in taxes resulting from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign earnings in jurisdictions with lower tax rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(22.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(43.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(54.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign earnings subject to United States tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">25.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Excess tax benefits from share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred tax asset step-up</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(9.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">United States provision-to-return</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intra-group transfer to UK subsidiary</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,987.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Remeasurement of deferred tax assets from UK rate change</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(536.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Change in unrecognized tax benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">State tax provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">89.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,453.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">28.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Deferred tax assets and liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Components of deferred tax assets and liabilities:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.811%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.063%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accrued liabilities, reserves and compensation accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">79.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">78.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign deferred tax assets </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,500.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,531.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net operating loss and tax credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Capitalized research and experimental expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total gross deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,641.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,687.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(60.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(51.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,581.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,635.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Tax deductible goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(39.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(34.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(153.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(48.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(46.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(45.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(32.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total gross deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(287.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(113.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,293.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,522.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Changes in unrecognized tax benefits</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Changes in unrecognized tax benefits:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.737%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.063%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">58.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Decrease based on tax positions in prior fiscal years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Increase based on tax positions in current fiscal year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">307.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lapses of statutes of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">353.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Decrease based on tax positions in prior fiscal years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lapses of statutes of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">336.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI https://asc.fasb.org/extlink&amp;oid=126976462&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002068055744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of earnings per share</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.285%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.135%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October 31,</span></td><td colspan="9" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions, except for earnings per share)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">385.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,944.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">238.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">Basic:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Weighted average common shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.83&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">59.80&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.85&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">Diluted:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Weighted average common shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Effect of dilutive stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Diluted weighted average common shares</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49.6&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.76&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">59.16&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.81&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Stock options to purchase common stock and restricted stock units not included in diluted earnings per share calculation due to antidilutive effect</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table sets forth stock options to purchase our common stock and restricted stock units that were not included in the diluted earnings per share calculation because their effect would have been antidilutive for the periods presented:</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.325%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.248%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.248%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.251%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October 31,</span></td><td colspan="9" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In thousands, except exercise prices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Stock option shares excluded</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Exercise prices</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$300.12 - $406.17</span></div></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">345.74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">304.54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Restricted stock units excluded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002068045488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Changes in accumulated other comprehensive (loss) income</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Analysis of Changes in Accumulated Other Comprehensive Income (Loss):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.594%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.979%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.979%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Minimum Pension Liability</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(403.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(43.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(447.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gross change in value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(17.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(16.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(33.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(402.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(56.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(472.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gross change in value</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">82.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">146.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(15.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(320.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(34.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(341.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gross change in value</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(234.7)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">107.4&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">36.6&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(90.7)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(34.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(555.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">94.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(466.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table details the changes in accumulated other comprehensive income:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.658%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.378%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance as of October 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(17.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amount recognized in other comprehensive income on interest rate swap contracts, gross ($20.0, net of tax)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amount reclassified from other comprehensive income into earnings, gross ($6.1, net of tax)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance gain as of October 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amount recognized in other comprehensive income on interest rate swap contracts, gross ($79.7, net of tax)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">105.1&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amount reclassified from other comprehensive income into earnings, gross ($1.7, net of tax)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance gain as of October 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">124.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock', window );">Schedule of share repurchases</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">For the years ended October&#160;31, 2022 and 2021, the Company's share repurchases were as follow:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.355%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.357%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Number of shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">191,165&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">69,622&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Average repurchase price per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">410.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">356.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total costs of shares repurchased (in millions)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">78.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23309-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTreasuryStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002059556272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Compensation expense and related income tax benefit for share-based awards</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Compensation expense and the related tax benefit recognized in our Consolidated Statements of Income for share-based awards, including the Employee Stock Purchase Plan, were as follows:</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.591%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.591%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.593%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">October 31,</span></td><td colspan="9" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">46.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">38.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total compensation expense</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">54.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">44.7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">38.6&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Related income tax benefit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Assumptions used in estimating fair value of stock options award granted</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.178%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.037%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Years Ended October&#160;31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.1 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.0 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.4 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">25.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">30.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of stock option plans</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The activity and status of our stock option plans are summarized below: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.508%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.971%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise&#160;Price<br/>Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Outstanding at October&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">972,692&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">245.09&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">122,760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">403.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(26,866)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">171.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(4,743)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">325.21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Outstanding at October&#160;31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,063,843&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">264.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.75</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Vested and expected to vest at October 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,038,594&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">262.91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.70</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">38,806,329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Vested and exercisable at October&#160;31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">624,512&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">223.45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.57</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35,586,767&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of non-vested RSUs</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The status of our non-vested RSUs is summarized below:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.248%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.190%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.192%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant&#160;Date&#160;Fair<br/>Value&#160;Per&#160;Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-vested RSUs at October&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">317,335&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">293.80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">113,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">399.21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Vested and issued</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(113,301)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">271.74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(27,875)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">324.67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-vested RSUs at October&#160;31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">289,238&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">340.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002062582944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock', window );">Changes in benefit obligation, changes in plan assets and funded status</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table sets forth the Plan's benefit obligations and fair value of the Plan assets at October&#160;31, 2022, 2021 and 2020 and the funded status of the Plan and net periodic pension costs for each of the years in the three-year periods ended October&#160;31, 2022. The net amounts recognized in the Consolidated Balance Sheets consist of noncurrent liabilities. The accumulated benefit obligation was $134.9 million, $207.6 million and $195.8 million for the years ended October&#160;31, 2022, 2021 and 2020.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Retirement Income Plan</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.049%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.677%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Change in benefit obligation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Benefit obligation, beginning of year</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">230.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">218.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">189.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzQtMC0xLTEtNTg1Mzc_111e8ddc-226d-4304-959a-b934b7d622c2"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzQtMC0xLTEtNTg1Mzc_36ebe715-6c70-4c33-ab4e-77078f30596f"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzQtMC0xLTEtNTg1Mzc_8ba49eaf-48ae-4cbc-b09c-7e9a7b0ad98d">Interest cost</span></span></span></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(11.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Actuarial (gain)/loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(93.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Benefit obligation, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">148.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">230.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">218.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Change in plan assets</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">199.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">159.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">136.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(43.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">38.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(11.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Fair value of plan assets, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">142.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">199.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">159.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Funded status at end of year</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(31.4)</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(59.3)</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock', window );">Amounts recognized in accumulated other comprehensive Income</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.049%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.677%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amounts recognized in accumulated other comprehensive income consist of:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net loss</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">44.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">74.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">44.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">74.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock', window );">Reconciliation of prepaid (accrued) pension cost</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.049%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.677%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Reconciliation of (prepaid) accrued pension cost:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(Prepaid)/Accrued pension cost at prior fiscal year end</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(14.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Contributions made during the year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(23.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(Prepaid)/Accrued pension cost at fiscal year end</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(14.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Components of net periodic pension costs and other amounts recognized in other comprehensive income</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.049%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.677%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Components of net periodic benefit cost and other amounts recognized in the Consolidated Statements of Income:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net periodic benefit cost:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzUtMC0xLTEtNTg1Mzc_07a95161-0974-465a-ac1c-175b72fdb90d"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzUtMC0xLTEtNTg1Mzc_34fc253a-7253-4b21-920e-c9ce51841c5c"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzUtMC0xLTEtNTg1Mzc_73a230e2-9634-4eba-833b-aa7156e9f4ce">Expected return on plan assets</span></span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(15.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzgtMC0xLTEtNTg1Mzc_08e3d8ed-42a7-4cda-a134-26367a3edca1"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzgtMC0xLTEtNTg1Mzc_40c89b78-ce45-4552-a50e-59b206d64cbd"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzgtMC0xLTEtNTg1Mzc_c32484f2-1db6-4923-b0d9-5be0212a7130">Recognized actuarial loss</span></span></span></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net periodic pension cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock', window );">Other changes in plan assets and benefit obligations recognized in other comprehensive income</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.049%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.677%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years Ended October&#160;31,<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Other changes in plan assets and benefit obligations recognized in other comprehensive income:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net (gain) loss</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(34.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(24.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amortizations of net gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total recognized in other comprehensive (income) loss</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(36.6)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(29.8)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total recognized in net periodic benefit cost and other comprehensive (income) loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(26.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(15.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">29.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock', window );">Weighted-average assumptions used in computing net periodic pension cost and projected benefit obligation</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.049%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.677%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Years Ended October&#160;31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Weighted-average assumptions used in computing the net periodic pension cost and projected benefit obligation at year end:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Discount rate for determining net periodic pension cost:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Projected Benefit Obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Service Cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.86&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest Cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Discount rate for determining benefit obligations at year end</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Rate of compensation increase for determining expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Rate of compensation increase for determining benefit obligations at year end</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Expected rate of return on plan assets for determining net periodic pension cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Expected rate of return on plan assets at year end</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Measurement date for determining assets and benefit obligations at year end</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10/31/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10/31/2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10/31/2020</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock', window );">Weighted-average asset allocations and fair value measurement of plan assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Plan Assets</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Weighted-average asset allocations at year end, by asset category are as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.719%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.450%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.450%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.453%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Years Ended October&#160;31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Asset category</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Equity mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">65.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">62.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">57.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Hedging Strategy Funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Bond mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">27.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of the measurement date of October&#160;31, 2022, the fair value measurement of plan assets is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.541%"><tr><td style="width:1.0%"/><td style="width:47.287%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.499%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in Active<br/>Markets for<br/>Identical&#160;Assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Significant<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Asset category</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Equity mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">93.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">93.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Hedging Strategy Funds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Bond mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">38.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">142.9&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">118.8&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock', window );">Estimated future benefit payments</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Estimated Future Benefit Payments</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.349%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.451%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Years<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2024</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2026</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2027</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2028-2032</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">66.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Reconciliation Of Prepaid (Accrued) Pension Cost [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in the benefit obligation, fair value of plan assets, and funded status of pension plans or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(b)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts related to pension plans and/or other employee benefit plans in accumulated other comprehensive income or loss that have not yet been recognized as components of net periodic benefit cost, such as the net gain (loss), net prior service cost or credit, and net transition asset or obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002069168032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock', window );">Schedule of business segment net sales</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table presents a summary of our business segment net sales:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.591%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.591%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.593%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperVision net sales by category:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Toric lens</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">737.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">697.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">598.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Multifocal lens</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">264.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">238.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">197.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Single-use sphere lens</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">661.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">616.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">529.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non single-use sphere, other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">579.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">599.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">518.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total CooperVision net sales</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,243.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,152.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,843.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CooperSurgical net sales by category:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Office and surgical products</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">633.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">451.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">358.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fertility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">431.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">319.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">229.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total CooperSurgical net sales</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,065.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">770.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">587.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,308.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,922.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,430.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of business segment information</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Information by business segment for each of the years in the three-year period ended October&#160;31, 2022, follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.312%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.591%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.120%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.591%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.594%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">CooperVision</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">CooperSurgical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,243.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,065.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,308.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">494.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">67.1&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(53.8)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">507.6&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">57.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other (income), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(25.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">475.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Identifiable assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,778.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,407.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">305.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11,492.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">144.5&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">166.6&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">147.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">179.5&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">223.0&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">242.0&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,152.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">770.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,922.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">481.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">71.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(47.3)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">505.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other (income), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">491.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Identifiable assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,965.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,395.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">244.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,606.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">148.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">163.2&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">110.4&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">146.1&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">190.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24.4&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">214.4&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,843.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">587.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,430.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">375.7&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(14.7)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(49.2)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">311.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">36.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">266.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Identifiable assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,236.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,293.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">207.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,737.5&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">138.2&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">149.9&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32.4&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">104.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">137.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">260.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">50.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">310.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock', window );">Schedule of information by geographical area by country of domicile</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Information by geographical area by country of domicile for each of the years in the three-year period ended October&#160;31, 2022, follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.591%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.591%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.591%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.594%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">United<br/>States</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Rest of<br/>World,&#160;Other<br/>Eliminations<br/>&amp; Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales to unaffiliated customers</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,638.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">987.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">682.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,308.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Sales between geographic areas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">514.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">897.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,411.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,152.9&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,884.5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(729.0)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,308.4&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">71.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">403.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">507.6&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-lived assets</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">856.1&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">310.8&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">266.0&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,432.9&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales to unaffiliated customers</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,339.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">957.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">625.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,922.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Sales between geographic areas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">494.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">815.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,310.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,834.1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,773.0&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(684.6)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,922.5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating (loss) income</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(26.8)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">416.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">116.4&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">505.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-lived assets</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">737.5&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">377.2&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">232.9&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,347.6&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales to unaffiliated customers</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,103.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">789.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">537.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,430.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Sales between geographic areas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">391.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">327.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(718.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net sales</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,495.3&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,116.9&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(181.3)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,430.9&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating (loss) income</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(14.5)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">304.4&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">311.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-lived assets</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">721.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">363.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">197.6&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,281.9&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002067994656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Derivatives and Hedging (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Derivative instruments recognized in condensed consolidated statements of income</a></td>
<td class="text"><div style="margin-bottom:7pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table summarizes the amounts recognized with respect to our derivative instruments within the accompanying Consolidated Statements of Income:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.080%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.301%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Periods Ended October 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Derivatives designated as cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Location of Loss (Income) Recognized on Derivatives</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest expense (income)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Changes in accumulated other comprehensive (loss) income</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Analysis of Changes in Accumulated Other Comprehensive Income (Loss):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.594%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.979%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.979%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Minimum Pension Liability</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(403.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(43.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(447.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gross change in value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(17.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(16.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(33.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(402.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(56.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(472.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gross change in value</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">82.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">146.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(15.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(320.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(34.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(341.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Gross change in value</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(234.7)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">107.4&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">36.6&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(90.7)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(34.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance at October 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(555.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">94.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(466.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The following table details the changes in accumulated other comprehensive income:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.658%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.378%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance as of October 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(17.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amount recognized in other comprehensive income on interest rate swap contracts, gross ($20.0, net of tax)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amount reclassified from other comprehensive income into earnings, gross ($6.1, net of tax)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance gain as of October 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amount recognized in other comprehensive income on interest rate swap contracts, gross ($79.7, net of tax)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">105.1&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amount reclassified from other comprehensive income into earnings, gross ($1.7, net of tax)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance gain as of October 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">124.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for cash flow hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002059638064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Oct. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2022 </div>
<div>USD ($) </div>
<div>business_unit</div>
</th>
<th class="th">
<div>Oct. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_NumberOfBusinessUnits', window );">Number of business units | business_unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerRefundLiability', window );">Refund liability for product returns</a></td>
<td class="nump">$ 14.5<span></span>
</td>
<td class="nump">$ 14.5<span></span>
</td>
<td class="nump">$ 13.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Net foreign exchange loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.0<span></span>
</td>
<td class="nump">$ 5.5<span></span>
</td>
<td class="nump">$ 1.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit charges</a></td>
<td class="nump">$ 9.2<span></span>
</td>
<td class="nump">33.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortizationPeriod', window );">Capitalized contract cost, amortization period (or less)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Total exit costs expected</a></td>
<td class="nump">$ 30.0<span></span>
</td>
<td class="nump">$ 30.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Total exit costs expected</a></td>
<td class="nump">$ 40.0<span></span>
</td>
<td class="nump">$ 40.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">40 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_NumberOfBusinessUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Business Units</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_NumberOfBusinessUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessExitCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessExitCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortizationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization period of cost capitalized in obtaining or fulfilling contract with customer, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126905575&amp;loc=SL49131251-203054<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortizationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerRefundLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 27<br> -URI https://asc.fasb.org/extlink&amp;oid=126920602&amp;loc=SL49130611-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerRefundLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002067158096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies - Inventory (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 173.7<span></span>
</td>
<td class="nump">$ 137.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">15.2<span></span>
</td>
<td class="nump">14.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">439.8<span></span>
</td>
<td class="nump">433.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">$ 628.7<span></span>
</td>
<td class="nump">$ 585.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002063560000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies - Property Plant and Equipment (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">$ 2,800.9<span></span>
</td>
<td class="nump">$ 2,655.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation</a></td>
<td class="nump">1,387.2<span></span>
</td>
<td class="nump">1,308.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">1,413.7<span></span>
</td>
<td class="nump">1,347.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization', window );">Finance lease ROU assets, net</a></td>
<td class="nump">19.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property, plant and equipment, net</a></td>
<td class="nump">1,432.9<span></span>
</td>
<td class="nump">1,347.6<span></span>
</td>
<td class="nump">$ 1,281.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember', window );">Land and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">18.7<span></span>
</td>
<td class="nump">20.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">415.6<span></span>
</td>
<td class="nump">388.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">1,973.6<span></span>
</td>
<td class="nump">1,863.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">$ 393.0<span></span>
</td>
<td class="nump">$ 383.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002060443536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Operating Leases - Leases on the Consolidated Condensed Balance Sheet (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 230.1<span></span>
</td>
<td class="nump">$ 257.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other assets<span></span>
</td>
<td class="text">Other assets<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current</a></td>
<td class="nump">$ 35.5<span></span>
</td>
<td class="nump">$ 35.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other current liabilities<span></span>
</td>
<td class="text">Other current liabilities<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, non-current</a></td>
<td class="nump">$ 205.5<span></span>
</td>
<td class="nump">$ 231.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Accrued pension liability and other<span></span>
</td>
<td class="text">Accrued pension liability and other<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 241.0<span></span>
</td>
<td class="nump">$ 267.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (in years)</a></td>
<td class="text">9 years 9 months 18 days<span></span>
</td>
<td class="text">10 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Assets And Liabilities, Lessee [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002069401136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease expense</a></td>
<td class="nump">$ 45.0<span></span>
</td>
<td class="nump">$ 44.1<span></span>
</td>
<td class="nump">$ 41.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002063655104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Operating Leases - Minimum Rental Payments Required Under Operating Leases (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 42.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">36.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">32.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">30.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">26.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">115.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">284.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: interest</a></td>
<td class="nump">43.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 241.0<span></span>
</td>
<td class="nump">$ 267.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002059787680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions and Joint Venture - Total Purchase Consideration for Business and Asset Acquisitions (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems', window );"><strong>Schedule Of Business Acquisitions And Asset Acquisition, By Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 3,609.7<span></span>
</td>
<td class="nump">$ 2,574.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_BusinessAcquisitionAndAssetAcquisitionAxis=coo_SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember', window );">Series Of Individually Immaterial Business Acquisitions And Asset Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems', window );"><strong>Schedule Of Business Acquisitions And Asset Acquisition, By Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Total identifiable intangible assets</a></td>
<td class="nump">786.5<span></span>
</td>
<td class="nump">208.0<span></span>
</td>
<td class="nump">$ 20.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,184.8<span></span>
</td>
<td class="nump">91.6<span></span>
</td>
<td class="nump">15.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet', window );">Net tangible liabilities</a></td>
<td class="num">(286.5)<span></span>
</td>
<td class="num">(10.8)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="num">(1.5)<span></span>
</td>
<td class="num">(39.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total closing purchase price</a></td>
<td class="nump">1,683.3<span></span>
</td>
<td class="nump">249.7<span></span>
</td>
<td class="nump">35.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_BusinessAcquisitionAndAssetAcquisitionAxis=coo_SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember', window );">Series Of Individually Immaterial Business Acquisitions And Asset Acquisitions | Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems', window );"><strong>Schedule Of Business Acquisitions And Asset Acquisition, By Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Total identifiable intangible assets</a></td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">178.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_BusinessAcquisitionAndAssetAcquisitionAxis=coo_SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember', window );">Series Of Individually Immaterial Business Acquisitions And Asset Acquisitions | In-Process Research &amp; Development (IPR&amp;D)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems', window );"><strong>Schedule Of Business Acquisitions And Asset Acquisition, By Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Total identifiable intangible assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">20.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_BusinessAcquisitionAndAssetAcquisitionAxis=coo_SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember', window );">Series Of Individually Immaterial Business Acquisitions And Asset Acquisitions | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems', window );"><strong>Schedule Of Business Acquisitions And Asset Acquisition, By Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Total identifiable intangible assets</a></td>
<td class="nump">729.2<span></span>
</td>
<td class="nump">7.5<span></span>
</td>
<td class="nump">11.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_BusinessAcquisitionAndAssetAcquisitionAxis=coo_SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember', window );">Series Of Individually Immaterial Business Acquisitions And Asset Acquisitions | Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems', window );"><strong>Schedule Of Business Acquisitions And Asset Acquisition, By Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Total identifiable intangible assets</a></td>
<td class="nump">55.4<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">5.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_BusinessAcquisitionAndAssetAcquisitionAxis=coo_SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember', window );">Series Of Individually Immaterial Business Acquisitions And Asset Acquisitions | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems', window );"><strong>Schedule Of Business Acquisitions And Asset Acquisition, By Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Total identifiable intangible assets</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="nump">$ 3.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination And Asset Acquisition, Recognized Identifiable Assets Acquired And Liabilities Assumed, Tangible Assets (Liabilities), Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination And Asset Acquisition, Recognized Identifiable Assets Acquired, Goodwill, And Liabilities Assumed, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination And Asset Acquisitions, Contingent Consideration, Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination And Asset Acquisitions, Recognized Identifiable Assets Acquired And Liabilities Assumed, Intangible Assets, Other Than Goodwill</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule Of Business Acquisitions And Asset Acquisition, By Acquisition [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_BusinessAcquisitionAndAssetAcquisitionAxis=coo_SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_BusinessAcquisitionAndAssetAcquisitionAxis=coo_SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002056162288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Joint Venture - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 17, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Feb. 01, 2021</div></th>
<th class="th"><div>Jan. 19, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">16 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,609,700,000<span></span>
</td>
<td class="nump">$ 2,574,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries', window );">Proceeds from sale of interest in a subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,100,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to form joint venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Equity method investment realized gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_AssetAquisitionAxis=coo_PrivatelyHeldMedicalDeviceCompanyDevelopedMaraWaterVaporAblationSystemMember', window );">Privately-Held Medical Device Company, Developed Mara Water Vapor Ablation System</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=coo_EssilorInternationalSASMember', window );">Essilor International SAS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to form joint venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=coo_SightGlassVisionIncMember', window );">SightGlass Vision, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">19 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Term Loan Facility 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from line of credit</a></td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=coo_CookMedicalsReproductiveHealthBusinessMember', window );">Cook Medicals Reproductive Health Business | Forecast | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase price to acquire business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 875,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to acquire business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">675,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Payables incurred in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=coo_CookMedicalsReproductiveHealthBusinessMember', window );">Cook Medicals Reproductive Health Business | Forecast | Subsequent Event | Payables First Installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Payables incurred in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=coo_CookMedicalsReproductiveHealthBusinessMember', window );">Cook Medicals Reproductive Health Business | Forecast | Subsequent Event | Payables Second Installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Payables incurred in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=coo_CookMedicalsReproductiveHealthBusinessMember', window );">Cook Medicals Reproductive Health Business | Forecast | Subsequent Event | Payables Third Installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Payables incurred in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=coo_CookMedicalsReproductiveHealthBusinessMember', window );">Cook Medicals Reproductive Health Business | Forecast | Subsequent Event | Payables Fourth Installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Payables incurred in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=coo_GenerateLifeSciencesMember', window );">Generate Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to acquire business</a></td>
<td class="nump">$ 1,663,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Ownership percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Measurement period adjustment to goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual', window );">Actual revenue generated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">249,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual', window );">Actual net income generated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 1,177,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=coo_GenerateLifeSciencesMember', window );">Generate Life Sciences | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=coo_GenerateLifeSciencesMember', window );">Generate Life Sciences | Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=coo_GenerateLifeSciencesMember', window );">Generate Life Sciences | Line of Credit | Term Loan Facility 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from line of credit</a></td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember', window );">Privately-Held Medical Device Company, Spectacle Lenses, Portion Attributable To Former Equity Interest Owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow', window );">Undiscounted range of the contingent consideration, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Undiscounted range of the contingent consideration, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 139,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_BusinessCombinationPaymentToSettleContingentConsideration', window );">Payment to settle former equity interest owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss', window );">Equity investment gain realized before acquisition of remaining equity interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_BusinessCombinationPaymentToSettleContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Payment to Settle Contingent Consideration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_BusinessCombinationPaymentToSettleContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6405-128476<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements and indemnification assets recognized in connection with a business combination, this element represents an estimate of the low-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>In a business combination achieved in stages, this element represents the amount of net gain (loss) recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the deconsolidation of a previously consolidated subsidiary or the sale of investment in consolidated subsidiaries (generally greater than 50 percent).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_AssetAquisitionAxis=coo_PrivatelyHeldMedicalDeviceCompanyDevelopedMaraWaterVaporAblationSystemMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_AssetAquisitionAxis=coo_PrivatelyHeldMedicalDeviceCompanyDevelopedMaraWaterVaporAblationSystemMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=coo_EssilorInternationalSASMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=coo_EssilorInternationalSASMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=coo_SightGlassVisionIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=coo_SightGlassVisionIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=coo_TermLoanFacility2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=coo_TermLoanFacility2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=coo_CookMedicalsReproductiveHealthBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=coo_CookMedicalsReproductiveHealthBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis=coo_PayablesFirstInstallmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis=coo_PayablesFirstInstallmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis=coo_PayablesSecondInstallmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis=coo_PayablesSecondInstallmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis=coo_PayablesThirdInstallmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis=coo_PayablesThirdInstallmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis=coo_PayablesFourthInstallmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis=coo_PayablesFourthInstallmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=coo_GenerateLifeSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=coo_GenerateLifeSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002063753952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions and Joint Venture - Recognized Identified Assets Acquired and Liabilities Assumed (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Dec. 17, 2021</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 3,609.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,574.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=coo_GenerateLifeSciencesMember', window );">Generate Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Trade accounts receivable, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expense and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Total current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,177.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,128.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesEmployeeRelatedLiabilities', window );">Employee compensation and benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Total current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">147.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredRevenue', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">192.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">465.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,663.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=coo_GenerateLifeSciencesMember', window );">Generate Life Sciences | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">718.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=coo_GenerateLifeSciencesMember', window );">Generate Life Sciences | Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Employee-related Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Deferred Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Operating Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=coo_GenerateLifeSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=coo_GenerateLifeSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002067139792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Joint Venture - Proforma Information (Details) - Generate Life Sciences - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenue</a></td>
<td class="nump">$ 3,344.3<span></span>
</td>
<td class="nump">$ 3,183.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 370.7<span></span>
</td>
<td class="nump">$ 2,959.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=coo_GenerateLifeSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=coo_GenerateLifeSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002159651840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Joint Venture - Contingent Consideration Reconciliation (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">$ 97.4<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Purchase price contingent consideration</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">31.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Payments</a></td>
<td class="num">(55.2)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value</a></td>
<td class="num">(10.3)<span></span>
</td>
<td class="nump">66.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">$ 33.4<span></span>
</td>
<td class="nump">$ 97.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList', window );">Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Selling, general and administrative expense<span></span>
</td>
<td class="text">Selling, general and administrative expense<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement in which net income is reported that includes gain (loss) from liability measured at fair value using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002068194080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets - Goodwill (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Oct. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, beginning</a></td>
<td class="nump">$ 2,574.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Net additions</a></td>
<td class="nump">1,184.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustment</a></td>
<td class="num">(149.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, ending</a></td>
<td class="nump">3,609.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=coo_CoopervisionSegmentMember', window );">CooperVision</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, beginning</a></td>
<td class="nump">1,841.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Net additions</a></td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustment</a></td>
<td class="num">(131.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, ending</a></td>
<td class="nump">1,710.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=coo_CoopersurgicalSegmentMember', window );">CooperSurgical</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, beginning</a></td>
<td class="nump">733.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Net additions</a></td>
<td class="nump">1,183.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustment</a></td>
<td class="num">(17.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, ending</a></td>
<td class="nump">$ 1,899.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=coo_CoopervisionSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=coo_CoopervisionSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=coo_CoopersurgicalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=coo_CoopersurgicalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002063592816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Oct. 31, 2022 </div>
<div>USD ($) </div>
<div>reporting_unit</div>
</th>
<th class="th">
<div>Oct. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Number of reporting units | reporting_unit</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of definite-lived intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of indefinite-lived intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=coo_CoopersurgicalSegmentMember', window );">CooperSurgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill deductible for tax purposes</a></td>
<td class="nump">214,100,000<span></span>
</td>
<td class="nump">137,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=coo_CoopervisionSegmentMember', window );">CooperVision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill deductible for tax purposes</a></td>
<td class="nump">$ 22,400,000<span></span>
</td>
<td class="nump">$ 24,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=coo_CoopersurgicalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=coo_CoopersurgicalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=coo_CoopervisionSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=coo_CoopervisionSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002068257456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets - Other Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 2,919.0<span></span>
</td>
<td class="nump">$ 2,143.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">1,044.7<span></span>
</td>
<td class="nump">881.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets with definite lives, net</a></td>
<td class="nump">$ 1,874.3<span></span>
</td>
<td class="nump">1,261.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Amortization Period (in years)</a></td>
<td class="text">16 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Intangible assets with indefinite lives, net</a></td>
<td class="nump">$ 10.8<span></span>
</td>
<td class="nump">10.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total other intangibles, net</a></td>
<td class="nump">1,885.1<span></span>
</td>
<td class="nump">1,271.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">209.6<span></span>
</td>
<td class="nump">156.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">$ 62.4<span></span>
</td>
<td class="nump">49.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Amortization Period (in years)</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=coo_CompositeMember', window );">Composite intangible asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 1,061.9<span></span>
</td>
<td class="nump">1,061.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">$ 354.0<span></span>
</td>
<td class="nump">283.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Amortization Period (in years)</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 504.1<span></span>
</td>
<td class="nump">513.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">$ 317.5<span></span>
</td>
<td class="nump">287.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Amortization Period (in years)</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 1,092.7<span></span>
</td>
<td class="nump">378.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">$ 287.0<span></span>
</td>
<td class="nump">240.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Amortization Period (in years)</a></td>
<td class="text">19 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=coo_LicenseAndDistributionRightsAndOtherMember', window );">License and distribution rights and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 50.7<span></span>
</td>
<td class="nump">33.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">$ 23.8<span></span>
</td>
<td class="nump">$ 21.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Amortization Period (in years)</a></td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=coo_CompositeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=coo_CompositeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=coo_LicenseAndDistributionRightsAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=coo_LicenseAndDistributionRightsAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002065730032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets - Estimated Amortization Expenses for Intangible Assets with Definite Lives (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 183.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2024</a></td>
<td class="nump">179.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2025</a></td>
<td class="nump">169.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2026</a></td>
<td class="nump">162.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour', window );">Thereafter</a></td>
<td class="nump">1,180.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets with definite lives, net</a></td>
<td class="nump">$ 1,874.3<span></span>
</td>
<td class="nump">$ 1,261.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Assets, Amortization Expense, After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002063729552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financing Arrangements - Total Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowingsAbstract', window );"><strong>Short-term Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsCurrentNet', window );">Less: unamortized debt issuance cost</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="num">$ (0.1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ShortTermDebtNetOfDebtIssuanceCosts', window );">Short-term debt, excluding financing leases</a></td>
<td class="nump">395.7<span></span>
</td>
<td class="nump">82.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Financing lease liabilities</a></td>
<td class="nump">$ 16.9<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Short-term debt<span></span>
</td>
<td class="text">Short-term debt<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Short-term debt</a></td>
<td class="nump">$ 412.6<span></span>
</td>
<td class="nump">$ 83.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAbstract', window );"><strong>Long-term Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNoncurrentNet', window );">Less: unamortized debt issuance cost</a></td>
<td class="num">(3.1)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, excluding financing leases</a></td>
<td class="nump">2,347.1<span></span>
</td>
<td class="nump">1,396.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Financing lease liabilities</a></td>
<td class="nump">$ 3.7<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Long-term debt<span></span>
</td>
<td class="text">Long-term debt<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">$ 2,350.8<span></span>
</td>
<td class="nump">$ 1,397.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Total debt</a></td>
<td class="nump">2,763.4<span></span>
</td>
<td class="nump">1,481.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=coo_OverdraftAndOtherCreditFacilitiesMember', window );">Overdraft and other credit facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowingsAbstract', window );"><strong>Short-term Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt</a></td>
<td class="nump">57.7<span></span>
</td>
<td class="nump">83.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=coo_TermLoansMember', window );">Term loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowingsAbstract', window );"><strong>Short-term Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt</a></td>
<td class="nump">338.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Term loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAbstract', window );"><strong>Long-term Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">2,350.0<span></span>
</td>
<td class="nump">850.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=coo_OtherDebtMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAbstract', window );"><strong>Long-term Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAbstract', window );"><strong>Long-term Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 546.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_ShortTermDebtNetOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short-Term Debt, Net Of Debt Issuance Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_ShortTermDebtNetOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtLongtermAndShorttermCombinedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate of total long-term debt, including current maturities and short-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtLongtermAndShorttermCombinedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsCurrentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs classified as current. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsCurrentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNoncurrentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNoncurrentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=coo_OverdraftAndOtherCreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=coo_OverdraftAndOtherCreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=coo_TermLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=coo_TermLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=coo_OtherDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=coo_OtherDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002058838608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financing Arrangements - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 17, 2021</div></th>
<th class="th"><div>Nov. 02, 2021</div></th>
<th class="th"><div>Apr. 01, 2020</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=coo_TermLoanFacility2021Member', window );">Term Loan Facility 2021 | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term and Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Aggregate principal amount</a></td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit', window );">Potential additional borrowing capacity</a></td>
<td class="nump">1,125,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from line of credit</a></td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.44%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=coo_TermLoanFacility2021Member', window );">Term Loan Facility 2021 | Line of Credit | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term and Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=coo_TermLoanFacility2021Member', window );">Term Loan Facility 2021 | Line of Credit | Fed Funds Effective Rate Overnight Index Swap Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term and Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=coo_TermLoanFacility2021BaseRateLoansMember', window );">Term Loan Facility, 2021 Base Rate Loans | Line of Credit | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term and Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=coo_TermLoanFacility2021AdjustedLIBORateLoansMember', window );">Term Loan Facility 2021, Adjusted LIBO Rate Loans | Line of Credit | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term and Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=coo_TermLoanAgreement2021364DayMember', window );">Term Loan Agreement 2021, 364 Day | Term loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term and Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">364 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Original debt amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 840,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Repayments of short-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 502,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=coo_TermLoanAgreement2021364DayMember', window );">Term Loan Agreement 2021, 364 Day | Term loans | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term and Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=coo_CreditAgreement2020Member', window );">Credit Agreement 2020 | Line of Credit | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term and Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,290,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 445,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.13%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=coo_CreditAgreement2020Member', window );">Credit Agreement 2020 | Line of Credit | Revolving Credit Facility | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term and Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=coo_CreditAgreement2020Member', window );">Credit Agreement 2020 | Line of Credit | Revolving Credit Facility | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term and Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=coo_CreditAgreement2020Member', window );">Credit Agreement 2020 | Line of Credit | Term Loan Facility 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term and Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.13%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=coo_CreditAgreement2020Member', window );">Credit Agreement 2020 | Line of Credit | Revolving Credit Facility And Term Loan Facility 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term and Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit', window );">Potential additional borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,605,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=coo_CreditAgreement2020Member', window );">Credit Agreement 2020 | Line of Credit | Revolving Credit Facility And Term Loan Facility 2020 | London Interbank Offered Rate (LIBOR) | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term and Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=coo_CreditAgreement2020Member', window );">Credit Agreement 2020 | Line of Credit | Revolving Credit Facility And Term Loan Facility 2020 | London Interbank Offered Rate (LIBOR) | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term and Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=coo_CreditAgreement2020Member', window );">Credit Agreement 2020 | Line of Credit | Revolving Credit Facility And Term Loan Facility 2020 | Base Rate | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term and Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=coo_CreditAgreement2020Member', window );">Credit Agreement 2020 | Line of Credit | Revolving Credit Facility And Term Loan Facility 2020 | Base Rate | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term and Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=coo_EuropeanCreditFacilityMember', window );">European Credit Facilities | Line of Credit | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term and Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,700,000<span></span>
</td>
<td class="nump">$ 35,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Weighted average interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.46%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=coo_AsianPacificCreditFacilitiesYenDenominatedMember', window );">Asian Pacific Credit Facilities - Yen-Denominated | Line of Credit | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems', window );"><strong>Schedule of Long Term and Short Term Debt Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73,000,000<span></span>
</td>
<td class="nump">$ 95,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Weighted average interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Accordion Feature, Increase Limit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Long Term And Short Term Debt Instruments [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1336-112600<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1314-112600<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=coo_TermLoanFacility2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=coo_TermLoanFacility2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=coo_TermLoanFacility2021BaseRateLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=coo_TermLoanFacility2021BaseRateLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=coo_TermLoanFacility2021AdjustedLIBORateLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=coo_TermLoanFacility2021AdjustedLIBORateLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=coo_TermLoanAgreement2021364DayMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=coo_TermLoanAgreement2021364DayMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=coo_TermLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=coo_TermLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=coo_CreditAgreement2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=coo_CreditAgreement2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=coo_TermLoanFacility2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=coo_TermLoanFacility2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=coo_RevolvingCreditFacilityAndTermLoanFacility2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=coo_RevolvingCreditFacilityAndTermLoanFacility2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=coo_EuropeanCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=coo_EuropeanCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=coo_AsianPacificCreditFacilitiesYenDenominatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=coo_AsianPacificCreditFacilitiesYenDenominatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002056307104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.80%<span></span>
</td>
<td class="num">(499.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory', window );">Deferred tax asset, intra-entity sale of certain intellectual property rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,987.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_EffectiveIncomeTaxRateReconciliationChangeInEnactedForeignTaxRateAmount', window );">Tax benefit related to remeasurement of deferred tax assets due to UK change in tax rate</a></td>
<td class="nump">$ 536.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 336.9<span></span>
</td>
<td class="nump">$ 353.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact the effective tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">324.3<span></span>
</td>
<td class="nump">336.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued gross interest and penalties related to uncertain tax positions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
<td class="nump">$ 6.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit', window );">Significant change in unrecognized tax benefits that is reasonably possible during the next twelve months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Federal net operating losses expiring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Federal net operating losses not subject to expiration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 97.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_EffectiveIncomeTaxRateReconciliationChangeInEnactedForeignTaxRateAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Change In Enacted Foreign Tax Rate, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_EffectiveIncomeTaxRateReconciliationChangeInEnactedForeignTaxRateAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from intra-entity transfer of asset within consolidated group. Excludes intra-entity transfer of inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002063638784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Income Before Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Income before income taxes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">United States</a></td>
<td class="nump">$ 31.4<span></span>
</td>
<td class="num">$ (31.0)<span></span>
</td>
<td class="num">$ (88.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="nump">443.9<span></span>
</td>
<td class="nump">522.5<span></span>
</td>
<td class="nump">354.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">$ 475.3<span></span>
</td>
<td class="nump">$ 491.5<span></span>
</td>
<td class="nump">$ 266.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002068235104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Income Tax Provision (Benefit) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 10.2<span></span>
</td>
<td class="nump">$ 21.0<span></span>
</td>
<td class="nump">$ 1.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">21.7<span></span>
</td>
<td class="nump">26.7<span></span>
</td>
<td class="nump">26.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current income tax expense (benefit)</a></td>
<td class="nump">35.7<span></span>
</td>
<td class="nump">49.0<span></span>
</td>
<td class="nump">29.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">10.5<span></span>
</td>
<td class="num">(8.8)<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(2.2)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">45.6<span></span>
</td>
<td class="num">(2,492.9)<span></span>
</td>
<td class="num">(4.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred income tax expense (benefit)</a></td>
<td class="nump">53.9<span></span>
</td>
<td class="num">(2,502.2)<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">$ 89.5<span></span>
</td>
<td class="num">$ (2,453.2)<span></span>
</td>
<td class="nump">$ 28.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002056151584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation between the Expected Provision for Income taxes at the US Federal Statutory Rate and the Provision for Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Provision for income taxes at United States statutory tax rate</a></td>
<td class="nump">$ 99.8<span></span>
</td>
<td class="nump">$ 103.2<span></span>
</td>
<td class="nump">$ 56.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign earnings in jurisdictions with lower tax rates</a></td>
<td class="num">(22.3)<span></span>
</td>
<td class="num">(43.6)<span></span>
</td>
<td class="num">(54.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings', window );">Foreign earnings subject to United States tax</a></td>
<td class="nump">20.7<span></span>
</td>
<td class="nump">25.4<span></span>
</td>
<td class="nump">32.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Excess tax benefits from share-based compensation</a></td>
<td class="num">(2.6)<span></span>
</td>
<td class="num">(13.0)<span></span>
</td>
<td class="num">(6.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Deferred tax asset step-up</a></td>
<td class="num">(3.4)<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
<td class="num">(9.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_EffectiveIncomeTaxRateReconciliationChangeInDomesticFederalTaxReturnAmount', window );">United States provision-to-return</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
<td class="nump">7.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationDispositionOfAssets', window );">Intra-group transfer to UK subsidiary</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(1,987.8)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Remeasurement of deferred tax assets from UK rate change</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(536.7)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount', window );">Change in unrecognized tax benefits</a></td>
<td class="num">(12.7)<span></span>
</td>
<td class="num">(7.6)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State tax provision</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other, net</a></td>
<td class="nump">4.5<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">$ 89.5<span></span>
</td>
<td class="num">$ (2,453.2)<span></span>
</td>
<td class="nump">$ 28.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_EffectiveIncomeTaxRateReconciliationChangeInDomesticFederalTaxReturnAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Change In Domestic Federal Tax Return, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_EffectiveIncomeTaxRateReconciliationChangeInDomesticFederalTaxReturnAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Change In Unrecognized Tax Benefits, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32059-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to disposition of asset. Includes, but is not limited to, intra-entity transfer of asset other than inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to repatriation of foreign earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002060506992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Accounts receivable</a></td>
<td class="nump">$ 4.9<span></span>
</td>
<td class="nump">$ 3.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventories</a></td>
<td class="nump">6.3<span></span>
</td>
<td class="nump">6.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued liabilities, reserves and compensation accruals</a></td>
<td class="nump">79.9<span></span>
</td>
<td class="nump">78.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign', window );">Foreign deferred tax assets</a></td>
<td class="nump">2,500.5<span></span>
</td>
<td class="nump">2,531.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Share-based compensation</a></td>
<td class="nump">14.5<span></span>
</td>
<td class="nump">28.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards', window );">Net operating loss and tax credit carryforwards</a></td>
<td class="nump">19.6<span></span>
</td>
<td class="nump">19.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">6.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Capitalized research and experimental expenses</a></td>
<td class="nump">15.4<span></span>
</td>
<td class="nump">13.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total gross deferred tax assets</a></td>
<td class="nump">2,641.1<span></span>
</td>
<td class="nump">2,687.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(60.1)<span></span>
</td>
<td class="num">(51.8)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">2,581.0<span></span>
</td>
<td class="nump">2,635.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill', window );">Tax deductible goodwill</a></td>
<td class="num">(39.7)<span></span>
</td>
<td class="num">(34.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets', window );">Intangible assets</a></td>
<td class="num">(153.8)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Plant and equipment</a></td>
<td class="num">(48.8)<span></span>
</td>
<td class="num">(46.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign', window );">Foreign deferred tax liabilities</a></td>
<td class="num">(45.5)<span></span>
</td>
<td class="num">(32.5)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total gross deferred tax liabilities</a></td>
<td class="num">(287.8)<span></span>
</td>
<td class="num">(113.0)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="nump">$ 2,293.2<span></span>
</td>
<td class="nump">$ 2,522.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Operating Loss Carryforwards And Tax Credit Carryforwards</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Purchase Accounting Adjustments, Foreign</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966508&amp;loc=d3e9972-128506<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126966508&amp;loc=d3e9979-128506<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002066838176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Changes in Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Beginning of the period</a></td>
<td class="nump">$ 353.8<span></span>
</td>
<td class="nump">$ 58.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Decrease based on tax positions in prior fiscal years</a></td>
<td class="num">(12.5)<span></span>
</td>
<td class="num">(8.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increase based on tax positions in current fiscal year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">307.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Settlements</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(1.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Lapses of statutes of limitations</a></td>
<td class="num">(4.2)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">End of the period</a></td>
<td class="nump">$ 336.9<span></span>
</td>
<td class="nump">$ 353.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002060560400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Basic and Diluted (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income, basic</a></td>
<td class="nump">$ 385.8<span></span>
</td>
<td class="nump">$ 2,944.7<span></span>
</td>
<td class="nump">$ 238.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net income, diluted</a></td>
<td class="nump">$ 385.8<span></span>
</td>
<td class="nump">$ 2,944.7<span></span>
</td>
<td class="nump">$ 238.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares (in shares)</a></td>
<td class="nump">49.3<span></span>
</td>
<td class="nump">49.2<span></span>
</td>
<td class="nump">49.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per share (in dollars per share)</a></td>
<td class="nump">$ 7.83<span></span>
</td>
<td class="nump">$ 59.80<span></span>
</td>
<td class="nump">$ 4.85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Effect of dilutive stock options (in shares)</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average common shares (in shares)</a></td>
<td class="nump">49.7<span></span>
</td>
<td class="nump">49.8<span></span>
</td>
<td class="nump">49.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per share (in dollars per share)</a></td>
<td class="nump">$ 7.76<span></span>
</td>
<td class="nump">$ 59.16<span></span>
</td>
<td class="nump">$ 4.81<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002068164720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Stock Options to Purchase Common Stock and Restricted Stock Units Not Included in Diluted Earnings Per Share Due to Antidilutive Effect (Details) - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of exercise prices, lower limit (in dollars per share)</a></td>
<td class="nump">$ 300.12<span></span>
</td>
<td class="nump">$ 345.74<span></span>
</td>
<td class="nump">$ 304.54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Range of exercise prices, higher limit (in dollars per share)</a></td>
<td class="nump">$ 406.17<span></span>
</td>
<td class="nump">$ 345.74<span></span>
</td>
<td class="nump">$ 304.54<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Stock option shares and restricted stock units excluded (in shares)</a></td>
<td class="nump">227<span></span>
</td>
<td class="nump">107<span></span>
</td>
<td class="nump">207<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Stock option shares and restricted stock units excluded (in shares)</a></td>
<td class="nump">87<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002063477488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Changes in Accumulated Other Comprehensive Income (Loss) Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">$ 6,942.0<span></span>
</td>
<td class="nump">$ 3,824.8<span></span>
</td>
<td class="nump">$ 3,628.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Gross change in value</a></td>
<td class="num">(90.7)<span></span>
</td>
<td class="nump">146.3<span></span>
</td>
<td class="num">(33.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Tax effect</a></td>
<td class="num">(34.8)<span></span>
</td>
<td class="num">(15.6)<span></span>
</td>
<td class="nump">8.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">7,174.7<span></span>
</td>
<td class="nump">6,942.0<span></span>
</td>
<td class="nump">3,824.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(341.3)<span></span>
</td>
<td class="num">(472.0)<span></span>
</td>
<td class="num">(447.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(466.8)<span></span>
</td>
<td class="num">(341.3)<span></span>
</td>
<td class="num">(472.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(320.3)<span></span>
</td>
<td class="num">(402.3)<span></span>
</td>
<td class="num">(403.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Gross change in value</a></td>
<td class="num">(234.7)<span></span>
</td>
<td class="nump">82.2<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Tax effect</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(555.0)<span></span>
</td>
<td class="num">(320.3)<span></span>
</td>
<td class="num">(402.3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">13.1<span></span>
</td>
<td class="num">(13.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Gross change in value</a></td>
<td class="nump">107.4<span></span>
</td>
<td class="nump">34.3<span></span>
</td>
<td class="num">(17.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Tax effect</a></td>
<td class="num">(26.1)<span></span>
</td>
<td class="num">(8.2)<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">94.4<span></span>
</td>
<td class="nump">13.1<span></span>
</td>
<td class="num">(13.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Minimum Pension Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(34.1)<span></span>
</td>
<td class="num">(56.7)<span></span>
</td>
<td class="num">(43.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Gross change in value</a></td>
<td class="nump">36.6<span></span>
</td>
<td class="nump">29.8<span></span>
</td>
<td class="num">(16.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Tax effect</a></td>
<td class="num">(8.7)<span></span>
</td>
<td class="num">(7.2)<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">$ (6.2)<span></span>
</td>
<td class="num">$ (34.1)<span></span>
</td>
<td class="num">$ (56.7)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33775-111570<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002060525872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stockholders' Equity - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2011</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Share repurchase program, maximum amount authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Share repurchase program, remaining authorized amount</a></td>
<td class="nump">$ 256,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002159688720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Share Repurchases (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Number of shares</a></td>
<td class="nump">191,165<span></span>
</td>
<td class="nump">69,622<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average repurchase price per share (in dollars per share)</a></td>
<td class="nump">$ 410.4<span></span>
</td>
<td class="nump">$ 356.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Total costs of shares repurchased (in millions)</a></td>
<td class="nump">$ 78.5<span></span>
</td>
<td class="nump">$ 24.8<span></span>
</td>
<td class="nump">$ 47.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002061717952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Plans - Narrative (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 18, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2016 </div>
<div>director </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Total unrecognized compensation cost related to nonvested options | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54.2<span></span>
</td>
<td class="nump">$ 44.7<span></span>
</td>
<td class="nump">$ 38.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Total unrecognized compensation cost expected to be recognized over a remaining weighted-average vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted in period (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Total unrecognized compensation cost expected to be recognized over a remaining weighted-average vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Total unrecognized compensation cost related to nonvested units | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Total unrecognized compensation cost expected to be recognized over a remaining weighted-average vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Total unrecognized compensation cost related to nonvested units | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Units | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned', window );">Target percentage of shares earned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Units | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned', window );">Target percentage of shares earned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember', window );">Third Amended and Restated 2007 Long-Term Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee', window );">Number of non-employee directors in committee | director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized to be granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,930,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares remaining for future grant (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">690,596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember', window );">Third Amended and Restated 2007 Long-Term Incentive Plan | Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair value of each option granted (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90.41<span></span>
</td>
<td class="nump">$ 84.10<span></span>
</td>
<td class="nump">$ 70.45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Total intrinsic value of options exercised | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.6<span></span>
</td>
<td class="nump">$ 64.7<span></span>
</td>
<td class="nump">$ 22.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Award expiration date (no more than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember', window );">Third Amended and Restated 2007 Long-Term Incentive Plan | Stock Options | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember', window );">Third Amended and Restated 2007 Long-Term Incentive Plan | Stock Options | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember', window );">Third Amended and Restated 2007 Long-Term Incentive Plan | Restricted Stock Units (RSUs) | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember', window );">Third Amended and Restated 2007 Long-Term Incentive Plan | Restricted Stock Units (RSUs) | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=coo_DirectorsPlan2020Member', window );">2020 Directors Plan | Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Award expiration date (no more than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=coo_EmployeeStockPurchasePlanMember', window );">Employee Stock Purchase Plan | Employee Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized to be granted | shares</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Exercise price percentage of fair market value on date of grant of awards</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Number of shares issued to employees | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,695<span></span>
</td>
<td class="nump">17,575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of shares remaining available for future issuance | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">948,090<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Target Percentage Of Shares Earned</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Terms Of Award, Grants In Period, Number Of Non Employee Directors In Committee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=coo_DirectorsPlan2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=coo_DirectorsPlan2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=coo_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=coo_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002063564640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Plans - Compensation Expense and Related Income Tax Benefit for Share-Based Awards (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total compensation expense</a></td>
<td class="nump">$ 54.2<span></span>
</td>
<td class="nump">$ 44.7<span></span>
</td>
<td class="nump">$ 38.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Related income tax benefit</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">5.6<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total compensation expense</a></td>
<td class="nump">46.7<span></span>
</td>
<td class="nump">38.4<span></span>
</td>
<td class="nump">32.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total compensation expense</a></td>
<td class="nump">4.5<span></span>
</td>
<td class="nump">3.9<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total compensation expense</a></td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">$ 2.4<span></span>
</td>
<td class="nump">$ 2.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002056320912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Plans - Assumptions Used in Estimating Fair Value of Stock Options Award Granted (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">4 years 1 month 6 days<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">25.80%<span></span>
</td>
<td class="nump">30.30%<span></span>
</td>
<td class="nump">24.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.02%<span></span>
</td>
<td class="nump">0.02%<span></span>
</td>
<td class="nump">0.02%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002056131696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Plans - Stock Option Plans (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Oct. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest at end of period (in shares) | shares</a></td>
<td class="nump">1,038,594<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Vested and exercisable at end of period (in shares) | shares</a></td>
<td class="nump">624,512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted- Average Exercise&#160;Price Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Vested and expected to vest at end of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 262.91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Vested and exercisable at end of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 223.45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Vested and expected to vest at end of period, Weighted-Average Remaining Contractual Term (in years)</a></td>
<td class="text">5 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Vested and exercisable at end of period, Weighted-Average Remaining Contractual Term (in years)</a></td>
<td class="text">4 years 6 months 25 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Vested and expected to vest at end of period, Aggregate Intrinsic Value | $</a></td>
<td class="nump">$ 38,806,329<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Vested and exercisable at end of period, Aggregate Intrinsic Value | $</a></td>
<td class="nump">$ 35,586,767<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, beginning balance (in shares) | shares</a></td>
<td class="nump">972,692<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares) | shares</a></td>
<td class="nump">122,760<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares) | shares</a></td>
<td class="num">(26,866)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Forfeited or expired (in shares) | shares</a></td>
<td class="num">(4,743)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, ending balance (in shares) | shares</a></td>
<td class="nump">1,063,843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted- Average Exercise&#160;Price Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 245.09<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">403.44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share) | $ / shares</a></td>
<td class="nump">171.87<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Forfeited or expired (in dollars per share) | $ / shares</a></td>
<td class="nump">325.21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, ending balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 264.85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding, ending balance, Weighted Average Remaining Contractual Term (in years)</a></td>
<td class="text">5 years 9 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002063729440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Plans - Non-Vested RSUs (Details) - Restricted Stock Units (RSUs)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Oct. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Number&#160;of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested RSUs, beginning balance (in shares) | shares</a></td>
<td class="nump">317,335<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">113,079<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested and issued (in shares) | shares</a></td>
<td class="num">(113,301)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited or expired (in shares) | shares</a></td>
<td class="num">(27,875)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested RSUs, ending balance (in shares) | shares</a></td>
<td class="nump">289,238<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted- Average Grant&#160;Date&#160;Fair Value&#160;Per&#160;Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Non-vested RSUs, beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 293.80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">399.21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested and issued (in dollars per share) | $ / shares</a></td>
<td class="nump">271.74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited or exercised (in dollars per share) | $ / shares</a></td>
<td class="nump">324.67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Non-vested RSUs, ending balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 340.68<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002059658384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="nump">$ 134.9<span></span>
</td>
<td class="nump">$ 207.6<span></span>
</td>
<td class="nump">$ 195.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation', window );">Discount rate</a></td>
<td class="nump">2.76%<span></span>
</td>
<td class="nump">2.78%<span></span>
</td>
<td class="nump">3.13%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligationIncreaseDecrease', window );">Discount rate, decrease</a></td>
<td class="nump">0.02%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationEffectOfChangeInDiscountRate', window );">Projected defined benefit plan benefit obligation</a></td>
<td class="nump">$ 217.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_DefinedBenefitPlanAssumptionsUsedCalculatingAccumulatedBenefitObligationEffectOfChangeInDiscountRate', window );">Projected defined accumulated benefit obligation</a></td>
<td class="nump">194.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Defined benefit obligation, actuarial gain (loss)</a></td>
<td class="nump">$ 93.2<span></span>
</td>
<td class="num">$ (2.0)<span></span>
</td>
<td class="num">$ (20.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage', window );">Expected long-term return on diversified portfolio</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Company's contribution to the pension plan</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">12.7<span></span>
</td>
<td class="nump">23.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent', window );">Maximum annual contributions per employee in 401k savings plan</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer', window );">Contributions by employer in 401k savings plan</a></td>
<td class="nump">$ 9.0<span></span>
</td>
<td class="nump">$ 7.2<span></span>
</td>
<td class="nump">$ 6.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Equity Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Diversified portfolio, allocation of assets in equities</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Equity Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Diversified portfolio, allocation of assets in equities</a></td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember', window );">Change In Assumptions For Defined Benefit Plans, Change In Key Assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Defined benefit obligation, actuarial gain (loss)</a></td>
<td class="nump">$ 97.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember', window );">Change In Assumptions For Defined Benefit Plans, Change In Demographic Experience</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Defined benefit obligation, actuarial gain (loss)</a></td>
<td class="num">(3.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember', window );">Change In Assumptions For Defined Benefit Plans, Change In Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Defined benefit obligation, actuarial gain (loss)</a></td>
<td class="nump">72.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInAssumedPaymentFormElectionProbabilitiesMember', window );">Change In Assumptions For Defined Benefit Plans, Change In Assumed Payment Form Election Probabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Defined benefit obligation, actuarial gain (loss)</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember', window );">Change In Assumptions For Defined Benefit Plans, Change In Lump Sum Determination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Defined benefit obligation, actuarial gain (loss)</a></td>
<td class="nump">$ 24.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_DefinedBenefitPlanAssumptionsUsedCalculatingAccumulatedBenefitObligationEffectOfChangeInDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Assumptions Used Calculating Accumulated Benefit Obligation, Effect Of Change In Discount Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_DefinedBenefitPlanAssumptionsUsedCalculatingAccumulatedBenefitObligationEffectOfChangeInDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Projected Benefit Obligation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligationIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Projected Benefit Obligation, Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligationIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationEffectOfChangeInDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Assumptions Used Calculating Projected Benefit Obligation, Effect Of Change In Discount Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationEffectOfChangeInDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Plan Assets, Target Allocation, Expected Long Term Return, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions made by employer into fund established for purposes of making future disbursement to individual in accordance with deferred compensation arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated benefit obligation for defined benefit plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingEstimateByTypeAxis=coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingEstimateByTypeAxis=coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingEstimateByTypeAxis=coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInAssumedPaymentFormElectionProbabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingEstimateByTypeAxis=coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInAssumedPaymentFormElectionProbabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingEstimateByTypeAxis=coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002063674640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Changes in Benefit Obligation, Changes in Plan Assets and Funded Status (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Change in benefit obligation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation, beginning of year</a></td>
<td class="nump">$ 230.9<span></span>
</td>
<td class="nump">$ 218.8<span></span>
</td>
<td class="nump">$ 189.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">18.3<span></span>
</td>
<td class="nump">17.2<span></span>
</td>
<td class="nump">13.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">5.1<span></span>
</td>
<td class="nump">4.4<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(13.1)<span></span>
</td>
<td class="num">(11.5)<span></span>
</td>
<td class="num">(10.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (gain)/loss</a></td>
<td class="num">(93.2)<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">20.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation, end of year</a></td>
<td class="nump">$ 148.0<span></span>
</td>
<td class="nump">$ 230.9<span></span>
</td>
<td class="nump">$ 218.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList', window );">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Accrued pension liability and other<span></span>
</td>
<td class="text">Accrued pension liability and other<span></span>
</td>
<td class="text">Accrued pension liability and other<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, beginning of year</a></td>
<td class="nump">$ 199.5<span></span>
</td>
<td class="nump">$ 159.5<span></span>
</td>
<td class="nump">$ 136.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="num">(43.5)<span></span>
</td>
<td class="nump">38.8<span></span>
</td>
<td class="nump">10.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">12.7<span></span>
</td>
<td class="nump">23.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(13.1)<span></span>
</td>
<td class="num">(11.5)<span></span>
</td>
<td class="num">(10.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, end of year</a></td>
<td class="nump">142.9<span></span>
</td>
<td class="nump">199.5<span></span>
</td>
<td class="nump">159.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status at end of year</a></td>
<td class="num">$ (5.1)<span></span>
</td>
<td class="num">$ (31.4)<span></span>
</td>
<td class="num">$ (59.3)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes interest cost component of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002060549392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefits - Amounts Recognized in Accumulated Other Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract', window );"><strong>Amounts recognized in accumulated other comprehensive income consist of:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Net loss</a></td>
<td class="nump">$ 8.0<span></span>
</td>
<td class="nump">$ 44.4<span></span>
</td>
<td class="nump">$ 74.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">$ 8.0<span></span>
</td>
<td class="nump">$ 44.4<span></span>
</td>
<td class="nump">$ 74.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002063519808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Reconciliation of Prepaid (Accrued) Pension Cost (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_AccruedPensionCostRollForward', window );"><strong>Reconciliation of (prepaid) accrued pension cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_AccruedPrepaidPensionCosts', window );">(Prepaid)/Accrued pension cost at prior fiscal year end</a></td>
<td class="num">$ (13.0)<span></span>
</td>
<td class="num">$ (14.8)<span></span>
</td>
<td class="num">$ (3.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">10.1<span></span>
</td>
<td class="nump">14.5<span></span>
</td>
<td class="nump">12.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Contributions made during the year</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(12.7)<span></span>
</td>
<td class="num">(23.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_AccruedPrepaidPensionCosts', window );">(Prepaid)/Accrued pension cost at fiscal year end</a></td>
<td class="num">$ (2.9)<span></span>
</td>
<td class="num">$ (13.0)<span></span>
</td>
<td class="num">$ (14.8)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_AccruedPensionCostRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Pension Cost [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_AccruedPensionCostRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_AccruedPrepaidPensionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued (Prepaid) Pension Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_AccruedPrepaidPensionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002066669680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Components of Net Periodic Pension Costs and Other Amounts Recognized in Other Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Components of net periodic benefit cost and other amounts recognized in the Consolidated Statements of Income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 18.3<span></span>
</td>
<td class="nump">$ 17.2<span></span>
</td>
<td class="nump">$ 13.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">$ 5.1<span></span>
</td>
<td class="nump">$ 4.4<span></span>
</td>
<td class="nump">$ 5.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList', window );">Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Expected Return (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Other Nonoperating Income (Expense)<span></span>
</td>
<td class="text">Other Nonoperating Income (Expense)<span></span>
</td>
<td class="text">Other Nonoperating Income (Expense)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">$ (15.5)<span></span>
</td>
<td class="num">$ (12.5)<span></span>
</td>
<td class="num">$ (10.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList', window );">Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Immediate Recognition of Actuarial Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Other Nonoperating Income (Expense)<span></span>
</td>
<td class="text">Other Nonoperating Income (Expense)<span></span>
</td>
<td class="text">Other Nonoperating Income (Expense)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit', window );">Recognized actuarial loss</a></td>
<td class="nump">$ 2.2<span></span>
</td>
<td class="nump">$ 5.4<span></span>
</td>
<td class="nump">$ 4.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic pension cost</a></td>
<td class="nump">$ 10.1<span></span>
</td>
<td class="nump">$ 14.5<span></span>
</td>
<td class="nump">$ 12.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss), recognized immediately as component of net periodic benefit (cost) credit, for change in value of benefit obligation or plan assets from experience different from that assumed, change in actuarial assumption, or consequence of temporarily deviating from substantive plan. Includes, but is not limited to, amount in excess of 10 percent of greater of fair value of plan assets or benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes expected return (loss) on plan asset component of net periodic benefit (cost) credit for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes actuarial gain (loss) recognized immediately as component of net periodic benefit (cost) credit for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002063519808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract', window );"><strong>Other changes in plan assets and benefit obligations recognized in other comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax', window );">Net (gain) loss</a></td>
<td class="num">$ (34.1)<span></span>
</td>
<td class="num">$ (24.4)<span></span>
</td>
<td class="nump">$ 20.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax', window );">Amortizations of net gain</a></td>
<td class="num">(2.5)<span></span>
</td>
<td class="num">(5.4)<span></span>
</td>
<td class="num">(4.0)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Total recognized in other comprehensive (income) loss</a></td>
<td class="num">(36.6)<span></span>
</td>
<td class="num">(29.8)<span></span>
</td>
<td class="nump">16.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax', window );">Total recognized in net periodic benefit cost and other comprehensive (income) loss</a></td>
<td class="num">$ (26.2)<span></span>
</td>
<td class="num">$ (15.2)<span></span>
</td>
<td class="nump">$ 29.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized in net periodic benefit cost (credit) and other comprehensive (income) loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net period benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002059722752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Weighted-Average Assumptions Used in Computing Net Periodic Pension Cost and Projected Benefit Obligation (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract', window );"><strong>Discount rate for determining net periodic pension cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation', window );">Projected Benefit Obligation</a></td>
<td class="nump">2.76%<span></span>
</td>
<td class="nump">2.78%<span></span>
</td>
<td class="nump">3.13%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost', window );">Service Cost</a></td>
<td class="nump">2.79%<span></span>
</td>
<td class="nump">2.86%<span></span>
</td>
<td class="nump">3.18%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost', window );">Interest Cost</a></td>
<td class="nump">2.28%<span></span>
</td>
<td class="nump">2.07%<span></span>
</td>
<td class="nump">2.78%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate for determining benefit obligations at year end</a></td>
<td class="nump">5.74%<span></span>
</td>
<td class="nump">2.76%<span></span>
</td>
<td class="nump">2.78%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease', window );">Rate of compensation increase for determining expense</a></td>
<td class="nump">3.60%<span></span>
</td>
<td class="nump">3.60%<span></span>
</td>
<td class="nump">3.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of compensation increase for determining benefit obligations at year end</a></td>
<td class="nump">3.60%<span></span>
</td>
<td class="nump">3.60%<span></span>
</td>
<td class="nump">3.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected rate of return on plan assets for determining net periodic pension cost</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd', window );">Expected rate of return on plan assets at year end</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Interest Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Projected Benefit Obligation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Service Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate Of Return On Plan Assets At Year End</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002060461904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefits - Weighted-Average Asset Allocations by Asset Category (Details)<br></strong></div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Asset allocation</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Asset allocation</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">11.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquityFundsMember', window );">Equity mutual funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Asset allocation</a></td>
<td class="nump">65.80%<span></span>
</td>
<td class="nump">62.80%<span></span>
</td>
<td class="nump">57.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_HedgeFundsMember', window );">Hedging Strategy Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Asset allocation</a></td>
<td class="nump">5.20%<span></span>
</td>
<td class="nump">4.70%<span></span>
</td>
<td class="nump">4.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=coo_BondMutualFundsMember', window );">Bond mutual funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Asset allocation</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">27.50%<span></span>
</td>
<td class="nump">26.20%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquityFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquityFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_HedgeFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_HedgeFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=coo_BondMutualFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=coo_BondMutualFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002061856608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefits - Fair Value Measurement of Plan Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 142.9<span></span>
</td>
<td class="nump">$ 199.5<span></span>
</td>
<td class="nump">$ 159.5<span></span>
</td>
<td class="nump">$ 136.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted&#160;Prices in Active Markets for Identical&#160;Assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">118.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">24.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">2.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember', window );">Cash and cash equivalents | Quoted&#160;Prices in Active Markets for Identical&#160;Assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">2.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember', window );">Cash and cash equivalents | Significant Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember', window );">Cash and cash equivalents | Significant Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquityFundsMember', window );">Equity mutual funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">93.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquityFundsMember', window );">Equity mutual funds | Quoted&#160;Prices in Active Markets for Identical&#160;Assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">93.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquityFundsMember', window );">Equity mutual funds | Significant Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquityFundsMember', window );">Equity mutual funds | Significant Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_HedgeFundsMember', window );">Hedging Strategy Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">7.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_HedgeFundsMember', window );">Hedging Strategy Funds | Quoted&#160;Prices in Active Markets for Identical&#160;Assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">7.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_HedgeFundsMember', window );">Hedging Strategy Funds | Significant Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_HedgeFundsMember', window );">Hedging Strategy Funds | Significant Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=coo_BondMutualFundsMember', window );">Bond mutual funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">38.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=coo_BondMutualFundsMember', window );">Bond mutual funds | Quoted&#160;Prices in Active Markets for Identical&#160;Assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">14.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=coo_BondMutualFundsMember', window );">Bond mutual funds | Significant Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">24.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=coo_BondMutualFundsMember', window );">Bond mutual funds | Significant Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems', window );"><strong>Defined Benefit Plan, Plan Assets, Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquityFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquityFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_HedgeFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_HedgeFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=coo_BondMutualFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=coo_BondMutualFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002058662096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefits - Estimated Future Benefit Payments (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Oct. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract', window );"><strong>Defined Benefit Plan, Expected Future Benefit Payment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 9.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2024</a></td>
<td class="nump">11.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2025</a></td>
<td class="nump">11.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2026</a></td>
<td class="nump">11.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2027</a></td>
<td class="nump">11.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">2028-2032</a></td>
<td class="nump">$ 66.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002069337664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment Information - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Oct. 31, 2022 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002063914320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment Information - Business Segment Net Sales (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 3,308.4<span></span>
</td>
<td class="nump">$ 2,922.5<span></span>
</td>
<td class="nump">$ 2,430.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=coo_CoopervisionSegmentMember', window );">CooperVision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,243.3<span></span>
</td>
<td class="nump">2,152.0<span></span>
</td>
<td class="nump">1,843.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=coo_CoopersurgicalSegmentMember', window );">CooperSurgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,065.1<span></span>
</td>
<td class="nump">770.5<span></span>
</td>
<td class="nump">587.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=coo_ToricLensMember', window );">Toric lens | CooperVision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">737.4<span></span>
</td>
<td class="nump">697.5<span></span>
</td>
<td class="nump">598.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=coo_MultifocalLensMember', window );">Multifocal lens | CooperVision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">264.4<span></span>
</td>
<td class="nump">238.6<span></span>
</td>
<td class="nump">197.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=coo_SingleUseSphereLensMember', window );">Single-use sphere lens | CooperVision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">661.6<span></span>
</td>
<td class="nump">616.3<span></span>
</td>
<td class="nump">529.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=coo_NonSingleUseSphereAndOtherMember', window );">Non single-use sphere, other | CooperVision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">579.9<span></span>
</td>
<td class="nump">599.6<span></span>
</td>
<td class="nump">518.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=coo_OfficeAndSurgicalProductsMember', window );">Office and surgical products | CooperSurgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">633.6<span></span>
</td>
<td class="nump">451.3<span></span>
</td>
<td class="nump">358.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=coo_FertilityMember', window );">Fertility | CooperSurgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 431.5<span></span>
</td>
<td class="nump">$ 319.2<span></span>
</td>
<td class="nump">$ 229.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=coo_CoopervisionSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=coo_CoopervisionSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=coo_CoopersurgicalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=coo_CoopersurgicalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=coo_ToricLensMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=coo_ToricLensMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=coo_MultifocalLensMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=coo_MultifocalLensMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=coo_SingleUseSphereLensMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=coo_SingleUseSphereLensMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=coo_NonSingleUseSphereAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=coo_NonSingleUseSphereAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=coo_OfficeAndSurgicalProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=coo_OfficeAndSurgicalProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=coo_FertilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=coo_FertilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002058968752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment Information - Business Segment Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 3,308.4<span></span>
</td>
<td class="nump">$ 2,922.5<span></span>
</td>
<td class="nump">$ 2,430.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">507.6<span></span>
</td>
<td class="nump">505.8<span></span>
</td>
<td class="nump">311.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">57.3<span></span>
</td>
<td class="nump">23.1<span></span>
</td>
<td class="nump">36.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other expense (income), net</a></td>
<td class="num">(25.0)<span></span>
</td>
<td class="num">(8.8)<span></span>
</td>
<td class="nump">8.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">475.3<span></span>
</td>
<td class="nump">491.5<span></span>
</td>
<td class="nump">266.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">11,492.3<span></span>
</td>
<td class="nump">9,606.2<span></span>
</td>
<td class="nump">6,737.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">166.6<span></span>
</td>
<td class="nump">163.2<span></span>
</td>
<td class="nump">149.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization expense</a></td>
<td class="nump">179.5<span></span>
</td>
<td class="nump">146.1<span></span>
</td>
<td class="nump">137.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="nump">242.0<span></span>
</td>
<td class="nump">214.4<span></span>
</td>
<td class="nump">310.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=coo_CoopervisionSegmentMember', window );">CooperVision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,243.3<span></span>
</td>
<td class="nump">2,152.0<span></span>
</td>
<td class="nump">1,843.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=coo_CoopersurgicalSegmentMember', window );">CooperSurgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,065.1<span></span>
</td>
<td class="nump">770.5<span></span>
</td>
<td class="nump">587.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="num">(53.8)<span></span>
</td>
<td class="num">(47.3)<span></span>
</td>
<td class="num">(49.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">305.6<span></span>
</td>
<td class="nump">244.7<span></span>
</td>
<td class="nump">207.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization expense</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | CooperVision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,243.3<span></span>
</td>
<td class="nump">2,152.0<span></span>
</td>
<td class="nump">1,843.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">494.3<span></span>
</td>
<td class="nump">481.3<span></span>
</td>
<td class="nump">375.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">6,778.9<span></span>
</td>
<td class="nump">6,965.9<span></span>
</td>
<td class="nump">4,236.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">144.5<span></span>
</td>
<td class="nump">148.3<span></span>
</td>
<td class="nump">138.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization expense</a></td>
<td class="nump">32.3<span></span>
</td>
<td class="nump">35.7<span></span>
</td>
<td class="nump">32.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="nump">223.0<span></span>
</td>
<td class="nump">190.0<span></span>
</td>
<td class="nump">260.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | CooperSurgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,065.1<span></span>
</td>
<td class="nump">770.5<span></span>
</td>
<td class="nump">587.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">67.1<span></span>
</td>
<td class="nump">71.8<span></span>
</td>
<td class="num">(14.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">4,407.8<span></span>
</td>
<td class="nump">2,395.6<span></span>
</td>
<td class="nump">2,293.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">22.1<span></span>
</td>
<td class="nump">14.9<span></span>
</td>
<td class="nump">11.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization expense</a></td>
<td class="nump">147.2<span></span>
</td>
<td class="nump">110.4<span></span>
</td>
<td class="nump">104.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="nump">$ 19.0<span></span>
</td>
<td class="nump">$ 24.4<span></span>
</td>
<td class="nump">$ 50.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=coo_CoopervisionSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=coo_CoopervisionSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=coo_CoopersurgicalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=coo_CoopersurgicalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002061730560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment Information - Information by Geographical Area by Country of Domicile (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="num">$ (3,308.4)<span></span>
</td>
<td class="num">$ (2,922.5)<span></span>
</td>
<td class="num">$ (2,430.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">507.6<span></span>
</td>
<td class="nump">505.8<span></span>
</td>
<td class="nump">311.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Long-lived assets</a></td>
<td class="nump">1,432.9<span></span>
</td>
<td class="nump">1,347.6<span></span>
</td>
<td class="nump">1,281.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="num">(1,638.5)<span></span>
</td>
<td class="num">(1,339.2)<span></span>
</td>
<td class="num">(1,103.6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="num">(987.2)<span></span>
</td>
<td class="num">(957.9)<span></span>
</td>
<td class="num">(789.8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=coo_RestOfTheWorldMember', window );">Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="num">(682.7)<span></span>
</td>
<td class="num">(625.4)<span></span>
</td>
<td class="num">(537.5)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=srt_GeographyEliminationsMember', window );">Geography Eliminations | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">514.4<span></span>
</td>
<td class="nump">494.9<span></span>
</td>
<td class="nump">391.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=srt_GeographyEliminationsMember', window );">Geography Eliminations | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">897.3<span></span>
</td>
<td class="nump">815.1<span></span>
</td>
<td class="nump">327.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=srt_GeographyEliminationsMember', window );">Geography Eliminations | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,411.7<span></span>
</td>
<td class="nump">1,310.0<span></span>
</td>
<td class="nump">718.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=srt_ReportableGeographicalComponentsMember', window );">Reportable Geographical Components | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="num">(2,152.9)<span></span>
</td>
<td class="num">(1,834.1)<span></span>
</td>
<td class="num">(1,495.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">71.8<span></span>
</td>
<td class="num">(26.8)<span></span>
</td>
<td class="num">(14.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Long-lived assets</a></td>
<td class="nump">856.1<span></span>
</td>
<td class="nump">737.5<span></span>
</td>
<td class="nump">721.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=srt_ReportableGeographicalComponentsMember', window );">Reportable Geographical Components | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="num">(1,884.5)<span></span>
</td>
<td class="num">(1,773.0)<span></span>
</td>
<td class="num">(1,116.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">403.8<span></span>
</td>
<td class="nump">416.2<span></span>
</td>
<td class="nump">21.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Long-lived assets</a></td>
<td class="nump">310.8<span></span>
</td>
<td class="nump">377.2<span></span>
</td>
<td class="nump">363.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=coo_CorporateReconcilingItemsAndEliminationsMember', window );">Eliminations, Corporate and Reconciling Items | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">729.0<span></span>
</td>
<td class="nump">684.6<span></span>
</td>
<td class="nump">181.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">32.0<span></span>
</td>
<td class="nump">116.4<span></span>
</td>
<td class="nump">304.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Long-lived assets</a></td>
<td class="nump">$ 266.0<span></span>
</td>
<td class="nump">$ 232.9<span></span>
</td>
<td class="nump">$ 197.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=coo_RestOfTheWorldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=coo_RestOfTheWorldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=srt_GeographyEliminationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=srt_GeographyEliminationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=srt_ReportableGeographicalComponentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=srt_ReportableGeographicalComponentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=coo_CorporateReconcilingItemsAndEliminationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=coo_CorporateReconcilingItemsAndEliminationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002066719568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Derivatives and Hedging - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 31, 2022 </div>
<div>USD ($) </div>
<div>interest_rate_swap_contract</div>
</th>
<th class="th">
<div>Oct. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 06, 2020 </div>
<div>USD ($) </div>
<div>interest_rate_swap_contract</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_AOCICashFlowHedgeCumulativeGainLossBeforeTax', window );">Pre-tax impact of gain (loss) on derivatives recognized in other comprehensive income (loss)</a></td>
<td class="nump">$ 124.5<span></span>
</td>
<td class="nump">$ 17.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax', window );">Gain (loss) on derivatives recognized in other comprehensive income (loss), net of tax</a></td>
<td class="nump">30.1<span></span>
</td>
<td class="nump">$ 13.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Derivative loss expected to be realized in earnings over the next twelve months</a></td>
<td class="nump">38.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of interest rate swap contracts held | interest_rate_swap_contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative notional amount</a></td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_NumberOfInterestRateDerivativesMatured', window );">Number of interest rate swap contracts matured | interest_rate_swap_contract</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeTermOfContract', window );">Interest rate swap contracts, contract term (or less)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_AOCICashFlowHedgeCumulativeGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>AOCI, Cash Flow Hedge, Cumulative Gain (Loss), Before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_AOCICashFlowHedgeCumulativeGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_NumberOfInterestRateDerivativesMatured">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Interest Rate Derivatives Matured</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_NumberOfInterestRateDerivativesMatured</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfInterestRateDerivativesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of interest rate derivative instruments held by the entity at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfInterestRateDerivativesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002068097520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Derivatives and Hedging - Derivative Instruments Recognized in Condensed Consolidated Statements of Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember', window );">Interest expense | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Loss recognized on derivatives within interest expense</a></td>
<td class="num">$ (2.3)<span></span>
</td>
<td class="nump">$ 8.0<span></span>
</td>
<td class="nump">$ 3.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002066718688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Derivatives and Hedging - Changes in Accumulated Other Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward', window );"><strong>AOCI Attributable To Parent, Before Reclassification And Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">$ 6,942.0<span></span>
</td>
<td class="nump">$ 3,824.8<span></span>
</td>
<td class="nump">$ 3,628.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Amount recognized in other comprehensive income on interest rate swaps contracts, net of tax</a></td>
<td class="nump">79.7<span></span>
</td>
<td class="nump">20.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount reclassified from other comprehensive income into earnings, net of tax</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">6.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">7,174.7<span></span>
</td>
<td class="nump">6,942.0<span></span>
</td>
<td class="nump">3,824.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember', window );">Accumulated Gain (Loss), Net, Cash Flow Hedge, Before Tax, Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward', window );"><strong>AOCI Attributable To Parent, Before Reclassification And Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">17.2<span></span>
</td>
<td class="num">(17.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">124.5<span></span>
</td>
<td class="nump">17.2<span></span>
</td>
<td class="num">(17.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward', window );"><strong>AOCI Attributable To Parent, Before Reclassification And Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">13.1<span></span>
</td>
<td class="num">(13.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount recognized in other comprehensive income on interest rate swap contracts, gross</a></td>
<td class="nump">105.1<span></span>
</td>
<td class="nump">26.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Amount reclassified from other comprehensive income into earnings, gross</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">8.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">$ 94.4<span></span>
</td>
<td class="nump">$ 13.1<span></span>
</td>
<td class="num">$ (13.0)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>AOCI Attributable To Parent, Before Reclassification And Tax [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>coo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140002068155056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II (Details) - SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance Beginning of Year</a></td>
<td class="nump">$ 51.8<span></span>
</td>
<td class="nump">$ 45.3<span></span>
</td>
<td class="nump">$ 41.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Additions</a></td>
<td class="nump">13.3<span></span>
</td>
<td class="nump">8.8<span></span>
</td>
<td class="nump">5.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Reductions/ Charges</a></td>
<td class="num">(5.0)<span></span>
</td>
<td class="num">(2.3)<span></span>
</td>
<td class="num">(2.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Year</a></td>
<td class="nump">$ 60.1<span></span>
</td>
<td class="nump">$ 51.8<span></span>
</td>
<td class="nump">$ 45.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>coo-20221031_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:coo="http://www.coopercos.com/20221031"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="coo-20221031.xsd" xlink:type="simple"/>
    <context id="i430ebcbddebc425c968858950136be1a_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i944d7fd0de234233b44eb4bcb8fa8987_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i5c6912625915414abeea18d6c508ec80_I20221201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <instant>2022-12-01</instant>
        </period>
    </context>
    <context id="i92626cab45db4a19a73bbd1ffef1f631_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:GenerateLifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="ia9670e8e6c214908bb980ca8b9163492_D20211217-20211217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:GenerateLifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-17</startDate>
            <endDate>2021-12-17</endDate>
        </period>
    </context>
    <context id="i7d0f2b3e11b74394ad583fa260d2434b_I20211217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:GenerateLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-17</instant>
        </period>
    </context>
    <context id="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i893b343911d346c78ad0d7715f7d33d0_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i15080967286843b083f296cee9e2bdd7_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="ic40025e930f74fd19b2ce688c42296d1_I20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:CommonStockExcludingTreasuryStockParNetValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-31</instant>
        </period>
    </context>
    <context id="i4c34808bb01e43038bfe5000593b89e4_I20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-31</instant>
        </period>
    </context>
    <context id="iebd4ad7541d14f359dbe82c616c0ab00_I20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:TreasuryStockParNetValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-31</instant>
        </period>
    </context>
    <context id="i640e2b66e7b443a4a5e3988728a72e3d_I20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-31</instant>
        </period>
    </context>
    <context id="i4862aa9bb8ef43508c2cc981078ef274_I20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-31</instant>
        </period>
    </context>
    <context id="ide1724bcbd604d64aec96d6a7f39d61b_I20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-31</instant>
        </period>
    </context>
    <context id="i8cb5a13a16e74334a69daeb5cb71f84c_I20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-31</instant>
        </period>
    </context>
    <context id="i5167c03ea3ab44e7b464a93ec06fc66e_I20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <instant>2019-10-31</instant>
        </period>
    </context>
    <context id="i538b018151b043f48a11b745f431a4dc_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ieafb6aa788314d68858bdce8b8cc9452_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ib49675071eae40dfab504de223e18ee9_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:CommonStockExcludingTreasuryStockParNetValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i979761737a724a468a53d50ec7fdc9d4_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i81f7068bcd6a4b5092ed7c04a932aa4c_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i03991b00df3c49439458880f97362831_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:CommonStockExcludingTreasuryStockParNetValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="iffb2fe484e3846c9bd0a06b30ea69c83_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i29dbc102232c4927bebb87096c5efbd1_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:TreasuryStockParNetValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="id99ee9ce8f314279b8ed0d124990935e_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i15ff03e12d5e49abb65998853b7f5c15_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="ie9c7c5de6c0d4c81bba6613a87b7c142_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i76280949e11f40589848621ccf9e17d7_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="iae603271d4564d759045232140ef888b_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="i4ff34bac9bd34f02a659325f60bd6946_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="i92ad3fcf3fa24292a93bc23096208379_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:CommonStockExcludingTreasuryStockParNetValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="i91a298fab24f46b08cad8c03bf310938_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="i813ba48615004049bda2cd1adc7a200f_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="i7a9a9c9f91ca422180b746b351012dba_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i10b91becc0cf4d67b8ccd40f10fc6633_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="if0e07227018a48699fc5b6e0852505fe_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:CommonStockExcludingTreasuryStockParNetValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i84e5415a196749599d0e6e0005250229_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i6ba42cdb4ce44091bf3d217dca29f463_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:TreasuryStockParNetValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i33dae8774a9d446da11e92d8456741ad_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="id1debae85ed14b3aa606b0f2a2bf613a_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i5fca87f8caea41ba87bb56ee5ee38701_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="ie9c8cbde74104a3982b2d1bdc730d863_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i74ee878bb50944f89b4a3dc97d5aec72_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i864fde92b4e34849bbc81ca4a0f19094_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i18d6974b69cf479299decdec035def9e_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:CommonStockExcludingTreasuryStockParNetValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="ieb7ea73d4acf4eb7aae210fcfd94fd7a_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="ia9123c64ce444cffba4dda081d73bc13_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="ia71ce847bd5e4c5989f4eeafd6a550a9_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:CommonStockExcludingTreasuryStockParNetValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i685c57aff67b45abacf0deaf8e923fa0_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i27bf67955d844c6798e8e8fa5d42494d_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:TreasuryStockParNetValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="if2fe242b18cf42e7bc71473cf1d4fa86_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i13f3c04d8bda4a5ea3fcba710edd83fb_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="idc5e797e87ea4a7caf9a6a4e9c552fc7_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="ieb24416eba0042eea28cba51d9346b77_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i464c13efabb24917bf19bc8289bce72b_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="ic23b9b3f6d3c4e14bc47f1dc4aaaf851_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i7961f9072dbe43cd94f80a154bca4da3_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="ic287f5f4035d4d3da007edafaf1a3fa0_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="iead04709e17747fe86865c67855d124e_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i3c4f820f05374f5f815a531d9a560aa7_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i2c73a0636d374fd6b53feb1438cbe3ff_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="if513250ff04c4191b9e9da3d94c6c176_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i9a3c8a9647004da681ccc361aa33e519_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="id75b52051d824284a67f698730bd6d07_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i0e7e9ff574584a7d870bff7258dbde9e_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i9b2af60b11694e86bd8e533c1e3014ba_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="idabbabf9caaa404aac078818ec07abc5_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="ib13a9242898a43f9842a944029424ab7_D20220801-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i3a728882a111429c8b376cccf1bd73ef_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i628a683f9df74396a991320942dabd37_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i4377d2468ae64603815ed52f5106831e_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i4755ba4225344dd7b4f9fae0941a7939_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i4490227610e34141bead62dd395b0373_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i0f75554f20cb46aca33f75fa5f6502ee_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="ia9b719bd522e4ee9954e7e380e5d3eeb_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i942ea2bc8344447e8693e560ce6e340b_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i907460a095fa4821a0921af76f91e5e4_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="ibf1a11a6c31f47a18aa6688a9b14bd5b_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i226050fcb98849a48ca2d0868ba5c7bc_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i76bc41d306494128a518ecbb65cf02e7_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i6adfb3a01e034e82af78c7dad7558f19_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i7f59291a9d824a74b48fc9ac4fbaead3_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i7f5ad20d5b9a49469f369636c87ebb17_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i3f19b0d477094c1d871e211e7657ece7_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="ieba1d7a126cf491983e2cc68fca1e7ab_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i94797e6c57ca4c538683063a5cffce19_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i0a09f770943a476f971ff4bc25761545_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i8955c25df4054801abf90c55eec9954c_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="iad97efcffb85427888b5504029d82982_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="coo:BusinessAcquisitionAndAssetAcquisitionAxis">coo:SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i12e4f0e0cd4a46a0bf59c1a45e99906c_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:CookMedicalsReproductiveHealthBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="ic10ee393b7e044b093750ebeec1f6c8a_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:CookMedicalsReproductiveHealthBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="coo:BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis">coo:PayablesSecondInstallmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="if7818a8cacc84e89aa1d06e47767b0bc_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:CookMedicalsReproductiveHealthBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="coo:BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis">coo:PayablesThirdInstallmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i7fec09130d504bee8c893a02191e8224_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:CookMedicalsReproductiveHealthBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="coo:BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis">coo:PayablesFirstInstallmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i6b34bc1e1b3d46e09f4bc621ba4b91f4_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:CookMedicalsReproductiveHealthBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="coo:BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis">coo:PayablesFourthInstallmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:GenerateLifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-17</instant>
        </period>
    </context>
    <context id="i3f3295cb8a9341809bbb733c539b6249_D20211217-20211217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:GenerateLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanFacility2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-17</startDate>
            <endDate>2021-12-17</endDate>
        </period>
    </context>
    <context id="iefe968cac09746bc97e9dc95581ecbbd_I20211217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:GenerateLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-17</instant>
        </period>
    </context>
    <context id="i7e939ba156464566a17cd5b1cde99696_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:GenerateLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="ic738218133bd484dabc79502af59dec3_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:GenerateLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i3211f44a486b4d46a6d52e32c86746c2_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:GenerateLifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="i99d2bd9111f1487a8c7a382f53e39f32_I20210201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="coo:AssetAquisitionAxis">coo:PrivatelyHeldMedicalDeviceCompanyDevelopedMaraWaterVaporAblationSystemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="ic28dd8b3e9104664aab70f457f386c99_I20210119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-19</instant>
        </period>
    </context>
    <context id="i1cdebe36232d41e6a395e5517f2650a0_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie874cf747ecd4b75835fe8d98669733f_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i369447ccf1304ac393c75433b2da8574_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">coo:PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="ic12ec65ec7b84054a21489d444adacc6_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0e049c53ca9040a0b53609d89212a62b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">coo:SightGlassVisionIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0e7cdc32ae2445039739777ea8b26dae_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">coo:EssilorInternationalSASMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6a591cbb772f491288113182f88e2c51_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="idd2d0c2eeead43aab5ae86328389cce3_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i7331fcd87a2241c0b7dfa12a4cdaa7b3_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i144fdaeefe67410baf1810389c09a562_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="iaeae5667d45b495b88915bbc72c256cd_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i3421ee2f74cd428aa2c026d3ac5f1798_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i445d23b2879040a09a5d53dc620f8b08_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="icfbfa01dbda3465490aba1443bc5a27e_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="iebeef7c0d08c42438b2be3731f602914_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i0c3cf741cce74b56b90505abfc3135d4_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i30ee62456f6841a38e22988758ba7ea5_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">coo:CompositeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i407ff2a6ca46463ea28d8844c283b1d7_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">coo:CompositeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i1d0efd8be16c45d2873b2c8fa83fee18_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">coo:CompositeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i77b415e656bc4ea68b948eb7f695456d_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i1433809bee9a4008bf8d115c1d460826_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="id2afa4e343dd4305a9d4850614554f7e_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i115d9ee442ae4c56a41f07744f19fbc4_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i08f13a8230854e86893bff6282ab94ac_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i878f78528c3f40cd99f777c89d5d2e00_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="ia510700702624ebfb92ea3d3b9bb1934_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">coo:LicenseAndDistributionRightsAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i0b16c8a519f143b9a35f452e86b54283_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">coo:LicenseAndDistributionRightsAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="iaf516f29728c49ea8d13657c5e377a8e_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">coo:LicenseAndDistributionRightsAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="ia4917c3481374f0a93818dc20a45502a_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">coo:OverdraftAndOtherCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i1b0fe802f23047fd86412c4b0a12e7f4_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">coo:OverdraftAndOtherCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i3ab931d901624913a0875c155dd2c744_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">coo:TermLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i57b61e00e7774e95a89c8142b3bf5838_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">coo:TermLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="if9659d4a6cff4b4dbd9b2f26ba14ea06_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i2fad6966df8143e8a4914f53e33375a2_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i55a407bf120641c6a3267ea45f9bc655_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i0b694e0c04a748c58139e1321f99fd2a_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i4c45cfe81e384f56bae429ccfb71c2ec_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">coo:OtherDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i18d4ac0f0b1a4888ac43f875e832794d_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">coo:OtherDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="ifca29665c5264825877b7058a88003d2_I20211217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanFacility2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-17</instant>
        </period>
    </context>
    <context id="id51c61469fa640639cd76808539e31f4_D20211217-20211217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanFacility2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-17</startDate>
            <endDate>2021-12-17</endDate>
        </period>
    </context>
    <context id="i6b809e82e20145e888d01efebc590393_D20211217-20211217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanFacility2021BaseRateLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-17</startDate>
            <endDate>2021-12-17</endDate>
        </period>
    </context>
    <context id="i53ffe4696c6f4b47b2e4b518a1cf3c2a_D20211217-20211217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanFacility2021AdjustedLIBORateLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-17</startDate>
            <endDate>2021-12-17</endDate>
        </period>
    </context>
    <context id="i2a01079f97ba4d5783870ec5bc57cdca_D20211217-20211217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanFacility2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-17</startDate>
            <endDate>2021-12-17</endDate>
        </period>
    </context>
    <context id="ifffdb3949fef4f5385e7019378e75442_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanFacility2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i228f4290d6fd4f95876b3825317e8cd3_D20211102-20211102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanAgreement2021364DayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">coo:TermLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-02</startDate>
            <endDate>2021-11-02</endDate>
        </period>
    </context>
    <context id="ia94dc74dbbad4a8d9eb7e9f6962a812c_I20211102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanAgreement2021364DayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">coo:TermLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-02</instant>
        </period>
    </context>
    <context id="idfb7453c47b34db1bb9c7e36494babea_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanAgreement2021364DayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">coo:TermLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i227390cb7d3741d68bbf2a306e8d317d_D20211102-20211102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanAgreement2021364DayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">coo:TermLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-02</startDate>
            <endDate>2021-11-02</endDate>
        </period>
    </context>
    <context id="ia014d234e2444dd4bb45dd43ef342980_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="i1e590effe8254728b5dd3d8a3dd2c200_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">coo:TermLoanFacility2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="ifc00728eabe64bf9abfe0f08253a79f6_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">coo:TermLoanFacility2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="i91b88612cab0454c851fa2d99d1c3fd4_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="i99285324fc244ac586029dfa2f4f68a8_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">coo:RevolvingCreditFacilityAndTermLoanFacility2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="i9500e33949584e7fba3a70a9736253fa_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">coo:RevolvingCreditFacilityAndTermLoanFacility2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="i9e8360d369424d82ba580ad6e272eaf1_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">coo:RevolvingCreditFacilityAndTermLoanFacility2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="id5ae1b08f4874f7aa187763d59539a86_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">coo:RevolvingCreditFacilityAndTermLoanFacility2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="ib107e383db7648e0a06edb90e19e4ed9_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">coo:RevolvingCreditFacilityAndTermLoanFacility2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="i2b1692dde0d0413fa5ee769ae29445c9_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="i6d7d408231a140f9950399b4dc433531_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="i1d41f939e43e4627b5b87dc3739b80c0_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">coo:TermLoanFacility2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i29e6d6b4446144a4b28b291aa1417e38_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:CreditAgreement2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i20f77777d3384f55a365a87853e42b20_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:EuropeanCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i43df8cc9f4d3428b869e34da6854f047_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:EuropeanCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i6cb922e3a6634ae5b78e0db7ecf40f80_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:AsianPacificCreditFacilitiesYenDenominatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="if3dec29ada164a17b0ecfcff9b29d05d_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:AsianPacificCreditFacilitiesYenDenominatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i945bc86fd16b49b48c0754f8f46cd4cc_D20211217-20211217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">coo:TermLoanFacility2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-17</startDate>
            <endDate>2021-12-17</endDate>
        </period>
    </context>
    <context id="ia18ddf672b66483baceea8655de8da4b_I20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="i9a8c7e344a6d4ca6aa5bbb5af896bb9a_D20210501-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="i1fdb5f114ab64b349676d31f17804de9_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i4fec0e4443b8407cbcb12c6d06cf6eaa_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i735d9bf4f5c64cc190f684cf557f76ac_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i9037379de7ad40cb960f5f67523ae233_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="i994f6d46a07848c48bb5f57d06e47f95_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i60a5f62358f3456f94c7622fcccd1de1_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i5b52a596f80946beb247cfd6e8e457d0_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="i5e5449ed4ace4f148ff5db6afd1d1441_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ic2a66fe928654ff892f449b28dccbcea_I20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-31</instant>
        </period>
    </context>
    <context id="i4939e43dc1c44e3c84ba8a60db483c8f_I20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-31</instant>
        </period>
    </context>
    <context id="i767587fb433c468584f3f7356b9737e4_I20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-31</instant>
        </period>
    </context>
    <context id="ic33f40436aa045c7a3aa5a02afaafef0_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="iac86d4da8948474188bad8e7f5a66f87_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ia1ce184d806940dc9e3ac0e3283e5a05_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i984b27946ae74a7a86ccd23408d602d5_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="ie2b158c1317d4810ba6145502cf9fa62_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="ia689d6db1dcf416ba5f2200ae5e5f4b5_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="ib785f9fe0b6f449a807bde4146343b94_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="i57f3229c828a483a94464d9bda7f0fc2_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="i65542b1a9cb447ac8968bcb17317427b_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="ibd134a9b985a4f77a31f6656483a2e78_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i4d514c5d060040099cd2656f450fc3e6_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="iaf2ee51bda7b413c809c36bd987d5e20_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="ic6d7c5e2927b491cb9d48756d4126817_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i105b86b96182466c89e084e2d8117b5e_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="ib9244242144c45aa9048eeaa500730b3_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i4d0f42512b5a468fa0175b728ddf3071_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i27afd0c9af1c4f46a1ee89390596bd3b_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="ifbc93be7f95b42e8959f15b98f6e9285_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i26915257e03c4b6fbdd14345564b2a64_I20111231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <instant>2011-12-31</instant>
        </period>
    </context>
    <context id="i00964b16a5864689921a5cd1f5431741_I20170331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
        </entity>
        <period>
            <instant>2017-03-31</instant>
        </period>
    </context>
    <context id="iaaeec49689584b009b3148ed2f1bb819_D20160301-20160331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-03-01</startDate>
            <endDate>2016-03-31</endDate>
        </period>
    </context>
    <context id="ic2850480bc384efa8b688e7df1dd278a_I20160331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-03-31</instant>
        </period>
    </context>
    <context id="i5a96f2cd61fa40c1b78c32485036c8cf_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="ia678a09e2bb14a1d80e45900f2d335b2_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="i34c6e3ecdc714534b64a27e81133d571_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="id3c66c33e415421ca03a2aadddb8dbaa_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="i60fe14742746448cac80ed3337c5356e_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i74e4fb1d833e4139a5e462dc894a6a8c_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i9e7be87b88184c459d07d5e3a87d0602_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="i5316f98d06b94776b210ad2c61336af0_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="iadbfb62be93b49f19b18d5333619cf75_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="ib43f171b08e2457494485fe6afa22232_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="i14f3575ceef54408bd5ad9d8562d1bb6_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i53613739fd6240a4ade0fbe47617e606_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i7bf32de8054e4d5cb01fb90b42cafafc_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i36efa04f987e49038157484c638ab7d6_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i27ec16ba40e149c58fa3c4003f0419fa_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="i8f3a691bb67a4ed98d8c94bd5d067867_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ic67deac3adaf43fc8e4e0743d905cdbe_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i2a6b156ffce448468a38a7cb9a9f5284_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i45529f605588475bb1f13e0535eaa215_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:DirectorsPlan2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="ib5093ad2403f457e815c9833c4647814_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i27a4fb29e4284efe98e1175e5c0e2891_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:ThirdAmendedAndRestated2007LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i2e988aefd55b4136aafbe1e6601e0d10_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i57f5c7d0d50a48669bf760069cb4c005_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i55102374da8b426cb0c7d8637de24dc2_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i8553c50d62874816b3cf637114eb13b1_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i419dcfba3297431ba7f0c26398d2e903_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="ieb72813cd59747189c7d292f82b5c7d5_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="iaf39cdcb16094b55b8a7d809ab1a25b6_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i342792221366432e9408d5dc0256f8b3_D20190318-20190318">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-18</startDate>
            <endDate>2019-03-18</endDate>
        </period>
    </context>
    <context id="id9037d5644ce4d68b1a7e215ab8301e5_I20190318">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-18</instant>
        </period>
    </context>
    <context id="i4291f2db677e4d3aa394368650faea88_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i1a09d9736b484620af2ea6732aa8cf6f_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="i6b2d744fbde74052be31c86e76d32cdb_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">coo:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i63cbbcb6c872410eb8569b17394ff5b7_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">coo:ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i624452a49f29415dbd617b4589408c5a_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">coo:ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i81df2e32936447de9004b3e72091ab2b_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">coo:ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i0436b7aab9ec44818925071f5beef55c_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">coo:ChangeInAssumptionsForDefinedBenefitPlansChangeInAssumedPaymentFormElectionProbabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i5e6b59d888914091a12f486903db9b8f_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">coo:ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i7a4fc69a1c8544d984b2860446a8cc59_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="id7fe4c21857c4580a2bb918c4d443e6c_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i35a7d060cc03406aa06d6d2e52af7aa8_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i6f8e8579bd9f4de1bc128c354594f563_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquityFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i334d9d36817a404198eaa63d441b7876_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquityFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i6b597c9875e84d9dbaa5078086f54163_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquityFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i3a8c5a86d4af47dd80e81eee5d90e1df_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="id997ec317814462ba72540f4ef32a2a3_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i9c1611da45144b90bea4e31bcb16786b_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i26a8e3f73198439181c7db0f9541574a_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">coo:BondMutualFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i03153ed49cfc47abba8d0d3108d50a1f_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">coo:BondMutualFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i986cc010c8c04831b70f7128a9b44c17_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">coo:BondMutualFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="ib85025a9deaf4843aee211787d365a16_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i8c51826bf4c24060b6544fe06a5f0acc_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i8c61c0e5f7d448f083a8214f4affcc5d_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i3c6597a1b5d9405b8074c5402317fb16_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="iab1f3fcc011d42c9b46e9e09fd09d128_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="idb7d578f2c5c4230b76ef6494dab18ee_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquityFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i3e74d409e85a41d5a2c110a4229eb2bc_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquityFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="ib60d652edf684fe681874a2a2fa83fa0_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquityFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i3e523df95698455d89c863a25a39cc0a_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i9478c54d56244163bd2004c364491b0a_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i64acac4cceb34e55a9056341c5bb4477_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i50b1c25ad93b40649c4bcf9197d4e9d0_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">coo:BondMutualFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i5edcbbc801c346c28e2c94d9e4d8c524_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">coo:BondMutualFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i4f08d2ac862b4de1a91c5b0e239533aa_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">coo:BondMutualFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i0a330158da9f4490afbea9f2a383c0cc_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i9bcdee130e56454594be5def8b90a9e9_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="iffb0171583b6494dbb6fea0de231f654_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i25cde43e219544f999a9522e40885def_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:ToricLensMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="ifc3c52f498cc45aea41930decf8ee38f_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:ToricLensMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="ia253e12523d043d49f3b05b362ac4db3_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:ToricLensMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i4d10aa172f4241199dca5d1ca8ce9dc3_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:MultifocalLensMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i85d55c68caa34e448ff17017cfacbd34_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:MultifocalLensMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="ifc783e59e8564dc5a184e25dc3297b9e_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:MultifocalLensMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="iccd45949f93e4f0d856a82cc74ad6f30_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:SingleUseSphereLensMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="ib621e690024248a09198dea9ac20e44d_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:SingleUseSphereLensMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="ib8bb2845023f4ba69135007f32f07bfd_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:SingleUseSphereLensMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ib70d98549d8f495a9abc9b2d97f90135_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:NonSingleUseSphereAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i8072fe66c6ab44ba885a43c3d95061e4_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:NonSingleUseSphereAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="iae8aae422ef74e84b2422bd0e0d79312_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:NonSingleUseSphereAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i102f306f3b6e41189c2e3d4c415079d8_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="ie9d6919196ca46a88ce3671aa7019026_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i9dd5db5ac5f0464c9c4532ca81435932_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:OfficeAndSurgicalProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="if06952d7a77e4c6d9f9444b9a19fa7aa_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:OfficeAndSurgicalProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="if6ed314c0ed34367adef4b03b91bf0e0_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:OfficeAndSurgicalProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i25dfc4b265ed4288baedea76cb9d2444_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:FertilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i51cce661b93d48838c95d5583bafe501_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:FertilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="i309196da87d847b0b037f6d29c6d95e8_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">coo:FertilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="idb221ec949be4a1a87f43dd831ca8d8c_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="ibca59e6c981d48c5a555d3d4902818d1_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i7bc30f40f79641898ba6c790c0142777_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i6eec52445a764506b37023f966f522cd_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i114133db3f4f46f0be519e2bb98d778d_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="if236740745ec431d90e33cfc8a948539_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i1e7e37cad2a94f059cebebab71490b56_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="ib0a609362bee4d6c9058db39abefa7dc_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i1636568fa5e84bdabf27c057ce6618aa_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="ib7703e214bc54be8bcb93e4d048e2560_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="if848d1e35557456494fec2c118fc8064_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="if5bd3183833a4311ba1940f6e13e8c58_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i706aed7d18eb42adb67c45317cebd9df_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i7fac46c673ae44a6a51e56072ef333f6_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="ifda5545cd7a64877bb275e348b90dff5_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i949cdb7296c2413c8bd74737698ae04c_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i936768573f894f27889c7dd715937761_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ib167cd4900e94a9d8cbe4bf12709f074_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopervisionSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="ib2fed7da6fdf4c2d84c04555713219a8_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">coo:CoopersurgicalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i4195fe02b707490a8d61b963c66350fa_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i2772f61aefe64ddbba24fc95a9137207_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="ia1c3c38f11c44e2da46bd9a800f94386_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i203ba6d20b6f4590bfc5a2c49c100182_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i9ca5a267e7864693ae8d23449d787c29_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="ib878f9b3ae04474a863b123b65f168ab_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="ibbf6d52286234783b4187fc8c1b84be2_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="ie853cb4e9b8e4c04b1094493101d98a5_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i872ddcd0dec342a68a42c53d1feac123_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i7b2584e8265f4b1eb31b69d99591c665_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">coo:CorporateReconcilingItemsAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="if091820da3fa469ca8e63a4e7e623ebb_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="idee380fa4cc94aa2949150146bc1b833_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i98cba8f6abe845659e16156082ad2d25_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">coo:CorporateReconcilingItemsAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="ia9a9fbd6fa9745abbc18a527935e6729_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="i24ed2c06038c4e21a954497f6fc03687_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="i632fce02d0a14ee2a54b08cb02f4a530_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="i5472d5f5ea1840df9d91ec3db5081155_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="i0d31ba7c78554e01be3531b7db972065_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="i6ac8281323054a3383ab48d0fa752407_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="ib5e3fde5895f43fba4395a3f2a394105_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="ie429681883c245819521a0c57f11ffa7_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="i89ef065c99254e85b8c2f8427f8cc1cf_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">coo:CorporateReconcilingItemsAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="i11563134ef8a45bda7a59afedae161f7_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="ib09f048a3bb546ec9d3d473f3290ba4b_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="if12e23677c7d4f59bf1b6b56f97c0a96_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">coo:CorporateReconcilingItemsAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="ib3982025069c42019719d3ae187bfac5_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i3d212cf3f853423d91d402573665e3a3_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ie3a74826cb834e35868ee80db8fd1abf_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i00b1d9c5ee034b9c8a36252aa25fa6a0_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="iec65f950a0dc4854914e26a734104e19_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i1599f6e5dec74f248141c4cf3566bf65_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:GeographyEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ib3910c6d00f04f0abdb3fbfd16d3e64e_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ia32d9258c18848e5abfe9c919bc12cfe_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i750be365ff0047e49e7f299808203d52_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">coo:CorporateReconcilingItemsAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i81cc03f2a4a74c3986074b3bee49852f_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i92fdd7459bad4408a8a71b8370a03266_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ReportableGeographicalComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i04406ea9810f4b8190f8776aa444ef9f_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">coo:CorporateReconcilingItemsAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">coo:RestOfTheWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i9149d6cbeb354638969dcb45da4ca29a_I20200406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-06</instant>
        </period>
    </context>
    <context id="ib93ee62619474af5844402d5b5e2fc5e_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i306e8ebbe94442a5b09f45b81f9f9362_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="ib09f9a58a78443b18bed2336686e605e_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i18b387b0bc824160a72bc4a7fa134526_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="ifc574a9b39cc4fd0b3d2a6b2e338dea8_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i1dda5d68145148858749f4a3d0187b10_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i2357db2168d54d15b89a15c1f04fcf81_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i007a38e974f04b6fa9067c5041cfd72b_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">coo:AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="iea2aa42170064029a14838912d3185ac_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="iedb5b89d45e54e028ef271a4be6338b8_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i1a10babdc03d448fb7f6f049b019e92b_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="ib9b7be6dd72e444c91e43d8ed9b4980b_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i92f0a4209532457b97330c2599af126b_D20201101-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="i8b0bc537a9784c479a6e47674c4a3455_I20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-31</instant>
        </period>
    </context>
    <context id="ibb1e445d83e7435f82ac0109d212736a_D20191101-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000711404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="business_unit">
        <measure>coo:business_unit</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="reporting_unit">
        <measure>coo:reporting_unit</measure>
    </unit>
    <unit id="director">
        <measure>coo:director</measure>
    </unit>
    <unit id="segment">
        <measure>coo:segment</measure>
    </unit>
    <unit id="interest_rate_swap_contract">
        <measure>coo:interest_rate_swap_contract</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF80L2ZyYWc6YzM5NDkxZWQxZWNiNDM1NmExN2I3NjkzNGZmZTg4YzkvdGFibGU6Y2NkODMzOTYxNzA4NDBlNTk2ZDhlMTlmZTc4OGUxMTMvdGFibGVyYW5nZTpjY2Q4MzM5NjE3MDg0MGU1OTZkOGUxOWZlNzg4ZTExM18yLTEtMS0xLTU4NTM3_dea16023-0511-4f11-89de-7cf79aa954c2">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF80L2ZyYWc6YzM5NDkxZWQxZWNiNDM1NmExN2I3NjkzNGZmZTg4YzkvdGFibGU6Y2NkODMzOTYxNzA4NDBlNTk2ZDhlMTlmZTc4OGUxMTMvdGFibGVyYW5nZTpjY2Q4MzM5NjE3MDg0MGU1OTZkOGUxOWZlNzg4ZTExM18zLTEtMS0xLTU4NTM3_6cb2d39d-6041-408e-8daa-253753f84b66">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF80L2ZyYWc6YzM5NDkxZWQxZWNiNDM1NmExN2I3NjkzNGZmZTg4YzkvdGFibGU6Y2NkODMzOTYxNzA4NDBlNTk2ZDhlMTlmZTc4OGUxMTMvdGFibGVyYW5nZTpjY2Q4MzM5NjE3MDg0MGU1OTZkOGUxOWZlNzg4ZTExM180LTEtMS0xLTU4NTM3_7083212e-fe94-438b-a76d-f4a92e6e7e0c">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF80L2ZyYWc6YzM5NDkxZWQxZWNiNDM1NmExN2I3NjkzNGZmZTg4YzkvdGFibGU6Y2NkODMzOTYxNzA4NDBlNTk2ZDhlMTlmZTc4OGUxMTMvdGFibGVyYW5nZTpjY2Q4MzM5NjE3MDg0MGU1OTZkOGUxOWZlNzg4ZTExM181LTEtMS0xLTU4NTM3_ac1610bf-fe42-4314-809f-d36589a1ab4d">0000711404</dei:EntityCentralIndexKey>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTktMC0xLTEtNTg1Mzc_56db2c71-ed4a-4692-8d61-7c04b7423899">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201613Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfMi0wLTEtMS01ODUzNw_f2af3d8b-af98-47fa-9e18-c521fd473e5f">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfMi0wLTEtMS01ODUzNw_fafffb75-d216-4f4d-8142-6f0bc8bdcc25">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNC0wLTEtMS01ODUzNw_20f60483-65f4-4940-bd27-ff3038fea748">http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNC0wLTEtMS01ODUzNw_238f6c6d-7462-42ec-bc2d-2f272994dc20">http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNS0wLTEtMS01ODUzNw_cd2a4655-0b1b-4300-89ec-ea2b04899df1">http://www.coopercos.com/20221031#LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNS0wLTEtMS01ODUzNw_efad86ee-3171-4680-acc9-262cd136b6e2">http://www.coopercos.com/20221031#LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzQtMC0xLTEtNTg1Mzc_9604cf56-7a6c-46d2-bdf5-d8f031e83daf">http://fasb.org/us-gaap/2022#SellingGeneralAndAdministrativeExpense</us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList>
    <us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzQtMC0xLTEtNTg1Mzc_b92a1fd2-f912-44aa-9c7e-af89ec70cb06">http://fasb.org/us-gaap/2022#SellingGeneralAndAdministrativeExpense</us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzctMC0xLTEtODU4NTc_141e84ec-4e7b-4dbb-a1d9-b69da3b28fc9">http://fasb.org/us-gaap/2022#DebtCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzctMC0xLTEtODU4NTc_47c29b41-9b44-43cc-a1c4-67a03e586316">http://fasb.org/us-gaap/2022#DebtCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzE2LTAtMS0xLTg1ODY1_1411df30-957e-4c30-8c9d-b44d0a42fc69">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzE2LTAtMS0xLTg1ODY1_b721c839-4714-4bc4-a058-6a751c018797">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i945bc86fd16b49b48c0754f8f46cd4cc_D20211217-20211217"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xNzkwL2ZyYWc6NWQ0OWIwYjE4NmU3NDFmNmE1YzFkYTU5ZDdjODJjZWMvdGV4dHJlZ2lvbjo1ZDQ5YjBiMTg2ZTc0MWY2YTVjMWRhNTlkN2M4MmNlY180OTQ3ODAyMzI1MzU1_b04d29e5-f2a7-4238-a299-a4ac2bc32024"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ic67deac3adaf43fc8e4e0743d905cdbe_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzY3ODM_6bc749ef-684e-4774-a7cb-72940d101aed">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ib5093ad2403f457e815c9833c4647814_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzc1MjA_66aa3933-ae43-4ccf-b4c9-c3b93a1275c1">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzQtMC0xLTEtNTg1Mzc_111e8ddc-226d-4304-959a-b934b7d622c2">http://www.coopercos.com/20221031#LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzQtMC0xLTEtNTg1Mzc_36ebe715-6c70-4c33-ab4e-77078f30596f">http://www.coopercos.com/20221031#LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzQtMC0xLTEtNTg1Mzc_8ba49eaf-48ae-4cbc-b09c-7e9a7b0ad98d">http://www.coopercos.com/20221031#LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzUtMC0xLTEtNTg1Mzc_07a95161-0974-465a-ac1c-175b72fdb90d">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzUtMC0xLTEtNTg1Mzc_34fc253a-7253-4b21-920e-c9ce51841c5c">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzUtMC0xLTEtNTg1Mzc_73a230e2-9634-4eba-833b-aa7156e9f4ce">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzgtMC0xLTEtNTg1Mzc_08e3d8ed-42a7-4cda-a134-26367a3edca1">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzgtMC0xLTEtNTg1Mzc_40c89b78-ce45-4552-a50e-59b206d64cbd">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzgtMC0xLTEtNTg1Mzc_c32484f2-1db6-4923-b0d9-5be0212a7130">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList>
    <dei:DocumentType
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDgw_f65d1ff4-b667-4bde-a27a-ffc458cee7dd">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGFibGU6N2VhZmU0ZDhlYmQzNDkyZDg1NmI3ZjI5Mjg2ZmY2ZTQvdGFibGVyYW5nZTo3ZWFmZTRkOGViZDM0OTJkODU2YjdmMjkyODZmZjZlNF8wLTAtMS0xLTU4NTM3_e4b5e514-c8fa-4fd9-bf6d-4b490c8cbaf8">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18xNjk_f04c0670-9baf-4e8a-8e31-bc84a36749a5">2022-10-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18xNjk_c003a6b2-66cd-49ac-b489-b1661d1b2a63">--10-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGFibGU6ZjhhODJjODE4MjIyNDY1MWExYzY5MzZiZjE4ZjVhOTcvdGFibGVyYW5nZTpmOGE4MmM4MTgyMjI0NjUxYTFjNjkzNmJmMThmNWE5N18wLTAtMS0xLTU4NTM3_a30a444d-0eb2-465f-ad40-babf1a953e65">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDY3_bbb3ed75-d0b2-45f7-b6b9-adbd1ca8bc68">001-08597</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDcz_f3600aa4-e629-45fc-bdb9-626b87fe2f68">THE COOPER COMPANIES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGFibGU6YWQ0NmQyYjY0MjI1NDYzMThmMGZmYzk2OGFiYmQxNjQvdGFibGVyYW5nZTphZDQ2ZDJiNjQyMjU0NjMxOGYwZmZjOTY4YWJiZDE2NF8wLTAtMS0xLTU4NTM3_86d7741b-fcf5-4093-8cd1-eb957a4b15a8">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGFibGU6YWQ0NmQyYjY0MjI1NDYzMThmMGZmYzk2OGFiYmQxNjQvdGFibGVyYW5nZTphZDQ2ZDJiNjQyMjU0NjMxOGYwZmZjOTY4YWJiZDE2NF8wLTEtMS0xLTU4NTM3_107c6ae1-c0a9-495e-826c-082c902c50b5">94-2657368</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDc0_fc4895fd-7762-4d02-910f-b2690b923a52">6101 Bollinger Canyon Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDc1_577bd5cc-f94e-4267-958d-956d9e55f895">Suite 500</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDgx_c33ca152-dbd3-4c01-9038-7727285c1c2e">San Ramon</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDY4_e81ca4f9-f58a-4230-8d49-8c9e98144600">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDc2_f5aa0416-dd33-41d4-bddf-1039e5a79cf6">94583</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDgy_1bbaad5c-ae85-4033-8cbc-51fc23d4089d">925</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDgz_2cf00e3f-685f-4169-833a-a8ca048ade7e">460-3600</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGFibGU6YmIxYzA0MmQ5N2I3NDE3Y2JkZTA0ZGIzOWIxMjE3Y2QvdGFibGVyYW5nZTpiYjFjMDQyZDk3Yjc0MTdjYmRlMDRkYjM5YjEyMTdjZF8xLTAtMS0xLTU4NTM3_a02b6fd3-e970-4d37-b1dd-b7da86058683">Common Stock, $.10 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGFibGU6YmIxYzA0MmQ5N2I3NDE3Y2JkZTA0ZGIzOWIxMjE3Y2QvdGFibGVyYW5nZTpiYjFjMDQyZDk3Yjc0MTdjYmRlMDRkYjM5YjEyMTdjZF8xLTItMS0xLTU4NTM3_8447f10f-9755-4865-9633-567b0894686e">COO</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGFibGU6YmIxYzA0MmQ5N2I3NDE3Y2JkZTA0ZGIzOWIxMjE3Y2QvdGFibGVyYW5nZTpiYjFjMDQyZDk3Yjc0MTdjYmRlMDRkYjM5YjEyMTdjZF8xLTQtMS0xLTU4NTM3_3ea30890-6c23-4d0e-ac27-13d8588aef38">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDc3_4f777701-fabf-48f7-b655-f1348f3ce5d4">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDg0_f28f36ef-5f3b-4e78-99ea-10d9caf74ab4">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDcx_73a56202-ff1f-4052-aaba-60e59bdd980b">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDYz_93da0be6-6fdc-4580-bb71-f91160b723cf">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDY5_77498162-0529-43b8-9c13-232ac6cbf2b9">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDcy_ff345cbc-9808-4277-9da2-435bdf5b04d2">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDY0_e31b6ee3-41ea-4d7b-a13d-f943476b7dee">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDcw_0656a9ca-086b-427d-aa02-4a267da4b6b1">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDY1_b76b0e45-5905-48fc-9e2a-3ecde529feb1">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i944d7fd0de234233b44eb4bcb8fa8987_I20220430"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zMTU3_a1654248-6815-49f1-b8be-01af24583bb1"
      unitRef="usd">17700000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i5c6912625915414abeea18d6c508ec80_I20221201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDE4_d20628ca-b73f-48c2-97d7-4c01cb81b272"
      unitRef="shares">49354384</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18zNDY2_e6f7c8b7-3b3f-406f-aac0-4d39b8b7d91f">&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.124%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Document&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Part of Form 10-K&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Portions of the Proxy Statement for the Annual Meeting&lt;br/&gt;of Stockholders scheduled to be held in March 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Part&#160;III&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our independent registered public accounting firm is KPMG LLP, San Francisco, CA, Auditor ID: 185.&lt;/span&gt;&lt;/div&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorName
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18xMDk5NTExNjMxNTE3_077f5627-3202-4c5a-8c13-23d97ab192e8">KPMG LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18xMDk5NTExNjMxNTE2_2de8332c-83ab-4932-9fc3-6fb892e41b64">San Francisco, CA</dei:AuditorLocation>
    <dei:AuditorFirmId
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xL2ZyYWc6ZDVlZDdlMzRkZmViNDg2OThkMDUzMmVhM2ZmZGVhNzMvdGV4dHJlZ2lvbjpkNWVkN2UzNGRmZWI0ODY5OGQwNTMyZWEzZmZkZWE3M18xMDk5NTExNjMxNTEy_ff760178-1457-4579-a38e-fe7bbd9cd7e8">185</dei:AuditorFirmId>
    <us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual
      contextRef="i92626cab45db4a19a73bbd1ffef1f631_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83My9mcmFnOjUyNjQ3MWVlMjI4ZTQ3YjdhMzQ0MDBhNTQ4YTI4YmI0L3RleHRyZWdpb246NTI2NDcxZWUyMjhlNDdiN2EzNDQwMGE1NDhhMjhiYjRfMTcwNDI0MzAyNTM1OTM_8fc17235-8111-4d18-b216-167609d950ab"
      unitRef="usd">249500000</us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ia9670e8e6c214908bb980ca8b9163492_D20211217-20211217"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83My9mcmFnOjUyNjQ3MWVlMjI4ZTQ3YjdhMzQ0MDBhNTQ4YTI4YmI0L3RleHRyZWdpb246NTI2NDcxZWUyMjhlNDdiN2EzNDQwMGE1NDhhMjhiYjRfMjM2Mzk1MDAwMzI0Njc_401e261a-3c82-4e00-aa15-c924174d6bb1"
      unitRef="usd">1663000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i7d0f2b3e11b74394ad583fa260d2434b_I20211217"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83My9mcmFnOjUyNjQ3MWVlMjI4ZTQ3YjdhMzQ0MDBhNTQ4YTI4YmI0L3RleHRyZWdpb246NTI2NDcxZWUyMjhlNDdiN2EzNDQwMGE1NDhhMjhiYjRfMjM2Mzk1MDAwMzI0ODQ_bb6f1c15-1fb3-460d-863e-40f9114e89c7"
      unitRef="usd">718300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMS0xLTEtMS01ODUzNw_fc0fdf11-8691-4acc-85d5-4b32134cfaa9"
      unitRef="usd">3308400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMS0zLTEtMS01ODUzNw_ffbc6875-b2d6-471c-9f7a-4c8e9d55b4ef"
      unitRef="usd">2922500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMS01LTEtMS01ODUzNw_e8b5cdd6-6939-463b-a873-565ebd2eafa7"
      unitRef="usd">2430900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMi0xLTEtMS01ODUzNw_22b06dd0-78cf-4da3-b676-c30fd0eb3cd2"
      unitRef="usd">1168800000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMi0zLTEtMS01ODUzNw_cdf69deb-65be-418b-93c7-c905d6b27add"
      unitRef="usd">966700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMi01LTEtMS01ODUzNw_91167c7c-5a31-47c3-87aa-917414308386"
      unitRef="usd">896100000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMy0xLTEtMS01ODUzNw_cca8734d-da65-4f15-91eb-539be09aad8b"
      unitRef="usd">2139600000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMy0zLTEtMS01ODUzNw_e68f2ac9-caad-4d56-8fa6-b476a8d78b02"
      unitRef="usd">1955800000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMy01LTEtMS01ODUzNw_62c9a9c5-c8a1-4f04-9e68-a97d5136646e"
      unitRef="usd">1534800000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfNC0xLTEtMS01ODUzNw_6797ec11-65bd-4d24-adbd-f42da410aef9"
      unitRef="usd">1342200000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfNC0zLTEtMS01ODUzNw_5f720ff2-3388-4e0b-86e1-24a45108625a"
      unitRef="usd">1211200000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfNC01LTEtMS01ODUzNw_e25be993-e324-4bb5-bc6d-f61ee8c36e89"
      unitRef="usd">992500000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfNS0xLTEtMS01ODUzNw_31a6094a-c980-4a05-9dd0-053b66ef7e53"
      unitRef="usd">110300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfNS0zLTEtMS01ODUzNw_32e81b14-0410-4c07-b25f-49e762265305"
      unitRef="usd">92700000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfNS01LTEtMS01ODUzNw_b31f463f-0871-48d5-87ad-5fef0265f9f8"
      unitRef="usd">93300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfNi0xLTEtMS01ODUzNw_e97ada0e-2426-4b0a-b44d-8af332df28d2"
      unitRef="usd">179500000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfNi0zLTEtMS01ODUzNw_c450dae1-f0e8-4cca-afa7-54b17726fbcd"
      unitRef="usd">146100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfNi01LTEtMS01ODUzNw_693a8657-53bd-4729-ae7c-dccc66361f64"
      unitRef="usd">137200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OperatingIncomeLoss
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfOS0xLTEtMS01ODUzNw_9e588c8c-9e6a-44c6-b62b-cb268eb67d5e"
      unitRef="usd">507600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfOS0zLTEtMS01ODUzNw_26ca817f-38e6-49b9-bc88-3d646850f392"
      unitRef="usd">505800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfOS01LTEtMS01ODUzNw_3c6094e2-0f8c-4d2e-b07c-ed48731d0b0f"
      unitRef="usd">311800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMTAtMS0xLTEtNTg1Mzc_e68b74f9-5010-4ad1-88d7-7cc356eaaf5d"
      unitRef="usd">57300000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMTAtMy0xLTEtNTg1Mzc_074413ed-3c81-4348-b6a3-6b1f4b95656e"
      unitRef="usd">23100000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMTAtNS0xLTEtNTg1Mzc_275f1189-2f59-4c4c-bbae-d3b739feff55"
      unitRef="usd">36800000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMTMtMS0xLTEtNTg1Mzc_506268d5-1bc3-43c4-936c-91f2b9838208"
      unitRef="usd">25000000.0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMTMtMy0xLTEtNTg1Mzc_ab036cb6-4732-469d-82ed-f53986de2dbd"
      unitRef="usd">8800000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMTMtNS0xLTEtNTg1Mzc_af96d44f-f4f0-42a0-98aa-075abfcf2700"
      unitRef="usd">-8500000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMTQtMS0xLTEtNTg1Mzc_54fc7ac6-9475-4021-bdff-b3d0ac0262d3"
      unitRef="usd">475300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMTQtMy0xLTEtNTg1Mzc_cee215bb-80dd-4232-83a8-51f52dc0b2b7"
      unitRef="usd">491500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMTQtNS0xLTEtNTg1Mzc_f74ad240-5b45-4f59-b234-e3298839d70b"
      unitRef="usd">266500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMTUtMS0xLTEtNTg1Mzc_11157a28-bd21-40ab-93f1-2fa425bd5595"
      unitRef="usd">89500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMTUtMy0xLTEtNTg1Mzc_23d7eb6f-c830-410b-a486-cf7ad86378be"
      unitRef="usd">-2453200000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMTUtNS0xLTEtNTg1Mzc_bf58d96a-48de-4ae0-a026-66be1466ee29"
      unitRef="usd">28100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMTYtMS0xLTEtNTg1Mzc_24ded758-845f-4f74-aee5-53eb1712dc0e"
      unitRef="usd">385800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMTYtMy0xLTEtNTg1Mzc_d9cd0e5d-f261-481b-8262-8b675624c34f"
      unitRef="usd">2944700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMTYtNS0xLTEtNTg1Mzc_8380f3df-3172-40da-9ac9-e22c9e2ad5e8"
      unitRef="usd">238400000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMjAtMS0xLTEtNTg1Mzc_dccef1f4-0824-4e06-af65-3a4ba6913b7d"
      unitRef="usdPerShare">7.83</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMjAtMy0xLTEtNTg1Mzc_872844dc-ae68-415a-b0b6-bb0fff7be6f5"
      unitRef="usdPerShare">59.80</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMjAtNS0xLTEtNTg1Mzc_5ae330b3-4a9d-49a5-ba76-69a9f9387774"
      unitRef="usdPerShare">4.85</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMjEtMS0xLTEtNTg1Mzc_92c5790e-eaff-41d1-bc0f-cde1744f60e2"
      unitRef="usdPerShare">7.76</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMjEtMy0xLTEtNTg1Mzc_38dbffec-8153-491b-98c2-cf6072bd04b2"
      unitRef="usdPerShare">59.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMjEtNS0xLTEtNTg1Mzc_42fe8677-63d5-44c1-8d98-ebd85b1f4db0"
      unitRef="usdPerShare">4.81</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMjMtMS0xLTEtNTg1Mzc_0ad32d14-c854-4e80-bae0-de99af14503e"
      unitRef="shares">49300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMjMtMy0xLTEtNTg1Mzc_6eb9f889-e445-48ec-bac9-711d7af8f51f"
      unitRef="shares">49200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMjMtNS0xLTEtNTg1Mzc_75c99196-b3d5-4c27-bf53-9176461fd51e"
      unitRef="shares">49100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMjQtMS0xLTEtNTg1Mzc_bc367a3b-ebe0-4719-8bd3-ead7392edda8"
      unitRef="shares">49700000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMjQtMy0xLTEtNTg1Mzc_20f716d7-fdae-494c-a506-49bc548b77a4"
      unitRef="shares">49800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83Ni9mcmFnOmJkNTkxOTNjNTY5ZjQ0YzA5YjY0Mzg1N2M4ZGM4YWVjL3RhYmxlOjU2MzU2OTNlYmQxZDQ1NjU4Y2U3OGYxNDUyZGNmMzk0L3RhYmxlcmFuZ2U6NTYzNTY5M2ViZDFkNDU2NThjZTc4ZjE0NTJkY2YzOTRfMjQtNS0xLTEtNTg1Mzc_8011c3a7-38a3-449f-85c5-9745775a67c4"
      unitRef="shares">49600000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfMS0xLTEtMS01ODUzNw_32e00dd1-b001-4c65-a95c-32c0cca0a560"
      unitRef="usd">385800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfMS0zLTEtMS01ODUzNw_bfe52e2e-5411-434f-b1c1-03c027d2ef70"
      unitRef="usd">2944700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfMS01LTEtMS01ODUzNw_addb743c-89e6-41c5-9e21-0d85da7efb2b"
      unitRef="usd">238400000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfMy0wLTEtMS01ODUzNy90ZXh0cmVnaW9uOjc0ODVjYmQzZTAwMjRjMTJhNTlmZGFiZjVkYjhiNDE1XzQ3_c5e05bd1-ad48-4fd5-8b88-37ec6559976c"
      unitRef="usd">26100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfMy0wLTEtMS01ODUzNy90ZXh0cmVnaW9uOjc0ODVjYmQzZTAwMjRjMTJhNTlmZGFiZjVkYjhiNDE1XzU1_0f8dd16b-c57b-42b3-ade3-441c0a2c7b11"
      unitRef="usd">8200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfMy0wLTEtMS01ODUzNy90ZXh0cmVnaW9uOjc0ODVjYmQzZTAwMjRjMTJhNTlmZGFiZjVkYjhiNDE1XzE3MDQyNDMwMjMwNjUw_4d5d9781-0062-42ff-987d-b02fa145be74"
      unitRef="usd">-4100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfMy0xLTEtMS01ODUzNw_fae8f4db-120d-4432-9209-54f55946d099"
      unitRef="usd">81300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfMy0zLTEtMS01ODUzNw_41b7d92c-7b8f-4360-ab6e-660213b1f3ca"
      unitRef="usd">26100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfMy01LTEtMS01ODUzNw_04b38089-6258-4176-a6de-755b11f148f6"
      unitRef="usd">-13000000.0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfNC0wLTEtMS01ODUzNy90ZXh0cmVnaW9uOmI4ZWQ2MDQyMDI2NzRhZWNiNDdjNTY5M2ExMTY2ODA5XzY2_a52c69ba-39b7-4276-a34b-bb7615b2db5b"
      unitRef="usd">-8700000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfNC0wLTEtMS01ODUzNy90ZXh0cmVnaW9uOmI4ZWQ2MDQyMDI2NzRhZWNiNDdjNTY5M2ExMTY2ODA5Xzcx_61f0c3e4-6b2b-4abf-8b38-2f5d42fe923d"
      unitRef="usd">-7200000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfNC0wLTEtMS01ODUzNy90ZXh0cmVnaW9uOmI4ZWQ2MDQyMDI2NzRhZWNiNDdjNTY5M2ExMTY2ODA5Xzc5_5550cd77-d9b2-4dbf-be1e-5c1c60e28cae"
      unitRef="usd">4000000.0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfNC0xLTEtMS01ODUzNw_ee253d3e-b82f-4b61-b047-a60fdf275ed4"
      unitRef="usd">-27900000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfNC0zLTEtMS01ODUzNw_490a869b-950e-4225-aae4-22662576262b"
      unitRef="usd">-22600000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfNC01LTEtMS01ODUzNw_daefd5b9-b6db-4836-af95-15d07c4c360e"
      unitRef="usd">12800000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfNS0xLTEtMS01ODUzNw_b5423280-4ccd-4ee6-8e1f-bfd21c6f3ad7"
      unitRef="usd">-234700000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfNS0zLTEtMS01ODUzNw_75df0a94-6714-46f6-9c3a-e8b17a727309"
      unitRef="usd">82000000.0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfNS01LTEtMS01ODUzNw_0ebb7c4f-7547-48f3-8a66-00613fc7456e"
      unitRef="usd">900000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfOC0xLTEtMS01ODUzNw_b83319f4-b6d7-4564-ae14-0a7d4b83f1d1"
      unitRef="usd">-125500000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfOC0zLTEtMS01ODUzNw_c12243ab-4cec-4470-9d04-2557d200b340"
      unitRef="usd">130700000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfOC01LTEtMS01ODUzNw_00930435-bc16-4023-ba74-ad2c1206cf27"
      unitRef="usd">-24900000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfOS0xLTEtMS01ODUzNw_3fdb60a7-275b-49df-9841-de1b05688ce1"
      unitRef="usd">260300000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfOS0zLTEtMS01ODUzNw_48480add-4911-4276-9fd5-b52ba37e94e4"
      unitRef="usd">3075400000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF83OS9mcmFnOjdlNjZjMjU2MjBlYjRmODlhMGI2M2M4YTNlNzk3YWU3L3RhYmxlOjg2YzhkNzY4ZTMwYzRiNDY5NzY2YTYyNmI0YWIyNTkyL3RhYmxlcmFuZ2U6ODZjOGQ3NjhlMzBjNGI0Njk3NjZhNjI2YjRhYjI1OTJfOS01LTEtMS01ODUzNw_97d1bf78-068c-4d20-8dc8-9efc0f73fcce"
      unitRef="usd">213500000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMy0xLTEtMS01ODUzNw_d52d95ae-5f0c-42ef-b5a3-ef3a03ad2cd8"
      unitRef="usd">138200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMy0zLTEtMS01ODUzNw_fcd23e79-d73a-43a1-bb32-7ce83bed26df"
      unitRef="usd">95900000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNC0wLTEtMS01ODUzNy90ZXh0cmVnaW9uOmVkMTJiYzQyZTdhMDQ2ZDlhOTQ0NjI2ODMxZjQyYmFiXzc0_1a7c57e4-3ac0-4d39-b39d-5da397e032e8"
      unitRef="usd">20700000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNC0wLTEtMS01ODUzNy90ZXh0cmVnaW9uOmVkMTJiYzQyZTdhMDQ2ZDlhOTQ0NjI2ODMxZjQyYmFiXzEwMg_350db8f1-467a-43bc-b742-0abb4cdc42ff"
      unitRef="usd">9200000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNC0xLTEtMS01ODUzNw_2dad2362-2013-4889-a56a-ff2d057b1932"
      unitRef="usd">557800000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNC0zLTEtMS01ODUzNw_281fd75e-972a-47b8-9905-e4b3d9175f2e"
      unitRef="usd">515300000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNS0xLTEtMS01ODUzNw_f2b9a577-6162-4c39-8032-bed4dbf4e469"
      unitRef="usd">628700000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNS0zLTEtMS01ODUzNw_e2d5df0a-c9ab-4da8-9598-ab6015d635a2"
      unitRef="usd">585600000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNy0xLTEtMS01ODUzNw_b2b1860e-e9b8-40d5-b565-03c420bcca50"
      unitRef="usd">208900000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNy0zLTEtMS01ODUzNw_a917f58e-71ce-4db2-8222-25d24abcf4f7"
      unitRef="usd">179300000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfOC0xLTEtMS01ODUzNw_56f3fa5d-035e-40b3-a89e-1caabfc2c1c4"
      unitRef="usd">0</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfOC0zLTEtMS01ODUzNw_3cc28913-e45e-4e92-869a-a998e4e57cdd"
      unitRef="usd">89200000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfOS0xLTEtMS01ODUzNw_b69c083a-7231-4709-8b44-fee9dfa97a71"
      unitRef="usd">1533600000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfOS0zLTEtMS01ODUzNw_ff178016-bee3-4166-ad16-6355fe248123"
      unitRef="usd">1465300000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMTItMS0xLTEtNTg1Mzc_979763cb-a7f6-4b28-b29e-29185d6c05f8"
      unitRef="usd">1432900000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMTItMy0xLTEtNTg1Mzc_7bd99e2d-a2d7-4b00-a24c-68dd461fe4fd"
      unitRef="usd">1347600000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:Goodwill
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMTQtMS0xLTEtNTg1Mzc_372b7be6-fc82-4674-b32b-85e98a5b1dc0"
      unitRef="usd">3609700000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMTQtMy0xLTEtNTg1Mzc_46bb10bc-bdb1-4cf2-8041-5560a12f908b"
      unitRef="usd">2574000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMTUtMS0xLTEtNTg1Mzc_0daa77df-0c05-440a-ac46-bffc552c0d4b"
      unitRef="usd">1885100000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMTUtMy0xLTEtNTg1Mzc_55da9b79-dcad-44ed-8cab-af31b468bcef"
      unitRef="usd">1271500000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMTYtMS0xLTEtNTg1Mzc_60d864c9-a42b-43db-857f-668f12ff2866"
      unitRef="usd">2443100000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMTYtMy0xLTEtNTg1Mzc_84117ba0-312c-41c6-b48d-c3752e336791"
      unitRef="usd">2546600000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMTctMS0xLTEtNTg1Mzc_3f421fb9-f930-4caa-a254-86399ea7bc15"
      unitRef="usd">587900000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMTctMy0xLTEtNTg1Mzc_83ed9c40-ba3d-49e2-8bd5-9fee8746e3ae"
      unitRef="usd">401200000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMTgtMS0xLTEtNTg1Mzc_cc2841c4-a74d-4dbd-8048-3117615369a2"
      unitRef="usd">11492300000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMTgtMy0xLTEtNTg1Mzc_f4cbbd0a-72c5-409e-b121-50d7659462ac"
      unitRef="usd">9606200000</us-gaap:Assets>
    <us-gaap:DebtCurrent
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMjEtMS0xLTEtNTg1Mzc_8934dcc3-066e-4ceb-8fb0-fac420d20041"
      unitRef="usd">412600000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMjEtMy0xLTEtNTg1Mzc_1e6be9b6-c753-446f-843c-24eef14bb39f"
      unitRef="usd">83400000</us-gaap:DebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMjItMS0xLTEtNTg1Mzc_588f2119-e6b4-4174-a675-3f1ba6ec530a"
      unitRef="usd">248800000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMjItMy0xLTEtNTg1Mzc_c39f990c-004a-4b5a-8785-3ce23968251d"
      unitRef="usd">161400000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMjMtMS0xLTEtNTg1Mzc_b523d95b-2aa0-46b6-ad16-f6794bb5de35"
      unitRef="usd">152100000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMjMtMy0xLTEtNTg1Mzc_29cb0e33-ebe3-4408-a34b-bf9ca54dfe4c"
      unitRef="usd">148700000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMjQtMS0xLTEtNTg1Mzc_b963092f-5049-43bf-890b-c24b4142e675"
      unitRef="usd">93600000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMjQtMy0xLTEtNTg1Mzc_a16aa106-b137-402d-baf1-40f8211d983b"
      unitRef="usd">19000000.0</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMjYtMS0xLTEtNTg1Mzc_b82b68c8-8126-4cf3-b0bd-912ca46255f6"
      unitRef="usd">373100000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMjYtMy0xLTEtNTg1Mzc_97300513-4147-47ba-b9d9-94e132e99e96"
      unitRef="usd">317900000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMjctMS0xLTEtNTg1Mzc_0e996668-62c7-4ebe-ae6d-7639af56a546"
      unitRef="usd">0</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMjctMy0xLTEtNTg1Mzc_7638bc4a-70c7-4e65-9404-d42221ed29b7"
      unitRef="usd">1700000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMjgtMS0xLTEtNTg1Mzc_82fdc105-be58-4b3f-b5a7-85191ef34358"
      unitRef="usd">1280200000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMjgtMy0xLTEtNTg1Mzc_f32f9dac-67b6-425c-8e23-c4d93581ee15"
      unitRef="usd">732100000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMjktMS0xLTEtNTg1Mzc_5cccfc27-fe6e-4cab-bac1-62f24ccac11b"
      unitRef="usd">2350800000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMjktMy0xLTEtNTg1Mzc_fef1ab43-2423-4a5c-b346-cb82d0e057fe"
      unitRef="usd">1397600000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzAtMS0xLTEtNTg1Mzc_b76778ff-6bbd-47d1-852a-74bd85f6dec7"
      unitRef="usd">149900000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzAtMy0xLTEtNTg1Mzc_14fbdc32-c4fb-4d6d-aa9b-3866f8234dcf"
      unitRef="usd">24100000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzEtMS0xLTEtNTg1Mzc_1df4d1ed-e179-41ab-8521-08d89f5e4246"
      unitRef="usd">113200000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzEtMy0xLTEtNTg1Mzc_07202b8e-64e8-43c4-b388-3ea5ee6767c5"
      unitRef="usd">139600000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzAtMS0xLTEtMTAzNzM4_72637dbb-816c-434c-aef2-f424e5874c1f"
      unitRef="usd">198300000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzAtMy0xLTEtMTAzNzQ2_dff26a7b-d2b5-4887-bda3-fc0787a7fa13"
      unitRef="usd">100000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <coo:LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzMtMS0xLTEtNTg1Mzc_4f0ee0d4-7827-4788-aa27-657b6ce39f31"
      unitRef="usd">225200000</coo:LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent>
    <coo:LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzMtMy0xLTEtNTg1Mzc_0a0f51db-0262-4098-a213-64e1289fddc6"
      unitRef="usd">370700000</coo:LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent>
    <us-gaap:Liabilities
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzQtMS0xLTEtNTg1Mzc_c22696b3-392d-448b-86b9-82abfa2ea3aa"
      unitRef="usd">4317600000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzQtMy0xLTEtNTg1Mzc_9f13f5fb-e8da-4360-9544-eb5e73fc46e8"
      unitRef="usd">2664200000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzUtMS0xLTEtNTg1Mzc_7c7bfba7-2281-4735-af59-1fed6c853361"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzUtMy0xLTEtNTg1Mzc_280d28ca-9289-4ec6-85dc-cbff68ea48b9"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzctMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjo3MzFiYzM2ZTYxNzk0ZGFlYTNmZTExYTg4ZThiNjVkOF8yMQ_26c1f9f4-1a9f-4b44-9ec7-09c90e94f4a8"
      unitRef="usdPerShare">0.10</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzctMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjo3MzFiYzM2ZTYxNzk0ZGFlYTNmZTExYTg4ZThiNjVkOF8yMQ_9922a2e1-e6bc-42f2-9b60-67ae4531c877"
      unitRef="usdPerShare">0.10</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzctMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjo3MzFiYzM2ZTYxNzk0ZGFlYTNmZTExYTg4ZThiNjVkOF80MQ_99c058ce-fad3-4bb5-a722-2053f98f13a6"
      unitRef="shares">1000000.0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzctMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjo3MzFiYzM2ZTYxNzk0ZGFlYTNmZTExYTg4ZThiNjVkOF80MQ_efae0d1b-46ac-44e4-8262-98b9363df7cd"
      unitRef="shares">1000000.0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzctMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjo3MzFiYzM2ZTYxNzk0ZGFlYTNmZTExYTg4ZThiNjVkOF82Mw_0b35a8fc-00da-408f-8d4e-5d86b9fb6f2a"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzctMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjo3MzFiYzM2ZTYxNzk0ZGFlYTNmZTExYTg4ZThiNjVkOF82Mw_4b3f2208-82db-4316-a03a-af00f759aa87"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzctMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjo3MzFiYzM2ZTYxNzk0ZGFlYTNmZTExYTg4ZThiNjVkOF82Mw_54ab4a74-093f-4aee-9172-e3984c2e298d"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzctMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjo3MzFiYzM2ZTYxNzk0ZGFlYTNmZTExYTg4ZThiNjVkOF82Mw_c06e3e88-d9d1-4cf8-afe3-af7ba9b719c7"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzctMS0xLTEtNTg1Mzc_87fff49f-c10a-484e-9ec5-5211acec432a"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzctMy0xLTEtNTg1Mzc_f450ce60-a1f6-4b09-b152-541379573de8"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzgtMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjoxOWZiYjI0OGQzMDU0MDBmOTFkODA5ZWQxMGNiODhmMl8xOA_0fd460d6-752a-4d9a-9a94-af2b759a1128"
      unitRef="usdPerShare">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzgtMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjoxOWZiYjI0OGQzMDU0MDBmOTFkODA5ZWQxMGNiODhmMl8xOA_e26f950a-ed93-416a-a241-db9fad9a2256"
      unitRef="usdPerShare">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzgtMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjoxOWZiYjI0OGQzMDU0MDBmOTFkODA5ZWQxMGNiODhmMl8zOA_8aa91e1c-4832-4834-ac31-3a1961367c79"
      unitRef="shares">120000000.0</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzgtMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjoxOWZiYjI0OGQzMDU0MDBmOTFkODA5ZWQxMGNiODhmMl8zOA_a785ffd4-2a7c-499d-91c1-53cb1d006050"
      unitRef="shares">120000000.0</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzgtMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjoxOWZiYjI0OGQzMDU0MDBmOTFkODA5ZWQxMGNiODhmMl82MA_c5504aaf-b339-4785-9c9a-4a0e11603df2"
      unitRef="shares">53800000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzgtMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjoxOWZiYjI0OGQzMDU0MDBmOTFkODA5ZWQxMGNiODhmMl83NA_543d6fc9-ad33-4d91-9e1c-63e0ab6b9089"
      unitRef="shares">49300000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzgtMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjoxOWZiYjI0OGQzMDU0MDBmOTFkODA5ZWQxMGNiODhmMl8xMTM_5ad81376-1ff4-45fa-9989-62176b8301b4"
      unitRef="shares">53700000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzgtMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjoxOWZiYjI0OGQzMDU0MDBmOTFkODA5ZWQxMGNiODhmMl8xMjc_050b70eb-ffd6-41da-b876-167e3669a49c"
      unitRef="shares">49300000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzgtMS0xLTEtNTg1Mzc_1c0a21b1-9a73-4115-93ff-9483d82e3f59"
      unitRef="usd">5400000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzgtMy0xLTEtNTg1Mzc_642b08f5-6778-4e84-aa39-3af338d83317"
      unitRef="usd">5400000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzktMS0xLTEtNTg1Mzc_9417919a-5894-443b-a6ba-a6a050bba605"
      unitRef="usd">1765500000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfMzktMy0xLTEtNTg1Mzc_add689f0-80d2-4c21-bb7e-d0ece5142848"
      unitRef="usd">1715200000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNDAtMS0xLTEtNTg1Mzc_1f8f117c-2609-462f-83b2-07599eb1ead7"
      unitRef="usd">-466800000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNDAtMy0xLTEtNTg1Mzc_c54a0d8f-70f2-4f60-899b-f31238512ed5"
      unitRef="usd">-341300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNDItMS0xLTEtNTg1Mzc_af023b28-637f-4f1a-a7e0-d380f02a7800"
      unitRef="usd">6584900000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNDItMy0xLTEtNTg1Mzc_17cad631-4640-4007-b3e2-50a45b01ec34"
      unitRef="usd">6202100000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNDMtMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjozZmM0NGMxYmU3ZmY0MzRjOTVhMWNhN2Y2NzMzZjA5MV8yOA_cf027db6-491d-47c9-9736-e30dde98cc72"
      unitRef="shares">4500000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNDMtMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjozZmM0NGMxYmU3ZmY0MzRjOTVhMWNhN2Y2NzMzZjA5MV82Mg_9c7ead27-68fc-442c-806c-da1c6ff0cbf1"
      unitRef="shares">4400000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNDMtMS0xLTEtNTg1Mzc_13694475-59ef-4c23-82da-60c95965f51c"
      unitRef="usd">714500000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNDMtMy0xLTEtNTg1Mzc_3fc4f946-c3f2-4506-a673-5a487aa3017a"
      unitRef="usd">639600000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquity
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNDQtMS0xLTEtNTg1Mzc_fc8a996a-9321-4f64-93c9-48cc9592b222"
      unitRef="usd">7174500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNDQtMy0xLTEtNTg1Mzc_d72541c9-e882-4c58-91f4-603333c1be60"
      unitRef="usd">6941800000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNDUtMS0xLTEtNTg1Mzc_41111eba-7ae1-403d-ae64-67841674ea82"
      unitRef="usd">200000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNDUtMy0xLTEtNTg1Mzc_08813743-6bdb-47a1-8155-9046e805de81"
      unitRef="usd">200000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNDYtMS0xLTEtNTg1Mzc_dd3f1ad4-69da-4cb1-9be2-241927d64a82"
      unitRef="usd">7174700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNDYtMy0xLTEtNTg1Mzc_fec0f22b-a44a-44a1-8393-fbcf62ff5d10"
      unitRef="usd">6942000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNDctMS0xLTEtNTg1Mzc_a6ebc348-2181-43cc-8afe-e8bd99627e87"
      unitRef="usd">11492300000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84Mi9mcmFnOjdjNDFjNzI4NjMzYTQ0YTQ5ZjA3NDgxNWJjZmM3OGZiL3RhYmxlOjQ0YTBiMzhlNmVkNTQ3Y2Q4Zjc2ZWI2Y2Q5Y2I2Y2I4L3RhYmxlcmFuZ2U6NDRhMGIzOGU2ZWQ1NDdjZDhmNzZlYjZjZDljYjZjYjhfNDctMy0xLTEtNTg1Mzc_b2d9a3ea-bc8d-41e9-b02e-32d5776e6270"
      unitRef="usd">9606200000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ic40025e930f74fd19b2ce688c42296d1_I20191031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMi0xLTEtMS01ODUzNw_07c1191a-c93f-4694-bac9-236fd5484cc3"
      unitRef="shares">49100000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic40025e930f74fd19b2ce688c42296d1_I20191031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMi0zLTEtMS01ODUzNw_6300bb48-8070-4e15-8122-7961b2eed8bb"
      unitRef="usd">4900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i4c34808bb01e43038bfe5000593b89e4_I20191031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMi01LTEtMS01ODUzNw_3f8d89ff-f34b-408c-b335-88cc61b3b0de"
      unitRef="shares">4100000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iebd4ad7541d14f359dbe82c616c0ab00_I20191031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMi03LTEtMS01ODUzNw_d52bddc4-4666-4fdb-afe3-97fa22ad747c"
      unitRef="usd">400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i640e2b66e7b443a4a5e3988728a72e3d_I20191031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMi05LTEtMS01ODUzNw_4949d275-1230-430b-994e-a3a6656be913"
      unitRef="usd">1615000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4862aa9bb8ef43508c2cc981078ef274_I20191031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMi0xMS0xLTEtNTg1Mzc_3ebd32db-28b9-4e48-b529-f360cdecba77"
      unitRef="usd">-447100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ide1724bcbd604d64aec96d6a7f39d61b_I20191031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMi0xMy0xLTEtNTg1Mzc_cda954f6-0462-4fa2-adc3-eecbd9144b2c"
      unitRef="usd">3026400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4c34808bb01e43038bfe5000593b89e4_I20191031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMi0xNS0xLTEtNTg1Mzc_35e54a1f-7be9-41f1-9f3e-a7b9663fe268"
      unitRef="usd">-571200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8cb5a13a16e74334a69daeb5cb71f84c_I20191031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMi0xNy0xLTEtNTg1Mzc_ac8856d6-e897-4630-b29d-570110ea402b"
      unitRef="usd">200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5167c03ea3ab44e7b464a93ec06fc66e_I20191031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMi0xOS0xLTEtNTg1Mzc_53540b1b-fff7-432f-b3a3-03b3a4e67cb3"
      unitRef="usd">3628600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i538b018151b043f48a11b745f431a4dc_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMy0xMy0xLTEtNTg1Mzc_a765d34b-a0ef-490d-abbd-141235e05f83"
      unitRef="usd">238400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMy0xOS0xLTEtNTg1Mzc_f04ad4cc-d51b-44e2-adb6-18001a13fd95"
      unitRef="usd">238400000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ieafb6aa788314d68858bdce8b8cc9452_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfNC0xMS0xLTEtNTg1Mzc_130965be-c01a-49ac-ace3-b92c18b6693c"
      unitRef="usd">-24900000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfNC0xOS0xLTEtNTg1Mzc_9f985a59-0762-449f-9044-20308c05cbdd"
      unitRef="usd">-24900000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ib49675071eae40dfab504de223e18ee9_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfNS0xLTEtMS01ODUzNw_bf17f98c-d18c-4c68-a289-899611486a18"
      unitRef="shares">200000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i979761737a724a468a53d50ec7fdc9d4_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfNS05LTEtMS01ODUzNw_bb5b334e-9969-4554-985c-35f9da842319"
      unitRef="usd">-5000000.0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i81f7068bcd6a4b5092ed7c04a932aa4c_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfNS0xNS0xLTEtNTg1Mzc_b55b85fb-ffd9-4f15-bc43-e5f7bd8f711a"
      unitRef="shares">1700000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfNS0xOS0xLTEtNTg1Mzc_8e246801-a790-404a-aea0-681a96b7f9f5"
      unitRef="usd">-3300000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ib49675071eae40dfab504de223e18ee9_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfNy0xLTEtMS01ODUzNw_97e8cd84-55a1-4b1e-b093-ce837e4ac2c8"
      unitRef="shares">200000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i81f7068bcd6a4b5092ed7c04a932aa4c_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfNy01LTEtMS01ODUzNw_2dc3e145-a277-4bbd-abee-74b811294605"
      unitRef="shares">200000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i81f7068bcd6a4b5092ed7c04a932aa4c_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfNy0xNS0xLTEtNTg1Mzc_433293d8-7719-410c-9ae0-5d901541813d"
      unitRef="usd">47800000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfNy0xOS0xLTEtNTg1Mzc_886bf1da-a787-4dcd-9a1c-3b6f5d58515a"
      unitRef="usd">47800000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfOC0wLTEtMS01ODUzNy90ZXh0cmVnaW9uOjg4ZWI4M2RmMzZlOTQ0ZTliMmYwNGZhYzdjZDI3YzNiXzE3MDQyNDMwMjMwNTk3_c2be021d-fe9b-4e61-9ad2-bb481cd8ba3f"
      unitRef="usdPerShare">0.03</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCommonStock
      contextRef="i538b018151b043f48a11b745f431a4dc_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfOC0xMy0xLTEtNTg1Mzc_c386c3bd-522c-45cb-aef2-b8d46fce6801"
      unitRef="usd">3000000.0</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfOC0xOS0xLTEtNTg1Mzc_175bde55-814c-4c12-814a-4d74a2a45241"
      unitRef="usd">3000000.0</us-gaap:DividendsCommonStock>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i979761737a724a468a53d50ec7fdc9d4_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfOS05LTEtMS01ODUzNw_190b9a16-cd26-49f7-846c-9dce03dd635c"
      unitRef="usd">36800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfOS0xOS0xLTEtNTg1Mzc_527bae26-3a08-44e9-869c-0c7e64124e8b"
      unitRef="usd">36800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i03991b00df3c49439458880f97362831_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTAtMS0xLTEtNTg1Mzc_e0a25605-77ad-4534-9053-7be6869eb835"
      unitRef="shares">49100000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i03991b00df3c49439458880f97362831_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTAtMy0xLTEtNTg1Mzc_d3d22ddc-46be-464d-9051-1a40074f80c0"
      unitRef="usd">4900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="iffb2fe484e3846c9bd0a06b30ea69c83_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTAtNS0xLTEtNTg1Mzc_0662fdbc-e3cd-493d-a4cc-cd3e8e788b41"
      unitRef="shares">4300000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i29dbc102232c4927bebb87096c5efbd1_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTAtNy0xLTEtNTg1Mzc_6cee2203-9672-4077-9cf0-7d2994977be5"
      unitRef="usd">400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id99ee9ce8f314279b8ed0d124990935e_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTAtOS0xLTEtNTg1Mzc_1eb37c8b-ad06-49bc-9913-af3ddf0be905"
      unitRef="usd">1646800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i15ff03e12d5e49abb65998853b7f5c15_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTAtMTEtMS0xLTU4NTM3_b0f71a21-2743-46dc-bb6a-56848e1f49fe"
      unitRef="usd">-472000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie9c7c5de6c0d4c81bba6613a87b7c142_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTAtMTMtMS0xLTU4NTM3_de99d98d-30bb-403a-94a5-5af609c0e728"
      unitRef="usd">3261800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iffb2fe484e3846c9bd0a06b30ea69c83_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTAtMTUtMS0xLTU4NTM3_aa48ca81-f3c1-4ff3-9c46-26bf02d4e5c4"
      unitRef="usd">-617300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i76280949e11f40589848621ccf9e17d7_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTAtMTctMS0xLTU4NTM3_b01ea97a-8f33-444b-b461-f1113e70d22e"
      unitRef="usd">200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTAtMTktMS0xLTU4NTM3_e022a63a-c102-439e-89e5-e70371910560"
      unitRef="usd">3824800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="iae603271d4564d759045232140ef888b_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTEtMTMtMS0xLTU4NTM3_d2cde958-c08b-4527-b19c-770eaa3f7928"
      unitRef="usd">2944700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTEtMTktMS0xLTU4NTM3_a9f0e0a2-71cf-42f6-9913-01fca98950d8"
      unitRef="usd">2944700000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4ff34bac9bd34f02a659325f60bd6946_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTItMTEtMS0xLTU4NTM3_a8064364-1a8f-4110-886c-3b6fc386df59"
      unitRef="usd">130700000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTItMTktMS0xLTU4NTM3_b609b9ff-a8db-4edd-805b-4751490f4761"
      unitRef="usd">130700000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i92ad3fcf3fa24292a93bc23096208379_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTMtMS0xLTEtNTg1Mzc_31b0a616-05ae-4632-8b38-4a60eb512625"
      unitRef="shares">300000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i92ad3fcf3fa24292a93bc23096208379_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTMtMy0xLTEtNTg1Mzc_dd9b3bf5-af38-4d67-9aa8-902c89c9ab72"
      unitRef="usd">100000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i91a298fab24f46b08cad8c03bf310938_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTMtOS0xLTEtNTg1Mzc_f9b7a8bb-4558-42e2-a982-a82e892846c8"
      unitRef="usd">24600000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i813ba48615004049bda2cd1adc7a200f_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTMtMTUtMS0xLTU4NTM3_35d72727-bb8e-4204-a0de-bdecec19397b"
      unitRef="shares">2500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTMtMTktMS0xLTU4NTM3_e956b357-c078-48e6-8171-b79746891307"
      unitRef="usd">27200000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i92ad3fcf3fa24292a93bc23096208379_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTUtMS0xLTEtNTg1Mzc_ddc827ff-5536-4862-ae82-5f7725f63c73"
      unitRef="shares">100000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i813ba48615004049bda2cd1adc7a200f_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTUtNS0xLTEtNTg1Mzc_667d7baf-b935-43b2-8496-c063be985b6e"
      unitRef="shares">100000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i813ba48615004049bda2cd1adc7a200f_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTUtMTUtMS0xLTU4NTM3_bb9eb55d-8162-4b77-b006-17dca3019311"
      unitRef="usd">24800000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTUtMTktMS0xLTU4NTM3_e992f706-a6aa-4a8b-8dc0-7ff49536f5b5"
      unitRef="usd">24800000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTctMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjo3ODFmYmZhOTVmZDM0MjVkOThiYzNjOGQ2MzA3ZjVlZV8xNzA0MjQzMDIzMDU5Nw_e843de22-c61b-40b1-b315-0fbac08b1490"
      unitRef="usdPerShare">0.03</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCommonStock
      contextRef="iae603271d4564d759045232140ef888b_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTctMTMtMS0xLTU4NTM3_281c7447-d7b5-4cc7-8878-cb82a699d11f"
      unitRef="usd">3000000.0</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTctMTktMS0xLTU4NTM3_78b86891-c0ee-4a2d-9c8b-eaca0acf3b01"
      unitRef="usd">3000000.0</us-gaap:DividendsCommonStock>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i91a298fab24f46b08cad8c03bf310938_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTgtOS0xLTEtNTg1Mzc_90fbdf14-dd85-4703-a8d4-dc0234204683"
      unitRef="usd">43800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTgtMTktMS0xLTU4NTM3_3593dda1-2f83-46e7-b0cc-822b972f816d"
      unitRef="usd">43800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7a9a9c9f91ca422180b746b351012dba_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTktMTMtMS0xLTU4NTM3_d6655796-86d1-4b4d-9814-b306743db51a"
      unitRef="usd">-1400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i10b91becc0cf4d67b8ccd40f10fc6633_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMTktMTktMS0xLTU4NTM3_e3404d61-213f-40d9-a0a3-685c1ce3b36e"
      unitRef="usd">-1400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="if0e07227018a48699fc5b6e0852505fe_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjQtMS0xLTEtNTg1Mzc_0a4b4e17-fc13-49d4-b977-0ba156baa3df"
      unitRef="shares">49300000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if0e07227018a48699fc5b6e0852505fe_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjQtMy0xLTEtNTg1Mzc_c1123790-229e-49f3-8822-e19ccbbfc12b"
      unitRef="usd">5000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i84e5415a196749599d0e6e0005250229_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjQtNS0xLTEtNTg1Mzc_36aa7eb5-66be-4a71-a3b5-91acf795e156"
      unitRef="shares">4400000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6ba42cdb4ce44091bf3d217dca29f463_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjQtNy0xLTEtNTg1Mzc_c1c1dfa8-bd9d-4e7d-b5c0-fc9678ce88bf"
      unitRef="usd">400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i33dae8774a9d446da11e92d8456741ad_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjQtOS0xLTEtNTg1Mzc_0f81f829-d745-4d25-9f0d-c7fc1947d2a6"
      unitRef="usd">1715200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id1debae85ed14b3aa606b0f2a2bf613a_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjQtMTEtMS0xLTU4NTM3_a9113050-ad51-41f1-9cf7-c6f7ff439644"
      unitRef="usd">-341300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5fca87f8caea41ba87bb56ee5ee38701_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjQtMTMtMS0xLTU4NTM3_64d3a5f5-25ca-4527-87fa-dc38186ffa12"
      unitRef="usd">6202100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i84e5415a196749599d0e6e0005250229_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjQtMTUtMS0xLTU4NTM3_8a01c2b9-503a-4ddb-9fba-419f33f2d0a2"
      unitRef="usd">-639600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie9c8cbde74104a3982b2d1bdc730d863_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjQtMTctMS0xLTU4NTM3_c2896335-418c-4c4d-99ed-205a55720443"
      unitRef="usd">200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjQtMTktMS0xLTU4NTM3_e9dadd1e-e7a1-461e-b3f5-914a2836969b"
      unitRef="usd">6942000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i74ee878bb50944f89b4a3dc97d5aec72_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjUtMTMtMS0xLTU4NTM3_b8e825b5-195f-4888-b5b6-246b85b20049"
      unitRef="usd">385800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjUtMTktMS0xLTU4NTM3_b923ae0d-901f-45ca-8bfa-a52fc18317d7"
      unitRef="usd">385800000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i864fde92b4e34849bbc81ca4a0f19094_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjYtMTEtMS0xLTU4NTM3_8aa8653e-1406-42ea-912d-804e07e01c92"
      unitRef="usd">-125500000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjYtMTktMS0xLTU4NTM3_4a033747-410f-4a1a-8e03-3008c7b8f28c"
      unitRef="usd">-125500000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i18d6974b69cf479299decdec035def9e_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjctMS0xLTEtNTg1Mzc_bfbe9a60-25ee-4538-9d17-dc1d75764009"
      unitRef="shares">100000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ieb7ea73d4acf4eb7aae210fcfd94fd7a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjctOS0xLTEtNTg1Mzc_b38cb606-e4af-46b8-a5d0-0c91848c27fb"
      unitRef="usd">-2100000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ia9123c64ce444cffba4dda081d73bc13_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjctMTUtMS0xLTU4NTM3_732b05ac-c4b7-4415-ba4d-015c7cfcd6a5"
      unitRef="shares">3600000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjctMTktMS0xLTU4NTM3_40def1c2-0ab8-49fd-8b50-f0a7ba7cbb5c"
      unitRef="usd">1500000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i18d6974b69cf479299decdec035def9e_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjktMS0xLTEtNTg1Mzc_75e6cf8e-2394-4e58-a626-8c3ca8ce8228"
      unitRef="shares">100000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ia9123c64ce444cffba4dda081d73bc13_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjktNS0xLTEtNTg1Mzc_d41d0553-87c1-4f9c-83e7-bddd687bd579"
      unitRef="shares">100000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ia9123c64ce444cffba4dda081d73bc13_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjktMTUtMS0xLTU4NTM3_14e3fe1d-b5e6-4ef8-abeb-77c94f7bd43e"
      unitRef="usd">78500000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMjktMTktMS0xLTU4NTM3_d5a3530b-c8e2-4e75-b63e-006184e06e73"
      unitRef="usd">78500000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMzEtMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjoxZWFkZWY2M2ZmNjQ0MTEwOTUzZjBiYTVhMjc3YmYxY18zMQ_ee05da4e-f1f1-4e6d-a7a2-f39803384237"
      unitRef="usdPerShare">0.03</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCommonStock
      contextRef="i74ee878bb50944f89b4a3dc97d5aec72_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMzEtMTMtMS0xLTU4NTM3_9f693bc4-253b-43d6-b5ab-ff2f8cbd2ff0"
      unitRef="usd">3000000.0</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMzEtMTktMS0xLTU4NTM3_a42159ae-0c6d-41cb-8c50-2073ab0c8f9a"
      unitRef="usd">3000000.0</us-gaap:DividendsCommonStock>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ieb7ea73d4acf4eb7aae210fcfd94fd7a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMzItOS0xLTEtNTg1Mzc_7de4748b-aece-4fe0-8acd-b6f4e18dddd6"
      unitRef="usd">52400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMzItMTktMS0xLTU4NTM3_67f36d24-90eb-4ef7-b6b3-e2efe319c923"
      unitRef="usd">52400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ia71ce847bd5e4c5989f4eeafd6a550a9_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMzUtMS0xLTEtNTg1Mzc_f87ae15a-9120-4534-9d38-491100fa538c"
      unitRef="shares">49300000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia71ce847bd5e4c5989f4eeafd6a550a9_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMzUtMy0xLTEtNTg1Mzc_5e8665cf-5fdd-4922-81a0-cdfe57f739ce"
      unitRef="usd">5000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i685c57aff67b45abacf0deaf8e923fa0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMzUtNS0xLTEtNTg1Mzc_d6fc56e3-0b7f-4cac-8d26-bb7b638f9cce"
      unitRef="shares">4500000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i27bf67955d844c6798e8e8fa5d42494d_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMzUtNy0xLTEtNTg1Mzc_696e4e10-1b2c-44ee-8779-90ee3c6024ef"
      unitRef="usd">400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if2fe242b18cf42e7bc71473cf1d4fa86_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMzUtOS0xLTEtNTg1Mzc_7fcd1dec-d064-475a-9b12-5ef9cde83615"
      unitRef="usd">1765500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i13f3c04d8bda4a5ea3fcba710edd83fb_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMzUtMTEtMS0xLTU4NTM3_5ee4eb47-5d8f-4766-86a5-8bd222cb86a1"
      unitRef="usd">-466800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idc5e797e87ea4a7caf9a6a4e9c552fc7_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMzUtMTMtMS0xLTU4NTM3_5f2baf63-827d-4789-a0c7-11b069027eee"
      unitRef="usd">6584900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i685c57aff67b45abacf0deaf8e923fa0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMzUtMTUtMS0xLTU4NTM3_fc5348f9-1c77-4694-ba1c-9be637614879"
      unitRef="usd">-714500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieb24416eba0042eea28cba51d9346b77_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMzUtMTctMS0xLTU4NTM3_a7032821-c728-4bdf-8ab9-962c6f89802b"
      unitRef="usd">200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84NS9mcmFnOmI5MmM1NjU3Y2ZiOTRkYjQ4YjA1NjI3ODc0ZTc5ZDc5L3RhYmxlOjc5ZTg4NTc1MmJjNzQ4YWJiOGY1NjExZTg2ODlmMTE3L3RhYmxlcmFuZ2U6NzllODg1NzUyYmM3NDhhYmI4ZjU2MTFlODY4OWYxMTdfMzUtMTktMS0xLTU4NTM3_74128683-38e6-4c4e-a82a-409b7b68d705"
      unitRef="usd">7174700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMi0xLTEtMS01ODUzNw_baf7246f-741b-4666-9cb0-3a099486aa28"
      unitRef="usd">385800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMi0zLTEtMS01ODUzNw_dfbb5c56-10ad-4151-9830-e4e1c9940d62"
      unitRef="usd">2944700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMi01LTEtMS01ODUzNw_4cebf031-3270-4df8-8d04-9003921400d7"
      unitRef="usd">238400000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNC0xLTEtMS01ODUzNw_07cc17bb-d29e-443a-87cf-d477b76936e1"
      unitRef="usd">346100000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNC0zLTEtMS01ODUzNw_cea4197b-dec8-43e8-9d52-de5658cd376b"
      unitRef="usd">309300000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNC01LTEtMS01ODUzNw_e221d32e-84c9-4651-86a0-e716d2c34d9d"
      unitRef="usd">287100000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNS0xLTEtMS01ODUzNw_b1bb6f76-4a94-435e-bffc-c3198f8a77c9"
      unitRef="usd">2300000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNS0zLTEtMS01ODUzNw_afddd81d-19cf-4caf-9c11-fad73fc1fc05"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNS01LTEtMS01ODUzNw_1b6c29b8-e923-455a-aa83-cbf532bcddee"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ShareBasedCompensation
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNy0xLTEtMS01ODUzNw_06864616-0919-4fa7-9e2c-6f084f1d31a5"
      unitRef="usd">54200000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNy0zLTEtMS01ODUzNw_7ca6a2ec-b498-4b8f-bcac-a8d88df4dc04"
      unitRef="usd">43800000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNy01LTEtMS01ODUzNw_6f6fcb18-7879-4f6b-9f13-594faf2ebdbe"
      unitRef="usd">37600000</us-gaap:ShareBasedCompensation>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfOS0xLTEtMS01ODUzNw_bfa882de-00b0-4ba9-ab6b-2b07e1bd6c96"
      unitRef="usd">32200000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfOS0zLTEtMS01ODUzNw_1d19596c-21d2-43bf-a109-a9b316139a23"
      unitRef="usd">31800000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfOS01LTEtMS01ODUzNw_0fa9a572-caad-4f37-9c47-030d8ad7c33e"
      unitRef="usd">32500000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <coo:GainLossOnSaleOfAssetsAndAssetImpairmentChargesAndOther
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMTAtMS0xLTEtNTg1Mzc_4e8ca067-d4e9-442e-984d-ad7d0d561c72"
      unitRef="usd">-2200000</coo:GainLossOnSaleOfAssetsAndAssetImpairmentChargesAndOther>
    <coo:GainLossOnSaleOfAssetsAndAssetImpairmentChargesAndOther
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMTAtMy0xLTEtNTg1Mzc_3dcfcc58-8533-43b5-a353-8ce1b01e1346"
      unitRef="usd">5000000.0</coo:GainLossOnSaleOfAssetsAndAssetImpairmentChargesAndOther>
    <coo:GainLossOnSaleOfAssetsAndAssetImpairmentChargesAndOther
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMTAtNS0xLTEtNTg1Mzc_be652762-915f-4270-8f82-abd05787a679"
      unitRef="usd">-17700000</coo:GainLossOnSaleOfAssetsAndAssetImpairmentChargesAndOther>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMTEtMS0xLTEtNTg1Mzc_c818081c-2873-42b4-b8ed-1b28baf1d92d"
      unitRef="usd">-10300000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMTEtMy0xLTEtNTg1Mzc_5dc30a45-1f03-4155-82c1-3866619f6d9a"
      unitRef="usd">66100000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMTEtNS0xLTEtNTg1Mzc_5694a7c5-4511-46a9-b3a3-4aeb7302e703"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMTItMS0xLTEtNTg1Mzc_89009cf3-9791-415e-b7f8-91b8f77de7fe"
      unitRef="usd">53900000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMTItMy0xLTEtNTg1Mzc_4eb0a4ba-956e-4c69-b0a8-71fdbba97baf"
      unitRef="usd">-2502200000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMTItNS0xLTEtNTg1Mzc_b147a443-0fa0-43b4-81af-5af06ff168d6"
      unitRef="usd">-900000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMTgtMS0xLTEtNTg1Mzc_dc473573-5bb0-48b2-b7d4-b75a9c28c58b"
      unitRef="usd">33800000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMTgtMy0xLTEtNTg1Mzc_3176ae52-288e-42f5-8f26-17b4fc8275f9"
      unitRef="usd">75500000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMTgtNS0xLTEtNTg1Mzc_b6efd30e-e4b7-493d-a59c-4335e9f2229f"
      unitRef="usd">-8500000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMTktMS0xLTEtNTg1Mzc_30bc1d84-60b5-4d96-9e57-dc04d8ed6c26"
      unitRef="usd">40400000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMTktMy0xLTEtNTg1Mzc_1802da15-7859-4d7a-a429-a4c1e562ecb9"
      unitRef="usd">9200000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMTktNS0xLTEtNTg1Mzc_d51b9177-cde5-4986-a7ae-04edf6d179d1"
      unitRef="usd">62300000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjAtMS0xLTEtNTg1Mzc_89eaf58c-ea03-4fc9-8fd1-943d84f98fec"
      unitRef="usd">16900000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjAtMy0xLTEtNTg1Mzc_39b07c53-2eca-43ea-ad0d-e870496cc60a"
      unitRef="usd">69100000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjAtNS0xLTEtNTg1Mzc_2ffc5a28-63ff-44d1-ad23-4d153a2dce68"
      unitRef="usd">41100000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <coo:IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjEtMS0xLTEtNTg1Mzc_041d898d-3436-4e13-9c04-34e00a4f9d62"
      unitRef="usd">-51300000</coo:IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet>
    <coo:IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjEtMy0xLTEtNTg1Mzc_48cc5a9b-7140-45d0-9f8d-344a4f997311"
      unitRef="usd">-27500000</coo:IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet>
    <coo:IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjEtNS0xLTEtNTg1Mzc_c55347b5-04da-4b87-90b1-1c3ca6206707"
      unitRef="usd">-20000000.0</coo:IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjItMS0xLTEtNTg1Mzc_ffeeaa6a-8d71-4746-980e-0fa27ffb2c19"
      unitRef="usd">49900000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjItMy0xLTEtNTg1Mzc_0f8a5860-c5c6-4072-bdaf-608f499805d8"
      unitRef="usd">-16000000.0</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjItNS0xLTEtNTg1Mzc_bc3c81e0-f758-40ba-8b81-3b42f4b77345"
      unitRef="usd">23200000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjMtMS0xLTEtNTg1Mzc_5625e11a-d85d-4939-bcd2-6fd35660b4cf"
      unitRef="usd">32400000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjMtMy0xLTEtNTg1Mzc_08c280ee-14c4-484b-a78d-fc4ca34f3c9c"
      unitRef="usd">59100000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjMtNS0xLTEtNTg1Mzc_9887fc9c-570f-4fa4-848d-702085fc68df"
      unitRef="usd">-9300000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjQtMS0xLTEtNTg1Mzc_98540ca3-a5b1-41cc-8a53-0efce7f35214"
      unitRef="usd">-27400000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjQtMy0xLTEtNTg1Mzc_d831035f-4229-4019-a2e9-db6930035d7d"
      unitRef="usd">10000000.0</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjQtNS0xLTEtNTg1Mzc_5eead83d-3a4a-4329-b83e-3d04e08967f7"
      unitRef="usd">-12400000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjUtMS0xLTEtNTg1Mzc_351407b5-fcfc-464c-bbd0-389d1333506b"
      unitRef="usd">-34200000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjUtMy0xLTEtNTg1Mzc_cc2727bc-7123-4695-ac27-cdf5c67d84ba"
      unitRef="usd">-21700000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjUtNS0xLTEtNTg1Mzc_f676d702-6fcd-456c-80ec-6028b1a86895"
      unitRef="usd">-12400000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <coo:IncreaseDecreaseInContingentConsiderationLiability
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjEtMS0xLTEtMTAwNDQx_044c4d93-9f11-4005-a5df-7836b7962c44"
      unitRef="usd">-52300000</coo:IncreaseDecreaseInContingentConsiderationLiability>
    <coo:IncreaseDecreaseInContingentConsiderationLiability
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjEtMy0xLTEtMTAwNDUx_b2536ebc-fa85-4956-b3d8-04874f8d4fe5"
      unitRef="usd">0</coo:IncreaseDecreaseInContingentConsiderationLiability>
    <coo:IncreaseDecreaseInContingentConsiderationLiability
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjEtNS0xLTEtMTAwNDU5_fddc76b3-8798-4d46-91ef-4daed0f2c0b0"
      unitRef="usd">0</coo:IncreaseDecreaseInContingentConsiderationLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjYtMS0xLTEtNTg1Mzc_69f7ee41-65d5-413f-8fa2-b0d160e07d91"
      unitRef="usd">692400000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjYtMy0xLTEtNTg1Mzc_773dff8c-2375-496c-bd56-1b2a90c7adfb"
      unitRef="usd">738600000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjYtNS0xLTEtNTg1Mzc_e700688c-50ff-42ad-ae3d-de6ebbbbf69a"
      unitRef="usd">486600000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjgtMS0xLTEtNTg1Mzc_8109e19f-b396-4d55-bf0f-7178fa25f742"
      unitRef="usd">242000000.0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjgtMy0xLTEtNTg1Mzc_9a559fca-e3c8-4f34-8723-d1215eb77d38"
      unitRef="usd">214400000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjgtNS0xLTEtNTg1Mzc_3832b737-cc77-47b2-9433-f270ee7b1f29"
      unitRef="usd">310400000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <coo:PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjktMS0xLTEtNTg1Mzc_defe2f32-8d36-44b3-b860-9f593562999f"
      unitRef="usd">1641300000</coo:PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired>
    <coo:PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjktMy0xLTEtNTg1Mzc_1ef0ce10-eb60-462e-937e-6ee9bc39455e"
      unitRef="usd">235900000</coo:PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired>
    <coo:PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjktNS0xLTEtNTg1Mzc_5b9a3b03-9a06-4530-866c-16400d1ed386"
      unitRef="usd">54100000</coo:PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired>
    <us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjUtMS0xLTEtOTk4MDE_32758148-4c53-42fa-9a77-4a9acf27f408"
      unitRef="usd">52100000</us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries>
    <us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjUtMy0xLTEtOTk4MTE_b6734f55-395c-44f6-8aa4-6d3c68e747d2"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries>
    <us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMjUtNS0xLTEtOTk4MTc_0cfa050d-dc56-4457-97ee-2e59ce80297b"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzEtMS0xLTEtNTg1Mzc_30706d5d-c4bf-4f4b-9803-500423761e4f"
      unitRef="usd">-1831200000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzEtMy0xLTEtNTg1Mzc_ac2d40cf-44fd-4e30-a4b3-0106a6b7c4cd"
      unitRef="usd">-450300000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzEtNS0xLTEtNTg1Mzc_f73a7a4c-0b0e-4901-985d-ef337184a4cb"
      unitRef="usd">-364500000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzMtMS0xLTEtNTg1Mzc_f488dee7-1487-443b-bbc2-a2cbe390a1da"
      unitRef="usd">1511000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzMtMy0xLTEtNTg1Mzc_1f65663d-23fd-4a4c-b4a6-5daf6c311daa"
      unitRef="usd">1427400000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzMtNS0xLTEtNTg1Mzc_cf3afd40-bff2-465d-ba62-ee3372e0e374"
      unitRef="usd">3199800000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzQtMS0xLTEtNTg1Mzc_6025f7d4-4218-4a11-a0c7-a1e25197add4"
      unitRef="usd">561500000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzQtMy0xLTEtNTg1Mzc_fd95c058-213a-4ca3-bd58-8d6df9ff5b45"
      unitRef="usd">1416000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzQtNS0xLTEtNTg1Mzc_e06cb524-cf06-4855-ada8-0c04f410a3f8"
      unitRef="usd">3235900000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzYtMS0xLTEtNTg1Mzc_90118d1e-30b4-4d15-94a6-09a30107181c"
      unitRef="usd">329300000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzYtMy0xLTEtNTg1Mzc_fff6beae-0a53-42bd-b2bc-13c6fc8d76fc"
      unitRef="usd">-321300000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzYtNS0xLTEtNTg1Mzc_ac95c81f-ef3f-4c04-aaa3-5276c36b04d2"
      unitRef="usd">-4500000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzgtMS0xLTEtNTg1Mzc_3ecb1833-84d9-4d96-af3b-71f044a412a7"
      unitRef="usd">78500000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzgtMy0xLTEtNTg1Mzc_f7528fc1-9711-42ec-a5c0-88d0c95f564f"
      unitRef="usd">24800000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzgtNS0xLTEtNTg1Mzc_3586823a-be00-42a2-b094-4618197ec4ad"
      unitRef="usd">47800000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzktMS0xLTEtNTg1Mzc_fd4ffb87-9c12-4c13-bc7a-516ba6868d5d"
      unitRef="usd">8900000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzktMy0xLTEtNTg1Mzc_da7109bc-10ee-4769-a4ce-9468c4e09774"
      unitRef="usd">33700000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfMzktNS0xLTEtNTg1Mzc_3161c570-49a5-4dc9-9703-3304aede830d"
      unitRef="usd">13500000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNDAtMS0xLTEtNTg1Mzc_5d6cd64d-2cfa-4786-ad2d-e39344d3a829"
      unitRef="usd">16800000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNDAtMy0xLTEtNTg1Mzc_41f8a673-9079-4546-a3d7-60f35021891d"
      unitRef="usd">13200000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNDAtNS0xLTEtNTg1Mzc_4d451059-73c9-4ac4-a634-dd879fe9a35b"
      unitRef="usd">20300000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNDMtMS0xLTEtNTg1Mzc_f5f163cc-1ddd-4169-8544-44f2b115660d"
      unitRef="usd">3000000.0</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNDMtMy0xLTEtNTg1Mzc_2e42df64-f63d-495c-83c2-7b19aeb55e77"
      unitRef="usd">3000000.0</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNDMtNS0xLTEtNTg1Mzc_98df6278-2057-4638-91eb-cf03885aeb73"
      unitRef="usd">3000000.0</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNDQtMS0xLTEtNTg1Mzc_f309b4be-5d87-42f9-90ec-c8eea9cac0f0"
      unitRef="usd">7200000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNDQtMy0xLTEtNTg1Mzc_7546991e-7496-4bae-957e-fd5c3786c97e"
      unitRef="usd">5800000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNDQtNS0xLTEtNTg1Mzc_5ebfd15b-a73e-4821-acea-fceb9c3d5b75"
      unitRef="usd">2700000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNDctMS0xLTEtNTg1Mzc_0f8d2450-bc15-4c86-b71c-94efd07abf7d"
      unitRef="usd">2900000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNDctMy0xLTEtNTg1Mzc_f57c1881-3991-4e0a-bb4b-0bd2b07d42da"
      unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNDctNS0xLTEtNTg1Mzc_97d70f09-a9d9-45c6-a944-04b89b552914"
      unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTAtMS0xLTEtNTg1Mzc_2bab77d0-3bf1-462a-9d73-ff329471d469"
      unitRef="usd">1193700000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTAtMy0xLTEtNTg1Mzc_314f1ad8-4f7a-4af9-ad71-bbb546b6799a"
      unitRef="usd">-311400000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTAtNS0xLTEtNTg1Mzc_daf267e2-a975-4523-a7cc-8d1ed06ba726"
      unitRef="usd">-95500000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTEtMS0xLTEtNTg1Mzc_98de1902-fbcb-4d42-ad19-9e6da10594e5"
      unitRef="usd">-12900000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTEtMy0xLTEtNTg1Mzc_eb7837f0-c19e-4cdf-b4a3-813f8f4e07f7"
      unitRef="usd">2900000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTEtNS0xLTEtNTg1Mzc_bd4b4695-a708-4c47-a7a5-0569597c0609"
      unitRef="usd">700000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTItMS0xLTEtNTg1Mzc_7b9558bf-ef7b-478e-9726-914e6c7947d7"
      unitRef="usd">42000000.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTItMy0xLTEtNTg1Mzc_e20b1d48-315f-4a4a-bd93-9813b933e2b0"
      unitRef="usd">-20200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTItNS0xLTEtNTg1Mzc_66d1bfa9-61bf-42d9-a46b-ca5347063f54"
      unitRef="usd">27300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTMtMS0xLTEtNTg1Mzc_40661b36-ff88-4ddd-a043-3fcfcd382d4d"
      unitRef="usd">96600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTMtMy0xLTEtNTg1Mzc_84d4ccec-dae2-4383-b755-fdd05731c0f3"
      unitRef="usd">116800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5167c03ea3ab44e7b464a93ec06fc66e_I20191031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTMtNS0xLTEtNTg1Mzc_3c634be2-ddc0-4d56-a4e4-597029c3683b"
      unitRef="usd">89500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTQtMS0xLTEtNTg1Mzc_85a7c19d-27ff-404d-bcbb-1e648c3369ce"
      unitRef="usd">138600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTQtMy0xLTEtNTg1Mzc_917e4fd2-c45f-4ad7-b1d7-63d7a612640c"
      unitRef="usd">96600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTQtNS0xLTEtNTg1Mzc_3a53a5eb-594e-4d0b-a466-7a2571d7f191"
      unitRef="usd">116800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTctMS0xLTEtNTg1Mzc_7d6b61fc-3f6e-4565-8575-6b96930658fb"
      unitRef="usd">49100000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTctMy0xLTEtNTg1Mzc_4f11cf96-b155-435f-afcf-afc98a08e6b2"
      unitRef="usd">28400000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTctNS0xLTEtNTg1Mzc_386fb12f-44b8-4cd1-874b-ab373d15f00a"
      unitRef="usd">46500000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTgtMS0xLTEtNTg1Mzc_7fbb3789-2b51-4db1-af90-326514aebddd"
      unitRef="usd">66600000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTgtMy0xLTEtNTg1Mzc_135e6b6c-856d-49d7-ab7b-4191014634fb"
      unitRef="usd">63200000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTgtNS0xLTEtNTg1Mzc_ecff98b2-e586-4f09-bd42-3e2276d1d48a"
      unitRef="usd">51100000</us-gaap:IncomeTaxesPaid>
    <us-gaap:OperatingLeasePayments
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTktMS0xLTEtNTg1Mzc_5c6e4d92-b399-4509-8a03-7cf80dfa24b8"
      unitRef="usd">45300000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTktMy0xLTEtNTg1Mzc_21a3cfba-0117-4772-965f-89e642385b19"
      unitRef="usd">37400000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNTktNS0xLTEtNTg1Mzc_0e5d48fd-c6f3-45a2-ae37-d70232639c18"
      unitRef="usd">40600000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNjItMS0xLTEtNzU2NDk_30291e04-bd27-4aa9-9fc4-15a046496299"
      unitRef="usd">29800000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNjItMy0xLTEtNzU2NTg_747853a4-6446-4c04-b9b3-48eb4ed9b6fb"
      unitRef="usd">26500000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNjItNS0xLTEtNzU2Njc_cf4d57e8-22fd-4f5e-915f-492bada354b0"
      unitRef="usd">17700000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNjEtMS0xLTEtNTg1Mzc_8fc8aeb4-61a9-4462-b70f-b03173c1bbe7"
      unitRef="usd">138200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNjEtMy0xLTEtNTg1Mzc_5f5ee187-7d4e-4b46-8b1d-beb4c7c418a5"
      unitRef="usd">95900000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNjEtNS0xLTEtNTg1Mzc_0266038d-fca9-4c4c-bb50-16ca42bf3302"
      unitRef="usd">115900000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNjItMS0xLTEtNTg1Mzc_8ee1ada1-7be9-412a-a78e-b23bc8c644f0"
      unitRef="usd">400000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNjItMy0xLTEtNTg1Mzc_91588827-24c2-425d-8b12-2a7bbc0bafef"
      unitRef="usd">400000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNjItNS0xLTEtNTg1Mzc_9004f026-84a0-41a4-b91a-ab3c12437d1c"
      unitRef="usd">900000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNjMtMS0xLTEtNTg1Mzc_79c9988e-e356-4ef2-a431-4fef4a24a02c"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNjMtMy0xLTEtNTg1Mzc_f87d5fbb-e4cf-4ac5-a0bf-207aa1f3681e"
      unitRef="usd">300000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNjMtNS0xLTEtNTg1Mzc_8c2e5285-6a58-449e-b113-fa5cac3837b1"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNjQtMS0xLTEtNTg1Mzc_e27aa3dd-661f-4281-a519-9e9b947f2d98"
      unitRef="usd">138600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNjQtMy0xLTEtNTg1Mzc_908b9207-a357-4fe4-ad61-c517b03d30bc"
      unitRef="usd">96600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF84OC9mcmFnOmY1NjA2ZmRlZmE3MzQ2OTE5NWRlOTMxYTZjMjdjYzljL3RhYmxlOjQzOTU3MzlhODNhMjQxYzg4YmNlMjY4NDkzZDNkOTdkL3RhYmxlcmFuZ2U6NDM5NTczOWE4M2EyNDFjODhiY2UyNjg0OTNkM2Q5N2RfNjQtNS0xLTEtNTg1Mzc_42aeb229-7566-43bf-a5c0-e5c325417598"
      unitRef="usd">116800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMzM5Mzk_8adbe11f-29b4-47ac-b654-7f49efd9a3ca">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Note 1. Organization and Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Organization&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Cooper Companies, Inc. (Cooper, we or the Company) is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt"&gt;CooperVision primarily develops, manufactures and markets a broad range of soft contact lenses for the worldwide vision correction market.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:32.68pt"&gt;CooperSurgical primarily develops, manufactures, markets medical devices and procedures solutions, and provides services to improve health care delivery to women, babies and families. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The financial statements in this report include the results of all of Cooper's consolidated entities. All significant intercompany transactions and balances are eliminated on consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The preparation of Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of net sales and expenses during the reporting period. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;In particular, the COVID-19 pandemic negatively impacted business and healthcare activity globally. As a result of healthcare systems responding to the demands of managing the pandemic, governments around the world imposing measures designed to reduce the transmission of the COVID-19 virus, and individuals responding to the concerns of contracting the COVID-19 virus, many optical practitioners and retailers, hospitals, medical offices and fertility clinics closed their facilities, restricted access, or delayed or canceled patient visits, exams and elective medical procedures, and many customers that have reopened are experiencing reduced patient visits. These factors have had, and in the future may have, an adverse effect on our sales, operating results and cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The full extent to which the pandemic will directly or indirectly impact the Company's business, results of operations, and financial condition, including sales, expenses, manufacturing, clinical trials, research and development costs, reserves and allowances, fair value measurements, asset impairment charges, contingent consideration obligations, and the effectiveness of the Company's hedging instruments, will depend on future developments that are highly uncertain and difficult to predict. These developments include, but are not limited to, the duration and spread of the outbreak (including new and more contagious variants of COVID-19), its severity, the actions to contain the virus or address its impact, the timing, distribution, public acceptance and efficacy of vaccines and other treatments, United States and foreign government actions to respond to the reduction in global economic activity, and how quickly and to what extent normal economic and operating conditions can resume. There was not a material impact to the estimates in the Company&#x2019;s Consolidated Financial Statements for fiscal 2022. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company continually monitors and evaluates the estimates used as additional information becomes available. Adjustments will be made to these provisions periodically to reflect new facts and circumstances that may indicate that historical experience may not be indicative of current and/or future results. The Company&#x2019;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material changes to the estimates and material impacts to the Company&#x2019;s Consolidated Financial Statements in future reporting periods. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Revenue recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Sales &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company sells its products principally to a limited number of distributors, group purchasing organizations, eye care or health care professionals including independent practices, corporate retailers, hospitals and clinics or authorized resellers (collectively, its Customers). These Customers may subsequently resell the Company&#x2019;s products to eye care or health care providers and patients. In addition to product supply and distribution agreements with Customers, the Company enters into arrangements with health care providers and payors that provide for government-mandated and/or privately negotiated rebates, chargebacks and discounts with respect to the purchase of the Company&#x2019;s products. The Company considers purchase orders, which in some cases are governed by master sales agreements, to be contracts with a customer. As part of its consideration of the contract, the Company evaluates certain factors including the customer&#x2019;s ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Revenues from product sales are recognized when the Customer obtains control of the Company&#x2019;s product, which occurs at a point in time, typically upon shipment or delivery to the Customer. Taxes collected from Customers relating to product sales and remitted to governmental authorities are excluded from revenues. The Company expenses incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that the Company would have recognized is one year or less. See Note 12. Business Segment Information for disaggregation of revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reserves for Variable Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Revenues from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration for which reserves are established and which result from discounts, returns, chargebacks, rebates and other allowances that are offered within contracts between the Company and its Customers, health care providers, payors and other indirect customers relating to the Company&#x2019;s sales of its products. These reserves are based on the amounts earned or to be claimed on the related sales and are classified primarily in current liabilities. Variable consideration is estimated based on the most likely amount or expected value approach, depending on which method the Company expects to better predict the amount of consideration to which it will be entitled. Once the Company elects one of the methods to estimate variable consideration for a particular type of performance obligation, the Company applies that method consistently.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Where appropriate, these estimates take into consideration a range of possible outcomes which are probability-weighted for relevant factors such as the Company&#x2019;s historical experience, current contractual and statutory requirements, specific known market events and trends, industry data and forecasted customer buying and payment patterns. Overall, these reserves reflect the Company&#x2019;s best estimates of the amount of consideration to which it is entitled based on the terms of the contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade Discounts and Allowances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company generally provides Customers with discounts, which include incentive fees that are stated in the Company&#x2019;s contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Product Returns&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Consistent with industry practice, the Company generally offers Customers a limited right of return for a product that has been purchased from the Company. The Company estimates the amount of its product sales that may be returned by its Customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized. Historically, returns have been infrequent and insignificant relative to our total sales. Our refund liability for product returns was $14.5 million &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;and&#160;$13.7 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;at&#160;October&#160;31, 2022 and 2021, respectively, which is included in Accrued Liabilities on our Consolidated Balance Sheets and represents the expected value of the aggregate refunds that will be due to our customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Rebates and Chargebacks&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Rebates are estimated based on contractual terms, historical experience, customer mix, trend analysis and projected market conditions in the various markets served.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Chargebacks for fees and discounts to providers represent the estimated obligations resulting from contractual commitments to sell products to qualified healthcare providers at prices lower than the list wholesale prices charged to the Company&#x2019;s direct customers. For certain office and surgical products in CooperSurgical, customers charge the Company for the difference between what they pay for the product and the ultimate selling price to the qualified healthcare providers. These reserves are established in the same period that the related revenue is recognized, resulting in a reduction of product revenue. Chargeback amounts are generally determined at the time of resale to the qualified healthcare provider by customers. CooperSurgical rebates are predominately related to the Medicaid rebate provision that is estimated based upon contractual terms, historical experience, and trend analysis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Deferred revenue primarily represents prepaid stem cell storage as part of the CooperSurgical business unit. Revenue related to stem cell storage is recognized over the service period, which can range from one year to the lifetime of a customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We grant various share-based compensation awards, including stock options, performance unit shares, restricted stock and restricted stock units. The Company accounts for share-based compensation expense based on estimated grant-date fair value, and expenses the amount over the vesting period of the award. Determining the fair value of share-based awards at the grant date requires judgment, including estimating Cooper's stock price volatility, employee exercise behaviors and related employee forfeiture rates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The expected life of the share-based awards is based on the observed and expected time to post-vesting forfeiture and/or exercise. Groups of employees that have similar historical exercise behavior are considered separately for valuation purposes. In determining the expected volatility, management considers implied volatility from publicly-traded options on Cooper's common stock at the date of grant, historical volatility and other factors. The risk-free interest rate is based on the continuous rates provided by the United States Treasury with a term equal to the expected life of the award. The dividend yield is based on the projected annual dividend payment per share, divided by the stock price at the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Forfeitures are estimated at the time of grant, based on historical experience, and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Most of our operations outside the United States use their local currency as their functional currency. We translate these assets and liabilities into United States dollars at year-end exchange rates. We translate income and expense accounts at average rates for each month. We record gains and losses from the translation of financial statements in foreign currencies into United States dollars in other comprehensive income. We record gains and losses from changes in exchange rates on transactions denominated in currencies other than each reporting location's functional currency in net income for each period. We recorded in other expense and income a net foreign exchange loss of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;$22.0 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt; for fiscal&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt; 2022, $5.5 million for fiscal 2021 and $1.2 million for fiscal 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Financial Derivatives and Hedging&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Derivatives are recorded on the Consolidation Balance Sheets at fair value. Accounting for gains or losses resulting from changes in the values of those derivatives depends on the use of the derivative instrument and whether it qualifies for hedge accounting.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;The gain or loss on derivative instruments designated and qualifying for cash flow hedge accounting is deferred in other comprehensive income. The changes in fair value for all trades that are not designated for hedge accounting are recognized in current period earnings. Deferred gains or losses from designated cash flow hedges are reclassified into earnings in the period that the hedged interest expense affects earnings. The effectiveness of cash flow hedges is assessed at inception and quarterly thereafter. The Company does not offset fair value amounts recognized for derivative instruments in its Consolidated Balance Sheets for presentation purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:107%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Accounting standards define fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value. An asset&#x2019;s or liability&#x2019;s level is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are valued and disclosed in one of the following three levels of the valuation hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Level 1: Quoted market prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Level 3: Unobservable inputs reflecting the reporting entity&#x2019;s own assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The carrying value of cash and cash equivalents, accounts receivable, prepaid expense and other current assets, lines of credit, accounts payable and other current liabilities approximate fair value due to the short-term nature of such instruments and the ability to obtain financing on similar terms. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The carrying value of the Company's revolving credit facility and term loans approximates fair value based on current market rates (Level 2).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The fair value of the Company's&#160;interest&#160;rate&#160;swap&#160;contracts is measured on a recurring basis by netting the discounted future fixed cash payments and the discounted expected variable cash receipts. The variable cash receipts are based on the expectation of future interest rates (forward curves) derived from observable market interest rate&#160;curves. The&#160;interest&#160;rate&#160;swap&#160;contracts were categorized as Level 2 in the fair value hierarchy, as the inputs to the derivative pricing model are generally observable and do not contain a high level of subjectivity. The gain or loss on the derivatives is recorded as a component of accumulated other comprehensive income and subsequently reclassified into interest expense in the same period during which the hedged transaction affects earnings. Refer to Note 13. Financial Derivatives and Hedging for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company uses fair value measures when determining assets and liabilities acquired in an acquisition, which are considered a Level 3 measurement. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The fair value of the Company's contingent consideration for which a liability is recorded and the initial measurement of the joint venture interest are&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt; a Level 3 measurement&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;and the change in fair value is recognized in selling, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;general and administrative expense in the Consolidated Statements of Income.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt; Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Note 3. Acquisitions and Joint Venture for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Income taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;Income taxes are estimated based on enacted income tax laws and the results of operations in each jurisdiction. Deferred tax assets and liabilities are estimated based on temporary differences between the financial reporting basis and income tax basis of assets and liabilities. Deferred tax assets are also estimated based on net operating loss and tax credit carryforwards. Deferred tax assets are reduced by a valuation allowance to the extent it is more likely than not they are not expected to be realized. Adjustments to deferred tax assets and liabilities due to changes in tax laws, changes in jurisdiction from intra-group transfers of assets, and changes in judgment regarding a valuation allowance are recognized in provision for income taxes in the quarter in which such changes occur. Long-term tax payable is estimated income tax to be paid for unrecognized tax benefits. A tax benefit is recognized if it is more likely than not a tax position will be sustained based on its technical merits in a tax authority examination, based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority. Adjustments to unrecognized tax benefits due to changes in judgment are recognized in provision for income taxes in the quarter in which such changes occur. Interest and penalties related to unrecognized tax benefits are recognized in provision for income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Earnings Per Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We determine basic earnings per share (EPS) by using the weighted average number of shares outstanding. We determine diluted EPS by increasing the weighted average number of shares outstanding in the denominator by the number of outstanding dilutive equity awards using the treasury stock method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company considers all short-term, highly liquid investments purchased with maturities of three months or less to be&#160;cash equivalents.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Inventories are stated at the lower of cost or net realizable value. Cost is computed using standard cost that approximates actual cost, on a first-in, first-out basis.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.802%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;173.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;137.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;439.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;433.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;628.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;585.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;In assessing the value of inventories, we make estimates and judgments regarding aging of inventories and other relevant issues potentially affecting the salable condition of products and estimated prices at which those products will sell. On an ongoing basis, we review the carrying value of our inventory, measuring number of months on hand and other indications of salability. We reduce the value of inventory if there are indications that the carrying value is greater than net realizable value, resulting in a new, lower-cost basis for that inventory. Subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis. While estimates are involved, historically, obsolescence has not been a significant factor due to long product dating and lengthy product life cycles. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We record property, plant, and equipment at cost. We compute depreciation expense using the straight-line method over the estimated useful lives of the assets. Useful lives are generally 3 to 15 years except for buildings which are depreciated over 30 to 40 years and leasehold improvements, which we amortize over the shorter of the useful life or the lease term. We charge maintenance and repairs to expense as we incur them.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.802%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Land and improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;20.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;415.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;388.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,973.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,863.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;393.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;383.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, at cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,800.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,655.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,387.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,308.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,413.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,347.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease ROU assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,432.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,347.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Leases &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We consider an arrangement a lease if the arrangement transfers the right to control the use of an identified asset in exchange for consideration. We have operating leases, but do not have material financing leases. The Company primarily has operating leases for office, manufacturing and warehouse space, vehicles, and office equipment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Lease right-of-use assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make payments arising from the lease agreement. These assets and liabilities are recognized at the commencement of the lease based upon the present value of the future minimum lease payments over the lease term. The lease term reflects the noncancellable period of the lease together with periods covered by an option to extend or terminate the lease when management is reasonably certain that it will exercise such option. Changes in the lease term assumption could impact the right-of-use assets and lease liabilities recognized on the Consolidated Balance Sheets. As our leases typically do not contain a readily determinable implicit rate, we determine the present value of the lease liability using our incremental borrowing rate at the lease commencement date based on the lease term on a collateralized basis.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s operating leases typically include non-lease components such as common-area maintenance costs. The Company has elected to include non-lease components with lease payments for the purpose of calculating lease right-of-use assets and liabilities, to the extent that they are fixed. Non-lease components that are not fixed are expensed as incurred as variable lease payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Leases with a term of one year or less are not recognized on the Consolidated Balance Sheets, while the associated lease payments are expensed in the Consolidated Statements of Income and Comprehensive Income on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Operating leases are classified in &#x201c;Other current liabilities&#x201d;, &#x201c;Accrued pension liability and other&#x201d;, and &#x201c;Other assets&#x201d; on our consolidated balance sheets. Operating lease expense is recognized on a straight-line basis over the expected lease term and included in selling, general and administrative expenses in the Consolidated Statements of Income. Financing leases are classified in "Property, plant and equipment", "Short-term debt", and "Long-term debt" on our consolidated balance sheets. See Note 2. Operating Leases and Note 5. Financing Arrangements for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%"&gt;Cloud Computing Arrangements &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;The Company capitalizes certain costs related to the acquisition and development of internal use software, including implementation costs incurred in a cloud computing arrangement, during the application development stages of projects. Capitalized implementation costs are amortized on a straight-line basis over the expected term of the hosting arrangement, which includes consideration of the non-cancellable contractual term and reasonably certain renewals. Costs incurred during the preliminary project or the post-implementation/operation stages of the project are expensed as incurred. Implementation costs are included in &#x201c;Other assets&#x201d; in the Consolidated Balance Sheets. Amortization of capitalized implementation costs is included in the same line item in the Consolidated Statements of Income as the expense for fees for the associated hosting arrangement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%"&gt;Valuation of goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We evaluate goodwill for impairment annually during the fiscal third quarter and when an event occurs or circumstances change such that it is reasonably possible that impairment may exist. Goodwill is tested for impairment at the reporting unit level by performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. We perform a qualitative assessment to test each reporting unit's goodwill for impairment, which &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;includes industry and market considerations, overall financial performance and other relevant events and factors affecting each reporting unit. Based on our qualitative assessment, if we determine that the fair value of a reporting unit is more likely than not to be less than its carrying amount, the fair value of a reporting unit will be compared with its carrying amount and an impairment charge will be recognized for the amount that the carrying value exceeds the fair value of the reporting unit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%"&gt;Long-lived Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We review long-lived assets held and used, intangible assets with definite useful lives and assets held for sale for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If an evaluation of recoverability is required, the estimated undiscounted future cash flows associated with the asset group are compared to the asset group's carrying amount to determine if a write-down is required. If the undiscounted cash flows are less than the carrying amount, an impairment loss is recorded to the extent that the carrying amount exceeds the fair value. If management has committed to a plan to dispose of long-lived assets, the assets to be disposed of are reported at the lower of carrying amount or fair value less estimated costs to sell.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Indefinite-lived Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We assess indefinite-lived intangible assets annually in the third quarter of the fiscal year, or whenever events or changes in circumstances indicate that the carrying amount of an indefinite-lived intangible asset (asset group) may not be recoverable. We evaluate whether the indefinite-lived intangible asset is impaired by comparing its carrying value to its fair value. If the carrying value of an indefinite-lived intangible asset is not recoverable, an impairment loss is recognized based on the amount by which the carrying value exceeds the fair value.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Business combinations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We routinely consummate business combinations. Results of operations for acquired companies are included in our consolidated results of operations from the date of acquisition. We recognize separately from goodwill, the identifiable assets acquired, including acquired in-process research and development, the liabilities assumed, and any noncontrolling interest in the acquiree at the acquisition date fair values as defined by accounting standards related to fair value measurements. Key assumptions routinely utilized in allocation of purchase price to intangible assets include discount rates and projected financial information such as revenue projections for companies acquired. As of the acquisition date, goodwill is measured as the excess of consideration given, over the net of the acquisition date fair values of the identifiable assets acquired and the liabilities assumed. Direct acquisition costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We are subject to various legal proceedings, claims, litigation, investigations and contingencies arising out of the ordinary course of business. If we believe the likelihood of an adverse legal outcome is probable and the amount is estimable, we accrue a liability in accordance with accounting guidance for contingencies. We consult with legal counsel on matters related to litigation and seek input both within and outside the Company.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Treasury Stock&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We record treasury stock purchases under the cost method whereby the entire cost of the acquired stock is recorded as treasury stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Exit costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;During the second quarter of fiscal 2022, the Company initiated a plan to exit its contact lens care business, a non-core business unit of the CooperVision segment. We expect the exit activity to be substantially completed in the first half of fiscal 2023. Exit charges recognized in the three and twelve months ended October 31, 2022, were $9.2&#160;million and $33.2&#160;million, of which $26.7&#160;million is recognized in cost of sales and $6.5&#160;million is recognized in selling, general, and administrative expense in the Consolidated Statements of Income. Exit costs primarily related to inventory write-down, asset impairments and employee-related costs. Total exit costs are expected to be in a range of $30.0&#160;million to $40.0&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Recently Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"&gt;On November 1, 2021, we prospectively adopted ASU 2021-08, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%"&gt;Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"&gt; to the business combinations entered into during fiscal 2022. This update requires that an acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts with Customers.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Issued Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;and subsequent amendment to the initial guidance:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt; ASU 2021-01, Reference Rate Reform (Topic 848)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;: Scope (collectively, &#x201c;Topic 848&#x201d;). Topic 848 provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The guidance generally can be applied from March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of ASU 2020-04 on the Consolidated Condensed Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;In November 2021, the FASB issued ASU 2021-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;This update requires annual disclosures about transactions with a government that are accounted for by applying a grant or contribution accounting model by analogy. This standard is effective for fiscal years beginning after December 15, 2021, and should be applied either prospectively or retrospectively. Early adoption is permitted. The Company is currently evaluating the impact of ASU 2021-10 on the Consolidated Condensed Financial Statements.&lt;/span&gt;&lt;/div&gt;No other recently issued accounting pronouncements had or are expected to have a material impact on our Consolidated Financial Statements.</us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock>
    <coo:NumberOfBusinessUnits
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMTk1_9670d14f-fc92-4ced-ad56-3eae3a83da7c"
      unitRef="business_unit">2</coo:NumberOfBusinessUnits>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNDk0NzgwMjM5NTY1Mg_f8169c5a-31bd-4887-a5c0-93fbcc4300eb">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The financial statements in this report include the results of all of Cooper's consolidated entities. All significant intercompany transactions and balances are eliminated on consolidation.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMzM5NDA_15cd8d02-6bbe-4774-988e-ada30fde2793">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The preparation of Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of net sales and expenses during the reporting period. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;In particular, the COVID-19 pandemic negatively impacted business and healthcare activity globally. As a result of healthcare systems responding to the demands of managing the pandemic, governments around the world imposing measures designed to reduce the transmission of the COVID-19 virus, and individuals responding to the concerns of contracting the COVID-19 virus, many optical practitioners and retailers, hospitals, medical offices and fertility clinics closed their facilities, restricted access, or delayed or canceled patient visits, exams and elective medical procedures, and many customers that have reopened are experiencing reduced patient visits. These factors have had, and in the future may have, an adverse effect on our sales, operating results and cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The full extent to which the pandemic will directly or indirectly impact the Company's business, results of operations, and financial condition, including sales, expenses, manufacturing, clinical trials, research and development costs, reserves and allowances, fair value measurements, asset impairment charges, contingent consideration obligations, and the effectiveness of the Company's hedging instruments, will depend on future developments that are highly uncertain and difficult to predict. These developments include, but are not limited to, the duration and spread of the outbreak (including new and more contagious variants of COVID-19), its severity, the actions to contain the virus or address its impact, the timing, distribution, public acceptance and efficacy of vaccines and other treatments, United States and foreign government actions to respond to the reduction in global economic activity, and how quickly and to what extent normal economic and operating conditions can resume. There was not a material impact to the estimates in the Company&#x2019;s Consolidated Financial Statements for fiscal 2022. &lt;/span&gt;&lt;/div&gt;The Company continually monitors and evaluates the estimates used as additional information becomes available. Adjustments will be made to these provisions periodically to reflect new facts and circumstances that may indicate that historical experience may not be indicative of current and/or future results. The Company&#x2019;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material changes to the estimates and material impacts to the Company&#x2019;s Consolidated Financial Statements in future reporting periods.</us-gaap:UseOfEstimates>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMzM5MjI_06cfe132-ab71-439e-8fee-cbbb11bfe087">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Revenue recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Sales &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company sells its products principally to a limited number of distributors, group purchasing organizations, eye care or health care professionals including independent practices, corporate retailers, hospitals and clinics or authorized resellers (collectively, its Customers). These Customers may subsequently resell the Company&#x2019;s products to eye care or health care providers and patients. In addition to product supply and distribution agreements with Customers, the Company enters into arrangements with health care providers and payors that provide for government-mandated and/or privately negotiated rebates, chargebacks and discounts with respect to the purchase of the Company&#x2019;s products. The Company considers purchase orders, which in some cases are governed by master sales agreements, to be contracts with a customer. As part of its consideration of the contract, the Company evaluates certain factors including the customer&#x2019;s ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Revenues from product sales are recognized when the Customer obtains control of the Company&#x2019;s product, which occurs at a point in time, typically upon shipment or delivery to the Customer. Taxes collected from Customers relating to product sales and remitted to governmental authorities are excluded from revenues. The Company expenses incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that the Company would have recognized is one year or less. See Note 12. Business Segment Information for disaggregation of revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reserves for Variable Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Revenues from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration for which reserves are established and which result from discounts, returns, chargebacks, rebates and other allowances that are offered within contracts between the Company and its Customers, health care providers, payors and other indirect customers relating to the Company&#x2019;s sales of its products. These reserves are based on the amounts earned or to be claimed on the related sales and are classified primarily in current liabilities. Variable consideration is estimated based on the most likely amount or expected value approach, depending on which method the Company expects to better predict the amount of consideration to which it will be entitled. Once the Company elects one of the methods to estimate variable consideration for a particular type of performance obligation, the Company applies that method consistently.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Where appropriate, these estimates take into consideration a range of possible outcomes which are probability-weighted for relevant factors such as the Company&#x2019;s historical experience, current contractual and statutory requirements, specific known market events and trends, industry data and forecasted customer buying and payment patterns. Overall, these reserves reflect the Company&#x2019;s best estimates of the amount of consideration to which it is entitled based on the terms of the contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade Discounts and Allowances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company generally provides Customers with discounts, which include incentive fees that are stated in the Company&#x2019;s contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Product Returns&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Consistent with industry practice, the Company generally offers Customers a limited right of return for a product that has been purchased from the Company. The Company estimates the amount of its product sales that may be returned by its Customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized. Historically, returns have been infrequent and insignificant relative to our total sales. Our refund liability for product returns was $14.5 million &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;and&#160;$13.7 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;at&#160;October&#160;31, 2022 and 2021, respectively, which is included in Accrued Liabilities on our Consolidated Balance Sheets and represents the expected value of the aggregate refunds that will be due to our customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Rebates and Chargebacks&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Rebates are estimated based on contractual terms, historical experience, customer mix, trend analysis and projected market conditions in the various markets served.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Chargebacks for fees and discounts to providers represent the estimated obligations resulting from contractual commitments to sell products to qualified healthcare providers at prices lower than the list wholesale prices charged to the Company&#x2019;s direct customers. For certain office and surgical products in CooperSurgical, customers charge the Company for the difference between what they pay for the product and the ultimate selling price to the qualified healthcare providers. These reserves are established in the same period that the related revenue is recognized, resulting in a reduction of product revenue. Chargeback amounts are generally determined at the time of resale to the qualified healthcare provider by customers. CooperSurgical rebates are predominately related to the Medicaid rebate provision that is estimated based upon contractual terms, historical experience, and trend analysis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Deferred revenue primarily represents prepaid stem cell storage as part of the CooperSurgical business unit. Revenue related to stem cell storage is recognized over the service period, which can range from one year to the lifetime of a customer.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:CapitalizedContractCostAmortizationPeriod
      contextRef="i464c13efabb24917bf19bc8289bce72b_I20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNzEwOA_a5f0b866-92f4-465a-bdfa-4d1056e4e2c8">P1Y</us-gaap:CapitalizedContractCostAmortizationPeriod>
    <us-gaap:ContractWithCustomerRefundLiability
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMTAyNjY_4b2af2e5-3ab2-447d-bee6-3bb914dc573f"
      unitRef="usd">14500000</us-gaap:ContractWithCustomerRefundLiability>
    <us-gaap:ContractWithCustomerRefundLiability
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMTAyNzM_ddb079b7-a072-474a-a5d4-34dd05d91c3a"
      unitRef="usd">13700000</us-gaap:ContractWithCustomerRefundLiability>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNDk0NzgwMjUwNTUyOA_a52c3b3f-b155-444c-aa36-058759721c3e">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We grant various share-based compensation awards, including stock options, performance unit shares, restricted stock and restricted stock units. The Company accounts for share-based compensation expense based on estimated grant-date fair value, and expenses the amount over the vesting period of the award. Determining the fair value of share-based awards at the grant date requires judgment, including estimating Cooper's stock price volatility, employee exercise behaviors and related employee forfeiture rates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The expected life of the share-based awards is based on the observed and expected time to post-vesting forfeiture and/or exercise. Groups of employees that have similar historical exercise behavior are considered separately for valuation purposes. In determining the expected volatility, management considers implied volatility from publicly-traded options on Cooper's common stock at the date of grant, historical volatility and other factors. The risk-free interest rate is based on the continuous rates provided by the United States Treasury with a term equal to the expected life of the award. The dividend yield is based on the projected annual dividend payment per share, divided by the stock price at the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Forfeitures are estimated at the time of grant, based on historical experience, and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNDk0NzgwMjUwNTUyOQ_724af340-f9ae-4c31-9c40-b52d9ff1a029">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;Most of our operations outside the United States use their local currency as their functional currency. We translate these assets and liabilities into United States dollars at year-end exchange rates. We translate income and expense accounts at average rates for each month. We record gains and losses from the translation of financial statements in foreign currencies into United States dollars in other comprehensive income. We record gains and losses from changes in exchange rates on transactions denominated in currencies other than each reporting location's functional currency in net income for each period.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMTY0OTI2NzU3MDY2Ng_6141fb35-5f89-4fb6-881d-cc7fddca87dc"
      unitRef="usd">-22000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMTY0OTI2NzU3MDY4Nw_db8b5f8a-78a3-49ad-a154-cb37ac8258d8"
      unitRef="usd">-5500000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMTY0OTI2NzU3MDcxMQ_9a302159-a0a5-4987-a2e0-d8b5bc4be5ff"
      unitRef="usd">-1200000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNDk0NzgwMjUwNTUzMA_e1c55a8e-4378-454f-9d90-e0f3fb5a8cd1">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Financial Derivatives and Hedging&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Derivatives are recorded on the Consolidation Balance Sheets at fair value. Accounting for gains or losses resulting from changes in the values of those derivatives depends on the use of the derivative instrument and whether it qualifies for hedge accounting.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;The gain or loss on derivative instruments designated and qualifying for cash flow hedge accounting is deferred in other comprehensive income. The changes in fair value for all trades that are not designated for hedge accounting are recognized in current period earnings. Deferred gains or losses from designated cash flow hedges are reclassified into earnings in the period that the hedged interest expense affects earnings. The effectiveness of cash flow hedges is assessed at inception and quarterly thereafter. The Company does not offset fair value amounts recognized for derivative instruments in its Consolidated Balance Sheets for presentation purposes.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNDk0NzgwMjUwNTUzMQ_2ffd3811-abbe-4c2a-a1b6-882ba8111100">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:107%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Accounting standards define fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value. An asset&#x2019;s or liability&#x2019;s level is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are valued and disclosed in one of the following three levels of the valuation hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Level 1: Quoted market prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Level 3: Unobservable inputs reflecting the reporting entity&#x2019;s own assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The carrying value of cash and cash equivalents, accounts receivable, prepaid expense and other current assets, lines of credit, accounts payable and other current liabilities approximate fair value due to the short-term nature of such instruments and the ability to obtain financing on similar terms. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The carrying value of the Company's revolving credit facility and term loans approximates fair value based on current market rates (Level 2).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The fair value of the Company's&#160;interest&#160;rate&#160;swap&#160;contracts is measured on a recurring basis by netting the discounted future fixed cash payments and the discounted expected variable cash receipts. The variable cash receipts are based on the expectation of future interest rates (forward curves) derived from observable market interest rate&#160;curves. The&#160;interest&#160;rate&#160;swap&#160;contracts were categorized as Level 2 in the fair value hierarchy, as the inputs to the derivative pricing model are generally observable and do not contain a high level of subjectivity. The gain or loss on the derivatives is recorded as a component of accumulated other comprehensive income and subsequently reclassified into interest expense in the same period during which the hedged transaction affects earnings. Refer to Note 13. Financial Derivatives and Hedging for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company uses fair value measures when determining assets and liabilities acquired in an acquisition, which are considered a Level 3 measurement. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The fair value of the Company's contingent consideration for which a liability is recorded and the initial measurement of the joint venture interest are&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt; a Level 3 measurement&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;and the change in fair value is recognized in selling, &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;general and administrative expense in the Consolidated Statements of Income.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt; Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Note 3. Acquisitions and Joint Venture for further information.&lt;/span&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNDk0NzgwMjUwNTUzMg_4fbc5f90-782d-44fb-b104-27fd0f9ca38c">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Income taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;Income taxes are estimated based on enacted income tax laws and the results of operations in each jurisdiction. Deferred tax assets and liabilities are estimated based on temporary differences between the financial reporting basis and income tax basis of assets and liabilities. Deferred tax assets are also estimated based on net operating loss and tax credit carryforwards. Deferred tax assets are reduced by a valuation allowance to the extent it is more likely than not they are not expected to be realized. Adjustments to deferred tax assets and liabilities due to changes in tax laws, changes in jurisdiction from intra-group transfers of assets, and changes in judgment regarding a valuation allowance are recognized in provision for income taxes in the quarter in which such changes occur. Long-term tax payable is estimated income tax to be paid for unrecognized tax benefits. A tax benefit is recognized if it is more likely than not a tax position will be sustained based on its technical merits in a tax authority examination, based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority. Adjustments to unrecognized tax benefits due to changes in judgment are recognized in provision for income taxes in the quarter in which such changes occur. Interest and penalties related to unrecognized tax benefits are recognized in provision for income taxes.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNDk0NzgwMjUwNTUzMw_b5959d41-d63c-4b87-859a-c7e34ee207a5">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Earnings Per Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We determine basic earnings per share (EPS) by using the weighted average number of shares outstanding. We determine diluted EPS by increasing the weighted average number of shares outstanding in the denominator by the number of outstanding dilutive equity awards using the treasury stock method.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNDk0NzgwMjUwNTUzNA_338277a8-23e2-4705-a854-843cc90a5872">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company considers all short-term, highly liquid investments purchased with maturities of three months or less to be&#160;cash equivalents.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNDk0NzgwMjUwNTUzNQ_7d44622a-e982-4012-bb2b-7dd5379f1535">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Inventories are stated at the lower of cost or net realizable value. Cost is computed using standard cost that approximates actual cost, on a first-in, first-out basis.&lt;/span&gt;&lt;/div&gt;In assessing the value of inventories, we make estimates and judgments regarding aging of inventories and other relevant issues potentially affecting the salable condition of products and estimated prices at which those products will sell. On an ongoing basis, we review the carrying value of our inventory, measuring number of months on hand and other indications of salability. We reduce the value of inventory if there are indications that the carrying value is greater than net realizable value, resulting in a new, lower-cost basis for that inventory. Subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis. While estimates are involved, historically, obsolescence has not been a significant factor due to long product dating and lengthy product life cycles.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNDk0NzgwMjUwNTUzNg_60460e6c-7871-4bdc-b774-46325ffdbfe3">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.802%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;173.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;137.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;439.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;433.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;628.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;585.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOjMyNDNkYmE2Yzc5NTQ1MzFiYTZjNzQ0ZGE0OTQ1ZmY0L3RhYmxlcmFuZ2U6MzI0M2RiYTZjNzk1NDUzMWJhNmM3NDRkYTQ5NDVmZjRfMS0xLTEtMS02Nzk4Nw_5f9793f5-10e0-4f3f-bded-2fe9208b051c"
      unitRef="usd">173700000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOjMyNDNkYmE2Yzc5NTQ1MzFiYTZjNzQ0ZGE0OTQ1ZmY0L3RhYmxlcmFuZ2U6MzI0M2RiYTZjNzk1NDUzMWJhNmM3NDRkYTQ5NDVmZjRfMS0zLTEtMS02Nzk4Nw_817df8a6-8954-4d90-8d48-1762efdba889"
      unitRef="usd">137700000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOjMyNDNkYmE2Yzc5NTQ1MzFiYTZjNzQ0ZGE0OTQ1ZmY0L3RhYmxlcmFuZ2U6MzI0M2RiYTZjNzk1NDUzMWJhNmM3NDRkYTQ5NDVmZjRfMi0xLTEtMS02Nzk4Nw_46e8350c-f4b8-4940-b76c-55e6b2628568"
      unitRef="usd">15200000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOjMyNDNkYmE2Yzc5NTQ1MzFiYTZjNzQ0ZGE0OTQ1ZmY0L3RhYmxlcmFuZ2U6MzI0M2RiYTZjNzk1NDUzMWJhNmM3NDRkYTQ5NDVmZjRfMi0zLTEtMS02Nzk4Nw_f91fbfbd-ea74-439d-abe1-6cfce39c5189"
      unitRef="usd">14000000.0</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOjMyNDNkYmE2Yzc5NTQ1MzFiYTZjNzQ0ZGE0OTQ1ZmY0L3RhYmxlcmFuZ2U6MzI0M2RiYTZjNzk1NDUzMWJhNmM3NDRkYTQ5NDVmZjRfMy0xLTEtMS02Nzk4Nw_a974f8ae-7cbf-48d6-9abc-97e759d6fe8b"
      unitRef="usd">439800000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOjMyNDNkYmE2Yzc5NTQ1MzFiYTZjNzQ0ZGE0OTQ1ZmY0L3RhYmxlcmFuZ2U6MzI0M2RiYTZjNzk1NDUzMWJhNmM3NDRkYTQ5NDVmZjRfMy0zLTEtMS02Nzk4Nw_66882bd9-4be0-4221-8fff-9ae195b9c637"
      unitRef="usd">433900000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOjMyNDNkYmE2Yzc5NTQ1MzFiYTZjNzQ0ZGE0OTQ1ZmY0L3RhYmxlcmFuZ2U6MzI0M2RiYTZjNzk1NDUzMWJhNmM3NDRkYTQ5NDVmZjRfNC0xLTEtMS02Nzk4Nw_d06a9f40-6c39-4781-9672-f100e04a05e3"
      unitRef="usd">628700000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOjMyNDNkYmE2Yzc5NTQ1MzFiYTZjNzQ0ZGE0OTQ1ZmY0L3RhYmxlcmFuZ2U6MzI0M2RiYTZjNzk1NDUzMWJhNmM3NDRkYTQ5NDVmZjRfNC0zLTEtMS02Nzk4Nw_6b5f416d-440d-460d-b724-7b585b43714a"
      unitRef="usd">585600000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNDk0NzgwMjUwNTUzOA_5a52ee72-b066-48c1-bd35-745bf084ac78">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We record property, plant, and equipment at cost. We compute depreciation expense using the straight-line method over the estimated useful lives of the assets. Useful lives are generally 3 to 15 years except for buildings which are depreciated over 30 to 40 years and leasehold improvements, which we amortize over the shorter of the useful life or the lease term. We charge maintenance and repairs to expense as we incur them.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ic23b9b3f6d3c4e14bc47f1dc4aaaf851_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMTQ5OTI5_c85ece8a-19a0-44a1-9a74-681216cdfa3a">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i7961f9072dbe43cd94f80a154bca4da3_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMTQ5OTM0_4fe40283-551d-4b89-b425-b0657145ba44">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ic287f5f4035d4d3da007edafaf1a3fa0_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMTQ1MjY5_78ff7f52-4d36-43f1-aa10-0c6ef4d78d0c">P30Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="iead04709e17747fe86865c67855d124e_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMTQ5OTM4_a6aa27d1-d849-40d3-a329-c53ad1f4b28b">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNDk0NzgwMjUwNTUzOQ_bd4933b5-bb08-40e6-a744-107dc4572994">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.802%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Land and improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;20.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;415.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;388.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,973.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,863.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;393.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;383.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, at cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,800.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,655.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,387.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,308.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,413.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,347.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease ROU assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,432.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,347.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i3c4f820f05374f5f815a531d9a560aa7_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfMS0xLTEtMS02ODAwMA_6c90407a-72dc-4a49-a8c6-18d94ce3ee65"
      unitRef="usd">18700000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i2c73a0636d374fd6b53feb1438cbe3ff_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfMS0zLTEtMS02ODAwMA_938617af-7bfb-4c32-a2eb-543bfe5333cf"
      unitRef="usd">20300000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="if513250ff04c4191b9e9da3d94c6c176_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfMi0xLTEtMS02ODAwMA_d205193b-bde7-4b25-a728-e24bb890615b"
      unitRef="usd">415600000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9a3c8a9647004da681ccc361aa33e519_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfMi0zLTEtMS02ODAwMA_9ad91e42-39f1-4d6d-bc20-c5ab391f0036"
      unitRef="usd">388000000.0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="id75b52051d824284a67f698730bd6d07_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfMy0xLTEtMS02ODAwMA_2a8d392d-7273-409a-8b81-40921501ec66"
      unitRef="usd">1973600000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i0e7e9ff574584a7d870bff7258dbde9e_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfMy0zLTEtMS02ODAwMA_29ac16d5-5f1a-418c-b44b-cfc37684acf6"
      unitRef="usd">1863600000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9b2af60b11694e86bd8e533c1e3014ba_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfNC0xLTEtMS02ODAwMA_045543a0-6647-4be8-aa7d-e4726f719f30"
      unitRef="usd">393000000.0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="idabbabf9caaa404aac078818ec07abc5_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfNC0zLTEtMS02ODAwMA_8545381d-1290-4740-8a90-b15b30478fff"
      unitRef="usd">383800000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfNS0xLTEtMS04NTY4OA_bdb84bcc-65c9-4d1c-bff9-c8e0271b16e2"
      unitRef="usd">2800900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfNS0zLTEtMS04NTY4OA_b27e058c-d818-4a02-93a4-a43766768926"
      unitRef="usd">2655700000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfNi0xLTEtMS02ODAwMA_86cfa77e-fc76-44e6-aec7-1b8d0b283a10"
      unitRef="usd">1387200000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfNi0zLTEtMS02ODAwMA_a8651c8b-449b-459c-8339-05cd09f7b4bd"
      unitRef="usd">1308100000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfNy0xLTEtMS02ODAwMA_1d601ec9-d07b-4b7f-bea1-41ebe4eba4cd"
      unitRef="usd">1413700000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfNy0zLTEtMS02ODAwMA_7d3b891b-e2f4-4ae9-9475-629a19e9e704"
      unitRef="usd">1347600000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfOS0xLTEtMS05NTMwMA_677811be-aae1-4323-a580-ca834d0121b9"
      unitRef="usd">19200000</us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfOS0zLTEtMS05NTMwNA_91fed10c-0cfe-4bf8-a736-94f21aa77cd4"
      unitRef="usd">0</us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfOS0xLTEtMS05OTk4NQ_1179959c-5e23-4b1f-afba-36bafd97b9d3"
      unitRef="usd">1432900000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RhYmxlOmM3NjVjYmUwODJkNzQ5MTQ5NGYzNTVkNjgxZjhlY2U1L3RhYmxlcmFuZ2U6Yzc2NWNiZTA4MmQ3NDkxNDk0ZjM1NWQ2ODFmOGVjZTVfOS0zLTEtMS05OTk4NQ_048cf6cd-8e49-47b0-b6c0-8d65d9563c1b"
      unitRef="usd">1347600000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMzQwMTY_2f6d8c18-9bd2-4e95-8748-fe29b668f8d2">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Leases &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We consider an arrangement a lease if the arrangement transfers the right to control the use of an identified asset in exchange for consideration. We have operating leases, but do not have material financing leases. The Company primarily has operating leases for office, manufacturing and warehouse space, vehicles, and office equipment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Lease right-of-use assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make payments arising from the lease agreement. These assets and liabilities are recognized at the commencement of the lease based upon the present value of the future minimum lease payments over the lease term. The lease term reflects the noncancellable period of the lease together with periods covered by an option to extend or terminate the lease when management is reasonably certain that it will exercise such option. Changes in the lease term assumption could impact the right-of-use assets and lease liabilities recognized on the Consolidated Balance Sheets. As our leases typically do not contain a readily determinable implicit rate, we determine the present value of the lease liability using our incremental borrowing rate at the lease commencement date based on the lease term on a collateralized basis.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s operating leases typically include non-lease components such as common-area maintenance costs. The Company has elected to include non-lease components with lease payments for the purpose of calculating lease right-of-use assets and liabilities, to the extent that they are fixed. Non-lease components that are not fixed are expensed as incurred as variable lease payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Leases with a term of one year or less are not recognized on the Consolidated Balance Sheets, while the associated lease payments are expensed in the Consolidated Statements of Income and Comprehensive Income on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;Operating leases are classified in &#x201c;Other current liabilities&#x201d;, &#x201c;Accrued pension liability and other&#x201d;, and &#x201c;Other assets&#x201d; on our consolidated balance sheets. Operating lease expense is recognized on a straight-line basis over the expected lease term and included in selling, general and administrative expenses in the Consolidated Statements of Income. Financing leases are classified in "Property, plant and equipment", "Short-term debt", and "Long-term debt" on our consolidated balance sheets.</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:InternalUseSoftwarePolicy
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNDk0NzgwMjUwNTU0MQ_ecd2c0ee-0ec9-4058-a92b-4a24e2242246">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%"&gt;Cloud Computing Arrangements &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;The Company capitalizes certain costs related to the acquisition and development of internal use software, including implementation costs incurred in a cloud computing arrangement, during the application development stages of projects. Capitalized implementation costs are amortized on a straight-line basis over the expected term of the hosting arrangement, which includes consideration of the non-cancellable contractual term and reasonably certain renewals. Costs incurred during the preliminary project or the post-implementation/operation stages of the project are expensed as incurred. Implementation costs are included in &#x201c;Other assets&#x201d; in the Consolidated Balance Sheets. Amortization of capitalized implementation costs is included in the same line item in the Consolidated Statements of Income as the expense for fees for the associated hosting arrangement.&lt;/span&gt;&lt;/div&gt;</us-gaap:InternalUseSoftwarePolicy>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMzM4ODU_eff1de0e-ed97-466d-bc89-3d94bafa25d6">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%"&gt;Valuation of goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We evaluate goodwill for impairment annually during the fiscal third quarter and when an event occurs or circumstances change such that it is reasonably possible that impairment may exist. Goodwill is tested for impairment at the reporting unit level by performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. We perform a qualitative assessment to test each reporting unit's goodwill for impairment, which &lt;/span&gt;&lt;/div&gt;includes industry and market considerations, overall financial performance and other relevant events and factors affecting each reporting unit. Based on our qualitative assessment, if we determine that the fair value of a reporting unit is more likely than not to be less than its carrying amount, the fair value of a reporting unit will be compared with its carrying amount and an impairment charge will be recognized for the amount that the carrying value exceeds the fair value of the reporting unit.</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNDk0NzgwMjUwNTU0Mw_a744a5c8-0eb5-4587-bf5d-41e041bdff30">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%"&gt;Long-lived Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We review long-lived assets held and used, intangible assets with definite useful lives and assets held for sale for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If an evaluation of recoverability is required, the estimated undiscounted future cash flows associated with the asset group are compared to the asset group's carrying amount to determine if a write-down is required. If the undiscounted cash flows are less than the carrying amount, an impairment loss is recorded to the extent that the carrying amount exceeds the fair value. If management has committed to a plan to dispose of long-lived assets, the assets to be disposed of are reported at the lower of carrying amount or fair value less estimated costs to sell.&lt;/span&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNDk0NzgwMjUwNTU0NA_05f4928d-4cf9-4c19-8462-c050a89779d7">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Indefinite-lived Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We assess indefinite-lived intangible assets annually in the third quarter of the fiscal year, or whenever events or changes in circumstances indicate that the carrying amount of an indefinite-lived intangible asset (asset group) may not be recoverable. We evaluate whether the indefinite-lived intangible asset is impaired by comparing its carrying value to its fair value. If the carrying value of an indefinite-lived intangible asset is not recoverable, an impairment loss is recognized based on the amount by which the carrying value exceeds the fair value.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMzM4Njg_1c78bc9a-ebfe-46d9-98b6-28a5671dbdc3">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Business combinations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We routinely consummate business combinations. Results of operations for acquired companies are included in our consolidated results of operations from the date of acquisition. We recognize separately from goodwill, the identifiable assets acquired, including acquired in-process research and development, the liabilities assumed, and any noncontrolling interest in the acquiree at the acquisition date fair values as defined by accounting standards related to fair value measurements. Key assumptions routinely utilized in allocation of purchase price to intangible assets include discount rates and projected financial information such as revenue projections for companies acquired. As of the acquisition date, goodwill is measured as the excess of consideration given, over the net of the acquisition date fair values of the identifiable assets acquired and the liabilities assumed. Direct acquisition costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMzM4OTI_290b7937-789c-4949-89ed-268c9d69a99d">LitigationWe are subject to various legal proceedings, claims, litigation, investigations and contingencies arising out of the ordinary course of business. If we believe the likelihood of an adverse legal outcome is probable and the amount is estimable, we accrue a liability in accordance with accounting guidance for contingencies. We consult with legal counsel on matters related to litigation and seek input both within and outside the Company.</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:StockholdersEquityPolicyTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMzM5Mzc_4f6d496f-96d0-4088-a168-3de6e24daaa7">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Treasury Stock&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We record treasury stock purchases under the cost method whereby the entire cost of the acquired stock is recorded as treasury stock.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityPolicyTextBlock>
    <us-gaap:BusinessExitCosts1
      contextRef="ib13a9242898a43f9842a944029424ab7_D20220801-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMjc0ODc3OTI1MzQxOA_e32ff1e2-d4d5-4b09-a32e-b207aea299a3"
      unitRef="usd">9200000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMjc0ODc3OTI1MzQzMg_9ee49e97-6f88-4154-863c-0b500809c9e8"
      unitRef="usd">33200000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i3a728882a111429c8b376cccf1bd73ef_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMjc0ODc3OTI1MzQ0Nw_7bd6adc6-7191-4fe3-8dee-da1f5b0f4ec0"
      unitRef="usd">26700000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i628a683f9df74396a991320942dabd37_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMjc0ODc3OTI1MzQ2Mg_f1b6c28e-5474-4333-b65f-e789f971059b"
      unitRef="usd">6500000</us-gaap:BusinessExitCosts1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i464c13efabb24917bf19bc8289bce72b_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMjc0ODc3OTI1MzQ3Ng_d56bb594-21c3-4b3e-bf0f-17bd4590edc8"
      unitRef="usd">30000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i4377d2468ae64603815ed52f5106831e_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfMjc0ODc3OTI1MzQ5MQ_822e7b14-09a2-4661-b970-bcb84ee3340e"
      unitRef="usd">40000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85NC9mcmFnOjNkZjc2ZWZkN2RmODRhYTlhMDMwMjU3MjAwZWY2M2JjL3RleHRyZWdpb246M2RmNzZlZmQ3ZGY4NGFhOWEwMzAyNTcyMDBlZjYzYmNfNDk0NzgwMjM5NTc0Mw_25bd7e8f-2c22-4814-8a68-c5e80363a3e5">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Recently Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"&gt;On November 1, 2021, we prospectively adopted ASU 2021-08, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%"&gt;Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"&gt; to the business combinations entered into during fiscal 2022. This update requires that an acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts with Customers.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Issued Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;and subsequent amendment to the initial guidance:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt; ASU 2021-01, Reference Rate Reform (Topic 848)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;: Scope (collectively, &#x201c;Topic 848&#x201d;). Topic 848 provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The guidance generally can be applied from March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of ASU 2020-04 on the Consolidated Condensed Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;In November 2021, the FASB issued ASU 2021-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;This update requires annual disclosures about transactions with a government that are accounted for by applying a grant or contribution accounting model by analogy. This standard is effective for fiscal years beginning after December 15, 2021, and should be applied either prospectively or retrospectively. Early adoption is permitted. The Company is currently evaluating the impact of ASU 2021-10 on the Consolidated Condensed Financial Statements.&lt;/span&gt;&lt;/div&gt;No other recently issued accounting pronouncements had or are expected to have a material impact on our Consolidated Financial Statements.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RleHRyZWdpb246OGJiMDg3MzE2NTdhNDc0OGI0ZjEyZGY4NzljMjk3MzVfMjc3NA_d671feb5-543a-4567-96a9-4472eefafefa">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Note 2. Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The following table presents information about leases on the Consolidated Balance Sheets: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.013%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;October&#160;31,&lt;br/&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfMi0wLTEtMS01ODUzNw_f2af3d8b-af98-47fa-9e18-c521fd473e5f"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfMi0wLTEtMS01ODUzNw_fafffb75-d216-4f4d-8142-6f0bc8bdcc25"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;230.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;257.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNC0wLTEtMS01ODUzNw_20f60483-65f4-4940-bd27-ff3038fea748"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNC0wLTEtMS01ODUzNw_238f6c6d-7462-42ec-bc2d-2f272994dc20"&gt;Operating lease liabilities, current&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;35.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;35.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNS0wLTEtMS01ODUzNw_cd2a4655-0b1b-4300-89ec-ea2b04899df1"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNS0wLTEtMS01ODUzNw_efad86ee-3171-4680-acc9-262cd136b6e2"&gt;Operating lease liabilities, non-current&lt;/span&gt;&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;205.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;231.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;241.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;267.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;9.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Operating lease expense for the fiscal years ended October&#160;31, 2022, 2021 and 2020 was $45.0&#160;million, $44.1&#160;million and $41.2&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Maturity of Lease Liabilities &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The minimum rental payments required under operating leases that have initial or remaining noncancellable lease terms in excess of one year as of October&#160;31, 2022 are: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.126%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;42.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;36.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;30.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;115.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;284.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Less: interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;43.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;241.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <coo:AssetsAndLiabilitiesLesseeTableTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RleHRyZWdpb246OGJiMDg3MzE2NTdhNDc0OGI0ZjEyZGY4NzljMjk3MzVfMjc2OQ_a70ccd10-34cf-4344-89c6-19cf9b2403a6">&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The following table presents information about leases on the Consolidated Balance Sheets: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.013%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;October&#160;31,&lt;br/&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfMi0wLTEtMS01ODUzNw_f2af3d8b-af98-47fa-9e18-c521fd473e5f"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfMi0wLTEtMS01ODUzNw_fafffb75-d216-4f4d-8142-6f0bc8bdcc25"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;230.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;257.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNC0wLTEtMS01ODUzNw_20f60483-65f4-4940-bd27-ff3038fea748"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNC0wLTEtMS01ODUzNw_238f6c6d-7462-42ec-bc2d-2f272994dc20"&gt;Operating lease liabilities, current&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;35.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;35.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNS0wLTEtMS01ODUzNw_cd2a4655-0b1b-4300-89ec-ea2b04899df1"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNS0wLTEtMS01ODUzNw_efad86ee-3171-4680-acc9-262cd136b6e2"&gt;Operating lease liabilities, non-current&lt;/span&gt;&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;205.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;231.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;241.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;267.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;9.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</coo:AssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfMi0yLTEtMS01ODUzNw_8789a14e-7022-4f9a-b213-8a35243ab8c3"
      unitRef="usd">230100000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfMi00LTEtMS01ODUzNw_84eb453b-906b-420e-b874-5c764fe8d385"
      unitRef="usd">257000000.0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNC0yLTEtMS01ODUzNw_7f804bbd-9f85-418b-b193-12979cc830c2"
      unitRef="usd">35500000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNC00LTEtMS01ODUzNw_672229bd-a07c-4534-a4f9-c903621bfdac"
      unitRef="usd">35700000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNS0yLTEtMS01ODUzNw_a865ed3f-eed8-410e-bb75-9b795be981ec"
      unitRef="usd">205500000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNS00LTEtMS01ODUzNw_72aef861-c4da-4a21-86df-dffd177a2220"
      unitRef="usd">231700000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNi0yLTEtMS01ODUzNw_68d576a4-818b-4327-9807-c4bad13b53c1"
      unitRef="usd">241000000.0</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfNi00LTEtMS01ODUzNw_94e2a440-44a3-47ff-996d-88830bb8133f"
      unitRef="usd">267400000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfOC0yLTEtMS01ODUzNw_f6b4ef3b-f140-48d2-a81a-ee429b2c09e4">P9Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfOC00LTEtMS01ODUzNw_7119c9a7-5a9d-4675-b39b-0e1ceeee2146">P10Y7M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfOS0yLTEtMS01ODUzNw_13f650e9-e4f6-442d-af15-52186748df70"
      unitRef="number">0.03</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjFkYzA3YjdlZjNhZjRlZDJiZmE5OTk1Y2IyNWY2NjAyL3RhYmxlcmFuZ2U6MWRjMDdiN2VmM2FmNGVkMmJmYTk5OTVjYjI1ZjY2MDJfOS00LTEtMS01ODUzNw_c3e425f2-48ea-46fd-8aa6-bad9c6387e60"
      unitRef="number">0.03</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseCost
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RleHRyZWdpb246OGJiMDg3MzE2NTdhNDc0OGI0ZjEyZGY4NzljMjk3MzVfNTQ5NzU1ODIyOTg2_c8e3cb6e-3e01-4e37-91d8-c0c2b51567e9"
      unitRef="usd">45000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RleHRyZWdpb246OGJiMDg3MzE2NTdhNDc0OGI0ZjEyZGY4NzljMjk3MzVfNTQ5NzU1ODIzMDA1_70ef7149-22ce-4f48-a6bf-53bde2ba8fb5"
      unitRef="usd">44100000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RleHRyZWdpb246OGJiMDg3MzE2NTdhNDc0OGI0ZjEyZGY4NzljMjk3MzVfNTQ5NzU1ODIzMDIx_0adf5bf7-56ab-474b-9343-01cdb851adf3"
      unitRef="usd">41200000</us-gaap:OperatingLeaseCost>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RleHRyZWdpb246OGJiMDg3MzE2NTdhNDc0OGI0ZjEyZGY4NzljMjk3MzVfMjc3MQ_e7f2c0ed-e5ab-48b5-867d-a6a30532890f">&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The minimum rental payments required under operating leases that have initial or remaining noncancellable lease terms in excess of one year as of October&#160;31, 2022 are: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.126%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;42.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;36.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;30.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;115.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;284.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Less: interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;43.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;241.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjRkZDNmZTBlZWQ1YzRiMmZiMGM0Nzg2MDY2MmNiNjNlL3RhYmxlcmFuZ2U6NGRkM2ZlMGVlZDVjNGIyZmIwYzQ3ODYwNjYyY2I2M2VfMS0yLTEtMS01ODUzNw_a058f708-3f47-4d45-b720-b4f496e60a0d"
      unitRef="usd">42200000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjRkZDNmZTBlZWQ1YzRiMmZiMGM0Nzg2MDY2MmNiNjNlL3RhYmxlcmFuZ2U6NGRkM2ZlMGVlZDVjNGIyZmIwYzQ3ODYwNjYyY2I2M2VfMi0yLTEtMS01ODUzNw_3cd7c452-eb87-487d-90f0-8ac80a4fc6bf"
      unitRef="usd">36600000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjRkZDNmZTBlZWQ1YzRiMmZiMGM0Nzg2MDY2MmNiNjNlL3RhYmxlcmFuZ2U6NGRkM2ZlMGVlZDVjNGIyZmIwYzQ3ODYwNjYyY2I2M2VfMy0yLTEtMS01ODUzNw_b21bd95e-eb7b-4ad3-a785-d5d3dbb9a08e"
      unitRef="usd">32800000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjRkZDNmZTBlZWQ1YzRiMmZiMGM0Nzg2MDY2MmNiNjNlL3RhYmxlcmFuZ2U6NGRkM2ZlMGVlZDVjNGIyZmIwYzQ3ODYwNjYyY2I2M2VfNC0yLTEtMS01ODUzNw_0ceb8e13-c39d-4e53-914f-7959e95413c7"
      unitRef="usd">30200000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjRkZDNmZTBlZWQ1YzRiMmZiMGM0Nzg2MDY2MmNiNjNlL3RhYmxlcmFuZ2U6NGRkM2ZlMGVlZDVjNGIyZmIwYzQ3ODYwNjYyY2I2M2VfNS0yLTEtMS01ODUzNw_a4f6fe56-ca33-47b9-b29c-b53e60d73555"
      unitRef="usd">26600000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjRkZDNmZTBlZWQ1YzRiMmZiMGM0Nzg2MDY2MmNiNjNlL3RhYmxlcmFuZ2U6NGRkM2ZlMGVlZDVjNGIyZmIwYzQ3ODYwNjYyY2I2M2VfNi0yLTEtMS01ODUzNw_73012021-aa7f-46d5-834d-3ea90f311290"
      unitRef="usd">115800000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjRkZDNmZTBlZWQ1YzRiMmZiMGM0Nzg2MDY2MmNiNjNlL3RhYmxlcmFuZ2U6NGRkM2ZlMGVlZDVjNGIyZmIwYzQ3ODYwNjYyY2I2M2VfNy0yLTEtMS01ODUzNw_8709d745-f0d5-47dd-afb5-ad6be56503ae"
      unitRef="usd">284200000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjRkZDNmZTBlZWQ1YzRiMmZiMGM0Nzg2MDY2MmNiNjNlL3RhYmxlcmFuZ2U6NGRkM2ZlMGVlZDVjNGIyZmIwYzQ3ODYwNjYyY2I2M2VfOC0yLTEtMS01ODUzNw_c5777bbd-34c3-4f7f-9266-eaa38fc9bdf6"
      unitRef="usd">43200000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF85Ny9mcmFnOjhiYjA4NzMxNjU3YTQ3NDhiNGYxMmRmODc5YzI5NzM1L3RhYmxlOjRkZDNmZTBlZWQ1YzRiMmZiMGM0Nzg2MDY2MmNiNjNlL3RhYmxlcmFuZ2U6NGRkM2ZlMGVlZDVjNGIyZmIwYzQ3ODYwNjYyY2I2M2VfOS0yLTEtMS01ODUzNw_de9579d6-3fbb-486c-af72-3370b60b5f31"
      unitRef="usd">241000000.0</us-gaap:OperatingLeaseLiability>
    <coo:BusinessCombinationAndAssetAcquisitionTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzkzOTA_cfc21157-eac1-4604-8abf-f17cf08ccc09">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Note 3. Acquisitions and Joint Venture&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The following is a summary of the allocation of the total purchase consideration for business and asset acquisitions that the Company completed during fiscal 2022, 2021, and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.190%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.190%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.193%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;178.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;In-Process Research &amp;amp; Development (IPR&amp;amp;D)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;20.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;729.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;55.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total identifiable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;786.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;208.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;20.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,184.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;91.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net tangible liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(286.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(10.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(39.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Total closing purchase price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,683.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;249.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;35.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;All acquisitions were funded by cash generated from operations or facility borrowings. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;For business acquisitions, the Company recorded tangible and intangible assets acquired and liabilities assumed at their fair values as of the applicable date of acquisition. For asset acquisitions, the Company recorded tangible and intangible assets acquired and liabilities assumed at their estimated and relative fair values as of the applicable date of acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company believes these acquisitions strengthen CooperSurgical's and CooperVision's businesses through the addition of new distributors or complementary products and services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Fiscal Year 2022&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;On May 31, 2022, CooperVision completed the acquisition of a privately-held Denmark-based contact lens distributor focusing on orthokeratology and scleral contact lenses. This acquisition expands CooperVision's ortho-k eye care portfolio in the Nordic market.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;On April 6, 2022, CooperSurgical completed the acquisition of a private cryopreservation services company that specializes in cryogenic services. The purchase price allocation is preliminary, and the Company is in the process of finalizing information primarily related to the effect on taxes and the corresponding impact on goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:110%"&gt;Refer to "Fiscal Year 2021" below for details on formation of a joint venture with Essilor International and related activities that occurred in fiscal year 2022 following the acquisition of SightGlass Vision, Inc. (SGV) in fiscal year 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;On April 6, 2022, CooperSurgical entered into an asset purchase agreement to acquire Cook Medical's Reproductive Health business, a manufacturer of minimally invasive medical devices focused on the fertility, obstetrics and gynecology markets. The aggregate consideration is $875.0&#160;million in cash, with $675.0&#160;million payable at the closing and the remaining $200.0&#160;million payable in $50.0&#160;million installments following each of the first, second, third and fourth anniversaries of the closing. The transaction is subject to customary closing conditions, such as receipt of required regulatory approvals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:112%"&gt;Generate Life Sciences&#xae;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;On December 17, 2021, CooperSurgical completed the acquisition of 100% of the equity interests in Generate Life Sciences (Generate), a privately held leading provider of donor egg and sperm for fertility treatments, fertility cryopreservation services and newborn stem cell storage (cord blood &amp;amp; cord tissue), and paid an aggregate purchase consideration of approximately $1.663&#160;billion, reflecting working capital, and other adjustments. The cash consideration was funded through a combination of $1.5&#160;billion in proceeds from the issuance of a senior unsecured term loan and available cash on hand.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;The Company has accounted for the acquisition of Generate as a business combination, in accordance with ASC Topic 805, Business Combinations. The following table summarizes the preliminary fair values of assets acquired and liabilities assumed as of the acquisition date:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.335%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.465%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:107%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;58.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Trade accounts receivable, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;18.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Prepaid expense and other current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;33.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;113.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;42.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,177.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;718.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;54.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Other assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;Total assets acquired&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;2,128.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Accounts payable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Employee compensation and benefits&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;12.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;68.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;105.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;147.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Deferred revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;192.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;465.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%"&gt;Total purchase price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;1,663.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;The Company is in the process of finalizing purchase accounting information primarily related to deferred tax adjustments and the corresponding impact on goodwill. The Company recorded measurement period adjustments of $115.3&#160;million to goodwill in fiscal 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;Deferred revenue was recognized in accordance with ASC Topic 606, Revenue from Contracts with Customers, as a result of the adoption of ASU 2021-08. See Note 1. Organization and Significant Accounting Policies for additional information. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company currently estimates that customer relationships will be amortized over 20 years and trademarks will be amortized over 15 years. Goodwill is primarily attributable to assembled workforce and expected synergies to be achieved. The goodwill recognized is not deductible for tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The transaction costs associated with the acquisition consisted primarily of legal, regulatory and financial advisory fees, which were expensed as incurred as selling, general and administrative expense.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Generate's revenue and net income for the period from the acquisition date to October 31, 2022, were &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;$249.5&#160;million and $27.8&#160;million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;, respectively. The following unaudited pro forma information summarizes the combined results of operations of the Company and Generate as if the acquisition had been completed at the beginning of the Company&#x2019;s fiscal 2021:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.318%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.220%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.050%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.425%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:107%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:107%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;3,344.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;3,183.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;370.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;2,959.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The unaudited pro forma information for fiscal 2022 and 2021 was calculated after applying the Company's accounting policies and the impact of acquisition date fair value adjustments. The adjustments primarily include increased amortization for the fair value of acquired intangible assets, increased depreciation for the fair value of acquired property, plant, and equipment, &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;increased revenue as a result of the ASU 2021-08 deferred revenue adjustments, decreased interest expense as a result of the reversal of Generate's historical interest expense partially offset by additional interest expense on the debt obtained to finance the transaction.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The pro forma information does not reflect the effect of costs or synergies that would have been expected to result from the integration of the acquisition. The pro forma information does not purport to be indicative of the results of operations that actually would have resulted had the acquisition occurred at the beginning of fiscal 2021, or of future results of the consolidated entities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Subsequent Event&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;On November 1, 2022, subsequent to the fiscal year ended October 31, 2022, CooperVision closed an Agreement and Plan of Merger (the &#x201c;Merger Agreement&#x201d;) to acquire a U.S. based privately held leading expert in specialty contact lenses for both normal and irregular corneal conditions. The Company is in the process of finalizing purchase accounting information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Fiscal Year 2021&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;On May 3, 2021, CooperSurgical completed the acquisition of a privately-held medical device company that develops single-use illumin&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;ating medical devices.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;On April 26, 2021, CooperVision completed the acquisition of a privately-held UK contact lens manufacturer focusing on specialty contact lenses. This acquisition expands CooperVision&#x2019;s specialty eye care portfolio and accelerates its development of myopia management solutions in the UK.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;On March 1, 2021, CooperSurgical completed the acquisition of a privately-held medical device company that designed and developed an innovative obstetric product for use in urgent obstetrics to reduce risks associated with childbirth.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;On February 1, 2021, CooperSurgical acquired all of the remaining equity interests of a privately-held medical device company that developed the Mara&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt; Water Vapor Ablation System, which is used for endometrial ablation. The Company accounted for this acquisition as an asset acquisition, whereby the Company allocated the total cost of the acquisition to the net assets acquired on the basis of their estimated relative fair values on the acquisition date with no goodwill recognized. The primary asset acquired in this asset acquisition is Technology.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;On January 19, 2021, CooperVision acquired all of the remaining equity interests of SGV, a privately-held medical device company that developed spectacle lenses for myopia management. The transaction included potential payments of future consideration that were contingent upon the achievement of the regulatory approval milestone (the regulatory approval payment) and the acquired business reaching certain revenue thresholds over a specified period (the revenue payments). The undiscounted range of the contingent consideration was zero to $139.1&#160;million payable to the other former equity interest owners.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The fair value of the regulatory approval payment was determined using an option pricing framework based on the expected payment under the contractual terms and the estimates of the probability of achieving the regulatory approval. The fair value of the revenue payments was determined using a Monte Carlo simulation based on the revenue projections and the expected payment for each simulation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;In March 2022, the entities amended the terms of the contingent consideration, which resulted in CooperVision paying $42.9&#160;million to the former equity interest owners in exchange for the elimination of the revenue payments. CooperVision recognized a net gain of $12.2&#160;million during fiscal 2022. As of October 31, 2022, the remaining contingent liability related to regulatory approval payment was $31.8&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;In March 2022, CooperVision and Essilor International SAS (Essilor) entered into a Contribution Agreement and a Stock Purchase Agreement under which Essilor paid CooperVision $52.1&#160;million in exchange for a 50% interest in SGV and a proportionate share of certain revenue-based milestone payments related to the January 2021 acquisition of SGV by CooperVision. As part of these agreements, each party contributed their interest in SGV and $10&#160;million in cash to form a new joint venture. CooperVision then remeasured the fair value of its retained equity investment in the joint venture at $90.0&#160;million which resulted in a $56.9&#160;million gain in Other (income) expense on deconsolidation of SGV. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The fair value of the joint venture was determined using the income valuation approach. Under the income approach, we used a discounted cash flow model (&#x201c;DCF&#x201d;) in which cash flows anticipated over several periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate expected rate of return. The discount rate used for cash flows reflects capital market conditions and the specific risks associated with the business. This valuation approaches is considered a Level 3 fair value measurement. Fair value determination requires complex assumptions and judgment by management in projecting future operating results, selecting guideline companies for comparisons, determining appropriate &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;market value multiples, selecting the discount rate to measure the risks inherent in the future cash flows. Any material changes in key assumptions, including failure to meet business plans, deterioration in the financial market, an increase in interest rate or an increase in the cost of equity financing by market participants within the industry or other unanticipated events and circumstances, may affect such estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;On December 31, 2020, CooperSurgical completed the acquisition of a privately-held in vitro fertilization (IVF) cryostorage software solutions company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The pro forma results of operations of these acquisitions have not been presented because the effect of the business combinations described above was not material to the consolidated results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Fiscal Year 2020&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;On August 7, 2020, CooperVision completed the acquisition of a privately-held U.S contact lens manufacturer focusing on ortho-k lenses. This acquisition expands CooperVision&#x2019;s specialty eye care portfolio and its leadership in addressing the increasing severity and prevalence of myopia.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;On December 13, 2019, CooperSurgical completed the acquisition of a privately-held distributor of IVF medical devices and systems.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The pro forma results of operations of these acquisitions have not been presented because the effect of the business combinations described above was not material to the consolidated results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Contingent Consideration&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Certain of the Company&#x2019;s business combinations involve potential payments of future consideration that are contingent upon the achievement of regulatory milestones and/or the acquired business reaching certain revenue thresholds. A liability is recorded for the estimated fair value of the contingent consideration on the acquisition date. The fair value of the contingent consideration is remeasured at each reporting period, and the change in fair value is recognized in selling, general and administrative expense in the Consolidated Statements of Income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the beginning and ending balances of contingent consideration:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.898%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;97.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Purchase price contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;31.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(55.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzQtMC0xLTEtNTg1Mzc_9604cf56-7a6c-46d2-bdf5-d8f031e83daf"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzQtMC0xLTEtNTg1Mzc_b92a1fd2-f912-44aa-9c7e-af89ec70cb06"&gt;Change in fair value&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(10.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;66.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;33.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;97.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</coo:BusinessCombinationAndAssetAcquisitionTextBlock>
    <coo:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedAndAssetAcquisitionsTableTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzkzOTE_02733cda-f0d6-43fe-93e3-6fbb0520c3ca">&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The following is a summary of the allocation of the total purchase consideration for business and asset acquisitions that the Company completed during fiscal 2022, 2021, and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.190%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.190%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.193%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;178.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;In-Process Research &amp;amp; Development (IPR&amp;amp;D)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;20.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;729.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;55.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total identifiable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;786.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;208.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;20.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,184.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;91.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net tangible liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(286.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(10.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(39.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Total closing purchase price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,683.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;249.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;35.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</coo:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedAndAssetAcquisitionsTableTextBlock>
    <coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i4755ba4225344dd7b4f9fae0941a7939_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzEtMS0xLTEtNTg1Mzc_7900e262-2467-4baa-ac1c-c0ecd75c4de0"
      unitRef="usd">1900000</coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i4490227610e34141bead62dd395b0373_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzEtMy0xLTEtNTg1Mzc_6bdd99e8-3af4-480d-a993-21775215d4b3"
      unitRef="usd">178600000</coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i0f75554f20cb46aca33f75fa5f6502ee_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzEtNS0xLTEtNTg1Mzc_d30c2a64-5441-4b27-a81d-de1feb4f19e3"
      unitRef="usd">0</coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ia9b719bd522e4ee9954e7e380e5d3eeb_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzItMS0xLTEtNTg1Mzc_730c1105-ad18-45ac-8e20-24d30e0bf7e5"
      unitRef="usd">0</coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i942ea2bc8344447e8693e560ce6e340b_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzItMy0xLTEtNTg1Mzc_d897b762-cbf0-4a12-a546-d625273a1f31"
      unitRef="usd">20000000.0</coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i907460a095fa4821a0921af76f91e5e4_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzItNS0xLTEtNTg1Mzc_53097561-ea7b-4e32-97e4-10677b80289f"
      unitRef="usd">0</coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ibf1a11a6c31f47a18aa6688a9b14bd5b_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzMtMS0xLTEtNTg1Mzc_d56f0345-c344-4228-a3e5-6451ead5a6b9"
      unitRef="usd">729200000</coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i226050fcb98849a48ca2d0868ba5c7bc_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzMtMy0xLTEtNTg1Mzc_82d018f1-f805-4c7e-9591-1cbe814b489a"
      unitRef="usd">7500000</coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i76bc41d306494128a518ecbb65cf02e7_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzMtNS0xLTEtNTg1Mzc_40107cd0-ab84-49b4-bbfc-871643e4cfc4"
      unitRef="usd">11400000</coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i6adfb3a01e034e82af78c7dad7558f19_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzQtMS0xLTEtNTg1Mzc_44f6c9e6-7911-4091-927a-16f801087bb5"
      unitRef="usd">55400000</coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i7f59291a9d824a74b48fc9ac4fbaead3_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzQtMy0xLTEtNTg1Mzc_6cbc55f0-8ecb-4d4c-a507-594c8d000d75"
      unitRef="usd">1300000</coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i7f5ad20d5b9a49469f369636c87ebb17_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzQtNS0xLTEtNTg1Mzc_ae61cefd-506f-4f4b-9373-ec352b9e01dd"
      unitRef="usd">5100000</coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i3f19b0d477094c1d871e211e7657ece7_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzUtMS0xLTEtNTg1Mzc_291ef362-4bc7-4011-be7d-82e460203078"
      unitRef="usd">0</coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ieba1d7a126cf491983e2cc68fca1e7ab_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzUtMy0xLTEtNTg1Mzc_e30dd4a1-48d0-42c5-8650-be7dd916d61b"
      unitRef="usd">600000</coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i94797e6c57ca4c538683063a5cffce19_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzUtNS0xLTEtNTg1Mzc_1a95ed9d-433e-4bef-9784-3627040264d9"
      unitRef="usd">3900000</coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i0a09f770943a476f971ff4bc25761545_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzYtMS0xLTEtNTg1Mzc_982ac9bc-7ae7-4000-8ac0-69b4ce8f57ec"
      unitRef="usd">786500000</coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i8955c25df4054801abf90c55eec9954c_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzYtMy0xLTEtNTg1Mzc_0ea9a3c2-1f85-42fa-9956-5c3023378ce3"
      unitRef="usd">208000000.0</coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="iad97efcffb85427888b5504029d82982_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzYtNS0xLTEtNTg1Mzc_361b6537-aa34-4c9e-90cd-a94748f38ac3"
      unitRef="usd">20400000</coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:Goodwill
      contextRef="i0a09f770943a476f971ff4bc25761545_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzgtMS0xLTEtNTg1Mzc_89f85d01-f1e4-4c8e-b942-fc470a5e1351"
      unitRef="usd">1184800000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i8955c25df4054801abf90c55eec9954c_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzgtMy0xLTEtNTg1Mzc_addc39be-c244-4d9e-b386-10b9a64c51aa"
      unitRef="usd">91600000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iad97efcffb85427888b5504029d82982_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzgtNS0xLTEtNTg1Mzc_4fe1b3c3-88d1-4dec-979a-6ba9a4bf5400"
      unitRef="usd">15300000</us-gaap:Goodwill>
    <coo:BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet
      contextRef="i0a09f770943a476f971ff4bc25761545_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzktMS0xLTEtNTg1Mzc_816af264-de64-4737-877b-9ca724250ad9"
      unitRef="usd">-286500000</coo:BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet>
    <coo:BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet
      contextRef="i8955c25df4054801abf90c55eec9954c_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzktMy0xLTEtNTg1Mzc_0d39e9a3-7eb3-4c54-8914-dca4a7a40805"
      unitRef="usd">-10800000</coo:BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet>
    <coo:BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet
      contextRef="iad97efcffb85427888b5504029d82982_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzktNS0xLTEtNTg1Mzc_a8669371-599e-4469-9c46-92a332f594a3"
      unitRef="usd">-300000</coo:BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet>
    <coo:BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability
      contextRef="i0a09f770943a476f971ff4bc25761545_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzEwLTEtMS0xLTU4NTM3_0d264b86-66a0-45aa-9590-f84e6cc19f5a"
      unitRef="usd">1500000</coo:BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability>
    <coo:BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability
      contextRef="i8955c25df4054801abf90c55eec9954c_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzEwLTMtMS0xLTU4NTM3_6951684a-af2b-4864-b3b5-97395c7bdd09"
      unitRef="usd">39100000</coo:BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability>
    <coo:BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability
      contextRef="iad97efcffb85427888b5504029d82982_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzEwLTUtMS0xLTU4NTM3_007fb6ab-3ee7-4b7c-80e8-261abab7e300"
      unitRef="usd">0</coo:BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability>
    <coo:BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i0a09f770943a476f971ff4bc25761545_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzExLTEtMS0xLTU4NTM3_a2046389-a033-4288-8851-fe278e97b28c"
      unitRef="usd">1683300000</coo:BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <coo:BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i8955c25df4054801abf90c55eec9954c_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzExLTMtMS0xLTU4NTM3_b2fd4a90-a049-4d7a-aedc-9a9ee35979b8"
      unitRef="usd">249700000</coo:BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <coo:BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="iad97efcffb85427888b5504029d82982_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTpmNDYyOTJmNjYyYmI0ZDJkYTk3ODE1ODg2NWI1NzgxYy90YWJsZXJhbmdlOmY0NjI5MmY2NjJiYjRkMmRhOTc4MTU4ODY1YjU3ODFjXzExLTUtMS0xLTU4NTM3_017f799d-fcef-4490-8e66-437c1377f8ba"
      unitRef="usd">35400000</coo:BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i12e4f0e0cd4a46a0bf59c1a45e99906c_D20221101-20230131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMjI1Njg_070f88fc-fb7f-4bd9-b12b-b237cbf8f5ab"
      unitRef="usd">875000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i12e4f0e0cd4a46a0bf59c1a45e99906c_D20221101-20230131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMjI1ODQ_6026eb66-bda6-4961-bb87-9d09d521a0ef"
      unitRef="usd">675000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="i12e4f0e0cd4a46a0bf59c1a45e99906c_D20221101-20230131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMjI2MDA_0b790353-75e1-4966-aac9-4d6ef644e639"
      unitRef="usd">200000000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="ic10ee393b7e044b093750ebeec1f6c8a_D20221101-20230131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMjUxMjc_160b8d12-b4e5-46f9-ac7c-79aaaccfdf29"
      unitRef="usd">50000000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="if7818a8cacc84e89aa1d06e47767b0bc_D20221101-20230131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMjUxMjc_68f26dc5-ee29-4965-8f68-1f9608a41797"
      unitRef="usd">50000000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="i7fec09130d504bee8c893a02191e8224_D20221101-20230131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMjUxMjc_9b29ed67-108b-4170-9aca-e227e6f34c97"
      unitRef="usd">50000000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="i6b34bc1e1b3d46e09f4bc621ba4b91f4_D20221101-20230131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMjUxMjc_e3b559d1-ba36-465f-b174-c6382fd440e6"
      unitRef="usd">50000000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMjUxMjE_c0ee469a-e12f-4fb4-8734-60e5cb968abf"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ia9670e8e6c214908bb980ca8b9163492_D20211217-20211217"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMjI2MTc_401e261a-3c82-4e00-aa15-c924174d6bb1"
      unitRef="usd">1663000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i3f3295cb8a9341809bbb733c539b6249_D20211217-20211217"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMjI2MzM_0c4db9c5-e376-4459-bad1-cc849233c24b"
      unitRef="usd">1500000000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzQ5NDc4MDIzOTMzNzU_c2c7c746-e3d0-44fe-a65d-865593e23f4e">The following table summarizes the preliminary fair values of assets acquired and liabilities assumed as of the acquisition date:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.335%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.465%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:107%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;58.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Trade accounts receivable, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;18.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Prepaid expense and other current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;33.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;113.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;42.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,177.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;718.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;54.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Other assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;Total assets acquired&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;2,128.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Accounts payable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Employee compensation and benefits&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;12.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;68.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;105.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;147.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Deferred revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;192.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;465.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%"&gt;Total purchase price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;1,663.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzItMS0xLTEtNzcxNzQ_b2fcdf25-bd4c-489b-8311-93530b435012"
      unitRef="usd">58600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzMtMS0xLTEtNzcxNzQ_c2065bbd-bbc3-448f-b6c0-63157a37dc2c"
      unitRef="usd">18100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzQtMS0xLTEtNzcxNzQ_038b540c-6be7-47e5-9f92-57ce4873363d"
      unitRef="usd">3300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzUtMS0xLTEtNzcxNzQ_c6aefc04-625a-46c7-a689-df55fb9d806e"
      unitRef="usd">33500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
      contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzYtMS0xLTEtNzcxNzQ_648751ac-8d1a-4b78-93d6-6664a00c2794"
      unitRef="usd">113500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzctMS0xLTEtNzcxNzQ_d7bddd7d-11c1-4a18-a487-ec4872495048"
      unitRef="usd">42600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:Goodwill
      contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzktMS0xLTEtNzcxNzQ_e4ebb135-358d-462b-b387-858fc297d3af"
      unitRef="usd">1177300000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i7d0f2b3e11b74394ad583fa260d2434b_I20211217"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzEwLTEtMS0xLTc3MTc0_bb6f1c15-1fb3-460d-863e-40f9114e89c7"
      unitRef="usd">718300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="iefe968cac09746bc97e9dc95581ecbbd_I20211217"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzExLTEtMS0xLTc3MTc0_cfd40a85-b11f-4a34-97e5-457045ff6f2a"
      unitRef="usd">54900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzEzLTEtMS0xLTc3MTc0_deb9d979-42ad-41b9-ab65-9a8d92198be7"
      unitRef="usd">21500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzE0LTEtMS0xLTc3MTc0_0c3f9cc8-befb-4762-a30f-c7dda52442fd"
      unitRef="usd">2128100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzE3LTEtMS0xLTc3MTk4_b56dce8f-2caa-4c06-856e-7ef252363f7b"
      unitRef="usd">12600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <coo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesEmployeeRelatedLiabilities
      contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzE4LTEtMS0xLTc3MTk4_2c2c011f-6600-4098-bd97-650c9b26c579"
      unitRef="usd">12300000</coo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesEmployeeRelatedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzIwLTEtMS0xLTc3MTk4_0a552122-a961-48db-a614-ebec66b06c1c"
      unitRef="usd">68000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzIxLTEtMS0xLTc3MTk4_e955b0eb-f9f7-459e-8267-6b0f6e9488f4"
      unitRef="usd">12400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzIyLTEtMS0xLTc3MTk4_0fb4a7b8-967b-40d3-87b2-3659a1a0c998"
      unitRef="usd">105300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzIzLTEtMS0xLTc3MTk4_0e73c8e7-bfe9-4b6b-bcd4-d51000131428"
      unitRef="usd">147300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <coo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability
      contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzI0LTEtMS0xLTc3MTk4_910fd79a-bc34-4904-b1dc-92ef309fffa9"
      unitRef="usd">16600000</coo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability>
    <coo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredRevenue
      contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzI1LTEtMS0xLTc3MTk4_0eb39bf5-16fa-4d3e-9122-c83e5756253a"
      unitRef="usd">192200000</coo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredRevenue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzI4LTEtMS0xLTEwMzM2NQ_e58dddac-e9db-4f78-b3c0-a69b30f0fcb9"
      unitRef="usd">3600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzI3LTEtMS0xLTc3MTk4_1efe0dd0-1d49-4814-b39f-d61cd08d5009"
      unitRef="usd">465000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="if6bd5c970b0a4d2c9105bb367ec69a91_I20211217"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo5NDlmOWRmMGFiMWQ0NzcxYTI0YmM3ZjY2Y2Y3YjUxOS90YWJsZXJhbmdlOjk0OWY5ZGYwYWIxZDQ3NzFhMjRiYzdmNjZjZjdiNTE5XzI5LTEtMS0xLTc3MjA3_8c42dd77-2074-4cf9-8017-4c1619eae15e"
      unitRef="usd">1663100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i92626cab45db4a19a73bbd1ffef1f631_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMzc5NTM_85455ff7-43ea-4a68-b4c1-876773590415"
      unitRef="usd">115300000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i7e939ba156464566a17cd5b1cde99696_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzQ5NDc4MDIzOTM2NjE_0e58836c-311d-4957-905f-b2ed40c42cdd">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ic738218133bd484dabc79502af59dec3_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzQ5NDc4MDIzOTM2NjI_d48634dd-7eea-4e37-abf3-840c71dc5c78">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual
      contextRef="i92626cab45db4a19a73bbd1ffef1f631_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMzgwMzQ_8fc17235-8111-4d18-b216-167609d950ab"
      unitRef="usd">249500000</us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual
      contextRef="i92626cab45db4a19a73bbd1ffef1f631_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMzgwNTA_95dfa9da-a732-498e-a0ca-f53703c160ee"
      unitRef="usd">27800000</us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzQ5NDc4MDIzOTMzNzY_59be055b-166f-4e3f-b05b-406da0a92245">The following unaudited pro forma information summarizes the combined results of operations of the Company and Generate as if the acquisition had been completed at the beginning of the Company&#x2019;s fiscal 2021:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.318%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.220%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.050%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.425%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:107%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:107%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;3,344.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;3,183.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;370.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;2,959.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i92626cab45db4a19a73bbd1ffef1f631_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo1NmI5Y2JmYWRiZjM0MDM4ODgyZTFjMjg1MTQ2ODg0ZS90YWJsZXJhbmdlOjU2YjljYmZhZGJmMzQwMzg4ODJlMWMyODUxNDY4ODRlXzEtMi0xLTEtNzc0MzQ_1cb1c4cd-bd5f-4bab-9064-3bf953f0004e"
      unitRef="usd">3344300000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i3211f44a486b4d46a6d52e32c86746c2_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo1NmI5Y2JmYWRiZjM0MDM4ODgyZTFjMjg1MTQ2ODg0ZS90YWJsZXJhbmdlOjU2YjljYmZhZGJmMzQwMzg4ODJlMWMyODUxNDY4ODRlXzEtNC0xLTEtODU3OTU_dadb37df-6fed-4c30-93d6-a8d92ce9d21c"
      unitRef="usd">3183200000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i92626cab45db4a19a73bbd1ffef1f631_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo1NmI5Y2JmYWRiZjM0MDM4ODgyZTFjMjg1MTQ2ODg0ZS90YWJsZXJhbmdlOjU2YjljYmZhZGJmMzQwMzg4ODJlMWMyODUxNDY4ODRlXzItMi0xLTEtODU3OTg_fa59ec59-3f08-470d-b65b-d4438336385e"
      unitRef="usd">370700000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i3211f44a486b4d46a6d52e32c86746c2_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo1NmI5Y2JmYWRiZjM0MDM4ODgyZTFjMjg1MTQ2ODg0ZS90YWJsZXJhbmdlOjU2YjljYmZhZGJmMzQwMzg4ODJlMWMyODUxNDY4ODRlXzItNC0xLTEtODU3OTg_b6bc4238-928a-4c17-88f1-952452da08e1"
      unitRef="usd">2959800000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:Goodwill
      contextRef="i99d2bd9111f1487a8c7a382f53e39f32_I20210201"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzQ5NDc4MDI0MTg0MTU_9b92b5df-ef57-42f8-9037-64f85e972f37"
      unitRef="usd">0</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow
      contextRef="ic28dd8b3e9104664aab70f457f386c99_I20210119"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzQ5NDc4MDIzOTMzNzg_8acd52dd-295e-4ee2-a395-aa1fbe4cb028"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="ic28dd8b3e9104664aab70f457f386c99_I20210119"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMjUxODI_e4e27847-9fca-4ace-8148-0495b22c6301"
      unitRef="usd">139100000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <coo:BusinessCombinationPaymentToSettleContingentConsideration
      contextRef="i1cdebe36232d41e6a395e5517f2650a0_D20220301-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMjUyMTg_6a18b24c-d0be-45ba-8086-5a88e5a55872"
      unitRef="usd">42900000</coo:BusinessCombinationPaymentToSettleContingentConsideration>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss
      contextRef="ie874cf747ecd4b75835fe8d98669733f_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMjUyODU_68971140-6eb7-4edf-ac5b-8435a7f1eadc"
      unitRef="usd">12200000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i369447ccf1304ac393c75433b2da8574_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMjUzMTQ_b4bc60c2-e5e8-4728-bdcf-cfba3d69e1e8"
      unitRef="usd">31800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
      contextRef="ic12ec65ec7b84054a21489d444adacc6_D20220301-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzE2NDkyNjc1MDk5ODc_204e0a85-4c38-4ea0-afb5-94a6dff0736a"
      unitRef="usd">52100000</us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i0e049c53ca9040a0b53609d89212a62b_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzQ5NDc4MDIzOTMzODk_85edc28a-fd1b-4d5b-8788-0fa990ad0716"
      unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="ic12ec65ec7b84054a21489d444adacc6_D20220301-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzE2NDkyNjc1MDk5NzU_7ba80524-1c62-4542-88e4-20943f9a818c"
      unitRef="usd">10000000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i0e7cdc32ae2445039739777ea8b26dae_D20220301-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzE2NDkyNjc1MDk5NzU_fc2eeed7-c964-4d2a-bf78-e3f462aa45f7"
      unitRef="usd">10000000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i6a591cbb772f491288113182f88e2c51_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzQ5NDc4MDIzOTMzOTU_79c34028-fbaf-4a4f-aacb-102440a316cf"
      unitRef="usd">90000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="ic12ec65ec7b84054a21489d444adacc6_D20220301-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzI3NDg3NzkxMjUzODY_f7972be1-96d2-460a-aee3-97ae8df90a88"
      unitRef="usd">56900000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90ZXh0cmVnaW9uOmNkNGE3MjU3YTZmYjRhNzZhZTlhZjU2ZWRmYTk5NjBjXzkzOTM_55e91409-6b9c-4e62-84b6-0738bc755e59">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the beginning and ending balances of contingent consideration:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.898%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;97.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Purchase price contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;31.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(55.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzQtMC0xLTEtNTg1Mzc_9604cf56-7a6c-46d2-bdf5-d8f031e83daf"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzQtMC0xLTEtNTg1Mzc_b92a1fd2-f912-44aa-9c7e-af89ec70cb06"&gt;Change in fair value&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(10.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;66.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;33.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;97.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzEtMS0xLTEtNTg1Mzc_fe3bd0ff-63a3-4996-979e-50706a2b4b50"
      unitRef="usd">97400000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzEtMy0xLTEtNTg1Mzc_0fb7efa4-6ffa-4218-b250-be123141dd70"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzItMS0xLTEtNTg1Mzc_188cd24a-4ba4-404a-ad48-880ad89086ea"
      unitRef="usd">1500000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzItMy0xLTEtNTg1Mzc_d5e4c08e-0a92-47ab-bc06-7b6dccf5f990"
      unitRef="usd">31300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzMtMS0xLTEtNTg1Mzc_db4e48b7-af3d-4441-9a8b-bfbd2f0b1a72"
      unitRef="usd">55200000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzMtMy0xLTEtNTg1Mzc_17f6f00e-3077-474f-962a-4a71d403d3a0"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzQtMS0xLTEtNTg1Mzc_9d3cdde6-8dd7-4b93-abff-d8d7fa8bafbd"
      unitRef="usd">-10300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzQtMy0xLTEtNTg1Mzc_216ffafb-d6bb-4151-8d06-a234c1c82dd0"
      unitRef="usd">66100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzUtMS0xLTEtNTg1Mzc_54e17b90-5e6d-4f05-96be-dd599f1fbbf3"
      unitRef="usd">33400000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDAvZnJhZzpjZDRhNzI1N2E2ZmI0YTc2YWU5YWY1NmVkZmE5OTYwYy90YWJsZTo4MTNmZDNjMjI5NGE0ODdkOTJjZTc3NDI4NWVjNDM3NS90YWJsZXJhbmdlOjgxM2ZkM2MyMjk0YTQ4N2Q5MmNlNzc0Mjg1ZWM0Mzc1XzUtMy0xLTEtNTg1Mzc_45fd5416-d5aa-4db3-b9ab-8b75b1e4409f"
      unitRef="usd">97400000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90ZXh0cmVnaW9uOjFlZTViYzliZDZiMzRmMDliOWU0MDEyNjUyMDhjZjg4XzU0Mzg_569faf36-c3cf-449b-8465-055170ea7ad5">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Note 4. Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company has three reporting units: CooperVision and within the CooperSurgical segment, Office/Surgical and Fertility, reflecting the current way the Company manages its business. There was no impairment of goodwill in its reporting units in fiscal 2022, 2021, and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;CooperVision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;CooperSurgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,841.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;733.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,574.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,183.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,184.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(131.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(17.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(149.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,710.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,899.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,609.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Of the October&#160;31, 2022 goodwill balance, $214.1 million for CooperSurgical and $22.4 million for CooperVision is expected to be deductible for tax purposes. Of the October&#160;31, 2021 goodwill balance, $137.2&#160;million for CooperSurgical and $24.6&#160;million for CooperVision was expected to be deductible for tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Other Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.012%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;&#160;October 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:10pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Weighted Average Amortization Period (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Intangible assets with definite lives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;209.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;62.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;156.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Composite intangible asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,061.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;354.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,061.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;283.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;504.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;317.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;513.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;287.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,092.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;287.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;378.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;240.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;License and distribution rights and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;50.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;23.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;33.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;21.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,919.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,044.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,143.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;881.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Less: accumulated amortization and translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,044.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;881.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Intangible assets with definite lives, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,874.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,261.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Intangible assets with indefinite lives, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total other intangibles, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,885.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,271.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible assets with indefinite lives include technology and trademarks.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Balances include foreign currency translation adjustments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Intangible assets with definite lives are amortized over the estimated useful life of the assets. As of October&#160;31, 2022, the estimate of future amortization expenses for intangible assets with definite lives is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Fiscal years:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;183.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;179.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;169.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;162.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,180.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total remaining amortization for intangible assets with definite lives&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,874.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company considered the impact on its near and long-term forecasts from the general deterioration of economic and market conditions as a result of higher inflation, regional and global conflict, supply chain disruption, and the ongoing disruptions of the COVID-19 pandemic and determined that it was not more likely than not that the fair value of reporting units or relevant asset groups was below carrying amounts. Therefore, the Company determined that there was no impairment to either its definite-lived or indefinite-lived intangible assets during fiscal 2022, 2021 and 2020. There was an immaterial impairment charge related to our exit from the contact lens care business.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:NumberOfReportingUnits
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90ZXh0cmVnaW9uOjFlZTViYzliZDZiMzRmMDliOWU0MDEyNjUyMDhjZjg4XzkzNDU4NDg4NzAwMDU_4e0ea5f3-3875-4043-b9a7-9ec08b224f9c"
      unitRef="reporting_unit">3</us-gaap:NumberOfReportingUnits>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90ZXh0cmVnaW9uOjFlZTViYzliZDZiMzRmMDliOWU0MDEyNjUyMDhjZjg4XzkzNDU4NDg4NzAxODA_6188646a-efe4-4234-9ca7-00be7d732f2f"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90ZXh0cmVnaW9uOjFlZTViYzliZDZiMzRmMDliOWU0MDEyNjUyMDhjZjg4XzkzNDU4NDg4NzAxODA_682ee9fa-4b6e-4e4c-a1e5-3a6e3926722b"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90ZXh0cmVnaW9uOjFlZTViYzliZDZiMzRmMDliOWU0MDEyNjUyMDhjZjg4XzkzNDU4NDg4NzAxODA_b260c016-ae03-407e-81c6-6bf66f5d0ff0"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90ZXh0cmVnaW9uOjFlZTViYzliZDZiMzRmMDliOWU0MDEyNjUyMDhjZjg4XzU0MTk_08cf14c8-ac38-4373-8ac8-e7c6b06bd882">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;CooperVision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;CooperSurgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,841.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;733.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,574.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,183.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,184.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(131.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(17.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(149.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,710.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,899.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,609.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="idd2d0c2eeead43aab5ae86328389cce3_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTpiNzNlOTdkNDZmNGM0Y2EyYTM3N2MzMzc0YjMyNmI0Zi90YWJsZXJhbmdlOmI3M2U5N2Q0NmY0YzRjYTJhMzc3YzMzNzRiMzI2YjRmXzQtMS0xLTEtNTg1Mzc_0ddf0110-9a3f-4c3b-9606-f313ce739b84"
      unitRef="usd">1841000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7331fcd87a2241c0b7dfa12a4cdaa7b3_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTpiNzNlOTdkNDZmNGM0Y2EyYTM3N2MzMzc0YjMyNmI0Zi90YWJsZXJhbmdlOmI3M2U5N2Q0NmY0YzRjYTJhMzc3YzMzNzRiMzI2YjRmXzQtMy0xLTEtNTg1Mzc_81f18017-2b4c-49f9-9e48-52dfb35de24f"
      unitRef="usd">733000000.0</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTpiNzNlOTdkNDZmNGM0Y2EyYTM3N2MzMzc0YjMyNmI0Zi90YWJsZXJhbmdlOmI3M2U5N2Q0NmY0YzRjYTJhMzc3YzMzNzRiMzI2YjRmXzQtNS0xLTEtNTg1Mzc_03d5344b-887c-4e89-9a6c-a4dfcc4d99ef"
      unitRef="usd">2574000000</us-gaap:Goodwill>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="i144fdaeefe67410baf1810389c09a562_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTpiNzNlOTdkNDZmNGM0Y2EyYTM3N2MzMzc0YjMyNmI0Zi90YWJsZXJhbmdlOmI3M2U5N2Q0NmY0YzRjYTJhMzc3YzMzNzRiMzI2YjRmXzUtMS0xLTEtNTg1Mzc_2c6c36c6-a59d-4dcd-a03c-7c65a75a2044"
      unitRef="usd">900000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="iaeae5667d45b495b88915bbc72c256cd_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTpiNzNlOTdkNDZmNGM0Y2EyYTM3N2MzMzc0YjMyNmI0Zi90YWJsZXJhbmdlOmI3M2U5N2Q0NmY0YzRjYTJhMzc3YzMzNzRiMzI2YjRmXzUtMy0xLTEtNTg1Mzc_023401d2-0b4b-4691-9e51-1ec1f2bb6093"
      unitRef="usd">1183900000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTpiNzNlOTdkNDZmNGM0Y2EyYTM3N2MzMzc0YjMyNmI0Zi90YWJsZXJhbmdlOmI3M2U5N2Q0NmY0YzRjYTJhMzc3YzMzNzRiMzI2YjRmXzUtNS0xLTEtNTg1Mzc_2cbe4c61-ba53-433d-91eb-93b935b6dd7d"
      unitRef="usd">1184800000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i144fdaeefe67410baf1810389c09a562_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTpiNzNlOTdkNDZmNGM0Y2EyYTM3N2MzMzc0YjMyNmI0Zi90YWJsZXJhbmdlOmI3M2U5N2Q0NmY0YzRjYTJhMzc3YzMzNzRiMzI2YjRmXzctMS0xLTEtNTg1Mzc_e6914ec4-f738-4df4-972b-afa444ae7c90"
      unitRef="usd">-131600000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="iaeae5667d45b495b88915bbc72c256cd_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTpiNzNlOTdkNDZmNGM0Y2EyYTM3N2MzMzc0YjMyNmI0Zi90YWJsZXJhbmdlOmI3M2U5N2Q0NmY0YzRjYTJhMzc3YzMzNzRiMzI2YjRmXzctMy0xLTEtNTg1Mzc_aca283fb-8adb-4620-97da-9f3208fa7247"
      unitRef="usd">-17500000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTpiNzNlOTdkNDZmNGM0Y2EyYTM3N2MzMzc0YjMyNmI0Zi90YWJsZXJhbmdlOmI3M2U5N2Q0NmY0YzRjYTJhMzc3YzMzNzRiMzI2YjRmXzctNS0xLTEtNTg1Mzc_8c0d3445-8de4-47b3-9a98-589046884611"
      unitRef="usd">-149100000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i3421ee2f74cd428aa2c026d3ac5f1798_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTpiNzNlOTdkNDZmNGM0Y2EyYTM3N2MzMzc0YjMyNmI0Zi90YWJsZXJhbmdlOmI3M2U5N2Q0NmY0YzRjYTJhMzc3YzMzNzRiMzI2YjRmXzgtMS0xLTEtNTg1Mzc_9970a4af-a64e-47e5-bc04-82b47ddca015"
      unitRef="usd">1710300000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i445d23b2879040a09a5d53dc620f8b08_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTpiNzNlOTdkNDZmNGM0Y2EyYTM3N2MzMzc0YjMyNmI0Zi90YWJsZXJhbmdlOmI3M2U5N2Q0NmY0YzRjYTJhMzc3YzMzNzRiMzI2YjRmXzgtMy0xLTEtNTg1Mzc_1e619ab6-e190-41fc-999c-565ca491d400"
      unitRef="usd">1899400000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTpiNzNlOTdkNDZmNGM0Y2EyYTM3N2MzMzc0YjMyNmI0Zi90YWJsZXJhbmdlOmI3M2U5N2Q0NmY0YzRjYTJhMzc3YzMzNzRiMzI2YjRmXzgtNS0xLTEtNTg1Mzc_3444a1bc-fe80-43c1-80bd-9c9b6909622b"
      unitRef="usd">3609700000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i445d23b2879040a09a5d53dc620f8b08_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90ZXh0cmVnaW9uOjFlZTViYzliZDZiMzRmMDliOWU0MDEyNjUyMDhjZjg4Xzcy_fe7bff45-2da4-41b6-a157-65eeebeb8d3a"
      unitRef="usd">214100000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i3421ee2f74cd428aa2c026d3ac5f1798_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90ZXh0cmVnaW9uOjFlZTViYzliZDZiMzRmMDliOWU0MDEyNjUyMDhjZjg4XzEwNw_bd965af1-4cb2-4228-89e0-861fa9cad3c0"
      unitRef="usd">22400000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i7331fcd87a2241c0b7dfa12a4cdaa7b3_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90ZXh0cmVnaW9uOjFlZTViYzliZDZiMzRmMDliOWU0MDEyNjUyMDhjZjg4XzIyNA_6983e079-f809-41f7-b064-e00048ddad5d"
      unitRef="usd">137200000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="idd2d0c2eeead43aab5ae86328389cce3_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90ZXh0cmVnaW9uOjFlZTViYzliZDZiMzRmMDliOWU0MDEyNjUyMDhjZjg4XzI1MA_9358d99d-fd52-4e0e-94a5-e1ec8fed6314"
      unitRef="usd">24600000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90ZXh0cmVnaW9uOjFlZTViYzliZDZiMzRmMDliOWU0MDEyNjUyMDhjZjg4XzU0MTE_1a25e083-c9ec-4b9d-8229-1a835d829e5f">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Other Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.012%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;&#160;October 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:10pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Weighted Average Amortization Period (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Intangible assets with definite lives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;209.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;62.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;156.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Composite intangible asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,061.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;354.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,061.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;283.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;504.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;317.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;513.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;287.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,092.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;287.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;378.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;240.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;License and distribution rights and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;50.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;23.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;33.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;21.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,919.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,044.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,143.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;881.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Less: accumulated amortization and translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,044.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;881.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Intangible assets with definite lives, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,874.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,261.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Intangible assets with indefinite lives, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total other intangibles, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,885.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,271.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible assets with indefinite lives include technology and trademarks.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90ZXh0cmVnaW9uOjFlZTViYzliZDZiMzRmMDliOWU0MDEyNjUyMDhjZjg4XzU0Mjg_d6ee0b5b-a151-4e12-b728-ba9b016a128a">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Other Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.012%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;&#160;October 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:10pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Weighted Average Amortization Period (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Intangible assets with definite lives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;209.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;62.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;156.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Composite intangible asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,061.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;354.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,061.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;283.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;504.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;317.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;513.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;287.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,092.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;287.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;378.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;240.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;License and distribution rights and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;50.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;23.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;33.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;21.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,919.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,044.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,143.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;881.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Less: accumulated amortization and translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,044.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;881.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Intangible assets with definite lives, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,874.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,261.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Intangible assets with indefinite lives, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total other intangibles, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,885.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,271.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible assets with indefinite lives include technology and trademarks.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="icfbfa01dbda3465490aba1443bc5a27e_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzMtMS0xLTEtNTg1Mzc_905ef449-1017-4f57-9e52-72657a0c06f3"
      unitRef="usd">209600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="icfbfa01dbda3465490aba1443bc5a27e_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzMtMy0xLTEtNTg1Mzc_6cf1733f-2eaa-4c50-b531-405bfc0a6290"
      unitRef="usd">62400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iebeef7c0d08c42438b2be3731f602914_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzMtNS0xLTEtNTg1Mzc_bca31500-5470-4c81-b9e0-4c42e3c6a234"
      unitRef="usd">156700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iebeef7c0d08c42438b2be3731f602914_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzMtNy0xLTEtNTg1Mzc_529daefc-d71a-4641-ba63-70a837a31d1c"
      unitRef="usd">49100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i0c3cf741cce74b56b90505abfc3135d4_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzMtOS0xLTEtNTg1Mzc_1bff90c2-e9c6-4fd6-9336-6e00c17b866f">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i30ee62456f6841a38e22988758ba7ea5_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzQtMS0xLTEtNTg1Mzc_590004c2-11b1-4afe-ace9-d346fcd43565"
      unitRef="usd">1061900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i30ee62456f6841a38e22988758ba7ea5_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzQtMy0xLTEtNTg1Mzc_c9ed9151-103c-490a-96b4-172a994486b4"
      unitRef="usd">354000000.0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i407ff2a6ca46463ea28d8844c283b1d7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzQtNS0xLTEtNTg1Mzc_44af8063-6cc2-4e55-a29e-8ccc1a7c4ed6"
      unitRef="usd">1061800000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i407ff2a6ca46463ea28d8844c283b1d7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzQtNy0xLTEtNTg1Mzc_327e312e-5951-4e9d-8eda-9d1fe538c100"
      unitRef="usd">283200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i1d0efd8be16c45d2873b2c8fa83fee18_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzQtOS0xLTEtNTg1Mzc_2f8d4d34-b5bf-4290-a49a-47630da0dda2">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i77b415e656bc4ea68b948eb7f695456d_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzUtMS0xLTEtNTg1Mzc_dbfa9022-bf06-4f5c-8e23-c6c664c8e569"
      unitRef="usd">504100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i77b415e656bc4ea68b948eb7f695456d_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzUtMy0xLTEtNTg1Mzc_517cc929-6995-40f6-a5c5-b3bb5287da42"
      unitRef="usd">317500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1433809bee9a4008bf8d115c1d460826_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzUtNS0xLTEtNTg1Mzc_d49808d9-bbd2-46f1-9b15-08e39ca33cfb"
      unitRef="usd">513000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1433809bee9a4008bf8d115c1d460826_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzUtNy0xLTEtNTg1Mzc_43de74d5-2dd5-43d7-ac47-0cb29b23deb2"
      unitRef="usd">287900000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="id2afa4e343dd4305a9d4850614554f7e_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzUtOS0xLTEtNTg1Mzc_5263a8cd-2941-4d8f-a044-df9af29fbdbb">P12Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i115d9ee442ae4c56a41f07744f19fbc4_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzYtMS0xLTEtNTg1Mzc_b9cd33a3-2c40-4b8d-8aa0-4e090dd771f4"
      unitRef="usd">1092700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i115d9ee442ae4c56a41f07744f19fbc4_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzYtMy0xLTEtNTg1Mzc_4987a1e0-c035-4517-8df4-aa0052ae8741"
      unitRef="usd">287000000.0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i08f13a8230854e86893bff6282ab94ac_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzYtNS0xLTEtNTg1Mzc_f6999412-ccbc-4dc1-872d-3c9d4fec91e2"
      unitRef="usd">378400000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i08f13a8230854e86893bff6282ab94ac_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzYtNy0xLTEtNTg1Mzc_acece41d-81d1-4313-bd8f-aa9a38f8d912"
      unitRef="usd">240100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i878f78528c3f40cd99f777c89d5d2e00_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzYtOS0xLTEtNTg1Mzc_dc0c9520-49ef-464f-9e3b-86688caabc62">P19Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia510700702624ebfb92ea3d3b9bb1934_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzctMS0xLTEtNTg1Mzc_f61f748c-c99c-47c1-a31c-3b4fc354b8bd"
      unitRef="usd">50700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia510700702624ebfb92ea3d3b9bb1934_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzctMy0xLTEtNTg1Mzc_636176fe-5d67-461c-b313-66c9a850d145"
      unitRef="usd">23800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0b16c8a519f143b9a35f452e86b54283_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzctNS0xLTEtNTg1Mzc_d1dd6849-a2b0-43ec-b6ec-95fa37c75e9b"
      unitRef="usd">33400000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0b16c8a519f143b9a35f452e86b54283_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzctNy0xLTEtNTg1Mzc_e8ce8d43-44cc-4930-b756-9516c58b47c8"
      unitRef="usd">21600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="iaf516f29728c49ea8d13657c5e377a8e_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzctOS0xLTEtNTg1Mzc_02d7e4d9-7101-4344-85d9-3234a9437c7e">P11Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzgtMS0xLTEtNTg1Mzc_1280e26f-91ea-48ec-b918-55a6b2f2a304"
      unitRef="usd">2919000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzgtMy0xLTEtNTg1Mzc_22822022-3327-43cc-9a92-fa627a2c7bbc"
      unitRef="usd">1044700000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzgtNS0xLTEtNTg1Mzc_06303774-a5ce-4a9f-8432-ea43312ee802"
      unitRef="usd">2143300000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzgtNy0xLTEtNTg1Mzc_5e8e1535-6bc7-4ca0-be6f-9f2bee557b0b"
      unitRef="usd">881900000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzgtOS0xLTEtNTg1Mzc_74560454-59ca-4cbb-a5fd-bce81c87d6e0">P16Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzktMS0xLTEtNTg1Mzc_22822022-3327-43cc-9a92-fa627a2c7bbc"
      unitRef="usd">1044700000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzktNS0xLTEtNTg1Mzc_5e8e1535-6bc7-4ca0-be6f-9f2bee557b0b"
      unitRef="usd">881900000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzEwLTEtMS0xLTU4NTM3_50448438-f315-45a0-bd65-1200e5a68bde"
      unitRef="usd">1874300000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzEwLTUtMS0xLTU4NTM3_b3656d28-2b14-4f90-9684-8d18dd9dc816"
      unitRef="usd">1261400000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzExLTEtMS0xLTU4NTM3_4993c5ec-9ca0-41c7-859a-35968b539d4f"
      unitRef="usd">10800000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzExLTUtMS0xLTU4NTM3_3ee7f101-1c1b-49f9-93dd-59b01b77a6c3"
      unitRef="usd">10100000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzEyLTEtMS0xLTU4NTM3_af55fce9-d220-43a8-903e-fd4c79a38ec4"
      unitRef="usd">1885100000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTo1YmY2MWUwMjI5MGQ0MGRjOGVkOTcxNjU2YWQ0ZDY3ZS90YWJsZXJhbmdlOjViZjYxZTAyMjkwZDQwZGM4ZWQ5NzE2NTZhZDRkNjdlXzEyLTUtMS0xLTU4NTM3_66403fdc-1f56-4e8f-88be-6f827898f2d1"
      unitRef="usd">1271500000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90ZXh0cmVnaW9uOjFlZTViYzliZDZiMzRmMDliOWU0MDEyNjUyMDhjZjg4XzU0MjA_1b4b2117-c1bf-40f4-a7ab-e628a93c72b0">As of October&#160;31, 2022, the estimate of future amortization expenses for intangible assets with definite lives is as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Fiscal years:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;183.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;179.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;169.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;162.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,180.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total remaining amortization for intangible assets with definite lives&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,874.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTplNTYxMmRhNjVmNjg0YzkxYWI0N2RhZjE2NTA3OTBmYS90YWJsZXJhbmdlOmU1NjEyZGE2NWY2ODRjOTFhYjQ3ZGFmMTY1MDc5MGZhXzEtMS0xLTEtNTg1Mzc_96a5dcf1-bcc0-49dc-aa2a-8892ef6a7ccb"
      unitRef="usd">183200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTplNTYxMmRhNjVmNjg0YzkxYWI0N2RhZjE2NTA3OTBmYS90YWJsZXJhbmdlOmU1NjEyZGE2NWY2ODRjOTFhYjQ3ZGFmMTY1MDc5MGZhXzItMS0xLTEtNTg1Mzc_24c14a7b-fd3c-46fd-80de-727f7b1e214c"
      unitRef="usd">179200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTplNTYxMmRhNjVmNjg0YzkxYWI0N2RhZjE2NTA3OTBmYS90YWJsZXJhbmdlOmU1NjEyZGE2NWY2ODRjOTFhYjQ3ZGFmMTY1MDc5MGZhXzMtMS0xLTEtNTg1Mzc_b9552af2-b744-4a5a-b723-c00ebf23574b"
      unitRef="usd">169300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTplNTYxMmRhNjVmNjg0YzkxYWI0N2RhZjE2NTA3OTBmYS90YWJsZXJhbmdlOmU1NjEyZGE2NWY2ODRjOTFhYjQ3ZGFmMTY1MDc5MGZhXzQtMS0xLTEtNTg1Mzc_1e579209-6da2-4fdb-afc0-e6e0fe0be663"
      unitRef="usd">162000000.0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <coo:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTplNTYxMmRhNjVmNjg0YzkxYWI0N2RhZjE2NTA3OTBmYS90YWJsZXJhbmdlOmU1NjEyZGE2NWY2ODRjOTFhYjQ3ZGFmMTY1MDc5MGZhXzUtMS0xLTEtNTg1Mzc_227f0c4b-92d7-4769-83a5-a3e66d689948"
      unitRef="usd">1180600000</coo:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90YWJsZTplNTYxMmRhNjVmNjg0YzkxYWI0N2RhZjE2NTA3OTBmYS90YWJsZXJhbmdlOmU1NjEyZGE2NWY2ODRjOTFhYjQ3ZGFmMTY1MDc5MGZhXzYtMS0xLTEtNTg1Mzc_98b295c2-fa42-476d-acba-241623f89499"
      unitRef="usd">1874300000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90ZXh0cmVnaW9uOjFlZTViYzliZDZiMzRmMDliOWU0MDEyNjUyMDhjZjg4XzUzMDA_2fbb094e-4baf-4e59-8bc9-9f5bbf3b0c56"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDMvZnJhZzoxZWU1YmM5YmQ2YjM0ZjA5YjllNDAxMjY1MjA4Y2Y4OC90ZXh0cmVnaW9uOjFlZTViYzliZDZiMzRmMDliOWU0MDEyNjUyMDhjZjg4XzUzMDA_a63d7f50-6096-4282-bf07-902c366f487a"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzc0ODk_6783866d-e6a2-4c19-b214-206f5e8584d1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Note 5. Financing Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company had outstanding debt as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.107%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.413%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Overdraft and other credit facilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;57.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;83.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Term loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;338.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt issuance cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Short-term debt, excluding financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;395.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;82.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzctMC0xLTEtODU4NTc_141e84ec-4e7b-4dbb-a1d9-b69da3b28fc9"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzctMC0xLTEtODU4NTc_47c29b41-9b44-43cc-a1c4-67a03e586316"&gt;Financing lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Short-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;412.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Revolving credit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;546.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Term loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,350.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;850.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt issuance cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Long-term debt, excluding financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,347.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,396.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzE2LTAtMS0xLTg1ODY1_1411df30-957e-4c30-8c9d-b44d0a42fc69"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzE2LTAtMS0xLTg1ODY1_b721c839-4714-4bc4-a058-6a751c018797"&gt;Financing lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,350.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,397.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,763.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,481.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;As of October&#160;31, 2022, the Company was in compliance with all debt covenants.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Term Loan Agreement on December 17, 2021&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;On December 17, 2021, the Company entered into a Term Loan Agreement (the 2021 Credit Agreement) by and among the Company, the lenders from time to time party thereto, and PNC Bank, National Association, as administrative agent. The 2021 Credit Agreement provides for a term loan facility (the 2021 Term Loan Facility) in an aggregate principal amount of $1.5&#160;billion, which, unless terminated earlier, matures on December 17, 2026. In addition, the Company has the ability from time to time to request an increase to the commitments under the 2021 Term Loan Facility or to establish a new term loan facility under the 2021 Credit Agreement in an aggregate principal amount not to exceed $1.125&#160;billion, upon prior written notice to the administrative agent and subject to the discretionary participation of the lenders funding such term loans and certain limitations set forth in the 2021 Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Amounts outstanding under the 2021 Term Loan Facility will bear interest, at the Company&#x2019;s option, at either (i) the alternate base rate, which is a rate per annum equal to the greatest of (a) the administrative agent&#x2019;s prime rate, (b) one-half of one percent in excess of the federal funds effective rate and (c) one percent in excess of the adjusted London interbank offered rate (&#x201c;LIBOR&#x201d;) for a one-month interest period on such day, or (ii) the adjusted LIBOR, plus, in each case, an applicable rate of, initially, zero basis points, in respect of base rate loans, and 75 basis points, in respect of adjusted LIBOR loans. Following a specified period after the closing date, the applicable rates will be determined quarterly by reference to a grid based upon the Company&#x2019;s ratio of consolidated net indebtedness to consolidated EBITDA, each as defined in the 2021 Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company may prepay loan balances from time to time, in whole or in part, without premium or penalty (other than any related breakage costs).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;On December 17, 2021, the Company borrowed $1.5&#160;billion under the 2021 Term Loan Facility and used the proceeds to fund the acquisition of Generate. Refer to Note 3. Acquisitions and Joint Venture for more details.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The interest rate on the 2021 Term Loan Facility was 4.44% at October&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The 2021 Credit Agreement contains customary restrictive covenants, as well as financial covenants that require the Company to maintain a certain Total Leverage Ratio and Interest Coverage Ratio, each as defined in the 2021 Credit Agreement, consistent with the 2020 Credit Agreement discussed below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Term Loan Agreement on November 2, 2021&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;On November 2, 2021, the Company entered into a 364-day, $840.0&#160;million, term loan agreement by and among the Company, the lenders party thereto and The Bank of Nova Scotia, as administrative agent, which matured subsequent to year end on November 1, 2022. The Company used part of the funds to partially repay outstanding borrowings under the 2020 Revolving Credit Facility and for general corporate purposes. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We repaid $502.0&#160;million during fiscal 2022. Amounts outstanding under the 2021 364-Day Term Loan Agreement will bear interest, at the Company&#x2019;s option, at either the alternate base rate, or the adjusted LIBOR (each as defined in the 2021 364-Day Term Loan Agreement), plus, in the case of adjusted LIBOR loans, an applicable rate of 60 basis points.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The 2021 364-Day Term Loan Agreement contains customary restrictive covenants, as well as financial covenants that require the Company to maintain a certain total leverage ratio and interest coverage ratio, each as defined in the 2021 364-Day Term Loan Agreement, consistent with the 2020 Credit Agreement discussed below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Revolving Credit and Term Loan Agreement on April 1, 2020&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;On April 1, 2020, the Company entered into a Revolving Credit and Term Loan Agreement (the 2020 Credit Agreement), among the Company, CooperVision International Holding Company, LP, CooperSurgical Netherlands B.V., CooperVision Holding Kft. the lenders from time to time party thereto, and KeyBank National Association, as administrative agent. The 2020 Credit Agreement provides for (a)&#160;a multicurrency revolving credit facility (the 2020 Revolving Credit Facility) in an aggregate principal amount of $1.29 billion and (b)&#160;a term loan facility (the 2020 Term Loan Facility) in an aggregate principal amount of $850.0 million, each of which, unless terminated earlier, mature on April 1, 2025. The Company used $850.0&#160;million under the 2020 Term Loan Facility and $445.0&#160;million under the 2020 Revolving Credit Facility to fully repay all borrowings outstanding under a previously existing term loan agreement and transfer all letters of credit and borrowings outstanding under a previously existing credit agreement to the 2020 Credit Agreement. The Company has an uncommitted option to increase the revolving credit facility or establish a new term loan in an aggregate amount up to $1.605&#160;billion.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;On October 30, 2020, the Company entered into Amendment No. 1 to the 2020 Credit Agreement, adding CooperVision International Limited as a revolving borrower and releasing certain borrowers in the 2020 Credit Agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"&gt;On December 17, 2021, the Company entered into Amendment No.2 to the 2020 Credit Agreement, modifying the 2020 Credit Agreement by, among other things, adding CooperSurgical Holdings Limited as a revolving borrower, releasing CooperVision Holding Kft as a borrower, and updating the benchmark replacement language in the 2020 Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%"&gt;The 2020 Credit Agreement will bear interest, at the Company&#x2019;s option, at either the base rate, or the adjusted LIBOR or adjusted foreign currency rate, plus, in each case, an applicable rate of between 0.00% and 0.50% in respect of base rate loans, and between 0.75% and 1.50% in respect of adjusted LIBOR or adjusted foreign currency rate loans, in each case in accordance with a pricing grid tied to the Total Leverage Ratio, as defined in the 2020 Credit Agreement. The Company may borrow, repay and re-borrow amounts available under the Revolving Credit Facility, subject to voluntary reduction of the revolving commitment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company pays an annual commitment fee that ranges from 0.10% to 0.20% of the unused portion of the 2020 Revolving Credit Facility based upon the Company&#x2019;s Total Leverage Ratio, as defined in the 2020 Credit Agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;At October&#160;31, 2022, the Company had $850.0 million outstanding under the 2020 Term Loan Facility and none outstanding under the 2020 Revolving Credit Facility. The interest rate on the 2020 Term Loan Facility was 4.13% at October&#160;31, 2022. The interest rate on the 2020 Revolving Credit Facility was 4.13% at October&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Payments on the outstanding long-term debt balance of $850.0&#160;million are due in the fiscal year ending October 31, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;European and Asian Pacific Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company maintains European credit facilities. The aggregate facility limit was $30.7 million and $35.8&#160;million at October&#160;31, 2022 and 2021, respectively. At October&#160;31, 2022, $12.3 million of the facilities was utilized and the weighted average interest rate on the outstanding balances was 2.46%. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company maintains Yen-denominated credit facilities in Japan. The aggregate facility limit was $73.0 million and $95.0&#160;million at October&#160;31, 2022 and 2021, respectively. At October&#160;31, 2022, $45.4 million of the combined facilities was utilized and the weighted average interest rate on the outstanding balances was 0.40%. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Each facility is supported by a continuing and unconditional guaranty.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzc0ODU_5dd48819-230b-47a0-8291-2402bafe63b6">&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company had outstanding debt as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.107%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.413%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Overdraft and other credit facilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;57.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;83.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Term loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;338.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt issuance cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Short-term debt, excluding financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;395.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;82.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzctMC0xLTEtODU4NTc_141e84ec-4e7b-4dbb-a1d9-b69da3b28fc9"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzctMC0xLTEtODU4NTc_47c29b41-9b44-43cc-a1c4-67a03e586316"&gt;Financing lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Short-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;412.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Revolving credit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;546.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Term loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,350.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;850.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt issuance cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Long-term debt, excluding financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,347.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,396.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzE2LTAtMS0xLTg1ODY1_1411df30-957e-4c30-8c9d-b44d0a42fc69"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzE2LTAtMS0xLTg1ODY1_b721c839-4714-4bc4-a058-6a751c018797"&gt;Financing lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,350.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,397.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,763.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,481.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:ShortTermBorrowings
      contextRef="ia4917c3481374f0a93818dc20a45502a_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzMtMS0xLTEtNTg1Mzc_2a39eccb-4d9e-4b3d-9f37-fd84eb6f38bb"
      unitRef="usd">57700000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i1b0fe802f23047fd86412c4b0a12e7f4_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzMtMy0xLTEtNTg1Mzc_5bb4f16b-caf0-4555-aa48-160e8fc47159"
      unitRef="usd">83000000.0</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i3ab931d901624913a0875c155dd2c744_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzQtMS0xLTEtNTg1Mzc_00df01ee-7d0a-4840-8321-6c4ed10a3b0b"
      unitRef="usd">338000000.0</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i57b61e00e7774e95a89c8142b3bf5838_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzQtMy0xLTEtNTg1Mzc_04bbf450-54f2-48eb-99c4-7069b1a42452"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:DeferredFinanceCostsCurrentNet
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzUtMS0xLTEtNTg1Mzc_adf107d8-ee31-4805-8a28-2a7896bb2a7c"
      unitRef="usd">0</us-gaap:DeferredFinanceCostsCurrentNet>
    <us-gaap:DeferredFinanceCostsCurrentNet
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzUtMy0xLTEtNTg1Mzc_01a14898-1a1d-4fa2-a9f1-c466328b1fce"
      unitRef="usd">100000</us-gaap:DeferredFinanceCostsCurrentNet>
    <coo:ShortTermDebtNetOfDebtIssuanceCosts
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzYtMS0xLTEtNTg1Mzc_c1154961-92b0-468b-8f4a-78354c545ab6"
      unitRef="usd">395700000</coo:ShortTermDebtNetOfDebtIssuanceCosts>
    <coo:ShortTermDebtNetOfDebtIssuanceCosts
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzYtMy0xLTEtNTg1Mzc_106a685b-8362-40eb-9c64-b7f7715d43c3"
      unitRef="usd">82900000</coo:ShortTermDebtNetOfDebtIssuanceCosts>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzctMS0xLTEtNzc3MTM_27bca237-7658-435a-8a78-83c18c740960"
      unitRef="usd">16900000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzctMy0xLTEtNzc3Mjc_e4234995-53da-4743-a3fa-9df987fb78ed"
      unitRef="usd">500000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:DebtCurrent
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzgtMS0xLTEtNzc3MzU_3bdcdcaa-08b1-46b6-a551-b1e10cd089cf"
      unitRef="usd">412600000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzgtMy0xLTEtNzc3NTc_52cd860b-23a7-49d3-8a48-319297b4f8a0"
      unitRef="usd">83400000</us-gaap:DebtCurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if9659d4a6cff4b4dbd9b2f26ba14ea06_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzgtMS0xLTEtNTg1Mzc_1080c160-0c84-4679-8941-44a0eb4909b7"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2fad6966df8143e8a4914f53e33375a2_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzgtMy0xLTEtNTg1Mzc_ec76343a-176e-4b9f-997e-9ca756c40e85"
      unitRef="usd">546100000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i55a407bf120641c6a3267ea45f9bc655_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzktMS0xLTEtNTg1Mzc_f652b0be-0511-4cf0-be3f-89a06f8c88e4"
      unitRef="usd">2350000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i0b694e0c04a748c58139e1321f99fd2a_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzktMy0xLTEtNTg1Mzc_0c50c724-b44b-43b9-8781-6cdc910ea50c"
      unitRef="usd">850000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i4c45cfe81e384f56bae429ccfb71c2ec_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzEwLTEtMS0xLTU4NTM3_134b1c02-6c34-4b6f-b146-973f1f51269c"
      unitRef="usd">200000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i18d4ac0f0b1a4888ac43f875e832794d_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzEwLTMtMS0xLTU4NTM3_c1db2229-c0f6-49aa-b0a5-1c7dbd54e614"
      unitRef="usd">200000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNoncurrentNet
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzExLTEtMS0xLTU4NTM3_45f660fe-54bd-418e-9286-8e2a324a0876"
      unitRef="usd">3100000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:DeferredFinanceCostsNoncurrentNet
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzExLTMtMS0xLTU4NTM3_e8172579-e821-415c-80d1-eb7c6b1f1001"
      unitRef="usd">200000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzEyLTEtMS0xLTU4NTM3_3a34019d-0c73-4371-8eac-fe94d5ec2bf8"
      unitRef="usd">2347100000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzEyLTMtMS0xLTU4NTM3_15280b6a-9d10-4720-9db8-8f61cb94b384"
      unitRef="usd">1396100000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzE2LTEtMS0xLTc3ODc3_5f0f7fea-c9b6-4e7a-8510-e376084b9576"
      unitRef="usd">3700000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzE2LTMtMS0xLTc3ODg1_0f18d536-1f72-401c-b8aa-11ae782eddca"
      unitRef="usd">1500000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzE3LTEtMS0xLTc3ODk2_ac06660c-bc79-43f9-9150-24802fd801e9"
      unitRef="usd">2350800000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzE3LTMtMS0xLTc3OTIy_c238faf0-2462-45d9-8cd7-c0777733f882"
      unitRef="usd">1397600000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzE0LTEtMS0xLTU4NTM3_48ebab3d-7f70-414e-a1db-c4ea3699b4be"
      unitRef="usd">2763400000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90YWJsZTo4NWNkZGZjNTNjMjA0NGE5OTdmNDg4Yzk5NWY0Yzg4Mi90YWJsZXJhbmdlOjg1Y2RkZmM1M2MyMDQ0YTk5N2Y0ODhjOTk1ZjRjODgyXzE0LTMtMS0xLTU4NTM3_71b80aa2-df6b-4263-9611-8b4ae0ad185b"
      unitRef="usd">1481000000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ifca29665c5264825877b7058a88003d2_I20211217"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzE3MDQyNDMwMjYwNTM1_d2cd1701-5320-41d2-a735-093aa37b73e5"
      unitRef="usd">1500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <coo:LineOfCreditFacilityAccordionFeatureIncreaseLimit
      contextRef="ifca29665c5264825877b7058a88003d2_I20211217"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzE3MDQyNDMwMjYwNTY0_a1124d05-4de8-4913-863d-6330774fd79a"
      unitRef="usd">1125000000</coo:LineOfCreditFacilityAccordionFeatureIncreaseLimit>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="id51c61469fa640639cd76808539e31f4_D20211217-20211217"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzE3MDQyNDMwMjYwNTgz_0bea46b1-5020-465c-ae17-ae89503b9d7b"
      unitRef="number">0.01</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i6b809e82e20145e888d01efebc590393_D20211217-20211217"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzE3MDQyNDMwMjYwNjAx_7e6956e8-34cd-49a0-a251-2ded10971d21"
      unitRef="number">0</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i53ffe4696c6f4b47b2e4b518a1cf3c2a_D20211217-20211217"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzE3MDQyNDMwMjYwNjIz_d4729df4-b68b-4599-9857-4421a7acf061"
      unitRef="number">0.0075</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i2a01079f97ba4d5783870ec5bc57cdca_D20211217-20211217"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzE3MDQyNDMwMjYwNjQz_f75659ac-0d2b-4d8b-a9ab-07eae2cec49b"
      unitRef="usd">1500000000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="ifffdb3949fef4f5385e7019378e75442_I20221031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzE3MDQyNDMwMjYwNjc4_22f1e366-4560-46d0-b221-3fba19cd4c8a"
      unitRef="number">0.0444</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:DebtInstrumentTerm
      contextRef="i228f4290d6fd4f95876b3825317e8cd3_D20211102-20211102"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzIzNA_5f8508ab-16a0-452b-bcac-411c0716d0bc">P364D</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ia94dc74dbbad4a8d9eb7e9f6962a812c_I20211102"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzI0Mg_761f35ae-adf0-4c65-b433-505f3c8aec29"
      unitRef="usd">840000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="idfb7453c47b34db1bb9c7e36494babea_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzQ5NDc4MDIzNjM2OTc_bb371118-3ef9-480c-88c1-f42afb5b810d"
      unitRef="usd">502000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:DebtInstrumentTerm
      contextRef="i228f4290d6fd4f95876b3825317e8cd3_D20211102-20211102"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzE3MDQyNDMwMjYxNTEx_4b5a590d-1f6e-4068-8d72-c93ff4e6b6b0">P364D</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="i228f4290d6fd4f95876b3825317e8cd3_D20211102-20211102"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzE3MDQyNDMwMjYxNTE2_b013be8b-a061-4f37-aa87-f0e2e7901f0b">P364D</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i227390cb7d3741d68bbf2a306e8d317d_D20211102-20211102"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzE3MDQyNDMwMjYxNTMx_ac054bff-b84a-4b75-87bf-3141a7a3a75a"
      unitRef="number">0.0060</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentTerm
      contextRef="i228f4290d6fd4f95876b3825317e8cd3_D20211102-20211102"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzE3MDQyNDMwMjYxNTIx_be48f161-c084-44dd-9d8c-8cca9383432d">P364D</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="i228f4290d6fd4f95876b3825317e8cd3_D20211102-20211102"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzE3MDQyNDMwMjYxNTI2_31225f0f-7ebc-4df1-98f3-9a94b032efa3">P364D</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ia014d234e2444dd4bb45dd43ef342980_I20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzE1NzU_d43367fd-adb7-4b92-b88a-365f2f12c1b2"
      unitRef="usd">1290000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i1e590effe8254728b5dd3d8a3dd2c200_I20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzE2NzM_6c5367bd-ee19-4237-b7ce-984058e42626"
      unitRef="usd">850000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="ifc00728eabe64bf9abfe0f08253a79f6_D20200401-20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzQ5NDc4MDIzMzkwOTQ_7aea535d-f8cb-482a-ac6c-61e0f9dbaac8"
      unitRef="usd">850000000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i91b88612cab0454c851fa2d99d1c3fd4_D20200401-20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzQ5NDc4MDIzMzkxMTA_89e6e50b-7093-4b67-84bb-1d69c9015bf4"
      unitRef="usd">445000000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <coo:LineOfCreditFacilityAccordionFeatureIncreaseLimit
      contextRef="i99285324fc244ac586029dfa2f4f68a8_I20200401"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzQ5NDc4MDIzNDM4MDA_8e7aad8b-059c-43ef-8a32-841b46392f5f"
      unitRef="usd">1605000000</coo:LineOfCreditFacilityAccordionFeatureIncreaseLimit>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i9500e33949584e7fba3a70a9736253fa_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzIyNjY_fe45d59c-8fb2-4b03-b108-b06b075301ee"
      unitRef="number">0.0000</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i9e8360d369424d82ba580ad6e272eaf1_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzIyNzM_9d26e947-dc75-4748-9fc7-39c127cbccb4"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="id5ae1b08f4874f7aa187763d59539a86_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzIzMTk_e76ec421-210c-415f-bf1e-c1e6bc63bc9d"
      unitRef="number">0.0075</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ib107e383db7648e0a06edb90e19e4ed9_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzIzMjY_83167c72-4766-44b7-9fdd-25a7647b722e"
      unitRef="number">0.0150</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i2b1692dde0d0413fa5ee769ae29445c9_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzI4MDA_2dc8b5f6-f82b-4680-b87d-f6ccaf9727f9"
      unitRef="number">0.0010</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i6d7d408231a140f9950399b4dc433531_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzI4MDY_07979654-24ad-4017-ae93-b61c6659865f"
      unitRef="number">0.0020</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LongTermLineOfCredit
      contextRef="i1d41f939e43e4627b5b87dc3739b80c0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzM5ODY_f4946c7c-7a6d-4023-ab65-f74cb30381cc"
      unitRef="usd">850000000</us-gaap:LongTermLineOfCredit>
    <us-gaap:LongTermLineOfCredit
      contextRef="i29e6d6b4446144a4b28b291aa1417e38_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzQwMzk_506c60f4-f155-4cf0-ada9-38fe00b2da4f"
      unitRef="usd">0</us-gaap:LongTermLineOfCredit>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="i1d41f939e43e4627b5b87dc3739b80c0_I20221031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzQxNDk_1fde5f09-149a-4583-b76e-157fd1dcdf6b"
      unitRef="number">0.0413</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="i29e6d6b4446144a4b28b291aa1417e38_I20221031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzQyMzM_d978fd0e-6a3e-478e-90ee-6159066a5964"
      unitRef="number">0.0413</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:LongTermLineOfCredit
      contextRef="i1d41f939e43e4627b5b87dc3739b80c0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzEwOTk1MTE2MzEyNzcz_3256a1c9-fd89-4b48-ba4f-2d2d2f5d0764"
      unitRef="usd">850000000</us-gaap:LongTermLineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i20f77777d3384f55a365a87853e42b20_I20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzU1MzI_c8baecb8-2fdd-4ac1-80ed-b0f6b04a2172"
      unitRef="usd">30700000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i43df8cc9f4d3428b869e34da6854f047_I20211031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzE3MDQyNDMwMjY5OTI2_d03477df-6a82-4ed2-8021-85ce6439351c"
      unitRef="usd">35800000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCredit
      contextRef="i20f77777d3384f55a365a87853e42b20_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzU4ODg_bdc4a9ad-19f9-4420-81e0-6d87286fb9b3"
      unitRef="usd">12300000</us-gaap:LineOfCredit>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="i20f77777d3384f55a365a87853e42b20_I20221031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzU5OTA_ac61bb58-3fed-443e-b36c-cd0097241abe"
      unitRef="number">0.0246</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i6cb922e3a6634ae5b78e0db7ecf40f80_I20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzYxODE_9d0901d8-500d-4ccf-9d78-2c1c2cbec8b5"
      unitRef="usd">73000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="if3dec29ada164a17b0ecfcff9b29d05d_I20211031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzE3MDQyNDMwMjY5OTQx_1b1925d5-ebc1-4b4e-964e-47cc3272fd41"
      unitRef="usd">95000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCredit
      contextRef="i6cb922e3a6634ae5b78e0db7ecf40f80_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzY0MDQ_3a1ed716-42b3-43b9-bfcc-5db6c677c3d6"
      unitRef="usd">45400000</us-gaap:LineOfCredit>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="i6cb922e3a6634ae5b78e0db7ecf40f80_I20221031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDYvZnJhZzpjN2I0NDUzZjM5NjU0NjBmOWE0ZWUwYzc0NDUyN2M5ZC90ZXh0cmVnaW9uOmM3YjQ0NTNmMzk2NTQ2MGY5YTRlZTBjNzQ0NTI3YzlkXzY1MTU_e539f17f-e8b5-4e3e-b89f-f082f8fce430"
      unitRef="number">0.0040</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQzNzM_4b9bf354-48da-4b9a-827e-9d8037d5e748">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Note 6. Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Effective Tax Rate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;The effective tax rates for fiscal 2022 and 2021 were 18.8% and (499.1)%, respectively. The increase was primarily due to an intra-group transfer of intellectual property in fiscal 2021 and UK tax rate change in fiscal 2021, as discussed below. The increase was also due to changes in the geographic composition of pre-tax earnings and changes in excess tax benefits from share-based compensation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;The effective tax rate for fiscal 2022 was lower than the US federal statutory rate primarily due to foreign earnings in jurisdictions with lower tax rates and changes in unrecognized tax benefits, partially offset by foreign earnings subject to US tax. The effective tax rate for fiscal 2021 was lower than the US federal statutory tax rate primarily due to the intra-group transfer, UK tax rate change, and earnings in foreign jurisdictions with lower tax rates partially offset by foreign earnings subject to US tax. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"&gt;In November 2020, the Company completed an intra-group transfer of certain intellectual property and related assets of CooperVision to a UK subsidiary as part of a group restructuring to establish headquarters operations in the UK. Determining fair value involved significant judgment related to future revenue growth, operating margins, and discount rates. The transfer resulted in a step-up of the UK tax-deductible basis in the intellectual property and goodwill, creating a temporary difference between the book basis and the tax basis of these assets. As a result, the Company recognized a deferred tax asset of $1,987.9&#160;million, with a corresponding income tax benefit, during the first quarter of fiscal 2021. During the third quarter of fiscal 2021, the Company recognized a $536.7&#160;million tax benefit related primarily to the remeasurement of this deferred tax asset caused by the UK enactment of a 25% corporate tax rate.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Components of income before income taxes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.064%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Income before income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;31.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(31.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(88.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;443.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;522.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;354.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;475.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;491.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;266.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Components of provision for income taxes: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.064%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;26.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;35.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;29.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;45.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2,492.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;53.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2,502.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;89.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2,453.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;28.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Reconciliation between the expected provision for income taxes at the US federal statutory rate and the provision for income taxes:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.064%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Provision for income taxes at United States statutory tax rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;99.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;103.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;56.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(Decrease) increase in taxes resulting from:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Foreign earnings in jurisdictions with lower tax rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(22.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(43.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(54.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Foreign earnings subject to United States tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;25.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;32.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Excess tax benefits from share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(13.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Deferred tax asset step-up&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(9.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;United States provision-to-return&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Intra-group transfer to UK subsidiary&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1,987.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Remeasurement of deferred tax assets from UK rate change&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(536.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Change in unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(12.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(7.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;State tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;89.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2,453.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;28.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Components of deferred tax assets and liabilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Accrued liabilities, reserves and compensation accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;79.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;78.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Foreign deferred tax assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,500.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,531.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net operating loss and tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Capitalized research and experimental expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;15.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;13.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,641.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,687.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(60.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(51.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,581.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,635.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Tax deductible goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(39.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(34.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(153.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(48.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(46.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Foreign deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(45.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(32.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total gross deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(287.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(113.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,293.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,522.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;In assessing the realizability of deferred tax assets, the Company analyzes whether some or all deferred tax assets will not be realized. This analysis considers historical taxable income, the projected reversal of deferred tax liabilities, projected taxable income and tax planning strategies. Based upon this analysis, it is more likely than not the deferred tax assets, net of valuation allowance, will be realized. The increase in valuation allowance is primarily related to foreign tax attributes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;At October 31, 2022, the Company had federal net operating loss carryforwards of $65.4&#160;million and state net operating loss carryforwards of $97.3&#160;million. Federal net operating loss carryforwards of $17.1&#160;million expire on various dates between 2025 and 2037 and $48.3&#160;million do not expire. The state net operating loss carryforwards expire on various dates between 2026 through 2042.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;A tax benefit is recognized if it is more likely than not that a tax position will be sustained on its technical merits, based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Changes in unrecognized tax benefits:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.737%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;58.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Decrease based on tax positions in prior fiscal years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(8.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Increase based on tax positions in current fiscal year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;307.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Lapses of statutes of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;353.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Decrease based on tax positions in prior fiscal years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(12.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Lapses of statutes of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;336.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;These tax benefits, if recognized, would reduce provision for income taxes for 2022, 2021 and 2020, by $324.3&#160;million, $336.5&#160;million, and $46.0&#160;million, respectively. Interest and penalties related to unrecognized tax benefits are recognized in provision for income taxes. As of October 31, 2022, 2021 and 2020, accrued gross interest and penalties related to unrecognized tax benefits was $5.4&#160;million, $6.4&#160;million, and $7.3&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"&gt;Included in the balance of unrecognized tax benefits at October 31, 2022 is $9.1&#160;million related to tax positions for which it is reasonably possible that the total amounts could change during the next twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Filed tax returns are subject to examination by tax authorities in major tax jurisdictions after fiscal 2016, including the UK and the US.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQ5NDc4MDIzNDk3ODc_a2d09ac5-d369-44fb-ac8c-04af88ae7d8e"
      unitRef="number">0.188</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQ5NDc4MDIzNDk3OTQ_a0ca359c-8097-462b-a17e-3199ed8d18de"
      unitRef="number">-4.991</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory
      contextRef="ia18ddf672b66483baceea8655de8da4b_I20210131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQ5NDc4MDIzNDk4MDQ_3323cf81-39bd-40e7-8b04-9ee9fe3726ce"
      unitRef="usd">1987900000</us-gaap:DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory>
    <coo:EffectiveIncomeTaxRateReconciliationChangeInEnactedForeignTaxRateAmount
      contextRef="i9a8c7e344a6d4ca6aa5bbb5af896bb9a_D20210501-20210731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQ5NDc4MDIzNDk4MjI_fa4b1409-4713-4fe2-97de-45d957e52f9d"
      unitRef="usd">-536700000</coo:EffectiveIncomeTaxRateReconciliationChangeInEnactedForeignTaxRateAmount>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQzOTE_c07dae0a-4063-4bf8-9c6c-0f4343a43a54">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Components of income before income taxes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.064%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Income before income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;31.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(31.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(88.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;443.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;522.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;354.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;475.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;491.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;266.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo0ZmJhOTU2NTAwY2U0OTBkYTU1OTVmYTEzMDcwOGViYy90YWJsZXJhbmdlOjRmYmE5NTY1MDBjZTQ5MGRhNTU5NWZhMTMwNzA4ZWJjXzItMS0xLTEtNTg1Mzc_d0018468-43ca-4bbd-b6bb-f19e667e8245"
      unitRef="usd">31400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo0ZmJhOTU2NTAwY2U0OTBkYTU1OTVmYTEzMDcwOGViYy90YWJsZXJhbmdlOjRmYmE5NTY1MDBjZTQ5MGRhNTU5NWZhMTMwNzA4ZWJjXzItMy0xLTEtNTg1Mzc_7096ddf9-6981-4855-866f-b553b1898e37"
      unitRef="usd">-31000000.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo0ZmJhOTU2NTAwY2U0OTBkYTU1OTVmYTEzMDcwOGViYy90YWJsZXJhbmdlOjRmYmE5NTY1MDBjZTQ5MGRhNTU5NWZhMTMwNzA4ZWJjXzItNS0xLTEtNTg1Mzc_0fb04727-1bb8-4734-91e1-2ec2b5a10943"
      unitRef="usd">-88000000.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo0ZmJhOTU2NTAwY2U0OTBkYTU1OTVmYTEzMDcwOGViYy90YWJsZXJhbmdlOjRmYmE5NTY1MDBjZTQ5MGRhNTU5NWZhMTMwNzA4ZWJjXzMtMS0xLTEtNTg1Mzc_a79a2ad4-9f80-4d0b-aae5-4fbb435e576f"
      unitRef="usd">443900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo0ZmJhOTU2NTAwY2U0OTBkYTU1OTVmYTEzMDcwOGViYy90YWJsZXJhbmdlOjRmYmE5NTY1MDBjZTQ5MGRhNTU5NWZhMTMwNzA4ZWJjXzMtMy0xLTEtNTg1Mzc_08e099b3-31c5-48c3-9491-9fdbd15c204b"
      unitRef="usd">522500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo0ZmJhOTU2NTAwY2U0OTBkYTU1OTVmYTEzMDcwOGViYy90YWJsZXJhbmdlOjRmYmE5NTY1MDBjZTQ5MGRhNTU5NWZhMTMwNzA4ZWJjXzMtNS0xLTEtNTg1Mzc_ed7c7093-722c-4119-805f-4df55d3abdc6"
      unitRef="usd">354500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo0ZmJhOTU2NTAwY2U0OTBkYTU1OTVmYTEzMDcwOGViYy90YWJsZXJhbmdlOjRmYmE5NTY1MDBjZTQ5MGRhNTU5NWZhMTMwNzA4ZWJjXzQtMS0xLTEtNTg1Mzc_c6190f34-4203-42e5-a2f3-c7927ea36c4f"
      unitRef="usd">475300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo0ZmJhOTU2NTAwY2U0OTBkYTU1OTVmYTEzMDcwOGViYy90YWJsZXJhbmdlOjRmYmE5NTY1MDBjZTQ5MGRhNTU5NWZhMTMwNzA4ZWJjXzQtMy0xLTEtNTg1Mzc_740a61ea-6a7d-4768-9623-121ef21a909f"
      unitRef="usd">491500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo0ZmJhOTU2NTAwY2U0OTBkYTU1OTVmYTEzMDcwOGViYy90YWJsZXJhbmdlOjRmYmE5NTY1MDBjZTQ5MGRhNTU5NWZhMTMwNzA4ZWJjXzQtNS0xLTEtNTg1Mzc_e7d1a91f-6553-431c-80ce-2d17cd9ab1a5"
      unitRef="usd">266500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQzNjA_0e0e2e72-9a85-49ce-8da6-81a82a86e577">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Components of provision for income taxes: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.064%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;26.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;35.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;29.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;45.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2,492.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;53.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2,502.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;89.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2,453.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;28.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzItMS0xLTEtNTg1Mzc_492544c4-7e23-45fc-8691-6bff00b45466"
      unitRef="usd">10200000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzItMy0xLTEtNTg1Mzc_b7a0fa21-33a0-408c-b50f-a0ef766c7876"
      unitRef="usd">21000000.0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzItNS0xLTEtNTg1Mzc_87122fba-4dcf-46fb-9a15-6e4e46d92d58"
      unitRef="usd">1400000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzMtMS0xLTEtNTg1Mzc_ed7469a3-006a-45a2-8657-97ccc2d18f57"
      unitRef="usd">3800000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzMtMy0xLTEtNTg1Mzc_ee447f09-3a7c-4a11-a111-24671f0bdc44"
      unitRef="usd">1300000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzMtNS0xLTEtNTg1Mzc_f7352ef9-a381-4b39-b3c2-be6ab288dc8c"
      unitRef="usd">1100000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzQtMS0xLTEtNTg1Mzc_e9ace9fd-93cc-444b-8980-594253ffc23c"
      unitRef="usd">21700000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzQtMy0xLTEtNTg1Mzc_bcda9159-442b-4da2-8ca0-f0de2d2bfc3a"
      unitRef="usd">26700000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzQtNS0xLTEtNTg1Mzc_9a24ccf0-bb87-4306-9f63-62aa9357a6e6"
      unitRef="usd">26500000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzUtMS0xLTEtNTg1Mzc_7b4d8be0-ee6f-4add-83da-370b46021016"
      unitRef="usd">35700000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzUtMy0xLTEtNTg1Mzc_67b0a79c-0d85-4310-8cf1-052911c6f155"
      unitRef="usd">49000000.0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzUtNS0xLTEtNTg1Mzc_de7732db-89d6-4e3e-b21a-e6fb003272c4"
      unitRef="usd">29000000.0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzgtMS0xLTEtNTg1Mzc_00eb8fe4-7184-41fa-869b-944fdd8bb932"
      unitRef="usd">10500000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzgtMy0xLTEtNTg1Mzc_a81800b1-a15d-4f4e-9d4e-13b4c0e8b7f6"
      unitRef="usd">-8800000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzgtNS0xLTEtNTg1Mzc_9407dc3b-c911-47c6-bb36-e580f521e84b"
      unitRef="usd">3200000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzktMS0xLTEtNTg1Mzc_9a7f2945-32dd-4f15-9d5b-0df250fc322f"
      unitRef="usd">-2200000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzktMy0xLTEtNTg1Mzc_f6664963-22f8-428e-a501-f3b07e4be497"
      unitRef="usd">-500000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzktNS0xLTEtNTg1Mzc_1ed9b7d1-31c1-4ed8-b3b7-654c069323e1"
      unitRef="usd">800000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzEwLTEtMS0xLTU4NTM3_03aa61df-1613-4be6-8d1a-3e2efaca3fbd"
      unitRef="usd">45600000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzEwLTMtMS0xLTU4NTM3_9c49d757-ef60-4ca1-8a40-69518382c6b8"
      unitRef="usd">-2492900000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzEwLTUtMS0xLTU4NTM3_1ec126c3-a6c4-4661-9362-63660efce78b"
      unitRef="usd">-4900000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzExLTEtMS0xLTU4NTM3_936fa109-267b-4572-aa3a-780f26931cc8"
      unitRef="usd">53900000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzExLTMtMS0xLTU4NTM3_e5de104d-0ee7-4faa-a7ae-449da3ed81e0"
      unitRef="usd">-2502200000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzExLTUtMS0xLTU4NTM3_e00d7a51-e626-44e8-97a6-b54f46f9db15"
      unitRef="usd">-900000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzEyLTEtMS0xLTU4NTM3_72eb6e95-65ba-47ab-b349-4a60d831ed9b"
      unitRef="usd">89500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzEyLTMtMS0xLTU4NTM3_2f3aaaf7-7b9a-4ea9-b826-1e8c16538400"
      unitRef="usd">-2453200000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo4NDljN2Y0MmNmYzM0NDlmYmU5ZmM2Y2FjMjA3NTZlZS90YWJsZXJhbmdlOjg0OWM3ZjQyY2ZjMzQ0OWZiZTlmYzZjYWMyMDc1NmVlXzEyLTUtMS0xLTU4NTM3_6a261427-2d98-449f-8725-e26c252ee887"
      unitRef="usd">28100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQzODc_9450d5a0-6ce7-4e48-b584-a047507fa819">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Reconciliation between the expected provision for income taxes at the US federal statutory rate and the provision for income taxes:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.064%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Provision for income taxes at United States statutory tax rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;99.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;103.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;56.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(Decrease) increase in taxes resulting from:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Foreign earnings in jurisdictions with lower tax rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(22.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(43.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(54.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Foreign earnings subject to United States tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;25.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;32.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Excess tax benefits from share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(13.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Deferred tax asset step-up&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(9.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;United States provision-to-return&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Intra-group transfer to UK subsidiary&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1,987.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Remeasurement of deferred tax assets from UK rate change&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(536.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Change in unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(12.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(7.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;State tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;89.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2,453.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;28.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzEtMS0xLTEtNTg1Mzc_1c5dd94f-4779-48e2-9f44-7c010cf3f6b3"
      unitRef="usd">99800000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzEtMy0xLTEtNTg1Mzc_26e25180-5ae2-4d58-b1e6-9a8208dd4318"
      unitRef="usd">103200000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzEtNS0xLTEtNTg1Mzc_6c2e5b9d-14da-4ef9-a502-1aaac6382092"
      unitRef="usd">56000000.0</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzMtMS0xLTEtNTg1Mzc_0c72af81-b091-4bcc-aec6-62b4a11bf0ca"
      unitRef="usd">-22300000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzMtMy0xLTEtNTg1Mzc_1f18ee0e-bcfc-4be0-bcb1-7a25e5da8fa8"
      unitRef="usd">-43600000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzMtNS0xLTEtNTg1Mzc_e71d50cc-729d-4033-af4d-5ab383712e53"
      unitRef="usd">-54700000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationRepatriationOfForeignEarnings
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzQtMS0xLTEtNTg1Mzc_34034c35-3e9e-4c7a-b246-295d337e1219"
      unitRef="usd">20700000</us-gaap:IncomeTaxReconciliationRepatriationOfForeignEarnings>
    <us-gaap:IncomeTaxReconciliationRepatriationOfForeignEarnings
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzQtMy0xLTEtNTg1Mzc_221929ce-4cc7-46f7-9b58-09b0e5804b01"
      unitRef="usd">25400000</us-gaap:IncomeTaxReconciliationRepatriationOfForeignEarnings>
    <us-gaap:IncomeTaxReconciliationRepatriationOfForeignEarnings
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzQtNS0xLTEtNTg1Mzc_1a4ede86-82d9-4393-8fad-a6c7bf156dd3"
      unitRef="usd">32000000.0</us-gaap:IncomeTaxReconciliationRepatriationOfForeignEarnings>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzYtMS0xLTEtNTg1Mzc_36aa5304-ef97-4b08-8ecc-16b252defdab"
      unitRef="usd">-2600000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzYtMy0xLTEtNTg1Mzc_0224e829-9a28-4200-ac87-d5b2196d993a"
      unitRef="usd">-13000000.0</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzYtNS0xLTEtNTg1Mzc_f15e8614-5758-422f-a69d-a6443f2f49c5"
      unitRef="usd">-6200000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzctMS0xLTEtNTg1Mzc_31dd7fe0-b2e3-42e4-b0f3-6f0c72e4e48c"
      unitRef="usd">-3400000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzctMy0xLTEtNTg1Mzc_3f0a6147-7833-4d36-81f6-2276a4e36457"
      unitRef="usd">3200000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzctNS0xLTEtNTg1Mzc_6b8915ed-3aa6-4a59-a0f5-b8203feac9fd"
      unitRef="usd">-9000000.0</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <coo:EffectiveIncomeTaxRateReconciliationChangeInDomesticFederalTaxReturnAmount
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzgtMS0xLTEtNTg1Mzc_b4053f9a-a324-4fd6-b3c7-19ebd11db5da"
      unitRef="usd">500000</coo:EffectiveIncomeTaxRateReconciliationChangeInDomesticFederalTaxReturnAmount>
    <coo:EffectiveIncomeTaxRateReconciliationChangeInDomesticFederalTaxReturnAmount
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzgtMy0xLTEtNTg1Mzc_f06ba356-2b16-46df-86a7-a8d1880ae5f7"
      unitRef="usd">-1200000</coo:EffectiveIncomeTaxRateReconciliationChangeInDomesticFederalTaxReturnAmount>
    <coo:EffectiveIncomeTaxRateReconciliationChangeInDomesticFederalTaxReturnAmount
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzgtNS0xLTEtNTg1Mzc_403dcaec-503e-4f6f-bdbf-7e57ac1fbd63"
      unitRef="usd">7000000.0</coo:EffectiveIncomeTaxRateReconciliationChangeInDomesticFederalTaxReturnAmount>
    <us-gaap:IncomeTaxReconciliationDispositionOfAssets
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzktMS0xLTEtNTg1Mzc_ed1f40ae-ddc9-426d-9945-fc4e5b883cf0"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationDispositionOfAssets>
    <us-gaap:IncomeTaxReconciliationDispositionOfAssets
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzktMy0xLTEtNTg1Mzc_87f0208d-0c53-47b7-bf4b-9e1565087187"
      unitRef="usd">-1987800000</us-gaap:IncomeTaxReconciliationDispositionOfAssets>
    <us-gaap:IncomeTaxReconciliationDispositionOfAssets
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzktNS0xLTEtNTg1Mzc_f254eb0f-5017-4f0e-aa4b-5a7bef4f9bd8"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationDispositionOfAssets>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzEwLTEtMS0xLTU4NTM3_ff399e0f-c09d-4c31-acc2-47c70b3caa32"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzEwLTMtMS0xLTU4NTM3_5e5dfc92-a890-4641-8902-90005cf52120"
      unitRef="usd">-536700000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzEwLTUtMS0xLTU4NTM3_bcb6cfa0-3ab5-430f-8946-4e7d5e5822b0"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <coo:EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzExLTEtMS0xLTU4NTM3_b2404dea-8b0c-4fef-a93e-2d2a10b408bd"
      unitRef="usd">-12700000</coo:EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount>
    <coo:EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzExLTMtMS0xLTU4NTM3_1beffee3-4cbb-42a5-b999-6fb3336a21c6"
      unitRef="usd">-7600000</coo:EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount>
    <coo:EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzExLTUtMS0xLTU4NTM3_5581e904-5fbc-4b64-b2bf-7abf32a74aad"
      unitRef="usd">-100000</coo:EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzEyLTEtMS0xLTkyMjUx_ea795503-c260-4285-a193-8f0f5c004c29"
      unitRef="usd">5000000.0</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzEyLTMtMS0xLTkyMjUx_3c0ac939-57a7-4f00-a69d-902b46397376"
      unitRef="usd">800000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzEyLTUtMS0xLTkyMjUx_9fac0192-6666-416d-b1c2-05c8f8192531"
      unitRef="usd">1900000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzEyLTEtMS0xLTU4NTM3_4122b329-eb06-4938-872a-5c256e966441"
      unitRef="usd">4500000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzEyLTMtMS0xLTU4NTM3_9731ab42-b0b0-4008-a5c4-42efe02bfa2e"
      unitRef="usd">4100000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzEyLTUtMS0xLTU4NTM3_1f94d450-cd37-4bc1-85d8-f7fdb5e500a8"
      unitRef="usd">1200000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzEzLTEtMS0xLTU4NTM3_10ad87f1-1abe-49e9-b322-87d80f253795"
      unitRef="usd">89500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzEzLTMtMS0xLTU4NTM3_84967a83-5574-42c3-96ae-2272a931f0f8"
      unitRef="usd">-2453200000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo1YTkyY2Y5OWExOTI0NTY0ODg1Zjc0OTk0MWI3MzYzMi90YWJsZXJhbmdlOjVhOTJjZjk5YTE5MjQ1NjQ4ODVmNzQ5OTQxYjczNjMyXzEzLTUtMS0xLTU4NTM3_eb0a67ff-f1c2-4318-ba84-8ef411c7e7fc"
      unitRef="usd">28100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQzNjM_8f7af7ae-9a02-4e6d-9f47-8b3516ea28e5">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Components of deferred tax assets and liabilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Accrued liabilities, reserves and compensation accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;79.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;78.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Foreign deferred tax assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,500.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,531.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net operating loss and tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Capitalized research and experimental expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;15.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;13.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,641.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,687.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(60.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(51.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,581.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,635.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Tax deductible goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(39.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(34.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(153.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(48.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(46.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Foreign deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(45.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(32.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total gross deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(287.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(113.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,293.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,522.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzItMS0xLTEtNTg1Mzc_38a2b334-7a59-4b09-b7c4-f809d851beb7"
      unitRef="usd">4900000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzItMy0xLTEtNTg1Mzc_698cb5ea-dbfe-4a0a-b98e-a56d08cda6fc"
      unitRef="usd">3400000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzMtMS0xLTEtNTg1Mzc_62d58958-794e-4c11-91fa-86e6534c3d9b"
      unitRef="usd">6300000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzMtMy0xLTEtNTg1Mzc_aa02e103-f68d-441f-9ff6-bb83cfde05fd"
      unitRef="usd">6100000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzQtMS0xLTEtNTg1Mzc_a2ac3af3-0429-4cc1-af56-5f822439b0c8"
      unitRef="usd">79900000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzQtMy0xLTEtNTg1Mzc_d9b26a62-990a-43ee-a4d1-b2dd3c8a7565"
      unitRef="usd">78100000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzUtMS0xLTEtNTg1Mzc_6104bc25-fa24-4b9b-af65-d13fb0789c0e"
      unitRef="usd">2500500000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzUtMy0xLTEtNTg1Mzc_eaa0bf5f-6e81-4228-90be-5723e87ea311"
      unitRef="usd">2531500000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzYtMS0xLTEtNTg1Mzc_e1891336-254f-4df8-aa3c-eac17b1f69f0"
      unitRef="usd">14500000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzYtMy0xLTEtNTg1Mzc_79c4d464-63b0-4cb8-b8f1-877c1c171df7"
      unitRef="usd">28600000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <coo:DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzctMS0xLTEtNTg1Mzc_b38c0e2b-b950-4610-8601-9d90b332b520"
      unitRef="usd">19600000</coo:DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards>
    <coo:DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzctMy0xLTEtNTg1Mzc_914a3cd3-71ec-4247-9560-68edc9b3c9fa"
      unitRef="usd">19300000</coo:DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzgtMS0xLTEtNTg1Mzc_bc7050d3-2dcf-4756-b787-fbd831113438"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzgtMy0xLTEtNTg1Mzc_e7ce44ce-ebc4-4993-86c6-d946486548a8"
      unitRef="usd">6800000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzktMS0xLTEtNTg1Mzc_26fc84bb-5fb3-45bf-90b4-159fa5d9d37e"
      unitRef="usd">15400000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzktMy0xLTEtNTg1Mzc_7e621026-858c-4c8d-82a6-f7b833a514c7"
      unitRef="usd">13500000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzExLTEtMS0xLTU4NTM3_bdb1efc4-fc50-4e0d-9299-4f380ef2218b"
      unitRef="usd">2641100000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzExLTMtMS0xLTU4NTM3_4a839ec3-0c46-41da-b55d-0c364d89068e"
      unitRef="usd">2687300000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzEyLTEtMS0xLTU4NTM3_6ccb583d-a050-4b1d-a1ad-c23875bc9665"
      unitRef="usd">60100000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzEyLTMtMS0xLTU4NTM3_4ae0b98a-be98-4d07-aef2-d6933730b162"
      unitRef="usd">51800000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzEzLTEtMS0xLTU4NTM3_31afb6ef-4419-44fe-8f72-001001ee9442"
      unitRef="usd">2581000000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzEzLTMtMS0xLTU4NTM3_2f260b13-2d33-4fe2-b40b-7dd7dd45415b"
      unitRef="usd">2635500000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzE1LTEtMS0xLTU4NTM3_359a4d48-6021-4638-91de-e126d0b945c5"
      unitRef="usd">39700000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzE1LTMtMS0xLTU4NTM3_a42bd767-bd32-41cf-9262-323ac5fd5e61"
      unitRef="usd">34000000.0</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzE1LTEtMS0xLTk5OTk5_8316b6fe-f32e-4155-8d06-ebddc1f7c421"
      unitRef="usd">153800000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzE1LTMtMS0xLTk5OTk5_c878e2ba-1b53-4f3d-ac75-4fd809badbf2"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzE2LTEtMS0xLTU4NTM3_2d8b098f-b18d-4369-93b9-c7f9eba12a70"
      unitRef="usd">48800000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzE2LTMtMS0xLTU4NTM3_2155cc02-7d88-4241-b638-93b504fadd78"
      unitRef="usd">46500000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <coo:DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzE5LTEtMS0xLTU4NTM3_6459ea36-091e-4695-8f5f-f36f67a07417"
      unitRef="usd">45500000</coo:DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign>
    <coo:DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzE5LTMtMS0xLTU4NTM3_3429f9a2-bc42-49cb-b579-5205a251ec69"
      unitRef="usd">32500000</coo:DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzIyLTEtMS0xLTU4NTM3_55ec422d-fdee-414b-8586-74a02016e96c"
      unitRef="usd">287800000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzIyLTMtMS0xLTU4NTM3_c1cabf08-b4b7-40e6-a10b-855b4b52dcbf"
      unitRef="usd">113000000.0</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzIzLTEtMS0xLTU4NTM3_dcbf8eb7-7a69-47f8-bb1d-b992a88e774d"
      unitRef="usd">2293200000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTozY2E0ZjYzMGE4OGE0NjhjOWU0YTE0MjYzZTEwNmJjYy90YWJsZXJhbmdlOjNjYTRmNjMwYTg4YTQ2OGM5ZTRhMTQyNjNlMTA2YmNjXzIzLTMtMS0xLTU4NTM3_13e9ce4b-e78e-4521-8a52-707c3d5085f5"
      unitRef="usd">2522500000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i1fdb5f114ab64b349676d31f17804de9_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQ5NDc4MDIzNDk4Mzg_8b23b2b1-3f69-4036-990b-97cbfd331086"
      unitRef="usd">65400000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i4fec0e4443b8407cbcb12c6d06cf6eaa_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQ5NDc4MDIzNDk4NTM_19daf0b8-6682-4635-87ea-0c7ae9f59feb"
      unitRef="usd">97300000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="i1fdb5f114ab64b349676d31f17804de9_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQ5NDc4MDIzNDk4ODI_baf7ac2e-a37d-4f7b-8122-6e70811f5370"
      unitRef="usd">17100000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="i1fdb5f114ab64b349676d31f17804de9_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQ5NDc4MDIzNDk4OTc_31bb23e8-e961-4c1c-b6e6-e545214affbb"
      unitRef="usd">48300000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQzODI_c4882452-01e2-4b3a-858b-9e6fdd96c0ca">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Changes in unrecognized tax benefits:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.737%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;58.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Decrease based on tax positions in prior fiscal years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(8.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Increase based on tax positions in current fiscal year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;307.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Lapses of statutes of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;353.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Decrease based on tax positions in prior fiscal years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(12.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Lapses of statutes of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;336.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo2MmFmMDM1YWI4NzE0ZjZkYTE1ZjBiZmZjN2NhZjAyZC90YWJsZXJhbmdlOjYyYWYwMzVhYjg3MTRmNmRhMTVmMGJmZmM3Y2FmMDJkXzEtMS0xLTEtNTg1Mzc_d6a2e6d8-f818-45aa-8eda-836f50ad5cb2"
      unitRef="usd">58500000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo2MmFmMDM1YWI4NzE0ZjZkYTE1ZjBiZmZjN2NhZjAyZC90YWJsZXJhbmdlOjYyYWYwMzVhYjg3MTRmNmRhMTVmMGJmZmM3Y2FmMDJkXzItMS0xLTEtNTg1Mzc_312b4031-8152-4670-9158-9b936eda7993"
      unitRef="usd">8300000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo2MmFmMDM1YWI4NzE0ZjZkYTE1ZjBiZmZjN2NhZjAyZC90YWJsZXJhbmdlOjYyYWYwMzVhYjg3MTRmNmRhMTVmMGJmZmM3Y2FmMDJkXzMtMS0xLTEtNTg1Mzc_7fcfc40b-ec4f-47ff-800c-9ac3d3609415"
      unitRef="usd">307200000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo2MmFmMDM1YWI4NzE0ZjZkYTE1ZjBiZmZjN2NhZjAyZC90YWJsZXJhbmdlOjYyYWYwMzVhYjg3MTRmNmRhMTVmMGJmZmM3Y2FmMDJkXzQtMS0xLTEtNTg1Mzc_f2d47dcf-76a2-4a72-aef3-9be4bea8c44f"
      unitRef="usd">1900000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo2MmFmMDM1YWI4NzE0ZjZkYTE1ZjBiZmZjN2NhZjAyZC90YWJsZXJhbmdlOjYyYWYwMzVhYjg3MTRmNmRhMTVmMGJmZmM3Y2FmMDJkXzUtMS0xLTEtNTg1Mzc_21e847b1-5be0-44ed-bd65-183cdf8fe9ac"
      unitRef="usd">1700000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo2MmFmMDM1YWI4NzE0ZjZkYTE1ZjBiZmZjN2NhZjAyZC90YWJsZXJhbmdlOjYyYWYwMzVhYjg3MTRmNmRhMTVmMGJmZmM3Y2FmMDJkXzYtMS0xLTEtNTg1Mzc_f76066fc-70b9-41ff-be4b-5d5f95451c38"
      unitRef="usd">353800000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo2MmFmMDM1YWI4NzE0ZjZkYTE1ZjBiZmZjN2NhZjAyZC90YWJsZXJhbmdlOjYyYWYwMzVhYjg3MTRmNmRhMTVmMGJmZmM3Y2FmMDJkXzctMS0xLTEtNTg1Mzc_10a9943e-6c3f-486c-85a9-bb92a3ea001e"
      unitRef="usd">12500000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo2MmFmMDM1YWI4NzE0ZjZkYTE1ZjBiZmZjN2NhZjAyZC90YWJsZXJhbmdlOjYyYWYwMzVhYjg3MTRmNmRhMTVmMGJmZmM3Y2FmMDJkXzgtMS0xLTEtNTg1Mzc_edd6ccba-1dd8-4749-855e-dd156914ce5c"
      unitRef="usd">200000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo2MmFmMDM1YWI4NzE0ZjZkYTE1ZjBiZmZjN2NhZjAyZC90YWJsZXJhbmdlOjYyYWYwMzVhYjg3MTRmNmRhMTVmMGJmZmM3Y2FmMDJkXzEwLTEtMS0xLTU4NTM3_b7af7b27-af62-4f6d-9e6d-4ea3ce335dfa"
      unitRef="usd">4200000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90YWJsZTo2MmFmMDM1YWI4NzE0ZjZkYTE1ZjBiZmZjN2NhZjAyZC90YWJsZXJhbmdlOjYyYWYwMzVhYjg3MTRmNmRhMTVmMGJmZmM3Y2FmMDJkXzEyLTEtMS0xLTU4NTM3_9089eacc-51a8-44b2-840e-7ed72daa132f"
      unitRef="usd">336900000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQ5NDc4MDIzNDk5NTk_622a30be-eebc-4f68-bd7c-d86b50c3a6aa"
      unitRef="usd">324300000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQ5NDc4MDIzNDk5NzU_e8cb9807-b5d5-4a59-a316-fece3ffee0ad"
      unitRef="usd">336500000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQ5NDc4MDIzNDk5OTE_5f795435-06d5-49b2-85e3-3e65997579bf"
      unitRef="usd">46000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQ5NDc4MDIzNTAwMDY_31748eda-54cb-4b46-b694-aa406b460c11"
      unitRef="usd">5400000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQ5NDc4MDIzNTAwMjA_908f5420-9667-41e7-b24c-711fa1bbc82e"
      unitRef="usd">6400000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQ5NDc4MDIzNTAwMzQ_5c5658f2-4a4c-4f5a-8199-24652ec4f17f"
      unitRef="usd">7300000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMDkvZnJhZzo3ZjhmMzFlMDY3YmM0OWY0YmEzYmNjZjI3OGNjY2IxMS90ZXh0cmVnaW9uOjdmOGYzMWUwNjdiYzQ5ZjRiYTNiY2NmMjc4Y2NjYjExXzQ5NDc4MDIzNTAwNDg_397b30e2-4d0b-4f8b-99fe-2b8a50e4c6d1"
      unitRef="usd">9100000</us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90ZXh0cmVnaW9uOmMwNWEwMGE4ZjYwNzRiNTM5YjQ3YTVjZWNlNzg1MDJmXzI5OQ_ba31b2e6-012e-4d3b-92d6-00bd303f5dd6">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Note 7. Earnings Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions, except for earnings per share)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;385.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,944.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;238.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;Basic:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Weighted average common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Basic earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;59.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;Diluted:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Weighted average common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Effect of dilutive stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Diluted weighted average common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;59.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The following table sets forth stock options to purchase our common stock and restricted stock units that were not included in the diluted earnings per share calculation because their effect would have been antidilutive for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.248%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.248%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands, except exercise prices)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Stock option shares excluded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Exercise prices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$300.12 - $406.17&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;345.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;304.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Restricted stock units excluded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90ZXh0cmVnaW9uOmMwNWEwMGE4ZjYwNzRiNTM5YjQ3YTVjZWNlNzg1MDJmXzMwMQ_9349781c-6825-45bf-a891-77f1340484a9">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions, except for earnings per share)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;385.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,944.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;238.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;Basic:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Weighted average common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Basic earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;59.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;Diluted:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Weighted average common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Effect of dilutive stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Diluted weighted average common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;49.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;59.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzItMS0xLTEtNTg1Mzc_0c9a75d1-30e4-4bba-89c1-d51d275529a1"
      unitRef="usd">385800000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzItMS0xLTEtNTg1Mzc_31097b26-6c77-4775-b400-fc94b482772a"
      unitRef="usd">385800000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzItMy0xLTEtNTg1Mzc_c09de6c6-b135-4353-949d-f8960410c37c"
      unitRef="usd">2944700000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzItMy0xLTEtNTg1Mzc_fc3b2e52-5539-4283-a1c7-15b00b9c3745"
      unitRef="usd">2944700000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzItNS0xLTEtNTg1Mzc_5011ae34-c0b8-4389-b81f-ed9747614793"
      unitRef="usd">238400000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzItNS0xLTEtNTg1Mzc_c4ea812f-7526-4321-a4c4-6449a4ffae45"
      unitRef="usd">238400000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzQtMS0xLTEtNTg1Mzc_609a7ae3-b1c2-4577-a35e-473c350493f8"
      unitRef="shares">49300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzQtMy0xLTEtNTg1Mzc_4533d291-6db6-406b-875d-e42c4f59cea6"
      unitRef="shares">49200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzQtNS0xLTEtNTg1Mzc_b748fde4-3d85-41bb-8c1e-2b1ebbcecec3"
      unitRef="shares">49100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzUtMS0xLTEtNTg1Mzc_90fdf320-f538-4745-95fb-7aff14225c42"
      unitRef="usdPerShare">7.83</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzUtMy0xLTEtNTg1Mzc_711a5646-9afa-45fc-b33a-1fe80f701960"
      unitRef="usdPerShare">59.80</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzUtNS0xLTEtNTg1Mzc_d9825f69-5257-4854-aa28-eca7720b2b62"
      unitRef="usdPerShare">4.85</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzctMS0xLTEtNTg1Mzc_7f335c54-df3e-440c-a164-f976254f0ccc"
      unitRef="shares">49300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzctMy0xLTEtNTg1Mzc_7e910d86-67ee-4ba7-bfce-0830f1bf535b"
      unitRef="shares">49200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzctNS0xLTEtNTg1Mzc_9ad5e843-5bf4-47fd-8357-d4cdf9eee2fd"
      unitRef="shares">49100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzgtMS0xLTEtNTg1Mzc_5aadeb44-4d40-4258-9b61-a58ea5102a23"
      unitRef="shares">400000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzgtMy0xLTEtNTg1Mzc_4aa633a0-e3f2-424b-a2b1-61cd625831f0"
      unitRef="shares">600000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzgtNS0xLTEtNTg1Mzc_d4b47fd6-e061-4574-a0f8-46f15559d2d5"
      unitRef="shares">500000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzktMS0xLTEtNTg1Mzc_088558a0-3a81-4e1c-8fc5-3d7b4df31c55"
      unitRef="shares">49700000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzktMy0xLTEtNTg1Mzc_26ee0cb1-a1de-4258-8447-4cb492d8f095"
      unitRef="shares">49800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzktNS0xLTEtNTg1Mzc_bcb76925-be59-4f44-a783-fd6502d55277"
      unitRef="shares">49600000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzEwLTEtMS0xLTU4NTM3_726833be-22cd-4ee4-a748-6db7db78a70d"
      unitRef="usdPerShare">7.76</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzEwLTMtMS0xLTU4NTM3_352e0339-3726-481d-88cb-2dd6d0b23d98"
      unitRef="usdPerShare">59.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZTpkMmI4NWMyNjQ1OTU0MDIwYmEyNTNiNGE4Mjk1MzNlYS90YWJsZXJhbmdlOmQyYjg1YzI2NDU5NTQwMjBiYTI1M2I0YTgyOTUzM2VhXzEwLTUtMS0xLTU4NTM3_2ced4559-6380-4a45-a16f-f409306be22b"
      unitRef="usdPerShare">4.81</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90ZXh0cmVnaW9uOmMwNWEwMGE4ZjYwNzRiNTM5YjQ3YTVjZWNlNzg1MDJmXzMwOA_8cc567c6-80c1-4c55-9923-adae281be38c">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The following table sets forth stock options to purchase our common stock and restricted stock units that were not included in the diluted earnings per share calculation because their effect would have been antidilutive for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.248%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.248%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands, except exercise prices)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Stock option shares excluded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Exercise prices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$300.12 - $406.17&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;345.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;304.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Restricted stock units excluded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i735d9bf4f5c64cc190f684cf557f76ac_D20211101-20221031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZToyNWViMjY1MWY3NGQ0YTEzODc2MzFhYjU2ZTZjYmIwOS90YWJsZXJhbmdlOjI1ZWIyNjUxZjc0ZDRhMTM4NzYzMWFiNTZlNmNiYjA5XzItMS0xLTEtNTg1Mzc_00c04627-f074-4d3c-b3fc-329944cc0b74"
      unitRef="shares">227000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9037379de7ad40cb960f5f67523ae233_D20201101-20211031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZToyNWViMjY1MWY3NGQ0YTEzODc2MzFhYjU2ZTZjYmIwOS90YWJsZXJhbmdlOjI1ZWIyNjUxZjc0ZDRhMTM4NzYzMWFiNTZlNmNiYjA5XzItMy0xLTEtNTg1Mzc_1a288c49-11e9-48dc-bb91-f174602efd20"
      unitRef="shares">107000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i994f6d46a07848c48bb5f57d06e47f95_D20191101-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZToyNWViMjY1MWY3NGQ0YTEzODc2MzFhYjU2ZTZjYmIwOS90YWJsZXJhbmdlOjI1ZWIyNjUxZjc0ZDRhMTM4NzYzMWFiNTZlNmNiYjA5XzItNS0xLTEtNTg1Mzc_48d50320-0ca0-4dc3-ac2f-95614868d6a9"
      unitRef="shares">207000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZToyNWViMjY1MWY3NGQ0YTEzODc2MzFhYjU2ZTZjYmIwOS90YWJsZXJhbmdlOjI1ZWIyNjUxZjc0ZDRhMTM4NzYzMWFiNTZlNmNiYjA5XzMtMS0xLTEtNTg1MzcvdGV4dHJlZ2lvbjozMzVmMWUzMjY1NTI0N2FjYmRlZDA5M2U3ZjQ2ZDhjMF81NDk3NTU4MTM5MTY_4fd9a41b-5d29-41a9-8324-897b8b92c836"
      unitRef="usdPerShare">300.12</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZToyNWViMjY1MWY3NGQ0YTEzODc2MzFhYjU2ZTZjYmIwOS90YWJsZXJhbmdlOjI1ZWIyNjUxZjc0ZDRhMTM4NzYzMWFiNTZlNmNiYjA5XzMtMS0xLTEtNTg1MzcvdGV4dHJlZ2lvbjozMzVmMWUzMjY1NTI0N2FjYmRlZDA5M2U3ZjQ2ZDhjMF81NDk3NTU4MTM5MjY_455d2c4c-67b9-4e0e-8b0e-57e2a4611294"
      unitRef="usdPerShare">406.17</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZToyNWViMjY1MWY3NGQ0YTEzODc2MzFhYjU2ZTZjYmIwOS90YWJsZXJhbmdlOjI1ZWIyNjUxZjc0ZDRhMTM4NzYzMWFiNTZlNmNiYjA5XzMtMy0xLTEtNTg1Mzc_080d1a1e-6fd4-4557-96d5-6cfbae0ed05c"
      unitRef="usdPerShare">345.74</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZToyNWViMjY1MWY3NGQ0YTEzODc2MzFhYjU2ZTZjYmIwOS90YWJsZXJhbmdlOjI1ZWIyNjUxZjc0ZDRhMTM4NzYzMWFiNTZlNmNiYjA5XzMtMy0xLTEtNTg1Mzc_2d062b09-c799-47a9-ae09-8f2fce20169c"
      unitRef="usdPerShare">345.74</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZToyNWViMjY1MWY3NGQ0YTEzODc2MzFhYjU2ZTZjYmIwOS90YWJsZXJhbmdlOjI1ZWIyNjUxZjc0ZDRhMTM4NzYzMWFiNTZlNmNiYjA5XzMtNS0xLTEtNTg1Mzc_443906b0-be16-4ee2-9776-1681c74172f2"
      unitRef="usdPerShare">304.54</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZToyNWViMjY1MWY3NGQ0YTEzODc2MzFhYjU2ZTZjYmIwOS90YWJsZXJhbmdlOjI1ZWIyNjUxZjc0ZDRhMTM4NzYzMWFiNTZlNmNiYjA5XzMtNS0xLTEtNTg1Mzc_f5f6daea-ff28-44cf-8a18-87d8818ecf84"
      unitRef="usdPerShare">304.54</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i60a5f62358f3456f94c7622fcccd1de1_D20211101-20221031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZToyNWViMjY1MWY3NGQ0YTEzODc2MzFhYjU2ZTZjYmIwOS90YWJsZXJhbmdlOjI1ZWIyNjUxZjc0ZDRhMTM4NzYzMWFiNTZlNmNiYjA5XzQtMS0xLTEtNTg1Mzc_6ed7071d-6f8c-4608-8a2b-6382f04e2344"
      unitRef="shares">87000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5b52a596f80946beb247cfd6e8e457d0_D20201101-20211031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZToyNWViMjY1MWY3NGQ0YTEzODc2MzFhYjU2ZTZjYmIwOS90YWJsZXJhbmdlOjI1ZWIyNjUxZjc0ZDRhMTM4NzYzMWFiNTZlNmNiYjA5XzQtMy0xLTEtNTg1Mzc_d891cea3-b590-4146-9e9a-a5e2dfa71704"
      unitRef="shares">2000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5e5449ed4ace4f148ff5db6afd1d1441_D20191101-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTIvZnJhZzpjMDVhMDBhOGY2MDc0YjUzOWI0N2E1Y2VjZTc4NTAyZi90YWJsZToyNWViMjY1MWY3NGQ0YTEzODc2MzFhYjU2ZTZjYmIwOS90YWJsZXJhbmdlOjI1ZWIyNjUxZjc0ZDRhMTM4NzYzMWFiNTZlNmNiYjA5XzQtNS0xLTEtNTg1Mzc_b81ef11f-946c-4a3a-809b-c9e485b4791c"
      unitRef="shares">1000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90ZXh0cmVnaW9uOmUxMDM3MGE4MDUyODQxNTdhZmNhZjJkMTBlYjU1NDhhXzEyNjE_80beb470-76e0-4491-9838-7a64b1c621b7">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Note 8. Stockholders&#x2019; Equity&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Analysis of Changes in Accumulated Other Comprehensive Income (Loss):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.979%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.979%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Minimum Pension Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(403.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(43.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(447.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Gross change in value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(17.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(16.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(33.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(402.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(13.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(56.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(472.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Gross change in value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;82.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;146.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(8.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(15.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(320.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(34.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(341.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Gross change in value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(234.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;107.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;36.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(90.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(26.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(8.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(34.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(555.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;94.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(466.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Share Repurchases &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;In December 2011, the Company's Board of Directors authorized the 2012 Share Repurchase Program and through subsequent amendments, the most recent in March 2017, the total repurchase authorization was increased from $500.0 million to $1.0 billion of the Company's common stock. This program has no expiration date and may be discontinued at any time. Purchases under the 2012 Share Repurchase Program are subject to a review of the circumstances in place at the time and may be made from time to time as permitted by securities laws and other legal requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;For the years ended October&#160;31, 2022 and 2021, the Company's share repurchases were as follow:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Number of shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;191,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;69,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Average repurchase price per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;410.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;356.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total costs of shares repurchased (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;78.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;24.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;At October&#160;31, 2022, $256.4 million remained authorized for repurchase under the program.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90ZXh0cmVnaW9uOmUxMDM3MGE4MDUyODQxNTdhZmNhZjJkMTBlYjU1NDhhXzEyNTY_62211c89-9728-4277-b546-70f00a72d0b0">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Analysis of Changes in Accumulated Other Comprehensive Income (Loss):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.979%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.979%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Minimum Pension Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(403.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(43.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(447.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Gross change in value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(17.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(16.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(33.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(402.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(13.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(56.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(472.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Gross change in value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;82.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;146.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(8.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(15.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(320.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(34.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(341.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Gross change in value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(234.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;107.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;36.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(90.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(26.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(8.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(34.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance at October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(555.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;94.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(466.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The following table details the changes in accumulated other comprehensive income:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.658%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance as of October 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(17.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amount recognized in other comprehensive income on interest rate swap contracts, gross ($20.0, net of tax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;26.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amount reclassified from other comprehensive income into earnings, gross ($6.1, net of tax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance gain as of October 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amount recognized in other comprehensive income on interest rate swap contracts, gross ($79.7, net of tax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;105.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amount reclassified from other comprehensive income into earnings, gross ($1.7, net of tax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance gain as of October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;124.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic2a66fe928654ff892f449b28dccbcea_I20191031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzEtMS0xLTEtNTg1Mzc_69bed3f6-a9f7-4af4-9f27-6f7592d6a8fd"
      unitRef="usd">-403200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4939e43dc1c44e3c84ba8a60db483c8f_I20191031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzEtNS0xLTEtNTg1Mzc_b20218a0-dce9-4e00-9c9d-38dd4a6e74fc"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i767587fb433c468584f3f7356b9737e4_I20191031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzEtNy0xLTEtNTg1Mzc_51f4b72b-0b39-4cc2-9b48-485451598dd0"
      unitRef="usd">-43900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4862aa9bb8ef43508c2cc981078ef274_I20191031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzEtOS0xLTEtNTg1Mzc_9b586250-d3a7-4cb7-983d-f0858a13c5a6"
      unitRef="usd">-447100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="ic33f40436aa045c7a3aa5a02afaafef0_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzItMS0xLTEtNTg1Mzc_a49a1388-975f-4d33-8443-1c851ad51180"
      unitRef="usd">900000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="iac86d4da8948474188bad8e7f5a66f87_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzItNS0xLTEtNTg1Mzc_6bfedd7a-86d9-43f2-9d81-a5c0d770ed3d"
      unitRef="usd">-17100000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="ia1ce184d806940dc9e3ac0e3283e5a05_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzItNy0xLTEtNTg1Mzc_86defe1b-267b-4fe0-91a5-ee05228537d8"
      unitRef="usd">-16800000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzItOS0xLTEtNTg1Mzc_338aa336-e4e8-405b-a49d-611ac9463164"
      unitRef="usd">-33000000.0</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="ic33f40436aa045c7a3aa5a02afaafef0_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzMtMS0xLTEtNTg1Mzc_8624dd55-58d1-4f09-a6b3-a3d94c8209ff"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="iac86d4da8948474188bad8e7f5a66f87_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzMtNS0xLTEtNTg1Mzc_fef9700c-c7ef-4185-b577-e01a8a746dbf"
      unitRef="usd">-4100000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="ia1ce184d806940dc9e3ac0e3283e5a05_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzMtNy0xLTEtNTg1Mzc_306ec3e4-d4e8-4f3c-bdab-2de8c073429b"
      unitRef="usd">-4000000.0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzMtOS0xLTEtNTg1Mzc_fc1cafc2-bbcf-4c7c-a69a-3f50c929a5d9"
      unitRef="usd">-8100000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i984b27946ae74a7a86ccd23408d602d5_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzUtMS0xLTEtNTg1Mzc_b5986adf-6730-4128-a993-62bd2b7e2fef"
      unitRef="usd">-402300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie2b158c1317d4810ba6145502cf9fa62_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzUtNS0xLTEtNTg1Mzc_39e054bc-c03a-4202-8c5d-6f7b336fcc9d"
      unitRef="usd">-13000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia689d6db1dcf416ba5f2200ae5e5f4b5_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzUtNy0xLTEtNTg1Mzc_42b7f2e8-ea5f-48fe-bc24-a58a1338d298"
      unitRef="usd">-56700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i15ff03e12d5e49abb65998853b7f5c15_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzUtOS0xLTEtNTg1Mzc_b9492ee3-239f-45d0-aac0-ab3f0f0e918d"
      unitRef="usd">-472000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="ib785f9fe0b6f449a807bde4146343b94_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzYtMS0xLTEtNTg1Mzc_4e620fef-1483-44bc-b065-74584a092b0f"
      unitRef="usd">82200000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i57f3229c828a483a94464d9bda7f0fc2_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzYtNS0xLTEtNTg1Mzc_9e55a213-ae34-4c0c-9be3-122626aab4fc"
      unitRef="usd">34300000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i65542b1a9cb447ac8968bcb17317427b_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzYtNy0xLTEtNTg1Mzc_89e9e648-9b4c-483b-b2e4-4a43ace5525d"
      unitRef="usd">29800000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzYtOS0xLTEtNTg1Mzc_30e4d607-19b7-43a3-87df-3f1d8f974f92"
      unitRef="usd">146300000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="ib785f9fe0b6f449a807bde4146343b94_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzctMS0xLTEtNTg1Mzc_060599a5-aef3-4591-a691-2145f8bcecf1"
      unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i57f3229c828a483a94464d9bda7f0fc2_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzctNS0xLTEtNTg1Mzc_d70862ec-e3d2-4d74-bf06-f19778c4355e"
      unitRef="usd">8200000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i65542b1a9cb447ac8968bcb17317427b_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzctNy0xLTEtNTg1Mzc_a5df8a06-1ab3-4b73-b971-a8e17ac8f8d0"
      unitRef="usd">7200000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzctOS0xLTEtNTg1Mzc_8f481aa5-99bf-425d-b99b-8802f3f7b2bd"
      unitRef="usd">15600000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibd134a9b985a4f77a31f6656483a2e78_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzktMS0xLTEtNTg1Mzc_f1048b8a-00b0-436e-a5e4-11bf524472e1"
      unitRef="usd">-320300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4d514c5d060040099cd2656f450fc3e6_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzktNS0xLTEtNTg1Mzc_0a00bc7c-a733-4d36-9b59-7dc2f01f61f2"
      unitRef="usd">13100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaf2ee51bda7b413c809c36bd987d5e20_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzktNy0xLTEtNTg1Mzc_50dbbc47-bc89-4369-812e-1fe7afaee875"
      unitRef="usd">-34100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id1debae85ed14b3aa606b0f2a2bf613a_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzktOS0xLTEtNTg1Mzc_410a0b92-67f8-45fc-a630-3d8c4c9c6e0f"
      unitRef="usd">-341300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="ic6d7c5e2927b491cb9d48756d4126817_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzEwLTEtMS0xLTU4NTM3_807e631f-f5b3-45d9-9d47-0f6687dd2439"
      unitRef="usd">-234700000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i105b86b96182466c89e084e2d8117b5e_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzEwLTUtMS0xLTU4NTM3_de76d857-2941-4227-a170-9fa6297f82a1"
      unitRef="usd">107400000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="ib9244242144c45aa9048eeaa500730b3_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzEwLTctMS0xLTU4NTM3_5c7f4ce6-02cd-483c-9b5b-5fea66fdfd6b"
      unitRef="usd">36600000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzEwLTktMS0xLTU4NTM3_15310139-5fa4-45de-a52b-ec5d0b21b03a"
      unitRef="usd">-90700000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="ic6d7c5e2927b491cb9d48756d4126817_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzEyLTEtMS0xLTU4NTM3_a91af651-0eff-402f-b230-663328a87af0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i105b86b96182466c89e084e2d8117b5e_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzEyLTUtMS0xLTU4NTM3_4e6f1935-a56b-42ad-9ea5-251b39380047"
      unitRef="usd">26100000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="ib9244242144c45aa9048eeaa500730b3_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzEyLTctMS0xLTU4NTM3_47a90a6b-39e5-465a-b39f-e24bc21b91e6"
      unitRef="usd">8700000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzEyLTktMS0xLTU4NTM3_2d42f7ba-6c93-447e-a4a7-005accd88789"
      unitRef="usd">34800000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4d0f42512b5a468fa0175b728ddf3071_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzEzLTEtMS0xLTU4NTM3_f83808e7-91d8-4460-9a67-bef2b26fd1c0"
      unitRef="usd">-555000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i27afd0c9af1c4f46a1ee89390596bd3b_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzEzLTUtMS0xLTU4NTM3_be3e8b7f-a6a8-4840-ad2e-a9c3382ceab6"
      unitRef="usd">94400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifbc93be7f95b42e8959f15b98f6e9285_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzEzLTctMS0xLTU4NTM3_779442aa-057e-454b-a165-4d86b43cd379"
      unitRef="usd">-6200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i13f3c04d8bda4a5ea3fcba710edd83fb_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTo2MWMzMzlmMjMwYTg0NjQ3YmNkMzExNjAyMTczMzgwMC90YWJsZXJhbmdlOjYxYzMzOWYyMzBhODQ2NDdiY2QzMTE2MDIxNzMzODAwXzEzLTktMS0xLTU4NTM3_4e3d5bd2-0de5-439c-822b-7668d2894b26"
      unitRef="usd">-466800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i26915257e03c4b6fbdd14345564b2a64_I20111231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90ZXh0cmVnaW9uOmUxMDM3MGE4MDUyODQxNTdhZmNhZjJkMTBlYjU1NDhhXzM0Mw_0c662bf4-f8b1-4b6b-a138-73434b3d4f46"
      unitRef="usd">500000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i00964b16a5864689921a5cd1f5431741_I20170331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90ZXh0cmVnaW9uOmUxMDM3MGE4MDUyODQxNTdhZmNhZjJkMTBlYjU1NDhhXzM0OQ_ad531a41-0557-4a1c-8d73-981b5f34ee11"
      unitRef="usd">1000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:ScheduleOfTreasuryStockByClassTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90ZXh0cmVnaW9uOmUxMDM3MGE4MDUyODQxNTdhZmNhZjJkMTBlYjU1NDhhXzEyNTk_030977df-cc12-4b3b-b4fb-a73f5cc56913">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;For the years ended October&#160;31, 2022 and 2021, the Company's share repurchases were as follow:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Number of shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;191,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;69,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Average repurchase price per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;410.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;356.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total costs of shares repurchased (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;78.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;24.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfTreasuryStockByClassTextBlock>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTplOTNlZGZiYjM3ZTU0Zjc0YWNjNGY4MmEzYzgwY2Y4NC90YWJsZXJhbmdlOmU5M2VkZmJiMzdlNTRmNzRhY2M0ZjgyYTNjODBjZjg0XzEtMS0xLTEtNTg1Mzc_545a7c07-a730-4bc9-96be-61f3aec0d50a"
      unitRef="shares">191165</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTplOTNlZGZiYjM3ZTU0Zjc0YWNjNGY4MmEzYzgwY2Y4NC90YWJsZXJhbmdlOmU5M2VkZmJiMzdlNTRmNzRhY2M0ZjgyYTNjODBjZjg0XzEtMy0xLTEtNTg1Mzc_5457fb4d-cec3-4264-bd96-108dd1cd1aef"
      unitRef="shares">69622</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTplOTNlZGZiYjM3ZTU0Zjc0YWNjNGY4MmEzYzgwY2Y4NC90YWJsZXJhbmdlOmU5M2VkZmJiMzdlNTRmNzRhY2M0ZjgyYTNjODBjZjg0XzItMS0xLTEtNTg1Mzc_b03cfb78-df8e-48f6-82da-c02cf29393c0"
      unitRef="usdPerShare">410.4</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTplOTNlZGZiYjM3ZTU0Zjc0YWNjNGY4MmEzYzgwY2Y4NC90YWJsZXJhbmdlOmU5M2VkZmJiMzdlNTRmNzRhY2M0ZjgyYTNjODBjZjg0XzItMy0xLTEtNTg1Mzc_3ccd15ec-eefa-4f79-b417-01aab9141070"
      unitRef="usdPerShare">356.6</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTplOTNlZGZiYjM3ZTU0Zjc0YWNjNGY4MmEzYzgwY2Y4NC90YWJsZXJhbmdlOmU5M2VkZmJiMzdlNTRmNzRhY2M0ZjgyYTNjODBjZjg0XzMtMS0xLTEtNTg1Mzc_962db3d0-b971-455c-a03a-c927b98dfc83"
      unitRef="usd">78500000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90YWJsZTplOTNlZGZiYjM3ZTU0Zjc0YWNjNGY4MmEzYzgwY2Y4NC90YWJsZXJhbmdlOmU5M2VkZmJiMzdlNTRmNzRhY2M0ZjgyYTNjODBjZjg0XzMtMy0xLTEtNTg1Mzc_755561ef-025e-4775-9609-f56bb177e969"
      unitRef="usd">24800000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTUvZnJhZzplMTAzNzBhODA1Mjg0MTU3YWZjYWYyZDEwZWI1NTQ4YS90ZXh0cmVnaW9uOmUxMDM3MGE4MDUyODQxNTdhZmNhZjJkMTBlYjU1NDhhXzc3MA_48dcd173-271a-4f1c-801e-5d047395f633"
      unitRef="usd">256400000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzEwNDYz_8529556f-ca48-4fff-b9a0-50b1256acb19">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Note 9. Stock Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;2007 Long-Term Incentive Plan (2007 Plan)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;In March 2007, we received stockholder approval of the 2007 Plan. The 2007 Plan was subsequently amended and restated, and granted stockholder approval in March 2009, March 2011, and March 2016.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Third Amended and Restated 2007 Plan is designed to increase our stockholder value by attracting, retaining and motivating key employees and consultants who directly influence our profitability. The Third Amended and Restated 2007 Plan authorizes either our Board of Directors, or a designated committee thereof composed of two or more Non-Employee Directors, to grant to eligible individuals during the period ending December&#160;31, 2026, up to 6,930,000 shares in the form of specified equity awards including stock options, restricted stock units and performance share awards, subject to adjustment for future stock splits, stock dividends, expirations, forfeitures and similar events. RSUs have no dividend or voting rights prior to vesting. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;As of October&#160;31, 2022, 690,596 shares remained available under the Third Amended and Restated 2007 Plan for future grants. The amount of available shares includes shares which may be distributed under performance share awards.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Compensation expense and the related tax benefit recognized in our Consolidated Statements of Income for share-based awards, including the Employee Stock Purchase Plan, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.593%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;October 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;46.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;38.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;32.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;54.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;44.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;38.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Related income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Stock Options &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The fair value of each stock option award granted is estimated on the date of grant using the Black-Scholes option valuation model and assumptions noted in the following table. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.037%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Years Ended October&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.1 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.0 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.4 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;25.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;30.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;24.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The activity and status of our stock option plans are summarized below: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&#160;Price&lt;br/&gt;Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Outstanding at October&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;972,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;245.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;122,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;403.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(26,866)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;171.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(4,743)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;325.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Outstanding at October&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,063,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;264.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest at October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,038,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;262.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;38,806,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Vested and exercisable at October&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;624,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;223.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.57&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;35,586,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The weighted-average fair value of options granted during fiscal 2022, 2021 and 2020, estimated as of the grant date using the Black-Scholes option pricing model, for the 2007 Plan was $90.41, $84.10 and $70.45, respectively. The total intrinsic value of options exercised during the fiscal years ended October&#160;31, 2022, 2021 and 2020 was $6.6&#160;million, $64.7&#160;million and $22.6&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Stock options outstanding under our current plans have been granted at prices which are either equal to or above the market value of the common stock on the date of grant. Options granted under the 2007 Plan generally vest over a range of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzY3ODM_6bc749ef-684e-4774-a7cb-72940d101aed"&gt;three&lt;/span&gt; to five years based on service conditions and expire no later than ten years after the grant date. Options granted under the 2020 Directors' Plan generally vest in one year and expire no later than ten years after the grant date. We generally recognize compensation expense ratably over the vesting period. As of October&#160;31, 2022, there was &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;$21.0&#160;million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt; of total unrecognized compensation cost related to nonvested options, which is expected to be recognized over a remaining weighted-average vesting period of 2.3 years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;RSUs granted under the 2007 Plan generally vest over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzc1MjA_66aa3933-ae43-4ccf-b4c9-c3b93a1275c1"&gt;three&lt;/span&gt; to five years. The grant-date fair value of RSUs is estimated based on the market price of our common stock. We recognize compensation expense ratably over the vesting period. As of October&#160;31, 2022, there was &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;$64.4&#160;million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt; of total unrecognized compensation cost related to nonvested RSUs, which is expected to be recognized over a remaining weighted-average vesting period of 2.5 years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The status of our non-vested RSUs is summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.248%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.190%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant&#160;Date&#160;Fair&lt;br/&gt;Value&#160;Per&#160;Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Non-vested RSUs at October&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;317,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;293.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;113,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;399.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Vested and issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(113,301)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;271.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(27,875)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;324.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Non-vested RSUs at October&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;289,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;340.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Performance Units&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Performance units may be granted to selected key employees with vesting contingent upon meeting future reported earnings per share goals over a defined performance cycle, usually three years. Performance units, if earned, may be paid in cash or shares of common stock. We granted performance unit awards on December 8, 2020 under the 2007 Plan. The performance shares actually earned will range from zero to 200% of the target number of performance shares for performance periods ending in fiscal 2021 through fiscal 2024. Subject to limited exceptions set forth in the performance share plan, any shares earned will be distributed in the subsequent fiscal year after the performance period. The fair value of performance unit awards is estimated on the date of grant based on the current market price of our common stock and the estimate of probability of award achievement. This estimate is reviewed each fiscal quarter and adjustments are recorded if it is determined that the estimate of probability of award achievement has changed.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;We recognize compensation expense ratably over the vesting period. As of October&#160;31, 2022, there was $11.2&#160;million of total unrecognized compensation cost related to non-vested performance units, which is expected to be recognized over a remaining weighted-average vesting period of 1.8 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;On March 18, 2019, the Company received stockholder approval for the Employee Stock Purchase Plan (ESPP). The first offering period began on November 4, 2019 and offerings are generally made on a quarterly basis. The purpose of the ESPP is to provide eligible employees of the Company with the opportunity to acquire shares of common stock at 85% of the market price on the last business day of each offering period by means of accumulated payroll deductions. The ESPP initially authorized the issuance of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;1,000,000&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt; shares of common stock. These shares will be made available from shares of common stock reacquired by the Company as Treasury Stock. During fiscal 2022 and 2021, we issued 22,695 and 17,575 shares to our employees under the ESPP, respectively. At October&#160;31, 2022, the number of shares remaining available for future issuance under the ESPP was 948,090 shares. Total ESPP share-based compensation recognized during fiscal 2022 and 2021 was $1.1&#160;million and $1.0 million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <coo:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee
      contextRef="iaaeec49689584b009b3148ed2f1bb819_D20160301-20160331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzI4NDc_309da2b7-914c-4241-9ce5-8080872fb75d"
      unitRef="director">2</coo:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ic2850480bc384efa8b688e7df1dd278a_I20160331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzI5NjU_b381f079-990d-4844-ac87-f83a44eadad6"
      unitRef="shares">6930000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i5a96f2cd61fa40c1b78c32485036c8cf_I20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzQ0ODI_002d3b8a-1d5e-4981-bc11-b57016b0d7ce"
      unitRef="shares">690596</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzEwNDcx_2b50d2a1-b57a-4847-abe7-d9a4ad1e713d">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Compensation expense and the related tax benefit recognized in our Consolidated Statements of Income for share-based awards, including the Employee Stock Purchase Plan, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.593%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;October 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;46.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;38.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;32.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;54.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;44.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;38.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Related income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i628a683f9df74396a991320942dabd37_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo1ZWI1NWFiYzEwOTI0MGQ0ODUyMjY4YjJjOWY5YWVkYi90YWJsZXJhbmdlOjVlYjU1YWJjMTA5MjQwZDQ4NTIyNjhiMmM5ZjlhZWRiXzItMS0xLTEtNTg1Mzc_b8ee1141-5483-4058-9d72-1be4877d473b"
      unitRef="usd">46700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia678a09e2bb14a1d80e45900f2d335b2_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo1ZWI1NWFiYzEwOTI0MGQ0ODUyMjY4YjJjOWY5YWVkYi90YWJsZXJhbmdlOjVlYjU1YWJjMTA5MjQwZDQ4NTIyNjhiMmM5ZjlhZWRiXzItMy0xLTEtNTg1Mzc_acdb358d-07ac-48be-b873-ec8af77d0273"
      unitRef="usd">38400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i34c6e3ecdc714534b64a27e81133d571_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo1ZWI1NWFiYzEwOTI0MGQ0ODUyMjY4YjJjOWY5YWVkYi90YWJsZXJhbmdlOjVlYjU1YWJjMTA5MjQwZDQ4NTIyNjhiMmM5ZjlhZWRiXzItNS0xLTEtNTg1Mzc_51baf0eb-852b-4b8d-a908-c1c8f31b876f"
      unitRef="usd">32200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3a728882a111429c8b376cccf1bd73ef_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo1ZWI1NWFiYzEwOTI0MGQ0ODUyMjY4YjJjOWY5YWVkYi90YWJsZXJhbmdlOjVlYjU1YWJjMTA5MjQwZDQ4NTIyNjhiMmM5ZjlhZWRiXzMtMS0xLTEtNTg1Mzc_f656f854-f12f-49e1-a7fc-d9c019272f3b"
      unitRef="usd">4500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id3c66c33e415421ca03a2aadddb8dbaa_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo1ZWI1NWFiYzEwOTI0MGQ0ODUyMjY4YjJjOWY5YWVkYi90YWJsZXJhbmdlOjVlYjU1YWJjMTA5MjQwZDQ4NTIyNjhiMmM5ZjlhZWRiXzMtMy0xLTEtNTg1Mzc_5a68a865-f572-41b0-991e-bca6e6d4fdcd"
      unitRef="usd">3900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i60fe14742746448cac80ed3337c5356e_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo1ZWI1NWFiYzEwOTI0MGQ0ODUyMjY4YjJjOWY5YWVkYi90YWJsZXJhbmdlOjVlYjU1YWJjMTA5MjQwZDQ4NTIyNjhiMmM5ZjlhZWRiXzMtNS0xLTEtNTg1Mzc_65fe3493-ddec-4aa8-a798-e76da5845879"
      unitRef="usd">4000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i74e4fb1d833e4139a5e462dc894a6a8c_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo1ZWI1NWFiYzEwOTI0MGQ0ODUyMjY4YjJjOWY5YWVkYi90YWJsZXJhbmdlOjVlYjU1YWJjMTA5MjQwZDQ4NTIyNjhiMmM5ZjlhZWRiXzQtMS0xLTEtNTg1Mzc_84a2a1dc-b29f-44d5-9010-96f94a485422"
      unitRef="usd">3000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9e7be87b88184c459d07d5e3a87d0602_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo1ZWI1NWFiYzEwOTI0MGQ0ODUyMjY4YjJjOWY5YWVkYi90YWJsZXJhbmdlOjVlYjU1YWJjMTA5MjQwZDQ4NTIyNjhiMmM5ZjlhZWRiXzQtMy0xLTEtNTg1Mzc_d2c0a08f-39b9-4537-8d40-041496d037d8"
      unitRef="usd">2400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5316f98d06b94776b210ad2c61336af0_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo1ZWI1NWFiYzEwOTI0MGQ0ODUyMjY4YjJjOWY5YWVkYi90YWJsZXJhbmdlOjVlYjU1YWJjMTA5MjQwZDQ4NTIyNjhiMmM5ZjlhZWRiXzQtNS0xLTEtNTg1Mzc_e2b7136a-36f2-4aa4-a334-14d9018faea9"
      unitRef="usd">2400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo1ZWI1NWFiYzEwOTI0MGQ0ODUyMjY4YjJjOWY5YWVkYi90YWJsZXJhbmdlOjVlYjU1YWJjMTA5MjQwZDQ4NTIyNjhiMmM5ZjlhZWRiXzUtMS0xLTEtNTg1Mzc_37539f08-8c90-421f-9505-be7b7fef6b50"
      unitRef="usd">54200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo1ZWI1NWFiYzEwOTI0MGQ0ODUyMjY4YjJjOWY5YWVkYi90YWJsZXJhbmdlOjVlYjU1YWJjMTA5MjQwZDQ4NTIyNjhiMmM5ZjlhZWRiXzUtMy0xLTEtNTg1Mzc_ed1aa1a5-30a7-4f33-a62c-dff277ec6e15"
      unitRef="usd">44700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo1ZWI1NWFiYzEwOTI0MGQ0ODUyMjY4YjJjOWY5YWVkYi90YWJsZXJhbmdlOjVlYjU1YWJjMTA5MjQwZDQ4NTIyNjhiMmM5ZjlhZWRiXzUtNS0xLTEtNTg1Mzc_3acc71f2-467c-46ac-b868-d080f346e0c5"
      unitRef="usd">38600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo1ZWI1NWFiYzEwOTI0MGQ0ODUyMjY4YjJjOWY5YWVkYi90YWJsZXJhbmdlOjVlYjU1YWJjMTA5MjQwZDQ4NTIyNjhiMmM5ZjlhZWRiXzYtMS0xLTEtNTg1Mzc_9be3bb2b-dcc4-4a0a-9e10-d584b776951a"
      unitRef="usd">5000000.0</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo1ZWI1NWFiYzEwOTI0MGQ0ODUyMjY4YjJjOWY5YWVkYi90YWJsZXJhbmdlOjVlYjU1YWJjMTA5MjQwZDQ4NTIyNjhiMmM5ZjlhZWRiXzYtMy0xLTEtNTg1Mzc_7d3b80b5-6880-44b9-9353-1d3fc6d32eca"
      unitRef="usd">5600000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo1ZWI1NWFiYzEwOTI0MGQ0ODUyMjY4YjJjOWY5YWVkYi90YWJsZXJhbmdlOjVlYjU1YWJjMTA5MjQwZDQ4NTIyNjhiMmM5ZjlhZWRiXzYtNS0xLTEtNTg1Mzc_e7dd9176-5a0f-4528-84ed-9c2b5467a24b"
      unitRef="usd">4800000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzEwNDQ2_eaa8905e-b704-4202-8efb-5d67720cc53a">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.037%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Years Ended October&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.1 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.0 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.4 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;25.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;30.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;24.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;0.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="iadbfb62be93b49f19b18d5333619cf75_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo2ODg1NzJiNmRjNzk0MDVlYjYwMDAyOTA1NDM5MWY2Mi90YWJsZXJhbmdlOjY4ODU3MmI2ZGM3OTQwNWViNjAwMDI5MDU0MzkxZjYyXzEtMS0xLTEtNTg1Mzc_6dfd0e2e-22d8-47c4-b9e0-84fdcb58c683">P4Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ib43f171b08e2457494485fe6afa22232_D20201101-20211031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo2ODg1NzJiNmRjNzk0MDVlYjYwMDAyOTA1NDM5MWY2Mi90YWJsZXJhbmdlOjY4ODU3MmI2ZGM3OTQwNWViNjAwMDI5MDU0MzkxZjYyXzEtMy0xLTEtNTg1Mzc_a4cd4b12-4793-49fd-b72a-c747bd76343a">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo2ODg1NzJiNmRjNzk0MDVlYjYwMDAyOTA1NDM5MWY2Mi90YWJsZXJhbmdlOjY4ODU3MmI2ZGM3OTQwNWViNjAwMDI5MDU0MzkxZjYyXzEtNS0xLTEtNTg1Mzc_5252a810-bdc5-464e-9e83-d14b3f869e18">P4Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="iadbfb62be93b49f19b18d5333619cf75_D20211101-20221031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo2ODg1NzJiNmRjNzk0MDVlYjYwMDAyOTA1NDM5MWY2Mi90YWJsZXJhbmdlOjY4ODU3MmI2ZGM3OTQwNWViNjAwMDI5MDU0MzkxZjYyXzItMS0xLTEtNTg1Mzc_404f40a8-3cfd-48b3-9c63-bfcea2ceae4c"
      unitRef="number">0.258</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ib43f171b08e2457494485fe6afa22232_D20201101-20211031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo2ODg1NzJiNmRjNzk0MDVlYjYwMDAyOTA1NDM5MWY2Mi90YWJsZXJhbmdlOjY4ODU3MmI2ZGM3OTQwNWViNjAwMDI5MDU0MzkxZjYyXzItMy0xLTEtNTg1Mzc_7b370501-2103-4f12-8710-35ed33f1261f"
      unitRef="number">0.303</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i14f3575ceef54408bd5ad9d8562d1bb6_D20191101-20201031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo2ODg1NzJiNmRjNzk0MDVlYjYwMDAyOTA1NDM5MWY2Mi90YWJsZXJhbmdlOjY4ODU3MmI2ZGM3OTQwNWViNjAwMDI5MDU0MzkxZjYyXzItNS0xLTEtNTg1Mzc_4f24274d-6bdb-4a7f-b11d-e0c0d3277583"
      unitRef="number">0.245</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="iadbfb62be93b49f19b18d5333619cf75_D20211101-20221031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo2ODg1NzJiNmRjNzk0MDVlYjYwMDAyOTA1NDM5MWY2Mi90YWJsZXJhbmdlOjY4ODU3MmI2ZGM3OTQwNWViNjAwMDI5MDU0MzkxZjYyXzMtMS0xLTEtNTg1Mzc_cc147c2e-ffa3-4cb3-ba02-dc920a277db5"
      unitRef="number">0.011</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ib43f171b08e2457494485fe6afa22232_D20201101-20211031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo2ODg1NzJiNmRjNzk0MDVlYjYwMDAyOTA1NDM5MWY2Mi90YWJsZXJhbmdlOjY4ODU3MmI2ZGM3OTQwNWViNjAwMDI5MDU0MzkxZjYyXzMtMy0xLTEtNTg1Mzc_72bbe32f-6d8c-47f9-88da-c1ef5ad090d8"
      unitRef="number">0.003</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i14f3575ceef54408bd5ad9d8562d1bb6_D20191101-20201031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo2ODg1NzJiNmRjNzk0MDVlYjYwMDAyOTA1NDM5MWY2Mi90YWJsZXJhbmdlOjY4ODU3MmI2ZGM3OTQwNWViNjAwMDI5MDU0MzkxZjYyXzMtNS0xLTEtNTg1Mzc_d7bfa7d9-9ba2-430d-b05b-25d036d21afc"
      unitRef="number">0.016</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="iadbfb62be93b49f19b18d5333619cf75_D20211101-20221031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo2ODg1NzJiNmRjNzk0MDVlYjYwMDAyOTA1NDM5MWY2Mi90YWJsZXJhbmdlOjY4ODU3MmI2ZGM3OTQwNWViNjAwMDI5MDU0MzkxZjYyXzQtMS0xLTEtNTg1Mzc_766cd154-3a44-4ed3-a24a-c66857012303"
      unitRef="number">0.0002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ib43f171b08e2457494485fe6afa22232_D20201101-20211031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo2ODg1NzJiNmRjNzk0MDVlYjYwMDAyOTA1NDM5MWY2Mi90YWJsZXJhbmdlOjY4ODU3MmI2ZGM3OTQwNWViNjAwMDI5MDU0MzkxZjYyXzQtMy0xLTEtNTg1Mzc_0f5c52ce-3119-4b91-b302-59833eaf48f7"
      unitRef="number">0.0002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i14f3575ceef54408bd5ad9d8562d1bb6_D20191101-20201031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo2ODg1NzJiNmRjNzk0MDVlYjYwMDAyOTA1NDM5MWY2Mi90YWJsZXJhbmdlOjY4ODU3MmI2ZGM3OTQwNWViNjAwMDI5MDU0MzkxZjYyXzQtNS0xLTEtNTg1Mzc_1b4e11b8-d9d5-4abb-bec8-824dc80e141b"
      unitRef="number">0.0002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzEwNDg1_33a4820c-58fb-40ee-94e8-fac42ca2f69f">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The activity and status of our stock option plans are summarized below: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&#160;Price&lt;br/&gt;Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Outstanding at October&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;972,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;245.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;122,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;403.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(26,866)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;171.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(4,743)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;325.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Outstanding at October&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,063,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;264.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest at October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,038,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;262.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;38,806,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Vested and exercisable at October&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;624,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;223.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.57&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;35,586,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i53613739fd6240a4ade0fbe47617e606_I20211031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzEtMS0xLTEtNTg1Mzc_84663534-1d07-466b-9dff-e9ca78dccc86"
      unitRef="shares">972692</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i53613739fd6240a4ade0fbe47617e606_I20211031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzEtMy0xLTEtNTg1Mzc_bb8ed2ff-1153-4638-9110-8c63088a2303"
      unitRef="usdPerShare">245.09</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="iadbfb62be93b49f19b18d5333619cf75_D20211101-20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzItMS0xLTEtNTg1Mzc_766770ff-d9dd-4066-8cd7-d78710c43bfa"
      unitRef="shares">122760</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="iadbfb62be93b49f19b18d5333619cf75_D20211101-20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzItMy0xLTEtNTg1Mzc_c54cfe28-24c0-4ae1-aed6-752e73e9c92f"
      unitRef="usdPerShare">403.44</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="iadbfb62be93b49f19b18d5333619cf75_D20211101-20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzMtMS0xLTEtNTg1Mzc_a96a0e62-43cf-45f3-aedb-1dc1f3a9654c"
      unitRef="shares">26866</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="iadbfb62be93b49f19b18d5333619cf75_D20211101-20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzMtMy0xLTEtNTg1Mzc_47ac4b09-fafa-4be7-b641-c337d22c8ef8"
      unitRef="usdPerShare">171.87</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="iadbfb62be93b49f19b18d5333619cf75_D20211101-20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzQtMS0xLTEtNTg1Mzc_3641f33b-9422-4947-a7ad-40467ed3807f"
      unitRef="shares">4743</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="iadbfb62be93b49f19b18d5333619cf75_D20211101-20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzQtMy0xLTEtNTg1Mzc_61f46486-d2e8-483c-aaa7-e7fa424c11d8"
      unitRef="usdPerShare">325.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i7bf32de8054e4d5cb01fb90b42cafafc_I20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzUtMS0xLTEtNTg1Mzc_3e232295-a0e0-49b5-8f20-a77fec293838"
      unitRef="shares">1063843</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i7bf32de8054e4d5cb01fb90b42cafafc_I20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzUtMy0xLTEtNTg1Mzc_4ca19fd6-1356-4b18-ae36-7a74e6e7e922"
      unitRef="usdPerShare">264.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="iadbfb62be93b49f19b18d5333619cf75_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzUtNS0xLTEtNTg1Mzc_621769ec-9ec7-4129-a89f-2c885ee8f15a">P5Y9M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzYtMS0xLTEtNTg1Mzc_713acebd-e9ed-48e0-b9b8-60bf51a211ea"
      unitRef="shares">1038594</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzYtMy0xLTEtNTg1Mzc_80e9dbfc-433a-4540-bd11-fb225f0be88e"
      unitRef="usdPerShare">262.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzYtNS0xLTEtNTg1Mzc_0db6b12f-ab3e-49bc-a382-5d73beaadf76">P5Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzYtNy0xLTEtNTg1Mzc_ae19cd0d-3934-494d-8414-b84692573a7b"
      unitRef="usd">38806329</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzctMS0xLTEtNTg1Mzc_749ecba6-0fb0-47bd-b68e-9ffc57ac10d3"
      unitRef="shares">624512</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzctMy0xLTEtNTg1Mzc_36d4e9c8-397d-44a8-becb-08dc57146eee"
      unitRef="usdPerShare">223.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzctNS0xLTEtNTg1Mzc_7c313e03-5947-4fe8-bacd-fd68b1e83a2c">P4Y6M25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZTo5OGZlZTFmZGYyYjg0MTMxODU2ODNiNTQxNDkzYWMzZi90YWJsZXJhbmdlOjk4ZmVlMWZkZjJiODQxMzE4NTY4M2I1NDE0OTNhYzNmXzctNy0xLTEtNTg1Mzc_6301802d-731e-45bc-9a34-5163f477f3f7"
      unitRef="usd">35586767</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i36efa04f987e49038157484c638ab7d6_D20211101-20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzQ5NDc4MDIzNTQyMDA_ff61c6f1-ff75-4691-bed8-5149aaf3728c"
      unitRef="usdPerShare">90.41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i27ec16ba40e149c58fa3c4003f0419fa_D20201101-20211031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzU0OTc1NTg0MjIxOA_4a31852f-fb22-450e-841e-840eee13407e"
      unitRef="usdPerShare">84.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i8f3a691bb67a4ed98d8c94bd5d067867_D20191101-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzU0OTc1NTg0MjIyNg_bddca365-9d14-4060-acbf-145ea8a3ea74"
      unitRef="usdPerShare">70.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i36efa04f987e49038157484c638ab7d6_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzI3NDg3NzkwOTg0OTM_41120ab7-ed08-4c5a-8f5f-53f959726dff"
      unitRef="usd">6600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i27ec16ba40e149c58fa3c4003f0419fa_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzY1MTc_e7f1beea-243b-47eb-a9bd-1c7e083da46a"
      unitRef="usd">64700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i8f3a691bb67a4ed98d8c94bd5d067867_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzY1MjQ_54546418-67f3-4472-b935-2e722ed02a7a"
      unitRef="usd">22600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i2a6b156ffce448468a38a7cb9a9f5284_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzY3ODk_413fef31-df53-42c0-8fcf-459508f41fd3">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i36efa04f987e49038157484c638ab7d6_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzY4NDU_1e7b3389-de97-4fad-a95f-8e21c1e0a09a">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i45529f605588475bb1f13e0535eaa215_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzY5MzU_ff411f84-45c3-41ea-b662-f3bad2490f07">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i45529f605588475bb1f13e0535eaa215_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzY5NjM_1b26c1c2-94ad-460f-84f6-27e7d1410930">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzI3NDg3NzkwOTg1MjE_c17db738-1421-428b-b270-a7f8644effe7"
      unitRef="usd">21000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="iadbfb62be93b49f19b18d5333619cf75_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzI3NDg3NzkwOTg1NDI_747a2d8d-8684-4cff-a91d-d3b034c183c5">P2Y3M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i27a4fb29e4284efe98e1175e5c0e2891_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzc1MjY_107651d6-1423-40ea-b229-ae2f86eefdae">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i2e988aefd55b4136aafbe1e6601e0d10_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzI3NDg3NzkwOTg1NjU_4783dc7f-225c-4cc2-83c1-c40efe4c37ae"
      unitRef="usd">64400000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i57f5c7d0d50a48669bf760069cb4c005_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzc5NDg_58dd37de-538b-4936-a4bf-c47c0802cfbb">P2Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzEwNDg5_6d9482d3-e77b-408f-bc8b-74d699444ec1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The status of our non-vested RSUs is summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.248%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.190%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant&#160;Date&#160;Fair&lt;br/&gt;Value&#160;Per&#160;Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Non-vested RSUs at October&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;317,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;293.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;113,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;399.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Vested and issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(113,301)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;271.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(27,875)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;324.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Non-vested RSUs at October&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;289,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;340.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i55102374da8b426cb0c7d8637de24dc2_I20211031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZToxNDA5NjVmYjAzZDY0NWU2YjNlY2M1MTdiNmQzYjg3My90YWJsZXJhbmdlOjE0MDk2NWZiMDNkNjQ1ZTZiM2VjYzUxN2I2ZDNiODczXzEtMS0xLTEtNTg1Mzc_f760b392-2071-400f-8174-f8d3a8a1229b"
      unitRef="shares">317335</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i55102374da8b426cb0c7d8637de24dc2_I20211031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZToxNDA5NjVmYjAzZDY0NWU2YjNlY2M1MTdiNmQzYjg3My90YWJsZXJhbmdlOjE0MDk2NWZiMDNkNjQ1ZTZiM2VjYzUxN2I2ZDNiODczXzEtMy0xLTEtNTg1Mzc_951cc14a-b081-4ef7-a467-bf43d3d06c37"
      unitRef="usdPerShare">293.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i57f5c7d0d50a48669bf760069cb4c005_D20211101-20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZToxNDA5NjVmYjAzZDY0NWU2YjNlY2M1MTdiNmQzYjg3My90YWJsZXJhbmdlOjE0MDk2NWZiMDNkNjQ1ZTZiM2VjYzUxN2I2ZDNiODczXzItMS0xLTEtNTg1Mzc_514a1854-4ad5-4092-8943-9087402bb120"
      unitRef="shares">113079</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i57f5c7d0d50a48669bf760069cb4c005_D20211101-20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZToxNDA5NjVmYjAzZDY0NWU2YjNlY2M1MTdiNmQzYjg3My90YWJsZXJhbmdlOjE0MDk2NWZiMDNkNjQ1ZTZiM2VjYzUxN2I2ZDNiODczXzItMy0xLTEtNTg1Mzc_58d44bcd-5280-42ff-a76b-77afc24e0773"
      unitRef="usdPerShare">399.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i57f5c7d0d50a48669bf760069cb4c005_D20211101-20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZToxNDA5NjVmYjAzZDY0NWU2YjNlY2M1MTdiNmQzYjg3My90YWJsZXJhbmdlOjE0MDk2NWZiMDNkNjQ1ZTZiM2VjYzUxN2I2ZDNiODczXzMtMS0xLTEtNTg1Mzc_a98f6f63-fc95-4c67-a323-2190803b68e3"
      unitRef="shares">113301</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i57f5c7d0d50a48669bf760069cb4c005_D20211101-20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZToxNDA5NjVmYjAzZDY0NWU2YjNlY2M1MTdiNmQzYjg3My90YWJsZXJhbmdlOjE0MDk2NWZiMDNkNjQ1ZTZiM2VjYzUxN2I2ZDNiODczXzMtMy0xLTEtNTg1Mzc_65d32e93-fcb6-48ec-a5ff-23c19b56f202"
      unitRef="usdPerShare">271.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i57f5c7d0d50a48669bf760069cb4c005_D20211101-20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZToxNDA5NjVmYjAzZDY0NWU2YjNlY2M1MTdiNmQzYjg3My90YWJsZXJhbmdlOjE0MDk2NWZiMDNkNjQ1ZTZiM2VjYzUxN2I2ZDNiODczXzQtMS0xLTEtNTg1Mzc_80fd9249-6081-4c0f-9959-b5e3f1c59c22"
      unitRef="shares">27875</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i57f5c7d0d50a48669bf760069cb4c005_D20211101-20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZToxNDA5NjVmYjAzZDY0NWU2YjNlY2M1MTdiNmQzYjg3My90YWJsZXJhbmdlOjE0MDk2NWZiMDNkNjQ1ZTZiM2VjYzUxN2I2ZDNiODczXzQtMy0xLTEtNTg1Mzc_e3b5f7c8-267c-4b5c-822c-48fed9ef886a"
      unitRef="usdPerShare">324.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i2e988aefd55b4136aafbe1e6601e0d10_I20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZToxNDA5NjVmYjAzZDY0NWU2YjNlY2M1MTdiNmQzYjg3My90YWJsZXJhbmdlOjE0MDk2NWZiMDNkNjQ1ZTZiM2VjYzUxN2I2ZDNiODczXzUtMS0xLTEtNTg1Mzc_a1e342bf-a851-479a-aca4-398c6b390eb1"
      unitRef="shares">289238</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i2e988aefd55b4136aafbe1e6601e0d10_I20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90YWJsZToxNDA5NjVmYjAzZDY0NWU2YjNlY2M1MTdiNmQzYjg3My90YWJsZXJhbmdlOjE0MDk2NWZiMDNkNjQ1ZTZiM2VjYzUxN2I2ZDNiODczXzUtMy0xLTEtNTg1Mzc_0bf580f5-fba9-40ad-8fde-ab8c8507836c"
      unitRef="usdPerShare">340.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i8553c50d62874816b3cf637114eb13b1_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzgyMTA_8641b635-a493-4e67-8ec1-8ad49feb5464">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <coo:ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned
      contextRef="i419dcfba3297431ba7f0c26398d2e903_D20211101-20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzg0MjI_4e0d3d99-8c7a-42f3-8238-dc3a721ad1cb"
      unitRef="number">0</coo:ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned>
    <coo:ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned
      contextRef="ieb72813cd59747189c7d292f82b5c7d5_D20211101-20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzg0Mjg_f738a903-da5e-4675-9cb1-734ae7c64607"
      unitRef="number">2</coo:ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="iaf39cdcb16094b55b8a7d809ab1a25b6_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzkxNDU_82432018-1b86-422b-99c5-8edf1c1f7845"
      unitRef="usd">11200000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i8553c50d62874816b3cf637114eb13b1_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzkzMTY_c179345f-6b4c-49e0-8216-f0b1624c6580">P1Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i342792221366432e9408d5dc0256f8b3_D20190318-20190318"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzk2OTM_cc9e33c7-2d85-40cd-8e33-64102655c7aa"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="id9037d5644ce4d68b1a7e215ab8301e5_I20190318"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzk5OTE_9302cb18-8ebc-4340-b6b7-1629df2cf1ee"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="i4291f2db677e4d3aa394368650faea88_D20211101-20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzEwMTY2_69eedb2d-f6eb-462e-879d-a8f91a75f53d"
      unitRef="shares">22695</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="i1a09d9736b484620af2ea6732aa8cf6f_D20201101-20211031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzEwMTcz_9337ccac-6647-4c8a-b68b-659911865760"
      unitRef="shares">17575</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i6b2d744fbde74052be31c86e76d32cdb_I20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzEwMzMx_384632c6-94a2-451f-bc2f-f4b9f5d255b4"
      unitRef="shares">948090</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4291f2db677e4d3aa394368650faea88_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzEwNDIx_d37851ad-e388-43d0-940b-5ba26b3dbb00"
      unitRef="usd">1100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1a09d9736b484620af2ea6732aa8cf6f_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMTgvZnJhZzpmMjY2MDVmYWRjMmQ0OWFlYWViZmJkZWNiM2EzODI5ZS90ZXh0cmVnaW9uOmYyNjYwNWZhZGMyZDQ5YWVhZWJmYmRlY2IzYTM4MjllXzEwNDI4_6fca45af-fdec-45d6-8457-77dbdf818315"
      unitRef="usd">1000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzY4MTY_921b1a1d-b5ee-4307-b793-72a8ddb97a57">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Cooper's Retirement Income Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company's Retirement Income Plan (Plan), a defined benefit plan, is only available to full-time United States employees, subject to the soft freeze mentioned below. The Company's contributions are designed to fund normal cost on a current basis and to fund the estimated prior service cost of benefit improvements. The unit credit actuarial cost method is used to determine the annual cost. The Company pays the entire cost of the Plan and funds such costs as they accrue. Virtually all of the assets of the Plan are comprised of equities and participation in equity and fixed income funds.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company uses individual spot rates along the yield curve that correspond with the timing of each benefit payment to determine the service and interest costs of components of its net periodic benefit cost utilizing the correlation of projected cash outflows and corresponding spot rates on the yield curve. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The following table sets forth the Plan's benefit obligations and fair value of the Plan assets at October&#160;31, 2022, 2021 and 2020 and the funded status of the Plan and net periodic pension costs for each of the years in the three-year periods ended October&#160;31, 2022. The net amounts recognized in the Consolidated Balance Sheets consist of noncurrent liabilities. The accumulated benefit obligation was $134.9 million, $207.6 million and $195.8 million for the years ended October&#160;31, 2022, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Retirement Income Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.049%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Benefit obligation, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;230.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;218.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;189.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;18.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzQtMC0xLTEtNTg1Mzc_111e8ddc-226d-4304-959a-b934b7d622c2"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzQtMC0xLTEtNTg1Mzc_36ebe715-6c70-4c33-ab4e-77078f30596f"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzQtMC0xLTEtNTg1Mzc_8ba49eaf-48ae-4cbc-b09c-7e9a7b0ad98d"&gt;Interest cost&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(13.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(11.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(10.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Actuarial (gain)/loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(93.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;20.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Benefit obligation, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;148.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;230.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;218.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Change in plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;199.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;159.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;136.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(43.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;38.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;12.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(13.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(11.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(10.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;142.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;199.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;159.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Funded status at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(5.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(31.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(59.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.049%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Amounts recognized in accumulated other comprehensive income consist of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;44.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;74.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;44.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;74.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.049%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Reconciliation of (prepaid) accrued pension cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(Prepaid)/Accrued pension cost at prior fiscal year end&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(13.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(14.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;12.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Contributions made during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(12.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(23.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(Prepaid)/Accrued pension cost at fiscal year end&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(13.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(14.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.049%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Components of net periodic benefit cost and other amounts recognized in the Consolidated Statements of Income:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;18.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzUtMC0xLTEtNTg1Mzc_07a95161-0974-465a-ac1c-175b72fdb90d"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzUtMC0xLTEtNTg1Mzc_34fc253a-7253-4b21-920e-c9ce51841c5c"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzUtMC0xLTEtNTg1Mzc_73a230e2-9634-4eba-833b-aa7156e9f4ce"&gt;Expected return on plan assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(15.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(12.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(10.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzgtMC0xLTEtNTg1Mzc_08e3d8ed-42a7-4cda-a134-26367a3edca1"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzgtMC0xLTEtNTg1Mzc_40c89b78-ce45-4552-a50e-59b206d64cbd"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzgtMC0xLTEtNTg1Mzc_c32484f2-1db6-4923-b0d9-5be0212a7130"&gt;Recognized actuarial loss&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net periodic pension cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;12.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.049%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Other changes in plan assets and benefit obligations recognized in other comprehensive income:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(34.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(24.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;20.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amortizations of net gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(5.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total recognized in other comprehensive (income) loss&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(36.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(29.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total recognized in net periodic benefit cost and other comprehensive (income) loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(26.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(15.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;29.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.049%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Years Ended October&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Weighted-average assumptions used in computing the net periodic pension cost and projected benefit obligation at year end:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Discount rate for determining net periodic pension cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Projected Benefit Obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Service Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Interest Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Discount rate for determining benefit obligations at year end&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase for determining expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase for determining benefit obligations at year end&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Expected rate of return on plan assets for determining net periodic pension cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Expected rate of return on plan assets at year end&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Measurement date for determining assets and benefit obligations at year end&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10/31/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10/31/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The discount rate enables us to state expected future cash flows at a present value on the measurement date. The discount rate used for the Plan is based primarily on the yields of a universe of high-quality corporate bonds rated AA or above, with durations corresponding to the expected durations of the benefit obligations. A change in the discount rate will cause the present value of benefit obligations to change in the opposite direction. If a discount rate of 2.76%, which is 0.02% lower than prior fiscal year, had been used, the projected benefit obligation would have been $217.2 million, and the accumulated benefit obligation would have been $194.2 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The expected rate of return on plan assets was determined based on a review of historical returns, both for this plan and for medium- to large-sized defined benefit pension funds with similar asset allocations. This review generated separate expected returns for each asset class listed below. These expected future returns were then blended based on this Plan's target asset allocation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Reasons for Significant Liability Gains and Losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The projected benefit obligation experienced a net gain of approximately $93.2&#160;million during the year. This net gain is primarily due to gains from assumption changes of approximately $97.1&#160;million, offset by losses of approximately $3.9&#160;million &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;due to demographic experience. The key assumption changes were the increase in the discount rate (gain of $72.7&#160;million), a change in the assumed payment form election probabilities (gain of $0.3&#160;million), and changes in assumptions for lump sum determination (gain of $24.1&#160;million). The primary reasons for demographic losses were the net effect of retirement rates, termination rates, salary increases and other experience that was different from assumed. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Plan Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Weighted-average asset allocations at year end, by asset category are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.719%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.450%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.450%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Years Ended October&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Asset category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Equity mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;65.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;62.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;57.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Hedging Strategy Funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Bond mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;27.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;26.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Plan invests in a diversified portfolio of assets intended to minimize risk of poor returns while maximizing expected portfolio returns. To achieve the long-term rate of return, plan assets will be invested in a mixture of instruments, including but not limited to, corporate common stock (may include the Company's stock), investment grade bond funds, cash, balanced funds, real estate funds, small or large cap equity funds and international equity funds. The allocation of assets will be determined by the investment manager and will typically include 50% to 70% equities with the remainder invested in fixed income, hedging strategy funds and cash. Presently, this diversified portfolio is expected to return roughly 8% in the long run.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;As of the measurement date of October&#160;31, 2022, the fair value measurement of plan assets is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.541%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.287%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.188%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;br/&gt;in Active&lt;br/&gt;Markets for&lt;br/&gt;Identical&#160;Assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Asset category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Equity mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;93.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;93.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Hedging Strategy Funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Bond mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;38.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;24.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;142.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;118.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;24.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Plan has an established process for determining the fair value of plan assets. For investments in equity and bond mutual funds, and real estate funds, fair value is based on observable, Level 1 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;While the Company believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Plan Cash Flows&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Contributions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company made no contributions to the Plan in fiscal 2022. The Company contributions to the Plan were $12.7&#160;million for fiscal 2021 and, $23.4&#160;million for fiscal 2020. The Company closely monitors the funded status of the Plan with respect to legislative and accounting rules. The Company does not expect to make a contribution to the Plan during fiscal 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Estimated Future Benefit Payments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2028-2032&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;66.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Plan Soft Freeze&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;On June 18, 2019 the Board of Directors of the Company approved a soft freeze of the Plan effective August 1, 2019. The Plan was closed to employees hired on or after August 1, 2019, including former participants or employees rehired on or after August 1, 2019 and employees hired in connection with a stock or asset acquisition, merger or other similar transaction on or after August 1, 2019. Existing employees already covered by the Plan, continue to accrue their benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Cooper's 401(k) Savings Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Cooper's 401(k) savings plan provides for the deferral of compensation as described in the Internal Revenue Code and is available to substantially all United States employees. Employees who participate in the 401(k) plan may elect to have up to 75% of their pre-tax salary or wages deferred and contributed to the trust established under the Plan. Cooper's contributions on account of participating employees, were $9.0 million, $7.2 million and $6.8 million for the years ended October&#160;31, 2022, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzY4MzI_a328962b-d602-4519-8ba7-745e788318b2">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The following table sets forth the Plan's benefit obligations and fair value of the Plan assets at October&#160;31, 2022, 2021 and 2020 and the funded status of the Plan and net periodic pension costs for each of the years in the three-year periods ended October&#160;31, 2022. The net amounts recognized in the Consolidated Balance Sheets consist of noncurrent liabilities. The accumulated benefit obligation was $134.9 million, $207.6 million and $195.8 million for the years ended October&#160;31, 2022, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Retirement Income Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.049%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Benefit obligation, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;230.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;218.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;189.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;18.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzQtMC0xLTEtNTg1Mzc_111e8ddc-226d-4304-959a-b934b7d622c2"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzQtMC0xLTEtNTg1Mzc_36ebe715-6c70-4c33-ab4e-77078f30596f"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzQtMC0xLTEtNTg1Mzc_8ba49eaf-48ae-4cbc-b09c-7e9a7b0ad98d"&gt;Interest cost&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(13.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(11.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(10.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Actuarial (gain)/loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(93.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;20.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Benefit obligation, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;148.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;230.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;218.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Change in plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;199.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;159.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;136.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(43.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;38.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;12.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(13.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(11.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(10.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;142.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;199.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;159.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Funded status at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(5.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(31.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(59.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzE3NTkyMTg2MDU5NzU2_b7c63d33-ee8f-4868-8342-8242f99beca6"
      unitRef="usd">134900000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzE3NTkyMTg2MDU5NzYy_7908d1cc-e0f7-41cf-8374-3f72f43db3be"
      unitRef="usd">207600000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation
      contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzE3NTkyMTg2MDU5ODA4_b9743713-214d-4174-83fe-aa4865829775"
      unitRef="usd">195800000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzItMS0xLTEtNTg1Mzc_e5dfc34c-0b34-4550-9c9f-a4af690b616d"
      unitRef="usd">230900000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzItMy0xLTEtNTg1Mzc_c489e2f7-5c2d-4351-be8b-030616fbd6cb"
      unitRef="usd">218800000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i5167c03ea3ab44e7b464a93ec06fc66e_I20191031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzItNS0xLTEtNTg1Mzc_33ff8018-06b5-4752-ab41-9386559c6783"
      unitRef="usd">189700000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzMtMS0xLTEtNTg1Mzc_a059f12c-ba3b-493e-8711-d40b73049188"
      unitRef="usd">18300000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzMtMy0xLTEtNTg1Mzc_fab976ab-18d4-4b7f-85ed-4b9721e5b79c"
      unitRef="usd">17200000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzMtNS0xLTEtNTg1Mzc_69d7d563-d882-419b-bc4d-636e10cc360b"
      unitRef="usd">13900000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzQtMS0xLTEtNTg1Mzc_40f6581d-af22-4bdd-b210-9c2e596cb61d"
      unitRef="usd">5100000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzQtMy0xLTEtNTg1Mzc_85cf87be-3887-487b-ae65-e40f1c08deb8"
      unitRef="usd">4400000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzQtNS0xLTEtNTg1Mzc_3922735f-0f1f-4967-bf8d-152e84b046ea"
      unitRef="usd">5200000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzUtMS0xLTEtNTg1Mzc_c9ce3a18-7d5c-44fa-a24c-3cbc7fddead5"
      unitRef="usd">13100000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzUtMy0xLTEtNTg1Mzc_41ee9c5a-074f-4fa0-86f8-ef80d5654572"
      unitRef="usd">11500000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzUtNS0xLTEtNTg1Mzc_748b18d5-8ebd-4390-ac1f-807c1d08f63b"
      unitRef="usd">10000000.0</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzctMS0xLTEtNTg1Mzc_b3389574-83de-4848-ad93-700d461a0e06"
      unitRef="usd">93200000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzctMy0xLTEtNTg1Mzc_71fd6b8c-69d5-468f-a015-f01b898c9cc5"
      unitRef="usd">-2000000.0</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzctNS0xLTEtNTg1Mzc_70964152-b1d0-4135-87f7-9637cfa6301d"
      unitRef="usd">-20000000.0</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzgtMS0xLTEtNTg1Mzc_f48384a4-c685-4ca6-82c2-966b8724f3f0"
      unitRef="usd">148000000.0</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzgtMy0xLTEtNTg1Mzc_e745ded4-b4b4-4e7f-a194-d5df019f5a5b"
      unitRef="usd">230900000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzgtNS0xLTEtNTg1Mzc_1f348857-028b-4681-b2ff-631da1ae3810"
      unitRef="usd">218800000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzEwLTEtMS0xLTU4NTM3_f2e747ba-2055-423f-8af6-a1e49da10532"
      unitRef="usd">199500000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzEwLTMtMS0xLTU4NTM3_b45c771c-7a9a-44f0-be89-35bbd0bc09e8"
      unitRef="usd">159500000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5167c03ea3ab44e7b464a93ec06fc66e_I20191031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzEwLTUtMS0xLTU4NTM3_98748e92-2ed4-4823-88ea-0de4f35a532c"
      unitRef="usd">136000000.0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzExLTEtMS0xLTU4NTM3_5481cb25-3799-40dc-8909-319fda0b12c1"
      unitRef="usd">-43500000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzExLTMtMS0xLTU4NTM3_6808ab58-2af1-43a3-aa85-45fd7a526524"
      unitRef="usd">38800000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzExLTUtMS0xLTU4NTM3_0883cc3a-b370-40bd-98e7-59508e91fdc8"
      unitRef="usd">10100000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzEyLTEtMS0xLTU4NTM3_2ee30d79-3622-4cd9-9cd9-600783cc361c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzEyLTMtMS0xLTU4NTM3_0db83d8e-ffbe-4b71-8bdf-70f18f600f54"
      unitRef="usd">12700000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzEyLTUtMS0xLTU4NTM3_40c937d7-a650-4ff6-ac24-4369de0d4151"
      unitRef="usd">23400000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzEzLTEtMS0xLTU4NTM3_9d5cabfb-aa09-44a9-b1cd-9d3764870c0a"
      unitRef="usd">13100000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzEzLTMtMS0xLTU4NTM3_0941d511-583d-4c9d-8126-1b80e08b5726"
      unitRef="usd">11500000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzEzLTUtMS0xLTU4NTM3_6f6cbc62-463e-4331-af6c-a8c94cbfe5cb"
      unitRef="usd">10000000.0</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzE0LTEtMS0xLTU4NTM3_abf7b95c-e087-4989-a525-ccfd0d690a8a"
      unitRef="usd">142900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzE0LTMtMS0xLTU4NTM3_306a9676-d354-4853-8284-c343812f01a7"
      unitRef="usd">199500000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzE0LTUtMS0xLTU4NTM3_d592bada-3269-4fc0-8a31-50cf3d4b814e"
      unitRef="usd">159500000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzE1LTEtMS0xLTU4NTM3_7bceb846-98d3-4d09-842b-a8e7932f28c2"
      unitRef="usd">-5100000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzE1LTMtMS0xLTU4NTM3_e202be1d-daac-420c-a8f9-4155641b3486"
      unitRef="usd">-31400000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo1OTAzNTc4MWM5MTQ0YjMzODMxYzhiNmFhNzhmMTM5Ni90YWJsZXJhbmdlOjU5MDM1NzgxYzkxNDRiMzM4MzFjOGI2YWE3OGYxMzk2XzE1LTUtMS0xLTU4NTM3_e3b7b120-674a-4bfc-a7df-8eb76715d901"
      unitRef="usd">-59300000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzY3NzQ_ca621a10-bf6c-4255-a9bd-236521f05a99">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.049%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Amounts recognized in accumulated other comprehensive income consist of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;44.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;74.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;44.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;74.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZToyMGEzNTA0Y2IzYWU0OThiYjhlNjNmODRmZjcyMzllOS90YWJsZXJhbmdlOjIwYTM1MDRjYjNhZTQ5OGJiOGU2M2Y4NGZmNzIzOWU5XzQtMS0xLTEtNTg1Mzc_604083cf-fa8d-4f4a-9015-33fcac5c2c02"
      unitRef="usd">-8000000.0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZToyMGEzNTA0Y2IzYWU0OThiYjhlNjNmODRmZjcyMzllOS90YWJsZXJhbmdlOjIwYTM1MDRjYjNhZTQ5OGJiOGU2M2Y4NGZmNzIzOWU5XzQtMy0xLTEtNTg1Mzc_ae7472c7-d47c-42c0-a9df-d25ef2318698"
      unitRef="usd">-44400000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZToyMGEzNTA0Y2IzYWU0OThiYjhlNjNmODRmZjcyMzllOS90YWJsZXJhbmdlOjIwYTM1MDRjYjNhZTQ5OGJiOGU2M2Y4NGZmNzIzOWU5XzQtNS0xLTEtNTg1Mzc_0a0406da-f29a-4d44-9ef8-d7a46337ca4e"
      unitRef="usd">-74200000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZToyMGEzNTA0Y2IzYWU0OThiYjhlNjNmODRmZjcyMzllOS90YWJsZXJhbmdlOjIwYTM1MDRjYjNhZTQ5OGJiOGU2M2Y4NGZmNzIzOWU5XzUtMS0xLTEtNTg1Mzc_067c51bb-6084-4e16-8cd7-376ab4258ecc"
      unitRef="usd">8000000.0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZToyMGEzNTA0Y2IzYWU0OThiYjhlNjNmODRmZjcyMzllOS90YWJsZXJhbmdlOjIwYTM1MDRjYjNhZTQ5OGJiOGU2M2Y4NGZmNzIzOWU5XzUtMy0xLTEtNTg1Mzc_b8fe8e2e-0fee-4dc1-bfc8-3dabbf97f22f"
      unitRef="usd">44400000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZToyMGEzNTA0Y2IzYWU0OThiYjhlNjNmODRmZjcyMzllOS90YWJsZXJhbmdlOjIwYTM1MDRjYjNhZTQ5OGJiOGU2M2Y4NGZmNzIzOWU5XzUtNS0xLTEtNTg1Mzc_a5c1a4c3-7c66-4406-ac65-3d266860c584"
      unitRef="usd">74200000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <coo:ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzY4NTE_5d43830a-6952-4ff7-807e-fd453cf820c7">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.049%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Reconciliation of (prepaid) accrued pension cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(Prepaid)/Accrued pension cost at prior fiscal year end&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(13.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(14.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;12.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Contributions made during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(12.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(23.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(Prepaid)/Accrued pension cost at fiscal year end&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(13.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(14.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;</coo:ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock>
    <coo:AccruedPrepaidPensionCosts
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowODk0NTQ2MDAwZDI0YTg5ODk3ZmExMmM3NDcwZGY4Ni90YWJsZXJhbmdlOjA4OTQ1NDYwMDBkMjRhODk4OTdmYTEyYzc0NzBkZjg2XzItMS0xLTEtNTg1Mzc_b9714f1f-7d07-4d63-ac10-6a095adbfaa4"
      unitRef="usd">-13000000.0</coo:AccruedPrepaidPensionCosts>
    <coo:AccruedPrepaidPensionCosts
      contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowODk0NTQ2MDAwZDI0YTg5ODk3ZmExMmM3NDcwZGY4Ni90YWJsZXJhbmdlOjA4OTQ1NDYwMDBkMjRhODk4OTdmYTEyYzc0NzBkZjg2XzItMy0xLTEtNTg1Mzc_b375453a-772b-4cea-abba-277570e4b02d"
      unitRef="usd">-14800000</coo:AccruedPrepaidPensionCosts>
    <coo:AccruedPrepaidPensionCosts
      contextRef="i5167c03ea3ab44e7b464a93ec06fc66e_I20191031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowODk0NTQ2MDAwZDI0YTg5ODk3ZmExMmM3NDcwZGY4Ni90YWJsZXJhbmdlOjA4OTQ1NDYwMDBkMjRhODk4OTdmYTEyYzc0NzBkZjg2XzItNS0xLTEtNTg1Mzc_ff74edc8-6fbe-4716-bc15-58b71af6644f"
      unitRef="usd">-3700000</coo:AccruedPrepaidPensionCosts>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowODk0NTQ2MDAwZDI0YTg5ODk3ZmExMmM3NDcwZGY4Ni90YWJsZXJhbmdlOjA4OTQ1NDYwMDBkMjRhODk4OTdmYTEyYzc0NzBkZjg2XzMtMS0xLTEtNTg1Mzc_cb22d3f8-fdd9-4ccc-9ac9-e957a2bf5439"
      unitRef="usd">10100000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowODk0NTQ2MDAwZDI0YTg5ODk3ZmExMmM3NDcwZGY4Ni90YWJsZXJhbmdlOjA4OTQ1NDYwMDBkMjRhODk4OTdmYTEyYzc0NzBkZjg2XzMtMy0xLTEtNTg1Mzc_bbde0642-e59e-4ecf-aa42-820af28bd696"
      unitRef="usd">14500000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowODk0NTQ2MDAwZDI0YTg5ODk3ZmExMmM3NDcwZGY4Ni90YWJsZXJhbmdlOjA4OTQ1NDYwMDBkMjRhODk4OTdmYTEyYzc0NzBkZjg2XzMtNS0xLTEtNTg1Mzc_93f4de72-7865-4748-95d6-a4923387293e"
      unitRef="usd">12300000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowODk0NTQ2MDAwZDI0YTg5ODk3ZmExMmM3NDcwZGY4Ni90YWJsZXJhbmdlOjA4OTQ1NDYwMDBkMjRhODk4OTdmYTEyYzc0NzBkZjg2XzQtMS0xLTEtNTg1Mzc_5ffa3eae-1039-4134-a391-250d0987b177"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowODk0NTQ2MDAwZDI0YTg5ODk3ZmExMmM3NDcwZGY4Ni90YWJsZXJhbmdlOjA4OTQ1NDYwMDBkMjRhODk4OTdmYTEyYzc0NzBkZjg2XzQtMy0xLTEtNTg1Mzc_3bdb3c3d-b9d3-4dc4-8d89-610f6083bfd9"
      unitRef="usd">12700000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowODk0NTQ2MDAwZDI0YTg5ODk3ZmExMmM3NDcwZGY4Ni90YWJsZXJhbmdlOjA4OTQ1NDYwMDBkMjRhODk4OTdmYTEyYzc0NzBkZjg2XzQtNS0xLTEtNTg1Mzc_9b611026-b658-474d-bc4a-68f93d014aa2"
      unitRef="usd">23400000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <coo:AccruedPrepaidPensionCosts
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowODk0NTQ2MDAwZDI0YTg5ODk3ZmExMmM3NDcwZGY4Ni90YWJsZXJhbmdlOjA4OTQ1NDYwMDBkMjRhODk4OTdmYTEyYzc0NzBkZjg2XzYtMS0xLTEtNTg1Mzc_2b4433da-4d4d-4620-80f0-2322866edb6d"
      unitRef="usd">-2900000</coo:AccruedPrepaidPensionCosts>
    <coo:AccruedPrepaidPensionCosts
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowODk0NTQ2MDAwZDI0YTg5ODk3ZmExMmM3NDcwZGY4Ni90YWJsZXJhbmdlOjA4OTQ1NDYwMDBkMjRhODk4OTdmYTEyYzc0NzBkZjg2XzYtMy0xLTEtNTg1Mzc_56b3712a-b35c-49a3-81f5-bfce5d91746b"
      unitRef="usd">-13000000.0</coo:AccruedPrepaidPensionCosts>
    <coo:AccruedPrepaidPensionCosts
      contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowODk0NTQ2MDAwZDI0YTg5ODk3ZmExMmM3NDcwZGY4Ni90YWJsZXJhbmdlOjA4OTQ1NDYwMDBkMjRhODk4OTdmYTEyYzc0NzBkZjg2XzYtNS0xLTEtNTg1Mzc_b01161fc-5da4-4067-852f-6cbaa837036f"
      unitRef="usd">-14800000</coo:AccruedPrepaidPensionCosts>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzY4NTg_1654d2a6-e4a8-4fdd-b824-16be988468be">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.049%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Components of net periodic benefit cost and other amounts recognized in the Consolidated Statements of Income:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;18.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzUtMC0xLTEtNTg1Mzc_07a95161-0974-465a-ac1c-175b72fdb90d"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzUtMC0xLTEtNTg1Mzc_34fc253a-7253-4b21-920e-c9ce51841c5c"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzUtMC0xLTEtNTg1Mzc_73a230e2-9634-4eba-833b-aa7156e9f4ce"&gt;Expected return on plan assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(15.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(12.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(10.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzgtMC0xLTEtNTg1Mzc_08e3d8ed-42a7-4cda-a134-26367a3edca1"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzgtMC0xLTEtNTg1Mzc_40c89b78-ce45-4552-a50e-59b206d64cbd"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzgtMC0xLTEtNTg1Mzc_c32484f2-1db6-4923-b0d9-5be0212a7130"&gt;Recognized actuarial loss&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net periodic pension cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;12.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzMtMS0xLTEtNTg1Mzc_fd2ae3a4-f5e7-4e80-9a9d-ebc834b76fcd"
      unitRef="usd">18300000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzMtMy0xLTEtNTg1Mzc_a34731d6-99a0-4845-9e39-3639c74d154a"
      unitRef="usd">17200000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzMtNS0xLTEtNTg1Mzc_07bab2b3-1805-46fc-b162-ee66300f302e"
      unitRef="usd">13900000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzQtMS0xLTEtNTg1Mzc_4bf827d7-6969-4637-919e-c62bb94f9d33"
      unitRef="usd">5100000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzQtMy0xLTEtNTg1Mzc_ede3ff50-68a1-4d42-a4ad-8fa64f9b620f"
      unitRef="usd">4400000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzQtNS0xLTEtNTg1Mzc_ed731229-c2e4-4bb7-ba76-f3ecd0195738"
      unitRef="usd">5200000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzUtMS0xLTEtNTg1Mzc_4d709e3a-de1f-4459-9995-f1f1228cd529"
      unitRef="usd">15500000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzUtMy0xLTEtNTg1Mzc_7d0ef009-32b7-4287-af60-3a190ff799c0"
      unitRef="usd">12500000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzUtNS0xLTEtNTg1Mzc_0b264eb1-4664-4a7d-8205-127a58e65273"
      unitRef="usd">10800000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzgtMS0xLTEtNTg1Mzc_86208c96-e140-4983-80ae-5a9b1c524595"
      unitRef="usd">-2200000</us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit>
    <us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzgtMy0xLTEtNTg1Mzc_7de0eece-8972-4c83-8d0b-3b59b45f376d"
      unitRef="usd">-5400000</us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit>
    <us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzgtNS0xLTEtNTg1Mzc_6d277249-e45f-4b66-a487-781c4819a3c9"
      unitRef="usd">-4000000.0</us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzktMS0xLTEtNTg1Mzc_830619b4-0deb-42a4-968b-3b651c2e2543"
      unitRef="usd">10100000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzktMy0xLTEtNTg1Mzc_65b55523-1e63-4ceb-bb77-fdaac6d238ff"
      unitRef="usd">14500000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMTZmNmQ4NzAzNWY0Mzk5OTc2ODRiYjBjZGQ1NzMyMC90YWJsZXJhbmdlOmExNmY2ZDg3MDM1ZjQzOTk5NzY4NGJiMGNkZDU3MzIwXzktNS0xLTEtNTg1Mzc_a623b436-b0c0-4b5e-bc27-7ce07afefe9e"
      unitRef="usd">12300000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzY3NzU_16af6f9c-d756-4e95-bfab-ef1fc59b6dd0">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.049%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years Ended October&#160;31,&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Other changes in plan assets and benefit obligations recognized in other comprehensive income:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(34.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(24.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;20.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amortizations of net gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(5.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total recognized in other comprehensive (income) loss&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(36.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(29.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total recognized in net periodic benefit cost and other comprehensive (income) loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(26.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(15.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;29.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo0ZTliNjkxOTc5MGU0ZTdlODAyYWUxNWQ3NGI3OTkzOC90YWJsZXJhbmdlOjRlOWI2OTE5NzkwZTRlN2U4MDJhZTE1ZDc0Yjc5OTM4XzQtMS0xLTEtNTg1Mzc_2b50d695-547c-4e48-83bb-3b496cd77bef"
      unitRef="usd">-34100000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo0ZTliNjkxOTc5MGU0ZTdlODAyYWUxNWQ3NGI3OTkzOC90YWJsZXJhbmdlOjRlOWI2OTE5NzkwZTRlN2U4MDJhZTE1ZDc0Yjc5OTM4XzQtMy0xLTEtNTg1Mzc_086f1171-595a-404c-b19d-bec1198e13f6"
      unitRef="usd">-24400000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo0ZTliNjkxOTc5MGU0ZTdlODAyYWUxNWQ3NGI3OTkzOC90YWJsZXJhbmdlOjRlOWI2OTE5NzkwZTRlN2U4MDJhZTE1ZDc0Yjc5OTM4XzQtNS0xLTEtNTg1Mzc_10cf517f-e277-43ab-9918-91d0d905e82c"
      unitRef="usd">20800000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo0ZTliNjkxOTc5MGU0ZTdlODAyYWUxNWQ3NGI3OTkzOC90YWJsZXJhbmdlOjRlOWI2OTE5NzkwZTRlN2U4MDJhZTE1ZDc0Yjc5OTM4XzctMS0xLTEtNTg1Mzc_55df281c-02b6-47dc-806c-b619b43d9670"
      unitRef="usd">2500000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo0ZTliNjkxOTc5MGU0ZTdlODAyYWUxNWQ3NGI3OTkzOC90YWJsZXJhbmdlOjRlOWI2OTE5NzkwZTRlN2U4MDJhZTE1ZDc0Yjc5OTM4XzctMy0xLTEtNTg1Mzc_d461f6f9-c1bd-4348-b574-6da06dc7f666"
      unitRef="usd">5400000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo0ZTliNjkxOTc5MGU0ZTdlODAyYWUxNWQ3NGI3OTkzOC90YWJsZXJhbmdlOjRlOWI2OTE5NzkwZTRlN2U4MDJhZTE1ZDc0Yjc5OTM4XzctNS0xLTEtNTg1Mzc_b1db127b-14f2-43df-aedd-94850e75a81b"
      unitRef="usd">4000000.0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo0ZTliNjkxOTc5MGU0ZTdlODAyYWUxNWQ3NGI3OTkzOC90YWJsZXJhbmdlOjRlOWI2OTE5NzkwZTRlN2U4MDJhZTE1ZDc0Yjc5OTM4XzExLTEtMS0xLTU4NTM3_2f50dd83-c232-405a-9914-e6afbb71ca34"
      unitRef="usd">-36600000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo0ZTliNjkxOTc5MGU0ZTdlODAyYWUxNWQ3NGI3OTkzOC90YWJsZXJhbmdlOjRlOWI2OTE5NzkwZTRlN2U4MDJhZTE1ZDc0Yjc5OTM4XzExLTMtMS0xLTU4NTM3_2eaafbd4-7519-47ed-8e54-8952624aec02"
      unitRef="usd">-29800000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo0ZTliNjkxOTc5MGU0ZTdlODAyYWUxNWQ3NGI3OTkzOC90YWJsZXJhbmdlOjRlOWI2OTE5NzkwZTRlN2U4MDJhZTE1ZDc0Yjc5OTM4XzExLTUtMS0xLTU4NTM3_049e6bf8-138a-40a1-8985-9076b92decb6"
      unitRef="usd">16800000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo0ZTliNjkxOTc5MGU0ZTdlODAyYWUxNWQ3NGI3OTkzOC90YWJsZXJhbmdlOjRlOWI2OTE5NzkwZTRlN2U4MDJhZTE1ZDc0Yjc5OTM4XzEyLTEtMS0xLTU4NTM3_b5f3273a-53dd-4658-a141-730970c81aac"
      unitRef="usd">-26200000</us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo0ZTliNjkxOTc5MGU0ZTdlODAyYWUxNWQ3NGI3OTkzOC90YWJsZXJhbmdlOjRlOWI2OTE5NzkwZTRlN2U4MDJhZTE1ZDc0Yjc5OTM4XzEyLTMtMS0xLTU4NTM3_606bf593-ad46-4b83-aed9-6bcb88bad9b8"
      unitRef="usd">-15200000</us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTo0ZTliNjkxOTc5MGU0ZTdlODAyYWUxNWQ3NGI3OTkzOC90YWJsZXJhbmdlOjRlOWI2OTE5NzkwZTRlN2U4MDJhZTE1ZDc0Yjc5OTM4XzEyLTUtMS0xLTU4NTM3_611b579e-44dc-4603-9cc1-6b0504ce88c5"
      unitRef="usd">29000000.0</us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:ScheduleOfAssumptionsUsedTableTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzY3NzE_dc6a747d-b0f9-425d-b513-bab38b445796">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.049%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Years Ended October&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Weighted-average assumptions used in computing the net periodic pension cost and projected benefit obligation at year end:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Discount rate for determining net periodic pension cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Projected Benefit Obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Service Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Interest Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Discount rate for determining benefit obligations at year end&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase for determining expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase for determining benefit obligations at year end&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Expected rate of return on plan assets for determining net periodic pension cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Expected rate of return on plan assets at year end&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Measurement date for determining assets and benefit obligations at year end&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10/31/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;10/31/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAssumptionsUsedTableTextBlock>
    <coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzMtMS0xLTEtNTg1Mzc_b57c3e5b-1e93-4cb2-85e8-a7582b588f85"
      unitRef="number">0.0276</coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation>
    <coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzMtMy0xLTEtNTg1Mzc_43dbfda8-92ac-4b33-ba56-7218af4e8981"
      unitRef="number">0.0278</coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation>
    <coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzMtNS0xLTEtNTg1Mzc_80b0f202-e917-4d86-8e40-3c460113ec3f"
      unitRef="number">0.0313</coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation>
    <coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzQtMS0xLTEtNTg1Mzc_63112f7a-8696-4eb1-b97e-ff71cee7cce4"
      unitRef="number">0.0279</coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost>
    <coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzQtMy0xLTEtNTg1Mzc_0143dbfe-1758-4ed5-a036-518207579ecc"
      unitRef="number">0.0286</coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost>
    <coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzQtNS0xLTEtNTg1Mzc_62f3356c-4f07-425e-be37-eb7cc68d1ae9"
      unitRef="number">0.0318</coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost>
    <coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzUtMS0xLTEtNTg1Mzc_c371b325-bfa0-4ee1-ba2d-10b60e51d7f7"
      unitRef="number">0.0228</coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost>
    <coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzUtMy0xLTEtNTg1Mzc_98a05296-916f-446b-9a33-e060ad33fb7e"
      unitRef="number">0.0207</coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost>
    <coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzUtNS0xLTEtNTg1Mzc_c4e3247b-192a-471a-9534-42dcd20ed7bc"
      unitRef="number">0.0278</coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzYtMS0xLTEtNTg1Mzc_6b8ebde4-1a23-4d0c-b5e0-0ab3da5e90f9"
      unitRef="number">0.0574</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzYtMy0xLTEtNTg1Mzc_c070e61a-b08a-4b2f-9f41-166068061425"
      unitRef="number">0.0276</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzYtNS0xLTEtNTg1Mzc_07e9e085-aecf-45f7-90f2-dea24fd1e28b"
      unitRef="number">0.0278</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzctMS0xLTEtNTg1Mzc_261bdf66-97b8-430d-87c4-2ce03f96d646"
      unitRef="number">0.0360</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzctMy0xLTEtNTg1Mzc_ea5f3146-0c5c-4cde-99eb-3de0c00895ee"
      unitRef="number">0.0360</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzctNS0xLTEtNTg1Mzc_cfb1b2e1-f506-4d3f-826b-222c6ec6f9cf"
      unitRef="number">0.0360</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzgtMS0xLTEtNTg1Mzc_401c2374-9d3b-4bcf-9085-d3672f3b4ad6"
      unitRef="number">0.0360</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzgtMy0xLTEtNTg1Mzc_31aa376c-a4cc-44c7-b2cd-2fbd4152c6e3"
      unitRef="number">0.0360</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzgtNS0xLTEtNTg1Mzc_d874beea-e8e4-46cc-b8ae-2f7fb95bf50d"
      unitRef="number">0.0360</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzktMS0xLTEtNTg1Mzc_2762618b-9821-421a-a683-3ba3053071ed"
      unitRef="number">0.0800</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzktMy0xLTEtNTg1Mzc_8750bda1-58e0-48c4-aac5-fc6e4800c562"
      unitRef="number">0.0800</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzktNS0xLTEtNTg1Mzc_ed1c7389-88a6-44b8-b46a-f2098d3bd401"
      unitRef="number">0.0800</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzEwLTEtMS0xLTU4NTM3_871a3cd7-749b-40c2-b298-bcfed055e859"
      unitRef="number">0.0800</coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd>
    <coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzEwLTMtMS0xLTU4NTM3_63df3679-b4bb-48d1-b4a6-7773b125fb22"
      unitRef="number">0.0800</coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd>
    <coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd
      contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTphMDdlM2FlNDA0YmE0NDU2OTdlNTZlNGU0YTRlZjllMi90YWJsZXJhbmdlOmEwN2UzYWU0MDRiYTQ0NTY5N2U1NmU0ZTRhNGVmOWUyXzEwLTUtMS0xLTU4NTM3_9af59132-708b-4b9b-86a7-af80daa3ece7"
      unitRef="number">0.0800</coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd>
    <coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzE2ODA_3ea4d0e4-8aab-4d12-96df-d226e1b1e8b0"
      unitRef="number">0.0276</coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation>
    <coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligationIncreaseDecrease
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzE2OTM_d141bcf4-1992-478d-aa71-122ca982039c"
      unitRef="number">-0.0002</coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligationIncreaseDecrease>
    <coo:DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationEffectOfChangeInDiscountRate
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzE3OTA_10092c73-5a37-4a78-8d63-df9ed894ccde"
      unitRef="usd">217200000</coo:DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationEffectOfChangeInDiscountRate>
    <coo:DefinedBenefitPlanAssumptionsUsedCalculatingAccumulatedBenefitObligationEffectOfChangeInDiscountRate
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzE4NDk_0072cccb-49ec-4d16-b56c-5764a9d04ded"
      unitRef="usd">194200000</coo:DefinedBenefitPlanAssumptionsUsedCalculatingAccumulatedBenefitObligationEffectOfChangeInDiscountRate>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzIzNjk_7bb4abc4-0aaf-4604-9837-11a704e53ca3"
      unitRef="usd">93200000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i63cbbcb6c872410eb8569b17394ff5b7_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzI0Njc_6c54aec3-3c29-4519-91f3-947d5799362a"
      unitRef="usd">97100000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i624452a49f29415dbd617b4589408c5a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzI0OTk_53f26d91-f371-4dea-a9f3-35946dadbf03"
      unitRef="usd">-3900000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i81df2e32936447de9004b3e72091ab2b_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzI2MDg_4347cbe4-4614-4084-9596-ecb82a5503ee"
      unitRef="usd">72700000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i0436b7aab9ec44818925071f5beef55c_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzI2NzI_695ee8fe-fa53-4c22-8bd1-14287fca0691"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i5e6b59d888914091a12f486903db9b8f_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzI3NDA_49c0845b-dbca-422e-adb1-64b2312c1f3f"
      unitRef="usd">24100000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzY3ODE_d184fb02-e6c8-4c9a-866f-072b53ae1f86">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Plan Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Weighted-average asset allocations at year end, by asset category are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.719%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.450%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.450%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Years Ended October&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Asset category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Equity mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;65.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;62.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;57.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Hedging Strategy Funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Bond mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;27.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;26.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;As of the measurement date of October&#160;31, 2022, the fair value measurement of plan assets is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.541%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.287%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.188%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;br/&gt;in Active&lt;br/&gt;Markets for&lt;br/&gt;Identical&#160;Assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Asset category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Equity mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;93.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;93.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Hedging Strategy Funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Bond mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;38.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;24.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;142.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;118.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;24.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i7a4fc69a1c8544d984b2860446a8cc59_I20221031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTozZjFmYmI4YmFhMDM0NGY3YjI4NTdmM2E4OGJiZWNhNS90YWJsZXJhbmdlOjNmMWZiYjhiYWEwMzQ0ZjdiMjg1N2YzYTg4YmJlY2E1XzItMS0xLTEtNTg1Mzc_b63d8a62-cdc2-4fa3-b8fb-8e57b5c2be74"
      unitRef="number">0.020</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="id7fe4c21857c4580a2bb918c4d443e6c_I20211031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTozZjFmYmI4YmFhMDM0NGY3YjI4NTdmM2E4OGJiZWNhNS90YWJsZXJhbmdlOjNmMWZiYjhiYWEwMzQ0ZjdiMjg1N2YzYTg4YmJlY2E1XzItMy0xLTEtNTg1Mzc_7c6fb297-71d0-4ea2-9eee-5032b03261f9"
      unitRef="number">0.050</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i35a7d060cc03406aa06d6d2e52af7aa8_I20201031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTozZjFmYmI4YmFhMDM0NGY3YjI4NTdmM2E4OGJiZWNhNS90YWJsZXJhbmdlOjNmMWZiYjhiYWEwMzQ0ZjdiMjg1N2YzYTg4YmJlY2E1XzItNS0xLTEtNTg1Mzc_3bd2b0aa-e150-45e1-9276-91e2ac411baa"
      unitRef="number">0.118</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i6f8e8579bd9f4de1bc128c354594f563_I20221031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTozZjFmYmI4YmFhMDM0NGY3YjI4NTdmM2E4OGJiZWNhNS90YWJsZXJhbmdlOjNmMWZiYjhiYWEwMzQ0ZjdiMjg1N2YzYTg4YmJlY2E1XzQtMS0xLTEtNTg1Mzc_ada7ac63-62d1-4263-88c3-fab35e4e77eb"
      unitRef="number">0.658</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i334d9d36817a404198eaa63d441b7876_I20211031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTozZjFmYmI4YmFhMDM0NGY3YjI4NTdmM2E4OGJiZWNhNS90YWJsZXJhbmdlOjNmMWZiYjhiYWEwMzQ0ZjdiMjg1N2YzYTg4YmJlY2E1XzQtMy0xLTEtNTg1Mzc_276da1ca-e28a-493f-a2fe-c946955268ce"
      unitRef="number">0.628</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i6b597c9875e84d9dbaa5078086f54163_I20201031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTozZjFmYmI4YmFhMDM0NGY3YjI4NTdmM2E4OGJiZWNhNS90YWJsZXJhbmdlOjNmMWZiYjhiYWEwMzQ0ZjdiMjg1N2YzYTg4YmJlY2E1XzQtNS0xLTEtNTg1Mzc_1a6652b3-f705-446c-84b3-4077ab845bcf"
      unitRef="number">0.577</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i3a8c5a86d4af47dd80e81eee5d90e1df_I20221031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTozZjFmYmI4YmFhMDM0NGY3YjI4NTdmM2E4OGJiZWNhNS90YWJsZXJhbmdlOjNmMWZiYjhiYWEwMzQ0ZjdiMjg1N2YzYTg4YmJlY2E1XzUtMS0xLTEtNTg1Mzc_38263b08-1795-4f46-99a6-b26b5f53fce3"
      unitRef="number">0.052</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="id997ec317814462ba72540f4ef32a2a3_I20211031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTozZjFmYmI4YmFhMDM0NGY3YjI4NTdmM2E4OGJiZWNhNS90YWJsZXJhbmdlOjNmMWZiYjhiYWEwMzQ0ZjdiMjg1N2YzYTg4YmJlY2E1XzUtMy0xLTEtNTg1Mzc_83332306-b010-46d9-bf9b-c88a0856768e"
      unitRef="number">0.047</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i9c1611da45144b90bea4e31bcb16786b_I20201031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTozZjFmYmI4YmFhMDM0NGY3YjI4NTdmM2E4OGJiZWNhNS90YWJsZXJhbmdlOjNmMWZiYjhiYWEwMzQ0ZjdiMjg1N2YzYTg4YmJlY2E1XzUtNS0xLTEtNTg1Mzc_5a125bbb-1a69-4bfa-931c-54669910be04"
      unitRef="number">0.043</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i26a8e3f73198439181c7db0f9541574a_I20221031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTozZjFmYmI4YmFhMDM0NGY3YjI4NTdmM2E4OGJiZWNhNS90YWJsZXJhbmdlOjNmMWZiYjhiYWEwMzQ0ZjdiMjg1N2YzYTg4YmJlY2E1XzctMS0xLTEtNTg1Mzc_d9a3ea37-86e7-41f1-a791-6c645d766b48"
      unitRef="number">0.270</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i03153ed49cfc47abba8d0d3108d50a1f_I20211031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTozZjFmYmI4YmFhMDM0NGY3YjI4NTdmM2E4OGJiZWNhNS90YWJsZXJhbmdlOjNmMWZiYjhiYWEwMzQ0ZjdiMjg1N2YzYTg4YmJlY2E1XzctMy0xLTEtNTg1Mzc_f203846f-90f2-4100-8348-1c7e8ad7ad7c"
      unitRef="number">0.275</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i986cc010c8c04831b70f7128a9b44c17_I20201031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTozZjFmYmI4YmFhMDM0NGY3YjI4NTdmM2E4OGJiZWNhNS90YWJsZXJhbmdlOjNmMWZiYjhiYWEwMzQ0ZjdiMjg1N2YzYTg4YmJlY2E1XzctNS0xLTEtNTg1Mzc_b0d8b127-6faf-4bc9-901f-bda1276aff87"
      unitRef="number">0.262</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTozZjFmYmI4YmFhMDM0NGY3YjI4NTdmM2E4OGJiZWNhNS90YWJsZXJhbmdlOjNmMWZiYjhiYWEwMzQ0ZjdiMjg1N2YzYTg4YmJlY2E1XzgtMS0xLTEtNTg1Mzc_cf6e7fdd-5264-4227-854b-3f1dfd38ec10"
      unitRef="number">1.000</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTozZjFmYmI4YmFhMDM0NGY3YjI4NTdmM2E4OGJiZWNhNS90YWJsZXJhbmdlOjNmMWZiYjhiYWEwMzQ0ZjdiMjg1N2YzYTg4YmJlY2E1XzgtMy0xLTEtNTg1Mzc_bf8d1554-76fd-472f-86fb-c33157258cb1"
      unitRef="number">1.000</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTozZjFmYmI4YmFhMDM0NGY3YjI4NTdmM2E4OGJiZWNhNS90YWJsZXJhbmdlOjNmMWZiYjhiYWEwMzQ0ZjdiMjg1N2YzYTg4YmJlY2E1XzgtNS0xLTEtNTg1Mzc_8150243d-7fb1-45d0-9f2a-47eb387ab80c"
      unitRef="number">1.000</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="ib85025a9deaf4843aee211787d365a16_I20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzM1Nzc_0e954f34-8165-4757-b2f7-c55045edbbc5"
      unitRef="number">0.50</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i8c51826bf4c24060b6544fe06a5f0acc_I20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzM1ODM_fcc8312a-df7e-4918-a4fe-ff5e55130fdd"
      unitRef="number">0.70</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <coo:DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzM3NDQ_7a09c4a3-14a7-4245-8338-c34dad2360a9"
      unitRef="number">0.08</coo:DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7a4fc69a1c8544d984b2860446a8cc59_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzItMS0xLTEtNTg1Mzc_c4bb6a30-04c4-450f-82f1-9ba33fd010c1"
      unitRef="usd">2900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8c61c0e5f7d448f083a8214f4affcc5d_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzItMy0xLTEtNTg1Mzc_5ba64cb7-9bf6-4f99-902e-364c8992b2e1"
      unitRef="usd">2900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3c6597a1b5d9405b8074c5402317fb16_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzItNS0xLTEtNTg1Mzc_3e937c13-46d4-4b6c-a0aa-246e9c5bea40"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iab1f3fcc011d42c9b46e9e09fd09d128_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzItNy0xLTEtNTg1Mzc_4b1566b2-025d-470e-953a-cb05e0232eaa"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6f8e8579bd9f4de1bc128c354594f563_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzQtMS0xLTEtNTg1Mzc_bb5269a4-4a78-4d5b-8560-0dfdcf9016d3"
      unitRef="usd">93900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="idb7d578f2c5c4230b76ef6494dab18ee_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzQtMy0xLTEtNTg1Mzc_46266706-f4d3-428d-aeea-46bc33d937ec"
      unitRef="usd">93900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3e74d409e85a41d5a2c110a4229eb2bc_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzQtNS0xLTEtNTg1Mzc_b70d28ad-c804-445f-82b6-428a31a1df43"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib60d652edf684fe681874a2a2fa83fa0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzQtNy0xLTEtNTg1Mzc_124b768d-d486-4524-ae1e-6ea62537f6ba"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3a8c5a86d4af47dd80e81eee5d90e1df_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzUtMS0xLTEtNTg1Mzc_c654f8bc-c368-485c-9a15-cff4398d5c5b"
      unitRef="usd">7500000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3e523df95698455d89c863a25a39cc0a_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzUtMy0xLTEtNTg1Mzc_40c5088c-a508-4104-afd7-7329f0c608d8"
      unitRef="usd">7500000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9478c54d56244163bd2004c364491b0a_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzUtNS0xLTEtNTg1Mzc_969269b0-5394-4361-8b9e-8b42aeed4e6c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i64acac4cceb34e55a9056341c5bb4477_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzUtNy0xLTEtNTg1Mzc_5dabd018-af1c-4ca5-a06a-4a84b4ae6ba1"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i26a8e3f73198439181c7db0f9541574a_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzYtMS0xLTEtNTg1Mzc_d3857191-2d8e-4972-962d-cf0f0584ab62"
      unitRef="usd">38600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i50b1c25ad93b40649c4bcf9197d4e9d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzYtMy0xLTEtNTg1Mzc_36074d13-8d12-4ecc-92ee-7a259b513974"
      unitRef="usd">14500000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5edcbbc801c346c28e2c94d9e4d8c524_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzYtNS0xLTEtNTg1Mzc_fab7a57e-fec3-4b47-9e8e-2d6b86eeec37"
      unitRef="usd">24100000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4f08d2ac862b4de1a91c5b0e239533aa_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzYtNy0xLTEtNTg1Mzc_a63eadc5-d212-4e1f-b7f5-78e61c0e136a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzctMS0xLTEtNTg1Mzc_1cb30f54-8857-474c-97fb-e8d392a54af3"
      unitRef="usd">142900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0a330158da9f4490afbea9f2a383c0cc_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzctMy0xLTEtNTg1Mzc_9dc51cfa-465f-4e93-a3e5-fa817b4a1b00"
      unitRef="usd">118800000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9bcdee130e56454594be5def8b90a9e9_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzctNS0xLTEtNTg1Mzc_ca95669a-e465-45a4-8192-79e17d41d37e"
      unitRef="usd">24100000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iffb0171583b6494dbb6fea0de231f654_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTowNTAxZDFiN2IwNWQ0ZWViYWNhNmQxNTNmYTM4NDQ2Yi90YWJsZXJhbmdlOjA1MDFkMWI3YjA1ZDRlZWJhY2E2ZDE1M2ZhMzg0NDZiXzctNy0xLTEtNTg1Mzc_b9b00b42-a9ed-4527-92e0-aa3377eab060"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzQ5NDc4MDIzNDAwNzk_611aacf7-64f6-46ac-bc84-37223bebbb87"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzQ5NzA_d9a8b7da-25b0-477f-b23f-64a99d66ba19"
      unitRef="usd">12700000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzQ5OTQ_29477878-1b0b-4992-98b2-882b4b8e9ead"
      unitRef="usd">23400000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzY3NTM_552417a5-f4f3-478c-b385-d08de3f9c748">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Estimated Future Benefit Payments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Years&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2028-2032&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;66.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTpkNjBkNDFjOWQzMjA0MjVmOTNiNmQzMDFjZjU5YzM1Ny90YWJsZXJhbmdlOmQ2MGQ0MWM5ZDMyMDQyNWY5M2I2ZDMwMWNmNTljMzU3XzEtMS0xLTEtNTg1Mzc_9ef9c9fe-07b2-4fac-8ade-3aedbcb3dd20"
      unitRef="usd">9400000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTpkNjBkNDFjOWQzMjA0MjVmOTNiNmQzMDFjZjU5YzM1Ny90YWJsZXJhbmdlOmQ2MGQ0MWM5ZDMyMDQyNWY5M2I2ZDMwMWNmNTljMzU3XzItMS0xLTEtNTg1Mzc_59438799-b6a9-4adb-a1b9-2ec440933887"
      unitRef="usd">11000000.0</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTpkNjBkNDFjOWQzMjA0MjVmOTNiNmQzMDFjZjU5YzM1Ny90YWJsZXJhbmdlOmQ2MGQ0MWM5ZDMyMDQyNWY5M2I2ZDMwMWNmNTljMzU3XzMtMS0xLTEtNTg1Mzc_c977adbf-fc38-4f30-aaa8-4e03ec0e53b3"
      unitRef="usd">11900000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTpkNjBkNDFjOWQzMjA0MjVmOTNiNmQzMDFjZjU5YzM1Ny90YWJsZXJhbmdlOmQ2MGQ0MWM5ZDMyMDQyNWY5M2I2ZDMwMWNmNTljMzU3XzQtMS0xLTEtNTg1Mzc_03fb1d18-c259-4922-be65-27f3bb24ad06"
      unitRef="usd">11400000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTpkNjBkNDFjOWQzMjA0MjVmOTNiNmQzMDFjZjU5YzM1Ny90YWJsZXJhbmdlOmQ2MGQ0MWM5ZDMyMDQyNWY5M2I2ZDMwMWNmNTljMzU3XzUtMS0xLTEtNTg1Mzc_09f68529-2bb5-46d2-91f2-eeaa631f0208"
      unitRef="usd">11900000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90YWJsZTpkNjBkNDFjOWQzMjA0MjVmOTNiNmQzMDFjZjU5YzM1Ny90YWJsZXJhbmdlOmQ2MGQ0MWM5ZDMyMDQyNWY5M2I2ZDMwMWNmNTljMzU3XzYtMS0xLTEtNTg1Mzc_11313761-9381-451f-985b-27c70ae41562"
      unitRef="usd">66100000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzYwMTY_ea8ff2ea-c531-48a0-b273-e2d7a546d624"
      unitRef="number">0.75</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent>
    <us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzYxODU_6ab4bd47-4233-47df-ac7e-7a4c11e240df"
      unitRef="usd">9000000</us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer>
    <us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzYxODk_bfac7f97-fc9a-4b14-934e-54f81836c248"
      unitRef="usd">7200000</us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer>
    <us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjEvZnJhZzpjNTEyYjhmOTYzNDg0MDVkYmUxOGY0NTJiM2Y4M2ZkNy90ZXh0cmVnaW9uOmM1MTJiOGY5NjM0ODQwNWRiZTE4ZjQ1MmIzZjgzZmQ3XzYxOTY_a350478e-7650-4839-a070-687a633a52f4"
      unitRef="usd">6800000</us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMjcvZnJhZzo0NTIzNDdkMTQ5ZTg0ZTg2ODU0NjhmZWJiOTM1NWQ2My90ZXh0cmVnaW9uOjQ1MjM0N2QxNDllODRlODY4NTQ2OGZlYmI5MzU1ZDYzXzc3OQ_82d01316-3275-4e12-b778-e8ab945e8f38">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Note 11. Contingencies &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company is involved in various lawsuits, claims and other legal matters from time to time that arise in the ordinary course of conducting business, including matters involving our products, intellectual property, supplier relationships, distributors, competitor relationships, employees and other matters. The Company does not believe that the ultimate resolution of these proceedings or claims pending against it could have a material adverse effect on its financial condition or results of operations. At each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;. Legal fees are expensed as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90ZXh0cmVnaW9uOjZkMTQ1NDM0ZTYyMzQ0OWM5M2I0NzU1NmNmMTdiZDE3XzI1Mjk_eac9c0fa-e311-4d74-812d-fafbd7f69888">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Note 12. Business Segment Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company discloses information about its operating segments, which were established based on the way that management organizes segments within the Company for making operating decisions and assessing financial performance. The Company's two operating segments are described below. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.68pt"&gt;CooperVision. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Competes in the worldwide contact lens market by developing, manufacturing and marketing a broad range of products for contact lens wearers, featuring advanced materials and optics.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.68pt"&gt;CooperSurgical. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Competes in the general health care market with a focus on advancing the health of women, babies and families through a diversified portfolio of products and services focusing on women's health and fertility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company uses operating income, as presented in our financial reports, as the primary measure of segment profitability. The Company does not allocate costs from corporate functions to segment operating income. The Company uses the same accounting policies to generate segment results as it does for consolidated results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;No customers accounted for 10% or more of our consolidated net revenue in fiscal 2022, 2021 and 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Total identifiable assets are those used in continuing operations except cash and cash equivalents, which the Company includes as corporate assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The following table presents a summary of our business segment net sales:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.593%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;CooperVision net sales by category:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Toric lens&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;737.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;697.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;598.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Multifocal lens&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;264.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;238.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;197.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Single-use sphere lens&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;661.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;616.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;529.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Non single-use sphere, other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;579.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;599.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;518.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total CooperVision net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,243.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,152.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,843.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;CooperSurgical net sales by category:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Office and surgical products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;633.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;451.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;358.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fertility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;431.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;319.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;229.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total CooperSurgical net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,065.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;770.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;587.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,308.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,922.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,430.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Information by business segment for each of the years in the three-year period ended October&#160;31, 2022, follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;CooperVision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;CooperSurgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,243.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,065.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,308.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;494.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;67.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(53.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;507.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;57.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other (income), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(25.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;475.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Identifiable assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;6,778.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4,407.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;305.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;11,492.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;144.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;166.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;32.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;147.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;179.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;223.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;242.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,152.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;770.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,922.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;481.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;71.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(47.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;505.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;23.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other (income), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;491.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Identifiable assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;6,965.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,395.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;244.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;9,606.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;148.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;163.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;35.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;110.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;146.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;190.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;24.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;214.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,843.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;587.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,430.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;375.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(14.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(49.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;311.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;36.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;266.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Identifiable assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4,236.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,293.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;207.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;6,737.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;138.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;149.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;32.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;104.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;137.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;260.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;50.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;310.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Information by geographical area by country of domicile for each of the years in the three-year period ended October&#160;31, 2022, follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;United&lt;br/&gt;States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Rest of&lt;br/&gt;World,&#160;Other&lt;br/&gt;Eliminations&lt;br/&gt;&amp;amp; Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales to unaffiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,638.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;987.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;682.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,308.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Sales between geographic areas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;514.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;897.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1,411.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,152.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,884.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(729.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,308.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;71.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;403.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;32.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;507.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;856.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;310.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;266.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,432.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales to unaffiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,339.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;957.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;625.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,922.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Sales between geographic areas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;494.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;815.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1,310.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,834.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,773.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(684.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,922.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Operating (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(26.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;416.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;116.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;505.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;737.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;377.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;232.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,347.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales to unaffiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,103.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;789.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;537.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,430.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Sales between geographic areas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;391.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;327.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(718.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,495.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,116.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(181.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,430.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Operating (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(14.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;304.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;311.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;721.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;363.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;197.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,281.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90ZXh0cmVnaW9uOjZkMTQ1NDM0ZTYyMzQ0OWM5M2I0NzU1NmNmMTdiZDE3XzI4Mw_802ab368-288f-40aa-a9ea-689ce2d80af3"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90ZXh0cmVnaW9uOjZkMTQ1NDM0ZTYyMzQ0OWM5M2I0NzU1NmNmMTdiZDE3XzI1MjY_44f1a512-a999-4ad6-a471-fbfa329f9f1a">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The following table presents a summary of our business segment net sales:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.593%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;CooperVision net sales by category:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Toric lens&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;737.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;697.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;598.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Multifocal lens&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;264.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;238.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;197.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Single-use sphere lens&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;661.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;616.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;529.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Non single-use sphere, other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;579.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;599.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;518.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total CooperVision net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,243.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,152.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,843.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;CooperSurgical net sales by category:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Office and surgical products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;633.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;451.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;358.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fertility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;431.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;319.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;229.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total CooperSurgical net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,065.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;770.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;587.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,308.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,922.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,430.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i25cde43e219544f999a9522e40885def_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzItMS0xLTEtNTg1Mzc_b83ae601-ca9e-4716-a2ac-ef337d0ae915"
      unitRef="usd">737400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifc3c52f498cc45aea41930decf8ee38f_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzItMy0xLTEtNTg1Mzc_c10c0ccf-2fca-46a5-b809-8285d1937a08"
      unitRef="usd">697500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia253e12523d043d49f3b05b362ac4db3_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzItNS0xLTEtNTg1Mzc_293bb21a-b197-4c6f-ac51-d09656226c76"
      unitRef="usd">598200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4d10aa172f4241199dca5d1ca8ce9dc3_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzMtMS0xLTEtNTg1Mzc_2543d7a9-836f-4d80-8ac9-9b4e9a7e8a77"
      unitRef="usd">264400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i85d55c68caa34e448ff17017cfacbd34_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzMtMy0xLTEtNTg1Mzc_0c3f2323-8d3d-4c33-aa1e-6ffebfc1a85b"
      unitRef="usd">238600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifc783e59e8564dc5a184e25dc3297b9e_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzMtNS0xLTEtNTg1Mzc_04d57c35-5f2e-4bca-821f-7deffaaea021"
      unitRef="usd">197000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iccd45949f93e4f0d856a82cc74ad6f30_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzQtMS0xLTEtNTg1Mzc_6309276a-544d-4e85-9943-1308fb462dbe"
      unitRef="usd">661600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib621e690024248a09198dea9ac20e44d_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzQtMy0xLTEtNTg1Mzc_cd9b5232-b19b-4d9a-b3f9-4a6ddcd8f732"
      unitRef="usd">616300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib8bb2845023f4ba69135007f32f07bfd_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzQtNS0xLTEtNTg1Mzc_2b20bc8e-efa1-4ba9-a368-e9b859da5a66"
      unitRef="usd">529000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib70d98549d8f495a9abc9b2d97f90135_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzUtMS0xLTEtNTg1Mzc_ccfe34ba-d408-4591-ab93-d2c252a9bfc9"
      unitRef="usd">579900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8072fe66c6ab44ba885a43c3d95061e4_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzUtMy0xLTEtNTg1Mzc_5598492b-c93d-49c8-b298-a1eda4334fb7"
      unitRef="usd">599600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iae8aae422ef74e84b2422bd0e0d79312_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzUtNS0xLTEtNTg1Mzc_f690d70c-cc25-45d3-a768-bb4d256c30f9"
      unitRef="usd">518800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i144fdaeefe67410baf1810389c09a562_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzYtMS0xLTEtNTg1Mzc_555758cc-ad1b-4b43-a2df-37cdc723f116"
      unitRef="usd">2243300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i102f306f3b6e41189c2e3d4c415079d8_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzYtMy0xLTEtNTg1Mzc_d404c7c3-e801-4e08-b250-af12bf46818c"
      unitRef="usd">2152000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie9d6919196ca46a88ce3671aa7019026_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzYtNS0xLTEtNTg1Mzc_fb2082f0-6d48-4b3e-86c6-b44402627bb6"
      unitRef="usd">1843000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9dd5db5ac5f0464c9c4532ca81435932_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzgtMS0xLTEtNTg1Mzc_05e27896-4b9b-495a-a4cc-458f2f24ac6d"
      unitRef="usd">633600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if06952d7a77e4c6d9f9444b9a19fa7aa_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzgtMy0xLTEtNTg1Mzc_ac8c3ccb-db99-4eff-8b8f-46dd5a1358e2"
      unitRef="usd">451300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if6ed314c0ed34367adef4b03b91bf0e0_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzgtNS0xLTEtNTg1Mzc_e7c5b18c-322b-41f6-81e0-0eef1343d1b0"
      unitRef="usd">358800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i25dfc4b265ed4288baedea76cb9d2444_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzktMS0xLTEtNTg1Mzc_df543a00-1a7d-445f-b792-24cf97750cf3"
      unitRef="usd">431500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i51cce661b93d48838c95d5583bafe501_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzktMy0xLTEtNTg1Mzc_2a3cc6ef-3de1-4c24-b4ef-f43e0d34e39b"
      unitRef="usd">319200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i309196da87d847b0b037f6d29c6d95e8_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzktNS0xLTEtNTg1Mzc_4a38178f-f08f-4fdd-8826-b926dc78063f"
      unitRef="usd">229100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaeae5667d45b495b88915bbc72c256cd_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzEwLTEtMS0xLTU4NTM3_8d005f62-c69c-4876-b3e9-d04531894429"
      unitRef="usd">1065100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idb221ec949be4a1a87f43dd831ca8d8c_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzEwLTMtMS0xLTU4NTM3_d0a972d8-fe60-4b7f-b5de-af232f40d7c0"
      unitRef="usd">770500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibca59e6c981d48c5a555d3d4902818d1_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzEwLTUtMS0xLTU4NTM3_7add32a6-f21d-4a04-b1ce-893692ec38bf"
      unitRef="usd">587900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzExLTEtMS0xLTU4NTM3_bc6fd2d7-0aeb-48b2-9412-383518fe987c"
      unitRef="usd">3308400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzExLTMtMS0xLTU4NTM3_66059faa-f1d3-468a-a90c-c0c552777416"
      unitRef="usd">2922500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo2OTllN2E0NmVjNmQ0OTczOTFmMmM1YzAwYTMxMjAyNC90YWJsZXJhbmdlOjY5OWU3YTQ2ZWM2ZDQ5NzM5MWYyYzVjMDBhMzEyMDI0XzExLTUtMS0xLTU4NTM3_34d88d56-5f4c-469d-b8ab-a6b3da22dbc2"
      unitRef="usd">2430900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90ZXh0cmVnaW9uOjZkMTQ1NDM0ZTYyMzQ0OWM5M2I0NzU1NmNmMTdiZDE3XzI1MDM_eb4b6086-d56e-4508-ac2f-0d8eae39c26f">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Information by business segment for each of the years in the three-year period ended October&#160;31, 2022, follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;CooperVision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;CooperSurgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,243.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,065.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,308.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;494.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;67.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(53.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;507.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;57.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other (income), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(25.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;475.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Identifiable assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;6,778.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4,407.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;305.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;11,492.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;144.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;166.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;32.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;147.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;179.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;223.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;242.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,152.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;770.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,922.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;481.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;71.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(47.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;505.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;23.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other (income), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;491.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Identifiable assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;6,965.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,395.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;244.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;9,606.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;148.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;163.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;35.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;110.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;146.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;190.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;24.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;214.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,843.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;587.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,430.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;375.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(14.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(49.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;311.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;36.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;266.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Identifiable assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4,236.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,293.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;207.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;6,737.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;138.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;149.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;32.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;104.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;137.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;260.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;50.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;310.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7bc30f40f79641898ba6c790c0142777_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzItMS0xLTEtNTg1Mzc_c46ce756-54d7-426e-882c-a2cc2d3f7aef"
      unitRef="usd">2243300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6eec52445a764506b37023f966f522cd_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzItMy0xLTEtNTg1Mzc_a5be65b3-aefa-4c13-b622-0a52a6abc798"
      unitRef="usd">1065100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i114133db3f4f46f0be519e2bb98d778d_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzItNS0xLTEtNTg1Mzc_f4d57399-115f-4aaf-af55-3b5abdc6781e"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzItNy0xLTEtNTg1Mzc_dcbabc2c-86f2-4569-8db3-f959d1ce4636"
      unitRef="usd">3308400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7bc30f40f79641898ba6c790c0142777_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzMtMS0xLTEtNTg1Mzc_e9e0662a-4dda-451c-8c28-2873e29d5580"
      unitRef="usd">494300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6eec52445a764506b37023f966f522cd_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzMtMy0xLTEtNTg1Mzc_2a3865b2-57b2-491e-abf3-6774ee083767"
      unitRef="usd">67100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i114133db3f4f46f0be519e2bb98d778d_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzMtNS0xLTEtNTg1Mzc_18c82d57-9996-4a6c-b5c3-8e3a708497ac"
      unitRef="usd">-53800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzMtNy0xLTEtNTg1Mzc_5199d062-4e6f-4da7-a6d4-3a1d4f6cfdd1"
      unitRef="usd">507600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzQtNy0xLTEtNTg1Mzc_6c708d46-2616-42f7-820d-7afea2e378d7"
      unitRef="usd">57300000</us-gaap:InterestExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzUtNy0xLTEtNTg1Mzc_dab2110a-0d26-4644-a8d5-2702d5a254ad"
      unitRef="usd">25000000.0</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzYtNy0xLTEtNTg1Mzc_a198a35f-074d-4146-ba2f-85e07fb29864"
      unitRef="usd">475300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:Assets
      contextRef="if236740745ec431d90e33cfc8a948539_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzctMS0xLTEtNTg1Mzc_d43779fe-b94d-4dbe-8ea6-d4fc31a1aa4a"
      unitRef="usd">6778900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i1e7e37cad2a94f059cebebab71490b56_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzctMy0xLTEtNTg1Mzc_db88b8c9-d8ba-49ca-b14e-c5c9962d2c06"
      unitRef="usd">4407800000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ib0a609362bee4d6c9058db39abefa7dc_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzctNS0xLTEtNTg1Mzc_fc57baa5-9f2d-4afe-87c4-20029cd2bf1d"
      unitRef="usd">305600000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzctNy0xLTEtNTg1Mzc_7554e1d7-c6f7-403e-bcd8-7ba670549682"
      unitRef="usd">11492300000</us-gaap:Assets>
    <us-gaap:Depreciation
      contextRef="i7bc30f40f79641898ba6c790c0142777_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzgtMS0xLTEtNTg1Mzc_222f6d91-1d71-44bf-90b2-6752e9f8c4e0"
      unitRef="usd">144500000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i6eec52445a764506b37023f966f522cd_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzgtMy0xLTEtNTg1Mzc_c7c6b6f5-986a-4067-9352-2ee98de40cd4"
      unitRef="usd">22100000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i114133db3f4f46f0be519e2bb98d778d_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzgtNS0xLTEtNTg1Mzc_d0f181b7-af4c-43b6-ba28-9389acb1f585"
      unitRef="usd">0</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzgtNy0xLTEtNTg1Mzc_05e1bca5-7133-420c-acbe-7758220f2dfd"
      unitRef="usd">166600000</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization
      contextRef="i7bc30f40f79641898ba6c790c0142777_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzktMS0xLTEtNTg1Mzc_4aa0d4f0-eeff-45cc-a8d4-b631842831ac"
      unitRef="usd">32300000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i6eec52445a764506b37023f966f522cd_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzktMy0xLTEtNTg1Mzc_1119244c-a6c7-4e8d-a8fd-dcf176708eb0"
      unitRef="usd">147200000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i114133db3f4f46f0be519e2bb98d778d_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzktNS0xLTEtNTg1Mzc_7c828a1d-17c9-4117-bce7-ef5abf429aaa"
      unitRef="usd">0</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzktNy0xLTEtNTg1Mzc_fc0bbb5e-e2e3-4adb-9202-d21d9862cf0b"
      unitRef="usd">179500000</us-gaap:AdjustmentForAmortization>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i7bc30f40f79641898ba6c790c0142777_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzEwLTEtMS0xLTU4NTM3_3d98b866-0535-4e78-b87c-04b832a2b825"
      unitRef="usd">223000000.0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i6eec52445a764506b37023f966f522cd_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzEwLTMtMS0xLTU4NTM3_0ba89a3d-8099-457b-8537-8a0eeb5dea82"
      unitRef="usd">19000000.0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i114133db3f4f46f0be519e2bb98d778d_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzEwLTUtMS0xLTU4NTM3_a1458681-6462-4aa0-a949-cf806fa9620a"
      unitRef="usd">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzEwLTctMS0xLTU4NTM3_32965a8b-4abb-46b1-bdff-3d41bce9fa2e"
      unitRef="usd">242000000.0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1636568fa5e84bdabf27c057ce6618aa_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzEyLTEtMS0xLTU4NTM3_af69f8fd-c55e-4cf3-bced-05be0710a45e"
      unitRef="usd">2152000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib7703e214bc54be8bcb93e4d048e2560_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzEyLTMtMS0xLTU4NTM3_790c2985-f852-449b-abb0-6c98b541a176"
      unitRef="usd">770500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if848d1e35557456494fec2c118fc8064_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzEyLTUtMS0xLTU4NTM3_0ca6e8ef-418e-47a8-8353-e9e9eb5cb521"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzEyLTctMS0xLTU4NTM3_de9a869b-5f69-4872-82ab-78f588c0c1e8"
      unitRef="usd">2922500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1636568fa5e84bdabf27c057ce6618aa_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzEzLTEtMS0xLTU4NTM3_19fdd26d-45a0-4e1d-b53d-d5d721ff763f"
      unitRef="usd">481300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib7703e214bc54be8bcb93e4d048e2560_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzEzLTMtMS0xLTU4NTM3_67c3f6ad-864a-4b81-8ee5-add957818702"
      unitRef="usd">71800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if848d1e35557456494fec2c118fc8064_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzEzLTUtMS0xLTU4NTM3_af019527-e842-4e67-9ea2-d98d101376bb"
      unitRef="usd">-47300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzEzLTctMS0xLTU4NTM3_f20f7902-77b2-4096-b5de-612097eb399a"
      unitRef="usd">505800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzE0LTctMS0xLTU4NTM3_66291326-9ca6-4c21-b85c-470290d06fe3"
      unitRef="usd">23100000</us-gaap:InterestExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzE1LTctMS0xLTU4NTM3_2c6c4626-2a07-4644-a6c0-a18f09e24084"
      unitRef="usd">8800000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzE2LTctMS0xLTU4NTM3_dc84ecce-14e1-4cc5-9885-fd23df7a0a0f"
      unitRef="usd">491500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:Assets
      contextRef="if5bd3183833a4311ba1940f6e13e8c58_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzE3LTEtMS0xLTU4NTM3_92839ddd-90ad-48a7-ae71-4fa83ec478a8"
      unitRef="usd">6965900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i706aed7d18eb42adb67c45317cebd9df_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzE3LTMtMS0xLTU4NTM3_762cd039-77d3-4d1d-ac68-faad60c6877d"
      unitRef="usd">2395600000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i7fac46c673ae44a6a51e56072ef333f6_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzE3LTUtMS0xLTU4NTM3_49ae13fc-1a41-4ace-b65e-5881dfb2d7e2"
      unitRef="usd">244700000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzE3LTctMS0xLTU4NTM3_82bef8aa-5019-472d-af68-cc66ac562b0b"
      unitRef="usd">9606200000</us-gaap:Assets>
    <us-gaap:Depreciation
      contextRef="i1636568fa5e84bdabf27c057ce6618aa_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzE4LTEtMS0xLTU4NTM3_910e6c7c-b58d-4afe-baba-bb41f845f8f2"
      unitRef="usd">148300000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ib7703e214bc54be8bcb93e4d048e2560_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzE4LTMtMS0xLTU4NTM3_432deca5-d109-4e61-a33d-4630c5dffeb3"
      unitRef="usd">14900000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="if848d1e35557456494fec2c118fc8064_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzE4LTUtMS0xLTU4NTM3_013030b1-085e-41d5-a89f-3c997d99f81e"
      unitRef="usd">0</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzE4LTctMS0xLTU4NTM3_7f031c85-a7be-4867-a064-7ab98c857662"
      unitRef="usd">163200000</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization
      contextRef="i1636568fa5e84bdabf27c057ce6618aa_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzE5LTEtMS0xLTU4NTM3_44e72cf9-0adf-490c-b8b7-d2917a6f55d7"
      unitRef="usd">35700000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="ib7703e214bc54be8bcb93e4d048e2560_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzE5LTMtMS0xLTU4NTM3_53355865-ace5-40fc-8dc0-6dec0df7f729"
      unitRef="usd">110400000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="if848d1e35557456494fec2c118fc8064_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzE5LTUtMS0xLTU4NTM3_b6dfa306-bd6c-41d7-a070-35004ec1fe4d"
      unitRef="usd">0</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzE5LTctMS0xLTU4NTM3_e7d2016b-e081-45e5-8e12-31682d153c31"
      unitRef="usd">146100000</us-gaap:AdjustmentForAmortization>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i1636568fa5e84bdabf27c057ce6618aa_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzIwLTEtMS0xLTU4NTM3_9322faf2-2111-4277-909d-3efc98790fc5"
      unitRef="usd">190000000.0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ib7703e214bc54be8bcb93e4d048e2560_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzIwLTMtMS0xLTU4NTM3_577720a3-119e-4ca2-a8b3-581f2c38b19e"
      unitRef="usd">24400000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if848d1e35557456494fec2c118fc8064_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzIwLTUtMS0xLTU4NTM3_baaf3651-0a42-4286-abd3-b60bb89e235c"
      unitRef="usd">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzIwLTctMS0xLTU4NTM3_49dd5f72-b833-4ed5-8335-88c191566abb"
      unitRef="usd">214400000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifda5545cd7a64877bb275e348b90dff5_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzIyLTEtMS0xLTU4NTM3_fc2fa297-aed4-4920-b595-f6aa17c90ac3"
      unitRef="usd">1843000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i949cdb7296c2413c8bd74737698ae04c_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzIyLTMtMS0xLTU4NTM3_56aebea8-1997-4a87-a7a9-368d4373a759"
      unitRef="usd">587900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i936768573f894f27889c7dd715937761_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzIyLTUtMS0xLTU4NTM3_7a1efc39-9573-4d17-bd60-e6f13a262fcd"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzIyLTctMS0xLTU4NTM3_1e6e3610-7e10-4246-b37b-9b2ba4d547df"
      unitRef="usd">2430900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifda5545cd7a64877bb275e348b90dff5_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzIzLTEtMS0xLTU4NTM3_c8510eed-91b2-4cfd-a11d-06170c0fd8cb"
      unitRef="usd">375700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i949cdb7296c2413c8bd74737698ae04c_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzIzLTMtMS0xLTU4NTM3_6bc2aad7-d38f-4d64-aa84-191ed87231cd"
      unitRef="usd">-14700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i936768573f894f27889c7dd715937761_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzIzLTUtMS0xLTU4NTM3_a84a1ef7-026d-40e5-aca2-9fea015f4b22"
      unitRef="usd">-49200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzIzLTctMS0xLTU4NTM3_5984f60b-89b3-4a7f-91d8-6ad82282db11"
      unitRef="usd">311800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzI0LTctMS0xLTU4NTM3_3317a563-6ab1-426c-979a-d058660b46a0"
      unitRef="usd">36800000</us-gaap:InterestExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzI1LTctMS0xLTU4NTM3_f2f5f55d-d635-4778-98d1-cf76d454e86f"
      unitRef="usd">-8500000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzI2LTctMS0xLTU4NTM3_fdd77cb4-1448-47c2-9eca-c206387b9fb2"
      unitRef="usd">266500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:Assets
      contextRef="ib167cd4900e94a9d8cbe4bf12709f074_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzI3LTEtMS0xLTU4NTM3_08921989-ca34-4a6e-a848-1ed36eca6683"
      unitRef="usd">4236300000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ib2fed7da6fdf4c2d84c04555713219a8_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzI3LTMtMS0xLTU4NTM3_3089f72b-c963-43e4-9b4c-5301fb14fa18"
      unitRef="usd">2293800000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i4195fe02b707490a8d61b963c66350fa_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzI3LTUtMS0xLTU4NTM3_c2d2ca7a-07c3-43b6-9068-fcbf63ba132e"
      unitRef="usd">207400000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzI3LTctMS0xLTU4NTM3_8fbfedb2-1da2-418b-9f0c-7955a1a43a8a"
      unitRef="usd">6737500000</us-gaap:Assets>
    <us-gaap:Depreciation
      contextRef="ifda5545cd7a64877bb275e348b90dff5_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzI4LTEtMS0xLTU4NTM3_4f813065-0368-4902-8703-6ae909d62e6d"
      unitRef="usd">138200000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i949cdb7296c2413c8bd74737698ae04c_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzI4LTMtMS0xLTU4NTM3_c673f5e6-ddca-4eeb-82e6-2c3955da9508"
      unitRef="usd">11700000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i936768573f894f27889c7dd715937761_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzI4LTUtMS0xLTU4NTM3_a5b6f3c3-26c4-47f5-9fa9-0b2af629d88c"
      unitRef="usd">0</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzI4LTctMS0xLTU4NTM3_802e228b-1bd0-44a3-834b-d19c087af7ce"
      unitRef="usd">149900000</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization
      contextRef="ifda5545cd7a64877bb275e348b90dff5_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzI5LTEtMS0xLTU4NTM3_9eacbc57-51fb-4314-b311-2582cf5220a3"
      unitRef="usd">32400000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i949cdb7296c2413c8bd74737698ae04c_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzI5LTMtMS0xLTU4NTM3_e4b5fbd5-c067-43b8-8bea-783f439e8bd5"
      unitRef="usd">104800000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i936768573f894f27889c7dd715937761_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzI5LTUtMS0xLTU4NTM3_e5943c8a-1821-4fc4-be27-ba0d5f681810"
      unitRef="usd">0</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzI5LTctMS0xLTU4NTM3_c68bf30d-59a0-43dc-a697-5981597a6215"
      unitRef="usd">137200000</us-gaap:AdjustmentForAmortization>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ifda5545cd7a64877bb275e348b90dff5_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzMwLTEtMS0xLTU4NTM3_8c3bbeed-e22e-4ef8-a12a-af83591042c9"
      unitRef="usd">260300000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i949cdb7296c2413c8bd74737698ae04c_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzMwLTMtMS0xLTU4NTM3_a00065ab-9d5f-409d-bb19-50b98e46e0e6"
      unitRef="usd">50100000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i936768573f894f27889c7dd715937761_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzMwLTUtMS0xLTU4NTM3_f7b1b3c2-2121-486b-87de-505101d9be30"
      unitRef="usd">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTo0NzcwZGJhYWU0ZWU0ODNlOWEyMDY2NjU3ZThjNzFmYy90YWJsZXJhbmdlOjQ3NzBkYmFhZTRlZTQ4M2U5YTIwNjY2NTdlOGM3MWZjXzMwLTctMS0xLTU4NTM3_d51b0e87-d797-48e2-bfd4-c301b12a45c9"
      unitRef="usd">310400000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90ZXh0cmVnaW9uOjZkMTQ1NDM0ZTYyMzQ0OWM5M2I0NzU1NmNmMTdiZDE3XzI1Mjc_9248fc77-f349-4b5f-8a97-7c97d609968e">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Information by geographical area by country of domicile for each of the years in the three-year period ended October&#160;31, 2022, follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;United&lt;br/&gt;States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Rest of&lt;br/&gt;World,&#160;Other&lt;br/&gt;Eliminations&lt;br/&gt;&amp;amp; Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales to unaffiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,638.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;987.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;682.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,308.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Sales between geographic areas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;514.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;897.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1,411.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,152.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,884.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(729.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,308.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;71.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;403.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;32.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;507.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;856.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;310.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;266.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,432.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales to unaffiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,339.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;957.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;625.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,922.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Sales between geographic areas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;494.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;815.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1,310.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,834.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,773.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(684.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,922.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Operating (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(26.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;416.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;116.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;505.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;737.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;377.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;232.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,347.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales to unaffiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,103.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;789.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;537.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,430.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Sales between geographic areas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;391.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;327.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(718.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,495.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,116.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(181.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,430.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Operating (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(14.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;304.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;311.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;721.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;363.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;197.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,281.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2772f61aefe64ddbba24fc95a9137207_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzItMS0xLTEtNTg1Mzc_5f34697a-4972-4ed2-9063-cc51ae9a3d6e"
      unitRef="usd">1638500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia1c3c38f11c44e2da46bd9a800f94386_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzItMy0xLTEtNTg1Mzc_67a88d5a-f7e9-4802-b8ed-3d1ea25ab151"
      unitRef="usd">987200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i203ba6d20b6f4590bfc5a2c49c100182_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzItNS0xLTEtNTg1Mzc_a82cb585-e0a4-4f3a-b76a-5ec26987059b"
      unitRef="usd">682700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzItNy0xLTEtNTg1Mzc_a986481d-b0f3-41ba-ae92-fbb1e526951f"
      unitRef="usd">3308400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9ca5a267e7864693ae8d23449d787c29_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzMtMS0xLTEtNTg1Mzc_02f5b9d9-c44a-4c3f-8c54-74c8d6594342"
      unitRef="usd">-514400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib878f9b3ae04474a863b123b65f168ab_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzMtMy0xLTEtNTg1Mzc_2f5cd192-bbd6-4d4f-a811-802bac0d362d"
      unitRef="usd">-897300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibbf6d52286234783b4187fc8c1b84be2_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzMtNS0xLTEtNTg1Mzc_de5c2eaa-b820-4378-82d6-3315b45493d5"
      unitRef="usd">-1411700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie853cb4e9b8e4c04b1094493101d98a5_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzQtMS0xLTEtNTg1Mzc_3c92d269-8593-4078-9d1b-cb676478aa11"
      unitRef="usd">2152900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i872ddcd0dec342a68a42c53d1feac123_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzQtMy0xLTEtNTg1Mzc_4dd175eb-df32-428e-9407-5a9e5c467972"
      unitRef="usd">1884500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7b2584e8265f4b1eb31b69d99591c665_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzQtNS0xLTEtNTg1Mzc_3b664b35-be3a-404b-825a-57da881c254d"
      unitRef="usd">-729000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzQtNy0xLTEtNTg1Mzc_a13857dc-b026-45c7-903b-9a18acbc9834"
      unitRef="usd">3308400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie853cb4e9b8e4c04b1094493101d98a5_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzUtMS0xLTEtNTg1Mzc_6a011098-189d-4166-88f6-0e2f2126c2c9"
      unitRef="usd">71800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i872ddcd0dec342a68a42c53d1feac123_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzUtMy0xLTEtNTg1Mzc_20230ea0-8373-45c8-be6f-c6265135d602"
      unitRef="usd">403800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7b2584e8265f4b1eb31b69d99591c665_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzUtNS0xLTEtNTg1Mzc_e16558db-0716-48ec-9bd6-a3a3cd0e33ff"
      unitRef="usd">32000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzUtNy0xLTEtNTg1Mzc_c64e58a6-5fe0-4039-ad17-b82ebcc84db0"
      unitRef="usd">507600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="if091820da3fa469ca8e63a4e7e623ebb_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzYtMS0xLTEtNTg1Mzc_87ad2509-cecf-4ec4-8692-7fc3569ef2e5"
      unitRef="usd">856100000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="idee380fa4cc94aa2949150146bc1b833_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzYtMy0xLTEtNTg1Mzc_e85640ea-708b-4f42-9b8e-1be509c2dbd6"
      unitRef="usd">310800000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i98cba8f6abe845659e16156082ad2d25_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzYtNS0xLTEtNTg1Mzc_2dc12d46-ff6d-440f-8482-0bba087e5918"
      unitRef="usd">266000000.0</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzYtNy0xLTEtNTg1Mzc_d256c815-cf02-4119-b17b-08e55eb117f4"
      unitRef="usd">1432900000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia9a9fbd6fa9745abbc18a527935e6729_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzgtMS0xLTEtNTg1Mzc_71eef9c5-bec0-4aec-a761-277c963dbc97"
      unitRef="usd">1339200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i24ed2c06038c4e21a954497f6fc03687_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzgtMy0xLTEtNTg1Mzc_47a70459-aa79-46e0-9981-7d322a6c3043"
      unitRef="usd">957900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i632fce02d0a14ee2a54b08cb02f4a530_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzgtNS0xLTEtNTg1Mzc_7aa501ed-143c-4316-b633-2ca57088abb5"
      unitRef="usd">625400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzgtNy0xLTEtNTg1Mzc_de8c0db8-82f8-41be-b72f-728f1f465ffc"
      unitRef="usd">2922500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5472d5f5ea1840df9d91ec3db5081155_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzktMS0xLTEtNTg1Mzc_bac843e7-7dbd-440a-92c7-743e61e5561d"
      unitRef="usd">-494900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0d31ba7c78554e01be3531b7db972065_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzktMy0xLTEtNTg1Mzc_e9567066-b660-4158-b32b-32a91e43c5e3"
      unitRef="usd">-815100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6ac8281323054a3383ab48d0fa752407_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzktNS0xLTEtNTg1Mzc_e89c3fea-5d2b-4308-9034-bd9054a50f84"
      unitRef="usd">-1310000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib5e3fde5895f43fba4395a3f2a394105_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzEwLTEtMS0xLTU4NTM3_16c6a59f-e401-4995-9dea-8722328a55b2"
      unitRef="usd">1834100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie429681883c245819521a0c57f11ffa7_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzEwLTMtMS0xLTU4NTM3_53144d17-80be-497f-acf6-45319ff04267"
      unitRef="usd">1773000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i89ef065c99254e85b8c2f8427f8cc1cf_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzEwLTUtMS0xLTU4NTM3_4bd6b926-ff42-49ef-854b-7806420645ec"
      unitRef="usd">-684600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzEwLTctMS0xLTU4NTM3_85af0ec4-5d9a-4c15-b51d-6f99c65ea67c"
      unitRef="usd">2922500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib5e3fde5895f43fba4395a3f2a394105_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzExLTEtMS0xLTU4NTM3_bdf67e45-7cf2-43d6-846c-b13684ba4e6e"
      unitRef="usd">-26800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie429681883c245819521a0c57f11ffa7_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzExLTMtMS0xLTU4NTM3_2242cd16-4829-4195-820f-7380025b1aa3"
      unitRef="usd">416200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i89ef065c99254e85b8c2f8427f8cc1cf_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzExLTUtMS0xLTU4NTM3_bd349919-8e2b-4863-ae3c-64e482e2b1cd"
      unitRef="usd">116400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzExLTctMS0xLTU4NTM3_beee020b-68aa-4298-9569-b2f030275df5"
      unitRef="usd">505800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i11563134ef8a45bda7a59afedae161f7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzEyLTEtMS0xLTU4NTM3_a638efff-27c9-46c0-816c-9a41dbb4cb01"
      unitRef="usd">737500000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="ib09f048a3bb546ec9d3d473f3290ba4b_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzEyLTMtMS0xLTU4NTM3_f475f59f-dc50-429a-bd1d-a0fd2e31ffc8"
      unitRef="usd">377200000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="if12e23677c7d4f59bf1b6b56f97c0a96_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzEyLTUtMS0xLTU4NTM3_0735731b-213c-4333-8ce6-e2160684595e"
      unitRef="usd">232900000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzEyLTctMS0xLTU4NTM3_8c182961-8906-46dd-ae11-86722b17f067"
      unitRef="usd">1347600000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib3982025069c42019719d3ae187bfac5_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE0LTEtMS0xLTU4NTM3_c9099757-4bd4-4eab-b0aa-f31498833dbd"
      unitRef="usd">1103600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3d212cf3f853423d91d402573665e3a3_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE0LTMtMS0xLTU4NTM3_586456aa-87d6-4921-b28f-f40450d5f822"
      unitRef="usd">789800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie3a74826cb834e35868ee80db8fd1abf_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE0LTUtMS0xLTU4NTM3_cf244139-0a18-4c00-8924-7ce6101c32e6"
      unitRef="usd">537500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE0LTctMS0xLTU4NTM3_d30cbe0d-8024-44db-8591-f454e3183fee"
      unitRef="usd">2430900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i00b1d9c5ee034b9c8a36252aa25fa6a0_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE1LTEtMS0xLTU4NTM3_58c08773-1be2-4219-b473-9952c9732aba"
      unitRef="usd">-391700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iec65f950a0dc4854914e26a734104e19_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE1LTMtMS0xLTU4NTM3_628641f7-55ad-4bdd-bd2e-ed859aa4a21f"
      unitRef="usd">-327100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1599f6e5dec74f248141c4cf3566bf65_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE1LTUtMS0xLTU4NTM3_3d544a5e-005f-45ea-b61c-edd1a917e24c"
      unitRef="usd">-718800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib3910c6d00f04f0abdb3fbfd16d3e64e_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE2LTEtMS0xLTU4NTM3_4419f218-48fc-4c43-bd73-80fe785968a9"
      unitRef="usd">1495300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia32d9258c18848e5abfe9c919bc12cfe_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE2LTMtMS0xLTU4NTM3_7489dca5-0749-426f-ab7c-d8426392a490"
      unitRef="usd">1116900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i750be365ff0047e49e7f299808203d52_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE2LTUtMS0xLTU4NTM3_ecde6d6a-bb61-4dfb-beba-3c8e98e0d9dd"
      unitRef="usd">-181300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE2LTctMS0xLTU4NTM3_cedf7ce2-d90f-4ec7-a99c-5615a94c7431"
      unitRef="usd">2430900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib3910c6d00f04f0abdb3fbfd16d3e64e_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE3LTEtMS0xLTU4NTM3_330d60ce-1b1c-4ea0-ac9b-a6b66dee01be"
      unitRef="usd">-14500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia32d9258c18848e5abfe9c919bc12cfe_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE3LTMtMS0xLTU4NTM3_67514481-be7e-46fb-be4a-4e4f04632032"
      unitRef="usd">21900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i750be365ff0047e49e7f299808203d52_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE3LTUtMS0xLTU4NTM3_42fcf37d-6800-486d-80cb-7b56cef746e6"
      unitRef="usd">304400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE3LTctMS0xLTU4NTM3_32ea34ad-b07b-47db-ac64-8445fae657d5"
      unitRef="usd">311800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i81cc03f2a4a74c3986074b3bee49852f_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE4LTEtMS0xLTU4NTM3_ef5a9338-cca2-44d3-b1e9-925fa340d7f9"
      unitRef="usd">721300000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i92fdd7459bad4408a8a71b8370a03266_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE4LTMtMS0xLTU4NTM3_334a2274-bc1d-4827-8d67-d4e5f91262d0"
      unitRef="usd">363000000.0</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i04406ea9810f4b8190f8776aa444ef9f_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE4LTUtMS0xLTU4NTM3_6a0d6a81-3704-4aaa-b34a-dc35d16637d0"
      unitRef="usd">197600000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i8e27b9c1b1554fa3893ad8bdd281a530_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzAvZnJhZzo2ZDE0NTQzNGU2MjM0NDljOTNiNDc1NTZjZjE3YmQxNy90YWJsZTozNDZjMTMxN2JjYzQ0Y2UzOGI2NmU1NWQ1ZGRiZjhkYy90YWJsZXJhbmdlOjM0NmMxMzE3YmNjNDRjZTM4YjY2ZTU1ZDVkZGJmOGRjXzE4LTctMS0xLTU4NTM3_1ff49b10-1530-4eb0-b73f-9e3df9146d3c"
      unitRef="usd">1281900000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90ZXh0cmVnaW9uOmYzNzc3OGI5MDUxMTQ3YTk4OTA2OWYxNjA4ZmI4NjczXzMyNDA_01ef3762-997f-4ae1-aff3-37c83c944dfa">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Note 13. Financial Derivatives and Hedging&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;As part of the Company&#x2019;s overall risk management practices the Company enters into financial derivatives, interest rate swaps designated as cash flow hedges, to hedge the Company's exposure to changes in cash flows associated with its variable rate debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;Credit risk related to derivative transactions reflects the risk that a party to the transaction could fail to meet its obligation under the derivative contracts. Therefore, the Company&#x2019;s exposure to the counterparty&#x2019;s credit risk is generally limited to the amounts, if any, by which the counterparty&#x2019;s obligations to the Company exceed the Company&#x2019;s obligations to the counterparty. The Company&#x2019;s policy is to enter into contracts only with financial institutions which meet certain minimum credit ratings to help mitigate counterparty credit risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;On April 6, 2020 the Company entered into six interest rate swap contracts which were used to hedge its exposure to changes in cash flows associated with its variable rate debt and were designated as derivatives in a cash flow hedge. The payment streams were based on a total notional amount of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;$1.5&#160;billion&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt; at the inception of the contracts. As of October&#160;31, 2022, three of the six interest rate swap contracts have matured and the outstanding contracts have a total notional amount of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;$1.0&#160;billion and remaining maturities of five years or less.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company did not have any cross-currency swaps or foreign currency forward contracts as of October&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The pre-tax impact of gain on derivatives designated for hedge accounting recognized in other comprehensive income (loss) was&#160;$124.5 million&#160;($30.1 million, net of tax) as of October&#160;31, 2022. The pre-tax impact of gain on derivatives designated for hedge accounting recognized in other comprehensive income (loss) was&#160;$17.2&#160;million&#160;($13.1&#160;million, net of tax) as of October&#160;31, 2021. The fair value of derivative instruments are classified in "Other non-current assets" on our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The following table summarizes the amounts recognized with respect to our derivative instruments within the accompanying Consolidated Statements of Income:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.301%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Periods Ended October 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Derivatives designated as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Location of Loss (Income) Recognized on Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Interest expense (income)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The Company expects that ($38.3 million) recorded as a component of accumulated other comprehensive income (loss) will be realized in the Consolidated Statements of Income over the next twelve months and the amount will vary depending on prevailing interest rates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The following table details the changes in accumulated other comprehensive income:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.658%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance as of October 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(17.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amount recognized in other comprehensive income on interest rate swap contracts, gross ($20.0, net of tax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;26.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amount reclassified from other comprehensive income into earnings, gross ($6.1, net of tax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance gain as of October 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amount recognized in other comprehensive income on interest rate swap contracts, gross ($79.7, net of tax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;105.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amount reclassified from other comprehensive income into earnings, gross ($1.7, net of tax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Balance gain as of October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;124.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="i9149d6cbeb354638969dcb45da4ca29a_I20200406"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90ZXh0cmVnaW9uOmYzNzc3OGI5MDUxMTQ3YTk4OTA2OWYxNjA4ZmI4NjczXzk3NzU_23924947-d381-471c-8fcf-cb7fa09149bf"
      unitRef="interest_rate_swap_contract">6</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9149d6cbeb354638969dcb45da4ca29a_I20200406"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90ZXh0cmVnaW9uOmYzNzc3OGI5MDUxMTQ3YTk4OTA2OWYxNjA4ZmI4NjczXzk3Nzk_f41a0483-8cb8-46e7-b70e-53902d80eef3"
      unitRef="usd">1500000000</us-gaap:DerivativeNotionalAmount>
    <coo:NumberOfInterestRateDerivativesMatured
      contextRef="ib93ee62619474af5844402d5b5e2fc5e_I20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90ZXh0cmVnaW9uOmYzNzc3OGI5MDUxMTQ3YTk4OTA2OWYxNjA4ZmI4NjczXzk3ODM_fe9d2d59-54ac-4251-9d9f-f46ba6c3ebd1"
      unitRef="interest_rate_swap_contract">3</coo:NumberOfInterestRateDerivativesMatured>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="i9149d6cbeb354638969dcb45da4ca29a_I20200406"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90ZXh0cmVnaW9uOmYzNzc3OGI5MDUxMTQ3YTk4OTA2OWYxNjA4ZmI4NjczXzk3ODc_3e1e7019-6d7c-490a-beb5-563163abfb2e"
      unitRef="interest_rate_swap_contract">6</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib93ee62619474af5844402d5b5e2fc5e_I20221031"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90ZXh0cmVnaW9uOmYzNzc3OGI5MDUxMTQ3YTk4OTA2OWYxNjA4ZmI4NjczXzk3OTU_6643189e-8261-43d1-a220-432728048440"
      unitRef="usd">1000000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeTermOfContract
      contextRef="i306e8ebbe94442a5b09f45b81f9f9362_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90ZXh0cmVnaW9uOmYzNzc3OGI5MDUxMTQ3YTk4OTA2OWYxNjA4ZmI4NjczXzk3OTE_66a3d227-8b68-4512-8766-e7e9db3cd7d1">P5Y</us-gaap:DerivativeTermOfContract>
    <coo:AOCICashFlowHedgeCumulativeGainLossBeforeTax
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90ZXh0cmVnaW9uOmYzNzc3OGI5MDUxMTQ3YTk4OTA2OWYxNjA4ZmI4NjczXzIzMTk_ae2ed5ce-29d7-4aa6-bca4-95ee4ff33862"
      unitRef="usd">124500000</coo:AOCICashFlowHedgeCumulativeGainLossBeforeTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i893b343911d346c78ad0d7715f7d33d0_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90ZXh0cmVnaW9uOmYzNzc3OGI5MDUxMTQ3YTk4OTA2OWYxNjA4ZmI4NjczXzIzMjM_fcbee02f-6c13-4dbf-abc9-6e95f529d0be"
      unitRef="usd">30100000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <coo:AOCICashFlowHedgeCumulativeGainLossBeforeTax
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90ZXh0cmVnaW9uOmYzNzc3OGI5MDUxMTQ3YTk4OTA2OWYxNjA4ZmI4NjczXzI0ODk_e3414c10-0a2e-4289-858a-1041824413f9"
      unitRef="usd">17200000</coo:AOCICashFlowHedgeCumulativeGainLossBeforeTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i15080967286843b083f296cee9e2bdd7_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90ZXh0cmVnaW9uOmYzNzc3OGI5MDUxMTQ3YTk4OTA2OWYxNjA4ZmI4NjczXzI0OTM_06e7d1cf-56b9-4b8e-af29-e3d25523331c"
      unitRef="usd">13100000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90ZXh0cmVnaW9uOmYzNzc3OGI5MDUxMTQ3YTk4OTA2OWYxNjA4ZmI4NjczXzMyMzc_b6ac8b95-eb29-468b-b714-031d1b878a3d">&lt;div style="margin-bottom:7pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;The following table summarizes the amounts recognized with respect to our derivative instruments within the accompanying Consolidated Statements of Income:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.301%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Periods Ended October 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Derivatives designated as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Location of Loss (Income) Recognized on Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Interest expense (income)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ib09f9a58a78443b18bed2336686e605e_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90YWJsZToyOGZmYmJlZDExZDY0MTI2YmEyNmE0ZjkwMzU1YmIyZi90YWJsZXJhbmdlOjI4ZmZiYmVkMTFkNjQxMjZiYTI2YTRmOTAzNTViYjJmXzMtMy0xLTEtNTg1Mzc_d4367511-cc31-47cf-9c2d-3702e196ca85"
      unitRef="usd">2300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i18b387b0bc824160a72bc4a7fa134526_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90YWJsZToyOGZmYmJlZDExZDY0MTI2YmEyNmE0ZjkwMzU1YmIyZi90YWJsZXJhbmdlOjI4ZmZiYmVkMTFkNjQxMjZiYTI2YTRmOTAzNTViYjJmXzMtNS0xLTEtNTg1Mzc_320da99f-c2d5-49a4-ad9f-4accb1d82ad7"
      unitRef="usd">-8000000.0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ifc574a9b39cc4fd0b3d2a6b2e338dea8_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90YWJsZToyOGZmYmJlZDExZDY0MTI2YmEyNmE0ZjkwMzU1YmIyZi90YWJsZXJhbmdlOjI4ZmZiYmVkMTFkNjQxMjZiYTI2YTRmOTAzNTViYjJmXzMtNy0xLTEtNTg1Mzc_28d8addf-8273-4723-b114-b64209213047"
      unitRef="usd">-3700000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90ZXh0cmVnaW9uOmYzNzc3OGI5MDUxMTQ3YTk4OTA2OWYxNjA4ZmI4NjczXzI5MjQ_09248a02-1604-4cc3-971a-1e65eb65bce7"
      unitRef="usd">-38300000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1dda5d68145148858749f4a3d0187b10_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90YWJsZTplNWRmY2M2ZGE4MmU0NjMyOTlhMjAxODMwNTgwMjZmMi90YWJsZXJhbmdlOmU1ZGZjYzZkYTgyZTQ2MzI5OWEyMDE4MzA1ODAyNmYyXzEtMi0xLTEtNTg1Mzc_6363d860-9852-4aac-9824-afc73bc50317"
      unitRef="usd">-17100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90YWJsZTplNWRmY2M2ZGE4MmU0NjMyOTlhMjAxODMwNTgwMjZmMi90YWJsZXJhbmdlOmU1ZGZjYzZkYTgyZTQ2MzI5OWEyMDE4MzA1ODAyNmYyXzItMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjo2OTQwNjgxMTY1ZjQ0M2VkOTRjZWE2MmRlOTE5ZWNmOF85Mg_c2981de8-e032-4878-bf96-687255d864ce"
      unitRef="usd">20000000.0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i57f3229c828a483a94464d9bda7f0fc2_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90YWJsZTplNWRmY2M2ZGE4MmU0NjMyOTlhMjAxODMwNTgwMjZmMi90YWJsZXJhbmdlOmU1ZGZjYzZkYTgyZTQ2MzI5OWEyMDE4MzA1ODAyNmYyXzItMi0xLTEtNTg1Mzc_2c2f53d2-e0dd-40dd-b2e0-01e76bf514fe"
      unitRef="usd">26300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i67182972093c47b3b4c40654faf96dd0_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90YWJsZTplNWRmY2M2ZGE4MmU0NjMyOTlhMjAxODMwNTgwMjZmMi90YWJsZXJhbmdlOmU1ZGZjYzZkYTgyZTQ2MzI5OWEyMDE4MzA1ODAyNmYyXzMtMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjoxYjdmMTcxNzJkZjI0N2EyOTE3MTcyZjdhNGU4NTlkZV83OA_d88249c0-8f7f-45d7-81cb-6f736fb96c08"
      unitRef="usd">-6100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i57f3229c828a483a94464d9bda7f0fc2_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90YWJsZTplNWRmY2M2ZGE4MmU0NjMyOTlhMjAxODMwNTgwMjZmMi90YWJsZXJhbmdlOmU1ZGZjYzZkYTgyZTQ2MzI5OWEyMDE4MzA1ODAyNmYyXzMtMi0xLTEtNTg1Mzc_7ad0c142-4d5b-4424-9ec4-a9476001e674"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2357db2168d54d15b89a15c1f04fcf81_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90YWJsZTplNWRmY2M2ZGE4MmU0NjMyOTlhMjAxODMwNTgwMjZmMi90YWJsZXJhbmdlOmU1ZGZjYzZkYTgyZTQ2MzI5OWEyMDE4MzA1ODAyNmYyXzQtMi0xLTEtNTg1Mzc_096b6d7e-dcdb-42fc-8687-306f8953d793"
      unitRef="usd">17200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90YWJsZTplNWRmY2M2ZGE4MmU0NjMyOTlhMjAxODMwNTgwMjZmMi90YWJsZXJhbmdlOmU1ZGZjYzZkYTgyZTQ2MzI5OWEyMDE4MzA1ODAyNmYyXzUtMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjpjYzczZDRlZTllZjg0ZmQ0ODIwYWU3M2Q5NGY2NTIzMl8yNzQ4Nzc5MDY5NTY5_5ddd6880-5a5d-4020-b351-8f2d89e2ac3d"
      unitRef="usd">79700000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i105b86b96182466c89e084e2d8117b5e_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90YWJsZTplNWRmY2M2ZGE4MmU0NjMyOTlhMjAxODMwNTgwMjZmMi90YWJsZXJhbmdlOmU1ZGZjYzZkYTgyZTQ2MzI5OWEyMDE4MzA1ODAyNmYyXzUtMi0xLTEtNTg1Mzc_17fc38a0-6c4d-4385-a40c-9fc1bcba8a04"
      unitRef="usd">105100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90YWJsZTplNWRmY2M2ZGE4MmU0NjMyOTlhMjAxODMwNTgwMjZmMi90YWJsZXJhbmdlOmU1ZGZjYzZkYTgyZTQ2MzI5OWEyMDE4MzA1ODAyNmYyXzYtMC0xLTEtNTg1MzcvdGV4dHJlZ2lvbjo3ZTlkM2ZiM2EzNzY0NjBlOTFiMjM5YjkwNzE5YTk5Ml8yNzQ4Nzc5MDY5NTUx_af08ab80-29d8-4a15-b782-bce3ff5fbe08"
      unitRef="usd">-1700000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i105b86b96182466c89e084e2d8117b5e_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90YWJsZTplNWRmY2M2ZGE4MmU0NjMyOTlhMjAxODMwNTgwMjZmMi90YWJsZXJhbmdlOmU1ZGZjYzZkYTgyZTQ2MzI5OWEyMDE4MzA1ODAyNmYyXzYtMi0xLTEtNTg1Mzc_c6658d7c-4523-46ca-9741-2ffe6bd7487c"
      unitRef="usd">-2200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i007a38e974f04b6fa9067c5041cfd72b_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xMzMvZnJhZzpmMzc3NzhiOTA1MTE0N2E5ODkwNjlmMTYwOGZiODY3My90YWJsZTplNWRmY2M2ZGE4MmU0NjMyOTlhMjAxODMwNTgwMjZmMi90YWJsZXJhbmdlOmU1ZGZjYzZkYTgyZTQ2MzI5OWEyMDE4MzA1ODAyNmYyXzctMi0xLTEtNTg1Mzc_80a3c198-1435-4c25-84a0-ffbfbe5f021c"
      unitRef="usd">124500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
      contextRef="i430ebcbddebc425c968858950136be1a_D20211101-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xNzUvZnJhZzo5NDZlYzM0MjZhNTc0MGZkYTU1ZTcyOWE3YjUwYTk3Ni90ZXh0cmVnaW9uOjk0NmVjMzQyNmE1NzQwZmRhNTVlNzI5YTdiNTBhOTc2XzI3Mw_6aed0499-908d-45ef-806b-6705e4f4acda">&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Schedule II&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;THE COOPER COMPANIES, INC. AND SUBSIDIARIES&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;VALUATION AND QUALIFYING ACCOUNTS&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"&gt;Three Years Ended October&#160;31, 2022 &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.203%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Balance&lt;br/&gt;Beginning&lt;br/&gt;of Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Reductions/ Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Balance&lt;br/&gt;at End&lt;br/&gt;of Year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Deferred income tax valuation allowance:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Year Ended October&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;51.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;60.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Year Ended October&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;45.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;51.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Year Ended October&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;41.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;45.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="iea2aa42170064029a14838912d3185ac_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xNzUvZnJhZzo5NDZlYzM0MjZhNTc0MGZkYTU1ZTcyOWE3YjUwYTk3Ni90YWJsZToyMWVlYjMzNDdhMzc0MzkxYjc4N2RkZTE0N2YyZTFmNS90YWJsZXJhbmdlOjIxZWViMzM0N2EzNzQzOTFiNzg3ZGRlMTQ3ZjJlMWY1XzItMS0xLTEtNTg1Mzc_241c030c-bd57-4472-8f22-2c7111b7c76b"
      unitRef="usd">51800000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="iedb5b89d45e54e028ef271a4be6338b8_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xNzUvZnJhZzo5NDZlYzM0MjZhNTc0MGZkYTU1ZTcyOWE3YjUwYTk3Ni90YWJsZToyMWVlYjMzNDdhMzc0MzkxYjc4N2RkZTE0N2YyZTFmNS90YWJsZXJhbmdlOjIxZWViMzM0N2EzNzQzOTFiNzg3ZGRlMTQ3ZjJlMWY1XzItMy0xLTEtNTg1Mzc_1c529819-0657-4df3-ad66-f972fd58324d"
      unitRef="usd">13300000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="iedb5b89d45e54e028ef271a4be6338b8_D20211101-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xNzUvZnJhZzo5NDZlYzM0MjZhNTc0MGZkYTU1ZTcyOWE3YjUwYTk3Ni90YWJsZToyMWVlYjMzNDdhMzc0MzkxYjc4N2RkZTE0N2YyZTFmNS90YWJsZXJhbmdlOjIxZWViMzM0N2EzNzQzOTFiNzg3ZGRlMTQ3ZjJlMWY1XzItNS0xLTEtNTg1Mzc_98fffc59-4235-420e-afcb-09e1fa77acb3"
      unitRef="usd">5000000.0</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i1a10babdc03d448fb7f6f049b019e92b_I20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xNzUvZnJhZzo5NDZlYzM0MjZhNTc0MGZkYTU1ZTcyOWE3YjUwYTk3Ni90YWJsZToyMWVlYjMzNDdhMzc0MzkxYjc4N2RkZTE0N2YyZTFmNS90YWJsZXJhbmdlOjIxZWViMzM0N2EzNzQzOTFiNzg3ZGRlMTQ3ZjJlMWY1XzItNy0xLTEtNTg1Mzc_f36d0ff2-486c-4604-8802-134327fffc21"
      unitRef="usd">60100000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ib9b7be6dd72e444c91e43d8ed9b4980b_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xNzUvZnJhZzo5NDZlYzM0MjZhNTc0MGZkYTU1ZTcyOWE3YjUwYTk3Ni90YWJsZToyMWVlYjMzNDdhMzc0MzkxYjc4N2RkZTE0N2YyZTFmNS90YWJsZXJhbmdlOjIxZWViMzM0N2EzNzQzOTFiNzg3ZGRlMTQ3ZjJlMWY1XzMtMS0xLTEtNTg1Mzc_21be9857-db78-4f25-896f-347337142dd1"
      unitRef="usd">45300000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i92f0a4209532457b97330c2599af126b_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xNzUvZnJhZzo5NDZlYzM0MjZhNTc0MGZkYTU1ZTcyOWE3YjUwYTk3Ni90YWJsZToyMWVlYjMzNDdhMzc0MzkxYjc4N2RkZTE0N2YyZTFmNS90YWJsZXJhbmdlOjIxZWViMzM0N2EzNzQzOTFiNzg3ZGRlMTQ3ZjJlMWY1XzMtMy0xLTEtNTg1Mzc_bd24090d-79aa-4209-af71-685dc704153b"
      unitRef="usd">8800000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i92f0a4209532457b97330c2599af126b_D20201101-20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xNzUvZnJhZzo5NDZlYzM0MjZhNTc0MGZkYTU1ZTcyOWE3YjUwYTk3Ni90YWJsZToyMWVlYjMzNDdhMzc0MzkxYjc4N2RkZTE0N2YyZTFmNS90YWJsZXJhbmdlOjIxZWViMzM0N2EzNzQzOTFiNzg3ZGRlMTQ3ZjJlMWY1XzMtNS0xLTEtNTg1Mzc_7f8d0181-ecab-400a-b8e4-ac80d2a056ec"
      unitRef="usd">2300000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="iea2aa42170064029a14838912d3185ac_I20211031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xNzUvZnJhZzo5NDZlYzM0MjZhNTc0MGZkYTU1ZTcyOWE3YjUwYTk3Ni90YWJsZToyMWVlYjMzNDdhMzc0MzkxYjc4N2RkZTE0N2YyZTFmNS90YWJsZXJhbmdlOjIxZWViMzM0N2EzNzQzOTFiNzg3ZGRlMTQ3ZjJlMWY1XzMtNy0xLTEtNTg1Mzc_004e8e46-09c1-4c43-b5c6-2029964dc69f"
      unitRef="usd">51800000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i8b0bc537a9784c479a6e47674c4a3455_I20191031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xNzUvZnJhZzo5NDZlYzM0MjZhNTc0MGZkYTU1ZTcyOWE3YjUwYTk3Ni90YWJsZToyMWVlYjMzNDdhMzc0MzkxYjc4N2RkZTE0N2YyZTFmNS90YWJsZXJhbmdlOjIxZWViMzM0N2EzNzQzOTFiNzg3ZGRlMTQ3ZjJlMWY1XzQtMS0xLTEtNTg1Mzc_91126e41-7c3f-4481-9cec-85e1ef420b33"
      unitRef="usd">41500000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ibb1e445d83e7435f82ac0109d212736a_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xNzUvZnJhZzo5NDZlYzM0MjZhNTc0MGZkYTU1ZTcyOWE3YjUwYTk3Ni90YWJsZToyMWVlYjMzNDdhMzc0MzkxYjc4N2RkZTE0N2YyZTFmNS90YWJsZXJhbmdlOjIxZWViMzM0N2EzNzQzOTFiNzg3ZGRlMTQ3ZjJlMWY1XzQtMy0xLTEtNTg1Mzc_0db2d83e-49c1-4150-8674-104676af59ec"
      unitRef="usd">5900000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ibb1e445d83e7435f82ac0109d212736a_D20191101-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xNzUvZnJhZzo5NDZlYzM0MjZhNTc0MGZkYTU1ZTcyOWE3YjUwYTk3Ni90YWJsZToyMWVlYjMzNDdhMzc0MzkxYjc4N2RkZTE0N2YyZTFmNS90YWJsZXJhbmdlOjIxZWViMzM0N2EzNzQzOTFiNzg3ZGRlMTQ3ZjJlMWY1XzQtNS0xLTEtNTg1Mzc_03495ec8-92fc-486c-875d-aeb07e1e6061"
      unitRef="usd">2100000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ib9b7be6dd72e444c91e43d8ed9b4980b_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjZDk5YjZkZjQxMDRmODBiZTkzOGNlNzdkYzgyODhkL3NlYzpmY2Q5OWI2ZGY0MTA0ZjgwYmU5MzhjZTc3ZGM4Mjg4ZF8xNzUvZnJhZzo5NDZlYzM0MjZhNTc0MGZkYTU1ZTcyOWE3YjUwYTk3Ni90YWJsZToyMWVlYjMzNDdhMzc0MzkxYjc4N2RkZTE0N2YyZTFmNS90YWJsZXJhbmdlOjIxZWViMzM0N2EzNzQzOTFiNzg3ZGRlMTQ3ZjJlMWY1XzQtNy0xLTEtNTg1Mzc_e3951e67-cf76-406d-a0c2-e224b7d58e8a"
      unitRef="usd">45300000</us-gaap:ValuationAllowancesAndReservesBalance>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>111
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M%[W^T-5R,QHF3*E5N95QPL8S0#XOQX+1>DRXP(73UT(RFB%,J54AE2G"QB/
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MX1",3CB$E4-X[!"?<(@JA^B]#G'E$%ME2BI6AR76>#Z5XH"DL08T\V+%M-Y
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M1IT"L$@ZV4O"(V9=)+\A48O7I.8U.<OK?RM$'Z-)G\)#=WC$J&L61'ZG\/6
MA?$I6H'_JU'QS^_<%J737"J85N$=^9T#V&,6^>-AHT"7;/K@@J@A34G':[1@
M!9$;V\HJR,..Z[*%J6?K=OG>-HE'\P^FC;:MW2^8L@=_Q')#N4*,K $2=(>8
M9-G6E@,MMK;16PD-;:-]S>&O )'& +ZOA=!O [- _>=B_A]02P,$%     @
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M&K=DU3ZJA1:E*Z@SH4UY=M/<=%R4UL"<9T+H]<)>T/3P^"]02P,$%     @
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M?EOBCP:T"\#W"Z7LUG )NE]7]A=02P,$%     @ #8*)5:W(48A/"@  C30
M !D   !X;"]W;W)K<VAE971S+W-H965T,3 N>&ULK9M;DYLX%L>_"N6=VDJJ
MVC:Z@.UL=U<E9J8V#]FDTI/99XSE-AN,/ +W93_]2@(C0 ?AWG$>TKX<'?.7
M=(Y^.H+;9RY^%GO&2N_ED.7%W61?EL</\WF1[-DA+F;\R'+YS8Z+0US*M^)Q
M7AP%B[>ZT2&;8]\/YX<XS2?WM_JS;^+^EI_*+,W9-^$5I\,A%J^?6,:?[R9H
M<O[@>_JX+]4'\_O;8_S('ECYX_A-R'?SQLLV/;"\2'GN";:[FWQ$'Z* J ;:
MXH^4/1>MUYZ2LN'\IWKS>7LW\=45L8PEI7(1RS]/;,VR3'F2U_%G[732_*9J
MV'Y]]OZ;%B_%;.*"K7GV[W1;[N\FRXFW9;OXE)7?^?,_62TH4/X2GA7Z?^^Y
MMO4G7G(J2GZH&\LK.*1Y]3=^J3NBU0"% PUPW0#W&]"!!J1N0"YM0.L&5/=,
M)47W0Q27\?VMX,^>4-;2FWJA.U.WEO+37(W[0RGDMZEL5]ZO>5[P+-W&)=MZ
M#Z7\(P>U+#R^\]9QL?=^DQ.C\*;>CX?(>_?+>^\7+\V]+VF6R4$K;N>EO 3E
M:)[4/_>I^CD\\',(>U]X7NX+[]=\R[9=!W-Y[8T ?!;P"3L]?DW*F4?0C8=]
MC($+6E_>' '-H\N;^PXUI!D.HOV1H>%0?;[3?;X3_.#)^!9QF>:/58"D9<J*
M#U"W5VXI[%8ECP_%,4[8W41FAX*))S:Y__O?4.C_ ^JR:SJ+KN2LTYVTZ4[J
M\G[_+YDXTSSA!P;U6=4VT&U5?GRZ)\M@MKR=/[4[P[;"*TIGBZY9!)B1Y8PV
M5IWK#YKK#YS3X>/V/S(%5!%9<IEG$YXG:<:\O!&F/E?O$C5SCH(_I3*NO,WK
MY5,GN.;4N::SZ$K..ET?-ET?.J=.Q*33)(VKU2G?>O&!BS+]K_X ZL;*W:(]
MFV@X0[W9!%CYJQGI32;;"B\7+5\=18M&T<*IZ//A&*="32:5W=.\C//'=),Q
M,(TO["OH7^6ZL@E;-GY/A\NBHV'9:%@Z-3SL8\&F:J'?>G+V2_HIJA%B+^HU
M&.9+2TI 9[BGQ3:BI)\*(MN(+&8AK&C5*%JY4Q3/ISIV3;QF3.IS*5K9UX$M
M18 1LA2!G@)8$?(-4_B7SC05.1DO)%#DWC8MCKR(,S7]9*:2>LO7&^^8Q;4=
M^_.4'E6K&_V6EWLF0,3P@<G9EU\;M>?>-.BI!QRA12NS=^6WD HYY:_W,K*8
M J6=[ ;O*<Y.3&F6R5N-K^H6^;*0B5H,9I/Z)]J7-D6^%8* 61C._%7[7U\T
MNC0H$3:*\4BRW#$A9$R>UZ3X!4XKM9].,)+9JJ_*MIKBP+<&.8(,_9:[KAP#
M86B$PIH!C(N"R;57S^(TWJ39\#**KHI@5_467<M;MS\-A2$WAGU,$GY2#"-7
M5)8^Q7+1 7N0VJ-)K"R\ALP6P<P*;MML.9C:#) A)W3<?\Z?9/QRD0[,[\"^
M-NJW,+"6 )BM9FCEC%N@3=A>E+N*#.<@-^A\56FVGNB@)!M&IBBT8Q8P"U<C
MJ0AH0]$0YR #.LA-.E][2ZE0F_\IWTU/\@T<TC<*HD'Y-@E- V0G8L ,+^Q)
M:1/1% ^E7P-%R$U%37P=X]?!X ((9V6/XM*^/A3V1=BN,&GEYJX* T+(34)2
MA3BQSJB 0D!FL2+,M@I6?1J/ "L9A\1O_QN8C=C0$';3T%G7V-J(;1I14ZBO
M#-M@@_K<#;E">&@WB@W98#?95+DBX_GCM&3B,#94&( 88K,W9(:1M<.&S!RB
M#+Q@-[P\L++,V'E?]!9(PP!^!/8^J39S;92<)EU=AF*P<U77Q8^+J@*@-&*#
MY<H.,\!L09:S?L8 S.@R'-HZ80,6F+ZI7);*U;FXI.:!G<#R5EB[JK?H6MZZ
M?6H(![L)Y]M))'NY:A:CVS2P8P-@@:-6Q ,L@Q'M3Z\(LB/('XQY SW8#3T?
M$RFB2%5@:YV;4R$M"J5:UWHT(V@FT#E!3;-8-1']FG6M&F0D:F,"9(A)T%^'
M(\@NH$-DA T983<9?1,\86Q;AXO<B[.Z%L3D5"KUCL<K3AN9]M)8O()2;="1
M*:]?YL+CM2&G25>> 2'L!J$FY9T*O>"""0%492/-%"T)LM<JP) &UL8\@NQ(
M2(<V(-A0$EZ]*>7MTCS.DTM2GI.^WISRKNDMNI:W[IF+(33B)K1N5!B\V;)-
MV22!M"A.LJ>9Q(("WBD1@,P"U \- A2=J,UY$6!'Y ZQM1WNJC401]P0]YW)
M;4)SRM=5"\H"N"L(47]OLR9V86F*J+5[@-R1;@[L"C,@1]P@IZ+_V!G*=Z*M
M];U7[+DHVV,[6&,D-MH1;!7JUX"9%&/E_0BR&TP&I'5:Z$8\.93U:EVAZ^'
M<Z\H>?(3U&13V'2QM,<1,,/4*AU#9G0Q.#T-TQ%WL:@)1L$R?2I=<CEN V7_
M^#D66S@8H?)/?[L+&!%B;3P *T0&!\^ %AD!K?/,_(M" 49"H54U \V(55&%
MS+ _5&4B!KC(R'%:JK8@^58?!(Q.U-#.)%;DC=M$;INN$H-09.08[;P.]"+.
MVW'AL<,QXZ^,U1\UT:GH&51JT]3"8@[ R#JFC@ C/'2400Q0D9'SMO][;TP
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M9(QQ4SVH\R46DM4+F>=WTJ7<.,EK$M6S+]6;DA_UTR ;7I;\H%_N62QW\LI
M?K_CO#R_43_0/(%T_S]02P,$%     @ #8*)53O7N2P%)P  87@  !D   !X
M;"]W;W)K<VAE971S+W-H965T,3$N>&ULM5UID]M&DOTKB%[M6HI 4WU(LBP?
M$:W#,]JU+:W:1TQL[ <0*)*P0(!& =WB_/K-EYEU@6"K/3OSQ5:30%565N;+
MLXK?W';]1[LQ9L@^;9O6?GNR&8;=B\>/;;DQV\(NNIUIZ9M5UV^+@?[LUX_M
MKC=%Q2]MF\<79V?/'F^+NCWY[AO^['W_W3?=.#1U:][WF1VWVZ+?OS1-=_OM
MR?F)^^!#O=X,^.#Q=]_LBK6Y-L,ON_<]_?78CU+56]/:NFNSWJR^/;DZ?_'R
M"9[G!WZMS:V-_IUA)<NN^X@_WE;?GIR!(-.8<L (!?WOQKPR38.!B(P_=,P3
M/R5>C/_M1O^>UTYK61;6O.J:W^IJV'Q[\OPDJ\RJ&)OA0W?[5Z/K>8KQRJZQ
M_-_L5I\].\G*T0[=5E\F"K9U*_\O/BD?[O/"A;YPP73+1$SEZV(HOONF[VZS
M'D_3:/@'+Y7?)N+J%IMR/?3T;4WO#=^]Z]=%6_^]$!:U579=K]MZ59=%.V17
M9=F-[5"WZ^Q]U]1E;>PWCP>:%>\^+G6&ES+#Q9$9SB^R'[MVV-CL35N9*AW@
M,9'K:;YP-+^\N'/$=^6PR"[/\^SB[.+BCO$N/0\N>;S+>_ @SUYUK:7%5H$E
M[WMC33O(!]TJ^[YNB[:LBR:[I@\-B>A@L_^Y6MJA)R'[WSD6"0%/Y@F XKVP
MNZ(TWY[L,%=_8TZ^^X]_.W]V]O4=RWOBE_?DKM'_*5M\]PP_=8/)SA?9GYTI
M?>'GC2'F$]ST]+_MCKXP-L_>MN4B>RB?Y]FMR;H^&_A)/+)_E-4V*[)UTRUI
M/[:FHLD:4LN;NC19*<]DNW%)$S;[C#:(1#"CR3#$3W^[?I,]Q']?O'KW[M'"
MS8[_T+Y:>JCOQO4F&VZ[;#E:6K6UV=C6@\WUV5]KZ]8J'UR/_1HD+++_^+?G
M%Q?/ODX?W/4U85]-I!")A(@[&FE;M..*!&>DK>>1Z(F/9L"REGU75%E?M&L#
MP;/=:J!%D2B60]80,M(+*^4'@5]3$7:8[$:F*KN^5^B3 :<D.5(_2U3N*4KY
M*]3N^JXT%1-/>C-B0GI#O[DA@NASDFA^?NBR>HN/3;8Q13-LLK+H#0W7$#3W
M>WQ_VY$^Y82TRUHG6!7;NJ$_%J2(->G=KJ$OB!NIHD)Z5EXQ;5#,&IM-0M*;
M7=</]&?9C,0E\(QH)O#FP8JFD3'!F2\LN*R#D[S0./7 %%S18S82ZKH=3._$
MC*2KM06S7"@GD21ZL Q:)*V1\)O'X]V)B%]DOUC>X#=VH*V Z&$YA 6[HO>P
M\RHF:1:#:AX7EKH>]F1(B+]_N;IZ3^O\8ZRQ0;2K9&GQ,%B]+3X267Y*4%Q8
MLLX[6<&P*8:L6*U(B)1;8"#-76RAR,(V:UE2Z=6FIBUKF$_\=U7;LNDL"08>
MA-22ZF/F8^_(+%@>7AB.[">)EB48H'TH[%&R6O)F;-$H)>;33G2%I!3P$]["
M7[3?=5?1UI*PTTQ.)@BL&BR"UM]GJ[[;TFN=C?BU(&C*:'^&NAR;@K")4>G=
MKV]?GYY_15^0L=O6)9&R+N!XD':1Z)-T$*4>2T"=* +K ;LHV#J!LV9/5 $&
MA"8L+'K8[BVQ!')M=UU;\<(Z82'Y;6W%C. -=VMV-.79FC2P;T5H"L(X(L-C
M",CL+-[9FL*R7I,.D\P3X31!3[I>BOJPO&]K:U5 $P;<U/VH.% 3=00$Q-TY
M:DDR2B+&.BF!#7443T?;0LTZDD^!+3P)636]L+(W0U$W]%>>T5[MZH%FS#UH
M=:N5!RW:U &"M\]*,F9U2?M-LFJ8#37M=U&J6.:@>.AKWK>BI/?I(X)<@JQB
M#U7N"<)H 0W]>T<;#0$' $-0S:=BJQ+(3BBAGJ,E@&:ND$\+$W</BV'5VQ0W
MD%/XWY@;$/()PFI()8@_LA'361= #A)38'='(_$@FZ)R.R%Z-0+7:=(]?X_O
MLJ(BD8!\B\)C1\=>E"A7BRBSBGI@M+*PFVQ%;KW,2L.25II/@\++[:8N-XG@
M$231$U4-NT3Z0+R#:.A?HAVQ;2<8=IJ2QUBMU'@[$V"BA&B)&R<X#Y)U#0X%
M8MM&7^<J ?0V;3,+#%RPHB?:&<;$)#)FEIT=]'MRT10Q&V( HWQ.3"?9N2F:
MT3C=\9!%D,<KK'L9:5/T:[P2X2), IE+!_CDLJSC58(QLCDD2(P>3N4\MS:F
M8F6O6Q+94><6GAM:/!L>W?MH60[IZ=,-Q3"T%2,TDE2I52"'X@" :%/))I$$
M#T[,DF'4M)+Q'F6XMB,WA:S>P- A"$E"'_Q#"23=0BAF7-+?'[.'8?-:BNM8
M0;K>B.NSKKO1$I=ILQ3M'4H\HET?X&V0))-JRWS.'A/M_+JJ  ,*)+"HJA[,
MQ)LB@O+> &M-TD%FC.1B.8I4B2?)0+ ;L.NBWF!04>Y!S U]!Y'E+SH:B=PS
M6M2@N_%+R]Q@HZU01"LC=(TP.:99\=*!)2L]LX_6H4ZOH75U6Z9*S(?(RX:B
M!#+[Y4?:T$)&N,4^JX*VB&GCET&N5W.O2!;PQLJW-;SIM VW9'FQM44&0PBE
M\<HK5 :?0KFM(@K_\_S+K^T]7!FXM2OR(.A31'D+C0[$T1*E&6$A23"(HYT:
M  /E4]<])F,$M!/5M-F\*E#<2D8#O%P2%[;8CALR'\6RH95>5;\3&@LMK$%+
MX"7\1EZB->+=6F:1N!# D&8OF[8"X+/P F@4+NN^'+=V$)>0=0X(# @LX?0(
MZ).X=3W#D4=[06IPG(C0QV%,8#!'<O(A,6WU&!P3Y5:L3)CF>:_/ )*L97%3
M]=L6Y-<.\(U9Z\?(\U0%2WPOD6VU,[GZ2^JIU&T0#8(ZPC=[*!MB]Q(!\D_]
M>8&IV[#ZU+4C/GP@2&A'?%5V6"36]1,A\C7[B+%H65J=@ 'M+W0-_^"HPVUN
MX2&M';=+A(NK !+,BC5Y5#N""C(A!3M2713FPA+MC<0]M&-Q&$0SK@Q[4_"4
M @;2EC-\8Z_$Z2G%=/2T4$C.G-\C(J?.#7!N)/^UK_]N>)-HE? S'I9=HZY)
MLQ?T?.6<D$<.X_TG+(9V7%H*)X@68H>,-+MCGGW$LCL6C !1E5<=&7&LG::*
MS>&A:.K=3L$L1N6L6/?&.%6EL3W!>4P9HCA,12$;;6+/077TTEUT[3OGD^DW
M#$\!L$_A;[-HJAZ2R-S0WT0LN?_=4/-WO5E"[G,U_LNB_!@B)0E=F!) O@E@
MJG)D)N;^@-$'$&EE">']OF*>B%]&^F*)27#B-$"5]2 \(50M*+CH70SE^9N#
MJ*7Q?KI27'C7E0,6!$6@MA[LU*E9.9>?7Y_LCP=OYWTX)S:H K^M<WD.2 S)
MRDE[E3V$3PXW9<CZVGXD.?Z>/C$%+7I^XL KYC?%>K45H$> @_C/\3B786@9
MRD3+DDCT#8XU&**&JM:K&MZYZ=G. ,4CE\Y#DI78THNX,+SW4 5]O=T8-:.Z
M<AH)_+&RGJ[YC&BX+>]*,A<<:!?9KJLY?0$_ASRV8;]3\S62NY'932T>KT0Z
M/CD3$T'R5GS"9@F$$)V\DH 6/85(@P9ZD_5QK$8@*HYAI$F$Z0I4DA/@H(>]
M2AV^5[:ETNXC?-H)<;HY&+ :+S"W0$GA)8"]@59Y2V_!CE)\)'S$<*6F%,B2
M:'Y2K(GCM;CT# JQ+-VR&=30S>\@R0E%J=F>P@JPE'A "[@V)I/,*;DW+UU*
MX-JLF?-O(_\$:$-R5JQ)$==>DY05$"6-1_#<KW",R85ADQDT[S[BUH/+NIZ0
M02$L(]E]&"6WY*-' 4EX@VQDVMD/5CI2! ")\EJ(HGKV"NCAVFX$0\,C\":8
M9 ^2B+_(SK<ID.8.7B._.X1F(<+ID,^!3A%N2;I,@6QIAEMC$G=50N;8)N;S
M9B)W-B+,[0+;**B/]6%.6X7=BIL)JEN3<@ME*)_%=FDODJU6$A**T4U!JNT?
MX]GISZ"!&(D>(H=#D,IG@<$7]2NC!-TBB%:ZI778^2HE;4L:2$-\A"$4,D&>
MURZ)E(L=K950-=<@E1VF5B5@:P@,JM1,\.M65CD,C,X<DT;<T%Q21*3/1Y!5
M</X\IW4;4RVR=ZVFM/PD#<\!I77>,5,B[HRN]BX9+Z+4(-"5QYDW!JDQ(G8@
MV:WQ@2R?A[<#^UR+[#<.PIAMM&=$1ZX12="_ 9E==G12RHI02]AUM/&@G:)N
MB7Z$/RK82S6JI[=<US0<IT*(R$H3?YUEMB->L;/R/!O*Y%ZTG.HAZ<JY /+E
MX4#O7;I:/0XX0TBW9Q_;[M;5,C+ F<95%%ZWE47&IR)=H_?)%2M\:%W"DZF\
M&F;+<<^60!P[AEIR/ =D($D.R X1:CB&>J5S =W<,I?$]A3Z[BN'4!P5P51O
MB)JMG3I+A 2H7F6OO;>(-5P%C(L-XMJTO))]*,($P\P^6X2G"8SC_Z"*#-C*
MQ,C)*?CJ6$0?@-1!2[ HDL)VB8M@N=Q8:EACE'(&RC]I(W.*0I!\_4$L@=@Z
M5A!9G!<%%RZE.A:XP^8@YDV([GK(O5"+29Q6Z\R:H<7VD]%P/G;E*@5^KHF?
M$C0TD9$(\16@?7I@:90 <<P3<Z2.%/ALI<CEH>E?P/2_>GU&K*A&6%P=9D+=
MKGJ)##77'!?*Q/C=L%N-Q/+0P47CM9+:C8"6U1A5A/;,[T"13(;,TX/S)XNG
MV98PW&41'YQ?+KX,GPS9.P(G1.:N1X"?HG^<YRZXTH#7>_$J_"S>5V79C_3/
M'Z+BE*;#DS3$2ZGN9==HOG![L9-> 9OZD6+I'#2H&V=TS;K9SBI5HV>2]QW@
MXP7OYE44/_K/>S-GA6.0953)C\.R N2V_I0+IM)D1;.WM:_S_BZK40B.<H0N
MJ4KV$,E95RYF]"3)B0GFQ)XQT\A78@2-NCT;DXQ1%0=0ZAL"REGEXH62.2,5
MUM1VQRF=)!WQ!STD/D]43HMB_D$<7)L1M")]NRED>>2?TC9M.I)9DEOWD#BA
MU3&O;NH&2C3J(ERI28G]"^5X)96^3ROU>>1-RK0)K+E6 "E:<N+0>;6W&J?L
M.4)V#SKU<N4%,)31 RSC!!K[_KJRN]DVZZC&;KW*B"VV$?@40X) L\B31WM=
MMU-8FX!6+&S>->;LAL?\RD 3ZC8$.XB!!2)Y8^^S7F!QM*>3CHH^TDIXIYU4
M_CEC)BO5.7[D>F#MDD,AJ2R\F7&M.3Z_OUI[!\DK,XC5&#A&N->&9*:/]B#$
M Q&J<4M"#6?-D,Y!L3!KL6:#X_(^@V_D\0Q)NF?B?*SGQN&(B1!D2!&( $DS
MB<J0PW"N4K!ORW#@HVWE,VVD<;L<9ZNN25C,Z4OF+-3(4(S+DO4;24P/P^4P
MS?*3L@=E_&1Q6_3B?OJ"X]"1\'4[3??&7C^6+T.EE65Y14S(Y$/N-TK=B*)4
MU(0B'R5,DR+!& 11XJ6=<JM%J%GF:;-$[*$XWM]@")]8]P8-'%B0!(E>N3Q=
M5 U%[U)$IK#,:9_PN1*#J(TJOX\5IT%BMBKY^*=OTQ$6"4S==' Q&BZ F>VN
MZ?8&)MCT)=)Y2T.>2MUYITD$SS]'G%R96NH'TMWQ<VS (3]NN3,K(5%-'/AN
M*:;/<Y0'80&$H:.P^-2Q,II8D\>.Y$7V%Q02.!!P=,:M 98<5427B>9/5BM!
MOD8@$"GI* (2078DX\HIG;$GLK2KI9KL9/!C(A9'O40A@5IO$;W&#VK"23OP
M3ET'GO88=6T6M5QMM\@]BBJDW4 L(PG(13.$K(N&I;)Y2/Z>DDMJI$L+81I7
M2Z:;I=5$*+FT_2G&L[^-!]*:[<\]E_;W+O4-5F7F#X;B+F57+#6J)#^S?<;P
M1/2^-DUU0$]PM(H61<[PO ]8C:I]KM]Y4F-]F&,A>Q\J;U.G<6(,E>6>M#L,
M#)D,$CK"XAJM5^B1*7J4D]JH6N2*<7A&+=<J(N7.1JOOM43^BE,'Y1Z1<&L;
MD=P?D61"EG?LH\X0I#4@DS,;.%JC;3Y-A]64;E3)8Z#]9VQ++1.[+Q>P"(-.
M:S0_<*23C1,OZ9Q5UY"J,N3!+)T:Q@4IC3K 228@V$-U)D+D@/H(R)&H<*^R
M*G-A8HM&:QY)HL)LS64")K"SUJ5_ATV82MVH8ZV3KCM!^?"9Y<&C946$(>K-
M!LW[-VXQGZ?+E8KK=L(<5HVXNY+4H7/=E'5"G;9<P&=GEH1J,'8;;W]AYS88
MPR#IK8SW+'7M@;]%&0V_3+\U'._*CO$HCFU^&5@F^/S@XF)QYF/529=#GCUX
M&L6VZ;?G&NLN+HX\<+:(*N.O#9<@:]>F]%=M#4H^C[,TG<OKQ$VUTQ!WB(SZ
M(N[HYGHH[RG*&[*ETP@M;*[$BLWHTF4==Q(%PB01;!U-8RA^AJ>B)B=7R)'$
M^^ ==U$,-$5YY2%J!(/7''WUNB_M_,"N\]&5=G7DO5NQ;X [F(0K@\ZC_HQ6
M@)R(.9';Q"DGU-=A-*-4'%I!(LKF5CFM(48Y?77>4"^@!^TBN/[3'93"2YAH
MLEXO0:&(P-C@1CY(-:F%X9>K8)6]%G%WFXTH^WFNY^V "B0HN)M%C!@2F#O?
M8D9;UM,\#=M',MVK@4N7D3===4;ZF2@81TTOV@ 70$:,Y%K<O+#0<CD]=T>2
M2)):T7&2X'=]CVE_Y6E_C)H'8RU#[U#%#B?)%L53":FN>LT1.R>4N!3)^</2
MU#<:9G'W3JOE2U"#<"ZN=1=1#HX[ *5QH$GZVWUB07-!4NRH=X7:)ZF8^%6P
M$Z)-HH'D34U&K"\W2-/67/+]N\8==;L;)5<3/-3!E)NV_F-T[5QH8)<94E#2
MM?D$#,39+<A_V*!O\<#S0KX'%2O^$FE9D.$C\3B=J9[>?,,GFB!F'8.RZ/M:
MA#3>N5[1L(K[YA4W0@%JU2'5+RXYG%JFTE<) I\\5U]D/_!"SE]D_SUV4>).
M$U>U.Q/G\W603NE=@$E1[R;B'U<!9="+%]D[#G*X_B4#:$RDFT?OC6T7GG%[
MZD ,YU.Z)3<P:<L)$X?BC9OD\@7Y&8=#:#7FL)6?JREADU$NB@XT*-+2'C"
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M_ ;G?$#S*,=D".+:->NF/B!7,J"IER M363R4J-A^,P?CJE.%!6P@9LOG=
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MB/^Y,05Y\'B OE]UW>#^P 3^5X6_^S]02P,$%     @ #8*)56GWH<>F P
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MWG_0.Y>0"*Q72&-=IK%*:ZJ&R I&** 22<)H2*C N'N&=&,7GN+F6T  %<4
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M5V1IT%T5RLV'_5 E^7<BWJTA^:@=DO_,=&5K2MZ?PO5'PYG;D@,* %.Y>M"
M2Y2<9D58E1G=F.%%L\?Q69^]GQKA?_A;?V[?FRK&@_M]MOO.,7U;8CLZ.\;U
M#'W25.6<)6%6!% 6[5K2F',-N,[33[EP;HRX:ER >R_X\+?$69"V/D?_!1M:
MP'@_8/#<NE!#GC!W/C&% 6O8J&&?9W,7 CRQ=-T0EM,F'D,>T?;S-EH%,,ZS
MF:[J)8OZ4LVJAD8@^Z3MAB!YWB7),&;=&@+^I!M[94+Q4OAIY=\EX92/$C86
M5S/7@XC;-0WO CJ&]_!4FA2"7 ;L!!T0S_[Q?K!O3J0V?(\*<+&]STAK0;;9
MN@\FW1:+9]MM_%.%VS4/\HF7D/;F?,.77R1!'?)];^=QYZZC?VD+A+%Y"[.K
MVPFE4?.H.9+1;WLX96R*3OKMC@VPN_P50<[><KDS@_RXL]R^^CCX68_A1D*F
MM'7?%8.M*-\Q@G?8$V4'W75!>(D&2.W<P)?A_J35817EKH=]_Z9L;<'M9L@T
M3NRM^3SU!)#;%,I5RUV/>$:.6]3=JK2=D%:T.<%#8Q1'J+:%FO42:EV:' F4
MNVSI4N9<DZBNJ3L*N)*>#T(?)[[!R%#-?(A 70L509#=1QVHM?A# 7'!QP]'
M=.)A:\?%>[^;0U+EQ)\-1Q#F'I P3&U[0/T;:F(&,D6C,4:NC=\-$GZD0M,N
M/C93R96BT8''&]YL+=8,Y&B47K4B5P[Q\0"\:X.Z.8GG#RS-W/QM[7H+\H70
M6NU@?K^<?;/L$8Z/HB$3R2HW*/ZKQJ?&GF0MK<I\<D<%(P$VI>;T21M>';5$
MO YET$%"?M&#3[1JRN\Y**^<;SA*2-@M7-9%/W& %=ZU.QTGE_'$CA'KUYR&
M**DO &GDKJ'9\X/]N$_85&[27S\:#$G.U L*+!XBTA@V<+1]"BL15RS]-HCN
MY[Y(,V%:VQN3?LO)#R>C;HRR99U^$H:==^^"WU[=BB-_ZWACI]D-+6GH1C3Z
M4%^*V]JDG\5-@,/=;1<QSKIA4=Z$Z+%T.!U'J6'39%),AW_N#(O;J I^86K0
M:2X _N'T=DFHC[K)?NKSYTBZ_-K&T,91A5"_&*MO[N9C493YF'&V+O74WHWB
M#7BT\QPT=-M!6]:>"PO$]BYY#D=;^]S<;</#V>_N^R<:-IR4CP71R)LGW]F.
MN89FB7T;WP;,G7(#B(!R^Z<F4-<.+^,M\>U0E3#@6128'!SXYW8GCMS8ZC@>
M*F2J:UL[]>[+?!O'.':E/=?^\WB,7O6#<(H4V" 1']K$[1\*MV@PZ4"B%%%Y
M8\W/Z8#)RF0J%T>^<WU^_;)M5G501?LPY= :%:5DE^(::VE&0['*]=72'*FA
M28YC'S?\5,R/0VA';N[/>6JPN325_H/R(_EUQ)]S5^B)=[-).4RFK6\L'JH;
M!46;SRM_\@P>T%0>_ ::[F:+EB.1_+C&ACUH?VXCZIG;RN'A1+JGM6 HZU&*
M;^ZV;46]F6VK ]OE-T)T8A([1K2[D\3G+H-?.)K^,(3U+=D7M_E5=DQ_:K(%
M>_YL'?=];A?\D]^#]WC/CWMPP0]@Z,A'V*=?-."6SA=[+!JV6/@;M,''-0)S
M;*/(0%ZA7C*0UF"V1[[>LA0<P.O %1)6N"ZH%>D".2#5UIC(5P5)"CX(U;H<
MRS7RLUK'VAEX$,SR2YWS.K0DC0P#T*21:!!+FW!@QR_=[ELXZ0:N:W7C3<'I
MP:<_YY75YGT'%US'Y#.5IPF69N'TD!MH4L05?C?-OZJ+K+$UG<:N/+9LBC@X
MJ2[X3<945VFSLC4--"'.2D(3;BS)YVM:/)?T#LCX0C[\%]M_L'NG:YI)ND,J
M?KY]]/KCRV,^KA*.H%@SK^\I"W1#"=_V;,XUO[;;L7F>E(>4-/?DV:I/)M1,
MJ%32"*$_HXT#.#Z(0?G8IBAO%*XSY#W.T42V=35?7WO#RIV,;LW,ACR7:A8P
MISCOZ_SGYE+)[7<.IL+IS__0.(J*,4TR@5*7NN0ZFF7025S/*!SH*Y<1B@$^
M:0140Z=!W(D<U]#VG7/$\T5JPO\EYXR/VN(^?'+KX!^?O^*AB_W_YH?7'22_
M[G6UUQY<[MGJV\T98);)[]0/SQ3D]XT4HOZ@1;ELG9/X=-6/S@E0+Z)V1-ON
M>$7;2K6SJ&W8MG<LL&="M0_^[:7##+5P%\IBP%TI[@AH/,^@JSO5['L*.MW1
M+:(W3W+\P+9Y*%37L3O=UOC36O8UX\W=)\[\D4:WLP?1Z*<8O:ZTVQ'B?4=W
M!&8F<RY57_N1R?X]YF<M24]''(K+\^0T^IW/3?\PT%[UT[FL"?TNYR9X\M%T
MFHR['[5<[](W_61F<BS.SM#QO>A)1!O;$^:$&=KUB[&3Z$=_*]I%HI\V4J0!
M&+G?_[57VU]/7KD?#7:/NY]>HC^&)B@%S_'J,#F?'@!&\<\9W9?:E/P3PIFI
M:[/BCTM.U_0 [L\-0ME_H07:WY0^_2=02P,$%     @ #8*)51\/[]N#!@
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MT&K6+TXO_1_93#LT,_^XP ^U,+0!WRN-2;U[H0,VO^AG_P)02P,$%     @
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M?*L*&U,8.D8 #[RDZFU%LLQ=]JP S!1]OF HW]IF&+B%L;4<CO>2CMB .IB
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MAQVF_7=-_V#5VGU+G"EKU<K=TH&OT+0 O\^5LM4#;5!_7+[^+U!+ P04
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MPY<)14%+*/)C=WKHT*@Q2OUQRV<<\=#S?'HPB?R(/G'BQ_2)IOZ$/F&24O>
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M/=)D$HC9,@JFRUFO0:,H19,'W4H<3#;J:O+L]O?ZV$APMK=U_BDKW4$MX.%
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MEA;@_<*@J@L_"$']O>K;_P)02P,$%     @ #8*)51^Z$6>( P  BP<  !D
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M.,[HG'!]:2GL>"8.?"-%GKG\+OB':1=O&AS[ZY?NRY.4ZTE5S/M.97;$]%
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M0L/#.!B&@^DEA,.^#<'P%J;SWC2\#8,)F>$IN)\'LW T++8>Y\%]^/TY'/Z
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MP0-(@B<J@**R!WT WJ%HR"?6#MYV1GJP#T%3%MJ("#6 4;RJ!!,EBA8;=39
M2+*L(:  2=& _"$T6(@$P-NPS20PB,JF ]H)QBSH;KLGS"Q;W\OO@-J"F#4P
M@,S/ I@.LG-CZL$&W8F0!9!'*W0=C[0UW09?4;B(MLI5-@#^JG8;O4ID#&\.
M"!*A1U"YR*VMK4C970,B.\C<S',+BR>+*'NOEA60'K[=@G,+6S&@1H(J-0+D
MJ#@(0+"I8)- @OL@9MDP8O,7L&L\7-/V!9KCGJ"#$1*$/OE9'&*$A4 TL8+/
M'XK[:?,:</A)0=J.H*('.&L'#UR&S1*T#RCQ '8=OO% 4P>JS?,%1P%HI]=%
M!0A04 )-577(3'R319#?Z]&- .D ,P9R 2LBJ=H/L"TE <&^QUUG]48&F?*
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M:N= ]D8IN]^X!.-_;_D_4$L#!!0    (  V"B569WKXSFP8  )T2   9
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M,7+#,K;A6I'1)[I*F!I?3#3(QU&3N)!U8V7Y)V1Y/OD@,KU3Y"Y;LW5;P 2
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MB!&I  M@4AI!9"*+<RF1>PFG*YYPS9FR"F@<YVF>& G'+B7/5)&A%TR=!:2
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M%@Z(M%]R[(46>_/U9"6T%JGI[AB\2TL< ,\W KA>7*""ZGO:U5]02P,$%
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MVSJG>IW/Y/D O:%E\T,.+EZ^H")\W>-KM/4UZK-^<8M6+#:5)&I.IEW"=!M
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M<D\>9-YH^.%NS+*1\I5=(D"T5 61EN (Z$E-42<=0P5M#SUK@R<%LY>7*]6
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M5Y2$5&0-]/<+SM7F(+M M95X^C]02P,$%     @ #8*)51V5I=&Z @  *0<
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M#<#[<RG-;F+[U.J[9/P?4$L#!!0    (  V"B56M?T@.;@(  ((&   9
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M$B!M@EE?":'W$[M!_]O)_P%02P,$%     @ #8*)57._73<) P  *0L  !D
M  !X;"]W;W)K<VAE971S+W-H965T-#,N>&ULK99=;YLP%(;_BL6JJ9.V\!GR
ML02I335M4JM%[;I=3+MPDI/$JL'4=I+VW^\8**.%D@KM)L'@]_7SV@:?R4'(
M.[4%T.0AYHF:6ENMT[%MJ^468JIZ(H4$GZR%C*G&IMS8*I5 5YDHYK;G.*$=
M4Y98T22[-Y?11.PT9PG,)5&[.*;R\1RX.$PMUWJZ<<TV6VUNV-$DI1NX 7V;
MSB6V[-)EQ6)(%!,)D;">6F?N>.9F@JS'3P8'5;DF)LI"B#O3^+::6HXA @Y+
M;2PH_NUA!IP;)^2X+TRM<DPCK%X_N7_)PF.8!54P$_P76^GMU!I:9 5KNN/Z
M6AR^0A&H;_R6@JOLEQR*OHY%ECNE15R(D2!F2?Y/'XJ)J C<X!6!5PB\MPK\
M0N!G07.R+-8%U32:2'$@TO1&-W.1S4VFQC0L,<MXHR4^9:C3T?<4)-4LV9!+
MP-E0Y!.Y8@F+=S&YAD133N;T$9=-*VS?[YB$%;E-5B!)37EZ 9HRKCZ@Q^W-
M!3D]^4!."$O0D'-<,C6Q-1*;<>UE07>>TWFOT2UUC_CN1^(YGM<@G[U=[CZ7
MVSA/Y61YY61YF9__BE\1]/?90FF)&_!/4Z+<(FBV,&_E6*5T"5,+7SL%<@]6
M]/Z=&SJ?F_+])[-G:?TRK=_F'N&D^4T!<U4_4YFOQ#X*O!ZNSKX*WFK=$3PH
MP8-CX$$3>*X:5,#]L!>^ &^U[@C>+\'[Q\#[3>#].KC7&[X ;[7N"!Z6X.$Q
M\+ )/*R#.[6MTFK=$7Q0@@^.@0^:P <U<*^^55JM.X(/2_!A*_B/+>"IO=8@
MF_"'-7S7[==V3.L('?E')?^HG5^8LX6;#RI)BQ.F*<FHOA##H+:%6L?JF,1U
M_AVA3FN62U!JC <=+@8HW7C*.;48@5]+T3Y,UQB52L!MC3$WIHDF>\IW0,2Z
M6!W.Z()QIADT'^"YZ:BZ0H'[,IE;.S.\<- +RFXYLEVI8TP1>47EAB4*0=:H
M<WH#-)!Y798WM$BSTF8A-!9*V>46:UF0I@,^7PNAGQJF6BJKX^@O4$L#!!0
M   (  V"B55Z2\W$4@4  #4A   9    >&PO=V]R:W-H965T<R]S:&5E=#0T
M+GAM;,U:;6_;-A#^*X17% G0R*+DU]0VD)CHYF%=@J3M/@S[P,BT380278JV
M&V _?J2DZ)41XH KG ^Q7NX>WSUW1]Y)GARX>(PWA$CP(V11/.ULI-Q>=KMQ
ML"$ACAV^)9&ZL^(BQ%*=BG4WW@J"EXE2R+J>ZPZZ(:919S9)KMV*V83O)*,1
MN14@WH4A%D_7A/'#M ,[SQ?NZ'HC]87N;++%:W)/Y-?MK5!GW1QE24,2Q91'
M0)#5M',%+Y'7UPJ)Q#=*#G'I&&A7'CA_U">+Y;3C:HL((X'4$%A][,F<,*:1
ME!W?,]!._IU:L7S\C/XI<5XY\X!C,N?L+[J4FVEGU %+LL([)N_XX3>2.908
M&' 6)__!(9-U.R#8Q9*'F;*R(*11^HE_9$24%&#O!04O4_!>J^!G"OYK%7J9
M0B]A)G4EX0%AB6<3P0] :&F%I@\2,A-MY3Z-=-SOI5!WJ=*3LZO@^X[&5,<@
M!CA:@M\YC23X1B*Y$P1<@"]<8@9N=R+8*'K!7,G1)1$XB9K*.W"]BQ5FG&I?
MQ;'*U0KH&2(24Q:?*["O]PB<O3L'[P"-P&?*F):8=*5R1)O3#3*CKU.CO1>,
MO@FD WSX 7BNYQG4YZ]7AP9U]'IUMZK>5>SG(?#R$'@)GO\"WKVJY>6.$7"S
M*LBL4'AE8O8#N'XJGX.__U"J8"%)&/]CXC2UHF>V0J\OE_$6!V3:40M(3,2>
M=&;O?X$#]Z.)89M@R!)8A7T_9]]O0Y_]ROGRH#+1Q%BJV4\T]0*ZG_D#=^P,
M)]U]F8M4;%P2\_K#7E4(M5KQ1A][N8^]5A_OB: DUOFUB)9T3Y<[S-@36*BE
M7JI;JKZ/R#MCO;9^_[&Y91,,60*K\-[/>>^?1&7W;;)O$PQ9 JNP/\C9'[1F
M?;ISJ<TJDG1%\8.*@]K:<+2F^A!KUHVYG*(.2^4\' V<?JWH4ZE!N>C=4:WF
M!XWUPW.=8F&H>#7,O1J^>;T:-BR'<-1S:F;-FV)CZ/3'Y;^:(P;@ON.;'1GE
MCHQ:'?E3)7T>#:;B0YG*=F(,R:CQ_1>>(28&,>C6W4<&*?<E9\:Y,^-69SYA
M*L >LQT!? 4"KE(N6JO$TX=%OV1R;6RPN>&80<@?.[#FV+B1DJ[9*^@6W:'[
MBAH*&%>+UQILG[O K: !,?9M;C-3!B._1&_6H#7EO%YC9T4&,;__4@7!4L\+
M?^)^"/X%7TBPB3CCZR<C*:W6'+L^6T5#MM"JD2A:7W@:O2^TVOQ:14.VT*HA
M*/I?V-X OW6;S& KI>Z,ZW5N$!J.G$&]SOU7+UU%SPM_9M.KBGP17=P*'FB%
M.Q4'K-9"\!Z'VX\ D3UA?!OJ!?]L<7N77$7G1M:L=LI6T9 MM&K BF89GD:W
M#*VVRU;1D"VT:@B*CAG^/RTS;';#;GTE,#7,]66@#:;J4M$NP_9^V?HR,$\>
MRA$!!&%)5Q=OZ-;,2JME1R>:331D"ZT:E:+WAZ/3J/76&>3H$-A$0[;0JB$H
M)A;8/K*\N=:;P\C0&SM>O=X-8O6Y!AF$('RIO_>*J<5KGUKL]_<"+TF(Q:.1
MD79KCGZR:A,-V4*K1J*8M#QX$G7N61VQK*(A6VC5$)3>+K3.#V^N\PRV7)O]
M\NR=4=64@O5I'YF@2D\OJHX5@XO7/KA8K_(;N2'"2(6EA_<993;1D"VT:A"*
M*<OKG4:!6YV;K*(A6VC5$!1SD]<Z%+R]P/N-]U;UICT3*3_!=AO#NT'(+ST(
M2+WJEEY1ZQ\4?,9B355V,+)26JXS5.HB?4>?GDB^3=Y:/W"IVNWD<$/4+BRT
M@+J_XEP^G^@7X?DO)6;_ 5!+ P04    "  -@HE5&CAY1#X.  !EO@  &0
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M\M? \A7)D^S%J#LNU9DU6]R!&JA"_T!]O^%</J[H=ZW*E_&6_P-02P,$%
M  @ #8*)5>5L]J&9 @  <@8  !D   !X;"]W;W)K<VAE971S+W-H965T-#<N
M>&ULK57);MLP$/V5@1H4"=!:FYVMLH#8Z9(B:8T820]%#XPTMHA0I$-2=OKW
M)2E9=1S9Z*$7B1S.>WR/RS!9"?FH"D0-SR7C:N@56B_.?5]E!99$]<0"N1F9
M"5D2;;IR[JN%1)([4,G\* B._9)0[J6)BTUDFHA*,\IQ(D%594GD[Q$RL1IZ
MH;<.W-)YH6W 3Y,%F>,4]=UB(DW/;UER6B)75'"0.!MZ%^'Y>&#S7<(]Q97:
M:(-U\B#$H^U<Y4,OL(*08:8M S&_)8Z1,4MD9#PUG%X[I05NMM?LGYQWX^6!
M*!P+]H/FNAAZIQ[D.",5T[=B]04;/TY@)IAR7U@UN8$'6:6T*!NP45!27O_)
M<[,.&X#P> <@:@#1-J"_ Q W@-@9K94Y6Y=$DS218@729ALVVW!KX]#&#>5V
M%Z=:FE%J<#J]R)XJJJA=4@6$Y_!54*[A'KFN),)[F$CAS@I<\?K,V,4_O$1-
M*%-')N$S<I1$(US3&<(TH\@S5&;@;GH)AP='< "4PPUES,Z1^-JHMG/[6:-P
M5"N,=B@,([@17!<*/O(<\Y<$OK';>H[6GD?17L;OF>Y!'+Z#*(BB#D'C?X>'
M>^3$[1;$CB_>P3>JE(DH!1M[ 3^O30RN-);J5]>:U93];DI[]<_5@F0X],S=
M5BB7Z*5OWX3'P8<NO_^)[(7[?NN^OX\]O<4E\@J[/-; @0/::K1,X[C?[\6)
MO]Q4WY$6GL:]J$U[H6O0ZAKLU?7-5%#*,U%V2AN\GO,DZ)UL*7N=%9T-SGJG
M6\K\C>M;HIR[JJ8@$Q77]:ENHVWAO'#U8BL^,@6UKG]_:>IJ?$/DG)H;SG!F
M*(U2(TK6%:[N:+%P1>)!:%-R7+,PCP)*FV#&9T+H=<=.T#XSZ1]02P,$%
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MT78JN6$*L1594 RNI,1*@G?@(Q("F>4 ;U*L$*'R[=17^F7&Q,\:\+P&PV?
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M9V-=_XFZ&Z\'BI>V/UUPI;M=>[G&*,?"3-#/EYRK[<"\H/U-)/D!4$L#!!0
M   (  V"B55%#76Z9@4   L?   9    >&PO=V]R:W-H965T<R]S:&5E=#4Q
M+GAM;+5976_;-A3]*X17#"G06B8I2W)F&TB<M0N0H$&SK@_#'A2+L8E*HD?2
M<;-?/^HC^K H.@[HE\22[CT\]^KR\HB<[AC_(=:$2/ SB5,Q&ZREW)P[CEBN
M21**(=N05#UY9#P)I;KD*T=L. FCW"F)'30:>4X2TG0PG^;W[OA\RK8RIBFY
MXT!LDR3DSY<D9KO9  Y>;GREJ[7,;CCSZ29<D7LBOVWNN+IR*I2()B05E*6
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MK_/LAMV6XX'/Y&+\GT55RT&]&<X_;$* VH%0&H72&)3&430]:91QZ)T<8D*
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M"&=)H%8=E,9BPWU7_< HR8?<CW3MAJ1VL^[W]@;N8DR2)U$F4R%75#NJ-.U
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M]R=%4;\^:0(\%^6/MGOG_P-02P,$%     @ #8*)5>:/;<RU!0  ?"(  !D
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MZ)(L;[7EBQ9;>\];"HVW1ONX 8K7,". WU="Z/V+F:#^W\+\7U!+ P04
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MO^_?A.1PIOXQN;NF"\QT*M'<B0JG9&Y!)A&$;XD5?_[DA>X7DZLN299<B.S
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MK@#P?<F8W'?4!.V#,OX/4$L#!!0    (  V"B57_0Q%$QP,  -0/   9
M>&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;,U7VV[C-A#]%4(MBEU@:UTL7S:U
M#211B@;H=@V[:1^*/C#2V"(BD2I)Q>G?=TC)BN0H1G8AH/MBB]3,X9PS'(JS
M. CYH%( 39[RC*NEDVI=7+BNBE/(J1J) CB^V0F94XU#N7=5(8$FUBG/W,#S
MIFY.&7=6"SNWEJN%*'7&.*PE466>4_GO%63BL'1\YSBQ8?M4FPEWM2CH'K:@
M[XJUQ)';H"0L!ZZ8X$3";NE<^A>1;QVLQ1\,#JKU3 R5>R$>S. V63J>B0@R
MB+6!H/CW"->0908)X_BG!G6:-8UC^_F(_K,ECV3NJ8)KD?W)$ITNG;E#$MC1
M,M,;<?@%:D(3@Q>+3-E?<JAM/8?$I=(BKYTQ@ISQZI\^U4*T'/SI*PY![1"<
M.H2O.(QKA_%;'<+:(;3*5%2L#A'5=+60XD"DL48T\V#%M-Y(GW&3]ZV6^):A
MGU[=4,D9WRNR!DFV*95 ?B1;+>('\KDPF5%$"[(N99RBNN1:Y#EFJS*@/"$;
M4%JR6$-23]YQIA7Y36ARR^.L3/ %XR1B66EL>I:+2C!+7'+-$F.%VX#<[':X
M+\B["#1EF7J/,7U/7**,@SK^(>SOJ2@5AJ$6KD8Q#"4WKHE?5<2#5XC[ ?DD
MN$X5N>$89!? 114;*8.CE%?!6<3/L1Z1L?^!!%X0] 1T_79WO\<]>KN[=X;-
MN-D88XLW?@6ODX\MQ*5DFJ'J-T]U5G=2Y&8_%*6FMH3%KB^]?_V*P.160Z[^
M[LM2%478'X4Y]2Y406-8.GBL*9"/X*Q^^,Z?>C_U*3PD6#006$?]L%$_/(>^
MVE"^!Z,H/(&,&59>@54&Z@/!@QJUS5C.L#ZP!!*1950J4N"L+8SW?2I7J\WM
M:N93\+@:>][(QVWZV-:OQRR<C&9AURSJ0PM'DV>S#N=)PWGRE9Q3/+R_@O3D
M19BA-QWYLQ/2+\UZ2?>8G2$];4A/SY+N'+5]),ZZ?VE]# D6#036D6W6R#;[
M)DZGV9#J#PD6#03647_>J#]_PZ85=M,>O\;F,B"?+P/*FI3V,@#'I)C2K<Q[
MZ[5:=-JJL" X+=:7-KYW8A/UX+1L.HP_-HP_GC^;^J\Y[S;;NWXN9^&^=.,,
M"18-!-:1T?>>KYO>-U&X=1@#)6!0M&@HM&X*6C=^__^HWGK5=MG-3ZNWQ^;D
M"A+UF/@GM>NVVIT<Y-ZVC8K$HN2ZNJXWLTUK>FD;LI/Y*].RVC;J&:;J=S]1
MN6?8^V2P0TAO-,.OOZQ:R&J@16&;JGNAL46SCRFVW2"- ;[?":&/ [- T\BO
M_@-02P,$%     @ #8*)5?0.JIBB!0  TAX  !D   !X;"]W;W)K<VAE971S
M+W-H965T-C,N>&ULO5E=<^(V%/TK&KK3[LXLQI*-#2DPD^!MFYE-DTEVVX=.
M'X01X*YML;* Y-]7_HB_)'O)1!,>$FSN/;KG6CH<I-F)LF_)CA .'J,P3N:#
M'>?[B]$H\7<DPHE!]R06GVPHBS 7EVP[2O:,X'66%(4C9)K.*,)!/%C,LGMW
M;#&C!QX&,;EC(#E$$69/5R2DI_D #IYOW ?;'4]OC!:S/=Z2!\*_[N^8N!J5
M*.L@(G$2T!@PLID/+N&%AZ9I0A;Q5T!.2>T]2*FL*/V67EROYP,SK8B$Q.<I
M!!;_CF1)PC!%$G5\+T 'Y9AI8OW],_IO&7E!9H43LJ3AW\&:[^:#R0"LR08?
M0GY/3W^0@M XQ?-IF&1_P:F(-0? /R2<1D6RJ" *XOP_?BP:44N 3D<"*A)0
M.\'N2+"*!.O<!+M(L+/.Y%2R/GB8X\6,T1-@:;1 2]]DS<RR!?T@3I_[ V?B
MTT#D\<4#I_ZW'0W7A"6_@$_?#P%_ D.PW.%X2Q(0Q.#2]P_1(<2<K,$MWQ$&
MEC02<VR7/OPC =>Q3R,"WG^F2?*AO/((QT$H;@S!UP</O'_W ;Q+T6Z",!3/
M.YF-N*@^K6'D%Y5>Y96BCDHA C<TYKL$?(K79-T$& G:)7?TS/T*]2+>^MP
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M@GF:P!K]A6;E9,S7"W2!T5(&V%:L91'7D"S;;:\L%9IMNUWR &NN#+Y2( J
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M]1/U=FCW$-KWPZ ?]#N@&SW'9D'?3[U:]S%S^V,COM%P[/]P0H2-><"QB(V
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M?(0\-YHTQX]*J5?;-(*'[9WV&^N\=F9.)'SD^7>:J=7$&WHH@P59Y^J.;[]
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M!MU8/R_"56ZNHWAIJZ4Y5[KVLLV5KG9!F 5Z?L&YVG6,@;I^3GX#4$L#!!0
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M( >A!H=FIYO#!G/O='/'$(U[N"!NBN<>P?/458C(<G\]P#S $?"H\ ,F$D[
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M#U"_KQB3^P,]P6'[\/0_4$L#!!0    (  V"B55@KLOWR00  ,,2   9
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M\Q.3_$:R77:&L&)2LCB[W&(48:X-U/,U8_)XHU]0GEO-_P502P,$%     @
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M"NTB,J4K11PBJNEX*,6.2".-:&90!+/01O<9-[S/M<1=AGIZ?)_EJ?@!0";
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M$XC"1.&<D[[BX?DA4CZ1;)X=JSPR*5F2#6= (N Z0%V?,"8W$WU24Q[E^?\
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M5B $4(, 2N-0FD#1S*)I@R  KD"H6<U>TQOW1P\$BXYHG6UH9X^BF=G6G7U
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M2;XM/QQ@(**'C%<OAYNCS<<)[\M7\H/CM_ &5Y\8M##5%P_WH1"A>,9+R$9
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M-AA(4$'(&U/@=PI\<V^P+2D/S;<NFBZY?&_EA.G$-&1>KPE7<#!L5K[2S*O
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M5XK'R65(<$"$-H#W:\[5\XT>(#]KG?T'4$L#!!0    (  V"B55M:)$5)@,
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M]I9$49+X$<#\"J((0^!MQ!%, 6C D"BJ]\&]_2A<[U/AYG]WHU]02P,$%
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M4$L! A0#%     @ #8*)574MQO7N    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ #8*)59E<G",0!@  G"<
M !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    "  -@HE5+ZQS]K<'  !+,   &               @($-"   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ #8*)58D0?ADS @  K04
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M965T-BYX;6Q02P$"% ,4    "  -@HE5*/8PDU4#  "S"P  &
M    @($Z)@  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @
M#8*)54VRC)G,"P  EX0  !@              ("!Q2D  'AL+W=O<FMS:&5E
M=',O<VAE970X+GAM;%!+ 0(4 Q0    (  V"B54"7MQZA (  ,8&   8
M          " @<<U  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4
M    "  -@HE5K<A1B$\*  "--   &0              @(&!.   >&PO=V]R
M:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    (  V"B54[U[DL!2<  &%X
M   9              " @0=#  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL
M4$L! A0#%     @ #8*)56GWH<>F P  5 @  !D              ("!0VH
M 'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    "  -@HE5S8!$
MA-03  !?.@  &0              @($@;@  >&PO=V]R:W-H965T<R]S:&5E
M=#$S+GAM;%!+ 0(4 Q0    (  V"B54?#^_;@P8  *X/   9
M  " @2N"  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @
M#8*)59!T*T_""P  +B4  !D              ("!Y8@  'AL+W=O<FMS:&5E
M=',O<VAE970Q-2YX;6Q02P$"% ,4    "  -@HE5!%GLUP8+  !H'@  &0
M            @('>E   >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4
M Q0    (  V"B54I5-MKA0,  "\(   9              " @1N@  !X;"]W
M;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ #8*)5:WWM9X,!0
M'@L  !D              ("!UZ,  'AL+W=O<FMS:&5E=',O<VAE970Q."YX
M;6Q02P$"% ,4    "  -@HE5@I.7V30+  !%'0  &0              @($:
MJ0  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    (  V"B57_
MIMU\)P\  +LJ   9              " @86T  !X;"]W;W)K<VAE971S+W-H
M965T,C N>&UL4$L! A0#%     @ #8*)51^Z$6>( P  BP<  !D
M     ("!X\,  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  V"B55[^W9/;@,  -<'   9              "
M@9K\  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ #8*)
M5>-8VV"! P  ; @  !D              ("!/P ! 'AL+W=O<FMS:&5E=',O
M<VAE970R-RYX;6Q02P$"% ,4    "  -@HE5<@ZE3_$%  !-#P  &0
M        @('W P$ >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0
M   (  V"B55TYO/HO 0  $@/   9              " @1\* 0!X;"]W;W)K
M<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ #8*)51).[/DK P   P<
M !D              ("!$@\! 'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q0
M2P$"% ,4    "  -@HE5F=Z^,YL&  "=$@  &0              @(%T$@$
M>&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    (  V"B547-0 Y
MK@,  $8)   9              " @489 0!X;"]W;W)K<VAE971S+W-H965T
M,S(N>&UL4$L! A0#%     @ #8*)56XGC&6P!   S L  !D
M ("!*QT! 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    "  -
M@HE5#1SY*A,%  !X#   &0              @($2(@$ >&PO=V]R:W-H965T
M<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    (  V"B5494>:V)@@  %L;   9
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M970S.2YX;6Q02P$"% ,4    "  -@HE5.&A_:$@$  "]&   &0
M    @(&S1 $ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    (
M  V"B55&.WATE ,  *,,   9              " @3)) 0!X;"]W;W)K<VAE
M971S+W-H965T-#$N>&UL4$L! A0#%     @ #8*)5:U_2 YN @  @@8  !D
M             ("!_4P! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"
M% ,4    "  -@HE5<[]=-PD#   I"P  &0              @(&B3P$ >&PO
M=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    (  V"B55Z2\W$4@4
M #4A   9              " @>)2 0!X;"]W;W)K<VAE971S+W-H965T-#0N
M>&UL4$L! A0#%     @ #8*)51HX>40^#@  9;X  !D              ("!
M:U@! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    "  -@HE5
M(<\=4OL%  "8)P  &0              @('@9@$ >&PO=V]R:W-H965T<R]S
M:&5E=#0V+GAM;%!+ 0(4 Q0    (  V"B57E;/:AF0(  '(&   9
M      " @1)M 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%
M  @ #8*)5>0A'>2C P  :0H  !D              ("!XF\! 'AL+W=O<FMS
M:&5E=',O<VAE970T."YX;6Q02P$"% ,4    "  -@HE5+Y_.ZV$#  # #
M&0              @(&\<P$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+
M 0(4 Q0    (  V"B57YI=OIF ,  !\1   9              " @51W 0!X
M;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ #8*)544-=;IF
M!0  "Q\  !D              ("!(WL! 'AL+W=O<FMS:&5E=',O<VAE970U
M,2YX;6Q02P$"% ,4    "  -@HE5W5N@J]8"   ?"0  &0
M@(' @ $ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    (  V"
MB57M3NQC P4  $\:   9              " @<V# 0!X;"]W;W)K<VAE971S
M+W-H965T-3,N>&UL4$L! A0#%     @ #8*)58+)2SMY"P  D(H  !D
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M=#4X+GAM;%!+ 0(4 Q0    (  V"B576IM*E?P0  / 0   9
M  " @5^F 0!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @
M#8*)5<Q]]-5B P  O D  !D              ("!%:L! 'AL+W=O<FMS:&5E
M=',O<VAE970V,"YX;6Q02P$"% ,4    "  -@HE5^9]F#+(#  !<#@  &0
M            @(&NK@$ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4
M Q0    (  V"B57_0Q%$QP,  -0/   9              " @9>R 0!X;"]W
M;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ #8*)5?0.JIBB!0
MTAX  !D              ("!E;8! 'AL+W=O<FMS:&5E=',O<VAE970V,RYX
M;6Q02P$"% ,4    "  -@HE5F^ \OH "  !S!P  &0              @(%N
MO $ >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    (  V"B579
M4N_A^P(  -((   9              " @26_ 0!X;"]W;W)K<VAE971S+W-H
M965T-C4N>&UL4$L! A0#%     @ #8*)5;QW.X/3"@  @7   !D
M     ("!5\(! 'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6Q02P$"% ,4
M"  -@HE5"4W2BN4#  !Y$@  &0              @(%AS0$ >&PO=V]R:W-H
M965T<R]S:&5E=#8W+GAM;%!+ 0(4 Q0    (  V"B57%VR:>; ,  (0-   9
M              " @7W1 0!X;"]W;W)K<VAE971S+W-H965T-C@N>&UL4$L!
M A0#%     @ #8*)5?^E2,;U!   ^A4  !D              ("!(-4! 'AL
M+W=O<FMS:&5E=',O<VAE970V.2YX;6Q02P$"% ,4    "  -@HE5X*8ID6H#
M  !+"P  &0              @(%,V@$ >&PO=V]R:W-H965T<R]S:&5E=#<P
M+GAM;%!+ 0(4 Q0    (  V"B54?F78-C 8  $HL   9              "
M@>W= 0!X;"]W;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#%     @ #8*)
M56"NR_?)!   PQ(  !D              ("!L.0! 'AL+W=O<FMS:&5E=',O
M<VAE970W,BYX;6Q02P$"% ,4    "  -@HE5\X2JIGL"   -!P  &0
M        @(&PZ0$ >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4 Q0
M   (  V"B56/;@VI(0,  &T)   9              " @6+L 0!X;"]W;W)K
M<VAE971S+W-H965T-S0N>&UL4$L! A0#%     @ #8*)50G !TD!!   'PX
M !D              ("!NN\! 'AL+W=O<FMS:&5E=',O<VAE970W-2YX;6Q0
M2P$"% ,4    "  -@HE5!RK]5#@#  #7"0  &0              @('R\P$
M>&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4 Q0    (  V"B54AGPO>
MH@,  '(-   9              " @6'W 0!X;"]W;W)K<VAE971S+W-H965T
M-S<N>&UL4$L! A0#%     @ #8*)52:_[@^. P  UA,  !D
M ("!.OL! 'AL+W=O<FMS:&5E=',O<VAE970W."YX;6Q02P$"% ,4    "  -
M@HE5SW6X/#D(   M8P  &0              @('__@$ >&PO=V]R:W-H965T
M<R]S:&5E=#<Y+GAM;%!+ 0(4 Q0    (  V"B56W9FD6<0(  'D&   9
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M970X-"YX;6Q02P$"% ,4    "  -@HE5?LYF_"L$  !U$0  &0
M    @(&['P( >&PO=V]R:W-H965T<R]S:&5E=#@U+GAM;%!+ 0(4 Q0    (
M  V"B55-<,KKZP(  'L(   9              " @1TD @!X;"]W;W)K<VAE
M971S+W-H965T.#8N>&UL4$L! A0#%     @ #8*)58JDBDVA!   =Q4  !D
M             ("!/R<" 'AL+W=O<FMS:&5E=',O<VAE970X-RYX;6Q02P$"
M% ,4    "  -@HE5;6B1%28#  !#"0  &0              @($7+ ( >&PO
M=V]R:W-H965T<R]S:&5E=#@X+GAM;%!+ 0(4 Q0    (  V"B549Q'B5- ,
M ,@3   -              "  70O @!X;"]S='EL97,N>&UL4$L! A0#%
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K @!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !@ &  5QH  '$_ @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>365</ContextCount>
  <ElementCount>518</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>107</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Consolidated Statements of Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/ConsolidatedStatementsofIncome</Role>
      <ShortName>Consolidated Statements of Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Consolidated Statements of Comprehensive Income (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical</Role>
      <ShortName>Consolidated Statements of Comprehensive Income (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Organization and Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/OrganizationandSignificantAccountingPolicies</Role>
      <ShortName>Organization and Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Operating Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/OperatingLeases</Role>
      <ShortName>Operating Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Acquisitions and Joint Venture</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/AcquisitionsandJointVenture</Role>
      <ShortName>Acquisitions and Joint Venture</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/IntangibleAssets</Role>
      <ShortName>Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Financing Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/FinancingArrangements</Role>
      <ShortName>Financing Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Stock Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/StockPlans</Role>
      <ShortName>Stock Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Employee Benefits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/EmployeeBenefits</Role>
      <ShortName>Employee Benefits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/Contingencies</Role>
      <ShortName>Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Business Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/BusinessSegmentInformation</Role>
      <ShortName>Business Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Financial Derivatives and Hedging</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/FinancialDerivativesandHedging</Role>
      <ShortName>Financial Derivatives and Hedging</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Schedule II</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/ScheduleII</Role>
      <ShortName>Schedule II</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Organization and Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Organization and Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.coopercos.com/role/OrganizationandSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Organization and Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesTables</Role>
      <ShortName>Organization and Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.coopercos.com/role/OrganizationandSignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Operating Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/OperatingLeasesTables</Role>
      <ShortName>Operating Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.coopercos.com/role/OperatingLeases</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Acquisitions and Joint Venture (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/AcquisitionsandJointVentureTables</Role>
      <ShortName>Acquisitions and Joint Venture (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.coopercos.com/role/AcquisitionsandJointVenture</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/IntangibleAssetsTables</Role>
      <ShortName>Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.coopercos.com/role/IntangibleAssets</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.coopercos.com/role/IncomeTaxes</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.coopercos.com/role/EarningsPerShare</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.coopercos.com/role/StockholdersEquity</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Stock Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/StockPlansTables</Role>
      <ShortName>Stock Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.coopercos.com/role/StockPlans</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Employee Benefits (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/EmployeeBenefitsTables</Role>
      <ShortName>Employee Benefits (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.coopercos.com/role/EmployeeBenefits</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Business Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/BusinessSegmentInformationTables</Role>
      <ShortName>Business Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.coopercos.com/role/BusinessSegmentInformation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Financial Derivatives and Hedging (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/FinancialDerivativesandHedgingTables</Role>
      <ShortName>Financial Derivatives and Hedging (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.coopercos.com/role/FinancialDerivativesandHedging</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Organization and Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Organization and Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Organization and Significant Accounting Policies - Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesInventoryDetails</Role>
      <ShortName>Organization and Significant Accounting Policies - Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Organization and Significant Accounting Policies - Property Plant and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails</Role>
      <ShortName>Organization and Significant Accounting Policies - Property Plant and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Operating Leases - Leases on the Consolidated Condensed Balance Sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails</Role>
      <ShortName>Operating Leases - Leases on the Consolidated Condensed Balance Sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Operating Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/OperatingLeasesNarrativeDetails</Role>
      <ShortName>Operating Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Operating Leases - Minimum Rental Payments Required Under Operating Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails</Role>
      <ShortName>Operating Leases - Minimum Rental Payments Required Under Operating Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Acquisitions and Joint Venture - Total Purchase Consideration for Business and Asset Acquisitions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails</Role>
      <ShortName>Acquisitions and Joint Venture - Total Purchase Consideration for Business and Asset Acquisitions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Acquisitions and Joint Venture - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails</Role>
      <ShortName>Acquisitions and Joint Venture - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Acquisitions and Joint Venture - Recognized Identified Assets Acquired and Liabilities Assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails</Role>
      <ShortName>Acquisitions and Joint Venture - Recognized Identified Assets Acquired and Liabilities Assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Acquisitions and Joint Venture - Proforma Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/AcquisitionsandJointVentureProformaInformationDetails</Role>
      <ShortName>Acquisitions and Joint Venture - Proforma Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Acquisitions and Joint Venture - Contingent Consideration Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/AcquisitionsandJointVentureContingentConsiderationReconciliationDetails</Role>
      <ShortName>Acquisitions and Joint Venture - Contingent Consideration Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Intangible Assets - Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails</Role>
      <ShortName>Intangible Assets - Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Intangible Assets - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails</Role>
      <ShortName>Intangible Assets - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Intangible Assets - Other Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails</Role>
      <ShortName>Intangible Assets - Other Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Intangible Assets - Estimated Amortization Expenses for Intangible Assets with Definite Lives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails</Role>
      <ShortName>Intangible Assets - Estimated Amortization Expenses for Intangible Assets with Definite Lives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Financing Arrangements - Total Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails</Role>
      <ShortName>Financing Arrangements - Total Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Financing Arrangements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails</Role>
      <ShortName>Financing Arrangements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Income Taxes - Income Before Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Income Before Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Income Taxes - Income Tax Provision (Benefit) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails</Role>
      <ShortName>Income Taxes - Income Tax Provision (Benefit) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Income Taxes - Reconciliation between the Expected Provision for Income taxes at the US Federal Statutory Rate and the Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Reconciliation between the Expected Provision for Income taxes at the US Federal Statutory Rate and the Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Income Taxes - Changes in Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/IncomeTaxesChangesinUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Changes in Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Earnings Per Share - Basic and Diluted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails</Role>
      <ShortName>Earnings Per Share - Basic and Diluted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Earnings Per Share - Stock Options to Purchase Common Stock and Restricted Stock Units Not Included in Diluted Earnings Per Share Due to Antidilutive Effect (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails</Role>
      <ShortName>Earnings Per Share - Stock Options to Purchase Common Stock and Restricted Stock Units Not Included in Diluted Earnings Per Share Due to Antidilutive Effect (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - Stockholders' Equity - Changes in Accumulated Other Comprehensive Income (Loss) Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails</Role>
      <ShortName>Stockholders' Equity - Changes in Accumulated Other Comprehensive Income (Loss) Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - Stockholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/StockholdersEquityNarrativeDetails</Role>
      <ShortName>Stockholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - Stockholders' Equity - Share Repurchases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/StockholdersEquityShareRepurchasesDetails</Role>
      <ShortName>Stockholders' Equity - Share Repurchases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - Stock Plans - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/StockPlansNarrativeDetails</Role>
      <ShortName>Stock Plans - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - Stock Plans - Compensation Expense and Related Income Tax Benefit for Share-Based Awards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails</Role>
      <ShortName>Stock Plans - Compensation Expense and Related Income Tax Benefit for Share-Based Awards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - Stock Plans - Assumptions Used in Estimating Fair Value of Stock Options Award Granted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails</Role>
      <ShortName>Stock Plans - Assumptions Used in Estimating Fair Value of Stock Options Award Granted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - Stock Plans - Stock Option Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/StockPlansStockOptionPlansDetails</Role>
      <ShortName>Stock Plans - Stock Option Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - Stock Plans - Non-Vested RSUs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails</Role>
      <ShortName>Stock Plans - Non-Vested RSUs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - Employee Benefits - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails</Role>
      <ShortName>Employee Benefits - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - Employee Benefits - Changes in Benefit Obligation, Changes in Plan Assets and Funded Status (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails</Role>
      <ShortName>Employee Benefits - Changes in Benefit Obligation, Changes in Plan Assets and Funded Status (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - Employee Benefits - Amounts Recognized in Accumulated Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails</Role>
      <ShortName>Employee Benefits - Amounts Recognized in Accumulated Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - Employee Benefits - Reconciliation of Prepaid (Accrued) Pension Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/EmployeeBenefitsReconciliationofPrepaidAccruedPensionCostDetails</Role>
      <ShortName>Employee Benefits - Reconciliation of Prepaid (Accrued) Pension Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - Employee Benefits - Components of Net Periodic Pension Costs and Other Amounts Recognized in Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails</Role>
      <ShortName>Employee Benefits - Components of Net Periodic Pension Costs and Other Amounts Recognized in Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - Employee Benefits - Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails</Role>
      <ShortName>Employee Benefits - Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0000077 - Disclosure - Employee Benefits - Weighted-Average Assumptions Used in Computing Net Periodic Pension Cost and Projected Benefit Obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails</Role>
      <ShortName>Employee Benefits - Weighted-Average Assumptions Used in Computing Net Periodic Pension Cost and Projected Benefit Obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0000078 - Disclosure - Employee Benefits - Weighted-Average Asset Allocations by Asset Category (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails</Role>
      <ShortName>Employee Benefits - Weighted-Average Asset Allocations by Asset Category (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0000079 - Disclosure - Employee Benefits - Fair Value Measurement of Plan Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails</Role>
      <ShortName>Employee Benefits - Fair Value Measurement of Plan Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>0000080 - Disclosure - Employee Benefits - Estimated Future Benefit Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetails</Role>
      <ShortName>Employee Benefits - Estimated Future Benefit Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>0000081 - Disclosure - Business Segment Information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/BusinessSegmentInformationNarrativeDetails</Role>
      <ShortName>Business Segment Information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>0000082 - Disclosure - Business Segment Information - Business Segment Net Sales (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails</Role>
      <ShortName>Business Segment Information - Business Segment Net Sales (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>0000083 - Disclosure - Business Segment Information - Business Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails</Role>
      <ShortName>Business Segment Information - Business Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>0000084 - Disclosure - Business Segment Information - Information by Geographical Area by Country of Domicile (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails</Role>
      <ShortName>Business Segment Information - Information by Geographical Area by Country of Domicile (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>0000085 - Disclosure - Financial Derivatives and Hedging - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails</Role>
      <ShortName>Financial Derivatives and Hedging - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>0000086 - Disclosure - Financial Derivatives and Hedging - Derivative Instruments Recognized in Condensed Consolidated Statements of Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails</Role>
      <ShortName>Financial Derivatives and Hedging - Derivative Instruments Recognized in Condensed Consolidated Statements of Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>0000087 - Disclosure - Financial Derivatives and Hedging - Changes in Accumulated Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails</Role>
      <ShortName>Financial Derivatives and Hedging - Changes in Accumulated Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="coo-20221031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>0000088 - Disclosure - Schedule II (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coopercos.com/role/ScheduleIIDetails</Role>
      <ShortName>Schedule II (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.coopercos.com/role/ScheduleII</ParentRole>
      <Position>88</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 3 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:DebtInstrumentBasisSpreadOnVariableRate1, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 -  coo-20221031.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" original="coo-20221031.htm">coo-20221031.htm</File>
    <File>coo-20221031.xsd</File>
    <File>coo-20221031_cal.xml</File>
    <File>coo-20221031_def.xml</File>
    <File>coo-20221031_lab.xml</File>
    <File>coo-20221031_pre.xml</File>
    <File>coo-ex21_20221031x10k.htm</File>
    <File>coo-ex23_20221031x10k.htm</File>
    <File>coo-ex311_20221031x10k.htm</File>
    <File>coo-ex312_20221031x10k.htm</File>
    <File>coo-ex321_20221031x10k.htm</File>
    <File>coo-ex322_20221031x10k.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>coo-20221031_g1.jpg</File>
    <File>coo-20221031_g2.jpg</File>
    <File>coo-20221031_g3.jpg</File>
    <File>coo-20221031_g4.jpg</File>
    <File>coo-20221031_g5.jpg</File>
    <File>coo-20221031_g6.jpg</File>
    <File>coo-20221031_g7.jpg</File>
    <File>coo-20221031_g8.jpg</File>
    <File>coo-20221031_g9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2022</BaseTaxonomy>
    <BaseTaxonomy items="1362">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="38">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>117
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "coo-20221031.htm": {
   "axisCustom": 3,
   "axisStandard": 30,
   "contextCount": 365,
   "dts": {
    "calculationLink": {
     "local": [
      "coo-20221031_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "coo-20221031_def.xml"
     ]
    },
    "inline": {
     "local": [
      "coo-20221031.htm"
     ]
    },
    "labelLink": {
     "local": [
      "coo-20221031_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "coo-20221031_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "coo-20221031.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 792,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 25,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 29
   },
   "keyCustom": 39,
   "keyStandard": 479,
   "memberCustom": 47,
   "memberStandard": 54,
   "nsprefix": "coo",
   "nsuri": "http://www.coopercos.com/20221031",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "role": "http://www.coopercos.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000010 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Organization and Significant Accounting Policies",
     "role": "http://www.coopercos.com/role/OrganizationandSignificantAccountingPolicies",
     "shortName": "Organization and Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Operating Leases",
     "role": "http://www.coopercos.com/role/OperatingLeases",
     "shortName": "Operating Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "coo:BusinessCombinationAndAssetAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Acquisitions and Joint Venture",
     "role": "http://www.coopercos.com/role/AcquisitionsandJointVenture",
     "shortName": "Acquisitions and Joint Venture",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "coo:BusinessCombinationAndAssetAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Intangible Assets",
     "role": "http://www.coopercos.com/role/IntangibleAssets",
     "shortName": "Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Financing Arrangements",
     "role": "http://www.coopercos.com/role/FinancingArrangements",
     "shortName": "Financing Arrangements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Income Taxes",
     "role": "http://www.coopercos.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Earnings Per Share",
     "role": "http://www.coopercos.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Stockholders' Equity",
     "role": "http://www.coopercos.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Stock Plans",
     "role": "http://www.coopercos.com/role/StockPlans",
     "shortName": "Stock Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "dei:DocumentsIncorporatedByReferenceTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0000002 - Document - Audit Information",
     "role": "http://www.coopercos.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "dei:DocumentsIncorporatedByReferenceTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Employee Benefits",
     "role": "http://www.coopercos.com/role/EmployeeBenefits",
     "shortName": "Employee Benefits",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Contingencies",
     "role": "http://www.coopercos.com/role/Contingencies",
     "shortName": "Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Business Segment Information",
     "role": "http://www.coopercos.com/role/BusinessSegmentInformation",
     "shortName": "Business Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Financial Derivatives and Hedging",
     "role": "http://www.coopercos.com/role/FinancialDerivativesandHedging",
     "shortName": "Financial Derivatives and Hedging",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Schedule II",
     "role": "http://www.coopercos.com/role/ScheduleII",
     "shortName": "Schedule II",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Organization and Significant Accounting Policies (Policies)",
     "role": "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies",
     "shortName": "Organization and Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Organization and Significant Accounting Policies (Tables)",
     "role": "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesTables",
     "shortName": "Organization and Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "coo:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Operating Leases (Tables)",
     "role": "http://www.coopercos.com/role/OperatingLeasesTables",
     "shortName": "Operating Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "coo:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "coo:BusinessCombinationAndAssetAcquisitionTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "coo:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedAndAssetAcquisitionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Acquisitions and Joint Venture (Tables)",
     "role": "http://www.coopercos.com/role/AcquisitionsandJointVentureTables",
     "shortName": "Acquisitions and Joint Venture (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "coo:BusinessCombinationAndAssetAcquisitionTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "coo:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedAndAssetAcquisitionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Intangible Assets (Tables)",
     "role": "http://www.coopercos.com/role/IntangibleAssetsTables",
     "shortName": "Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Consolidated Statements of Income",
     "role": "http://www.coopercos.com/role/ConsolidatedStatementsofIncome",
     "shortName": "Consolidated Statements of Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Debt (Tables)",
     "role": "http://www.coopercos.com/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.coopercos.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Earnings Per Share (Tables)",
     "role": "http://www.coopercos.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Stockholders' Equity (Tables)",
     "role": "http://www.coopercos.com/role/StockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Stock Plans (Tables)",
     "role": "http://www.coopercos.com/role/StockPlansTables",
     "shortName": "Stock Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Employee Benefits (Tables)",
     "role": "http://www.coopercos.com/role/EmployeeBenefitsTables",
     "shortName": "Employee Benefits (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Business Segment Information (Tables)",
     "role": "http://www.coopercos.com/role/BusinessSegmentInformationTables",
     "shortName": "Business Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Financial Derivatives and Hedging (Tables)",
     "role": "http://www.coopercos.com/role/FinancialDerivativesandHedgingTables",
     "shortName": "Financial Derivatives and Hedging (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "coo:NumberOfBusinessUnits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "business_unit",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Organization and Significant Accounting Policies - Narrative (Details)",
     "role": "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Organization and Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "coo:NumberOfBusinessUnits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "business_unit",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Organization and Significant Accounting Policies - Inventory (Details)",
     "role": "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesInventoryDetails",
     "shortName": "Organization and Significant Accounting Policies - Inventory (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Consolidated Statements of Comprehensive Income",
     "role": "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome",
     "shortName": "Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Organization and Significant Accounting Policies - Property Plant and Equipment (Details)",
     "role": "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails",
     "shortName": "Organization and Significant Accounting Policies - Property Plant and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "coo:AssetsAndLiabilitiesLesseeTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Operating Leases - Leases on the Consolidated Condensed Balance Sheet (Details)",
     "role": "http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails",
     "shortName": "Operating Leases - Leases on the Consolidated Condensed Balance Sheet (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "coo:AssetsAndLiabilitiesLesseeTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Operating Leases - Narrative (Details)",
     "role": "http://www.coopercos.com/role/OperatingLeasesNarrativeDetails",
     "shortName": "Operating Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Operating Leases - Minimum Rental Payments Required Under Operating Leases (Details)",
     "role": "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails",
     "shortName": "Operating Leases - Minimum Rental Payments Required Under Operating Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Acquisitions and Joint Venture - Total Purchase Consideration for Business and Asset Acquisitions (Details)",
     "role": "http://www.coopercos.com/role/AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails",
     "shortName": "Acquisitions and Joint Venture - Total Purchase Consideration for Business and Asset Acquisitions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "coo:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedAndAssetAcquisitionsTableTextBlock",
       "coo:BusinessCombinationAndAssetAcquisitionTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i0a09f770943a476f971ff4bc25761545_I20221031",
      "decimals": "-5",
      "lang": "en-US",
      "name": "coo:BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Acquisitions and Joint Venture - Narrative (Details)",
     "role": "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails",
     "shortName": "Acquisitions and Joint Venture - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "ic12ec65ec7b84054a21489d444adacc6_D20220301-20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Acquisitions and Joint Venture - Recognized Identified Assets Acquired and Liabilities Assumed (Details)",
     "role": "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails",
     "shortName": "Acquisitions and Joint Venture - Recognized Identified Assets Acquired and Liabilities Assumed (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "if6bd5c970b0a4d2c9105bb367ec69a91_I20211217",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i92626cab45db4a19a73bbd1ffef1f631_D20211101-20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Acquisitions and Joint Venture - Proforma Information (Details)",
     "role": "http://www.coopercos.com/role/AcquisitionsandJointVentureProformaInformationDetails",
     "shortName": "Acquisitions and Joint Venture - Proforma Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i92626cab45db4a19a73bbd1ffef1f631_D20211101-20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i15080967286843b083f296cee9e2bdd7_I20211031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Acquisitions and Joint Venture - Contingent Consideration Reconciliation (Details)",
     "role": "http://www.coopercos.com/role/AcquisitionsandJointVentureContingentConsiderationReconciliationDetails",
     "shortName": "Acquisitions and Joint Venture - Contingent Consideration Reconciliation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i8e27b9c1b1554fa3893ad8bdd281a530_I20201031",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i15080967286843b083f296cee9e2bdd7_I20211031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Intangible Assets - Goodwill (Details)",
     "role": "http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails",
     "shortName": "Intangible Assets - Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GoodwillPeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Consolidated Statements of Comprehensive Income (Parenthetical)",
     "role": "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical",
     "shortName": "Consolidated Statements of Comprehensive Income (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportingUnits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "reporting_unit",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Intangible Assets - Narrative (Details)",
     "role": "http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails",
     "shortName": "Intangible Assets - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportingUnits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "reporting_unit",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Intangible Assets - Other Intangible Assets (Details)",
     "role": "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails",
     "shortName": "Intangible Assets - Other Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Intangible Assets - Estimated Amortization Expenses for Intangible Assets with Definite Lives (Details)",
     "role": "http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails",
     "shortName": "Intangible Assets - Estimated Amortization Expenses for Intangible Assets with Definite Lives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredFinanceCostsCurrentNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Financing Arrangements - Total Debt (Details)",
     "role": "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails",
     "shortName": "Financing Arrangements - Total Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredFinanceCostsCurrentNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "ifca29665c5264825877b7058a88003d2_I20211217",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Financing Arrangements - Narrative (Details)",
     "role": "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails",
     "shortName": "Financing Arrangements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "ifca29665c5264825877b7058a88003d2_I20211217",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Income Taxes - Narrative (Details)",
     "role": "http://www.coopercos.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Income Taxes - Income Before Income Taxes (Details)",
     "role": "http://www.coopercos.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails",
     "shortName": "Income Taxes - Income Before Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Income Taxes - Income Tax Provision (Benefit) (Details)",
     "role": "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails",
     "shortName": "Income Taxes - Income Tax Provision (Benefit) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Income Taxes - Reconciliation between the Expected Provision for Income taxes at the US Federal Statutory Rate and the Provision for Income Taxes (Details)",
     "role": "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails",
     "shortName": "Income Taxes - Reconciliation between the Expected Provision for Income taxes at the US Federal Statutory Rate and the Provision for Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)",
     "role": "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails",
     "shortName": "Income Taxes - Deferred Tax Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Consolidated Balance Sheets",
     "role": "http://www.coopercos.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i15080967286843b083f296cee9e2bdd7_I20211031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Income Taxes - Changes in Unrecognized Tax Benefits (Details)",
     "role": "http://www.coopercos.com/role/IncomeTaxesChangesinUnrecognizedTaxBenefitsDetails",
     "shortName": "Income Taxes - Changes in Unrecognized Tax Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Earnings Per Share - Basic and Diluted (Details)",
     "role": "http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails",
     "shortName": "Earnings Per Share - Basic and Diluted (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Earnings Per Share - Stock Options to Purchase Common Stock and Restricted Stock Units Not Included in Diluted Earnings Per Share Due to Antidilutive Effect (Details)",
     "role": "http://www.coopercos.com/role/EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails",
     "shortName": "Earnings Per Share - Stock Options to Purchase Common Stock and Restricted Stock Units Not Included in Diluted Earnings Per Share Due to Antidilutive Effect (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i15080967286843b083f296cee9e2bdd7_I20211031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Stockholders' Equity - Changes in Accumulated Other Comprehensive Income (Loss) Income (Details)",
     "role": "http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails",
     "shortName": "Stockholders' Equity - Changes in Accumulated Other Comprehensive Income (Loss) Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i00964b16a5864689921a5cd1f5431741_I20170331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - Stockholders' Equity - Narrative (Details)",
     "role": "http://www.coopercos.com/role/StockholdersEquityNarrativeDetails",
     "shortName": "Stockholders' Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i00964b16a5864689921a5cd1f5431741_I20170331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - Stockholders' Equity - Share Repurchases (Details)",
     "role": "http://www.coopercos.com/role/StockholdersEquityShareRepurchasesDetails",
     "shortName": "Stockholders' Equity - Share Repurchases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "1",
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockAcquiredAverageCostPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - Stock Plans - Narrative (Details)",
     "role": "http://www.coopercos.com/role/StockPlansNarrativeDetails",
     "shortName": "Stock Plans - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - Stock Plans - Compensation Expense and Related Income Tax Benefit for Share-Based Awards (Details)",
     "role": "http://www.coopercos.com/role/StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails",
     "shortName": "Stock Plans - Compensation Expense and Related Income Tax Benefit for Share-Based Awards (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - Stock Plans - Assumptions Used in Estimating Fair Value of Stock Options Award Granted (Details)",
     "role": "http://www.coopercos.com/role/StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails",
     "shortName": "Stock Plans - Assumptions Used in Estimating Fair Value of Stock Options Award Granted (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i745e1665db444bebbb33ddc9ccafe18f_D20191101-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - Stock Plans - Stock Option Plans (Details)",
     "role": "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails",
     "shortName": "Stock Plans - Stock Option Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.coopercos.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i55102374da8b426cb0c7d8637de24dc2_I20211031",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - Stock Plans - Non-Vested RSUs (Details)",
     "role": "http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails",
     "shortName": "Stock Plans - Non-Vested RSUs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i55102374da8b426cb0c7d8637de24dc2_I20211031",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - Employee Benefits - Narrative (Details)",
     "role": "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails",
     "shortName": "Employee Benefits - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i15080967286843b083f296cee9e2bdd7_I20211031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - Employee Benefits - Changes in Benefit Obligation, Changes in Plan Assets and Funded Status (Details)",
     "role": "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails",
     "shortName": "Employee Benefits - Changes in Benefit Obligation, Changes in Plan Assets and Funded Status (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i5167c03ea3ab44e7b464a93ec06fc66e_I20191031",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - Employee Benefits - Amounts Recognized in Accumulated Other Comprehensive Income (Details)",
     "role": "http://www.coopercos.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails",
     "shortName": "Employee Benefits - Amounts Recognized in Accumulated Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "coo:ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i15080967286843b083f296cee9e2bdd7_I20211031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "coo:AccruedPrepaidPensionCosts",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - Employee Benefits - Reconciliation of Prepaid (Accrued) Pension Cost (Details)",
     "role": "http://www.coopercos.com/role/EmployeeBenefitsReconciliationofPrepaidAccruedPensionCostDetails",
     "shortName": "Employee Benefits - Reconciliation of Prepaid (Accrued) Pension Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "coo:ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i5167c03ea3ab44e7b464a93ec06fc66e_I20191031",
      "decimals": "-5",
      "lang": "en-US",
      "name": "coo:AccruedPrepaidPensionCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - Employee Benefits - Components of Net Periodic Pension Costs and Other Amounts Recognized in Other Comprehensive Income (Details)",
     "role": "http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails",
     "shortName": "Employee Benefits - Components of Net Periodic Pension Costs and Other Amounts Recognized in Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - Employee Benefits - Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Details)",
     "role": "http://www.coopercos.com/role/EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails",
     "shortName": "Employee Benefits - Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - Employee Benefits - Weighted-Average Assumptions Used in Computing Net Periodic Pension Cost and Projected Benefit Obligation (Details)",
     "role": "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails",
     "shortName": "Employee Benefits - Weighted-Average Assumptions Used in Computing Net Periodic Pension Cost and Projected Benefit Obligation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "4",
      "lang": "en-US",
      "name": "coo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000078 - Disclosure - Employee Benefits - Weighted-Average Asset Allocations by Asset Category (Details)",
     "role": "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails",
     "shortName": "Employee Benefits - Weighted-Average Asset Allocations by Asset Category (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000079 - Disclosure - Employee Benefits - Fair Value Measurement of Plan Assets (Details)",
     "role": "http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails",
     "shortName": "Employee Benefits - Fair Value Measurement of Plan Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i0a330158da9f4490afbea9f2a383c0cc_I20221031",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "ic40025e930f74fd19b2ce688c42296d1_I20191031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - Consolidated Statements of Stockholders' Equity",
     "role": "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "ic40025e930f74fd19b2ce688c42296d1_I20191031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000080 - Disclosure - Employee Benefits - Estimated Future Benefit Payments (Details)",
     "role": "http://www.coopercos.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetails",
     "shortName": "Employee Benefits - Estimated Future Benefit Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000081 - Disclosure - Business Segment Information - Narrative (Details)",
     "role": "http://www.coopercos.com/role/BusinessSegmentInformationNarrativeDetails",
     "shortName": "Business Segment Information - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000082 - Disclosure - Business Segment Information - Business Segment Net Sales (Details)",
     "role": "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails",
     "shortName": "Business Segment Information - Business Segment Net Sales (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i25cde43e219544f999a9522e40885def_D20211101-20221031",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000083 - Disclosure - Business Segment Information - Business Segment Information (Details)",
     "role": "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
     "shortName": "Business Segment Information - Business Segment Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:NonoperatingIncomeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000084 - Disclosure - Business Segment Information - Information by Geographical Area by Country of Domicile (Details)",
     "role": "http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails",
     "shortName": "Business Segment Information - Information by Geographical Area by Country of Domicile (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i2772f61aefe64ddbba24fc95a9137207_D20211101-20221031",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "coo:AOCICashFlowHedgeCumulativeGainLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000085 - Disclosure - Financial Derivatives and Hedging - Narrative (Details)",
     "role": "http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails",
     "shortName": "Financial Derivatives and Hedging - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i893b343911d346c78ad0d7715f7d33d0_I20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "coo:AOCICashFlowHedgeCumulativeGainLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "ib09f9a58a78443b18bed2336686e605e_D20211101-20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000086 - Disclosure - Financial Derivatives and Hedging - Derivative Instruments Recognized in Condensed Consolidated Statements of Income (Details)",
     "role": "http://www.coopercos.com/role/FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails",
     "shortName": "Financial Derivatives and Hedging - Derivative Instruments Recognized in Condensed Consolidated Statements of Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "ib09f9a58a78443b18bed2336686e605e_D20211101-20221031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i15080967286843b083f296cee9e2bdd7_I20211031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000087 - Disclosure - Financial Derivatives and Hedging - Changes in Accumulated Other Comprehensive Income (Details)",
     "role": "http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails",
     "shortName": "Financial Derivatives and Hedging - Changes in Accumulated Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "iea2aa42170064029a14838912d3185ac_I20211031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000088 - Disclosure - Schedule II (Details)",
     "role": "http://www.coopercos.com/role/ScheduleIIDetails",
     "shortName": "Schedule II (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i8b0bc537a9784c479a6e47674c4a3455_I20191031",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000009 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)",
     "role": "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical",
     "shortName": "Consolidated Statements of Stockholders' Equity (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "coo-20221031.htm",
      "contextRef": "i430ebcbddebc425c968858950136be1a_D20211101-20221031",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 107,
   "tag": {
    "coo_AOCIAttributableToParentBeforeReclassificationAndTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AOCI Attributable To Parent, Before Reclassification And Tax [Roll Forward]",
        "label": "AOCI Attributable To Parent, Before Reclassification And Tax [Roll Forward]",
        "terseLabel": "AOCI Attributable To Parent, Before Reclassification And Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentBeforeReclassificationAndTaxRollForward",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "coo_AOCICashFlowHedgeCumulativeGainLossBeforeTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), Before Tax",
        "label": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), Before Tax",
        "terseLabel": "Pre-tax impact of gain (loss) on derivatives recognized in other comprehensive income (loss)"
       }
      }
     },
     "localname": "AOCICashFlowHedgeCumulativeGainLossBeforeTax",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "coo_AccruedPensionCostRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Pension Cost [Roll Forward]",
        "label": "Accrued Pension Cost [Roll Forward]",
        "terseLabel": "Reconciliation of (prepaid) accrued pension cost:"
       }
      }
     },
     "localname": "AccruedPensionCostRollForward",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsReconciliationofPrepaidAccruedPensionCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "coo_AccruedPrepaidPensionCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued (Prepaid) Pension Costs",
        "label": "Accrued (Prepaid) Pension Costs",
        "periodEndLabel": "(Prepaid)/Accrued pension cost at fiscal year end",
        "periodStartLabel": "(Prepaid)/Accrued pension cost at prior fiscal year end"
       }
      }
     },
     "localname": "AccruedPrepaidPensionCosts",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsReconciliationofPrepaidAccruedPensionCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "coo_AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Before Tax, Parent [Member]",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Before Tax, Parent [Member]",
        "terseLabel": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Before Tax, Parent"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeBeforeTaxParentMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_AsianPacificCreditFacilitiesYenDenominatedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asian Pacific Credit Facilities - Yen-Denominated [Member]",
        "label": "Asian Pacific Credit Facilities - Yen-Denominated [Member]",
        "terseLabel": "Asian Pacific Credit Facilities - Yen-Denominated"
       }
      }
     },
     "localname": "AsianPacificCreditFacilitiesYenDenominatedMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_AssetAquisitionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Aquisition",
        "label": "Asset Aquisition [Axis]",
        "terseLabel": "Asset Aquisition [Axis]"
       }
      }
     },
     "localname": "AssetAquisitionAxis",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "coo_AssetAquisitionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Aquisition [Domain]",
        "label": "Asset Aquisition [Domain]",
        "terseLabel": "Asset Aquisition [Domain]"
       }
      }
     },
     "localname": "AssetAquisitionDomain",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets And Liabilities, Lessee [Table Text Block]",
        "label": "Assets And Liabilities, Lessee [Table Text Block]",
        "terseLabel": "Leases on the Consolidated Condensed Balance Sheet"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "coo_AuditInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit Information [Abstract]",
        "label": "Audit Information [Abstract]"
       }
      }
     },
     "localname": "AuditInformationAbstract",
     "nsuri": "http://www.coopercos.com/20221031",
     "xbrltype": "stringItemType"
    },
    "coo_BondMutualFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond Mutual Funds [Member]",
        "label": "Bond Mutual Funds [Member]",
        "terseLabel": "Bond mutual funds"
       }
      }
     },
     "localname": "BondMutualFundsMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_BusinessAcquisitionAndAssetAcquisitionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition And Asset Acquisition [Axis]",
        "label": "Business Acquisition And Asset Acquisition [Axis]",
        "terseLabel": "Business Acquisition And Asset Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAndAssetAcquisitionAxis",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "coo_BusinessAcquisitionAndAssetAcquisitionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Business Acquisition And Asset Acquisition",
        "label": "Business Acquisition And Asset Acquisition [Domain]",
        "terseLabel": "Business Acquisition And Asset Acquisition [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAndAssetAcquisitionDomain",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.coopercos.com/role/AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails": {
       "order": 3.0,
       "parentTag": "coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination And Asset Acquisition, Recognized Identifiable Assets Acquired And Liabilities Assumed, Tangible Assets (Liabilities), Net",
        "label": "Business Combination And Asset Acquisition, Recognized Identifiable Assets Acquired And Liabilities Assumed, Tangible Assets (Liabilities), Net",
        "terseLabel": "Net tangible liabilities"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssetsLiabilitiesNet",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.coopercos.com/role/AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination And Asset Acquisition, Recognized Identifiable Assets Acquired, Goodwill, And Liabilities Assumed, Net",
        "label": "Business Combination And Asset Acquisition, Recognized Identifiable Assets Acquired, Goodwill, And Liabilities Assumed, Net",
        "totalLabel": "Total closing purchase price"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "coo_BusinessCombinationAndAssetAcquisitionTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination And Asset Acquisition",
        "label": "Business Combination And Asset Acquisition [Text Block]",
        "terseLabel": "Acquisitions and Joint Venture"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionTextBlock",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVenture"
     ],
     "xbrltype": "textBlockItemType"
    },
    "coo_BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.coopercos.com/role/AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails": {
       "order": 4.0,
       "parentTag": "coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination And Asset Acquisitions, Contingent Consideration, Liability",
        "label": "Business Combination And Asset Acquisitions, Contingent Consideration, Liability",
        "negatedLabel": "Fair value of contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionsContingentConsiderationLiability",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "coo_BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.coopercos.com/role/AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails": {
       "order": 1.0,
       "parentTag": "coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination And Asset Acquisitions, Recognized Identifiable Assets Acquired And Liabilities Assumed, Intangible Assets, Other Than Goodwill",
        "label": "Business Combination And Asset Acquisitions, Recognized Identifiable Assets Acquired And Liabilities Assumed, Intangible Assets, Other Than Goodwill",
        "terseLabel": "Total identifiable intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Consideration Transferred Liabilities Incurred By Type",
        "label": "Business Combination Consideration Transferred Liabilities Incurred By Type [Axis]",
        "terseLabel": "Business Combination Consideration Transferred Liabilities Incurred By Type [Axis]"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeAxis",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "coo_BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Consideration Transferred Liabilities Incurred By Type [Domain]",
        "label": "Business Combination Consideration Transferred Liabilities Incurred By Type [Domain]",
        "terseLabel": "Business Combination Consideration Transferred Liabilities Incurred By Type [Domain]"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurredByTypeDomain",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_BusinessCombinationPaymentToSettleContingentConsideration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Payment to Settle Contingent Consideration",
        "label": "Business Combination, Payment to Settle Contingent Consideration",
        "terseLabel": "Payment to settle former equity interest owners"
       }
      }
     },
     "localname": "BusinessCombinationPaymentToSettleContingentConsideration",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesEmployeeRelatedLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Employee-related Liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Employee-related Liabilities",
        "terseLabel": "Employee compensation and benefits"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesEmployeeRelatedLiabilities",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredRevenue": {
     "auth_ref": [],
     "calculation": {
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Deferred Revenue",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredRevenue",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "coo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Operating Lease, Liability",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Operating Lease, Liability",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInAssumedPaymentFormElectionProbabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change In Assumptions For Defined Benefit Plans, Change In Assumed Payment Form Election Probabilities",
        "label": "Change In Assumptions For Defined Benefit Plans, Change In Assumed Payment Form Election Probabilities [Member]",
        "terseLabel": "Change In Assumptions For Defined Benefit Plans, Change In Assumed Payment Form Election Probabilities"
       }
      }
     },
     "localname": "ChangeInAssumptionsForDefinedBenefitPlansChangeInAssumedPaymentFormElectionProbabilitiesMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change In Assumptions For Defined Benefit Plans, Change In Demographic Experience [Member]",
        "label": "Change In Assumptions For Defined Benefit Plans, Change In Demographic Experience [Member]",
        "terseLabel": "Change In Assumptions For Defined Benefit Plans, Change In Demographic Experience"
       }
      }
     },
     "localname": "ChangeInAssumptionsForDefinedBenefitPlansChangeInDemographicExperienceMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change In Assumptions For Defined Benefit Plans, Change In Discount Rate [Member]",
        "label": "Change In Assumptions For Defined Benefit Plans, Change In Discount Rate [Member]",
        "terseLabel": "Change In Assumptions For Defined Benefit Plans, Change In Discount Rate"
       }
      }
     },
     "localname": "ChangeInAssumptionsForDefinedBenefitPlansChangeInDiscountRateMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change In Assumptions For Defined Benefit Plans, Change In Key Assumptions [Member]",
        "label": "Change In Assumptions For Defined Benefit Plans, Change In Key Assumptions [Member]",
        "terseLabel": "Change In Assumptions For Defined Benefit Plans, Change In Key Assumptions"
       }
      }
     },
     "localname": "ChangeInAssumptionsForDefinedBenefitPlansChangeInKeyAssumptionsMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change In Assumptions For Defined Benefit Plans, Change In Lump Sum Determination [Member]",
        "label": "Change In Assumptions For Defined Benefit Plans, Change In Lump Sum Determination [Member]",
        "terseLabel": "Change In Assumptions For Defined Benefit Plans, Change In Lump Sum Determination"
       }
      }
     },
     "localname": "ChangeInAssumptionsForDefinedBenefitPlansChangeInLumpSumDeterminationMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_CommonStockExcludingTreasuryStockParNetValueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Excluding Treasury Stock Par Net Value [Member]",
        "label": "Common Stock, Excluding Treasury Stock Par Net Value [Member]",
        "terseLabel": "Common Shares"
       }
      }
     },
     "localname": "CommonStockExcludingTreasuryStockParNetValueMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_CompositeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Composite [Member]",
        "label": "Composite [Member]",
        "verboseLabel": "Composite intangible asset"
       }
      }
     },
     "localname": "CompositeMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_CookMedicalsReproductiveHealthBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cook Medicals Reproductive Health Business",
        "label": "Cook Medicals Reproductive Health Business [Member]",
        "terseLabel": "Cook Medicals Reproductive Health Business"
       }
      }
     },
     "localname": "CookMedicalsReproductiveHealthBusinessMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_CoopersurgicalSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Coopersurgical Segment [Member]",
        "label": "Coopersurgical Segment [Member]",
        "terseLabel": "CooperSurgical"
       }
      }
     },
     "localname": "CoopersurgicalSegmentMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails",
      "http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails",
      "http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_CoopervisionSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Coopervision Segment [Member]",
        "label": "Coopervision Segment [Member]",
        "terseLabel": "CooperVision"
       }
      }
     },
     "localname": "CoopervisionSegmentMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails",
      "http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails",
      "http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_CorporateReconcilingItemsAndEliminationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate Reconciling Items And Eliminations",
        "label": "Corporate Reconciling Items And Eliminations [Member]",
        "terseLabel": "Eliminations, Corporate and Reconciling Items"
       }
      }
     },
     "localname": "CorporateReconcilingItemsAndEliminationsMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_CreditAgreement2020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Agreement 2020 [Member]",
        "label": "Credit Agreement 2020 [Member]",
        "terseLabel": "Credit Agreement 2020"
       }
      }
     },
     "localname": "CreditAgreement2020Member",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards": {
     "auth_ref": [],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Operating Loss Carryforwards And Tax Credit Carryforwards",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards And Tax Credit Carryforwards",
        "terseLabel": "Net operating loss and tax credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "coo_DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign": {
     "auth_ref": [],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Purchase Accounting Adjustments, Foreign",
        "label": "Deferred Tax Liabilities, Purchase Accounting Adjustments, Foreign",
        "negatedTerseLabel": "Foreign deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPurchaseAccountingAdjustmentsForeign",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "coo_DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "",
        "label": "Defined Benefit Plan, Amount Recognized In Net Periodic Benefit Cost (Credit) And Other Comprehensive (Income) Loss, Before Tax1 [Abstract]",
        "terseLabel": "Other changes in plan assets and benefit obligations recognized in other comprehensive income:"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmountRecognizedInNetPeriodicBenefitCostCreditAndOtherComprehensiveIncomeLossBeforeTax1Abstract",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "coo_DefinedBenefitPlanAssumptionsUsedCalculatingAccumulatedBenefitObligationEffectOfChangeInDiscountRate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Assumptions Used Calculating Accumulated Benefit Obligation, Effect Of Change In Discount Rate",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Accumulated Benefit Obligation, Effect Of Change In Discount Rate",
        "terseLabel": "Projected defined accumulated benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingAccumulatedBenefitObligationEffectOfChangeInDiscountRate",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Interest Cost",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Interest Cost",
        "terseLabel": "Interest Cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Projected Benefit Obligation",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Projected Benefit Obligation",
        "terseLabel": "Discount rate",
        "verboseLabel": "Projected Benefit Obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligation",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligationIncreaseDecrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Projected Benefit Obligation, Increase (Decrease)",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Projected Benefit Obligation, Increase (Decrease)",
        "negatedTerseLabel": "Discount rate, decrease"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateProjectedBenefitObligationIncreaseDecrease",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Service Cost",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Service Cost",
        "terseLabel": "Service Cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "coo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate Of Return On Plan Assets At Year End",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate Of Return On Plan Assets At Year End",
        "terseLabel": "Expected rate of return on plan assets at year end"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermRateOfReturnOnPlanAssetsAtYearEnd",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "coo_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationEffectOfChangeInDiscountRate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Assumptions Used Calculating Projected Benefit Obligation, Effect Of Change In Discount Rate",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Projected Benefit Obligation, Effect Of Change In Discount Rate",
        "terseLabel": "Projected defined benefit plan benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationEffectOfChangeInDiscountRate",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "coo_DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Plan Assets, Target Allocation, Expected Long Term Return, Percentage",
        "label": "Defined Benefit Plan, Plan Assets, Target Allocation, Expected Long Term Return, Percentage",
        "terseLabel": "Expected long-term return on diversified portfolio"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsTargetAllocationExpectedLongTermReturnPercentage",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "coo_DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost And Benefit Obligation [Abstract]",
        "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost And Benefit Obligation [Abstract]",
        "terseLabel": "Weighted-average assumptions used in computing the net periodic pension cost and projected benefit obligation at year end:"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedinCalculatingNetPeriodicBenefitCostAndBenefitObligationAbstract",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "coo_DirectorsPlan2020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Directors Plan 2020 [Member]",
        "label": "Directors Plan 2020 [Member]",
        "terseLabel": "2020 Directors Plan"
       }
      }
     },
     "localname": "DirectorsPlan2020Member",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_EffectiveIncomeTaxRateReconciliationChangeInDomesticFederalTaxReturnAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Change In Domestic Federal Tax Return, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Change In Domestic Federal Tax Return, Amount",
        "terseLabel": "United States provision-to-return"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDomesticFederalTaxReturnAmount",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "coo_EffectiveIncomeTaxRateReconciliationChangeInEnactedForeignTaxRateAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Change In Enacted Foreign Tax Rate, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Change In Enacted Foreign Tax Rate, Amount",
        "negatedTerseLabel": "Tax benefit related to remeasurement of deferred tax assets due to UK change in tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedForeignTaxRateAmount",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "coo_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Change In Unrecognized Tax Benefits, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Change In Unrecognized Tax Benefits, Amount",
        "terseLabel": "Change in unrecognized tax benefits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "coo_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan [Member]",
        "label": "Employee Stock Purchase Plan [Member]",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_EssilorInternationalSASMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Essilor International SAS",
        "label": "Essilor International SAS [Member]",
        "terseLabel": "Essilor International SAS"
       }
      }
     },
     "localname": "EssilorInternationalSASMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_EuropeanCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "European Credit Facility [Member]",
        "label": "European Credit Facility [Member]",
        "terseLabel": "European Credit Facilities"
       }
      }
     },
     "localname": "EuropeanCreditFacilityMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_FertilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fertility [Member]",
        "label": "Fertility [Member]",
        "terseLabel": "Fertility"
       }
      }
     },
     "localname": "FertilityMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Assets, Amortization Expense, After Year Four",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "coo_GainLossOnSaleOfAssetsAndAssetImpairmentChargesAndOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) On Sale Of Assets And Asset Impairment Charges And Other",
        "label": "Gain (Loss) On Sale Of Assets And Asset Impairment Charges And Other",
        "negatedTerseLabel": "Impairment and loss on disposal of property, plant and equipment, and other"
       }
      }
     },
     "localname": "GainLossOnSaleOfAssetsAndAssetImpairmentChargesAndOther",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "coo_GenerateLifeSciencesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generate Life Sciences",
        "label": "Generate Life Sciences [Member]",
        "terseLabel": "Generate Life Sciences"
       }
      }
     },
     "localname": "GenerateLifeSciencesMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails",
      "http://www.coopercos.com/role/AcquisitionsandJointVentureProformaInformationDetails",
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_IncreaseDecreaseInContingentConsiderationLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Contingent Consideration Liability",
        "label": "Increase (Decrease) In Contingent Consideration Liability",
        "terseLabel": "Settlement of contingent consideration"
       }
      }
     },
     "localname": "IncreaseDecreaseInContingentConsiderationLiability",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "coo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Operating Lease, Right-Of-Use Asset And Liability, Net",
        "label": "Increase (Decrease) In Operating Lease, Right-Of-Use Asset And Liability, Net",
        "terseLabel": "Operating lease right-of-use assets and liabilities, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "coo_LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability, Defined Benefit Pension Plan And Other, Noncurrent",
        "label": "Liability, Defined Benefit Pension Plan And Other, Noncurrent",
        "terseLabel": "Accrued pension liability and other"
       }
      }
     },
     "localname": "LiabilityDefinedBenefitPensionPlanAndOtherNoncurrent",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "coo_LicenseAndDistributionRightsAndOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License and Distribution Rights and Other [Member]",
        "label": "License And Distribution Rights And Other [Member]",
        "terseLabel": "License and distribution rights and other"
       }
      }
     },
     "localname": "LicenseAndDistributionRightsAndOtherMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_LineOfCreditFacilityAccordionFeatureIncreaseLimit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Accordion Feature, Increase Limit",
        "label": "Line Of Credit Facility, Accordion Feature, Increase Limit",
        "terseLabel": "Potential additional borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityAccordionFeatureIncreaseLimit",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "coo_MultifocalLensMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Multifocal Lens [Member]",
        "label": "Multifocal Lens [Member]",
        "terseLabel": "Multifocal lens"
       }
      }
     },
     "localname": "MultifocalLensMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_NonSingleUseSphereAndOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non Single-Use Sphere And Other [Member]",
        "label": "Non Single-Use Sphere And Other [Member]",
        "terseLabel": "Non single-use sphere, other"
       }
      }
     },
     "localname": "NonSingleUseSphereAndOtherMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_NumberOfBusinessUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Business Units",
        "label": "Number Of Business Units",
        "terseLabel": "Number of business units"
       }
      }
     },
     "localname": "NumberOfBusinessUnits",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "coo_NumberOfInterestRateDerivativesMatured": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Interest Rate Derivatives Matured",
        "label": "Number Of Interest Rate Derivatives Matured",
        "terseLabel": "Number of interest rate swap contracts matured"
       }
      }
     },
     "localname": "NumberOfInterestRateDerivativesMatured",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "coo_OfficeAndSurgicalProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Office And Surgical Products [Member]",
        "label": "Office And Surgical Products [Member]",
        "terseLabel": "Office and surgical products"
       }
      }
     },
     "localname": "OfficeAndSurgicalProductsMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Assets And Liabilities, Lessee [Abstract]",
        "label": "Operating Lease, Assets And Liabilities, Lessee [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseAssetsAndLiabilitiesLesseeAbstract",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "coo_OtherDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Debt [Member]",
        "label": "Other Debt [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherDebtMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_OverdraftAndOtherCreditFacilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Overdraft And Other Credit Facilities [Member]",
        "label": "Overdraft And Other Credit Facilities [Member]",
        "terseLabel": "Overdraft and other credit facilities"
       }
      }
     },
     "localname": "OverdraftAndOtherCreditFacilitiesMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_PayablesFirstInstallmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payables First Installment",
        "label": "Payables First Installment [Member]",
        "terseLabel": "Payables First Installment"
       }
      }
     },
     "localname": "PayablesFirstInstallmentMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_PayablesFourthInstallmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payables Fourth Installment",
        "label": "Payables Fourth Installment [Member]",
        "terseLabel": "Payables Fourth Installment"
       }
      }
     },
     "localname": "PayablesFourthInstallmentMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_PayablesSecondInstallmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payables Second Installment",
        "label": "Payables Second Installment [Member]",
        "terseLabel": "Payables Second Installment"
       }
      }
     },
     "localname": "PayablesSecondInstallmentMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_PayablesThirdInstallmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payables Third Installment",
        "label": "Payables Third Installment [Member]",
        "terseLabel": "Payables Third Installment"
       }
      }
     },
     "localname": "PayablesThirdInstallmentMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired": {
     "auth_ref": [],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments To Acquire Businesses And Assets, Net Of Cash Acquired",
        "label": "Payments To Acquire Businesses And Assets, Net Of Cash Acquired",
        "negatedLabel": "Acquisitions of businesses and assets, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesAndAssetsNetOfCashAcquired",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "coo_PrivatelyHeldMedicalDeviceCompanyDevelopedMaraWaterVaporAblationSystemMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Privately-Held Medical Device Company, Developed Mara Water Vapor Ablation System",
        "label": "Privately-Held Medical Device Company, Developed Mara Water Vapor Ablation System [Member]",
        "terseLabel": "Privately-Held Medical Device Company, Developed Mara Water Vapor Ablation System"
       }
      }
     },
     "localname": "PrivatelyHeldMedicalDeviceCompanyDevelopedMaraWaterVaporAblationSystemMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Privately-Held Medical Device Company, Portion Attributable To Former Equity Interest Owners",
        "label": "Privately-Held Medical Device Company, Portion Attributable To Former Equity Interest Owners [Member]",
        "terseLabel": "Privately-Held Medical Device Company, Spectacle Lenses, Portion Attributable To Former Equity Interest Owners"
       }
      }
     },
     "localname": "PrivatelyHeldMedicalDeviceCompanyPortionAttributableToFormerEquityInterestOwnersMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_RestOfTheWorldMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rest Of The World [Member]",
        "label": "Rest Of The World [Member]",
        "terseLabel": "Rest of World"
       }
      }
     },
     "localname": "RestOfTheWorldMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_RevolvingCreditFacilityAndTermLoanFacility2020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Facility And Term Loan Facility 2020 [Member]",
        "label": "Revolving Credit Facility And Term Loan Facility 2020 [Member]",
        "terseLabel": "Revolving Credit Facility And Term Loan Facility 2020"
       }
      }
     },
     "localname": "RevolvingCreditFacilityAndTermLoanFacility2020Member",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule Of Business Acquisitions And Asset Acquisition, By Acquisition [Table]",
        "label": "Schedule Of Business Acquisitions And Asset Acquisition, By Acquisition [Line Items]",
        "terseLabel": "Schedule Of Business Acquisitions And Asset Acquisition, By Acquisition [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionLineItems",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "coo_ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Business Acquisitions And Asset Acquisition, By Acquisition [Table]",
        "label": "Schedule Of Business Acquisitions And Asset Acquisition, By Acquisition [Table]",
        "terseLabel": "Schedule Of Business Acquisitions And Asset Acquisition, By Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsAndAssetAcquisitionByAcquisitionTable",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "coo_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedAndAssetAcquisitionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Recognized Identified Assets Acquired And Liabilities Assumed And Asset Acquisitions [Table Text Block]",
        "label": "Schedule Of Recognized Identified Assets Acquired And Liabilities Assumed And Asset Acquisitions [Table Text Block]",
        "terseLabel": "Total purchase consideration for business and asset acquisitions"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedAndAssetAcquisitionsTableTextBlock",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "coo_ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Reconciliation Of Prepaid (Accrued) Pension Cost [Table Text Block]",
        "label": "Schedule Of Reconciliation Of Prepaid (Accrued) Pension Cost [Table Text Block]",
        "terseLabel": "Reconciliation of prepaid (accrued) pension cost"
       }
      }
     },
     "localname": "ScheduleOfReconciliationOfPrepaidAccruedPensionCostTableTextBlock",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "coo_ScheduleofLongTermAndShortTermDebtInstrumentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of Long Term And Short Term Debt Instruments [Table]",
        "label": "Schedule of Long Term And Short Term Debt Instruments [Line Items]",
        "terseLabel": "Schedule of Long Term and Short Term Debt Instruments [Line Items]"
       }
      }
     },
     "localname": "ScheduleofLongTermAndShortTermDebtInstrumentsLineItems",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "coo_ScheduleofLongTermAndShortTermDebtInstrumentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Long Term And Short Term Debt Instruments [Table]",
        "label": "Schedule of Long Term And Short Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long Term and Short Term Debt Instruments [Table]"
       }
      }
     },
     "localname": "ScheduleofLongTermAndShortTermDebtInstrumentsTable",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "coo_SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series Of Individually Immaterial Business Acquisitions And Asset Acquisitions [Member]",
        "label": "Series Of Individually Immaterial Business Acquisitions And Asset Acquisitions [Member]",
        "terseLabel": "Series Of Individually Immaterial Business Acquisitions And Asset Acquisitions"
       }
      }
     },
     "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsAndAssetAcquisitionsMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Target Percentage Of Shares Earned",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Target Percentage Of Shares Earned",
        "terseLabel": "Target percentage of shares earned"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentageOfSharesEarned",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "coo_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Terms Of Award, Grants In Period, Number Of Non Employee Directors In Committee",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Terms Of Award, Grants In Period, Number Of Non Employee Directors In Committee",
        "terseLabel": "Number of non-employee directors in committee"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardGrantsInPeriodNumberOfNonEmployeeDirectorsInCommittee",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "coo_ShortTermDebtNetOfDebtIssuanceCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-Term Debt, Net Of Debt Issuance Costs",
        "label": "Short-Term Debt, Net Of Debt Issuance Costs",
        "totalLabel": "Short-term debt, excluding financing leases"
       }
      }
     },
     "localname": "ShortTermDebtNetOfDebtIssuanceCosts",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "coo_SightGlassVisionIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SightGlass Vision, Inc.",
        "label": "SightGlass Vision, Inc. [Member]",
        "terseLabel": "SightGlass Vision, Inc."
       }
      }
     },
     "localname": "SightGlassVisionIncMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_SingleUseSphereLensMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Single Use Sphere Lens [Member]",
        "label": "Single Use Sphere Lens [Member]",
        "terseLabel": "Single-use sphere lens"
       }
      }
     },
     "localname": "SingleUseSphereLensMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_TermLoanAgreement2021364DayMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Agreement 2021, 364 Day",
        "label": "Term Loan Agreement 2021, 364 Day [Member]",
        "terseLabel": "Term Loan Agreement 2021, 364 Day"
       }
      }
     },
     "localname": "TermLoanAgreement2021364DayMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_TermLoanFacility2020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Facility 2020 [Member]",
        "label": "Term Loan Facility 2020 [Member]",
        "terseLabel": "Term Loan Facility 2020"
       }
      }
     },
     "localname": "TermLoanFacility2020Member",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_TermLoanFacility2021AdjustedLIBORateLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Facility 2021, Adjusted LIBO Rate Loans",
        "label": "Term Loan Facility 2021, Adjusted LIBO Rate Loans [Member]",
        "terseLabel": "Term Loan Facility 2021, Adjusted LIBO Rate Loans"
       }
      }
     },
     "localname": "TermLoanFacility2021AdjustedLIBORateLoansMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_TermLoanFacility2021BaseRateLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Facility, 2021 Base Rate Loans",
        "label": "Term Loan Facility, 2021 Base Rate Loans [Member]",
        "terseLabel": "Term Loan Facility, 2021 Base Rate Loans"
       }
      }
     },
     "localname": "TermLoanFacility2021BaseRateLoansMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_TermLoanFacility2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Facility 2021",
        "label": "Term Loan Facility 2021 [Member]",
        "terseLabel": "Term Loan Facility 2021"
       }
      }
     },
     "localname": "TermLoanFacility2021Member",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_TermLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loans [Member]",
        "label": "Term Loans [Member]",
        "terseLabel": "Term loans"
       }
      }
     },
     "localname": "TermLoansMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_ThirdAmendedAndRestated2007LongTermIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third Amended And Restated 2007 Long-Term Incentive Plan [Member]",
        "label": "Third Amended And Restated 2007 Long-Term Incentive Plan [Member]",
        "terseLabel": "Third Amended and Restated 2007 Long-Term Incentive Plan"
       }
      }
     },
     "localname": "ThirdAmendedAndRestated2007LongTermIncentivePlanMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_ToricLensMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Toric Lens [Member]",
        "label": "Toric Lens [Member]",
        "terseLabel": "Toric lens"
       }
      }
     },
     "localname": "ToricLensMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "coo_TreasuryStockParNetValueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock Par Net Value [Member]",
        "label": "Treasury Stock Par Net Value [Member]",
        "terseLabel": "Treasury Stock Par Net Value"
       }
      }
     },
     "localname": "TreasuryStockParNetValueMember",
     "nsuri": "http://www.coopercos.com/20221031",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r805",
      "r806",
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r805",
      "r806",
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r805",
      "r806",
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r805",
      "r806",
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r803"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r833"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-Known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r805",
      "r806",
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r801"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.coopercos.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r131",
      "r195",
      "r208",
      "r209",
      "r210",
      "r211",
      "r213",
      "r215",
      "r219",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r316",
      "r317",
      "r319",
      "r321",
      "r322",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
      "http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r131",
      "r195",
      "r208",
      "r209",
      "r210",
      "r211",
      "r213",
      "r215",
      "r219",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r316",
      "r317",
      "r319",
      "r321",
      "r322",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
      "http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r2",
      "r143",
      "r150",
      "r156",
      "r242",
      "r510",
      "r511",
      "r512",
      "r554",
      "r555",
      "r638",
      "r641",
      "r643",
      "r644",
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r2",
      "r143",
      "r150",
      "r156",
      "r242",
      "r510",
      "r511",
      "r512",
      "r554",
      "r555",
      "r638",
      "r641",
      "r643",
      "r644",
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r2",
      "r143",
      "r150",
      "r156",
      "r242",
      "r510",
      "r511",
      "r512",
      "r554",
      "r555",
      "r638",
      "r641",
      "r643",
      "r644",
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of investment including named security. Excludes entity that is consolidated.",
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Continent of Europe.",
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_GeographyEliminationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in geographic consolidation.",
        "label": "Geography Eliminations [Member]",
        "terseLabel": "Geography Eliminations"
       }
      }
     },
     "localname": "GeographyEliminationsMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r300",
      "r301",
      "r302",
      "r303",
      "r327",
      "r360",
      "r458",
      "r461",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r765",
      "r768",
      "r798",
      "r799"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails",
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r300",
      "r301",
      "r302",
      "r303",
      "r327",
      "r360",
      "r458",
      "r461",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r765",
      "r768",
      "r798",
      "r799"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails",
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r222",
      "r301",
      "r302",
      "r390",
      "r393",
      "r724",
      "r764",
      "r766"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r222",
      "r301",
      "r302",
      "r390",
      "r393",
      "r724",
      "r764",
      "r766"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r290",
      "r300",
      "r301",
      "r302",
      "r303",
      "r327",
      "r360",
      "r410",
      "r458",
      "r461",
      "r497",
      "r498",
      "r499",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r765",
      "r768",
      "r798",
      "r799"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails",
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r290",
      "r300",
      "r301",
      "r302",
      "r303",
      "r327",
      "r360",
      "r410",
      "r458",
      "r461",
      "r497",
      "r498",
      "r499",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r765",
      "r768",
      "r798",
      "r799"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails",
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ReportableGeographicalComponentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical components of an entity reporting separate financial information in the entity's financial statements.",
        "label": "Reportable Geographical Components [Member]",
        "terseLabel": "Reportable Geographical Components"
       }
      }
     },
     "localname": "ReportableGeographicalComponentsMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r151",
      "r459",
      "r810"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact.",
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r151",
      "r156",
      "r299",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of investment including named security. Excludes entity that is consolidated.",
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r138",
      "r821"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "terseLabel": "Schedule II"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.coopercos.com/role/ScheduleII"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r223",
      "r224",
      "r390",
      "r394",
      "r767",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r811",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r223",
      "r224",
      "r390",
      "r394",
      "r767",
      "r784",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r811",
      "r812"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r151",
      "r156",
      "r299",
      "r459",
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2022",
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.coopercos.com/role/ScheduleIIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r132",
      "r133",
      "r134",
      "r136",
      "r137",
      "r821"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.coopercos.com/role/ScheduleIIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r144",
      "r145",
      "r146",
      "r147",
      "r232",
      "r233",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r510",
      "r511",
      "r512",
      "r554",
      "r555",
      "r585",
      "r586",
      "r587",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r677",
      "r678",
      "r684",
      "r685",
      "r686",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "terseLabel": "Accounting Standards Update [Extensible Enumeration]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r49",
      "r709"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r228",
      "r229"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Trade accounts receivable, net of allowance for credit losses of $20.7 at October\u00a031, 2022 and $9.2 at October\u00a031, 2021"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "auth_ref": [
      "r29",
      "r731",
      "r750"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.",
        "label": "Accrued Income Taxes, Noncurrent",
        "terseLabel": "Long-term tax payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r65",
      "r71",
      "r80",
      "r81",
      "r82",
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Minimum Pension Liability"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r19",
      "r285"
     ],
     "calculation": {
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Less: Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r71",
      "r80",
      "r81",
      "r82",
      "r83",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Derivatives",
        "verboseLabel": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r36",
      "r68",
      "r70",
      "r71",
      "r752",
      "r776",
      "r780"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "verboseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r80",
      "r81",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r67",
      "r71",
      "r80",
      "r81",
      "r82",
      "r140",
      "r141",
      "r142",
      "r609",
      "r706",
      "r771",
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r63",
      "r71",
      "r80",
      "r81",
      "r82",
      "r609",
      "r669",
      "r670",
      "r671",
      "r672",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Translation Adjustment"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r34",
      "r709"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r140",
      "r141",
      "r142",
      "r510",
      "r511",
      "r512",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r113",
      "r273"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r464",
      "r515",
      "r516"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r503"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Share-based compensation expense",
        "verboseLabel": "Total compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails",
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r40",
      "r230",
      "r245"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Trade accounts receivable, allowance for credit losses"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r113",
      "r267",
      "r273"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangibles"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax": {
     "auth_ref": [
      "r451"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized in net periodic benefit cost (credit) and other comprehensive (income) loss.",
        "label": "Defined Benefit Plan, Amount Recognized in Net Periodic Benefit Cost (Credit) and Other Comprehensive (Income) Loss, before Tax",
        "terseLabel": "Total recognized in net periodic benefit cost and other comprehensive (income) loss"
       }
      }
     },
     "localname": "AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Stock option shares and restricted stock units excluded (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax": {
     "auth_ref": [
      "r68"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax",
        "terseLabel": "Gain (loss) on derivatives recognized in other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "AociLossCashFlowHedgeCumulativeGainLossAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r23",
      "r125",
      "r203",
      "r210",
      "r217",
      "r238",
      "r309",
      "r310",
      "r311",
      "r313",
      "r314",
      "r315",
      "r316",
      "r318",
      "r320",
      "r322",
      "r323",
      "r605",
      "r610",
      "r654",
      "r707",
      "r709",
      "r729",
      "r749"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets",
        "verboseLabel": "Identifiable assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r13",
      "r48",
      "r125",
      "r238",
      "r309",
      "r310",
      "r311",
      "r313",
      "r314",
      "r315",
      "r316",
      "r318",
      "r320",
      "r322",
      "r323",
      "r605",
      "r610",
      "r654",
      "r707",
      "r709"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r5",
      "r6",
      "r8",
      "r9",
      "r10",
      "r282",
      "r288"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Current",
        "terseLabel": "Assets held-for-sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r468",
      "r469",
      "r470",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r489",
      "r490",
      "r492",
      "r493",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails",
      "http://www.coopercos.com/role/StockPlansNarrativeDetails",
      "http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails",
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Buildings and improvements"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Building"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r457",
      "r460",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails",
      "http://www.coopercos.com/role/AcquisitionsandJointVentureProformaInformationDetails",
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r457",
      "r460",
      "r576",
      "r577",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails",
      "http://www.coopercos.com/role/AcquisitionsandJointVentureProformaInformationDetails",
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails",
      "http://www.coopercos.com/role/AcquisitionsandJointVentureProformaInformationDetails",
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Ownership percentage"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r574",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Schedule of business acquisition, pro forma information"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "auth_ref": [
      "r598"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "verboseLabel": "Goodwill deductible for tax purposes"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r574",
      "r575"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureProformaInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r574",
      "r575"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureProformaInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]",
        "terseLabel": "Business Combination And Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r590",
      "r591",
      "r593"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Purchase price to acquire business"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": {
     "auth_ref": [
      "r588",
      "r590",
      "r591",
      "r595"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.",
        "label": "Business Combination, Consideration Transferred, Liabilities Incurred",
        "terseLabel": "Payables incurred in acquisition"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r112",
      "r599"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "verboseLabel": "Change in fair value of contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r597"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Undiscounted range of the contingent consideration, maximum"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow": {
     "auth_ref": [
      "r597"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements and indemnification assets recognized in connection with a business combination, this element represents an estimate of the low-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low",
        "terseLabel": "Undiscounted range of the contingent consideration, minimum"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r589",
      "r592",
      "r596"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual": {
     "auth_ref": [
      "r573"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.",
        "label": "Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual",
        "terseLabel": "Actual net income generated"
       }
      }
     },
     "localname": "BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual": {
     "auth_ref": [
      "r573"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.",
        "label": "Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual",
        "terseLabel": "Actual revenue generated"
       }
      }
     },
     "localname": "BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r579"
     ],
     "calculation": {
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
        "totalLabel": "Total assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r579"
     ],
     "calculation": {
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": {
     "auth_ref": [
      "r579"
     ],
     "calculation": {
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r579"
     ],
     "calculation": {
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "terseLabel": "Prepaid expense and other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r579"
     ],
     "calculation": {
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Trade accounts receivable, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": {
     "auth_ref": [
      "r579"
     ],
     "calculation": {
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r579"
     ],
     "calculation": {
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": {
     "auth_ref": [
      "r579"
     ],
     "calculation": {
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": {
     "auth_ref": [
      "r579"
     ],
     "calculation": {
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r579"
     ],
     "calculation": {
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r578",
      "r579"
     ],
     "calculation": {
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Finite-lived intangibles"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r578",
      "r579"
     ],
     "calculation": {
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r579"
     ],
     "calculation": {
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "totalLabel": "Total liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r579"
     ],
     "calculation": {
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r579"
     ],
     "calculation": {
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r578",
      "r579"
     ],
     "calculation": {
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r579"
     ],
     "calculation": {
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Total purchase price"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss": {
     "auth_ref": [
      "r572"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In a business combination achieved in stages, this element represents the amount of net gain (loss) recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net",
        "terseLabel": "Equity investment gain realized before acquisition of remaining equity interest"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "Business combinations"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r139",
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and accounting policies concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Business Description and Accounting Policies [Text Block]",
        "terseLabel": "Organization and Significant Accounting Policies"
       }
      }
     },
     "localname": "BusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessExitCosts1": {
     "auth_ref": [
      "r113"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Business Exit Costs",
        "terseLabel": "Exit charges"
       }
      }
     },
     "localname": "BusinessExitCosts1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostAmortizationPeriod": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization period of cost capitalized in obtaining or fulfilling contract with customer, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Capitalized Contract Cost, Amortization Period",
        "terseLabel": "Capitalized contract cost, amortization period (or less)"
       }
      }
     },
     "localname": "CapitalizedContractCostAmortizationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r11",
      "r16",
      "r115"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets",
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r108",
      "r115",
      "r118"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of year",
        "periodStartLabel": "Cash, cash equivalents, restricted cash and cash held for sale at beginning of year",
        "totalLabel": "Total cash, cash equivalents, restricted cash and cash held for sale"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]",
        "terseLabel": "Reconciliation of cash flow information:"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r108",
      "r667"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "auth_ref": [
      "r632"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months",
        "negatedTerseLabel": "Derivative loss expected to be realized in earnings over the next twelve months"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ChangeInAccountingEstimateByTypeAxis": {
     "auth_ref": [
      "r151",
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of change in accounting estimate.",
        "label": "Change in Accounting Estimate by Type [Axis]",
        "terseLabel": "Change in Accounting Estimate by Type [Axis]"
       }
      }
     },
     "localname": "ChangeInAccountingEstimateByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ChangeInAccountingEstimateTypeDomain": {
     "auth_ref": [
      "r151",
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the accounting estimate that was changed that had the effect of adjusting the carrying amount of an existing asset or liability, or that will alter the subsequent accounting for existing or future assets or liabilities.",
        "label": "Change in Accounting Estimate, Type [Domain]",
        "terseLabel": "Change in Accounting Estimate, Type [Domain]"
       }
      }
     },
     "localname": "ChangeInAccountingEstimateTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in the benefit obligation, fair value of plan assets, and funded status of pension plans or other employee benefit plans.",
        "label": "Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan [Table Text Block]",
        "terseLabel": "Changes in benefit obligation, changes in plan assets and funded status"
       }
      }
     },
     "localname": "ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r56",
      "r736",
      "r757"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "verboseLabel": "Contingencies (Note 12)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r296",
      "r297",
      "r298",
      "r304",
      "r785"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/Contingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r305",
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Litigation"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Number of shares remaining available for future issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockDividendsPerShareCashPaid": {
     "auth_ref": [
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Cash Paid",
        "terseLabel": "Dividends on common stock (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareCashPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r33",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Common stock, ending balance (in shares)",
        "periodStartLabel": "Common stock, beginning balance (in shares)",
        "terseLabel": "Common stock, outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r33",
      "r709"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, $10 cents par value, 120.0 shares authorized, 53.8 issued and 49.3 outstanding at October\u00a031, 2022 and 53.7 issued and 49.3 outstanding at October\u00a031, 2021"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets and Liabilities [Abstract]",
        "terseLabel": "Components of Deferred Tax Assets and Liabilities [Abstract]"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "localname": "ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r76",
      "r78",
      "r88",
      "r604",
      "r613",
      "r740",
      "r760"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r119",
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r379",
      "r380",
      "r391"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r379",
      "r380",
      "r391"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerRefundLiability": {
     "auth_ref": [
      "r392"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer.",
        "label": "Contract with Customer, Refund Liability",
        "terseLabel": "Refund liability for product returns"
       }
      }
     },
     "localname": "ContractWithCustomerRefundLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r208",
      "r209",
      "r210",
      "r211",
      "r213",
      "r219",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r94",
      "r724"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails",
      "http://www.coopercos.com/role/StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r126",
      "r550",
      "r558"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r126",
      "r550"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r126",
      "r550",
      "r558",
      "r560"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current income tax expense (benefit)"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r126",
      "r550",
      "r558"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails",
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.coopercos.com/role/AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails",
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of debt and lease obligation, classified as current.",
        "label": "Debt, Current",
        "terseLabel": "Short-term debt (Note 5)",
        "totalLabel": "Short-term debt"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets",
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r122",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r341",
      "r348",
      "r349",
      "r350",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Financing Arrangements"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r25",
      "r26",
      "r28",
      "r124",
      "r131",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r331",
      "r337",
      "r338",
      "r339",
      "r340",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r352",
      "r353",
      "r354",
      "r355",
      "r682",
      "r730",
      "r733",
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Debt instrument, basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r28",
      "r351",
      "r733",
      "r747"
     ],
     "calculation": {
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebtNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Long-term debt, gross"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r324",
      "r352",
      "r353",
      "r680",
      "r682",
      "r683"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "verboseLabel": "Original debt amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r55",
      "r124",
      "r131",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r331",
      "r337",
      "r338",
      "r339",
      "r340",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r352",
      "r353",
      "r354",
      "r355",
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtLongtermAndShorttermCombinedAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt.",
        "label": "Debt, Long-Term and Short-Term, Combined Amount",
        "totalLabel": "Total debt"
       }
      }
     },
     "localname": "DebtLongtermAndShorttermCombinedAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions made by employer into fund established for purposes of making future disbursement to individual in accordance with deferred compensation arrangement.",
        "label": "Deferred Compensation Arrangement with Individual, Contributions by Employer",
        "terseLabel": "Contributions by employer in 401k savings plan"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r126",
      "r551",
      "r558"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsCurrentNet": {
     "auth_ref": [
      "r681"
     ],
     "calculation": {
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails": {
       "order": 2.0,
       "parentTag": "coo_ShortTermDebtNetOfDebtIssuanceCosts",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as current. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Current, Net",
        "negatedTerseLabel": "Less: unamortized debt issuance cost"
       }
      }
     },
     "localname": "DeferredFinanceCostsCurrentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNoncurrentNet": {
     "auth_ref": [
      "r681"
     ],
     "calculation": {
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebtNoncurrent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Noncurrent, Net",
        "negatedLabel": "Less: unamortized debt issuance cost"
       }
      }
     },
     "localname": "DeferredFinanceCostsNoncurrentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r126",
      "r551",
      "r558"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r523",
      "r524"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r113",
      "r126",
      "r551",
      "r558",
      "r559",
      "r560"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes",
        "totalLabel": "Total deferred income tax expense (benefit)"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r30",
      "r31",
      "r540",
      "r732",
      "r746"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total gross deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r523",
      "r524"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r126",
      "r551",
      "r558"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory": {
     "auth_ref": [
      "r548"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from intra-entity transfer of asset within consolidated group. Excludes intra-entity transfer of inventory.",
        "label": "Deferred Tax Asset, Intra-entity Transfer, Asset Other than Inventory",
        "terseLabel": "Deferred tax asset, intra-entity sale of certain intellectual property rights"
       }
      }
     },
     "localname": "DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Assets, Goodwill and Intangible Assets",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r541"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total gross deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "auth_ref": [
      "r548",
      "r549"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.",
        "label": "Deferred Tax Assets, Inventory",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r543"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r543"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration",
        "terseLabel": "Federal net operating losses not subject to expiration"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration",
        "terseLabel": "Federal net operating losses expiring"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign": {
     "auth_ref": [
      "r546",
      "r548",
      "r549"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Foreign",
        "terseLabel": "Foreign deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "auth_ref": [
      "r546",
      "r548",
      "r549"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "terseLabel": "Capitalized research and experimental expenses"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r548",
      "r549"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "auth_ref": [
      "r548",
      "r549"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "terseLabel": "Accrued liabilities, reserves and compensation accruals"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "auth_ref": [
      "r548",
      "r549"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.",
        "label": "Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Less: valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill": {
     "auth_ref": [
      "r548",
      "r549",
      "r600",
      "r601"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from goodwill.",
        "label": "Deferred Tax Liabilities, Goodwill",
        "negatedTerseLabel": "Tax deductible goodwill"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": {
     "auth_ref": [
      "r548",
      "r549"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.",
        "label": "Deferred Tax Liabilities, Intangible Assets",
        "negatedTerseLabel": "Intangible assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r548",
      "r549"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedTerseLabel": "Plant and equipment"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax": {
     "auth_ref": [
      "r66",
      "r71",
      "r426"
     ],
     "calculation": {
      "http://www.coopercos.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax",
        "totalLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax": {
     "auth_ref": [
      "r71",
      "r426"
     ],
     "calculation": {
      "http://www.coopercos.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax",
        "negatedTerseLabel": "Net loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "auth_ref": [
      "r405",
      "r451"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "terseLabel": "Actual return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "auth_ref": [
      "r401"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "negatedTerseLabel": "Actuarial (gain)/loss",
        "terseLabel": "Defined benefit obligation, actuarial gain (loss)"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit": {
     "auth_ref": [
      "r397",
      "r424",
      "r448"
     ],
     "calculation": {
      "http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss), recognized immediately as component of net periodic benefit (cost) credit, for change in value of benefit obligation or plan assets from experience different from that assumed, change in actuarial assumption, or consequence of temporarily deviating from substantive plan. Includes, but is not limited to, amount in excess of 10 percent of greater of fair value of plan assets or benefit obligation.",
        "label": "Defined Benefit Plan, Actuarial Gain (Loss), Immediate Recognition as Component in Net Periodic Benefit (Cost) Credit",
        "negatedLabel": "Recognized actuarial loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate",
        "terseLabel": "Discount rate for determining benefit obligations at year end"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase",
        "terseLabel": "Rate of compensation increase for determining benefit obligations at year end"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r430",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets",
        "terseLabel": "Expected rate of return on plan assets for determining net periodic pension cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase",
        "terseLabel": "Rate of compensation increase for determining expense"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r398"
     ],
     "calculation": {
      "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "periodEndLabel": "Benefit obligation, end of year",
        "periodStartLabel": "Benefit obligation, beginning of year"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r402",
      "r455"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "negatedLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "auth_ref": [
      "r410",
      "r411",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r432",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash and cash equivalent in which defined benefit plan asset is invested.",
        "label": "Defined Benefit Plan, Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "DefinedBenefitPlanCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "terseLabel": "Change in benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "terseLabel": "Change in plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r406",
      "r411",
      "r413",
      "r449",
      "r451",
      "r452"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "negatedNetLabel": "Contributions made during the year",
        "terseLabel": "Employer contributions",
        "verboseLabel": "Company's contribution to the pension plan"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsReconciliationofPrepaidAccruedPensionCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Expected Future Benefit Payment [Abstract]",
        "terseLabel": "Defined Benefit Plan, Expected Future Benefit Payment [Abstract]"
       }
      }
     },
     "localname": "DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [
      "r419"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "terseLabel": "2028-2032"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [
      "r419"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "auth_ref": [
      "r419"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "auth_ref": [
      "r419"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "auth_ref": [
      "r419"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [
      "r419"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r397",
      "r423",
      "r447",
      "r451",
      "r452"
     ],
     "calculation": {
      "http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r404",
      "r411",
      "r413",
      "r414",
      "r451"
     ],
     "calculation": {
      "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "periodEndLabel": "Fair value of plan assets, end of year",
        "periodStartLabel": "Fair value of plan assets, beginning of year",
        "terseLabel": "Fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r396",
      "r408",
      "r451"
     ],
     "calculation": {
      "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "totalLabel": "Funded status at end of year"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r397",
      "r400",
      "r422",
      "r446",
      "r451",
      "r452"
     ],
     "calculation": {
      "http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r420",
      "r444",
      "r451",
      "r452"
     ],
     "calculation": {
      "http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "terseLabel": "Net periodic benefit cost",
        "totalLabel": "Net periodic pension cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsReconciliationofPrepaidAccruedPensionCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]",
        "terseLabel": "Components of net periodic benefit cost and other amounts recognized in the Consolidated Statements of Income:"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList": {
     "auth_ref": [
      "r420",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of income or comprehensive income that includes expected return (loss) on plan asset component of net periodic benefit (cost) credit for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Expected Return (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "terseLabel": "Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Expected Return (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList": {
     "auth_ref": [
      "r420",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of income or comprehensive income that includes actuarial gain (loss) recognized immediately as component of net periodic benefit (cost) credit for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Immediate Recognition of Actuarial Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "terseLabel": "Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Immediate Recognition of Actuarial Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditImmediateRecognitionOfActuarialGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList": {
     "auth_ref": [
      "r420",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of income or comprehensive income that includes interest cost component of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "terseLabel": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Abstract]",
        "terseLabel": "Amounts recognized in accumulated other comprehensive income consist of:"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation": {
     "auth_ref": [
      "r440",
      "r441",
      "r451"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated benefit obligation for defined benefit plan with accumulated benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation",
        "terseLabel": "Accumulated benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsAllocationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan, Plan Assets, Allocation [Line Items]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Allocation [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsAllocationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsAllocationTable": {
     "auth_ref": [
      "r410",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment allocation of defined benefit plan assets. Includes, but is not limited to, investment allocation percentage or range of percentages.",
        "label": "Defined Benefit Plan, Plan Assets, Allocation [Table]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Allocation [Table]"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsAllocationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "auth_ref": [
      "r407",
      "r455"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "negatedLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Line Items]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsCategoryLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable": {
     "auth_ref": [
      "r411",
      "r413",
      "r418",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about defined benefit plan asset investment. Includes, but is not limited to, fair value of category of plan asset and its level within fair value hierarchy.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Table]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Table]"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsCategoryTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage": {
     "auth_ref": [
      "r410",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.",
        "label": "Defined Benefit Plan, Plan Assets, Target Allocation, Percentage",
        "terseLabel": "Diversified portfolio, allocation of assets in equities"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsTargetAllocationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r399",
      "r421",
      "r445",
      "r451",
      "r452"
     ],
     "calculation": {
      "http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsChangesinBenefitObligationChangesinPlanAssetsandFundedStatusDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsComponentsofNetPeriodicPensionCostsandOtherAmountsRecognizedinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.",
        "label": "Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage",
        "verboseLabel": "Asset allocation"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssetAllocations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]",
        "terseLabel": "Discount rate for determining net periodic pension cost:"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssumptionsUsedinComputingNetPeriodicPensionCostandProjectedBenefitObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.",
        "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent",
        "terseLabel": "Maximum annual contributions per employee in 401k savings plan"
       }
      }
     },
     "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r113",
      "r283"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails",
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r61",
      "r620",
      "r622",
      "r625",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails",
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r633",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Financial Derivatives and Hedging"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedging"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails",
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivatives and hedging activities.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Table]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails",
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r615",
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTermOfContract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Derivative, Term of Contract",
        "verboseLabel": "Interest rate swap contracts, contract term (or less)"
       }
      }
     },
     "localname": "DerivativeTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r130",
      "r614",
      "r616",
      "r618",
      "r619",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Financial Derivatives and Hedging"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r467",
      "r468",
      "r504",
      "r505",
      "r507",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "verboseLabel": "Stock Plans"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": {
     "auth_ref": [
      "r5",
      "r6",
      "r8",
      "r288"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents",
        "terseLabel": "Cash held for sale"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsCommonStock": {
     "auth_ref": [
      "r373",
      "r745"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
        "label": "Dividends, Common Stock",
        "negatedTerseLabel": "Dividends on common stock ($0.03 per share)"
       }
      }
     },
     "localname": "DividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Domestic Tax Authority"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings per share (Note 7)"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r89",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r157",
      "r160",
      "r170",
      "r171",
      "r172",
      "r176",
      "r177",
      "r644",
      "r645",
      "r741",
      "r761"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)",
        "verboseLabel": "Basic earnings per share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome",
      "http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Basic:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r89",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r160",
      "r170",
      "r171",
      "r172",
      "r176",
      "r177",
      "r644",
      "r645",
      "r741",
      "r761"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)",
        "verboseLabel": "Diluted earnings per share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome",
      "http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Diluted:"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r173",
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r173",
      "r174",
      "r175",
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r667"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "verboseLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Employee compensation and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Total unrecognized compensation cost expected to be recognized over a remaining weighted-average vesting period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r506"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Total unrecognized compensation cost related to nonvested units"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r506"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Total unrecognized compensation cost related to nonvested options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r503"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Related income tax benefit"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employee Stock"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails",
      "http://www.coopercos.com/role/StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails",
      "http://www.coopercos.com/role/StockPlansNarrativeDetails",
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r80",
      "r81",
      "r82",
      "r140",
      "r141",
      "r142",
      "r145",
      "r153",
      "r155",
      "r181",
      "r242",
      "r372",
      "r373",
      "r510",
      "r511",
      "r512",
      "r554",
      "r555",
      "r643",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r674",
      "r706",
      "r771",
      "r772",
      "r773"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails",
      "http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityFundsMember": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An investment that pools funds from many investors to invest in a combination of underlying investments, primarily equity investments.",
        "label": "Equity Funds [Member]",
        "terseLabel": "Equity mutual funds"
       }
      }
     },
     "localname": "EquityFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Equity method investment, ownership percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": {
     "auth_ref": [
      "r90",
      "r91",
      "r113"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment.",
        "label": "Equity Method Investment, Realized Gain (Loss) on Disposal",
        "terseLabel": "Equity method investment realized gain"
       }
      }
     },
     "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r17",
      "r204",
      "r235"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity method investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r234",
      "r748",
      "r781",
      "r782",
      "r783"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Equity Securities"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r648",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r339",
      "r352",
      "r353",
      "r411",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r451",
      "r649",
      "r712",
      "r713",
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r339",
      "r411",
      "r413",
      "r418",
      "r451",
      "r649",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "verboseLabel": "Quoted\u00a0Prices in Active Markets for Identical\u00a0Assets (Level 1)"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r339",
      "r352",
      "r353",
      "r411",
      "r413",
      "r418",
      "r451",
      "r649",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "verboseLabel": "Significant Observable Inputs (Level 2)"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r339",
      "r352",
      "r353",
      "r411",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r451",
      "r649",
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "verboseLabel": "Significant Unobservable Inputs (Level 3)"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r650",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Contingent consideration reconciliation"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r651"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "verboseLabel": "Change in fair value"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": {
     "auth_ref": [
      "r652"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases",
        "terseLabel": "Purchase price contingent consideration"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r652"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "negatedLabel": "Payments"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r650"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r339",
      "r352",
      "r353",
      "r411",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r451",
      "r712",
      "r713",
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList": {
     "auth_ref": [
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement in which net income is reported that includes gain (loss) from liability measured at fair value using unobservable input (level 3).",
        "label": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "terseLabel": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]"
       }
      }
     },
     "localname": "FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureContingentConsiderationReconciliationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FederalFundsEffectiveSwapRateMember": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap having its variable-rate leg referenced to Federal Funds effective rate with no additional spread over Federal Funds effective rate on that variable-rate leg.",
        "label": "Fed Funds Effective Rate Overnight Index Swap Rate [Member]",
        "terseLabel": "Fed Funds Effective Rate Overnight Index Swap Rate"
       }
      }
     },
     "localname": "FederalFundsEffectiveSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r688"
     ],
     "calculation": {
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Financing lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current finance lease liability.",
        "label": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r688"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Financing lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent finance lease liability.",
        "label": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization": {
     "auth_ref": [
      "r687"
     ],
     "calculation": {
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, before Accumulated Amortization",
        "terseLabel": "Finance lease ROU assets, net"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Useful life",
        "verboseLabel": "Weighted Average Amortization Period (in years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails",
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r21",
      "r272"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r274"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.",
        "label": "Finite-Lived Intangible Assets Amortization Expense [Table Text Block]",
        "terseLabel": "Remaining amortization expenses for intangible assets with definite lives"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r274"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r274"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r274"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r268",
      "r269",
      "r272",
      "r276",
      "r725",
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails",
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r272",
      "r726"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r268",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails",
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r272",
      "r725"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Intangible assets with definite lives, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsEstimatedAmortizationExpensesforIntangibleAssetswithDefiniteLivesDetails",
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r663",
      "r664",
      "r665",
      "r666"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "negatedLabel": "Net foreign exchange loss"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r20",
      "r251",
      "r253",
      "r260",
      "r264",
      "r709",
      "r728"
     ],
     "calculation": {
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      },
      "http://www.coopercos.com/role/AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails": {
       "order": 2.0,
       "parentTag": "coo_BusinessCombinationAndAssetAcquisitionRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Balance, ending",
        "periodStartLabel": "Balance, beginning",
        "terseLabel": "Goodwill (Note 4)",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails",
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.coopercos.com/role/AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails",
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets",
      "http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "verboseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r263",
      "r264",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Valuation of goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for indefinite-lived intangible assets (that is, those intangible assets not subject to amortization). This accounting policy also may address how the entity assesses whether events and circumstances continue to support an indefinite useful life and how the entity assesses and measures impairment of such assets.",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Indefinite-Lived, Policy [Policy Text Block]",
        "terseLabel": "Indefinite-lived Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r258"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "verboseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r113",
      "r252",
      "r257",
      "r263",
      "r264"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill impairment"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails",
      "http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillPeriodIncreaseDecrease": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Period Increase (Decrease)",
        "terseLabel": "Net additions"
       }
      }
     },
     "localname": "GoodwillPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r259",
      "r570"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Measurement period adjustment to goodwill"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r93",
      "r125",
      "r203",
      "r209",
      "r213",
      "r216",
      "r219",
      "r238",
      "r309",
      "r310",
      "r311",
      "r314",
      "r315",
      "r316",
      "r318",
      "r320",
      "r322",
      "r323",
      "r654"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgeFundsMember": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in registered hedge funds.",
        "label": "Hedge Funds [Member]",
        "terseLabel": "Hedging Strategy Funds"
       }
      }
     },
     "localname": "HedgeFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r113",
      "r277"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.",
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Impairment of intangibles"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "auth_ref": [
      "r113",
      "r277"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.",
        "label": "Impairment of Intangible Assets, Finite-Lived",
        "terseLabel": "Impairment of definite-lived intangible assets"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r113",
      "r277"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)",
        "terseLabel": "Impairment of indefinite-lived intangible assets"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Long-lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In-Process Research &amp; Development (IPR&amp;D)"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r127",
      "r561"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r85",
      "r203",
      "r209",
      "r213",
      "r216",
      "r219",
      "r727",
      "r737",
      "r743",
      "r762"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://www.coopercos.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome",
      "http://www.coopercos.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r127",
      "r561"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]",
        "terseLabel": "Income before income taxes:"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r287",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails",
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails",
      "http://www.coopercos.com/role/StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails",
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails",
      "http://www.coopercos.com/role/StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r128",
      "r527",
      "r538",
      "r545",
      "r556",
      "r562",
      "r566",
      "r567",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r129",
      "r154",
      "r155",
      "r201",
      "r525",
      "r557",
      "r564",
      "r763"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "totalLabel": "Provision for income taxes",
        "verboseLabel": "Provision for income taxes (Note 6)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome",
      "http://www.coopercos.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails",
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r79",
      "r521",
      "r522",
      "r538",
      "r539",
      "r544",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r526"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Deferred tax asset step-up"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": {
     "auth_ref": [
      "r520",
      "r526"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount",
        "terseLabel": "Remeasurement of deferred tax assets from UK rate change"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationDispositionOfAssets": {
     "auth_ref": [
      "r526"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to disposition of asset. Includes, but is not limited to, intra-entity transfer of asset other than inventory.",
        "label": "Effective Income Tax Rate Reconciliation, Disposition of Asset, Amount",
        "terseLabel": "Intra-group transfer to UK subsidiary"
       }
      }
     },
     "localname": "IncomeTaxReconciliationDispositionOfAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r526"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Foreign earnings in jurisdictions with lower tax rates"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r526"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Provision for income taxes at United States statutory tax rate"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r526"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount",
        "terseLabel": "Excess tax benefits from share-based compensation"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r526"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings": {
     "auth_ref": [
      "r526"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to repatriation of foreign earnings.",
        "label": "Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount",
        "terseLabel": "Foreign earnings subject to United States tax"
       }
      }
     },
     "localname": "IncomeTaxReconciliationRepatriationOfForeignEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r526"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State tax provision"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesReconciliationbetweentheExpectedProvisionforIncometaxesattheUSFederalStatutoryRateandtheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r110",
      "r117"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Accrued income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Change in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Liabilities",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedTerseLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r161",
      "r162",
      "r163",
      "r172",
      "r466"
     ],
     "calculation": {
      "http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Effect of dilutive stock options (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r275"
     ],
     "calculation": {
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Intangible assets with indefinite lives, net"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r266",
      "r270"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Other intangibles, net (Note 4)",
        "totalLabel": "Total other intangibles, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets",
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r84",
      "r197",
      "r679",
      "r681",
      "r742"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r107",
      "r109",
      "r117"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails",
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InternalUseSoftwarePolicy": {
     "auth_ref": [
      "r279",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.",
        "label": "Internal Use Software, Policy [Policy Text Block]",
        "terseLabel": "Cloud Computing Arrangements"
       }
      }
     },
     "localname": "InternalUseSoftwarePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r41",
      "r248"
     ],
     "calculation": {
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesInventoryDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r12",
      "r47",
      "r709"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesInventoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories (Note 1)",
        "totalLabel": "Inventories, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets",
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r15",
      "r45",
      "r120",
      "r180",
      "r246",
      "r247",
      "r249",
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r43",
      "r248"
     ],
     "calculation": {
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesInventoryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r42",
      "r248"
     ],
     "calculation": {
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesInventoryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandAndLandImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real estate held and assets that are an addition or improvement to real estate held.",
        "label": "Land and Land Improvements [Member]",
        "terseLabel": "Land and improvements"
       }
      }
     },
     "localname": "LandAndLandImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Minimum rental payments required under operating leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r698"
     ],
     "calculation": {
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r698"
     ],
     "calculation": {
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r698"
     ],
     "calculation": {
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r698"
     ],
     "calculation": {
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r698"
     ],
     "calculation": {
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r698"
     ],
     "calculation": {
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r698"
     ],
     "calculation": {
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r698"
     ],
     "calculation": {
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less: interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r52",
      "r125",
      "r211",
      "r238",
      "r309",
      "r310",
      "r311",
      "r314",
      "r315",
      "r316",
      "r318",
      "r320",
      "r322",
      "r323",
      "r606",
      "r610",
      "r611",
      "r654",
      "r707",
      "r708"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r39",
      "r125",
      "r238",
      "r654",
      "r709",
      "r735",
      "r755"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r14",
      "r54",
      "r125",
      "r238",
      "r309",
      "r310",
      "r311",
      "r314",
      "r315",
      "r316",
      "r318",
      "r320",
      "r322",
      "r323",
      "r606",
      "r610",
      "r611",
      "r654",
      "r707",
      "r708",
      "r709"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r5",
      "r6",
      "r8",
      "r9",
      "r10",
      "r282",
      "r288"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current",
        "terseLabel": "Liabilities held-for-sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r28",
      "r733",
      "r747"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit",
        "terseLabel": "Debt outstanding"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Commitment fee percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective interest rate at the end of the reporting period.",
        "label": "Line of Credit Facility, Interest Rate at Period End",
        "terseLabel": "Interest rate"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r50"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "verboseLabel": "Aggregate principal amount"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR)"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Unclassified [Abstract]",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebtAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-Term Debt and Lease Obligation",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets",
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "totalLabel": "Long-term debt, excluding financing leases"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermLineOfCredit": {
     "auth_ref": [
      "r55",
      "r306",
      "r307"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit, Noncurrent",
        "verboseLabel": "Debt outstanding"
       }
      }
     },
     "localname": "LongTermLineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r55",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermDebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.",
        "label": "Long-Term Debt, Weighted Average Interest Rate, at Point in Time",
        "terseLabel": "Weighted average interest rate"
       }
      }
     },
     "localname": "LongtermDebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "verboseLabel": "Machinery and equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MediumTermNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instruments with maturities ranging from five to ten years.",
        "label": "Medium-term Notes [Member]",
        "terseLabel": "Term loans"
       }
      }
     },
     "localname": "MediumTermNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r60",
      "r125",
      "r238",
      "r309",
      "r314",
      "r315",
      "r316",
      "r322",
      "r323",
      "r654",
      "r734",
      "r754"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r108",
      "r111",
      "r114"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r10",
      "r74",
      "r77",
      "r82",
      "r86",
      "r114",
      "r125",
      "r144",
      "r148",
      "r149",
      "r150",
      "r151",
      "r154",
      "r155",
      "r168",
      "r203",
      "r209",
      "r213",
      "r216",
      "r219",
      "r238",
      "r309",
      "r310",
      "r311",
      "r314",
      "r315",
      "r316",
      "r318",
      "r320",
      "r322",
      "r323",
      "r645",
      "r654",
      "r738",
      "r758"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome",
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r148",
      "r149",
      "r150",
      "r151",
      "r157",
      "r158",
      "r169",
      "r172",
      "r203",
      "r209",
      "r213",
      "r216",
      "r219"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Net income, basic"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r159",
      "r164",
      "r165",
      "r166",
      "r167",
      "r169",
      "r172"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "terseLabel": "Net income, diluted"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Accounting Pronouncements Recently Adopted and Accounting Pronouncements Issued Not Yet Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r140",
      "r141",
      "r142",
      "r373",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r97"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "negatedLabel": "Other expense (income), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfInterestRateDerivativesHeld": {
     "auth_ref": [
      "r615",
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of interest rate derivative instruments held by the entity at the reporting date.",
        "label": "Number of Interest Rate Derivatives Held",
        "terseLabel": "Number of interest rate swap contracts held"
       }
      }
     },
     "localname": "NumberOfInterestRateDerivativesHeld",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportingUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.",
        "label": "Number of Reporting Units",
        "terseLabel": "Number of reporting units"
       }
      }
     },
     "localname": "NumberOfReportingUnits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r203",
      "r209",
      "r213",
      "r216",
      "r219"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating income (loss)",
        "totalLabel": "Operating income",
        "verboseLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
      "http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails",
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r693",
      "r699"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r688"
     ],
     "calculation": {
      "http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "totalLabel": "Total operating lease liabilities",
        "verboseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails",
      "http://www.coopercos.com/role/OperatingLeasesMinimumRentalPaymentsRequiredUnderOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r688"
     ],
     "calculation": {
      "http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "verboseLabel": "Operating lease liabilities, current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r688"
     ],
     "calculation": {
      "http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "verboseLabel": "Operating lease liabilities, non-current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.",
        "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r690",
      "r694"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r687"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "terseLabel": "Non-cash operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.",
        "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r697",
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r696",
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term (in years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OperatingLeasesLeasesontheConsolidatedCondensedBalanceSheetDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r546"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r208",
      "r209",
      "r210",
      "r211",
      "r213",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTax": {
     "auth_ref": [
      "r80",
      "r81",
      "r87",
      "r236",
      "r668",
      "r673",
      "r674",
      "r739",
      "r759"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Tax",
        "terseLabel": "Gross change in value"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r64",
      "r68"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Cash flow hedges, net of tax of $26.1, $8.2 and $(4.1), respectively"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": {
     "auth_ref": [
      "r69"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax",
        "terseLabel": "Cash flow hedges, tax provision (benefit)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r64",
      "r68"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Amount recognized in other comprehensive income on interest rate swaps contracts, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r64",
      "r68",
      "r621",
      "r623",
      "r631"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Amount recognized in other comprehensive income on interest rate swap contracts, gross"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r68",
      "r72"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedTerseLabel": "Amount reclassified from other comprehensive income into earnings, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r68",
      "r72",
      "r624"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "negatedLabel": "Amount reclassified from other comprehensive income into earnings, gross",
        "negatedTerseLabel": "Loss recognized on derivatives within interest expense"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingDerivativeInstrumentsRecognizedinCondensedConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r75",
      "r78",
      "r80",
      "r81",
      "r83",
      "r87",
      "r372",
      "r668",
      "r673",
      "r674",
      "r739",
      "r759"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income (loss), net of tax",
        "totalLabel": "Other comprehensive (loss) income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive (loss) income:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax": {
     "auth_ref": [
      "r66",
      "r68"
     ],
     "calculation": {
      "http://www.coopercos.com/role/EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment and Tax",
        "terseLabel": "Net (gain) loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax": {
     "auth_ref": [
      "r66",
      "r68",
      "r425",
      "r451"
     ],
     "calculation": {
      "http://www.coopercos.com/role/EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax",
        "totalLabel": "Total recognized in other comprehensive (income) loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r66",
      "r68"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTerseLabel": "Change in minimum pension liability, net of tax of $8.7, $7.2 and $(4.0), respectively"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax": {
     "auth_ref": [
      "r66",
      "r69",
      "r604"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax",
        "negatedTerseLabel": "Change in minimum pension liability, tax provision (benefit)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax": {
     "auth_ref": [
      "r68",
      "r72",
      "r73",
      "r425"
     ],
     "calculation": {
      "http://www.coopercos.com/role/EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net period benefit cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, before Tax",
        "negatedTerseLabel": "Amortizations of net gain"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsOtherChangesinPlanAssetsandBenefitObligationsRecognizedinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTax": {
     "auth_ref": [
      "r69",
      "r80",
      "r87",
      "r525",
      "r563",
      "r565",
      "r668",
      "r671",
      "r674",
      "r739",
      "r759"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Tax",
        "negatedTerseLabel": "Tax effect"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherDepreciationAndAmortization": {
     "auth_ref": [
      "r95",
      "r113",
      "r283"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.",
        "label": "Other Depreciation and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "OtherDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r53",
      "r709"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedLabel": "Other (income) expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "negatedTerseLabel": "Settlement of contingent consideration"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividends on common stock"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedTerseLabel": "Payments related to share-based compensation awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r100",
      "r594"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Payments to acquire business"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r100"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "terseLabel": "Payments to form joint venture"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property, plant and equipment",
        "verboseLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r410",
      "r412",
      "r418",
      "r431",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r451",
      "r453",
      "r454",
      "r456",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Employee Benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefits"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Units"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "auth_ref": [
      "r410",
      "r411",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r432",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]"
       }
      }
     },
     "localname": "PlanAssetCategoriesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsFairValueMeasurementofPlanAssetsDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.coopercos.com/role/EmployeeBenefitsWeightedAverageAssetAllocationsbyAssetCategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r468",
      "r469",
      "r470",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r489",
      "r490",
      "r492",
      "r493",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r468",
      "r469",
      "r470",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r489",
      "r490",
      "r492",
      "r493",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r32",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r32",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r32",
      "r709"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $10 cents par value, 1.0 shares authorized, zero shares issued or outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expense and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the deconsolidation of a previously consolidated subsidiary or the sale of investment in consolidated subsidiaries (generally greater than 50 percent).",
        "label": "Proceeds from Divestiture of Interest in Consolidated Subsidiaries",
        "terseLabel": "Proceeds from sale of interest in a subsidiary"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails",
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "terseLabel": "Proceeds from long-term debt, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r102",
      "r509"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds related to share-based compensation awards"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLongTermLinesOfCredit": {
     "auth_ref": [
      "r103"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Proceeds from Long-Term Lines of Credit",
        "terseLabel": "Proceeds from line of credit"
       }
      }
     },
     "localname": "ProceedsFromLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from (Repayments of) Short-Term Debt",
        "terseLabel": "Net proceeds from (repayments of) short-term debt, other"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockPlans": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period.",
        "label": "Proceeds from Stock Plans",
        "terseLabel": "Issuance of common stock for employee stock purchase plan"
       }
      }
     },
     "localname": "ProceedsFromStockPlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r286",
      "r692"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Property, plant and equipment, net",
        "verboseLabel": "Long-lived assets"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails",
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets",
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails",
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r18",
      "r284"
     ],
     "calculation": {
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "verboseLabel": "Property, plant and equipment, at cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails",
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r286",
      "r709",
      "r744",
      "r756"
     ],
     "calculation": {
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r286",
      "r787",
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails",
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property, plant and equipment, useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r208",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Schedule of business segment net sales"
       }
      }
     },
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesChangesinUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedLabel": "Repayments of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfShortTermDebt": {
     "auth_ref": [
      "r105"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Repayments of Short-Term Debt",
        "terseLabel": "Repayments of short-term debt"
       }
      }
     },
     "localname": "RepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r518",
      "r723",
      "r800"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r16",
      "r115",
      "r118"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Current",
        "terseLabel": "Restricted cash included in other current assets"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails",
      "http://www.coopercos.com/role/StockPlansNarrativeDetails",
      "http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r291",
      "r293",
      "r294",
      "r295"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "terseLabel": "Total exit costs expected"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r35",
      "r373",
      "r709",
      "r753",
      "r775",
      "r780"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r140",
      "r141",
      "r142",
      "r145",
      "r153",
      "r155",
      "r242",
      "r510",
      "r511",
      "r512",
      "r554",
      "r555",
      "r643",
      "r771",
      "r773"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r194",
      "r195",
      "r208",
      "r214",
      "r215",
      "r222",
      "r223",
      "r226",
      "r389",
      "r390",
      "r724"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "negatedTerseLabel": "Net sales",
        "terseLabel": "Net sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails",
      "http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails",
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r121",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r695",
      "r699"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Operating lease ROU assets obtained in exchange for lease obligations"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r71",
      "r673",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Changes in accumulated other comprehensive (loss) income"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingTables",
      "http://www.coopercos.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.",
        "label": "Schedule of Allocation of Plan Assets [Table Text Block]",
        "terseLabel": "Weighted-average asset allocations and fair value measurement of plan assets"
       }
      }
     },
     "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.",
        "label": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Other changes in plan assets and benefit obligations recognized in other comprehensive income"
       }
      }
     },
     "localname": "ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Stock options to purchase common stock and restricted stock units not included in diluted earnings per share calculation due to antidilutive effect"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": {
     "auth_ref": [
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions [Table Text Block]",
        "terseLabel": "Weighted-average assumptions used in computing net periodic pension cost and projected benefit obligation"
       }
      }
     },
     "localname": "ScheduleOfAssumptionsUsedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r576",
      "r577",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails",
      "http://www.coopercos.com/role/AcquisitionsandJointVentureProformaInformationDetails",
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for cash flow hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.",
        "label": "Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]",
        "terseLabel": "Derivative instruments recognized in condensed consolidated statements of income"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Deferred tax assets and liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r438",
      "r439",
      "r442",
      "r443",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of earnings per share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation between the expected provision for income taxes at the US federal statutory rate and the provision for income taxes"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r502",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Compensation expense and related income tax benefit for share-based awards"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.",
        "label": "Schedule of Expected Benefit Payments [Table Text Block]",
        "terseLabel": "Estimated future benefit payments"
       }
      }
     },
     "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r268",
      "r271",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r268",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of finite-lived intangible assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails",
      "http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Income before income taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r275",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of indefinite-lived intangible assets"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r15",
      "r44",
      "r45",
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of inventory"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Components of net periodic pension costs and other amounts recognized in other comprehensive income"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts related to pension plans and/or other employee benefit plans in accumulated other comprehensive income or loss that have not yet been recognized as components of net periodic benefit cost, such as the net gain (loss), net prior service cost or credit, and net transition asset or obligation.",
        "label": "Schedule of Net Periodic Benefit Cost Not yet Recognized [Table Text Block]",
        "terseLabel": "Amounts recognized in accumulated other comprehensive Income"
       }
      }
     },
     "localname": "ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "terseLabel": "Schedule of non-vested RSUs"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails",
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of recognized identified assets acquired and liabilities assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "auth_ref": [
      "r92",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]",
        "terseLabel": "Schedule of information by geographical area by country of domicile"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r203",
      "r206",
      "r212",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails",
      "http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r203",
      "r206",
      "r212",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "verboseLabel": "Schedule of business segment information"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r463",
      "r465",
      "r468",
      "r469",
      "r470",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r489",
      "r490",
      "r492",
      "r493",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails",
      "http://www.coopercos.com/role/StockPlansNarrativeDetails",
      "http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails",
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r472",
      "r488",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of stock option plans"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Assumptions used in estimating fair value of stock options award granted"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": {
     "auth_ref": [
      "r374",
      "r375",
      "r376",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table Text Block]",
        "terseLabel": "Schedule of share repurchases"
       }
      }
     },
     "localname": "ScheduleOfTreasuryStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r537",
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Changes in unrecognized tax benefits"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r190",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r208",
      "r209",
      "r210",
      "r211",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r219",
      "r226",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r264",
      "r293",
      "r295",
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails",
      "http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails",
      "http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r190",
      "r192",
      "r193",
      "r203",
      "r207",
      "r213",
      "r217",
      "r218",
      "r219",
      "r220",
      "r222",
      "r225",
      "r226",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Business Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails",
      "http://www.coopercos.com/role/BusinessSegmentInformationInformationbyGeographicalAreabyCountryofDomicileDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative expense"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, general and administrative expense"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails",
      "http://www.coopercos.com/role/StockPlansCompensationExpenseandRelatedIncomeTaxBenefitforShareBasedAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited or expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited or exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r482",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Nonvested RSUs, ending balance (in shares)",
        "periodStartLabel": "Nonvested RSUs, beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r482",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Non-vested RSUs, ending balance (in dollars per share)",
        "periodStartLabel": "Non-vested RSUs, beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted- Average Grant\u00a0Date\u00a0Fair Value\u00a0Per\u00a0Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested and issued (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested and issued (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails",
      "http://www.coopercos.com/role/StockPlansNarrativeDetails",
      "http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails",
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]",
        "terseLabel": "Number\u00a0of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of shares authorized to be granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares remaining for future grant (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Vested and exercisable at end of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Vested and exercisable at end of period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r490"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Total intrinsic value of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedTerseLabel": "Forfeited or expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited or expired (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)",
        "verboseLabel": "Options granted in period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails",
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average fair value of each option granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r473",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding, ending balance (in shares)",
        "periodStartLabel": "Outstanding, beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r473",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding, ending balance (in dollars per share)",
        "periodStartLabel": "Outstanding, beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted- Average Exercise\u00a0Price Per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r492"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Vested and expected to vest at end of period, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Vested and expected to vest at end of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Vested and expected to vest at end of period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period",
        "terseLabel": "Number of shares issued to employees"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r468",
      "r469",
      "r470",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r489",
      "r490",
      "r492",
      "r493",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails",
      "http://www.coopercos.com/role/StockPlansNarrativeDetails",
      "http://www.coopercos.com/role/StockPlansNonVestedRSUsDetails",
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r471",
      "r494",
      "r495",
      "r496",
      "r497",
      "r500",
      "r513",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "terseLabel": "Range of exercise prices, lower limit (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit",
        "terseLabel": "Range of exercise prices, higher limit (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/EarningsPerShareStockOptionstoPurchaseCommonStockandRestrictedStockUnitsNotIncludedinDilutedEarningsPerShareDuetoAntidilutiveEffectDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Award expiration date (no more than)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansAssumptionsUsedinEstimatingFairValueofStockOptionsAwardGrantedDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r508"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Vested and exercisable at end of period, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Vested and exercisable at end of period, Weighted-Average Remaining Contractual Term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Outstanding, ending balance, Weighted Average Remaining Contractual Term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Vested and expected to vest at end of period, Weighted-Average Remaining Contractual Term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Exercise price percentage of fair market value on date of grant of awards"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r24",
      "r709",
      "r730",
      "r751"
     ],
     "calculation": {
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails": {
       "order": 1.0,
       "parentTag": "coo_ShortTermDebtNetOfDebtIssuanceCosts",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-Term Debt",
        "terseLabel": "Short-term debt"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermBorrowingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt [Abstract]",
        "terseLabel": "Short-term Debt"
       }
      }
     },
     "localname": "ShortTermBorrowingsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-Term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-Term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails",
      "http://www.coopercos.com/role/FinancingArrangementsTotalDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit": {
     "auth_ref": [
      "r529"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date.",
        "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit",
        "terseLabel": "Significant change in unrecognized tax benefits that is reasonably possible during the next twelve months"
       }
      }
     },
     "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r7",
      "r190",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r208",
      "r209",
      "r210",
      "r211",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r219",
      "r226",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r264",
      "r289",
      "r293",
      "r295",
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
      "http://www.coopercos.com/role/BusinessSegmentInformationBusinessSegmentNetSalesDetails",
      "http://www.coopercos.com/role/IntangibleAssetsGoodwillDetails",
      "http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r58",
      "r80",
      "r81",
      "r82",
      "r140",
      "r141",
      "r142",
      "r145",
      "r153",
      "r155",
      "r181",
      "r242",
      "r372",
      "r373",
      "r510",
      "r511",
      "r512",
      "r554",
      "r555",
      "r643",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r674",
      "r706",
      "r771",
      "r772",
      "r773"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails",
      "http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r140",
      "r141",
      "r142",
      "r181",
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r32",
      "r33",
      "r372",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of common stock for stock plans, net and employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r32",
      "r33",
      "r372",
      "r373",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockPlansStockOptionPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r32",
      "r33",
      "r372",
      "r373"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common stock for stock plans, net and employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Share repurchase program, maximum amount authorized"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Share repurchase program, remaining authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r33",
      "r37",
      "r38",
      "r125",
      "r231",
      "r238",
      "r654",
      "r709"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Cooper stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r2",
      "r3",
      "r81",
      "r125",
      "r140",
      "r141",
      "r142",
      "r145",
      "r153",
      "r238",
      "r242",
      "r373",
      "r510",
      "r511",
      "r512",
      "r554",
      "r555",
      "r602",
      "r603",
      "r612",
      "r643",
      "r654",
      "r668",
      "r669",
      "r674",
      "r706",
      "r772",
      "r773"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Stockholders\u2019 equity (Note 8)"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets",
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.coopercos.com/role/FinancialDerivativesandHedgingChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.coopercos.com/role/StockholdersEquityChangesinAccumulatedOtherComprehensiveIncomeLossIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r123",
      "r359",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r373",
      "r378",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "verboseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityPolicyTextBlock": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.",
        "label": "Stockholders' Equity, Policy [Policy Text Block]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "StockholdersEquityPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r675",
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r675",
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r675",
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosures of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails",
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/AcquisitionsandJointVentureNarrativeDetails",
      "http://www.coopercos.com/role/AcquisitionsandJointVentureRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.coopercos.com/role/AcquisitionsandJointVentureTotalPurchaseConsiderationforBusinessandAssetAcquisitionsDetails",
      "http://www.coopercos.com/role/IntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "verboseLabel": "Average repurchase price per share (in dollars per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/StockholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockCommonMember": {
     "auth_ref": [
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockCommonMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "periodEndLabel": "Treasury stock, ending balance (in shares)",
        "periodStartLabel": "Treasury stock, beginning balance (in shares)",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockCommonValue": {
     "auth_ref": [
      "r59",
      "r374",
      "r377"
     ],
     "calculation": {
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Value",
        "negatedLabel": "Treasury stock at cost: 4.5 shares at October\u00a031, 2022 and 4.4 shares at October\u00a031, 2021"
       }
      }
     },
     "localname": "TreasuryStockCommonValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r33",
      "r372",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Number of shares",
        "verboseLabel": "Treasury stock repurchase (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.coopercos.com/role/StockholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r372",
      "r373",
      "r374"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedTerseLabel": "Treasury stock repurchase",
        "terseLabel": "Total costs of shares repurchased (in millions)"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.coopercos.com/role/StockholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r519",
      "r531"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "End of the period",
        "periodStartLabel": "Beginning of the period",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesChangesinUnrecognizedTaxBenefitsDetails",
      "http://www.coopercos.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r532"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedTerseLabel": "Decrease based on tax positions in prior fiscal years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesChangesinUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r534"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedTerseLabel": "Settlements"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesChangesinUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r528"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Accrued gross interest and penalties related to uncertain tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r533"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Increase based on tax positions in current fiscal year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesChangesinUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r535"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedTerseLabel": "Lapses of statutes of limitations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesChangesinUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r536"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "verboseLabel": "Unrecognized tax benefits that would impact the effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": {
     "auth_ref": [
      "r132",
      "r133",
      "r134",
      "r136",
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward.",
        "label": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset"
       }
      }
     },
     "localname": "ValuationAllowanceOfDeferredTaxAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ScheduleIIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r132",
      "r137"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Balance at End of Year",
        "periodStartLabel": "Balance Beginning of Year"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ScheduleIIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r135"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ScheduleIIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r136"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "negatedLabel": "Reductions/ Charges"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ScheduleIIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r132",
      "r133",
      "r134",
      "r136",
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ScheduleIIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r132",
      "r133",
      "r134",
      "r136",
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ScheduleIIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r159",
      "r172"
     ],
     "calculation": {
      "http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted weighted average common shares (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome",
      "http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Number of shares used to compute earnings per share:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r157",
      "r172"
     ],
     "calculation": {
      "http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average common shares (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.coopercos.com/role/ConsolidatedStatementsofIncome",
      "http://www.coopercos.com/role/EarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 9
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e777-108305"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33775-111570"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905575&loc=SL49131251-203054"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144439"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(21))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "40",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=118172244&loc=d3e17916-109280"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=16397303&loc=d3e19379-109286"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2473-110228"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=d3e1314-112600"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=d3e1336-112600"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21459-112644"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130611-203046-203046"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(b)(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32059-109318"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e39076-109324"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e7008-128479"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "740",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966508&loc=d3e9972-128506"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "740",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966508&loc=d3e9979-128506"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28228-110885"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r801": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r802": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r803": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r804": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r805": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r806": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r807": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r808": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r809": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r810": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "11",
   "Subsection": "03"
  },
  "r811": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r812": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r813": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column B",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r814": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column C",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r815": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column D",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r816": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column E",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r817": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column F",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r818": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column G",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r819": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column H",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r820": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column I",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r821": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09"
  },
  "r822": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "01"
  },
  "r823": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "02"
  },
  "r824": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(ii)",
   "Subsection": "01"
  },
  "r825": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)",
   "Subsection": "01"
  },
  "r826": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "01"
  },
  "r827": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "02"
  },
  "r828": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "01"
  },
  "r829": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "02"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r830": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(C)",
   "Subsection": "02"
  },
  "r831": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "01"
  },
  "r832": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "02"
  },
  "r833": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>118
<FILENAME>0000711404-22-000053-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000711404-22-000053-xbrl.zip
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MBEWA&/0M!ZXJ5L&8H'1L CVE2BY[5M$9IUSEF]OZL+:VV+5LV(C #K1#G7R
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M^(.=GDF7Y1^Z,F-<R%Z+7\#B)0 GAS%1U&"R>'HNVMCI&7,S8"QN9M3D72J
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MLCN3%^M,IB4Y:$J<>_:>/&80F11;DK8E6Y)37G/W';1;2J;EA!HY(C(8PS4
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M;()C"ZU&6*G5=6"):"/*/[,%EI3G"XE*#B9Y,J MQ5P"!!M\BL@*J -,VBB
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M/CQR8=SMH##^9;)VS9^O5]PR*TZM4$F^]71^!K[L_UI\^?,UQDG)Z-([NTE
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M[2ZL5,4KX48S#@%;#/$')2];1YCN)LD5E?8HS([],34H:JJ35$Z^PM\UBAC
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M$V(L R:M-PF%74GF'H"VX>'*V"CGS;8V1GU"RPK?Z'%8U7^J<QA<O>V:I,^
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MLF_,\((AEN.@D1VAH)]J60<VXJ[I]K3!:H]M\!HKVHR9T-;S;4X07:LGIPR
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M41:W[F/;M?XLBY(-KA-DR,X"\+%CER1MT(;YWZYGNQ8ZA#U;.W\8=8A]JZ2
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MG;+& $OR%U?"!AZ7V?[AR\9B@C.%@I*Z_"Y$A/P\'A'G%]H_K/N=T&9MN#[
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M<'15-]9<+F0YN"?[J\D) PH(2Z%O9>2C6)4 P^+*2-Y.%QO+CQ+Q9?A,B:&
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MD_Y@Z:T2!-7H>1B!"^NV&8]^Q)3:CU(6I:KA\>BGV&(6+.+<1BQU<)LFD)H
M2<.45*?0+IV1->A$AH>QJ'C-PMV@3AR%_"B#Y"6_LK&N*<Q.3H<N:W3C&:&>
M]+XOB)ML&8F1D_0ET"&Y-+VE(5B\@==MX'654E[=XBRRPO?0/@OO'?T +@81
M=EH6NYNPAD0'Q9QZ2>]^AT 4*_W;A[4VK47AYVA9SC=_^^S+L(M8YJFH'?.W
MHT=?_S-J-<.;E1B4+_]EQ#WA&9YDH_/H\^,O.1RS"N='L'K7TK[(/:;.OA>4
M"4<QL^VN33CJ(5IF<%>&[C S'SXS/J"GPS(8]^\&^&:4]3 [3,K'WBZD-^#0
M=WOSZ!9(NERK=M[GOLSRVA1N^FVYU"VY+)?]SQ_F]\^<WQ0D[6#^1,7<O,^]
M\CBFZS/OUTWV3]2_'U;FZT,CZ_V#O1SLR1\Z+Q;*IZ#5G>ZB:,N<ET72VIW2
MJTQ*24J$(T697* RW'K2%=\8@=*J-LP>SOR/-H<MXQ.!MQO=%_/F:69[\P@(
M,24'7VV[#O_]MBU^5PU&R7@Y*HY:W;T9 [H0AZ^ II6/;2Y >#3.: K+-2EM
MQJ-MK5>1T!Y\Q]N:8U05;1XPPWFLRR4+2S<L*TF%C?-(#RBD93E;.( .HGE]
M\<.R^U/]?W4@(M45J5Q\8 VW!'UYDKIB6["D9C6BKU;F&G"Z0K@VGZ.SRN('
M4@NB62MB#OPRZ$?G^OW@!\6T.%W="RR-TJ6&X>M:A5O)"9N9YIB[:5BBDL39
MIOJ-TN*5 &.GG-UA.7TDSY:'#GC$J@C5]UJ;>7)U62Y 'L<O5(2>IW9K-1UN
MY9GIPUP;<NBT83OUZ&7L%#N9;F0Y/&UFLZ/OVJ)^,_H5!97S30O\R*N2C=!2
MWE2)UY>)4BY^_>=_!&M:3=#:S=_E3Y[WJ4EQ6UHCEP6ZEL]^'OWT])6D!G\>
M/?OEZ:O#BOL8!BQ5=U$L87X"32)P68IK&HSI]71)ZJG"?]HAWPX3\Z=.3%$M
M46HDL";Q"=)6/RU1Q#/2AU-5I7;>BKHH?^7ITFZ.RK?L48IGB<!]D'J2,EJ=
M%!C6X>A8;@Z)PC]Y.@6#L\S19 D!Z<!:NJ-2Q"%*%Q"\U63417&I!'/#L#Q7
M N#%@'5/EPMS+$X*?,_+IK62YD IZ; $_LPE4 .OB2-/*4]8BY?,(\!@H.X$
MJ4G35MW*JO\)'S,$>07SSK)"2C.5QWU5+BXV![/)UQW+U"*Z#H(5S7R.U3@H
M%>&LM (Z"/!=YM,*9N.]^>U;ZH+38NVX58 :*K9=K!W'-U<N+ ^@2-H A[7Y
M)[H!&79DUJRUXAXY:O-XH^%Z"P\)A+F@1W;]-08ZQ1OK]2@T?A4<H<>!SMC9
MB(^'J9)_WX((%6 (,S7-&B<<V-T5_6Y/&58:@:J$4@LB)0%")%U<VDFZ;C9"
MK"(\F=Q;MFZ+U:1:D,D)8(>CB;JT?8_U8#(_4CR4,OO%HBU='Z_"CF6A&N X
M4:1F>7[&2=;E3YFQPW3]B=.UK16?X!!P<"GC<0/(G/*W:>XA^24T" GM6?<V
M?0PY_AKK<TV63\7.GFROLX/IGH"$.G8).I"(('=R8Y=ZBN0LE X/XDMFY9H0
M7G0*$12 \& \4,Z$Z0*)GE+,.[87Y476?&&*)+3QL5=F<]Q..["3X]$/S148
M=<9YWZ%!*Q7:-01:W8\8P]M%*I2-#<*=!X4-P^9>*XYS4FZNL%<DZ<Q!5USG
M38/T?PG,>5_[S>B[<M)"7&/T^'-C(9<!JD?(E!/DR5.["XM]6T])+IC^)/[%
M+D8VF _\-(L'NWFCYAAKW"78]X1.%:(''$+@]1";9-B[S12'2V0%T=:A^"CQ
M3F"0$$*Y;1TL%J!TC+KD^,),&_XUQ]3%UD&M0:1@P'LX_CNNXTT2B*MF)K1'
ML2U$O6A03E!?.Y$&C7T,H(F!K-NI#V+.O/3Q.X05P@,:WF.]W4@H*K^9%&U;
M,2)RZ-ZI916;U(Z46?P,F-Q'#CL*2[%UW1IFY;[0%9J-0'>0 JG]/(=KJQ]M
MH&LI)*24OV!$K>]S789W^+DV9J?1S_\8CTZ#Q9\5X]%Y,.F_E^V21O;O(2+3
M'B99=.F -A+.6",KPV&SU9K!:1M>OZ (A)0+XNYC1:$Y MEF>+JGP&EW;T8O
M2;&O76OHG1;^F-27GK[RXS:LB9N^$K="5HOK#@#%?YKC-UDVPK^:UJ6MEBZ:
MR%*<$S92!%?BJ+FJ%>/, "KX)&;GD]W!):J-4.".'NC:J%HOJ]26J^82*DX&
MYST/AJ=4,KY?HX0L4;)H@7!";:^A:1)LY+96%LN8[)80X:'V3XBK:D]G!S ,
MD+V=M?+U8-'I1?CHM'7&"+N[-0^QXS]I3=I,8E+4BE4\/\*05[-MC]45$V7?
M>!D.2W)=C]4\ZID7_A8Y-9 5H9?LJJV)KKJ3! <A^N3%V'%NX,%<,H]Q2')]
MG!41-JR,>CQ,4AE,\;L(8]M+(@RCBY$@]"0-13B#;$):7M+^@DI+VNYYM9Y9
M*&MBKE7Q)>4RK&V_V>4A(,2CD*\9J-N6CE1Y#@F-/WW%E/5%07Z,?@$MS6^:
M_@U.-T:CO<6ET\-3,!+QPDTFYH+.*[CGEKD: YZ-_I?A/VI]"FOHM9_"96&S
MCI#]KY#8@HH<EES9JJ0WF_/8%R>&"2U_"D\!]0;^K"^H$N"RWCZAI;)<J<+<
ME.*SK&>XH=%VQJ=$$@;;C%:.'JE[AAS_$M\G\^.M'8]C%O$LW!SP=2^J266$
MC?)UEJJW;[?MM8YG> 074:M]OQ]>_[.:C=I+%1ZU\PKPK3PWDAN=HHO\E)[G
M50.OW\L8]W%(PW&F8>*0QY6Q%T3KX\_ 0N3<A&Z$1-0:>62\M78)71GIP8H*
M0B*4,E3+J&=LB*?GH.&B(%?/'/.IU"32T;,@Q.YM)K'MZ]VU83X*N0G7?MW4
M1_8FRL\_AF&MXR[GCG*B"5;BJF?Q;KVNX9P9Q#^"9 ^Z2GM$J, 97F,60N@2
M+H $+9C"U':5YC:$<KJ2E=L1;$L7C--X'%P[#BU7X*W=KR\T=3:83L+'M.U?
MWN5Z/!3S:YY 0W]UV!E_QRQNJX%_$J%D;09KN9<TT)'4VZ;.YY0+>?^LU_A]
MTE[_OH#^;PZ _OL#Z/]7,9SYDL-JVY'A)W4D&RI10(8"2P1C$0E[<X/8=X]0
M'?6PQ.%R<C$+2ZL"/$)S UJBS?):/0#4ZY9GRW5TN%Y0.AE_,GCC20C7-V#I
MY6$TWG<E-NWN_:L!K<:^S_>Y>O/GAF$\#89X6BU]#BU8E?(2IV**"''2IG/T
M>/1LCAH0N@WFHGS98."AWE,URXC!Y4.E(6W:GF.JH,EJHZ8T8;Q\FW[$>R6P
M%Y,ERN<PUPJ\AL(4[-2^\? 1MD"34"I6CI*RT28_[&(.GM=U3IFHX1#HL>GV
MTKBDM9$5PHP&:^RU0^M,?>)U V!I.8YBI$  >+X[5*9B[_4@V*2JYVT1&3\B
M,Q=\H1WR?D)73!5#%2CH@*G+E8.RQ">(Q0%D> G=@8LM4L*S:GX]@.1R YA7
M#9SSP"^;)DOZ$F<M<OBS F$:T N27!/1X^H9DGW&2H@3%*%I&"W.^  X35XN
M&#PC6/$0<GRY5Z@9I^4\CIY,DCP81["ROKS Y:7B-^SHZ<: 2Q<;/V63I))'
M\NK2&C-XUJ)P[*@)!Z75& _(BH0TWO%-L^/1))(9='LPK?E=)RPR.R1R6S+.
MC[:U,,R*?A5'-!A_X4WD.+ER5F2C6Q5XN&MK-N!=YUEU-_'@&OEJ)[FJNQ8T
M[6<A&6;(3>R:0^QW-LJ#WPV^;=%=C.;&"SQ4:WU' E[=-4+7,+9S3*=\MPE9
MCL@EB^T# +Y[$LF^'FRPOJ! 3R3B2^Q-'M$E,LG3>,;@4#7P@WR@4)1Z+^9,
MQ<^Q(Y61[PQ!(>&^Z.185UA47>];M.P5!B:9T:%G-)IO6\\0FJ*9NB3S4L%T
MQ]H:TO?@VG9.03:TC6]8J$FHVVR8YTW<3S@Y-O' O)DL<4Z>#+2YK8CP6$OL
M)](-N)'Q5PKI'"\>G#M&[_@2)=*6X6'FL2@]ARP7R\XBY!@F>,E(6\H]\V(:
M4:)F^$M+EXZ%W'597",R!X8TS#T*A^OPUCB&H)W$./9MH4HWU+(7Y;29/GL3
MW (C->Y38MGDCW5FPDNG#@CBEFAIVK*!+.!,^/W,VY##"M2:NT^4&"#%"(FU
ML$\[M"T3.$;:>,_9$5\W>BC31QAF8H!&:45B3<88P;M74$!PR[3!2/U(PR6Y
M8HM-7S?^9]GWR)Z#4#DK2._"3\<.3^T(?I#4NGV&M>DT]9?JSKCF?L'Z'=@@
MNA>'E^ [;8HG T"9/BEI!NSNO<,P'=MMX'!C5I4'SS\-Y/C46L;"W,V"QRA$
M'8 8HN5MB5[;\.3I?O!VI'?./A,QAV&W5FWY9'05'-ORJ$'*&1XQ4CO!.3*^
MS?C%,>FBUQ(81BYHQIA/,A<1?14^B2Z$=E%@KBVN'*LE$VL<L!X/\*1MP@OF
M /@!DBV#M=(6QD"FIXR;$:SMG,7*LG45'V1=K4O2_@=+$-958Y&CZRV<AC"$
M:J'PF]?@IBVD7347B'PB.WY&PQ8?$)9[7LC^C.5WW0.;*(?C@+V8T [%4Z2%
M(2[T_F?9$P$+>5RD[).E$!F.=SBS4RAO^FKASHE ^^J"!,,,^ZA=K')&#)56
MHA>UP8F_>V??V^5M4'@!DSJFG!]IRB/P^8G8+'J4LM^WNC$$HE:U/8)+D6"Z
M+P>$.QT:7:_#Q\1MOK)?U2FO\,$'@@/;8IYU_+6IGQ-C1SH\@ CY4T\T&'XC
M*1 5/@G#<3,"8P#*4QZYJ,*AZ:I;#A3I%S/6>R$!&Z?(6PZ0<&ZIR*AW:7!+
M9GN?B*\XU9(+,AZW74=8GB,0YPH^$-C!BTL[Q>32.VB*1&+,2PIIF19=BGJ
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M)VQV73:YQ^,LW&4%F[]&(C7YGZU83M :@!'TN(_XR\:E_\( _<<SM_<:[_K
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MEW8Z!7.8^J?$ ?.Q43D>MXM$4DG(;R6%08YBA2PDH.$F]]$IF B[O:@%P8%
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MR5]OT#J0XP1>$NP:\ C'R[BS_6*FJ0T?OTI53$#HJ(IT1JL*";X(U:KT7I3
MU64N)H64N2I'9=46Z'L)09U=6U8QD"QXNW8&>@4(;W!?NXV_:E]SM5!M!^F1
MC46FM1O1]JUY:+QA\11I-5OZF)7U:!=Y@N -#D#M<P1V7BT,98/IOUC'J7-
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M'N#&CZ+7KO6_GR0-ZM(@Q :? ['V*!-$]:M1")-G($ 3="'R3*W[=B%S^+[
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M8@X41&?-2'D&7^RY!WRQ>CN\MI-?,WJQ%K5G'M;Q#BB87RG++, R]$<<%%[
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MV/)1>$KY,"2Z)-@>N<*NO-;3U.9KP+85XE^S/8<B6<$$T'9&"'L :AM"O_G
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MA3ZT(R3.JMUU< 8;"E]IWYAVBMR#T!TW<7W&>!R)F>PNJ>V+3$V*+K[4=P6
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MIKX%NMHEWT5^(P,KVZWC[6Y3G(IJJS4]O\MUNZ=QH2U?QAFZ!RQTSFB$8R3
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MAIN$3'!6DD0K5 V>\/6PHI W;))2D]*%\?_IMIA@S-1Y",%H/6Q^K7U@3&S
MB4KJGL#8( #>8S(X?H2QU,]WV?ON<@OL/RSD89L/0:\3NI+-LT"Y)#)<\.C#
MQXS7>UAM^CL&_5UX4-*.<G>FLV2!%20*,RP>2&V"P(L<#6KOB^0KL8?4'0J#
M490M=Y<EVB X'(+C:(/@V" X[GC?KH^B?C2:'>QPL2)3BB2DNAA\B,8BZ/.
M[V48)5(;XBPKZCOWK:VF=YX$GB#N12C.@)FC]1Y]7-SQ-0D@\I(O($)].H(4
M!&D+0%S/C=I%65C?9DK-MTZQ+*A#V?928K%@?6/Y1 UG,&[\>'504N@03X<:
MA#0["M(5FC-F26.P-MU73EIN%]23]OZHT\%HG9CM^N']XSB(5>4-A]PZ< XY
M[;*2-,#PJL$YBOZ=/6F4U]"@*NTT<:^7THAD0PF$40MQ9.$4L@- OM0L0Y]5
MMT* P3=R!QRCR=$>=IT&AWH\Q).W64 /TC#L!"X,/[-55?B,HI">LK&W5\[O
MI6R,</[9)E(><J\&Z'Q^R48LI8#!D'.R51V=3MO:X>P'+5WQU<\]$-D8FK!D
M>FN9]R$X'Y($:FD8"!T8G7-;"'&@!1EM![FS:#^\-G/$%H*(SIRX>":0M<QQ
M;4*</U]HY")X.$<OZH5M8)!HG@2&H/HQE<#4O3 :52ESK"%DV$TB_(4\)=)F
MR?G3I>"8_!.LZ"G@'8F))M][V=4"ZO4S46]9%1E>6 T) [H-W>GT?"XK9#AQ
M?8Q)RS#H%*$X0'*V0O7I&I%L.GH5XIP@YFNVIU>R4!HHR@HRHY G)H[R<JRD
MJ)(.,[D=9NGKEZ0($D#D):4$P,;@RXX9<'BHF*0% D-'Y3I_'U<T_$NO+DAH
M',T__.S'\9SY=<F0G7@-#%AD^\^?/8NV3G\^1]3B^W]&/[;P7-$KUE 4*_>W
M9+YX$9W-1]62<8(GDDW'#[=^?'5VLNU.:THQOHI)4H<F&J%&]E.7'G'3G&G^
M22=.\[,H# %;%<:,8']5=JTQ]A4^I5/P59"Q(%_!.C&VU34WNB].LF16E$1"
M(7@D 1 WJ ^@"3I)1#.7SO#S*GJYH]\0X4#28B9,W='^L^>^=\7#,09>E-[(
MOVZ'9D)J:@NX=X.Z.>*_XT.0O0]E%9 @*&'-3/*%QF.,-AINJ9Y5R;RV3ZO:
M&]RB+C4 0F5E[$OY_;C+O\@,OINB$LD\IY[GD\Q=GGFIT!7C:+/B(^KBG_ R
MH9$ _]W7K?6[";I2--6$T"[2O%-JBX/>*6).PG.4&%%0#$8(!JB?3.BJ/9&I
M *WQ#T+:S-11^F:.YKY/9\\>HZ/?E&P/4ET;'@=MW'=]<XF JWM6+[7Y15TI
MF;20T6]X@0;CB?8 +:KT^OR4@%UR$"Y\P*"N(12D\B3N#*+V)$>0BDV$2"YB
M>4P>AWW$($5[9EW<ZE=^S)T*"I<=DH(7W'MESJ:^.*Y7N.<Q(U=!2H)!&1F#
MB(2WD,&GQGX)R+R7?L_* EY1//8Q1*> +';.%KM\7-'O\PV9KWTD02OX]/4E
MK^ K"=""LI,2P, Y/X'E0ZVRI*,WP \&%K<,';/.6%"J$V7@M:MAE%2*!"QO
M$"1RE2T">CZN%>)E=KPI-EMIM.1$/OW8_[*LG(>EI/5-8.?8E5%Y O(RJ&6Z
M_[RT&,3_L]/(H:%ZB=*/YS F"^X(+P</F*42L3O,HSB>6#-$%Y>5!CS'DV#?
M5S7%&IJ=ARV,>.7*6+/]OYI)\L?3=]]=K 3#^5+2<+NNML:O8! 8Z/,4R2F4
MW^A@%,K'PFZN\;DO@]^D&O5!<%:@%ST3-FY8,7-R;+SJMG.E>,%:Y7+_)=2Y
MQEX&99'UX *IN<!6P)<&+V2,09BR96RM9M38WHU>EMP7$LAV\Z>!(8+'K_WS
M!Z'>ZNO'0N/."0GR?$QZ$@OCY,+AXV+%7%L1\"+P)]JFZ&C2WW=8E<\MRRU:
MIM0WT1GWL-C*"XZ_C%YOW29<#KJ4;J_#XWTU;!>DV24ZBO %&M_H!!;^UL6/
MER<L@WJP'YWNOMI]NXN\)4VT?_"4?F_K1@%&"@^$NMS!XC\\O\"9\:;\3*JA
M<Y_R>+AO/$C90'+XH/E-#^0:+3'^O68 &74B.\T/.)'P6*2\"++($.2B0WEI
M*N<RB'X^X:K^1;B>/O3TP5-SS8M+MZJ2.,#:GDN9N=_8Q6RJ?ODAQ!*.T*)9
M?1]A$G1\^?0?#KH9TH;"'_A]S.J/$6R5IH5^6\^!J5N=NLD]VBXV<94[[=P]
M QH9YCR-+.^]\U&N^<4$(=KM7;G=LIJ@/TS\T.Z#Y3CS8B]%69CV%WR5'N%$
M," !RK3'6#K$']TA)66U(V6.IK[2S)".JGA.EW+4,4\1FG&4KEJ-L8Q'R&S@
M&O$#?(5N \Z]8?<IF.W*;U:,C.:$W0%KE2WX=F[?<M*;0SL<%?G153G'R!_?
M ;M^W=<-WCB$VLHNHEA%\GGN<5<_8F?_W0*IN4T)S:@Y='%0HPQ?(QLSWJQJ
M9^'&8*0SP2MB'P[QM5ERP1$H.NJYR0HN10?P</;L@0?_UUML/]X4VS?%]KMS
MGQ:59ZR&MZ&PWC'\X8A_R$,"-RC6V@MU7G70Y#6"+ZGTHQU*T='^WA8UCCMB
M^8O7)X:%$#%D&O\Y7'(2_> ,S\\2Y)^8,L76#S^#/S:ERA/$;_PRQE=1CXF/
M/T7M6:I(2YZIW;:(\R*75$[U( BRII;\7"[1\W52>XW@9]Z LFFD(SZ"QR>6
MF4X+H/]*=]3PV^&X^8?PFGV2E.P01@8D=/B[[R@$5_[(>:1BO'1Q,,/$3S L
M!."G*N1(?@"YU'!I=F5&Y;$$?WV*XSDW=_G*-S-.+D.\YRTPX&[US2Q!0S*+
M_ >.@UX[H[2$BX$FW]LM "T3=ARFLNJNYH%B7R<YH.1C(TK;8J9E&7:G8+DU
M616@@*$M CHWK6K;Y)UXPNCSP#)/B<U3Z@(,6AWLZ92Z%6<J?!EAL"MVM#3[
M#OR5'7%8AILOE:PTZ!3WM4N8B6;'>3S#+E=W6KD+RNMRK=F*7]%.:6J!AI?7
M$P9:]?>9%P7MJ%ZI[BIV4;9LA>HK="EG_/597HY\2Y5T3[L5DAF]3E//O,HJ
MTI*@,)?6]2(OEQ!A+4F[0;*B_E%=7:0#^M4.?$Q#EU6/9U?Z\ID4PX'J8T<2
M[):-ZLH:GLL)"WX*S3M,1Y%2MD-IWBU$IJ!([;J3F'PTE5?7\V]J6^[<T#*!
M6R+2^A"L$<H5N.B!AE=/I=0W'W68[J593@DX*;'-Y#?\"%-N?+=9+K-D1^UD
MEC("1M<E<075L6\GB<T.EY(98_3%CL7=(*S_NDID,O#6[J-P74NED)8V+FA?
MTZ/(B@B3!(^]U/(LDC=%TU2[D7G1T]*6@)/8_]VR'X9#_]Z'UQ(N.'@-'C$J
M:8P*3S#LF*N426YHY7FC<L]50N?%-(?);[6:Q["A: D+1JA*V/GH%(O-O.MD
MXWFWTHS1F.$W\7)P[3%315GP$^9,KD79H.[&Y;A,G&C(F)PB8:+!XB%ZUI1#
M@W?)!'94"/P5X_3=:-CVWG.8_ H(*)*I8$4,J7@Y@N X9G(Z07%S40* S]V.
MYUIVZ+3IM!VP@ZNOT$@^!Y< 6E'W$W%8?;4*M1/=H]WOF'F @[K+.LT!6S7>
M@WOV$DI.71-.@Y95[,OQYE&H[>RJ;9B23G\@"YL2W%677\(S!EAL)\TKK>PK
M%AV:ME5.(1(FA6@ TSF>;JE<F5IVW&=^&3Z.8^(R1?%,!'''O']168\+^U3]
M?//O\Y<[^\_!N,')/\_&9(TK+?2_IJUXL'>PYYUP=,C@&K 2*+%HU3[Q$- =
M@]M7Y?]6:1?M1I?MB+W01A[PIQ8647A#YIOR4UP6.P0/Z-SYSKL%*'-JRG4U
MD(S8EP5KQ%Q67D"B)1P2<4B!.3&_$Y(L[GS,:A88%(^?8'7$P80X!^J/ Z?Z
M)F'YB[JQSK.[?VK&+(!QG.-4T+CL&V7KMLDI(8 RYS R6 Y9Y F5N>9XD#?E
M#;' LR]/2<Z:8/&.2R]45'2Q8ZSMH3H;^_W94%#,JFL$4Q),>>9D?'#[AIV=
MBI2>\$L464/0RXFA%#-0>J9Y-+<WAT2("O+LC!0=!AL\X$Q 88P:I\K#?A/Z
M-S%;.P"_HQ'J;:"P0=CH\=C>1+)N$HZ5"TH4"8=#H.'H./_%#9JG24UBR/?9
MR53;($8XK%C!+8PU14M*AI04BARY]LK8P%-NJ0?O3.EM9.9#X0EY^+XK4&(-
M_GUE5WTL1Y=1[ ENXZ8Z]LT3G?9$]NV;%9[R0Y]<&NKRI?6=G:A6&UP*3,T\
MJ^O,R%K_)>EEZ(PQF//NF"E(L<0\@HBP>?)$Z5"B?OQ!70T,Z8A6,Z3U['//
M(O\6NP2#3BQU6YH;![AQO!0*Y! *'4&C-Y]P$0)W@\,W32K!+'7W([LPP0)%
M[S 5EEW>!WKYS,N8.V2^9J#,(_1<44PC@JVEE"CL)Q0-F!.S:LE:+-Q'K./(
ME&X&;T8>O<D,^0:J())PO&EY6LS@0@5+S*%?GF&LH TSPQL0%WC(F?B).\LV
M)Y!=9RGP]<_W4(;S#-R),>:=L6[,P::PVSC#V]&\;_F84D!Y4/-F& RUOLV0
M)R.76D, :G%@%M_&0KU"'1(1^8UK87D$9N@(!O0?(;?&/<?$#*P9'EK=54*T
M$NG*B1* #:S.A)E_P9.[3L9+2Z#@\O^M=,1;4'@XP? 4CJ\E^H<)P\RY1//&
M< %Y".\D, 2]-OH>ZL3<L7R41MAB\JC47%YEHZP)\!F^:0W"S=KER4VSJ:?H
M[HI $@2>VR621FM<$9(\%VC=N#M=(F=IKL WB?U[V*?:VM^^>XKA!UL'V\.S
MO!MU]J ?5+<%T8R1/*VR>G/N;-JRYT4$Y/A05\L:#[C"A]V8-Q%H%(/ON4:$
M.4L$9P1M(0_=OPZ,YCY&KPQ=.+Q,)F*P.)IU:C-4=YL<>E]:/I)SWX "'"C@
MZ084L $%W'$("<&^-F-8>:/!HY6M IW"G,A4BB_E'UQY*#OMG8[D*D<8Q=?(
MZ_:6B-;>&J3B.2Z75'A47DENZNRC5'K?,F3]93KB+YS]IP4?]5&\JGL' O%K
MDMX7_I77BV(&\$BN4$5!W;[!=&U/1G+=YGQ%AXTO0N@FHRY?1QYITUIN.-+5
MPV?X:SCTN!M<X?4U2=J<\):6_,'?=5%R B>1O-0/Z-;55W"%EL_W*B?7-6VK
MDFY"[5-XBB]3EN]4(KC2B_HECI" ?%"$MGJ+HQP G-$;8S->\'"=K[L>]LPM
M'DJ'-$SH"K>BW-6DS,&G8]!HXUF!!"WNV=HUSY%CY#=%7'11%CM:J4+;HV,S
M10[Z^+:)"1(H/.1<K=1RKBOF=G51[R6T]D/J6R8P!"YS$KR;#.FK5LHRRU4Q
M.R2QJ-2YV:F3G/W0E%&]-+0\GGZ .0M*^F.>%X1]9;TI":78.U%!UA 1!-/J
M^1XJQQ;IVA==2H#OT']"JJ@DQ2HPB#N3KF DKLJ<Z!/1&\:,""6&!;HJA%5U
M4U&B@#6>P37"$RAU_4_T,^Y$=Q@2TFS'/NERLH.1T [_-\O.B" =J208BD)I
MRB<7@8=+S:!;581:,Z 1/[>6<(!]?$>C 8ZZV[I4,;*KTI(HZEHFC<O:O[^T
M=J]:^N4(?!M/J#%*<F%%IQ8#W[V5Y@3:;B1^(FD8]!;@/LM'DO20?O'K-L?=
M(48BTT.:)4KQM;J('H88CIJU/Y,H(=KOBA]X18Z4"XGS7$X.<PJ)I-X07$&#
MQ,?-QW2R0[^GD<"BD%,D-+V\F![$(O$\^T@%.?\SO(I>TE\H'N",DYW4UFGG
MR>N;9&$W$>X&N$_2/4;ZMV$2"Z;A@$<<5]F(C>>_4+)X_W W>N7VXDMLM!>U
M9'SH'\%Y$0P!E3JL=?:_(HD" ?__DEHH7:AGS0Q.7!VDRO# 2W'?-1^@Y%0Z
MAM)\&2;T[\!F!B;U\<(QWU'[MNM]\(-^*C7,$]>1N_7JE.6G.&VL532<N)_A
MR[!&R"D?)<6'Z T&,S")Z(@S2F#KY_,?WKQ%A:>B@%-*Z'"E#KG_E"T?5E*1
MJ;#@;BP!G+7))#6]L!'>09H>1YC0J.@YP%CSG>A&_)^L#8%U3BFU2M5;RYZG
M)R2XDU5S89FE!A7->Q% P ,>AV\;Z,\G^9C36?0,D;V] USC&6M.^YU)6I1L
M_2?1UOO+E]O\XYC+%B5,V$V:?N#,XTVY,X<IO8K@>W(/&B_&,8NX#_;FU:3Z
MYF[/=5]$IS)[#KZ.OP2\,C8M\Y6T)"@"5NYBX%AD.<Q7D>(5#VDGDLLV1SJY
M12[&P%3E>:&,TJ3RMH;4 YWU(QO")7?IQ$8-$AZ7WES2EY$P@'=CS[:AKI8X
M T2ZH8JO48*<3_CU_O+@JLA\3AE;7+'$A"0WPN>1PJG?WXIX_92:'P<17O5*
MQ[JV-7$J:B-NKM9^NW$K51&7CC8O0O,@75 209@'6N4WU\ZBAIEJ9 MT [=N
M1_+J1FP$MX[@)<C!O%<D;&0+N^)1<)A,,\_C2ZO:.'+K-BHK6U@D"W_CF'O'
MBDUQ-?\!B20?0MA!?22'V?!:^/[3>N-@IX-OLB-Y[6-,AB,.LICMY.D4[O@,
M_D()S(R4!+_?P;]\[F3L?=^<NB:/_W!-JEN>H3,Z3W:/:3@">D*-#AS253GI
MG.&$U5EB29V3&I,67+JEJ3N]V,S6'SI;ZF%Q#\B$<*<-F8AVA.%_PTFQ("(8
M)_45)7G8?)I<&J**5)U'CB"[.V-NC:.F$G UE6([N4ZRO(,J\/<@7"<B[\J*
M5&;'R0(ETF+]#R')RQIIEQXSYY#BCE9@D.' +JO&(GYU98[+:E&21Z!5V,T:
M_&/7H-2X\;C.TX]"$D"<-#F$#E*MCCD>2 1J5@8\GT'/DN:LG#6QDEC"E;.9
MTC]V2DEOE/K0&G:X%VG#25[L-YV@M!$&Y9P"9%^4D[7\10Q./+ @QUE%*[*9
MM3_Z,- ,] QI=])J*-E%J:<2TZ&X33=3\F?91N-$C<JJ0C??MU;B"5E3M]'*
M^=B,_L-'_Y:B"3M,K$J]I FRN?]526_;41?^A@L5BX2OQ7Q]-K?"$%4'S,JJ
M<3NO&ZDNT-'(L6[:\[K0$YLFUZ4DZ5-$Q;MNRL<1W+X9'!(,;'$P?)#OO3D'
MOK_&4P;"_<0U]!DX6G=CI<4,CR7"*OOV ^T")'D6)C$M8:G@2,+?J%F$K:0D
M?%;RNY6U?9@>_7@AG$:D+3]-\,_DMU =4@BPN&7L)D'VVKAW"?*FQ^,TMX2&
MOD.=5^#G3'EO2&CNAS=[ML&;;?!F=^0U_^V<*MW*HHW*;:B$(8M#CRQH6I:F
M;>V?\?&[E?=B,S"E9C-51J5.,Q*2^&):V30 CR/E^ O,"[9KX1$Z/)33TA_4
MOC_-DE-3@\7@;[.:?#DG8%L1*W==IU2JNH:)5WH$& %4(V/2A;)JIF6>E82*
M]JO&+P[^K9143WWDW%U.<^27H#4H?T@)[XVD*\)<)G_W%\0/VPJS+5BZH&0R
M%\HT$)<*"D$IB&H;7U3>":$IIJ=>WEW*(>[8&A@HQK5@6?NZMV\0Y<$@DVSL
M?H4+7#@+B/-%N]F'A!+P#EA=&H3AB _0@7K<=M6@=K0"XK0:G.92874WW[9N
MSMM]H9SODH]IO>[/3O /LU-0 1P)NV-J?1=Z+&+(P4],8X?03X79J5F*7/D+
M<+W()W2<1%AU(4G*6_PQOP!6$$2M9%9>LS%>U7-( ]#@HC 62_Y=F7HQ.,Y$
M5Z)3$7EXVM#F&>2:Y\5WNP;FA(MEX_[D>VXI-[-.B*8#]L.O!Z;672/PVFE+
M)_ _R3S%%'>7,D=I@=^0/'KM%2C.M')R6NYX!G,<D9<FS[WUYNST)6(PM+ M
M_<=PA78>4VQ#X85KRDXG&J/BZ.NOB.>SG=,[5-)QOG_TW^%H,DW&?8<4NT%;
M)LI7O;9ULV>?L%YO75<!\ $%?/+6K1EC0Y:!A:$Q[C>.X5#FV+29#JS"6B_I
M=@FV?<WI5+[A]JD O$+/ONI&W,,5W$WM5P@F0!P!RGTL(/!6MEYZ+DKS%DO^
M1M*G\L?A0.\@\3817-<9B7JSG\#/%AC>$#*+IWN._4Z-YE/(?PH/<-- X,AR
MF4-&]!&1[KE1<@*D7\#\3T!ILAL%Y"?*[\B)@TFTM;KTSE_9%K^N,]),H@)_
M]".KE\9G*(8@AF&EBSK $ (7#I(AD.>,%0/'[;@(3IR?7>NR 0EDK48H7*7=
M[(,;T^W'L9$Q5^/ERIUIX]=R9$GAKKWK' _3*Z$=$*R2NUY0M;+J&79F.:6T
M\C%I<PX\JS&T;NL');/T([5DX^7$0Q;WDI#@0HM"]9BB5MT0_VO$/T]2(G[
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M^P5<?UA$_&P3U$LB\_,]M^+"M[[Y^\\BE.CVAHS79QJ*"A_BL8S%"?(X?:2
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M/Q%X?$QA G+7O,$7-)OZ>)MZ0;![Y(,HH??NVM^6P#-/I&-6[#?>-F_+6Q(
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M^=SXY7%L\IW4?-R]KDV<ROY?(,'N7JWPR?+GJ'_$!G&,#]XNT;RBBDM<=G8
M6=*M=JW RH6^GPQ*T&M,!_S$!HQ:3OCA?\8)3P9J*Y@^6+P+'UQO\PK3E*75
MLG?%"OF$96;*1@H:/E%IR D-;W%,WPT5+@SHO*#%KXZ[@H@^@6@-U.'8O]6
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MO '_(@"12!2Z4-VB;;1-F1\Z/\%>4*"*PNJUZ10Y]MM%.66H]Z[\\BVEG+%
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M#\'HE=9DN>Q%FTJ%NK<4DB(M),7LU9XQMEQA7 6(^'8/AUDZA(^+'D+\Y?B
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M!$W#<)SEY7/D?$,.A??26].>=+!Q:Q?X4+Z;R/!W$#DTR,($Y@(!A\DB,).
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M;!$Y.G.2-A5'3DM(1O%=<5[G?E\J,/@BN=5">'R1BM6MTDM^("U(?1';+>9
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M_JVHC^?E\WA'D4A;:I/%*VE2NZ!;<J@MS(UE484*YJUG690LUH1/5+GH(KI
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M!RD@["><?0+^ /=;XE!/+$W$<(%Y$E@)+WVO*E,K ^;#PBH!RL.;N_$5DB;
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MK_7:INZL]-:[KSG::D\^I[%Z"[WU'N?HDND^G-RJ4NLIF95(^QOSLUSY,(B
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M7(283%PX(-2D\A<)QO#\:%P2^/-UC,)I0\U\C<U+-5*T&'3YN0;C+KEHK"3
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MXYUCIBLQI^07.VC&E-AI;]=/1RZ.>YP^Z17%N\W0$3<:AS@&-YI.1P=/>99
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MOPHIM ]<29<5E[30EKA[)G55W+LS0:OBMJNXLU9IS+0G<!9!HS> 4M#24()
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M"<,*92)DE%"KK-(TCS736[L\W4DW*(QYR%M8-S'G)@9E6T4R2E!%HCFG0N=
MQG$> <<+'3'?M90S$/--B7E!U<F99B!.***%B0FC.24R2Q)B0=]-,AJIT-*M
MW6AE^?&!FA\/-2=1FJF0&D$%J"\FDRQE@E.CPM2J-#5(S:"\#-2\4=2\U/Y$
MI114SYB WAD":TY24$$,(PG/PI@KFN94;NWF?&A_LAF*QDJ_#R@5!KZ^1)WX
M;J7P6A:8S5NX_[J[!7@\Z VREZ2,\BC2E*4JRX4.=99%B<TTI=K+8G?M[!K0
M^T;HO5P!+D]$IB*N29Q92UC(-)%*2A*9E.6*TI0K@\TC\MMK5C>EE0>V/P^@
M-X#>8$UZ'*"WH(#R*#/,ZI@HYGQM.B,RPHXY5&<BC>*4A6H]UJ0!\P;,^]$Q
M;S"Z_8B8MZ2FPU:)Q$B":1^@IH<2/84IR42<9 !^-N+1FHQN]P5ZC\Q;F*VN
M5C@]._/5"L4HT$6M1F4]K3!=SGK5W8[*\Z 8^TH3L%O/+G4&7F-I>GM&85=T
M.94CL[1IE]HTUV$7?<JC?&1FJ=4G^KDK>B,*Y]/^OM-ZW="AX1EK0TDOT/'-
M.5R7=', P06-F[<Q*C\ZX775'!^/?+KV\/OV#+T&C#HP0Y#:S43/Y?JRF4YE
M&EE%J$U!]$S2A.1)EI!4\I33,$UR*[=V&=^)-LA#M":!8<"=1XL[:T^4'G#G
MEKBSV!C;1I&"O2!HN2",)I8(J]Q_>"["W*0RWMJ-\Q6UH0;<&7!G4W%G[3'_
M ^[<#G>63&UY:F446P+;@]G3.B)YQB01DF941XD-0P'R3KIY$3'_F@@Y,O"O
M+C[O_E_X3_OJYJS&&1SFL[(NG*&IPN;PQ6?SRWFA)R?M0>[=)<O)I#Q]%LYN
M$;(N1]/)Y;?T!JT,GLMU$V047D6/,8XIB[M-<&O1_^])U8[F3!P;(BLC/@%3
M@<$^$Z-S<5%O_6MN3J?%N'TXC1P>+,[>SW'W_\H*[ESQWO[#1'4,ST.K4N(0
MWVW9;,6=S0E6:23.:O.L_?"++NJSD;AX5HS=7-U-OS3/:K8)![9P1-QN^)]G
M8]X)_;@;FT+SYN;G'??3PL'UOZ713IY?_G.X$UWZV[<>&X4[/.+?]=AO_Y:&
MWW?G%8-->/[C#/:ZC[W"R/2]]LF.-.[=2/G!B*H.7HZQ+O>AFI325 &-MN<H
M] $&YE<.F'GIR^H_ V9@*KQJ:_>G5^, WCB"K^N?%U#D&Y*E1XP& ZYTU/RR
M!-";95Q&"\\U3,HWL;8^N@6*A@7Z]@*%<PNT)J?,#V- 5^6I"2;BRW*_@9O,
M^-$IE:OF^'B4RCLPHN,Y>H?'"/7*0:F\D5)YO&Q$MZ#G9SDGL4PBPK2,0.7@
M(:%QFD1,&-@ZO;6;KB]F[0<*2QMP9[,F][!&] %W;H4["T;TB"8FE:DB>9)J
MPKC.B)!8Y@HS\R*64H;.NY0^QA[Q ^X\6MRY R/Z@#NWP9U%([I1UO)<QL0D
M>4H8=K&36,&<FCC.4HVELL36;A+=/FA@\_IG7UM5G)1G#T5KAV>NL^/X.!BY
MDJ.CIL'CBC9U=^*+].:&S8?1[_)%/NSD'E)M[([5'WBJFK:B0_3_S=#TTY+V
MF*C4,,UC(BG'3J" IKD(*<F4S4-M1<QDOK7+DMO7";N52[([]QL?"C' SR;
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M7$];JJD^P-3=.*];C0TD):%%1#)I *:B6!"1Y8;(F$J5JY0Q&V[MAH^QR-Q
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M,Q[F/.32\CAG.:C3EHL-@IWWM1.@NEV^@?WF/@9].;F? 4F+JBM<>*5A"J$
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MPK?'CH!>]4QA*.J"D"..00H\[L2XYD1?'GIXDS"S.]6S;ZBUOFG]%CCOO]"
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MA_C@^"B-6&0E34AB<TZ8E2G)\P@.FLJLU@KA56WMQO%.N)G1'[TR2YM).BX
M9?M&(7MI%N4QS^*04\4R224#"2G%AG66IUJ'CH+"EH)6QD@-%'0O%,0.SH^T
MS"40CR!9+BAA7&@BHH01)6DF5!XGN<ZW=I-OA?7-EPJ+'+NXR8')6&*B-$TT
MB$1,&BDEI4"\7"EA391;/# 1;P_,ROZ&PX&YCP.CONS_><0%A4U..!&A2.#
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M<%Q&H#+%YR;"T=6X'3<%=)"T,9*R7R-.]++J7%%P7W!O--=:IXN0;D+N?>6
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M%JPMZZ8'_/6&=/$-3G,E%"]RJP'8!F"[LW9] ["M&]B^+@!;'F7:YB(E.4]
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M\%)4K76F<2F=8=8RIO?> @'P[-\> 584K/B6#M[$<C6Z< XGYL$CXIR%Y9)
MZ.]4*ZY6$P[*KB9+8TYL@*EW+,_FA?@3X>KU+_K<7%\+,>MLT>ZS3S6Z4E];
M67+DFF'"?K)6:<YEJBV+0F;S4!I.<V6R3*/S+M=''"OSW%\CG:X.L"\#O#$V
M^XO69G]2?/BXQPZ^[G\Y^/B>?GB''9I.BH/?/WS9/\5WJN3#UU<)_!XMVNP/
M?_]WL?_BF.Y_?1D?O-,G!R]4>/C[*WCORPMGP_\Z^KC_\1/\_A?Z;>C!WI%.
ML\ABY9&$44$8Z+4$ PL(8UELC!46_K_Y"=J7U7A^< >2*LMGWJZ\-]8]8[(_
MBN\P<^ )'\#_G[TO;VHCR?;]*@K>77HB2";WQ7V#"-K8?>DW$EYP>^ ?(E<0
M%A)/$K;AT[^359+0AD$@0$#-@D&EJLKEG%^>_=#=CX=68>\#P8AQGQ!GG"-M
MO$3$^&3@F9C9V]1POCHQGBIH.A^T"32NLD]'OVS$4K;\Z$UD]962RZ!D^LT]
M!][<JN.3*"9>OG5D4"[:HA4-/\YZ\<WPE]]SV8Z6O7C3;!>S*&[Z?7(=\Y2G
MNJ(5YK_R\I5)=@.79ME!Z^#!FP>7-XI+4SW>RFM2;P#W7'L9;Y [7A.2W^G.
M7PV6L VA]#,:K+[U@.:T&!U2!Z#A#<U(YWWSAD;24PWY5J5AZ,RI@G]M[Q[$
M?Y=R#VC;Q7GR&ZB5@\B%WL@"=)^>][=:MM(CL$H+M[:93\'7O@#D%@OPH*QV
M8ZO@9\"#XXU>IB2Z)?9(7N09U_8:Q6/M1N_S@E4:Y"/39RK^LZKT>4W_Y/&W
MPE,\:OY$QS"DV'[SW$3YLK/PR7MX]Q;;/PFM@Y/&\<')I];!]E_-@]-WN0,P
MV:<[%XVO^[1QLG4QW5FX_O7327T[-!OT[],Z?7_:^//O;_73OT[W][[!O7^?
M[)_LD(.3?5K?_BO5F_C'H+,PV=W^<MGX<9BH32QHAVPR&G&5+#*1Y)@Q2E+@
MBD61JA5?ZHI;8#BG! J42,03#T@33I%,V'GM@O=4S#3;FM>D;@3+D_\L@EU3
MW'_K1O9S4..Y-J0?K1-=#"75XJVMGP8L;Q_<K0USC#-#2&!<>J5MP$$I(I(*
MC 5\V^#N26O?5$OYU0G:?A[P<3$%'UII8PF/2.$<Y)N,18X2AK1E@G)FG?8,
MA&$&2N=,I'>%$15&W!,CB,B)F5)1+35G#FN6J)$@ IM(70BJP A28<2C8@2>
MQ@@>'1?,(8.E0YSBB)Q6' FO)$]1!Z9!Q*!"S<D&>2P5>BIPEPR,J8^ON+W2
M9U1Z9J5G/A0D-=[.:#T4)XFY9DB*Q'/)-XQ<H KE5@M,IV@5U]6*+W7%85FE
MEP&I7/R;4UA,YVE -%%%C>'!4SRK9TXT/1\$KCR\HGE7"!D*6%-0\KQ%K(=1
MPX:.\(NWY:96,M9B[#6MAZFD,7<N().T0)QHAQPQ#!%JE/%>,^SIVB83<ZH1
M5!ST+)64BH/NQT'36@KL#Z4&.,ABY1'H*QQ9G@SR!C-)B4O!^H*#9DN^5'Z^
M2KY]2F+^/"-M^4 MET(@[ BHW SC7-+8HVBI [G7F)!(M>++7/&8;- R1L2(
M(HA+C9'UWB JJ0\Y2E!&>H-\6]1'G"?CUI[:Y?WBC^@'%G(;G;:O3NF[L-FT
MG&NU%#&PA&(,N49?MB5F[Z5QR@@7C2;1Y^";I0FZ%1>MC*!;<=%=N6A:UE74
MQJ0E09X'B[BE!&D9$@HI!:*4!4DXES=DY%D(NZMMS)T?U%86RNM<+PX\A7/T
M5D%CK\5S>NO%>(%NU0<6ARKX7@2^9X,NI Y"2<N1SG8^SJA"1F,%:.XLZ!I.
M, _:'>7D;@[5"E<J7'F6 F*%*XOARK18:'BDEG.,.+<L1]\F9(P,2&O-L'.:
M,)9RU6NUP:M C25'Z3/@]M YS\E[*YQ+<+]15GK!C6#ZM?@C9_GGAK]'N0#&
MJ6VVKU2$W(V^]ENS79:6N$V26>6\N^[(FIOJO8CL^ZM3:;B36^5&?AKN8W%Q
M#W9QLIIT-K^_">?=O*W5Z77CZ;4[ZP)/TO&8F$.)Y"-,!XJL)A;%R*EQU&,3
M>6[AHJ_MP%CQT))X:!$YK^*A)^2A&<,@(<8;JY"P)B NE4".&8=P)+![,5+"
MY=HFP1OR#DQ4^< 7/_XG6D97#HREZJ?M\UR$:RFF+[H0CFT/-C67COP0NW[<
MHX%HA5PW(]>L8Y"P) 6.!D6>)"BP-"";B$""$BT52 -)X;5--J.W_F?%5 _/
M5'>S^U1,]=A,-2T.> :RLTBY>T>T( ZD@+2U$CD;C)=,JRCOS%1+D ;^6=0M
MVKR^/^RMZL2O3/FHZ>"@88NO7$^R;&4Z5E-RH@OIJ K-H!5IYJ:BI&11'/:'
M[3UM3\I)OLV=E)Y)(Z5'KH?6V/L(S_@"W+=SL;MW1 ^]CLP[&1&+L-@\,H4,
M"1IY[*D31$@5S=HF%S>U45I?K,F@(IH:1;%AGBO''/<<2\&3348&$('R_N/A
M_B]LKJ_V_Q;[?UG?WB*'"L>D"#>(4A]S<0:-K'0)">8"G)RY-X& _>=SDJOO
MUY96<1&)E"(XSKF+SCF0?8,WWML4B2YZD1(S) %<D<##D,#.ST-L0Q(N@48N
MK4-<<8<,Z"<($Q^<%@0N,R !<E-3VMFRW$]X_LTOX5FWN0%?_R)7("[(9*+W
MTF,V>YM7)G;D91P.\[67[F3UCX=1)>IQ#"B*3)W:"03:%JA>TC(L&-4&IV=3
MNC/W5ST]/ZWE"$.0L\[L15E6>5"#/-2*\G_305N#'@%%D>5A#XNB1/?0;P-T
MZG,QSU:K*,UYY<;)-4&+=@J]HI4'2+>%;%>SQ9]S1;M<V_E%5@/5:H-0^4P*
M;)H-0ZZ_.O[4Y=;"+!=[]6IA/D+9RXFO/I(I^+&6>[Z%!=B=/81M:I%%NG4\
MUM,NU4P\UD)SO-'2]K23>X*PS5^*/Q\&Q^+V>6S F_=^Q-;W6(=A'/>>N]0^
M,+=]^G:PW3@]V/NC=?#U(]F__-2LGQXTZW_6<X=;6M_>I_731K-QTFA-F]L:
M?W[Z5J<'K?J??[<.MO\^:?RY<W%PNO-C__(CV]W>_]$XV;_8ISNT3D&"FI/<
M@H5."FO$$E>(!RZ0 S4<.=#\C(P26QQ UJ?7ROKWX0-RZW##$3\\9EC.DX,Q
M?] P@05+><T%Y@J\%@&O?1"U]WYT*LQ:!+-F8]&9#\IS05%T&C!+@_('.A]&
MVGJ-+4]>NK2VR>15Q,!=,6L^;CP.9CU3 5(\J'/S5YAU6V&RPJR%,>NX&V.%
M6HN@UL4,:CE*7# B FHIA[@-#%FE!0HBL."<L5B#7LOH5;!@)6D]&FK)2M)Z
M<:CUOG/>K4!K =":4^,+>Y"Q(F'(LQR<&05#AO"$E!$F&L$)\PI "]]?/:Q$
MK85!2U6BULL#K>;W2M):"+3FV+1XDBD*B;QE.:?0&>2H\<@)%B7L(!,B%W]>
M@GY825J+,=_><>S&HB%Q)6^]*.C:RGM:X===\&O6OJ48)D4K;&M50EP&@33C
M ;%H#4Z,$&KPVB8AXOZJ8B5U+0A@10V=,IYB&*SQ%![3:RLZO I?ZBUG7\'Y
M7>&\0O!%$'S6UJ<5-D%Q@1(&\.8JY,P@)Y -TH%@*C"S$210S9?F5KT=2U3"
MZ2_X,3/'FUHS]W6-O7XEH#Y_1/O2'N:RQO"N"'K<.LU_5?"V +S-*7O@A5(J
M5_YGW(."G4!*-51*%*UE.GGC0I)KFYQ55L''YL / %UPAM>^V]9YS"&]RRGR
MN!QI=1#7.U70IY)E[[\VU;GPNLJU/1+RSYI60S1"F2 12RXG7T@/@JVBB#&%
MG<1.)'9M&<A[";;WXH]['1F_SOB=DP$\52Z.9QXYZ_2:10A[-[: ++_'J_2%
M_YQ,3QE,%%_=8AU,Z[Q__2UCD\HIZ+&[;#XG^%8)+1I/9HF,_SP>5=$[LT<1
MN6ZTWU!A"7YC6S_L16_MGY-I)<WV\.%"%S S/?M;)5JORM+L_>^[VMO=W0_O
M/L$_]0];C9UWG]=K.XVW&[6MQG;M\Y<_/N]L[VQ]@H]7?"Z_2LIH=/HY-ZE3
M>]MI%ZQH<UV9]\VV;?N<H_2Y#Q],VLR&D[Q^-V_QE;Q(!9HG'XQQ,B1.,$\:
MNVB8]E&IX#75.AP"^:P];#Z?[W3>_''>@_7H]=YV3AU,/B_35CL4C5VW_/\[
M;Y:,O2)Y?/"\K>\'[;^.#R[/X#V?CAN7.Z1!WU$X%O#^GJ?[7[^(_:_[I''Z
M][>R ,3^C_T+@P_^?8S]Z=]M^]6<[YXVOC7^?,?JQ1%V<+I_DI]S<'RPUSH^
M./E"#[Y^*@I -$[^./GW)8Q[;^O0)P]K*!2H#3ZW+\$<:>L22D3YA+7W'IM2
M.FBVSV/8RFF[3'# =9$D-9I[(5TRG&KA8HS2:ZUOD?B7SPHS*4:>G/?ZS73Q
M5$FHF6UJ#)#@BC9Z1?KT7YTFR/)_ \.<=^-C)*-FXOWLCV,X;\7=] F8_*@-
M,PD[ <;03,U8$G&O&&D7_FJ'L7Q9N ;C"7-(O;=*B:M/1/#O#C%5C/E@LU50
M(LY21(9%AB3(4EA0[)FWM\]<S;0UDWSY9(FLJ=-J=7[DW-,FT&X-" '&5J15
MYS(B%B[Z @>'G_0+1\K9>=<?9P45"+C7#+$\4HKJ(VZ H04CV$Q/-3O.'T4&
M;'X2@"Q,^@(><7K6BOG ">?=/)!![9*K\B3KH_HD;VZ3SDKX)$J,#MUGD^$J
MR 8W9NFYJ(1O$'.[9-2G3YQ]?H-E59KOO=-\YTR[9-]5FG@1Q$<?)GGY^2P
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MS/O:S4L-3)8U16"09ON[[>6[3LN' 7F4W%W +8RJ4S)=RG)\EEK7:QW7ZT>
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M(]I91#T%MNOU<PC0]]&]]UKO:UL&/=I&_%E,L!__NS<22O)<V[&?%P0.O9+
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M.&!I1Q:[_C$LZW&G!2)C483#ED)B:N:IEMGKOPW-<_G[PTG_HUPBT*- +1N
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MD;F 4T*268:X,1(992(26&%IJ>-.X+5-HS;XDY;P'G'+RK<;J$!K%4!+1ZI
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M,1@O\CF"!TO%CI==L_\9N]UW-7NE5VKV>E?R'$38Z\ %FK=WB*\V2BN'R&O
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MPJ\Z%WA9SE$!R;P8;@4D3PXD([26Q:A2CL(@GCC$33+(L!"0, X3IY25GA5
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M&?#V0:%I5\"+QX+.X=X:G1P4N)M&@?<J@38SBG!','IJ_(P!7<3.U68)?J&
M_(A(MHOZYL8!3<YAPR/BSB;$HP!Z[;Q!)@GG$G/8"SF3EGW.6?]X->/5!$^9
M8"M94$E@)+&1B%--D4M8(8.I9U(FKI5=66^UQY3EV!L%:I=34>NU:[%1IJ0"
M] QE#Q5342MX_\A[XX9 Z'<R%*4RG*L,:\Q+H\!(>($'Z%3 #D!AXR0'.W8:
M</"U&P%<[AS&6A$[GM&J70.+O!9_ JA>:HZ\/K.Z:8+IGC$PUER_"^#6G11H
M?5.UWJ54U__;=7Z[5V#DF_W.@!/P3!K&8_TOPR[_:^7&MP9L"U]]Q3H@5OW>
M]*],BCI]YLV"@O=H,;*JKOW,MUO 4/+!&"=#X@3SI+&+AFD?E0I>4ZW# <$9
M=\MO'76N@AD/(W*=:+^CPBOXSC;/['EWY;>;TP1S-+@EH0NV-CIF]YJY91G0
MO?_9 BJU^]?69_A5_VMC9WOKRVIM>^?#6FUC9[/VY>O[+]N;VQN?X>TE?Y;;
MXEIWVCVX# #8!V"0V80H  U4G&WY#'I?>O!&D1(Q]I#39[/\^;3Y YO1]38!
MQ9OM;K^S1*D!^P-]>WJ\0\$RW?QZ\>VX+D!'XIWC]R>[_VQAT,-G^Q<^?W:^
M0^OBVZB^/:DSL$SQSM[.2?WB.UBUGVC]CWVQO_<9]/#[XYV+_-DV WW\_5\X
MS^[F]P.I--,2[-(H\V:*)P8Y2CB,GDPBPMCR0$93 X!P.>9)MFDU)]Y;01V<
M1X1 D@G"CZ8&/$O]M+'PY$(6\RJMB;7AN@0%OM'I@&:?M#*?=ME]\4<Q])MQ
M-^4%N&1I*8M8>U\/8,%PK6'%488=XLIBI*F!(>28 KV/DCDY:2U-R>-8!L?!
MD04^V>]U@3V&PLJ&N;Z9HW*_G)27E$DBQ1K!:OZ9)&*-$_:@T][^F9#WRT^9
M^6;OETWS1&DO"\'88L&,YGS=T.M+EHTS.5UE<N')%YN3DU70#)E&]\CU?GD#
M0&;)11J"**C_.Q+XG^O(UW;#KR.\91?N)G3 DBV</F6-,]^)(7MOK&\TP?*?
M87NXR@=[N_E@EANB/..:,,43MH9IHH.GV'(A,+7WW=S]<M3N]/9BY^1]N]-I
MG\%(+5.2U\/,BD&M&K[SS\[W;W]\.P:3XKA^O(%W_M@2NWOA9&?SD.]??!<[
M_^QCN#]>;XS6JCDD^_3S]V\G=5*G]?/ZYB>\OP?'TWTP.XZ.=_>^DV_'GX]W
M-P_/)\4U4\M,]!XLDF#R1@,+R"2F4 J:1R<3T\ZMK OU^"YX+ZQ^?(5D%9*-
MU^AR.$6-:0(CGBN0$<ES=02'+:%1)7[?&ET5DLT!R4:[?3O'$Y$.>9LP LTB
MD+5<(P"IJ)/GB@BSLJ[9XP.E7UFVZH+#%'-(2;,-IZB2.*;B#K/.,!(,)I("
MF6(6:R4\$2($ZA7G%8-Z+MP9S]# ."1,8D0J8(NXYAAI1@F2GL= L&5%?T_&
M]%)E:%3]!N8MHT(Y22+&42G%HQ%6&Z\)IXZY)#33C^(&=P305+)[3]D=X0R8
M.Y>XP$CP1$%VHT/&>(X4EL81RRD7= 6D5%-"?U\BZ7T3#J@_8[?[#B3NJC1?
ML<'4Z';[N5PA/'AWK,A^E7DU]Y#ZS9ABIQ-#N:L</\"H=S\4A2%[8R'U%30]
M$)K&<ZML2 2KH%&,C  T88&TS:W^K-)&.@>__=R@:8ZY5?.NP?M*!?F7!50&
MOTN2*XF=36)'R02QA&NC$?P.B"=+D36)(,^E9%0[DCPLMTE=BWZMDB"?2,P*
M,EVFK63RL%J+P^R#6KJ,DFI&VQW?RIK%M'F<,W@)X>F9,[PO;9X<+@985,:-
M;0^87@%4%3S-!$_CZ7F>$,&-),A0AQ&7VB&=N$5*,\&]X,(ZN;+.C'C\5L^L
M4O&"G!B/:-GRLL7\L22D$O,G$O,1%D*PM%(+$&XF*>(XNS2\Y,BIE$$Y<):;
M)VJZ9IY:RBM/Q[W%\/I5X2P>-7ZB([BEV'I7"<"M N![]0^E .QNYNX[( "<
M1,UA#'E4.:S!.01\W" G3;#,49V\J89\KD/.E:?&<: 6+A?'8][#D'N.I+*8
M1:$E(S(7A[]!N&O-AG6C860W?SV;+^")(CB7C6I?JY*1%>Z?>1K^',S"^< 3
M4"G@685AR+,O/*OOU0^H<MY2II"20H,P"(NT51KTL2?:*PXD"N>*;8]7P(]R
M!EPN^9?EM5MHJ<D%^.PJ49VGJ)Y?$]5C?Q Y9=P8@00+%G'%&;(L661",EHE
MIW0,V6,WKQY]\Y#4M^BV>QJ3Y-Z!F8MD!P\M+_;HOJEOC!)E1T0%JP^!U<.;
M#.CBZP%SP0=O+<+:$<2ED\@*09 CD6 ?L#8^K:QS0A]?%/*)?! /(T=WN!E?
M!6K=DRF],MA:7GY8X=8C<.L:'<QN#$%]T!([1)E5N>$1 \N-:\2(H48YGK3%
M100Y?Q&P-6"*([5^B"@3[I^_5?+=3[OH9LXSWN&;H.*?XX]V\T?VVI7)GX\)
M=WQUJ5"3GO'U;/DE(X4)W$J?$G<\N& <350Z2WBT6,["K;=;W5ZGGPO1?!@4
MNMPHZEQ6\8/S)N&7^X :>U!*"'O-@80K@[3A0,>YQ=%Q@XU3RQC:_$QDNX*E
MY7JX&6"))ANDD3(D33B+.J>7\R189(PI8>DLU'DZ+%7P\S N/8"?Z)5DG%E$
ME,QYY28A8U1$QELEI.<X:K&R+KB<$ Y9Y54L<\;E"PZZGB6;2UB.E4N$8LF)
MEY91J:+E(AGGI1#SYS[+VX[@)2#0]S$"E*2@#KN(L"! >WS"R$66@ 4!=4W:
M:QWYRCI=90+/+26\2J!81EG&3AH>L<?<*JZ]T(292!@ER9@4!O5G*L+PS.(Z
MFCWA!?:*<N0X=X@S!_:*TCF-.GA#<+3P<:[?O%S"^B9<0+NY]E=5G6%Z6P7/
MA4]1D\@T&"+2V<BI\3XY13R-?CY<H<*7&?!EZRQC2TD)<HQBG1T0QAWQF *B
M, X6B4S($2Z142R1) B5QN=@CV5J'%Y5:9C[OIL.W'J<<$[OUUI;SUG22D3-
MJ#(\5%Q@(;):ORFKG@1'*34(9DHB;JQ%#EN!B%?!!<&C)'S99/5-^ ZJF@R/
M2^5^RJ(,.^V6K[*Y'XA!/\?X A=)2IPB$MP%Q(F.R% MD8[4,LIS":Z<+[DL
MZ=R5V^!%U5VHA/5QPCI"&,#X4E0H@Z*F!(15>*1Q("@ZY:4C"2:?3"8,5>V%
M)^,*EQU#J](+RUEZ80A0>:8NT[(O@:G:GI@C9)V/\0MF&<?$!(2]8H@S18!:
M6(]2!#-41$]=TL7^!%=SVR-]4Q49W@  S(NA5 #P'  PPEF(H!H[F=/-"$9<
M40ROG$8Z2>*=X8YIGONE,S._((E%UZRN>KE4!29>F.#2/_<V!H)[2'8W]TFN
M,$%"8B"N0D7$/;S2'A2YXSQ@RVGRLJHP,><Q=XH2KYD!G"1Y]\9S9+'02%HE
MB,=$*Z.>J<3$$Q".EY*U]*0%**X3CXI;S"@N0^/"L]U-SPY$PDFE:)$W3N9*
M.!9I 2PC,B6QY@Z0JW!>+G%7GX47J'C#<OZDU2LJ.7^$G->OR?DA.<")Z""8
M1"2I7.V->.2TM8@0&Y6F,01OP8:86P6+)Y?S-^@9?9:,NI>5#?XZ<[Z?PEV[
MT0H?[&FC9YL%R.XZ&)&B$7"W\M[,$7G938;UG1Y8CZ64&/#6*[!*6#+(@-I$
ME.?^<$%C$LTPO%PO-$QE(<4L*I!:IF=;L$NY JGG JEK]'!O^_S 4Z93;H=(
M>2X&+()!V@>%/%;P#V-):UJZF-7<:O$LA 6^1*?L7AL$8C8&>).%EV/VCL$@
MAW;?->,E$Y]S*:&7DO<\Y^%Y/?N$\ZR2EH$]VRX ZD69OOSZ0_O$P?V%*J]Q
M[J".QP,3=70V-^I626'$"8^YP+5#GD?+I#&.NYB9IY)SJ%0T7Y%Z&3V]*URM
M</7YJ[A5N/K<N#H2CZ&(T]A:BD*2#G$J&3*2$*0=MQ';0+1PF2QS3>;=0WQ1
MN%KP[-]Z%JX(OT/CQ_KPN7;Z)R ^?OV_BS?+AW*=WZXV3HOW+S]\3B&E64@W
MNK5VJNWZ7MO%3CGVC*S6,HU9K?6.8@U$!^[KO'9FN[5&"\3VY+39*')4SAJ]
MHYIMEM0;/O@16[;5ZZY->;1%/;>:^-Q%\8X_VW#EC<-.C#GYK 88M1E]/(&1
MJ!%5# )9LH>9/(F[$V[\YNS!X\5.##"#O7;-UB8]_2_Y^/S-VH>B0-W51[_6
MW'G-MD+-G@"V7C]O>9%F;(%L=6NITSZI]>#):G"1XO>I[?3.\S&=V&NO%N?X
M:^=#[;UM?5^M[12N"S#=-KK=MF\4?\$QW9H-)XU6H]OKP%L_8LT>PCVLU?:F
MW5[MM-/^T0@PG@#K\'"]85V66K*^V"F[]FQ73_YQ\.&O>5G#W_803GAH>W#7
MG4;+-T[ASFRA+[*$_+]9ZKUY"]I+"B^HY)H*K9136&BK-<8L# LK4:)N:#,]
MYOJ!B=Y-Y>,.[[9N?S9.^E<]K3_84_BD=WX_G69>J$[[]N\1]B=_M^P_IK][
M4F?[QY\PZ+63^L5WNK/WB=;_V!?[>Y^;W_;>'^]<Y,^VV?Y%\WMVYH#^.M_9
MK)_5C_?/0#^1@T!]( H3)!C-O#]09!43"!MF+8.I8E'<MM?G&LUFL53/CAK^
M:!560C-VN\6R:[1@_81:M)UF(W96:S A_0XLS G((M=JV[#H0/>4Z_ZZM!Z!
M$.2_!QN]$P0+?G?B__5CMY>7+BS73A&GDS\^RMF#)R>-7I:-+MP=R&;MEO5?
M Z&![\&I0'TUN@#IM1;@T@0I&CG5F!S>*4>M=J^XU$]0VN$Y1$I>[YHV29PV
MO =B !?_&(NIVAZ,Y)\-&,!*INXG4_OXP,+8\X %XB%JQ UA2$LPK25C6"F>
M@C+%_CFA=TI5_Q26 BP=6)9GG0;0]U9>-PU_N;HGJ8="M73[[CCZWO"XT.C"
M9!8ZIG->J*)&7HW%4@-$OZ&Y8&GG:+=NWQ]=K?QN<58/Q,_"TF[F)5%ZVVO=
MV,MK _@/?#!5():-"4UA@(5L D;U>P !Y3C<#1IG,%TU!T"7*06H]VX/5'?O
M.HH5)3'5[W#BTX%F[]5B(W.!VB^-7\N9;,)7,V367$8OF- X0-5: P:_>*-V
M"E^P+9"^&@ >8,E@=F&0X=-NH9Q_L;].71F7MP%+ZF1XC5_<KX#),!"VF?()
MX'6^CA^@6 :H;G>X2%*$P8 +YT72K8&U 6LLG[ZXN[Q"?O&_UJ9B&=PXH/X(
MG 5!O"1<FF0EQY(9'Y346 MF(B.)'VP.X0Q-PC5Z>Q6%][;;Z'XYA0$*NZV_
M;:>1[9+/<+?D!J+E6-J,:F> @-W8N@0T1-\\HAU>'&!8W%PZ8 DXLP10/<A&
MF \;M1&8.1,46+&P<,;P;/I*LN&XW\T$X<]V*[1;I>@X(,-P0"KX>;&F?LEK
MEN+?_]Q^O_NY>$U^_W5 ;O.J!19>($\I=_ERC7;('*. KV"!EK>SD VE[/*J
M^7RKM=-FO[M:W)R%PSU(WFJAMT_!L/-YJ91WT4[Y(& G8.+!&6=;X-)I;**F
MD6+"1=1:!TQBBLX+@YEA=RQP/)<%/JD,,N)O?7$?;_P\4%$:(4%3,^Y#K@N"
MD:6"(!IB(-@HX,1D93T/W/CJ=GGP:Z=M6'_E,H)%>)K5+BSR2Q@O]6=I\<VV
M<@0#40!DE%[F8MG*T<B=(-H2GYBG]HZ5PQ^^<JH5,EPAVQ<'@2MJ0N+(Y0;7
M7!B#C!8*<4Z)5=8G+&&%J'$V=^OZN E%Y2)9JWUL-YN%,0OXE@]MI 8<,H U
MFWH#*N*;[6X^*!0JO$"VFY#5';(26 ^E-0:G <[0@3^:Y]F)T<D5!&*KY)(6
M.$0C%&LVE*QS$GO)7**=[QU6:>$U+"R\5LSPGAU?,;0*ZZ]]\X"M]]M[FQNK
M)<:".1=B*F[GY?/%O6N&ZHD%8MV)I_"K,!6=;6;7X 174+$2SH[:,%7MS!D+
M/KY:^!"!>.:3G#2 XL%GI[$%O/"\]DN[X(J]HZR;6GGNFL7(.A#>[T#MBAHY
MW5]?QJ#=[:%SA4=G1K.86DRP,LDH9WD02C.M</0"U*S*K:/N ,MQE]-?G7:V
MS;L?8?Z&D4?9;NX.#>?*)KX?A'ZZ.$A*2&&L1SC0W$ 9<-0:ZQ!6T4;JH^?&
MW<//= ]C+&O9?D:Q?-#I8 JSY&63I41*_W_]1K<QM'W_B*V8$7.M]CDC8CYT
MIPU:FZW5-JZ.+.W?_V0DK_T-^-3OQ(*%GK0[!<3:1G/IO/W3,>N2+Y?LMG6[
M>0N0/1MO22D%QPPW*:9<15^+J# Q3.FH!&C-R:$A8W1EDI-J>W#GF:=L]/XJ
M].)6*U0&VY6X>7Y :2*120ED16:#+6#D8, 12\X2,+"YUW9EG:_Q\5B._\J^
MB8E[8"]G>4]VR>8E:AL@R1YX%URID_4HD.%&Z<*XW+0K]EW.(K G^#TH*V.;
M5Y]G-=PK7,X-D/WK>@N@XP2N4+C([*6SK(S)^S/^ )@!5?VY(%$9389K&;Y_
M_;/9B-)JP;4:P"3A$8MMR,&A>'P$LA>PW\W@Z"*PS)$)G;!+.]+GB^<I.&V7
MB/BN("$P<K^?-4+O:!CH<.U;@QUH?/45ZX 5]GO3OW)MJ]D7^W3/']Q<K"(M
M1\;FVL^CR_9GIS!GJ.!@J*#F[VSSS)YW5WZ[\4S O8<G%[I8Q:-/?ZL<+=O0
M[/W/5NW#[NY?6Y_A5_VOC9WMK2^KM>V=#Z O=S9K7[Z^_[*]N;WQ&=Y>\F<I
M QM  ;4+PZ;UKF 7^:B5]4P!"MKPX;HE\_$2#;[TX(UB5VD&5+S'(2"#&:<:
MK7[IG"]TF?/&,4^2Y51SXKT5U$FE10@DF2#\RA)&#^P IA44G[ZLX('1^[XU
M=N"_;T#FB#U"=>+4X"!3X,D(K:1CF@I&5-0^#-U^!%,T?'&[OR8/]+C3.O0[
MP9Z_.=*S?;&S<2"2%EB#&4&D!9H#4H&<!R.#$^*Q(D![',@&DWQ4MZ'",3R+
M=6D-#U[QX)P-W.I@HE/1)&DDM9I0/]AT+2;QBM)N[WR\?4Z!UL:W$(CWB(G&
M]<,#)4EBPD9D0X*)]E(@QQE# HO$@,M&3PTH;3Z]D</)<$OU:B_?7L+5_4)Z
M;@3P%%_(7/-]N661<</6OOAVKV&G!NX,-_3*4(ABD[:;(Q=:Q3[M>=Y!A&O=
M0,\A]ZY==S45]FV^G<MMN6([#LY1[.SF38I:Z8FZOI'IAG$R(X$0N';5CW-
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M?K&_EM:SK9WTF[U&66[19Z ?CK4O3S"6:7:+@VG^"6<6$QXHXY'RK-FX<US
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M^683@N5*"=CJ=]JGT9;ALQO=!KSZR^::HGX$YQMQO([-<@G[39=>8Y!O=/F
M-X-Y&KDN0?[&5<#.99A/4;N^4&LS59?$*;<WS:T--4]"6":%U4H+  ;JZ!0D
MJ.)]GP0BOI+ZQ?:!U\Y&[S2BV:_-K2=(XQB0P\"0,+>4*+JRSO":FFZ+S1IE
MR5E(VGN3>& <>(V6)C(>K-2")\RG-&>KEL'39XV)W9PU%C#C(*0)>)"FB,=
M84U06!C"1\F988+DBD!B:OOTRX4QA1,5*Z8,U1GLD#1^Q"988]-=/4\/,Q,(
M1T4T[D81OKMY>.""Y];8@(C)Y40XQ4B3B)$,.K=@3,XXMK).Z-HX<[[RZ RJ
M\%PJGT*]]'OPUT4.E1H4GBWU6WYCX.V<:(_=*-DSK"'] "OL02MIW H;=)#,
M&Z__#.Y_H[S]Z\;86[; O@+T;!Q8+XES0B.60 =Q,!B08](C'S VBG)BBPZZ
M:WR\)_I_+;T?>S+YVH\M@)%6>Y@9,\;!,LW^#RBQUIS)F/3.4!J9E9)Q&X4#
M>Q<'IZ)/'"==D;'G7/[[/W<WMPY,P :3H)' &):_]PF9H(";>>*I=S%O-:ZL
M*W:;8WQ6,I98R(7?;+!$<DN4P[  ?$K&4;@=$2HRMD R]NGG 7'$4!$$B@ZX
M.9CM$1G)LWO*>T85T'9.5M;-W5DO"R)C#X.9BHP]"$4P+)\#9DD,BD@$%(4A
MSIQ!+GF/1'#22Z4\"W)EG8L)/>A'R9@?M+E>+E;VL"55L;('+"A2W_MZ$ 4S
MB:B$(N@?L <S*],FH9Q0FW3RD3.<PQ[XA+"'^[$RLSA6MI6#ZRZI5*-;Z_9/
M<W!&+EMRGJODE(6DBV9".<6B!6^4+59MLW;8MQW;ZIU/* )_O0#U&R\#KZ:7
M@<^W6\A4\L$8)T/B!'.081<-TSZ"Z>4UU3H<$&Q6JN+Q5?'X>12/OZ5$%4 9
M$"T7 OSD5'@CM1:Y02-ATD4RN5CM3;VRG?-GXY[]N=GHYA9C_4[<@_._;[;]
M]X5KD.\##=)FWXZ/0 -\;()68?LG=;S[SS[>/]FZV#_9.?YVO,W@>L?[=/MG
M_<N(!CD.)[M_[%_40=/L'(?&_L4G\>WX<V-_;Z>Q3T&K''L.OX_WC[=^_GOQ
MZ2(G47!G7&*"(ZY#+M=G+-)4Q5PQ#3,51%1<KPRA%K1P9G8),Z82DT+&R+G1
M6ANIDO$1*##\!\HX@F(^S6NYTX\K"U4MDS>.B@Y(15ONO"!JL"(F;! MY8[7
M94M:N.<<3ACO@R,YFKV1SA>\AS<&,U@-?"]7C79[\%1E?[]<E.E:Z>)+6P@(
M;2?.2$L?!!VWE :]G(5+0,DS\>&2C^R>QA(UN\M$49\=8*YEGW]GNYO^P-*
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M+-HC35*!@DF?+$;,.H& E"40;2X1CRJ V&M*W?R\B-7^QP,%M92*7""XW^J
MO!RVX-OA1OKY6]O]6&RBQZP[N%^O31L<.*C)WZTV<!^"8C_'C Y'.>8A6J0=
M]HBGF) U+"(:J"78<:Q=6%DG]%'\I/*-+K.,+S[\JI+Q^<KXB!%"''"'F'.Y
MO'.(4RN0,\8@F8"*,FDI\3)':3RFBD0EXLLLXO-/^ZA$?+$B/F*,"*%)-)@C
MD5PN#"XY<C0'8EF7&+6*6QMR)#59#A%_6WL@1<Y'87)<IGT\__;&T[1-)OBE
M[FX4D[+1"G^V88PNCXE5(<(9L>C\RJ3X?EX__OKS(%IEA, ,>2HQT TMD"5%
M.4*<A,>8>VI6UL6"@T(OY>%EN3U?BA@_5PYY)<9S$^/Z33%F'EMOF$%"V2*^
M I=E:PRFCDMF%%,R4XIY-6RNQ'@)Q?BY-B\J,9Z;&'^]*<8F60]31)&$?Q G
M,B!'/$58>)TT?"!@RM;)FEDB,7Y;6Q2[O:/86:VU8N^M[40LH5E03,9&..YW
M>SEBK0*@AYL# ]<$)Y0Z1@V*#@, &::15M0BX:F0T4C).0 0?WR2=^6"7&+Y
M?2Y[H)+?N=D! _D%HD^LXQ0Y[,"<QU@C*SS/A>%2!%L@61JS_(Z[%BOY?3WR
M^UR&0"6_<S, AKM_R?# !48^L%Q#WA.D1= HJ12<B +CW#-T4O&%%Y\CL=R\
M_Z_A9D .T:LU"GG(NP3CG<KO>FS7[H380:41]8[!H(=VWS5C;?@4@P-Z[=-W
M>4JZ[68C7'YX)W(MW]#]OP6.T.O!]*>SJ09%Q0>[O!6&SX;A%V,V%,$V:)4(
M B86P8:*!H%)1<&0"AHG*I@R8F5=F[E5RIJ?O"PX$+V"S@HZ7T;0W)T@6E4)
MF"?"CEBYFANIK&9(")5M6\^0D3;F^LC4&D823L"2Z2H7DVHDSYRJ4^%KA:]O
M#E^7PMU04=-' N>(>R$Z;*5*":6\J\@9T<A9S9&.B1/B553) W#JQ_L'EP8Z
M"^_$;ST+%X7?H?%C??AH._T3D U?_IT7=*-5%CE?_^_BL/))7>>W]<NG+MZ'
M'\/G'D@,SR(UK"7RKA.;-@?:_G[6"+VCH3A=^]9@-/#55ZR#!^_WIG_EVC/[
M"*+7>?YH!)KO29N;8W']YU%G>#>G]C BUXGV.[();O:=;9[9\^[*;S>>Z:31
M&IY<Z *51I_^7G.P+$.S]S];M0^[NW]M?89?];\V=K:WOJS6MG<^K-4V=C9K
M7[Z^_[*]N;WQ&=Y>\F<I)0P NMTIY.$=R'7LY*-6UG?:N2)ZKUW[T&X5PFIS
MH?2/C99M^89MEB73"V?PV$-.G\WRYX@4EA#O!)>YB0V+R?+@K5,"?B01HTXT
M=TFN#;X3PT:FV]0'!PPP8($9%YSIZ(4U1C.ODL%<72JV@?3/P<ER4W=]\4<Q
M])MQ-XUU4<@A,PWK&DT0^MC=RY"T!Y=^WVS[[R]4HWW[]PC[D[];]A_3WST.
M)[M_@-;ZY^O9SG%H[(-&^G;\N;&_M]/8ISLG]6//X??Q_O'6SW\O/F4M=:"3
MLO!?1,9B4$@Q5_=+7"'MF" R6JHCL(,(>O\TBT>G'Z\CPW.2HD+&<[N]=BNO
M[FG5<6PKU)I7D_QNJJB?V,YAHU4H/G&3)E]*?J&TKI1&H2CA49OVM!O?#5_\
M/NQ2W6@5]UM\Z??!V0>:)E]@1$D6URL_OH+=-5Q"[\"9/[CRX..UXJ,1Q5]^
MIL2:)F3JQWAM^F>WG9; #4GZH-/>_IF0_&ENEMWKM'=LF,RX+W(9C?4<8J$F
MV@K[T7:ZM:W<J+*VZWMM%SLE761D]0;<+^#N;E-FOVRW:G#%)KS=_75$)4TW
MNV^9GU)TGR=^]+Z3DQ75U%BU\:>:NJW^D@> W!B 9]JP?*ZGOF^OS&O*Z $^
MI7L9:O=8/ ^/[WZ2FWSNZ-7%+HH-[W,*9[?6B3XV?F2J\)B(@7M[^1;[U/?W
M\DUZQ@6E!SR!GTX;YAAGAI# N/1*VX"#4D0D%1@+^&#[?CO'8X8-O!B^-_#8
M?8[P/#]B-GE@S77Z<*;+UG$?VYW-=M_U4K\Y7(^OQ;-WL4^WX/Q@ _VQQ7?_
MV,([QT?'N_]\Q?M[6[@.[W_;VSK;.?G/\?[YJ&</SK7W&<Y</]O?.^3[>Y_H
M[A]U\6WO\U%][]/YSO%.$^Z=YFO_>[$]W@966^H8XTCE1G+<88.<\APEC4W0
M@KCH5([[>W3BP*/BAAZ6_W-'W%\%6*\6L(C L'ZEHEIJSAS6+%$C0=6;2%T(
MJ@"L>X0?5X"U>, :J?0NC?9.1(N"2Q%QBRUR1D=DA0Q8^V!EFM*W>G& ]=R%
M$!8KI]NM'V#,M3N-\1#'EYIR^9(XU7#XSRNHF0EJZF/<2-*0??@:*<,!:CPA
MR)!DD991"L8]"\:MK,LUMD1)E6\\-_HE<8E*4!\LJ".<P%I,(\P 2E('Q#E)
MR*0DD7.YRU.(6.26V')NP0DO,?MYX?ZC3C_>V.%:K74&U+G8^_+MD\RGRQU<
M.V#2SY\J_6)@:<$^F7(^K^U*5R V$XA]&F,;EEK/;&((<VJ ;7B";!(2B:0I
MA8EVV.N5=65>HRNFDNME<5U4<OUHN1XA)V D4&DE1<9@BSB+$5D>"'(Y"LEK
MJX04(-=S")VL/!8/%,^/[0[\V9H8EU.Y,!9"03[ WXW>!]OIG*=VY\QV0G<P
M2V\B1>:9T.KKN,^#8.X\%;"Z*$?<&0<L1 H4"$L.*VT\CCE#1F \MS3$RN^Q
MC-+]E$2DDNYGDNX1+A*MQ2Z)A&34!'%*-3+8120495&K:!DAA70SLE32_;:<
M)5^.;"<B9[OQIEND\H8L@S?DP[49 <MI6..^F+3W><ZN'_"AW7TUV6?/A%K[
M8YPD$FT(8Q)1P1/B(6ED+?,H6D^4(TF:A%?6R:*+RU6>D9=+2"H9?VX9'V$F
MRG@>N.1(LEQ_SCN-G$X$::4\ 3$G(:DBP72\?4WE)7D>4=V)O5K[-.9LB-9A
MK=GNEALWV5?B"SY?\]<)?>4X>3*VDMORC*'8[G!J_H29N6%: 8)-MKDJU)H)
MM?P8,W%,>PS:!SDC<N-?@I&6F" 3P*QBC#J1&_\2\WC4JEPE2RS/CV4FE3PO
M2IY'6(@A' R+P) BT2-.N4)&2(RDCL$;Q[Q)MI#G90KY>EO.D>U6S[8.&SG!
MN=RAJ;PBS^\5^:/=#F>-9A.0Z&H^RH]>>ROR9\*FPW&NX146&+")!I\05T(B
MI[1"R07-""$PT7ING<@K1\@2B_63.4)N%>M*?&<3W]&M%^4CYSZB7"$&<9-;
MY4DO43!<<BT%U[E MWQ\HZW*O_% "?Q@3QL]N)&+&(K05-OQ1X6'(_X$*M[(
MM8ELL_BCU:U26Y8G+N3S8*XJB)H)HKZ/,0PJD]?<N=Q>F"$N7,J[PQP1 6:/
M""8P%<'Z$8_/K:N\&4LLOL\<^%&)[T/%=W0+)4H 52J1%MHC[G5 FEJ)DG*:
M,2L(]PK$E[W:R ZFEIUB[+4SA8 'ZG8G!9L^QI4QM8+-:X>KIW-RY&FJXM'F
M!UE;/\=:7KC@2$RYWHC/&R@1!V2H,8@GIG%,,&_:Y8 TR<G<XN/O)RDOR-WQ
M9D7_Z1PAE>C/7_1'>C%PJYF)GB'L>6Y9'"QR0@3XDTD>M,%2%Y'F4JO';[<\
MB^C/TUVR_%SFS]CMOJO]L,U!U64[K'KSUCPCLS24>3*R\O=P'BZ+#U4(-1M"
MC?<TEMX[H5E %F=RX@B\(A:6+&5:">>-S)E[$D]@)C.WBJE<(4LIKT_&,"IY
MG8.\CC&*B)W1P".BT8@'K) %&P(%:1A3##LBZ<JZ(!/V6!8BK_/T?0BQ['QA
M0EWA)_%WO &[Y\E8Q$Y\&QWHG@NCQGM\,F*3DS'E*D4&?J2(=%(480RK@(!>
MX9P6&7B:K.&GMGI>H\_C#8C_DY&22OSG+OXC%(4F*H&'Y" NQA!(/T6.8X<4
M3%L(7' B2G\G$W/+9GMR\7][;1$F-NJI>B.\S8AD@$^ V= '&<U1R8>#(+JW
M%I>\8#?8M9)5MX0Q#C^J--ELFHR,$UEA+ ]<(PE< W')-#(D1!0)E0',<"Z\
M6%EG9DT]PMBNPI"768J?@(=64OS$4CS"1RV'F5)2(1<819SXA R5%#'*K!<I
MB"@)2#&?8(LN1(K?5D3R?'*=WHBK?F&<HDJ5F!NW^"YVX?\#S8AT,D64&(V
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M_%=V<+OOK8X@J9P'GPXBL,&G.6])>(#CPE^('(VP!EJ#,?SZ=^66Q" )&X$
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MCY%=9'[ON=84"!?")(+%Z)C-D5X.F2A3"$9Z[.U:$8&WGF:)[P[BVG-2FW?
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MGL!C>^(.\36W8-)XXG)GU^RG:G][W^VT/N2Y^@"/V<G?_3">Q@K Y@*PW2D
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M%+P1;(WA+"+I64)<2X^TL 8Y9ZAET>;FQ4 IG[$*XES8M10% )<;&"L'X K
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MSHT\N;!*_V+-GW;SYA)YS['.?F[ #::&M^W^L-;-;OLVE>E]BK;7:5O7//\
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MA?HI78@5O[P/($PX#WF4B1@F@%5*ASBU 9EH!:*".&:8QIBKM4TJ%Q$<M(Q
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M4<.ULR/LI:0N<92T(PBF([-2II%B,"6.A>SD6=L4&,_PV!:@(<T\V?W.7 *
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MRY>$V4@-8*.-9J-_/ISK.SW&Y<K>*V*CC)#/9YM.@5HO8-VWHT<NSY$3#'+
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MF8*Y\)8F:=)4FO12UD/(%0CL:&[+6@"]ONT/>KF<0&?0O5F)X+0)5RI 4@H
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M/PGNS85Q%1%>)+I-$&$ON$^1:D2YQXC;2)"-02(E:%0L&F]H6MODF&UP_O+
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MKXR,9_D*UO]WG!L6+4Y(Y'WFY6(\QJDR%!"-2<ES22C'.HC@,14R:<?JQJ<
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M5$0I*0*8I0"X>.6 F0>EI%P#I+MC/NXY8<3ZQFP%(WX&(V;)LDD5ID5$E-"
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M9VYS+3GB:"0H"2P1#RPA3:5#E%(OHY?)^%10Y\ENKBT7*Y;-MLW8;"N N2K
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M/X<QG'_HOF;@.-*#W9V/+%H><.1(6PN^8B 4&1D2"I3*"*%#U [?P-_R-]"
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MDR$=PQ5J#W\83^W@6J@R&6 UD&C!WZFOY3OP;Z,##U*- .Q8%9<,YX.<Z07
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M36$XT\H8Y*0UB-O@D(6(&M'H.<>&,9TW8 AX\ ]!>[,4QCT9GU$4G['XC \
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MS_6\[:=1XX]!C.=Q926/CU0">M!K_'/<BPVB7S1R 755TOI[WPY"+JC=;0]
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MWCI\30_^_- YZN[#O=^1#[M'Y_\Y]^S@]4=- \PHD8A1)3+).T5.*8VBMLX
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ML@TP<KFE9AI=3.))$O;O>Q&>;"H\4U/AU51X#Y@*[_L.G:L.()8Y<[F4,]<
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M8K=B]V;L:I")*25C.>3GD_=>B!B##<'EQ$:5 >NISM7"[I3[0T T)DI%9(:
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MI72MF4/[AJJCD]**DU)S/W5Z@\'<Y?V>\";D4SX*L7"'WN'52I^EO%D%\'P
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M>H]$G7*-.IQ'2CI/;)29 +61>,\LD=1;DT EFM3&MJ1;K *U K4"=26=K_,
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MR,09QHBA'"<XC4+QN+%MK%['TLSKOJI_FF=9^ZRBY-PH%-':" _,Z!Q,8-Z
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MQ#LW3'!!)3@AC' >3*39:<F!WL9[61/0+^>:GSE>:FP0.3DB(ZYT$-241$Q
M?+3EV4N:31.O40)HYT@95Q?\HR_XFH"^)J"OV0@7464)U9X<4SE#G$%D[T!8
MZ43F3EA@]#9*;A6"2R0$=S\5 3@R:5_#P=&^>,=44$[:3!+@4P1K);$1A:+1
MG MNG)1^E-)9P!W.O]7LJ957#Y&##[A5AADC @=IF)6<.1JDSHQE5.$KKU:/
M5_M7>24% RCY$@SUB93 $N)"+HE4!;,Y4^"J"6K26MSA]$CE5>750[@;C$V9
M*AFLY1*2D=X$CF8GU]F$P$*N7L3EAM/KJW "'Y6WO!QL XYP2ID8"9YH0Q5P
M_+],86-;&;@FMTO-05^IM!Q:5(VG6#]0A:N@,M)E6C*=R&A+&6TFB9<L$I6M
M#4HFI_2/!E34)/2+34+_4Z<W&/RCYJ)_\HD YZJC?'?'W0UZ94T)>&<<?YYQ
MPOF8E4X@B0X9]481%3&@ O%,H+*(3R^I5!(B7)/(9>Y]J)KDM+)MZ=CVF#Z^
M2K1%$&W*3<<Y\!";M,W<$L"G1 RGF6AA*.72,^?$QC8P->_)P\JURK6UY-H"
M7(&5:XOGVNMI34V M<P2DTK0D%&"N"0"49"0=/@:"W%CFR'7YJW=5KE6N;:.
M7%NX-[%R;1%<FW((^I02/@9/E'&.H(IMB)7*$L\S%91K&;,L6>GE"I406J<H
MO)J5OJ8:W&@S)I5@ E(V#J2/3CMI74[1E62I63>I!F^!T)HC==F(?#[C$W1*
M&.1D)ER'DH(C4&*8"L0Z8-&C%/64;6QKH>^P05.3I%9R/5 D,;69@G'">PDJ
M!1M%!"VRX)9Z![Z2:X7)->7[RZ!E+B'%,4A:=$E'?&21.)HC3X+E',S&MM!Z
M;M]?)5<EUX-7 F(\<:&T#CH"3FN?F5=>JFQUH,ZJ2JX5)M>4=X]J(;5@GG#6
M9"\2@IB0%$D<J:0,2"O+/NPR)G"NY*KDFK86)374*LT-3EWAJ1&96Q52LHG[
M&)?*6JS1?HO$VG2T7R@N6,6(L52A*1E1%TL,_\2YP3W3F8[.3 B8O^CD8WOQ
M5BW<[\;,]+1FIJ^MK)GI:V;Z)Y_/T0MK$(B2*AN 4V8ULU&@Q#+:9Q>:X%5F
M)SN&M)X_6':-A,XXMX.EUFJI"?@(!)+SQ%/G2!8,K#%"1%_"*#;QV<ZKD=1$
ML14L-X!%1,YXR"(;*8"+:%D$Y(P62LDDG'@8L%1VS,F.Z1/@1H%4KJ2HB&C-
M6,Z(YR:3#!0DC3(;SC>VM;'SABI4<E1RW!1T+IP&PU7P1D 2. 5-2J:D),Z1
M.9\K.9:2'%/NW9 Y !.64,<,@4 I,98#T2$I?'1!\*0VMN7\6^J5')4<-Y!#
M@TP,]8OH < G[STJMS'8$%Q&B^:!R%&-F45B9<J]&@4-/M%(#$68 $1/C+0,
M%1*)LH(9D5/9-=H$01^C7,Z:.5!K=OK%YK&FGD4;9$I4@+?!.*&XY,YQF9UR
M]!9\JAEH'HM%;,:Q(DV@1FM!F$^< "]%B '_M%;R8+7@SKN-;6'9EJZ)K-=X
M6:>@9+:2.AH#& F60>+*:0&,0F*V+NOE7M93/@_%C0*6-9'2Q>(TC<1'GDB*
MJ&DX!XZSC,N:ZYJ??O66]3R)/9BT-JLD<:EJ0'/6,& !0A92*9_5;?9&ZKI^
MQ'4]Y9$040(XF0BE,A,T%1WQB@5<UY$YRW3B$#:V-3.+R/Q1EW3-0+_2>_TU
M _V3RT7HT52A045*,X5,G8]>9)\C4U$D!:FZSU9,!O(9DQ6 V<R+0][D0""
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M7\TD:Q7?:6I1L>6E7TO%Y=^M>JRL%!5IN\>N_L[8\JEY8_?66'6MQ^ZV$(N
MQQYX2EH=I3BK]DA\:C^:%*_X==F*!=T67).ECH_7&#A]7C*@,4P5Q/\"OP=Y
M^_BZO#@A]N'W*]GW&QU?UXYURNH,<_OAG%V0<@?,"+;)Y"VMC'.PXY%F(SI
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M87+MS7UR?6,(2@57E&H,GA8*B_2R^*DX\\#D$>_; _@*7^SC\E,8D788=,D
M)H6;E_C_/@T'([PF9/ 1=N\]&UW2WC=22UH$MG?@>/RO<^PA=<&<\<#*I2)#
MQ@,?@&W#5^N$H\7@BF%53FF/M9W33#9I)MHFNXW"9493+AQ)$KFJI*1N&OSQ
M;?%*$T+R7>!A(Z999KR6+"5$@TYH3EB[)BQ%>I+%_Q.AL!6%Y',*.R *2TYL
MR:HB&Z9QX2JJ;MK*U)+:"H89KZD)]2TO))DT\.=ACJ$VCG/Q.$H:3C#PZ%Y-
MDG&W=-&MTX!T7BDBHY#>$M$&?*8#HDW%,J;V^?[2<)@42C$37$\%W%<=N]Q
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MLZF<3BHX968$TS];@3N"_W4&7?_U_P-02P,$%     @ #8*)58/-3T.R&
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M]:P0:M5]DE>W8&!E.'1(ZY?,#YCG.KA$&T$CA"<?L,D UG9S$UNO9*-%Y"W
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MW9!.I#]]>AZJ_G87-RY%?%^NBOU^>M  CWR6GI6:E.:%8@U1%+A$_X3$':T
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MR59@0).+#*QU1YJC"OA<4S-/:C8=0KHG,J]NYFXEESES:4'8VD0^U-M5#=/
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M>TU$[6K6AI<;+1G:Q)R[3XJ+1_PRF\]GW\B3Z4:BQ,)5O68IR=J^D;3F?>U
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M!4IY 5X2-(9,!86L\&Q[NE]?PSENLK32PTV*N*846;!WB>SI9#;_#><?)GF
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M"0A*9 N><44SR&BG13+!^5X6["I C]A4:2_P#OEKUS!=S(5U0&UBFFS AI6
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M@"]*@?8J>G0A)],Z=/L(K[-O0[8NJMCW=?9-[A,4*T5@G*1EZWT"61)-"J/
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M:2X.*=Y-WN)\/L);1C:0' O+5A/,6(O-*G+%><E@DA:6QZQI&]C@%MS& (Z
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MOP^K[%Z,TY>0E65,B018HJ E5C@(WC) #$:;F'/":VTK5T;\;GW!;F\!M]3
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MDWR/\Z%S+,O P1I@.L5<OP*RG_AJ0T5=I\#64NZN>JUST@(MU&IBH"JRF+,
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M.F[W,"FO"&JBI!Y<AY^VR&N2F$Y.!Y9!._*<Z72W$&OSHA2UQ)*$=<W[3SY
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M(3Z\5/]].?M]@9AES>2D_NB^L+UE(J4@H'"YJ)=AX!TO@"DFSY1BP6_5^G!
M86_+V^O^<ZQ NK\-F4,OF&M;HV:@KQEBW$BFC0*7I:F3BPKXVET[Z9 1D;$@
MC^U(OL?$ZQ(X.#3N8]T>&NMW9/P?./[ZK2[P[S@-7W%E<2_FRE?YEVOY,U<8
M6A]I.2<!*FI3AP9I8(X[I"5>@CBVQ="=RQ-:+4<7&NX#2$<82MN2XU'(61A=
M&^<;3FSF.NJ914[GHK;$JJU_GN9Z.:%%,A!*#[.H.D'LJ*J#'@P[/LFJL<7P
MZ!V(R&B/4P;!1[ZX]"6"+<[QX8/5[=A[75'[KJ@#0>VH1M^MQ4RWX]89X8N0
MU54S%I2EC21X[8!I%7((I*#MFJ8/N; Z<?BZMOI>6_T![A0#^4_O+8X7Q2/Q
M[6O/<.4M^!0LE,"3B+98*YKWECPDPZ^+KV=3<3@X'G?BX$DVN5P60T-D3(,2
MW$,=84;ZTI&KP*,ZNCC>3J[8,289GE1,5+$8] :2"F1@B:S !>&@:!N-0)5T
M;MV(]+ <O^Z'/>^' P+RN%,83[.)*7OZ%W)Q!E0P&2)*"QA=-HPG;=71=!7I
MQMKK NMY@?4!L2-,D)SEO,!-.'\[GM6[Q L+*]:FF&D^*DR2Y5 BF%*0?!@?
M(#">P2,KAG[A2OL;Z7TR=$*KYCC2'NW@T5<$*6YF+G;>D3YA52[]_,WD<L'J
M53BOK;C$R$:7E'0>&-9I)D46\)HL;B$X-Q@**K?5$+"N*V)8-D]HG;0':JN^
M;@.AK*^$QQXL=S9.'Y,$'P59F/*<04)!DI 8R5"E;V5@6?C$#>_G,M91</^Z
M#$\>DT=X[#UNV3[.,OF%7I/1#38$!RHA@^A5 (?$KB-[/)5>'*EAV7Q=;Z>#
MLB-,F6S>8LZ^?IWBUS"OC?RFX\O9."TZG(VDU4FF$@"U(4696O/GR)W,RB6>
M57+"')N?M3.SKXOLU!#75T:DS>[R,V-\%(M/:$RBK</4]K )(2JG@?04=##<
M&-]+ZK$7;EX7R]%AYOYJT,?30C+FE.GLM.!<(/EBYO25MJ 9YU887XSJ;Z;C
MGL2?4 O)O4)R!U'V<;:0K*$,;;2#S&N /R@#410/J$1!M,IE;%T[_,Q:2';"
MP),M)+OHXJB*;)_HW;4-3Z\M)#NUD.P$DR%Z\>VBXU/!;V"ZQ,P1T-D,BG%1
M+24%UA?TVHF2^6L+R=.$;1?5#MI"DHQR%0,1)F,=*Y DG2UUK  &[D)B"E/S
M,_FYMY#LI.NM6TAV4=3@+21_GUPN@Q.?/O_9I'_D@P]LVSQR,\WK(]]4<+1W
M>*LR*NE=9%XH4@1*6:00=K3AV0=O&ZD3$1QS!#H>:5?4M0$Y,0)6165DS-EA
MZQ;N^U-]L# OZ7"Y -_]]]5X_N/]Y8P\IL6>\,A5;B8)'\I*\-[4&S:\3HPT
M&I2)BLE2O/:MN_$.QMP1;LUM\=XL5MLK;(ZIW^1]_N;?</KE6[CFOVZ"WQ>;
MX'5S <VUD$%E8$PG4-8@Q*PE9&E-+4\-9*$=R_KHRMP)K8]^ =IJ&?6*KF.Z
M?[^1T9_O>(Y,TB(6P4!+N;C<XB&(E"&0$>B2"=&;H^G]W)&WUT4T]"+: UO'
M-&-N(Y]+8_R&SU2L+$8)R,Z0+R65!J\CV0G2F!"RL I/YR3ZF;?7-33T&MH#
M6\=4U;*1S^L[F7=8]9X[4;0 ;JP#%1T=N9@X1)XC0_2YZ*/I9]B=O=>5-/1*
MV@]AQW23=P?K->KB4X"B:PFX+;H&K!/DP#13V?%<V,DLI2=]HZ/4PEK-XL(L
M>AOF>#.5].[B48)I*[@#7U3M3Y1KJP=;0"1ILQ6))7$T+;#Z$<$);8T'C@8=
M 01/RMG=7APC$Y-+G+28-"I0/$J(T24(K BCO"@\'LW@GH9\G]#:.P;P'^%"
M[H3<DUJ]3[8C>T 0@BM30K& R9(9*EP&9Z*!PF)!J5GF\G2LGH[,OZ[CXUS'
M?6+XA&-FFP7A>9),&06:.1)$B X"%@1K>8G*&IY/-JCVNIA/=#'WB>%3#-[5
MVQE;2,%@D4E9B+YH4-Z*ZY[T.:D@E \FGHZ#VX7SUV5\G,NX-_2>9LQP"Z/$
M1/(O; ;FL(X5RPC>%0,956(Q:A3B=,[B77WC0][,4EF60&(&%VLU@F?TE6$*
MO,T\,$[>GVH^M.\%WLS:*Z9W$&4?Y\TL[4SF442(6!L$1F; <SH%K*5CP&DI
M;6I=5/+,;F9UPL"3-[.ZZ.)4;K9LP]/KS:Q.-[,ZP62(*RZ[Z/A4\)NTXUKI
M.K116U!%&'",&'22D5G%L\;\>C/K-&';1;4]P/436;;3<6WFL;@]\B<I9/;I
M\Y_7EW[06I$9D:2C)/N&(=DWL2 4GTL5H+6YM1GY)$%'Z"#WKO-)7PH;Z);6
MZDK9+WA)#YS/?@_3VDS_.^Y^3VOC(UO<U.I&]]I=+6V3--)FYZ)7685H?(R%
M9:9YD8+YT<:G[[>LWU:N,5\_O<+OMC_*K?LB>'*$" \Y6$)+$@Y\M@$XIJ"]
MC(:[UH&VK0C;=U.[_Y(_EH?%XG+<?XSGW\Y2NKJX.B?G??6IC_%\_'4UY.'=
MWPEGLX^E?OYL-L/Y[*:ST5-_<\22=,R3/QAR%2@SM/QD5,"CP9A"9$7W+]!A
M>!U^*VZ/Z?6]]21PT_ .%NUZ#_!,A%]=+$-??]9S+YRG2G>=2(SS929CG*X_
M_V8RFU<M3*XNYY^(MS^FD_]<M :[SZ.UCAOF TB.'!36/I:H/6BA$RNYEEGJ
M#?O^D/0^)WP?K9X;&K1#\OC^,DV1[+VWN/S_2*08M?<)E!:LYNTRQ&#K_  9
MF<N9#OU\1-A>I_\5ZP? 0<-BC*X\/\[1NU+H%Q_+FV_5OWE_>5<.(Z.%,5Y+
M\IUK)V+B"*+4"IQ2D3/2%%N?5;TWRG>C]"7C>0#=-JP\Z,K=4U;4D_Q97X+R
M.0#CY!.K6BOE2N)D<'&=M43DTC7&[JZTOF3T#J+?'K+N#_!8.TU/Q^'\'Z2!
M#Y/9;)1<+)P !38P.B%B)/D)%2%E]-$4$JIH73"^!5G/"6U]::.')JP/N)HW
M/N.7,/V*\[/SQ5.J]XG3A)?S\!5'L2#*6E(2LS1 @/>$\)S ELA2X1AB:%VQ
MO!NE+P-6S776</K=PUOOXQ2OFGI_F%Q^K0WR/^'\:OH3'S$RP34''W0F/AQQ
M9"2"2,KJ4$R=Z;W3$;H[3<\)90?55P^SXN[SLIC ,(Y7BX/_EQ_7(?#IB(21
M&/>RIBHD$5H0?/W#">F=129#CKUO:H\0]YP0UJ]F[D/(-8+07>HJM;^%O\<7
M5Q=GEY=7X?PGT@G]J\3*]4(8F50\([1#+,Q"'34 0;/:BC,(@9)KG5L/NVA
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M#Y,DD_<=XROO-^8,;8(V#SACJ&>@!V XP0!X0/\!T'8 IW5<_!ZY EP!],%
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M%A%;[;CRJ-_US2J/_<_<5]$\-8W?'R]Q/*]BZ$@;8KO N&^_H$\^TTQX2?D
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M&Y+N?./BFVMPG,$<\:I%!P1WUV]: $-H&T5[1^DOZ!+>8*>WU8V&D% ^1="
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MOOC#:[YUC?1K=WJ<C*GMVX\0F@MPVB*%TEE*AM##2.K@VS\A\J^;GJNE8C^
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M8WG@LXW64,$W:Y)95G-IV"023-16#EX6VO*U-+%I KJ9H=TJ-4N7CSS&>CJ
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M]W];RG3AB^'&]A1&EV)#JB5<IP?X&Q@&WD #='+Q0B\3]0N()7U6N%<G'-V
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MK.=&@QKK+Q17YPD$2G1+7(P1*9POZ3:_NBAM)-?_=U[,H+QH(D3]JU%:,@W
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MT^XQJ?UB4.6GG 7;[_'RSKB[=IK!]>:'EZR]_&AZ11J%U/9LQ^"608K4 ;"
M*E+P,>>3L3VG]:KV#V]NR,@5I%O=<>E0\$ZW_/S#/YHS#+%=2M*$MRMKL6#!
MHK!?:!0-$*<E^ GY8CM/DP;@)NO8A^]FG,)VVL&R?YY\Z6WV>J%^6O+.W><M
MR3]AEVB &$,03UA@!YRY39'\Z!=,:;TIC2RM<1!;0%2>(O6W_)JO(UEGJ2T\
M\,[PU_219\MZ_K)S^5[8N]O^@P4CX:YP2U\J>NSKYR_A#Z1MKP?JS:926L&5
MF%]S*30 S@P^@2$$XW^6XJ87>KI?;*L-L.L;VW=:B;C%PS\U)#W:TQ?Y/:?V
MBJ<R6;<DB>MZ\B-=[_F5UL!OXBHX9!I9J31L\>NL9/68JH_=3\U6%<MAWVRO
MR"]2]WH5 \[+;_S0.2EZQ@N7>7_X8'=RG)!)=]ELHCNAL)G:/];BAYMS&M$2
MO%HKFT.I=0T.OUAS-9;X^M'"T,5/[Y.;KUVX06*ALM;B31=,R;SJU%->\X@S
MY B<[Z?@125#ZL8<%M71'.LRHJ:Y;4BP&E;M2B;_&*H]ZK_T>B'TT>58+WGA
MYZN698F],A3%;>2G*DGE6(U+03/3'N&:Y>MK4=LEU$$PBQHR+0*QU55([-B&
MJ0]"P<RHBC5"4U1GPD-WU;AK=I&QR>U\&6<,OPVQVNH\B67>V/9JIT<V ET3
MTDRZ1)9I&P<I;:9[S?&WG?>L7  GSLKJI$>6_2BDB$N2KS;T-LSR"=U+7Y+/
MD6A=:!4Q*<H/+U<?1I'%5]]:6B1OLP0U'=( SR8N%"3^ZE\#"6W")YPNUV?-
M>5MS+AG]\659FC;%.DU"-!0N?W:5.A-P:MN)A$VQ#9[CFMR8CW9_9HN?;+I(
M;D>^6E#4+F7KJTK[0S&MQ+;H8C542LKWX/D1B1>0N:!W_]FG?12ZX+XJ_%?3
M<3\Q'6=ZXT</&%8X*&L%9S%4D#/2$_D*[0NAEU@/J-%GW&]S5]6!BX+"ZU(5
M-C3 8KE8%)@%"T(AAIJ&!#./E,!G@4K=-NBR)P?VVNZ/D6_'<8T+K\QT81NP
M4_^7)T&L5#KA+YRXB4;T&FQ'S%_<=E14->7R"-P0J5QZFL[9<L%QFC'C22D@
MP 2P--XQ*T)WG4KJ$((73J\FPO#V&["S4%9< ?0J+JZ%4!T&L1E5MG8852P(
ML_+*]Q>Z:/]Y_]E>?T!4+_-BK$I'4O_GUW(?[T?4+;N\A5;/K _"M)5#Y_?Z
MG31.!V7GF#5[*'MXUV_0 *<;0*0*#W+H!W"<&I"?"+,>FQ^6:HQ;$#O#_L8N
M,ESD^@=+BWW##,E\D_Q72+/$(_9_;#\GA*UVPG&&?9CI3()\IF'<V>E38\?[
MG8*G44W -P'9 8H7I?Q$QR\-R(##UH785[@N^EAUTC_&[C575X4B"8;=W.S2
M,'U>I<49>!6E)8+%,RTU'0QL>J(X5L+$)V[5?7<]ZMSJ9))R?2&:=#W?XG(<
M3X9?KBBYU]&V+J?/.K3FUU:X4H2M"S[+SJ%V:=GWY_I5:J2M[X'[+T@UALRG
M0G"E-!?A^2"UJ 0U)9T61:73G]4X)>PA*MN@T"Q4/V,(-.%*ZFOQ^NT#HBN]
M=9(CUI)N0>5PB)YM4X(?4:64B+1-,ASR6_TR7@^O7B=<G.8T^-%XSR7;0_W1
MM5?R[S,$TD\\G2M"X(S@1#G=G&T:@ 3:1/!I>6"-P.Q>XMPC=N.=+]N#[#!]
M>\][ Y+)!?RS;-72=UUVSB5BOX=%"Z<*)'9J6N9F#JH)]LG4^1GSOQW963@M
MEF>?6(';^/-AH=ZC-U!7VWS<.J@.]*F@C??OS:9*L@L1A>-:<-]&D+2@YW#;
MX]_HZ31BV%8:]0*I+#$*->*0D%.N.O^X)\>EG._[]ZI,@26QY]R.X&U'>MTT
M;"1:DYB(1@0RD67>YTIGFQB>CX!W6+>;6<H>/R.<)/-KD,41;RR:WO1'RM4^
M-8IKN[]^*,O$1U+<)Z^ZM3$G&+X_67XT-W$]ISX%Y.BJ;#R647\$<7<_JAQ&
M3=19?W4Z0X>(I$Z A?ZDQ5#5B5PDQHU<&N YV>?CU"01U8G3&IJV_:W:KOP(
M-:&N+PIX.6[Q\473G1B*K><6VH,&(,K%=YL^ ^+,$/\'9>\=U=37[?U&49$F
M79J""D@'I4J1_"R -",U]*@T(0:DMY HO4=00$&(B$@G] Z1+B"]=P("@I2$
M$@*$Y,9[[SGC.>][QOL^YX\U,C(R,O9:>\TUY^>[UUQS1T+*(B.03G4^Q?2=
M+,]K$-?D;F5JU7[,3H(^+5PY\OWN_L[7D[O<'G!;_VYOAAS4K]>_<+<7+%/\
MK;#OA<I;)SU,>?EJ949=]I>(PPF=%>Q2<*H6%[C4O^4_,\7?X9E.M?. ,Y$T
MO*\*U/G.>9)ABJQBW0W<4T ?\8!6CK+'NI&_'%G1OP8>TG0!#M7P]Y0A\"QR
M<:<<B,MKYI -$#Q3OTS#3FR0XHU+T4[W?BB7+:(.M>#K)__0D/0Z<#&3"JB"
M)"!QCH@A--T.V;$XRH!M 9IY=^*F,G['>?>Y25 U;YMZ(O_Y)Q:+S!-U9%F2
M-4XN-).M!B_V9@%,Z:L"6.L4^R><F*:(7LS+J[#KDWYS]LOK].J$1WQBF@@!
M%JL4V6)+JY$:NP7AH8[G>>,MPSD"\SSK"ZL(-60+FX;8$A40"<2_8MTR7-R)
M*=/GB5K0)USM3?_\8+9#)4HZ5W="(SE)]5DRR,='<8!T726"_&S)G21[N.5,
ML&[S,)CGJAIM!,/RYG7>T8%\EK12AN4#W1QJ:GTT$VN*$=_(KJ<A2"<@2HC;
MFPI V4GC?7-R2'OZI4$"( &2>OO$L6 AT?R\U=SVRYO1JZASK\LO,[VKX:XY
MT43\P%9@-O/QU<N+:YL'^/Z9UFGN7^5]\'K8[-+&=@ /=%;?=U@@VDF8KL^%
M*4Z6%\:[EI-J&K:8;E/V+C6]N9?<'U.7K/8V77=/[S8JJ7J'C/H!(5W3CLZ!
MT.XZK2^N=WU7QT3JRB!<Q9_B%%:.,D7";D/NWW^#OJ\3>)Q-N91R#=DB)><9
M2#K1H7B!A]$ 6EA+1I:B-[$$3R1*Z$SS)0C)KZ,FQ&S4IQ!Y!6K<C2C_(9+H
M9F[=I9_LPFU35/"]/$+X&O\FTG5@$DUT.:W1D+)?A$PCO_-HB@TI_L%66;O0
MMP>&9Y2A!1YBN'/:]:7RI+D_W;;MJQ%(<,V\4"F_/NB[ZK<#0SP<[1K,M&>^
MCY6&31_#!SK0)(FU<'A ,;*E#ECN%^W-*WMS4!':H#PQ3@O#NU:V.N[2K[V?
M=#XZ%*0SR"YD/ 6>)B%4*:V0:IU->SR46$!*=EEDL3MI#;1+YXY?BY*1<9,E
M*RT!WK:(5@H^E7_PRHW]G.MKC;#[/RX]F:@@\1!%3E.;KU+Z_8#EFF_P)5*H
MB(E7NN>:V2>J])N,QYYY,CU$PU+,$VZU!7[A-H/7OVY/VV.=2J=<I+G]<^.G
MB9I2<IT#;[ 5ALFH:-@OYQ$E&1.+IM'':8]:E'O]%&.9GKX5H?,_]_K[%2/]
M\U'9EKJ6N;S?,O8]-BHG\(RULTJNERZMY^M^*RY(U2E!1XMM19X@:-.G1@4X
M8:>]<-@6R'3FH1[-<] "9(H4FM[6C@39PF0SK"D3;-+?"03'.Z0H_[-Q[W1*
M)MQV[. \C3$9:-WZ?1J'=,7$"W*<?J9HPB^5$GABX>PK*-:-&IY4]LU'*PHZ
M5\JZ;G1Y\>O]W$@JS).>??9!Z"7F?EI1@6'_^#J,XIQA-N2-ZPZ:L=[:U>@"
MGV8A'3!16#X?Y&1A.Y(#?KV(-'Q70M8''9GV?LA0(Z5<6T1@Z]=YA],9Z?!;
MC[3-KTF=14K#D(OI]:R;733U+ =7K3I-4-0>(DL P[X1:F(4BV\EPG S 3>P
MY9G,S$>O0#>T.12^0Y,*SE[K^@W<DJ -(>XT!.NZ$Y]"!51&=J!"#XU(N[/?
MD3@I_%KT <O-79.S8=$96V)Q"E\*"KI1MR0E(UI?W_5;Q&XNX[V(B.I13APR
M+'-Z#YRDJM3D;C*Z[7,59.H_X0#S"0X0J5$1Y5F!R&M/7^(Y6^>**WCN*O<B
M:25Y!-R4:MA\^KC^3H&_E?N4\E&V4T:QWP2RX<%;4!2R-'?KQ'D9.+5.UEH$
M10_YNQX;JG3:749W-RESA@Q5_YYT?/2T1_1Q0IC4!1-4/Y!T0V7S7A&E&XVW
MW)F&MF(9,')NFMPDN8=J5W@\?SK$EVQO2V.*9?@&./K<&6>UMP[?GVX&?#JM
M*:1-/@]R,3-UH?+\SM;=SW"Q<?+MY;N/=Z'%(#,\"%45SS;;IW YF6#OPY/:
ME&"A4WI;Y*WNS>8PD@D^%)?Z?>>BSB(P;)ZI;+#R:Z9^1'4YZH+++]CP@%22
MG4M&^8!4BM]S_=L:@_@Q*?-PO7PQGJ"2PNJ%529NO7"^D:\SQKJ6,SH+R(:'
MKM!I8+C<.:N)Z/TF3:-OEVM#MBD79S;#F#]R?T+L #R_)YR'OSF1G+9%MCQ$
MND9C%[.:9:H3FWG]+UGW,1']ATN>A(TZB+3E^6>]/5#@A@8]#[R?</+@COW^
MVA8+7H46J2LQ+2@V. .ALZ;8XD6F6)FR57O:A2RB]4>8960ZX+V$9)+X[>9;
M>NK,<:OU0O3^#VA_86T4_>;/VL+/79V:_:(>KJSV.-V1[1$,]N6?Q/88-<F"
MU_2?2SZ.).O%4 &,$V/[1S*GL,F57'/%=74X"*0UL4K<QWKA;2E*<-/3DDH(
M21R\14>8Z*AO1,B0C*6OD1S 1FD,&KQEKH<%PJ63WZ>[8^_8!W!"NS^J<*XJ
M(\'(Q7A@I5@'>CJ5PI"%+USVZQ+(=VLT*G!1,3].R5*#)9&L%FRL=#S)S)5E
MWY-N=_W\^6@Q!A)'$U>/L)-=RWXHN//RG%^;U6K" @>N*G;)+1F7@; 6D.,N
M;ES7@+R,5V46^<?JD948O'H5MH7.(K,L(NG)"GBW5/P>[C!B<S^8]6%I3.^C
MX4K2N5=6UIU9PM%<K[A- ><]%O$^O\T]/Y44311ZNNT,O?!=]O@0N,]U74 ]
M]_=[8Y? )D,K\2]-"KV,!\@WTYAILI)FRE9*9>V1SA>@\ &+G9$MYOO<HQG_
MS&#5])6ZJCN"15_9CR]CY%1SMCR/CJ"'R.]U&[^JFA+L+PV L!06%)C& (L#
MV'^[&@')G1@U <1=)TTLJ>-/0EQEW'*GV6Y0 5-2VQ(Y"1?3 JQ=;Z0\#SHS
MCM7P";YO:VU6/^8D%MS7UG-TX"1"!:B="K35,UH4'#1HR371!',U.HV4:-O%
M$)E-'G:G L[H(K<Z L6_8,V!HO]Z60TI"J,S/KMS08 *>(J. 3(W7YDV]"K>
M$.1-W#]1?V60"F+ZNGJ.KO!1&>_W;9M+!T>$$PE2;UL]F"R )#R>_O,D0J+(
M[0"F3)2X<B%A-2C6XXJ#X -V1?^K =S'1W:6&$2[4-EAC(8]$$76.E'TE]TS
M;VBR[ITI1+%^;]U8T972R*]Q* _1G5^L#IH(_>C([6$Q4#2<9#B2K)PYGM)G
M71"L=J@SZ/BQ0_HFZ\;8\UFS1Z.&5H<)ZPO9MH&^SJM=;9@0)#OE;V9.9;-Z
M:$>@Z*R*IG #A&V=*-_>^JB2.+JI_ .<9YYPX9-@^A65!Q #9 L=0@Q^MY9&
MG7XD)EQ&35SE$?S>R^.MCG$42T]31Z-4P4^#I&O=\1X:(I<[X1V=7A 89%W-
MKC"G+VLC$-;4E]S7<,_#64.2H,\I.Q[_-DX^681;^-P5,,\B< I*="'9XHHA
M+>A+"("_RH-AC7\N3GCW*;29#[;DY9^#97"?[:E]?K;TVME_ .86!@G?Z*YJ
M5TE\R]*?JCST]</VG<X[U38>9P+IK,(M%-? T]^JP3;5$^4G9%0/*TG%:F-:
M+F*ABJE739P6YJSUX2E=/=?'=A&APGO%<J1KJ:$^5$ TNC1RZRY^H&68"FA?
MLQL6>CP">/75QL;%+_&AU\S:LX$J!)J$)-X^1<%%+V1!<9"I![B2CY>+'<8#
MOP8BWWB3S'>GHF28LZX+.CB\UE.^=\VCPQ5^ZS0-ZRP7HI;168.'++*&P*\'
M!0 BMG=:*=P5(RN9TA&3.^=<+3W/M-SYT?=J\0Z4/=S"HM^E0.^+;W/S\(EO
M53\9R8DC@+C%[^5:CK@2RXF^"TU;N\ ;P,68Z85-K25@* 5XFDP%P- \LR1W
MT^H)YWJ85+L0A])=^L?8<G_[F" 7F>6&B+F5A$=7ZNMWI*YM"*L'SU 89W!"
MK]&LR,78:60$U@G#T)?E?[41ZB(6450BFA$VI.OC)5$;U[\CK'5;3HTC0)>[
M],SW$U0GL'1MTXO M*1"EAFX0OEI1S\&UQN1'O[#,R]0D^2R<E7D;7)[R9VC
M3YS?U][8@FC:\PWPG*;RY-0ZFH_"0C+I&)_VJE@G4L3P6U7'U@H OFS+H1 .
M6AAV. ..Q&UJ21=\N_28Q^-5W"CL9OH)J+=\P=" <$4GLCC=I%/K<8^>9VCR
M4AK$,> P")JUO(#798*J0T@W)UI(1?9:#W#B<R'>\\,_^A$YL9S;AD:D'9H$
M,SVER0+GA1GU5DB92NR^$-L AE2@SZM=[.@B8#G9%R"7#+L2_DG=#=80D\]X
M]3'H)\^"YE6X) F"1[;1O&HT7(3D_MG?6H^C,ML OXHZ']^\-]98:P86J^LT
M=/+/)@:2>);=HZ>!G1@>\@W\=N[2 FM7A1;A*O$=5VJ*'H,C>T]OG6_*\T9R
MSH<X#NB,Q4N?*^<E%<5X>S3RJTO2K-0#J0#; ?:E4NX*QC$"V_ML3:<D7Y<F
ML\.9XTU?12.M0.?W__$8@WM="( <<\7N//A[N"U]XNO?(P'@ BJ@B94R8.?T
MG_O@'^7^_WWP]T9:\-N';_[MW69:LP:RNB=D+-LJ+_N>J6-_MTD%B%'Z+,9$
M<]JF;75\A.9CM'R.0]/Z*^\62SRHA^XH9IM,F<>=*%*6?\=("/LD7WZH:@X(
MW=*'?$3G_9?C2/^'QHODK+H\K"G@'VJFW6;]N\;X^B'[;:%B.#W$$S&D@GY&
M$EZRW(N?ANI0 <%OT2=*<!5($<G/4/J\RV$2Q)/FB1 /EN[JKW)=GY8YW:$
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M&4H =@@Q^6 OP?D(5:@(LF&PPZ"+&B4[5Z!V__#YF?3N2PU3IF5/'L_-Z%\
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ME%V]\PE[I^WDSK<<D!\B"0&MVQ1>1K95B3KPMW3Y;]ZX1O&B.S;U(GOB;Y3
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MM5TD8\ZL]P2U=^WY L=K"J6^#P:C6Z8=')"][V%'><#Q*NC>2].Z,I/@&?+
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M#<'5'44R;<"!\_G<16Y4P)QYXFLGXI51NTND!GSNDN!']R(2_9)=:/&TK:T
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MF=UQ;#I>[N)'K __HN,*Z_\=TD$T#KO0??T-L\6:*N83]N5.F! ;\(4[2<(
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M=4U'MDOO?'3!-KL-NHTNM""\% TB7PO?NH,Y=XTLN7B#T-F0:[IPE*^38D9
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MZEXXJCF$[4>!X?A825Z8_S.]0>V.^OF[W8"/7S,$GM. ><@698S3,6!:C&'
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M*^H.<%<5J4/T+$U]FM!5YQG22Y*07<[G3HDO'S I-1M>*1036]EY@SG?S(T
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M.C?,@OR2K#4S]\PUU]SK7O3?]&G 22,]0SW D:-' '<9/P#Z!H#KV@/8?1>
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MS.:L"<34+5$QT%%FI=DXN2']5[V4AO68\ ^4/SEJL2OQ#6T T>*D2,"L&3/
MS9]T918XJ@%U9#4ER'[%<'?C/38&4JL#^^].''U_D)?ZXQZ;WON*6LO;MD]
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MOOT.:$*^!O-N]1=6%&[MSA'*BO+Q![+#@A>3=R"@+&H]&?[9(VFK ,+5"#E
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MQ+!Z;**F"#; 2*E?/_Y.Z9)?-OLM2KN&D 7N$+T8J=T%51_N0Y8J42+A9G2
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M0VRV;!- LCP<:OSY@_GS&/]<SA=9YWV4ES*V^\LW$)][H1<1G4@N.,\'BM4
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M.'/%=UDY1 V'ZY\/2ZO4OGT CHF<=]L"PZ) O,YK,FG3\@31>6"%BV7TH.Z
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M@)_?@[LOV#IG&]<KD.M-W4G*8GTOG':NC<Q5S<T.H;0&%7&1>0-2<@P[FUV
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MEP]$?VXR><<L.1(J)F^#5I2=K%]%JW<:+GD)'OV9&L<,G-1H552)Y!R,T57
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M+=3W3!JJ!Y7P65O05UY-3Z *"M52 :F!YB]H\5XHGBW>NKS0LW(GTZU.S%
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MF/E_N"V&DHQ:"B*Z4>M!A/?(X,)MSLD?J_-NP:#--GH>[D!^P+-2M=ZA.FF
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M"NZ8Z^]E35![_Q:[#*3J;V\_G2!K%A,+(<G6^//Y"LO+K:Y)WNAKZ'GFN\R
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M))ER?ID&>-WG%:HYO89(&YTHA/SR4X:4PJ3QZ7CU,(+0^EO?ER>Z=%?N;]$
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M-9KPSL<@5K& 8=%=Q 9^)X:9,D5B08&H%XD?ZB&+Q39MX:1 0O:M+C_>;W'
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M:8!N (X&(%6#CDUE/-W)L;MZQI9WD/2P8PXNC;W94QJ_0<_$PQD^XCQ&T"_
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M8NL8X<@I2+XQ!@.G-Q=._W8ZZU#]I=/==82[]*?Y X[LH)&/45]>:[L?E=(
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M\ZILN%E1W.'NM$FN4/3"]<DBW",G Z>484/%%4/LM)O:OGI0@;4H7N3#/ W
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MCD.QN)"8V\GTK.+NA<?WY</BI5>Z#%\7LIZ;5M=<1!+O:,ZC6Q"1RG(?&F_
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M"<T 9_6J:Z\^OE*,\"A(.=?J::+I)OREI73E6:KE^4L_S<1<[K3[#K0!IWS
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M#FET0Y4?1A[L,'MQH#7"VGS&X^:G)T5#BBO#ZA+)J-F/UY]D:_?Y?K0'1-^
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MK%H\R9[>3L'S3IU5G#_QGX_;&PJSC'#L\2Z.QM"#[%<%V5)FV%E82O* @W3
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M0Y_?E25/<\+W> T5GS6[-'#X8!Q?P#E5.I"0DKM@@-/ =0%E$(H&C A*"$X
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M3-"?/-?&6J(>?#;Z[+1[O?!*XS5Z)MW'A@L(*; <Z0VQ&'*!M=ZHE=Q23)T
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M\I0HPK"DECDBS!K.:Q+MY(CB'.C0'VYK2DW)9@4\-ZR<CGY;?"'O#T-[INF
M5LA.43/[Z@<.(BU=9QUXU'" ,P9[P:D)I6URQ+R9FM[@]G<57B$N.1@Q<OM4
MEU2EL>7Y+Z)U$<\/J&X[7C^8WR+M_O6)VY3)'<T^B_/O$QJ^W9Z>,K]K8E[@
M?E>_T45)?+_%/O5[\38"EQ*.R&-%T,8H'7"+; E-APMT:WU%&] 6*U29$N'$
MCG+W@N9LRM6T]$^W- \)Q?/5YW5'LHOPY )88^1:./,8F,/(8Q=:*RT@Y4[3
M_>].66PE6UG6N@BE_)!_IQS_->AI5VH%7%\#%UQ=_7Y;_)H+/_,"SR/>/WEE
MV(B1^HKF3DU@[F;9T*8)O\^,WH+.\=LW*PXD;SHI*OCBDR=,_MQP<K9_1L0E
MB0F():M!?5TO-A"PV;#M7""P(64*+M/-CW+]@+I,>647'E 'AI]+_S%G&W>?
MI*!V\+W"#@47 ?[^B'. JYWTOUO<19AVZ%'X#HP_-,5AR:&O)B-?H"-1$?VP
M8N980WCEXMO^*ZU)'O>=&P58;ZNW-1L#4MX+R!26M!C#9!1S'3[+0"1,+^K>
MD3N#FUB:1%E65R,<C4JSC\&-;01S\SRDR9^N?]SO+K M)Q$6^NHF0KDBT5J'
M,^+)2 B)6BZ@U66_O%SI%2S[@O2@+.]@/6-_EV#? _$:K9AD\T_IFZ1Y"$<4
M;[[6N63YM<N8J0,.#Z#E/[3P75YR429TCQS'=2ZTD-/#!3(.E'&H3:['8I\O
MV:&^,"'H6;P"S \R)\&CSSGSCWKWU-LV@'2U\:Z;:UN"+4EF0U*X)HDV8950
MEX=)!;O] MZCX2^X +E\:TL1NS92A7X/A:!@LA7+T/03<]"DGP<G *IF2D=7
M/O_6#8)DE,^9?;5G=0QU^:,W&5L@GQ]3T8%Y\V2U#T3HW;.,!Y<WY*B(0_<(
MC'V/6A\FDOOLJ255EJU9DUFT+XSUA+/@.'D]#J[ 41RDJ/@NZ22.PVGG6CNV
M&(ERKO<#0IQF""+QWUPCK[EJ!93<>\R_ 6/)5)!/8)HJ6+M"*&UKFQ25TXL>
M8,P PVUNX>.1'.M('+[]_ALN(/JJ+ZFW^*&-*WHA;W6*"[0YK/F@+"Y>3,5I
MPXVL!A!U"0DYE-E.Z]D22 -:"[U "X+)LP)H#N1IX@66=PWJ(.W1=XY9P1<?
MIH!98Z*[EZ.\C7'QM[L_9GH/#MKJ'N(?X^4]9 Y"(5&=:0''P&5:ZT:02=;U
M[8%+'4?RO8YGGG'T.^WH[N!V-MYFP$8M'G,8?WGH5PAVWIPQVTX70;0(1_1;
M,NV-C+;Q82G"TI!K[A480N=FR'YT7]&?8.UW.,PN(W<74K'4FIMV/!=H[FI;
M\HRUWBQ-UP7^)7:I6?AO 2.P=5RW-%;T?VNI/[!,HDK1]!A>8&@,/8&1#C:7
M@ >(%D@NX#1E95/YK,OKA6.6N?*0YJ6D+'Y+56FI?N!VQ&=,"Y[:R=R#[L5*
ME(.-S LHQ >60ADEJ8)QGQ#R:,LU7Z8.=_GYRWP!E5S-G8?4=H1\YE58#.T<
M:6Z$(\I/KR%B:3_69P;(*/$$[[@N+_K@TF^L?<N4R:C:YO31)C%&1LI5B<\?
M';LOA+4><WD%]T$=9Q?! D8RNZUI#?U&&?#M5J9+\)V@HE<:"EH34G3,_6S@
MALOGWTU>#Z5_7T=5<BZ_GMEG!Z",N("$*Z^Q7.-=O1K3U\:0 5W,UX9HU[>2
MP6FZKX-'EVO-O*IXT:G,4S,R]S[[MQ_TN_3Z*S'T#I:I@GX;AGX-X[N%C_M.
MKQB$[O1O:G_9\8H>T'?XQJKBDU_O^MZ9O-^XN^^YP\U*ZZ\'AU;OV/]S:+A7
MQ>'4^*\LZSLZ[B^25Z=69=-7YE;4Z,.\UK#_Q=_6(!0O<9*GHQ+]$4?X+&V$
M"-UIA EL '<+#7"!G>AAO)2AU[M.Q+:!9J2OYPTG$4RI(_J=1D"LIG!-7K]*
MS3=L-A0W323-P!D>+CG05EC?_9R3M"GL\WD0W_?G>H)5FL%$@T17X9Z0ZTV.
MN0\?OSYO&Q64__KB=.U$9,'MHJ3R5CE&XX@ '1=NNW^[DV2RZ NKG39J"5.Q
MAV!Q6!RDAPO,A5 6L/W8V?6E@;AEF 0IYV=H +'C<>1IV1YM^:>66A=C7\_X
M6>V$R,RX]V*4>84L"2ID@-;P08]R =K)]4Q5-78A>N]%Z/[E<^#-]+GM+\AY
M4JZC%S.\4C><YN*-\U\F%/V"S4@-\L+B4,OZ+A2/.<1GH:1H6B<IP\Z1-"[0
MWY!2]-L"D[[57&5;<;P[HOQUI>+1?M_=1R2-WP%W#MB='4?94=C^?[B \YCI
ML&7-$T/*I0DJM3[W$^Y^F8?LH?-.QHU9H[VM(NYG/R2X__O6WQL.LTO1LBPG
M\&$I$KU)@?9EN(@C4XBJ.BD>+SHG3)YWM7:("="<0DQ"]$,_#ZD0J_Q"B95?
M!*)EI/DVK..80J@3((&>3%PRI\(J ]V*$(G=.@O(YF.CJ,/7-\PJD!\\]<]:
M;1PR]JJ93_AT;;$?[3_ MX(/S %UA*@OZ9V,Q,EN*V0 1U0PG#S=T<;<GE^!
MC#S>T2:K>+/[9RM)9:QP^/)"MCG^(+"W81YW6NAM!X(E53K?3WJQ4L74XGS
MRYD:R8=8?%[[DURQ7!-+O3W-N?T])NZ+X]H)UW+C4*--#9DW";'=?.R$+N<J
M5C2(H7]G)-+K<VM]4/JTQ&B=Q)]LB$N!;L5C/<U@\^WNOEU5OR]?K-XG\>J%
M(,_N .H=G9^Q@V[XA#Z_!!F$SVX.=-CG1-#/]NX*+#8<__7.VJ,T_N93.=<V
M8XN5(R4_DE[4][7^&I)9A3<AUH;)B%DQLG4*#=HC]2X\J'R &EYYL7+7XL?7
M_9^?])!EK]SHHIZNR6\S_?KS_PIF<)I$F@ER.[/J^6S-;.J#O4],1MHVK>!#
M^F^10'014-2(UD Y@C&T#$)T2A\FO?O0F)4IA;W[XTAU2!&C3.;9LW+?FB']
MVLJ$C[D^".8-U@GV"[0<2^ZD"T.9_<0$D^9C-1'QP(3I?:#/>O=)0^*)9+L[
M?[*&6Q4#K^Q]]#2KP &R\3@36L!1X6%&J2YOYG'DB NXQ:N8I>RR']U68,&;
ML(ARU+YQ21Z>Y$/>AO\@5M2/H]Y8PRW($&-DGOE (/^WG)D*CJ@4\P#O)VQ^
M(J3!-H;']*^L<")'9AK?=)5N,)U27[MFZH1Z\99Q]E2ZH>_9EPJ%989A+;G8
M 90,CRL? P677.;T3K-K,-<1:8LZ[#*KJQWOW@TFJH,/1EO3*"'F#[K,IJ+/
M'?%,/C:C:']49?SMN;2L.SF4$0DPDC GB$U":99X!'GZ/+E>\ ?]Z/E<N2QC
M5+=W4#EP6VE<SVE@6_T'_DOQ8A=VS<U)9Q_\H!]6&EM=<@D0.B)H\?].^)WT
M:9:T%.,F&,F\C=3DB"PON4@+=ZLC-WL54U)-8KR'/]>ZO7^J'OXX;?>QKCSC
M3)G&0JU=<9VPN7#&0U"/J<(2HT.HFDQ;< P& 6&]C SKAJHA@;Q[XM^5 W,'
M:G^L:Y;NK=1JCEO$B_% I39Z@40[ZQ*+D<:06_ [T%*KUCM DMQ %FP)0HC!
MR\ZCY@H3<'>L+_N6?TM3>B@]U([8KS&_F"LK,I1[!%8RI[=)9'CS"B:)=9P>
MR9+"])#:1JB2S%U(_/D6.B;UQS6M!+)V/OA4WP2\HO[+N?UFGH=]VQ[3SMYW
MFD\SS2Z8"8W#F[D 2[J9H<%^9KT+C%QVC[6V_LI0-$K_%5.G8P.7*_SP Q$A
M=D6PO_PT/+6\X,(049BX8X<(OPG?#]P9/3U=OTLV"@*J.-Q_0?1\]  J3R.!
MBR""?G;Y5!7S,GH0K\H*8%JCPB8^.E>"WWNVZDRS7VK$RD1X&_HS#Z^A;N([
M]6]<:#7V"4?P0LZ$-YUD7A!9&FK2!EDR),;Q_+Y%T;@^5\XHAJ]V]\2M_IR#
MNU8[W*Q'KX3%;ZAM#+?.+%]O^7/ P0?')Y/UR2+IGCGCNUHVLN"8U-'1=O']
MYIJQ;Z(^7]AFL5/"V<>)&<P9@<K"@K#Q^U%6H#K3#5E#)J51?SG?<7"B8Q.I
M)4^F+D3*Q*^()!L:7+A[-7$_8J:D=>$-"0H!=?\:JI CTFZ?QE,S@'T_)P<-
MG4/A:3R]<%N=K?&27,"@Y8Y:G&GQ=O%\>X$C3QK+?I5 1M_HO><"_HBY>48@
MNZE;F4@/8%P$YRE<0.GK+BHDYBF\-NO:IZMV5@Z[O(:R3]RL/OBCY>N]_RDR
M]0]"]2^JXN2/^Q0T'Q>X%\_#<IR^DWI<P-X4B'DF[7I$\'\WD:&O4__:OH)=
MB/=O2 U@A(*'2K_CE;O-/LIF#U*@O1D(JMA7/V6I.Q;;4URRG 3?)KY.CXRZ
M&NZ%?V'0P)*)&4";3W<?X@77T5\Y -+RR!2N/*47R\]2"&!\8UDO'2$%=4UF
MH#GDYU\7#Q)[;]8^WZ\@SY_'KN>AFB9K&="=WG:&G<$%KG"!V?5^+)1C=4'
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M/D?;8DG&,#[0BN-\*7!Q#.$6S\M!'7Z/W8KN9#U/>Z;E]L$^3C-+VB'I_&F
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M:JT'1H\,=&NU%G\Y0KL_T""ZZIFXK\RJJ?^ZU]M;=F[:\>10JVD>VFG#K/$
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M[J(E)I4DNLN_?9*G9$Z:YW+3W(!3@"IT<K<V%9J?NEM;1/^MWY5J .84V/
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M[N/[LPEI#Z#W>!9$L\9&R$'X[: !ZS?XF]8?+XM"_.[#)^<C.@R4\1WFCY>
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M?]E@A<$9>:VPDA'^RZ>PP*$*^"U4]=B*-XU $<&'$"<F>1(-@$-\2]P&3$2
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MYN,U?>N@*=TGM'NJNM6Y.J5ICXN,(B+W?&?LO+DH_$.72B 0 7L)%"VPB^O
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M5T'%KL\=:&$_K ?3C[,]9ENY?61#39#>K9RML[O%^=_LA;VOFES4X5]#]""
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MIY4A$.1<,4G$XA]W/N-LBJ=Z'F7&8-RU4+:4V6)4-Z^6E.SK9)Q@BC34'FO
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M25<.43MC.)&;(N5=EG_K[YG&PCOYX1/&?<0[3&Y0D/=.&[65# F''D%UEA&
M'Q*./%OLL?;AUW10T&JQS>"Q[]_%*@QNCIP$C5C>$X(F%\B^<(31A9@'1;_.
M;+RE*2&E^"^OJB&OU7VK)(Q^AN)QEQX/V 3(" RQ'03ZV8%H(<2@095(O C\
M7B,02G+V#\Y;4&IL*G*:-7<-+;DQW"(48O\ZT2-(Y4O1&*N(E%:9':8?';VO
MV6<*CQ3-C)E00FWIMTP_K+E@?&U63_K)L,XGX>%8_:$XS=H,Z0TV;V<BC 7
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M<+#WN8L?/"Z'I3IK9A7+K7!)GNK:,>4>UQU0> RZ0FWWIN8>5"L=@EP/0?R
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M*2PYL83DQV-> 7@X>#UVK/C:SGUL]$2QRJXF[T$QG\7*M5,;*7$I]K!ZS*#
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M ?^"?L26V*U[0]U[6XLSEV!"9U1AJM3 ^T.6II<$_0=%JK"_<L$C\%BL (Q
MVHK%<K?KDQ=I# X*F6<:?/)7T/-',Q>1]N_:Y:$JO(&L4#[F'\RK<-.C7>31
M[BJQZ%H5.G\5479]BI(X/0(60.CT/%G=_V87.ILC^-;EV5EI$-NI!U]#V0Q
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M" ("2E.J!0D6FJB(!02$B(@T(2J"*"%;0'I' 44E"B(J0D1 JH0.H@A(KX$
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M%O5V,&IY_E2ML]+9%TI7A(>$#O,G'N;9L#'O+J":&0VHOB/*0N-UV"UX].N
M7XT&#QRF[<_G7IR1W&-W\KISF*G]D<2L_>>EK\H+/1>YSJ7WA.8[;E:'&N"O
MEB"*$5 !'V5]C:N2SQ5U70HW[S&--XVKMA._X)P2H5@,^(G9IA+:*1_;Y@J8
MNRC3 V9-B[%WP0B2WCF*RV6:U8V#3:6D1RXE<?V*0QM'JC7/Q=*\WE9!@[28
MD] IPD$LWJQCG':]TX8#P")'[Y*OZ,_'?=BD$YIL#-R\$,:M(L;5U7$QH@X3
MSP$$8"U/^U<1HUB1S_K9F5)@\7+<T9.E!9^*[![@K786=]UH>3W;LM_Q'5?-
M/KUZZ#8L(,J4A$K&+=@9E0>9AW^F.6E*7NW6[:O/W._#)5\G6W.8)_F*<,$5
M=2NI-C&NN2);67H.(P1281Z '"M=Z154GZ2Q/$/NR<]O''GO-$^\LXZM;(5;
MU R*_7IZA88'FV[[,+-2N+-<I'FNR+ES+5N; &+_345\S8(^Q;@!O6&*Y822
M1U\C<;ZS,OZ->QY=I^[MA0;#FT8[GSWT"[G(I3J[/7BG; OAS4S"6^5G.N[O
M';[X"ZUM\E,SD\8Q'I^/1!M[14&2M+8&PE9(S97VA#K6OA)>_"%0[?$U>; 0
M:SP8;!M^VC\DK^C-U2V?Q_<!<BC:$P3)K-\1OF&E0)\$OH&305G]G[WNWLJY
M]$"#ZB%A_637UJT]HE3M:N'0TBO"3W']JXPA]@N\[SCN_HT9FSRJA@JU)&S!
MAW78-R= >4'-BL]363RCXUC?!B__K0J7EB34PWI,^+W]*8+DT<=DP2II/"]4
MQMPS75[Y9902=6"X=>$)SZ7'RP$_BD/V2EVE6NV^</O%H7/RUQ(M2IA"A*\<
MH)@X-SSZ266TJ<$J'I;NQ<N,G9E^+JMX)%WC^ +J24L(U4YIUW;KA>9C1Z8\
M=Z5YIEQ"B7& D&-0UOAJ R8.E&'=H?./:WLF];..!,IZ]HP?=5S](?4JG%LL
MY*)]D]3Y^N/O]NS-\'4JY "\%NQGA(.LVY#+F)4PX2M!(1PEBS>B7W%2;B]Z
M,Q5G-$+;A4VT6)(6?K:1LB3T]64<E41HQ!:@$CC %5P,442O0BMZFU/.&'I[
M0*;C34'NEP<H#6J/S<,FM>\$2GZ=>5/6PKVTX=PZNHEXGR)EZ#M.Y($XP.AB
M?>O!NA*":/FGU'7*N>\C"UOLI:D76E]&)YM:;W(<N:24I2"4]_V>$98=0Q[-
MHL'MQ*)3P31!1A,D>6/4*I: =BANSX][EWCTKM-P)73"%Z6]@?X\47/*8O/N
MH]S%#J*,7&0XXN$>8N%4B%Y"%*SR_19N\VRZ5CUY;A 3?KNG?1CT"+CU8FDQ
M.WW7-G=[,YOS:1-QD3O$WWM-RYYEG*.K-*('TFHPQ?R-LQB41PEF:Q&S&7_P
M)73SAT-)1<8$K\[0L.5FI9>>4DT;&OTK8QN//LN90DEQ@!H9^%! )V*>5MB!
MU7F'; HIIDI>)5J#1,+O:?6[<2!4BNE8\[#,6E2VX'EME?FUO?; )Z;7S*9<
ML.8"Z!IDH]JBT9WR]>W+)6[</K9G4PQF-)LLS7+!-'  2?R6SK!>EAI*TN%G
MU3;:2<3_<-GT TW7%:M2[U!M]DS>UMVA+[XI3<2-^SN\FU!+D23L)'22^3'N
M%:1(>#N*5G@R?F2A07>:NNU=A)&7RC<.X'9QNZKRT4:+_=7?(&\F+]P!%N+F
M#<;;HC"%!DWHS7T!:E2G5WZRX!&Z9O"AX<;'-[\M?+??.!DG'6JI/#PGZ;7[
M@U&U.W<,M(*XD1J][3[HJ0RIO('>HL)ZMI7<NZ:' 68RU&A3S]Q>S]A:W\EP
M>J&H_:GH>%-SBW>_TDUI&2E[9H))*B-HV_>@$_)E@>X#HXH;7K3$]2F&Z&0\
MM?U*_HB>VTL79;RCM44:20<D7*2]>O/"\XQ=2;@?*#3P;: D[%7\1L72TF J
MU]5?)TXT;JZO>!RCP]='-@E UTIP@*VPW$]X0_M4\HR&H&E)Y]SDI[2IQ\Y1
M+D<5@3L[3$^ASMPP1C]&%_;6)T2B!3"C;XG%DK&P-$NZB^7[=L##_F&B>[KC
M9*7F\1&']U=US+/3Y#<41"1.39KJS5-HUNC(])Q:!"55LM/FI9W'K 2][,G1
MMG4E<NJ=E6?'2G%S?A89 WHBE5KWE(Z(>FT--F[BELV9ZV;RXFT@<28.;\S.
M7P%E(?!,"72_1'C879]F)3H]K?'U["Z+2(4SF1HOQ4_V?[/-]L?23N/Z. "6
M70!>G61GX%'4DVIUI_5SO*[WING'3O/8K/6+W3 K\JV>V1!6S6\(!/3.HY#9
M$*5CJSE  @9%$($Z&R2(J$HU*C8\=3T[(78GK?W3AR=V*2'O1/,G]]HUYOY:
M.V;^ZMC.)"//>98KTY%UY@DC&-K+E/R9(?]==U$\8*J&OUYN+]WUJ?"(B4^4
MFTY8P1'\F\V%@ZV_/DY>J-[A<%VA;7X34X)E#RW2\L'0C)VE-,WB%Q<AB;KC
M126]\F4B[O9?!0V]<_M;HLUWRHE."%7$!IX(ML1-5&DA :->Z2S*DH;BF-HL
MK]!C=.2;-I3]S]2[)9'J]@[>]M_$G3^>CTV-%54:?3TD<.ISTKTNKO:+>#\D
MO&,"!!GGOAN:T ^.GHKB )LH+!7!;"B947?Z(U,C-41J+?U;Y[XXATOR:OO.
M*YF/:IXI!%VL!K%4_D;2P-EQR;E>*E',8V171^4.%UD.$%;IZ)$38X?3<#V_
M=N5<_4VM1:&7D6^E-E#VN"H&,LJ1/.1A-= VNC5X%"4,=VS;F1!YK=(.E^<E
MZ#I6)FI:'J];VQ_CGS*1K'1=B;V<C NJ#Y.1., !>,B7*+$(4R5[82.)19--
MC4'<6",C&M7>R>[DV+2&E.,[:]7=9VPNO$#)&=?'%0I87&LVWH>&#$K@$V?/
M(( 8\1J<UGL6",YWTU89^/=LHI$"W@1*HY&/]Q0?LJVSRG$XU).AB<-I/MXF
M(V-YN;I\?VG2,0^YO4IAU4-?&]-8HEB&#OWVG ;-X#2D04V0\:B2MV.9Z+_Q
M>MWG8,&UX4)F7.:5FW>E#F^6>39QR?N+"]Q/^1 Q_P AL#8(;8XE",)=]EK!
M1:! EF76!8NQ@D"M04<!"_\?)W(>":?K[K@9W1;Z>-L](R/V1R-!EB4[%AR-
M'.&'9*F!GR7/]U3Z7</;>HD-)O>=*DFK'50,$3&_M"7VC=_E33RV^="40S?^
M$.*KPY#=V/Q6"\6BWJK-'XFY2B)B6C[O/7V!XXFF2B7W0[O$I:;$9^^6L$2;
M&BE(BG5!B<"MY&*MIEFB9$!6_;;^[DSZZX*!:SXN%Y('O]Q/Y/$L\+[B^.)^
M\J5<_9F?1E*$)B>M" 81-R@XKER8.1Q .DE3DI.B_7B<)1V77?YJ7&,HV?SM
M#PN[(1[!R(X^G\3$:NX&</0YL2"AEAQ+E"0($%J) +QM>IMFV:M9[*"<?'>1
M@UCX271=HK/CCUM<4:F.F1H3:<D&->C]I !V>94<W):*+IRJMXHDB\"2T_8]
M.6\AC^59M_+.AM;YR4[%HRX>URY(FAF(J,8I-BHEELH\?@2%OT \A8GX=,H(
M]*5!3JN3/)IYP"<6WM-%Z,S3C!OCDID3_+#/)24J1405-N\%6[3O%HK^)!:O
MSH4Q+^&O0PEC<8&CV'E,5H#H$9IWZ8&MS[0B",-[*O8^&I@Q?9BBS:/\UZDZ
M0(24<7.#5$J_)4.71JRU0K=R -$NB\45+]>TNP,G?=6.>W?%&QFWY(4<OCXA
MLL4%[@&+))LHX1Q 0J9FP-"_2HAFP))?M>VA".4KE)0GSSIM'C%](EM)2FO)
M/ZY@F'_1>T \:AG5+SE*:=0*(6_!Z6(2L-NRZ:M1*[*>#K.+0A8^SF?"]V7&
M*R7L,SD7>1T9@'AM"R,W^BQ# JJANS%:.S$>N"UPNWZY39S7Z&P<;]')HX>9
MUU(M#C0_^.Q1;A*_7\D672F?:+K1;\V=^_,8,FQ)<+O<[M\$B$(8+#]V5_/9
MN!5JAF[GU*@[KI'"\-OH+7CG6G_"KNNDNNO332W^,54;V&5DSV%11A;$-8J)
MMI\**\:B\)XT\:HW?CD>]H*#%MEM.W./ORO4S7?=&2+1\G;L\9%8OEPGQ/U"
M;%D.[9C1IU6*[) %@C;D/SJ;L2.:,>AX<MLMB?<[APR.:3]&I<_1=M_3Y]U\
MYR;O+1VPY@"L=I'E!O'2K^(B1]""M+.U_G?5&6I>1G[@;D7!KR0.H'Y;>>,9
M-+]ADO'VM"B,YV(\I3@M$O18Y&89T)6C$!/Y6#MH;$820^V3V/#)_"$I+9=2
M#^5?8K7/!UJ$GH_?W+N5Z^P 6+,5G-PNMX4#O$_-XP YFV;>$6FGB+'DK; 6
MRY..KD9%PS+O:25-LOJ^U"T8I^\YZ;,GJY)\#"Q\7*['ONO5>5HR))*0;*7.
MMX*%5"AS!51R7R?#J]-H0T!NTP$P$GVBLBQCY)=5I]/0[E:UX\V#$T$3.A^E
M>,:YMU^YYXN HE8XFNL%^Q&L!#UIP C<:O6JKU+KX "%NI?7[PYA*9Y+]1I%
M/[T_\W:GXC12%*O/*#V0UK1"M&9)4PT'0!,^HVG'L2'H0I7(%>7 QW@_+KI9
MBCY4_T&FHLXKJ4[!0I-OGS)06T5BDS!7$@9=QIL:YU6HMC5M V03FE'*6(5M
M0MV !ZVY,E4Z^V2AXT'+E%^/KNJYGCZCW8):5%)OVX9@RX%*%WH%0ZV,G8%Q
MQR48R"G2*ZOD#ZR0$[9]B=3CV:G19WP!I7&I7OU>O'1SS?[G*,UN/<?C%%AP
M_,:8C)WR-C"*(%(<7[9=M-)U3&)>]6!BN U*[-*>'>$!"B3" *9@JDXK%E-,
MJ6X+I0"PC/NZ^&HHSBS2T.WMSVVW_+..=^Q ,D.#XC$^)X_+2<YGDP7,ZP0K
M>S^R=-G)AMA7<&>5&KN(H#AC+Y9AT%VIMC5TC*UV0L<B9[J],=K>+-G$3NF.
MJ_$I<7Q12\A$*DFB ''&VXA-I@E1Q:VGF+" C*NW*W7XR@CTEF).RZS1&*CJ
M<N^Y]OBTNKR)%(59?%[PGBJW%KQ5EM84GC!W)S.@"")\89[#'RXHV4;L/SLO
M9]NWF)#VP\7_ZZ^2?<VD2OQ^#J"P$L&^8\(!G@NLS<("9YD2$),Q#QU^A1>G
M-<46@5OZ^J"0+?;>QQF;?)22QL,#[JN)> N0JX8K;JA(#1SH)0?H#];K.TD6
M%-#/V,5 &LEJJ>^3!B1= 1_'F8W\T@.^L>,JTO+;;OTWBM!_E'^4_V/*6<W\
MO'=Y+S]]*C5W#A/\HIXO;FW\^;(5P/7-ZQX--^_(- S@  W6 5JU1+%WFGJ"
M;X[=O753*;'I=4ER(?6[G;!+!?O+N\=AQ(F#Y;[&<F$F=]3!$NQ<@D'3.7:Z
M,S2518Z[4N;EONPGDN(5IB1ER,ZP2I<27UI='!(8-[3-F2U?B!D+DEBLSU#J
MSGNGRS;J7] BD90O4$O"Q J;%^IYSY^V4+G'"SAD5M:-2LX_8^Z!NPY\(XVU
M!:,EKQD>!E]<FO&W=FCC*="<KZAMW28M>ENF\^9$<(:).X1CO( $J1Q YC!M
MM8XLG.?C=[#BRY>#@,8/A\#9)R>"W@H&AA_>4I_D-F7^[+'_1^.!/F#Q-4F/
M[C8?Q-P?H&C3HTL4Q9\(04%FN+PYE@D^55*[W\- -%$A>F%AWX#@U9T/+YM=
M]+DX?KWM9=;+:%DI[??-\A/"QH(FO@=(C9CPNUH-CBJCX=G4P5MTIY)7%ST/
M^$2_GE=/?9]BIWSYK8W>ETN2:J7A@A5>+J^>;XA6_3^J;+4:)]<]DQGGK[&2
M8.VB2WS23'&F8K:.>)3<?:@IGN>2+A&7S9-H=+J_9M^^FM'>&O #M@$5C4@/
MV_E#.7 ]YB,N[!+=L7@Q^EH>BY^N=LI4N ;$O3J\Y:6F/JF581JVB3ES94?L
MVX:FGU;U*!YW4(2UZ1WK 'W?T^ER1LJ-' H[=2PS[7.Z?ASCP%)<<;S4393>
MI),T.Q(OXT&7PIM#"729^@R]BH*NL-6(3FSJ1H0O+!!JQ)-*-;S%3._46X^Y
M$L[ZCQI^;:Z6XT+4@F8AW0P1W@.BH_P-WBZC-F%O\7MH;O%Y>7E8LT\!*X*.
M1\:RA'1,%0623.E1PL*/KP0\W'^R!35DG_KDI=?'O%<S/?JKUZ,4;X<$='<=
MT"X7R2EUM9&[S^UD06MC[**IU'W2LJ!](]'5&D?V=!ABWN7GC;$E&]/K;=]/
MKT9>:% H#5-.-+WPT.)*DG#(^],M[_8Y+$(J!J&&UO0*:EH]']TVEK4_AW6T
MN'#;_71,C)S,&[^-/A(W;G.;$17VU;M'YE\@:CL7B"D;&[H<[R&HLS00#'^&
M=ZR HFA>)PKH;O%&0H[# 8+U<I)=5S)XBPLCG=&WW)T\E,(/+;2\R]OL^3PK
MW(B+UG:ZMVBQ[PM#M:M2<TGV!.MVA="C;W9?O$34=JULSN'O$DUG'X=\::)U
M51OH(@&S%^BFQ52R2%.69I)D%-Y*7<2QZ3+IQQW!B:-BEW3&GH7@$M\N7NTK
MG<"CF'SX#33^F"*,\,_4 S%] 6?MR-V5BF,Q,9'?GF0ZC3QMT]U8$*&4W"!A
M=BNR;*E[7S7_C]7Y'3>HE C[IB:*)$OQ4S?+EGD *J2^O(MK:(Q6S:SJ]+.^
MO:6!TN?X!?]DX@+/PA.9UG-J2TU[V29T8N,BHBKX,%<?PP8#)KJP3 =^U]8L
M%V^?^.^?/2]C=QC7[1D2V)QH/O%TM%<V'ZPQA'F\[H(Q+"4]M% _9-4THG0R
ML $6^$".TITWA0QO&MY_%%=_Q"Q:85:L.>>2%+?\BIPD.[E*). @XT$7V=-[
MPZ%3*.$9@D1HW=* QIJ$L%V]BZKBO<T[ZJWC*TPW"0CNE4?SL 39V3 /] L6
M%!^E1%9MAXJU(K/IDG5W=%O/VL)U71J9:1=3J:,Q[LZE87*J(EK*NI=?^#_7
M_'%D#CP]^VT%W1\Z%I[#/-5'Z%FU? W6.N0$7( (0WE]$A07[<\[O@;>"?I>
MTIKQB/I)Y)Z :N;_WD5M"@OMBH$[RF]7L]$-Q,*V,!^6:3HJ9JY82QHZ>ZHL
MP,>O=9O\O%ZF+GA0S2#MDYA(R\:!V3*95G#T:7I;-7; ;53VQS.:+;4MTA!S
M=T2B<QDG&V#4N.YPY]:3U\.57Y[<TO@X/)6 -PTP'BYP4%/8#@2],<$;,/GA
M;Y(@@$A@LF3E?IH:MB>AUE'-N.ACUS4_V>.6K_DCKTK\6KM1>?^Q4KSB#O_/
MKK^Z+RRI(0HZY"7K,!T5;*2*![#B%XO)M;EMD:X$Q:&+-RZ;[Q'4K5297-+N
M++-=VQ0I8F1MC';NP'(C3I6,'=CZBQ'#3CM+U7^CA:06%.OXKC$'(LIK<Q93
MFQKX\<&IXO*X$C/O2&>J,EHI7BQA3WHGTA@._@:K0EYT7T8$%$3+H?)'JL.B
M9GG*<:.#;T@GEAQFU&0$IS6V&9O^5/*5?!PBG62 V_L1,/J1624$\3/5B/?0
M-!O+82V&%]T@DCRVZ2-TMX0BFK?BZ.G5]^1LF4?J@&2RS56/(25;[AOJ8OMY
MU,)(WDBKCSW18N!8&@F_BY8SNAAEZ.U+FDGML6]\,.;0Z>U?[C.N46,78NXR
M4A!Y4[AML52VFK_]G&T=D6;FP 'Z/2U)VZ?1@H;BXQ0!B%$W]SZ@J98LK&=6
M7EX0=R)LLWISA//EHY/B);M]3NL_T&)MY^< RILQ<[<[P>5-LSW--\GSE3_"
MN8D/!CZ;I?<6KP_,<("[AI6+VG!CB]IXV?Y/3R_F!3H-:[GARH@X:^P767%F
M!,L8M_Z( TRBX1F"#@<0)L/9'&#-E@.4$;LFQ5D%'6;_Z@XT788#S& Y0 K(
M?,P^];L*,;">CP.\28"M.<#"BS]5L(;(2[Y1\',)Q '@IEL<X/N^W&4GLCCU
MQ!.V4YO:Y$@GL;_"UR%U7:5XN&2AK6]?H $\\ME]?&W_H4RRQJ*W_4@+T_^P
MB9AM>"#R>IKK?]/"OX/N>P)J\$_?FD=S.]O1,WNBIZ$Q+WNV\,N6JC=7O*>B
M\E@_DTW#[B>;[":GCN^Y=RX4:T#XQ@'>$QMQH4(!A>-@**4V0PI*H>*XIM?Y
MB#EJANM!L>_?KI6L:B8E%%W4X?5^&\R?RN4VTHJ]A(2&,OP%^V%UGDESLM-M
MBR86J]S'&>YWR9H1\>A)QT3</[5>.3.(PRFY=RP8W]F9>G+A1+)0:[+V@;;^
M;++WI]L,SR 9*@*$N_(#/IR\O-[3V5@>GD%W:+V2+R'3_2%:M:%9Y6N?H+&2
M2=RJT!KF*-+>H9\<H& JW@B 6\JG:DC]6DVIJ01]NL;<:CDEH?*,;$YI51EF
MVF#2^2QSSMG%.LSJX;.&4RQL/Y81P/YDM/'G>G@*770\)WCEBX9!;?(TS$=C
MI&3JQ87EC1_84UJ^E&G[4+/M3-/7!XD7BX,.F0#X-*8ZH85".TT,0XM>(\%[
M"5U&(@C0:1;>S@T@GFPO0BDP+U2D[M(O*N&3G^-YI6 Z=^?ZNTL\7&9V6?@#
MOY?I G!CKJWOV<\)<K/P7CG#]/4!;US=ASH7S?NVFRXW#I\?3]1W"+"5EZT8
ME$GH0.;O,6L/).N;C;_<PP$\T'+3 R8E,:RC8X-;MLT,'DFUT,B;S\NPT_G1
MG%2Y=/#+EP_*(JJG48F%K$$.P(^0GL^A**;L,H6]X2[S;M4.#A!ZCP-,U$2P
MX]=Q</"A(-P&\+,K\A6I@-66.HY;4RH@KRQ@DZ!0Q*\9:RSW/^0# 4EN-:7H
M)6\8@PSW,&8Y?C=;DO0M 3+@AD^2FS@ XV .G-2 S5QAV5*M6&E2%+H66UF%
M@8H@+YE>X@#(X\MO>,6LL5N#'EF;_#X0\?>*&Q334"5&"WM+"2BI'R"D<7_L
M>F+]*9[GZC)O,T\[7YBXK5G/,E;8@SXS@NZ>Q^7ME(Z>^3;F&@?'O@RU>?W?
M>I G7Z=)3IW.ET#22WT&3M8KG)%L.?IY5;[7S>DV70TV]>< ^9N<XNTVGJL?
M.#XS3#!+>=KUQI*_E:^S?/#4!)KVWM"1 QP&66D)'" J"Y;@CR'_U.( R70.
M0->+,PGB[[Y.::Z:P)-Z;Q!_+6$#.8".V]_>I0O65M-OLWDYP)(3!E8N>)TU
M4XJ;P-Y$Y8]CIB:J5N&K;2QUE"38CN3(G>,<@.K. <*"J8OK@HA#5(*LDR[6
M9O_4"-JQ$6S['+3(:L.^3_E1$.[AH$Y7V]MTQ@1_\D\^A;7D (G>9/9U*S:/
M;0.:=AW->K0'\1 *<FN[RNM1[WV=W!P Z[*6D2,]6P.UK:]H-;,.9T:K,0-@
M_3_8 L89'!U"K>ES #0'Z%L@KIN)$V)ZI\Q8,L$(BE"0SC)E$=@TIY(Z[L)J
M=!78,A8'I<$/1)G\=90UQ3W@&+A^+B1:E11A]/4O!S_^3FFF3]/?T.+FL%L)
M]>5#!9%%:\4[-7@K*GAU#KSA,XD554D52.LOTEX8,CI")[)$S1@"])QZF1YV
MKI'1#'R03NM$G^VF-&"%%(O+PKL/NSW6D'>O:O5\+@+(")OJ-'K-'X?J8 $U
MI@*,H,KVE5:S.G!KE1$D62NWD3[%P!OIEM&Y4F7/.Q<-QWC=D=RE5S#BNN>!
M]"_I#\PKSL;BH&M;OR3C\/NJ+B,5L 89/X_!+UMLS4O/=RT_P8CIYV11# Y>
M(A<_T)8:4MO=$ONN5/U^BD)5Y_OT&6JM8 P34_B-EGL2]X-_Z>F]XPO;]5'2
MLC>P!G 3I;"D#A>,%K>*@,7L _@ZC3OP6].='L';>ZJZW\WRS^]2ZAW(&+SE
MV!!RGXOB[&&\+^C-<O'_S4H"%IG.FO.L&_30T=7&/'ZJ6STZPF!$#4(K)^4,
M>%I<_DK_:1][M\A6U.DDL';%+61GV+837#^T<Q5%E  F-7J-:((P&'U"+^9#
M=U@<N0DK$O!@S'&R <[VF Q(_X$>/IAJ&1@US!J7??'+VOEAV$55/^6=[["0
MHLI](U7H*,-P+X+6V&ZMHL!%,<I%B&=V<Z-?>V2<]^"6%J78Y);<6.]$X3H!
M8+TE&JJ !>A,]0"U)B+W"@>('R#%X,]KQ>GFO/\(W7!YY?G]I?_J!ZO->P<=
M!AK]OZA_/RBJO+DR=L^%:KG"W #R.+8.(3U/ZD !9;K(,/XL&G4YK?[ T/-3
MY5Z'W3,73S\H+'NH?0RUWN^P3S4Y!5B-5J-B(>6(T%M:<43:<9S@ .MB%][D
M]72)[?K\8J1W4<QL<44//^/9K.$IQLN+%F6#=\S[=&-?G)J\:O.& _!8]E2B
MMH;2 W]O2."=26:N67C3T@-6P8:68I]OC[7N3S<I$;E3&9%H6M,5U!/Q8RU*
MB7O!7FT2 ZEA:\EA<CO9J2Q;NB U/F+\I/^X&8U55[L.AD]5[O$8N&=VY5.J
MVDW% 1G$9ZNOF(_O.)+J#8<B;4[139]1D7B+&:LJR,&?>M((!-S<IZDW^] O
MU8YZ-=Z\S^+7#Q6;&(W/PJ'??(WE>O\K><F_3HI1__K#J[/P,AO],Z!_BIG6
M2LC!(##T'2W_A_O=74CC /*#X/HH<7TC*1HS.HI9V^/, 5RJGG" YU98KVEP
M:4O)[XJ0C]%0%KP5\=8'?&C&P6GR.L]*:S5ER?X2.#L'Z@R/8]84"X@K,W]@
MW33KVO^76&<[262)6YYAW]==',R'M08MC)1GJ%CN:=P+AX C#GX1IQ0<DA0N
MVXF]?S"!CW4.G9"M3NAJ60MDY$$YS!OHJ!*8BQT,\T)GX(7:@?Y*YW&TZ'"#
ME-W$$=I @W2JOO^%C_O]AYX?%P,.ZW*-HVEFLF:,K550Q?@.IMA/M-"[%L@'
M!9E;Q>_\J$J91I<M'3O1A)DU$#%FEO(_)=RW_48I(#=H#10ZT;TI]T!$.@2G
M\T<8>FV-7;TK&8G?[[>YW;-'4-?C@-"'YO;*FX8\(3785I[=\_O7E?]&!.['
MQ*_?KA]V&<V)N44*67]JXZ191IN<<Y*N>'2O *NKN>-:"3>J)'DC?_)&*=)]
M\NA3#B!9R4]MB^, M->P[J 793-!_V=ZP[L2>Q/V2C-.S(0O1;RXY=M"M>-C
M)_V*04T&3V[C-^YM3";5)HY*$<8?[+V% J#X0^B+G[YK7NHH]KBLF7K[I*CZ
M6>T00=Z;[XP5Y6U;44P1UDFHB7GV)[E(JPF]%;(]4D9+B![K>;>(W__&\K;1
MN^E7]H-YY96)]>T.FUYH?ZAB-*MF\;2,RKDQC\)-J^2M' !'#H8-V$2C'="'
M*42[X2V-7M!%X%7[U%ME'1HC$N7I5U1<*Y7,+YD_5'?[>NY\2S23<N8#_+WS
M1R?<>Z@T73O<RT/?_-[*;DIM4)-BB=X2+VDNCP/PZA'',PKI^N! 3/5=I\?4
M(/LA+YMRFWM+3H=?-D(.,EZ/G;6DS =.OA1G3Y!4MD[F=AF)#L,]$I1BL#[O
M8 -%Z!9.%.+QH T%G&G<8FC/ 2X/ZXQ=>_E,0=EL;\2=_8FO]^J+?A4P-L3"
MFT2I:.$H#N >2!*&0AWIV]<Q#8&#%U2Z%B<^?<J0\;L2?VAIKYOW6X!G99E$
MA+EGL (OV,4L@W>$8;"0U$".@(WHF%@)#G"L1R]!Q'! (OOMIT:(NH2/K+]Q
M)S;R==QN4K-4V&=2 ?DRJI]_'#M7=H-^!B<$9=49B+".T,]3(G69GPXM[(1;
MRY[<$:ZTVG:G.?OAQ($'1;&;)[RFB0#&G11'D*91[I.]!4G C&)MU9["WOEB
M<*-&>]KIU(ZOJ6,O,O0<;"@)>Y,FMCY)W+TX!!@*P@)[F>B1"WA7R)7N.VI6
MCY' -":(X4]%"UI^[,D.&/_>K90^&JGS0=#AG'FP *!:;_%#YT=5.3O?2,4+
MB[ F5THD5KQ2M\9/@[MF/6PA??(H3YGY]OIZN>=&W\V>D[B@;.;O,R>G#,_3
M?]6CI8RV$SI!5*4>[@U"M*_^9,R/]526?E^N[A<V4VK_V'NU/EE[]&!8VY?M
MGE6%5.P]\G9X!^LL/2V<H(BW>]]E) BEC<VZZX\(.7"Q7VP9>EUP\F;O3H.]
MJJ[R:?NUM9H%?.314G@^B$C%W@>%,2Y:8NYWX^H<\>?;_0*M(G5TWWWW:E-/
MJO0=WOLY_<*/1^7-_<XM(6))6%<"PI.VD-T3ME_$3F?P=!KNI5H)S+2[)PU!
MOHY=5XJ21P(=S\Z+?LV;^+*]PW+3L8"^71NVYR_YH_=#"/7BF:';WL?[T6Z?
MA]Y0/\EQ@!.0>.:,C9&X]YZ6JSW*94$%0T.-/W.])X_E1G9,#JNT5G(5L3V,
MT=N&P)I#&'>K<,J'[>@/'&".0C>KO6O&:(I:U"-*.WH.X+_;5_J:Y^L.NNN7
MZE><=[FQ@TW=P>O?,J/+.DN;A04,:!2&'?WD0@G3'O*ND@<]!C 1B\MM HW>
M+N_#P/%&0:SB%E_=V):-<?U5QZ1&23W+I_D_@[(<P(T#0+LD&]';(0Q5ZUZ5
M#OX0+8>EF"ZF(9'VQKT-?[D[.]AF818ETYB_*5FU_^89?;S!(O80.IX#C#ZA
M;,2X@Q%W]1;GO9\/0%/44\_&KG9.T6^EK?IW/ GWN*J>=%C)7<'NU<W<PK#:
M40!8-XT&UD09=NQ(T,.J+X)QD]96E]"_6C\"E--%H/2ITU#(P!)%(_^38*&Z
MI=AKV?F7YL<LDX3/G!9!'63:@5<X0/0(.G2<OQ%[/V-/.TN#[D5]:H-V(T=S
M^^4@7-PEV#F**UG^ZE4Y+\-6H2_F.2UL2NNRGA@7]2XF H/3$'3LO.;7)H;7
MI4=$3-+BLC/*TY\:V/NU=]MHE!A83!Y5]SVJN(!3BBRM#7FDM(+^D# W/H;M
M-QB5"Z:A:R6_.PZZOV^^^BEU3YSO#762[G=OGKFS2G'%-_WSNS\W6F5:&R.
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MN6.7VORM)[9+^W"_%_%%U?YY$=_K7Q;QM<E_6<3O(:]M)6]X39HF0<$L%0Z
M01+$Z#D.L&;'FN( PD^B,5.M:!8?R'K/7OG3@PE_JGR6MCL:0^6G$5D(+>,
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MNMLX/-PX,KM 8.F]QO2VC?V[=__NW;][]^_>_;MW_X_U[KV5&%.&I0TD4E;
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MR;INY5='0'<5DF=]%6>B-H*IRCR)2K(KK,!!3!.@J6-N=]/8&MH@S.D*!2L
MI+L@RY._&43L1S[+[[BG2K7*4OSTYHDRXFPBH@=3YT;58;IP!C'2''[.YW9U
MFA^;"\HP6+(6:Z&558UV!RD]=0K9$'$@]5]/RB^TM-D]:\)';9<%VD@P9999
M$]!$MFP[R079M-:YM.B^,-'MUIJ0>-6O=S;>/_S50.?]5WL[%J]Z2;Y"?YVO
M34NGS9X "*]1/EF#W6B=R2)G&J,R_KF_7=&V_M_Q5\A[ DG?P^-MA0P.PQ<Q
M@!:.ZK0 E4'W_4E?1;S\*;T\+X72H<  .Y.)?,)8.#5RSX?(>([NT2?ME@F8
MIW;-@UE;8. 0 5O!+FI70$'&VB& =)=26J9\;I7)K>-@XIQ2&D=,-DMZT0WQ
M/4:FYI7L'DOS[WR,ZB@E A5"<[$!J&7H#S,$HI@W*N9UZ+DP'UCZC.+I@EGU
MNW7I(M]2,LKVN0CN-U/?*X*_SP6%N@$'XXC8=%@C(IO'\U?P:J$XL,]\]\UH
ME-$$R_Z)WI]K!(R)\CRU:,_/B(5-!5OEE\)XF;23U_>NH6R (8J?$$?L& F<
M'*<F1ZNF%C;0&)0_JM$KW=<;\9=+/$M=Z\U3EKRS9P5UN2!7E5@3/L9QV=];
M4%+YO!HKGFF,\F8WMRL//_-%!I*7\JCUB4*=V\7^OSY5[9FL&33MZ27O/SUX
M,Z_$7]*,JGL@Q@_6QP7-SB]4$WIY5&W*D8UK."X!!K.BQBZWP!&2R_J6%T7L
M])1C(W,^7^P]KW' 2M!O&@2)<(<=PG1:8>"07()2NQ$K$N"C#UX8NP&?3VW7
M=5&%^H_5XVL2&X6*UZ EJFO2D&L"5S+99(%&(W3EOU@KI/LWT$VANO&,L,M-
M!MBTJY'W>J>=;HBGZF>\+_2.F+,[+=%\2&CAA,H4T6UF@9$(7%GX82V#+.K#
MQE J,U 3M+[T6/@0S-V;)AS7^"8M-/#2WCBCVWDQ6>, AFF'4@2>4;*Q_$B-
MOL-?X8V>:4ON(]<:B^?^=*F_;VYN>BCE&WTZNR'(0[__[,E&ZR,\TI5(#:!7
M=&(SH?5"V8:SY^E%F>A]@XCJG]MVQXFC?7"$Q5K@QSU%QBJQR\LP'_1(0E,W
M9GJSFW.077<##S:9J4BS$K^QN[_Q$!83GE?7$SF4,ES<<K9$_F.TS3!(#6>/
MDJS =#JBC[,L "^:+N,!4'?K69B%$(_#2;E6 "G=DPE>=TV.J@4T;LPXJ[3<
MM_^J?K^=DUU7?<-Z'_LMQX1U ?A$W^XD[+Y1;7YBS%H Z0G_JV33R;=BRM3[
M7C!R2:][L%%<()]RO!9"(  @H>D)KR5"+QXXA.@3FY\V)N&HYC3G*?MQ!"J1
MDC:"LB_]V>B W-^<YY@[<XQ/(LO'R''NMZ:_D42B91>F8;L/=@='<[_#SL:$
M(*1#K/>-M9XG;4^Q3%^'6DB'K@?0^Z(T[UK$CZUE1Y1]% G@@@Y=_3O_!,3/
M'09"RG-$T^E-E."D6%YXL>THD6_^M-5"R()\WF!9C*&T8F+TK%4[/=O@;T>X
MH'+=*^_%OT5<;C'>G'):@,Q,,78J+$A/YXZS,SFB\\!);WTK>?9+,M66F!">
M]2Y\6+;JR?<0I]#[BCZF?(Y&&F:D' 7^GSS?Q 4I<Q19!R?JJ\5Z$[8&7ZY@
M]__X8_VP[,M/^:D2;W$-QPBX2H&%NGK+G9FD7.+5<R@S8(E62?E>\>H'#,SR
M*7J7=T>=\W5<JZ%X;L4U-*?$YY*-D>9=R_@S-RW2.H04@K0IV%E^,H0EDTV>
MQZ*5.5^@PC [.H8($0'X3* 9)3*CU3/>!I+EA<&%RM&>3H'Y?U4*,]XK"1P4
M?N]?R3C/BS-WD-*,<AJD!YMI+44[W<X/]/$47T 7B75ISW"3R:ZHGNT\E.9A
M4*FYX?"3[,?_:I'LDV0]\Y1@BN*%Z=VV["J3>4"[J-MPYMW@!=H&D$+D@B1?
M6T&K?!K3'P4WB4>[C\:M.;I'"IV3V.S;U5;!:&?CH:'8%$(3H1LRW4+B@ACB
MG(<+; /'6\?#B-BZ+^!C FDA[Q$ZSGHYI7+[%'24TT#6G:_\->ERF62PQ#Q0
M1YRY[^D3612D/_<D_DB7C4"(OY/RM(<3U!F8I?11;9E1G.$I@B FF)"=4'1'
MDX[K<<LPMXC@@G*V5"T<Z\;K>]XV7? .N'^H85#OMW*GAS"?E^:;EZ3UF4>,
MQW1"+B&4D,K93W]].[Z,I3H2R075EA5TPO=-/"PM]DZ=*,'<1WLK'=OO?>+N
M*:("@Y24B*#Y+B"ZYF<TR$/8'ER*OT&V+XWS_*I<PIVS+G(+RO6195H>L?ON
MYQBES#^1_>2UA.W$ 0<=,]M5=K9*YH!7T/(TZ)U8F S+F;XXISBJ'YLK'F&2
M>\#XQ:!,$28H\[YJ=OWJ'G.K1YD=ZDQJ!99 >@(1WX+FY ,I9.M'"X'D41DN
M2+A!.+BI"4?458^@7[*521&$W,<5:AQ0]#HF $K4N"3?A9N)(R%ZUQ4 +'F[
MVU EU]&7EK,"SC1I-EEY%%__6^S=[OS@W&-?E7/VL&=^(WAC0F72\Q885 #!
M- 5P/4J.&?7X#&N!"%O?+#&%<S#Q%7??KT-1P2J,U=&/^6TO,V\''_I@@WHB
M9,D1J>:"= ZQJZ&K5QNXH+'L=R#FP+]:D/D6GPNIAW4:3B^=KOMD?81E5S,J
M^ R:7^XSH.9;N1PM^%Z?XEEXLU_%(2=>[6F+#VN:G8]R2F3:8CICK/60!90:
M<W,(.#;W7%_GI)=5]1W/[3<7J_)UF"W/[GEIWH 71F[Q,3BY3!^4P*=?7PV[
M"H"N]5.3ILV3JO)V=&@Z?BN;:O/7K^2Y/\)E#QP]KYY[=2P A'>L JN@3&@8
MHLMC*6:/DL]0%'DH4M_+H1F$:&S.,5H[9]-Q-<Y!]=/P&6&@9)LC>IR^1#'L
M!N?-UQ.ZLJF0,[3U+LC>S@H@KGMJQNWO=U^<#OMF1I;-:9[\$:.04?XA:?:W
M)O]Z@BX9/Z/!$=6@OYOU91>Q')G6KD]GEC%J!@$I9\=:;2L4>^ZGP674791U
MKR-4%6X/WQ==.-" "<;,PAE%K<!CIB-+%L@,*D-.^0".Y4,OD)Y^T@YP^4^J
M 0_OC3Z1<MI^&.#1+:?\2*OV,!\C598.7>5%Y=UR!(!)5B9DSND!/>5AGG,*
M-+FR5R@[6DZQU,4P'U>6N$"VUNNI_10BT>""FI_OX";$0!99P7,.I9P1M I/
M](:\1G;3]2RL."IT,+'9!#[/9U,!TC>Y.R6LF;42]]?4Y=E[%S>5(RDF/:#$
M)XB=L\F:@1]<4)TS<E$[[]SH:P(9\NA,<YY#DL'FH18'C=@^NN[>ZR<6+\P+
M8D)VH'&][LHR#4[9_?H=ZDB5=='K;&206YV?032NU7ZN5<4BTJ&S6T4)V/1Y
MB]U9Q@.$Q/D$+5]H!BR&$=>S)/CMCWGQI5FFO'\=P[C)^_HVG L2P@3!9G07
MRIMHLYW]+P'C/FI@Q2QO;/K+^RIAPP=O1QH0'8V:HU5G]V55@FPZ2\%-[=KH
M"<@NSAY@NQNSAZ,-+# A/O3$GS[(:S-+I]_IO/BXH1EP\)MW3E!3OX+Z&]TV
MIP[U*0RL<+YAKI(^WX.1Q 2X91"46^.?P[W4#M(;'U4^5[J9SC"N<(F*>3[
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MFGCFF\![AV\!-KD*L8?FFA? T]V,7N 34PNH)#7U(F9L;>KIGFU/>RHNAG'
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M[ R!$E31$6*MCDJ@G0;3S/X(C:MU=T^=3WQG&5Q_V*JE[.3:8%C63U&^9)L
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M&I]^N;X30EL3I0.F[J[:<$.J\/=-]T6+I_J#]AG I@8V@$']I.C$O/) +&'
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M>9"R_&93GN*J7%4-]F5W%)R<J_JJDV\EI??U7GG'28<'/Y^<*^W;4]D8)#^
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MAWQV+M"98 $9+UPV>S)JP<!;,TWJC$YL*13J30><V$_((?TZ84TXA_L,7 N
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M**+E7B"%#KB>N^&Y?[$!LSU"Y9(NWJPX\MHH.7!B]). Y:Q_M@\:&DQV6,]
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M4\#+CZ4ZM):TUXPA>LQOTGKRG?OE]2S14B["1_-[[LT29_FT5H_3W[%:P.F
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MMI(AJ;G>.P7\3#:6):XL0A/D*DHD _/+[(##!A8:XKU:UD9IO^U%>\^Q.YJ
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MJMV9J%9C,;W]Z[]K.KZP2V6Q"W%WX!YJ-=<U86(HDEP0?4!OF^Z#O0E?!QN
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MNI;G<PN+9,07=L>S$=.H=#)?UBM=N)QKPS%$\'DU+*.<^WLK]/&^=E1+I%7
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M+XE@I68JO#-QDQ ]CS+'L/S[QZ;-)D93(JDBD I7I5KD("F+P2AQF:P?GOU
M6"9,N.SZ:M)J/H>S_)!@#5QL,FG6)U@$XSF[U+6 0ROZ;[_#@Q>5Y]D;\+Q1
MZ+0P7\8=XNXRI,M;DVV5_^'W1C.!BZ+QM<GB9O<QGKW >N,]\MU3P UE 9P1
MIA81^8H(^@IS(DZ=G (L7>6<'VO=KJJENX:T^WH[4Y3T7#E(81BS!.=4EEE:
M8#XC+J^0[&3G4546XO!21Z#GQU<U$\H/<^@G:,I;QMJ+W$V]&=B!SA_N>WVO
MI*\I/=<-@6&ZI[<1I&"H$;"&?;NQ@KC7#KQQJ'7(PV@Q!KUSTJ0A.CZ@V&7\
MG)!CEAU",& 8*_0-IGEZI/QM3=L8>*=+#U[C9;.MDKTX]V6R-;=>7KQ_>A-Z
MJ/S^=ME7$]EII<['A=6&(7\H^04IJW#Y:M.5U:T@'Y4%PEE*AWZ#V"XN;"\L
M@M'1[7"ZA6Y>'GP7\A_)OG)*U.KPB[@A;D2"<*5)U/-7W&%ZT@RNI;CIG6)L
M 5XC5@X>!:Y&MBZ>D295#ESQM.P"SV;2)6N3F\7&9L8A6CP<5=TM/YH?-^5*
M&AR@R*RNB]/1+=8D/K(RT1TG2'@QM6VQT'7@(H0!7B:^LDP>V\E0>I^NEJ7+
M(BWSM&S]2F?SV^%SWH?Z.^]Q"#-*'LQVA)TL0X2Q?%_80@)I->M;ZH-, VSM
M,AY8"UP=99/Z<+MMMCGK5?/Z$B2N L0.=%FH+-0SB K5]O997N&Q'7(4-W4]
M$&.=ZLVVI.E\_II#(8B_M=7B>_+O69_%DD?J%CJIFPS:A!4_CQ'O#S@$F45\
M-0#)#DG#2G1$U$A<);]$I8YT9'P(Q#0TU:0%EG]O">][_NB!_:U>ON. <]4#
ME]U!BU\5IV-; O 2'6#:$'9GQ2VRS(1#U81L-()%KJZR*$#4,*C4U<!MBU_J
M1UG#@;RDU:+,'?FDLT0!W<+9U.*6.A8N(L5"VA6_$,,721-A[K9=O)>99CIO
M>GOH+ 5(O^0WPW_D]/?AAK@/=%%G3@'5I<0UK/W:S@62-%&^EY>!./IR:6,;
M._9GC]%&#![!+,'+,GFK<9_\N3W21,NJ(0;3B1CD(3>E[S&5Y>1(I]@$S?0+
M"1@M:GOI/3/PCJ&LT%F3A79@%CE/.N&S<I*^SF\L-J7?>,![?O-/."Q_O1=4
MX5]%S+"8W3H%H+D)5?CX=HEX,$,(@Q,(((>Z80[!DBT7(*'MO]0*+@CWZ%UT
MN_G%4ZY3&A"=E96H4M<BLA2_PX=?PP![XL. 5UMD2$H+Q&H]O!N^'1M_?>,;
MF._IJ_5$2?3'9[?$I ZNAD:_?70QWI?_GJAWV[;(7A7YGU);*2E?JT:[UFD&
M8[IN)4'[D> ]?]=?9))49T\<'9V ED:&]%'R<=;.W8HE_S[WQ*HF4Q (M%BR
M\'UO&[^(FHDV));G0@():UBUHTBWL6FK1((S0FYVJ_135==&0ZG'$S[A.[$Y
MAB6 +^\C3P$TP$QL??LI8&:!\ KGWRVFOAHL\W3"#81YH<^7%J<S8.9^54,$
M-O!4 GVRYI]JF2AC">.$N>FC:8TIA2B,4C3U2B5>HR>'%^<3#WQKVS1:2W?9
M<#FT:M/SRO?DED%5LVCFE;N:SW8U3UQU\3W9>#Z"]9CO"'IVL29IGIB(MFQ&
M .0_%DY4\ T.XF8SP4)9?3?=KU=7?3$]SG3T'!%XVW>0I?[RYD5*3/[EWL7D
MEZ3&8@6MFN2LV971^A\5AWX@];B7V78-T"8(,0C2\R:MEU/_Z-/*LRC=?N$,
M*W1>XUQJU-XJG!O2=( Y(K-+= SAE@Q-J_%['UZ KS]QO.>TQW>_GING#C=K
M@KYR(?#>VJ4&8!RJ>GKGHBDADVA?1);#7ZK$@B). 4P^8D_:ZE,S[*J?P.SJ
MIZ^'UI][ZB7*),T7;L\<>FXIXVCO5RF!K0'7N\.)"/DUKTHTS8=P5GQQE?A_
MJCO3=RC8OH]/I5 A95*VJ8ADC1"&R24ILDQEN82YA&R)E S&3"64M61+EI E
M@VD(60=#8C#9=V/&DMT,AF&V6\?Q/,]Q7,=]O^B^WCTOOO_ >1[G[_R>R^?[
MVX. ])##4%C%2+Z.]6W(J:HW>\8*[QSP"#AZ[="&12L7$/4((<[PUWKYQ4>(
M4+1867EA?N+$#W+7LC$T93G\C/'8C9EQ(K^8[I.25 E=,%ZA^:XZOPXTT:[_
MJ,V3L&LZ/E??UI;, %UZ/6DU[K/-#V746+T"X80<L9Z8\R(S<JZ!O06%*H&:
MQ>+GVL;SWGXI>@O.:7T#SZ$TP0,VY6MHXD3!9#+Z$"8FXW2X'Z#,-N'0'CD>
MTZ"YF;93Q=7?43/9@U5P\99?UQ&W<@-! @AH]H*U75!N?:?@SLGLBCU7AVC"
MIU6_-M%:$ 2F%:<#=1RAM;M7SM%:G]:+3XS#0ULG3KO3?4XN'.<SZJKQW1+6
MHS3GI&>8I.2\1!%.#*CR7P)#EIS)F6*,T,W9GGH9%KA7>;D6F,<2Z'Z<><R!
MG9Y=D6QI:ON'G1_ @](P5N<\U#YZO9'^:3:EMN92;L0G@RJKZ9JZL;O;/9'C
MD'LYG5"2C>:&-3CHG;606ELA17[0Y*+]4K&K_-D#TYM>(]I^O=;=!DH.Q!KW
M[$AFSN3_M;!,E)QZ*// *F'F3W,^_2\)EKP_[*0^9YSI5M)@-%'6QEW^B@JS
MF5O0"PT'A=F5B$^:5VW6":[B>^H=NYPNGHJ_'L-P6BIL0*H-/H*E3?ER 58M
MYLE7-C;&D;SSMHK& Y]?H_N+0YZ@7D*-@.W^_Y&MLLCS2 TO*VC\.&_M9V\_
MUHYMY#%-"I #[($:'AX\=K:NUDPF7O7V%?LDN:< 2;,0#^8%9!<4H55J(0YO
MZK_C6!6U95EYYINF1 $7D/?"7R]B7SW"?DL7[Y*B99U7BCH<C%MS@"TZCWWW
M4S0/CK[]:1Y(,RWE K2ZD<E:.+>X9T] O&#U69+B(Z^ [X(Y?K4O6Z$'02NQ
M/QEQ>H!]W>>R<;S?G"^<8-W  L=GE+B $D(6<_/0_@@"%8O_$9,#=.7X=-(/
MGLNN,O_PWZ+<_Z-],YFC.9NB491H&X@HY\@\&O1*VE#V4VXSP %Z>>;'DS0A
MYBI[M8YZMJ6N)1<_XM! ,SV6D"0O@I;>]YP/_%S(DYVUZ]6](4.&IHQ^8&LS
M)JSBART#>Z2\'\,O6 28:\TVF_L9/C>>@B22N8"7.$M+PJ,_D8ON9NR,[N2M
M8$A9V182U,PRI(XR#8CJ[<[,\9_[-YGMD(F5^H'%"08.K)#(F)D4@%%PC401
MA'*W1DV(YE1SJL! ,CO+W[TWM]K^2K?NMN><;9C?Y;$##S,NE?3:=?NC!#T'
M=01Q>1:NP1[J1OX>CX2OG_'UM4I8XRLL9^^Y*8*]+2&%C:^(>SQXM;8Z9WLV
M;8'\\*#7=2.259E%(3+DY!3L<^M290FG-7,?A2%7R%CK;;:T\SPV-DP:G3=S
M9R1&E5:_<^'ES>)Y.%H7K"1B;:LH!5)N,A0PL#MR_>R3I:3VE=75BZW.#[63
MU/(4CJQJ5TPO)8Z.#_\9\OU<=N2"]A^_28T*1I$=JR^"Q(?;+M;\5>U39N_Z
MN0;VU'9'P=N'(1 ,Y9$0?JX3N=U5QVS:(=-4PI?\?_KUV(^&:LNXM'_\^&(J
MS\'VV9P1(E_8:?F2C<-C5"H;.;4(]Q&&FX?.%[(RY[>2"[(CMW/F_^VG3/IA
M=?L;29NTB_&Z^Z\8M=V% _;T]54_>%_@)4J=M[-*J!35.LHW^5Q$L:OU \!?
M@XY:FF>J#"$NQ8).P ?.K93/.OS XXV=,_!EUQ?&>0T6$/:K>HW3*0^"2M90
MAX-VEP1I,6O%)5!07:^9J6/2#1.I5ED/29[_9+%YCYU"H>H83JV"[!06%6N*
MBM)<[QMP9.F[!L9@9V-SX1P&KZY($$VE3$@?62&-);O.[%9(.@1.4.N0A;ZP
M1>B4WJDOWD*BJ(3+V9$*3S?^":O[-VY7E(W&.8/V<GJ";GEN3EB_I:#A6+>B
MCRC%!L$S:8(.N@>8A%'I\RAMCCQ+EK;5B#I.G,2\3.6I$/V\%E85^YAX].I4
MA.&"7F,CC]#0P>EZ-800PX<VU80AJ[P<V>OPAYKW@[<S&=W?F31]M?Q\B=#H
M(\; '=A^QJL8\J"$LC)=E5W?!\&/H_Q9J0-<0,I#7#A#6>9FR^2RQ3'2$I%E
MO>O0 A&]/:0W(C;ER%XN  MJ)@X/+#CX\67>H3:BQA:ML1(-_.0'1]P(>I4A
M^&]\<NXT.TX\X1'X@,^+6#E>J+E0(2MU7']^(6[V/O%\A]I]^\]?VQ\<<P#-
M9G0^\?HUB+7KO_63ZI?JM"9E*W_:>DJ=?%,5UC*V#]3D&^_"1A0)/<&H%>,B
M@EA(,5IB;/[#<]<.UUOUJGZW3;M_KS7DPXK4@D*H.I[MMO^2TI8C&M;JC%-H
M9MM(\M=AW.8V6%K;4E-&.M<F3HK)BX1;GWZV9*2)TX<8_8VT&:)"GK)NT41A
M47CDT9Z)V5ESV]BC9U=6QH'&GW8.Q^_WW[5;J'O$DZP[&7KF<))9]S[D.C15
MWU6RV02YS05XK<3=A&.*]4$(36H$7H#_L1"?ARD/XF3> ]=T7.TRRWA#$K O
MDL$Y15F2O9DN=CS=<5R:HP(YBPD&N>%K05&=(\6.U!Q2$:ZI)K!.UWY6_P"G
MBR/*T+U;N<:#&YB)$Q6+RA?^67A%:!R&+"9%[YE+@,)BIRZDI"%/#S9?;[=
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M"_D[@(7VO/IY,ZIS@H#S+.>H6,Z1NP! BH[4_U#O'."_EG/GJ2Y07Z2AJ,%
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M9E>3 :$'5:>BKET?R[U$2P=_DXSSX4N$/8HO!D6^I5P!_[UP; '/P5>9X&0
M5)\,^#R9/EE(H"8#WFF0 418!2G,QH22$@F>!E8,'!^ 3[E[ATFZ0=KLIEU
MS_]+3SF?<84VZ &2;WQ1R^U/M0%]*N,0FM.)8 Z%M]=UW]_?'BAZZ+U:0/.B
M6: 8!8VW,,FK'^VJC+V5>-[[9W0BTH>HV^K[^Q?3@+Y&2[_@S3[5&]<BBX3*
M8-L6)"Y,;Q1,1%S5?OI&2GI]^H=9]$YPC^1&52/UK04S/X?I73( <*;.==DH
M/"_*U'J"# !M- U;[8>UB3B"I!E> G<F/ZS/F. 7]Q#+I)#Q8=/^B1Q39M#]
MF(&S$J4_RQ*'HVF_#;4YDHK^[TTFO,@ 5I"8OR[*YO7"5<R+ST)/DMS=/LC/
MW22QVVPL?M[3=M&)M](V?IAJE7^DYS90:I(7D;\UGAQG4M::5%6R-?,BO-"@
M=%OUK7)]_1^;H.A5^JBV_.RT0TBO["S7XXD9*"-,+,-2#63B:A5?\P"\^4&]
M![D;O$(:@FO@?F%6>H#<QW=F4GM&'T0?.A1T;#P/5 "NP+U&*SDZ)[>O:+1[
MWW!Z+O?S?N&]?>ZS$_B;PSE";-2WA3:E?N;7;NQG_4[ZHZ>FRX1Z?JGJ(4D#
MQ;B]'?/Y!'VVL92Y4<?<-C+ ]G"^XW]&+EK!2[*$-[)DP/8:_(CWD/Z(#'B-
M/* ; _^C?E!3<<K5OW::7:]+!@AQGX%_[#OFQN#"]M[\3_JC-K%[^J?KLB>M
M>ICU8BA);MZ,?53=Y)<Z/^L.8Q.\E8C:G]RVXN?X%=WQJ'MTM:3BM$*KD"&V
M(JQX2&_V(*1PF-/O?5-XM8VYE7#5O48]H9<1'"+^?F&P@*\XU6WEBO59A1<N
MINYIK;TG$.1&!I:9R3_O'L8F6XE)-'AJV2PS,NZ,A:19$3L@WS?% _4_(0,4
M=@]V)B) RC/!R!_#N3&2 QJW<__S>[7_G2R1U&#>OT,8<?"!X'35UA'@SB[8
MSV;!=N7=:Y(P6BUI^&W'<[FIJ-\Y D[Z]D3OO<&7-K+,H9U]K0&>/6K([0H[
M"*9P)3*<Q.0(=QZSLMIZDH._^)$/M09><-_[K&&)YE'"-"2V7?4O7#:-*L"H
MQ"IQ9@=<$M+L>E5HITWB %8\2=8K:;N.,6E=L0Y<Z6H3';-K:FD*'NF_1DB]
M%'I[Z=QW#@2T 7W"A*I651]:*#E)=Q>9#I&MN(MD6 :)=CO4-9HVZ[D*D#SW
MR #JT5)[2@2[#_O^OUHCIH6POU#S\#-X$P6F> KOT?YKQ $#Q5$H5;9_09Y-
M&%(Q<!I(B+,])"2<Q8A71('^B.?& /YG<GTO=)G)M-,B9BO0X&>"-BK2V(,X
MP=_]./?+J[CE%1'OOK=K#^\;^CJ>,%_ ;3S 9"5^/,=BK0,>D8Y>"^XMP4^L
MP4X*G!O.I F!V1\]APW8[/GA2<<"XSMM5)CYQ+@=A?"8 Q&@8\,02;VME("4
M(KQP2>VG)99)/SN%?P=-2OQ:B;/I*T_Y&Q)/^2CARS^RZ?^,D_\Q,4->A@5\
MABFA"R9C6W0]JAE\3H6>'/ZZAJ\JVNLB6:5\5RJX;BPY;K19^K-9N*G>P:1,
ME;W@<5[MXV;W7!W=GHHX"Z[V(7KE&GB]RV:[@7*G+^.!;?&19KO8']4D*(=_
M0W<&&9"@KNFU#&=S9O8*\,;G)S6=FS;R?703X,WAMPSM@K/ GF#L2)*8*Z<!
MEZ:DQPCO,<S-O'AFF]7D *50Z#?TT*61GS?F1B>^MHG-XDM_^NR1=%%7(%T^
M7G.F4HIYP' _TN%AL)KL!PK$'FWT_[OL,]#]NQ8%.7_=A8]ZDP&_#0+2*)]
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MH]!(>TO[J&+..JB+ESF\]N,Q&<#FXIOA$U["U=B*;#1[%JUKXN!Y/M'3!>-
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ML.!3D</59H[#-2GU@L@-6,V)386EI7LF$7)'KJN'.T'[%\U K84-GI"^:3L
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MVN*W\Y ?#V^>L>]4&<T9.4@$5;G/U\P:U8Y;_FBF$)_\@-!_G-]-03,0=8K
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M =>K@YM%RS.SX:)]U,RH-INJ8DAKY=(#<H5I+)P_F=-.+GH"W,K5-2GS)5R
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MN6_I;.CSX'$3*'4-YWH#^$MQH\&%[QK0PZBE:!FU.BM*<3<(>O4*C>XMEU.
MA#*!J4F<*&!$8D'-K38S !?2FY#CQ;U:HZ7<Q!T/*IIAR1I6SG(\F?[QRU'!
M"A$=JHY],,\3'A( ?PIH,5%Z. L%ZP[4VBC%>TS.LD#-FA..%9>7<P"[=M$=
M]N$;,CD#)Z%;6ED0#MR,UM<W+J&1MQ_G*CD(+.],RU<(%:5N#<<51/?S[?84
M;XE)C#3*A?QP:RD#NG6;W,JU+4CR\H)4V/9&@^;\0%<I-TB.Y"@8Y$2"TD?A
M*AWV0 55+Z6Q^5N,9S:XV^+O);7J1I1<ZIE3;[\MZ9=B?=S6 O;#G$=8"?9+
M]8Z+SEO\(#8L:C(1E>%<2OEYTQN@<3:17H4!9&GG[8K!K>&ERBA^V@)8)3[A
MN2\#SGDNH1$YOE?_?I:>0@_EZFPZYBU "KPWU(!_X%E>CAI+B%<%>:O9VM:W
M2_.F-^B<,R4YUI&_"5=45>/OCOBQA3F[>[E8RM-=^]+1;Y;[K+;]T@?N>'>>
M#P]4SO4UV7C:VPS]T,K3#ZV0GQ$]*<R?OLLRF.F+E&=)&BA,-$2=7]1V(H4Y
M@'8$L+8'CA9B">Z+"$Z2,G6UMZBN0;IR"OAL3.FEW*_&K:0NZ-!MH/GQ0<TT
MO\IKAJ5]9OE?I&;;UD0:U[8[0?A,OF9*L(CD/:H]1I&8N0G=Q* 3=WC;>P0;
MY8Y#?!\Q3'M4K!2BM]W!),)]&' SRHE5[H9UHO*9W1VUZ[=NJ.7#W,DQ< 9*
MGZ40[A )<\B>F8 F-]K.0;V:CP5/)L!CV<U:U_ %(8=1B[9Z!1STT?<^%,Y^
MPIQ%7Z-T8^BE,'Z("S"@<P;4ZUE$?$?C=&*5[9WM[:72R"[-^[\%8MJS ^H7
M<4=^":!M RQW7>$%5DB":'CJ\>Q(JS@P84%RF<GN9-6QH].GNWW6JRN;^JUX
M]O'$K>]U38W_>\L$XB/(W8 /A\!J[(7^XX/A<<,IH$RTJP>T9 9*6$&^%#P%
M1,4J(6(4V4)OH0*5</]*Q>0_7Z(3%-8IW]QZ0WH=D:(@W/MS^RW0;!^:A@^P
MWO,W[<@676''?F3'Q@6.V?/I#N+M:8>,'6,K-2T4^TWJ:&(3]I_NMJEU)BQ
M,#2%:H=E:VJ4)U]'BXW"X5,GF/D78XN40 YW*E6Q0[D'QNUM@8A1<WBE%%#(
M*8!.29M*SHX!E __.C/+_>#V0<MUN2+>;Q7F@GDY\9%;Q686.MN0],Y1>C6T
M0.9WV[;8^69?0\4ND$@;FC@X9_8PC<.FMKIQ6;"\C)OC&(Z/"UJVD,(95V,N
MR%!T]AZ^M7+Q0,N%P(8IBP4H5>*90<-30#GP1 _MAB:2194K-''% AEH<O>X
M)S]YV("?<ER$FA/&<B]PZ["9KX\>>R;$^9R-K0BQ>&Q_R'Q&,%C0)%);K7,P
MJ5?JC[M<(D13N6?4@LN7P2WE%"":FSA8NU-8[OO2 M;[\U8!$QU)'=<6^K[!
MV8O@$[^X-<IA*$R.Z<<P^@8XCZX8V ]G*)F&=I%5X]X:S/=J&UD^5KEF:/M/
MN>1_X94E..D*J-)K\O3C-LJ#N*7A3>#94\"2;N4IX!<5#M>NCD:D(_[4'6=.
M_@$MO:KCG-!58<733 7\LTU;'YBP933)N-?6IX TTV:&4T#D'U"A]\&'!*SO
M*V>E<QLE9V(@BJ68(T[V4X MRBIH)2/M=?KA OK0JG7AUL,EXUA,M,ZVD9+4
M7^M?H7C\MY:^O>GL@I=:/Q>K@Y[79M_P,30X#*\%YCPML22B=&BUF6(\2B3)
M_S#SCR>>O-^2X:8Q#QNC:R<T>Y4U0I=1Z/O$BQV&H:+YG;5B>IJ:.E_2E5<D
MKQYQ-6&(%'IY#Q3MA5A99@M+=E6^M9]9B%F#:1V1+A&L%FF?M.5BT%V\838$
MOHL030M[="'8@%/X&^N2T2F F^3N*9MH(Y@:'=<022?M0M63/K7(^A&^C$4=
M]K>_%(LR%QR/7G^)'L%ZS(!!6W;VQV]JUET(8F">Z)/)4X!X\UQ^,_3!^J6*
M0T$*XM-VQ6$\U]//O%:ZY<6VG 9U5<^\F"!+MK_%T;>A%QL?RD)#!*/O^S'4
M2CYTSH2,(79^XD5$JQ,87X";D^'QX!47@P73':+'P &$B@T;24%MZ0R/.CSJ
M:(_7@&@QWNO\:VJ)Z0._G=$*Q$"PI"+HZ>\ ;K*9.EJ=!3]U[10P*]W8;[&_
M^ZXZ?0R3C\#-?EH=ZBD127?J;*="#0U>CNX4$(JX(GWE,YA%ZZKR;MEW 0;B
MU\\QQ)&[A Q$WA1WMP;!,<1L1U,A8(PBG!08NI/[)  XWR#^-*K!Z*IE!5YH
M>6.2:L8R"=K?V6^-Y)2R+^;;/HJ?,8BZW_?%W6]#4<7H>VQTM,/6@_96]<+^
M?;'D'Q,;QQY<V3&VHL'QSW95'_$_>+ M!W2U\ J@B!+3FVH@VX(GGL7XI2F)
M*9H3\2'X0[[A1<PYF!JA3@1!/Z6>4.HL,\5"53)CI*8UCE7*A(^1%SC)UL3W
MEE$<[>]J'4W".A&8NYP88-(7X*U7XFCFM8&FK%9 P0N@0 6#<CHSS,WERI.[
MK:Q46+(K@?.<T,Z@4C;S<)B6=!:H#Z1N*MVYG.>#$;W7K5. S3&RC7\"_9+]
MB_3.Z]EV"I)$V=MT27F4FAD,ECY&[9X@K;[_JA7'LS<IB4PR9*_&N"&61Q9I
MET[>.S>EOS8KVQMV,,BDAG9OU[&<09Y1D**LYQ)5*-K:_RO[IU@WT\^_M//C
M_'V(,J>$@K(_\/J(-Q 54&<FJH"; G$8_"XH&PI[+/I*;WMTPZ=6 85T+@6O
M>>Q3A:@)8?Z?;EQSQM+DRN3C7C:7_TP4S6Z7 6VF"9P"QAV+?\)O#,18](F7
MJDN4[_88<RO>6S,Z'M5FK!C&>VQ0USWF)+7GG0VPX-6&'L6^[# 'V2MWVSIB
M(>I[E$9Q- =?:SIO]E2_=+/,@(+#X?2++U3DQF05%;H?Q7<7RXD$'(8I\&>W
M"F'PMDEA*;()T.)BLIYDSS\0O!VWVVH8(DW7V8",UQ05CZ7&<:DU7+7:85["
M 'Y)=O?]">'ASS>X4KA<%%@:4>.>^[UV]X3PT:_]=C;T:<CC(YOJNJF( Q45
M_C4@OH *>I%I#ZL2N@9; H+YZ>,);QXA=@B[H+.BU6EJ7X=F1)0*X0D*QXG;
M9CH.#[V%C\<.R@QM:7^J"P/.C"0B%(MBKH>9H"M^VW+J^KI]<3IVYI>>]T9&
MUCK\;"14!X667;[^)96P@O4''];+/R*<+79$IS/J(YI_)'S'+'H>\; ^B$^B
M\,J0+3!TH"["R4X(&C X\%@X9#[:N(=>!M=^PSGSPM] ;\40]^;-W IS[+T#
MQOA732;D8;Z7).UV69>EC'R5@/5-"TZ61;-QF/N?<Z\LKN*R@2J(GDV<?.<.
M,FDK\-G^+--8$[=OZ]=V@1!BH 'HL/O-+,F$&/3CYYTTH7CF(!&"KF -8E97
M)(:8M&I?=/S!Z6Q"DQ9L^!0@G^9KWGLO'Z^/$';N:#X.S,U[.RJT9S D7/4U
MTJ8R+A6YH/V6]E91<ZQ!5//2TO9,QO^PI_!,WASF2D4 2<NQ@!E6&@-I_)3:
M7\'0YNX7M7W!IUZDR>W!*V_)E,^*CZEA-JYT%8H\\6K4G= 2LAO\\_EYVGNK
M0[LQ"+?:22#:,=BEMB_RIJ(4/!4$[#J&\[2X]1A_\!SV/B"!^']0,\@R4R%C
MJNA/:JAB6* (2-W6/T+5BV'O!P&.25,;J#(5Y1KS?A#L-A317T:O\D[J*$^C
MZY")'J9,3;[E338?ELV!1YZ5C55*T\DXD+GA,FQU,-L3SDZL68"<@]2=D-%C
MKL5>1T,^('"OTA@JM66)V9+ ^W_B?OT>[#&[_0)K[>@&IG-;,3"T&=?6#*0G
MHMX9LJ,MJ"PNP2Q<E,*;C!.>9:T @PSC-.XO)Y7L*87&F7IF=&M-?[CP3_O]
M^*0W=3H70X6UPG@A!J> '53R\6C@1^, W6@=@%%?DLVWP?U)GS,#EY@EB !0
M-FSU:L^00U.-\_8I($@I(3##>UAX7/ 00SS_%P*B#OXI!% OFN5TK,0")CB-
MCKBZ@+G0ML )>3-XL/G)]MU\Y,QCNH?08OS/WT><WFF.G0>*8(.1(OAXP5LO
M=O>K?G>[NOGA[]11&9BY'TJ73@'^CH0O8)8FQIMXQC!GMQZ:B\9[YYA^&"^"
M<")'K9ABHFDYD//+:U?]A9A8?A^!LK)L8@Z"U=6"1YLNV-78-!JBFE7X?B:A
M%G&12D!1&4HN_S;OS25J+HAO =E5SO<&BP>-+_<^:B9%K"F]HR?0#W?IFAAE
M\JAPOHSO-IYD,C5^B\_G':S:MV&-FT->132^G ^S>+TT+0$6VTR+1C&D/\>-
M;7$8%L*=]5+6]5WBU\?(8JG/#'-R>9,JJ;3IPE_2!!#@\;, !U#$H<F/)YU_
M@ @!E93+LX>ABNFHU?1W1K=5K,R8U*XRFD95RV2$H +3I6^;G + '[8M.8B?
MYM-9/_&E^RQ/\967S%N3Y&7G=-"B;]'NY_V^N*@I6SA39R4F/)F$Y,E29UU\
MMW/2PM<[NM=;+KKJ^H$^<^?U-"E][130=6PN?.6)8>0-LVYX/@F].+I6X$P/
M/6E2$J7C2X8QSQV4I2_'X'BY__IC"5A1[S_\,3#UKS_2_",1/?[VW\5S]AP9
M=/*R1<XW4I(/*XLD/&XGGT%YHVX2;^>02UHO'B2(.KS;9CI16P9F@.*\L3"O
M*\,K+:V\":MD?NR#]PE"C"\1#A3P()44U)Y;^U>ZEC'%8N;R3P%,DR9$@V\P
ME7(_CR2^@I%1>IIG3M?<?/U:.$X!GT8;6(_G3U1@LJ> @"J<<O,LDU6PPG%@
MG/!8["F@M_'-,\3N34'X,\EB"36]2P^N1SY&K3M?*I$.FQ^?%R!O2"*(]'7+
MIX 8=V"7I82-\^5FEU85G[)O&-PM']0I0'"9F>IUP\CV_Y>>:XR;<\[!W6F_
M08';/$=>(2N/+J^+G-7YU;&JE*UOE&?4*^=[T). N)AM(S1>N&QR\YT=?>YU
MRINZ$_7ANY[=8K,FQ:<  \]+41>WL+T&PE4T(KX-*.0"O7A)4?[=;,S/4X#T
MT?VM2A]V[+UM_XK(&20I?27L[\/FH_W'_RF0 9?U.+4OK:EXSK 3FQ:TF"#E
M/Q"E=]LX$O$WD78[Q-5)UC_]QJ--?<U-\05.$6MO'.=SNS4,$:,S/KF!L _S
M*+9;6I*D.TONCJ#.Z\>,$426'3/6O>\EHA<-K_M]>;S^URDEH#%/)R'Y0"RW
MZRE ,9T9U7]R"J@O(1KUO-F]W#;35'.D2#D%[/W>_ZITW;^0YTE%TN0*IF,5
MI6O"QXD?#:PUSO#(QPGS)YN@36CF26 <LZ,E&IXM%YO;*6VWXLLJ5[JIG,2X
M^8<:S)__4P<:0,Q'29W'C_BR<:(:)TI!GOG5\T5VE[(.]7D1,J X+X/4>5[@
M"4V3H:FZN=0+IGN(\@_.0TG]J)[?PY3?8:G:.SA3\7JR\!GEC;$'+WVR444[
M>*I?5C'^2[MX4)V@2<=Y$Z+ZR3-HD$IY^>Z6)S<2JRAU)F#73O /V":FZS%E
M&9YCU '$&>CX,RP @^1T6GG%!CW;@K;AG3^*([4*FB]8;15CSU%JN,C QJUE
M&Y@.U_WW 9Y_3@$MM>#9;10>F 3-CZX=#5BVI-W[=C1*?!]]4K=*89G[>>L[
M)D]G^?K_2\<9E!:1=>&^JY7[O$_(94?WU4D[D,L7'A] RS,@]C?JUDB1IYFB
MF&,JBZ;F9-:+UV71J^W,/.$11'EHKW-G(91FR^$4<,&<",&C"(EA<Q4D45]$
MXS&V+#;!5:6@_8S9G\9\!=TMJSTIQH';:P;JO<^))C/BXOXW_%%*IG$6>=.*
MUM7"CA98S,O9/[\^A*\JV%QR?YF%TLVI&T,76A+,UJJ!WTN-_"BSP(K9)N<Q
MEGE(4/,.)]'( ']S0_:SO*_\8WM2OY,,38W5#=H;1O$SDM[;5<%6:7+(L5,
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M+6.(N>Q5 IEX'X]\,LABBMM85^(?..CF,DN$#)EE5\6/6OV\OQ4J>3Y=Y)=
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ME'O[MJHN9+P'%UV\SBW\L[AZ P;$=Q(6R'EH@/WL.04?X3:L[2E@P7SF?O6
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M&0XYWZP1T,G/>BEW<^HMG^XXOV2!X8MO=ZO?&Q[G$HS(U116RA#FJM)-$LN
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M=FX!%<O$_#2]4WY8T3JS<3]J1;4W,T]/[4$3L ?]A]APPDKI!?$H<:RE7U2
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MR?!SZYSD3V:!F+>DA@3LM)?9 .S^=TLHTA*M:<9-9R+F+&9]\OMIJ,G8XB]
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M)K[W^$BM\<N>0&:]X7S/-;/[P&#T\%F3;C6D,OW5\]79RL(V&;:))WL-;><
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M@A(W'K?#D1SOP(!G"YOR);FN$A_BS)T?ZP-]S-;VGX8V3X5>NI<K%QR4,3/
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M1.9*::=7WA-B%>'7%=EGD]]D"+$W14=/<K(6@H^+JG\_GJ-3+))/!_2-^_C
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MIQS30TO,TBM,NS$PT2NX]$AB],AQ#*S8XZIWYIV#)Y/>MUXAKJ-G%SGB3JT
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MI0,J0.MY.8@F"_AU$A?6H#T&OX0390RCERQ-BF),"*\Y1YLP?N0ROSRA\7J
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MWA?_4^&EQ2(X6@$;"RV%?0-Q(7Z OLQ_DR1K3D4&23IEP9WOD^4KW9T_NA;
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M80&N^EPCIT#7JYH^KL]Y=,Y[>IJ]V> TPRYHMU^->6/3#\F0X+]E>,7<A9$
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M9*[E9G#?D*__JY;K___C"'WTOP!02P,$%     @ #8*)53\<""517P  ,W
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MQ+<T#X8R_TH;(N3EZJ;..8N%EXD/H]7K[2#U%C7^MF=\1"H.'=20[T?\S+I
M+:2=P'Y#<% ""7S-$Y).6$/*G1*2VHSW[KO ]XFGY>4V3MLYU)<]DME:=YG;
M_P&X'<<BP7@SWU%%W#"%DTSC<*ZA1D%<?>-I"@1(X[KCS'K/"WA(+BR2#JP?
M_3GD*.UPM.88[[FOIE?7/D@>*W&I'0MHZ(RH9(Q3CPY,OX<P(:;3(&5M6+(%
M/&C@255_#EDWZD.S4O%078%F:60;$+!=8VG_Y9I?X?<I&0%*$\,I+S*N]:(#
M=S9C(95'G &2+WX6)_D2X8$<TVH[/T$Q(%1A9U:U3BBQA\%$;,HK[]6GN:_)
MR=U.T8+%\B:\UHXRR7S,K7V"X#].8TMBN(L<%;/3@QRR(,4P;LY$$_02.4VR
MSEYA7QB'^2P,F<0]JC01U[X,WQZMR%Z_H!3-5L)S$W2+,0P9B@/U/4.%<BA>
M3UYYQK>E9RRL-4MP,! D- %3QTF^HNB$BA%XBW/&'0V"A&XXU6*3M!,F1ILE
M.F7K6KE'NQ+Y1"3Q+#/)^12N=!I;$&,DPK\P.EZ\60)]&%&*W+!VP+23N=U7
M1YAJN.Z"5^$[YG*-PS;1CCUG$_P;9\6$6=<1TR^QG-J2=. (F.$TX9L03\2X
MXO7:WLUZ7]PJ'>!V%P'5BNCG?.X)\/;URA_5?ZE4K&TCZY<(2CT>+P;P/ :V
ML21)];54@A>--9P.L"C>HC6ARJK;Z  ?##5-+,83%ULP6GWUEQ'$IVY>\F^*
MF6X]8^>Z=>X#\4;2,]L+$]X:D_.UOB2M9B?2)K[0C"0=-DT'QM)QS-71]0&S
M)ID09_R)JESFD@3Q&W&VIAW>QRU_^_<DUR2Z=@A>P14A&H40TPPW^++7"AZ+
M5 3@ZB0_ E<;I*)]77B6WX<F1AJ'XG<SH]\Q-]2#9.W'RIQ-58)Y><^;"-?K
ML1M^%[F2^[/+EZ2]UTYCB;M,3:<H32KTF^7>F5W7WR*;.PXHCX\7!3]*_B7\
MO?Z5X>''$/]/GR/ !'!,O6..(RFNJ78]*S]_XAS9<5UW^5RT*VU+D[-(I['P
M#6"AQ_U_0PXE%<% WR9%ZVF]!):G*NFKD1^N[Z4%6F)Z?_FX2O+XZN%I3V?J
MKMZ9F>#\V73T==U5UP<)9^\"\E& &Q"P)C/!?>@5'0#!#Q^@B:LDL('Z)"*3
MV)QWS74[H"Z"6C.1%9"QD%U%@N)_]K2>A$WVSTQ&\59Z^WBO5\)VGMNL2!F>
M:2N+FBR,U/_EU^W3>XF?ID0*P=,!G/Q'7O!).'O.ZA>'G^>J8NS[16L-[PFQ
M6(A^L=D3&NQV:<: "1Q9*IF(*^68"EL#1\?.FRGGOU^VJGQR^LAAT%V9>>Y#
M9KX<I(A9!W-.\P_VF!SATNI7U/4;/[\D)?'[JQ^13*QI\\Q+8G3U+91Y:R64
M+S(P3O;-$8G6O'1NG_<O3YZ^>2K!8><&LW! LZX@05O:%V<.&EDYU3*>8[)Z
M[<W9Y=="0@*%N7 =/$=41%K>B^EPD9\+VOLA:FGW++Z_.R*D]$GL3,*.:JD>
M< ^&GME[7 \;,IU%'O$0Z.@OT6O+"O)6DT66=6D:@=_FNSS4=6TLU%R,AJOC
M8)93+5G@T@&Q%]7ZJ4,OI*[VG[EX434T%FCOPXB06*Y@3:VNX761;@$B\+IT
M4R6IN>N1'(R1OC8\$# UGQEN7O<\,#6WPY^+#PF0/NH8EZD@+?R=__1]2W,
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M%NFV0Y6R<9UU,8I^04'*1N)%H>7*G$9[JL[8X._:\M^5WGR^.UQ=0-U\$FJ
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M<Q$O(3++JS]U#WM"U'(^E@>Q*H&Z'1FI"&V [MDV=FX'6^J&D'<A5W]\)C_
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M@2=[KEG=<ZL6?AS7D/[YP):,;!!T6C$^;2$N1;'M]FO\XFNSO4+!Z2XPX&_
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MGT23P_3X+ 3^$PT,?R_5&8 2Z*"7,'85K\A&B3MG1HIC.M7LJNI;%^(M]ZQ
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MH>E0WF@,U1"[,G S6813%_ V&F0XEK7(_ZMD^/^+@>D3_P-02P,$%     @
M#8*)59.QBR5!B@$ 4&@0 !0   !C;V\M,C R,C$P,S%?;&%B+GAM;-R]>X_C
M.)8G^O]^"MX>8+<*,+OTH![LG9E%5#YJ$C<K,S<S:WH;A0N#SPA-.^P82<[*
MV$]_23UL1=AADS(IJP<%5$8X9/&<'Z4?#P_/XY__U_?[%?@FRJK8K/_E3^&?
M@S\!L68;7JQO_^5/OWU]"_,__:]__6__[9__'PC_S\^?WX/7&[:]%^L:O"H%
MJ04'?Q3U'?@K%]7?@2PW]^"OF_+OQ3<"X;\V7WJU>7@LB]N[&D1!%#W_:_D7
M%H9!D" $,488(BP0)#DB,(Z0P FB:4+HXO8OJ41A(%,$HU0RB-($04HR 2.,
M,T2SA 3J8WW35;'^^U_T_RBI!%#*K:OFUW_YTUU=/_SEIY_^^..//W^GY>K/
MF_+VIR@(XI_ZJ__47?[]X/H_XN;J$&/\4_/7W:55<>Q"==OPI__SZ_LO[$[<
M$UBLJYJLF1Z@*OY2-1^^WS!2-YB?E0N\>(7^#?:70?T1#",8AW_^7O$__>M_
M Z"%H]RLQ&<A@?[WM\_O7AP2_Z2O^&DM;O7,?A)EL>%?:E+6[PD5*R5]<[?Z
M\4'\RY^JXOYA)?K/[DHAC]]V599/[JJEQ%K*,-52_M-+@_UT@?B.Y*T/974@
M7*/N!U<RGL+T@S-QORI^$/X%'@QSL<CM _5FS:=Z=G=#72RZ?XE=/1:;FJPF
M>"SVPPQ$7ND/WJN?NF'TC4Z0:3-.1]T#4<7W6JRY:-GRR:U!P?_E3^JGY;:"
MMX0\+'_>5L5:5-4-^\]M416:O&^^%]421W&:!FD$998F$$D<P%P*!GD@:4:S
ME*<Q7]:[1WLIUO"W+[T4S5!&X_S)0L_ZA?>U%-5F6[+]2G>_.K9\J95+KW7Y
M3VMR+ZH'TGU!":N-@E;^?^W%! ,YP>]:TO_OGW_:ZS8>U]54:*WF!]2&/1%G
MI8V%3?D<A@TSA6'_#E9*@P8#22K:*-'=XB=MG_TD5G75?P+U)\V+>&Z4GPYF
M^:;L-2 E.S,)W14_L8VRD1YJ^&0^M$UII6J]L7I 6H"5"'\"FY*+4MG 1]0Y
M>&A?;<M26<%O-Z4H;M=?R?<WWQ_$NA(_B[601;TDB- DX1G,0Z+,6IIFD 8L
MA9%4;$!Q$.2QL"&%,^/-C1PZ.>V(X!RF9H3@$"G/Q-!)"CI1@9(5=,*"'SIQ
M?W1'$8; .***<Z--2AF&JC^G#M.OC:.0[K;M(.SQ:TG6%6&:GZJ;-6]^735;
MQ.K39E6H"Y2M\K/2ZN]+*N(\XCB& F4Q1)%4Y((P@QG*4)0)0:C,;<AEM"0S
MI1W0:P(&LMMQT?C),6.I22#WS%_'T>ZT &3-A_!7H%4$_-[]JS4"C4H.S:"+
M877$?N/EF)07+X;K.6->?L-Q7/INS4I!*O%:M/^^6W^L[T3Y0<'0<OC[@M!B
MI:P_42WS"$=9&$K(::[HDPBAK#1,8":0R,,$)2R3-O1I,_C<&+.1%*PVZUNH
MAKL'J[VH=H1I-0-F'.D+5\^TV(L-?N@%_Q$4:] BO1<>O#> VIH QV#FB/.L
MAIZ4YL: \IS91MUC')F]%E*H6W(UY.9>*+/SIJI$77T0]9+2*$H$"V!,.%>6
M7TC4MA))J.S E,0$Y8Q8;2M?'FIN1-5+"FJU2R*-E'8$=0)5,SIR@Y5G\MG!
MU$K9["E;.1= 2>J.:,ZCX8A63@PT*8F<5_@Y91A\8RQ!T/K=NJK+YB3V%2G+
MQV)]>W._V:[K98JR#"5Y"#G7GB<LJ;)N&((HR626122+<&9'$2\/-C>2>+^S
M8[B2>@%NRTUE31,GL#4E"C>(>::*!JRO&JS7#5B_G 1K!$&<1\$919P8:F*2
M.*_T(4T8?,>.*-AFLWPCI5 [KV]B1S^?22T^"ZV)LE.:7=BK._5 J M>JPNJ
MNF!OA;HW6>EK1;TMU]UC'R8IBFD00BDB 9'(8HBS*( ADV% >2Z2C)I0BENQ
MYD8^OZT+'0_SI5;Z5."AW'PK=% -K#>P;,0V(R+'<W>:LJXW(Y[);:?4T!#2
M>H&GBBU JYJZ#/3*@4Z[]CN-?@O0:GB5*>1=R%7SG1E.Y1/Y_NM,J?&*YP?Y
M=FU4]V[6NS!HH[K^R?%@DZR.?@#JUU%/=[=?<96]7ZP%[TZ'/JF']Z]"1SX*
M?O--C70KE/V_O7]HW)^_58(7ZU=DQ;;:(;J^5;N"-HZH8-T-7FVJ^F;=W^XC
M716WC1XW5-D*A-7++,F#)* 8YCA4EK[Z&6(>(!B*.$Y0C%.<&R_+$\L^M[6[
M5Q:25EOM8>C5!5NEK_;@J2?K8:OU!?6= &M1@X=.:Z"/!758!U-Z-R<?:OG_
M#_5$JB_2%@.PV8$ 2 T>!2F!6/._F*\H4S]>YRV'&3\T_MTL6G/0R0JT[@O0
M:P\Z]<% ?_!;]Q0-(- >&="#L+N7A@$H''8?[)$ O_=8&,987>.Y,3=79OS\
M3&33S/@YLC)_KC23)VRDJ26:S)"Z$M1#:^M:(OAU@ORV+M7GM^OB_PJN+NS$
MJ;I-6,(2%H0LA7%. XBRG, \RAF,PE!$<1!DF$0^?" GI9J;&=5MO!0[;0=B
M-T<VG1EDZ(UU.W=N?2#.9F2&+I"A;LWUO79^'2"GI\^/_\/9-,[8_3%^.KTY
M/XQ@=^3[.#W6+%T?1O",]7R8W=Q1T,+36-E7F[5:_+=J_?^H-LUM"-ANQY!F
M+!$H0S#)L8 H24)(D4QA0(,PC2C.@S2]**K!7):YK:B]*H9^ A>S,3(:P@_&
M5PB7. C!5XRZTP;LU7&ZB7((JZ^X"PM)KAN880_9V<B-$;<<1Z-]MM*;[^V^
MJ J7B@4C1&0,49RJG0<A#.8D)1#QG,59R#C.XS'YA?LAYD9Z6C+ [DAY:QN%
M>@0^,SJ[#!3/++7+(&R :<1SGSEXJ+GCI,'! %?)%SQ4\*54P2-7CGN;/Y4=
MD7RI-^SO7]03+:J/VUI7@] %-I9$"II@C"$G.D)+O^3J": PR"@1+ @Q#ZU2
MA\^,-[?W?"<NJ+2\"[#9RPI^*-:@:C1X.0=N%.AFA. 02L_LL$?Q2XMB*RP8
M2.N.+0QA<40=YT:;E$<,57].*J9?<Q$*VN3-DU#@A(52;:2DLA+4=@KF,8YA
MQ#+"@BQ'0B3C T#G6(I 2PCV(HZJ0G $2-.-T"7P>-_?6"%S89"GAXH#1P:X
M8D#GJ3H#)ZX<]VKKXE%\NQ(?Y;LUUR<N12W>%]_TKD1QQVU!5Z(-*/]*U(_[
M!%1!4YD%$D&E;@Y1KI@ YV$,\RP)6( S'B)B\_Z/E&-N)-&K 382%#M%X$IK
MHC[H51F56S)VJLP89H()\$Q#0^SW.L!&";#7HLM4 ;\WBOC)$+X03$>T-E:*
M2;GO0JB>$^2EMQN[!=L\B+)^U*?4^I3YS7]NBP?-T$VZPY)$<9['@8"()2E$
M4C$F20B%F<B31(0X#$FV_"9*NC'?@YT:T.:E' [K<_O0RKL #UKB)GI-]#(O
M=*R:#FJSW8*=!-UT!^8*2.\;L![!3SL$W^P1=)Q78P:+LPW8R<$FWG^9*'ZX
M_3+ZUDAR(8_Z5M5'^;KX5G"QYM6KS?W]9MWL]9:"H%0FB,,LB%)=! I!3(3Z
ME> 4QS(B(:++84F^\^_$R0&-WHFSM0:=[C]Z*4$3'*LE;7T]EGQR&F=#/KD<
MNXGXI!-46TL?2UZL2?D(=C+KTZ@&QR\G<;3G%2-X7/'*Z<&FY14CQ0]XQ>Q;
MEYT"J3M2-?WZ@.GS[N3^G1JL+F1!=@934]JN%%S1VZ *01.$)_BK@_($_>G6
M9_%-K+=BB65*0R%R&%-]RL19 HE,.:0QDB')DPSA<,P!TR32SVV;N3M1+EOY
MQIU?33/Q=D=CLYO.J4[=!HHOP%YU,-2]W[KVVC=&X$!-T &P *\.R[\LP.ZI
M^7SFJ1E]O#?I[#D^.9Q&]JL<2DXZ+2^==TXKQ+@E\8;SIG8K67TB!7^W?D4>
MBIJLEKE:H"3*"&01"2#*XQ!B&A*(<\XB)D3& ZO3CA?&F=LRLQ<3/"@YH4Y/
M:R6U6W!>@M5L:7  EF<2'^"D16P39T[C9$VQ9U!P1(8OC3(I;9U1]3G!G+O<
MQ9GGSZ0JJB\/I2#\X_K?2=D0EHZ!#9<DX$&<L Q2+D-=+2N%>10%D!,4QR$)
MB93!^)/0EP>>&UDTIX#%3O %H%IT4#6RZYWYMTYZ4"KQ+SDW/3$98TY3W4 \
M[1GK C12@R\[='O!FVA]7V>OYZ'R<B)[8M@KGM.>!^/TZ:W!]\=2E[HI:Z/R
MEWF*22@0AWF&,XA"'*J?H@R&*,]E@I)09LB.GO8WGQ\%[64#HHVFM26: 72F
M9#(.$.^$L1?+)1T<*NOLE1_<>N+7^E"IPU?WR#4C0RZT[^Z=VM (_GI;%NO;
MKBU5$[35_/%CF]7ZYKLH65$)OHS#.$:"AC#F.%$O,8M@+M(0$DY3D1,<,AG;
M^?CMA9B?WW\GVO@PSA%S81A.X0??B2(IM)10K4\*6K5MUSS:<NI-6>HDKR;*
MBSZ"X76=JQK<_$%*O@"==@O0ZU?I75$+@L,XB]$HNPJQL!=@VNB*T0 =!%:,
MO]-EN7Z[DJ8#KX^NI\MH)DB6(IA(H?9=0:8X,0@)S"E)LB!,>9[R9;WKZF6<
M:_;">%:VS@LMRUR^H[H:!W=5KO@EC$TM(&?(>3>*.L"\5RP^@X7C]+F71KM*
MBMP9U5]*@SOWM7$LTN7.K6_?ZWKJSRJ(O"XJIK.2]:9+T1D3N@1'*B7.<P%Y
M%.40$88AY6$( \Q2%L5<Q-+*U6LKP-SV5+LR07W1,M[)/,*-8ST99OSC$V+/
MA+03'32R'ZG*U,O?^'46H%/!'6&-!<\1@UD//RFEC07G.<>-OL^E0?W=L5CU
M5JGVYKOBBS59O=I6]>9>48<^8MLHF71X;$N]/S_^(C:W)7FX*QA1P"IIGP63
MLR 7"<DE%'E U4Z4YQ#3#*F))7DJ*0MC;.7M]B?JW(CT:6J W)3W[9Y*[:-N
M!YH 94\3_6'S3)2/^G*^N2]8L;)D6X]/@>$>>!9SZWNO/)C63LVV17VO)]@I
MVH9KZ(+X;4Y";X"JR1[J"QJ%)\I/\#4SSE,8G MZI2P'7X"_G CA;<2+FMHV
M%>R;T5E3'OE9&]8LISG.>0B%S)093I49CED>P8RJG3T3*;(,%S0:=79+1FUM
M8INA:\;?SC'S3,5]T%LC<$>VK"O'[K_EK1E,;AO?GAGS&NUOS6!XH0FNX9='
MMV]LZ^R(2@>*+#&*2(1S!M-0E[Q!,8.$) @R$@8\2S!.)+;LT#B\_]S(I"L^
M56OYK+LN/@'.C#TN@,,S3^S+<(FJ"=ARVAGQF-+NFA\^N?O4_0V/J7:DA>'1
MRT8&9*[K@A>KK:X]^$6P;=FX!=]\9ZLM%UQ;-*^:>OG-5NJC?$/*M=IE5VH;
MW1Q,O"_6XETM[JNE3!EA/,(PT"VM42XES'4YG#"+HB"-,8JE57TK5X+-C26&
M>H&]8J#7K-W;#'33^YY>.^V=:@\%P>]:0]"H:%DCP]F4F]'4-2;2,[]-.H?V
M@:R. 7<5^>I*K&E#91V#>1!;Z_K^]M75?U'&GSYJ>%](\8450N%2_2KNJ2B7
M(>64QQQ#%&$*4< II(BD,$,9ID+F89P9D?KI8>9&T;VD0(L*>EG-:V:? /0T
M9;J#R3,!'D<(_-X*:M'5Y 14YO7"W4 V40%PRX?+JH+W>2!.E.0^\>7):FR?
M5V!8--O@ZI&1,47UL*G(ZI=RLWU0]K;B8D6ZS3%24S)6\%W%V%>DNE/[:?V/
MKDGPC:QT.O%2$)9PE LHI=KUHEC$,)>YA DF,@U8K(:U:]][J41SXU@M'K@3
M*V4K;4J@-+.-([YXBLRLUTF!]\S:O2Z@468!=NJ H3[[VM@+T,R2]O,U/PRT
M<AC/XPI@5Q$_%\LS;4R0*_@.HH:<W?@JCHFNZ0@*:,))B*$(< X1"R3$3&#(
M99Q%>9*C2%KU)' BU=RXN DN!9LFNK2+\FY>>O5O719-^\.FV@O8KHNZ J+?
MY8X."G<SMY.X'V;7#\B1[\%=ZQ@O0,_#YW"-WO-.873L;7#28N:]J"HAG@9L
M]1&ICWT]GM=;<2,5]_U-D/*M$G9)"(\S&N<P8XDRJ&DH84X5I8L@PR)6EC86
M5L?5HZ28&W%_O1.E(%I"._X=-P5F?.L=6,_\VLJ_  >!HSLE%J#> "J:@ZT%
M:. '6A&@-7''IQ<!Z8@_Q\DP*5]>!--S?KSL9N/X4)O,]:/FW<U:W?[UYIX4
MZR7%"8F"D,$XD1%$ 8DAS@6'813@5)*8$63%=T='F1N?M4*"G93@]U9.RP.N
MXXB:T=?%.'FF)WN(K(GG) 2.B.7X&),2QTDUGQ/#Z8OMSUSZ7GZ#%KMO-^5A
M1]ZJO_"]NNS+]OZU4._A?5?EJ7.4)R*.<IPB&*1I#%&6!C#'>09Q*(5$DF<!
MEJ:'- [EFANY[/MI#OMP*^W L?;=U; !IU82*"W!$S7-3SE<SO;Y$Z0KS:%G
MXG,^?2-.JUS.H_GQUI7F<Z+SL"O,J]69F@?T3QS"N1QMLE,[#Q -C_E\W'YD
MVM>65N(_M^JE>/--_>^KNDMG7$8\I@CIA*V$)Q"EF$!,>08#D7 <I9G,8J,U
M^.Q(<UM5]X*"1E*@11UIM[\,KYGM[@0TS\O82+SL$Y#.8>$J?^C%<:9-_SFG
M[D'VSMDOC(V!5V^=J.HNL+Y;[$66IE01 4PS;:(G20X)0Q1&.!&Y3'2C)ZO@
MV*.CS(T:>B''%0H[#J09$5P,CV<2V"'3)\VX,UF,(' 6+7]LC(ECYD^H>1@Y
M?^IB^TW\H0DR,%%^JP1_159LNVI<B3=,6=/ZY]WU'^FJN&ULDS=2"E9_E+W]
M,LQ77TJ:"AJG&.929,JRH"&D822@LC,R'@0L#,S*94PE\-Q8Z%.Y^0_1G&'S
M;C]!]IH!VNTM-CO=S'>#DTS_^>W^W";5,W<>VQ4NGNP=?VNJJNV5!@.M=U_;
MZ[T K>;@HQSL+9]4!9G9,V'N.IC;LS&13V%6SXB5MV'*"3OAAIA$C,G\$U."
M.G1<3#KNN.W*;^MRURKB*_G>#5V]6S-=ED!4GT6U76GYFMB0-H>XK4NHKOZT
MJ9JZ\-4R"8(DBHF /(P3B"(BM9&20\:"+ T1"GD8V>QOW(@U-U.D%U\7;A=-
M37%=5O"A%U?7[V1=AKU44TQ6X%$0R] .1Q-JML^:?IH\&Q=#A9JJ!KU*3;!T
M.WD[I;I(NV[&6KV:+^TT<[>=<XNTH_V?(Z$FW3"Z!?+Y#M/QW>TXO2KK[ISZ
M5U'?;?B[]3>UV17B@WK@.S^J[@K' Q3"0'"UF0S23/%T@J&4*!5,,D*QD1_J
M_%#SXUXM8=O904MIZ:(VP/8T9;I%S+M_RA8L8T(SQ^$42:F[# A*_;8G)X,!
M)B$<<T5[$K'XQCAC[RTIRG\GJZWX59'1MFRJC'_:K KVV/Y_7WX.HS2-J,Y<
M8RR%B,L88B12F*(\S/(\PD+=UL*>,QYY;K2A!0>-Y& @NF5Y%W/<S<PN+VAZ
MII3C0"Y *S'XO?O72S$^:[P<V4?FXTYJ EG#\=S*L;^!O6_]4UE\4]O;U>._
MB17_57!=*N^U^%8PH8/PR%H-56ICZ::NRX)NZZ: WN;MIKP794NBO;?_XQ]K
M111]00/&F&!1"(50=(;2C$$B4?-K&*62A#(RR@?S)^+<&'"G)=1J@DY/T"H*
M.DT7X,N#8#5A*P'>Z[.52K_99=O28J ^^+H!+0"@"V3='86U&)A[6CT](.?]
M[=>?=L]4;3CCH^9W1-"=IXDV=Z)??\(G<IO[G'@W[G&_4W'"(>YIX,E<X'Z!
M&SJ]/8\TNM7-,T_\SH;Y*#O'O*BK92K2($0TA#S+ HBP3A>7>08Y3F,A11P(
MAI</;5^>FI2UV>['<'0;1G@N@V?#_5MCN&\D>%!_ZQKA+  5M\5:)XCJO]B[
MJDTG)5? )VD<P3 *(XBH,MQ(0B3D82*C.*!Q&-!N4MZL#;NS>9N27H*K3(A8
M<[]3@1&-<!AF,,5,A[G&"<0B2J&4F,8)">/0KIR"AVF8S"MP; K\H&[F%?"
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MN"!Q8-3S]1K"SVT-VZ5GEZU\YH0Y^;2?7^+F/)F>E\CC!0GWVH.A^MVN /0
M- [N@9J@PV#H\!O^O7$8MH_-Y]D_-N;K])P?GXG6^;D^1E;&PK7F\82Q,;E(
MDQDKUP)[:.Q<389Q7O0/HM;9AI_*S;>"JPW^XV^5+K_Q5HF^9L7Z]D:W-VC&
M7<;*U E0J&R;A F(\DQ DB0QS/,TY")#)$Z$314>\Z&M#)4)"O+HKFQ,IP _
M=+)K)]8/VZI)_?X1R%X#0'8JV#D2+6;%S)/H!VO/=H2&N<FT_C2$^;<>YIWP
MX.8\S-8>1'O$'+D0+0:>U(=H#\AS)^*(.XPCM?>*@3_*=JO9>4B2B*:4YP$,
M0]T<-*.!SF$,((TSM4F+8HJCU.;0Z7"(N>VFM(2ZL'<KHQW_' '0C&<N@\5[
MQ,<0$8=>H?/:.^*&(P-,R@$O*_C\73]QY=C.Y.*!%+PK"-9'$[1&U*LN;$9F
MC,4BB&& &546"D[42ZY^C;.$TIAS&J+ KC/YV3'G]M9W(N\J ^Z;^_:;'M*(
M;]N7_#SX9@3A&%+/C-&C^6: 9EL>9G>6Z2H$:01 SMJ2GQ]QXK;DQA <MB4W
M_ZH=#U5EO7RUO=^NB.[WUC9^:SL:?I0W?/,P*/B6H40&,0DAHHU/&"E;(Y<9
MC) (11!D(<=&2;WF0\Z-A?92@U;L1=>@M.E]UXEN66#/8@).4Y$?6#TSD2-$
MC>G('J13;*3N-F B]=N>A2P&FH2$[!7O.6C$-\>:0ALF!*_>*J%?%[H(=M-P
M]:-\UY65>Z>C,ZK-JN#Z4.U+W^)3NPLH"@2/A5"T)&*(0HDA3@2#,@Y(0!))
MX]@J^.X"6>9&6KTJ0#\,H"*K9K.P*]57K $9W2[UDBDS-:PFF0CO!M=P#@9Z
MZ*EX-YB*H2Y@J(Q+2^QB1)U9:.,EF=ARNQBR0XON\ENZ"C#OAWRUJ>IE$#$B
M(A9 AF-%IX(RF),801PJ>@TC'.',MNS_B>'F1I:[=Y$IX2Z-DGV"JQG=N4/+
M,Z,=CX?=P??J%'P.PEZ/H>(MUO7)8%<.<#VF^/FHUJ/?&MW/67>1>B^(>AG[
M])A!CE>&@R@0:0BY2 *( BX@R?-8[1*S-$N8#(0TJL]B.-[<"&1_>K/2$N\R
M'*W/RL[A;,8G#M'S3"B=I* 1=;&+87ATFQ%GB8N[9LHG1YNZ>;*)ZD>:)1M]
M;60#3'8G^':E[)_C;9.^U!OV]ZY#DFY^U%:CVE??^*I##[Z*[_7/2M6_+UF4
M8192# .D0^AE&$$L0F7)Y&&H-HI)*#*K^G-NQ9L;9PV+V'2G_4 ;I/=$=T,%
M4C=H^Z8[3NG=2J55!9ON<J*U![>Z-Y5I[+VG*3?CP^M-I&?Z[!734W2B=5^C
MW[Y%WT[%)X6,?F^T!%I-T.CI\"S1SP2XZK'G5KAIN^5Y ?:@[YV?4<8M&BYC
MTH:?]#7-"<^#.$4Q9#'5#9&E6D5H$$(6R#A#(N1ICFU6$<_RSFU9>3_6]/4]
MKV9+Q8QFR_/:X2DB>?BACSKZ$TV0H[7%M[23+C830?]\]9EJV$OW,+H8Q6;=
M='>5+_3\>V:]<I+R3#TS$+,@A@A+ G.4Q3 /\S3*<QSBV,IK<H$L<UM&FKC*
MIGJ'W)07=&.]9'IL-Q=>09]P)['7HSVH>KF]Z$2;AM' .M\AV$MRI>W :,A>
MMOW'WW(<LW95&,0747XKF#C>?'O7.+O9B%1-=^'AW[7O^\.F_INH]VM&&\?P
M=E-V'^GKPF4JTY@%2$"*=+13GE-(TXQ#]7F..,M3P:S(>%KQY\;?;9OG[7K0
M2) -]&I.VIJX3J;/O.L-H&+8='#S392 J$]TA(EV1_W1]46'I&V,#IK#4_6'
MAP8-NT5AXB?+;!V9[_/B>^DYYK@J2UU"6?_<' 6T2O?^+*VE^K0&CZ(>[%AV
M463:9!@HZVY)NLX<.5K%)A9^TH7O.A/S?*V\DA0C-RY:.OI<NL&+]_/C_I*A
MMZ]S]+WY+DI65'K%_VM'SC<M-W_N6?M5UP9V2U:Z2&^X#$049R'-($N95!N>
M*( 4JPU/FJ8,14A*AIG5AF=Z'>:VT/Y[RXS:'R/VV@"B5M=U$T_;+I +T"L(
M.PW!3D4PT!$TA:M_*-9-Q;CJ1\O=UA6>*<-=VKR?E F7V*'^PW56YZ.>.$/:
MG1X-D-@_5.#\0^5P8WB]N72UH;R"!M-N1*\W10<;V"N*<JE+\:VZ?2W>%]]T
M:G&M!"YV;LYGOJI44)F&.(,)#6.($A1!@C"""68"A0'/4[L SA$RS&UE'+JT
M9*,$7&DM=!1\I\:H_,$QTV/K2O0"^H0NQ%9^V"@ ]AKTQTC3N VM073N+C27
MX$IN0FN(7G8/VM]J9,)02]%JX]2=]/3G0Z+ZI=Q4U9)E0N0\DY#2@*E-!A6Z
M)+> 4<1PBA(9X<QJDW%NP+GQ7B^O]JJ15F) .Y$M$WW.06U&:RX!],QA0^PZ
M8<%>V@5HY'68E6.(C*O4FW/#39M?8ZC\01*-Z??&9LJ4Q;<FZ[$WZ[ZJ&W7)
MN(CG(@@9@6E(=39TDD&LK:X4A3QA/$:46H68GAIL;KRREW6WM[/,>C:"V(Q3
M7 'GF4]&838B4^8\&,[R9$X,-7&6S'FE#W-D#+XSCC8:ZOE4;F11+TE(6< Y
MA4&8*Y8(4:[[5 @H@DR&,8DQC1.;XG*#>UN1P@35XQK1=.DX:5N6:0B8V3L_
M$@;/KWB+P*?3"%B_TD=T=?0&#^\\Z0M[1*7G[^>Q2^Q>1RZ*Y9MU7=2/G\5M
MH2.\UO4'-7M+K'8$*!$29H$N^)@F6&>HA5 W$,^SB =8"I.5^Z4!YK9:MS*"
MO9! 2VGVBKX(XNGWU 4TGE]62U2,7]MSJA]Y=RO!_GR[^?:3^FK[VJH?]F_K
MBS><Y)4]IT[_WIZ]SE6R^ILN4N3M5N?+]W_H-@)_$Z1\JQZ1)1-I&**40!8(
M73(M(A#CA,(XB@FF4<9E;!6Z/U*.N5&!>JC22[/:S2; U';W#JMWL_Y8'GRO
M!6C5V/^U560!M"9 J^(S2=X*2V_9\V927#FMW@JJ\_GV=K<;60UVL[YM&AX/
M2E(NHRB7*):1LFUT$T(4)#"G*85JGT$$IX@QP>UZ0AX;QN;]FZ;]XVM!:[#9
MUE5-UKQ8WUK6A3T&I1F#70J/9WK2XL&V _F3*K%^LNI/@>&J5.RQ(:8M%GM"
MR8-RL:>NO2!8ZR"4[/ 0^R U\RTI2IV2*0;IF#U/O2YTZ>HU_TQJL4Q8RH,X
M03#)X@2B0 :0!)C"+,)1GJ=()M0^-,NGQ'.SLGK9P&,A5K99\=ZGU_  >DZ3
MYONX^O*8**UUDTTOAIGT T-P]TQHW1T'0$TQ32[#G;S*.WUPTQ3P'PUEFF1@
M^V9UA^;P8"S=&^$56;&FG.CZ]E.Y^8]F[.[JCW15W#:ZM(5&U:)YIU5ZMWY=
M5&RS7=<-A\4XC*(T$S )4YV9CS"DDE.=L",)2GD:,63:GLZ_N'-;GW9: -[M
M7FFW/]7]T7>_;';*F;<>FV#N3Z]?\YO1JS@@AN5<FLXR Y7!?O[[+^VU7G1U
MF,%'M55H- ?OUJ#7_?3J=8VGP;SUW+R>BHF:S<WHZ;#J+S?=9)WH*#>!$)/U
MD)L.T&'7N E'=;F;;CZM;K;UW:;425>_K=4=!Z6-M")]-+CX5!9,?-:2_?;P
M(,KFI_?%?5$O>2101%FN:^=2B*2D,)=Q $5,9!K1,!0\OGPC[4;8N=DHC63:
M7]6E,@GPH$576ZJ[XE9W*EEIJ9OT)+Y9K4A9Z?0F4&DPQJ0J^7H&+MEM3S^S
M$VZTC^;WMGKM,HL$:+0"C3(+T"C6_@(:U7SOH]U.@-<MM"-19[![=@NZV<;9
M\9BNSKH/5L+N@^H3*?A2,D0IX0A&.$DA2I& 1"(*DYS',LG5<H/0<BUN=?WX
ML:?<)R4P8A;<,LM0#G\$TTL'=+>D2P^Z3Z,_]H#[<D2ON:\\MB78@?[I%.@.
MSK.-H/-VCGUZ]"N?7QM!<_[<VNPV([-U%-EJ'V77O.S3IJI+41=EZZ[LQM&F
M_6I3;<M!QIPR_K,("0Z#E"&("*6*YY($IBD.<O5'EB=6/4['"C(W$[FO,;%[
M 2U3>L;.AQGS38&R9PK\O)-WSW&_>\E4O!0L5UE!8\68-EOH0K .LH@NO=_(
M^!U=27]?E#8*8Q01B6$8(*FL.4D@H8S 2$2"!8(11.PZ.3^Y_=RXJY7.I"RL
M"7:&H3JC$?$=I&,,AGU$SE&=7<7B/+WYM%$X1Q4[B+\Y?M5(7Z'>#]YM5NH;
MU9O_W!;UX[LU6VUUN-FG3=F<O]9U6=!MW20Y;W2$E<XMVJS436_[%CQ+*2.$
M1$K5FZT;;+$@@U1@#*,DCU">Q'$<1C8I06[$LB*(";*)AEK]]W_*HS#[GT T
MVH$?/FQJ 7);+Y^;V<N"(.19FD(BXARB6(20Q)FR39-8"!GB.$G395MHZ4M-
MRGJN<_A<1)][\MMBW=0!HF2E6\A<9=Y$S/0:&L&(9A2B*)>0\BR'F>!I1I.
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M'X?#$3T\N_FD%'!<L>>O^0M7C:YSHP/7Q&O1_OMNW:<?*Z.HR:I/U3L<(I)
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M*85WL\!/WN%NU;S]9FJ6WRRJGFAU=?(/Q7(WIJYL+_PO^=*YM@FQD'J;PH*
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M@UAA!)5 29;*.$5N&=4'1YH:Y;Z=%T]U;?&GE2FYU^F&Y1Q[>@A<.P;U MG
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M@T&:GJP'N6#CD]>*'F]^LG-U/PKX(A^;!]VJC\7B_DXN']Y)MIIE>B>=98C
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M\X'F2]/83U9GV6U^H"%!*?Y6S/5C#'U^T50^HSA@<:BWQFG,38D2O6#I12N
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M=4GI1G-F36 *NKZO*8C3,PRZ+1-I''<F*EL+L"=6>]T_3P0B%CS)H PS8BH
M9! ',H(D)'$<$92$D5."G^/X4S.9UN(W[2!V:X_W;H/H.#%V.]L!X1[Z7,D'
MTNZ!P/WP\A74ZSCZN &Z_:#9";;M^1@WNBN7J]E?Z0^3ZM:<[)$P#A*2)3#
MH=E#BAB:5A4P950%IJ$%C94-D>T\>6H4U0AGQSZ[.!WGE;.T'Y@Q&KD\GC4>
MU/;8]ZYOZGSK^E^;[WSW>:-\P0?5:+_-PQ>X^XENG^52+*E:M3E>6]&*VH9I
MHV-X(N,P(:;^G2G4*9&I'!! ID@JB8SU5VH5+.@PYM2^U+78589M4>5O-M&
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M<?G.QTD4[.I1F7JLT02LM"K@N]$%Y)4R^C<2R%:CZN*E=5[+F1-H1\+#3\K
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MEWR9$9$RA$C5+B*&" 7:Y$=1 +,@"!16"2,L< MT?S7"U+BK"==NI*RJZ/X
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M;IH6(LIED4!!E":D),.0QHK!5+*4)C*.D?1R)UY%B[%1725K'81CL\V71ES
M2Y6J)+"+]X #O""=MY?CFO8K[%PG8 \!:&)0IINMZQ*IPKX?S2#W"H@)J*"H
M;IB ^L7ZT'BQ+"#5%;UNB(>;T/[VV@/H<.UM_'#3Y. A&%"8SN&N-KM K^@-
M(4Y7;RXD$860,40REQ!%&8&$)"E$!>=Q+G(6%6E=R?R;5R"KCQA.S/>RIOFW
M(=:]2RN8^\Z&V^+4![B#A8F6*5#&_F_(/GE=5KNOJMH=H0L7Q>DU^M"!F5V@
M.1)KV>DQ75NOS+=E;YCY?/F#:D77^NEW<BU7W^7ZO11;;AV[4RZ04'D4PRB1
MF>G7*B%A10%9DJJTD$H54OIU;' =N@.W]1XR4,OV+^#= UW=^W8'<$;=C<^"
M(CE05:X/[T!=D6D"X@1&9 )V>H"](I;(:E4F8*=,R%8P?N@%:Q'C..S K6/\
MP#AL*>-Y?S?:*D^Q&\;DXGC8>6T:FL#SE7S0UN+LNRQ=-I^7Z_5;J98KX[R9
M,D$*Q54!B6E]@O(D@YAR A5G(J8Q8CGUJKT56L"Q>33**/)&7,QL 19R Y[J
MA!16):1PK633W]'4T[1:-)K^ N9:5S\*#?X&N%'M->>U?]OR6 J25;CIN= S
M?3+U"+PI3U1^:7@BWKV<\D_5E!L83'5D X0Q9\,1>E]S%(CX@XLWZ +1%[BO
M%Y+>QNFVX-@QWDL]!"\CK?2XS1+L4T8+P=),0D$BI1<0E4-2Z)^R(B)*)K1(
M"^&S@)P;<&P+0E-4^_'3AK!^U'X6:S>J#HE@S]1;$N4!A#<N$'K3HRLN@>CN
M['"#TI>K\J_IR/D^/WI9KS;3.U-'[%?YR.1JFE)<*,$SF.5<FZ%8"4@42V$:
MRSQG18YHYF2&OGKNV,CBJRDHM-[,N+8A?Y74')K:5LM_O%\^TMG"\>C_-7CM
MM' !)'WOA;NBX?SIG]"][0O7MS2^;OVW_9?]^FF#?, G5*B_TU._[ECN_D%_
MV:8[U7O)-KM272S%!4DR!3').42%DI#QA$ 4%TDFDR3*$J\644='&=VG:H2$
MMJF<$7/B7RZM'52WM?QBJ/K^A"U*W_Q0ZM#WO06%8-W9CXTQ< _U%C4/.YVW
M7=SQ#' 7RO.R9,&=G!OOLMEVK&WE>-9HG[[>A9NEJ$@88A@B+O3_BI1 )G$"
M.9)Q+!5F>>[%$Y>),SY"T9)"*RJH9 6-QO2= P OG#3'D\/!IJ)WPC*S\/:2
M6? _.PP"7JBCQ,N$&?9D,0AP!P>-89[:C6)/I*GM3];NY'H[-W49/FHX/M.G
MM9;RYNEIKJUD-I?&9-Z:BC*?9X^SLCKI>JHW28P4C,,D10HB4TV!T"2%1:ZR
M)%$YR1+2(12C!U%'&JYA9;=-Z->ET/;G^5YN/T;N8X[=:/I:4S8,=[?D(^\T
M!#L-@>$38'4TL[G7$E1JFG_][##'WGS?XRP$6@3ZD'#0E:%'B%\O%WT.%:HR
MY?$C@FDF,,=13F FLPRBW)3!QP6&21SE!:(B07X;=]>!QV9Z_W;J@/;2JI G
M<$]$+B235*.MN-X-11QB' M(62S2C*>*<^53<JT7W <HN?8"=V-G&8+N$7?'
MO4P/:%[EB/K\:72?)2_;0>NM?.6)8:]<BK(=C/-E)<_<WW&=6.HW:C/C[\R)
M\NJY.BV(I-*+@K3]DF--3I1#@A&'$LF$4(QHS@JO1>'8*&-; 6HAK=EXL]T\
M+%=MZ<H><#IRSJ4@]4TP1_$!?Y2"AO2%M $1BC2.CC$L0[2I>4 'K1=W^_9/
MQDWKGS_.%B9 T19^?-7HZ4;IK_&&\^WCUCI#6B,_F#8A)<Z@5'$$41$GD# F
M8,J2(I,QHSF)?(BD?Y''QDK[W(6GPX21B8DK]&.H 2:=1CRG.,UA)O2:@1(:
M0<;,S-,TY3C/2!$Q']-V9),^@%'\)YQTE1&D] <.,1<((HFE-ADX@UF>(L6D
M9$@JOUHSXYKV82K4?%XN[N%\]MWDN7;(>AY@GMULF7'-7<^&T:OTLLG+_#+[
MMTKGJB7F83M-?8]1'31T'RKD;;BI"F2Z#2#PH';@<!/PVJ@<<.1N%NJWE0WY
M>K8]?$SZC*SSH,W6]U>I]R!B&N%4T )I\S+-"_T_12&5$8*X2#"G^I,MHKS#
MT9;+V",]JZI%!VLC.UC))_WDA[;V)MW19RFF(C$UE45$(2)9!EF11A GN6!)
M0E11>'5W"P;[X D_QFE9'A":@^%U W9ADGG XVP^-Y[]TQZW[K/@MBJ'QK;G
M=77W&EMYRQ1(.=E5 IF4?LQ2['#KH0](@58TIR$'79-\0'B]JGC=VVU=^$UN
M]FDLTX0QDX5((4=1#A%-):1Z28 L9U%4$,95E/KL-U\\?6Q;0^/0+S,#_6CD
M)60XSE%!(PSUIDVS-L<<8I3&L,CS!$6D4(JF?KNUSJ -L[$* QOA1%L57,"4
MF$S8F)D^2;E^YXB*9(*D2(G786GW-VV@$]'+(7-;F3H#T?,29#"HJ@J^,:+]
M FXVF]6,;3<V2F2S!%_H*F@1D:-(!%IG7CY[T 7EJ%JO5X[C%UV0E/AIL=&S
M.=M54:J/M_220!6F4&:%WC%0_1F3!#.(6*2$8HKRQ,LKW3+6V#YJ*VJ'E,,3
M2+I]W8'PZ?E;+Q,-]V+6E>?"'W YX!$RP?#$2,/G%K:K?#2M\,PM_AF%[TJO
MQ>R[_*"4Y-61^JVZ$4O;LM$FWF#%"<(QUIM:4[BL(!R:/HB0JR25BB4RR9TV
MM:X#CHTE]C*#4NA)%41BHR0KP;T2G9RA;V>4/@#MF5:"8.F5S>@#T 5ICD[#
M#);_Z*-T,S'2Z[Z.&9-;MI;_O=5FXH?O^G^[]+Y4ZGV#T-N'*".:9;@I&\99
M I."T8)F6<+SU"MG\O@X8R.7O9C RGE!UN0)8-VLD@!P]4P=G9#RSYQLQR%4
M[N2)48;-GFQ7]2!_\LSEW>C@H]37TOG'[4*L2\[1Y//U!WTR?: KNQI31?,D
M*F"!%(8HT:8(1@6'.,<IC5.58Z%\J,%AS+'1A!896'G!3N"R=_OM=[E:F!,I
M;:L+^1,8->QO_,C#91K<B"0PN#V3BC^N/>R /" +Q#\N(P[*11X0O.8EGUN#
M]5?XNI%/UI&_GIF_FK/BS;/>GDG]<FX^+2H?O[R3C_LR'7^CL\7MROH!HU3$
M+%="6S>20R24@MB$AW$ITHBC"*F<7-@[X3()Q\9_I?A@MOBNI;>!)/=:5K"2
M=&Z3VZKJ<'2OL-E0:*VJ#INROK_4_^+V"1?.OQN57G56>R;>XVT/C'J@H=\$
M5!-?JVAJ"M9*FB3&AIK Z%DYIFVJ1Z\M#<),1'_M"BZ4[]JM",+ Z]!F(-!
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MUR/*MN:Y'KN^8U4N4^I/3WV9B)#R&)M6:9+(!")DLEJY$C!&J&!"TTRLO.(
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M,NC8R&E?MWDO-:C%-G%#G=NB.DV!&U>%!K9GG@J"J3=-^8 4B**<AAR4GGQ
M>$U-7O?ZT9*0L^G[J@I-::/=R:?E:C,M9%3DDB8PI28)6(H(:AI*(%%"<AIC
M_0].)_RG!A@;W=0RUCN;4DHW8CD)8CN)A("F[YV@'RK.U'!.]2,TL);\K_?+
M[_^B;RT90/^P__!//G"0C_R<.O4'??8Z_X_WL[RG\P^:%#;/I>D02946,8$B
M)A0B3@6D41Q!SE3&DP@A*@K7[_;5L\?VR5KQ0"F?ER%P#+?SG^H%:/3\E?H
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MH]RK1_39(<?&.E_Y@Q3;N;6;GBKI)]8&JJRD6@//EM+GL7=CI+"(]DQ'7W8
M?MD!N!,8_/'-[G.-X,!*'K(]M3-,H9I6GQ]PV%;6S@ <-+AVO]._[?7-5LPV
MC=)=CG7NVVX=T?MN16Q6P?/N%]"*D7O?Y1!8#=1PN1-F7GV6SX'1TF#YY*V#
M=58^)WRSI?+9:[O:#5+)U4H*NT'Z^D#U])?;I"E">1H7:0&5OA,B1!C$4<8@
MBD6<%[G$L?!JD79ZJ+'9"3M)2W?)!,S*+?^;V0*LK=R>U89:4':U#$)@U[M%
M4,/VM82ME+-RF(1<_\^!$6S=/SG0P.O].84/U_FS=_BO[Q_6Z]E\N;)GD:7W
MF,Z_WGRM-MV(2X0C02'+DQPBEDN3*$EA$>%41)1*3)R*29P=:6QL40D+7D@+
MM+CN5D$[LN?-IV!X]<P0)Z$Z[[GPQ,S=G J&W4 VE?_KYF50.<'18E6UWS^8
M:>6D1M.^<KLA6'^WJI+&T;9'_RGIZIN&6$Z3+"YR3%-H>G1H3N7FM"O.H<QC
M'"NI\EPY);%>*LC8*%>_==G%/=K<IL#-/AL"V)ZYN5./M@DPJ@"K2Z]-VKS0
M[*])FYL8UV[2Y@660Y,VO^==V*V[#E+X*N_+)G VFS\ND*(9A^9/B!)L LJ*
M%,9*L#2+14IPVJE=]['1QL9VM6R=BORTX^K&;L'0ZIG"7('JWHN[#8#0S;B/
MCG6=;MQM:I]LQ]UZTPC"5K=Z?[S8E%=.BSQBFE4(%"F/(2)402KT7S'*\T1*
M(2.<^#1^[$U2+W(:H$]D63N1ER(":F6\8ISJBTEU8[=13%7/S-A7=&HU[3?M
MTW[=N-1C4S+&D-07<OYYHU&/P=UK(.K1 ;MNU-GF_6S-YTO3-J(1.H%%+GD6
M0<K,/AS+ E*.!52*8451C*6?^7EBG+$9GA_UW"RX[4.[6IFZ'!W:\)R"U'5?
M?3%0O6^;V0;L101_]!+R< :'8!O>XZ,,O)]M5?5PN]I^N7^2^)?54FRY9IV%
M^"I7WV=<KJM"207/8Q$5".)<?_PH1SDD#!.("I6*.%)Q+)V"SUM'&1L)5():
M(Z"2U+,853NH[400#*K>SSX[H.25-GX6A0O2QD\_>["T\;/J-=/&SU_L7T"R
M+'OW]4'.YZ9,!5T\3XLX2].$1!#995_*"))$Q!!SC! 33%'F7$/R\/%C^]"K
MNHE61%#)Z%Y'\@A\[5_VY:#T?5CI@X=7.<G3:G>J*'GD<8,5E3RM2K.N9,M5
M'<(,.5]MI?BRDD]T)KZ88C++A2E)OYYBE:<X0A**7!40*9E#*@H!2:YXE*(T
M3Z-X^F0S/[YNZ&K3_MFV#^;SIKX>LK^7]DTEZ2__4DD.GDJ9;6<+0#?@28NR
M DJ;3'0.GLWIC5PX-KHX@WY.$8\3%D.!N.9,PE/(\HS 3"DBBHQ'2M-E"<6'
MQ9E"::&QKP>\)O)]8-[.L>%0[)EK:\AV(()*4-LIQ''+>08JCPC;() -%6/;
M$3J_,-NSB+0%VIZ^>;A0V[,*O BV/7]UUP:@?"7I6KZ7Y9^VT*D9JN'7FB8Y
M3_*,*4C35$(4$;V*<41A+#B.4A8QK+S:,KD,.C9CM'ZKYWL1?1M\.B#MYH0*
MC5_/7%J+"][4 O]2E4&VB'YV0+1#<T]WB(+U]G08<N#6GNX@'';V]+BW&_?\
MOMA7W/U&?U9Q'.MZ1--3=#LWQ88^:LV^&"NQS)'6UWY9EH6)3%L%%6&5(<BP
M9!#A1+,4DPCBB&1<I3B3*>M0\3B$;$Z?X/"UCFL= +-)NWI=WM"?X*F6VGR:
M!R:Y)]<%F5DW+AQLHH;ARJ8ZID1M'=^VGH#=O.U4*JL86Z6JL@_VEIU>X>@T
M),J!Z#:(2(/2<4@07]-UT&=W#)BKDIEOU<W<OE'ZF;?*Q.N51Z$V ;=QA(D8
MBB1B4"*40I33"%)!3$"=**(T0B2-_0KG> T_-O/R/^3L_D$O )!^ERM38M$&
MK@"Z4V5M/?F*SE;@NZD1 A[UO&Y7]@34IH_KQW6*=O&<-C=6[F\R>N;?9D;^
M7G3S-R/\KJQ%C\GDW: +%>OG-_BPP7^=@#F(!NSVE.Y>X?U>_6XYGW]<KG[0
ME9BR1. X4AP*FF.(5,HAU?8J3%.]IY:%3"+LE,MZ=J2Q$9T)JUEPO8'8?5AO
MGFH_$3WBI_Q7?U?;<<3='9,7XSB0;[+I5@-_&%E!):Q/_G\K:/XNRHO!&]A+
MV07$3I[*5F <G)7'[Q_<7]FJQC&79?L-W4S-SU)SM;Q]TJ:2L6D_&Q.W]DL\
MUXD@[TTAM9^;;S_D_+O\=;G8/*RG-(V9.2B'463.XP@O(*$%@VD><XD)CWGF
M50>XJR!C8V7]UJ5^9F/G*7 S((< MF>:+E68@)T2P&HQV3D\GR=@LP1,@B]Z
M]:L2UVX7 =/6+@4QD%'968Q!S<M+P7IM:%[\O&[4^*L4L^WC-[EZ_&VYD74!
M0E(@'!=Y!",L$XA$3$S#, PSQ8H\%U05A1?O'1UE;*1FQ /S)6UQA'E Z,9;
M%P/3,RF5\L&-@<9*V$.)QE8, G'*\3$&)8Q6-5^S0?O%_KO+PZ38YA9V=2\W
M^^UMG2[[>;FX-Q+<R<UVU>CI,,T09R*-"D@+$T:<Y1FD"F-(<AP54F09*IRR
M"4(+-C9"V>6>S[7 Y3>TLB+;?I&S[UJ$LKN@:1VNEO/9TGT?%G1"S^]UKS5-
M/=/;\9H!#=?=!)3:-9Q[C9H"1D-@EXU2QV;3FRM-I?L._%I3.M"&_1I3Z[71
M[P/_%K] T.$&<R/T 5+3Z]#+\SNV=3YN^O^F02HS!'>)Z;>J2FRC\_HP[L//
MC7&<L+F^<;V9,BY1CD@,\UC&$$E60$Q$JHUX)F11L(S%7OE^ 64;VR+=MMW>
MZS<!.PV-#WJGX^[P'/RQ5Q-\6&B&6]F7QK/:1<B7P&T'<J6I[7EAO]JL^K<"
M#H]_J%[  24;MAEP>$@/N@'W,$2W9<-T "D+ZNJ%ZH?IJF.RRN[D6JZ^[Q,_
M,YYPI"*(4\$@0@722T$A8(0$Y2C.!);$9SUP&71L1/_UPSM0G^9.0)S B)1=
M;\J3Q;TF-G*BUL4S5=1K5MP(.C36?4=$] 2S-['ZX!:(,9V&')0*?4!XS7%>
M]_JGJ;];+M;+^4S8(3YILJP_BTPQD<1$0:;T_Y#0M,4DBF"<%C%!.)'<+=:A
M;9"QD=,+.8$5M$.2^DE(VYDF%% ],TLGC+Q2U,^!<$&&^LE'#Y:@?DZY9G[Z
MV6L[AGQNV5K^]U9;11^^Z_]5)R5<T#C-HPA&45Z8ZOP88AY3R$V)FH*Q2&]B
MO2([CXTRM@]^+R2P4GH&81X%TLV>N!B>O@V(5\CT<.+4"D&HT,BC8PP; =FF
MYD&@8^O%_N4HWE=NWB]U^O)[O2&:JA@AP:Q/*A,FCC&#&"$%A4JB-$$LH=+I
M6S\YPMB^\UK(.N%"BPF,G.Z%*8X#V?ZM!X&G[[,77V2\2E2T:M^I2L7Q)PY6
MJ*)5H6:MBO8++\[5X/KIV[E)/KO=/,B5*8>QD@_&G_%=?EKPY:/\O%R_S@+
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M5 H^ 8_TY^QQ^PBH%1S0G2:>+BS'^7#T/85'N6^GD9$8[$4&7VJ ]U*#4NR
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MN:$_/1LB>$ZA&]OU.#%][T5OWWV:E <\1G!@)3=Y"+7LH)RURGMIZQ4;YV7
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M,\&=\M#/#32VQ;.6%93"@DI:9[?L66#;UZZ0</6\FIQ ZOG\J8T?8.YA8J&
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M991>HMY5F21)1@E)"@&3E'.(BHA 6G )(XXR12.>%ZE7#Y>VP<;&\-]65$A
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M3,&L4"G$.1.0I!)#)@J$,,U4Q.UKDGN),#9'5FD!&C6J-Z]5!!A-@%$%&EW
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M7L4L3TLQI8HQS#,!<YXCB E-((UE#I%4BA114@CI&A^>'71LGF@K*-"KT/:
MR&C@A:;-R@S6T9Q7<,.'; ;*AI]M*_&DFZ=;-]?0<GN-R:Q1\A=XG1]RZ.C*
M&H0#(93]9]W+>VZY6MYL1*FM>+->5[25IJG2C#Y,62H*F4829G$<0<PP@RQ&
M C+*(RD1E4CDMO4]QX<9F_^Y???Q*VA$!1U9@1'6OL+G!*ZGW8L_M ([E'Y
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M*_JSRNK^8=U&W:L1K<\9!S5-^+/$NBG#T?GQ+ZT1V*E4U\B\,&2KEO^>#3Y
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M5)Z!Z^H\P?>Z ,_7C=U/UCMC=R: +_I%>*0K><.YJ00TE<+;+8=5PZLRI:G
M3&$"8\4(Q+&.[2@J(AB+.(\0P05#PF'?[C)I1KI+U_(*B=8AF!TYYRCP0D.=
M/U4/C/L5G.Z+4+)5!.PTZ>RAF4:"M3*#6,/^Z'T8JPQT$!_0.DXG\I>#>N)\
M_H*;#W9:?SD W;-[#W?KTT7\4.99)S/R[?/NDB9Q\L;,GZ:2:76GJN]_UU>O
M5[?S+W)9+L3GC2EANE.?%_,/3S]FBV<IWY=+/<\NEOJ:NOW;6LJIPISEO,BA
MQ#B!.#*'55+/@5PHK!05&:?<NL+H:FJ,;1U3BVW.LN>+.92-Y$"THIMC+MX*
M[]*L^VK/R?DY]^]A_=!I#)T,YRX,W31G4^1R,!/: # !%1RF<*;YN88$W,Y!
M#8I>6M5/E[[DLTF1;I^N+33FVG=_JZ?+I</\W^$I&ZQQ_=_F:7.KU+JZD4\5
M=UU/N.'JP:YN@!<E9->7IM^.\3_H;%/+.ILM_C+%!Z;@[:M<R>5/N7JG97[0
MD>;BW6*UUK__\,OH)J<994E$(P8S;'C^8RE@D644,E:@3*2%2I@3C5 O*<86
M4=T(45<,NFWV]K. W09O<%Q#QRH?WFT+=2< Q3 B$[!5"NRTJOI_MWI-P-84
M$U K6;?-7:VKZQH]_>WR7@2SIYW=?C(,NIM[$4S[.[B7W:S' KA\>%S_;I+"
M_E&E]MW.><L)PW*$4NT",TDBB"5*((NH7JXJ$F&1(:47J=;KTV.CC,W9[00%
MM:159>2_.83R1_&T6,?Y0"FTZSH,4 ]NHA-/GOV:Q =B0RT9'!\MM[C]'!"G
MPNJCGQTNZCTG_HN@].S%EU;T?-V6,-X*4Z2J2EF3)=0,"DO]TUQT-BGUW_03
M)*J2B%T!"<-"Q1QE4%"60AQI5TJ)T,%E7*0JCC"ERHFNW[-\HW.]G3J4;@WI
M5D- *Q4!;72L@I[."9CYNU&S;WF0'ZO;1;!7M&7H":)CQIUN8*=<D\4 ;KIF
M[/9R;30<J,3(*_[>2X_\2'>EDB2OT!XO5?([3,^YH^]&2<-H<+=9K];Z12CG
M#_4&R53E"J>L()")-(&XR"ED4G)(4<YID1&*(S3]46VI?%O3Y=IR#O$MIXOG
MV9<V8!+H3DS39^FAG,_-63"CLXH8I7<?>O]FSA5+4Q9AF-,DAC@S!$8\SR B
M,8J3(D$%HHV9/\PMVY&-P,BMK .96%;_CM&^EN' -2TVAH,Y=O*HI-%2?],U
M>JVIQY@@E!%\107>Y1LV+@@%[ZO((-A O;/734%FIU;NLUS7AR$E;WYK]O-J
M!G.SI<?74GR5Z\VR8JPPQ325W'>J+LN[.U2K]^'7VORH8YI/Y6H]922."3;M
MS3&C>EY)=/B01 44$1(YU]%#1E+'A/?!E1C;"O5P9:WI=-0"L?W3&X/%;TW?
M@ EH\0 U(%N2F"TJ9K74=.-='.G2^WT'#O@PUQ%LG;%KN>-VU8?1;A(<^R,6
M>)[\FSU=?6H&KF9>?V4&PZLP=&7"U8QTH)CA>K+TF^K-_1=SDYIZIU[58NSM
M0K#5>DGY>AKS+"5)(B"/$KW0IX)#HE>$^NDKD$H*IN=N[#)3]Y!A;!/M3@7C
MN0Z40+W:,_S>JN(X'?8QF-UL%M@,@2>C(!9PGC(NP-"3Q^\CP: .^P*(]OWM
M);?JS0W^0R[7S\:W5^D,_[TI?QB/K1W]5$8DS;,$P3A# N($Q9 1K*"2A!*)
M&.=)[-*D]M1@3@YP@+:TK:P3\,-(6[ULLI5W8HITG8FXCP-MY\]\P1?8<>V0
M^[)%[L,.N<\GD.O#9WT6$G]TU,>'&II-^JS2!\B@SW^FGPOYH)0.^^[4AU^\
MHC$SG83NYH8#U/QG!OI)9\:G?97:994F0C1_J'.J.K_H7#D5"5%%K!C,"8EU
M1!812% <P40E&!?$-)LD+A%9 !G'%K'5*II8039*@J7IJ%5_OS(<T:;-]J1N
MMBUWBE0OZ'*K9O5W-]\6X@FP<XE7MFM@3[HS::M?W21-F_)=9<J*"KDC^P3L
MU&HN:=)7N[]\^8EW"U/3MZG[#C1[#AX;@0>TD"?''D+"0>>#@!#O3R,AAW+/
MG/VH9[2*'+/)6B2QGBUR/4UDN="SAHY>]3H^0S#7*WB6%3C)8ZM6- ?N/39O
MOQ7//MMS'ZW3'O9"# )[QJUD/;)>]W&PSW6] (^!,EP=<'%*;CVB^8F4UOU/
M#);(>D34;OKJL4OZQ;\?:;DT-0/R#TE7FYJ5\Y_E^O'/^8*9F@&3Y'0[_[$Q
M3M'(KT>NG@+]TV:YU//N6[HJ5^W2_KEER:_;KDAQ._] ER9W9C5E4I 4$^W0
M4&1(6HH",JIRF&21PEADJA#2C;A^,-E=WI5AJ.YWG,M*@P!^&A3<PM[A#&\7
M#(_2F*$G F.[2ND)Z*@-_M)Z@Z[BH-8<O%3=!,R-\J#2?K+=47V>=+N)@!8%
M\\"T./B+D@<WG:?8>3BY!XVH!S?'?IP]O #]YKZVK>6[Q1,KYY4(]7KR00NL
MOUN5HEE2=I)_5E_-=W?J;K,VQW^K2M'_+!\>IR*7G.=)!%7"&<0IDK"0!8<)
MX4HJA#,9YR[;/G[%&]L:X,^Y*%<5)X]V2Y7X9JM@_2@!WRIIOMUI.0%/])?I
M+^ VT7FVLMUL=CW;!9ZRMCV!.YJUVS"5R5XHU\W1-/L[K9E;#2?M[&>T]#<A
MA4'?TZSC6;A!IY8PP.[/'X%&<=^B^4*?S5RU^JA?G_7C[7RUIK.9&:Q9?!=)
MFL5Y)F",3$,NDBE89*F 7$\ 69$7-$56?04LQAJ;^V[%!;6\H".P_6;&.7S/
M;_)X1"WTP>)QP'IL YU#SGY;R"." VT3]7GTG/:++"$YL7]T[@Z#[2=9JM+=
M7[+]2,_])NW0M=2?],I ;B/\SUJ1FNB]DW-77UG2V9=%W5%^+RFXH *E,F,P
MDQ)#S$@.:8P4S#,6QUDB6<&<3EF]238V5]TH!BK-7FP1[+3;2_;=:@A:%3VE
MC_LSO^6NTC6,&GK7Z#KV=-\6\HV]KVT?;W(-NZWC&\Y7VS;>!QBX%MJ<RZZ?
MS8RUK.*05=5-Y/Z1SIO*K(^+I9+EVFPAU7G@4XPHH52F4#'"(,[3!)*42LA2
M(8LXQAF6>8^.CP.J8.68KD(W7\MI*D:JAA_ZV^'K:GL\$G83R]@L_+>IQ:WU
M!QT 0-UR::TAV%7J[IZ?LB4T'4&E;G_C7;N&MX?D?X_JWOXF\5;W>X$(%W2V
MTS/SMM%26XI4DV#RG$A.HP1BD45Z9808))'*(><49YE>-B52MI.:W7QV>L >
M4U#@V:?V*'JZJ1O;REK.'HGO9Y"VFRL\H#=D[[NNI&UYYYM&V./S=K\F>&=1
M\=D+[_A@P[?$.ZOXP<YXYS_EOLE=9T5NZQGOZ2^3%_GR9+9.-[F=?YA3DP39
M],UH+KUY,J=X4Y.]&,D$093%'.(HSR##6$ A"8KC/(ZC@CHV8?(DVDA#9%,,
MU_1!!TLY,\,:/EYS7KY+!=&+]Q<=FQH..[&IN'O__'^;#'D3)9D_FZ1Y^UUD
M7Z8_OT\_I"6'3&_O5, ;<U8)[OM).DVNUNT<-)JU;82V'YF 6KWA+6=_3G %
M"PYTGC"H)9T.(CQC?N+ PM=(@QUL>(:F>P#B^]:^6'_,?TTQ[:QZ;K0<G_0U
MMVOYM)JJ+(MR+CGDDBFSDX4@2>("LIAFB!<L0TA<1MAS<ORQ'7H<9D,Q7[==
M4'=:@.]&#U I<C$?SFDSV:T8 H(?>%H,@+L'IA@K](*1O)P>_<K\+%;0G*=6
ML;N-^^I$^^"E.9!X+^M_;^>[EK3FYZ^&S/M._;F2U>@=FH%G4YN."ZH*D<<P
M*IA>E*2*0)9D^L><")D4(N6Q%3G*Y:*,S4'N>D#/C/!@::2'"P4W^@>ZX^CH
M$&0[[)]X,-WY1<5P!@GL-%M%P)M6%9.RWVW371_U5@K!.P7_-#U*C4[@ID.C
M\GR:G\"W@>S7#L,9:J EPS &<UHK^,'XQ!+AP@$&6QGX :*[(/!TQ[[K@&7Y
MD];+D>T!@Q[B/Z5X,-ULS4JE\L[ORQ6?+<S&T:JS*HBIXJ8C62$SO2I0PB1)
MQ3E,BHPG>9%'D5M-PD72C&T*W"GSXCC2S'J-/F"G$.AH=-%ZX1)SVJX>!C)2
M\+5$4/OT6%=XP-7;*N,2609><WB [?4*Q,=-^[GD&ZZ#C$VU85^=RAQ@A33U
M:MKWWZE[^FM*4"10K#A$"2$0,RQ@@5,)\S@I)(\3FB'D5OGL*('+.SU,_7)'
M ;"H3AWY"U99;3''?I&N1K%SI0&!#NP\NPC7Y[H'>7M;KE_#$[Q09A_;G[_L
M"9XG#^DZ^J ^L2<T^UZP[VU\;4E7K7#J')<_3=X,G7$CC6&^/TBUVY+L?EK,
M'TR+WYIL]Z[9.9IB+B*2RP1RTRT2(YQ DN ,1D2P#/$\+2*KEI%#"3RV@'9+
MY%UQIU5]T"I"[\6\XH%LMW748@F$U (]E55;F[E^]W^T'.$FG<!LS7*M_:5;
MX9X?C[Y[Y]<S^E4VVSOJ@C^K3,V=PH?YX(W2'1IXHS<TBC>$;:HEAM>/16<G
M/^2&?1B3!=OA]RSNE8\$PH!__@PAT+CNAPX'"I!?-XDS17(6;>+>U=43G3^T
M;>N_UCD_G;],(ZER$DD,&4LIQ'&4PD*R HJ4)#SA'$=ZI6!Y7'$M)48W*3:2
M5BN,;<*ZV41HDJ\L%QI7?3#.'X;\'<P=>#H\S$UQH(EH1:EDV49T AHTNG_4
MDV4#"&PS]SI__1L\3_9G-W^'YVJ@4Y_1/U].!T;7-NR)HZ:KB3;8(=6UP>\>
M;UU=%O< [=W"I,'_K-JW?Y,/'>*+"!68LES"!"D&<5$4L(AS"HLBCB.:2:Y2
MZPCJZ"AC"W%J0>MN]O:3SW$0ST<;7J )' YT902-D#VH5H[#9#^)>H%KH%FN
M'VQ.4\]9.$[,#<<_.YCS/BM^U[N>O[CG(53EC!M_.RV2 G&B"-3K1P5QR@FD
MG&:0I3C*]-H1(\%=FMV\N+N3NQN@N\V]&0,TM 3-IJ;C8=$+\"R/@OI"$OJ@
MITFK;23S>'QS2&%?AS,O[CWLT<LAM5X=K!R\R.U-%;*<?M#!T_KYVQ.=S=HP
M:YJKG!)$(OV&)I$.482 -,,I%#%'A4SRA+'$)D0Y<O^Q!2>UB*"2$;1"VKVN
MQQ \_<)ZP"7P*^L&B?6+>T;Q Z_N2O)_>UC\_'?]R?JMU=_L7M9C]QOD=3VC
M3/O"GKO,R^:O7NK4F7UFZ5,SWMBLD'Y?+,1?Y6QV<*5D,FB1R*5B>G4B!,40
M1Y)IGX 1Q%*O7I*4%XI%-K/VL&*/-!R8+5;F@.N'ONVC2<W]L2RY0RWL@&;O
MM9D[ F->8?NV2I=N$J=WBEMONDU J__D1>+UB_TWIYSY 1^3B_9H1_"X7'%7
M]MJ/S:4;L8&MY[;U&DJ8:VZV!@;XS/9JZ-%[-A^O>RW>SK\L%_^J#M:;L_8[
M-BL?:,UDU+9VN%.=BK^Y^+B9"RD,1>!F5?_IWLA_+W^MWVHS_-=4D#1F+",P
M4E(O>E*I((U--U[""%=))H39H'#H4AY0V+&MH!I=#<='RQ>RV&HYV?;(+%]F
M>9GS)E5I"E:5JHZ=S4,^#78[+F.Q<>A]ZIW]MHIN4[,ZJD[ KE^02<IZ451M
MK%WK#&JEMU=\KQ0'1G-0J>ZSP?H %O+5B3VDJ,.V;!\ ]%>]W8<8L]^T]7EC
M=M/OU%?Y8[$TR6)_SDN32RPTM%&!(<^0,NWF,DBR+(()C04GE&4HMNK-<'J8
ML4T5M91UZF\C)]C,K7.<SF!JY[8O1RJPP]V!M!41_'D2)&?'>!H#3R[MR""#
M.J/3BNZ[D3-7]V3#/%F,^V0&^A]:LU37K(UQEN68XQ3B1,409UQ"FC$"59RE
M.194<FY%"M%7@-$YC<4<5GW5=[2/-2=$PYOI2)GI:@X[KQ(2Y,#^Y@@MP*)#
M"U#QAFU5 !_. .].MMD3/5_TFZ[##TO(V1.<5Q2=?>\S,$]^]=O5[6JUZ=">
MYXA%--%.4>:Q@%CF"2Q2[1FYX#1-45$0X=1.Q:MTH_.8VPBBIK,'926NH>24
M3;Z;8\3EUYAV+O5J)@KL;SVPU-<:@EK%45'0G\+^VB3S!V7[>]#(GX+5&U'\
MR4%Z]],JU_)3^=/<<:T%*+?;QN8,B0N,,\6Q=NA"Q[N4Y9 RE,!(<)GIY3$3
MB=4)L]UP8SL9WHG8;HI6G;6%J3S3:H"9UL.%U<P2=#OOZP_*P.ZT%A16DH(.
MI.W6HY>#,#=4_'6".C78T.V=+!0_T+/)YE,] \SU@O_7XV*F/[&J>UQ\6<Q*
M_KS;QT\1*G*$%61IRB#F4D)F6O*Q6+*4%'&<<:=3G;,CCBT0O%]67.TZEC"2
M.X9\9^&U#.-\@A8Z-.O(^G\WO8 FH)87?&_^#7)488V2KR#J['C#!D:VZK\*
M=JP_V,_)A*T^JEA1IA3S/%(9U<[)M I5.8-$H0(F,>(*16F19DX;?@/(/#9'
M5U,(M3GW'5)8-Y\WA+7MO.;(;!C8[PY9NEKI[L]Q#V@H3ZY_"(D'G3P&-,'^
M]#/DT.ZYXM_XHQ2;F5RHEH-$#_SM<;%<F^_?2[;NL!-^VM)X<B%1%@L&:<01
MQ(R: Z@<P1C%$I&,*QY;%ZGV$V%LTTNKA=E2-7J BG[(^)U*E?I'H\P+)E!W
M&M8+C'9Z6AG&%*&C\X-6N!F3%>R3HL-;8Z $YRZ^%7=;3S-563>>*G@O _=$
M_G'/&P^62WR9XMV\X OO-/"98=/)]&ZS7JVU6R[G#U\7L]G'Q=+\<2H2A44J
M,ICEA9[0E/Y"1)1 F25,_X8C*=4@AX<GQ1S;I+<[1:P/!@8Z,3QMRL!'A]X,
M-/XSQ&TOZXZRX+M1%S3Z^MS>"FJ0:Q\LGA;R[W'": 6TMZ-&N]'Z32)?EB91
M;/UL4GE-MPNS+?C#C'RO[_=^\43+^30I8BJB*(<Y-@6M*-6+':I_I#P1BB<%
M$D7A,B-8C#DV]U[1J-:G9O<OSLS ]UI@Q]81-K#;>6_/8 9VQ1?@Z.Q&'9#Q
MY!-M1AS4P3E L.^M7#[J[;3@0#'=#=.!,^7K*>*\B#@U>RPLAUCB K(TQI#+
MJ* Z7LTXM]IHZ3?\V!R2?:4L^-[JX.BC'.W3>ZO>$^I7V'6O-K5Z >YCY]P"
MMW";X*<&O_9^M@4P%EO3-G?Q4>2P[2\V92@K"IHAJ+ T+1-4#HN$(\B*6.8$
MR02SS"7!Z\@X8\OLJCD_]NL5>A]+'D,W%CD1$4U@3BF%F"8$TICGD+&BB$1F
M#HZ%6^<>#_@.TZ'GB[Z96<S^;,M- T%L-P5X@"VPKW]5Y+$5,E05QRL4@A1K
M[$:Y8DW&*U5/EUZ\OKR?TS75K+5?G\T6?U$MN*EG_:I?C.5/N7I+9^97TX(*
MG"1<^X<T+2#.HP@648J@7N$R2I(D99).Z_XJW]9TN;9S%%9CNSS_^Q($#'MJ
MX<!;^5#.JPXSVGW\'TF/)P5<@#[.)48$YS BK&+.8I#(1'ML3FF<9")!*6K0
M_S 75\6^'3\\\G0-]& A8;=SV]Z!#+WK^^'=]G1M E"L'ZH)V"H!=EI447RK
M1U6\M_%)O>F$FR>W;S?FH). $PS[4X+;AWT>I]5[KWJP6SW"W/2H-!LBJSIO
M<BJC+*$,I9"@--;3A4ITL*XC]H3HQY,J*@AU2D;L(</8-B;J0Q3VZK#%QX'8
M:6-<<MKE#>(!C[*V1U2=4ZRP:=?]H0MZZ'1:@A&<*%E!9'=<9'<K[_5G!RJ>
M331R_]=BFA#.(RH$E"+709O "E)AFC:H.$:*H:3(G?(%>DDQ-B^HGUSLK0[M
M!/AV/B\XI(&]WLFJM4ZSPZXRDRI<!EJ100K:SN,8OL[MA QC*7\[#Y-#59S%
MS=S3@+=45YW4XD]2_U+N\=[A@B><Q0Q2G#$3^V6PB)(8BKQ@F0X'"5=6#6Y=
M!AV;FZMV:%:FE^CZ4>IP;[[2\Y"H>ESI'X2QB #M0O;;HW1AY[4VQ&D?& K>
MP"ZO+=MX6:TQ ;78+D2 _8&US\\- ?! &;G^@'9*NG5%[$2:K?6M!DNL=56N
MFTKK_-E R;.K,]E8O^LKUZN6^>&?TC $27'S4R[I@_SP2RYYN9)?#&_]-!%,
M)0HA&"$J]$R1"$AYEL(LR80J)$YB[I>.QY_L8YMP*LGUG/*FG .QF,WH<F7:
MG=?4/;]Y3KKU^ A<LC=Q=<,.N*=Q+#UW99N?6R.P8_F9@!8%T,  6AS EY-=
M)?RG[?JWWE"YO!XE'\%V3%"3.&?]!A"AWY3XNHG[COJW^>7J"RW%E+&(X%Q/
M9131&.)825B@HH I-4UNDH@7JIC.Y4/5(]3*\=D.;>6U2.VUN@($/*5KI ,_
MM'AN\X\UWG:3AU<,A_'\C<B@)4@W D]><J%O\?UR"E]G7^T*EB=':SWLH%[2
M%8Q]%^?\^=[^22Z74MS37UM6I&WV:81YG!')H90H@9@4,20*$T@2E.01E5$4
M.=4HG!IL;$%Q*RM8TU\-.=I_.+NBX]!:NQ\O@(5W.3566LXNZUF0I%T;3/QY
MEN-##>U-SBI]P(.<_TP_KW$[YX;72[Z7];^W\XHH8IMD5H]G>MH4.$>Q(5<T
MV5\DA05G!<11AK H,([E-J:YMW<C=J/W"&ON!^,)JAV*FS^Q!-W.LWC$<!@?
MTPH,WK0B_V86I#6<N]S2F]/ .GL;-YP\^1W+00?U0&Y [/LBQT^[]Q&^V8A2
M6_*3,:C96(_R+$M3F<$,"6889!2D).4P04JOJO1?XLRZA_#>O<<6J33B@58^
M^];!^Z"==AT70A'Z;,<6!:=NP4?T[=4I>/]>@W4)/J)$MT/PL4OZ-O3^6,[D
M\IV>4Q\6R^=IQ@BB,B^@BJB>_172+V-!")0L$1%%&==OIEM#[Q?W']L+68L(
M*AE!*Z1K0^^7")Y_,R_$)?#;Z09)CX;>!Q6_H*'WR_L-W-#[H#*O&WH?OLP7
ME;&>LF<;PXOPQ22$+.8WZ_6R9)MU=6"X^*QU6<S76B]]TX?;N7ZOY&JWO(U%
MBG#,$!04Z>F79%2_\2F!62I0DA694,JIKMBO>&-S&%WM_J__5<0H_]] 5EHZ
M;CEXMJ+E =O5;!/Z#.T@%_-6.=!H![KJF0XG+Q4$K89!=D/"@!^,XODBX:[,
M!^T#V//DT5Y&Z=G?N*;__"CU1^CLGOYJ\O^:[>9IDHB48*D@(CB!.(HSR+ D
M.JH3$5<RPZIPZAAY9KRQ>>E&3L<NP6<PM7.Q'I$*[#-;PN-&U&I'N!$6O&G$
M/9Y2XMY?UPX87RURSXPV;)=;.]5?-:JU_)AKDN]&>Z7GZ9_?IFDF.*>20D6B
M6'L)'0022@7D"4LPPR(G=E2'NUN.S1&8GIQ-&VG;(O\./J??^'Y:!WZI__Q\
M>__A/?AV?W/_X9N/5,U]'4\LU)J+Z]>S^6'W9G9N-5 BYK[HNS3+5W_QQN#T
M9;GXN%@^T=NY,O]4J?ET:0K'5W?+3XO5ZDXUO-[R6ZGE[["KO-?/Z U?;^AL
MB@2-$$\4I+$Y@RG2ZKL((LPBDB2(Y%J*R[B>O @ZMM>]ELHTP0):YL63! _:
M5R[-@='%W$]^+&L71(S!7H$=U>$N#EI+4*D).GI.0*LIJ':-]8<6JNWH(,'*
MJ/N"@,HH/ &URD$IJ+P:)1Q9E1\QKTUKY15L"P(LO^/UFV%,O3\W[NMP&F7;
M=AHGN<(495 ';'J^0%$"&4V07O.E9K4GB)XP7.8+NV''YOV[I?>\FTC=J_>W
M)?24ZS6UR#+(<Q-#"Y-X%5&BH^D\*PC-2$2X&ZV6?_"'8=FJ><P& ]YN)O4/
M9NB=S-,,!Q/__=3=(/(T2UD..NB<XP;$_@SB^.F>^WZ+IZ=R7:7-W\SU_><F
M(T/.>2E74XDP32.60DZ2#.(D%K!@10$)C^(T%U%$TLC-$YT8;7SNYX5XX,WG
MQ5H"%#O61)W"UW+_SP]FH??^=E)6]$\OY/2XYW<>#%_[?2=&&G:O[[S*K_;Y
M+#[BGMWQ3?+-LEP_?_C%'\WL\5D_#M.8\"1-20934X^)281@096.5O(T5CAB
M'*56YP+'!AA=2-C("%HA@9'2/L'C((BG'8$/:$+'&&ZH..5XG%*]5Y+'P1L.
MEN5Q2IUNFL?)ZZ[>W^AD;:XJXD)J!P QB_67B,:0D5S!+#)%(YE)P<S<.3\'
MDM[EK1J.-;0C_ 2P+74H:YA !JG>]O1TT#AB0D\,$*/89.?F!-)(AY8QBY(L
MST2*<N+*23K:9R,\J^F+)T/6?93^CH^%73 \0D,/N'SWV&MK3&7\?FTVOG9<
M?Z/R?;^F"-BP*V#9OFFAK-=*L[+FAU1?Y4\YW\B/&LUO\J%:5=TONM1<.X(G
M29-")!F#0L42XI0+R+)4?Q?AC$N&$\&LDMTO%V5TZZ9.6U;6GM2M:AVJX]45
MG;EV3;C 4':SS3#P!YY 7BIA\&_4 ,8_@%81D[SZ@F\N!%&7/V ]>?D+!!G4
M<5\.V+XO]G#'GLUZ3/&?\?]+^:BG@/*GO*TR*\P!Z#NZ>OPX6_SUGU(\R-]I
M.3>_U)+.Z&I5JK(N4+I1VF'=TU]3RA)$>9Q FJ1Z)1%+"5F12)B2"&4QCE64
MDAXEQMX$M'("PU<AUWS\8+F56K_LE2M85/6TO*MYF_52SK5[D,UA]:1RV-J1
MK.DOQSXWWFQOY\"'->5 O70J*[U0"M1:@3=&A=\FP*@&C&Z@4FX"C'K;O^[K
M. '4:&G2=3UVX_&-O*_^/=[D&K;CCV\X7_4(\CY S_R4JAC\3KTO5S\6.B;\
M?;G8_-C61>C?\NHT8R-%4S^^F#=9S5.1QG'*&($D+JCI]D9U\!TKR"E7<<0+
M%K/8*6>EMRAC"[X;2M9'.1-0+9;0Q-J.*13]S6*95C$(V(%=<RL\J*3OEHMU
M%0!;#29;PIQ&%X\Y&!?CZ2LOH[\@P^9J7 S8J_R-R^_HSK;^=C$7?VQ,HN#'
MS5RL_I!/3"ZG2200H3B#."HXQ&G.(<7ZBTHC1+%I*Q%GMM3J!T<8F\<S0H*G
M2DJ@C)CV;-Z'$3SMQ;S@$M@Y59#4 H)*0O"]EM&!Z?PP-O:TYA=C-!"'>0^L
MG,C*3^)P@IG\\.<&HR$_*7:7<_STA=YJ8\P>QL.\_!\I;H7IW:-*NNME46=2
MBY?$Y_IO^OD1II2V=K6=OU4A\)1R7F11)&'*<PFUDXP@83F&,E<4T90FBN<7
M5LH$$'ML_K=>I,X6\P>HAWOJWQEW(*O;!:GCLV7H.>-@3<U.9]!5&K2='QJU
MJSS CG*@T7P"=KJ_;!%1J1^TOB:@N<)5VX00^MJU-P$-85&)$W+TOH>.V^UW
MDZ]I&!W^6:X?WVU6Z\637'[XU2P;C(SZ_X;8<\KC),D0S2'388*AZ*6P,.4Z
M>J(B%&4QQ<2I2*>'#&.;=S[W/4ET1S^1(A&8%E!*R2#F,M'H,P5)G,8I1U&<
MR+3'Z4,H(PQ_SC"@+6R/<X,^W\'/<3NGMJW\X"^M &@U,+4\[8Y3JX3?;?T+
M(/1V8NLNP<!'M;TA>GU&V_]6[EM'[_6LQ[7Y5X9L7N,>-<M[3%&<Q*8OGX@Y
MQ%AP2"(]UU#!E,JY_B.R6A&=&&-LTXB1#&QEK1HHV&^2',/Q_!:2!W2"[W!W
M,0$53N[;2,<0LM](\H#40%M)O1!SVDPZ@\6)[:1CGQQL0^F,Z-TMI7.7^FK1
M\TTN?Y9<OENLUM,\HC@KJ(0I2C,=8.<Q9%F4PI0KD?,HS]/<B<GRY&AC\X&-
M:(!KV2[MP],%U2Y6\P95:(=XL.-.B]V[4]AYZ+%S )-@C76Z8UVYF\X!M<^W
MT#GTH7Y.XQ]TMJES'F:SQ5^FTN).O6JXT4QI<4%C;-@<(B3,=C+BL"@*\P7G
M69SF*7(C7G(8>W0.Y<,[T*8!3P"*840F8*L/V"HT :][RK@Y(!<#V;FC0+ '
M=DZ7(.XQ2+D 1$_>S&7D07U;#TCV/5V?6_3S>[\O%N*O<C:[F;_J'/_Z9V$<
M<-MH_LMB5O+G:<+B."XB!@N>:6>H_P=)&BF8DP0+:IAE(ZLT!%\"C<U#[H2$
M,R,EV&EQKKE-&(/9.<<AS1#88[:J5&=7K]"?'/[5UFB53A-0:P6^-_\&J:#P
MA;DG!WNQ.(-Z75_@[;MB;_?MS^6SF%>TXN_HCW)-9U4UW>JK7.G85XJ/B^7'
MS7JSE+>KU<9,%-,HD3A%203CK)"F4U("6<083(L,1T1%2F&G!:ZS!&/SP)\W
M9IXTM0U5K?0*+.43+:M:>_J3EK/JG%LMED!5:H"RT<.=%,C-4':.."C\@3UO
M+3NHA#<5#)7X=57S"K0*5-#7*H#;<]#W(A?J!9]'RB&W\0<G(NH%SR%ZHGXW
M<B<M>K?X*9>[IK8)S:C@.NQ$B?9W!8\AX1F"*!,LCZ.4L%3:LA6]N//8_%@E
MG$W3D3. G?8[%\$0W)]8(N!$1G10VUXL1"_O-!C]T$$%NKQ#AR_HVPON'XO9
M1D<^R[I?U6I*42JQ>?=2A@3$F4PATVL_*#.*J2P(B^VR*X^.,+87L6E^MI6R
M;H-FN8X[CN/Y]_)B= *_GZ[ ].@+=T3Y"SK#[=]QX-YP1Q1ZW1WNV(67[?O<
M/OV@Y=*<F9H"P&F*:1XA1&&<1@CBF"E8Q)3")$^*%$6YRI13A_C#PXSMA=[N
M$)1;,?MMRNRAZ;;5TA^C@390)F G8L6P[W_KXS &GC<T]@:YRC;%846/;3X<
MN;KW^?C+C63]S3O]<[E^1Y?+9[T<,_0\*QVQR_)A/BV8HJ;3#Q0Q*:">T04L
M>$)@0I5B$48JB5P/S!V&'YNK:,0"HCU<6=-?O;J_.UK!^H0]$+;AC]SWSJI6
MD^K[6GKP0OP):!3P>@S? SA_Y_(N@P]]4-\#F ,G]WWNTI,2M::Z^2I_F(Z+
M\X?MPA>1A*129# NA.G"@"0DB<(PBU&JW9BDL7 *;HX--#:?U<@)MH(Z;R*<
MA=;./?D +/3Q>A^LW.D3SP#AB^_PV###$A2>4?85H^"YZWVE!;ZK2)AOY\VO
M[MBL?*A+B1:SV<?:)TUYFJ>D0 +&I"+]HRED&3'U.2G+$"4%8TX%.?W$&)M+
MJ64&Y1RP)DENL17[TL1"*[-8QT.!P0X?%QU(1=RAW_Y^IP?X;C0!C2H>?=9E
M6 9+8;02XLJYC2Y G4]Z=+J;FZ]<+=?3;US.Z;(T;<TDIZMUDU,7<9RIE!(H
MBDPO Z7)=^1Q#(LL%RI"G&295?!T?(BQ^;A6.CM_=@*ZT[[*#R"!_5 KF,<,
MPO-ZG_(9^M,=?Z%_VOF*$S<>Q ^<5ZQ]QRVN]!7KO'TV7ZO%USNZE@^+I2F
M_E6NIBE#$4FHA$AQ!3'+<DCBF$"2YCC%A.0%<EH5.8P]MC?^\&Q;U?AL2;UJ
M!9[ULD KX+A\<C%+WP#'"]A7B6IZX>PAC#F+6+#8Y?C(5PY8SD)R/DHY?XN!
M&]Y\I.72Y%7+BO:A)I__6J[^Z^-2ZF!*NQ>Y6G_5DDYE7HA$) 5,B3G/5JR
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M>=Z3/.,+>(S@@-5G"O6!E/$LKLW#+S63Y1)Q./!#KQ,;34S'DY<V:'[2ZDQ
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MY[R($,U32ISR5/M(,3:O:Y3XCZVW=<Q=[64&.[<9'-S #K.6?P)>L91ME9B
MKAJ@UL-[4ME%./K*H.TEP[ IMI? ]"H']Z*;]7.)G^5Z%S3?_*3EK#I56'0Z
MB#>ED>_+V4://<U%(HJ<*$BCA$*L$@(+*3#,(HISKI(TH9F+.W268&RNT!1\
MU>>I$R!J$=W\H;L-['QA4&0#^T$#:A,AOC'B_P:V"I@@OE8!='4P)#ZGP7=V
M@KT!].0 W<<?U/GUAF??\?6_4<_#3KHT:;FK+[)FF6A?JXR2@F8*06D6V+BB
M=\0X@5R[O#1"25QD3J[MR#AC<V"-6."-7A.+Q6Q&ERN]=%[6E#B_.1XF'H%6
MB)BGG&209%('T04JH.E'#W,EF<REH#17TY]RR18#@ML=+SR\LA%XAVU0Q"V/
M82]',?!,T$IHBJKK\^\ GOX,#+[..(^,,NQ9Y6E57YTYGKE\X+XAU9=_F$R8
M^4-]IHFF2B L&2:02L. (1F'+,I3R%0LJ4A0D>9NG60]"C<V7U\GB_RL930^
M1PLY4"N00Z:S<U+7,LB B2(]&WS4YFPT;&@G1M#%XP3NUV[8<4BTOT=OCA.@
M>FO#<6H,]^:5[Q;SU6)6BFKT*N6D*E-7*6-%Q".HA-E!D"F#A/,$ZA";9XJF
M$<=6+9V.#S$VK_M"RCJQRZGJ_P28ISVH'X@"^\$>Z#CUM3P-P 5]+8_<>+"^
MEJ<5Z_:U/'-E@..4EN#Q_4;^'[WRN?]K,:59DC#",RAC@2#FL81%BA#,L"1$
M8)5BZ=2\VW'\L3D%_2AACP<G!P#W<&1R&8PC."Q9+P"3.FPJ=;1D- !:A8&.
M28YC-\0!R8'1QW,T<AP:IT.1$[?Q5(SZ6:ZG11P7*%(Q%%EBZN:S"#(4IS#.
M8QRE+*<L1Q>5HNI!G)S3 (6H[[T7GQHD[1S2I?@$]CH'"T_-><5"5;T6FS7<
M;+;XBY[J@'-Y-6H'EU"UJ&:(ZU:B=I0\6X?:O=9KDMXTYDK')TD!,R$BB'%<
MP"+.%41$NP:6Z]5,YI0$<F2<L<4H+_*WC"MH^$_]I,M-12Q1$9,<%A%A&E7$
M8"%E 7-*"YZB7/^73.M-JF]KNEP/ANW^F.$0?BL?RGG%%J3=Q_I1]MJ3.X9O
M%"F4\#R"/,GUS!4K 4EJ0$YE3F/!8I6I!M\/<S$PNNV( 8\.YB($JG:SF ><
M D]D1Y,S@V=<>IZUCHTRADS)8W/7N<LOCE\[).<GR%M>DT21&*%$)+#0BW6(
M"<ZACG!SJ!#C.&*9S GM461UL6!6[\WP55/^>*1ZVLLYI X(_Q7B[Q<=6X=A
MFKH,0/^!>D]YKA757P;?B27 A3?NF4I4-8SX)OEF68W\AWQB<CF5.:9YI!<)
M+"X2B(N40<93!0WO 4$<\9@BITRB@\.,;;502PEV8CIFLAS&TL[#78Y08+?U
M"ASPO9;19XG_21!\9;$<'F38)):3BK[*83E]M7N7E[>;53F7J]6[Q1,KY_7A
MZEQ4#N6&Z\&:FK)WB[G9LY3SM3E_*46UA[F8;[<OIX3P/"T2'5UE*M?K7ZE@
M@5 ,&<,XC_(D1XEL@ZW3CL*C5#TBK<!^Y2,ME^ GG6TJ%B6^E=]\NU/ OC&&
M+_.=]DQ#FV08-]9J!#HJ50U-*J5 5ZL)V.D%7BC6.:$9WFKV34JN8+V!6H\,
M9D6G5B:>\3[1H,372(.U'?$,3;>9B.];]PND=P4 ID"_'FRCQVM._A9M'?ZV
M3%2N6DJTJ> XYQQCB%/S)<Z1GD%S"6,A6"2*-,MRI^;F%\@RMI#\SWEI<L^_
M:8?B&HY?8A&[F'T@G //B"_+E"IBE)TJ8*?+:]Y'LV?1*N1O$> !54\KA4LD
M&70YX0&R_36'CUOV[7$[EW>J;O3TD?+*.9M*JK*F/Y'RB]1/O@XQ'N04"Q(G
M,:(PS7$!<4X9+%B>P:) 4N$LIU@Y[5,XC#TV3[D3$RA9'1@U@KJVN+5'W\Y+
M!L(TL%<T4IO56BTW: 6?@ [.6G;PY3S./9KB.B/FK3^N_<@#M\IUAN1UUUSW
M6_3(&=\\;6;:0?Z4'Y22O.EA=Z=NQ.+'2R*G9GLP1T5&&6.01W$$<40+2#BE
M4!524)Q+%BLKIMD^@X_.AVWE![4"DZ8FQ+R)K1*3#H^;0_JYJUU..[?0: ?V
M;LY >]SLO02Z2Y+=78<<+@V^)Q@O$N3[WJ-?C-:AHULLN\R;4QYG$8DR!55.
M.<0)3R M"AV;"<)9%*4R4E;%,6='&IOOZLH&9$V1[!9Z'0?5+M#R E5@Q],5
MRU_ =%9S3^'1\7$&#8;.JKL?^IS_0( *FC_HVIQ7/>\UT)",8YJB&**LR"!F
MS/ AIQ$DB*@$(5H@X=3GI(<,8W,=?Y3S\FGS!)8F^IR!'TU5@/[YOS>ER139
MS+5-P&);)C(S2CINA_6QE>4"+ZP%0B_T+(IP6B6"MC2Y ,8AZG&.2#">FIS3
M$#G5Y9RYE9NS%+*<?IBO]>UNA%@:XK/Z'[,>C:=8)D0F7,*,Z94?3G(%F>0Q
MS'(N=2258"43&W=X<I2Q.;Q:4-"(.&F_ =6FRZD"-P=@3_LN;W %]DZ]D;)V
M/U9('' P*\G_[6'Q\]_UYVO?HK_9N933=QW$:5@IUKH%NXM[DL64#_.*R'N^
M?O=H& QNY\<X9%=?M1]:S+7;>?ZR6*VJ-+^*)O%.U1_1PXKFZFG,>!3%#$'&
MDQAB9+)O!$X@R1G"61SG*A=.O#%AY!R;\^FH"7BE)RCG.L0Z4BD$UH]T#4H3
MC;4J&];M2F<@]#2A(P93H3$W,<'Z+SG[*<'38KY^=&U,%^@IL8OA1F#[P)ZT
M:_9W6[,?K2$Q%M\I"EI-MSV.%@KLM&T_Y9&Z)JP]?+'8!))R6$*;L%"_XK8)
M/)R_X!1-(R%21!,.:5H@B&DN8*&(@"I.!&*<%#I>O30X'1W%V,F0ZVYNN:EW
M&MC^P>F8",!Z(^4E.#U%R=4_.!V(3<M*,9O@M"^_5>N.3C6A,>VI(E4HQ/6J
M-$V8@)A)'6XJ%D-&!)(H+Z(DQYZ;EHVWQY@)$&1UON*OJ9B?'F#C;]GU(LUL
M,ER[K6&[8XVJF57/WE/]6T69D\@ORX78\/7=LNGR6+&\"9I*_9_V'4)QB#G.
M(1%FORM*LS1!+.)V_9^.#3"V&**1L>H'U(CI3)AW$,CS60F7PA/8-?1 QBFS
MX)3Z%V0/'+SM8!D"IY3J9@&<O*Y??/"?4CS(CYNYV)6&(E$4(H)Y6F"($Y.O
MI!#1H4%,*%=8(>ITP+\_P-A>92.?V>/YME[J,./A&52RNLW_KT"TF_ O@2;P
M:UR)5D,1H [TF.*>)O!7MQ]TQCZFW/X4??0Z]WK/WGRZ]W3Y(->[Q,@[55VW
M,JSJ4DRC0C&49Q@658I/KI29UA.(<4H*C$6&2&KC"P+*.#9W4DO;2<\V.XE5
MWX15U6'!MOE.2+.>]DXC,5;H[6(;<O.W)\G-&U/OE 5WJKY^!3Z,Q-3VQ:0C
M,/E Q:77-;U3Q>G_U]VU]3:.6^'W_@H"!=H9P 1TH6Y;8('L3'818':RG4O[
M, \!Q<M$J",'DIW=]->7I"Y6'%](F92U76!G,HXEGO-1^LC#<W,\*4<R4%V-
M/%E&JF/HAAFJKH<:M[,7Q@)AC*K\KD^L"SJ30ZRJ]1=6/;QG^?J.8,^+$Q)!
MFLL2#\PC,//R"'(<"H,^3)D7$Y/MOM:H<UNT9774QU;P)D/R3=7++A;PMV(%
M%^)#(<L#H$*!!5C) Q8S*T%O0O1,!^LPNS\6&*+[Z26Z2FHHQ092;GN&AA%,
MEJP/O3$G-4F,8-BU4\PN'ET7L"A[7Z=L:R__;RI@O9-F^:IJ@O7N,,68)ID/
M$YHCB%**8)9''%*6QB'!B,5,*YW*>.2Y<58K>!>: *38"_5G7_2YD[\-:]4\
MFS2?$SW*<H*T8]JR"?*8FGYF@-FKW:<Y[M0U^LS@V%.+S_ &MLCL^H]'1M:,
M?F+K357>#L:]\WV6QTF8RQ);.43<]V"&.85IBEF:\I PG^B5V!HS_ @_K&-:
MZV0%E1(6"+/L4;YN(ZN7ZD_$6!([$]Q+\EB/=2-[5R)$0#Y@.)=\=AH[9Y1V
M9.@+L]II4$X3F\8]QG';GF),G_K8MALJ=H8%+W!?O505:*H8O2KIH/RI^-WF
M@5'EH_XH8-I4,C.J?0^%>>5E6>1#89=BB(B/(0X)@B2+!1?2"">Q4?Z8<XGG
MMC%L@C/&\*7[R=4CV5E-F6-FWE?I;@&VZH*AOBTE@TYCY64?Z Q:I1>@>0BV
M>ELG\\GFR-(*X%[>29>-R>#?76NF&WALG3[!L:Q>7S<9^G>4,Q3% 8.9YZ<0
ML11!C$,,?9)X"?;]."%&C7%V[C\W\N_$&U>A8!<\/;H^ Q+'Y-JC<7T"C1%%
M[/;J;*TPW<N[3UQL;J]JKPO([?_:N-?V5TSN!:]4SX(H9#GLQT&E'APE./!H
M!I,XQ;(+4P#S*(H@\F(28)(%,DOAB57Y2O<E/C*:R=,['-/=0]P+JU9[UHEK
M]F8?PU?O+;>$F>,W_B58O9P.8I@T\+#$!L=&FI09-%3>90F=2\9:HL62%N7W
M]B$."26$ASFD08@@XBB#N2=_"G.9Y,0CYFN%*NV__=R6^4XZ4_ON!62ZQMA8
M()Q;3HU@#M[M_3I;LT1>W'QBLV&?8J_W^'N_9>LT7,8\,MF\<+VI;[G\Y"[E
M7I;)]HJ<HQRB**(P2WD(O3"(LH2(_V)LV,+VY*!&[_0$+6T;"4&M1 18;.&;
M]H#/#!L&&FA!/O:\^SP@+W+.W2+[YFO)U4]O02.^1%=^P^41]V&XG!UM[QGR
MPD?:AT$X?91]Y-KS>A#VE:T'!Q-W0>@G840(I'Y&($J$K8&QET.2QTV#P23G
M?3JD>4OM?6..\,%]F8".U!C@>[6J:T"'W;:76]''-1/<"[PV'9V'XZ5; /XB
M\;3?]N\8'I8[^NT=ZB+-^HXI?:@/W]%KS!,O7M.5.MI4)5GKKS(@%"^)*MQ:
M?O_(VJJM!6F__VY5K]\7-9$E'SZ)][H[4I&?W_DHR,(\22'#20A1[,<PS>(<
MLB#B <51D@:Q;NZ%.S'G9ACU)WY2./WP>X?S>)S8YC,[%]F9#10%7U4\_E95
M\+&)L%?*]M=)M1:@4QA(C55CU9G-NG[>Q3QF?Z+4BQD\!4;Y%^XGYT@*AL/!
M)\O"< _@,!%C@M'&V1RR0^2_9(/(P;;C5X;KC=B2W$H'ZJ:2A>9^PG51?RU7
M><VJ)^E$O2D?-VOI7RUE/POU<O8JK,I/J^7RYU4E,TGN(C_*(R\.(,=<]AC#
M8KL04 (YB3V6!I[/B5$>AW.)Y[9S4$T\E<:+%R$5G=(R+*Y7&RB]%V"H.5"J
M@Y>Z+\! >_!-Z@]:  S#L=T_0GHFV*P>#,>;EAD]$\:FX63S9,F^="_OI$;J
M9/#O6KK3#6Q>.^@SN6=TLV2W7$K8M?+\YP8O"_XLA+HB:O&MY2J\7$F1M[7J
M?1H2FM-0%B*APA[.$X@Y9Y!D$8[BD$<!TZI5>*8<<UNV.E7 S8U^Z:%SYN'X
M*C$ANHZY__/U.]!IL@!^ +ULT7\@/0>]<BK48*L>Z/0#6P7!-ZLM!2RA?$:]
MI'-&GZRLD@6(AM67;-S.E@_UWZSX?K]F].J)5?@[VS%S;LJ3ALY57J\K3-9W
M.?4CG*<$9IS)*D_4DQX/!BG)?911EJ2I48M-A[+.C7O[\P=9.0KP504HDRGB
M12EIH&S*P#0'%S)&3E(%$>K\<*XWU][DCW4"7V1*+W)"V6D*6E5?'U85I=YY
M%?C6*>TT1]3ZU#CS4]N3],+N;>N0G_:*VQ]R9+C]PZ.P-^3)\6TEZ/!Q5>/E
M+?^P*K]_*)Z$>"JD_Z8DRXT,*+HIU^*-*_KL@-]6RX(\-W]N=YB$48]%$8-Q
MC!A$7AZ*G7Z0P QY!*4X(![&1B'[]F6<VTHDE8%+J<VI1)_)9E%O:;GPW#A>
M4K;:B9<*=/I)XT%-V(?!A$GW1:LEV*K9_[+1$7QK_W;2H,SA7-C*BW @X;2Y
M%>X@?I6?X7 H\T")CZORLQAFR<3R]/GQGE5,F$XJ_ZL-1N:^('N>$(@1YQ E
M"8(YDQV/<.J'A$=AZ''=<(=3@\V-O86\H%8"PTW-0*U$-BHQI07QZ4@$F\ Y
MIE:)62,K%,*"1EH@Q&U37T\&A9OCI^_3MXGC1)[YL_$T\JOK G3$.W[R%I/Y
MN'65&7JJM:\9V9)N;$5"F:.S?KXIA7&P:>I\29F^W./RMC$OA.!/K!:6QXX%
M\HNX]?H]7K/>__#".QW2$%,?09HBE<(701SP&'J,1W%,2>IQH^R<F>DWMP6E
MDQWVIQ9*_+_]U8^]?T@EFI^V[LWFW\),;'Y0V!FVMYO7C.BVQ9N7U#-:7[6*
MY.9'B^0V&($!2.U:LA8P@1:G!>B1VG/8IM "$BZP?5B='*3-]$FPU<AO9MI-
MVP!P9LH?,-CF*J:YL?=E517D@]"@:RG"TC3RDA3&2>)#E"(&<R_-8)1EOH\C
M%*18RW6_Y]YS6WF5>& IY-,W/';A.FVGG0&"XV6CT5^*-L("VP5"W^ Z Y")
M["L38(Q,J0.J'[&<=J^8S% Z(.K0+CKT%5M^\RLB9ELZ1MKJ0WM:I/W$^*J2
M*4)WH1_&)/*$F9*1""+&<I@QF1'H"P,F]7Q$D_R\K&03<8RH;H($P8'LS5$5
M("\: A9*_'-]W483-M:=[6H:+N*Q'L[+OD:-;QJ%W@)9[7,!<J68W7Z-=A!V
MYG@V$N;"ON4QP)UV'X^ZZWGIUC\7)1882-]SO:WY]I&M[T(/(T;B%(89"B'"
M.(0YBA%DU(\)3J*0>;EQ">3C8VJ]Q)/6/?[ ZOH'L!%?655K5?A1]ID 15UO
MI HJ<&A<NO5AX+7IT@*84S&BP.RFPTR)NAA4P5S(Z!S[V=<GD;&<@GUXO(OD
M89]4_U R]ND+SPY*X;N.S>L_6H_G+ZL5_;U8BN>?!V&4,@H)EYY'GV.8X=2#
MF4\#Q)&/@DC+.ATU^MSLUV'$ A=;N$[\\0$E&C-@'"IB%]<)@T#XZ]@.\*87
M'G32OW42U*&/FOUP#8VQ+Q6(H0_+D1 +@YN,XS09N+%NF^U\$;=XOWK 17D7
M, ^' <$PS65M3$%E, MB"L,XQCC":8Q\HW8X^X>9&TNIZ*EUURYJ :2DX%LC
MJV%:Y0%<]2CI?+0<<X\"ZHLI4,8D<QP'2VQR8)!):>.XHKO\<.+;XXC@A7.@
ME!T>BDJY![9I)WUX?^B%(:%1!IF7,(@(CF%./0YIZ/N"("@)S8I?&XP]-\K8
MRMH=E]0Z?L2SIT"/2!P!ZYA=1F)J3"\CT+'$.28C3TI$(R#99:<QMQ@9C;3&
M:]9LDSZO5^0_]ZNEN+AN_);]FX+#'(<HI#!) @11[L4PQ9A"%'JQYZ?43PQC
MA'1&G1M-]4)+6V$H]M^[<(JQI*4W"7IT91U:QT1E!57SD!(3E&P%>FB-.6WX
MA0D,KX(BC"X>VS*DK0GXLOI!_W';X:!=XJ[6/S-Q;[Q4)4G%$_"\O5[(>D>2
M./.")(-)RF0A'D\U*$U@3A**:$+#) O,&HY8E&YN=/=;M7HJ5&*LS)YM/(:R
MR"A3!9"_EH5T8JEGH&X*(TN-5!52F7)KVMS$YC1KGEE=:O(<$^HUYXRLI3>Q
MD5 5.I4R[I2ZD;/8Z@1ZI7:O68"K!YE&;;,[BP/8K?5VL2G;Q)UA',#ZNJ^,
MBT'&K0P?V?H=KN\52U%&?WINDFL;OX6J^"#>@::C5;>!BH/(\[PTA!%+/(@H
MCP7]\QQF7ISRU,NST*P/A;D(<^-X*3[@R]7O;?-WWHD.<"^[84F$$?.BQ]=N
MT79,RK+R@ *[$U_&9[]I:Q2\!;T28*N%DWWO>! M4>P( 2;ET?$ [9+E&7<Z
M+YI#\*OR<]R4XJ[7Y5KLQK]4N*S%;]7G?0CR3?DD=N^"E^^$;4\XX0@F-,@@
M0B02]GV6P(RE?A+AR,\]H\/(\:+,C2'?#\OKJ\:M"^EZK3!D2AU0XZ;D%&'5
M&A>E_"5;+L4.;"/V58_5ZE%\_@PJ&=P]LB;_B/DTBQYQ.TO.PTH&]?ROF@FZ
M&4Y0I\JB^>TPSZ77QW[<R7A,+0>DC!#D(I$JXP$[%,)RQAUMA33OK^_R3@A7
MK&\>'L1?8B/<]FB5.^E;?B6)HRKP\A=!)C(*='#*TFR?;_=%!%[_L9;_S)?L
M0U&O[SC%L6#M&!)"&$01BB".8P_Z-"!I1'B$,3JO<-B%-)OA\K GS'=OG:DW
M$J"WH(%(<%0'$AB@)!>2'B<@@0)O)%1O%^#%.6EKI:]VXX?;S[]M00/7Y>9!
M&&'R[H:GTK.9]-&QXW^"A]3]ZOC_\'Q:B'*_\+/@+&#^4GI=./;^PM-Y.HS_
MT@*.[=S:M)!_SVI2%8^M_[FMGBJ,5E5U2)BL@XIP21PP'$4PP;*E:T0"F.<^
M%W\@'*>$!CPR;.YJ*,'<M@2WU7=<%O_=EA_^7(@IY@61Z?);/4"GB&F?6-,)
MTEL\G<+N>)'K9 <#X17R>]"V7.WY;/BL-:XU'7_BWK8CX7G=_G;LC<;QX2=6
M,W'1O1CD/7MBRY5JDMWZ.=I4Z"1D,1)6%:0XR"$2= @SRG+($X81(6GH948,
MJ#'FW#BO$UF]=70K-&"-U&8<IP.Z'JM9AM)YS-X Q8&\H!7803=M X L,97.
MB)-RDP$$NVQD<NG8B.):AM?@)>L+=H0!"E+FP8A%'**,9S!/<@PCSPM8GG@L
M9$8UX5^-,#=N4?6YA4TI#]H--TNOT=.CC;,P<4P2'1Q*.@>,<%!W:V&[N_>?
M.#CW@'JO0W /?7'<F[S=HPBSKJ2XHO771RH,O)VSKBS%24Y)!L-(6%&(9A1B
MG%)9F"\E":<\3;2*K1J..[>W?K!U[^4&C>"6CC=U)T2/,AS [)A(K")L3#.&
M>%DB']U1)Z4D0RAVB<KT<LOT%7A^[(=&RZO6O?XD;XH4&?JA@X78""77[\>+
M,>?Q=NR#0?O=V'OQH3=C.*<?Q$\__J7[1/R1XYK]^)?_ 5!+ P04    "  -
M@HE5>N Z/\+B  #1D H %    &-O;RTR,#(R,3 S,5]P<F4N>&ULW+U9<UM)
MDB[XWK\BI^9UO#/VI:V[KVG-UEQ52B,IN^Z=%UBL%+I @ . 2JE__7@<D" (
MDB"6.#A1*LN2*(I"^/*%A[N'A_N__H_OEY-?OJ7Y8CR;_MM?Z#^3O_R2IF$6
MQ].+?_O+'U_>@OG+__CW?_JG?_T_ /[7RT_O?WD]"]>7:;K\Y=4\N66*O_PY
M7G[]Y6\Q+?[^2Y[/+G_YVVS^]_$W!_#OW3]Z-;OZ,1]??%W^P@ACVW\[_Y=
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M8J0UTEG*@K2*"41V>"QR9R&:[)5PRKE0P^^\M^A^.&@X WFJ()O P9O+-+_
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M_/X\N45ZG5:_KZ5'#+)LK8,8;'DU3#,891D0F8W@))<KW#ZN/$^B>M@#]YP
M/;.&&W /=W'\RBV^OIW,_OR/%"_2;VX\+=]\D7'Q3RE,W&*Q'F&)*BD/"C*A
MGM <@1-)03BMP7F& B"*>,:%E+ZV[UB3_F$-\;FQ=P#T>P5"XYO@8_E&QUCW
M4V56UCPMQ_/.)-W< 'Z<N.GB1?ROZ\6R?/=66Z/RA"9+IL 'C:Z_L:K,60L0
M@O!:D1"M.:>U/X&588^ AK?&N>!Q:O7-E[-LEK>S.4:LTU5[[_#CRQP9+UV_
M5X:A_&FR LU#85"AI+-> \OXBW!"@A=!@93$:.YD$JGV+70_G S[L*?AK7(F
M<#1^GJQY8MZ0D#'H(4%S0 82.($"3S&&1 Q-@0P1"@S[E*AA^!ZEN ;*.1YA
MYY85_-/J5?#'\HX!-;Q<SL?^>NG\)'V9/5$I)Y7 PP7/*J8] 9&Y!A2( ,8T
MT<9A@&5V#3TX[JUM51:&M=#GC&>'U'TUZ ^87_[8:?0K.G3!3?I--M]?ZNR9
MYQV<#I2&MIR&P$V 1&QYC2<B..XXY."RCYXAYFH[A&=.0]<)N<N1Y)@43CJ'
M&['$VXH'C+>)@BR8D%&K8&7MRKQJQ/]CI;\/064_*99#]=VX/[QW %WX)BY0
MEFF"S"(I16T8!X2801D=.5%E!.$Y$XR'T/Z/E43O"^:]:;MV?J1/I^.E0PY#
M^OPUE5?1IWD5]S^KOMNP@];Z?L';\107&[L)XF)\KT$;%=3)8 0041ZJ1>;
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M&WQM9UE2M(+&8# 0+#LI6@?6F 3:<H*\6>9"[4S T]0,>S'<C_:?AM@IJF@
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M-_O2T@B2CM#SK$>A-PZBU[-+-YZ.$HF2:,DA2V%17-&6!SH4 J=!26T\M^>
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M9-E,;P;S3&IMX$#?7[*CF+W':"Z M+)P%E,IUO"0DS71H._N7>VQW?M3UV3
MTQ<^>U):NP'/V_'43<,3D:-VV7GC@);&<H*5_EL&XSI3>K%ZGTTRU<?K'DQE
M(P-4SQ3PU%)7 _9Q\R@HDR60+SP'WL^F%U_2_/)U\LN1]M$E*2-PCIM8,);
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MV]JKS^FB,+[1Z^$(X[7CP^I8LGVIK94L6RWS*5W-YMVPV?4=#46<A63 6$=
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MFTRPT6KI?'5'>1<]/T.;@T-P]C /5TE7#;1"^J/,$G^S6(XO442+D0X.CYB
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M>$8Y@3ZY#Q&,1!>)F(0!8U8IVG@^H[X7S?OA_B>^_#FKTAL ^2.#*&ZK5U1
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MJ^9DG2I9W6G<SG+^E#K[\VJV6"XZ_\F7:<\?W8_[W6",\-3'G(&(5&80,(2
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M%LKH$U.7MF9CMD8'<A*EKK,9,(,KQ!)2G,$E2JYOCND9 E4]O"LU4?7C\#E
M[OT!:-NM6))UW(<ZLE'5=$&&@$Q"9.3S&RZUNEG]U!H\/;PH-5+RP] Y0.+]
MU0W]4DGR>1%FRTNJ?J;,WVR6T.;??EP9H&7%ARSK%@Q)!J@42=%3,)E,T!$9
M4^SFNNM="RH.HF?<CJF3W'ZCJ>\90/;2](5EPG*=@,LZ[S3$#'4@*82@/)(Z
M$BOA1*#M95+4:9'4&,H'J'7LQ]GPHQX R]^GB^7JS6RY"F=GUWJX0T[!U&8R
M05(#Y3*26\,+$'>L9%V*<8\5[#S^+4\;=(?H?#Z( CJ!TJ?:^9AOL\*M-DJA
M!*POS:IH#RYZ Y+511K%:IUW*>U]Y&O&Z\WH"$PM5- )FCY_G2[NX"3[HGR,
M GC$6LP9$CG-6'=0&6&T5EGG77**#W_+>%T/'6&I@0(Z@5)=';7Z>@<K26N1
M<P9DGCP&FP2X0(%3T<&:$-#XG;HH'_F:\7H).@)3"Q5T\-#QDKYRNOH]I'63
MP]KM-(+KX)4$KR79 Y,,0L("A4<5N4O%N=8E6+>I&'=4PDG?7(]407<@NC0P
MHTM=5N%!)^= <700-5N',"EYB3'?[ MI#*,>'EF/U>V#4#E T!V Y2W9T_NR
MX63[RI>4*T85R'1"@M*<@4NIM@B6Q+G+P<K6)\YM*GH"RB&:O;F4Z#@Q=P"4
M5QC78>3BHEZO&]MA1DKE$V1G!%VN7!$'N;:1*NY\5#J%UATAMZD8=U'?2:^F
M(U70'8C>A?.KNK&0,UKN(7E!Q[ 7":+TCFP+/1E)LCJF0:'TDY9Q3YYC=?P@
M9 X4^,AAUF=<G+^=A]GV."9-\LLS5"4M8[VN,:]37$%!M(Z8TEK:S+V7?I=W
M[ON_H2<P'*J]>7-1=G"2_#Z=36L!\_?;HVA^^_%'^*_YXN=$:+19<NTD&%.E
M%4V$D"G6=-QD@4GI+%CCPV4/\L;=^WG2"VPHI?6-QY^,7;/@))1FL5BH-=&@
M,!LR7K+@PIGE]6%>X DQ>1>)(T_1'@HJNT/R:+UU ,N'YM=J@TX;98'GV@3$
M"OD5TM9J#AZ31FZM:?ZR=.3PX3'@=CP,]I@IO(]..H#7K6&UWB<ADJ>@MC:!
M*)7K/2$-F&*=ED'%)%L_,QTT4WBXN>HG!-)1TA^]&GWK=VS:=_[ U=<YB>P[
M+E?5V;W]NXA5;.L#GYMD(PD(@LCD@V"=7Z6T!30\,85&A9MS60^L63^<QG'7
M:9^N>>94:AP9KO?Q<6G%V7O42EC0B4<R/%/J"JT *:#W&<D!D3NMGWH$D ]3
M,68SQ:E0,!]$)6./JYY^^;KZ1[T8_DE&.9^]F:6KH-PRID2=VQ1%W<?J('C+
M #$8;6+."6_,(KU[ /5]7S >9%IJ;]Y:E"/B(>-T\A:_A+/7L]4V1U48%U:1
MCR!E<J!"B13:> %"&^>#3"CB0X[Z$M/_]V7^_=_HHS>'"_WBY[ERQQ?NA K_
MI.^N8\4\,D(V5%_:BBJQ"&,5<%X[S+1DX!@W@%G6V+>P=','YY[PN/YMXYP8
M1ZMKWD!V(]\2KY?+Z=E\L>YSWQ3;A+-/+SYM.]VEB+[6SI 12&(DQ_H8+  =
MRZ*F)H7;9<_T@U\RGNX/U]E\" &.C(3- +5?YP\)0GPLW$+2=/XIJ^@XM/0K
M=-D'%LB3LKO,_;SCHW?3.GO2UT$+J?8%BFT/F)815<R W 10DMSL*,C#9IEY
MEZ,M61\ B[%[.HY6U?UJ/T!N8U>A/C8ZY7*#'N8_PB+\JRZ*_F?X-E^\B)OG
MQT\_R/<^OSP%;0VW"MVBN=1+M4@++J %5K3UAFOG99/A-WO0U W,#H'&/B-N
MAM)3!^_$=QS=;Z_F)V.T2)Z< ZSY9I6]@6@I1O,\1A<%#P5;-X$_1,]N>'NV
M@RP/TTM'&-NA&IU/D ?-:L.*0#(BY3V'*(.!0DP5ADQ&U7KQYC[T=3>D\$!4
MW .WYBKJ 'X?PH_ZU+G\/+\<B;9E%I?_6,R7%*\68R1/"F+"""I1@.&9=<!,
MHO\5C\ZTGM3[&$W=S3=L [.FJN@ 6L?UV= %X740(D'RM:.*[*<:$D*001M$
MC<7NE)P8YJR[@^+NAAR>_/0[5HT=@?::&#_@(E5-?B'GYI_SNM]E.[3Q:I/%
MQ*<<LA$94JJ/.YP9\,5ZX-%+FU12L0P%UOTH'7<0Q^ @'5!M'8!SO68>\_)W
M$NS;^>S+NBZV\KWMT9AHC%XE%X#K.L];6@&NYB>M0L-$, 5O5A8??UL_1M2X
M77C#7==-E=$!NK;K>#Y<+-+7L,07*<TOUONL7N3_NMBDQ)>3Y*K)A #>8,U[
M:PDA!7)R1<2B,CJ66H<@.Q$V;D/-8"AKKY0.D'9_M=F?2RP79W7 ]\0S$746
M"HKRA0*I1#Y#K;(P,ANC2Y!6MUYHN@M=X]:]#X:SYBKI &9W>*YT:-?IV^'-
MK-1_U=_ZB-]Q=D%.PG8F^*?I+.$U ;\**_K/U44XF[ALE'564?#E$JBZ/2VB
M<4". Q<Y1)9RZWZOYDR,6^)WRC#EA,I^,FA_'18SNCR6[Q=OY\OE3G+P03EK
M:YU"#+[N5B"MZ%*@ME;I*(V1:1S0[\_+N"5"(V-_8-5W8 )7J[BU-RS:0%;K
M,X)R19)GQ#)Y1J8X(8M@<B@G=>2Z@\$=T;UD.^J:\X<?L.[:T_MBL2#/9SV
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M+>IX*#TSV[J4 ),N<YLLF%C=O>(9!!TM1"61<U6"R3U'$'M8S^!3C)ZQ]1P
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M!B'50:<%?5WMH6ULG5Y_@)R11P2>$&BM=#+R)?=VFG"V1 K!*>1>+:;Q8CW
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MOIFEQ6:,X?ET-=&,95N(GQ2#(3G2<>^\X)!EXLEPI-M?[7 8[OW%3Z1CY3C
M#:^2#H[!7R7V6UA.EY^(EI#?SZX_4/")DHRND5I!STWU+"@>B77OD#,1=1$Z
MR4'&]^U"VQ,I36]S_ VBL Z ^&$Q3XAY^3L)>"O,*K'EUOPF+@:BFTFHBQI
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MSX)/N%J=X?JA[U_3U5?Z\U5)%ZNO\\7F>49KA85K#DF*3(>"J?*7!;0*RH1
M5Z5JG1]HRL"XS[A/T3Q. )3N;X^/F[G<9/V_".%M^+;$]^7%MV]GTQ3B&6X6
M==!OO9V>3S>P6DXBCUAR(76(H,BQY'2%*FX@,H&.%90AGLADCF%CW-?HIV@X
M)P--]^8S\=E+&8JCVY*GNF:^@"OD2C*%44>>@G:M1[X>$Q@/UJ#T%&&\E_*.
M#(Q?S_* [^/;'2 DSFWW(%G@++^:GI']Y</?Q'?\X#;OX(=PT>CM^^977STN
M2N9"CEQ!SA+IM"J28)<VRU=U$=Y9V7KPRWVT''N$O</5YAFU=O>]^$ZRK&?T
MY_G+^?EYG0,Z3__]=7Y&Q\1R+?B)$,KQZ*JQU6VS%!:#\[Y <B$(H^G7JG6@
MN">)X[X%-L',S:-J2"5U$++MSMZET4^"RR'Z*"%K\A04J\MG.6-@F/**_.UL
M2NO2A;V)'/>];F0<'J*H#I!XYV7S<XZ?<!YMY$2]SK4D4H'+Q@/SQ;JH13"L
M=7_ @P2-^_8U",+:*: #-/T+IU^^DA6\^(Z+\ 7?79Q'7+PO:\:6[R]6RQ7Y
M,<3MYM!.@4G/E:M=RG4J5/'@:S^6T9S(5TQHWSHML1>!?=VK1P!C?BHM'0Q!
MHB3.ASS2)AA+3,74@UB0FQ"5!N](?A1.2>EM=#&V=N/N)*2O2[(=J(Z7>I?@
MN;S6KT3$&3>)I00ZU 9WGC.$Q#A@L%$GYE&4H6_$&R2-^^!]DCOQ&"5T<"NN
M\T_U)3V<7?J-ZY/VQ6JUF,:+U<:C_#GNZ$/X4?_PB\6B%L%MM@)D=%G;0 %-
MLIHLT],A7)P G;4ODCN?T@ KE8ZDNJ_[\R@0W1Z^?TJ-=H#A>WR&2Z'><ATF
MP1BO<JJ<F;K\47D(TADP2)=,,3'PT+H>>D\2^[J(6Z)S2%UUT--^C^@FF(A.
ME.N96R0R9W-U5&L5I$E61.TU&_J-<I^'D).%J2VAU4+V#?V\H1,(ZP>>]]_6
M&;O5?-LV=>WQARSH(Y)<IW6WWOIW_IQ-5\MW\_IL=':1D0SL4D:W1'>!J_F+
MV6J:Z\^GWW&S.ZU=DF)$XH=)A/2BC:&3+2)Q5KBC*$FDV@=3*RNDTT!FQ#G#
MX@W&)Y)L^92^8KXXJ^GP:[+]A.EB4T6R281B7A=DS<^_7:PN$Z<W"?I<?:I)
M"E*GS!*PH.OC:@C@BBK F1$F%(HV5>N)-VTYZ,LE/@AQ-Z^$$57<@5]\),^_
M_;C[ U[\/5U.9,AUJ&@ 0]<H*,P1G&4,I(ATIT:KDFX=] W(SKC0'Q.E\SXA
MTZWUO OG^&I^'J:SB=%.&%_SNM)(4-Y*<'7P,S&5DT=N>/,J[<=H&A?'W8!G
M)U ?J,D.D/F:'.[Y#[SN<_Z!-8Z>).<X#ZK&-BJ"4A0^14\AL] ZJQPI?M*M
M>T#O):9'+!ZJ\YN19A,%=("DNR*2CY_^O&0FHREH*/K.7(NZ K2^O=1&G)0E
MR:J([%O[^@\2-.ZKV*"(:J>(#E!UY#U D3B^6>'Y<J(P>9:E!$RA@.**@@#-
M-+ 4N9=:.L=:%Z^WHGU<K#X?C_(P,#Q](]@47T^T3HZ'@$#N3YU9'AFXK#F@
M9#H(5;ATK5,530CO\?(?&G-M@7\  #I _=V+<2XSD)L&K?_!_.>,]'_->:KC
MY4@RN$C3)7Z@>Q _UF3DV_E?N-C\JC:G3)@H3"F%Y/1[N@:UMR051\Y5BJDP
M)Z2.K1=_#<E/C^[,B6VD&[@\-]/Y\]NW7V3ADHX,D8&0V=7=%Z(^IRJ0T2GD
MGD<F6WM20_(S;A+S^9G.,7!I9CJM$Z;7*^#KX-+5CZO172]2NCB_.*O]A^]7
M7W%11;C KR1%4NG/HOK-KP[/>K:FH$WJ<E"Y-,H_WJ;QW7SU,R?D3"E220I(
M?%TI)94#%Y.#XIRRG@ODLO6LHX<I.CI:V$WPE^%8%)&[>K&I)$&)3-ZAD:+N
MHLGHE/ F- ^+]Z!OY&1*.^3<\NB'4E(/W@=I:%W]=WDB7(W(7+^^!Z6%K2L#
M?:JE6#Q$\)YYNJWJJA*!K.36E<4/$C1R>#D8#F[>\<V4T@'";O!P^6AJL4AF
M6("8>=U[)#-$+!IXJHNV-/+$6N>1[R1D[$.KF:)OIBJ.EGH'T-G!X"Y?RKGF
MNKB0 :U5H,C<ZK8_!3$(%P2=[]FU3H#M3-S(]37' V'_Z_  K731:7.-M<\+
MBIC.-FJZ&D1_R5<H.A>L=<G&6%"UO-3Y8"%(44QVAH[\UB5?NU'6_?UX"##N
MAU\K'?5UU/V##+3Z$>]P]3(LO_Y^-O_KWS%_P0]K)5RRIW,6)$,-,C!1Y]3+
M^CXL@7N1K(Y&>FP=">U)XLC/G*?&8G.M]07*5UCJ *#+^3SKYZ1;)I>$-A1+
M.9#&$'>L% B"G%\GN%0HA8BQ>=)J+PI'?CX\-21;ZZPO1#X4@OU\:G6BD*L<
M%3!F&2B=$T1K H2DO?'H@HRM^_GWI;'[@[)-4#NHZGJ YON7;WYMMMP<_70A
MO"]U<-JUB6G)JNQC,*"]<^1^4U!7UTR#2#H@LXX@U?PE;W?RNO<BC\#)35 .
MI+0.\'C[0733</1_VWNSY3:/9%WT_KQ+GEWS<',B:%GJI=BVY".KNV-?(6K(
MHK 6"7@!I-I:3[^S ,XCAOKQ%^AV=\B41!,Y?%F563E-9Z>_S1<K;=YC_-.<
M9#N[("KH)YY^G!$EN+R82)V\=K8 :IU .:XAV.(@>JV<,"0//_R3^RZ4CXSB
MH8#UZ*GPX%KN9@_!2\?#3UCFM8SMSPD:X>K65PC*4S08Z](PAQ'H"R-,*E+I
MUA[ 1H2-?.T?")_M==3!T?JRH_3GQ)#!!#(HR'5_@<)4Y^BF#"'&X'UP)#UU
M0,AM"K;A(I\.P+:M7OJ9;]SHB$\Y<BTE!^9$725,YN6<Y9!$]IH;"OI8\S[5
MPUWD@PT3.K*+?!LM=STW^8E\?E@L0JV]:EF8\^B'#E5K\S+UARF?H7/.1T]!
MDI2"U166$7P*A!4CLXN<%YY:/] -6SZS^NE?\(^KL0N_+>:GBW!^6P:W+J;F
MD^)D8L%EX*S45RY-GH8-",:H'(K/!6WS"N+-2!L[_]P,+T^>9XU5TX'K]S1;
M7_!\/2K_EK_;[[GFE!>+DF4)6I?5<A)+1S.QRSC/VCJ/W!T&A)M0.W(?TZ%Q
MV5R!1U0=NZH=ON5VCS6]F__LH6[9C7@YS&7+;':V%D\[GQ&48@5\J9Z8$KP$
M"CBD&=[?;GG9?JT;F2X7/U:?<E5PGNA3"-D3$W@4J H4'^OFF&S 997!.B,$
M"T&4T#KB?8&<KB_5;7#Q\/!JI8(.+M)[K%PS<34=\-U\>7'=-3$IP@FC8@+,
MDH+VQ!1X+@4D&Q1/EB=DK1<V;TI;UY=D,YRU4DX7%5[W./M'.+O$:_8J7[\B
MW?YY0L:C59 &@DYIG5&BX%F"E8PDYX6QNO5BBTWH&O<1[U!P:Z&4OKVO525&
MJ]>,IW]80_]J VH;.52W"^0_E[O-;5]PE0VN6%BNCIUX9X#Q\@:!:!(AP4@P
MJ[-(N+KEQ&E@-B;A$RK+6\]EVH_B=H,,GVX*O#O;^:<?CT<_US?+=5T'XR5:
M57CMB5$UL@D0BT_@I,W:Q1!5;I[D;47\N,[> 3'[_)##0ZJ_ ]>QGDAU_LYZ
M0)A%[0QCH*6OF>NDP1DEP96L9-9">-$:NG<_OY<)@@>%P+R1/CK"TE5?!"L^
M*),C6*4#*,\3V:.IZ1,M;0C.(F_=\':?@G'QM+LFGX'$#F(=$13D DV^?ILN
M\LGYRI\Y6<]NK@<Y?8S]93X[_8J+\X^S1+(D9ZAR>=UNX+TQ(G HKJZIT8;\
M5.4<.)OI&/<R2"E?<>=V__0^0+.+KN<'%?S(T/J9(II$?[VLY)/JV74-MD_6
M>%X@LUB(!2TIB/8.3+!,H0M%*+,!=I[Y\>,^4C0"1PO1C:S]>\,CKP?%WP&R
MC5XY;A!BY 1DE Y")#0GSA4=Q,F9A^NJGT3!*Q\S[AM"(S2T%&4'/LC:#:-O
M7EV[)J7B5^NS<YU[+D5MQJA];!X3,T6IF%H_/MTCH)<)AF-ZM+MKI ,X[2ZX
M6[9G^8&IVJQ,29%!S'5I7@D(CGF*5EE=IJ<C8[$U*H?@8^2B\-UAM=$4J /J
MN .</S^-6?O G*>+1%DK07%OB"5R$35=+EEDJS V7XC8YSCL\7&R\0CM;936
M ?I>GMQLBY,^:@N(EBS:%@7!!0V<,1&R9T&6UI5V'8_0[@Z%[937 1)_PT69
M+\X#!<?KDH!K@^*F%%79D,+5"0B%V"@.;"E<1H.:_FG]EO4T*2,G+GM#7PN%
M=8"[>T?Y%0M,)Z<#RZ =!7/DP5B(BGZ;HI98DK"N^5B*)\@8MV.@.[SMJZ@1
ML;9<7$Q6\TE7'K-EQD8A+?AL7"T!T!"M,! 2G<\4\1>>-EI,03_U#K+H=[>H
MNO>!(Y];HX;"NTN^![A<H;QD)GF,'H04!93S GP2=*=+(MJPS%79:"S8)H 9
MT]W?0UD/U;V#Y$96^*_3V?3\\OR*\$@N&B;N@0G%0*E2B'FMZQQP(832SN2-
MVGU?4?F]#QU9Z;NH;-Y"?F,K/OQYA_ @F&91TR'G%3&=.(=0&^&"0I],(2&D
MC69JO*;XNQ\Z3EC53/$[RZ\#[_/5._&Y*_&7F\$AFOR<VA ,;#6-R]5.8$[>
MD%!<"K3.NI(;.ZO[4SVR;]O%\_R!=3]RXG!G;FO*?/FYK+[^&WWWQ?+C[+=5
MZ^ZGRVKRG\NG^>PZ.+C)L'Z<U>W5TXL+K/.>6++9);"LK(IZZPKU1-="R27E
M*$P0#WI8GLQ)CL=!YZ^OC7$Z/SK0'/-%<BV/A[LW)IZN2FUY ,UK2ZLUL<ZB
M,F"]0%.49C:W[EAISD3G#\;#&$X?D'A#-O$]3,_J;?]AOEB=)1,*(;)T3('C
M:$ Q+R$Z[P$SE\'Y+#&U'L8T%"^=/VH?AX7L!9!C-I1UZG-Y_X;])TY/OUW<
M=-JM_O+G<($?PG2Q:HN:*-*8$\& C-+3W6JQ3H:UH+B(W$?K2^C&?G9CL?.W
M^T[-Z@!P>@/6=KT [49"7^<7X>SC[&(QG2VG:2T3:6I+J^8@Z+0!Y55]1XT(
MTG"&7O*D0NOMUX?@:R.[TO^VJ\, YYB-:?7+/W!Y44>3K:3!)W5$*,M!0PB"
M>)?6@ZNOQCG&HGD6WO/6M08MZ=_(.,R_C:,M$'HQ@O@Z[_$A[^___&.Z6'WS
MFO.)5<9F(13P9!2HPLGZ-18H)DC-?7)2#%(@VX+XC>!OWS+\#PZ!#K!_4Q:"
MB^_3JU*D1VKX-)]])PO'M;$O5_?>W;^O#<Z?YA?_!R^^8)J?SNIKQYW:SN4$
M99!T %@0@GY1T5% 9S2"T\)K::RVS5<('H2QC6S&O5&;Z0\Z;]F>UL?+A_GB
MZH_J]_&)U4+*S U@2!2[91T@VI2@J%H2IF,NL?D&Q8-RN)&%^7];V*'!U(&I
MM7TG^=MBOB1M!5.\<@Q$$O7E,6IPQ6NP58UTV.B0FX_G;,_&9@E/]D:M9FQ<
M=#'B;+C+^>8GK?^CU;C]K]_"[/K"SEIP)5$"2Y%$)8L!GV)<A8&!:<E1M#:A
MT9C=S-#>6FG!Z&+?"F-'6[@3%J=8ARS6<1?A]+K::OD^+&:8)THC9Q$%!!T1
M%'<9'+<2?.%.>.'KP,]!JW)>)&\SPWAKI0.]Z+L7YVR7!Y6;20X+.E)6X]3.
MY[/UC(>U:"8NYYSJN ^?A085?,U7%0N%Y104TRZIYG/J!N-F,T-YTQ4$XZ.D
M%WO911'K0^+C<GF)^=IGG0BCK:M5^[)X!\I+NA]+;>P*PGCTP9(SVTL8\Q0#
MFUG%OPL 6F.A T.X8\KOPA]3\A;77'TA#"R^8WVT^'!Y<;G RF;MGIUXHX3F
M)@+CBIS!@!Z\+QJ\5%D7YXN3K<MAMB9R,T"_U<S[L#KM +0G9ZOON1NYW!7T
M^S_KES@)5GA/H0F$*.E.0ATA6,E!9UZGU"5C7>M>D\THVPR>;S7W/8#VCF#V
M^!,LACIQ<36R>+TR\6OX\VIO?)DO'@;E+4:6MZ*A]:3S0633QX!TIS)&\H$!
M5WYQ] )<B &XTZBS0:N:9XQZ&9"^T7O5U6% 7WTN#Q,F*TK7G6LE92:TE^!R
M6I4H,_*JG "63&%2)2--:S$.PLA1#T[?!LO/#TX?"Q8=^"WKH^SW.F.W2O:7
M*Q97 P2B4PR]B) D"T !A $7>7URY9SQK+ \;/O;&^$OD-/+B/71P#(?1G/]
M@O!JYHT7J:A@D*@7HKY[!HC,TF]11.NBP?9;*5XD:%P@-E/[9G#:00<= .IW
M7*U#_ANY9XMP=C++)_E\.IO62Z/.#;]RZ*X';OF812X)@:\6.JI #G[& EPX
MQNC_0IOF5<O;$-@EX'8!QL,+># M=0#!>LI_+K^'LQL&DI5:26$AL5P94 A!
M6@/>^*)D]AEYZR?91T2,V\\[')3VDW8'<*D/843 -[*"G_$[GLW_J!*Z,H%K
MEDQFR2<.P4M%W@)*B($'$-;QI)3DOK2^"#<@:]P&V.$@U5HC'8"LC>MZ^^1F
MG%,"4QTN5G>-!I)Q3+R.JQ1%>1X=;[Y/O3$+O4RY[R6H&!,A'1C(AN_ GHS;
M,IEJ=U\DUBQQQ86&DIW6*49C9.L5@RU?\8>"\ZC@V>U%?QM-'D]5Y^W+] =2
MTE-\*Z>%"%X!"YR!RK9F,D3UCNCW*CNNPR@G]ZN4CWM@]X3P$9!P!#FMD^7R
M\GQ=(_IWDL5T]GYY,3T/M3?U9M[!O-SM+[H=<86Y14:K#06M\UD#R*6/;):U
MTLH2! &V+DT1(D.(JFZ&3FA+L0ZQ]2-U+]FL5Y/FK\Q>%$J'F**#@AI!Q1HB
MZVQJ"..8#";8M-%8Y)TR6'L2?]19JVTP.]RZWVW4WX-O?F]KDDJJ<$&>FC%!
M@U)"01#, GJ5%2]"^M1ZL\KVZ]&.8.'O5B!X<3W:-AKI $Z["^Z%]0Q."!<\
MDY Q2%#)<9*!\."TY,XZ*;D]^"CA(U^/MA6L#K$>;1L==X#SYS=M84Z6[AH-
MTM89+45+<,QEP"B01&RB9ZWS$7^E]6A;X63C]6C;**T#]#6HZY3<)T1'9B\S
MQ<@8:H :,C#T!"\;G>>#-/OL174O[\ICN@<'UGTO:-^EF>DF!+\3IM<'FKJ:
MKD[BYA-GK>8%.202.BE"!E*$31"M3]*JPHKHIN7M56XZ/^T;X[)5QUM;D/1B
M+KLHXB5)_&-.(?CT;'KQXPN%XA,;G$;I!%C&2%-.*_ VA[I;7'B3>&*F=:KF
M &P=_5CVO0VH(]B\-4OZ,EW^UX<%XL<9$8C+BY5 E+'6J*3I0$'R.Q6Y!,'[
M B8:SGD4'E,WDSTW9>KH1[=W8T5[0^:MV=#UL?+S]/LTXRRO!,+0:6&]@4QN
M<UW>J2$6D8&4%0)J9W7S<IG!F3KZ.>W=V-#>D#F"[.R=]XS5[UOD6Y_[F:TS
MJ!O1WD=.-'M10B0D:^XC*%\<N.@5\$S_H%5:\=;)D;>2$XTYY1"<!><"TG&0
M.7VE+6C&N17&%Z.&Z^K[*^=$M\'L<#G1;=3?@<]R/U6"H: VVD'F28 *RD 4
MQ0,J49!$Z#*VGCW^)G.B6X'@Q9SH-AKI $Z#Y$$"TR5FCH#.9E","_!(0;7U
M!;UVHF3^[YSH=CG1K6!UB)SH-CKN .?/I]>4]2H&8D3&&K,F28= C5DQ<!<2
M4YB:'Z%_I9SH5CC9.">ZC=(Z0%^#H-6HF'5.%F*=BZ1\,K5HUT/4!8LH+(IX
MI"NKCR GNH][<&#='S/:K\J0/U]>+"_"+$]GIU_F9V<?YHOZEQ-M0K5Q!$;:
M *5+J0\X''A0-D7K/>NG*N!%3CH_Y1OCL?&@]@;@>%LFLMZK.HG"F1QM 9D=
MJVU-#$(@*:1BD2?.N,/FE=VMF3A2PVB(S.&,90>8[&PG?ZP:GWZ_"(N++JSE
MJ>4.)G&74BK@%%>U"0K!&>Z!\UP"2:DDWTUV<\^E'_U5!?1K,?M"I8>[I49+
MZWG /U\N;C8TKMB^F]*XV6V:)Z9$I1T6B'0L@.*&+G23%>2B'!KAA ZM5[5M
M3^61YNX'Q/JPBMX>RGX-Y1F>UN?_+HY^DG/!:1TSO#R9W5G<>&/B$QYR;0='
MP"Q#O1%)))FSNH9>>6^EL"QT=A&\RM21INC[O1;:PFA?R_K:<1PB#;'NE0$M
MN0$Z53+$U0F30U:>!T8'4&?FM%L<TM_<]G[-9S^8[!F'O)_U<17]8[T1:W5\
MK"NXY_6/'LO&6R92"@(*EZLJ.@;>\0*88O),*19\[,R$-N7M2->M]VM9@X"J
MAR!F3[E<N;SU]?Y* (P;R;11X+*D$T>; MY:"4F'C(B,!=F;G_>(B2-=U]ZO
M^>P'DS=@)W=T\D^<GGZKA\EW7(13O X:5]NVJK[*E;Z8*PRMCW1TU%*$J W$
MR#4PQQW2<5*"Z,V0MN?R2!_6NLO1# &JOX[934+.PNBB(!A.8LEU$0V+G.YO
M;4DTMOYZG+;V9G(]@R!\'(/<"F['DQUZMKCCR3?_%P5D;#$\>@<B,CI5E4'P
MD:\:;T6PQ3E^^*Q1._:.]-+KU"9'@MTQW(ZOB>::^\VDXXSP1<@:T!H+RM+1
M%;QVP+0*.012:#EXZ4-3#M],YNLH['(X\!V#:>Z;"'GY''.\*!Y)3E[4#0W>
M@D_!0@D\B6B+M:)YJ]68#+^9/%P7AML---^ '6\:$7"Y'K@'D3$-2G /G@5)
M^M61J\"CZN[5M&4 >@Q)OF.PS2'@]I=)"[XHL:AB,>@-)!4H(!!9@0O"0=$V
M&H$JZ=QZ&/:X'+^9%.(QV.T!P?D&+M4[V:27Q8(I>_H?Y.+JHGN3(:*T@-%E
MPWC25G4SH6P[UMY,@O(8C',(N+T!*SS)>5J_"&>W\RENATX4)LF5*!%,*4CQ
MN@\0&,^U*;48^@M7VF] &)*A(WT;ZB-1V0XJO=A-?%T8<>O3[PO65F[Z\W?S
MV4HTE^&LCA\5$QM=4M)Y8%B7:159P&MRWX7@W-29!<J)(:SIL&P>=ZZR(<A;
MS;4]$.+>@%%N[8 _)SD^";(PY3F#A((D)S&2,TZ_E8%EX1,W?)C^Z2ZX/^[4
M9K\F/!(^WX!E/^^]/R\BBIN]IL "; @.5$(&T:L #DD\CF*.5 8)' _+YI&Z
MM-W;ZM"(Z\4H!WWO.CD]7:RZL#Z2I*:SY32MIKI.I-5)IA( M2'%FEK%["C<
MSLHEGE5RPO065^[,['&G-0<VT.[1UXN9MCG)[@N"3V+Q"8U)=$R9.L8_(43E
M-)!>@PZ&&^,'*3$8A)OCSE$>Q4VX#WZ.8/SVI_EL?:I\^?WO369O/_D#6P_>
M?IWJ3J9N<ZN"T (T,QY49@G(6U(UW>6]SU*ETGJ?WEN9NJVR+$&C !=U N49
M?678:N<*IW,@<:6:CQSY]]3M+3$[W-3M;=3?@<-R?QBO=B;S*")$K&GMR QX
MSAU86Y1P6DJ;6L_B?)-3M[<"P8M3M[?12 =PVEUP+TS:3=IQK72=IJ MJ"(,
M.$:"<)*Y8GC6F/\]=7N[J=M;P>H04[>WT7$'./]"3MQB6B/9E6_W]]GT8DDN
MW?5B6VM%9L2"CE* 8H@0(L4"Q>=2!6YM;NT"O$A0YVF^P?$R'TIY'2"Q0:&"
M3EZHF"-@"<2QKHMQE?1@551&QIP=MEZQLS_5;V4"]SZNPH%U?\QHI\![_43R
M_K\OIQ<_/L[H"+A<J>>9X1U,!H?*2O"^1A.*<PC>:% F*B9+\=JWCH /QESG
M]T%CU+8RFD$A=,RV]5@>%]]P\?5;N))7??7ZOGKUNAI%H[D6,J@,C-4SSQJ$
MF+6$+*VI9=5!E&Z61V[+W)':UK#@;F6"@R+M>.8^["R>^YWY$Y.TB$4PH(!O
MU1KH(8B4(83$7#(A>M/-ZI4M>3O2LJ@W8H9[X.Q-7X3KW,^-7%*QLA@E(#LC
M04FEP>M(7HTT)H0LK,+CN0?O\W:DI4YOQ/[VP-D;&.'\JGBN&NKO2,A[[D31
M KBQ#E1TY"=@XA!YC@S1YZ*[&>Z\/7M'6M;T1HQQ/[3]%>SQL=<>=?$I0-&U
M%<(677>")LB!:::RX[FPH['&7>+#_BJ?WH@M[H.T8Q_+L+EP'A11K[SYG^DP
M^1"FBU4UV5U%*\&T%=R!+ZJ.5LQU3I0M()*TV8K$DNAFDN<P(CC26'/DY]0.
MX/BF8\W-Q3<Q,;G$2>M)HP+%HX0878+ BC#*B\)C-PM(&_)]I$^U/1A.AX?
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M/F&TU]_XO_''G>^]:D,UUM;9D 6"KFM[K-?5#:>H53JT@>O(@WG%Q6M&3*\
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M2HB>)VNDBL8./QIN=X]RA,?6/CS*+=36[7O7W4JQ-7<3$[QTFC.06HLZ$]\
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ML"0+Q17&3 YG9&9$N]F6GY[RG&_#E 9%U)%9UR-MO" &E2T=,=( ED0W,8D
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M'2:8YSJAY9",(XFH$B'8D$ [\KV0LQ!0;P" 9S]@G%3D,"AH(\61H?!I/GO
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M$$H$(<D&E$@%HDX:2A*!SDY=@FG>^MU3W;J.PM<Q'L[5R?O*U!=$NB&4\G1
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M4;>F&X^%.72I=8E?NQN[>?ZZ-_SMHJ7#I"BN_J+^$L,2_[__Y_\"4$L#!!0
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M#KH/CC;KK0?'OJ:UTZQW6P?/2NWKG=0VO'\+'P-&D_'T;:53N9=7O79VPUI
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MHGIU%DB6$@UA[^ND>D2Z=TO('$6\4@^7[ 6Q\UF]##.OY<[_ 5!+ P04
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M;V\M,C R,C$P,S$N>'-D4$L! A0#%     @ #8*)5<N/;A5<-   #"\" !0
M             ( !5'L$ &-O;RTR,#(R,3 S,5]C86PN>&UL4$L! A0#%
M  @ #8*)54D9! Q4@   GL0% !0              ( !XJ\$ &-O;RTR,#(R
M,3 S,5]D968N>&UL4$L! A0#%     @ #8*)51T"VY^$IP  U;4  !,
M         ( !:# % &-O;RTR,#(R,3 S,5]G,2YJ<&=02P$"% ,4    "  -
M@HE5OV\<:W9=  !N;0  $P              @ $=V 4 8V]O+3(P,C(Q,#,Q
M7V<R+FIP9U!+ 0(4 Q0    (  V"B55VZSR$\%@  %!D   3
M  "  <0U!@!C;V\M,C R,C$P,S%?9S,N:G!G4$L! A0#%     @ #8*)5<D6
MT,V SP  J@L! !,              ( !Y8X& &-O;RTR,#(R,3 S,5]G-"YJ
M<&=02P$"% ,4    "  -@HE50NR'EP1Q  "2E0  $P              @ &6
M7@< 8V]O+3(P,C(Q,#,Q7V<U+FIP9U!+ 0(4 Q0    (  V"B56RBR)QTI,
M %*C   3              "  <O/!P!C;V\M,C R,C$P,S%?9S8N:G!G4$L!
M A0#%     @ #8*)55A0&2JVC0  :IT  !,              ( !SF,( &-O
M;RTR,#(R,3 S,5]G-RYJ<&=02P$"% ,4    "  -@HE5>P,VB3Q@   /<0
M$P              @ &U\0@ 8V]O+3(P,C(Q,#,Q7V<X+FIP9U!+ 0(4 Q0
M   (  V"B54_' @E45\  #-P   3              "  2)2"0!C;V\M,C R
M,C$P,S%?9SDN:G!G4$L! A0#%     @ #8*)59.QBR5!B@$ 4&@0 !0
M         ( !I+$) &-O;RTR,#(R,3 S,5]L86(N>&UL4$L! A0#%     @
M#8*)57K@.C_"X@  T9 * !0              ( !%SP+ &-O;RTR,#(R,3 S
M,5]P<F4N>&UL4$L! A0#%     @ #8*)5=8MT$#="@  @0L! !D
M     ( !"Q\, &-O;RUE>#(Q7S(P,C(Q,#,Q>#$P:RYH=&U02P$"% ,4
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M,3!K+FAT;5!+ 0(4 Q0    (  V"B54C*K&=U@0  $<3   :
M  "  9E## !C;V\M97@S,C)?,C R,C$P,S%X,3!K+FAT;5!+!08     %0 5
+ 'L%  "G2 P    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
